PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Guo, DC; Grove, ML; Prakash, SK; Eriksson, P; Hostetler, EM; LeMaire, SA; Body, SC; Shalhub, S; Estrera, AL; Safi, HJ; Regalado, ES; Zhou, W; Mathis, MR; Eagle, KA; Yang, B; Willer, CJ; Boerwinkle, E; Milewicz, DM				Guo, Dong-chuan; Grove, Megan L.; Prakash, Siddharth K.; Eriksson, Per; Hostetler, Ellen M.; LeMaire, Scott A.; Body, Simon C.; Shalhub, Sherene; Estrera, Anthony L.; Safi, Hazim J.; Regalado, Ellen S.; Zhou, Wei; Mathis, Michael R.; Eagle, Kim A.; Yang, Bo; Willer, Cristen J.; Boerwinkle, Eric; Milewicz, Dianna M.		GenTAC Investigators; BAVCon Investigators	Genetic Variants in LRP1 and ULK4 Are Associated with Acute Aortic Dissections	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR-RELATED PROTEIN-1; BLOOD-PRESSURE; MARFAN-SYNDROME; ANEURYSMS; MUTATIONS; HYPERTENSION; DISEASE; INDIVIDUALS; POPULATION	Acute aortic dissections are a preventable cause of sudden death if individuals at risk are identified and surgically repaired in a non-emergency setting. Although mutations in single genes can be used to identify at-risk individuals, the majority of dissection case subjects do not have evidence of a single gene disorder, but rather have the other major risk factor for dissections, hypertension. Initial genome-wide association studies (GWASs) identified SNPs at the FBN1 locus associated with both thoracic aortic aneurysms and dissections. Here, we used the Illumina HumanExome array to genotype 753 individuals of European descent presenting specifically with non-familial, sporadic thoracic aortic dissection (STAD) and compared them to the genotypes of 2,259 control subjects from the Atherosclerosis Risk in Communities (ARIC) study matched for age, gender, and, for the majority of cases, hypertension. SNPs in FBN1, LRP1, and ULK4 were identified to be significantly associated with STAD, and these results were replicated in two independent cohorts. Combining the data from all cohorts confirmed an inverse association between LRP1 rs11172113 and STAD (p = 2.74 x 10(-8); OR = 0.82, 95% CI = 0.76-0.89) and a direct association between ULK4 rs2272007 and STAD (p = 1.15 x 10(-9); OR = 1.35, 95% CI = 1.23-1.49). Genomic copy-number variation analysis independently confirmed that ULK4 deletions were significantly associated with development of thoracic aortic disease. These results indicate that genetic variations in LRP1 and ULK4 contribute to risk for presenting with an acute aortic dissection.	[Guo, Dong-chuan; Prakash, Siddharth K.; Hostetler, Ellen M.; Regalado, Ellen S.; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA; [Grove, Megan L.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Eriksson, Per] Karolinska Univ Hosp Solna, Ctr Mol Med, S-17176 Stockholm, Sweden; [LeMaire, Scott A.] St Lukes Episcopal Hosp, Cardiovasc Surg, Texas Heart Inst, Houston, TX 77030 USA; [Body, Simon C.] Harvard Med Sch, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Shalhub, Sherene] Univ Washington, Div Vasc Surg, Seattle, WA 98195 USA; [Estrera, Anthony L.; Safi, Hazim J.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Cardiothorac Vasc Surg, Houston, TX 77030 USA; [Zhou, Wei; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Mathis, Michael R.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Eagle, Kim A.; Yang, Bo] Univ Michigan, Samuel & Jean Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Karolinska Institutet; Karolinska University Hospital; Saint Lukes Episcopal Hospital; Texas Heart Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Body, Simon/AAQ-7572-2020; Estrera, Anthony/ABG-4175-2021; Body, Simon C/O-2605-2013	Body, Simon/0000-0001-6721-7050; Body, Simon C/0000-0001-6721-7050; Eriksson, Per/0000-0002-5635-2692; Yang, Bo/0000-0002-2158-9155; Hostetler, Ellen/0000-0002-9258-7827; Mathis, Michael/0000-0002-9697-2212; LeMaire, Scott/0000-0002-8736-4266; Regalado, Ellen/0000-0002-5859-218X	Richard T. Pisani Funds; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NIH through the American Recovery and Reinvestment Act (ARRA) [5RC2HL102419];  [RO1 HL62594];  [P50HL083794-01];  [UL1 RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083794, R01HL114823, RC2HL102419, R01HL062594] Funding Source: NIH RePORTER	Richard T. Pisani Funds; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH through the American Recovery and Reinvestment Act (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are extremely grateful to the individuals involved in this study. The following sources provided funding for these studies: RO1 HL62594 (D.M.M.), P50HL083794-01 (D.M.M.), UL1 RR024148 (CTSA), and Richard T. Pisani Funds (D.M.M.). The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium" was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419).	Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Barbier M, 2014, AM J HUM GENET, V95, P736, DOI 10.1016/j.ajhg.2014.10.018; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Giusti B, 2014, ATHEROSCLEROSIS, V237, P135, DOI 10.1016/j.atherosclerosis.2014.08.049; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Guo DC, 2015, AM J HUM GENET, V96, P170, DOI 10.1016/j.ajhg.2014.11.015; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Harriott AM, 2015, EUR J NEUROL, V22, P1235, DOI 10.1111/ene.12735; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Howard DPJ, 2013, CIRCULATION, V127, P2031, DOI 10.1161/CIRCULATIONAHA.112.000483; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; Lang B, 2014, J CELL SCI, V127, P630, DOI 10.1242/jcs.137604; LeMaire SA, 2011, NAT GENET, V43, P996, DOI 10.1038/ng.934; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wang SQ, 2016, J CLIN INVEST, V126, P948, DOI 10.1172/JCI83778; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	34	46	48	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					762	769		10.1016/j.ajhg.2016.06.034	http://dx.doi.org/10.1016/j.ajhg.2016.06.034			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27569546	Green Published, Bronze			2022-12-18	WOS:000383114800022
J	Muona, M; Ishimura, R; Laari, A; Ichimura, Y; Linnankivi, T; Keski-Filppula, R; Herva, R; Rantala, H; Paetau, A; Poyhonen, M; Obata, M; Uemura, T; Karhu, T; Bizen, N; Takebayashi, H; McKee, S; Parker, MJ; Akawi, N; McRae, J; Hurles, ME; Kuismin, O; Kurki, MI; Anttonen, AK; Tanaka, K; Palotie, A; Waguri, S; Lehesjoki, AE; Komatsu, M				Muona, Mikko; Ishimura, Ryosuke; Laari, Anni; Ichimura, Yoshinobu; Linnankivi, Tarja; Keski-Filppula, Riikka; Herva, Riitta; Rantala, Heikki; Paetau, Anders; Poyhonen, Minna; Obata, Miki; Uemura, Takefumi; Karhu, Thomas; Bizen, Norihisa; Takebayashi, Hirohide; McKee, Shane; Parker, Michael J.; Akawi, Nadia; McRae, Jeremy; Hurles, Matthew E.; Kuismin, Outi; Kurki, Mitja I.; Anttonen, Anna-Kaisa; Tanaka, Keiji; Palotie, Aarno; Waguri, Satoshi; Lehesjoki, Anna-Elina; Komatsu, Masaaki		DDD Study	Biallelic Variants in UBA5 Link Dysfunctional UFM1 Ubiquitin-like Modifier Pathway to Severe Infantile-Onset Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCOVERY; DISRUPTION; FRAMEWORK; SYSTEM	The ubiquitin fold modifier 1 (UFM1) cascade is a recently identified evolutionarily conserved ubiquitin-like modification system whose function and link to human disease have remained largely uncharacterized. By using exome sequencing in Finnish individuals with severe epileptic syndromes, we identified pathogenic compound heterozygous variants in UBAS, encoding an activating enzyme for UFM1, in two unrelated families. Two additional individuals with biallelic UBAS variants were identified from the UK-based Deciphering Developmental Disorders study and one from the Northern Finland Intellectual Disability cohort. The affected individuals (n = 9) presented in early infancy with severe irritability, followed by dystonia and stagnation of development. Furthermore, the majority of individuals display postnatal microcephaly and epilepsy and develop spasticity. The affected individuals were compound heterozygous for a missense substitution, c.1111G>A (p.A1a371Thr; allele frequency of 0.28% in Europeans), and a nonsense variant or c.164G>A that encodes an amino acid substitution p.Arg5SHis, but also affects splicing by facilitating exon 2 skipping, thus also being in effect a loss-of-function allele. Using an in vitro thioester formation assay and cellular analyses, we show that the p.A1a371Thr variant is hypomorphic with attenuated ability to transfer the activated UFM1 to UFC1. Finally, we show that the CNS-specific knockout of Ufml in mice causes neonatal death accompanied by microcephaly and apoptosis in specific neurons, further suggesting that the UFM1 system is essential for CNS development and function. Taken together, our data imply that the combination of a hypomorphic p.A1a371Thr variant in trans with a loss-of-function allele in UBAS underlies a severe infantile-onset encephalopathy.	[Muona, Mikko; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Muona, Mikko; Laari, Anni; Anttonen, Anna-Kaisa; Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki 00290, Finland; [Muona, Mikko; Laari, Anni; Karhu, Thomas; Anttonen, Anna-Kaisa; Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, FIN-00290 Helsinki, Finland; [Muona, Mikko; Laari, Anni; Karhu, Thomas; Anttonen, Anna-Kaisa; Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland; [Ishimura, Ryosuke; Ichimura, Yoshinobu; Obata, Miki; Komatsu, Masaaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Biochem, Chuo Ku, Niigata 9518510, Japan; [Ishimura, Ryosuke; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Linnankivi, Tarja] Univ Helsinki, Childrens Hosp, Dept Child Neurol, FIN-00290 Helsinki, Finland; [Linnankivi, Tarja; Poyhonen, Minna] Helsinki Univ Hosp, Helsinki 00290, Finland; [Keski-Filppula, Riikka; Rantala, Heikki; Kuismin, Outi] Univ Oulu, PEDEGO Res Unit, Oulu 90014, Finland; [Keski-Filppula, Riikka; Rantala, Heikki; Kuismin, Outi] Univ Oulu, Med Res Ctr Oulu, Oulu 90014, Finland; [Keski-Filppula, Riikka; Kuismin, Outi] Oulu Univ Hosp, Dept Clin Genet, Oulu 90029, Finland; [Herva, Riitta] Oulu Univ Hosp, Dept Pathol, Canc & Translat Med Res Unit, Med Res Ctr Oulu, Oulu 90014, Finland; [Herva, Riitta] Univ Oulu, Oulu 90014, Finland; [Rantala, Heikki] Oulu Univ Hosp, Dept Children & Adolescents, Div Paediat Neurol, Oulu 90029, Finland; [Paetau, Anders] Univ Helsinki, Dept Pathol, Haartmaninkatu 3, FIN-00290 Helsinki, Finland; [Paetau, Anders] Helsinki Univ Cent Hosp, Helsinki 00290, Finland; [Poyhonen, Minna; Anttonen, Anna-Kaisa] Univ Helsinki, Med & Clin Genet, FIN-00290 Helsinki, Finland; [Uemura, Takefumi; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Bizen, Norihisa; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Chuo Ku, Niigata 9518510, Japan; [McKee, Shane] Belfast City Hosp, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland; [Parker, Michael J.] Sheffield Childrens Hosp NHS Fdn Trust, Western Bank, Sheffield S10 2TH, S Yorkshire, England; [Akawi, Nadia; McRae, Jeremy; Hurles, Matthew E.; Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Kurki, Mitja I.] Kuopio Univ Hosp, Neurosurg NeuroCtr, Kuopio 70029, Finland; [Kurki, Mitja I.; Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kurki, Mitja I.; Palotie, Aarno] Harvard Med Sch, Boston, MA 02114 USA; [Kurki, Mitja I.; Palotie, Aarno] Broad Inst Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Palotie, Aarno] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA 02141 USA; [Palotie, Aarno] Harvard Med Sch, Program Genet & Genom Biol & Biomed Sci, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Muona, Mikko] Blueprint Genet, Helsinki 00290, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Niigata University; Tokyo Metropolitan Institute of Medical Science; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Fukushima Medical University; Niigata University; Belfast City Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Wellcome Trust Sanger Institute; Kuopio University Hospital; University of Eastern Finland; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lehesjoki, AE (corresponding author), Folkhalsan Inst Genet, Helsinki 00290, Finland.; Lehesjoki, AE (corresponding author), Univ Helsinki, Ctr Neurosci, FIN-00290 Helsinki, Finland.; Lehesjoki, AE (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.; Komatsu, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Biochem, Chuo Ku, Niigata 9518510, Japan.	anna-elina.lehesjoki@helsinki.fi; komatsu-ms@med.niigata-u.ac.jp	Kurki, Mitja/GWM-5671-2022; Akawi, Nadia/AAX-2650-2020; Komatsu, Masaaki/B-8321-2011; Poyhonen, Minna/K-4866-2018; Takebayashi, Hirohide/AAO-1693-2020; Laari, Anni/C-6081-2015	Akawi, Nadia/0000-0001-6311-7028; Komatsu, Masaaki/0000-0001-7672-7722; Poyhonen, Minna/0000-0003-2037-2744; Laari, Anni/0000-0001-6242-0594; Palotie, Aarno/0000-0002-2527-5874; McKee, Shane/0000-0002-1772-0106; Kuismin, Outi/0000-0002-0157-8985; Linnankivi, Tarja/0000-0001-9190-2218				Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Cai YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005643; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Horie M, 2014, EUR J NEUROSCI, V40, P3458, DOI 10.1111/ejn.12711; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lek M, 2015, BIORXIV; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Watson C M, 2015, SAMJ, S. Afr. med. j., V105, P558, DOI [10.7196/SAMJnew.7917, 10.7196/SAMJNEW.7917]; Xie ST, 2014, ACTA CRYSTALLOGR F, V70, P1093, DOI 10.1107/S2053230X14014502; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	31	46	50	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					683	694		10.1016/j.ajhg.2016.06.020	http://dx.doi.org/10.1016/j.ajhg.2016.06.020			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545674	Green Published, Bronze			2022-12-18	WOS:000383114800013
J	Burrage, LC; Charng, WL; Eldomery, MK; Willer, JR; Davis, EE; Lugtenberg, D; Zhu, WM; Leduc, MS; Akdemir, ZC; Azamian, M; Zapata, G; Hernandez, PP; Schoots, J; de Munnik, SA; Roepman, R; Pearring, JN; Jhangiani, S; Katsanis, N; Vissers, LELM; Brunner, HG; Beaudet, AL; Rosenfeld, JA; Muzny, DM; Gibbs, RA; Eng, CM; Xia, F; Lalani, SR; Lupski, JR; Bongers, EMHF; Yang, YP				Burrage, Lindsay C.; Charng, Wu-Lin; Eldomery, Mohammad K.; Willer, Jason R.; Davis, Erica E.; Lugtenberg, Dorien; Zhu, Wenmiao; Leduc, Magalie S.; Akdemir, Zeynep C.; Azamian, Mahshid; Zapata, Gladys; Hernandez, Patricia P.; Schoots, Jeroen; de Munnik, Sonja A.; Roepman, Ronald; Pearring, Jillian N.; Jhangiani, Shalini; Katsanis, Nicholas; Vissers, Lisenka E. L. M.; Brunner, Han G.; Beaudet, Arthur L.; Rosenfeld, Jill A.; Muzny, Donna M.; Gibbs, Richard A.; Eng, Christine M.; Xia, Fan; Lalani, Seema R.; Lupski, James R.; Bongers, Ernie M. H. F.; Yang, Yaping			De Novo GMNN Mutations Cause Autosomal-Dominant Primordial Dwarfism Associated with Meier-Gorlin Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; GROWTH REFERENCE; GEMININ; INHIBITION; PROTEIN; CHILDREN	Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6. Mutations in these genes cause disruption of the origin of DNA replication initiation. To date, only an autosomal-recessive inheritance pattern has been described in individuals with this disorder, with a molecular etiology established in about three-fourths of cases. Here, we report three subjects with MGS and de novo heterozygous mutations in the 5' end of GMNN, encoding the DNA replication inhibitor geminin. We identified two truncating mutations in exon 2 (the 1 st coding exon), c.16A>T (p.Lys6*) and c.35_38delTCAA (p.Ile12Lysfs*4), and one missense mutation, c.50A>G (p.Lys17Arg), affecting the second-to-last nucleotide of exon 2 and possibly RNA splicing. Geminin is present during the S, G2, and M phases of the cell cycle and is degraded during the metaphase-anaphase transition by the anaphase-promoting complex (APC), which recognizes the destruction box sequence near the 5' end of the geminin protein. All three GMNN mutations identified alter sites 5' to residue Met28 of the protein, which is located within the destruction box. We present data supporting a gain-of-function mechanism, in which the GMNN mutations result in proteins lacking the destruction box and hence increased protein stability and prolonged inhibition of replication leading to autosomal-dominant MGS.	[Burrage, Lindsay C.; Charng, Wu-Lin; Eldomery, Mohammad K.; Leduc, Magalie S.; Akdemir, Zeynep C.; Azamian, Mahshid; Zapata, Gladys; Hernandez, Patricia P.; Beaudet, Arthur L.; Rosenfeld, Jill A.; Muzny, Donna M.; Gibbs, Richard A.; Eng, Christine M.; Xia, Fan; Lalani, Seema R.; Lupski, James R.; Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Willer, Jason R.; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Lugtenberg, Dorien; Schoots, Jeroen; de Munnik, Sonja A.; Roepman, Ronald; Vissers, Lisenka E. L. M.; Brunner, Han G.; Bongers, Ernie M. H. F.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Jhangiani, Shalini; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Burrage, Lindsay C.; Lupski, James R.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Zhu, Wenmiao; Eng, Christine M.; Xia, Fan; Lalani, Seema R.; Yang, Yaping] Baylor Miraca Genet Labs, Exome Lab, Houston, TX 77030 USA; [Pearring, Jillian N.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27701 USA	Baylor College of Medicine; Duke University; Radboud University Nijmegen; Baylor College of Medicine; Baylor College of Medicine; Duke University	Bongers, EMHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	ernie.bongers@radboudumc.nl; yapingy@bcm.edu	Vissers, Lisenka ELM/A-2598-2015; Roepman, Ronald/B-1339-2014; Lugtenberg, Dorien/B-6338-2018; Leduc, Magalie/R-9884-2019; Lalani, Seema/AAI-5090-2020	Vissers, Lisenka ELM/0000-0001-6470-5497; Roepman, Ronald/0000-0002-5178-8163; Willer, Jason/0000-0002-5869-3992; Pearring, Jillian/0000-0002-5352-2852; Davis, Erica/0000-0002-2412-8397; Azamian, Mahshid/0000-0002-8543-8284	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [U54HG006542]; Genzyme/ACMG Foundation for Genetic and Genomic Medicine Medical Genetics Training Award in Clinical Biochemical Genetics; National Urea Cycle Disorders Foundation; Urea Cycle Disorders Consortium (UCDC) part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) [U54HD061221]; Office of Rare Diseases Research (ORDR); National Center for Advancing Translational Science (NCATS); National Center for Advancing Translational Science (Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)); National Institutes of Health [T32 GM07526]; CPRIT [RP140102]; Regeneron Pharmaceuticals;  [P50 DK096415]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399, U54HD061221] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY025732] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI); Genzyme/ACMG Foundation for Genetic and Genomic Medicine Medical Genetics Training Award in Clinical Biochemical Genetics; National Urea Cycle Disorders Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Urea Cycle Disorders Consortium (UCDC) part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Rare Diseases Research (ORDR); National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Science (Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Regeneron Pharmaceuticals(Regeneron); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients and their families for participating in this study. We also thank S.D. van der Velde-Visser for technical support. This work was funded in part by the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) grant number U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics (BH-CMG). L.C.B. was supported by the Genzyme/ACMG Foundation for Genetic and Genomic Medicine Medical Genetics Training Award in Clinical Biochemical Genetics, the National Urea Cycle Disorders Foundation Fellowship, a fellowship from the Urea Cycle Disorders Consortium (UCDC; U54HD061221), which is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through collaboration between the Office of Rare Diseases Research (ORDR), the National Center for Advancing Translational Science (NCATS and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institutes of Health (T32 GM07526). W.-L.C. is supported by CPRIT training Program RP140102. N.K. is supported by P50 DK096415 and is a distinguished Jean and George Brumley Professor. J.R.L. holds stock ownership in 23andMe and Lasergen, is a paid consultant for Regeneron Pharmaceuticals, and is a co-inventor of multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the Baylor Miraca Genetics Laboratories.	BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Bongers EMHF, 2001, AM J MED GENET, V102, P115, DOI 10.1002/ajmg.1452; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; de Munnik SA, 2012, AM J MED GENET A, V158A, P2733, DOI 10.1002/ajmg.a.35681; de Munnik SA, 2012, EUR J HUM GENET, V20, P598, DOI 10.1038/ejhg.2011.269; Department of Health and Human Services Centers for Disease Control and Prevention. National Center for Health Statistics, 2000, SERIES, V11; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Gorlin R J, 1975, Birth Defects Orig Artic Ser, V11, P39; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MEIER Z, 1959, Helv Paediatr Acta, V14, P213; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Ozer BK, 2007, ECON HUM BIOL, V5, P280, DOI 10.1016/j.ehb.2007.03.007; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Suchyta M, 2015, GENES-BASEL, V6, P252, DOI 10.3390/genes6020252; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yoshida K, 2004, ONCOGENE, V23, P58, DOI 10.1038/sj.onc.1206987	36	46	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					904	913		10.1016/j.ajhg.2015.11.006	http://dx.doi.org/10.1016/j.ajhg.2015.11.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637980	Bronze, Green Published			2022-12-18	WOS:000368437900013
J	Isrie, M; Breuss, M; Tian, GL; Hansen, AH; Cristofoli, F; Morandell, J; Kupchinsky, ZA; Sifrim, A; Rodriguez-Rodriguez, CM; Dapena, EP; Doonanco, K; Leonard, N; Tinsa, F; Moortgat, S; Ulucan, H; Koparir, E; Karaca, E; Katsanis, N; Marton, V; Vermeesch, JR; Davis, EE; Cowan, NJ; Keays, DA; Van Esch, H				Isrie, Mala; Breuss, Martin; Tian, Guoling; Hansen, Andi Harley; Cristofoli, Francesca; Morandell, Jasmin; Kupchinsky, Zachari A.; Sifrim, Alejandro; Maria Rodriguez-Rodriguez, Celia; Porta Dapena, Elena; Doonanco, Kurston; Leonard, Norma; Tinsa, Faten; Moortgat, Stephanie; Ulucan, Hakan; Koparir, Erkan; Karaca, Ender; Katsanis, Nicholas; Marton, Valeria; Vermeesch, Joris Robert; Davis, Erica E.; Cowan, Nicholas J.; Keays, David Anthony; Van Esch, Hilde			Mutations in Either TUBB or MAPRE2 Cause Circumferential Skin Creases Kunze Type	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MCA/MR SYNDROME; DIFFERENTIATION; ANOMALIES; DISEASE; FOLDS	Circumferential skin creases Kunze type (CSC-KT) is a specific congenital entity with an unknown genetic cause. The disease phenotype comprises characteristic circumferential skin creases accompanied by intellectual disability, a cleft palate, short stature, and dysmorphic features. Here, we report that mutations in either MAPRE2 or TUBB underlie the genetic origin of this syndrome. MAPRE2 encodes a member of the microtubule end-binding family of proteins that bind to the guanosine triphosphate cap at growing microtubule plus ends, and TUBB encodes a b-tubulin isotype that is expressed abundantly in the developing brain. Functional analyses of the TUBB mutants show multiple defects in the chaperone-dependent tubulin heterodimer folding and assembly pathway that leads to a compromised yield of native heterodimers. The TUBB mutations also have an impact on microtubule dynamics. For MAPRE2, we show that the mutations result in enhanced MAPRE2 binding to microtubules, implying an increased dwell time at microtubule plus ends. Further, in vivo analysis of MAPRE2 mutations in a zebrafish model of craniofacial development shows that the variants most likely perturb the patterning of branchial arches, either through excessive activity (under a recessive paradigm) or through haploinsufficiency (dominant de novo paradigm). Taken together, our data add CSC-KT to the growing list of tubulinopathies and highlight how multiple inheritance paradigms can affect dosage-sensitive biological systems so as to result in the same clinical defect.	[Isrie, Mala; Cristofoli, Francesca; Vermeesch, Joris Robert; Van Esch, Hilde] Univ Hosp Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Isrie, Mala; Van Esch, Hilde] Katholieke Univ Leuven, Dept Human Genet, Lab Genet Cognit, B-3000 Louvain, Belgium; [Breuss, Martin; Hansen, Andi Harley; Morandell, Jasmin; Keays, David Anthony] Vienna Bioctr, Inst Mol Pathol, A-1030 Vienna, Austria; [Tian, Guoling; Cowan, Nicholas J.] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Kupchinsky, Zachari A.; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Sifrim, Alejandro] Katholieke Univ Leuven, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Dept Elect Engn, B-3001 Heverlee, Belgium; [Maria Rodriguez-Rodriguez, Celia; Porta Dapena, Elena] Ourense Hosp Complex, Dept Paediat, Orense 32005, Spain; [Doonanco, Kurston; Leonard, Norma] Univ Alberta, Med Genet Serv, Edmonton, AB T6G 2C8, Canada; [Doonanco, Kurston; Leonard, Norma] Stollery Childrens Hosp, Edmonton, AB T6G 2C8, Canada; [Tinsa, Faten] Childrens Hosp Tunis, Dept Pediat B, Tunis 1007, Tunisia; [Moortgat, Stephanie] Inst Pathol & Genet, Ctr Genet Humaine, B-6041 Gosselies, Belgium; [Ulucan, Hakan] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, TR-34098 Istanbul, Turkey; [Koparir, Erkan] Kanuni Sultan Suleyman Training & Res Hosp, Dept Med Genet, TR-34303 Istanbul, Turkey; [Karaca, Ender] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Marton, Valeria] Arctic Univ Norway, Dept Med Genet, N-9037 Tromso, Norway; [Vermeesch, Joris Robert] Katholieke Univ Leuven, Dept Human Genet, Lab Cytogenet & Genome Res, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); New York University; NYU Langone Medical Center; Duke University; KU Leuven; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; University of Alberta; Stollery Children's Hospital; Universite de Tunis-El-Manar; Hopital d'Enfants; Istanbul University; Istanbul University - Cerrahpasa; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; Baylor College of Medicine; UiT The Arctic University of Tromso; KU Leuven	Van Esch, H (corresponding author), Univ Hosp Leuven, Ctr Human Genet, B-3000 Louvain, Belgium.	hilde.vanesch@med.kuleuven.be	Breuss, Martin/AAL-9509-2021; Sifrim, Alejandro/AAY-2019-2021; Van+Esch, Hilde/AAU-5688-2020	Sifrim, Alejandro/0000-0001-8247-4020; Morandell, Jasmin/0000-0003-1190-8236; Vermeesch, Joris/0000-0002-3071-1191; Davis, Erica/0000-0002-2412-8397; Breuss, Martin Werner/0000-0003-2200-8604; Van Esch, Hilde/0000-0002-9604-5726	Concerted Research Actions KU Leuven [GOA/12/015]; Belgian Science Policy Office Interuniversity Attraction Poles program [IAP P7/43-BeMGI]; FWO [ZKC5737]; NIH [R01GM097376]; FWF [I914, P24367]; NHGRI/NHLBI [U54HG006542]; NIH-NIDDK [P50DK096415]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097376] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 914, P 24367] Funding Source: researchfish	Concerted Research Actions KU Leuven; Belgian Science Policy Office Interuniversity Attraction Poles program; FWO(FWO); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWF(Austrian Science Fund (FWF)); NHGRI/NHLBI; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the affected individuals and their families for their participation. We thank Shannon Fisher for the 1.4col1a1:egfp zebrafish line and acknowledge Igor Pediaditakis and Gaelle Hayot (zebrafish studies) and Christelle Golzio and Mikalai Malinouski (VAST Bioimager) for their technical assistance. This work was supported by a grant from Concerted Research Actions KU Leuven (GOA/12/015) and funding from the Belgian Science Policy Office Interuniversity Attraction Poles program through the project IAP P7/43-BeMGI. H.V.E. is a clinical investigator of FWO-Vlaanderen and acknowledges receipt of a FWO grant (ZKC5737). N.J.C. acknowledges receipt of a grant (R01GM097376) from the NIH. D.A.K. is an EMBO Young Investigator and is supported by FWF grants I914 and P24367. E.K. is supported by the NHGRI/NHLBI grant (U54HG006542) to the Baylor-Hopkins Center for Mendelian Genomics. N.K. is supported by a grant from the NIH-NIDDK (P50DK096415) and is a distinguished George W. Brumley Professor.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Basel-Vanagaite L, 2012, PEDIATR DERMATOL, V29, P89, DOI 10.1111/j.1525-1470.2011.01403.x; Breuss M, 2014, ADV EXP MED BIOL, V800, P75, DOI 10.1007/978-94-007-7687-6_5; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Brouhard GJ, 2015, MOL BIOL CELL, V26, P1207, DOI 10.1091/mbc.E13-10-0594; Cohen M M Jr, 1993, Clin Dysmorphol, V2, P39; Cowan NJ, 2002, ADV PROTEIN CHEM, V59, P73; Elliott AM, 1996, AM J MED GENET, V62, P23, DOI 10.1002/(SICI)1096-8628(19960301)62:1<23::AID-AJMG5>3.3.CO;2-U; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Goldspink DA, 2013, J CELL SCI, V126, P4000, DOI 10.1242/jcs.129759; Golzio C, 2013, CURR OPIN GENET DEV, V23, P240, DOI 10.1016/j.gde.2013.04.013; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Kondoh T, 2004, AM J MED GENET A, V125A, P290, DOI 10.1002/ajmg.a.20461; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KUNZE J, 1982, EUR J PEDIATR, V138, P301, DOI 10.1007/BF00442501; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Leonard NJ, 2002, AM J MED GENET, V112, P91, DOI 10.1002/ajmg.10665; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ngo L, 2014, HUM MOL GENET, V23, P5147, DOI 10.1093/hmg/ddu238; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Pardo-Martin C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2475; ROSS CM, 1969, DERMATOLOGY, V100, P320; Schnur RE, 1997, AM J MED GENET, V69, P221, DOI 10.1002/(SICI)1096-8628(19970317)69:2<221::AID-AJMG22>3.0.CO;2-M; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sifrim A, 2012, GENOME MED, V4, DOI 10.1186/gm374; Tian G, 2008, MOL BIOL CELL, V19, P1152, DOI 10.1091/mbc.E07-09-0861; Tinsa F, 2009, J CHILD NEUROL, V24, P224, DOI 10.1177/0883073808322673; Ulucan H, 2013, CLIN DYSMORPHOL, V22, P87, DOI 10.1097/MCD.0b013e32835cd5df; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wouters L, 2011, EUR J MED GENET, V54, P236, DOI 10.1016/j.ejmg.2011.01.003	33	46	53	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					790	800		10.1016/j.ajhg.2015.10.014	http://dx.doi.org/10.1016/j.ajhg.2015.10.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637975	Bronze, Green Published			2022-12-18	WOS:000368437900002
J	Logan, CV; Cossins, J; Cruz, PMR; Parry, DA; Maxwell, S; Martinez-Martinez, P; Riepsaame, J; Abdelhamed, ZA; Lake, AVR; Moran, M; Robb, S; Chow, G; Sewry, C; Hopkins, PM; Sheridan, E; Jayawant, S; Palace, J; Johnson, CA; Beeson, D				Logan, Clare V.; Cossins, Judith; Cruz, Pedro M. Rodriguez; Parry, David A.; Maxwell, Susan; Martinez-Martinez, Pilar; Riepsaame, Joey; Abdelhamed, Zakia A.; Lake, Alice V. R.; Moran, Maria; Robb, Stephanie; Chow, Gabriel; Sewry, Caroline; Hopkins, Philip M.; Sheridan, Eamonn; Jayawant, Sandeep; Palace, Jacqueline; Johnson, Colin A.; Beeson, David			Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII alpha 1 Chain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMAINS; MAINTENANCE; MATURATION; FRAMEWORK; END	The neuromuscular junction (NMJ) consists of a tripartite synapse with a presynaptic nerve terminal, Schwann cells that ensheathe the terminal bouton, and a highly specialized postsynaptic membrane. Synaptic structural integrity is crucial for efficient signal transmission. Congenital myasthenic syndromes (CMSs) are a heterogeneous group of inherited disorders that result from impaired neuromuscular transmission, caused by mutations in genes encoding proteins that are involved in synaptic transmission and in forming and maintaining the structural integrity of NMJs. To identify further causes of CMSs, we performed whole-exome sequencing (WES) in families without an identified mutation in known CMS-associated genes. In two families affected by a previously undefined CMS, we identified homozygous loss-of-function mutations in COL13A1, which encodes the alpha chain of an atypical non-fibrillar collagen with a single transmembrane domain. COL13A1 localized to the human muscle motor endplate. Using CRISPR-Cas9 genome editing, modeling of the COL13A1 c.1171delG (p.Leu392Sfs*71) frameshift mutation in the C2C12 cell line reduced acetylcholine receptor (AChR) clustering during myotube differentiation. This highlights the crucial role of collagen XIII in the formation and maintenance of the NMJ. Our results therefore delineate a myasthenic disorder that is caused by loss-of-function mutations in COL13A1, encoding a protein involved in organization of the NMJ, and emphasize the importance of appropriate symptomatic treatment for these individuals.	[Logan, Clare V.; Abdelhamed, Zakia A.; Lake, Alice V. R.; Johnson, Colin A.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Cossins, Judith; Cruz, Pedro M. Rodriguez; Maxwell, Susan; Palace, Jacqueline; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Neurosci Grp, Oxford OX3 9DS, England; [Parry, David A.; Sheridan, Eamonn] Univ Leeds, Leeds Inst Biomed & Clin Sci, Genet Sect, Leeds LS9 7TF, W Yorkshire, England; [Martinez-Martinez, Pilar] Maastricht Univ, Sch Mental Hlth & Neurosci, Div Neurosci, Neuroimmunol Grp, POB 616, NL-6200 MD Maastricht, Netherlands; [Riepsaame, Joey] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; [Moran, Maria; Chow, Gabriel] Nottingham Univ Hosp NHS Trust, City Hosp Nottingham, Dept Paediat Neurol, Nottingham NG5 1PB, England; [Robb, Stephanie; Sewry, Caroline] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Robb, Stephanie; Sewry, Caroline] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [Hopkins, Philip M.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Translat Anaesthesia & Surg Sci, Leeds LS9 7TF, W Yorkshire, England; [Jayawant, Sandeep] Oxford Radcliffe Hosp NHS Trust, John Radcliffe Hosp, Dept Paediat Neurol, Oxford OX3 9DU, England; [Palace, Jacqueline] Oxford Radcliffe Hosp NHS Trust, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England	University of Leeds; University of Oxford; University of Leeds; Maastricht University; University of Oxford; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Leeds; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Johnson, CA (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England.	c.johnson@leeds.ac.uk; david.beeson@ndcn.ox.ac.uk	Lake, Alice/AAB-2739-2020; Hopkins, Philip/ABE-5970-2020; Rodriguez Cruz, Pedro M/ABF-9346-2021	Hopkins, Philip/0000-0002-8127-1739; Rodriguez Cruz, Pedro M/0000-0001-5416-8341; Martinez Martinez, Pilar/0000-0002-5990-3373; Logan, Clare/0000-0003-4323-1602; Johnson, Colin/0000-0002-2979-8234; Parry, David/0000-0003-0376-7736	Sir Jules Thorn Award for Biomedical Research [JTA/09]; Medical Research Council (MRC) [MR/K011154/1]; MRC [MR/M006824/1]; MRC [MR/K011154/1] Funding Source: UKRI; Medical Research Council [MR/K011154/1, MR/M006824/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Sir Jules Thorn Award for Biomedical Research; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	The authors thank the individuals and families for participating in this study and acknowledge the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics for generating sequencing data. We thank Martin Smith at Birmingham Children's Hospital UK for referring study participants. This work was supported by a Sir Jules Thorn Award for Biomedical Research (JTA/09 to C.A.J. and E.S.), a Medical Research Council (MRC) project grant (MR/K011154/1 to C.A.J.), and a MRC programme grant (MR/M006824/1 to D.B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruz PMR, 2014, J NEUROL, V261, P2234, DOI 10.1007/s00415-014-7520-7; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; Eymard B, 2013, HAND CLINIC, V113, P1469, DOI 10.1016/B978-0-444-59565-2.00016-2; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Finlayson Sarah, 2013, Pract Neurol, V13, P80, DOI 10.1136/practneurol-2012-000404; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Kvist AP, 2001, AM J PATHOL, V159, P1581, DOI 10.1016/S0002-9440(10)62542-4; Latvanlehto A, 2010, J NEUROSCI, V30, P12230, DOI 10.1523/JNEUROSCI.5518-09.2010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maselli RA, 2012, ANN NY ACAD SCI, V1275, P36, DOI 10.1111/j.1749-6632.2012.06807.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Parry DA, 2013, AM J HUM GENET, V93, P1135, DOI 10.1016/j.ajhg.2013.10.027; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P16922; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Snellman A, 2000, J BIOL CHEM, V275, P8936, DOI 10.1074/jbc.275.12.8936; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; TIKKA L, 1988, P NATL ACAD SCI USA, V85, P7491, DOI 10.1073/pnas.85.20.7491; Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200	23	46	47	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					878	885		10.1016/j.ajhg.2015.10.017	http://dx.doi.org/10.1016/j.ajhg.2015.10.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26626625	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000368437900010
J	Yehia, L; Niazi, F; Ni, Y; Ngeow, J; Sankunny, M; Liu, ZG; Wei, W; Mester, JL; Keri, RA; Zhang, B; Eng, C				Yehia, Lamis; Niazi, Farshad; Ni, Ying; Ngeow, Joanne; Sankunny, Madhav; Liu, Zhigang; Wei, Wei; Mester, Jessica L.; Keri, Ruth A.; Zhang, Bin; Eng, Charis			Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANEMIA TYPE-II; ENDOPLASMIC-RETICULUM STRESS; INTEGRATIVE GENOMICS VIEWER; TO-MESENCHYMAL TRANSITION; UNFOLDED PROTEIN RESPONSE; ALVEOLAR EPITHELIAL-CELLS; HAMARTOMA-TUMOR-SYNDROME; SYNDROME PLEASE STAND; DNA-SEQUENCING DATA; VESICLE TRAFFICKING	Cancer-predisposing genes associated with inherited cancer syndromes help explain mechanisms of sporadic carcinogenesis and often inform normal development. Cowden syndrome (CS) is an autosomal-dominant disorder characterized by high lifetime risks of epithelial cancers, such that similar to 50% of affected individuals are wild-type for known cancer-predisposing genes. Using whole-exome and Sanger sequencing of a multi-generation CS family affected by thyroid and other cancers, we identified a pathogenic missense heterozygous SEC23B variant (c.1781T>G [p.Val594Gly]) that segregates with the phenotype. We also found germline heterozygous SEC23B variants in 3/96 (3%) unrelated mutation-negative CS probands with thyroid cancer and in The Cancer Genome Atlas (TCGA), representing apparently sporadic cancers. We note that the TCGA thyroid cancer dataset is enriched with unique germline deleterious SEC23B variants associated with a significantly younger age of onset. SEC23B encodes Sec23 homolog B (S. cerevisiae), a component of coat protein complex II (COPII), which transports proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. Interestingly, germline homozygous or compound-heterozygous SEC23B mutations cause an unrelated disorder, congenital dyserythropoietic anemia type II, and SEC23B-deficient mice suffer from secretory organ degeneration due to ER-stress-associated apoptosis. By characterizing the p.Val594Gly variant in a normal thyroid cell line, we show that it is a functional alteration that results in ER-stress-mediated cell-colony formation and survival, growth, and invasion, which reflect aspects of a cancer phenotype. Our findings suggest a different role for SEC23B, whereby germline heterozygous variants associate with cancer predisposition potentially mediated by ER stress "addiction."	[Yehia, Lamis; Niazi, Farshad; Ni, Ying; Ngeow, Joanne; Sankunny, Madhav; Liu, Zhigang; Wei, Wei; Mester, Jessica L.; Zhang, Bin; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Yehia, Lamis; Niazi, Farshad; Ni, Ying; Ngeow, Joanne; Sankunny, Madhav; Liu, Zhigang; Wei, Wei; Mester, Jessica L.; Zhang, Bin; Eng, Charis] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Yehia, Lamis] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Ni, Ying] Case Western Reserve Univ, Sch Med, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA; [Ngeow, Joanne] Natl Canc Ctr, Div Med Oncol, Singapore 169610, Singapore; [Ngeow, Joanne] Duke NUS Grad Med Sch, Oncol Acad Clin Program, Singapore 169857, Singapore; [Wei, Wei] Chinese Acad Med Sci, Dept Pediat, Inst Hematol, Tianjin 300020, Peoples R China; [Wei, Wei] Chinese Acad Med Sci, Dept Pediat, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Wei, Wei] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Ni, Ying; Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; National Cancer Centre Singapore (NCCS); National University of Singapore; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA.	engc@ccf.org	Keri, Ruth/ABF-2209-2021; Joanne, Ngeow/G-9610-2019; Liu, Zhigang/L-6598-2019; Ngeow, Joanne/O-1250-2013; Yehia, Lamis/AAI-4996-2020	Keri, Ruth/0000-0002-1640-3088; Joanne, Ngeow/0000-0003-1558-3627; Ngeow, Joanne/0000-0003-1558-3627; Yehia, Lamis/0000-0002-6389-3059	National Cancer Institute [P01CA124570, R01CA118989, R25TCA094186]; American Cancer Society [RPG-02-151-01-CCE]; Breast Cancer Research Foundation; William Randolph Hearst Foundations; Doris Duke Distinguished Clinical Scientist Award; NHLBI [R01HL094505]; Dr. Michael H. Fakih pre-doctoral endowed scholarship; NATIONAL CANCER INSTITUTE [R01CA118980, R25CA094186, P01CA124570] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094505] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Breast Cancer Research Foundation; William Randolph Hearst Foundations; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dr. Michael H. Fakih pre-doctoral endowed scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the members of family 616 and all Cowden syndrome (CS)- and CS-like-affected individuals who contributed to this study. We thank the Genomic Medicine Biorepository of the Cleveland Clinic Genomic Medicine Institute and our database and clinical research teams. We also thank Dr. Thomas La-Framboise and Darcie Seachrist (Case Western Reserve University) and Todd Romigh, Charissa Petersen, and Jessica Altemus (Cleveland Clinic Genomic Medicine Institute) for technical advice and helpful discussions. This study was funded in part by the National Cancer Institute (P01CA124570 and R01CA118989), American Cancer Society (RPG-02-151-01-CCE and Clinical Research Professorship), Breast Cancer Research Foundation, William Randolph Hearst Foundations, and Doris Duke Distinguished Clinical Scientist Award (all to C.E.) and the NHLBI (R01HL094505 to B.Z.). L.Y. is an International Fulbright Science and Technology Doctoral Fellow at the Cleveland Clinic Genomic Medicine Institute and recipient of the Dr. Michael H. Fakih pre-doctoral endowed scholarship. Y.N. is a CoGEC Scholar funded in part by National Cancer Institute grant R25TCA094186. J.N. was and M.S. is an Ambrose Monell Foundation Cancer Genomic Medicine Fellow at the Cleveland Clinic Genomic Medicine Institute. C.E. is the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic and an American Cancer Society Clinical Research Professor.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bennett KL, 2010, JAMA-J AM MED ASSOC, V304, P2724, DOI 10.1001/jama.2010.1877; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bianchi P, 2009, HUM MUTAT, V30, P1292, DOI 10.1002/humu.21077; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eng C, 2000, J CLIN ENDOCR METAB, V85, P1755, DOI 10.1210/jc.85.5.1755; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; GELLERA C, 1990, NEUROLOGY, V40, P495, DOI 10.1212/WNL.40.3_Part_1.495; Goldenring JR, 2013, NAT REV CANCER, V13, P813, DOI 10.1038/nrc3601; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hemminki K, 1999, EUR J CANCER, V35, P1109, DOI 10.1016/S0959-8049(99)00066-0; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Khoriaty R, 2014, MOL CELL BIOL, V34, P3721, DOI 10.1128/MCB.00287-14; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Lepoutre-Lussey C., 2015, MOL CELL ENDOCRINOL; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ngeow J, 2011, J CLIN ENDOCR METAB, V96, pE2063, DOI 10.1210/jc.2011-1616; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Ni Y, 2012, HUM MOL GENET, V21, P300, DOI 10.1093/hmg/ddr459; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; Orloff MS, 2013, AM J HUM GENET, V92, P76, DOI 10.1016/j.ajhg.2012.10.021; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Punzo F, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-89; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russo R, 2014, AM J HEMATOL, V89, pE169, DOI 10.1002/ajh.23800; Russo R, 2013, BLOOD CELL MOL DIS, V51, P17, DOI 10.1016/j.bcmd.2013.02.003; Russo R, 2011, AM J HEMATOL, V86, P727, DOI 10.1002/ajh.22096; Satchwell TJ, 2013, HAEMATOLOGICA, V98, P1788, DOI 10.3324/haematol.2013.085522; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Scriven P, 2009, BRIT J CANCER, V101, P1692, DOI 10.1038/sj.bjc.6605365; Tan MH, 2012, CLIN CANCER RES, V18, P400, DOI 10.1158/1078-0432.CCR-11-2283; Tan MH, 2011, AM J HUM GENET, V88, P42, DOI 10.1016/j.ajhg.2010.11.013; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Tao JY, 2012, P NATL ACAD SCI USA, V109, pE2001, DOI 10.1073/pnas.1209207109; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu XY, 2015, MOL MED REP, V11, P2341, DOI 10.3892/mmr.2014.2956; Yu WF, 2015, HUM MOL GENET, V24, P142, DOI 10.1093/hmg/ddu425; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	77	46	47	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					661	676		10.1016/j.ajhg.2015.10.001	http://dx.doi.org/10.1016/j.ajhg.2015.10.001			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26522472	Green Published, Bronze			2022-12-18	WOS:000364803000003
J	Jeanson, L; Copin, B; Papon, JF; Dastot-Le Moal, F; Duquesnoy, P; Montantin, G; Cadranel, J; Corvol, H; Coste, A; Desir, J; Souayah, A; Kott, E; Collot, N; Tissier, S; Louis, B; Tamalet, A; de Blic, J; Clement, A; Escudier, E; Amselem, S; Legendre, M				Jeanson, Ludovic; Copin, Bruno; Papon, Jean-Francois; Dastot-Le Moal, Florence; Duquesnoy, Philippe; Montantin, Guy; Cadranel, Jacques; Corvol, Harriet; Coste, Andre; Desir, Julie; Souayah, Anissa; Kott, Esther; Collot, Nathalie; Tissier, Sylvie; Louis, Bruno; Tamalet, Aline; de Blic, Jacques; Clement, Annick; Escudier, Estelle; Amselem, Serge; Legendre, Marie			RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; OUTER DYNEIN ARM; REGULATORY COMPLEX; FLAGELLAR MOTILITY; CENTRAL APPARATUS; BODY ASYMMETRY; IMMOTILE-CILIA; CHLAMYDOMONAS; GENE; PROTEIN	Primary ciliary dyskinesia (PCD) is a rare autosomal-recessive condition resulting from structural and/or functional defects of the axoneme in motile cilia and sperm flagella. The great majority of mutations identified so far involve genes whose defects result in dynein-arm anomalies. By contrast, PCD due to CC/RS defects (those in the central complex [CC] and radial spokes [RSs]), which might be difficult to diagnose, remains mostly unexplained. We identified non-ambiguous RSPH3 mutations in 5 of 48 independent families affected by CC/RS defects. RSPH3, whose ortholog in the flagellated alga Chlamydomonas reinhardtii encodes a RS-stalk protein, is mainly expressed in respiratory and testicular cells. Its protein product, which localizes within the cilia of respiratory epithelial cells, was undetectable in airway cells from an individual with RSPH3 mutations and in whom RSPH23 (a RS-neck protein) and RSPH1 and RSPI-14A (RS-head proteins) were found to be still present within cilia. In the case of RSPH3 mutations, high-speed-videcnnicroscopy analyses revealed the coexistence of immotile cilia and motile cilia with movements of reduced amplitude. A striking feature of the ultrastructural phenotype associated with RSPH3 mutations is the near absence of detectable RSs in all cilia in combination with a variable proportion of cilia with CC defects. Overall, this study shows that RSPH3 mutations contribute to disease in more than 10% of PCD-affected individuals with CC/RS defects, thereby allowing an accurate diagnosis to be made in such cases. It also unveils the key role of RSPH3 in the proper building of RSs and the CC in humans.	[Jeanson, Ludovic; Duquesnoy, Philippe; Kott, Esther; Clement, Annick; Escudier, Estelle; Amselem, Serge; Legendre, Marie] Sorbonne Univ, Univ Paris 06, INSERM, UMR S933, F-75012 Paris, France; [Copin, Bruno; Dastot-Le Moal, Florence; Montantin, Guy; Collot, Nathalie; Tissier, Sylvie; Escudier, Estelle; Amselem, Serge; Legendre, Marie] Hop Armand Trousseau, AP HP, Serv Genet & Embryol Med, F-75012 Paris, France; [Papon, Jean-Francois; Coste, Andre; Louis, Bruno] Univ Paris Est Creteil, INSERM, UMR S955, Equipe 13, F-94000 Creteil, France; [Papon, Jean-Francois] Hop Bicetre, AP HP, Serv Otorhinolaryngol & Chirurg Cervicomaxillofac, F-94275 Le Kremlin Bicetre, France; [Cadranel, Jacques] Hop Tenon, AP HP, Serv Pneumol, Ctr Expert Malad Pulm Rares, F-75020 Paris, France; [Cadranel, Jacques] Sorbonne Univ, Univ Paris 06, F-75020 Paris, France; [Corvol, Harriet; Tamalet, Aline; Clement, Annick] Hop Armand Trousseau, AP HP, Serv Pneumol Pediat, F-75012 Paris, France; [Corvol, Harriet; Tamalet, Aline; Clement, Annick] Ctr Natl Reference Malad Resp Rares, F-75012 Paris, France; [Corvol, Harriet] Sorbonne Univ, Univ Paris 06, INSERM, UMR S938, F-75012 Paris, France; [Coste, Andre] Hop Intercommunal Creteil, Serv Otorhinolaryngol & Chirurg Cervicofaciale, F-94000 Creteil, France; [Coste, Andre] Grp Hosp Henri Mondor Albert Chenevier, AP HP, F-94000 Creteil, France; [Desir, Julie] Univ Libre Bruxelles, Dept Genet Med, B-1020 Brussels, Belgium; [Desir, Julie] Hop Erasme, B-1020 Brussels, Belgium; [Souayah, Anissa] Hop Univ Enfants Reine Fabiola, Serv Otorhinolaryngol, B-1020 Brussels, Belgium; [de Blic, Jacques] Grp Hosp Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, F-75015 Paris, France; [de Blic, Jacques] Univ Paris 05, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Amselem, S (corresponding author), Sorbonne Univ, Univ Paris 06, INSERM, UMR S933, F-75012 Paris, France.	serge.amselem@inserm.fr	Louis, Bruno C/R-1862-2018; Legendre, Marie/AAD-7018-2021; Corvol, Harriet/N-5922-2018; Louis, Bruno/AGB-7050-2022	Louis, Bruno C/0000-0001-9587-9932; Legendre, Marie/0000-0003-2178-0846; Corvol, Harriet/0000-0002-7026-7523; Louis, Bruno/0000-0001-9587-9932; Papon, Jean Francois/0000-0002-2323-9239; COSTE, Andre/0000-0002-8386-3455	Fondation pour la Recherche Medicale [DEQ20120323689]; Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation	We are grateful to the affected persons and their families, whose cooperation made this study possible, and we thank all referring physicians. We thank Anne-Marie Vojtek and Catherine Faucon for their high-quality technical assistance for transmission-electronic-microscopy studies. This work was supported by grants from the Fondation pour la Recherche Medicale (DEQ20120323689), the Legs Poix from the Chancellerie des Universites, and the Milena Carvajal ProKartagener Foundation.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; AFZELIUS BA, 1985, CRC CR REV BIOCH MOL, V19, P63, DOI 10.3109/10409238509086788; AlSaadi MM, 2012, ANN HUM GENET, V76, P211, DOI 10.1111/j.1469-1809.2012.00704.x; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; CURRY AM, 1993, CELL MOTIL CYTOSKEL, V24, P224, DOI 10.1002/cm.970240403; Diener DP, 2011, CYTOSKELETON, V68, P389, DOI 10.1002/cm.20520; DIENER DR, 1993, J CELL BIOL, V123, P183, DOI 10.1083/jcb.123.1.183; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Frommer A, 2015, AM J RESP CELL MOL B; Gupta A, 2012, J CELL BIOL, V198, P115, DOI 10.1083/jcb.201111041; Hirokawa N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000802; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; HUANG B, 1981, J CELL BIOL, V88, P80, DOI 10.1083/jcb.88.1.80; Jivan A, 2009, J BIOL CHEM, V284, P29437, DOI 10.1074/jbc.M109.048181; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Nakhleh N, 2012, CIRCULATION, V125, P2232, DOI 10.1161/CIRCULATIONAHA.111.079780; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Papon JF, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-78; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; ROSSMAN CM, 1984, AM REV RESPIR DIS, V129, P161; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sivadas P, 2012, J CELL BIOL, V199, P639, DOI 10.1083/jcb.201111042; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Stannard W, 2004, AM J RESP CRIT CARE, V169, P634, DOI 10.1164/rccm.200306-782OC; Tamalet A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e86; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Vallet C, 2013, EUR J PEDIATR, V172, P1053, DOI 10.1007/s00431-013-1996-5; WARNER FD, 1974, J CELL BIOL, V63, P35, DOI 10.1083/jcb.63.1.35; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Yang C, 2006, MOL BIOL CELL, V17, P227, DOI 10.1091/mbc.e05-07-0630; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zietkiewicz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033667	58	46	51	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					153	162		10.1016/j.ajhg.2015.05.004	http://dx.doi.org/10.1016/j.ajhg.2015.05.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26073779	Bronze, Green Published			2022-12-18	WOS:000358189500013
J	Torres, JM; Gamazon, ER; Parra, EJ; Below, JE; Valladares-Salgado, A; Wacher, N; Cruz, M; Hanis, CL; Cox, NJ				Torres, Jason M.; Gamazon, Eric R.; Parra, Esteban J.; Below, Jennifer E.; Valladares-Salgado, Adan; Wacher, Niels; Cruz, Miguel; Hanis, Craig L.; Cox, Nancy J.			Cross-Tissue and Tissue-Specific eQTLs: Partitioning the Heritability of a Complex Trait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DEPENDENT DIABETES-MELLITUS; COMMON SNPS EXPLAIN; MISSING HERITABILITY; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GENETIC-VARIATION; LARGE PROPORTION; STARR COUNTY	Top signals from genome-wide association studies (GWASs) of type 2 diabetes (T2D) are enriched with expression quantitative trait loci (eQTLs) identified in skeletal muscle and adipose tissue. We therefore hypothesized that such eQTLs might account for a disproportionate share of the heritability estimated from all SNPs interrogated through GWASs. To test this hypothesis, we applied linear mixed models to the Wellcome Trust Case Control Consortium (WTCCC) T2D data set and to data sets representing Mexican Americans from Starr County, TX, and Mexicans from Mexico City. We estimated the proportion of phenotypic variance attributable to the additive effect of all variants interrogated in these GWASs, as well as a much smaller set of variants identified as eQTLs in human adipose tissue, skeletal muscle, and lymphoblastoid cell lines. The narrow-sense heritability explained by all interrogated SNPs in each of these data sets was substantially greater than the heritability accounted for by genome-Wide-significant SNPs (similar to 10%); GWAS SNPs explained over 50% of phenotypic variance in the WTCCC, Starr County, and Mexico City data sets. The estimate of heritability attributable to cross-tissue eQTLs was greater in the WTCCC data set and among lean Hispanics, whereas adipose eQTLs significantly explained heritability among Hispanics with a body mass index >= 30. These results support an important role for regulatory variants in the genetic component of T2D susceptibility, particularly for eQTLs that elicit effects across insulin-responsive peripheral tissues.	[Torres, Jason M.] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Below, Jennifer E.; Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77225 USA; [Valladares-Salgado, Adan; Wacher, Niels; Cruz, Miguel] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Unidades Invest Med Bioquim, Mexico City 06720, DF, Mexico; [Valladares-Salgado, Adan; Wacher, Niels; Cruz, Miguel] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Unidad Epidemiol Clin, Mexico City 06720, DF, Mexico	University of Chicago; University of Chicago; University of Toronto; University Toronto Mississauga; University of Texas System; University of Texas Health Science Center Houston; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Cox, NJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ncox@bsd.uchicago.edu	Lopez, Miguel Cruz/O-5493-2018; Gamazon, Eric/I-6873-2018; Below, Jennifer E/W-2179-2018	Lopez, Miguel Cruz/0000-0001-9985-6172; Gamazon, Eric/0000-0003-4204-8734; Below, Jennifer E/0000-0002-1346-1872; wacher, niels/0000-0002-7717-6704; Below, Jennifer/0000-0002-6372-6402; parra, esteban J/0000-0002-2057-8577	NIH [R01 HL102830, U01 DK085501, R01 MH101820, R01 MH090937, P30 DK020595, F31 DK101202]; Fondo Sectorial de Investigacion en Salud y Seguridad Social (SSA/IMSS/ISSSTE-CONACYT) In Mexico [150352]; Fundacion Instituto Mexicano del Seguro Social Scholarship; Canadian Institutes of Health Research; Banting and Best Diabetes Centre; Center for Inherited Disease Research from the NIH [HHSN268200782096C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000432, UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, F31DK101202, U01DK085501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090937, R01MH101820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Sectorial de Investigacion en Salud y Seguridad Social (SSA/IMSS/ISSSTE-CONACYT) In Mexico; Fundacion Instituto Mexicano del Seguro Social Scholarship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre; Center for Inherited Disease Research from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants R01 HL102830 (C.L.H.), U01 DK085501 (C.L.H.), R01 MH101820 (N.J.C.), R01 MH090937 (N.J.C), P30 DK020595 (G.I.B), and F31 DK101202 (J.M.T). In Mexico, this work was supported by the Fondo Sectorial de Investigacion en Salud y Seguridad Social (SSA/IMSS/ISSSTE-CONACYT, project 150352), and M.C. is a recipient of the Fundacion Instituto Mexicano del Seguro Social Scholarship. E.J.P. was supported by an operating grant from the Canadian Institutes of Health Research and the Banting and Best Diabetes Centre. Genotyping services were provided by the Center for Inherited Disease Research, funded through a federal contract (HHSN268200782096C) from the NIH to the Johns Hopkins University. We thank Lea K. Davis, Hae Kyung Im, and Anna Plushnikov for insightful comments and suggestions regarding heritability partitioning. We also thank Graeme I. Bell, David Carmody, and Honggang Ye for useful discussions regarding analyses of type 2 diabetes in the Mexican American and Mexican data sets.	Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carpentier A, 2000, DIABETES, V49, P399, DOI 10.2337/diabetes.49.3.399; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Farooqi IS, 2011, CELL METAB, V13, P7, DOI 10.1016/j.cmet.2010.12.016; Frayling TM, 2002, DIABETES, V51, P2313, DOI 10.2337/diabetes.51.7.2313; Gamazon E.R., 2013, ARXIV13036227; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gloyn AL, 2001, DIABETIC MED, V18, P206, DOI 10.1046/j.1464-5491.2001.00449.x; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huang K, 2014, OBESITY, V22, P984, DOI 10.1002/oby.20647; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martin AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004549; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Development Core Team, 2011, R LANG ENV STAT COMP; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	63	46	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					521	534		10.1016/j.ajhg.2014.10.001	http://dx.doi.org/10.1016/j.ajhg.2014.10.001			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439722	Green Published, Bronze			2022-12-18	WOS:000344845000004
J	Janer, A; Antonicka, H; Lalonde, E; Nishimura, T; Sasarman, F; Brown, GK; Brown, RM; Majewski, J; Shoubridge, EA				Janer, Alexandre; Antonicka, Hana; Lalonde, Emilie; Nishimura, Tamiko; Sasarman, Florin; Brown, Garry K.; Brown, Ruth M.; Majewski, Jacek; Shoubridge, Eric A.			An RMND1 Mutation Causes Encephalopathy Associated with Multiple Oxidative Phosphorylation Complex Deficiencies and a Mitochondrial Translation Defect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; RIBOSOMAL-SUBUNIT; REGULATES TRANSLATION; LEIGH-SYNDROME; BIOGENESIS; RNA; EXPRESSION; DISEASE; C7ORF30; ERAL1	Mutations in the genes composing the mitochondrial translation apparatus are an important cause of a heterogeneous group of oxidative phosphorylation (OXPHOS) disorders. We studied the index case in a consanguineous family in which two children presented with severe encephalopathy, lactic acidosis, and intractable seizures leading to an early fatal outcome. Blue native polyacrylamide gel electrophoretic (BN-PAGE) analysis showed assembly defects in all of the OXPHOS complexes with mtDNA-encoded structural subunits, and these defects were associated with a severe deficiency in mitochondrial translation. Immunoblot analysis showed reductions in the steady-state levels of several structural subunits of the mitochondrial ribosome. Whole-exome sequencing identified a homozygous missense mutation (c.1250G>A) in an uncharacterized gene, RMND1 (required for meiotic nuclear division 1). RMND1 localizes to mitochondria and behaves as an integral membrane protein. Retroviral expression of the wild-type RMND1 cDNA rescued the biochemical phenotype in subject cells, and siRNA-mediated knockdown of the protein recapitulated the defect. BN-PAGE, gel filtration, and mass spectrometry analyses showed that RMND1 forms a high-molecular-weight and most likely homopolymeric complex (similar to 240 kDa) that does not assemble in subject fibroblasts but that is rescued by expression of RMND1 cDNA. The p.Arg417Gln substitution, predicted to be in a coiled-coil domain, which is juxtaposed to a transmembrane domain at the extreme C terminus of the protein, does not alter the steady-state level of RMND1 but might prevent protein-protein interactions in this complex. Our results demonstrate that the RMND1 complex is necessary for mitochondrial translation, possibly by coordinating the assembly or maintenance of the mitochondrial ribosome.	[Janer, Alexandre; Lalonde, Emilie; Majewski, Jacek; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Janer, Alexandre; Antonicka, Hana; Nishimura, Tamiko; Sasarman, Florin; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Brown, Garry K.; Brown, Ruth M.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	McGill University; McGill University; University of Oxford	Shoubridge, EA (corresponding author), McGill Univ, Dept Human Genet, 1205 Penfield Ave, Montreal, PQ H3A 1B1, Canada.	eric@ericpc.mni.mcgill.ca	janer, alexandre/AAV-3192-2021	Lalonde, Emilie/0000-0002-8573-1966; Antonicka, Hana/0000-0002-2525-2867	Canadian Institutes of Health Research (CIHR); Reseau de Medecine Genetique Appliquee; Canada Research Chair	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau de Medecine Genetique Appliquee; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported in part by Canadian Institutes of Health Research (CIHR) grants to E.A.S. and J.M. E.L. was supported by a CIHR fellowship. A.J. is supported by a post-doctoral fellowship from the Reseau de Medecine Genetique Appliquee. E.A.S. is an International Scholar of the Howard Hughes Medical Institute. J.M. is a recipient of a Canada Research Chair. The authors wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre (Montreal, Canada). We thank T. Johns and S. Salomon for technical assistance.	Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Barrientos A, 2003, MOL BIOL CELL, V14, P2292, DOI 10.1091/mbc.E02-10-0636; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cerna D, 2005, J MOL BIOL, V351, P923, DOI 10.1016/j.jmb.2005.06.025; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Rorbach J, 2012, NUCLEIC ACIDS RES, V40, P4097, DOI 10.1093/nar/gkr1282; Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Uchiumi T, 2010, NUCLEIC ACIDS RES, V38, P5554, DOI 10.1093/nar/gkq305; Wanschers BFJ, 2012, NUCLEIC ACIDS RES, V40, P4040, DOI 10.1093/nar/gkr1271; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	29	46	47	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					737	743		10.1016/j.ajhg.2012.08.020	http://dx.doi.org/10.1016/j.ajhg.2012.08.020			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23022098	Green Published, Bronze			2022-12-18	WOS:000309568500016
J	Ramocki, MB; Bartnik, M; Szafranski, P; Kolodziejska, KE; Xia, ZL; Bravo, J; Miller, GS; Rodriguez, DL; Williams, CA; Bader, PI; Szczepanik, E; Mazurczak, T; Antczak-Marach, D; Coldwell, JG; Akman, CI; McAlmon, K; Cohen, MP; McGrath, J; Roeder, E; Mueller, J; Kang, SHL; Bacino, CA; Patel, A; Bocian, E; Shaw, CA; Cheung, SW; Mazurczak, T; Stankiewicz, P				Ramocki, Melissa B.; Bartnik, Magdalena; Szafranski, Przemyslaw; Kolodziejska, Katarzyna E.; Xia, Zhilian; Bravo, Jaclyn; Miller, G. Steve; Rodriguez, Diana L.; Williams, Charles A.; Bader, Patricia I.; Szczepanik, Elzbieta; Mazurczak, Tomasz; Antczak-Marach, Dorota; Coldwell, James G.; Akman, Cigdem I.; McAlmon, Karen; Cohen, Melinda P.; McGrath, James; Roeder, Elizabeth; Mueller, Jennifer; Kang, Sung-Hae L.; Bacino, Carlos A.; Patel, Ankita; Bocian, Ewa; Shaw, Chad A.; Cheung, Sau Wai; Mazurczak, Tadeusz; Stankiewicz, Pawel			Recurrent Distal 7q11.23 Deletion Including HIP1 and YWHAG Identified in Patients with Intellectual Disabilities, Epilepsy, and Neurobehavioral Problems	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTIN-INTERACTING PROTEIN-1; WILLIAMS-BEUREN-SYNDROME; INFANTILE SPASMS; COPY-NUMBER; MENTAL-RETARDATION; HUMAN GENOME; MEDIATED ENDOCYTOSIS; STRUCTURAL VARIATION; AMPA RECEPTORS; MICRODELETION	We report 26 individuals from ten unrelated families who exhibit variable expression and/or incomplete penetrance of epilepsy, learning difficulties, intellectual disabilities, and/or neurobehavioral abnormalities as a result of a heterozygous microdeletion distally adjacent to the Williams-Beuren syndrome region on chromosome 7q11.23. In six families with a common recurrent similar to 1.2 Mb deletion that includes the Huntingtin-interacting protein 1 (HIP1) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma (YWHAG) genes and that is flanked by large complex low-copy repeats, we identified sites for nonallelic homologous recombination in two patients. There were no cases of this similar to 1.2 Mb distal 7q11.23 deletion copy number variant identified in over 20,000 control samples surveyed. Three individuals with smaller, nonrecurrent deletions (-180-500 kb) that include HIPI but not YWHAG suggest that deletion of HIP1 is sufficient to cause neurological disease. Mice with targeted mutation in the Hip1 gene (Hip1(-/-)) develop a neurological phenotype characterized by failure to thrive, tremor, and gait ataxia. Overall, our data characterize a neurodevelopmental and epilepsy syndrome that is likely caused by recurrent and nonrecurrent deletions, including HIP1. These data do not exclude the possibility that YWHAG loss of function is also sufficient to cause neurological phenotypes. Based on the current knowledge of Hip1 protein function and its proposed role in AMPA and NMDA ionotropic glutamate receptor trafficking, we believe that HIP1 haploinsufficiency in humans will be amenable to rational drug design for improved seizure control and cognitive and behavioral function.	[Bartnik, Magdalena; Bocian, Ewa; Mazurczak, Tadeusz; Stankiewicz, Pawel] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Ramocki, Melissa B.; Rodriguez, Diana L.; Akman, Cigdem I.] Baylor Coll Med, Dept Pediat, Sect Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA; [Ramocki, Melissa B.; Rodriguez, Diana L.; Akman, Cigdem I.] Texas Childrens Hosp, Houston, TX 77030 USA; [Szafranski, Przemyslaw; Kolodziejska, Katarzyna E.; Xia, Zhilian; Bravo, Jaclyn; Kang, Sung-Hae L.; Bacino, Carlos A.; Patel, Ankita; Shaw, Chad A.; Cheung, Sau Wai; Mazurczak, Tadeusz; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Miller, G. Steve; Coldwell, James G.] Childrens Med Ctr Hillcrest, Tulsa, OK 74104 USA; [Miller, G. Steve] Univ Oklahoma, Tulsa, OK 74135 USA; [Williams, Charles A.; Mueller, Jennifer] Univ Florida, Coll Med, Dept Pediat, Div Genet & Metab,Raymond C Philips Res & Educ Un, Gainesville, FL 32611 USA; [Bader, Patricia I.] NE Indiana Genet Counseling Ctr, Ft Wayne, IN 46845 USA; [Szczepanik, Elzbieta; Mazurczak, Tomasz; Antczak-Marach, Dorota] Inst Mother & Child Hlth, Clin Neurol Children & Adolescents, PL-01211 Warsaw, Poland; [McAlmon, Karen] Childrens Hosp Boston, Boston, MA 02115 USA; [McAlmon, Karen] Harvard Univ, Sch Med, Boston, MA 02115 USA; [McAlmon, Karen] Winchester Hosp, Winchester, MA 01890 USA; [Cohen, Melinda P.] Vanderbilt Univ, Div Med Genet & Genom Med, Nashville, TN 37232 USA; [McGrath, James] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [McGrath, James] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Roeder, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Genet & Metab Disorders, San Antonio, TX 78229 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Oklahoma System; University of Oklahoma - Tulsa; State University System of Florida; University of Florida; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Yale University; Yale University; University of Texas System; University of Texas Health San Antonio	Stankiewicz, P (corresponding author), Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland.	pawels@bcm.edu	Stankiewicz, Paweł/AAP-7906-2021; Patel, Ankita/D-3247-2013; Szczepanik, Elżbieta/X-6617-2018	Stankiewicz, Paweł/0000-0002-6456-7490; Szczepanik, Elżbieta/0000-0001-9942-8522; Bartnik-Glaska, Magdalena/0000-0002-9533-3494; Shaw, Chad/0000-0001-7267-5398	Polish Ministry of Science and Higher Education [R13-0005-04/2008]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [5K08NS062711-03]; National Institute of General Medical Sciences [T32GM008307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS062711] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank all of the families who participated in this study. We thank B.A. Bejjani, J. Belmont, J.R. Lupski, D.L. Nelson, and S.K. Prakash for helpful discussion, as well as P. Hixson, J. Bratic, and M. Bedell for technical assistance. P.S. was supported in part by grant R13-0005-04/2008 from the Polish Ministry of Science and Higher Education. M.B.R. is grateful for the support of grant 5K08NS062711-03 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke. J.B. was supported by grant T32GM008307 from the National Institute of General Medical Sciences. Some authors are based in the Department of Molecular and Human Genetics at Baylor College of Medicine, which offers extensive genetic laboratory testing, including use of arrays for genomic copy number analysis, and which derives revenue from this activity. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagshaw ATM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-179; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Ferland RJ, 2006, AM J MED GENET A, V140A, P1305, DOI 10.1002/ajmg.a.31259; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Komoike Y, 2010, GENESIS, V48, P233, DOI 10.1002/dvg.20607; Kurotaki N, 2005, GENET MED, V7, P479, DOI 10.1097/01.GIM.0000177419.43309.37; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Marshall CR, 2008, AM J HUM GENET, V83, P106, DOI 10.1016/j.ajhg.2008.06.001; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Metzler M, 2007, J NEUROSCI, V27, P2298, DOI 10.1523/JNEUROSCI.5175-06.2007; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Mizugishi K, 1998, J HUM GENET, V43, P178, DOI 10.1007/s100380050064; Morimoto M, 2003, EPILEPSIA, V44, P1459, DOI 10.1046/j.1528-1157.2003.34703.x; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Oravecz-Wilson KI, 2004, HUM MOL GENET, V13, P851, DOI 10.1093/hmg/ddh102; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Parker JA, 2007, J NEUROSCI, V27, P11056, DOI 10.1523/JNEUROSCI.1941-07.2007; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Rao DS, 2001, MOL CELL BIOL, V21, P7796, DOI 10.1128/MCB.21.22.7796-7806.2001; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rothlisberger B, 2010, AM J MED GENET A, V152A, P434, DOI 10.1002/ajmg.a.33220; Ross TS, 1998, BLOOD, V91, P4419, DOI 10.1182/blood.V91.12.4419.412k43_4419_4426; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Stock AD, 2003, AM J MED GENET A, V120A, P320, DOI 10.1002/ajmg.a.20055; Tercero MFB, 2005, AM J MED GENET A, V133A, P213, DOI 10.1002/ajmg.a.30486; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Waelter S, 2001, HUM MOL GENET, V10, P1807, DOI 10.1093/hmg/10.17.1807; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Wu YQ, 1999, J MED GENET, V36, P928	49	46	49	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					857	865		10.1016/j.ajhg.2010.10.019	http://dx.doi.org/10.1016/j.ajhg.2010.10.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21109226	Green Published, Bronze			2022-12-18	WOS:000285564600013
J	Regier, DA; Friedman, JM; Marra, CA				Regier, Dean A.; Friedman, Jan M.; Marra, Carlo A.			Value for Money? Array Genomic Hybridization for Diagnostic Testing for Genetic Causes of Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC MENTAL-RETARDATION; MULTIPLE CONGENITAL-ANOMALIES; DEVELOPMENTAL DELAY; CLINICAL UTILITY; CHROMOSOMAL-ABNORMALITIES; AFFECTED CHILDREN; CGH; INDIVIDUALS; REARRANGEMENTS; IMBALANCES	Array genomic hybridization (AGH) provides a higher detection rate than does conventional cytogenetic testing when searching for chromosomal imbalance causing intellectual disability (ID). AGH is more costly than conventional cytogenetic testing, and it remains unclear whether AGH provides good value for money. Decision analytic modeling was used to evaluate the trade-off between costs, clinical effectiveness, and benefit of an AGH testing strategy compared to a conventional testing strategy The trade-off between cost and effectiveness was expressed via the incremental cost-effectiveness ratio. Probabilistic sensitivity analysis was performed via Monte Carlo simulation. The baseline AGH testing strategy led to an average cost increase of $217 (95% CI $172-$261) per patient and an additional 8.2 diagnoses in every 100 tested (0.082; 95% CI 0.044-0.119). The mean incremental cost per additional diagnosis was $2646 (95% CI $1619-55296). Probabilistic sensitivity analysis demonstrated that there was a 95% probability that AGH would be cost effective if decision makers were willing to pay $4550 for an additional diagnosis. Our model suggests that using AGH instead of conventional karyotyping for most ID patients provides good value for money. Deterministic sensitivity analysis found that employing AGH after first-line cytogenetic testing had proven uninformative did not provide good value for money when compared to using AGH as first-line testing.	[Regier, Dean A.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Regier, Dean A.] Univ Oxford Somerville Coll, Oxford OX2 6HD, England; [Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Marra, Carlo A.] Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada	University of Oxford; University of Oxford; University of British Columbia; University of British Columbia	Regier, DA (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	dean.regier@sickkids.ca	Marra, Carlo/AAE-4904-2021	Marra, Carlo/0000-0002-2625-2121; Friedman, Jan/0000-0002-7482-9570; Regier, Dean/0000-0001-8876-0511	Genome Canada; Genome British Columbia; Canadian Foundation for Innovation; Canadian Institutes for Health Research; Canada Research Chair in Pharmaceutical Outcomes; Michael Smith Foundation	Genome Canada(Genome Canada); Genome British Columbia; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Pharmaceutical Outcomes(Canada Research Chairs); Michael Smith Foundation(Michael Smith Foundation for Health Research)	This study was supported by funding from Genome Canada, Genome British Columbia, and the Canadian Foundation for Innovation. D.A.R. was supported by a Canadian Institutes for Health Research Doctoral Research Award (Institute of Genetics). C.A.M. is supported by a Canada Research Chair in Pharmaceutical Outcomes and a Michael Smith Foundation for Health Research Scholar Award. The authors would like to thank Nancy Make la for assistance for collecting the data used in the chart review. There is no conflict of interest regarding the funding of the work represented in this manuscript.	Bejjani BA, 2008, ANNU REV GENOM HUM G, V9, P71, DOI 10.1146/annurev.genom.9.081307.164207; Briggs A., 2006, DECISION MODELLING H; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Crow YJ, 1998, J MED GENET, V35, P177, DOI 10.1136/jmg.35.3.177; De Civita M, 2005, PHARMACOECONOMICS, V23, P659, DOI 10.2165/00019053-200523070-00003; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Drummond MF, 1997, METHODS EC EVALUATIO; Edelmann L, 2009, ANN NY ACAD SCI, V1151, P157, DOI 10.1111/j.1749-6632.2008.03610.x; Foster MW, 2009, GENET MED, V11, P570, DOI 10.1097/GIM.0b013e3181a2743e; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Grosse SD, 2009, GENET MED, V11, P575, DOI 10.1097/GIM.0b013e3181af0a80; Krepischi-Santos ACV, 2006, CYTOGENET GENOME RES, V115, P254, DOI 10.1159/000095922; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Liang Jao-Shwann, 2008, Pediatrics and Neonatology, V49, P213, DOI 10.1016/S1875-9572(09)60013-9; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Miyake N, 2006, AM J MED GENET A, V140A, P205, DOI 10.1002/ajmg.a.31098; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Regier DA, 2009, CLIN GENET, V75, P514, DOI 10.1111/j.1399-0004.2009.01193.x; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Schoumans J, 2005, J MED GENET, V42, P699, DOI 10.1136/jmg.2004.029637; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Subramonia-Iyer S, 2007, GENET MED, V9, P74, DOI 10.1097/GIM.0b013e31803141f2; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; van Karnebeek CDM, 2005, EUR J HUM GENET, V13, P6, DOI 10.1038/sj.ejhg.5201279; van Karnebeek CDM, 2002, J MED GENET, V39, P546, DOI 10.1136/jmg.39.8.546; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Zahir F, 2007, CLIN GENET, V72, P271, DOI 10.1111/j.1399-0004.2007.00847.x	30	46	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					765	772		10.1016/j.ajhg.2010.03.009	http://dx.doi.org/10.1016/j.ajhg.2010.03.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20398885	Bronze, Green Published			2022-12-18	WOS:000278045300012
J	Mei, H; Cuccaro, ML; Martin, ER				Mei, H.; Cuccaro, M. L.; Martin, E. R.			Multifactor dimensionality reduction-phenomics: A novel method to capture genetic heterogeneity with use of phenotypic variables	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FALSE DISCOVERY RATE; SEROTONIN TRANSPORTER GENE; LOGISTIC-REGRESSION; COMPLEX DISEASE; SIMULATED DATA; HAPLOTYPE MAP; HUMAN GENOME; ASSOCIATION; AUTISM; MODELS	Complex human diseases do not have a clear inheritance pattern, and it is expected that risk involves multiple genes with modest effects acting independently or interacting. Major challenges for the identification of genetic effects are genetic heterogeneity and difficulty in analyzing high-order interactions. To address these challenges, we present MDR-Phenomics, a novel approach based on the multifactor dimensionality reduction (MDR) method, to detect genetic effects in pedigree data by integration of phenotypic covariates (PCs) that may reflect genetic heterogeneity. The P value of the test is calculated using a permutation test adjusted for multiple tests. To validate MDR-Phenomics, we compared it with two MDR-based methods: (1) traditional MDR pedigree disequilibrium test (PDT) without consideration of PCs (MDR-PDT) and (2) stratified phenotype (SP) analysis based on PCs, with use of MDR-PDT with a Bonferroni adjustment (SP-MDR). Using computer simulations, we examined the statistical power and type I error of the different approaches under several genetic models and sampling scenarios. We conclude that MDR-Phenomics is more powerful than MDR-PDT and SP-MDR when there is genetic heterogeneity, and the statistical power is affected by sample size and the number of PC levels. We further compared MDR-Phenomics with conditional logistic regression (CLR) for testing interactions across single or multiple loci with consideration of PC. The results show that CLR with PC has only slightly smaller power than does MDR-Phenomics for single-locus analysis but has considerably smaller power for multiple loci. Finally, by applying MDR-Phenomics to autism, a complex disease in which multiple genes are believed to confer risk, we attempted to identify multiple gene effects in two candidate genes of interest - the serotonin transporter gene (SLC6A4) and the integrin beta 3 gene (ITGB3) on chromosome 17. Analyzing four markers in SLC6A4 and four markers in ITGB3 in 117 white family triads with autism and using sex of the proband as a PC, we found significant interaction between two markers - rs1042173 in SLC6A4 and rs3809865 in ITGB3.	Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33101 USA; N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA	University of Miami; University of North Carolina; North Carolina State University	Martin, ER (corresponding author), Univ Miami, Miller Sch Med, Miami Inst Human Genom, POB 019132 M-860, Miami, FL 33101 USA.	emartin1@med.miami.edu			NIA NIH HHS [R01 AG020135, R01 AG20135] Funding Source: Medline; NINDS NIH HHS [NS26630, R01 NS036768, NS36768, P01 NS026630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036768, P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baron M, 2001, MOL PSYCHIATR, V6, P143, DOI 10.1038/sj.mp.4000845; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Coffey CS, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-49; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hahn Lance W, 2004, In Silico Biol, V4, P183; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Harley JB, 1995, GENET EPIDEMIOL, V12, P607, DOI 10.1002/gepi.1370120614; Hastie T., 2001, ELEMENT STAT LEARNIN; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Liao JG, 2004, BIOINFORMATICS, V20, P2694, DOI 10.1093/bioinformatics/bth310; Maestri NE, 1997, AM J MED GENET, V73, P337, DOI 10.1002/(SICI)1096-8628(19971219)73:3<337::AID-AJMG21>3.0.CO;2-J; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; Mei H, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S145; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Olivier M, 2003, PHYSIOL GENOMICS, V13, P3, DOI 10.1152/physiolgenomics.00178.2002; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Ramoz N, 2006, BIOL PSYCHIAT, V60, P186, DOI 10.1016/j.biopsych.2006.01.009; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Schmidt M, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1133; Singleton A, 2003, CLIN AUTON RES, V13, P88, DOI 10.1007/s10286-003-0091-9; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Weir B., 1996, GENETIC DATA ANAL; Weiss LA, 2006, HUM GENET, V120, P93, DOI 10.1007/s00439-006-0196-z; Zhang K, 2005, BIOINFORMATICS, V21, P131, DOI 10.1093/bioinformatics/bth482	41	46	46	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1251	1261		10.1086/522307	http://dx.doi.org/10.1086/522307			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999363	Green Published, Bronze			2022-12-18	WOS:000251098800010
J	Steinmann, K; Cooper, DN; Kluwe, L; Chuzhanova, NA; Senger, C; Serra, E; Lazaro, C; Gilaberte, M; Wimmer, K; Mautner, VF; Kehrer-Sawatzki, H				Steinmann, Katharina; Cooper, David N.; Kluwe, Lan; Chuzhanova, Nadia A.; Senger, Cornelia; Serra, Eduard; Lazaro, Conxi; Gilaberte, Montserrat; Wimmer, Katharina; Mautner, Viktor-Felix; Kehrer-Sawatzki, Hildegard			Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR REGION; HUMAN INHERITED DISEASE; B DNA CONFORMATIONS; NEUROFIBROMATOSIS TYPE-1; INTRACHROMOSOMAL RECOMBINATION; GENOMIC REARRANGEMENTS; MEIOTIC RECOMBINATION; V(D)J RECOMBINATION; MOLECULAR ANALYSIS; SOMATIC MOSAICISM	Approximately 5% of patients with neurofibromatosis type 1 (NF1) exhibit gross deletions that encompass the NF1 gene and its flanking regions. The breakpoints of the common 1.4-Mb (type 1) deletions are located within low-copy repeats (NF1-REPs) and cluster within a 3.4-kb hotspot of nonallelic homologous recombination (NAHR). Here, we present the first comprehensive breakpoint analysis of type 2 deletions, which are a second type of recurring NF1 gene deletion. Type 2 deletions span 1.2 Mb and are characterized by breakpoints located within the SUZ12 gene and its pseudogene, which closely flank the NF1-REPs. Breakpoint analysis of 13 independent type 2 deletions did not reveal any obvious hotspots of NAHR. However, an overrepresentation of polypyrimidine/polypurine tracts and triplex-forming sequences was noted in the breakpoint regions that could have facilitated NAHR. Intriguingly, all 13 type 2 deletions identified so far are characterized by somatic mosaicism, which indicates a positional preference for mitotic NAHR within the NF1 gene region. Indeed, whereas interchromosomal meiotic NAHR occurs between the NF1-REPs giving rise to type I deletions, NAHR during mitosis appears to occur intrachromosomally between the SUZ12 gene and its pseudogene, thereby generating type 2 deletions. Such a clear distinction between the preferred sites of mitotic versus meiotic NAHR is unprecedented in any other genomic disorder induced by the local genomic architecture. Additionally, 12 of the 13 mosaic type 2 deletions were found in females. The marked female preponderance among mosaic type 2 deletions contrasts with the equal sex distribution noted for type 1 and/or atypical NF1 deletions. Although an influence of chromatin structure was strongly suspected, no sex-specific differences in the methylation pattern exhibited by the SUZ12 gene were apparent that could explain the higher rate of mitotic recombination in females.	Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; Cardiff Univ, Sch Med, Inst Med Genet, Cardiff, Wales; Univ Hosp Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; Univ Cent Lancashire, Dept Biol Sci, Preston, Lancs, England; Med Univ Vienna, Dept Med Genet, Vienna, Austria	Ulm University; Cardiff University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Central Lancashire; Medical University of Vienna	Kehrer-Sawatzki, H (corresponding author), Univ Ulm, Inst Human Genet, Albert Einstein Allee 11, D-89081 Ulm, Germany.	hildegard.kehrer-sawatzki@uni-ulm.de	GARCIA, CONXI LAZARO/Q-2410-2016; Cooper, David N/H-4384-2011; Serra, Eduard/K-1332-2013	GARCIA, CONXI LAZARO/0000-0002-7198-5906; Cooper, David N/0000-0002-8943-8484; Serra, Eduard/0000-0003-2895-9857; Chuzhanova, Nadia/0000-0002-4655-3618				Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Calabrese P, 2007, P NATL ACAD SCI USA, V104, P4748, DOI 10.1073/pnas.0610195104; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Chuzhanova N, 2003, HUM MUTAT, V22, P245, DOI 10.1002/humu.10253; Chuzhanova NA, 2002, EVOLUTION, V56, P224; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; de la Cruz CC, 2007, CHROMOSOME RES, V15, P2007, DOI 10.1007/s10577-007-1126-1; De Raedt T, 2004, GENOMICS, V84, P346, DOI 10.1016/j.ygeno.2004.03.006; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; De Raedt T, 2006, GENE CHROMOSOME CANC, V45, P893, DOI 10.1002/gcc.20353; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; ENGLER P, 1993, MOL CELL BIOL, V13, P571, DOI 10.1128/MCB.13.1.571; Espinoza CR, 2007, MOL IMMUNOL, V44, P2675, DOI 10.1016/j.molimm.2006.12.002; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Forbes SH, 2004, GENE CHROMOSOME CANC, V41, P12, DOI 10.1002/gcc.20065; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gusev VD, 1999, BIOINFORMATICS, V15, P994; Holt D, 1999, AM J HUM GENET, V65, P1423, DOI 10.1086/302614; Hrzenjak A, 2005, J MOL DIAGN, V7, P388, DOI 10.1016/S1525-1578(10)60568-5; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Jenne DE, 2003, GENE CHROMOSOME CANC, V37, P111, DOI 10.1002/gcc.10206; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; KARLIN S, 1991, J AM STAT ASSOC, V86, P27, DOI 10.2307/2289712; KAYES LM, 1994, AM J HUM GENET, V54, P424; KAYES LM, 1992, J MED GENET, V29, P686, DOI 10.1136/jmg.29.10.686; Kehrer-Sawatzki H, 2005, HUM GENET, V116, P466, DOI 10.1007/s00439-005-1265-4; Kehrer-Sawatzki H, 2004, AM J HUM GENET, V75, P410, DOI 10.1086/423624; Kehrer-Sawatzki H, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e116; Kluwe L, 2004, HUM MUTAT, V23, P111, DOI 10.1002/humu.10299; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; Li WT, 1998, HUM HERED, V48, P266, DOI 10.1159/000022814; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; Mantripragada KK, 2006, J MED GENET, V43, P28, DOI 10.1136/jmg.2005.033795; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Micci F, 2006, CANCER RES, V66, P107, DOI 10.1158/0008-5472.CAN-05-2485; Nucci MR, 2007, AM J SURG PATHOL, V31, P65, DOI 10.1097/01.pas.0000213327.86992.d1; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petek E, 2003, J MED GENET, V40, P520, DOI 10.1136/jmg.40.7.520; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Riva P, 2000, AM J HUM GENET, V66, P100, DOI 10.1086/302709; Rizwana R, 1999, J CELL SCI, V112, P4513; Sato K, 2007, VIRCHOWS ARCH, V450, P349, DOI 10.1007/s00428-006-0345-8; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Spiegel M, 2005, EUR J HUM GENET, V13, P883, DOI 10.1038/sj.ejhg.5201419; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Uddin RK, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-18; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; van der Maarel SM, 2000, AM J HUM GENET, V66, P26, DOI 10.1086/302730; Venturin M, 2004, HUM GENET, V115, P69, DOI 10.1007/s00439-004-1101-2; Visser R, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.034355; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	80	46	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1201	1220		10.1086/522089	http://dx.doi.org/10.1086/522089			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999360	Bronze, Green Published			2022-12-18	WOS:000251098800007
J	Narkis, G; Ofir, R; Manor, E; Landau, D; Elbedour, K; Birk, OS				Narkis, Ginat; Ofir, Rivka; Manor, Esther; Landau, Daniella; Elbedour, Khalil; Birk, Ohad S.			Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR; FAMILY; VPS33B; ACTIVATION; 3-KINASE; KINASES	Lethal congenital contractural syndrome type 2 (LCCS2) is an autosomal recessive neurogenic form of arthrogryposis that is associated with atrophy of the anterior horn of the spinal cord. We previously mapped LCCS2 to 6.4 Mb on chromosome 12q13 and have now narrowed the locus to 4.6 Mb. We show that the disease is caused by aberrant splicing of ERBB3, which leads to a predicted truncated protein. ERBB3 (Her3), an activator of the phosphatidylinositol-3-kinase/Akt pathway-regulating cell survival and vesicle trafficking-is essential for the generation of precursors of Schwann cells that normally accompany peripheral axons of motor neurons. Gain-of-function mutations in members of the epidermal growth-factor tyrosine kinase-receptor family have been associated with predilection to cancer. This is the first report of a human phenotype resulting from loss of function of a member of this group.	Soroka Univ Med Ctr, Inst Genet, IL-84101 Beer Sheva, Israel; NIBN, Morris Khan Lab Human Genet, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University	Birk, OS (corresponding author), Soroka Univ Med Ctr, Inst Genet, POB 151, IL-84101 Beer Sheva, Israel.	obirk@bgu.ac.il		Birk, Ohad/0000-0003-1430-1296				Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; Carim L, 2000, CYTOGENET CELL GENET, V89, P92, DOI 10.1159/000015571; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Landau D, 2003, AM J MED GENET A, V117A, P37, DOI 10.1002/ajmg.a.10894; Lee H, 2001, CANCER RES, V61, P4467; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Lo B, 2005, BLOOD, V106, P4159, DOI 10.1182/blood-2005-04-1356; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Narkis G, 2004, AM J MED GENET A, V130A, P272, DOI 10.1002/ajmg.a.30266; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535	18	46	48	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					589	595		10.1086/520770	http://dx.doi.org/10.1086/520770			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701904	Green Published, Bronze			2022-12-18	WOS:000249128200015
J	Hiller, M; Huse, K; Szafranski, K; Jahn, N; Hampe, J; Schreiber, S; Backofen, R; Platzer, M				Hiller, M; Huse, K; Szafranski, K; Jahn, N; Hampe, J; Schreiber, S; Backofen, R; Platzer, M			Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; MUTATIONS; PROTEIN; GENE; SEQUENCE; DISEASE; DUPLICATIONS; LOCALIZATION; VARIANTS; NONSENSE	Aberrant or modified splicing patterns of genes are causative for many human diseases. Therefore, the identification of genetic variations that cause changes in the splicing pattern of a gene is important. Elsewhere, we described the widespread occurrence of alternative splicing at NAGNAG acceptors. Here, we report a genomewide screen for single-nucleotide polymorphisms ( SNPs) that affect such tandem acceptors. From 121 SNPs identified, we extracted 64 SNPs that most likely affect alternative NAGNAG splicing. We demonstrate that the NAGNAG motif is necessary and sufficient for this type of alternative splicing. The evolutionarily young NAGNAG alleles, as determined by the comparison with the chimpanzee genome, exhibit the same biases toward intron phase 1 and single-amino acid insertion/deletions that were already observed for all human NAGNAG acceptors. Since 28% of the NAGNAG SNPs occur in known disease genes, they represent preferable candidates for a more-detailed functional analysis, especially since the splice relevance for some of the coding SNPs is overlooked. Against the background of a general lack of methods for identifying splice-relevant SNPs, the presented approach is highly effective in the prediction of polymorphisms that are causal for variations in alternative splicing.	Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; Univ Jena, Inst Comp Sci, Chair Bioinformat, D-6900 Jena, Germany; Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; University of Kiel	Platzer, M (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	mplatzer@fli-leibniz.de	Hampe, Jochen/A-2555-2010	Hampe, Jochen/0000-0002-2421-6127; Huse, Klaus/0000-0003-3854-1884; Backofen, Rolf/0000-0001-8231-3323				Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chen YZ, 2004, APOPTOSIS, V9, P415, DOI 10.1023/B:APPT.0000031447.05354.9f; CONDORELLI G, 1994, J BIOL CHEM, V269, P8510; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; Karinch AM, 1997, BIOCHEM J, V321, P39, DOI 10.1042/bj3210039; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Xu ZH, 2002, PHARMACOGENETICS, V12, P11, DOI 10.1097/00008571-200201000-00003	25	46	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					291	302		10.1086/500151	http://dx.doi.org/10.1086/500151			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400609	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000236744900010
J	Jorgenson, E; Tang, H; Gadde, M; Province, M; Leppert, M; Kardia, S; Schork, N; Cooper, R; Rao, DC; Boerwinkle, E; Risch, N				Jorgenson, E; Tang, H; Gadde, M; Province, M; Leppert, M; Kardia, S; Schork, N; Cooper, R; Rao, DC; Boerwinkle, E; Risch, N			Ethnicity and human genetic linkage maps	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIOTIC RECOMBINATION; POLYMORPHISM; INVERSION; PATTERNS	Human genetic linkage maps are based on rates of recombination across the genome. These rates in humans vary by the sex of the parent from whom alleles are inherited, by chromosomal position, and by genomic features, such as GC content and repeat density. We have examined-for the first time, to our knowledge-racial/ethnic differences in genetic maps of humans. We constructed genetic maps based on 353 microsatellite markers in four racial/ethnic groups: whites, African Americans, Mexican Americans, and East Asians (Chinese and Japanese). These maps were generated using 9,291 subjects from 2,900 nuclear families who participated in the National Heart, Lung, and Blood Institute-funded Family Blood Pressure Program, the largest sample used for map construction to date. Although the maps for the different groups are generally similar, we did find regional and genomewide differences across ethnic groups, including a longer genomewide map for African Americans than for other populations. Some of this variation was explained by genotyping artifacts-namely, null alleles (i.e., alleles with null phenotypes) at a number of loci-and by ethnic differences in null-allele frequencies. In particular, null alleles appear to be the likely explanation for the excess map length in African Americans. We also found that nonrandom missing data biases map results. However, we found regions on chromosome 8p and telomeric segments with significant ethnic differences and a suggestive interval on chromosome 12q that were not due to genotype artifacts. The difference on chromosome 8p is likely due to a polymorphic inversion in the region. The results of our investigation have implications for inferences of possible genetic influences on human recombination as well as for future linkage studies, especially those involving populations of nonwhite ethnicity.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ Utah, Salt Lake City, UT USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; Loyola Univ, Med Ctr, Chicago, IL 60611 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Kaiser Permanente, Div Res, Oakland, CA USA	University of California System; University of California San Francisco; Stanford University; Fred Hutchinson Cancer Center; Washington University (WUSTL); Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Loyola University Chicago; University of Texas System; University of Texas Health Science Center Houston; Kaiser Permanente	Jorgenson, E (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Box 0560, San Francisco, CA 94143 USA.	jorg@itsa.ucsf.edu		Schork, Nicholas/0000-0003-0920-5013				Boerwinkle E, 2002, HYPERTENSION, V39, P3; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 2003, INST MATH S, V40, P237; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Catcheside D.G., 1977, GENETICS RECOMBINATI; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Little R.J., 2002, STAT ANAL MISSING DA, P3; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; ZAHN LM, 1995, GENOMICS, V28, P140, DOI 10.1006/geno.1995.1124	19	46	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					276	290		10.1086/427926	http://dx.doi.org/10.1086/427926			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15627237	Bronze, Green Published			2022-12-18	WOS:000226215100013
J	Kunkel, LM				Kunkel, LM			2004 William Allen Award address - Cloning of the DMD gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DUCHENNE MUSCULAR-DYSTROPHY; HUMAN X-CHROMOSOME; CLONED DNA-SEQUENCES; MDX MOUSE; MYOBLAST TRANSPLANTATION; GLYCOPROTEIN COMPLEX; SYSTEMIC DELIVERY; BETA-SARCOGLYCAN; SKELETAL-MUSCLE; SHORT ARM		Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Kunkel, LM (corresponding author), Childrens Hosp, Div Genet, Enders 570,300 Longwood Ave, Boston, MA 02115 USA.	kunkel@enders.tch.harvard.edu						ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; BAKKER E, 1985, LANCET, V1, P655; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BEGGS AH, 1990, HUM GENET, V86, P45; BENNETT RR, 2004, ASHG 54 ANN M AM SOC, P279; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER M, 1986, NATURE, V324, P582, DOI 10.1038/324582a0; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176; FRANCKE U, 1985, AM J HUM GENET, V37, P250; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504; KARPATI G, 1993, ANN NEUROL, V34, P8, DOI 10.1002/ana.410340105; KINGSTON HM, 1984, HUM GENET, V67, P6, DOI 10.1007/BF00270551; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Othmane Kamel Ben, 1992, Nature Genetics, V2, P315; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; RAY PN, 1985, NATURE, V318, P19; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; VERELLENDUMOULIN C, 1984, HUM GENET, V67, P115, DOI 10.1007/BF00270570; WOOD DS, 1987, NEW ENGL J MED, V316, P107; WORTON RG, 1984, SCIENCE, V224, P1447, DOI 10.1126/science.6729462; YAMAMOTO H, 1993, J BIOCHEM-TOKYO, V114, P132, DOI 10.1093/oxfordjournals.jbchem.a124128; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	58	46	47	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					205	214		10.1086/428143	http://dx.doi.org/10.1086/428143			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15714686	Green Published, Bronze			2022-12-18	WOS:000226215100003
J	Weatherall, D				Weatherall, D			2003 William Allan Award address - The thalassemias: The role of molecular genetics in an evolving global health problem	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							TRANSCRIPTIONAL REGULATOR ATRX; MENTAL-RETARDATION SYNDROMES; HEMOGLOBIN-H DISEASE; ALPHA-THALASSEMIA; BETA-THALASSEMIA; MESSENGER-RNA; HAEMOGLOBIN SYNTHESIS; CLINICAL-FEATURES; MUTATIONS; THALASSAEMIA		Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Weatherall, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	david.weatherall@imm.ox.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; BAGLIONI C, 1965, BIOCHIM BIOPHYS ACTA, V97, P37, DOI 10.1016/0304-4165(65)90267-9; BANK A, 1966, NATURE, V212, P1198, DOI 10.1038/2121198a0; BENZ EJ, 1971, J CLIN INVEST, V50, P2755, DOI 10.1172/JCI106778; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; CAO A, 1994, AM J HUM GENET, V54, P397; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; CLEGG JB, 1967, NATURE, V215, P1241, DOI 10.1038/2151241a0; CLEGG JB, 1968, NATURE, V220, P664, DOI 10.1038/220664a0; CLEGG JB, 1965, NATURE, V207, P945, DOI 10.1038/207945a0; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; FESSAS P, 1963, BLOOD, V21, P21, DOI 10.1182/blood.V21.1.21.21; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Giardini C, 1997, Curr Opin Hematol, V4, P79; Gibbons RJ, 2003, NAT GENET, V34, P446, DOI 10.1038/ng1213; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Haldane J.B.S., 1949, HEREDITAS, V35, P267; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HIGGS DR, 2001, THALASSAEMIA SYNDROM, P526; INGRAM VM, 1959, NATURE, V184, P1903, DOI 10.1038/1841903a0; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; NA-NAKRON S, 1970, American Journal of Human Genetics, V22, P645; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; NIENHUIS AW, 1971, J CLIN INVEST, V50, P2458, DOI 10.1172/JCI106745; OLD JM, 1978, CELL, V14, P289, DOI 10.1016/0092-8674(78)90115-0; Olivieri NF, 1997, LANCET, V350, P491, DOI 10.1016/S0140-6736(05)63080-2; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; OTTOLENGHI S, 1974, NATURE, V251, P389, DOI 10.1038/251389a0; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; POOTRAKUL S, 1967, ANN HUM GENET, V31, P149, DOI 10.1111/j.1469-1809.1967.tb00546.x; TAYLOR JM, 1974, NATURE, V251, P392, DOI 10.1038/251392a0; THOMAS ED, 1982, LANCET, V2, P227; Viprakasit V, 2001, HUM MOL GENET, V10, P2797, DOI 10.1093/hmg/10.24.2797; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WEATHERA.DJ, 1965, NATURE, V208, P1061, DOI 10.1038/2081061a0; Weatherall D, 2002, GENES IMMUN, V3, P331, DOI 10.1038/sj.gene.6363878; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; WEATHERALL DJ, 1969, ANN NY ACAD SCI, V165, P242, DOI 10.1111/j.1749-6632.1969.tb27795.x; WEATHERALL DJ, 1978, BRIT J HAEMATOL, V38, P305, DOI 10.1111/j.1365-2141.1978.tb01049.x; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WEATHERALL DJ, 1970, BRIT J HAEMATOL, V18, P357, DOI 10.1111/j.1365-2141.1970.tb01449.x; WEATHERALL DJ, 1975, PHILOS T R SOC B, V271, P411, DOI 10.1098/rstb.1975.0061; WHO, 2002, GEN WORLD HLTH; WILKIE AOM, 1990, AM J HUM GENET, V46, P1127; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112	51	46	47	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					385	392		10.1086/381402	http://dx.doi.org/10.1086/381402			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	15053011	Green Published, Bronze			2022-12-18	WOS:000220118500003
J	Noonan, JP; Li, J; Nguyen, L; Caoile, C; Dickson, M; Grimwood, J; Schmutz, J; Feldman, MW; Myers, RM				Noonan, JP; Li, J; Nguyen, L; Caoile, C; Dickson, M; Grimwood, J; Schmutz, J; Feldman, MW; Myers, RM			Extensive linkage disequilibrium, a common 16.7-kilobase deletion, and evidence of balancing selection in the human protocadherin alpha cluster	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MODERN HUMAN ORIGINS; HIGH-RESOLUTION; HAPLOTYPE FREQUENCIES; CADHERIN SUPERFAMILY; SEQUENCE VARIATION; MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; HUMAN-EVOLUTION; HUMAN GENOME	Regions of extensive linkage disequilibrium (LD) appear to be a common feature of the human genome. However, the mechanisms that maintain these regions are unknown. In an effort to understand whether gene density contributes to LD, we determined the degree of promoter sequence variation in a large tandem-arrayed gene family, the human protocadherin alpha cluster, on chromosome 5. These genes are expressed at synaptic junctions in the developing brain and the adult brain and may be involved in the determination of synaptic complexity. We sequenced the promoters of all 13 alpha protocadherin genes in 96 European Americans and identified polymorphisms in the promoters alpha1, alpha3, alpha4, alpha5, alpha7, alpha9, alpha11, and alpha13. In these promoters, 11 common SNPs are in extensive LD, forming two 48-kb haplotypes of equal frequency, in this population, that extend from the alpha1 through alpha7 genes. We sequenced these promoters in East Asians and African Americans, and we estimated haplotype frequencies and calculated LD statistics for all three populations. Our results indicate that, although extensive LD is an ancient feature of the alpha cluster, it has eroded over time. SNPs 3' of alpha7 are involved in ancestral recombination events in all populations, and overall alpha-cluster LD is reduced in African Americans. We obtained significant positive values for Tajima's D test for all alpha promoter SNPs in Europeans (D = 3.03) and East Asians (D = 2.64), indicating an excess of intermediate-frequency variants, which is a signature of balancing selection. We also discovered a 16.7-kb deletion that truncates the alpha8 gene and completely removes the alpha9 and alpha10 genes. This deletion appears in unaffected individuals from multiple populations, suggesting that a reduction in protocadherin gene number is not obviously deleterious.	Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Herrin Labs, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Myers, RM (corresponding author), Stanford Univ, Dept Genet, Sch Med, M-344, Stanford, CA 94305 USA.		Grimwood, Jane/ABD-5737-2021; Schmutz, Jeremy/N-3173-2013; Noonan, James/ABF-1320-2021	Schmutz, Jeremy/0000-0001-8062-9172; Li, Jun/0000-0001-6727-0812	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG000044, 5 T32 HG00044] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Angst BD, 2001, J CELL SCI, V114, P629; Bain G., 1998, CULTURING NERVE CELL, P189; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; BEASLEY A, 1999, PCR APPL, P55; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Donnelly P, 1996, CIBA F SYMP, V197, P25; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fu YX, 1997, GENETICS, V147, P915; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Hammer MF, 1997, GENETICS, V145, P787; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; LEWONTIN RC, 1964, GENETICS, V49, P49; LEWONTIN RC, 1995, GENETICS, V140, P377; Li J, 2002, AM J MED GENET, V114, P24, DOI 10.1002/ajmg.1618; MARJORAM P, 1994, GENETICS, V136, P673; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Roessli D, 2000, ARLEQUIN VERSION 2 0; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Suzuki ST, 1996, J CELL SCI, V109, P2609; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697	63	46	46	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					621	635		10.1086/368060	http://dx.doi.org/10.1086/368060			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12577201	Bronze, Green Published			2022-12-18	WOS:000181152600012
J	Ito, T; Chiku, S; Inoue, E; Tomita, M; Morisaki, T; Morisaki, H; Kamatani, N				Ito, T; Chiku, S; Inoue, E; Tomita, M; Morisaki, T; Morisaki, H; Kamatani, N			Estimation of haplotype frequencies, linkage-disequilibrium measures, and combination of haplotype copies in each pool by use of pooled DNA data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIPLOTYPE CONFIGURATION; RHEUMATOID-ARTHRITIS; RECONSTRUCTION; POLYMORPHISMS; ASSOCIATION; LOCUS	Inference of haplotypes is important for many genetic approaches, including the process of assigning a phenotype to a genetic region. Usually, the population frequencies of haplotypes, as well as the diplotype configuration of each subject, are estimated from a set of genotypes of the subjects in a sample from the population. We have developed an algorithm to infer haplotype frequencies and the combination of haplotype copies in each pool by using pooled DNA data. The input data are the genotypes in pooled DNA samples, each of which contains the quantitative genotype data from one to six subjects. The algorithm infers by the maximum-likelihood method both frequencies of the haplotypes in the population and the combination of haplotype copies in each pool by an expectation-maximization algorithm. The algorithm was implemented in the computer program LDPooled. We also used the bootstrap method to calculate the standard errors of the estimated haplotype frequencies. Using this program, we analyzed the published genotype data for the SAA (n = 156), MTHFR (n = 80), and NAT2 (n = 116) genes, as well as the smoothelin gene (n = 102). Our study has shown that the frequencies of major (frequency >0.1 in a population) haplotypes can be inferred rather accurately from the pooled DNA data by the maximum-likelihood method, although with some limitations. The estimated D and D' values had large variations except when \D\ values were >0.1. The estimated linkage-disequilibrium measure rho(2)for 36 linked loci of the smoothelin gene when one- and two- subject pool protocols were used suggested that the gross pattern of the distribution of the measure can be reproduced using the two-subject pool data.	Japan Biol Informat Consortium, Japan Biol Informat Res Ctr, Algorithm Team, Koto Ku, Tokyo 1350064, Japan; Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; Tokyo Womens Med Univ, Dept Appl Biomed Engn & Sci, Div Genom Med, Tokyo, Japan; Natl Cardiovasc Ctr, Res Inst, Dept Biosci, Osaka, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; National Cerebral & Cardiovascular Center - Japan	Ito, T (corresponding author), Japan Biol Informat Consortium, Japan Biol Informat Res Ctr, Algorithm Team, Koto Ku, Time24,Bldg 10F,2-45 Aomi, Tokyo 1350064, Japan.	ito@jbirc.aist.go.jp						Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P214; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; JUDSON R, 2000, PHARMACOGENOMICS, V1, P5; Kitamura Y, 2002, ANN HUM GENET, V66, P183, DOI [10.1046/j.1469-1809.2002.00112.x, 10.1017/S0003480002001124]; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEWONTIN RC, 1964, GENETICS, V49, P49; LONG JC, 1995, AM J HUM GENET, V56, P799; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; Moriguchi M, 2001, ARTHRITIS RHEUM, V44, P1266, DOI 10.1002/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tanaka E, 2002, J RHEUMATOL, V29, P2492; Templeton AR, 1999, ANNU REV ECOL SYST, V30, P23, DOI 10.1146/annurev.ecolsys.30.1.23; Urano W, 2002, PHARMACOGENETICS, V12, P183, DOI 10.1097/00008571-200204000-00002; Xu CF, 2002, HUM GENET, V110, P148, DOI 10.1007/s00439-001-0656-4; Zhang SL, 2001, AM J HUM GENET, V69, P906, DOI 10.1086/323622; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	26	46	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					384	398		10.1086/346116	http://dx.doi.org/10.1086/346116			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12533787	Green Published, Bronze			2022-12-18	WOS:000180680000018
J	Knappskog, PM; Majewski, J; Livneh, A; Nilsen, PTE; Bringsli, JS; Ott, J; Boman, H				Knappskog, PM; Majewski, J; Livneh, A; Nilsen, PTE; Bringsli, JS; Ott, J; Boman, H			Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CILIARY NEUROTROPHIC FACTOR; CNTF RECEPTOR; MICE LACKING; PROTEIN	In 1978, Sohar et al. described a strikingly peculiar syndrome in two Israeli sisters. These young women responded to environmental temperatures of 18degreesC-7degreesC with profuse sweating on large segments on their back and chest. Both had additional abnormalities, including a high-arched palate, nasal voice, depressed nasal bridge, inability to fully extend their elbows, and kyphoscoliosis. We have observed this disorder in two Norwegian brothers. Genomewide screening in the two families, followed by saturation marker studies and linkage analysis, identified a 1.4-Mb homozygous candidate region on chromosome 19p12. The maximum multipoint LOD score was 4.22. In both families, DNA sequencing of 25 genes within the candidate region identified potentially deleterious CRLF1 sequence variants that were not found in unaffected control individuals. Our findings confirm that the cold-induced sweating syndrome is an autosomal recessive disorder that is probably caused by impaired function of the CRLF1 gene, and they suggest important developmental functions for human CRLF1.	Haukeland Univ Hosp, Ctr Med Genet & Mol Med, Dept Orthoped Surg, N-5021 Bergen, Norway; Univ Bergen, Ctr Med Genet & Mol Med, Bergen, Norway; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	University of Bergen; Haukeland University Hospital; University of Bergen; Rockefeller University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Boman, H (corresponding author), Haukeland Univ Hosp, Ctr Med Genet & Mol Med, Dept Orthoped Surg, N-5021 Bergen, Norway.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG000008] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008, R01 HG000008] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Durham LK, 1997, AM J HUM GENET, V61, P830, DOI 10.1086/514891; Elson GCA, 1998, J IMMUNOL, V161, P1371; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEDDEDAH.T, 1973, HEREDITAS, V73, P211; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Lesser SS, 2000, NAT NEUROSCI, V3, P851, DOI 10.1038/78738; Maor G, 2002, J BONE MINER RES, V17, P1034, DOI 10.1359/jbmr.2002.17.6.1034; MCMEMY DD, 2002, NATURE, V416, P52; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; SOHAR E, 1978, LANCET, V2, P1073; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809	19	46	48	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					375	383		10.1086/346120	http://dx.doi.org/10.1086/346120			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12509788	Green Published, Bronze			2022-12-18	WOS:000180680000017
J	Blom, D; Speijer, D; Linthorst, GE; Donker-Koopman, WG; Strijland, A; Aerts, JMFG				Blom, D; Speijer, D; Linthorst, GE; Donker-Koopman, WG; Strijland, A; Aerts, JMFG			Recombinant enzyme therapy for Fabry disease: Absence of editing of human alpha-galactosidase A mRNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPLACEMENT THERAPY; TRANSIENT EXPRESSION; RNA; DEFICIENCY; GENE	For more than a decade, protein-replacement therapy has been employed successfully for the treatment of Gaucher disease. Recently, a comparable therapy has become available for the related lipid-storage disorder Fabry disease. Two differently produced recombinant alpha-galactosidase A (alpha-gal A) preparations are used independently for this purpose. Agalsidase a is obtained from human fibroblasts that have been modified by gene activation; agalsidase beta is obtained from Chinese hamster ovary cells that are transduced with human alpha-gal A cDNA. It has previously been claimed that alpha-gal A mRNA undergoes editing, which may result in coproduction of an edited protein (Phe 396 Tyr) that might have a relevant physiological function. We therefore analyzed the occurrence of alpha-gal A editing, as well as the precise nature, in this respect, of the therapeutic enzymes. No indications were obtained for the existence of editing at the protein or RNA level. Both recombinant enzymes used in therapy are unedited and are capable of functionally correcting cultured fibroblasts from Fabry patients in their excessive globotriaosylceramide accumulation. Although RNA editing is apparently not relevant in the case of alpha-gal A, a thorough analysis of the potential occurrence of editing of transcripts is nevertheless advisable in connection with newly developed protein-replacement therapies.	Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Internal Med Clin Haematol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.		Aerts, Johannes/A-1028-2009; Speijer, Dave/AAE-4613-2019	Aerts, Johannes/0000-0001-8168-2565; Speijer, Dave/0000-0002-2340-2753				BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; CALHOUN DH, 1985, P NATL ACAD SCI USA, V82, P7364, DOI 10.1073/pnas.82.21.7364; CHANG BHJ, 1998, MODIFICATION EDITING, P325; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DESNICK RJ, 1971, NEW ENGL J MED, V284, P739, DOI 10.1056/NEJM197104082841401; Desnick RJ, 1996, METABOLIC MOL BASES, P2741; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MARTENSSON E, 1966, BIOCHIM BIOPHYS ACTA, V116, P296, DOI 10.1016/0005-2760(66)90012-9; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; NOVO FJ, 1995, NUCLEIC ACIDS RES, V23, P2636, DOI 10.1093/nar/23.14.2636; Pastores GM, 2001, LANCET, V358, P601, DOI 10.1016/S0140-6736(01)05816-0; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Rueter S.M., 1998, MODIFICATION EDITING, P343; Sambrook J, 1989, MOL CLONING LAB MANU; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; WHERRETT JR, 1973, J BIOL CHEM, V248, P3046; ZEIDNER KM, 1993, AM J HUM GENET, V53, P1682	26	46	49	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					23	31		10.1086/345309	http://dx.doi.org/10.1086/345309			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12471562	Green Published, Bronze			2022-12-18	WOS:000180186800003
J	Chung, EK; Yang, Y; Rupert, KL; Jones, KN; Rennebohm, RM; Blanchong, CA; Yu, CY				Chung, EK; Yang, Y; Rupert, KL; Jones, KN; Rennebohm, RM; Blanchong, CA; Yu, CY			Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIELD GEL-ELECTROPHORESIS; CLASS-III REGION; STEROID 21-HYDROXYLASE GENES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPONENT C4; 4TH COMPONENT; C-4; DEFICIENCY; POLYMORPHISM; MECHANISM	The complex genetics of human complement C4 with unusually frequent variations in the size and number of C4A and C4B, as well as their neighboring genes, in the major histocompatibility complex has been a hurdle for accurate epidemiological studies of diseases associated with C4. A comprehensive series of novel or improved techniques has been developed to determine the total gene number of C4 and the relative dosages of C4A and C4B in a diploid genome. These techniques include (1) definitive genomic restriction-fragment-length polymorphisms (RFLPs) based on the discrete duplication patterns of the RCCX (RP-C4-CYP21-TNX) modules and on the specific nucleotide changes for C4A and C4B isotypes; (2) module-specific PCR to give information on the total number of C4 genes by comparing the relative quantities of RP1- or TNXB-specific fragments with TNXA-RP2 fragments; (3) labeled-primer single-cycle DNA polymerization procedure of amplified C4d genomic DNA for diagnostic RFLP analysis of C4A and C4B; and (4) a highly reproducible long-range-mapping method that employs Pmel-digested genomic DNA for pulsed-field gel electrophoresis, to yield precise information on the number of long and short C4 genes in a haplotype. Applications of these vigorously tested techniques may clarify the roles that human C4A and C4B gene-dosage variations play in infectious and autoimmune diseases.	Ohio State Univ, Childrens Res Inst, Columbus, OH 43205 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yu, CY (corresponding author), Ohio State Univ, Childrens Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	cyu@chi.osu.edu	Yu, Chack-Yung/E-4360-2011	Yu, Chack-Yung/0000-0002-5218-7503	NCRR NIH HHS [1P41 RR06009, P41 RR006009] Funding Source: Medline; NIAMS NIH HHS [R01 AR43969] Funding Source: Medline; NIDDK NIH HHS [P01 DK055546, P01 DK55546] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055546] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atkinson JP, 1999, SYSTEMIC LUPUS ERYTH, P91; AWDEH ZL, 1979, NATURE, V282, P205, DOI 10.1038/282205a0; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; Baldwin WM, 1999, TRANSPLANTATION, V68, P894, DOI 10.1097/00007890-199909270-00024; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BISHOF NA, 1990, J INFECT DIS, V162, P248, DOI 10.1093/infdis/162.1.248; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; Chung EK, 2002, AM J HUM GENET, V71, P823, DOI 10.1086/342777; COLLIER S, 1989, EMBO J, V8, P1393, DOI 10.1002/j.1460-2075.1989.tb03520.x; Colten H. R., 1998, HUMAN COMPLEMENT SYS, P217; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; DANIELS CA, 1969, SCIENCE, V165, P508, DOI 10.1126/science.165.3892.508; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; DUNHAM I, 1989, J EXP MED, V169, P1803, DOI 10.1084/jem.169.5.1803; FEUCHT HE, 1993, KIDNEY INT, V43, P1333, DOI 10.1038/ki.1993.187; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jaatinen T, 1999, HUM IMMUNOL, V60, P707, DOI 10.1016/S0198-8859(99)00047-6; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Kohl J, 2001, MOL IMMUNOL, V38, P175, DOI 10.1016/S0161-5890(01)00041-4; Mauff G, 1998, EXP CLIN IMMUNOGENET, V15, P249, DOI 10.1159/000019079; OLAISEN B, 1980, IMMUNOBIOLOGY, V158, P82, DOI 10.1016/S0171-2985(80)80044-1; ONEILL GJ, 1978, P NATL ACAD SCI USA, V75, P5165, DOI 10.1073/pnas.75.10.5165; Pfeifer PH, 2000, IMMUNOPHARMACOLOGY, V46, P163, DOI 10.1016/S0162-3109(99)00167-8; PINCKARD RN, 1975, J CLIN INVEST, V56, P740, DOI 10.1172/JCI108145; Porter R R, 1983, Mol Biol Med, V1, P161; SCHNEIDER PM, 1986, J CLIN INVEST, V78, P650, DOI 10.1172/JCI112623; Schneider PM, 2001, IMMUNOGENETICS, V53, P1, DOI 10.1007/s002510000288; SHEN LM, 1994, J BIOL CHEM, V269, P8466; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; Tsokos GC, 2000, MOL MED TODAY, V6, P418, DOI 10.1016/S1357-4310(00)01798-6; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; UKO G, 1986, J CLIN PATHOL, V39, P573, DOI 10.1136/jcp.39.5.573; WegRemers S, 1997, HUM GENET, V100, P548, DOI 10.1007/s004390050550; WELCH TR, 1985, CLIN IMMUNOL IMMUNOP, V34, P316, DOI 10.1016/0090-1229(85)90180-1; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WILD G, 1990, CLIN EXP IMMUNOL, V80, P167; Yang ZY, 1999, J BIOL CHEM, V274, P12147, DOI 10.1074/jbc.274.17.12147; Yu CY, 2000, IMMUNOL TODAY, V21, P320, DOI 10.1016/S0167-5699(00)01664-9; Yu CY, 2002, MANUAL CLIN LAB IMMU, V6th, P117; ZHANG WJ, 1990, J EXP MED, V171, P2101, DOI 10.1084/jem.171.6.2101	44	46	48	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					810	822		10.1086/342778	http://dx.doi.org/10.1086/342778			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12224044	Green Published, Bronze			2022-12-18	WOS:000178613800010
J	Evans, DM				Evans, DM			The power of multivariate quantitative-trait loci linkage analysis is influenced by the correlation between variables	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TESTS		Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Joint Genet Program, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Evans, DM (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.		Evans, David M/H-6325-2013	Evans, David M/0000-0003-0663-4621				Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Amos CI, 2001, HUM HERED, V51, P133, DOI 10.1159/000053334; Boomsma DI, 1996, BEHAV GENET, V26, P161, DOI 10.1007/BF02359893; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891	6	46	46	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1599	1602		10.1086/340850	http://dx.doi.org/10.1086/340850			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992269	Green Published, Bronze			2022-12-18	WOS:000175445700025
J	Holzinger, A; Maier, EM; Buck, C; Mayerhofer, PU; Kappler, M; Haworth, JC; Moroz, SP; Hadorn, HB; Sadler, JE; Roscher, AA				Holzinger, A; Maier, EM; Buck, C; Mayerhofer, PU; Kappler, M; Haworth, JC; Moroz, SP; Hadorn, HB; Sadler, JE; Roscher, AA			Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENTEROKINASE; TRYPSINOGEN; ACTIVATION	Enteropeptidase (enterokinase [E.C.3.4.21.9]) is a serine protease of the intestinal brush border in the proximal small intestine. It activates the pancreatic proenzyme trypsinogen, which, in turn, releases active digestive enzymes from their inactive pancreatic precursors. Congenital enteropeptidase deficiency is a rare recessively inherited disorder leading, in affected infants, to severe failure to thrive. The genomic structure of the proenteropeptidase gene (25 exons, total gene size 88 kb) was characterized in order to perform DNA sequencing in three clinically and biochemically proved patients with congenital enteropeptidase deficiency who were from two families. We found compound heterozygosity for nonsense mutations (S712X/R857X) in two affected siblings and found compound heterozygosity for a nonsense mutation (Q261X) and a frameshift mutation (FsQ902) in the third patient. In accordance with the biochemical findings, all four defective alleles identified are predicted null alleles leading to a gene product not containing the active site of the enzyme. These data provide first evidence that proenteropeptidase-gene mutations are the primary cause of congenital enteropeptidase deficiency.	Univ Munich, Dr Von Haunerschen Kinderspital, Dept Pediat, Div Clin Chem & Metab, D-80337 Munich, Germany; Univ Manitoba, Childrens Hosp, Winnipeg, MB, Canada; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	University of Munich; University of Manitoba; Children's Hospital Research Institute of Manitoba; Howard Hughes Medical Institute; Washington University (WUSTL)	Holzinger, A (corresponding author), Univ Munich, Dr Von Haunerschen Kinderspital, Dept Pediat, Div Clin Chem & Metab, Lindwurmstr 4, D-80337 Munich, Germany.		Sadler, Evan/D-8556-2011	Sadler, J. Evan/0000-0001-5705-469X	NIDDK NIH HHS [R01 DK050053] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DAVIE EW, 1955, J BIOL CHEM, V212, P515; EGGERMONT E, 1971, Acta Gastro-Enterologica Belgica, V34, P655; FOLLETT GF, 1976, ACTA PAEDIATR SCAND, V65, P653, DOI 10.1111/j.1651-2227.1976.tb04948.x; GHISHAN FK, 1983, GASTROENTEROLOGY, V85, P727; GREEN JR, 1984, J PEDIATR GASTR NUTR, V3, P630, DOI 10.1097/00005176-198409000-00026; HADORN B, 1969, LANCET, V1, P812; HAWORTH JC, 1975, ARCH DIS CHILD, V50, P277; HAWORTH JC, 1971, J PEDIATR-US, V78, P481, DOI 10.1016/S0022-3476(71)80231-7; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KAY J, 1971, J BIOL CHEM, V246, P6661; KITAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P4562, DOI 10.1021/bi00014a008; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; LAVALLIE ER, 1993, J BIOL CHEM, V268, P23311; LEBENTHAL E, 1976, GASTROENTEROLOGY, V70, P508; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Lu DS, 1999, J MOL BIOL, V292, P361, DOI 10.1006/jmbi.1999.3089; MAROUX S, 1971, J BIOL CHEM, V246, P5031; MARSHALL G, 1989, AUST PAEDIATR J, V25, P106; Moroz SP, 2001, AM J GASTROENTEROL, V96, P2251, DOI 10.1016/S0002-9270(01)02533-3; Pardou A, 1975, Pediatrie, V30, P544; POLONOVSKI C, 1970, ARCH FR PEDIATR, V27, P677; TARLOW MJ, 1970, ARCH DIS CHILD, V45, P651, DOI 10.1136/adc.45.243.651; WALTHER A, 2000, JAHRES BERICHT FORTS, V29; Zamolodchikova TS, 2000, FEBS LETT, V466, P295, DOI 10.1016/S0014-5793(00)01092-9	24	46	51	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					20	25		10.1086/338456	http://dx.doi.org/10.1086/338456			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11719902	Bronze, Green Published			2022-12-18	WOS:000172571900003
J	Almasy, L; Porjesz, B; Blangero, J; Goate, A; Edenberg, HJ; Chorlian, DB; Kuperman, S; O'Connor, SJ; Rohrbaugh, J; Bauer, LO; Foroud, T; Rice, JP; Reich, T; Begleiter, H				Almasy, L; Porjesz, B; Blangero, J; Goate, A; Edenberg, HJ; Chorlian, DB; Kuperman, S; O'Connor, SJ; Rohrbaugh, J; Bauer, LO; Foroud, T; Rice, JP; Reich, T; Begleiter, H			Genetics of event-related brain potentials in response to a semantic priming paradigm in families with a history of alcoholism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; QUANTITATIVE TRAITS; SCHIZOPHRENIA; CHROMOSOME-5; CONSISTENCY; PEDIGREES; MARKERS; P300; NUCLEAR; RISK	Event-related brain potentials (ERPs) are altered in patients with a variety of psychiatric disorders and may represent quantitative correlates of disease liability that are more amenable to genetic analysis than disease status itself. Results of a genomewide linkage screen are presented for amplitude of the N4 and P3 components of the ERP, measured at 19 scalp locations in response to a semantic priming task for 604 individuals in 100 pedigrees ascertained as part of the Collaborative Study on the Genetics of Alcoholism. N4 and P3 amplitudes in response to three stimuli (nonwords, primed words [i.e., antonyms], and unprimed words) all showed significant heritabilities, the highest being .54. Both N4 and P3 showed significant genetic correlations across stimulus type at a given lead and across leads within a stimulus, indicating shared genetic influences among the traits. There were also substantial genetic correlations between the N4 and P3 amplitudes for a given lead, even across stimulus type. N4 amplitudes showed suggestive evidence of linkage in several chromosomal regions, and P3 amplitudes showed significant evidence of linkage to chromosome 5 and suggestive evidence of linkage to chromosome 4.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Univ Iowa, Dept Psychiat Res, Iowa City, IA USA; Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06032 USA	Texas Biomedical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa; University of Connecticut	Almasy, L (corresponding author), SW Fdn Biomed Res, Dept Genet, POB 760549, San Antonio, TX 78245 USA.		Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019	Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008403, U10AA008401] Funding Source: NIH RePORTER; NIAAA NIH HHS [U10AA08403, U10 AA008401] Funding Source: Medline; NIMH NIH HHS [MH59490] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS J, 1993, SCHIZOPHR RES, V10, P247, DOI 10.1016/0920-9964(93)90059-R; ALEXANDER JE, 1994, INT J PSYCHOPHYSIOL, V17, P35, DOI 10.1016/0167-8760(94)90053-1; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ASCHAUER HN, 1990, HUM HERED, V40, P109, DOI 10.1159/000153915; BASSETT AS, 1988, LANCET, V1, P799; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; Begleiter H, 1998, EVOKED POTENTIAL, V108, P244, DOI 10.1016/S0168-5597(98)00002-1; BLACKWOOD DHR, 1991, ARCH GEN PSYCHIAT, V48, P899; Blangero J, 1997, AM J MED GENET, V74, P602; COHEN HL, 1994, ALCOHOL, V11, P583, DOI 10.1016/0741-8329(94)90087-6; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; GRILLON C, 1991, BIOL PSYCHIAT, V29, P467, DOI 10.1016/0006-3223(91)90269-R; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Knott V, 1998, EUR CHILD ADOLES PSY, V7, P209, DOI 10.1007/s007870050069; KUPERMAN S, 1995, ELECTROEN CLIN NEURO, V94, P462, DOI 10.1016/0013-4694(94)00312-9; Kutas M., 1988, ADV PSYCHOPHYSIOL, V3, P139; Olson JM, 1999, GENET EPIDEMIOL, V17, pS271; OWEN M, 1990, BRIT J PSYCHIAT, V157, P123, DOI 10.1192/bjp.157.1.123; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; Porjesz B., 1985, ALCOHOL BRAIN CHRONI, P139; PORJESZ B, 1996, ALCOH ALCOHOLISM, V2, P207; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; STRANDBURG RJ, 1993, NEUROPSYCHOLOGIA, V31, P413, DOI 10.1016/0028-3932(93)90058-8; SUAREZ BK, 1994, GENETIC APPROACHES M; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571	33	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					128	135		10.1086/316936	http://dx.doi.org/10.1086/316936			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	392FG	11102287	Bronze, Green Published			2022-12-18	WOS:000166399900011
J	Andresen, BS; Christensen, E; Corydon, TJ; Bross, P; Pilgaard, B; Wanders, RJA; Ruiter, JPN; Simonsen, H; Winter, V; Knudsen, I; Schroeder, LD; Gregersen, N; Skovby, F				Andresen, BS; Christensen, E; Corydon, TJ; Bross, P; Pilgaard, B; Wanders, RJA; Ruiter, JPN; Simonsen, H; Winter, V; Knudsen, I; Schroeder, LD; Gregersen, N; Skovby, F			Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: Identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE FAMILY; MITOCHONDRIA; PHENOTYPE; MUTATIONS; PRECURSOR; GENOTYPE; MEMBER; ACIDS; MCAD	Acyl-CoA dehydrogenase (ACAD) defects in isoleucine and valine catabolism have been proposed in clinically diverse patients with an abnormal pattern of metabolites in their urine, but they have not been proved enzymatically or genetically, and it is unknown whether one or two ACADs are involved. We investigated a patient with isolated 2-methylbutyrylglycinuria, suggestive of a defect in isoleucine catabolism. Enzyme assay of the patient's fibroblasts, using 2-methylbutyryl-CoA as substrate, confirmed the defect. Sequence analysis of candidate ACADs revealed heterozygosity for the common short-chain ACAD A625 variant allele and no mutations in ACAD-8 but a 100-bp deletion in short/branched-chain ACAD (SBCAD) cDNA from the patient. Our identification of the SBCAD gene structure (11 exons; >20 kb) enabled analysis of genomic DNA. This showed that the deletion was caused by skipping of exon 10, because of homozygosity for a 1228G-->A mutation in the patient. This mutation was not present in 118 control chromosomes. In vitro transcription/translation experiments and overexpression in COS cells confirmed the disease-causing nature of the mutant SBCAD protein and showed that ACAD-8 is an isobutyryl-CoA dehydrogenase and that both wild-type proteins are imported into mitochondria and form tetramers. In conclusion, we report the first mutation in the SBCAD gene, show that it results in an isolated defect in isoleucine catabolism, and indicate that ACAD-8 is a mitochondrial enzyme that functions in valine catabolism.	Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark; Aarhus Univ, Inst Human Genet, DK-8000 Aarhus, Denmark; Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; State Serum Inst, Copenhagen, Denmark; Roskilde Amtssygehus, Dept Pediat, Roskilde, Denmark; Emma Childrens Hosp, Dept Pediat, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Skejby Sygehus, Res Unit Mol Med, Fac Hlth Sci, DK-8200 Aarhus N, Denmark	Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Emma Children's Hospital; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Aarhus University	Andresen, BS (corresponding author), Skejby Sygehus, Res Unit Mol Med, Fac Hlth Sci, DK-8200 Aarhus N, Denmark.		Andresen, Brage/D-2515-2012; Bross, Peter/B-7219-2013	Andresen, Brage/0000-0001-7488-3035; Bross, Peter/0000-0001-9526-8525; Corydon, Thomas Juhl/0000-0003-3588-6350				AMIR N, 1989, J PEDIATR, V114, P98; ANDRESEN BS, 1994, AM J HUM GENET, V54, P975; Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Binzak B, 1998, BBA-PROTEIN STRUCT M, V1382, P137, DOI 10.1016/S0167-4838(97)00161-1; Bross P, 1998, PROG NUCLEIC ACID RE, V58, P301; Corydon MJ, 1997, MAMM GENOME, V8, P922, DOI 10.1007/s003359900612; Corydon MJ, 1996, PEDIATR RES, V39, P1059, DOI 10.1203/00006450-199606000-00021; Corydon TJ, 1998, J BIOL CHEM, V273, P13065, DOI 10.1074/jbc.273.21.13065; Gibson KM, 2000, PEDIATR RES, V47, P830, DOI 10.1203/00006450-200006000-00025; GIBSON KM, 1999, J INHERIT METAB DI S, V22, P1; GREGERSEN N, 1979, PEDIATR RES, V13, P1227, DOI 10.1203/00006450-197911000-00005; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MAQUAT LE, 1995, RNA, V1, P453; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; RASHED MS, 1995, PEDIATR RES, V38, P324, DOI 10.1203/00006450-199509000-00009; ROZEN R, 1994, GENOMICS, V24, P280, DOI 10.1006/geno.1994.1617; SAIJO T, 1994, J BIOL CHEM, V269, P4401; Tein I, 1999, NEUROLOGY, V52, P366, DOI 10.1212/WNL.52.2.366; Telford EAR, 1999, BBA-GENE STRUCT EXPR, V1446, P371, DOI 10.1016/S0167-4781(99)00102-5; Volchenboum SL, 2000, J BIOL CHEM, V275, P7958, DOI 10.1074/jbc.275.11.7958; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	23	46	50	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1095	1103		10.1086/303105	http://dx.doi.org/10.1086/303105			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11013134	Green Published, Bronze			2022-12-18	WOS:000165091600006
J	Eisenbarth, I; Vogel, G; Krone, W; Vogel, W; Assum, G				Eisenbarth, I; Vogel, G; Krone, W; Vogel, W; Assum, G			An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; HUMAN MHC; PSEUDOAUTOSOMAL BOUNDARY; SEQUENCE VARIATION; RICHEST BANDS; DNA; CHROMOSOMES; IDENTIFICATION; POLYMORPHISMS; GENOME	Whole-genome association studies will be a powerful tool to identify genes responsible for common human diseases. A crucial task for association-mapping studies is the evaluation of the relationship between linkage disequilibrium (LD) and physical distance for the genomic region under study. Since it is known that the extent of LD is nonuniformly distributed throughout the human genome, the required marker density has to be determined specifically for the region under study. These regions may be related to isochores and chromosomal bands, as indicated by earlier cytogenetic findings concerning chiasma distribution in meiosis. Therefore we analyzed the neurofibromatosis type 1 (NF1) gene region on chromosome 17q11.2, which is characterized by a nonuniform LD pattern and an L1-to-H2 isochore transition. Long-range LD within the NF1 gene was found to extend over 200 kb (D' = 0.937) in the L1 isochore, whereas, in the neighboring H2 isochore, no LD is apparent between markers spaced by 26 kb (D' = 0.144). Recombination frequencies derived from the LD are at .00019 thigh LD) and .01659 (low LD) per megabase, the latter identical to the average value from segregation analysis. The boundary between these regions coincides precisely with a transition in the GC content of the sequences, with low values (37.2%) in the region with long-range LD and high values (51%) in the other. Our results suggest a correlation between the LD pattern and the isochores, at least in the NF1 region. If this correlation can be generalized, the marker densities required for association studies have to be adjusted to the regional GC content and may be chosen according to the isochores.	Univ Ulm, Abt Humangenet, D-89081 Ulm, Germany	Ulm University	Eisenbarth, I (corresponding author), Univ Ulm, Abt Humangenet, Albert Einstein Allee 11, D-89081 Ulm, Germany.							Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Carrington M, 1999, IMMUNOL REV, V167, P245, DOI 10.1111/j.1600-065X.1999.tb01397.x; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Eisenbarth I, 2000, AM J HUM GENET, V66, P393, DOI 10.1086/302747; Fukagawa T, 1996, HUM MOL GENET, V5, P23, DOI 10.1093/hmg/5.1.23; FUKAGAWA T, 1995, GENOMICS, V25, P184, DOI 10.1016/0888-7543(95)80124-5; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HOFFMEYER S, 1994, HUM GENET, V93, P481; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; JORDE LB, 1993, AM J HUM GENET, V53, P1038; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; MESSIAEN L, 1993, HUM MOL GENET, V2, P485, DOI 10.1093/hmg/2.4.485; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Purandare SM, 1996, AM J HUM GENET, V59, P159; Saccone S, 1999, CHROMOSOME RES, V7, P379, DOI 10.1023/A:1009220131225; Saccone S, 1996, GENE, V174, P85, DOI 10.1016/0378-1119(96)00392-7; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Sanchez-Mazas A, 2000, EUR J HUM GENET, V8, P33, DOI 10.1038/sj.ejhg.5200391; Stephens R, 1999, J MOL BIOL, V291, P789, DOI 10.1006/jmbi.1999.3004; Tenzen T, 1997, MOL CELL BIOL, V17, P4043, DOI 10.1128/MCB.17.7.4043; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	25	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					873	880		10.1086/303085	http://dx.doi.org/10.1086/303085			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10978227	Bronze, Green Published			2022-12-18	WOS:000089651100011
J	Diaz, GA; Gelb, BD; Risch, N; Nygaard, TG; Frisch, A; Cohen, IJ; Miranda, CS; Amaral, O; Maire, I; Poenaru, L; Caillaud, C; Weizberg, M; Mistry, P; Desnick, RJ				Diaz, GA; Gelb, BD; Risch, N; Nygaard, TG; Frisch, A; Cohen, IJ; Miranda, CS; Amaral, O; Maire, I; Poenaru, L; Caillaud, C; Weizberg, M; Mistry, P; Desnick, RJ			Gaucher disease: The origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GLUCOCEREBROSIDASE GENE; TAY-SACHS-DISEASE; FACTOR-XI DEFICIENCY; COMMON ORIGIN; HUMAN GENOME; JEWS; POLYMORPHISM; LINKAGE; IDENTIFICATION; POPULATIONS	Type 1 Gaucher disease (GD), a non-neuronopathic lysosomal storage disorder, results from the deficient activity of acid beta-glucosidase (GBA). Type 1 disease is panethnic but is more prevalent in individuals of Ashkenazi Jewish (AJ) descent. Of the causative GBA mutations, N370S is particularly frequent in the AJ population, (q similar to .03), whereas the 84GG insertion (q similar to .003) occurs exclusively in the Ashkenazim. To investigate the genetic history of these mutations in the AJ population, short tandem repeat (STR) markers were used to map a 9.3-cM region containing the GBA locus and to genotype 261 AJ N370S chromosomes, GO European non-Jewish N370S chromosomes, and 62 AJ 84GG chromosomes. A highly conserved haplotype at four markers flanking GBA (PKLR, D1S1595, D1S2721, and D1S2777) was observed on both the AJ chromosomes and the non-Jewish N370S chromosomes, suggesting the occurrence of a founder common to both populations. Of note, the presence of different divergent haplotypes suggested the occurrence of de novo, recurrent N370S mutations. In contrast, a different conserved haplotype at these markers was identified on the 84GG chromosomes, which was unique to the AJ population. On the basis of the linkage disequilibrium (LD) delta values, the non-Jewish European N370S chromosomes had greater haplotype diversity and less LD at the markers flanking the conserved haplotype than did the AJ N370S chromosomes. This finding is consistent with the presence of the N370S mutation in the non-Jewish European population prior to the founding of the AJ population. Coalescence analyses for the N370S and 84GG mutations estimated similar coalescence times, of 48 and 55.5 generations ago, respectively. The results of these studies are consistent with a significant bottleneck occurring in the AJ population during the first millennium, when the population became established in Europe.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; UMDNJ, New Jersey Med Sch, Dept Neurosci, Newark, DE USA; Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Inst Genet Med, Porto, Portugal; Hop Cochin, Genet Lab, F-75674 Paris, France	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Stanford University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA.		Diaz, George/AAF-6199-2021; Amaral, Olga/AAD-4021-2020; sá Miranda, Maria Clara/K-3920-2013; Cohen, Ian/H-3358-2013; Amaral, Olga M/B-3011-2015	sá Miranda, Maria Clara/0000-0003-0123-5525; Amaral, Olga M/0000-0002-3478-2122	NICHD NIH HHS [5 P30 HD 28822] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BEUTLER E, 1992, GENOMICS, V12, P795, DOI 10.1016/0888-7543(92)90311-F; BONNETAMIR B, 1992, GENETIC DIVERSITY JE; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; CHASE GA, 1972, AM J HUM GENET, V24, P339; Choy FYM, 1997, AM J MED GENET, V71, P172, DOI 10.1002/(SICI)1096-8628(19970808)71:2<172::AID-AJMG10>3.0.CO;2-B; Demina A, 1998, HEMATOPATHOL MOL HEM, V11, P63; Diaz A, 1999, AM J HUM GENET, V64, P1233, DOI 10.1086/302341; DIAZ GA, 1998, AM J HUM GENET S, V63, pA211; Eng CM, 1997, JAMA-J AM MED ASSOC, V278, P1268, DOI 10.1001/jama.278.15.1268; Eto Y, 1999, NEUROCHEM RES, V24, P207, DOI 10.1023/A:1022553819241; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goodman R. M., 1979, GENETIC DISORDERS JE; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Kim JW, 1996, HUM MUTAT, V7, P214, DOI 10.1002/(SICI)1098-1004(1996)7:3<214::AID-HUMU5>3.0.CO;2-A; LACERDA L, 1994, J INHERIT METAB DIS, V17, P85, DOI 10.1007/BF00735401; LACERDA L, 1994, CLIN GENET, V45, P298; LENZNER C, 1994, HUM MOL GENET, V3, P523, DOI 10.1093/hmg/3.3.523-a; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; Patael Y, 1999, EUR J HUM GENET, V7, P555, DOI 10.1038/sj.ejhg.5200325; Peleg L, 1998, EUR J HUM GENET, V6, P185, DOI 10.1038/sj.ejhg.5200176; Peretz H, 1997, BLOOD, V90, P2654, DOI 10.1182/blood.V90.7.2654.2654_2654_2659; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Tayebi N, 1997, AM J MED GENET, V73, P41, DOI 10.1002/(SICI)1096-8628(19971128)73:1<41::AID-AJMG9>3.0.CO;2-S; Weinryb Bernard, 1972, JEWS POLAND SOCIAL E; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0; ZIMRAN A, 1990, AM J HUM GENET, V46, P902; Zivelin A, 1998, BLOOD, V92, P1119, DOI 10.1182/blood.V92.4.1119.416k39_1119_1124; ZLOTOGORA J, 1988, AM J HUM GENET, V42, P271; ZOOSSMANNDISKIN A, 1995, NAT GENET, V11, P13, DOI 10.1038/ng0995-13	37	46	48	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1821	1832		10.1086/302946	http://dx.doi.org/10.1086/302946			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10777718	Green Published, Bronze			2022-12-18	WOS:000088373800010
J	Yuan, B; Neuman, R; Duan, SH; Weber, JL; Kwok, PY; Saccone, NL; Wu, JS; Liu, KY; Schonfeld, G				Yuan, B; Neuman, R; Duan, SH; Weber, JL; Kwok, PY; Saccone, NL; Wu, JS; Liu, KY; Schonfeld, G			Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-B GENE; APO-B; HETEROZYGOUS HYPOBETALIPOPROTEINEMIA; FATTY LIVER; MUTATIONS; CHOLESTEROL; PEDIGREES; FORM	Familial hypobetalipoproteinemia (FHBL) is an apparently autosomal dominant disorder of lipid metabolism characterized by less than fifth percentile age- and sex-specific levels of apolipoprotein beta (apo beta) and low-density lipoprotein-cholesterol. In a minority of cases, FHBL is due to truncation-producing mutations in the apo beta gene on chromosome 2p23-24. Previously, we reported on a four-generation FHBL kindred in which we had ruled out linkage of the trait to the apo beta gene. To locate other loci containing genes for low apo beta levels in the kindred, a genomewide search was conducted. Regions on 3p21.1-22 with two-point LOD scores >1.5 were identified. Additional markers were typed in the region of these signals. Two-point LOD scores in the region of D3S2407 increased to 3.35 at empty set = 0. GENEHUNTER confirmed this finding with an nonparametric multipoint LOD score of 7.5 (P = .0004). Additional model-free analyses were conducted with the square root of the apoa level as the phenotype. Results from the Loki and SOLAR programs further confirmed linkage of FHBL to 3p21.1-22. Weaker linkage to a region near D19S916 was also indicated by Loki and SOLAR. Thus, a heretofore unidentified genetic susceptibility locus for FHBL may reside on chromosome 3.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA	Washington University (WUSTL)	Schonfeld, G (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Campus Box 8046,660 S Euclid Ave, St Louis, MO 63110 USA.		Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL46420, R01HL59515] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmed A, 1998, AM J GASTROENTEROL, V93, P2598, DOI 10.1016/S0002-9270(98)00613-3; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Contois JH, 1996, CLIN CHEM, V42, P515; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; FARESE RV, 1992, J INTERN MED, V231, P643, DOI 10.1111/j.1365-2796.1992.tb01253.x; FAZIO S, 1991, J INTERN MED, V229, P41, DOI 10.1111/j.1365-2796.1991.tb00304.x; HASSTEDT SJ, 1994, PEDIGREE ANAL PACKAG; HAVEL RJ, 1995, METABOLIC BASIS INHE, P1853; HAVEL RJ, 1995, METABOLIC MOL BASES, P1841; HEATH SC, 1996, AM J HUM GENET, V58, P1323; HOBBS HH, 1989, J CLIN INVEST, V84, P656, DOI 10.1172/JCI114212; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP G, 1984, P NATL ACAD SCI USA, V81, P344; *NAT HEART LUNG BL, 1982, LIP LIP AN; Pulai JI, 1998, AM J MED GENET, V76, P79, DOI 10.1002/(SICI)1096-8628(19980226)76:1<79::AID-AJMG15>3.3.CO;2-E; SCHONFELD G, 1995, ANNU REV NUTR, V15, P23, DOI 10.1146/annurev.nu.15.070195.000323; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tarugi P, 1996, GASTROENTEROLOGY, V111, P1125, DOI 10.1016/S0016-5085(96)70082-3; Welty FK, 1998, ARTERIOSCL THROM VAS, V18, P1745, DOI 10.1161/01.ATV.18.11.1745; Wu JS, 1999, J LIPID RES, V40, P955	22	46	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1699	1704		10.1086/302904	http://dx.doi.org/10.1086/302904			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762553	Green Published, Bronze			2022-12-18	WOS:000088373700025
J	Petryshen, TL; Kaplan, BJ; Liu, MF; Field, LL				Petryshen, TL; Kaplan, BJ; Liu, MF; Field, LL			Absence of significant linkage between phonological coding dyslexia and chromosome 6p23-21.3, as determined by use of quantitative-trait methods: Confirmation of qualitative analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							READING-DISABILITY; LOCUS; DEFICITS; 6P	We recently reported the absence of significant linkage of phonological coding dyslexia (PCD) to chromosome 6p23-p21.3 in 79 families with at least two affected siblings, even though linkage of dyslexia to this region has been found in four other independent studies. Whereas, in our previous analyses, we used a qualitative (affected, unaffected, or uncertain) PCD phenotype, here we report a reanalysis of linkage to the chromosome 6p region, by use of four quantitative measures of reading disability: phonological awareness, phonological coding, spelling, and rapid-automatized-naming (RAN) speed. The phonological-coding and spelling measures were highly correlated with each other and with the qualitative PCD phenotype, whereas the phonological-awareness and RAN-speed measures were only moderately correlated with the other measures. Using two-point and multipoint quantitative-trait sib-pair linkage analyses and variance-components analyses, we were unable to detect significant evidence for a locus in the 6p23-p21.3 region influencing any of the quantitative reading measures, supporting our previous qualitative linkage results. The most likely explanation for our inability to detect linkage between dyslexia and this region is that families with subtypes of dyslexia linked to this region are underrepresented in our sample, because of either chance or varying ascertainment criteria.	Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Paediat, Calgary, AB T2N 4N1, Canada; Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary	Field, LL (corresponding author), Univ Calgary, Fac Med, Dept Med Genet, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	field@ucalgary.ca	Petryshen, Tracey/X-5850-2019	Petryshen, Tracey/0000-0002-7972-4612	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, 1P41 RR03655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOWERS PG, 1991, J EXP CHILD PSYCHOL, V51, P195, DOI 10.1016/0022-0965(91)90032-N; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; *CAS W RES U, 1997, SAGE STAT AN GEN EP; DENCKLA M B, 1974, Cortex, V10, P186; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; FELTON RH, 1990, BRAIN LANG, V39, P485, DOI 10.1016/0093-934X(90)90157-C; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; FIELD LL, 1998, AM J HUM GENET, V64, P334; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Jastak S, 1984, WIDE RANGE ACHIEVEME; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Petryshen TL, 1999, AM J HUM GENET, V65, pA32; ROSNER J, 1971, J LEARN DISABIL, V4, P384, DOI 10.1177/002221947100400706; *SAS I, 1990, SAS VERS 6; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WOLF M, 1986, CHILD DEV, V57, P988, DOI 10.1111/j.1467-8624.1986.tb00260.x; Woodcock R.W., 1989, WOODCOCK JOHNSON PSY	20	46	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					708	714		10.1086/302764	http://dx.doi.org/10.1086/302764			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677330	Bronze, Green Published			2022-12-18	WOS:000088373100037
J	Bonafe, M; Olivieri, F; Mari, D; Baggio, G; Mattace, R; Berardelli, M; Sansoni, P; De Benedictis, G; De Luca, M; Marchegiani, F; Cavallone, L; Cardelli, M; Giovagnetti, S; Ferrucci, L; Amadio, L; Lisa, R; Tucci, MG; Troiano, L; Pini, G; Gueresi, P; Morellini, M; Sorbi, S; Passeri, G; Barbi, C; Valensin, S; Monti, D; Deiana, L; Pes, GM; Carru, C; Franceschi, C				Bonafe, M; Olivieri, F; Mari, D; Baggio, G; Mattace, R; Berardelli, M; Sansoni, P; De Benedictis, G; De Luca, M; Marchegiani, F; Cavallone, L; Cardelli, M; Giovagnetti, S; Ferrucci, L; Amadio, L; Lisa, R; Tucci, MG; Troiano, L; Pini, G; Gueresi, P; Morellini, M; Sorbi, S; Passeri, G; Barbi, C; Valensin, S; Monti, D; Deiana, L; Pes, GM; Carru, C; Franceschi, C			p53 codon 72 polymorphism and longevity: Additional data on centenarians from continental Italy and Sardinia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							BREAST-CANCER; HAPLOTYPES; GENE; RISK; AGE		Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; Univ Bologna, Dept Stat Sci, I-40126 Bologna, Italy; Italian Natl Res Ctr Aging, Ancona, Italy; Italian Natl Res Ctr Aging, Florence, Italy; Univ Milan, Maggiore Hosp, IRCCS, Inst Internal Med, Milan, Italy; Univ Sassari, Inst Clin Biochem, I-07100 Sassari, Italy; Univ Sassari, Chair Geriatr & Gerontol, I-07100 Sassari, Italy; Univ Reggio Calabria, Chair Geriatr, Catanzaro, Italy; Univ Parma, Inst Internal Med & Med Therapy, I-43100 Parma, Italy; Univ Calabria, Dept Cell Biol, I-87036 Rende, Italy; Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; Univ La Sapienza, Dept Expt Med, Genet Sect, Rome, Italy; Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; Univ Florence, Inst Gen Pathol, Florence, Italy	University of Bologna; University of Bologna; IRCCS INRCA; IRCCS INRCA; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Sassari; University of Sassari; Universita Mediterranea di Reggio Calabria; University of Parma; University of Calabria; Universita di Modena e Reggio Emilia; Sapienza University Rome; University of Florence; University of Florence	Franceschi, C (corresponding author), Univ Bologna, Dept Expt Pathol, Via S Giacomo N 12, I-40126 Bologna, Italy.		Franceschi, Claudio/L-4484-2017; Pes, Giovanni Mario/AAH-3340-2019; Cardelli, Maurizio/I-5505-2014; Olivieri, Fabiola/K-6465-2016; Mari, Daniela/K-5663-2016; Monti, Daniela/G-9556-2012; Marchegiani, Francesca/AAB-8925-2019; Carru, Ciriaco/AAI-9996-2021	Franceschi, Claudio/0000-0001-9841-6386; Pes, Giovanni Mario/0000-0003-3265-2823; Cardelli, Maurizio/0000-0002-4480-2473; Olivieri, Fabiola/0000-0002-9606-1144; Mari, Daniela/0000-0002-6950-0789; Monti, Daniela/0000-0001-8651-8123; Carru, Ciriaco/0000-0002-6985-4907; sorbi, sandro/0000-0002-0380-6670; LISA, ROSAMARIA/0000-0001-6337-9503; Passeri, Giovanni/0000-0002-4039-1160				Bonafe M, 1999, AM J HUM GENET, V64, P292, DOI 10.1086/302196; Capurso A, 1997, ARCH GERONTOL GERIAT, V25, P149; De Benedictis G, 1998, ANN HUM GENET, V62, P115, DOI 10.1017/S0003480098006757; Deiana L, 1999, AGING CLIN EXP RES, V11, P142, DOI 10.1007/BF03399655; Murata M, 1998, INT J ONCOL, V12, P577; Sjalander A, 1996, CARCINOGENESIS, V17, P1313, DOI 10.1093/carcin/17.6.1313; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Toupance B, 1998, AM J HUM GENET, V62, P1525, DOI 10.1086/301865; Wang YC, 1999, CLIN CANCER RES, V5, P129; Wang-Gohrke S, 1998, ANTICANCER RES, V18, P2095; Weston A, 1997, CANCER EPIDEM BIOMAR, V6, P105; Weston A, 1998, CANCER GENET CYTOGEN, V102, P153; Yashin AI, 1999, AM J HUM GENET, V65, P1178, DOI 10.1086/302572; YASHIN AI, 1998, J EPIDEMIOL BIOSTAT, V3, P289; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330	15	46	49	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1782	1785		10.1086/302664	http://dx.doi.org/10.1086/302664			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577935	Green Published, Bronze			2022-12-18	WOS:000084282500036
J	Giannelli, F; Anagnostopoulos, T; Green, PM				Giannelli, F; Anagnostopoulos, T; Green, PM			Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-IX GENE; MALE-DRIVEN EVOLUTION; POINT MUTATIONS; SHORT ADDITIONS; DNA-SEQUENCES; DELETIONS; DATABASE; CPG; EDITION; MODEL	We estimated the rates per base per generation of specific types of mutations, using our direct estimate of the overall mutation rate for hemophilia B and information on the mutations present in the United Kingdom's population as well as those reported year by year in the hemophilia B world database. These rates are as follows: transitions at CpG sites 9.7 x 10(-8), other transitions 7.3 x 10(-9), transversions at CpG sites 5.4 x 10(-9), other transversions 6.9 x 10(-9), and small deletions/insertions causing frameshifts 3.2 x 10(-10). By taking into account the ratio of male to female mutation rates, the above figures were converted into rates appropriate for autosomal DNA-namely, 1.3 x 10(-7), 9.3 x 10(-9), 7.3 x 10(-9), 3.4 x 10(-9), 6.5 x 10(-10), where the latter is the rate for all small deletion/insertion events. Mutation rates were also independently estimated from the sequence divergence observed in randomly chosen sequences from the human and chimpanzee X and Y chromosomes. These estimates were highly compatible with those obtained from hemophilia B and showed higher mutation rates in the male, but they showed no evidence for a significant excess of transitions at CpG sites in the spectrum of Y-sequence divergence relative to that of X-chromosome divergence. Our data suggest an overall mutation rate of 2.14 x 10(-8) per base per generation, or 128 mutations per human zygote. Since the effective target for hemophilia B mutations is only 1.05% of the factor IX gene, the rate of detrimental mutations, per human zygote, suggested by the hemophilia data is similar to 1.3.	Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England	University of London; King's College London	Giannelli, F (corresponding author), Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, Guys Campus,8th Floor,Guys Hosp Tower,London Brid, London SE1 9RT, England.							Anagnostopoulos T, 1999, AM J HUM GENET, V64, P508, DOI 10.1086/302250; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Burks C, 1999, NUCLEIC ACIDS RES, V27, P1, DOI 10.1093/nar/27.1.1; Crow JF, 1999, NATURE, V397, P293, DOI 10.1038/16789; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; Drake JW, 1998, GENETICS, V148, P1667; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Giannelli F, 1998, NUCLEIC ACIDS RES, V26, P265, DOI 10.1093/nar/26.1.265; GIANNELLI F, 1990, NUCLEIC ACIDS RES, V18, P4053, DOI 10.1093/nar/18.14.4053; Giannelli F, 1997, NUCLEIC ACIDS RES, V25, P133, DOI 10.1093/nar/25.1.133; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; Green PM, 1999, AM J HUM GENET, V65, P1572, DOI 10.1086/302651; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; Li W-H., 1991, FUNDAMENTALS MOL EVO; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; NAYLOR JA, 1995, HUM MOL GENET, V4, P1217, DOI 10.1093/hmg/4.7.1217; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Sommer SS, 1996, HUM MOL GENET, V5, P1505, DOI 10.1093/hmg/5.Supplement_1.1505; TUDDENHAM EGD, 1994, HAEMOSTASIS THROMBOS, P859; Vogel F., 1997, HUMAN GENETICS PROBL; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	29	46	46	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1580	1587		10.1086/302652	http://dx.doi.org/10.1086/302652			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577911	Bronze, Green Published			2022-12-18	WOS:000084282500012
J	Schwarze, U; Starman, BJ; Byers, PH				Schwarze, U; Starman, BJ; Byers, PH			Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: Influence of intron splice order on outcome of splice-site mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; INTERVENING SEQUENCES; COL3A1 GENE; SELECTION; PROCOLLAGEN; DEFINITION; MECHANISM; INVITRO; DEFECTS; DNA	Most splice-site mutations lead to a limited array of products, including exon skipping, use of cryptic splice-acceptor or -donor sites, and intron inclusion. At the intron 8 splice-donor site of the COL1A1 gene, we identified a G+1-->A transition that resulted in the production of several splice products from the mutant allele. These included one in which the upstream exon 7 was extended by 96 nt, others in which either intron 8 or introns 7 and 8 were retained, one in which exon 8 was skipped, and one that used a cryptic donor site in exon 8. To determine the mechanism by which exon-7 redefinition might occur, we examined the order of intron removal in the region of the mutation by using intron/exon primer pairs to amplify regions of the precursor nuclear mRNA between exon 5 and exon 10. Removal of introns 5, 6, and 9 was rapid. Removal of intron 8 usually preceded removal of intron 7 in the normal gene, although, in a small proportion of copies, the order was reversed. The proportion of abnormal products suggested that exon 7 redefinition, intron 7 plus intron 8 inclusion, and exon 8 skipping all represented products of the impaired rapid pathway, whereas the intron-8 inclusion product resulted from use of the slow intron 7-first pathway. The very low-abundance cryptic exon 8 donor site product could have arisen from either pathway. These results suggest that there is commitment of the pre-mRNA to the two pathways, independent of the presence of the mutation, and that the order and rate of intron removal are important determinants of the outcome of splice-site mutations and may explain some unusual alterations.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.			Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR41223] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041223] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BATEMAN JF, 1994, BIOCHEM J, V302, P729, DOI 10.1042/bj3020729; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BYERS PH, 1995, METABOLIC MOL BASES, P4029; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; Cooper DN, 1995, METABOLIC MOL BASES, P259; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; GUDAS JM, 1990, MOL CELL BIOL, V10, P5591, DOI 10.1128/MCB.10.10.5591; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LANG KM, 1987, MOL CELL BIOL, V7, P3428, DOI 10.1128/MCB.7.10.3428; LANG KM, 1985, EMBO J, V4, P1991, DOI 10.1002/j.1460-2075.1985.tb03882.x; LANG KM, 1983, SCIENCE, V220, P1351, DOI 10.1126/science.6304877; Maquat LE, 1996, AM J HUM GENET, V59, P279; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; MICHAUD S, 1993, GENE DEV, V7, P1008, DOI 10.1101/gad.7.6.1008; Murray HL, 1999, CELL, V96, P599, DOI 10.1016/S0092-8674(00)80568-1; REED R, 1997, EUKARYOTIC MRNA PROC, P103; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwarze U, 1997, AM J HUM GENET, V61, P1276, DOI 10.1086/301641; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; WILLING MC, 1994, AM J HUM GENET, V55, P638; ZAFARULLAH K, 1990, NUCLEIC ACIDS RES, V18, P6180, DOI 10.1093/nar/18.20.6180	34	46	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					336	344		10.1086/302512	http://dx.doi.org/10.1086/302512			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417276	Green Published, Bronze			2022-12-18	WOS:000081836900009
J	Ellis, NA; Ciocci, S; Proytcheva, M; Lennon, D; Groden, J; German, J				Ellis, NA; Ciocci, S; Proytcheva, M; Lennon, D; Groden, J; German, J			The Ashkenazic Jewish bloom syndrome mutation blm(Ash) is present in non-Jewish Americans of Spanish ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLM	Bloom syndrome (BS) is more frequent in the Ashkenazic Jewish population than in any other. There. the predominant mutation, referred to as "blm(Ash)," is a 6-bp deletion and 7-bp insertion at nucleotide position 2281 in the BLM cDNA. Using a convenient PCR assay, we have identified blm(Ash) on 58 of 60 chromosomes transmitted by Ashkenazic parents to persons with BS. In contrast, in 91 unrelated non-Ashkenazic persons with BS whom we examined, blm(Ash) was identified only in 5, these, coming from Spanish-speaking Christian families from the southwestern United States, Mexico, or El Salvador. These data, along with haplotype analyses, show that blm(Ash) was independently established through a founder effect in Ashkenazic Jews and in immigrants to formerly Spanish colonies. This striking observation underscores the complexity of Jewish history and demonstrates the importance of migration and genetic drift in the formation of human populations.	Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; New York Blood Ctr, Lab Human Genet, New York, NY 10021 USA; Univ Cincinnati, Howard Hughes Med Inst, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Memorial Sloan Kettering Cancer Center; New York Blood Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Ellis, NA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.				NCI NIH HHS [CA50897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNAVI E, 1992, HIST ATLAS JEWISH PE; Berg M A, 1994, Acta Paediatr Suppl, V399, P112; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELLIS NA, 1994, AM J HUM GENET, V55, P453; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Eng CM, 1997, JAMA-J AM MED ASSOC, V278, P1268, DOI 10.1001/jama.278.15.1268; Gerber JS, 1992, JEWS SPAIN HIST SEPH; GERMAN J, 1989, CLIN GENET, V35, P57; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; GERMAN J, 1994, P NATL ACAD SCI USA, V91, P6669, DOI 10.1073/pnas.91.14.6669; GERMAN J, 1977, AM J HUM GENET, V29, P553; German J, 1998, GENETIC BASIS HUMAN, P301; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Li L, 1998, MOL GENET METAB, V64, P286, DOI 10.1006/mgme.1998.2733; ROCHLIN H, 1986, PIONEER JEWS; Straughen J, 1996, GENOMICS, V35, P118, DOI 10.1006/geno.1996.0330; Straughen JE, 1998, HUM MUTAT, V11, P175	18	46	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1685	1693		10.1086/302167	http://dx.doi.org/10.1086/302167			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837821	Green Published, Bronze			2022-12-18	WOS:000077707700014
J	Toupance, B; Godelle, B; Gouyon, PH; Schachter, F				Toupance, B; Godelle, B; Gouyon, PH; Schachter, F			A model for antagonistic pleiotropic gene action for mortality and advanced age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; MYOCARDIAL-INFARCTION; DELETION POLYMORPHISM; HUMAN LONGEVITY; CAENORHABDITIS-ELEGANS; LIFE-SPAN; DROSOPHILA; SENESCENCE; EVOLUTION; DISEASE	Association or linkage studies involving control and long-lived populations provide information on genes that influence longevity. However, the relationship be;tween allele-specific differences in survival and the genetic structure of aging cohorts remains unclear. We model a heterogeneous cohort comprising several genotypes differing in age-specific mortality. In its most general form, without any specific assumption regarding the shape of mortality curves, the model permits derivation of a fundamental property underlying abrupt age-related changes in the composition of a cohort. The model is applied to sex-specific survival curves taken from period life tables, and Gompertz-Makeham mortality coefficients are calculated for the French population. Then, adjustments are performed under Gompertz-Makeham mortality functions for three genotypes composing a heterogeneous cohort, under the constraint of fitting the resultant mortality to the real French population mortality obtained from life tables. Multimodal curves and divergence after the 8th decade appear as recurrent features of the frequency trajectories. Finally, a fit to data previously obtained at the angiotensin-converting-enzyme locus is realized, explaining what had seemed to be paradoxical results-namely, that the frequency of a genotype known as a cardiovascular risk factor was increased in centenarians. Our results help explain the well-documented departure from Gompertz-Makeham mortality kinetics at older ages. The implications of our model are discussed in the context of known genetic effects on human longevity and age-related pathologies. Since antagonistic pleiotropy between early and late survival emerges as a general rule, extrapolating the effects measured for a gene in a particular age class to other ages could be misleading.	Univ Paris 11, Lab Evolut & Systemat, CNRS, URA 2154, F-91405 Orsay, France; Inst Pasteur, Lab Human Genet, Paris, France; Inst Natl Agron Paris Grignon, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Schachter, F (corresponding author), Univ Paris 11, Lab Evolut & Systemat, CNRS, URA 2154, Bat 362, F-91405 Orsay, France.	Bruno.TOUPANCE@esv.u-psud.fr	Gouyon, Pierre-Henri/A-9603-2013	TOUPANCE, Bruno/0000-0002-8244-1824				ALLARD M, 1993, IUSSP SEM HLTH MORT; CAMBIEN F, 1994, CIRCULATION, V90, P669, DOI 10.1161/01.CIR.90.2.669; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; CHARLESWORTH B, 1994, EVOLUTION AGE STRUCT; Comfort A., 1979, BIOL SENESCENCE; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; Finch C.E., 1994, LONGEVITY SENESCENCE; Gavrilova N.S., 1991, BIOL LIFE SPAN QUANT; GUNBY P, 1995, JAMA-J AM MED ASSOC, V274, P597; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HAMMOND EC, 1971, CIRCULATION, V43, P31, DOI 10.1161/01.CIR.43.1.31; HUGHES KA, 1994, NATURE, V367, P64, DOI 10.1038/367064a0; *I NAT STAT ET EC, 1993, ANN STAT FRANC RES 1, V97; Ivanova R, 1998, HUM MOL GENET, V7, P187, DOI 10.1093/hmg/7.2.187; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; JOHNSON TE, 1987, P NATL ACAD SCI USA, V84, P3777, DOI 10.1073/pnas.84.11.3777; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KOWALD A, 1993, SCIENCE, V260, P1664, DOI 10.1126/science.8503014; Lasdon LS, 1978, ACM T MATH SOFTWARE, V4, P34, DOI DOI 10.1145/355769.355773; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; McClearn G E, 1987, Basic Life Sci, V42, P135; McClearn GE, 1997, EXP GERONTOL, V32, P49, DOI 10.1016/S0531-5565(96)00066-6; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; PROUST J, 1982, TISSUE ANTIGENS, V19, P168, DOI 10.1111/j.1399-0039.1982.tb01436.x; ROSE MR, 1985, THEOR POPUL BIOL, V28, P342, DOI 10.1016/0040-5809(85)90034-6; SACHER GA, 1977, HDB BIOL AGING, P582; SCHACHTER F, 1993, HUM GENET, V91, P519; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; TAKATA H, 1987, LANCET, V2, P824; TIRET L, 1993, LANCET, V341, P991, DOI 10.1016/0140-6736(93)91075-W; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1993, SCIENCE, V260, P1666, DOI 10.1126/science.8503016; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	36	46	46	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1525	1534		10.1086/301865	http://dx.doi.org/10.1086/301865			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585593	Green Published, Bronze			2022-12-18	WOS:000074174700031
J	Schmidtchen, A; Greenberg, D; Zhao, HG; Li, HH; Huang, Y; Tieu, P; Zhao, HZ; Cheng, SS; Zhao, ZY; Whitley, CB; Di Natale, P; Neufeld, EF				Schmidtchen, A; Greenberg, D; Zhao, HG; Li, HH; Huang, Y; Tieu, P; Zhao, HZ; Cheng, SS; Zhao, ZY; Whitley, CB; Di Natale, P; Neufeld, EF			NAGLU mutations underlying Sanfilippo syndrome type B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; MUCOPOLYSACCHARIDOSIS; GENE; CLONING	Sanfilippo syndrome type B (mucopolysaccharidosis III B) is a rare autosomal recessive disease caused by deficiency of alpha-N-acetylglucosaminidase, one of the enzymes required for the lysosomal degradation of heparan sulfate. The gene for this enzyme, NAGLU, recently was isolated, and several mutations were characterized. We have identified, in amplified exons from nine fibroblast cell lines derived from Sanfilippo syndrome type B patients, 10 additional mutations: Y92H, P115S, Y140C, E153K, R203X, 650insC, 901delAA, P358L, AG64V, and L682R. Four of these mutations were found in homozygosity, and only two were seen in more than one cell line. Thus, Sanfilippo syndrome type B shows extensive molecular heterogeneity. Stable transfection of Chinese hamster ovary cells, by cDNA mutagenized to correspond to the NAGLU missense mutations, did not yield active enzyme, demonstrating the deleterious nature of the mutations. Nine of the 10 amino acid substitutions identified to date are clustered near the amino or the carboxyl end of alpha-N-acetylglucosaminidase, suggesting a role for these regions in the transport or function of the enzyme.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Minnesota, Sch Med, Inst Human Genet, Minneapolis, MN 55455 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; University of Naples Federico II	Neufeld, EF (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, 33-257 CHS,POB 951737, Los Angeles, CA 90095 USA.		Schmidtchen, Artur/F-9507-2015	Greenberg, David/0000-0001-8959-8640	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010141] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 10141, NS22376] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aronovich E. L., 1996, American Journal of Human Genetics, V59, pA246; CHOW P, 1981, CARBOHYD RES, V96, P87, DOI 10.1016/S0008-6215(00)84698-4; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; FRIEDMAN LS, 1995, GENOMICS, V25, P256, DOI 10.1016/0888-7543(95)80133-7; KAKKIS ED, 1994, PROTEIN EXPRES PURIF, V5, P225, DOI 10.1006/prep.1994.1035; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; MURATA R, 1989, AM J NEURORADIOL, V10, P1165; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAW BH, 1991, AM J HUM GENET, V48, P1139; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAMAGAWA K, 1985, BRAIN DEV-JPN, V7, P599, DOI 10.1016/S0387-7604(85)80008-5; Weber B, 1996, HUM MOL GENET, V5, P771, DOI 10.1093/hmg/5.6.771; Zhao H. G., 1995, American Journal of Human Genetics, V57, pA185; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101; Zhao Z, 1996, MAMM GENOME, V7, P686, DOI 10.1007/s003359900206; Zhao Z, 1997, MAMM GENOME, V8, P161, DOI 10.1007/s003359900381	17	46	49	0	10	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					64	69		10.1086/301685	http://dx.doi.org/10.1086/301685			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443878	Bronze, Green Published			2022-12-18	WOS:000072127900011
J	Matsushita, S; Muramatsu, T; Arai, H; Matsui, T; Higuchi, S				Matsushita, S; Muramatsu, T; Arai, H; Matsui, T; Higuchi, S			The frequency of the methylenetetrahydrofolate reductase gene mutation varies with age in the normal population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RISK FACTOR; MILD HYPERHOMOCYSTEINEMIA; VASCULAR-DISEASE; COMMON MUTATION		Kurihama Natl Hosp, Natl Inst Alcoholism, Dept Psychiat, Kanagawa 239, Japan; Tohoku Univ, Sch Med, Dept Geriatr Med, Sendai, Miyagi 980, Japan	Tohoku University	Matsushita, S (corresponding author), Kurihama Natl Hosp, Natl Inst Alcoholism, Dept Psychiat, 5-3-1 Nobi, Kanagawa 239, Japan.			Matsui, Toshifumi/0000-0002-8478-2809				BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; *HLTH WELF STAT AS, 1995, TRENDS NAT HLTH COND; KANG SS, 1993, CIRCULATION, V88, P1463, DOI 10.1161/01.CIR.88.4.1463; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35	6	46	46	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1459	1460		10.1086/301640	http://dx.doi.org/10.1086/301640			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399898	Green Published, Bronze			2022-12-18	WOS:000071555900035
J	Barbujani, G				Barbujani, G			DNA variation and language affinities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							SEQUENCE DIVERSITY; HUMAN-POPULATIONS; GENETIC-EVIDENCE; EUROPE; ORIGIN; BOUNDARIES; DISTANCES; LINEAGES; BASQUES; AFRICA				Barbujani, G (corresponding author), UNIV FERRARA, DIPARTIMENTO BIOL, VIA L BORSARI 46, I-44100 FERRARA, ITALY.		Barbujani, Guido/ABE-9998-2020	Barbujani, Guido/0000-0001-7854-6669				Bandelt Hans-Juergen, 1994, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V34, P51; BARBUJANI G, 1991, TRENDS ECOL EVOL, V6, P151, DOI 10.1016/0169-5347(91)90056-4; BARBUJANI G, 1993, P NATL ACAD SCI USA, V90, P4670, DOI 10.1073/pnas.90.10.4670; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BERTORELLE G, 1995, GENETICS, V140, P811; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; EXCOFFIER L, 1992, GENETICS, V131, P479; GUGLIELMINO CR, 1995, P NATL ACAD SCI USA, V92, P7585, DOI 10.1073/pnas.92.16.7585; KIMURA M, 1964, GENETICS, V49, P561; Lahermo P, 1996, AM J HUM GENET, V58, P1309; MORTON NE, 1968, AM J HUM GENET, V20, P411; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; ROBERTS DF, 1988, BIOL ASPECTS HUMAN M; RUHLEN M, 1992, SFI S SCI C, V11, P159; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Semino O, 1996, AM J HUM GENET, V59, P964; SOKAL RR, 1992, P NATL ACAD SCI USA, V89, P7669, DOI 10.1073/pnas.89.16.7669; SOKAL RR, 1988, AM J PHYS ANTHROPOL, V76, P337, DOI 10.1002/ajpa.1330760308; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; Stenico M, 1996, AM J HUM GENET, V59, P1363; TORRONI A, 1992, GENETICS, V130, P153; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; Watson E, 1996, AM J HUM GENET, V59, P437	32	46	45	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1011	1014		10.1086/301620	http://dx.doi.org/10.1086/301620			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345113	Green Published, Bronze			2022-12-18	WOS:A1997YH01700005
J	Munoz, F; Lestringant, G; Sybert, V; Frydman, M; Alswaini, A; Frossard, PM; Jorgenson, R; Zonana, J				Munoz, F; Lestringant, G; Sybert, V; Frydman, M; Alswaini, A; Frossard, PM; Jorgenson, R; Zonana, J			Definitive evidence for an autosomal recessive form of hypohidrotic ectodermal dysplasia clinically indistinguishable from the more common X-linked disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIEMENS-TOURAINE SYNDROME; FEMALE; INHERITANCE; CHROMOSOME; ARGUMENT; LOCUS; MAP	A crucial issue in genetic counseling is the recognition of nonallelic genetic heterogeneity. Hypohidrotic (anhidrotic) ectodermal dysplasia (HED), a genetic disorder characterized by defective development of hair, teeth, and eccrine sweat glands, is usually inherited as an X-linked recessive trait mapped to the X-linked ectodermal dysplasia locus, EDA, at Xq12-q13.1. The existence of an autosomal recessive form of the disorder had been proposed but subsequently had been challenged by the hypothesis that the phenotype of severely affected daughters born to unaffected mothers in these rare families may be due to marked skewing of X inactivation. Five families with possible autosomal recessive HED have been identified, on the basis of the presence of severely affected females and unaffected parents in single sibships and in highly consanguineous families with multiple affected family members. The disorder was excluded from the EDA locus by the lack of its cosegregation with polymorphic markers flanking the EDA locus in three of five families. No mutations of the EDA gene were detected by SSCP analysis in the two families not excluded by haplotype analysis. The appearance of affected males and females in autosomal recessive HED was clinically indistinguishable from that seen in males with X-linked HED. The findings of equally affected males and females in single sibships, as well as the presence of consanguinity, support an autosomal recessive mode of inheritance. The fact that phenotypically identical types of HED can be caused by mutations at both X-linked and autosomal loci is analogous to the situation in the mouse, where indistinguishable phenotypes are produced by mutations at both X-linked (Tabby) and autosomal loci (crinkled and downless).	OREGON HLTH SCI UNIV, DEPT MOL & MED GENET L103, PORTLAND, OR 97201 USA; MINIST HLTH, ABU DHABI, U ARAB EMIRATES; UNIV WASHINGTON, SEATTLE, WA 98195 USA; CHILDRENS HOSP & MED CTR, SEATTLE, WA 98105 USA; INST HUMAN GENET, TEL HASHOMER, ISRAEL; S TEXAS GENET CTR, SAN ANTONIO, TX USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Seattle Children's Hospital					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011311] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01-DE11311-6] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anton-Lamprecht I, 1988, Birth Defects Orig Artic Ser, V24, P183; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; BROWNE DL, 1993, HUM MOL GENET, V2, P611, DOI 10.1093/hmg/2.5.611-a; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; CRUMP IA, 1971, J PEDIATR-US, V78, P466, DOI 10.1016/S0022-3476(71)80229-9; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; Ferguson B. M., 1996, American Journal of Human Genetics, V59, pA258; FREIREMAIA N, 1982, AM J HUM GENET, V34, P672; GORLIN RJ, 1970, Z KINDERHEILKD, V108, P1, DOI 10.1007/BF00440560; KISS P, 1990, PEDIATR DERMATOL, V7, P242, DOI 10.1111/j.1525-1470.1990.tb00291.x; KKERE J, 1996, NAT GENET, V13, P409; LIMON J, 1991, HUM GENET, V87, P338; MACDERMOT KD, 1990, HUM GENET, V84, P577; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Parant M, 1969, Rev Stomatol Chir Maxillofac, V70, P461; PASSARGE E, 1966, HUMANGENETIK, V3, P181, DOI 10.1007/BF00291298; PLOUGASTEL B, 1992, GENOMICS, V14, P523, DOI 10.1016/S0888-7543(05)80259-9; SOFAER JA, 1979, GENET RES, V33, P169, DOI 10.1017/S0016672300018309; SOFAER JA, 1974, GENET RES, V23, P219, DOI 10.1017/S0016672300014841; SYBERT VP, 1989, PEDIATR DERMATOL, V6, P76, DOI 10.1111/j.1525-1470.1989.tb01002.x; TURLEAU C, 1989, CLIN GENET, V35, P462; WEEKS DE, 1995, GENOMICS, V26, P39, DOI 10.1016/0888-7543(95)80080-6; ZONANA J, 1992, AM J HUM GENET, V51, P1036; ZONANA J, 1993, SEMIN DERMATOL, V12, P241	24	46	48	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					94	100						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245989				2022-12-18	WOS:A1997XM72800016
J	Langley, SD; Lai, K; Dembure, PP; Hjelm, LN; Elsas, LJ				Langley, SD; Lai, K; Dembure, PP; Hjelm, LN; Elsas, LJ			Molecular basis for Duarte and Los Angeles variant Galactosemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE; GENE; URIDYLTRANSFERASE; MUTATIONS	Human erythrocytes that are homozygous for the Duarte enzyme variant of galactosemia (D/D) have a characteristic isoform on isoelectric focusing and 50% reduction in galactose-1-phosphate uridyltransferase (GALT) enzyme activity. The Duarte biochemical phenotype has a molecular genotype of N314D/N314D. The characteristic Duarte isoform is also associated with a variant called the ''Los Angeles (LA) phenotype,'' which has increased GALT enzyme activity. We evaluated GALT enzyme activity and screened the GALT genes of 145 patients with one or more N314D-containing alleles. We found seven with the LA biochemical phenotype, and all had a 1721C-->T transition in exon 7 in cis with the N314D missense mutation. The 1721C-->T transition is a neutral polymorphism for leucine at amino acid 218 (L218L). In pedigree analyses, this 1721C-->T transition segregated with the LA phenotype of increased GALT activity in three different biochemical phenotypes (LA/N, LA/G, and LA/D). To determine the mechanism for increased activity of the LA variant, we compared GALT mRNA, protein abundance, and enzyme thermal stability in lymphoblast cell lines of D and LA phenotypes with comparable genotypes. GALT protein abundance was increased in LA compared to D alleles, but mRNA was similar among all genotypes. When LA/D and D/D GALT biochemical phenotypes were compared to N/N GALT phenotypes, both had 50%, as compared to 21%, reduction in GALT activity in the wild type (N/N) after exposure at identical initial enzyme activity to 50 degrees C for 15 min. We conclude that the codon change N314D in cis with the base-pair transition 1721C-->T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability. A favorable codon bias for the mutated codon with consequently increased translation rates is postulated as the mechanism.	EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA 30322	Emory University					NCRR NIH HHS [M01-RR00039] Funding Source: Medline; NICHD NIH HHS [P0-1 HD 29847] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD029847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON MW, 1984, HUM GENET, V68, P287; BEUTLER E, 1965, LANCET, V1, P353; BEUTLER E, 1966, J LAB CLIN MED, V68, P137; BEUTLER E, 1973, ISRAEL J MED SCI, V9, P1323; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; ELSAS LJ, 1995, AM J HUM GENET, V56, P630; ELSAS LJ, 1994, AM J HUM GENET, V54, P1030; ELSAS LJ, 1995, EARLY HOSP DISCHARGE, P249; FLACH JE, 1990, MOL BIOL MED, V7, P365; FridovichKeil JL, 1995, BIOCHEM MOL MED, V56, P121, DOI 10.1006/bmme.1995.1067; GREBER S, 1995, PEDIATR RES, V38, P434; IBARRA B, 1979, HUM GENET, V48, P121, DOI 10.1007/BF00273284; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; Lai K, 1996, J PEDIATR-US, V128, P89, DOI 10.1016/S0022-3476(96)70432-8; LESLIE ND, 1992, GENOMICS, V14, P474, DOI 10.1016/S0888-7543(05)80244-7; LIN HC, 1994, HUM GENET, V93, P167; MELLMAN WJ, 1968, ANN HUM GENET, V32, P1, DOI 10.1111/j.1469-1809.1968.tb00043.x; NG WG, 1973, ANN HUM GENET, V37, P1, DOI 10.1111/j.1469-1809.1973.tb01808.x; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; STROBL W, 1995, ENZYME PROTEIN, V48, P130; THOMAKOS A, 1977, HUM GENET, V36, P335, DOI 10.1007/BF00446285; VACCARO AM, 1984, HUM HERED, V34, P197, DOI 10.1159/000153463	23	46	49	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					366	372						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012409				2022-12-18	WOS:A1997WE93100015
J	Griffin, DK; Abruzzo, MA; Millie, EA; Feingold, E; Hassold, TJ				Griffin, DK; Abruzzo, MA; Millie, EA; Feingold, E; Hassold, TJ			Sex ratio in normal and disomic sperm: Evidence that the extra chromosome 21 preferentially segregates with the Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PATERNAL AGE; NONDISJUNCTION; RECOMBINATION	In humans, deviations from a 1:1 male:female ratio have been identified in both chromosomally normal and trisomic live births: among normal newborns there is a slight excess of males, among trisomy 18 live borns a large excess of females, and among trisomy 21 live borns an excess of males. These differences could arise from differential production of or fertilization by Y- or X-bearing sperm or from selection against male or female conceptions. To examine the proportion of Y- and X-bearing sperm in normal sperm and in sperm disomic for chromosomes 18 or 21, we used three-color FISH (to the X and Y and either chromosome 18 or chromosome 21) to analyze >300,000 sperm from 24 men. In apparently normal sperm, the sex ratio was nearly 1:1 (148,074 Y-bearing to 148,657 X-bearing sperm), and the value was not affected by the age of the donor. Certain of the donors, however, had significant excesses of Y- or X-bearing sperm. In disomy 18 sperm, there were virtually identical numbers of Y- and X-bearing sperm; thus, the excess of females in trisomy 18 presumably is due to selection against male trisomic conceptions. In contrast, we observed 69 Y-bearing and 44 X-bearing sperm disomic for chromosome 21. This is consistent with previous molecular studies, which have identified an excess of males among paternally derived cases of trisomy 21, and suggests that some of the excess of males among Down syndrome individuals is attributable to a nondisjunctional mechanism in which the extra chromosome 21 preferentially segregates with the Y chromosome.	CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH; EMORY UNIV,DEPT BIOSTAT,ATLANTA,GA 30322	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Emory University				Feingold, Eleanor/0000-0003-2898-6484	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341, P01HD032111] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21341, HD32111] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHAKYO CA, 1992, HUM GENET, V90, P79; FISHER JM, 1995, AM J HUM GENET, V56, P669; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; HASSOLD T, 1983, ANN HUM GENET, V47, P39, DOI 10.1111/j.1469-1809.1983.tb00968.x; HAWLEY RS, 1993, TRENDS GENET, V9, P310; Huether C., 1990, ISSUES REV TERATOL, V5, P283; Huether C, 1996, AM J MED GENET, V63, P382; JAMES WH, 1980, BRIT MED J, V281, P711, DOI 10.1136/bmj.281.6242.711; JAMES WH, 1985, J BIOSOC SCI, V17, P47, DOI 10.1017/S0021932000015467; JAMES WH, 1987, HUM BIOL, V59, P721; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; PETERSEN MB, 1993, HUM MOL GENET, V2, P1691; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Spriggs EL, 1996, AM J HUM GENET, V58, P356; ULIZZI L, 1994, HUM BIOL, V66, P1037; VISARIA PM, 1967, EUGEN QUART, V14, P132, DOI 10.1080/19485565.1967.9987713	17	46	49	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1108	1113						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900240				2022-12-18	WOS:A1996VN90000019
J	Kemp, TJ; Poulter, M; Carritt, B				Kemp, TJ; Poulter, M; Carritt, B			A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D-phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALU-ALU RECOMBINATION; FAMILIAL HYPERCHOLESTEROLEMIA; BLOOD; INDIVIDUALS; EXPRESSION; DELETION; LOCUS; POLYMORPHISMS; DEFICIENCY; SEQUENCES	We have studied the arrangement of Rh (rhesus) genes in donors who are completely null for the products of one of them, RHCE. We show that five of six homozygous individuals with the so-called Rh D-- phenotype, who express no red-cell antigens of the C/c and E/e series, have rearranged RHCE genes in which internal sequences have been replaced by the corresponding sequences from RHD. Moreover, although there is heterogeneity at the 3' end, the 5' boundary of this chimerism is within the same small interval around exon 2. This interval is characterized by an exceptionally high degree of sequence homology between RHCE and RHD, a high density of dispersed repetitive elements, and the presence of an alternating purine-pyrimidine copolymer tract, We suggest that these features may explain the mechanistic basis for the origin of the rearrangement.	UCL, MRC, HUMAN BIOCHEM GENET UNIT, LONDON NW1 2HE, ENGLAND	University of London; University College London								ARCE MA, 1993, BLOOD, V82, P651; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; BLUNT T, 1994, VOX SANG, V67, P397, DOI 10.1111/j.1423-0410.1994.tb01280.x; BLUNT T, 1994, ANN HUM GENET, V58, P19, DOI 10.1111/j.1469-1809.1994.tb00722.x; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; BUCHANAN DI, 1956, AM J CLIN PATHOL, V26, P21; CARRITT B, 1993, ANN HUM GENET, V7, P273; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; CHERIFZAHAR B, 1994, BLOOD, V84, P4354, DOI 10.1182/blood.V84.12.4354.bloodjournal84124354; CHERIFZAHAR B, 1993, BLOOD, V82, P656, DOI 10.1182/blood.V82.2.656.bloodjournal822656; COLIN Y, 1991, BLOOD, V78, P2747; CONTRERAS M, 1979, VOX SANG, V36, P81, DOI 10.1111/j.1423-0410.1979.tb04403.x; HUANG CH, 1995, BLOOD, V86, P784, DOI 10.1182/blood.V86.2.784.bloodjournal862784; KIM CL, 1992, P NATL ACAD SCI USA, V89, P10925; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LO YMD, 1993, LANCET, V341, P1147, DOI 10.1016/0140-6736(93)93161-S; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MILLER WL, 1988, AM J HUM GENET, V42, P4; MILOSAVLJEVIC A, IN PRESS IMPERIAL CA; MORA ML, 1990, HUM HERED, V40, P278; MOURO I, 1993, NAT GENET, V5, P62, DOI 10.1038/ng0993-62; MOURO I, 1994, BLOOD, V83, P1129, DOI 10.1182/blood.V83.4.1129.bloodjournal8341129; OLAFSDOTTIR S, 1983, FORENSIC SCI INT, V22, P183, DOI 10.1016/0379-0738(83)90012-9; Poulter M, 1996, VOX SANG, V70, P164, DOI 10.1111/j.1423-0410.1996.tb01316.x; Race RR., 1975, BLOOD GROUPS MAN; ROUILLAC C, 1995, BLOOD, V85, P2937, DOI 10.1182/blood.V85.10.2937.bloodjournal85102937; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SIMSEK S, 1994, VOX SANG, V67, P203, DOI 10.1111/j.1423-0410.1994.tb01661.x; STRINGER JR, 1985, MOL CELL BIOL, V5, P1247, DOI 10.1128/MCB.5.6.1247; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; Whitehouse H. L. K., 1982, GENETIC RECOMBINATIO; WOLPER LC, 1994, BLOOD, V84, P985	34	46	47	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1066	1073						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900235				2022-12-18	WOS:A1996VN90000014
J	Salem, AH; Badr, FM; Gaballah, MF; Paabo, S				Salem, AH; Badr, FM; Gaballah, MF; Paabo, S			The genetics of traditional living: Y-chromosomal and mitochondrial lineages in the Sinai Peninsula	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									SUEZ CANAL UNIV,FAC MED,DEPT ANAT,ISMAILIA,EGYPT; CAIRO UNIV,FAC MED,DEPT ANAT,CAIRO,EGYPT	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Cairo University	Salem, AH (corresponding author), UNIV MUNICH,INST ZOOL,POB 202136,D-80021 MUNICH,GERMANY.		Salem, Abdel Halim A/A-3026-2013	Salem, Abdel Halim A/0000-0002-0733-4631				ABUZAYED A, 1991, SAHARAN EGYPT N SINA; CHEN HM, 1994, HUM MUTAT, V4, P208, DOI 10.1002/humu.1380040306; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Nei M., 1987, MOL EVOLUTIONARY GEN; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; ROEWER L, 1992, HUM GENET, V89, P389; *SPEC NAT COUNC, 1979, SIN YEAR 2000, P73	8	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					741	743						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751879				2022-12-18	WOS:A1996VN62500032
J	Pizzuti, A; Novelli, G; Mari, A; Ratti, A; Colosimo, A; Amati, F; Penso, D; Sangiuolo, F; Calabrese, G; Palka, G; Silani, V; Gennarelli, M; Mingarelli, R; Scarlato, G; Scambler, P; Dallapiccola, B				Pizzuti, A; Novelli, G; Mari, A; Ratti, A; Colosimo, A; Amati, F; Penso, D; Sangiuolo, F; Calabrese, G; Palka, G; Silani, V; Gennarelli, M; Mingarelli, R; Scarlato, G; Scambler, P; Dallapiccola, B			Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; NEURAL CREST; MICRODELETIONS; DELETIONS; CHROMOSOME-22; 22Q11; ANOMALIES; DEFECTS	DiGeorge syndrome (DGS) is a developmental defect of some of the neural crest derivatives. Most DGS patients show haploinsufficiency due to interstitial deletions of the proximal long arm of chromosome 22. Deletions of 22q11 have also been reported in patients with the velocardio-facial syndrome and familial conotruncal heart defects. It has been suggested that the wide phenotype spectrum associated with 22q11 monosomy is a consequence of contiguous-gene deletions. We report the isolation of human cDNAs homologous to the Drosophila dishevelled (dsh) segment-polarity gene. Sequences homologous to the 3' UTR of these transcripts (DVL-22) were positioned within the DGS critical region and were found to be deleted in DGS patients. Human DVL mRNAs are expressed in several fetal and adult tissues, including the thymus and, at high levels, the heart. Two transcripts, 3.2 and 5 kb, were detected, in northern blot analysis, with different expression patterns in the surveyed tissues when different cDNAs were used. The isolated cDNAs exhibit high amino acid homology with the mouse and Xenopus Dvl-1 gene, the only other vertebrate dsh homologues so far isolated, The pivotal role of dsh in fly development suggests an analogous key function in vertebrate embryogenesis of its homologue genes. Since DGS may be due to perturbation of differentiation mechanisms at decisive embryological stages, a Dsh-like gene in the small-region overlap (SRO) might be a candidate for the pathogenesis of this disorder.	UNIV MILAN,IST NEUROL,I-20122 MILAN,ITALY; UNIV CATTOLICA SACRO CUORE,CATTEDRA GENET UMANA,ROME,ITALY; UNIV CHIETI,IST BIOL & GENET,CHIETI,ITALY; OSPED CSS,IRCCS,SAN GIOVANNI ROTO,ITALY; INST CHILD HLTH,MOLEC MED UNIT,LONDON WC1N 1EH,ENGLAND; UNIV ROMA TOR VERGATA,CATTEDRA GENET UMANA & MED,DIPARTIMENTO SANITA PUBBL & BIOL CELLULARE,I-00133 ROME,ITALY	IRCCS Istituto Neurologico Besta; University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; G d'Annunzio University of Chieti-Pescara; IRCCS Casa Sollievo Della Sofferenza; University of London; University College London; University of Rome Tor Vergata			Gennarelli, Massimo/B-1377-2010; sangiuolo, federica/I-4392-2019; Scambler, Peter/AAZ-6026-2020; Silani, Vincenzo/P-4421-2017; Novelli, Giuseppe/T-8822-2019; Scambler, Peter J/C-4998-2008; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/A-5195-2013; Gennarelli, Massimo/AAL-3542-2020; Amati, Francesca/J-8439-2012; Dallapiccola, Bruno/K-8692-2016	sangiuolo, federica/0000-0002-6227-4248; Scambler, Peter/0000-0002-1487-4628; Silani, Vincenzo/0000-0002-7698-3854; Scambler, Peter J/0000-0002-1487-4628; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Amati, Francesca/0000-0003-2209-2156; PIZZUTI, Antonio/0000-0003-3245-1925; Dallapiccola, Bruno/0000-0002-5031-1013; GENNARELLI, Massimo/0000-0003-4192-945X	Telethon [D.027] Funding Source: Medline	Telethon(Fondazione Telethon)		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BALDINI A, 1991, GENOMICS, V9, P770, DOI 10.1016/0888-7543(91)90374-N; BEIER DR, 1992, P NATL ACAD SCI USA, V89, P9102, DOI 10.1073/pnas.89.19.9102; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BRYANT PJ, 1992, CELL, V68, P621, DOI 10.1016/0092-8674(92)90136-Z; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BUDARF ML, 1995, HUM MOL GENET, V4, P763, DOI 10.1093/hmg/4.4.763; BURN J, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P559; CALABRESE G, 1994, GENOMICS, V23, P286, DOI 10.1006/geno.1994.1497; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; Dickinson ME, 1992, CURR OPIN GENET DEV, V2, P562, DOI 10.1016/S0959-437X(05)80172-8; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P569; FIDLEROVA H, 1994, CYTOGENET CELL GENET, V65, P203, DOI 10.1159/000133632; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/jmg.30.10.807; GREENBERG F, 1993, J MED GENET, V30, P803, DOI 10.1136/jmg.30.10.803; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KIRBY ML, 1985, ANAT RECORD, V213, P87, DOI 10.1002/ar.1092130112; KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KURAHASHI H, 1995, HUM MOL GENET, V4, P541, DOI 10.1093/hmg/4.4.541; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; MORROW B, 1995, AM J HUM GENET, V56, P1391; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; PAYNE RM, 1995, CIRCULATION, V91, P494, DOI 10.1161/01.CIR.91.2.494; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; SCAMBLER PJ, 1993, CURR OPIN GENET DEV, V3, P432, DOI 10.1016/0959-437X(93)90117-8; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; SPRITZ RA, 1992, AM J MED GENET, V44, P492, DOI 10.1002/ajmg.1320440422; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THEISEN H, 1994, DEVELOPMENT, V120, P347; VANMIEROP LHS, 1986, AM J CARDIOL, V58, P133, DOI 10.1016/0002-9149(86)90256-0; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087	52	46	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					722	729						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644734				2022-12-18	WOS:A1996UA38000008
J	GUO, SW				GUO, SW			PROPORTION OF GENOME SHARED IDENTICAL BY DESCENT BY RELATIVES - CONCEPT, COMPUTATION, AND APPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; PROBABILITY; INDIVIDUALS; PEDIGREES	One widely used measure of genetic similarity for pairs of relatives is gene identity-by-descent (IBD) sharing. Genes that are copies of a single gene in a common ancestor of the individuals who now carry them are said to be IBD. One obvious extension of the IBD concept is IBD gene(s) shared by more than two individuals. In this paper, I further extend the gene IBD concept to the proportion of genomes shared IBD by every member of a group of relatives. Genome may refer either to the entire autosomal genome or to one or more chromosomal segments or regions with known lengths. Consideration of a genome instead of one or two loci has several advantages. I present a model to describe the crossover process, based on the work of K. P. Donnelly. On the basis of this model, I give a mathematical definition of the proportion of genome shared IBD by relatives, or IBDP for short. Since the distribution of the IBDP is in general very difficult to determine, and since in most applications the mean and variance of the IBDP will suffice, I then provide a method for computing the first two moments of the IBDP. Applications to assessing gene survival, to genetic resemblance between two relatives, and to gene mapping are illustrated with examples. Finally, I discuss the utility of the IBDP in other areas.			GUO, SW (corresponding author), UNIV MICHIGAN,DEPT BIOSTAT,109 S OBSERV,ANN ARBOR,MI 48109, USA.				NHGRI NIH HHS [HG00209] Funding Source: Medline; NIGMS NIH HHS [GM52205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052205] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS CI, 1990, AM J HUM GENET, V47, P842; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; COCKERHAM CC, 1971, GENETICS, V69, P235; Cotterman C.W., 1940, THESIS OHIO STATE U; DENNISTON C, 1975, ANN HUM GENET, V39, P89, DOI 10.1111/j.1469-1809.1975.tb00110.x; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Fisher RA, 1949, THEORY INBREEDING; FOSS E, 1993, GENETICS, V133, P681; FRANKLIN IR, 1977, THEOR POPUL BIOL, V11, P60, DOI 10.1016/0040-5809(77)90007-7; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GUO SW, 1994, AM J HUM GENET, V54, P1104; GUO SW, 1994, GENETICS, V138, P953; Haldane JBS, 1919, J GENET, V8, P299; HILL WG, 1993, HEREDITY, V71, P652, DOI 10.1038/hdy.1993.190; JACQUARD A, 1971, BIOMETRICS, V28, P1101; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; LANDER ES, 1993, NAT GENET, V4, P5, DOI 10.1038/ng0593-5; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; Malecot G, 1948, MATH HEREDITE; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; Ott J., 1991, ANAL HUMAN GENETIC L; RASMUSON M, 1993, HEREDITY, V70, P266, DOI 10.1038/hdy.1993.38; RISCH N, 1979, ANN HUM GENET, V43, P177, DOI 10.1111/j.1469-1809.1979.tb02010.x; SUAREZ BK, 1979, HUM HERED, V29, P37, DOI 10.1159/000153013; THOMPSON EA, 1988, IMA J MATH APPL MED, V5, P261; THOMPSON EA, 1990, BIOMETRICS, V46, P905, DOI 10.2307/2532436; THOMPSON EA, 1974, BIOMETRICS, V30, P667, DOI 10.2307/2529231; THOMPSON EA, 1993, POPULATION MANAGEMEN; WEEKS DE, 1994, GENETICS, V136, P1217; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; ZHAO HY, 1995, GENETICS, V139, P1045	34	46	47	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1468	1476						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762570				2022-12-18	WOS:A1995RA79400026
J	FISCH, GS; SNOW, K; THIBODEAU, SN; CHALIFAUX, M; HOLDEN, JJA; NELSON, DL; HOWARDPEEBLES, PN; MADDALENA, A				FISCH, GS; SNOW, K; THIBODEAU, SN; CHALIFAUX, M; HOLDEN, JJA; NELSON, DL; HOWARDPEEBLES, PN; MADDALENA, A			THE FRAGILE-X PREMUTATION IN CARRIERS AND ITS EFFECT ON MUTATION SIZE IN OFFSPRING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEAT AMPLIFICATION; ANDROGEN RECEPTOR GENE; MYOTONIC-DYSTROPHY; HUNTINGTONS-DISEASE; MENTAL-RETARDATION; UNSTABLE DNA; PHENOTYPIC VARIATION; LENGTH VARIATION; FULL MUTATION; CAG REPEAT	The pattern of inheritance in the fragile X (fra(X)) mutation follows a multistage intergenerational process in which the premutation evolves into the full mutation and the characteristic phenotype of the fra(X) syndrome after passing through oogenesis or a postzygotic event. Findings from our multicenter study confirm a strong direct relationship between fra(X) premutation size in the mother and probability of a full mutation in offspring with the mutation. Remarkably, the best-fitting equations are nonlinear asymptotic functions. The close approximation to both the logistic model and Gompertz suggests a process of accumulation of errors in DNA synthesis, as has been proposed previously. We also note that a larger-than-expected number of daughters of transmitting males have premutations that are smaller than their fathers', and that proportion is significantly higher than the proportion of daughters whose premutations are smaller than their mothers'. Intergenerational decreases in premutation size have been reported in other trinucleotide-repeat disorders and also appear to be parent-of-origin specific. Thus, while intergenerational expansion to the full mutation in fra(X) may manifest a postzygotic event, decreases in mutation size may occur during or prior to meiosis.	SUNY HLTH SCI CTR,BROOKLYN,NY 11203; MAYO CLIN,ROCHESTER,MN; ONGWANADA RESOURCE CTR,KINGSTON,ON,CANADA; BAYLOR COLL MED,HOUSTON,TX 77030; GENET & IVF INST,FAIRFAX,VA 22039; VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,RICHMOND,VA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Mayo Clinic; Baylor College of Medicine; Virginia Commonwealth University	FISCH, GS (corresponding author), KINGS CTY HOSP,DEPT PSYCHIAT,BOX 32,451 CLARKSON AVE,BROOKLYN,NY 11203, USA.							ABELIOVICH D, 1993, AM J HUM GENET, V52, P1175; AMATO AA, 1993, NEUROLOGY, V43, P791, DOI 10.1212/WNL.43.4.791; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASHIZAWA T, 1994, AM J HUM GENET, V54, P414; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASHIZAWA T, 1993, NEUROLOGY, V44, P120; Ashley A. E., 1994, American Journal of Human Genetics, V55, pA39; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; CLAYTONSMITH J, 1993, AM J MED GENET, V47, P683, DOI 10.1002/ajmg.1320470519; COBO AM, 1993, LANCET, V341, P1159, DOI 10.1016/0140-6736(93)93186-5; CROXTON FE, 1949, APPLIED GENERAL STAT, P421; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FISCH GS, 1994, AM J MED GENET, V51, P339, DOI 10.1002/ajmg.1320510409; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HALL JG, 1990, DEVELOPMENT, P141; HANZLIK AJ, 1993, NAT GENET, V3, P44, DOI 10.1038/ng0193-44; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; HUNTER AGW, 1993, AM J MED GENET, V45, P401, DOI 10.1002/ajmg.1320450330; JANSEN G, 1994, AM J HUM GENET, V54, P575; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOLEHMAINEN K, 1994, AM J MED GENET, V51, P428, DOI 10.1002/ajmg.1320510425; KRAWCZAK M, 1991, AM J HUM GENET, V49, P735; LAIRD CD, 1987, GENETICS, V117, P587; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LEVINSON G, 1994, AM J MED GENET, V51, P527, DOI 10.1002/ajmg.1320510448; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; REIS A, 1994, AM J HUM GENET, V54, P741; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; RIGGS JE, 1993, MECH AGEING DEV, V66, P249, DOI 10.1016/0047-6374(93)90012-G; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SHERMAN SL, 1985, HUM GENET, V71, P184; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SHERMAN SL, 1993, 6TH INT C FRAG X SYN; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SNOW K, 1993, AM J HUM GENET, V53, P1217; STREHLER BL, 1986, EXP GERONTOL, V21, P283, DOI 10.1016/0531-5565(86)90038-0; STREHLER BL, 1980, MECH AGEING DEV, V14, P15, DOI 10.1016/0047-6374(80)90103-7; VAISANEN ML, 1994, HUM GENET, V93, P143; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WILLEMS PJ, 1992, HUM MOL GENET, V1, P511, DOI 10.1093/hmg/1.7.511; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; WOSILAIT WD, 1992, GROWTH DEVELOP AGING, V56, P249; 1993, CELL, V72, P971	65	46	46	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1147	1155						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726171				2022-12-18	WOS:A1995QU58600018
J	MITCHISON, HM; ORAWE, AM; TASCHNER, PEM; SANDKUIJL, LA; SANTAVUORI, P; DEVOS, N; BREUNING, MH; MOLE, SE; GARDINER, RM; JARVELA, IE				MITCHISON, HM; ORAWE, AM; TASCHNER, PEM; SANDKUIJL, LA; SANTAVUORI, P; DEVOS, N; BREUNING, MH; MOLE, SE; GARDINER, RM; JARVELA, IE			BATTEN-DISEASE GENE, CLN3 - LINKAGE DISEQUILIBRIUM MAPPING IN THE FINNISH POPULATION, AND ANALYSIS OF EUROPEAN HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FINLAND	The gene for Batten disease (juvenile-onset neuronal ceroid lipofuscinosis, or Spielmeyer-Sjogren disease), CLN3, maps to 16p11.2-12.1. Four microsatellite markers-D16S288, D16S299, D16S298, and SPN-are in strong linkage disequilibrium with CLN3 in 142 families from 16 different countries. These markers span a candidate region of similar to 2.1 cM. CLN3 is most prevalent in northern European populations and is especially enriched in the isolated Finnish population, with an incidence of 1:21,000, Linkage disequilibrium mapping was applied to further refine the localization of CLN3 in 27 Finnish families by using linkage disequilibrium data and information about the population history of Finland to estimate the distance of the closest markers from CLN3. CLN3 is predicted to lie 8.8 kb (range 6.3-13.8 kb) from D16S298 and 165.4 kb (132.4-218.1 kb) from D16S299. Enrichment of allele ''6'' at D16S298 (on 96% of Finnish and 92% of European CLN3 chromosomes) provides strong evidence that the same major mutation is responsible for Batten disease in Finland as in most other European countries and that it is therefore not a Finnish mutation. Genealogical studies show that Batten disease is widespread throughout the densely populated regions of Finland. The ancestors of two Finnish patients carrying rare alleles ''3'' and ''5'' at D16S298 in heterozygous form originate from the southwestern coast of Finland, and these probably represent other foreign mutations. Analysis of the number and distribution of CLN3 haplotypes from 12 European countries provides evidence that more than one mutation has arisen in Europe.	UNIV LONDON UNIV COLL,SCH MED,DEPT PAEDIAT,LONDON WC1E 6JJ,ENGLAND; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,ROTTERDAM,NETHERLANDS; UNIV GRONINGEN,DEPT HUMAN GENET,GRONINGEN,NETHERLANDS; UNIV HELSINKI,DEPT CHILD NEUROL,HELSINKI,FINLAND	University of London; University College London; UCL Medical School; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; University of Groningen; University of Helsinki			Mitchison, Hannah M./C-1891-2008; Mole, Sara/C-2024-2008; Breuning, Martijn H/E-3429-2010; Jarvela, Irma E/L-5836-2013; Taschner, Peter/J-8853-2014	Mole, Sara/0000-0003-4385-4957; Jarvela, Irma E/0000-0002-1770-6187; Taschner, Peter/0000-0001-9621-465X; Mitchison, Hannah/0000-0002-3163-6293	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; CLAUSSEN M, 1992, AM J MED GENET, V42, P536, DOI 10.1002/ajmg.1320420422; HAATAJA L, 1994, AM J HUM GENET, V54, P1042; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Hietala Marja, 1993, European Journal of Human Genetics, V1, P296; HILL WG, 1994, AM J HUM GENET, V54, P705; IKONEN E, 1991, P NATL ACAD SCI USA, V88, P11222, DOI 10.1073/pnas.88.24.11222; KESTILA M, 1994, AM J HUM GENET, V54, P757; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LERNER TJ, 1994, AM J HUM GENET, V54, P88; Luria SE, 1943, GENETICS, V28, P491; MITCHISON HM, 1993, GENOMICS, V16, P455, DOI 10.1006/geno.1993.1210; MITCHISON HM, 1994, GENOMICS, V22, P465, DOI 10.1006/geno.1994.1412; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NORIO R, 1973, ANN CLIN RES, V5, P109; Norio R., 1981, BIOCULTURAL ASPECTS, P359; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; Sirugo G., 1993, European Journal of Human Genetics, V1, P133; VOGEL F, 1990, PRINCIPLES PRACTICE, V1, P56; WEBER JL, 1990, GENOME ANAL, V1, P159; YAOUANQ J, 1994, AM J HUM GENET, V54, P252	27	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					654	662						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887419				2022-12-18	WOS:A1995QK91800014
J	SCHMITT, K; LAZZERONI, LC; FOOTE, S; VOLLRATH, D; FISHER, EMC; GORADIA, TM; LANGE, K; PAGE, DC; ARNHEIM, N				SCHMITT, K; LAZZERONI, LC; FOOTE, S; VOLLRATH, D; FISHER, EMC; GORADIA, TM; LANGE, K; PAGE, DC; ARNHEIM, N			MULTIPOINT LINKAGE MAP OF THE HUMAN PSEUDOAUTOSOMAL REGION, BASED ON SINGLE-SPERM TYPING - DO DOUBLE CROSSOVERS OCCUR DURING MALE MEIOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN SEX-CHROMOSOMES; HUMAN Y-CHROMOSOME; HUMAN X-CHROMOSOME; CHIASMA INTERFERENCE; GENETIC-DISTANCE; PHYSICAL MAP; DNA; RECOMBINATION; POLYMORPHISMS; SEQUENCES	Sperm typing was used to measure recombination fractions among pseudoautosomal markers and the beginning of the X/Y-specific sequences located at the pseudoautosomal boundary. These experiments included primer-extension preamplification and PCR followed by allele typing using gel electrophoresis. A newly developed data-analysis program allowed the construction of the first multipoint-linkage sperm-typing map, using results obtained on seven loci from three individuals. The large sample size not only confirmed the increased recombination activity of the pseudoautosomal region but allowed an estimate of interference of recombination to be made. The coefficient of coincidence was calculated to be .26 over a physical distance of only similar to 1,800 kb. The observation of a few sperm presumably resulting from double recombination argues that more than one crossover event can occur in this region during male meiosis.	UNIV SO CALIF,DEPT BIOL SCI,PROGRAM MOLEC BIOL,LOS ANGELES,CA 90089; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT BIOSTAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024; WHITEHEAD INST,HOWARD HUGHES RES LABS,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA	University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; HRL Laboratories; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			Foote, Simon J/F-2802-2013; Lazzeroni, Laura/F-2903-2010; Fisher, Elizabeth MC/C-2168-2008	Lazzeroni, Laura/0000-0002-1846-6920; Fisher, Elizabeth MC/0000-0003-2850-9936; Arnheim, Norman/0000-0003-1247-1347; Foote, Simon/0000-0002-9142-2107				ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FOSS E, 1993, GENETICS, V133, P681; FOX DP, 1973, CHROMOSOMA, V43, P289, DOI 10.1007/BF00294277; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; KENKE A, 1993, GENOMICS, V18, P478; KING JS, 1990, GENETICS, V126, P1127; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LAZZERONI LC, 1994, AM J HUM GENET, V55, P431; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; MORTON NE, 1990, ANN HUM GENET, V54, P235, DOI 10.1111/j.1469-1809.1990.tb00381.x; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PASCOE L, 1987, AM J HUM GENET, V40, P174; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; RILES L, 1993, GENETICS, V134, P81; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SCHMITT K, 1993, HUM MOL GENET, V2, P1978, DOI 10.1093/hmg/2.11.1978; SCHMITT K, IN PRESS GENET ENG; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SIMMLER MC, 1987, EMBO J, V6, P963, DOI 10.1002/j.1460-2075.1987.tb04846.x; SLIM R, 1993, GENOMICS, V16, P691, DOI 10.1006/geno.1993.1249; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; SPEED RM, 1990, HUM GENET, V84, P547; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G; WEISSENBACH J, 1987, DEVELOPMENT, V101, P67; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	44	46	46	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					423	430						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079986				2022-12-18	WOS:A1994PF50900002
J	WATKINS, WS; ZENGER, R; OBRIEN, E; NYMAN, D; ERIKSSON, AW; RENLUND, M; JORDE, LB				WATKINS, WS; ZENGER, R; OBRIEN, E; NYMAN, D; ERIKSSON, AW; RENLUND, M; JORDE, LB			LINKAGE DISEQUILIBRIUM PATTERNS VARY WITH CHROMOSOMAL LOCATION - A CASE-STUDY FROM THE VON-WILLEBRAND-FACTOR REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; VONWILLEBRAND-FACTOR GENE; MICROSATELLITE POLYMORPHISMS; RECEPTOR LOCUS; DISEASE; MAP; RECOMBINATION; PHENYLKETONURIA; POPULATION; MUTATIONS	Linkage disequilibrium analysis has been used as a tool for analyzing marker order and locating disease genes. Under appropriate circumstances, disequilibrium patterns reflect recombination events that have occurred throughout a population's history. As a result, disequilibrium mapping may be useful in genomic regions of <1 cM where the number of informative meioses needed to detect recombinant individuals within pedigrees is exceptionally high. Its utility for refining target areas for candidate disease genes before initiating chromosomal walks and cloning experiments will be enhanced as the relationship between linkage disequilibrium and physical distance is better understood. To address this issue, we have characterized linkage disequilibrium in a 144-kb region of the von Willebrand factor gene on chromosome 12. Sixty CEPH and 12 von Willebrand disease families were genotyped for five PCR-based markers, which include two microsatellite repeats and three single-base-pair substitutions. Linkage disequilibrium and physical distance between polymorphisms are highly correlated (r(m) = -.76; P<.05) within this region. None of the five markers showed significant disequilibrium with the von Willebrand disease phenotype. The linkage disequilibrium/physical distance relationship was also analyzed as a function of chromosomal location for this and eight previously characterized regions. This analysis revealed a general trend in which linkage disequilibrium dissipates more rapidly with physical distance in telomeric regions than in centromeric regions. This trend is consistent with higher recombination rates near telomeres.	UNIV UTAH, SCH MED, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA; ALAND CENT SJUKHUS, ALAND, FINLAND; FREE UNIV AMSTERDAM, INST HUMAN GENET, 1007 MC AMSTERDAM, NETHERLANDS; HELSINKI UNIV, CENT HOSP, DEPT OBSTET, HELSINKI, FINLAND	Utah System of Higher Education; University of Utah; Vrije Universiteit Amsterdam; University of Helsinki; Helsinki University Central Hospital					NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000347] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG-00347] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BLOMBACK M, 1992, HAEMOSTASIS, V22, P236; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; BROWN MB, 1977, J AM STAT ASSOC, V72, P309, DOI 10.2307/2286793; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1989, AM J HUM GENET, V45, P319; ELBEIN SC, 1992, AM J HUM GENET, V51, P1103; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177; GINSBURG D, 1991, MAYO CLIN PROC, V66, P506, DOI 10.1016/S0025-6196(12)62393-3; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEGELE RA, 1990, GENET EPIDEMIOL, V7, P69, DOI 10.1002/gepi.1370070114; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1994, AM J HUM GENET, V54, P705; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JORDE LB, 1994, AM J HUM GENET, V54, P884; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KUNKEL GR, 1990, NUCLEIC ACIDS RES, V18, P4961, DOI 10.1093/nar/18.16.4961-a; KUPKE KG, 1992, AM J HUM GENET, V50, P808; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LERNER TJ, 1994, AM J HUM GENET, V54, P88; LITT M, 1986, AM J HUM GENET, V39, P166; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MANTEL N, 1967, CANCER RES, V27, P209; NEI M, 1984, EVOL BIOL, V17, P73; NICHOLS WC, 1991, P NATL ACAD SCI USA, V88, P3857, DOI 10.1073/pnas.88.9.3857; OUDET C, 1991, AM J HUM GENET, V49, P311; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P723, DOI 10.1073/pnas.91.2.723; POUND SE, 1992, J MED GENET, V29, P247, DOI 10.1136/jmg.29.4.247; SADLER JE, 1993, THROMB HAEMOSTASIS, V69, P185; SADLER JE, 1989, METABOLIC BASIS INHE; SADLER JE, 1991, ANN NY ACAD SCI, V614, P114; SHERRINGTON R, 1991, AM J HUM GENET, V49, P966; SKRAASTAD MI, 1992, AM J HUM GENET, V51, P730; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; STRAIN L, 1991, NUCLEIC ACIDS RES, V19, P4017, DOI 10.1093/nar/19.14.4017-a; SVED J A, 1971, Theoretical Population Biology, V2, P125; TANZI RE, 1992, AM J HUM GENET, V50, P551; TEMPLETON AR, 1987, GENETICS, V117, P343; VANAMSTEL HKP, 1990, NUCLEIC ACIDS RES, V18, P4957, DOI 10.1093/nar/18.16.4957-a; von Willerbrand EA, 1931, ACTA MED SCAND, V76, P521; WEIR BS, 1978, GENETICS, V88, P633; Weir BS, 1990, GENETIC DATA ANAL; WEISSENBACH J, 1993, CURR OPIN GENET DEV, V3, P414, DOI 10.1016/0959-437X(93)90114-5; WIER BS, 1989, MULTIPOINT MAPPING L, V6, P81; WILLS C, 1990, NATURE, V348, P398, DOI 10.1038/348398a0; ZHANG ZP, 1992, AM J HUM GENET, V51, P850	52	46	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					348	355						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	7913583				2022-12-18	WOS:A1994NZ33600017
J	LERNER, TJ; BOUSTANY, RMN; MACCORMACK, K; GLEITSMAN, J; SCHLUMPF, K; BREAKEFIELD, XO; GUSELLA, JF; HAINES, JL				LERNER, TJ; BOUSTANY, RMN; MACCORMACK, K; GLEITSMAN, J; SCHLUMPF, K; BREAKEFIELD, XO; GUSELLA, JF; HAINES, JL			LINKAGE DISEQUILIBRIUM BETWEEN THE JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS GENE AND MARKER LOCI ON CHROMOSOME 16P12.I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE; REGION; CLN3; MAPS	The neuronal ceroid lipofuscinoses (NCL; Batten disease) are a collection of autosomal recessive disorders characterized by the accumulation of autofluorescent lipopigments in the neurons and other cell types. Clinically, these disorders are characterized by progressive encephalopathy, loss of vision, and seizures. CLN3, the gene responsible for juvenile NCL, has been mapped to a 15-cM region flanked by the marker loci D16S148 and D16S150 on human chromosome 16. CLN2, the gene causing the late-infantile form of NCL (LNCL), is not yet mapped. We have used highly informative dinucleotide repeat markers mapping between D16S148 and D16S150 to refine the localization of CLN3 and to test for linkage to CLN2. We find significant linkage disequilibrium between CLN3 and the dinucleotide repeat marker loci D16S288 (chi2(7) = 46.5, P < .005), D16S298 (chi2(6) = 36.6, P < .005), and D16S299 (chi2(7) = 73.8, P < .005), and also a novel RFLP marker at the D16S272 locus (chi2(1) = 5.7, P = .02). These markers all map to 16p12.1. The D16S298/D16S299 haplotype ''5/4'' is highly overrepresented, accounting for 54% of CLN3 chromosomes as compared with 8% of control chromosomes (chi2 = 117, df = 1, P < .001). Examination of the haplotypes suggests that the CLN3 locus can be narrowed to the region immediately surrounding these markers in 16p12.1. Analysis of D16S299 in our LNCL pedigrees supports our previous finding that CLN3 and CLN2 are different genetic loci. This study also indicates that dinucleotide repeat markers play a valuable role in disequilibrium studies.	HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; DUKE UNIV,MED CTR,DIV PEDIAT NEUROL,DURHAM,NC 27710	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Duke University	LERNER, TJ (corresponding author), MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BLDG 149,13TH ST,BOSTON,MA 02129, USA.		Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NHGRI NIH HHS [HG00324] Funding Source: Medline; NINDS NIH HHS [NINDS NS24279] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Boustany R M, 1988, Am J Med Genet Suppl, V5, P47; CALLEN DF, 1992, GENOMICS, V13, P1178, DOI 10.1016/0888-7543(92)90035-Q; CALLEN DF, 1991, AM J HUM GENET, V49, P1372; Dyken P R, 1988, Am J Med Genet Suppl, V5, P69; EIBERG H, 1989, CLIN GENET, V36, P217; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; HOFMAN IL, 1990, BARTIMEUS F SERIES; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KONRADI C, 1991, NUCLEIC ACIDS RES, V19, P5449, DOI 10.1093/nar/19.19.5449; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LERNER T, 1992, MAMM GENOME, V3, P92, DOI 10.1007/BF00431252; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MITCHISON HM, 1993, GENOMICS, V16, P455, DOI 10.1006/geno.1993.1210; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Sambrook J., 1989, MOL CLONING LAB MANU; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; Wisniewski K E, 1988, Am J Med Genet Suppl, V5, P27; YAN WL, 1993, AM J HUM GENET, V52, P89; 1993, CCELL, V72, P971	23	46	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					88	94						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279474				2022-12-18	WOS:A1994MQ70000012
J	NISHIGORI, C; ZGHAL, M; YAGI, T; IMAMURA, S; KOMOUN, MR; TAKEBE, H				NISHIGORI, C; ZGHAL, M; YAGI, T; IMAMURA, S; KOMOUN, MR; TAKEBE, H			HIGH PREVALENCE OF THE POINT MUTATION IN EXON-6 OF THE XERODERMA-PIGMENTOSUM GROUP-A-COMPLEMENTING (XPAC) GENE IN XERODERMA-PIGMENTOSUM GROUP-A PATIENTS IN TUNISIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMALITIES	Xeroderma pigmentosum (XP) patients in Tunisia who belong to the genetic complementation group A (XPA) have milder skin symptoms than do Japanese XPA patients. Such difference in the clinical features might be caused by the difference in the site of mutation in the XP A-complementing (XPAC) gene. The purpose of this study is to identify the genetic alterations in the XPAC gene in the Tunisian XPA patients and to investigate the relationship between the clinical symptoms and the genetic alterations. Three sites of mutation in the XPAC gene have been identified in the Japanese XPA patients, and about 85% of them have a G-->C point mutation at the splicing acceptor site of intron 3. We found that six (86%) of seven Tunisian XPA patients had a nonsense mutation in codon 228 in exon 6, because of a CGA-->TGA point mutation, which can be detected by the HphI RFLP. This type of mutation is the same as those found in two Japanese XPA patients with mild clinical symptoms. Milder skin symptoms in the XPA patients in Tunisia than in those in Japan, despite mostly sunny weather and the unsatisfactory sun protection in Tunisia, should be due to the difference in the mutation site.	KYOTO UNIV,FAC MED,DEPT EXPTL RADIOL,KYOTO 606,JAPAN; CHARLES NICCOLE HOSP,DEPT DERMATOL,TUNIS,TUNISIA	Kyoto University; Universite de Tunis-El-Manar; Hopital Charles Nicolle	NISHIGORI, C (corresponding author), KYOTO UNIV,FAC MED,DEPT DERMATOL,54 SHOGOIN KAWA HARA CHO,SAKYO KU,KYOTO 606,JAPAN.		Yagi, Takashi/AAR-7673-2021					CLEAVER JE, 1981, DNA REPAIR LABORATOR, P277; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Maniatis T., 1982, MOL CLONING; NISHIGORI C, IN PRESS ARCH DERMAT; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SATO K, 1987, BRIT J DERMATOL, V116, P101, DOI 10.1111/j.1365-2133.1987.tb05796.x; Satoh Y., 1988, GANN MONOGR CANC RES, V35, P113; SATOKATA I, 1992, MUTAT RES, V273, P193, DOI 10.1016/0921-8777(92)90080-M; SATOKATA I, 1992, MUTAT RES, V273, P203, DOI 10.1016/0921-8777(92)90081-D; TAKEBE H, 1987, JPN J CANCER RES, V78, P1135; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0	11	46	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1001	1006						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8105686				2022-12-18	WOS:A1993MC33300003
J	BROWN, CA; MAHURAN, DJ				BROWN, CA; MAHURAN, DJ			BETA-HEXOSAMINIDASE ISOZYMES FROM CELLS COTRANSFECTED WITH ALPHA-CDNA AND BETA-CDNA CONSTRUCTS - ANALYSIS OF THE ALPHA-SUBUNIT MISSENSE MUTATION ASSOCIATED WITH THE ADULT FORM OF TAY-SACHS-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GM2-GANGLIOSIDOSIS-B1 VARIANT; ENDOPLASMIC-RETICULUM; GM2 GANGLIOSIDOSIS; PROTEIN STABILITY; CODING SEQUENCE; ONSET; CHAIN; DNA; SUBSTITUTION; FIBROBLASTS	In vitro mutagenesis and transient expression in COS cells has been used to associate a missense mutation with a clinical or biochemical phenotype. Mutations affecting the alpha-subunit of beta-hexosaminidase A (alphabeta) (E.C.3.2.1.52) result in Tay-Sachs disease. Because hexosaminidase A is heterodimeric, analysis of alpha-chain mutations is not straightforward. We examine three approaches utilizing previously identified mutations affecting alpha-chain folding. These involve transfection of (1) the alpha cDNA alone; (2) a beta cDNA construct encoding a beta-subunit substituted at a position homologous to that of the alpha-subunit, and (3) both alpha and beta cDNAs. The latter two procedures amplified residual activity levels over that of patient samples, an effect not previously found with mutations affecting an ''active'' alphaArg residue. This effect may help to discriminate between protein-folding and active-site mutations. We conclude that, with proper controls, the latter method of cotransfection can be used to evaluate the effects and perhaps to predict the clinical course of some alpha-chain mutations. Using this technique, we demonstrate that the adult-onset Tay-Sachs mutation, alphaGly-->Ser269, does not directly affect alphabeta dimerization but exerts an indirect effect on the dimer through destabilizing the folded alpha-subunit at physiological temperatures. Two other a mutations linked to more severe phenotypes appear to inhibit the initial folding of the subunit.	HOSP SICK CHILDREN, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT CLIN BIOCHEM, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto								ALBER T, 1989, ANNU REV BIOCHEM, V58, P765, DOI 10.1146/annurev.biochem.58.1.765; BROWN CA, 1991, J BIOL CHEM, V266, P15855; BROWN CA, 1989, J BIOL CHEM, V264, P21705; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAZZO A, 1984, J BIOL CHEM, V259, P1070; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; HECHTMAN P, 1989, CLIN GENET, V35, P364; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; MOLZER B, 1976, CLIN CHIM ACTA, V73, P163, DOI 10.1016/0009-8981(76)90318-1; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; NAKANO T, 1988, J NEUROCHEM, V51, P984, DOI 10.1111/j.1471-4159.1988.tb01836.x; NAVON R, 1989, American Journal of Human Genetics, V45, pA209; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; ODOWD BF, 1986, J BIOL CHEM, V261, P2680; OHNO K, 1988, J NEUROCHEM, V50, P316, DOI 10.1111/j.1471-4159.1988.tb13266.x; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PROIA RL, 1984, J BIOL CHEM, V259, P3350; PROIA RL, 1982, P NATL ACAD SCI-BIOL, V79, P6360, DOI 10.1073/pnas.79.20.6360; SAGHERIAN C, 1991, BIOCHEM BIOPH RES CO, V179, P477, DOI 10.1016/0006-291X(91)91395-S; Sambrook J., 1989, MOL CLONING LAB MANU; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489; TANAKA A, 1990, AM J HUM GENET, V47, P567; TANAKA A, 1990, AM J HUM GENET, V46, P329; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; Trop Isabelle, 1992, Human Mutation, V1, P35, DOI 10.1002/humu.1380010106; WELLS JA, 1991, METHOD ENZYMOL, V202, P390	36	46	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					497	508						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328462				2022-12-18	WOS:A1993LN82000022
J	HECHT, JT; WANG, YP; CONNOR, B; BLANTON, SH; DAIGER, SP				HECHT, JT; WANG, YP; CONNOR, B; BLANTON, SH; DAIGER, SP			NONSYNDROMIC CLEFT-LIP AND PALATE - NO EVIDENCE OF LINKAGE TO HLA OR FACTOR-13A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; SHORT ARM; SPINOCEREBELLAR ATAXIA; SEGREGATION ANALYSIS; CHROMOSOME-6; LOCUS; JAPANESE; KINDREDS; DANISH; D6S89	Nonsyndromic cleft lip with or without cleft palate (CLP) is a common craniofacial anomaly, the etiology of which is not known. Population studies have shown that a large proportion of cases occur sporadically. Recently, segregation analyses applied to CLP families have demonstrated that an autosomal dominant/codominant gene(s) may cause clefting in cases. Associations of autosomal dominant CLP and nonsyndromic cleft palate (CP) with HLA and F13A genes on chromosome 6p have been suggested previously. Linkage to these two areas on chromosome 6p were tested in 12 autosomal dominant families with CLP. With a LOD score of -2 or less for exclusion, no evidence of linkage was found to four chromosome 6p markers. Multipoint analysis showed no evidence of a clefting locus in this region spanning 54 cM on chromosome 6p in these CLP families.	UNIV TEXAS, HLTH SCI CTR, GRAD SCH BIOMED SCI, HOUSTON, TX 77225 USA; UNIV VIRGINIA, CHARLOTTESVILLE, VA 22903 USA	University of Texas System; University of Texas Health Science Center Houston; University of Virginia	HECHT, JT (corresponding author), UNIV TEXAS, SCH MED, DEPT PEDIAT, POB 20708, HOUSTON, TX 77225 USA.		Blanton, Susan Halloran/ABF-1323-2021		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE009954] Funding Source: NIH RePORTER; NIDCR NIH HHS [R29 DE09954-02] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BLANCHE H, 1991, GENOMICS, V5, P139; BONAITIPELLIE C, 1982, J MED GENET, V11, P374; BONNER JJ, 1982, J IMMUNOGENET, V9, P243; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DEPAEPE A, 1989, J MED GENET, V26, P794, DOI 10.1136/jmg.26.12.794; EIBERG H, 1987, CLIN GENET, V32, P129; FARRALL M, 1992, AM J HUM GENET, V50, P270; FRASER FC, 1970, AM J HUM GENET, V22, P336; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; HECHT JT, 1990, J MED GENET, V27, P597, DOI 10.1136/jmg.27.9.597; HECHT JT, 1988, FAMILIAL COMPONENT E; KEATS BJB, 1991, AM J HUM GENET, V49, P972; KWIATKOWSKI TJ, 1991, GENOMICS, V10, P921, DOI 10.1016/0888-7543(91)90180-M; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MEHRA S, 1991, AM J HUM GENET, V49, P150; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; Ott J., 1991, ANAL HUMAN GENETIC L; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; RANUM LPW, 1991, AM J HUM GENET, V49, P31; TEMPLE K, 1989, J MED GENET, V26, P386, DOI 10.1136/jmg.26.6.386; VANDYKE DC, 1980, CLEFT PALATE J, V17, P189; WATANABE T, 1984, CLEFT PALATE J, V21, P293; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968; ZOGHBI HY, 1991, GENOMICS, V9, P713, DOI 10.1016/0888-7543(91)90365-L; ZOGHBI HY, 1990, GENOMICS, V6, P352, DOI 10.1016/0888-7543(90)90576-G	30	46	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1230	1233						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8099257				2022-12-18	WOS:A1993LG13300024
J	BASCOM, RA; GARCIAHERAS, J; HSIEH, CL; GERHARD, DS; JONES, C; FRANCKE, U; WILLARD, HF; LEDBETTER, DH; MCINNES, RR				BASCOM, RA; GARCIAHERAS, J; HSIEH, CL; GERHARD, DS; JONES, C; FRANCKE, U; WILLARD, HF; LEDBETTER, DH; MCINNES, RR			LOCALIZATION OF THE PHOTORECEPTOR GENE ROMI TO HUMAN CHROMOSOME-11 AND MOUSE CHROMOSOME-19 - SUBLOCALIZATION TO HUMAN 11Q13 BETWEEN PGA AND PYGM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ENDOCRINE NEOPLASIA TYPE-1; DEGENERATION SLOW RDS; RETINAL DEGENERATION; DIFFERENTIATION ANTIGEN; INSITU HYBRIDIZATION; MESSENGER-RNA; SMALL REGION; MUTANT MICE; LONG ARM	Rom-1 is a retinal integral membrane protein that, together with the product of the human retinal degeneration slow gene (RDS), defines a photoreceptor-specific protein family. The gene for rom-1 (HGM symbol: ROM1) has been assigned to human chromosome 11 and mouse chromosome 19 by Southern blot analysis of somatic cell hybrid DNAs. ROM1 was regionally sublocalized to human 11p13-11q13 by using three mouse-human somatic cell hybrids; in situ hybridization refined the sublocalization to human 11q13. Analysis of somatic cell hybrids suggested that the most likely localization of ROM1 is in the approximately 2-cM interval between human PGA (human pepsinogen A) and PYGM (muscle glycogen phosphorylase). ROM1 appears to be a new member of a conserved syntenic group whose members include such genes as CD5, CD20, and OSBP (oxysterol-binding protein), on human chromosome 11 and mouse chromosome 19. Localization of the ROM1 gene will permit the examination of its linkage to hereditary retinopathies in man and mouse.	HOSP SICK CHILDREN,RES CTR,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; STANFORD UNIV,DEPT PATHOL,STANFORD,CA 94305; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; ROOSEVELT INST CANC RES,DENVER,CO	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Baylor College of Medicine; Stanford University; Stanford University; Washington University (WUSTL)				Bascom, Roger/0000-0002-9106-8224				BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; EUBANKS JH, 1991, GENOMICS, V11, P720, DOI 10.1016/0888-7543(91)90080-X; FARRAR GJ, 1991, GENOMICS, V11, P870, DOI 10.1016/0888-7543(91)90009-4; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1978, HUM GENET, V66, P272; GERHARD DS, 1992, GENOMICS, V13, P1133, DOI 10.1016/0888-7543(92)90028-Q; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; HUMPHRIES P, IN PRESS PROGR RETIN; INGLEHEARN CF, 1992, AM J HUM GENET, V50, P590; JONES C, 1984, SOMAT CELL MOLEC GEN, V10, P423, DOI 10.1007/BF01535638; JORDAN SA, 1992, AM J HUM GENET, V50, P634; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; LAFRENIERE RG, 1991, GENOMICS, V11, P352, DOI 10.1016/0888-7543(91)90143-3; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LEVANON D, 1990, GENOMICS, V7, P65, DOI 10.1016/0888-7543(90)90519-Z; MCINNES RR, 1992, NAT GENET, V1, P155, DOI 10.1038/ng0692-155; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; RICHARD CW, 1991, AM J HUM GENET, V49, P1189; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SEARLE A G, 1987, Genomics, V1, P3, DOI 10.1016/0888-7543(87)90099-1; SELDIN MF, 1991, GENOMICS, V9, P678, DOI 10.1016/0888-7543(91)90361-H; SZEPETOWSKI P, 1992, GENOMICS, V12, P738, DOI 10.1016/0888-7543(92)90303-A; TEDDER TF, 1988, J IMMUNOL, V141, P4388; TEDDER TF, 1989, J IMMUNOL, V142, P2555; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; VANNIE R, 1978, TISSUE ANTIGENS, V12, P106, DOI 10.1111/j.1399-0039.1978.tb01305.x; WHITE MJD, 1969, ANNU REV GENET, V3, P75, DOI 10.1146/annurev.ge.03.120169.000451; WRIGHT AF, 1992, TRENDS GENET, V8, P85, DOI 10.1016/0168-9525(92)90195-A; YANGFENG TL, 1986, P NATL ACAD SCI USA, V83, P8679, DOI 10.1073/pnas.83.22.8679; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	42	46	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1028	1035						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415249				2022-12-18	WOS:A1992JU84000012
J	VNENCAKJONES, CL; PHILLIPS, JA				VNENCAKJONES, CL; PHILLIPS, JA			IDENTIFICATION OF HETEROGENEOUS PRP GENE DELETIONS IN CONTROLS BY DETECTION OF ALLELE-SPECIFIC HETERODUPLEXES (DASH)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PRION PROTEIN GENE		VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT & BIOCHEM,NASHVILLE,TN 37232	Vanderbilt University	VNENCAKJONES, CL (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT PATHOL & PEDIAT,NASHVILLE,TN 37232, USA.							BOSQUE P, UNPUB PRP GENE CODON; COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; LAPLANCHE JL, 1990, NUCLEIC ACIDS RES, V18, P6745, DOI 10.1093/nar/18.22.6745; PUCKETT C, 1991, AM J HUM GENET, V49, P320	5	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					871	872						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1347972				2022-12-18	WOS:A1992HL84800026
J	SHERRINGTON, R; MELMER, G; DIXON, M; CURTIS, D; MANKOO, B; KALSI, G; GURLING, H				SHERRINGTON, R; MELMER, G; DIXON, M; CURTIS, D; MANKOO, B; KALSI, G; GURLING, H			LINKAGE DISEQUILIBRIUM BETWEEN 2 HIGHLY POLYMORPHIC MICROSATELLITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOBIN GENE-CLUSTER; CYSTIC-FIBROSIS; HUMAN GENOME; HUMAN DNA; SEQUENCE; MARKERS; LOCI; RECOMBINATION; AMPLIFICATION; HAPLOTYPES	The PCR was used to amplify genomic DNA from two microsatellite (dC-dA)n.(dG-dT)n sequences found to be present in the same chromosome 5 genomic clone. Analysis of the haplotype frequencies of these two interspersed repeat sequences in individuals showed strong allelic association or linkage disequilibrium. Six alleles were found for p599(CA)n with a PIC value of 0.71 and 8 alleles were seen for lambda 599(CA)n with a PIC value of 0.74. The two microsatellites are separated by approximately 7 kb. Analysis of the length variations for the two microsatellites showed that they were positively correlated, a finding that has no obvious explanation. The strong linkage disequilibrium found demonstrates stability during evolution for these novel markers. Therefore they should be powerful new tools for studying genetic drift and admixture of populations. Furthermore, disequilibrium data from microsatellites can be used in the fine mapping and cloning of disease genes.	UNIV MANCHESTER,DEPT CELL & STRUCT BIOL,MANCHESTER M13 9PL,LANCS,ENGLAND	University of Manchester	SHERRINGTON, R (corresponding author), UNIV COLL & MIDDLESEX SCH MED,ACAD DEPT PSYCHIAT,MOLEC PSYCHIAT LAB,RIDDING HOUSE ST,LONDON W1P 7PN,ENGLAND.		Curtis, David/HGB-3921-2022; Gurling, Hugh M/A-5029-2010	Curtis, David/0000-0002-4089-9183; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DEAN M, 1990, NUCLEIC ACIDS RES, V18, P345, DOI 10.1093/nar/18.2.345; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; HAMADA H, 1984, MOL CELL BIOL, V4, P2622, DOI 10.1128/MCB.4.12.2622; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KENTER AL, 1981, NATURE, V293, P402, DOI 10.1038/293402a0; KMIEC EB, 1986, CELL, V44, P545, DOI 10.1016/0092-8674(86)90264-3; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LITT M, 1989, AM J HUM GENET, V44, P397; LITT M, 1986, AM J HUM GENET, V39, P166; LUTY JA, 1990, AM J HUM GENET, V46, P776; Maniatis T., 1982, MOL CLONING; MORTON NE, 1985, HUM GENET, V70, P231; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OTT J, 1985, Genetic Epidemiology, V2, P79, DOI 10.1002/gepi.1370020108; RAMSAY M, 1988, AM J HUM GENET, V43, P527; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; VOGT P, 1990, HUM GENET, V84, P301; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEIR BS, 1978, GENETICS, V88, P633; ZULIANI G, 1990, AM J HUM GENET, V46, P963	30	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					966	971						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928102				2022-12-18	WOS:A1991GM87300007
J	KAINULAINEN, K; STEINMANN, B; COLLINS, F; DIETZ, HC; FRANCOMANO, CA; CHILD, A; KILPATRICK, MW; BROCK, DJH; KESTON, M; PYERITZ, RE; PELTONEN, L				KAINULAINEN, K; STEINMANN, B; COLLINS, F; DIETZ, HC; FRANCOMANO, CA; CHILD, A; KILPATRICK, MW; BROCK, DJH; KESTON, M; PYERITZ, RE; PELTONEN, L			MARFAN-SYNDROME - NO EVIDENCE FOR HETEROGENEITY IN DIFFERENT POPULATIONS, AND MORE PRECISE MAPPING OF THE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENES; MICROFIBRILLAR ABNORMALITIES; HUMAN CHROMOSOME-15; CONNECTIVE-TISSUE; EXCLUSION; LINKAGE; DNA; ELASTIN	Marfan syndrome is a dominantly inherited connective tissue disorder with manifestations in the cardiovascular, ocular, and skeletal systems. The diagnosis is hampered by both high variability in the phenotypic expression and late manifestation of symptoms. The cause of Marfan syndrome remains unknown, but our group has recently reported the genetic linkage of Marfan syndrome to a polymorphic marker on chromosome 15. To analyze the possible heterogeneity behind Marfan syndrome, we have performed linkage analyses for four chromosome 15 markers in 17 families from five different populations: Scottish, English, Swiss, American, and Finnish. By combining the linkage data of all the studied families into a LINKMAP analysis we obtained a maximal LOD score of 11.2, which maps the Marfan syndrome locus between D15S25 and D15S45 on the long arm of chromosome 15. The data reveal no evidence for genetic heterogeneity behind Marfan syndrome and provide us with a more precise location of both the Marfan syndrome locus and flanking markers. This information will provide the basis for the DNA diagnostics of Marfan syndrome in the future.	NATL PUBL HLTH INST,MOLEC GENET LAB,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND; UNIV ZURICH,CHILDRENS HOSP,CH-8006 ZURICH,SWITZERLAND; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; JOHNS HOPKINS UNIV,DEPT PEDIAT,DIV PEDIAT CARDIOL,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,CTR MED GENET,DEPT MED,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21218; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON,ENGLAND; UNIV BIRMINGHAM,DEPT CLIN GENET,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; WESTERN GEN HOSP,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Finland National Institute for Health & Welfare; University Children's Hospital Zurich; University of Zurich; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; St Georges University London; University of Birmingham; University of Edinburgh			Pyeritz, Reed/A-1364-2010					ABRAHAM PA, 1982, J CLIN INVEST, V70, P1245, DOI 10.1172/JCI110723; APPEL A, 1979, J BIOL CHEM, V254, P2199; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BLANTON SH, 1990, J MED GENET, V27, P73, DOI 10.1136/jmg.27.2.73; BOUCEK RJ, 1981, NEW ENGL J MED, V305, P988, DOI 10.1056/NEJM198110223051705; BRISSENDEN JE, 1986, GENET EPIDEMIOL, V3, P231, DOI 10.1002/gepi.1370030404; BYERS PH, 1981, P NATL ACAD SCI-BIOL, V78, P7745, DOI 10.1073/pnas.78.12.7745; DALGLEISH R, 1987, J MED GENET, V24, P148, DOI 10.1136/jmg.24.3.148; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; FRANCOMANO CA, 1988, AM J MED GENET, V29, P457, DOI 10.1002/ajmg.1320290233; GODFREY M, 1990, AM J HUM GENET, V46, P661; GODFREY M, 1990, AM J HUM GENET, V46, P652; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; KAINULAINEN K, 1990, HUM GENET, V84, P233; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAGENIS RE, IN PRESS GENOMICS; MORTON NE, 1956, AM J HUM GENET, V8, P80; NAKAMURA Y, 1988, GENOMICS, V3, P342, DOI 10.1016/0888-7543(88)90125-5; OGILVIE DJ, 1987, AM J HUM GENET, V41, P1071; PULKKINEN L, 1990, J BIOL CHEM, V265, P17780; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; SCHECK M, 1979, J ANAT, V129, P645; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSIPOURAS P, 1986, CLIN GENET, V30, P428; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164	26	46	47	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					662	667						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1882844				2022-12-18	WOS:A1991GE36700020
J	MAEDA, N				MAEDA, N			DNA POLYMORPHISMS IN THE CONTROLLING REGION OF THE HUMAN HAPTOGLOBIN GENES - A MOLECULAR EXPLANATION FOR THE HAPTOGLOBIN-2-1 MODIFIED PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; CDNA; DUPLICATION; SEQUENCE	A haptoglobin 2-1 modified (Hp2-1mod) phenotype results when the amount of Hp2 polypeptide synthesized in Hp2/Hp1 heterozygotes is less than that of Hp1 polypeptide. Cloned Hp2 DNA from an individual with the Hp2-1mod phenotype is here shown to have a C in place of the normal A at nucleotide position -61 in one of the interleukin-6 (IL-6) responsive elements of the haptoglobin promoter region. Direct sequencing of the haptoglobin promoter region, amplified by PCR, from DNA from unrelated American blacks showed a C at -61 in all of 10 individuals with the Hp2-1mod phenotype, in two of four with a "possible Hp2-1mod" phenotype, but in none of 15 with the Hp2-1 phenotype. Thus the -61C mutation in the Hp2-61C allele is strongly associated with the Hp2-1mod phenotype. Sequencing results also show that there are three other promoter sequences in the population studied; each can be associated with either Hp2 or Hp1. The variability seen in the Hp2-1mod phenotype, a variability which ranges from close to Hp2-1 to close to Hp1-1, can be explained, in part, by the existence of several Hp2 alleles differing in their promoters - and possibly, in part, by differences in the promoters of the accompanying Hp1 allele. A further part of the variability may be the consequence of differences in the way that the Hp2-61C and the Hp2 alleles respond to the IL-6-dependent factor during an acute-phase response.			MAEDA, N (corresponding author), UNIV N CAROLINA,DEPT PATHOL & GENET CURRICULUM,CHAPEL HILL,NC 27599, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037567] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 37567] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZEVEDO E, 1969, HUM HERED, V19, P603; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; BLACK JA, 1968, CAN J BIOCHEM, V48, P123; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GIBLETT ELOISE R., 1963, NATURE, V197, P576, DOI 10.1038/197576a0; GIBLETT ER, 1964, COLD SPRING HARB SYM, V29, P321, DOI 10.1101/SQB.1964.029.01.034; GIBLETT ER, 1959, NATURE, V183, P192, DOI 10.1038/183192a0; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; GIBLETT ER, 1969, GENETIC MARKERS HUMA, P63; HARRIS H, 1960, ANN HUM GENET, V24, P63; HILL AVS, 1986, AM J HUM GENET, V38, P382; Hohn B, 1979, Methods Enzymol, V68, P299; Javid J, 1978, Curr Top Hematol, V1, P151; LINKE RP, 1984, ANAL BIOCHEM, V141, P55, DOI 10.1016/0003-2697(84)90424-X; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MAEDA N, 1986, P NATL ACAD SCI USA, V83, P7395, DOI 10.1073/pnas.83.19.7395; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; NANCE WE, 1967, THESIS U WISCONSIN M; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; PARKER WC, 1963, AM J HUM GENET, V14, P159; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; RAUGEI G, 1983, NUCLEIC ACIDS RES, V11, P5811, DOI 10.1093/nar/11.17.5811; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SUTTON HE, 1964, J HUM GENET, V16, P419; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; VANDERSTRATEN A, 1983, EMBO J, V2, P1003, DOI 10.1002/j.1460-2075.1983.tb01534.x; YANG FM, 1983, P NATL ACAD SCI-BIOL, V80, P5875, DOI 10.1073/pnas.80.19.5875	30	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					158	166						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063867				2022-12-18	WOS:A1991FW51100018
J	ASHER, JH; MORELL, R; FRIEDMAN, TB				ASHER, JH; MORELL, R; FRIEDMAN, TB			WAARDENBURG SYNDROME (WS) - THE ANALYSIS OF A SINGLE FAMILY WITH A WSI MUTATION SHOWING LINKAGE TO RFLP MARKERS ON HUMAN CHROMOSOME-2Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; NEURAL CREST; GENE; RECOMBINATION; PENETRANCE	Waardenburg syndrome type I (WS1; MIM 19350) is caused by a pleiotropic, autosomal dominant mutation with variable penetrance and expressivity. Of individuals with this mutation, 20%-25% are hearing impaired. A multilocus linkage analysis of RFLP data from a single WS1 family with 11 affected individuals indicates that the WS1 mutation in this family is linked to the following four marker loci located on the long arm of chromosome 2: ALPP (alkaline phosphatase, placental), FN1 (fibronectin 1), D2S3 (a unique-copy DNA segment), and COL6A3 (collagen VI, alpha-3). For the RFLP marker loci, a multilocus linkage analysis using MLINK produced a peak lod (Z) of 3.23 for the following linkage relationships and recombination fractions [(theta-i): (ALPP<--.000-->FN1)<--.122-->D2S3<--.267-->COL6A3.] A similar analysis produced a Z of 6.67 for the following linkage relationships and theta-i values among the markers and WS1: [(FN1<--.000-->WS1<--.000-->ALPP)<--.123-->D2S3<--.246-->COL6A3.] The data confirm the conclusion of Foy et al. that at least some WS1 mutations map to chromosome 2q.	MICHIGAN STATE UNIV,GENET PROGRAM,E LANSING,MI 48824; MICHIGAN STATE UNIV,NEUROSCI PROGRAM,E LANSING,MI 48824	Michigan State University; Michigan State University	ASHER, JH (corresponding author), MICHIGAN STATE UNIV,DEPT ZOOL,E LANSING,MI 48824, USA.		Morell, Robert James/Q-2042-2019	Morell, Robert/0000-0003-1537-7356	NINDS NIH HHS [NS07278-03] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahrendts H, 1965, Z Kinderheilkd, V93, P295, DOI 10.1007/BF00443569; ARIAS S, 1984, AM J MED GENET, V17, P863, DOI 10.1002/ajmg.1320170423; ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; CALINIKOS J, 1963, J Laryngol Otol, V77, P59, DOI 10.1017/S0022215100060369; COLOMBI M, 1987, NUCLEIC ACIDS RES, V15, P6761, DOI 10.1093/nar/15.16.6761; DAVIS LG, 1986, METHODS MOL BIOL; DELLEMAN JW, 1978, J PEDIAT OPHTH STRAB, V15, P341; DIGEORGE AM, 1960, J PEDIATR-US, V57, P649, DOI 10.1016/S0022-3476(60)80159-X; DIVEKAR MV, 1957, J ALL INDIA OPHTHALM, V5, P1; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Erickson C.A., 1987, P39; ERICKSON CA, 1983, J EMBRYOL EXP MORPH, V74, P97; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOY C, 1990, AM J HUM GENET, V46, P1017; FRANCKE U, 1990, NATURE, V343, P692, DOI 10.1038/343692a0; GLASS IA, 1989, J MED GENET, V26, P127, DOI 10.1136/jmg.26.2.127; GOLDBERG MF, 1966, ARCH OPHTHALMOL-CHIC, V76, P797; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; ISHIKIRIYAMA S, 1989, AM J MED GENET, V33, P505, DOI 10.1002/ajmg.1320330419; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LANGE K, 1976, AM J HUM GENET, V28, P167; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEDOUARIN NM, 1988, ANNU REV CELL BIOL, V4, P375, DOI 10.1146/annurev.cb.04.110188.002111; LITT M, 1986, NUCLEIC ACIDS RES, V14, P4378, DOI 10.1093/nar/14.10.4378; Maniatis T., 1982, MOL CLONING; MARTIN D, 1987, NUCLEIC ACIDS RES, V15, P9104, DOI 10.1093/nar/15.21.9104; MCKUSICK VA, 1988, MENDELIAN INHERITANC; NODEN DM, 1988, DEVELOPMENT, V103, P121; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; PANTKE O A, 1971, Birth Defects Original Article Series, V7, P147; PARTINGTON MW, 1964, CAN MED ASSOC J, V90, P1008; PATEL PI, 1990, AM J HUM GENET, V46, P801; PERRIS R, 1989, COMM DEV NEUROBIOL, V1, P61; PREUS M, 1983, AM J MED GENET, V15, P383, DOI 10.1002/ajmg.1320150303; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; STOLLER FM, 1962, ARCH OTOLARYNGOL, V76, P54; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WANG L, 1981, OTOLARYNG HEAD NECK, V89, P666, DOI 10.1177/019459988108900428; WEAVER EJ, 1988, NUCLEIC ACIDS RES, V16, P11386, DOI 10.1093/nar/16.23.11386; WEIL D, 1988, AM J HUM GENET, V42, P435	47	46	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					43	52						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1670751				2022-12-18	WOS:A1991ET18800007
J	KWIATKOWSKI, DJ; NYGAARD, TG; SCHUBACK, DE; PERMAN, S; TRUGMAN, JM; BRESSMAN, SB; BURKE, RE; BRIN, MF; OZELIUS, L; BREAKEFIELD, XO; FAHN, S; KRAMER, PL				KWIATKOWSKI, DJ; NYGAARD, TG; SCHUBACK, DE; PERMAN, S; TRUGMAN, JM; BRESSMAN, SB; BURKE, RE; BRIN, MF; OZELIUS, L; BREAKEFIELD, XO; FAHN, S; KRAMER, PL			IDENTIFICATION OF A HIGHLY POLYMORPHIC MICROSATELLITE VNTR WITHIN THE ARGININOSUCCINATE SYNTHETASE LOCUS - EXCLUSION OF THE DYSTONIA GENE ON 9Q32-34 AS THE CAUSE OF DOPA-RESPONSIVE DYSTONIA IN A LARGE KINDRED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; BETA-HYDROXYLASE ACTIVITY; TORSION DYSTONIA; HUMAN CHROMOSOME-9; LOCALIZATION; REGION	Dopa-responsive dystonia is a clinical variant of idiopathic torsion dystonia that is distinguished from other forms of dystonia by the frequent cooccurrence of parkinsonism, diurnal fluctuation of symptoms, and its dramatic therapeutic response to L-dopa. Linkage of a gene causing classic dystonia in a large non-Jewish kindred (DYT1) and in a group of Ashkenazi Jewish families, to the gelsolin (GSN) and arginino-succinate synthetase (ASS) loci on chromosome 9q32-34, respectively, was recently determined. Here we report the discovery of a highly informative (GT)n repeat VNTR polymorphism within the ASS locus. Analysis of a large kindred with dopa-responsive dystonia, using this new polymorphism and conventional RFLPs for the 9q32-34 region, excludes loci in this region as a cause of this form of dystonia. This provides proof of genetic heterogeneity between classic idiopathic torsion dystonia and dopa-responsive dystonia.	MASSACHUSETTS GEN HOSP,DEPT MED,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; UNIV VIRGINIA,HLTH SCI CTR,DEPT NEUROL,CHARLOTTESVILLE,VA 22903	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University; Oregon Health & Science University; University of Virginia			Burke, Robert/B-7226-2011	Burke, Robert/0000-0002-4760-8553	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001174, R29NS026836, R01NS026836] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL01582] Funding Source: Medline; NINDS NIH HHS [NS26836, NS01174] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAUDET AL, 1982, CELL, V30, P287, DOI 10.1016/0092-8674(82)90034-4; BECHHANSEN NT, 1989, NUCLEIC ACIDS RES, V17, P4004, DOI 10.1093/nar/17.10.4004; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; CRAIG SP, 1988, CYTOGENET CELL GENET, V48, P48, DOI 10.1159/000132584; de Yebenes J G, 1988, Adv Neurol, V50, P101; DEONNA T, 1986, NEUROPEDIATRICS, V17, P81, DOI 10.1055/s-2008-1052506; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; Fahn S, 1988, Adv Neurol, V50, P1; FAHN S, 1988, ANN NEUROL, V24, P179; FAHN S, 1989, J NEUROL NEUROSURG S, V52, P96; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLETCHER NA, 1989, J NEUROL NEUROSUR PS, V52, P112, DOI 10.1136/jnnp.52.1.112; FRYER AE, 1987, LANCET, V1, P659; Gimenez-Roldan S, 1988, Adv Neurol, V50, P73; Hodge SE, 1979, AM J HUM GENET, V31, P761; JOHNSON W G, 1988, Neurology, V38, P174; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KWIATKOWSKI DJ, 1989, NUCLEIC ACIDS RES, V17, P4425, DOI 10.1093/nar/17.11.4425; KWIATKOWSKI DJ, 1988, AM J HUM GENET, V42, P565; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LATHROP GM, 1988, GENOMICS, V3, P361; Lee L V, 1976, Adv Neurol, V14, P137; LITT M, 1989, AM J HUM GENET, V44, P397; MENKES JH, 1987, NEUROLOGY, V37, P779, DOI 10.1212/WNL.37.5.779; NORTHRUP H, 1989, GENOMICS, V5, P442, DOI 10.1016/0888-7543(89)90007-4; Nygaard T G, 1988, Adv Neurol, V50, P377; NYGAARD TG, 1990, NEUROLOGY, V40, P66, DOI 10.1212/WNL.40.1.66; NYGAARD TG, 1989, DISORDERS MOVEMENT C, P323; OTT J, 1976, AM J HUM GENET, V28, P528; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; PANDOLFO M, 1988, NUCLEIC ACIDS RES, V16, P7213, DOI 10.1093/nar/16.14.7213; PAULS DL, 1990, NEUROLOGY, V40, P1107, DOI 10.1212/WNL.40.7.1107; RISCH NJ, 1990, AM J HUM GENET, V46, P533; SCHUBACK DE, IN PRESS HUM GENET; Segawa M, 1976, Adv Neurol, V14, P215; SMITH M, 1989, CYTOGENET CELL GENET, V51, P202, DOI 10.1159/000132792; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILSON AF, 1988, AM J HUM GENET, V42, P160; WOOTEN GF, 1973, NEW ENGL J MED, V288, P284, DOI 10.1056/NEJM197302082880604; Zeman W, 1967, Psychiatr Neurol Neurochir, V70, P77; Ziegler M G, 1976, Adv Neurol, V14, P307; ZILBER N, 1984, J MED GENET, V218, P13; ZUFFARDI O, 1989, HUM GENET, V82, P17, DOI 10.1007/BF00288264	45	46	46	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					121	128						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985454				2022-12-18	WOS:A1991ET18800017
J	URABE, K; KIMURA, A; HARADA, F; IWANAGA, T; SASAZUKI, T				URABE, K; KIMURA, A; HARADA, F; IWANAGA, T; SASAZUKI, T			GENE CONVERSION IN STEROID 21-HYDROXYLASE GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KYUSHU UNIV,MED INST BIOREGULAT,DEPT GENET,3-1-1 MAIDSHI,HIGASHI KU,FUKUOKA,JAPAN	Kyushu University								AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BELT KT, 1984, CELL, V36, P907; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; EVANS GA, 1982, P NATL ACAD SCI-BIOL, V79, P1994, DOI 10.1073/pnas.79.6.1994; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARLEPP MJ, 1986, IMMUNOGENETICS, V23, P100, DOI 10.1007/BF00377968; GLOBERMAN H, 1988, J CLIN INVEST, V82, P139, DOI 10.1172/JCI113562; HARADA F, 1987, HUM GENET, V75, P91; HARADA F, 1987, P NATL ACAD SCI USA, V84, P8091, DOI 10.1073/pnas.84.22.8091; HIGASHI Y, 1988, P NATL ACAD SCI USA, V85, P7486, DOI 10.1073/pnas.85.20.7486; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LISKAY RM, 1983, CELL, V35, P157, DOI 10.1016/0092-8674(83)90218-0; Maniatis T., 1982, MOL CLONING; MATTESON KJ, 1987, P NATL ACAD SCI USA, V84, P5858, DOI 10.1073/pnas.84.16.5858; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MELLOR AL, 1983, NATURE, V306, P792, DOI 10.1038/306792a0; MICHELSON AM, 1983, J BIOL CHEM, V258, P5245; MILLER WL, 1988, AM J HUM GENET, V42, P4; MITTAL KK, 1976, VOX SANG, V31, P161, DOI 10.1111/j.1423-0410.1976.tb02206.x; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; PANG S, 1988, PEDIATRICS, V81, P866; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; RUPPERT S, 1984, NATURE, V308, P554, DOI 10.1038/308554a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER PM, 1986, J CLIN INVEST, V78, P650, DOI 10.1172/JCI112623; SEEMANN GHA, 1986, EMBO J, V5, P547, DOI 10.1002/j.1460-2075.1986.tb04245.x; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SPEISER PW, 1988, NEW ENGL J MED, V319, P19, DOI 10.1056/NEJM198807073190104; TERASAKI PI, 1978, AM J CLIN PATHOL, V69, P103; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; YAMAWAKIKATAOKA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2623, DOI 10.1073/pnas.79.8.2623; YU CY, 1987, IMMUNOGENETICS, V25, P383	40	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1178	1186						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	1971153				2022-12-18	WOS:A1990DF20200019
J	WU, JS; CARSON, NL; MYERS, S; PAKSTIS, AJ; KIDD, JR; CASTIGLIONE, CM; ANDERSON, L; HOYLE, LS; GENEL, M; VERDY, M; JACKSON, CE; SIMPSON, NE; KIDD, KK				WU, JS; CARSON, NL; MYERS, S; PAKSTIS, AJ; KIDD, JR; CASTIGLIONE, CM; ANDERSON, L; HOYLE, LS; GENEL, M; VERDY, M; JACKSON, CE; SIMPSON, NE; KIDD, KK			THE GENETIC-DEFECT IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A MAPS NEXT TO THE CENTROMERE OF CHROMOSOME-10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PEDIAT,NEW HAVEN,CT 06510; QUEENS UNIV,DEPT PAEDIAT & BIOL,KINGSTON K7L 3N6,ONTARIO,CANADA; HOP HOTEL DIEU,MONTREAL,QUEBEC,CANADA; HENRY FORD HOSP,DEPT MED,DETROIT,MI 48202	Yale University; Yale University; Queens University - Canada; Universite de Montreal; Henry Ford Health System; Henry Ford Hospital					NATIONAL CANCER INSTITUTE [R01CA032066] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NCI NIH HHS [CA32066] Funding Source: Medline; NCRR NIH HHS [RR00125] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEAUDET AL, 1989, AM J HUM GENET, V44, P319; DEVILEE P, 1988, Genomics, V3, P1, DOI 10.1016/0888-7543(88)90151-6; EASTON DF, 1989, AM J HUM GENET, V44, P208; FARRER LA, 1987, CANCER GENET CYTOGEN, V27, P327, DOI 10.1016/0165-4608(87)90015-X; FARRER LA, 1988, HUM GENET, V79, P109, DOI 10.1007/BF00280547; GAGEL RF, 1988, NEW ENGL J MED, V318, P478, DOI 10.1056/NEJM198802253180804; GAGEL RF, 1982, J PEDIATR-US, V101, P941, DOI 10.1016/S0022-3476(82)80014-0; GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; Hodge SE, 1979, AM J HUM GENET, V31, P761; JACKSON C E, 1988, American Journal of Human Genetics, V43, pA147; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, GENOMICS, V2, P157; LIOU GI, 1987, NUCLEIC ACIDS RES, V15, P3196, DOI 10.1093/nar/15.7.3196; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MYERS S, 1989, CYTOGENET CELL GENET, V51, P1050; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P374, DOI 10.1093/nar/16.1.374; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1989, GENOMICS, V5, P199, DOI 10.1016/0888-7543(89)90046-3; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1985, ANAL HUMAN GENETIC L; PAKSTIS AJ, 1986, CYTOGENET CELL GENET, V41, P189, DOI 10.1159/000132226; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SMITH M, 1989, CYTOGENET CELL GENET, V51, P202, DOI 10.1159/000132792; SOBOL H, 1988, LANCET, V1, P62; WELLS SA, 1978, ANN SURG, V188, P139, DOI 10.1097/00000658-197808000-00002; WHITE R, IN PRESS GENOMICS; WU J, 1989, CYTOGENET CELL GENET, V51, P1111; WU J, 1988, American Journal of Human Genetics, V43, pA163; WU J, 1988, CYTOGENET CELL GENET, V48, P246, DOI 10.1159/000132639; WU J, IN PRESS HUM GENET; WU JS, 1989, HUM GENET, V83, P383, DOI 10.1007/BF00291386; YAMAMOTO M, 1989, HUM GENET, V82, P287, DOI 10.1007/BF00291173	32	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					624	630						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1968709				2022-12-18	WOS:A1990CT66800027
J	GROSSMAN, A; SILVER, RT; ARLIN, Z; COLEMAN, M; CAMPOSANO, E; GASCON, P; BENN, PA				GROSSMAN, A; SILVER, RT; ARLIN, Z; COLEMAN, M; CAMPOSANO, E; GASCON, P; BENN, PA			FINE MAPPING OF CHROMOSOME-22 BREAKPOINTS WITHIN THE BREAKPOINT CLUSTER REGION (BCR) IMPLIES A ROLE FOR BCR EXON-3 IN DETERMINING DISEASE DURATION IN CHRONIC MYELOID-LEUKEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									LIFECODES CORP,SAW MILL RIVER RD,VALHALLA,NY 10595; NEW YORK MED COLL,DEPT MED,DIV HEMATOL ONCOL,VALHALLA,NY 10595; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT MED,DIV HEMATOL ONCOL,NEW YORK,NY 10021; UNIV MED & DENT NEW JERSEY,DEPT MED,DIV HEMATOL,NEWARK,NJ 07103	New York Medical College; Cornell University; NewYork-Presbyterian Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center			Silver MD, Richard T/GRE-5925-2022					BAER R, 1985, CELL, V43, P705, DOI 10.1016/0092-8674(85)90243-0; BARTRAM CR, 1987, BLUT, V55, P505, DOI 10.1007/BF00320220; BENN P, 1988, LEUKEMIA, V2, P760; BENN P, 1987, CANCER GENET CYTOGEN, V29, P1, DOI 10.1016/0165-4608(87)90025-2; BENN P A, 1988, Journal of Tumor Marker Oncology, V3, P101; BERNARDS A, 1987, MOL CELL BIOL, V7, P3231, DOI 10.1128/MCB.7.9.3231; BLENNERHASSETT GT, 1988, LEUKEMIA, V2, P648; CHEN SJ, 1988, LEUKEMIA, V2, P634; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; COLLINS S, 1987, MOL CELL BIOL, V7, P2370; DENNY CT, 1989, P NATL ACAD SCI USA, V86, P4254, DOI 10.1073/pnas.86.11.4254; DENNY CT, 1986, SCIENCE, V234, P197, DOI 10.1126/science.3092355; DOBROVIC A, 1988, BLOOD, V72, P2063; DREAZEN O, 1988, BLOOD, V71, P797; DUBE I, IN PRESS GENES CHROM; EISENBERG A, 1988, LEUKEMIA, V2, P642; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P226; GALE RP, 1988, LEUKEMIA, V2, P321; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HEISTERKAMP N, 1988, NUCLEIC ACIDS RES, V16, P10069, DOI 10.1093/nar/16.21.10069; HERMANS A, 1988, BLOOD, V72, P2066; HERMANS A, 1988, LEUKEMIA, V2, P628; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARANAS A, 1968, BLOOD, V32, P445, DOI 10.1182/blood.V32.3.445.445; KATO Y, 1988, LEUKEMIA, V2, P701; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; LEE M, 1988, BLOOD, V72, pA211; LEE MS, 1988, BLOOD, V72, P893; MENGLEGAW L, 1988, P NATL ACAD SCI USA, V85, P9171, DOI 10.1073/pnas.85.23.9171; MILLS KI, 1988, BLOOD, V72, P1237; NOWELL PC, 1960, SCIENCE, V132, P1497; NOWELL PC, 1988, CANCER GENET CYTOGEN, V34, P57, DOI 10.1016/0165-4608(88)90169-0; PRIEST JR, 1980, BLOOD, V56, P15; PROPP S, 1970, BLOOD-J HEMATOL, V36, P353, DOI 10.1182/blood.V36.3.353.353; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; RUSSO G, 1989, P NATL ACAD SCI USA, V86, P602, DOI 10.1073/pnas.86.2.602; SALGIO GG, 1988, BLOOD, V72, P1203; SANDBERG AA, 1980, CANCER GENET CYTOGEN, V2, P145, DOI 10.1016/0165-4608(80)90058-8; SELLERI L, 1987, BLOOD, V70, P1569; SHTALRID M, 1988, BLOOD, V72, P485; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SHTIVELMAN E, 1987, BLOOD, V69, P971; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; WEINSTEIN ME, 1988, CANCER GENET CYTOGEN, V35, P223, DOI 10.1016/0165-4608(88)90244-0; WHANGPENG J, 1970, BLOOD-J HEMATOL, V36, P448, DOI 10.1182/blood.V36.4.448.448	52	46	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					729	738						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2683759				2022-12-18	WOS:A1989AZ04900009
J	RAMSAY, M; BERNSTEIN, R; ZWANE, E; PAGE, DC; JENKINS, T				RAMSAY, M; BERNSTEIN, R; ZWANE, E; PAGE, DC; JENKINS, T			XX TRUE HERMAPHRODITISM IN SOUTHERN AFRICAN BLACKS - AN ENIGMA OF PRIMARY SEXUAL-DIFFERENTIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,MRC,HUMAN ECOGENET RES UNIT,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA; UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA	University of Witwatersrand				Ramsay, Michele/0000-0002-4156-4801				AFFARA NA, 1986, NUCLEIC ACIDS RES, V14, P5375, DOI 10.1093/nar/14.13.5375; ANDERSSON M, 1986, SCIENCE, V233, P786, DOI 10.1126/science.3738510; BUCKLE VJ, 1987, J MED GENET, V24, P197, DOI 10.1136/jmg.24.4.197; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DELACHAPELLE A, 1984, NATURE, V307, P170, DOI 10.1038/307170a0; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; DESOUZA JJL, 1984, S AFR MED J, V66, P855; Dinner M, 1969, S Afr J Surg, V7, P49; DONAHOE PK, 1978, J PEDIATR SURG, V13, P293, DOI 10.1016/S0022-3468(78)80403-5; EHRHARDT AA, 1981, SCIENCE, V211, P1312, DOI 10.1126/science.7209510; FERGUSONSMITH MA, 1966, LANCET, V2, P475; GELDWERTH D, 1985, EMBO J, V4, P1739, DOI 10.1002/j.1460-2075.1985.tb03844.x; GRACE H J, 1970, South African Medical Journal, V44, P1112; GRACE HJ, 1973, S AFR MED J, V47, P1553; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; KLEMPMAN SARAH, 1964, S AFRICAN MED J, V38, P234; MAGENIS RE, 1982, HUM GENET, V62, P271, DOI 10.1007/BF00333535; MAGENIS RE, 1987, HUM GENET, V75, P228, DOI 10.1007/BF00281064; MITTWOCH U, 1986, ANN HUM GENET, V50, P103; MULLER U, 1986, NUCLEIC ACIDS RES, V14, P6489, DOI 10.1093/nar/14.16.6489; NURSE GT, 1985, RES MONOGRAPHS HUMAN; OBERLE I, 1985, NEW ENGL J MED, V312, P682, DOI 10.1056/NEJM198503143121103; PAGE DC, 1984, AM J HUM GENET, V36, P565; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1985, NATURE, V315, P224, DOI 10.1038/315224a0; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; PAGE DC, 1986, COLD SPRING HARB SYM, V51, P229, DOI 10.1101/SQB.1986.051.01.028; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PETIT C, 1987, CELL, V49, P595, DOI 10.1016/0092-8674(87)90535-6; ROSENBERG HS, 1963, J CLIN ENDOCR METAB, V23, P203, DOI 10.1210/jcem-23-2-203; ROUX JP, 1974, S AFR MED J, V48, P2088; SKORDIS NA, 1987, J PEDIATR-US, V110, P244, DOI 10.1016/S0022-3476(87)80162-2; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SYKES BC, 1983, LANCET, V2, P787; Van Niekerk WA, 1974, TRUE HERMAPHRODITISM; VANNIEKERK WA, 1976, AM J OBSTET GYNECOL, V126, P890, DOI 10.1016/0002-9378(76)90677-3; VANNIEKERK WA, 1981, HUM GENET, V58, P117, DOI 10.1007/BF00284158; VANNIEKERK WA, 1981, S AFR MED J, V60, P195; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; Wilton E, 1969, S Afr J Surg, V7, P45; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; 1982, POPULATION CENSUS 19	43	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					4	13						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	3163890				2022-12-18	WOS:A1988N986300002
J	WALTER, MA; COX, DW				WALTER, MA; COX, DW			ANALYSIS OF GENETIC-VARIATION REVEALS HUMAN-IMMUNOGLOBULIN VH-REGION GENE ORGANIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto								BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; JOHNSON MJ, 1984, P NATL ACAD SCI-BIOL, V81, P7840, DOI 10.1073/pnas.81.24.7840; Kabat EA, 1983, SEQUENCES PROTEINS I; KEMP D J, 1981, Journal of Molecular and Applied Genetics, V1, P245; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; LINSLEY PS, 1983, P NATL ACAD SCI-BIOL, V80, P1997, DOI 10.1073/pnas.80.7.1997; LIVANT D, 1986, CELL, V47, P461, DOI 10.1016/0092-8674(86)90603-3; MATTHYSSENS G, 1980, P NATL ACAD SCI-BIOL, V77, P6561, DOI 10.1073/pnas.77.11.6561; MEYER J, 1986, P NATL ACAD SCI USA, V83, P6950, DOI 10.1073/pnas.83.18.6950; Noma Y, 1984, Mol Biol Med, V2, P337; PECH M, 1984, NUCLEIC ACIDS RES, V12, P9229, DOI 10.1093/nar/12.24.9229; RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405; Steel R.G.D., 1980, PRINCIPLES STAT; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TURNBULL IF, 1987, IMMUNOGENETICS, V25, P184, DOI 10.1007/BF00344033; WALTER MA, 1987, NUCLEIC ACIDS RES, V15, P4697, DOI 10.1093/nar/15.11.4697; WALTER MA, 1986, GENET SOC CAN B, V17, P71; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	21	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					446	451						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	2894757				2022-12-18	WOS:A1988M620600006
J	BOYD, CD; TOTHFEJEL, S; GADI, IK; LITT, M; CONDON, MR; KOLBE, M; HAGEN, IK; KURKINEN, M; MACKENZIE, JW; MAGENIS, E				BOYD, CD; TOTHFEJEL, S; GADI, IK; LITT, M; CONDON, MR; KOLBE, M; HAGEN, IK; KURKINEN, M; MACKENZIE, JW; MAGENIS, E			THE GENES-CODING FOR HUMAN PRO-ALPHA-1(IV) COLLAGEN AND PRO-ALPHA-2(IV) COLLAGEN ARE BOTH LOCATED AT THE END OF THE LONG ARM OF CHROMOSOME-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MED,NEW BRUNSWICK,NJ 08903; OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDRENS,DEPT MED GENET,PORTLAND,OR 97201	Rutgers State University New Brunswick; Rutgers State University Medical Center; Oregon Health & Science University	BOYD, CD (corresponding author), UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT SURG,1 ROBERT WOOD JOHNSON PL,NEW BRUNSWICK,NJ 08903, USA.				NIADDK NIH HHS [AM22051] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM022051] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOEDTKER H, 1985, ANN NY ACAD SCI, V460, P85, DOI 10.1111/j.1749-6632.1985.tb51159.x; BOYD CD, 1986, HUM GENET, V74, P121, DOI 10.1007/BF00282074; EMANUEL BS, 1986, AM J HUM GENET, V38, P38; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARNDEN DG, 1985, ISCN 1985 INT SYSTEM; HUERRE C, 1982, P NATL ACAD SCI-BIOL, V79, P6627, DOI 10.1073/pnas.79.21.6627; HUERREJEANPIERRE C, 1986, HUM GENET, V73, P64, DOI 10.1007/BF00292666; HUERREJEANPIERRE C, 1986, AM J HUM GENET, V38, P26; KURKINEN M, 1987, J BIOL CHEM, V262, P8496; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MOHANDAS T, 1986, SOMAT CELL MOLEC GEN, V12, P89, DOI 10.1007/BF01560731; PIHLAJANIEMI T, 1985, J BIOL CHEM, V260, P7681; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOLOMON E, 1983, CYTOGENET CELL GENET, V35, P64, DOI 10.1159/000131838; SOLOMON E, 1985, P NATL ACAD SCI USA, V82, P3330, DOI 10.1073/pnas.82.10.3330; STROM CM, 1984, SOMAT CELL MOLEC GEN, V10, P651, DOI 10.1007/BF01535232; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164	20	46	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					309	314						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3422542				2022-12-18	WOS:A1988M313300013
J	LITT, M; JORDE, LB				LITT, M; JORDE, LB			LINKAGE DISEQUILIBRIA BETWEEN PAIRS OF LOCI WITHIN A HIGHLY POLYMORPHIC REGION OF CHROMOSOME-2Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; UNIV UTAH,SCH MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132	Oregon Health & Science University; Utah System of Higher Education; University of Utah	LITT, M (corresponding author), OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201, USA.				NICHD NIH HHS [HD-16109] Funding Source: Medline; NIGMS NIH HHS [GM-32500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032500] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAKRAVARTI A, 1985, 8TH INT HUM GEN MAPP; GOLDING GB, 1984, GENETICS, V108, P257; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; HILL WG, 1977, THEOR POPUL BIOL, V11, P239, DOI 10.1016/0040-5809(77)90026-0; HUDSON RR, 1985, GENETICS, V109, P611; HUDSON RR, 1985, GENETICS, V111, P147; LANGE K, 1983, AM J HUM GENET, V35, P177; LEWONTIN RC, 1964, GENETICS, V49, P49; LITT M, 1986, AM J HUM GENET, V38, P288; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; MORTON NE, 1985, HUM GENET, V70, P231; NEI M, 1973, GENETICS, V75, P213; OHTA T, 1969, GENET RES, V13, P47, DOI 10.1017/S001667230000272X; WEIR BS, 1978, GENETICS, V88, P633; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1986, AM J HUM GENET, V38, P776; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WHITE RL, 1983, BANBURY REPORT, V14, P235; WILLARD HF, 1985, 8TH INT HUM GEN MAPP; ZOUROS E, 1977, GENETICS, V85, P543	28	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					166	178						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3019131				2022-12-18	WOS:A1986E145900002
J	INABA, T; JURIMA, M; KALOW, W				INABA, T; JURIMA, M; KALOW, W			FAMILY STUDIES OF MEPHENYTOIN HYDROXYLATION DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											INABA, T (corresponding author), UNIV TORONTO,FAC MED,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA.							EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; EVANS DAP, 1980, J MED GENET, V17, P102, DOI 10.1136/jmg.17.2.102; INABA T, 1984, CLIN PHARMACOL THER, V36, P670, DOI 10.1038/clpt.1984.238; INABA T, 1985, DRUG METAB DISPOS, V13, P443; JURIMA M, 1984, CLIN PHARMACOL THER, V35, P426, DOI 10.1038/clpt.1984.54; JURIMA M, 1985, BRIT J CLIN PHARMACO, V19, P483, DOI 10.1111/j.1365-2125.1985.tb02673.x; KALOW W, 1986, XENOBIOTICA; KUPFER A, 1984, CLIN PHARMACOL THER, V35, P33; KUPFER A, 1984, EUR J CLIN PHARMACOL, V26, P753, DOI 10.1007/BF00541938; KUPFER A, 1981, J PHARMACOL EXP THER, V218, P193; KUPFER A, 1982, J PHARMACOL EXP THER, V221, P590; KUPFER A, 1979, PHARMACOLOGIST, V21, P173; WEDLUND PJ, 1984, CLIN PHARMACOL THER, V36, P773, DOI 10.1038/clpt.1984.256	13	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					768	772						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3717162				2022-12-18	WOS:A1986C973000015
J	FALK, CT; SCHWARTZ, RC; RAMIREZ, F; TSIPOURAS, P				FALK, CT; SCHWARTZ, RC; RAMIREZ, F; TSIPOURAS, P			USE OF MOLECULAR HAPLOTYPES SPECIFIC FOR THE HUMAN PRO-ALPHA-2(I) COLLAGEN GENE IN LINKAGE ANALYSIS OF THE MILD AUTOSOMAL DOMINANT FORMS OF OSTEOGENESIS IMPERFECTA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT PEDIAT,PISCATAWAY,NJ 08854; UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT OBSTET GYNECOL,PISCATAWAY,NJ 08854; UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	FALK, CT (corresponding author), NEW YORK BLOOD CTR,NEW YORK,NY 10021, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM032380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029177] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-01224, AM032380] Funding Source: Medline; NIGMS NIH HHS [GM29177] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1974, GENETIC BASIS EVOLUT; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BYERS PH, 1983, J CLIN INVEST, V71, P689, DOI 10.1172/JCI110815; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHU ML, 1983, NATURE, V304, P78, DOI 10.1038/304078a0; DICKSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P4524, DOI 10.1073/pnas.81.14.4524; HODGE SE, 1983, AM J HUM GENET, V35, P1139; LEVIN LS, 1978, LANCET, V1, P332; MORTON NE, 1956, AM J HUM GENET, V8, P80; MYERS JC, 1983, J BIOL CHEM, V258, P128; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1974, AM J HUM GENET, V26, P588; PATERSON CR, 1983, J BONE JOINT SURG BR, V65, P35, DOI 10.1302/0301-620X.65B1.6822598; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; PROCHOWNIK EV, 1983, NEW ENGL J MED, V308, P1549, DOI 10.1056/NEJM198306303082601; RAMIREZ F, 1985, HUMAN GENES DISEASES; SCHWARTZ S, 1984, ORAL SURG ORAL MED O, V57, P161, DOI 10.1016/0030-4220(84)90206-8; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SIPPOLA M, 1984, J BIOL CHEM, V259, P4094; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Smith R., 1983, BRITTLE BONE SYNDROM; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; WENSTRUP R J, 1984, American Journal of Human Genetics, V36, p23S	29	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					269	279						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3006479				2022-12-18	WOS:A1986A578100001
J	MIGONE, N; DELANGE, G; PIAZZA, A; CAVALLISFORZA, LL				MIGONE, N; DELANGE, G; PIAZZA, A; CAVALLISFORZA, LL			GENETIC-ANALYSIS OF 8 LINKED POLYMORPHISMS WITHIN THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CNR, CTR IMMUNOGENET & ISTOCOMPATIBIL, I-10126 TORINO, ITALY; STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA; NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, AMSTERDAM, NETHERLANDS	Consiglio Nazionale delle Ricerche (CNR); Stanford University	MIGONE, N (corresponding author), UNIV TURIN, IST GENET MED, I-10124 TURIN, ITALY.			Piazza, Alberto/0000-0002-2355-4183	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; Bishop YM., 2007, DISCRETE MULTIVARIAT; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P283; CRAMER H, 1946, MATH METHODS STATIST; DONALD JA, 1984, ANN HUM GENET, V48, P269, DOI 10.1111/j.1469-1809.1984.tb01024.x; EGEL R, 1981, NATURE, V290, P191, DOI 10.1038/290191a0; FISHER RA, 1946, NATURE, V157, P48, DOI 10.1038/157048b0; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; KARLIN S, 1981, ANN HUM GENET, V45, P79, DOI 10.1111/j.1469-1809.1981.tb00308.x; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; Lefranc M P, 1983, Mol Biol Med, V1, P207; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811; MORTON NE, 1983, HUM GENET, V64, P103, DOI 10.1007/BF00327102; Natvig J B, 1973, Adv Immunol, V16, P1, DOI 10.1016/S0065-2776(08)60295-3; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; STEINMETZ M, 1982, NATURE, V300, P35, DOI 10.1038/300035a0; SVED J A, 1971, Theoretical Population Biology, V2, P125; SVED JA, 1973, THEOR POPUL BIOL, V4, P129, DOI 10.1016/0040-5809(73)90008-7; TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983; VANLOGHEM E, 1978, HDB EXPT IMMUNOLOGY, V1	27	46	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1146	1163						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	3936353				2022-12-18	WOS:A1985AXE3600011
J	ROMEO, G; BIANCO, M; DEVOTO, M; MENOZZI, P; MASTELLA, G; GIUNTA, AM; MICALIZZI, C; ANTONELLI, M; BATTISTINI, A; SANTAMARIA, F; CASTELLO, D; MARIANELLI, A; MARCHI, AG; MANCA, A; MIANO, A				ROMEO, G; BIANCO, M; DEVOTO, M; MENOZZI, P; MASTELLA, G; GIUNTA, AM; MICALIZZI, C; ANTONELLI, M; BATTISTINI, A; SANTAMARIA, F; CASTELLO, D; MARIANELLI, A; MARCHI, AG; MANCA, A; MIANO, A			INCIDENCE IN ITALY, GENETIC-HETEROGENEITY, AND SEGREGATION ANALYSIS OF CYSTIC-FIBROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PARMA,INST ECOL,I-43100 PARMA,ITALY; UNIV MILAN,PEDIAT CLIN 2,I-20122 MILAN,ITALY; CTR REG VENETO FIBROSI CIST,VERONA,ITALY; IST GIANNINA GASLINI,I-16148 GENOA,ITALY; UNIV ROME,PEDIAT CLIN 1,I-00100 ROME,ITALY; UNIV PARMA,CTR FISIOPATOL RESP INFANTILE,I-43100 PARMA,ITALY; UNIV NAPLES,FAC MED 2,PEDIAT CLIN,I-80138 NAPLES,ITALY; UNIV TURIN,PEDIAT CLIN,I-10124 TURIN,ITALY; UNIV FLORENCE,PEDIAT CLIN,I-50121 FLORENCE,ITALY; IST BURLO GAROFALO TRIESTE,TRIESTE,ITALY; UNIV BARI,IST POLICATTEDRA PEDIAT,I-70124 BARI,ITALY; OSPED BUFALINI,DIV PEDIAT,CESENA,ITALY	University of Parma; University of Milan; University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; University of Parma; University of Naples Federico II; University of Turin; University of Florence; IRCCS Burlo Garofolo; Universita degli Studi di Bari Aldo Moro	ROMEO, G (corresponding author), UNIV BOLOGNA,GENET LAB,VIA FOSCOLO 7,I-40123 BOLOGNA,ITALY.		MENOZZI, PAOLO/A-6234-2012; Devoto, Marcella/AAP-7595-2021	MENOZZI, PAOLO/0000-0001-8638-7370; DEVOTO, MARCELLA/0000-0002-4431-5114				BARRAI I, 1965, AM J HUM GENET, V17, P220; BIANCO M, 1983, THESIS U BOLOGNA BOL; Dahlberg G, 1947, MATH METHODS POPULAT, P61; DANKS DM, 1984, AM J HUM GENET, V36, P1401; DANKS DM, 1983, AM J HUM GENET, V35, P838; GIBSON LE, 1959, PEDIATRICS, V23, P545; MORONI A, 1977, HUMAN ADAPTABILITY, P153; MORONI A, 1964, ATTI A G I, V9, P220; PEDERZINI F, 1983, RIV ITAL PED, V9, P445; ROMEO G, 1981, RIV ITAL PED, V7, P201; ROMEO G, 1983, CLIN GENET, V24, P339, DOI 10.1111/cge.1983.24.5.339; ROMEO G, 1983, AM J HUM GENET, V35, P523; SCHAAP T, 1976, CYSTIC FIBROSIS PROJ, P291; STEINBERG AG, 1962, METHODOLOGY HUMAN GE, P76; TENKATE LP, 1977, INT J EPIDEMIOL, V6, P23	15	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					338	349						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	3985009				2022-12-18	WOS:A1985AGY5900008
J	KAZAZIAN, HH; WABER, PG; BOEHM, CD; LEE, JI; ANTONARAKIS, SE; FAIRBANKS, VF				KAZAZIAN, HH; WABER, PG; BOEHM, CD; LEE, JI; ANTONARAKIS, SE; FAIRBANKS, VF			HEMOGLOBIN-E IN EUROPEANS - FURTHER EVIDENCE FOR MULTIPLE ORIGINS OF THE BETA-E-GLOBIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									MAYO CLIN & MAYO FDN,DEPT LAB MED,ROCHESTER,MN 55901	Mayo Clinic	KAZAZIAN, HH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,GENET UNIT,BALTIMORE,MD 21205, USA.		Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM013983] Funding Source: NIH RePORTER; NIADDK NIH HHS [2R01-AM-13983-14] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; ANTONARAKIS SE, 1984, P NATL ACAD SCI US; BENZ EJ, 1981, J CLIN INVEST, V68, P118, DOI 10.1172/JCI110226; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; FAIRBANKS VF, 1980, AM J HEMATOL, V8, P109, DOI 10.1002/ajh.2830080112; FAIRBANKS VF, 1979, BLOOD, V53, P109; FEARON ER, 1983, BLOOD, V61, P1273; FLATZ G, 1967, HUMANGENETIK, V3, P189, DOI 10.1007/BF00273124; GEORGE DL, 1981, HUM GENET, V57, P138; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; MANIATIS T, 1976, CELL, V8, P163, DOI 10.1016/0092-8674(76)90001-5; MOSCHONAS N, 1982, NUCLEIC ACIDS RES, V10, P2109; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; ORKIN SH, 1983, PROGR HEMATOLOGY, V13; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TRAIGER J, 1980, NATURE, V288, P497	19	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					212	217						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6198908				2022-12-18	WOS:A1984SC43000019
J	ALLDERDICE, PW; EALES, B; ONYETT, H; SPRAGUE, W; HENDERSON, K; LEFEUVRE, PA; PAL, G				ALLDERDICE, PW; EALES, B; ONYETT, H; SPRAGUE, W; HENDERSON, K; LEFEUVRE, PA; PAL, G			DUPLICATION 9Q34 SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JANEWAY CHILD HLTH CTR,ST JOHNS,NEWFOUNDLAND,CANADA; CURTIS MEM HOSP,ST ANTHONY,NEWFOUNDLAND,CANADA; CHILDRENS REHABIL CTR,ST JOHNS,NEWFOUNDLAND,CANADA; PATON MEM HOSP,GANDER,NEWFOUNDLAND,CANADA	Memorial University Newfoundland	ALLDERDICE, PW (corresponding author), MEM UNIV NEWFOUNDLAND,FAC MED,ST JOHNS A1C 5S7,NEWFOUNDLAND,CANADA.							AFTIMOS SF, 1980, AM J DIS CHILD, V134, P848, DOI 10.1001/archpedi.1980.02130210032009; ALLDERDICE PW, 1975, AM J HUM GENET, V27, P690; BEALS RK, 1971, J BONE JOINT SURG AM, VA 53, P987, DOI 10.2106/00004623-197153050-00013; DEGROUCHY J, 1977, CLIN ATLAS HUMAN CHR, P81; LUCKY AW, 1977, SYNDROME IDENTIFICAT, V5, P3; MATTEI JF, 1980, CLIN GENET, V17, P129; PESCIA G, 1979, ANN GENET-PARIS, V22, P158; RYERITZ RE, 1979, N ENGL J MED, V300, P772; SUBRT I, 1976, HUM GENET, V34, P151, DOI 10.1007/BF00278883; TURLEAU C, 1975, HUMANGENETIK, V29, P233, DOI 10.1007/BF00297629; 1981, BIRTH DEFECTS ORIG A, V17; 1981, CYTOGENET CELL GENET, V31, P1	12	46	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					1005	1019						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6613995				2022-12-18	WOS:A1983RK60400020
J	DONLON, TA; LITT, M; NEWCOM, SR; MAGENIS, RE				DONLON, TA; LITT, M; NEWCOM, SR; MAGENIS, RE			LOCALIZATION OF THE RESTRICTION FRAGMENT LENGTH POLYMORPHISM D14S1 (PAW-101) TO CHROMOSOME 14Q32.1-]32.2 BY INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDRENS,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	DONLON, TA (corresponding author), OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201, USA.				NCI NIH HHS [CA-30565, CA-0027562] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALAZS I, 1982, P NATL ACAD SCI-BIOL, V79, P7395, DOI 10.1073/pnas.79.23.7395; BARTON P, 1982, J MOL BIOL, V156, P269, DOI 10.1016/0022-2836(82)90328-X; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DEMARTINVILLE B, 1982, AM J HUM GENET, V34, P216; GERHARD DS, 1981, P NATL ACAD SCI-BIOL, V78, P3755, DOI 10.1073/pnas.78.6.3755; HARPER ME, 1982, AM J HUM GENET, V34, P227; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; MALCOLM S, 1981, ANN HUM GENET, V45, P135, DOI 10.1111/j.1469-1809.1981.tb00315.x; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; NEEL BG, 1982, P NATL ACAD SCI-BIOL, V79, P7842, DOI 10.1073/pnas.79.24.7842; PARDUE ML, 1969, P NATL ACAD SCI USA, V64, P600, DOI 10.1073/pnas.64.2.600; SAWIN VL, 1978, HISTOCHEMISTRY, V59, P1, DOI 10.1007/BF00506472; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SEABRIGH.M, 1971, LANCET, V2, P971; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P194, DOI 10.1159/000131699; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P58, DOI 10.1159/000131687; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267; 1981, CYTOGENET CELL GENET, V31, P1; 1978, CYTOGENET CELL GENET, V21, P313	27	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1097	1106						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6650497				2022-12-18	WOS:A1983RU70500005
J	COHEN, MM; SIMPSON, SJ; HONIG, GR; MAURER, HS; NICKLAS, JW; MARTIN, AO				COHEN, MM; SIMPSON, SJ; HONIG, GR; MAURER, HS; NICKLAS, JW; MARTIN, AO			THE IDENTIFICATION OF FANCONI ANEMIA GENOTYPES BY CLASTOGENIC STRESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NORTHWESTERN UNIV, CHILDRENS MEM HOSP,SCH MED,DEPT PEDIAT,DIV GENET, CHICAGO, IL 60614 USA; NORTHWESTERN UNIV, CHILDRENS MEM HOSP,SCH MED,DEPT PEDIAT,DIV GENET, CHICAGO, IL 60614 USA; NORTHWESTERN UNIV, CHILDRENS MEM HOSP,SCH MED,DEPT PEDIAT, DIV HEMATOL, CHICAGO, IL 60614 USA; NORTHWESTERN UNIV, SCH MED, DEPT OBSTET & GYNECOL, GENET SECT, CHICAGO, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University					NICHD NIH HHS [1 HD-8-2822] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUERBACH AD, 1981, PEDIATRICS, V67, P128; AUERBACH AD, 1979, CANCER GENET CYTOGEN, V1, P21, DOI 10.1016/0165-4608(79)90006-2; AUERBACH AD, 1978, NATURE, V271, P69, DOI 10.1038/271069a0; AUERBACH AD, 1979, AM J HUM GENET, V31, P77; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; BERGER R, 1980, CANCER GENET CYTOGEN, V2, P259, DOI 10.1016/0165-4608(80)90032-1; BERGER R, 1980, CANCER GENET CYTOGEN, V2, P269, DOI 10.1016/0165-4608(80)90033-3; BLOOM GE, 1966, NEW ENGL J MED, V274, P8, DOI 10.1056/NEJM196601062740102; BUSHKELL LL, 1976, CLIN GENET, V9, P583; CERVENKA J, 1981, PEDIATRICS, V67, P119; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; COHEN MM, 1967, NEW ENGL J MED, V277, P1043, DOI 10.1056/NEJM196711162772001; COHEN MM, 1981, CANCER RES, V41, P1817; COHEN MM, 1982, CYTOGENET CELL GENET; DOSIK H, 1979, BRIT J HAEMATOL, V41, P77, DOI 10.1111/j.1365-2141.1979.tb03683.x; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; FINKELBERG R, 1976, AM J HUM GENET, V25, pA30; FUJIWARA Y, 1977, J MOL BIOL, V113, P635, DOI 10.1016/0022-2836(77)90227-3; GERMAN J, 1972, PROG MED GENET, V8, P61; KOSKULL HV, 1973, CYTOGENET CELL GENET, V12, P423, DOI 10.1159/000130485; KRAEMER KH, 1975, P NATL ACAD SCI USA, V72, P59, DOI 10.1073/pnas.72.1.59; LUBINIECKI AS, 1977, AM J HEMATOL, V2, P33, DOI 10.1002/ajh.2830020105; McIntosh S, 1979, Am J Pediatr Hematol Oncol, V1, P107; NORDAN UZ, 1979, AM J DIS CHILD, V133, P291, DOI 10.1001/archpedi.1979.02130030067011; NOVOTNA B, 1979, HUM GENET, V49, P41; SASAKI MS, 1973, CANCER RES, V33, P1829; SASAKI MS, 1975, NATURE, V257, P501, DOI 10.1038/257501a0; SASAKI MS, 1978, DNA REPAIR MECHANISM, P675; SCHROEDER TM, 1979, HUM GENET, V52, P309, DOI 10.1007/BF00278680; SCHROEDER TM, 1971, BLOOD-J HEMATOL, V37, P96, DOI 10.1182/blood.V37.1.96.96; SCHROEDER TM, 1977, BLUT, V34, P119, DOI 10.1007/BF00999858; SCHROEDER TM, 1976, HUM GENET, V32, P257, DOI 10.1007/BF00295817; SCHROEDER TM, 1964, HUMANGENETIK, V1, P194, DOI 10.1007/BF00389636; SCHULER D, 1969, HUMANGENETIK, V7, P314, DOI 10.1007/BF00283553; Siegel S, 1956, NONPARAMETRIC STATIS; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; SWIFT MR, 1966, ANN INTERN MED, V65, P496, DOI 10.7326/0003-4819-65-3-496; TAYLOR AMR, 1979, CANCER RES, V39, P1046; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211; ZAKRZEWSKI S, 1980, HUM GENET, V56, P81	41	46	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					794	810						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	6812413				2022-12-18	WOS:A1982PH24200010
J	HODGE, SE; SPENCE, MA				HODGE, SE; SPENCE, MA			SOME EPISTATIC 2-LOCUS MODELS OF DISEASE .2. THE CONFOUNDING OF LINKAGE AND ASSOCIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HODGE, SE (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,MENTAL RETARDAT RES CTR,LOS ANGELES,CA 90024, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-05615, HD-04612] Funding Source: Medline; NIMH NIH HHS [MH-33617] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARBOSA J, 1978, J CLIN INVEST, V62, P492, DOI 10.1172/JCI109151; DARSEE JR, 1979, NEW ENGL J MED, V300, P877, DOI 10.1056/NEJM197904193001602; EBRINGER RW, 1978, ANN RHEUM DIS, V37, P146, DOI 10.1136/ard.37.2.146; FELLER W, 1968, INTRO PROBABILITY TH, V1, P38; HODGE SE, 1981, AM J HUM GENET, V33, P381; HODGE SE, 1979, NEW ENGL J MED, V301, P442; KIDD KK, 1977, HLA DISEASE, P72; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; MORTON NE, 1956, AM J HUM GENET, V8, P80; OTT J, 1974, AM J HUM GENET, V26, P588; SACHS JA, 1978, BRIT MED BULL, V34, P275, DOI 10.1093/oxfordjournals.bmb.a071511; SEAGER K, 1979, NATURE, V277, P68, DOI 10.1038/277068a0; SUAREZ B, 1979, DIABETES, V28, P527, DOI 10.2337/diabetes.28.6.527; TIWARI JL, 1980, AM J HUM GENET, V32, P103	14	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					396	406						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	6941696				2022-12-18	WOS:A1981LT72500007
J	WEITKAMP, LR				WEITKAMP, LR			HLA AND DISEASE - PREDICTIONS FOR HLA HAPLOTYPE SHARING IN FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ROCHESTER, SCH MED & DENT, DEPT PEDIAT, ROCHESTER, NY 14642 USA	University of Rochester	WEITKAMP, LR (corresponding author), UNIV ROCHESTER, SCH MED & DENT, DEPT PSYCHIAT, DIV GENET, ROCHESTER, NY 14642 USA.				NICHD NIH HHS [N01-HD-8-2846] Funding Source: Medline; NIMH NIH HHS [5-K02-MH-00124] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTER M, 1976, NEUROLOGY, V26, P31, DOI 10.1212/WNL.26.1.31; BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BARBOSA J, 1978, J CLIN INVEST, V62, P492, DOI 10.1172/JCI109151; BENGSCH N, 1978, DIABETOLOGIA, V15, P447, DOI 10.1007/BF02342868; BERTRAMS J, 1976, Z IMMUNITATSFORSCH, V152, P200; BIRD TD, 1975, ARCH NEUROL-CHICAGO, V32, P414, DOI 10.1001/archneur.1975.00490480080009; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DRACHMAN DA, 1976, ARCH NEUROL-CHICAGO, V33, P406, DOI 10.1001/archneur.1976.00500060012004; ELDRIDGE R, 1978, ANN NEUROL, V3, P72, DOI 10.1002/ana.410030111; HENS L, 1978, TISSUE ANTIGENS, V11, P75, DOI 10.1111/j.1399-0039.1978.tb01230.x; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; JAWORSKI MA, 1980, DIABETOLOGIA, V19, P97, DOI 10.1007/BF00421852; JERSILD C, 1973, LANCET, V2, P1221; KRAWISZ JE, 1978, MAYO CLIN PROC, V53, P782; OLSSON JE, 1976, ARCH NEUROL-CHICAGO, V33, P808, DOI 10.1001/archneur.1976.00500120012002; RUBINSTEIN P, 1976, J EXP MED, V143, P1277, DOI 10.1084/jem.143.5.1277; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; STEWART GJ, 1977, J NEUROL SCI, V32, P153, DOI 10.1016/0022-510X(77)90231-3; SVEJGAARRD A, 1975, TRANSPLANT REV, V22, P1; THOMSEN M, 1975, TRANSPLANT REV-DENMA, V22, P125; THOMSEN M, 1979, TRANSPLANT P, V11, P633; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; TIWARI JL, 1980, AM J HUM GENET, V32, P103; TROUILLAS P, 1977, J NEUROL SCI, V32, P425, DOI 10.1016/0022-510X(77)90024-7; VISSCHER BR, 1979, NEUROLOGY, V29, P1354, DOI 10.1212/WNL.29.10.1354	26	46	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	5					776	784						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ232	7294026				2022-12-18	WOS:A1981MJ23200014
J	AUERBACH, AD; WARBURTON, D; BLOOM, AD; CHAGANTI, RSK				AUERBACH, AD; WARBURTON, D; BLOOM, AD; CHAGANTI, RSK			PRENATAL DETECTION OF THE FANCONI ANEMIA GENE BY CYTOGENETIC METHODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT PEDIAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT HUMAN GENET & DEV,NEW YORK,NY 10032	Columbia University; Columbia University	AUERBACH, AD (corresponding author), MEM SLOAN KETTERING CANC CTR,GENET LAB,1275 YORK AVE,NEW YORK,NY 10021, USA.			Auerbach, Arleen/0000-0002-6911-8379				AUERBACH AD, 1978, NATURE, V271, P69, DOI 10.1038/271069a0; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; BIRD MJ, 1953, PROC R SOC SER B-BIO, V140, P556, DOI 10.1098/rspb.1953.0008; GERMAN J, 1972, PROG MED GENET, V8, P61; KOLMARK HG, 1953, HEREDITAS, V39, P209; LATT SA, 1975, P NATL ACAD SCI USA, V72, P4066, DOI 10.1073/pnas.72.10.4066; NILSSON L R, 1960, Acta Paediatr, V49, P518, DOI 10.1111/j.1651-2227.1960.tb07767.x; PERRY P, 1975, NATURE, V258, P121, DOI 10.1038/258121a0; SASAKI MS, 1973, CANCER RES, V33, P1829; SCHROEDER TM, 1964, HUMANGENETIK, V1, P194, DOI 10.1007/BF00389636; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; SWIFT MR, 1966, ANN INTERN MED, V65, P496, DOI 10.7326/0003-4819-65-3-496; VANDUUREN BL, 1969, ANN NY ACAD SCI, V163, P633, DOI 10.1111/j.1749-6632.1969.tb24883.x; WOLMAN SR, 1975, LAB INVEST, V33, P670	14	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					77	81						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	433924				2022-12-18	WOS:A1979GR11500010
J	BEUTLER, E				BEUTLER, E			BIOCHEMICAL GENETICS OF THE HEXOSAMINIDASE SYSTEM IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											BEUTLER, E (corresponding author), CITY HOPE NATL MED CTR,DIV MED,DUARTE,CA 91010, USA.							BACH G, 1975, J BIOL CHEM, V250, P1328; BEUTLER E, 1975, J LAB CLIN MED, V85, P672; BEUTLER E, 1975, J LAB CLIN MED, V86, P195; BEUTLER E, 1977, ANN HUM GENET, V41, P163, DOI 10.1111/j.1469-1809.1977.tb01911.x; BEUTLER E, 1975, NATURE, V258, P262, DOI 10.1038/258262a0; BEUTLER E, 1976, BIOCHEM J, V159, P541, DOI 10.1042/bj1590541; BEUTLER E, 1973, AM J HUM GENET, V25, P42; BEUTLER E, 1975, AM J HUM GENET, V27, P628; BEUTLER E, 1974, INT RES COMMUN SYST, V2, P1090; BRADY RO, 1969, NEW ENGL J MED, V281, P1243, DOI 10.1056/NEJM196911272812213; CARMODY PJ, 1974, BIOCHIM BIOPHYS ACTA, V371, P117, DOI 10.1016/0005-2795(74)90160-3; CARREL R E, 1973, Clinical Research, V21, P294; CARROLL M, 1974, BIOCHEM J, V137, P217, DOI 10.1042/bj1370217; CHERN CJ, 1976, P NATL ACAD SCI USA, V73, P3637, DOI 10.1073/pnas.73.10.3637; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; CONZELMANN E, 1978, EUR J BIOCHEM, V84, P27, DOI 10.1111/j.1432-1033.1978.tb12137.x; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; GEIGER B, 1978, BIOCHEMISTRY-US, V17, P1713, DOI 10.1021/bi00602a020; GEIGER B, 1975, EUR J BIOCHEM, V56, P311, DOI 10.1111/j.1432-1033.1975.tb02235.x; GEIGER B, 1976, BIOCHEMISTRY-US, V15, P3483; GILBERT F, 1975, P NATL ACAD SCI USA, V72, P263, DOI 10.1073/pnas.72.1.263; GOLDSTON.A, 1971, FEBS LETT, V13, P68, DOI 10.1016/0014-5793(71)80667-1; HECHTMAN P, 1977, BIOCHEM J, V167, P693, DOI 10.1042/bj1670693; HOEKSEMA HL, 1977, AM J HUM GENET, V29, P14; HOOGHWIN.GJ, 1972, H-S Z PHYSIOL CHEM, V353, P839; HULTBERG B, 1969, LANCET, V2, P1195; IKONNE JU, 1973, BIOCHEM J, V135, P457, DOI 10.1042/bj1350457; JONES DD, 1975, ENZYME, V20, P129, DOI 10.1159/000458931; KABACK MM, 1974, PROG MED GENET, V10, P103; KELLY TE, 1976, CLIN GENET, V9, P540; LALLEY PA, 1974, P NATL ACAD SCI USA, V71, P1569, DOI 10.1073/pnas.71.4.1569; LEE JES, 1976, BIOCHEM J, V159, P535, DOI 10.1042/bj1590535; LI YT, 1973, J BIOL CHEM, V248, P7512; MARINKOVIC DV, 1977, BIOCHEM J, V163, P133, DOI 10.1042/bj1630133; MURPHY JV, 1972, CLIN CHIM ACTA, V42, P267, DOI 10.1016/0009-8981(72)90089-7; NAVON R, 1976, AM J HUM GENET, V28, P339; NAVON R, 1973, AM J HUM GENET, V25, P287; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1978, AM J HUM GENET, V30, P672; OKADA S, 1970, J PEDIATR-US, V77, P1063, DOI 10.1016/S0022-3476(70)80096-8; OKADA S, 1972, PEDIATR RES, V6, P606; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PRICE RG, 1972, BIOCHIM BIOPHYS ACTA, V271, P145, DOI 10.1016/0005-2795(72)90142-0; RAPIN I, 1976, ARCH NEUROL-CHICAGO, V33, P120, DOI 10.1001/archneur.1976.00500020048008; RATTAZZI MC, 1976, AM J HUM GENET, V28, P143; RATTAZZI MC, 1975, CYTOGENET CELL GENET, V14, P232; REUSER AJJ, 1976, FEBS LETT, V71, P1, DOI 10.1016/0014-5793(76)80884-8; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; ROBINSON D, 1972, LANCET, V1, P322; ROPERS HH, 1973, HUMANGENETIK, V20, P167, DOI 10.1007/BF00284854; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1968, LIFE SCI PT 1 PHYSI, V7, P283, DOI 10.1016/0024-3205(68)90024-6; SANDHOFF K, 1969, FEBS LETT, V4, P351, DOI 10.1016/0014-5793(69)80274-7; SLOAN HR, 1972, METABOLIC BASIS INHE; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2049; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; SRIVASTAVA SK, 1973, NATURE, V241, P463, DOI 10.1038/241463a0; SRIVASTAVA SK, 1972, BIOCHEM BIOPH RES CO, V47, P753, DOI 10.1016/0006-291X(72)90556-6; SRIVASTAVA SK, 1978, NATURE, V273, P245, DOI 10.1038/273245a0; STIRLING JL, 1972, BIOCHIM BIOPHYS ACTA, V271, P154, DOI 10.1016/0005-2795(72)90143-2; SUZUKI Y, 1970, NEUROLOGY, V20, P848, DOI 10.1212/WNL.20.9.848; SWALLOW DM, 1974, ANN HUM GENET, V37, P287, DOI 10.1111/j.1469-1809.1974.tb01836.x; SWALLOW DM, 1976, ANN HUM GENET, V40, P55, DOI 10.1111/j.1469-1809.1976.tb00164.x; TALLMAN JF, 1974, NATURE, V252, P254, DOI 10.1038/252254a0; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489; TEDESCO TA, 1973, AM J HUM GENET, V25, pA78; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0; VANSOMEREN H, 1973, HUMANGENETIK, V18, P1; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; VIDGOFF J, 1974, AM J HUM GENET, V26, pA89; WENGER DA, 1972, ARCH BIOCHEM BIOPHYS, V153, P116, DOI 10.1016/0003-9861(72)90427-4; WIKTOROWICZ JE, 1977, BIOCHEM J, V165, P49, DOI 10.1042/bj1650049; YOUNG EP, 1970, FEBS LETT, V9, P1, DOI 10.1016/0014-5793(70)80295-2	74	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					95	105						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	377957				2022-12-18	WOS:A1979GZ38600001
J	GLICK, NR; SNODGRASS, PJ; SCHAFER, IA				GLICK, NR; SNODGRASS, PJ; SCHAFER, IA			NEONATAL ARGININOSUCCINIC ACIDURIA WITH NORMAL BRAIN AND KIDNEY BUT ABSENT LIVER ARGININOSUCCINATE LYASE ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CLEVELAND METROPOLITAN GEN HOSP,CASE WESTERN RESERVE UNIV,DEPT PEDIAT,GENET CLIN,CLEVELAND,OH 44109; INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202; VET ADM HOSP,INDIANAPOLIS,IN	Case Western Reserve University; MetroHealth System; Indiana University System; Indiana University-Purdue University Indianapolis								BRAY RC, 1971, ARCH BIOCHEM BIOPHYS, V146, P531, DOI 10.1016/0003-9861(71)90158-5; CAMPBELL AG, 1973, NEW ENGL J MED, V288, P1, DOI 10.1056/NEJM197301042880101; CARTON D, 1969, ACTA PAEDIATR SCAND, V58, P528, DOI 10.1111/j.1651-2227.1969.tb04755.x; COLOMBO JP, 1968, 6TH P ANN S SOC STUD, P119; GOODMAN SI, 1973, CLIN GENET, V4, P236; HSIA YE, 1974, GASTROENTEROLOGY, V67, P347; JACOBY LB, 1972, AM J HUM GENET, V24, P321; KINT J, 1968, LANCET, V2, P635; LEVIN B, 1967, AM J DIS CHILD, V113, P162, DOI 10.1001/archpedi.1967.02090160212036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER AL, 1967, CLIN SCI, V32, P385; NUZUM CT, 1971, SCIENCE, V172, P1042, DOI 10.1126/science.172.3987.1042; POLLITT RJ, 1973, CLIN CHIM ACTA, V46, P33, DOI 10.1016/0009-8981(73)90099-5; RAIHA NCR, 1968, ACTA PAEDIATR SCAND, V57, P121, DOI 10.1111/j.1651-2227.1968.tb04663.x; RATNER S, 1973, ADV ENZYMOL RAMB, V39, P1; RATNER S, 1955, METHOD ENZYMOL, V2, P356, DOI 10.1016/S0076-6879(55)02212-X; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; SHIH VE, 1969, BIOCHEM GENET, V3, P81, DOI 10.1007/BF00485974; SHIH VE, 1972, METABOLIC BASIS INHE, P370; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; SOLITARE GB, 1969, J MENT DEFIC RES, V13, P153; TOMLINSON S, 1964, CLIN SCI, V26, P261	22	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					22	30						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	174426				2022-12-18	WOS:A1976BC88800004
J	MACLEAN, CJ; ADAMS, MS; LEYSHON, WC; WORKMAN, PL; REED, TE; GERSHOWITZ, H; WEITKAMP, LR				MACLEAN, CJ; ADAMS, MS; LEYSHON, WC; WORKMAN, PL; REED, TE; GERSHOWITZ, H; WEITKAMP, LR			GENETIC STUDIES ON HYBRID POPULATIONS .3. BLOOD-PRESSURE IN AN AMERICAN BLACK-COMMUNITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIDR, HUMAN GENET BRANCH, BETHESDA, MD 20014 USA; UNIV ROCHESTER, SCH MED & DENT, DEPT ANAT, DIV GENET, ROCHESTER, NY 14620 USA; UNIV MASSACHUSETTS, DEPT ANTHROPOL, AMHERST, MA 01002 USA; UNIV TORONTO, DEPT ZOOL, TORONTO, ONTARIO, CANADA; UNIV MICHIGAN, MED SCH, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Rochester; University of Massachusetts System; University of Massachusetts Amherst; University of Toronto; University of Michigan System; University of Michigan								ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; BOYLE E, 1970, J AMER MED ASSOC, V213, P1637, DOI 10.1001/jama.213.10.1637; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHIANG BN, 1969, CIRCULATION, V39, P403, DOI 10.1161/01.CIR.39.3.403; DAUBER TR, 1967, EPIDEMIOLOGY HYPERTE, P255; FEINLEIB M, 1969, 2 ANN M SOC EP RES C; GERSHOWITZ M, 1972, AM J HUM GENET, V24, pA38; GOLDMAN AG, 1972, J AMER MED ASSOC, V221, P378, DOI 10.1001/jama.221.4.378; GORDON I, 1966, 1000 US PUBL HEALTH; GUTMANN MC, 1971, MEDICINE, V50, P543, DOI 10.1097/00005792-197111000-00003; HAYES CG, 1971, ARCH INTERN MED, V128, P965, DOI 10.1001/archinte.128.6.965; HEYDEN S, 1969, J AMER MED ASSOC, V209, P1683, DOI 10.1001/jama.209.11.1683; JOHNSON BC, 1965, J CHRON DIS, V18, P147, DOI 10.1016/0021-9681(65)90098-6; KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x; Langford H G, 1968, Trans Assoc Am Physicians, V81, P135; LARAGH JH, 1972, AM J MED, V53, P649, DOI 10.1016/0002-9343(72)90160-X; LENNARD HL, 1955, J CHRON DIS, V5, P186; Li CC., 1955, POPULATION GENETICS; MACCLUER JW, 1963, AM J HUM GENET, V15, P191; MACLEAN CJ, 1973, ANN HUM GENET, V36, P459, DOI 10.1111/j.1469-1809.1973.tb00607.x; MACLEAN CJ, 1973, ANN HUM GENET, V36, P341, DOI 10.1111/j.1469-1809.1973.tb00596.x; MIALL WE, 1967, CLIN SCI, V33, P271; MIALL WE, 1967, BRIT MED J, V2, P660, DOI 10.1136/bmj.2.5553.660; Race R. R, 1968, BLOOD GROUPS MAN; RAO DVS, IN PRESS; REED TE, 1973, NATURE, V244, P575, DOI 10.1038/244575a0; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; ROBERTS JA, 1961, BRIT MED BULL, V17, P241; SCHULL WJ, 1970, J CHRON DIS, V23, P83, DOI 10.1016/0021-9681(70)90067-6; Smith A J, 1966, West Afr Med J, V15, P97; WEITKAMP LR, 1972, HUM HERED, V22, P566, DOI 10.1159/000152539; WINKELSTEIN W, 1966, J AMER MED ASSOC, V195, P848, DOI 10.1001/jama.1966.03100100100029; ZINNER SH, 1971, NEW ENGL J MED, V284, P401, DOI 10.1056/NEJM197102252840801; 1967, J AM MED ASSOC, V202, P1028; 1970, J AM MED ASSOC, V213, P1143	36	46	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	5					614	626						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U0241	4214416				2022-12-18	WOS:A1974U024100009
J	WARREN, RJ; RIMOIN, DL; SUMMITT, RL				WARREN, RJ; RIMOIN, DL; SUMMITT, RL			IDENTIFICATION BY FLUORESCENT MICROSCOPY OF ABNORMAL CHROMOSOMES ASSOCIATED WITH G-DELETION SYNDROMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MIAMI,MAILMAN CTR CHILD DEV,DEPT PEDIAT,MIAMI,FL 33152; UNIV CALIF,HARBOR GEN HOSP,SCH MED,DIV MED GENET,TORRANCE,CA 90509; UNIV TENNESSEE,DEPT PEDIAT,GENET SECT,MEMPHIS,TN 38103	University of Miami; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Tennessee System; University of Tennessee Health Science Center								ARMENDARES S, 1971, ANN GENET-PARIS, V14, P7; CASPERSSON T, 1970, EXP CELL RES, V63, P240, DOI 10.1016/0014-4827(70)90363-0; CASPERSSON T, 1969, EXP CELL RES, V58, P141, DOI 10.1016/0014-4827(69)90124-4; CHAUVEL PJ, 1972, HUMANGENETIK, V14, P164, DOI 10.1007/BF00273304; CRANDALL BF, 1972, CLIN GENET, V3, P264; GROSSE KP, 1971, HUMANGENETIK, V12, P142, DOI 10.1007/BF00291470; GROUCHY JD, 1969, BIRTH DEFECTS OAS, V5, P74; LEJEUNE J, 1964, CR HEBD ACAD SCI, V259, P4187; LEJEUNE J, 1968, ANN GENET-PARIS, V11, P79; LEJEUNE J, 1966, J PEDIATRIE, P78; MAGENIS RE, IN PRESS; RICHARDS BW, 1971, J MENT DEFIC RES, V15, P61; WARREN RJ, 1970, J PEDIATR-US, V77, P658, DOI 10.1016/S0022-3476(70)80209-8; WELEBER RG, 1968, AM J DIS CHILD, V115, P489, DOI 10.1001/archpedi.1968.02100010491015	14	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	1					77	81						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O5774	4265215				2022-12-18	WOS:A1973O577400010
J	HARTL, DL				HARTL, DL			RECURRENCE RISKS FOR GERMINAL MOSAICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEAUMONT HM, 1963, J EMBRYOL EXP MORPH, V11, P715; BORBERG A, 1951, OPERA DOMO BIOL HERE, V23, P1; BRIDGES CB, 1919, P SOC EXP BIOL MED, V17, P1; CLERMONT Y, 1962, AM J ANAT, V111, P111, DOI 10.1002/aja.1001110202; CROW JAMES F., 1961, PROGR MED GENET, V1, P1; DUNN LC, 1953, GENETICS, V38, P261; Haldane John Burdon Sanderson, 1938, HEREDITY POLITICS; HANNAH-ALAVA ALOHA, 1965, ADVANCE GENET, V13, P157, DOI 10.1016/S0065-2660(08)60049-8; HARTL DL, 1970, GENETICS, V65, P449; HECHT F, 1966, PEDIATRICS, V38, P982; Luria SE, 1943, GENETICS, V28, P491; MACKENZIE HJ, 1951, ANN EUGENIC, V16, P88, DOI 10.1111/j.1469-1809.1951.tb02460.x; MINZ B, 1968, J ANIMAL SCI, V27, P51; Mohr OL, 1932, GENETICS, V17, P0060; Mohr OL, 1923, HEREDITAS, V4, P142; MORGAN TH, 1925, BIBLIOGRAPHIA GENETI, V2; Muller HJ, 1920, J EXP ZOOL, V31, P443, DOI 10.1002/jez.1400310405; MULLER HJ, 1954, HEREDITY, V8, P153, DOI 10.1038/hdy.1954.16; PATAU K, 1964, SOMATIC CELL GENETIC, P78; PENROSE LS, 1955, LANCET, V2, P312; PORTER I H, 1969, Journal of Medical Genetics, V6, P310, DOI 10.1136/jmg.6.3.310; REED TE, 1955, AM J HUM GENET, V7, P28; REESE AB, 1949, ARCH OPHTHALMOL-CHIC, V42, P119; RUSSELL WL, 1962, REPORT UNITED NA S16; Sonnenblick BP, 1941, P NATL ACAD SCI USA, V27, P484, DOI 10.1073/pnas.27.10.484; Stern C., 1968, GENETIC MOSAICS OTHE; VOGEL F, 1963, GENETICS TODAY, V3, P833; Wright S, 1926, GENETICS, V11, P333	28	46	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	2					124	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J1653	5092478				2022-12-18	WOS:A1971J165300002
J	HECHT, F; KIMBERLING, WJ				HECHT, F; KIMBERLING, WJ			PATTERNS OF D-CHROMOSOME INVOLVEMENT IN HUMAN (DQDQ) AND (DQGQ) ROBERTSONIAN REARRANGEMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARNES DWH, 1968, NATURE, V219, P519; BAUCHINGER H, 1970, HUMANGENETIK, V8, P312; BLOOM GE, 1967, DEC M AM SOC HUM GEN; COHEN MM, 1968, AM J DIS CHILD, V115, P185, DOI 10.1001/archpedi.1968.02100010187006; COURTBROWN WM, 1967, HUMAN POPULATION CYT; DECAPOA A, 1970, CYTOGENETICS, V9, P396, DOI 10.1159/000130108; DECAPOA A, 1968, ANN HUM GENET, V32, P191, DOI 10.1111/j.1469-1809.1968.tb00063.x; DEKABAN AS, 1966, AM J HUM GENET, V18, P288; EMERIT I, 1969, ANN GENET-PARIS, V12, P94; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GIANNELLI F, 1966, CYTOGENETICS, V5, P186, DOI 10.1159/000129897; GIANNELLI F, 1965, NATURE, V208, P669, DOI 10.1038/208669a0; GILGENKRANTZ S, 1970, ANN GENET-PARIS, V13, P201; GROUCHY JD, 1970, ANN GENET-PARIS, V13, P19; HECHT F, 1968, SCIENCE, V161, P371, DOI 10.1126/science.161.3839.371; HECHT F, 1966, ANN GENET, V9, P155; HECHT F, 1969, MAY M SOC PED RES AT; Higurashi M, 1967, Paediatr Univ Tokyo, V14, P14; HIGURASHI M, 1969, Journal of Medical Genetics, V6, P401, DOI 10.1136/jmg.6.4.401; HSU LY, 1970, J AMER MED ASSOC, V211, P987, DOI 10.1001/jama.211.6.987; KOHNO SI, 1969, P JPN ACAD, V45, P121, DOI 10.2183/pjab1945.45.121; KRMPOTIC E, 1970, Clinical Genetics, V1, P232; KRMPOTIC E, 1968, Journal of Medical Genetics, V5, P205, DOI 10.1136/jmg.5.3.205; LEONARD A, 1967, NATURE, V214, P504, DOI 10.1038/214504a0; LUBS HA, 1970, HUMAN POPULATION CYT, P119; LUCAS M, 1969, ANN HUM GENET, V32, P347, DOI 10.1111/j.1469-1809.1969.tb00085.x; MIKKELSEN M, 1969, ANN GENET-PARIS, V12, P51; MIKKELSEN M, 1967, ANN HUM GENET, V30, P325, DOI 10.1111/j.1469-1809.1967.tb00033.x; NAKAGOME Y, 1969, CYTOGENETICS, V8, P296, DOI 10.1159/000130040; NAKAGOME Y, 1970, Journal of Medical Genetics, V7, P371, DOI 10.1136/jmg.7.4.371; NEU RL, 1969, ANN GENET-PARIS, V12, P250; Ott J, 1968, Lancet, V2, P1352; Palmer C G, 1969, J Med Genet, V6, P166, DOI 10.1136/jmg.6.2.166; PATAU K, 1964, NOV M AM SOC HUM GEN; REISMAN LE, 1969, GENETICS COUNSELING; ROWLEY JD, 1969, ANN GENET-PARIS, V12, P177; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; SPARKES RS, 1970, OBSTET GYNECOL, V35, P601; STENCHEVER MA, 1968, OBSTET GYNECOL, V32, P548; TIEPOLO L, 1967, ANN GENET-PARIS, V10, P114; VOGEL W, 1970, HUMANGENETIK, V9, P140, DOI 10.1007/BF00278929; WALZER S, 1969, J PEDIATR-US, V74, P438, DOI 10.1016/S0022-3476(69)80202-7; WHITE BJ, 1967, HEREDITAS-GENETISK A, V58, P284; YUNIS JJ, 1964, NEW ENGL J MED, V271, P1133, DOI 10.1056/NEJM196411262712203	45	46	46	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	4					361	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J8113	5097902				2022-12-18	WOS:A1971J811300003
J	FITCH, WM; NEEL, JV				FITCH, WM; NEEL, JV			PHYLOGENIC RELATIONSHIPS OF SOME INDIAN TRIBES OF CENTRAL AND SOUTH AMERICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1965, 11 P INT C GEN HAG, V3, P923; CHAGNON NA, 1968, YANOMAMA FIERCE PEOP; Cruxent J.M., 1968, BIOMEDICAL CHALLENGE, P11; de la Vega Garcilaso, 1966, ROYAL COMMENTARIES I; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; EDWARDS AWF, 1964, 6 SYST ASS PUBL, P67; FITCH WM, 1966, J MOL BIOL, V16, P9, DOI 10.1016/S0022-2836(66)80258-9; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GEERTS SJ, 1965, 11 P INT C GEN HA ED, V3, P923; GERSHOWITZ H, 1965, ACTA GENET STAT MED, V15, P261; GERSHOWITZ H, IN PRESS; HENNINGSEN K, 1949, ACTA PATHOL MIC SC, V26, P639; HOHENTHAL WD, 1957, 16 KROEB ANTHR SOC P; LAYRISSE M, 1961, SCIENCE, V134, P1077, DOI 10.1126/science.134.3485.1077; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P161, DOI 10.1002/ajpa.1330180302; LOUKOTKA L, 1967, ANN ASS AMER GEOG RA, V57, P437; MATSON GA, 1966, AM J PHYS ANTHROPOL, V24, P51, DOI 10.1002/ajpa.1330240107; MOHR J, 1963, ANN HUM GENET, V27, P85, DOI 10.1111/j.1469-1809.1963.tb00783.x; NEEL JAMES V., 1967, JAP J HUM GENET, V12, P1; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1968, P NATL ACAD SCI USA, V59, P680, DOI 10.1073/pnas.59.3.680; NEEL JV, 1964, COLD SPRING HARB SYM, V29, P85, DOI 10.1101/SQB.1964.029.01.014; NEEL JV, IN PRESS; OSBORNE RH, 1958, AM J PHYS ANTHROPOL, V16, P187, DOI 10.1002/ajpa.1330160204; POST RH, 1968, BIOMEDICAL CHALLENGE, P141; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SALZANO FM, 1957, AM J PHYS ANTHROPOL, V15, P555, DOI 10.1002/ajpa.1330150407; STEWARD J, 1946, HANDBOOK SOUTH AM ED; WEITKAMP LR, IN PRESS; WORKMAN PL, 1968, HUM BIOL, V40, P260; [No title captured]	33	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	4					384	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D7993	4893655				2022-12-18	WOS:A1969D799300006
J	ASHTON, GC; SIMPSON, NE				ASHTON, GC; SIMPSON, NE			C5 TYPES OF SERUM CHOLINESTERASE IN A BRAZILIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASHTON GC, 1965, AUST J BIOL SCI, V18, P665, DOI 10.1071/BI9650665; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; HARRIS H, 1962, NATURE, V196, P1296, DOI 10.1038/1961296a0; HARRIS H, 1963, LANCET, V2, P218; HARRIS H, 1963, NATURE, V200, P1185, DOI 10.1038/2001185a0; HARRIS H, 1962, ANN HUM GENET, V26, P59, DOI 10.1111/j.1469-1809.1962.tb01310.x; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MOTULSKY ARNO G., 1964, PROGR MED GENET, V3, P49; SIMPSON NE, 1964, AM J HUM GENET, V16, P180; SIMPSON NE, 1966, AM J HUM GENET, V18, P243; SIMPSON NE, 1965, AM J HUM GENET, V17, P156; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585	13	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	5					438	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	83834	4959098				2022-12-18	WOS:A19668383400004
J	CONEN, PE; ERKMAN, B				CONEN, PE; ERKMAN, B			FREQUENCY AND OCCURRENCE OF CHROMOSOMAL SYNDROMES .2. E-TRISOMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CARR DH, 1965, OBSTET GYNECOL, V26, P308; Carter C, 1951, BR J SOC MED, V5, P83; CLARKE ABD, 1962, P LONDON C SCIENT ED, P517; COHEN T, 1960, PERSONAL COMMUNICATI; COLLMAN RD, 1962, P LONDON C SCIENTIFI, P517; CONEN PE, 1966, AM J HUM GENET, V18, P374; CRAWFURD MA, 1961, LANCET, P2022; DAY RW, 1966, AM J HUM GENET, V18, P70; ECWARDS JH, 1960, LANCET, V1, P787; FERGUSONSMITH MA, 1962, LANCET, V2, P357; FIALKOW PJ, 1966, AM J HUM GENET, V18, P93; FINLEY WH, 1963, AM J DIS CHILD, V106, P591, DOI 10.1001/archpedi.1963.02080050593010; GERMAN JL, 1962, J PEDIATR-US, V60, P503, DOI 10.1016/S0022-3476(62)80111-5; GOLDSTONE R M, 1964, Guthrie Clin Bull, V33, P108; GOTTLIEB MI, 1962, AM J MED, V33, P763, DOI 10.1016/0002-9343(62)90253-X; GROUCHY JD, 1965, J PEDIAT, V66, P414; HECHT F, 1964, NEW ENGL J MED, V271, P1081, DOI 10.1056/NEJM196411192712102; HECHT F, 1963, J PEDIATR-US, V63, P605, DOI 10.1016/S0022-3476(63)80371-6; HEINRICHS EH, 1963, LANCET, V2, P468; HOLMAN GH, 1963, NEW ENGL J MED, V268, P982, DOI 10.1056/NEJM196305022681804; HOOK EB, 1965, LANCET, V2, P910; Jenkins RL, 1933, AM J DIS CHILD, V45, P506; KOENIG EU, 1962, YALE J BIOL MED, V35, P189; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; LEJEUNE J, 1963, ARCH FR PEDIATR, V20, P737; LEWIS AJ, 1964, J PEDIATR-US, V65, P92, DOI 10.1016/S0022-3476(64)80557-6; MALPAS P, 1937, J OBSTET GYN BR COMM, V44, P434; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; MOTULSKY AG, 1964, AM J OBSTET GYNECOL, V90, P1227, DOI 10.1016/0002-9378(64)90843-9; NAKAGOME Y, 1963, PAED U TOKYO, V8, P49; Oster J., 1953, MONGOLISM; OZONOFF MB, 1964, AMER J ROENTGENOL RA, V91, P618; PEARSON ES, 1962, BIOMETRIKA TABLES ST, P203; PENROSE LS, 1961, BRIT MED BULL, V17, P184, DOI 10.1093/oxfordjournals.bmb.a069906; PRADER VA, 1962, HELV MED ACTA, V29, P403; Record RG, 1955, BRIT J PREV SOC MED, V9, P10; ROHDE RA, 1964, PEDIATRICS, V33, P258; ROSENFIELD RL, 1962, AM J MED SCI, V244, P763; SMITH DW, 1962, J PEDIATR-US, V60, P513, DOI 10.1016/S0022-3476(62)80112-7; SMITH DW, 1964, AM J OBSTET GYNECOL, V90, P1055, DOI 10.1016/0002-9378(64)90835-X; SMITH DW, 1960, J PEDIATR-US, V57, P338, DOI 10.1016/S0022-3476(60)80241-7; STEINBERG JB, 1963, AM J DIS CHILD, V105, P213, DOI 10.1001/archpedi.1963.02080040215015; TAYLOR ANGELA I., 1964, GUY S HOSP REP, V113, P231; TONZ VO, 1965, SCHWEIZ MED WCHNSCHR, V95, P509; TOWNES PL, 1963, J PEDIATR-US, V62, P703, DOI 10.1016/S0022-3476(63)80040-2; TOWNES PL, 1962, J PEDIATR-US, V61, P755, DOI 10.1016/S0022-3476(62)80350-3; TOWNES PL, 1964, J PEDIATR-US, V65, P870, DOI 10.1016/S0022-3476(64)80011-1; TURNER B, 1964, J PEDIATR-US, V64, P601, DOI 10.1016/S0022-3476(64)80355-3; UCHIDA IA, 1963, CITED INDIRECTLY; VOORHESS ML, 1962, LANCET, V2, P992; VOORHESS ML, 1964, J PEDIATR-US, V65, P130, DOI 10.1016/S0022-3476(64)80595-3; WAGSHALIVES R, 1963, HUMAN CHROMOSOME NEW, P12; WEBER WW, 1964, PEDIATRICS, V34, P533; WIESS L, 1963, CITED INDIRECTLY; YUNIS JJ, 1964, LANCET, V2, P286; ZELLWEGER H, 1964, ARCH INTERN MED, V113, P598, DOI 10.1001/archinte.1964.00280100106016; 1960, 91 94 OFF REG GEN	57	46	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					387	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	81309	17948514				2022-12-18	WOS:A19668130900005
J	SIMPSON, NE; KALOW, W				SIMPSON, NE; KALOW, W			COMPARISONS OF 2 METHODS FOR TYPING OF SERUM CHOLINESTERASE AND PREVALENCE OF ITS VARIANTS IN A BRAZILIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COTTERMAN CW, 1947, CONTRIBUTIONS LABORA; GOEDDE HW, 1964, KLIN WOCHENSCHR, V42, P286, DOI 10.1007/BF01482376; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H, 1962, NATURE, V196, P1296, DOI 10.1038/1961296a0; HARRIS H, 1963, LANCET, V2, P218; HARRIS H, 1962, ANN HUM GENET, V26, P59, DOI 10.1111/j.1469-1809.1962.tb01310.x; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1964, ANESTHESIOLOGY, V25, P377, DOI 10.1097/00000542-196405000-00017; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KALOW W, 1957, CAN J BIOCHEM PHYSIO, V35, P1306; LIDDELL J, 1962, NATURE, V193, P561, DOI 10.1038/193561a0; MORTON NE, 1964, COLD SPRING HARBOR S, V29; SALDANHA PH, 1962, HUM BIOL, V34, P179; SIMPSON NE, 1964, AM J HUM GENET, V16, P180	15	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	2					156	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	62357	14262133				2022-12-18	WOS:A19656235700008
J	PLATO, CC; RUCKNAGEL, DL; GERSHOWITZ, H				PLATO, CC; RUCKNAGEL, DL; GERSHOWITZ, H			STUDIES ON DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY THALASSEMIA + OTHER GENETIC TRAITS IN COASTAL + MOUNTAIN VILLAGES OF CYPRUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AKSOY M, 1958, BRIT MED J, V5102, P937; ALASTONS D, 1955, CYPRUS HISTORY, pR13; ALASTONS D, 1955, CYPRUS HISTORY, P426; ALLISON AC, 1961, BRIT MED J, V1, P1346, DOI 10.1136/bmj.1.5236.1346; ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; ANGEL WL, CITED INDIRECTLY; BANTON AH, 1951, AM J HUM GENET, V3, P47; BERNINI L, 1960, RC ACCAD LINCEI, V29, P115; BLUMBERG BS, 1961, P C GENETIC POLYM ED, P159; CARCASSI U, 1957, Boll Ist Sieroter Milan, V36, P206; CARCASSI U, 1957, Haematologica, V42, P1635; CASPER J, 1956, AM J CLIN PATHOL, V26, P42; CEPPELLINI R, 1959, ACTA GENET MED RO S2, V8, P43; CLEARKIN PA, 1958, BRIT J MED, V5102, P939; CONSTANTOULIS N C, 1958, Vox Sang, V3, P145; CURTAIN CC, 1962, AM J PHYS ANTHROPOL, V20, P475, DOI 10.1002/ajpa.1330200408; DELIYANNIS GA, 1955, BMJ-BRIT MED J, V2, P299, DOI 10.1136/bmj.2.4934.299; EMANUEL B, 1961, J PEDIATR-US, V58, P263, DOI 10.1016/S0022-3476(61)80166-2; Fawdry AL, 1944, LANCET, V1, P171; Haldane J. B. S, 1949, RICERCA SCIENTIFIC S, V19, P3; HARRIS H, 1959, CIBA F S BIOCHEMISTR, P151; INGRAM VM, 1959, NATURE, V184, P1903, DOI 10.1038/1841903a0; KIDSON C, 1962, NATURE, V196, P49, DOI 10.1038/196049a0; KIDSON C, 1961, NATURE, V190, P1120, DOI 10.1038/1901120a0; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P161, DOI 10.1002/ajpa.1330180302; MALMOS B, 1962, BR J HEAMATOL, V8, P5; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; MOURANT A. E., 1954; Mourant AE., 1954, DISTRIBUTION HUMAN B, V2, P438; NEEL JV, 1961, AM J HUM GENET, V13, P262; NEEL JV, 1956, ANN HUM GENET, V21, P1, DOI 10.1111/j.1469-1809.1971.tb00262.x; Neel JV, 1954, HUMAN HEREDITY; NEWMAN P, 1953, SHORT HISTORY CYPRUS; OWEN JA, 1958, NATURE, V182, P1373, DOI 10.1038/1821373a0; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; SILVESTRONI E, 1958, Prog Med (Napoli), V14, P641; SINGER K, 1951, BLOOD, V6, P429, DOI 10.1182/blood.V6.5.429.429; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SINISCALCO M, 1955, 5 P INT C BLOOD TRAN, P483; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; Stevens WL, 1938, ANN EUGENIC, V8, P362, DOI 10.1111/j.1469-1809.1938.tb02188.x; STIJNS J, 1956, Ann Soc Belg Med Trop (1920), V36, P763; SZEINBERG A, 1957, BLOOD, V12, P603, DOI 10.1182/blood.V12.7.603.603; WOLSTENHOLME GEW, 1959, CIBA F S BIOCHEMI ED, P151; ZANNOSMARIOLEA L, 1961, BLOOD, V18, P34, DOI 10.1182/blood.V18.1.34.34; 1936, MEDICAL REPORT GOVER	48	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					267	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14204777				2022-12-18	WOS:A19642973A00004
J	STEINBERG, AG; WILSON, JA				STEINBERG, AG; WILSON, JA			STUDIES ON HEREDITARY GAMMA GLOBULIN FACTORS - EVIDENCE THAT GM (B) IN WHITES AND NEGROES IS NOT SAME AND THAT GM-LIKE IS DETERMINED BY AN ALLELE AT GM LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		FRANKLIN EC, 1962, P NATL ACAD SCI USA, V48, P914, DOI 10.1073/pnas.48.6.914; HARBOE M, 1962, SCIENCE, V136, P978; LINNET-JEPSEN P, 1958, Acta Genet Stat Med, V8, P164; PODLIACHOUK L, 1958, ANN I PASTEUR PARIS, V94, P659; RACE RR, 1962, BLOOD GROUPS MAN; ROPARTZ C, 1961, REV FR ETUD CLIN BIO, V6, P374; ROPARTZ C, 1962, 9 P C INT SOC BLOOD, P54; SINGER JM, 1960, ARTHRITIS RHEUM, V3, P515, DOI 10.1002/art.1780030605; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG A, 1961, AM J HUM GENET, V13, P355; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0; STEINBERG AG, 1962, VOX SANG, V7, P151, DOI 10.1111/j.1423-0410.1962.tb03239.x; STEINBERG AG, IN PRESS; STEINBERG AG, 1962, PROGRESS MEDICAL GEN, V2; THOMAS K, 1961, Dtsch Gesundheitsw, V16, P1185	15	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					96	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	17948482				2022-12-18	WOS:A19632969A00013
J	CLEVE, H; BEARN, AG				CLEVE, H; BEARN, AG			STUDIES ON GROUP SPECIFIC COMPONENT OF HUMAN SERUM - GENE FREQUENCIES IN SEVERAL POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARNICOT NA, 1960, ANN HUM GENET, V24, P171; CLEVE H, 1961, ANN NY ACAD SCI, V94, P218, DOI 10.1111/j.1749-6632.1961.tb35543.x; Cotterman C. W., 1947, CONTR LAB VERTEBRATE BIOL MICHIGAN UNIV, V33, P1; GLASS B, 1953, AM J HUM GENET, V5, P1; GRABAR P, 1953, BIOCHIM BIOPHYS ACTA, V10, P193, DOI 10.1016/0006-3002(53)90233-9; HIRSCHFELD J, 1960, NATURE, V185, P931, DOI 10.1038/185931b0; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V46, P229; HIRSCHFELD JAN, 1960, ACTA GENET ET STATIST MED, V10, P48; LAURELL CB, 1956, CLIN CHEM, V2, P99; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0	13	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	4					372	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2962A	13879929				2022-12-18	WOS:A19612962A00002
J	CURTH, HO; MACKLIN, MT				CURTH, HO; MACKLIN, MT			THE GENETIC BASIS OF VARIOUS TYPES OF ICHTHYOSIS IN A FAMILY GROUP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARGUELLESCASALS D, 1948, INFORMACIONES MED, V12, P129; BARKER LP, 1953, AMA ARCH DERM SYPH, V67, P443, DOI 10.1001/archderm.1953.01540050007002; BETT WR, 1952, BRIT J DERMATOL, V64, P59, DOI 10.1111/j.1365-2133.1952.tb16162.x; Blotevogel W, 1922, DERMATOL WOCHENSCHR, V74, P41; Blotevogel W, 1922, DERMATOL WOCHENSCHR, V74, P1; Bruhns C, 1912, ARCH DERMATOL SYPH-G, V113, P187, DOI 10.1007/BF01825764; BRUHNS C, 1931, HDB HAUT GESCHLECHTS, V8, P1; Cockayne EA, 1933, INHERITED ABNORMALIT; COHN W, 1914, DERMAT CENTRALBL, V17, P229; ELLIS FA, 1953, EXHIBIT BENIGN MALIG; Friedlander M, 1931, DERMATOL WOCHENSCHR, V93, P1333; FUHS H, 1924, ACTA DERM-VENEREOL, V5, P11; GASSMANN A, 1904, ARCH DERM SYPH ERGAN, V69; GATES RR, 1946, HUMAN GENETICS, V1, P310; GOTTRON H, 1943, ZENTRALBL HAUT GESCH, V69, P617; HERMANN H, 1951, Dermatol Wochenschr, V124, P1097; HOEDE K, 1940, HDB ERBBIOLOGIE MENS, P470; KOGOJ F, 1950, Acta Derm Venereol, V30, P206; Leven, 1922, ARCH DERMATOL SYPH-G, V139, P117, DOI 10.1007/BF02186571; MATRAS, 1933, ZBL HAUTKRKH, V45, P147; PAWLOWSKI S, 1951, Przegl Dermatol, V1, P41; PELLERAT MJ, 1953, B SOC FRANC DERM SYP, V2, P179; RAMAZZOTTI V, 1925, GIOR ITAL DERMAT, V66, P971; SIEMENS W, 1927, ZENTRALBL HAUT GESCH, V24, P737; WEHEFRITZ E, 1924, Z KONSTITUTIONSLEHRE, V10, P394; WINER LH, 1953, AMA ARCH DERMAT SYPH, V67, P443; WISE F, 1936, ARCH DERMAT SYPH, V34, P540	27	46	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	4					371	382						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB735	14349943				2022-12-18	WOS:A1954YB73500001
J	Dikilitas, O; Schaid, DJ; Kosel, ML; Carroll, RJ; Chute, CG; Denny, JA; Fedotov, A; Feng, QP; Hakonarson, H; Jarvik, GP; Lee, MTM; Pacheco, JA; Rowley, R; Sleiman, PM; Stein, CM; Sturm, AC; Wei, WQ; Wiesner, GL; Williams, MS; Zhang, YF; Manolio, TA; Kullo, IJ				Dikilitas, Ozan; Schaid, Daniel J.; Kosel, Matthew L.; Carroll, Robert J.; Chute, Christopher G.; Denny, Joshua A.; Fedotov, Alex; Feng, QiPing; Hakonarson, Hakon; Jarvik, Gail P.; Lee, Ming Ta Michael; Pacheco, Jennifer A.; Rowley, Robb; Sleiman, Patrick M.; Stein, C. Michael; Sturm, Amy C.; Wei, Wei-Qi; Wiesner, Georgia L.; Williams, Marc S.; Zhang, Yanfei; Manolio, Teri A.; Kullo, Iftikhar J.			Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC RISK; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; HEALTH; LOCI; IDENTIFICATION; INFERENCE; ANCESTRY; RECORDS	Because polygenic risk scores (PRSs) for coronary heart disease (CHD) are derived from mainly European ancestry (EA) cohorts, their validity in African ancestry (AA) and Hispanic ethnicity (HE) individuals is unclear. We investigated associations of "restricted" and genome-wide PRSs with CHD in three major racial and ethnic groups in the U.S. The eMERGE cohort (mean age 48 +/- 14 years, 58% female) included 45,645 EA, 7,597 AA, and 2,493 HE individuals. We assessed two restricted PRSs (PRSTikkanen and PRSTada; 28 and 50 variants, respectively) and two genome-wide PRSs (PRSmetaGRs and PRSLDpred; 1.7 M and 6.6 M variants, respectively) derived from EA cohorts. Over a median follow-up of 11.1 years, 2,652 incident CHD events occurred. Hazard and odds ratios for the association of PRSs with CHD were similar in EA and HE cohorts but lower in AA cohorts. Genome-wide PRSs were more strongly associated with CHD than restricted PRSs were. PRSmetaGRs, the best performing PRS, was associated with CHD in all three cohorts; hazard ratios (95% CI) per 1 SD increase were 1.53 (1.46-1.60), 1.53 (1.23-1.90), and 1.27 (1.13-1.43) for incident CHD in EA, HE, and AA individuals, respectively. The hazard ratios were comparable in the EA and HE cohorts (P-interaction = 0.77) but were significantly attenuated in AA individuals (P-interaction = 2.9 x 10(-3)). These results highlight the potential clinical utility of PRSs for CHD as well as the need to assemble diverse cohorts to generate ancestry- and ethnicity PRSs.	[Dikilitas, Ozan; Kullo, Iftikhar J.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Schaid, Daniel J.; Kosel, Matthew L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Carroll, Robert J.; Denny, Joshua A.; Wei, Wei-Qi] Vanderbilt Univ, Dept Biomed Informat, Dept Med, Med Ctr, Nashville, TN 37212 USA; [Chute, Christopher G.] Johns Hopkins Univ, Sch Med Publ Hlth & Nursing, Baltimore, MD 21205 USA; [Fedotov, Alex] Columbia Univ, Irving Inst Clin & Translat Res, Med Ctr, New York, NY 10032 USA; [Feng, QiPing; Stein, C. Michael] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Med Ctr, Nashville, TN 37212 USA; [Hakonarson, Hakon; Sleiman, Patrick M.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Jarvik, Gail P.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lee, Ming Ta Michael; Sturm, Amy C.; Williams, Marc S.; Zhang, Yanfei] Geisinger, Danville, PA 17822 USA; [Pacheco, Jennifer A.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Rowley, Robb; Manolio, Teri A.] Natl Human Genome Res Inst, Bethesda, MD 20892 USA; [Wiesner, Georgia L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37212 USA	Mayo Clinic; Mayo Clinic; Vanderbilt University; Johns Hopkins University; Columbia University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vanderbilt University	Kullo, IJ (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu	Zhang, Yanfei/AAL-2148-2021; Chute, Christopher/AAT-8540-2021	Zhang, Yanfei/0000-0002-9222-7725; 	National Human Genome Research Institute (NHGRI) [U01HG006828, U01HG006830, U01HG006389, U01HG006382, U01HG006375, U01HG006379, U01HG006380, U01HG006388, U01HG006378, U01HG006385]; NHGRI [U01HG8657, U01HG8685, U01HG8672, U01HG8666, U01HG6379, U01HG8679, U01HG8680, U01HG8684, U01HG8673, U01HG8701, U01HG8676, U01HG8664]; National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR002377]; NIH [K24 HL137010]	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to the investigators and participants of the electronic Medical Records and Genomics (eMERGE) Network. The eMERGE Network was initiated and funded by National Human Genome Research Institute (NHGRI) through the following grants: U01HG006828 (Cincinnati Children's Hospital Medical Center and Boston Children's Hospital); U01HG006830 (Children's Hospital of Philadelphia); U01HG006389 (Essentia Institute of Rural Health, Marshfield Clinic Research Foundation, and Pennsylvania State University); U01HG006382 (Geisinger Clinic); U01HG006375 (Group Health Cooperative and the University of Washington); U01HG006379 (Mayo Clinic); U01HG006380 (Icahn School of Medicine at Mount Sinai); U01HG006388 (Northwestern University); U01HG006378 (Vanderbilt University Medical Center); and U01HG006385 (Vanderbilt University Medical Center serving as the Coordinating Center). This phase of the eMERGE network was initiated and funded by the NHGRI through the following grants: U01HG8657 (Group Health Cooperative/University of Washington); U01HG8685 (Brigham and Women's Hospital); U01HG8672 (Vanderbilt University Medical Center); U01HG8666 (Cincinnati Children's Hospital Medical Center); U01HG6379 (Mayo Clinic); U01HG8679 (Geisinger Clinic); U01HG8680 (Columbia University Health Sciences); U01HG8684 (Children's Hospital of Philadelphia); U01HG8673 (Northwestern University); U01HG8701 (Vanderbilt University Medical Center serving as the Coordinating Center); U01HG8676 (Partners Healthcare and the Broad Institute); and U01HG8664 (Baylor College of Medicine). This work was also supported by the CTSA grant UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). I.J.K. was additionally supported by NIH grant K24 HL137010. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1016/j.jacc.2019.03.010, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677]; Barbalic M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002199; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bressler J, 2010, AM J EPIDEMIOL, V171, P14, DOI 10.1093/aje/kwp377; Brown SAN, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001613; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dehghan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144997; Ding KY, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-66; Dumitrescu L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171745; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Franceschini N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113203; Franceschini Nora, 2011, Circ Cardiovasc Genet, V4, P661, DOI 10.1161/CIRCGENETICS.111.960096; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Grinde KE, 2019, GENET EPIDEMIOL, V43, P50, DOI 10.1002/gepi.22166; Gurdasani D, 2019, NAT REV GENET, V20, P520, DOI 10.1038/s41576-019-0144-0; Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Iribarren C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25128-x; Ke WJ, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00019; Khera AV, 2019, CIRCULATION, V139, P1593, DOI 10.1161/CIRCULATIONAHA.118.035658; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kirby JC, 2016, J AM MED INFORM ASSN, V23, P1046, DOI 10.1093/jamia/ocv202; Knowles JW, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002546; Kullo IJ, 2007, NAT CLIN PRACT CARD, V4, P558, DOI 10.1038/ncpcardio0982; Kullo IJ, 2016, CIRCULATION, V133, P1181, DOI 10.1161/CIRCULATIONAHA.115.020109; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Manolio TA, 2019, AM J HUM GENET, V105, P233, DOI 10.1016/j.ajhg.2019.07.008; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marquez-Luna C, 2017, GENET EPIDEMIOL, V41, P811, DOI 10.1002/gepi.22083; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McPherson R, 2016, CIRC RES, V118, P564, DOI 10.1161/CIRCRESAHA.115.306566; Mensah GA, 2019, CIRC RES, V125, P7, DOI 10.1161/CIRCRESAHA.119.314970; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pal Choudhury P., 2020, PLOS ONE, V15; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2011, CIRCULATION, V123, P374, DOI 10.1161/CIRCULATIONAHA.110.976613; R Core Team, 2018, R LANG ENV STAT COMP; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Safarova MS, 2016, J CLIN LIPIDOL, V10, P1230, DOI 10.1016/j.jacl.2016.08.001; Stanaway IB, 2019, GENET EPIDEMIOL, V43, P63, DOI 10.1002/gepi.22167; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Tikkanen E, 2013, ARTERIOSCL THROM VAS, V33, P2261, DOI 10.1161/ATVBAHA.112.301120; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; Verweij N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03062-8; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wei Wei-Qi, 2014, AMIA Jt Summits Transl Sci Proc, V2014, P112; Wunnemann F, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.119.002481	65	45	45	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2020	106	5					707	716		10.1016/j.ajhg.2020.04.002	http://dx.doi.org/10.1016/j.ajhg.2020.04.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LK8FQ	32386537	Bronze, Green Published			2022-12-18	WOS:000531096100010
J	Nakka, P; Smith, SP; O'Donnell-Luria, AH; McManus, KF; Mountain, JL; Ramachandran, S; Sathirapongsasuti, JF; Agee, M; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; Hicks, B; Hinds, DA; Jewett, EM; Jiang, YX; Lin, KH; McCreight, JC; Huber, KE; Kleinman, A; Litterman, NK; McIntyre, MH; Noblin, ES; Northover, CAM; Pitts, SJ; Poznik, GD; Shelton, JF; Shringarpure, S; Tian, C; Tung, JY; Vacic, V; Wang, X				Nakka, Priyanka; Smith, Samuel Pattillo; O'Donnell-Luria, Anne H.; McManus, Kimberly F.; Mountain, Joanna L.; Ramachandran, Sohini; Sathirapongsasuti, J. Fah; Agee, Michelle; Auton, Adam; Bell, Robert K.; Bryc, Katarzyna; Elson, Sarah L.; Fontanillas, Pierre; Furlotte, Nicholas A.; Hicks, Barry; Hinds, David A.; Jewett, Ethan M.; Jiang, Yunxuan; Lin, Keng-Han; McCreight, Jennifer C.; Huber, Karen E.; Kleinman, Aaron; Litterman, Nadia K.; McIntyre, Matthew H.; Noblin, Elizabeth S.; Northover, Carrie A. M.; Pitts, Steven J.; Poznik, G. David; Shelton, Janie F.; Shringarpure, Suyash; Tian, Chao; Tung, Joyce Y.; Vacic, Vladimir; Wang, Xin		23andMe Res Team	Characterization of Prevalence and Health Consequences of Uniparental Disomy in Four Million Individuals from the General Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOZYGOSITY; MECHANISMS; PATTERNS; COMPLEX; RUNS	Meiotic nondisjunction and resulting aneuploidy can lead to severe health consequences in humans. Aneuploidy rescue can restore euploidy but may result in uniparental disomy (UPD), the inheritance of both homologs of a chromosome from one parent with no representative copy from the other. Current understanding of UPD is limited to similar to 3,300 case subjects for which UPD was associated with clinical presentation due to imprinting disorders or recessive diseases. Thus, the prevalence of UPD and its phenotypic consequences in the general population are unknown. We searched for instances of UPD across 4,400,363 consented research participants from the personal genetics company 23andMe, Inc., and 431,094 UK Biobank participants. Using computationally detected DNA segments identical-by-descent (IBD) and runs of homozygosity (ROH), we identified 675 instances of UPD across both databases. We estimate that UPD is twice as common as previously thought, and we present a machine-learning framework to detect UPD using ROH. While we find a nominally significant association between UPD of chromosome 22 and autism risk, we do not find significant associations between UPD and deleterious traits in the 23andMe database.	[Nakka, Priyanka; Smith, Samuel Pattillo; Ramachandran, Sohini] Brown Univ, Ctr Computat Mol Biol, 164 Angell St, Providence, RI 02912 USA; [Nakka, Priyanka; Smith, Samuel Pattillo; Ramachandran, Sohini] Brown Univ, Ecol & Evolutionary Biol, 80 Waterman St, Providence, RI 02912 USA; [Nakka, Priyanka; McManus, Kimberly F.; Mountain, Joanna L.; Sathirapongsasuti, J. Fah; 23andMe Res Team] 23andMe Inc, 223 N Mathilda Ave, Sunnyvale, CA 94086 USA; [O'Donnell-Luria, Anne H.] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA; [O'Donnell-Luria, Anne H.] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA	Brown University; Brown University; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Nakka, P (corresponding author), Brown Univ, Ctr Computat Mol Biol, 164 Angell St, Providence, RI 02912 USA.; Nakka, P (corresponding author), Brown Univ, Ecol & Evolutionary Biol, 80 Waterman St, Providence, RI 02912 USA.; Nakka, P; Sathirapongsasuti, JF (corresponding author), 23andMe Inc, 223 N Mathilda Ave, Sunnyvale, CA 94086 USA.	pnakka@wellesley.edu; fsathirapongsasuti@23andme.com		O'Donnell-Luria, Anne/0000-0001-6418-9592	US National Institutes of Health (NIH) [R01GM118652]; NIH COBRE award [P20GM109035]; National Science Foundation (NSF) CAREER award [DBI-1452622]; NIH National Child Health and Development Institute training grant [K12HD052896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118652, T32GM128596, P20GM109035] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE award; National Science Foundation (NSF) CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH National Child Health and Development Institute training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the 23andMe research participants who made this work possible. We also thank the employees of 23andMe who developed the infrastructure that made this research possible. This research has been conducted using the UK Biobank Resource under Application Number 44606. We gratefully acknowledge Uta Francke, Shai Carmi, Aaron Carrel, Kirk Lohmueller, Priya Moorjani, John Novembre, Ben Raphael, Suyash Shringarpure, Janie Shelton, and the Ramachandran Lab for helpful conversations. This research was supported in part by US National Institutes of Health (NIH) grant R01GM118652, NIH COBRE award P20GM109035, and National Science Foundation (NSF) CAREER award DBI-1452622 to S.R. Support was also provided by the NIH National Child Health and Development Institute training grant K12HD052896 to A.H.O.-L.	Abraham G, 2017, BIOINFORMATICS, V33, P2776, DOI 10.1093/bioinformatics/btx299; Borgulova I, 2018, J HUM GENET, V63, P803, DOI 10.1038/s10038-018-0444-9; Brun BN, 2018, NEUROMUSCULAR DISORD, V28, P592, DOI 10.1016/j.nmd.2018.04.003; Bruno DL, 2011, J MED GENET, V48, P831, DOI 10.1136/jmedgenet-2011-100372; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Campbell CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7260; Carmichael H, 2013, CLIN GENET, V84, P213, DOI 10.1111/cge.12064; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452; Danecek P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155014; Durand EY, 2014, BIORXIV; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hoppman N, 2018, GENET MED, V20, P1522, DOI 10.1038/gim.2018.24; Kalish JM, 2013, AM J MED GENET A, V161, P1929, DOI 10.1002/ajmg.a.36045; Kang JTL, 2016, HUM HERED, V82, P87, DOI 10.1159/000478897; King DA, 2014, GENOME RES, V24, P673, DOI 10.1101/gr.160465.113; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Koehler KE, 1998, ANN HUM GENET, V62, P467, DOI 10.1046/j.1469-1809.1998.6260467.x; Kotzot D, 2008, J MED GENET, V45, P545, DOI 10.1136/jmg.2008.058016; Liehr T, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-8; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Popadin K, 2018, GENOME RES, V28, P1, DOI 10.1101/gr.228411.117; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson WP, 2000, BIOESSAYS, V22, P452; Rodriguez-Purata J, 2015, FERTIL STERIL, V104, P1460, DOI 10.1016/j.fertnstert.2015.08.007; San Yeung K, 2018, J MED GENET, V55, P847, DOI 10.1136/jmedgenet-2018-105328; Scrucca L, 2016, R J, V8, P289; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Szpiech ZA, 2017, BIOINFORMATICS, V33, P2059, DOI 10.1093/bioinformatics/btx102; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; Wilfert AB, 2016, NAT GENET, V48, P1455, DOI 10.1038/ng.3697; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77	41	45	47	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2019	105	5					921	932		10.1016/j.ajhg.2019.09.016	http://dx.doi.org/10.1016/j.ajhg.2019.09.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JL9XL	31607426	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000495878800004
J	Helbig, I; Lopez-Hernandez, T; Shor, O; Galer, P; Ganesan, S; Pendziwiat, M; Rademacher, A; Ellis, CA; Humpfer, N; Schwarz, N; Seiffert, S; Peeden, J; Shen, J; Sterbova, K; Hammer, TB; Moller, RS; Shinde, DN; Tang, S; Smith, L; Poduri, A; Krause, R; Benninger, F; Helbig, KL; Haucke, V; Weber, YG; Balling, R; Barisic, N; Baulac, S; Caglayan, H; Craiu, D; De Jonghe, P; Depienne, C; Guerrini, R; Hjalgrim, H; Hoffman-Zacharska, D; Jahn, J; Klein, KM; Koeleman, BPC; Komarek, V; Leguern, E; Lehesjoki, AE; Lemke, JR; Lerche, H; Linnan-Kivi, T; Marini, C; May, P; Muhle, H; Pal, DK; Palotie, A; Rosenow, F; Schubert-Bast, S; Selmer, K; Serratosa, JM; Sisodiya, S; Stephani, U; Striano, P; Suls, A; Talvik, T; von Spiczak, S; Weckhuysen, S; Zara, F; Avillach, P; Bartels, A; Biswas, S; Bourgeois, F; Devkota, B; Glauser, T; Hallinan, B; Heath, A; Hirschhorn, J; Kilbourn, J; Kong, S; Krantz, I; Lee, IH; Mandl, KD; Marsh, E; Sund, K; Taylor, D; White, P				Helbig, Ingo; Lopez-Hernandez, Tania; Shor, Oded; Galer, Peter; Ganesan, Shiva; Pendziwiat, Manuela; Rademacher, Annika; Ellis, Colin A.; Huempfer, Nadja; Schwarz, Niklas; Seiffert, Simone; Peeden, Joseph; Shen, Joseph; Sterbova, Katalin; Hammer, Trine Bjorg; Moller, Rikke S.; Shinde, Deepali N.; Tang, Sha; Smith, Lacey; Poduri, Annapurna; Krause, Roland; Benninger, Felix; Helbig, Katherine L.; Haucke, Volker; Weber, Yvonne G.; Balling, Rudi; Barisic, Nina; Baulac, Stephanie; Caglayan, Hande; Craiu, Dana; De Jonghe, Peter; Depienne, Christel; Guerrini, Renzo; Hjalgrim, Helle; Hoffman-Zacharska, Dorota; Jahn, Johanna; Klein, Karl Martin; Koeleman, Bobby P. C.; Komarek, Vladimir; Leguern, Eric; Lehesjoki, Anna-Elina; Lemke, Johannes R.; Lerche, Holger; Linnan-Kivi, Tarja; Marini, Carla; May, Patrick; Muhle, Hiltrud; Pal, Deb K.; Palotie, Aarno; Rosenow, Felix; Schubert-Bast, Susanne; Selmer, Kaja; Serratosa, Jose M.; Sisodiya, Sanjay; Stephani, Ulrich; Striano, Pasquale; Suls, Arvid; Talvik, Tiina; von Spiczak, Sarah; Weckhuysen, Sarah; Zara, Federico; Avillach, Paul; Bartels, Anna; Biswas, Sawona; Bourgeois, Florence; Devkota, Batsal; Glauser, Tracy; Hallinan, Barbara; Heath, Allison; Hirschhorn, Joel; Kilbourn, Judson; Kong, SekWon; Krantz, Ian; Lee, In-Hee; Mandl, Kenneth D.; Marsh, Eric; Sund, Kristen; Taylor, Deanne; White, Peter		EuroEPINOMICS-RES Consortium; GRIN Consortium	A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; ILAE COMMISSION; POSITION PAPER; ADAPTER AP-2; PROTEIN; CLASSIFICATION; RECRUITMENT; BINDING	The developmental and epileptic encephalopathies (DEEs) are heterogeneous disorders with a strong genetic contribution, but the underlying genetic etiology remains unknown in a significant proportion of individuals. To explore whether statistical support for genetic etiologies can be generated on the basis of phenotypic features, we analyzed whole-exome sequencing data and phenotypic similarities by using Human Phenotype Ontology (HPO) in 314 individuals with DEEs. We identified a de novo c.508C>T (p.Arg170Trp) variant in AP2M1 in two individuals with a phenotypic similarity that was higher than expected by chance (p = 0.003) and a phenotype related to epilepsy with myoclonic-atonic seizures. We subsequently found the same de novo variant in two individuals with neurodevelopmental disorders and generalized epilepsy in a cohort of 2,310 individuals who underwent diagnostic whole-exome sequencing. AP2M1 encodes the mu-subunit of the adaptor protein complex 2 (AP-2), which is involved in clathrin-mediated endocytosis (CME) and synaptic vesicle recycling. Modeling of protein dynamics indicated that the p.Arg170Trp variant impairs the conformational activation and thermodynamic entropy of the AP-2 complex. Functional complementation of both the mu-subunit carrying the p.Arg170Trp variant in human cells and astrocytes derived from AP-2 mu conditional knockout mice revealed a significant impairment of CME of transferrin. In contrast, stability, expression levels, membrane recruitment, and localization were not impaired, suggesting a functional alteration of the AP-2 complex as the underlying disease mechanism. We establish a recurrent pathogenic variant in AP2M1 as a cause of DEEs with distinct phenotypic features, and we implicate dysfunction of the early steps of endocytosis as a disease mechanism in epilepsy.	[Helbig, Ingo; Galer, Peter; Ganesan, Shiva; Helbig, Katherine L.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Helbig, Ingo; Galer, Peter; Ganesan, Shiva; Helbig, Katherine L.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Helbig, Ingo; Pendziwiat, Manuela; Rademacher, Annika] Christian Albrechts Univ Kiel, Dept Neuropediat, D-24105 Kiel, Germany; [Helbig, Ingo; Ellis, Colin A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lopez-Hernandez, Tania; Huempfer, Nadja; Haucke, Volker] Leibniz Forsch Inst Mol Pharmakol, D-13125 Berlin, Germany; [Shor, Oded; Benninger, Felix] Rabin Med Ctr, Dept Neurol, IL-4941492 Petah Tiqwa, Israel; [Shor, Oded; Benninger, Felix] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [Huempfer, Nadja; Haucke, Volker] Free Univ Berlin, Fac Biol, Chem, Pharm, D-14195 Berlin, Germany; [Schwarz, Niklas; Seiffert, Simone; Weber, Yvonne G.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, D-72076 Tubingen, Germany; [Peeden, Joseph] Univ Tennessee, Dept Med, East Tennessee Childrens Hosp, Knoxville, TN 37916 USA; [Shen, Joseph] Univ Calif San Francisco, Dept Pediat, Div Genet, Fresno, CA 93701 USA; [Sterbova, Katalin] Charles Univ Prague, Fac Med 2, Dept Child Neurol, Prague 15006, Czech Republic; [Sterbova, Katalin] Univ Hosp Motol, Prague 15006, Czech Republic; [Hammer, Trine Bjorg; Moller, Rikke S.] Danish Epilepsy Ctr Filadelfia, DK-4293 Dianalund, Denmark; [Moller, Rikke S.] Univ Southern Denmark, Inst Reg Hlth Serv, DK-5230 Odense, Denmark; [Shinde, Deepali N.; Tang, Sha] Ambry Genet, Div Clin Genom, Aliso Viejo, CA 92656 USA; [Smith, Lacey; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA 02115 USA; [Poduri, Annapurna] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Krause, Roland] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4365 Esch Sur Alzette, Luxembourg; [Weber, Yvonne G.] Univ Tubingen, Dept Neurosurg, D-72076 Tubingen, Germany	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Kiel; University of Pennsylvania; Pennsylvania Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Free University of Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Charles University Prague; Motol University Hospital; University of Southern Denmark; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Luxembourg; Eberhard Karls University of Tubingen	Helbig, I (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.; Helbig, I (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.; Helbig, I (corresponding author), Christian Albrechts Univ Kiel, Dept Neuropediat, D-24105 Kiel, Germany.; Helbig, I (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	helbigi@email.chop.edu	Marini, Carla/AAC-2413-2022; Selmer, Kaja/AAM-7284-2021; Depienne, Christel/AAL-3835-2021; Shen, Joseph/AAY-5083-2020; Zara, Federico/U-3477-2017; May, Patrick/N-1019-2019; Striano, Pasquale/F-9117-2014; Hernandez, Tania Lopez/AAH-8754-2019; Lee, Inhee/AAK-7760-2021; Taylor, Deanne/AAY-6296-2020; Craiu, Dana/ABC-2986-2020; Weckhuysen, Sarah/HGB-9957-2022; Craiu, Dana/ABE-4886-2020; Muhle, Hiltrud/F-5715-2010; Helbig, Ingo/G-8467-2018; Baulac, Stephanie/O-2099-2016; Helbig, Katherine/B-7454-2012	Marini, Carla/0000-0002-9212-2691; Depienne, Christel/0000-0002-7212-9554; Shen, Joseph/0000-0002-5604-7639; Zara, Federico/0000-0001-9744-5222; May, Patrick/0000-0001-8698-3770; Striano, Pasquale/0000-0002-6065-1476; Taylor, Deanne/0000-0002-3302-4610; Weckhuysen, Sarah/0000-0003-2878-1147; Helbig, Ingo/0000-0001-8486-0558; Selmer, Kaja Kristine/0000-0003-4871-112X; Galer, Peter/0000-0002-6408-0906; Shor, Oded Lipa/0000-0002-4712-3847; Serratosa, Jose/0000-0003-2239-8948; Krause, Roland/0000-0001-9938-7126; Ganesan, Shiva Subbramaninan/0000-0002-2518-6505; Baulac, Stephanie/0000-0001-6430-4693; Palotie, Aarno/0000-0002-2527-5874; Helbig, Katherine/0000-0001-8249-0549; Linnankivi, Tarja/0000-0001-9190-2218; Guerrini, Renzo/0000-0002-7272-7079; Klein, Karl Martin/0000-0002-6654-1665; Moller, Rikke S./0000-0002-9664-1448; Lopez-Hernandez, Tania/0000-0002-0814-2850; Balling, Rudi/0000-0003-2902-5650; Hoffman-Zacharska, Dorota/0000-0001-7367-512X; Lee, In-Hee/0000-0002-8857-1355; Humpfer, Nadja/0000-0002-4349-4886	intramural funds of the Children's Hospital of Philadelphia; German Research Foundation within the EuroEPINOMICS European Science Foundation [HE5415/3-1]; German Research Foundation (DFG) [HE5415/5-1, HE5415/6-1, HA2686/13-1, WE4896/3-1]; DFG Research Unit [FOR2715, Le1030/16-1, We4896/4-1, He5415/7-1]; Luxembourg National Research Fund [INTER/DFG/17/11583046]; German Society for Epileptology; Genomics Research and Innovation Network (GRIN; Children's Hospital of Philadelphia; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; International League Against Epilepsy; National Institutes of Health (NIH) [NS108874]; Israel Science Foundation [1010/16]; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant [T32 NS091008-01]; intramural research funding program of the Faculty of Medicine Tu <spacing diaeresis> bingen [Fortune 2381-0-0]; Ministry of Health of the Czech Republic [AZV15-33041, DRO 00064203]; Boston Children's Hospital Translational Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS091008, U54NS108874] Funding Source: NIH RePORTER	intramural funds of the Children's Hospital of Philadelphia; German Research Foundation within the EuroEPINOMICS European Science Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG Research Unit(German Research Foundation (DFG)); Luxembourg National Research Fund(Luxembourg National Research Fund); German Society for Epileptology; Genomics Research and Innovation Network (GRIN; Children's Hospital of Philadelphia; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; International League Against Epilepsy; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural research funding program of the Faculty of Medicine Tu <spacing diaeresis> bingen; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Boston Children's Hospital Translational Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the participants and their family members for taking part in the study. We would like to thank Mahgenn Cosico and Margaret O'Brien for their support in enrolling research participants and for administrative assistance. The current study was supported by the EuroEPINOMICS-Rare Epilepsy Syndrome (RES) Consortium, which provided the capacity for exome sequencing. This work was supported by intramural funds of the Children's Hospital of Philadelphia; by the German Research Foundation (HE5415/3-1 to I.H.) within the EuroEPINOMICS framework of the European Science Foundation; by the German Research Foundation (DFG; HE5415/5-1, HE5415/6-1 to I.H., HA2686/13-1 [Koselleck Program] to V.H., and WE4896/3-1 to Y.G.W.); by DFG Research Unit FOR2715 (Le1030/16-1, We4896/4-1, and He5415/7-1 to I.H. and Y.G.W.); by the Luxembourg National Research Fund (INTER/DFG/17/11583046 to R.K.); by the German Society for Epileptology (to Y.G.W.); and by the Genomics Research and Innovation Network (GRIN, grinnetwork. org), a collaboration among the Children's Hospital of Philadelphia, Boston Children's Hospital, and the Cincinnati Children's Hospital Medical Center. I.H. also received support through the International League Against Epilepsy. This work was also partially supported by National Institutes of Health (NIH) grant NS108874. O.S. and F.B. were supported by the Israel Science Foundation (grant No. 1010/16). C.A.E. was supported in part by a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant, T32 NS091008-01. N.S. was in part supported from the intramural research funding program of the Faculty of Medicine Tu <spacing diaeresis> bingen (Fortune 2381-0-0). K.S. was supported by the Ministry of Health of the Czech Republic (AZV15-33041 and DRO 00064203). A.P. is supported by the Boston Children's Hospital Translational Research Program.	Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amrom D, 2017, AM J HUM GENET, V100, P179, DOI 10.1016/j.ajhg.2016.12.012; Bastarache L, 2018, SCIENCE, V359, P1233, DOI 10.1126/science.aal4043; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Deng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115692; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Djemie T, 2016, MOL GENET GENOM MED, V4, P457, DOI 10.1002/mgg3.217; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Frappier V, 2015, NUCLEIC ACIDS RES, V43, pW395, DOI 10.1093/nar/gkv343; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Hagman KDF, 2017, GENET MED, V19, P224, DOI 10.1038/gim.2016.95; Hamdan FF, 2017, AM J HUM GENET, V101, P664, DOI 10.1016/j.ajhg.2017.09.008; Helbig I, 2018, EPILEPSIA, V59, P1138, DOI 10.1111/epi.14193; Helbig I, 2017, NEUROLOGY, V89, P14, DOI 10.1212/WNL.0000000000004053; Helbig I, 2016, MOL SYNDROMOL, V7, P172, DOI 10.1159/000448530; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Heyne HO, 2018, NAT GENET, V50, P1048, DOI 10.1038/s41588-018-0143-7; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kadlecova Z, 2017, J CELL BIOL, V216, P167, DOI 10.1083/jcb.201608071; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kononenko NL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14819; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindy AS, 2018, EPILEPSIA, V59, P1062, DOI 10.1111/epi.14074; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Mitsunari T, 2005, MOL CELL BIOL, V25, P9318, DOI 10.1128/MCB.25.21.9318-9323.2005; Myers CT, 2017, AM J HUM GENET, V101, P516, DOI 10.1016/j.ajhg.2017.08.013; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schoneberg J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15873; Schubert J, 2014, NAT GENET, V46, P1327, DOI 10.1038/ng.3130; Stamberger H, 2016, NEUROLOGY, V86, P954, DOI 10.1212/WNL.0000000000002457; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Vogtle FN, 2018, AM J HUM GENET, V102, P557, DOI 10.1016/j.ajhg.2018.02.014; von Spiczak S, 2017, NEUROLOGY, V89, P385, DOI 10.1212/WNL.0000000000004152; Wolff M, 2017, BRAIN, V140, P1316, DOI 10.1093/brain/awx054	46	45	46	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1060	1072		10.1016/j.ajhg.2019.04.001	http://dx.doi.org/10.1016/j.ajhg.2019.04.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31104773	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000470240000004
J	Bell, S; Rousseau, J; Peng, HS; Aouabed, Z; Priam, P; Theroux, JF; Jefri, M; Tanti, A; Wu, HR; Kolobova, I; Silviera, H; Manzano-Vargas, K; Ehresmann, S; Hamdan, FF; Hettige, N; Zhang, X; Antonyan, L; Nassif, C; Ghaloul-Gonzalez, L; Sebastian, J; Vockley, J; Begtrup, AG; Wentzensen, IM; Crunk, A; Nicholls, RD; Herman, KC; Deignan, JL; Al-Hertani, W; Efthymiou, S; Salpietro, V; Miyake, N; Makita, Y; Matsumoto, N; Ostern, R; Houge, G; Hafstrom, M; Fassi, E; Houlden, H; Wassink-Ruiter, JSK; Nelson, D; Goldstein, A; Dabir, T; van Gils, J; Bourgeron, T; Delorme, R; Cooper, GM; Martinez, JE; Finnila, CR; Carmant, L; Lortie, A; Oegema, R; van Gassen, K; Mehta, SG; Huhle, D; Abou Jamra, R; Martin, S; Brunner, HG; Lindhout, D; Au, M; Graham, JM; Coubes, C; Turecki, G; Gravel, S; Mechawar, N; Rossignol, E; Michaud, JL; Lessard, J; Ernst, C; Campeau, PM				Bell, Scott; Rousseau, Justine; Peng, Huashan; Aouabed, Zahia; Priam, Pierre; Theroux, Jean-Francois; Jefri, Malvin; Tanti, Arnaud; Wu, Hanrong; Kolobova, Ilaria; Silviera, Heika; Manzano-Vargas, Karla; Ehresmann, Sophie; Hamdan, Fadi F.; Hettige, Nuwan; Zhang, Xin; Antonyan, Lilit; Nassif, Christina; Ghaloul-Gonzalez, Lina; Sebastian, Jessica; Vockley, Jerry; Begtrup, Amber G.; Wentzensen, Ingrid M.; Crunk, Amy; Nicholls, Robert D.; Herman, Kristin C.; Deignan, Joshua L.; Al-Hertani, Walla; Efthymiou, Stephanie; Salpietro, Vincenzo; Miyake, Noriko; Makita, Yoshio; Matsumoto, Naomichi; Ostern, Rune; Houge, Gunnar; Hafstrom, Maria; Fassi, Emily; Houlden, Henry; Wassink-Ruiter, Jolien S. Klein; Nelson, Dominic; Goldstein, Amy; Dabir, Tabib; van Gils, Julien; Bourgeron, Thomas; Delorme, Richard; Cooper, Gregory M.; Martinez, Jose E.; Finnila, Candice R.; Carmant, Lionel; Lortie, Anne; Oegema, Renske; van Gassen, Koen; Mehta, Sarju G.; Huhle, Dagmar; Abou Jamra, Rami; Martin, Sonja; Brunner, Han G.; Lindhout, Dick; Au, Margaret; Graham, John M., Jr.; Coubes, Christine; Turecki, Gustavo; Gravel, Simon; Mechawar, Naguib; Rossignol, Elsa; Michaud, Jacques L.; Lessard, Julie; Ernst, Carl; Campeau, Philippe M.			Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMATIN REMODELING COMPLEX; COFFIN-SIRIS SYNDROME; SYNAPTIC PLASTICITY; PROTEIN EXPRESSION; SWI/SNF COMPLEX; MEMORY; GENE; OLIGODENDROCYTE; TRANSCRIPTION; DISORDERS	We identified individuals with variations in ACTL6B, a component of the chromatin remodeling machinery including the BAF complex. Ten individuals harbored bi-allelic mutations and presented with global developmental delay, epileptic encephalopathy, and spasticity, and ten individuals with de novo heterozygous mutations displayed intellectual disability, ambulation deficits, severe language impairment, hypotonia, Rett-like stereotypies, and minor facial dysmorphisms ( wide mouth, diastema, bulbous nose). Nine of these ten unrelated individuals had the identical de novo c.1027G>A (p.Gly343Arg) mutation. Human-derived neurons were generated that recaptured ACTL6B expression patterns in development from progenitor cell to post-mitotic neuron, validating the use of this model. Engineered knock-out of ACTL6B in wild-type human neurons resulted in profound deficits in dendrite development, a result recapitulated in two individuals with different bi-allelic mutations, and reversed on clonal genetic repair or exogenous expression of ACTL6B. Whole-transcriptome analyses and whole-genomic profiling of the BAF complex in wild-type and bi-allelic mutant ACTL6B neural progenitor cells and neurons revealed increased genomic binding of the BAF complex in ACTL6B mutants, with corresponding transcriptional changes in several genes including TPPP and FSCN1, suggesting that altered regulation of some cytoskeletal genes contribute to altered dendrite development. Assessment of bi-alleic and heterozygous ACTL6B mutations on an ACTL6B knock-out human background demonstrated that bi-allelic mutations mimic engineered deletion deficits while heterozygous mutations do not, suggesting that the former are loss of function and the latter are gain of function. These results reveal a role for ACTL6B in neurodevelopment and implicate another component of chromatin remodeling machinery in brain disease.	[Bell, Scott; Peng, Huashan; Aouabed, Zahia; Theroux, Jean-Francois; Jefri, Malvin; Tanti, Arnaud; Wu, Hanrong; Kolobova, Ilaria; Silviera, Heika; Manzano-Vargas, Karla; Hettige, Nuwan; Zhang, Xin; Antonyan, Lilit; Turecki, Gustavo; Mechawar, Naguib; Ernst, Carl] McGill Univ, Douglas Hosp, Res Inst, Psychiat Genet Grp, Montreal, PQ H4H 1R3, Canada; [Rousseau, Justine; Ehresmann, Sophie; Hamdan, Fadi F.; Nassif, Christina; Rossignol, Elsa; Michaud, Jacques L.; Campeau, Philippe M.] Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Priam, Pierre; Lessard, Julie] Univ Montreal, IRIC, Montreal, PQ H3T 1J4, Canada; [Ghaloul-Gonzalez, Lina; Sebastian, Jessica; Vockley, Jerry; Nicholls, Robert D.] UPMC, Univ Pittsburgh, Div Med Genet, Dept Pediat,Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Begtrup, Amber G.; Wentzensen, Ingrid M.; Crunk, Amy] GeneDx, Gaithersburg, MD USA; [Herman, Kristin C.] Univ Calif Davis, Med Ctr, Sect Med Genom, Sacramento, CA 95817 USA; [Deignan, Joshua L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Al-Hertani, Walla] Alberta Childrens Prov Gen Hosp, Cumming Sch Med, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Al-Hertani, Walla] Alberta Childrens Prov Gen Hosp, Cumming Sch Med, Dept Paediat, Calgary, AB T3B 6A8, Canada; [Al-Hertani, Walla] Univ Calgary, Calgary, AB T3B 6A8, Canada; [Efthymiou, Stephanie; Salpietro, Vincenzo; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Makita, Yoshio] Asahikawa Med Univ, Educ Ctr, Asahikawa, Hokkaido 0788510, Japan; [Ostern, Rune; Hafstrom, Maria] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Pediat, Postbox 3250, N-7006 Trondheim, Norway; [Houge, Gunnar] Haukeland Hosp, Dept Med Genet, N-5021 Bergen, Norway; [Fassi, Emily] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA; [Wassink-Ruiter, Jolien S. Klein; Gravel, Simon] Univ Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Wassink-Ruiter, Jolien S. Klein; Gravel, Simon] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Nelson, Dominic] McGill Univ, Dept Human Genet, Montreal, PQ H3G 0B1, Canada; [Goldstein, Amy] Childrens Hosp Pittsburgh, Div Child Neurol, Pittsburgh, PA 15213 USA; [Dabir, Tabib] Belfast City Hosp, Belfast Hlth & Social Care Trust, Northern Ireland Reg Genet Ctr, Lisburn Rd, Belfast BT9 7AB, Antrim, North Ireland; [van Gils, Julien; Bourgeron, Thomas] Univ Paris Diderot, Inst Pasteur, Human Genet & Cognit Funct, UMR3571,CNRS, F-75015 Paris, France; [Delorme, Richard] Robert Debre Hosp, AP HP, Child & Adolescent Psychiat Dept, Paris, France; [Cooper, Gregory M.; Finnila, Candice R.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Martinez, Jose E.; Carmant, Lionel] Childrens Rehabil Serv, Mobile, AL 36604 USA; [Lortie, Anne] Univ Montreal, Dept Neurol, Montreal, PQ, Canada; [Oegema, Renske; van Gassen, Koen; Lindhout, Dick] Univ Med Ctr Utrecht, Dept Genet, NL-3508 AB Utrecht, Netherlands; [Mehta, Sarju G.; Huhle, Dagmar] Addenbrookes Hosp, Dept Clin Genet, Cambridge CB2 0QQ, England; [Abou Jamra, Rami; Martin, Sonja] Univ Med Ctr Leipzig, Inst Human Genet, D-04103 Leipzig, Germany; [Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 GA Nijmegen, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6202 AZ Maastricht, Netherlands; [Lindhout, Dick] SEIN, Heemstede, Netherlands; [Au, Margaret; Graham, John M., Jr.] Cedars Sinai Med Ctr, Med Genet, Los Angeles, CA 90048 USA; [Coubes, Christine] CHU Montpellier, Ctr Reference Anomalies Dev & Syndromes Malformat, Dept Genet Med, Serv Genet Clin, F-34295 Montpellier 5, France	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of London; University College London; Yokohama City University; Asahikawa Medical College; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; Washington University (WUSTL); University of Groningen; University of Groningen; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Belfast City Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; HudsonAlpha Institute for Biotechnology; Universite de Montreal; Utrecht University; Utrecht University Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leipzig University; Radboud University Nijmegen; Maastricht University; Maastricht University; Cedars Sinai Medical Center; Universite de Montpellier; CHU de Montpellier	Ernst, C (corresponding author), McGill Univ, Douglas Hosp, Res Inst, Psychiat Genet Grp, Montreal, PQ H4H 1R3, Canada.; Campeau, PM (corresponding author), Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	carl.ernst@mcgill.ca; p.campeau@umontreal.ca	Oegema, Renske/AAA-4323-2020; Abou Jamra, Rami/AAC-8192-2019; Lindhout, Dick/AAH-5765-2019; Vockley, Jerry/AAF-8523-2020; Ehresmann, Sophie/AAZ-9168-2021; Fassi, Farida/F-3571-2016; Al-Hertani, Walla/S-8854-2019; Vockley, Jerry/B-5210-2016; Campeau, Philippe/J-8614-2015; Tanti, Arnaud/AAA-2394-2019; Houlden, Henry J/C-1532-2008; Salpietro, Vincenzo/AAA-8706-2020; Cooper, Gregory/D-6914-2011	Oegema, Renske/0000-0002-7146-617X; Abou Jamra, Rami/0000-0002-1542-1399; Vockley, Jerry/0000-0002-8180-6457; Ehresmann, Sophie/0000-0002-4171-7222; Fassi, Farida/0000-0002-6423-7213; Al-Hertani, Walla/0000-0001-8967-8640; Vockley, Jerry/0000-0002-8180-6457; Campeau, Philippe/0000-0001-9713-7107; Houlden, Henry J/0000-0002-2866-7777; Delorme, Richard/0000-0002-5614-3663; Rousseau, Justine/0000-0002-3554-2673; Au, Margaret/0000-0001-8528-0387; Efthymiou, Stephanie/0000-0003-4900-9877; Cooper, Gregory/0000-0001-5509-9923; Tanti, Arnaud/0000-0003-4249-2317; Turecki, Gustavo/0000-0003-4075-2736; Rossignol, Elsa/0000-0002-9304-9385	FRQS doctoral; Indonesian Endowment Fund for Education PhD award; CONACYT (Mexico); MITACS; Genome Canada; Genome Quebec; Canada Research Chairs program; AMED; MEXT; JST; MHLW; Takeda Science Foundation; CIHR grant; MRC [MR/S01165X/1] Funding Source: UKRI	FRQS doctoral; Indonesian Endowment Fund for Education PhD award; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MITACS; Genome Canada(Genome Canada); Genome Quebec; Canada Research Chairs program(Canada Research Chairs); AMED(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); MHLW(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); CIHR grant(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge funding by FRQS doctoral (S.B.); Indonesian Endowment Fund for Education PhD award (M.J.); CONACYT (Mexico) and MITACS (K.M.V.); Genome Canada and Genome Quebec (J.L.M. and E.R.);Canada Research Chairs program (G.T. and C.E.); AMED, MEXT, JST, MHLW, and Takeda Science Foundation (N. Matsumoto); and CIHR grant (C.E. and P.M.C.). We are grateful to Gerald Crabtree who provided a custom antibody to BAF53B. C.E. is grateful to family R3 who collaborated with his lab from mutation detection to human neuron modeling.	Aref-Eshghi E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07193-y; Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Bell S, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3188; Bell S, 2018, STEM CELL REP, V11, P183, DOI 10.1016/j.stemcr.2018.05.018; Bell S, 2017, STEM CELL TRANSL MED, V6, P886, DOI 10.1002/sctm.16-0158; Bender HA, 2011, J GENET PSYCHOL, V172, P56, DOI 10.1080/00221325.2010.506604; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Bogershausen N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00252; Boggs JM, 2010, FEBS LETT, V584, P1771, DOI 10.1016/j.febslet.2009.11.074; Chen ES, 2014, AM J HUM GENET, V95, P490, DOI 10.1016/j.ajhg.2014.09.013; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kaczmarek R, 2016, GLYCOCONJUGATE J, V33, P963, DOI 10.1007/s10719-016-9716-9; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Laeremans A, 2013, J EXP NEUROSCI, V7, P60, DOI 10.4137/JEN.S12453; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Mari F, 2015, BRAIN DEV-JPN, V37, P527, DOI 10.1016/j.braindev.2014.08.009; Meagher RB, 2007, TRENDS CELL BIOL, V17, P325, DOI 10.1016/j.tcb.2007.06.001; Mino RE, 2016, J CELL SCI, V129, P3282, DOI 10.1242/jcs.187294; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Pretegiani E, 2016, J NEUROL, V263, P1659, DOI 10.1007/s00415-016-8194-0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Santen GWE, 2012, EPIGENETICS-US, V7, P1219, DOI 10.4161/epi.22299; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; Sokpor G, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00243; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Staahl BT, 2013, CURR OPIN NEUROBIOL, V23, P903, DOI 10.1016/j.conb.2013.09.003; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vogel-Ciernia A, 2014, NEUROPHARMACOLOGY, V80, P18, DOI 10.1016/j.neuropharm.2013.10.002; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yoo M, 2017, J NEUROSCI, V37, P3686, DOI 10.1523/JNEUROSCI.3220-16.2017	43	45	47	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					815	834		10.1016/j.ajhg.2019.03.022	http://dx.doi.org/10.1016/j.ajhg.2019.03.022			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW3QV	31031012	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000466608700004
J	Lacroix, AJ; Stabley, D; Sahraoui, R; Adam, MP; Mehaffey, M; Kernan, K; Myers, CT; Fagerstrom, C; Anadiotis, G; Akkari, YM; Robbins, KM; Gripp, KW; Baratela, WA; Bober, MB; Duker, AL; Doherty, D; Dempsey, JC; Miller, DG; Kircher, M; Bamshad, MJ; Nickerson, DA; Mefford, HC; Sol-Church, K				Lacroix, Amy J.; Stabley, Deborah; Sahraoui, Rebecca; Adam, Margaret P.; Mehaffey, Michele; Kernan, Kelly; Myers, Candace T.; Fagerstrom, Carrie; Anadiotis, George; Akkari, Yassmine M.; Robbins, Katherine M.; Gripp, Karen W.; Baratela, Wagner Ar; Bober, Michael B.; Duker, Angela L.; Doherty, Dan; Dempsey, Jennifer C.; Miller, Daniel G.; Kircher, Martin; Bamshad, Michael J.; Nickerson, Deborah A.; Mefford, Heather C.; Sol-Church, Katia		Univ Washington Ctr Mendelian Geno	GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DESBUQUOIS DYSPLASIA; MUTATIONS; PREDISPOSE; DELETIONS; DISEASE; PATIENT; GENE	Baratela-Scott syndrome (BSS) is a rare, autosomal-recessive disorder characterized by short stature, facial dysmorphisms, developmental delay, and skeletal dysplasia caused by pathogenic variants in XYLT1. We report clinical and molecular investigation of 10 families (12 individuals) with BSS. Standard sequencing methods identified biallelic pathogenic variants in XYLT1 in only two families. Of the remaining cohort, two probands had no variants and six probands had only a single variant, including four with a heterozygous 3.1 Mb 16p13 deletion encompassing XYLT1 and two with a heterozygous truncating variant. Bisulfite sequencing revealed aberrant hypermethylation in exon 1 of XYLT1, always in trans with the sequence variant or deletion when present; both alleles were methylated in those with no identified variant. Expression of the methylated XYLT1 allele was severely reduced in fibroblasts from two probands. Southern blot studies combined with repeat expansion analysis of genome sequence data showed that the hypermethylation is associated with expansion of a GGC repeat in the XYLT1 promoter region that is not present in the reference genome, confirming that BSS is a trinucleotide repeat expansion disorder. The hypermethylated allele accounts for 50% of disease alleles in our cohort and is not present in 130 control subjects. Our study highlights the importance of investigating non-sequence-based alterations, including epigenetic changes, to identify the missing heritability in genetic disorders.	[Lacroix, Amy J.; Adam, Margaret P.; Mehaffey, Michele; Kernan, Kelly; Doherty, Dan; Dempsey, Jennifer C.; Miller, Daniel G.; Bamshad, Michael J.; Mefford, Heather C.] Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA; [Stabley, Deborah; Sahraoui, Rebecca; Robbins, Katherine M.; Gripp, Karen W.; Sol-Church, Katia] Alfred L duPont Hosp Children, Nemours Biomed Res Dept, Wilmington, DE 19803 USA; [Sahraoui, Rebecca] Univ Delaware, Biol Sci, Newark, DE 19716 USA; [Adam, Margaret P.; Doherty, Dan; Bamshad, Michael J.; Nickerson, Deborah A.; Mefford, Heather C.] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA; [Myers, Candace T.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Fagerstrom, Carrie; Anadiotis, George; Akkari, Yassmine M.] Legacy Hlth, Portland, OR 97227 USA; [Baratela, Wagner Ar; Bober, Michael B.; Duker, Angela L.] Alfred L duPont Hosp Children, Div Orthogenet, Wilmington, DE 19803 USA; [Baratela, Wagner Ar] Univ Sao Paulo, Dept Pediat, Inst Crianca, Sao Paulo, SP, Brazil; [Kircher, Martin; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sol-Church, Katia] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Washington; University of Washington Seattle; Nemours Alfred I. duPont Hospital for Children; University of Delaware; Seattle Children's Hospital; Legacy Health; Nemours Alfred I. duPont Hospital for Children; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Washington; University of Washington Seattle; University of Virginia	Mefford, HC (corresponding author), Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA.; Sol-Church, K (corresponding author), Alfred L duPont Hosp Children, Nemours Biomed Res Dept, Wilmington, DE 19803 USA.; Mefford, HC (corresponding author), Brotman Baty Inst Precis Med, Seattle, WA 98195 USA.; Sol-Church, K (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	hmefford@uw.edu; ks5uq@virginia.edu	Kircher, Martin/HDL-9392-2022; Bober, Michael/AAH-4553-2021; Kircher, Martin/H-6909-2019	Kircher, Martin/0000-0001-9278-5471; Stabley, Deborah/0000-0002-4936-0854; Robbins, Katherine/0000-0002-3003-0193; Bober, Michael/0000-0002-6178-1264; Blue, Elizabeth/0000-0002-0633-0305	National Institute of General Medical Sciences of the National Institutes of Health [P30GM114736, P20GM103446]; Nemours Genetics Cluster funding (A. I. duPont Hospital for Children, Wilmington, DE, USA); NIH IDeA program; NHLBI [UM1 HG006493, U24 HG008956]; NHGRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U24HG008956, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114736, P20GM103446] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nemours Genetics Cluster funding (A. I. duPont Hospital for Children, Wilmington, DE, USA); NIH IDeA program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported by K.S.-C. in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under grants P30GM114736 and P20GM103446. This work was also supported by Nemours Genetics Cluster funding (A. I. duPont Hospital for Children, Wilmington, DE, USA) and by the NIH IDeA program. Exome sequencing was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by NHGRI and NHLBI grants UM1 HG006493 and U24 HG008956. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Genome library preparation was conducted by Molly Weaver at the University of Washington Center for Precision Diagnostics. We thank the patients and families for their participation.	Al-Jezawi NK, 2017, AM J MED GENET A, V173, P1773, DOI 10.1002/ajmg.a.38244; Baratela WAR, 2012, AM J MED GENET A, V158A, P1815, DOI 10.1002/ajmg.a.35445; Brisson D, 2002, CLIN GENET, V62, P220, DOI 10.1034/j.1399-0004.2002.620306.x; Bui C, 2014, AM J HUM GENET, V94, P405, DOI 10.1016/j.ajhg.2014.01.020; Dashnow H, 2018, DETECTING TANDEM REP, V19, P121, DOI DOI 10.1186/; Ehtesham N, 2002, AM J HUM GENET, V71, P947, DOI 10.1086/342669; Faust I, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0129-0; Favaro FP, 2014, AM J HUM GENET, V94, P120, DOI 10.1016/j.ajhg.2013.11.020; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Guo L, 2017, J HUM GENET, V62, P447, DOI 10.1038/jhg.2016.143; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; Hauer NN, 2018, GENET MED, V20, P630, DOI 10.1038/gim.2017.159; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Jamsheer A, 2016, J HUM GENET, V61, P577, DOI 10.1038/jhg.2016.30; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lalioti MD, 1999, HUM MOL GENET, V8, P1791, DOI 10.1093/hmg/8.9.1791; NANCARROW JK, 1995, HUM MOL GENET, V4, P367, DOI 10.1093/hmg/4.3.367; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; Prydz K, 2000, J CELL SCI, V113, P193; Schreml J, 2014, HUM GENET, V133, P29, DOI 10.1007/s00439-013-1351-y; Silveira C, 2016, AM J MED GENET A, V170, P3043, DOI 10.1002/ajmg.a.37858; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; van Koningsbruggen S, 2016, AM J MED GENET A, V170, P510, DOI 10.1002/ajmg.a.37453; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	26	45	45	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					35	44		10.1016/j.ajhg.2018.11.005	http://dx.doi.org/10.1016/j.ajhg.2018.11.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30554721	Green Published, Bronze			2022-12-18	WOS:000454775500006
J	Freund, MK; Burch, KS; Shi, HWB; Mancuso, N; Kichaev, G; Garske, KM; Pan, DZ; Miao, Z; Mohlke, KL; Laakso, M; Pajukanta, P; Pasaniuc, B; Arboleda, VA				Freund, Malika Kumar; Burch, Kathryn S.; Shi, Huwenbo; Mancuso, Nicholas; Kichaev, Gleb; Garske, Kristina M.; Pan, David Z.; Miao, Zong; Mohlke, Karen L.; Laakso, Markku; Pajukanta, Paivi; Pasaniuc, Bogdan; Arboleda, Valerie A.			Phenotype-Specific Enrichment of Mendelian Disorder Genes near GWAS Regions across 62 Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON VARIANTS; SUSCEPTIBILITY LOCI; MACULAR DEGENERATION; CYSTIC-FIBROSIS; HUMAN HEIGHT; EDUCATIONAL-ATTAINMENT; DISEASE; RISK	Although recent studies provide evidence for a common genetic basis between complex traits and Mendelian disorders, a thorough quantification of their overlap in a phenotype-specific manner remains elusive. Here, we have quantified the overlap of genes identified through large-scale genome-wide association studies (GWASs) for 62 complex traits and diseases with genes containing mutations known to cause 20 broad categories of Mendelian disorders. We identified a significant enrichment of genes linked to phenotypically matched Mendelian disorders in GWAS gene sets; of the total 1,240 comparisons, a higher proportion of phenotypically matched or related pairs (n = 50 of 92 [54%]) than phenotypically unmatched pairs (n = 27 of 1,148 [2%]) demonstrated significant overlap, confirming a phenotype-specific enrichment pattern. Further, we observed elevated GWAS effect sizes near genes linked to phenotypically matched Mendelian disorders. Finally, we report examples of GWAS variants localized at the transcription start site or physically interacting with the promoters of genes linked to phenotypically matched Mendelian disorders. Our results are consistent with the hypothesis that genes that are disrupted in Mendelian disorders are dysregulated by non-coding variants in complex traits and demonstrate how leveraging findings from related Mendelian disorders and functional genomic datasets can prioritize genes that are putatively dysregulated by local and distal non-coding GWAS variants.	[Freund, Malika Kumar; Garske, Kristina M.; Miao, Zong; Pajukanta, Paivi; Pasaniuc, Bogdan; Arboleda, Valerie A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Burch, Kathryn S.; Shi, Huwenbo; Kichaev, Gleb; Pan, David Z.; Miao, Zong; Pajukanta, Paivi; Pasaniuc, Bogdan; Arboleda, Valerie A.] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA; [Mancuso, Nicholas; Pasaniuc, Bogdan; Arboleda, Valerie A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio 70210, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Computat Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Freund, MK; Arboleda, VA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Arboleda, VA (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA.; Arboleda, VA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kumarm@ucla.edu; varboleda@mednet.ucla.edu	Mancuso, Nicholas/GLQ-8627-2022; Arboleda, Valerie/C-9608-2011	Pan, David Z./0000-0002-5705-2501; Mancuso, Nicholas/0000-0002-9352-5927; Arboleda, Valerie/0000-0002-9687-9122	National Institutes of Health (NIH) [T32HG002536]; NIH [DP5OD024579, R01HG009120, R01MH115676, R01HG006399, U01CA194393, F31HL142180, HL-095056, HL-28481]; NIH National Institute of Mental Health [T32MH073526]; NIH National Cancer Institute [T32LM012424]; NATIONAL CANCER INSTITUTE [U01CA194393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095056, F31HL142180, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536, R01HG006399, R01HG009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093757, F31DK118865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH115676, T32MH073526] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012424] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD024579] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Ruth Johnson, Megan Major, Megan Roytman, Claudia Giambartolomei, Arunabha Majumdar, Jazlyn Mooney, Brendan Freund, Robert Brown, Tommer Schwarz, and Robert Smith for helpful discussions. This work was funded by National Institutes of Health (NIH) Training Grant in Genomic Analysis and Interpretation T32HG002536 to M.K.F.; NIH Early Independence Award DP5OD024579 to V.A.A.; NIH awards R01HG009120, R01MH115676, R01HG006399, and U01CA194393 to B.P.; NIH National Institute of Mental Health grant T32MH073526 to K.S.B.; NIH grant F31HL142180 to K.M.G.; NIH National Cancer Institute grant T32LM012424 to D.Z.P.; and NIH grants HL-095056 and HL-28481 to P.P. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amininejad L, 2018, GASTROENTEROLOGY, V154, P2165, DOI 10.1053/j.gastro.2018.02.028; Arboleda VA, 2012, NAT GENET, V44, P788, DOI 10.1038/ng.2275; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Autism Spectrum Disorder Working Group of the Psychiatry Genomics Consortium, 2015, DAT PGC ASD SUMM STA; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Born HA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08825-x; Brunham LR, 2006, ANNU REV NUTR, V26, P105, DOI 10.1146/annurev.nutr.26.061505.111214; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chan YL, 2015, AM J HUM GENET, V96, P695, DOI 10.1016/j.ajhg.2015.02.018; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Dron JS, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0667-9; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gerich ME, 2014, NAT REV GASTRO HEPAT, V11, P287, DOI 10.1038/nrgastro.2013.242; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Goudie DR, 2011, NAT GENET, V43, P365, DOI 10.1038/ng.780; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hegele RA, 2018, J AM COLL CARDIOL, V71, P289, DOI 10.1016/j.jacc.2017.09.1158; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Henriksen MG, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00322; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Kanoni S, 2016, HUM MOL GENET, V25, P4094, DOI 10.1093/hmg/ddw227; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Kilpelainen TO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10494; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lim ET, 2014, AM J HUM GENET, V95, P509, DOI 10.1016/j.ajhg.2014.09.015; Lin A, 2017, J NEUROSCI, V37, P6183, DOI 10.1523/JNEUROSCI.3759-16.2017; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Moss DJH, 2017, LANCET NEUROL, V16, P701, DOI 10.1016/S1474-4422(17)30161-8; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Pan DZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03554-9; Pardoll DM, 2012, NAT IMMUNOL, V13, P1129, DOI 10.1038/ni.2392; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767; Reuter CM, 2018, J PEDIATR-US, V196, P291, DOI 10.1016/j.jpeds.2017.12.029; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosenson RS, 2018, NAT REV CARDIOL, V15, P9, DOI 10.1038/nrcardio.2017.115; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sztainberg Y, 2016, NAT NEUROSCI, V19, P1408, DOI 10.1038/nn.4420; Teumer A, 2016, DIABETES, V65, P803, DOI 10.2337/db15-1313; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai CW, 2015, J CLIN ENDOCR METAB, V100, pE345, DOI 10.1210/jc.2014-3340; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wheeler HE, 2017, CLIN CANCER RES, V23, P3325, DOI 10.1158/1078-0432.CCR-16-2809; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/nmeth.3484, 10.1038/NMETH.3484]; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	99	45	45	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					535	552		10.1016/j.ajhg.2018.08.017	http://dx.doi.org/10.1016/j.ajhg.2018.08.017			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30290150	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000446312200007
J	Song, JHT; Lowe, CB; Kingsley, DM				Song, Janet H. T.; Lowe, Craig B.; Kingsley, David M.			Characterization of a Human-Specific Tandem Repeat Associated with Bipolar Disorder and Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PSYCHIATRIC-DISORDERS; HEXANUCLEOTIDE REPEAT; CALCIUM-CHANNELS; RAN TRANSLATION; GENOME SEQUENCE; RISK LOCI; CACNA1C; GENE; EXPRESSION; SUSCEPTIBILITY	Bipolar disorder (BD) and schizophrenia (SCZ) are highly heritable diseases that affect more than 3% of individuals worldwide. Genomewide association studies have strongly and repeatedly linked risk for both of these neuropsychiatric diseases to a 100 kb interval in the third intron of the human calcium channel gene CACNA1C. However, the causative mutation is not yet known. We have identified a human-specific tandem repeat in this region that is composed of 30 bp units, often repeated hundreds of times. This large tandem repeat is unstable using standard polymerase chain reaction and bacterial cloning techniques, which may have resulted in its incorrect size in the human reference genome. The large 30-mer repeat region is polymorphic in both size and sequence in human populations. Particular sequence variants of the 30-mer are associated with risk status at several flanking single-nucleotide polymorphisms in the third intron of CACNA1C that have previously been linked to BD and SCZ. The tandem repeat arrays function as enhancers that increase reporter gene expression in a human neural progenitor cell line. Different human arrays vary in the magnitude of enhancer activity, and the 30-mer arrays associated with increased psychiatric disease risk status have decreased enhancer activity. Changes in the structure and sequence of these arrays likely contribute to changes in CACNA1C function during human evolution and may modulate neuropsychiatric disease risk in modern human populations.	[Song, Janet H. T.; Lowe, Craig B.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Song, Janet H. T.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lowe, Craig B.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.; Kingsley, DM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kingsley@stanford.edu		Song, Janet/0000-0002-7898-0227	NIDCR of the National Institutes of Health [K25DE025316]; National Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K25DE025316] Funding Source: NIH RePORTER	NIDCR of the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We wish to thank members of the Kingsley Lab for useful discussions and comments on the manuscript. Research reported in this publication was supported in part by the NIDCR of the National Institutes of Health (K25DE025316 to C.B.L.), and by a National Science Foundation Graduate Research Fellowship and a Stanford Graduate Fellowship (J.H.T.S.). D.M.K. is an Investigator of the Howard Hughes Medical Institute. DNA or tissue samples were obtained through the NIH Neurobiobank from the Human Brain and Spinal Fluid Resource Center (VA West Los Angeles Healthcare Center), the University of Maryland Brain and Tissue Bank, the Harvard Brain Tissue Resource Center, the University of Miami Brain Endowment Bank, the Mt. Sinai Brain Bank, and the Brain Tissue Donation Program at the University of Pittsburgh. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ament SA, 2015, P NATL ACAD SCI USA, V112, P3576, DOI 10.1073/pnas.1424958112; Andrade A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34233; Baldessarini RJ, 2006, CNS SPECTRUMS, V11, P465, DOI 10.1017/S1092852900014681; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Dao DT, 2010, BIOL PSYCHIAT, V68, P801, DOI 10.1016/j.biopsych.2010.06.019; Dedic N, 2018, MOL PSYCHIATR, V23, P533, DOI 10.1038/mp.2017.133; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Eckart N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157086; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Forstner AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171595; Gardiner SL, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.116; Gardiner SL, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0042-1; Gershon ES, 2014, MOL PSYCHIATR, V19, P890, DOI 10.1038/mp.2013.107; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; He KJ, 2014, BRIT J PSYCHIAT, V204, P36, DOI 10.1192/bjp.bp.113.126979; Hollister LE, 1999, CAN J PSYCHIAT, V44, P658, DOI 10.1177/070674379904400702; Hori H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00634; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Kronenberg ZN, 2018, SCIENCE, V360, P1085, DOI 10.1126/science.aar6343; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landefeld CC, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0120-z; Lee AS, 2012, MOL PSYCHIATR, V17, P1054, DOI [10.1038/mp.2012.71, 10.1038/mp.2012.149]; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131820; Lieberman D., 2013, STORY HUMAN BODY EVO; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Nie FY, 2015, AM J MED GENET B, V168, P637, DOI 10.1002/ajmg.b.32348; Nithianantharajah J, 2007, BIOESSAYS, V29, P525, DOI 10.1002/bies.20589; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Pennisi E, 2012, SCIENCE, V336, P974, DOI 10.1126/science.336.6084.974; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Srinivasan S, 2016, BIOL PSYCHIAT, V80, P284, DOI 10.1016/j.biopsych.2015.10.009; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143; Zamponi GW, 2016, NAT REV DRUG DISCOV, V15, P19, DOI 10.1038/nrd.2015.5; Zhang QM, 2012, NEUROPSYCHOPHARMACOL, V37, P677, DOI 10.1038/npp.2011.242; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	77	45	45	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					421	430		10.1016/j.ajhg.2018.07.011	http://dx.doi.org/10.1016/j.ajhg.2018.07.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30100087	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000443819500011
J	Vogtle, FN; Brandl, B; Larson, A; Pendziwiat, M; Friederich, MW; White, SM; Basinger, A; Kucukkose, C; Muhle, H; Jahn, JA; Keminer, O; Helbig, KL; Delto, CF; Myketin, L; Mossmann, D; Burger, N; Miyake, N; Burnett, A; van Baalen, A; Lovell, MA; Matsumoto, N; Walsh, M; Yu, HC; Shinde, DN; Stephani, U; Van Hove, JLK; Muller, FJ; Helbig, I				Voegtle, F. -Nora; Braendl, Bjorn; Larson, Austin; Pendziwiat, Manuela; Friederich, Marisa W.; White, Susan M.; Basinger, Alice; Kuecuekkoese, Cansu; Muhle, Hiltrud; Jaehn, Johanna A.; Keminer, Oliver; Helbig, Katherine L.; Delto, Carolyn F.; Myketin, Lisa; Mossmann, Dirk; Burger, Nils; Miyake, Noriko; Burnett, Audrey; van Baalen, Andreas; Lovell, Mark A.; Matsumoto, Naomichi; Walsh, Maie; Yu, Hung-Chun; Shinde, Deepali N.; Stephani, Ulrich; Van Hove, Johan L. K.; Mueller, Franz-Josef; Helbig, Ingo			Mutations in PMPCB Encoding the Catalytic Subunit of the Mitochondrial Presequence Protease Cause Neurodegeneration in Early Childhood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SULFUR CLUSTER BIOGENESIS; PLURIPOTENT STEM-CELLS; FE-S CLUSTER; PROCESSING PEPTIDASE; EPILEPTIC ENCEPHALOPATHY; HUMAN ES; DISEASE; COMPLEX; IMPORT; GENE	Mitochondrial disorders causing neurodegeneration in childhood are genetically heterogeneous, and the underlying genetic etiology remains unknown in many affected individuals. We identified biallelic variants in PMPCB in individuals of four families including one family with two affected siblings with neurodegeneration and cerebellar atrophy. PMPCB encodes the catalytic subunit of the essential mitochondrial processing protease (MPP), which is required for maturation of the majority of mitochondrial precursor proteins. Mitochondria isolated from two fibroblast cell lines and induced pluripotent stem cells derived from one affected individual and differentiated neuroepithelial stem cells showed reduced PMPCB levels and accumulation of the processing intermediate of frataxin, a sensitive substrate for MPP dysfunction. Introduction of the identified PMPCB variants into the homologous S. cerevisiae Mas1 protein resulted in a severe growth and MPP processing defect leading to the accumulation of mitochondrial precursor proteins and early impairment of the biogenesis of iron-sulfur clusters, which are indispensable for a broad range of crucial cellular functions. Analysis of biopsy materials of an affected individual revealed changes and decreased activity in iron-sulfur cluster-containing respiratory chain complexes and dysfunction of mitochondrial and cytosolic Fe-S cluster-dependent enzymes. We conclude that biallelic mutations in PMPCB cause defects in MPP proteolytic activity leading to dysregulation of iron-sulfur cluster biogenesis and triggering a complex neurological phenotype of neurodegeneration in early childhood.	[Voegtle, F. -Nora; Myketin, Lisa; Mossmann, Dirk] Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Braendl, Bjorn; Mueller, Franz-Josef] Univ Hosp Schleswig Holstein, Dept Psychiat & Psychotherapy, D-24105 Kiel, Germany; [Larson, Austin; Friederich, Marisa W.; Yu, Hung-Chun; Van Hove, Johan L. K.] Univ Colorado, Dept Pediat, Sect Clin Genet & Metab, Aurora, CO 80045 USA; [Pendziwiat, Manuela; Muhle, Hiltrud; Jaehn, Johanna A.; van Baalen, Andreas; Stephani, Ulrich; Helbig, Ingo] Christian Albrechts Univ Kiel, Dept Neuropediat, D-24105 Kiel, Germany; [White, Susan M.] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [White, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Basinger, Alice; Burnett, Audrey] Cook Childrens Phys Network, Dept Genet, Ft Worth, TX 76102 USA; [Kuecuekkoese, Cansu] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Keminer, Oliver] Fraunhofer Inst Mol Biol & Angew Okol IME, ScreeningPort, D-22525 Hamburg, Germany; [Helbig, Katherine L.; Helbig, Ingo] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Delto, Carolyn F.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Lovell, Mark A.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Walsh, Maie] Royal Melbourne Hosp, Adult Genet Med, Parkville, Vic 3052, Australia; [Shinde, Deepali N.] Ambry Genet, Div Clin Genom, Aliso Viejo, CA 92656 USA; [Mueller, Franz-Josef] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Yu, Hung-Chun] Human Longev Inc, San Diego, CA 92121 USA	University of Freiburg; University of Kiel; Schleswig Holstein University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Kiel; Murdoch Children's Research Institute; University of Melbourne; Cook Children's Medical Center; University of Freiburg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Wurzburg; Yokohama City University; University of Colorado System; University of Colorado Anschutz Medical Campus; Royal Melbourne Hospital; Max Planck Society	Vogtle, FN (corresponding author), Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.; Helbig, I (corresponding author), Christian Albrechts Univ Kiel, Dept Neuropediat, D-24105 Kiel, Germany.; Helbig, I (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	nora.voegtle@biochemie.uni-freiburg.de; helbigi@email.chop.edu	Larson, Austin/AAN-8673-2021; Müller, Franz-Josef/E-3336-2010; Vögtle, F.-Nora/T-4290-2017; Helbig, Ingo/G-8467-2018; Larson, Austin/GZG-9853-2022; Muhle, Hiltrud/F-5715-2010; Helbig, Katherine/B-7454-2012	Larson, Austin/0000-0002-2079-6929; Müller, Franz-Josef/0000-0001-9478-8430; Vögtle, F.-Nora/0000-0002-5062-3287; Helbig, Ingo/0000-0001-8486-0558; Burger, Nils/0000-0003-3227-8894; Helbig, Katherine/0000-0001-8249-0549; Yu, Hung-Chun/0000-0002-4980-8508	University of Kiel; German Research Foundation within EuroEPINOMICS framework of the European Science Foundation [HE5415/3-1]; German Research Foundation (DFG) [HE5415/5-1, HE5415/6-1]; BMBF [13GW0128A, 01GM1513D]; Deutsche Forschungsgemeinschaft (DFG) [MU3231/3-1]; Excellence Initiative of the German Federal & State Governments Schleswig-Holstein Cluster of Excellence [EXC 306]; Emmy Noether-Programm of the Deutsche Forschungsgemeinschaft; grant for Research on Measures for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science; Miracles for Mito; Children's Hospital Colorado Foundation; Summits for Samantha; Grants-in-Aid for Scientific Research [16H05357] Funding Source: KAKEN	University of Kiel; German Research Foundation within EuroEPINOMICS framework of the European Science Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Initiative of the German Federal & State Governments Schleswig-Holstein Cluster of Excellence; Emmy Noether-Programm of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); grant for Research on Measures for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Miracles for Mito; Children's Hospital Colorado Foundation; Summits for Samantha; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank all affected individuals and their family members for their participation in this study. Furthermore, we would like to thank Dr. Almuth Caliebe for her clinical care of one of the affected families. We thank Dr. Chris Meisinger for discussion, Dr. Elizabeth Craig for Jac1 antiserum, and Corina Mitchell and Jon Roberts for pathology work. The current study has been supported by the EuroEPINOMICS-Rare Epilepsy Syndrome (RES) consortium which provided capacity for exome sequencing. This work was supported by intramural funds of the University of Kiel (I.H.), the German Research Foundation (HE5415/3-1 to I.H.) within the EuroEPINOMICS framework of the European Science Foundation, the German Research Foundation (DFG, HE5415/5-1, HE5415/6-1 to I.H.), the BMBF (13GW0128A and 01GM1513D) (to B.B. and F.-J.M.), the Deutsche Forschungsgemeinschaft (DFG, MU3231/3-1 to F.-J.M.), the Excellence Initiative of the German Federal & State Governments Schleswig-Holstein Cluster of Excellence (EXC 306 Inflammation at Interfaces), the Emmy Noether-Programm of the Deutsche Forschungsgemeinschaft (to F.-N.V.), a grant for Research on Measures for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (to N. Matsumoto), and Grants-in-Aid for Scientific Research (A and B) from the Japan Society for the Promotion of Science (to N. Miyake and N. Matsuomto). This work also received financial support from Miracles for Mito, Summits for Samantha, and the Children's Hospital Colorado Foundation (J.L.K.V.H., A.L., and M.W.F.). Work included in this study has also been performed in partial fulfillment of the requirements for the doctoral thesis of C.K. In addition, D.N.S. is a full-time employee of Ambry Genetics. Exome sequencing is one of Ambry's commercially available tests.	Ahting U, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00123; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bhutani K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10536; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005; Choquet K, 2016, BRAIN, V139, DOI 10.1093/brain/awv362; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049; Debray FG, 2015, J INHERIT METAB DIS, V38, P1147, DOI 10.1007/s10545-015-9857-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farhan SMK, 2014, MOL GENET GENOM MED, V2, P73, DOI 10.1002/mgg3.46; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; Friederich MW, 2017, HUM MOL GENET, V26, P702, DOI 10.1093/hmg/ddw431; Fujita A, 2016, J HUM GENET, V61, P835, DOI 10.1038/jhg.2016.54; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Haack TB, 2013, J INHERIT METAB DIS, V36, P55, DOI 10.1007/s10545-012-9489-7; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; Jobling RK, 2015, BRAIN, V138, P1505, DOI 10.1093/brain/awv057; Joshi M, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000786; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kucera T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074518; Lebigot E, 2017, MOL GENET METAB, V122, P85, DOI 10.1016/j.ymgme.2017.08.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Marti M, 2013, NAT PROTOC, V8, P223, DOI 10.1038/nprot.2012.154; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Miyake N, 2015, AM J HUM GENET, V97, P555, DOI 10.1016/j.ajhg.2015.08.013; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; Mossmann D, 2014, CELL METAB, V20, P662, DOI 10.1016/j.cmet.2014.07.024; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Muthuswamy S, 2015, NEUROLOGIST, V20, P51, DOI 10.1097/NRL.0000000000000054; Nizon M, 2014, MITOCHONDRION, V15, P59, DOI 10.1016/j.mito.2014.01.003; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Poveda-Huertes D, 2017, CELL TISSUE RES, V367, P73, DOI 10.1007/s00441-016-2492-9; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Steinbeck JA, 2012, CELL MOL LIFE SCI, V69, P461, DOI 10.1007/s00018-011-0759-6; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Surkhart JM, 2015, J PROTEOME RES, V14, P4550, DOI 10.1021/acs.jproteome.5b00327; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105	72	45	47	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					557	573		10.1016/j.ajhg.2018.02.014	http://dx.doi.org/10.1016/j.ajhg.2018.02.014			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29576218	Bronze, Green Published			2022-12-18	WOS:000429340800005
J	Hauberg, ME; Zhang, W; Giambartolomei, C; Franzen, O; Morris, DL; Vyse, TJ; Ruusalepp, A; Sklar, P; Schadt, EE; Bjorkegren, JLM; Roussos, P				Hauberg, Mads Engel; Zhang, Wen; Giambartolomei, Claudia; Franzen, Oscar; Morris, David L.; Vyse, Timothy J.; Ruusalepp, Arno; Sklar, Pamela; Schadt, Eric E.; Bjorkegren, Johan L. M.; Roussos, Panos		CommonMind Consortium	Large-Scale Identification of Common Trait and Disease Variants Affecting Gene Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYGENIC RISK; SCHIZOPHRENIA; ASSOCIATION; GWAS; TARGETS; LOCI; EQTL	Genome-wide association studies (GWASs) have identified a multitude of genetic loci involved with traits and diseases. However, it is often unclear which genes are affected in such loci and whether the associated genetic variants lead to increased or decreased gene function. To mitigate this, we integrated associations of common genetic variants in 57 GWASs with 24 studies of expression quantitative trait loci (eQTLs) from a broad range of tissues by using a Mendelian randomization approach. We discovered a total of 3,484 instances of gene-trait-associated changes in expression at a false-discovery rate < 0.05. These genes were often not closest to the genetic variant and were primarily identified in eQTLs derived from pathophysiologically relevant tissues. For instance, genes with expression changes associated with lipid traits were mostly identified in the liver, and those associated with cardiovascular disease were identified in arterial tissue. The affected genes additionally point to biological processes implicated in the interrogated traits, such as the interleukin-27 pathway in rheumatoid arthritis. Further, comparing trait-associated gene expression changes across traits suggests that pleiotropy is a widespread phenomenon and points to specific instances of both agonistic and antagonistic pleiotropy. For instance, expression of SNX19 and ABCB9 is positively correlated with both the risk of schizophrenia and educational attainment. To facilitate interpretation, we provide this lexicon of how common trait-associated genetic variants alter gene expression in various tissues as the online database GWAS2Genes.	[Hauberg, Mads Engel; Zhang, Wen; Giambartolomei, Claudia; Sklar, Pamela; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Hauberg, Mads Engel; Zhang, Wen; Giambartolomei, Claudia; Sklar, Pamela; Roussos, Panos] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hauberg, Mads Engel] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Hauberg, Mads Engel] Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Aarhus, Denmark; [Hauberg, Mads Engel] Aarhus Univ, Ctr Integrat Sequencing, DK-8000 Aarhus, Denmark; [Franzen, Oscar; Sklar, Pamela; Schadt, Eric E.; Bjorkegren, Johan L. M.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Franzen, Oscar; Sklar, Pamela; Schadt, Eric E.; Bjorkegren, Johan L. M.; Roussos, Panos] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Morris, David L.; Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London SE1 1UL, England; [Ruusalepp, Arno; Bjorkegren, Johan L. M.] Clin Gene Networks AB, S-11444 Stockholm, Sweden; [Ruusalepp, Arno] Univ Tartu, Dept Pathophysiol, Inst Biomed & Translat Med, EE-50411 Tartu, Estonia; [Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, EE-50411 Tartu, Estonia; [Bjorkegren, Johan L. M.] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Bjorkegren, Johan L. M.] Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, EE-50411 Tartu, Estonia; [Roussos, Panos] James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr, New York, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of London; King's College London; University of London; King's College London; University of Tartu; Karolinska Institutet; University of Tartu; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Hauberg, ME; Roussos, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Hauberg, ME; Roussos, P (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Hauberg, ME (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark.; Hauberg, ME (corresponding author), Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Aarhus, Denmark.; Hauberg, ME (corresponding author), Aarhus Univ, Ctr Integrat Sequencing, DK-8000 Aarhus, Denmark.; Roussos, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Roussos, P (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Roussos, P (corresponding author), James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr, New York, NY 10468 USA.	hauberg@biomed.au.dk; panagiotis.roussos@mssm.edu	Zhang, Wen/I-7086-2018; Domenici, Enrico/K-8194-2016	Zhang, Wen/0000-0001-7370-4306; Domenici, Enrico/0000-0001-7436-6919; Morris, David/0000-0002-1754-8932; Ruusalepp, Arno/0000-0001-5816-8613; Johnson, Jessica/0000-0002-4519-3120; Dang, Kristen/0000-0002-7512-4476; Hauberg, Mads Engel/0000-0003-4873-2764; Buxbaum, Joseph/0000-0001-8898-8313; Perumal, Thanneer Malai/0000-0003-1168-8982	CGN; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	CGN; Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	J.L.M.B. is the founder and chair of Clinical Gene Networks AB (CGN). J.L.M.B., E.E.S., and A.R. are on the board of directors for CGN. J.L.M.B. and A.R. own equity in CGN and receive financial compensation from CGN.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Carter AJR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-160; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Franzen O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Fullard JF, 2017, HUM MOL GENET, V26, P1942, DOI 10.1093/hmg/ddx103; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Insolera R, 2014, NEURON, V83, P805, DOI 10.1016/j.neuron.2014.06.029; KAPLAN E, 1968, NEW ENGL J MED, V279, P65, DOI 10.1056/NEJM196807112790203; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pavlides JMW, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0338-4; Pearlson GD, 2008, SCHIZOPHRENIA BULL, V34, P722, DOI 10.1093/schbul/sbm130; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	34	45	45	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					885	894		10.1016/j.ajhg.2017.04.016	http://dx.doi.org/10.1016/j.ajhg.2017.04.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28552197	Bronze, Green Published			2022-12-18	WOS:000402700600005
J	Brynedal, B; Choi, J; Raj, T; Bjornson, R; Stranger, BE; Neale, BM; Voight, BF; Cotsapas, C				Brynedal, Boel; Choi, JinMyung; Raj, Towfique; Bjornson, Robert; Stranger, Barbara E.; Neale, Benjamin M.; Voight, Benjamin F.; Cotsapas, Chris			Large-Scale trans-eQTLs Affect Hundreds of Transcripts and Mediate Patterns of Transcriptional Co-regulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; REGULATORY VARIATION; IDENTIFICATION; DECOMPOSITION; ARCHITECTURE; BIOLOGY; TISSUES; CIS	Efforts to decipher the causal relationships between differences in gene regulation and corresponding differences in phenotype have been stymied by several basic technical challenges. Although detecting local, cis-eQTLs is now routine, trans-eQTLs, which are distant from the genes of origin, are far more difficult to find because millions of SNPs must currently be compared to thousands of transcripts. Here, we demonstrate an alternative approach: we looked for SNPs associated with the expression of many genes simultaneously and found that hundreds of trans-eQTLs each affect hundreds of transcripts in lymphoblastoid cell lines across three African populations. These trans-eQTLs target the same genes across the three populations and show the same direction of effect. We discovered that target transcripts of a high-confidence set of trans-eQTLs encode proteins that interact more frequently than expected by chance, are bound by the same transcription factors, and are enriched for pathway annotations indicative of roles in basic cell homeostasis. We thus demonstrate that our approach can uncover trans-acting transcriptional control circuits that affect co-regulated groups of genes: a key to understanding how cellular pathways and processes are orchestrated.	[Brynedal, Boel; Choi, JinMyung; Cotsapas, Chris] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Brynedal, Boel; Raj, Towfique; Neale, Benjamin M.; Cotsapas, Chris] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raj, Towfique] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Raj, Towfique] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Raj, Towfique; Neale, Benjamin M.] Harvard Med Sch, Boston, MA 02115 USA; [Bjornson, Robert] Yale Univ, Dept Comp Sci, New Haven, CT 06510 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Brynedal, Boel] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Raj, Towfique] Mt Sinai Hosp, Icahn Sch Med, Dept Neurosci, New York, NY 10029 USA; [Raj, Towfique] Mt Sinai Hosp, Icahn Sch Med, Dept Genet & Genome Sci, New York, NY 10029 USA	Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; University of Chicago; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Yale University; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cotsapas, C (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA.; Cotsapas, C (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Cotsapas, C (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.	cotsapas@broadinstitute.org	Raj, Towfique/ABD-7620-2021	Voight, Benjamin/0000-0002-6205-9994; Cotsapas, Chris/0000-0002-7772-5910; Brynedal, Boel/0000-0002-7872-2981	NIH [RR19895, RR029676-01]; Swedish Research Council [524-2012-6881]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895, S10RR029676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Computing resources at Yale were funded partly by NIH grants RR19895 and RR029676-01. B.B. was supported by a post-doctoral fellowship from the Swedish Research Council (grant 524-2012-6881).	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; [Anonymous], 1997, MODERN APPL STAT S P, DOI DOI 10.1007/978-1-4757-2719-7; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Cheng C, 2011, BIOINFORMATICS, V27, P3221, DOI 10.1093/bioinformatics/btr552; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Choi J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006121; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Donoho D, 2004, ANN STAT, V32, P962, DOI 10.1214/009053604000000265; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hore V, 2016, NAT GENET, V48, P1094, DOI 10.1038/ng.3624; KALINKA AT, 2013, ARXIV13050717; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Team T. R. C. D, 2014, R LANG ENV STAT COMP; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Williams RBH, 2006, NAT GENET, V38, P855, DOI 10.1038/ng0806-855; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	48	45	45	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					581	591		10.1016/j.ajhg.2017.02.004	http://dx.doi.org/10.1016/j.ajhg.2017.02.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28285767	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000398389600002
J	Ghoussaini, M; French, JD; Michailidou, K; Nord, S; Beesley, J; Canisus, S; Hillman, KM; Kaufmann, S; Sivakumaran, H; Marjaneh, MM; Lee, JS; Dennis, J; Bolla, MK; Wang, Q; Dicks, E; Milne, RL; Hopper, JL; Southey, MC; Schmidt, MK; Broeks, A; Muir, K; Lophatananon, A; Fasching, PA; Beckmann, MW; Fletcher, O; Johnson, N; Sawyer, EJ; Tomlinson, I; Burwinkel, B; Marme, F; Guenel, P; Truong, T; Bojesen, SE; Flyger, H; Benitez, J; Gonzalez-Neira, A; Alonso, R; Pita, G; Neuhausen, SL; Anton-Culver, H; Brenner, H; Arndt, V; Meindl, A; Schmutzler, RK; Brauch, H; Hamann, U; Tessier, DC; Vincent, D; Nevanlinna, H; Khan, S; Matsuo, K; Ito, H; Dork, T; Bogdanova, NV; Lindblom, A; Margolin, S; Mannermaa, A; Kosma, VM; Wu, AH; Van den Berg, D; Lambrechts, D; Floris, G; Chang-Claude, J; Rudolph, A; Radice, P; Barile, M; Couch, FJ; Hallberg, E; Giles, GG; Haiman, CA; Le Marchand, L; Goldberg, MS; Teo, SH; Yip, CH; Borresen-Dale, AL; Zheng, W; Cai, QY; Winqvist, R; Pylkas, K; Andrulis, IL; Devilee, P; Tollenaar, RAEM; Garcia-Closas, M; Figueroa, J; Hall, P; Czene, K; Brand, JS; Darabi, H; Eriksson, M; Hooning, MJ; Koppert, LB; Li, JM; Shu, XO; Zheng, Y; Cox, A; Cross, SS; Shah, M; Rhenius, V; Choi, JY; Kang, D; Hartman, M; Chia, KS; Kabisch, M; Torres, D; Luccarini, C; Conroy, DM; Jakubowska, A; Lubinski, J; Sangrajrang, S; Brennan, P; Olswold, C; Slager, S; Shen, CY; Hou, MF; Swerdlow, A; Schoemaker, MJ; Simard, J; Pharoah, PDP; Kristensen, V; Chenevix-Trench, G; Easton, DF; Dunning, AM; Edwards, SL				Ghoussaini, Maya; French, Juliet D.; Michailidou, Kyriaki; Nord, Silje; Beesley, Jonathan; Canisus, Sander; Hillman, Kristine M.; Kaufmann, Susanne; Sivakumaran, Haran; Marjaneh, Mandi Moradi; Lee, Jason S.; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Dicks, Ed; Milne, Roger L.; Hopper, John L.; Southey, Melissa C.; Schmidt, Marjanka K.; Broeks, Annegien; Muir, Kenneth; Lophatananon, Artitaya; Fasching, Peter A.; Beckmann, Matthias W.; Fletcher, Olivia; Johnson, Nichola; Sawyer, Elinor J.; Tomlinson, Ian; Burwinkel, Barbara; Marme, Frederik; Guenel, Pascal; Truong, Therese; Bojesen, Stig E.; Flyger, Henrik; Benitez, Javier; Gonzalez-Neira, Anna; Alonso, Rosario; Pita, Guillermo; Neuhausen, Susan L.; Anton-Culver, Hoda; Brenner, Hermann; Arndt, Volker; Meindl, Alfons; Schmutzler, Rita K.; Brauch, Hiltrud; Hamann, Ute; Tessier, Daniel C.; Vincent, Daniel; Nevanlinna, Heli; Khan, Sofia; Matsuo, Keitaro; Ito, Hidemi; Dork, Thilo; Bogdanova, Natalia V.; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Wu, Anna H.; Van den Berg, David; Lambrechts, Diether; Floris, Giuseppe; Chang-Claude, Jenny; Rudolph, Anja; Radice, Paolo; Barile, Monica; Couch, Fergus J.; Hallberg, Emily; Giles, Graham G.; Haiman, Christopher A.; Le Marchand, Loic; Goldberg, Mark S.; Teo, Soo H.; Yip, Cheng Har; Borresen-Dale, Anne-Lise; Zheng, Wei; Cai, Qiuyin; Winqvist, Robert; Pylkas, Katri; Andrulis, Irene L.; Devilee, Peter; Tollenaar, Rob A. E. M.; Garcia-Closas, Montserrat; Figueroa, Jonine; Hall, Per; Czene, Kamila; Brand, Judith S.; Darabi, Hatef; Eriksson, Mikael; Hooning, Maartje J.; Koppert, Linetta B.; Li, Jingmei; Shu, Xiao-Ou; Zheng, Ying; Cox, Angela; Cross, Simon S.; Shah, Mitul; Rhenius, Valerie; Choi, Ji-Yeob; Kang, Daehee; Hartman, Mikael; Chia, Kee Seng; Kabisch, Maria; Torres, Diana; Luccarini, Craig; Conroy, Don M.; Jakubowska, Anna; Lubinski, Jan; Sangrajrang, Suleeporn; Brennan, Paul; Olswold, Curtis; Slager, Susan; Shen, Chen-Yang; Hou, Ming-Feng; Swerdlow, Anthony; Schoemaker, Minouk J.; Simard, Jacques; Pharoah, Paul D. P.; Kristensen, Vessela; Chenevix-Trench, Georgia; Easton, Douglas F.; Dunning, Alison M.; Edwards, Stacey L.		kConFab AOCS; NBCS Collaborators	Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RISK VARIANTS; LOCUS; FOXA1; 2Q35	Genome-wide association studies (GWASs) have revealed increased breast cancer risk associated with multiple genetic variants at 5p12. Here, we report the fine mapping of this locus using data from 104,660 subjects from 50 case-control studies in the Breast Cancer Association Consortium (BCAC). With data for 3,365 genotyped and imputed SNPs across a 1 Mb region (positions 44,394,49545,364,167; NCBI build 37), we found evidence for at least three independent signals: the strongest signal, consisting of a single SNP rs10941679, was associated with risk of estrogen-receptor-positive (ER+) breast cancer (per-g allele ER+ = 1.15; 95% CI 1.13-1.18; p = 8.35 x 10(-3)). After adjustment for rs10941679, we detected signal 2, consisting of 38 SNPs more strongly associated with ER-negative (ER-) breast cancer (lead SNP rs6864776: per-a allele OR ER- = 1.10; 95% CI 1.05-1.14; p conditional = 1.44 x 10(-12)), and a single signal 3 SNP (rs200229088: per-t allele OR ER+ = 1.12; 95% CI 1.09-1.15; p conditional = 1.12 x 10(-05)). Expression quantitative trait locus analysis in normal breast tissues and breast tumors showed that the g (risk) allele of rs10941679 was associated with increased expression of FGF10 and MRPS30. Functional assays demonstrated that SNP rs10941679 maps to an enhancer element that physically interacts with the FGF10 and MRPS30 promoter regions in breast cancer cell lines. FGF10 is an oncogene that binds to FGFR2 and is overexpressed in similar to 10% of human breast cancers, whereas MRPS30 plays a key role in apoptosis. These data suggest that the strongest signal of association at 5p12 is mediated through coordinated activation of FGF10 and MRPS30, two candidate genes for breast cancer pathogenesis.	[Ghoussaini, Maya; Dicks, Ed; Shah, Mitul; Rhenius, Valerie; Luccarini, Craig; Conroy, Don M.; Pharoah, Paul D. P.; Easton, Douglas F.; Dunning, Alison M.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [French, Juliet D.; Beesley, Jonathan; Hillman, Kristine M.; Kaufmann, Susanne; Sivakumaran, Haran; Marjaneh, Mandi Moradi; Lee, Jason S.; Chenevix-Trench, Georgia; Edwards, Stacey L.] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld 4006, Australia; [Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Michailidou, Kyriaki] Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, CY-1683 Nicosia, Cyprus; [Nord, Silje; Borresen-Dale, Anne-Lise; Kristensen, Vessela] Radiumhospitalet, Inst Canc Res, Dept Canc Genet, Oslo Univ Hosp, N-0310 Oslo, Norway; [Canisus, Sander; Schmidt, Marjanka K.; Broeks, Annegien] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Milne, Roger L.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3004, Australia; [Milne, Roger L.; Hopper, John L.; Giles, Graham G.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Muir, Kenneth; Lophatananon, Artitaya] Univ Manchester, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Muir, Kenneth; Lophatananon, Artitaya] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Fasching, Peter A.; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Dept Gynaecol & Obstet, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fletcher, Olivia; Johnson, Nichola] Inst Canc Res, Toby Robins Breast Canc Now Res Ctr, London SW3 6JB, England; [Fletcher, Olivia; Johnson, Nichola; Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, London SW7 3RP, England; [Sawyer, Elinor J.] Kings Coll London, Guys Hosp, Res Oncol, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tomlinson, Ian] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford OX3 7BN, England; [Burwinkel, Barbara; Marme, Frederik] Heidelberg Univ, Dept Obstet & Gynecol, D-69120 Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, D-69120 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Guenel, Pascal; Truong, Therese] Univ Paris Saclay, Univ Paris 11, INSERM, Canc & Environm Grp,Ctr Res Epidemiol & Populat H, F-94807 Villejuif, France; [Bojesen, Stig E.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev & Gentofte Hosp, DK-2730 Herlev, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev & Gentofte Hosp, DK-2730 Herlev, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; [Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Canc Genet Program, Madrid 28029, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras, Valencia 46010, Spain; [Alonso, Rosario; Pita, Guillermo] Spanish Natl Canc Res Ctr, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid 28029, Spain; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 92697 USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA; [Brenner, Hermann; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Brenner, Hermann; Brauch, Hiltrud] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-81675 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Hereditary Breast & Ovarian Canc, D-50931 Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, CIO, D-50937 Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, D-72074 Tubingen, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, D-69120 Heidelberg, Germany; [Tessier, Daniel C.; Vincent, Daniel] McGill Univ, Montreal, PQ H3A OG1, Canada; [Tessier, Daniel C.; Vincent, Daniel] Genome Quebec Innovat Ctr, Montreal, PQ H3A OG1, Canada; [Nevanlinna, Heli; Khan, Sofia] Univ Helsinki, Dept Obstet & Gynecol, Helsinki Univ Hosp, Helsinki 00029, Finland; [Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi 4648681, Japan; [Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan; [Dork, Thilo; Bogdanova, Natalia V.] Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio 70211, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio 70211, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Wu, Anna H.; Van den Berg, David; Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium; [Floris, Giuseppe] Univ Hosp Gashuisberg, B-3000 Leuven, Belgium; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, UCCH, D-20246 Hamburg, Germany; [Radice, Paolo] Fdn IRCCS Ist Ricovero & Cura Carattere Sci, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, INT, I-20133 Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, I-20141 Milan, Italy; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Hallberg, Emily] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Le Marchand, Loic; Olswold, Curtis; Slager, Susan] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ H3G 2M1, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A8, Canada; [Teo, Soo H.] Canc Res Initiat Fdn, Subang Jaya 47500, Selangor, Malaysia; [Teo, Soo H.; Yip, Cheng Har] Univ Malaya, Canc Res Inst, Breast Canc Res Unit, Med Ctr, Kuala Lumpur 59100, Malaysia; [Zheng, Wei; Cai, Qiuyin; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Bioctr Oulu, Lab Canc Genet & Tumor Biol Canc Res & Translat M, SF-90220 Oulu, Finland; [Winqvist, Robert; Pylkas, Katri] Northern Finland Lab Ctr Oulu, Lab Canc Genet & Tumor Biol, Oulu 90220, Finland; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Med Genet, Toronto, ON M5S 1A8, Canada; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Tollenaar, Rob A. E. M.] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; [Garcia-Closas, Montserrat; Figueroa, Jonine] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA; [Figueroa, Jonine] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland; [Hall, Per; Czene, Kamila; Brand, Judith S.; Darabi, Hatef; Eriksson, Mikael; Li, Jingmei] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hooning, Maartje J.] Erasmus MC Canc Inst, Family Canc Clin, Dept Med Oncol, NL-3008 AE Rotterdam, Netherlands; [Koppert, Linetta B.] Erasmus MC Canc Inst, Family Canc Clin, Dept Surg Oncol, NL-3008 AE Rotterdam, Netherlands; [Zheng, Ying] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai 200336, Peoples R China; [Cox, Angela] Univ Sheffield, Dept Oncol & Metab, Sheffield Canc Res, Sheffield S10 2RX, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield S10 2HQ, S Yorkshire, England; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul 110799, South Korea; [Kang, Daehee] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul 110799, South Korea; [Hartman, Mikael; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Hartman, Mikael] Natl Univ Hlth Syst, Dept Surg, Singapore 117597, Singapore; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota 11001000, DC, Colombia; [Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok 10400, Thailand; [Brennan, Paul] Int Agcy Res Canc, Lyon 08, France; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung 40402, Taiwan; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei 115, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung 812, Taiwan; [Swerdlow, Anthony; Schoemaker, Minouk J.] Inst Canc Res, Div Genet & Epidemiol, London SM2 5NG, England; [Simard, Jacques] Univ Laval, Genom Ctr, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Kristensen, Vessela] Univ Oslo, Oslo Univ Hosp, Dept Clin Mol Biol, N-0450 Oslo, Norway	University of Cambridge; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Oslo; Netherlands Cancer Institute; Cancer Council Victoria; University of Melbourne; University of Melbourne; University of Manchester; University of Warwick; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; University of Helsinki; Helsinki University Central Hospital; Aichi Cancer Center; Aichi Cancer Center; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Southern California; Flanders Institute for Biotechnology (VIB); KU Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); Mayo Clinic; Mayo Clinic; Cancer Research Center of Hawaii; University of Hawaii System; McGill University; McGill University; Royal Victoria Hospital; Universiti Malaya; Vanderbilt University; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Edinburgh; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Shanghai Center for Disease Control & Prevention; University of Sheffield; University of Sheffield; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National University of Singapore; National University of Singapore; Pontificia Universidad Javeriana; Pomeranian Medical University; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); China Medical University Taiwan; Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Laval University; University of Oslo	Dunning, AM (corresponding author), Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England.; Edwards, SL (corresponding author), QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld 4006, Australia.		Garcia-Closas, Montserrat/AAZ-6930-2021; Gonzalez-Neira, Anna/C-5791-2015; Floris, Giuseppe/AFL-6620-2022; Arndt, Volker/AAI-7282-2020; Michailidou, Kyriaki/ABD-5122-2020; Fasching, Peter A/ABH-9912-2020; Flyger, Henrik/AAM-6494-2021; Pharoah, Paul/V-6658-2019; French, Juliet/AAV-4435-2020; DEVILEE, PETER/ABR-2140-2022; Figueroa, Jonine/GWD-1322-2022; truong, therese/A-2837-2013; Dörk, Thilo/J-8620-2012; Jakubowska, Anna/O-8050-2014; /AAM-5330-2020; Margolin, Sara/AAX-9034-2020; Matsuo, Keitaro/H-6758-2019; Radice, Paolo/O-3119-2013; Li, Jingmei/I-2904-2012; Van Den Berg, David J/G-8598-2017; Schmidt, Marjanka K/G-9058-2011; Zheng, Wei/O-3351-2013; Floris, Giuseppe/AAG-6754-2022; Guenel, Pascal/AAS-7688-2021; Brenner, Hermann/B-4627-2017; Devilee, Peter/GXV-8005-2022; Nord, Silje/R-5212-2016; Figueroa, Jonine/AAG-1065-2022; Teo, Soo-hwang/H-2353-2014; Bogdanova, Natalia V./Y-2205-2019; Yip, Cheng-Har/B-1909-2010; Lee, Jason/M-7522-2016; Lambrechts, Diether/AAJ-3167-2020; Zheng, Wei/GQQ-8951-2022; Guenel, Pascal/H-3728-2018; zhang, weihua/GXV-1334-2022; Arndt, Volker/B-4999-2014; Chenevix-Trench, Georgia/AAV-2014-2020; Brenner, Hermann/ABE-6383-2020; Shen, CY/F-6271-2010; Figueroa, Jonine/AFK-2752-2022; Hartman, Mikael/B-4324-2011; benitez, javier/H-5232-2015	Garcia-Closas, Montserrat/0000-0003-1033-2650; Gonzalez-Neira, Anna/0000-0002-5421-2020; Floris, Giuseppe/0000-0003-2391-5425; Arndt, Volker/0000-0001-9320-8684; Michailidou, Kyriaki/0000-0001-7065-1237; Fasching, Peter A/0000-0003-4885-8471; Pharoah, Paul/0000-0001-8494-732X; French, Juliet/0000-0002-9770-0198; Figueroa, Jonine/0000-0002-5100-623X; truong, therese/0000-0002-2943-6786; Dörk, Thilo/0000-0002-9458-0282; Jakubowska, Anna/0000-0002-5650-0501; Matsuo, Keitaro/0000-0003-1761-6314; Radice, Paolo/0000-0001-6298-4111; Li, Jingmei/0000-0001-8587-7511; Van Den Berg, David J/0000-0002-5404-5218; Schmidt, Marjanka K/0000-0002-2228-429X; Zheng, Wei/0000-0003-1226-070X; Floris, Giuseppe/0000-0003-2391-5425; Guenel, Pascal/0000-0002-8359-518X; Brenner, Hermann/0000-0002-6129-1572; Nord, Silje/0000-0002-3271-5356; Figueroa, Jonine/0000-0002-5100-623X; Lee, Jason/0000-0003-0879-934X; Lambrechts, Diether/0000-0002-3429-302X; Guenel, Pascal/0000-0002-8359-518X; Arndt, Volker/0000-0001-9320-8684; Chenevix-Trench, Georgia/0000-0002-1878-2587; Brenner, Hermann/0000-0002-6129-1572; Figueroa, Jonine/0000-0002-5100-623X; Schoemaker, Minouk/0000-0001-8403-2234; Sawyer, Elinor/0000-0001-8285-4111; Devilee, Peter/0000-0002-8023-2009; Beesley, Jonathan/0000-0003-1942-325X; Lubinski, Jan/0000-0003-2931-3003; Margolin, Sara/0000-0002-5526-5570; Pita, Guillermo/0000-0003-2393-0510; eriksson, mikael/0000-0001-8135-4270; Dunning, Alison Margaret/0000-0001-6651-7166; Brauch, Hiltrud/0000-0001-7531-2736; Southey, Melissa/0000-0002-6313-9005; Hartman, Mikael/0000-0001-5726-9965; Khan, Sofia/0000-0003-4185-8882; Cox, Angela/0000-0002-5138-1099; Thorne, Heather/0000-0003-3610-2511; Brand, Judith S./0000-0002-3720-1274; Hou, Ming-Feng/0000-0001-6030-9702; Kang, Daehee/0000-0003-4031-5878; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Swerdlow, Anthony/0000-0001-5550-4159; Bojesen, Stig/0000-0002-4061-4133; Durocher, Francine/0000-0001-8012-4641; benitez, javier/0000-0002-0923-7202; Fletcher, Olivia/0000-0001-9387-7116; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Sivakumaran, Haran/0000-0002-4691-4989; Simard, Jacques/0000-0001-6906-3390; Winqvist, Robert/0000-0003-0932-9104; Pylkas, Katri/0000-0002-2449-0521	MRC [MC_PC_14105] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U01CA116167, R01CA176785, R01CA148667, R01CA192393] Funding Source: NIH RePORTER; Cancer Research UK [16561, 16565] Funding Source: researchfish; Cancer Foundation Finland sr [150147, 110135] Funding Source: researchfish; The Francis Crick Institute [10124, 10119] Funding Source: researchfish; National Breast Cancer Foundation [ECF-12-04, IF-12-06] Funding Source: researchfish; Cancer Research UK [10124, 10119] Funding Source: Medline; Medical Research Council [MC_PC_14105] Funding Source: Medline; NCI NIH HHS [R01 CA148667, R01 CA176785, U01 CA116167, R01 CA192393] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Cancer Foundation Finland sr; The Francis Crick Institute; National Breast Cancer Foundation; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abolhassani A, 2014, J CANCER, V5, P537, DOI 10.7150/jca.7797; Belikov S, 2009, MOL CELL BIOL, V29, P5413, DOI 10.1128/MCB.00368-09; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chioni AM, 2009, EUR J CELL BIOL, V88, P371, DOI 10.1016/j.ejcb.2009.01.004; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2011, CANCER EPIDEM BIOMAR, V20, P2222, DOI 10.1158/1055-9965.EPI-11-0569; Quigley DA, 2014, MOL ONCOL, V8, P273, DOI 10.1016/j.molonc.2013.11.008; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Theodorou V, 2004, ONCOGENE, V23, P6047, DOI 10.1038/sj.onc.1207816; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780	25	45	45	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					903	911		10.1016/j.ajhg.2016.07.017	http://dx.doi.org/10.1016/j.ajhg.2016.07.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27640304	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000385333700010
J	Bauche, S; O'Regan, S; Azuma, Y; Laffargue, F; McMacken, G; Sternberg, D; Brochier, G; Buon, C; Bouzidi, N; Topf, A; Lacene, E; Remerand, G; Beaufrere, AM; Pebrel-Richard, C; Thevenon, J; El Chehadeh-Djebbar, S; Faivre, L; Duffourd, Y; Ricci, F; Mongini, T; Fiorillo, C; Astrea, G; Burloiu, CM; Butoianu, N; Sandu, C; Servais, L; Bonne, G; Nelson, I; Desguerre, I; Nougues, MC; Boeuf, B; Romero, N; Laporte, J; Boland, A; Lechner, D; Deleuze, JF; Fontaine, B; Strochlic, L; Lochmuller, H; Eymard, B; Mayer, M; Nicole, S				Bauche, Stephanie; O'Regan, Seana; Azuma, Yoshiteru; Laffargue, Fanny; McMacken, Grace; Sternberg, Damien; Brochier, Guy; Buon, Celine; Bouzidi, Nassima; Topf, Ana; Lacene, Emmanuelle; Remerand, Ganaelle; Beaufrere, Anne-Marie; Pebrel-Richard, Celine; Thevenon, Julien; El Chehadeh-Djebbar, Salima; Faivre, Laurence; Duffourd, Yannis; Ricci, Federica; Mongini, Tiziana; Fiorillo, Chiara; Astrea, Guja; Burloiu, Carmen Magdalena; Butoianu, Niculina; Sandu, Carmen; Servais, Laurent; Bonne, Gisele; Nelson, Isabelle; Desguerre, Isabelle; Nougues, Marie-Christine; Boeuf, Benoit; Romero, Norma; Laporte, Jocelyn; Boland, Anne; Lechner, Doris; Deleuze, Jean-Francois; Fontaine, Bertrand; Strochlic, Laure; Lochmuller, Hanns; Eymard, Bruno; Mayer, Michele; Nicole, Sophie			Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROMUSCULAR-JUNCTION; RESPIRATORY RHYTHM; KNOCKOUT MOUSE; BUTYRYLCHOLINESTERASE; MUTATIONS; RECEPTORS; ACETYLTRANSFERASE; NEUROTRANSMISSION; DEFICIENCY; EXPRESSION	The neuromuscular junction (NMJ) is one of the best-studied cholinergic synapses. Inherited defects of peripheral neurotransmission result in congenital myasthenic syndromes (CMS5), a clinically and genetically heterogeneous group of rare diseases with fluctuating fatigable muscle weakness as the clinical hallmark. Whole-exome sequencing and Sanger sequencing in six unrelated families identified compound heterozygous and homozygous mutations in SLC5A7 encoding the presynaptic sodium-dependent high-affinity choline transporter 1 (CHT), which is known to be mutated in one dominant form of distal motor neuronopathy (DHMN7A). We identified 11 recessive mutations in SLC5A7 that were associated with a spectrum of severe muscle weakness ranging from a lethal antenatal form of arthrogryposis and severe hypotonia to a neonatal form of CMS with episodic apnea and a favorable prognosis when well managed at the clinical level. As expected given the critical role of CHT for multisystemic cholinergic neurotransmission, autonomic dysfunctions were reported in the antenatal form and cognitive impairment was noticed in half of the persons with the neonatal form. The missense mutations induced a near complete loss of function of CHT activity in cell models. At the human NMJ, a delay in synaptic maturation and an altered maintenance were observed in the antenatal and neonatal forms, respectively. Increased synaptic expression of butyrylcholinesterase was also observed, exposing the dysfunction of cholinergic metabolism when CHT is deficient in vivo. This work broadens the clinical spectrum of human diseases resulting from reduced CHT activity and highlights the complexity of cholinergic metabolism at the synapse.	[Bauche, Stephanie; Sternberg, Damien; Buon, Celine; Bouzidi, Nassima; Fontaine, Bertrand; Strochlic, Laure; Eymard, Bruno; Nicole, Sophie] Univ Paris 06, Sorbonne Univ, Inst Cerveau & Moelle Epiniere, ICM,INSERM,U1127,CNRS,UMR 7225,UMR S 1127, F-75013 Paris, France; [O'Regan, Seana] Paris Descartes Univ, Membrane Transport Grp, Sorbonne Paris Cite, Neurophoton Lab,CNRS,UMR8250, F-75005 Paris, France; [Azuma, Yoshiteru; McMacken, Grace; Topf, Ana; Lochmuller, Hanns] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, MRC Ctr Neuromuscular Dis, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Laffargue, Fanny] Ctr Hosp Univ Clermont Ferrand, Gen Med Serv, Ctr Reference Auvergne Limousin Neuropathies Peri, F-63000 Clermont Ferrand, France; [Sternberg, Damien; Brochier, Guy; Lacene, Emmanuelle; Fontaine, Bertrand; Eymard, Bruno] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France; [Brochier, Guy; Lacene, Emmanuelle; Romero, Norma] Univ Paris 06, Sorbonne Univ, Unite Pathol Neuromusculaires, Inst Myol,UMRS 974,INSERM,CNRS,UMR 7215,U974, F-75013 Paris, France; [Remerand, Ganaelle] Ctr Hosp Univ Clermont Ferrand, Serv Neonatol, F-63000 Clermont Ferrand, France; [Beaufrere, Anne-Marie] Ctr Hosp Univ Clermont Ferrand, Serv Anat & Cytol Pathol, F-63000 Clermont Ferrand, France; [Pebrel-Richard, Celine] Ctr Hosp Univ Clermont Ferrand, Serv Cytogenet Med, F-63000 Clermont Ferrand, France; [Thevenon, Julien; Faivre, Laurence; Duffourd, Yannis] Ctr Hosp Univ Dijon, Federat Hosp Univ Med Translat & Anomalies Dev TR, F-21079 Dijon, France; [Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Genet, F-21079 Dijon, France; [Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [El Chehadeh-Djebbar, Salima] Hop Hautepierre, Inst Genet Med Alsace IGMA, Hop Univ Strasbourg, Serv Genet Med, F-67098 Strasbourg, France; [Ricci, Federica; Mongini, Tiziana] Univ Turin, Child Neurol & Psychiat Unit, Ctr Neuromuscular Dis, Regina Margherita Children Hosp, I-10124 Turin, Italy; [Ricci, Federica; Mongini, Tiziana] Univ Turin, Dept Neurosci, I-10124 Turin, Italy; [Fiorillo, Chiara] IRCCS Fdn Stella Maris, Mol Med, I-56018 Pisa, Italy; [Astrea, Guja] IRCCS Stella Maris Fdn, Dept Dev Neurosci, I-56018 Pisa, Italy; [Burloiu, Carmen Magdalena; Butoianu, Niculina; Sandu, Carmen] Alexandru Obregia Clin Hosp, Sos Berceni 10-12, Bucharest 041914, Romania; [Servais, Laurent; Bonne, Gisele; Nelson, Isabelle; Eymard, Bruno] Univ Paris 06, Sorbonne Univ, INSERM, Ctr Res Myol,Myol Inst,CNRS,FRE3617,UMRS974, F-75013 Paris, France; [Desguerre, Isabelle] Hop Necker Enfants Malad, Ctr Reference Malad Neuromusculaires Ouest Parisi, F-75743 Paris, France; [Nougues, Marie-Christine; Mayer, Michele] Hop Enfants Armand Trousseau, Neuropediat, F-75012 Paris, France; [Nougues, Marie-Christine; Mayer, Michele] Hop Enfants Armand Trousseau, Unite Electrophysiol Clin, Ctr Reference Malad Neuromusculaires EST Parisie, F-75012 Paris, France; [Nougues, Marie-Christine; Mayer, Michele] Hop Enfants Armand Trousseau, DHU I2B, F-75012 Paris, France; [Boeuf, Benoit] CHU Clermont Ferrand, Hop Estaing, Serv Reanimat Neonatale & Pediat, F-63000 Clermont Ferrand, France; [Laporte, Jocelyn] INSERM, U964, Dept Med Translat & Neurogenet, Inst Genet & Biol Mol & Cellulaire,CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, France; [Laporte, Jocelyn] Univ Strasbourg, FMTS, F-67000 Strasbourg, France; [Boland, Anne; Lechner, Doris; Deleuze, Jean-Francois] CNG, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Turin; IRCCS Fondazione Stella Maris; IRCCS Fondazione Stella Maris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Saclay	Nicole, S (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Cerveau & Moelle Epiniere, ICM,INSERM,U1127,CNRS,UMR 7225,UMR S 1127, F-75013 Paris, France.	sophie.nicole@inserm.fr	Fiorillo, Chiara/AAB-4142-2021; Butoianu, Niculina/AAL-8829-2021; Astrea, Guja/F-8960-2019; Bonne, Gisèle/G-3121-2013; Astrea, Guja/K-7339-2014; Ricci, Federica/AAY-9172-2021; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; AZUMA, Yoshiteru/I-7323-2014; Servais, Laurent/AAL-7384-2020; Sandu, Carmen/AAL-8650-2021; Strochlic, Laure/J-3610-2017; NICOLE, Sophie/N-4348-2018	Fiorillo, Chiara/0000-0001-9027-343X; Astrea, Guja/0000-0001-8588-0323; Bonne, Gisèle/0000-0002-2516-3258; Astrea, Guja/0000-0001-8588-0323; Strochlic, Laure/0000-0001-5373-4284; laporte, jocelyn/0000-0001-8256-5862; Ricci, Federica/0000-0003-2019-612X; Bauche, Stephanie/0000-0002-6926-339X; Buon, Celine/0000-0003-0743-4998; STERNBERG, Damien/0000-0001-7877-7395; Ricci, Benoit/0000-0002-8661-4200; Servais, Laurent/0000-0001-9270-4061; NICOLE, Sophie/0000-0001-8793-7928; nelson, isabelle/0000-0001-6390-622X; Azuma, Yoshiteru/0000-0002-5363-5638	AFM-Telethon [20030]; programs "Investissements d'avenir" [ANR-10-IAIHU-06, ANR-10-INBS-09]; Fondation Maladies Rares within the Myocapture sequencing project; Medical Research Council UK [G1002274, 98482]; European Union Seventh Framework Programme (FP7) [305444, 305121]; MRC [G1002274] Funding Source: UKRI; Medical Research Council [G1002274] Funding Source: researchfish	AFM-Telethon(Association Francaise contre les Myopathies); programs "Investissements d'avenir"(French National Research Agency (ANR)); Fondation Maladies Rares within the Myocapture sequencing project; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Seventh Framework Programme (FP7); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to the families for their invaluable participation in this study. This work was supported by AFM-Telethon (grant ID 20030), the programs "Investissements d'avenir" ANR-10-IAIHU-06 (IHU-A-ICM) and ANR-10-INBS-09 (France Genomique National infrastructure), and Fondation Maladies Rares within the Myocapture sequencing project. The study was also supported by the Medical Research Council UK (reference G1002274, grant ID 98482) and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 305444 (RD-Connect) and 305121 (Neuromics) to H.L. We thank Dr. Eric Krejci for his generous gift of toxins and antibodies specific to cholinesterases and the Plateforme d'Imagerie Cellulaire Pine Salpetriere (PICPS) and the Service Commun de Microscopie Universite PARIS DESCARTES for confocal microscopy. We thank the DNA and Cell Banks of Genethon and CRB-REFGENSEP, and the Celis, Histomics and Bioinformatics/Biostatistics (iCONICS) core facilities of the ICM for precious support. We wish to thank Drs. Rolf Stucka, Marina Dusl, Angela Abicht, and Jan Senderek, all at Ludwig-Maximilians-University Munich, Germany, for their contributions to exclude known genes linked to CMS in two families described in this study and for providing DNA samples, and Dr. Patricia Boffi, Turino, Italy, for the initial referral of one of the subjects.	Barwick KES, 2012, AM J HUM GENET, V91, P1103, DOI 10.1016/j.ajhg.2012.09.019; Bauche S, 2013, NEUROMUSCULAR DISORD, V23, P998, DOI 10.1016/j.nmd.2013.07.005; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Berse B, 2005, DEV BRAIN RES, V157, P132, DOI 10.1016/j.devbrainres.2005.03.013; Black Stefanie A. G., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P114; Byring RF, 2002, NEUROMUSCULAR DISORD, V12, P548, DOI 10.1016/S0960-8966(01)00336-4; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; English BA, 2010, AM J PHYSIOL-HEART C, V299, pH799, DOI 10.1152/ajpheart.00170.2010; English BA, 2009, J NEURODEV DISORD, V1, P252, DOI 10.1007/s11689-009-9033-8; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Habbout K, 2016, NEUROLOGY, V86, P161, DOI 10.1212/WNL.0000000000002264; Haga T, 2014, J BIOCHEM, V156, P181, DOI 10.1093/jb/mvu047; Haji A, 2000, PHARMACOL THERAPEUT, V86, P277, DOI 10.1016/S0163-7258(00)00059-0; HESSELMANS LFGM, 1993, ANAT REC, V236, P553, DOI 10.1002/ar.1092360315; Hrabovska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012892; Ingram Gillian, 2016, Pract Neurol, V16, P247, DOI 10.1136/practneurol-2015-001307; Li B, 2008, J PHARMACOL EXP THER, V324, P1146, DOI 10.1124/jpet.107.133330; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Minic J, 2003, BRIT J PHARMACOL, V138, P177, DOI 10.1038/sj.bjp.0705010; Nicole S, 2014, BRAIN, V137, P2429, DOI 10.1093/brain/awu160; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Okuda T, 2002, J BIOL CHEM, V277, P45315, DOI 10.1074/jbc.M207742200; Okuda T, 2012, J BIOL CHEM, V287, P42826, DOI 10.1074/jbc.M112.405027; Palace J, 2012, NEUROMUSCULAR DISORD, V22, P112, DOI 10.1016/j.nmd.2011.08.002; Petrov KA, 2014, J NEUROSCI, V34, P11870, DOI 10.1523/JNEUROSCI.0329-14.2014; PRIDMORE C, 1992, J MED GENET, V29, P197, DOI 10.1136/jmg.29.3.197; Schara U, 2010, EUR J PAEDIATR NEURO, V14, P326, DOI 10.1016/j.ejpn.2009.09.009; SCHUELER FW, 1955, J PHARMACOL EXP THER, V115, P127; Shao XM, 2005, NEUROSCIENCE, V130, P1069, DOI 10.1016/j.neuroscience.2004.10.028; Shen XM, 2011, HUM MUTAT, V32, P1259, DOI 10.1002/humu.21560; Thevenon J, 2016, CLIN GENET, V89, P700, DOI 10.1111/cge.12732; Tsujino A, 2003, P NATL ACAD SCI USA, V100, P7377, DOI 10.1073/pnas.1230273100	34	45	48	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					753	761		10.1016/j.ajhg.2016.06.033	http://dx.doi.org/10.1016/j.ajhg.2016.06.033			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27569547	Green Published, Bronze			2022-12-18	WOS:000383114800021
J	Divisato, G; Formicola, D; Esposito, T; Merlotti, D; Pazzaglia, L; Del Fattore, A; Siris, E; Orcel, P; Brown, JP; Nuti, R; Strazzullo, P; Benassi, MS; Cancela, ML; Michou, L; Rendina, D; Gennari, L; Gianfrancesco, F				Divisato, Giuseppina; Formicola, Daniela; Esposito, Teresa; Merlotti, Daniela; Pazzaglia, Laura; Del Fattore, Andrea; Siris, Ethel; Orcel, Philippe; Brown, Jacques P.; Nuti, Ranuccio; Strazzullo, Pasquale; Benassi, Maria Serena; Cancela, M. Leonor; Michou, Laetitia; Rendina, Domenico; Gennari, Luigi; Gianfrancesco, Fernando			ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CLINICAL CHARACTERISTICS; GENE	Paget disease of bone (PDB) is a skeletal disorder characterized by focal abnormalities of bone remodeling, which result in enlarged and deformed bones in one or more regions of the skeleton. In some cases, the pagetic tissue undergoes neoplastic transformation, resulting in osteosarcoma and, less frequently, in giant cell tumor of bone (GCT). We performed whole-exome sequencing in a large family with 14 PDB-affected members, four of whom developed GCT at multiple pagetic skeletal sites, and we identified the c.2810C>G (p.Pro937Arg) missense mutation in the zinc finger protein 687 gene (ZNF687). The mutation precisely co-segregated with the clinical phenotype in all affected family members. The sequencing of seven unrelated individuals with GCT associated with PDB (GCT/PDB) identified the same mutation in all individuals, unravelling a founder effect. ZNF687 is highly expressed during osteoclastogenesis and osteoblastogenesis and is dramatically upregulated in the tumor tissue of individuals with GCT/PDB. Interestingly, our preliminary findings showed that ZNF687, indicated as a target gene of the NFkB transcription factor by ChIP-seq analysis, is also upregulated in the peripheral blood of PDB-affected individuals with (n = 5) or without (n = 6) mutations in SQSTM1, encouraging additional studies to investigate its potential role as a biomarker of PDB risk.	[Divisato, Giuseppina; Formicola, Daniela; Esposito, Teresa; Gianfrancesco, Fernando] Natl Res Council Italy, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Merlotti, Daniela; Nuti, Ranuccio; Gennari, Luigi] Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy; [Pazzaglia, Laura; Benassi, Maria Serena] Rizzoli Orthopaed Inst, Expt Oncol Lab, I-40136 Bologna, Italy; [Del Fattore, Andrea] Bambino Gesu Pediat Hosp, Regenerat Med Unit, I-00146 Rome, Italy; [Siris, Ethel] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA; [Orcel, Philippe] Hop Lariboisiere, AP HP, Serv Rhumatol B, Pole Appareil Locomoteur, F-75010 Paris, France; [Brown, Jacques P.; Michou, Laetitia] Univ Laval, Dept Med, Div Rheumatol, Quebec City, PQ 42178, Canada; [Strazzullo, Pasquale; Rendina, Domenico] Univ Naples Federico II, Dept Med & Surg, I-80131 Naples, Italy; [Cancela, M. Leonor] Univ Algarve, Dept Biomed Sci & Med, P-8005139 Faro, Portugal; [Cancela, M. Leonor] Univ Algarve, Ctr Marine Sci, P-8005139 Faro, Portugal	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Siena; IRCCS Istituto Ortopedico Rizzoli; IRCCS Bambino Gesu; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Laval University; University of Naples Federico II; Universidade do Algarve; Universidade do Algarve	Gianfrancesco, F (corresponding author), Natl Res Council Italy, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy.	fernando.gianfrancesco@igb.cnr.it	Del Fattore, Andrea/H-4409-2015; Pazzaglia, Laura/C-7918-2019; Esposito, Teresa/AAA-5488-2019; Gennari, Luigi/J-7013-2016; Del Fattore, Andrea/AAP-2045-2020; Merlotti, Daniela/J-8245-2016; Cancela, M. Leonor/F-4665-2012; Formicola, Daniela/ABC-4081-2020; Gianfrancesco, Fernando/P-6853-2014; Formicola, Daniela/K-7005-2016	Del Fattore, Andrea/0000-0003-3848-412X; Pazzaglia, Laura/0000-0001-5937-4953; Esposito, Teresa/0000-0002-7879-8441; Gennari, Luigi/0000-0001-6833-4232; Del Fattore, Andrea/0000-0003-3848-412X; Merlotti, Daniela/0000-0002-3338-6339; Cancela, M. Leonor/0000-0003-3114-6662; Brown, Jacques/0000-0003-1910-788X; Michou, Laetitia/0000-0002-8364-4164; Gianfrancesco, Fernando/0000-0002-3812-2471; Rendina, Domenico/0000-0002-0331-0392; ORCEL, Philippe/0000-0001-7028-1133; Divisato, Giuseppina/0000-0003-4014-1716; Formicola, Daniela/0000-0001-9128-9775	Telethon Italy [11119A, GTB12001]; European Calcified Tissue Society/AMGEN fellowship; Italian Society for Osteoporosis, Mineral Metabolism and Skeletal Diseases; John G. Haddad Research Award from the Paget Foundation; Italian Association for Cancer Research [IG-2014, 15707]	Telethon Italy(Fondazione Telethon); European Calcified Tissue Society/AMGEN fellowship; Italian Society for Osteoporosis, Mineral Metabolism and Skeletal Diseases; John G. Haddad Research Award from the Paget Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	We thank Dr. Monica Autiero for helpful suggestions and manuscript editing, Mrs. Edith Gagnon at Quebec Research Centre for Sanger sequencing, Dr. Riccardo Muscariello at the Department of Medicine and Surgery at Federico II University for recruitment of PDB-affected individuals, and Dr. Federica Scotto di Carlo for her assistance in submitting this paper. This work was supported by Telethon Italy (grant no. 11119A, F.G. and L.G.), the European Calcified Tissue Society/AMGEN fellowship (F.G.), the Italian Society for Osteoporosis, Mineral Metabolism and Skeletal Diseases (F.G.), the John G. Haddad Research Award from the Paget Foundation (L.G.), and the Italian Association for Cancer Research (grant IG-2014 no. 15707, F.G.). The Short-term Mobility Program from the Italian National Research Council (F.G.) is gratefully acknowledged, as well as the Galliera Genetic Bank funded by Telethon Italy (grant no. GTB12001). This work is dedicated to the memory of Dr. Giuseppe Mossetti.	Albagha OME, 2011, NAT GENET, V43, P685, DOI 10.1038/ng.845; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Esposito T, 2013, HUM MOL GENET, V22, P3654, DOI 10.1093/hmg/ddt215; Esposito T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-91; Ganss B, 2004, CRIT REV ORAL BIOL M, V15, P282, DOI 10.1177/154411130401500504; Gebhart M, 1998, CLIN ORTHOP RELAT R, P187; Gennari L, 2010, J BONE MINER RES, V25, P1375, DOI 10.1002/jbmr.31; Gianfrancesco F, 2013, J BONE MINER RES, V28, P341, DOI 10.1002/jbmr.1750; Hansen MF, 2006, J BONE MINER RES, V21, pP58, DOI 10.1359/JBMR.06S211; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; JACOBS TP, 1979, CANCER-AM CANCER SOC, V44, P742, DOI 10.1002/1097-0142(197908)44:2<742::AID-CNCR2820440247>3.0.CO;2-U; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Michou L, 2011, BONE, V48, P456, DOI 10.1016/j.bone.2010.11.004; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Ralston SH, 2013, NEW ENGL J MED, V368, P644, DOI 10.1056/NEJMcp1204713; Rendina D, 2006, J BONE MINER RES, V21, P1828, DOI 10.1359/JBMR.060822; Rendina D, 2015, J BONE MINER RES, V30, P257, DOI 10.1002/jbmr.2349; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Whyte MP, 2006, ANN NY ACAD SCI, V1068, P143, DOI 10.1196/annals.1346.016; Whyte MP, 2006, NEW ENGL J MED, V355, P593, DOI 10.1056/NEJMcp060278; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060	25	45	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					275	286		10.1016/j.ajhg.2015.12.016	http://dx.doi.org/10.1016/j.ajhg.2015.12.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26849110	Green Published, hybrid			2022-12-18	WOS:000370502300004
J	Pan, W; Kwak, IY; Wei, P				Pan, Wei; Kwak, Il-Youp; Wei, Peng			A Powerful Pathway-Based Adaptive Test for Genetic Association with Common or Rare Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SET ANALYSIS; DISEASES	In spite of the success of genome-wide association studies (GWASs), only a small proportion of heritability for each complex trait has been explained by identified genetic variants, mainly SNPs. Likely reasons include genetic heterogeneity (i.e., multiple causal genetic variants) and small effect sizes of causal variants, for which pathway analysis has been proposed as a promising alternative to the standard single-SNP-based analysis. A pathway contains a set of functionally related genes, each of which includes multiple SNPs. Here we propose a pathway-based test that is adaptive at both the gene and SNP levels, thus maintaining high power across a wide range of situations with varying numbers of the genes and SNPs associated with a trait. The proposed method is applicable to both common variants and rare variants and can incorporate biological knowledge on SNPs and genes to boost statistical power. We use extensively simulated data and a WTCCC GWAS dataset to compare our proposal with several existing pathway-based and SNP-set-based tests, demonstrating its promising performance and its potential use in practice.	[Pan, Wei; Kwak, Il-Youp] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Wei, Peng] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA; [Wei, Peng] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Pan, W (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA.	weip@biostat.umn.edu; peng.wei@uth.tmc.edu	KWAK, IL YOUP/J-3354-2015; Wei, Peng/X-2306-2019	KWAK, IL YOUP/0000-0002-7117-7669; Wei, Peng/0000-0001-7758-6116	NIH [R01HL116720, R01GM113250, R01HL105397, R01GM081535, R01CA169122, R21HL126032]; Wellcome Trust [076113]; NATIONAL CANCER INSTITUTE [R01CA169122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116720, R21HL126032, R01HL105397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081535, R01GM113250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the reviewers for helpful and constructive comments. This research was supported by NIH grant R01HL116720. W.P. was also supported by NIH grants R01GM113250, R01HL105397, and R01GM081535, and P.W. by R01CA169122 and R21HL126032. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the WTCCC data is available from http://www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113.	Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Billmann-Born S, 2011, EUR J CELL BIOL, V90, P593, DOI 10.1016/j.ejcb.2010.10.015; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Fan JQ, 1996, J AM STAT ASSOC, V91, P674; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Newton MA, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1716; Pan W, 2015, GENET EPIDEMIOL, V39, P306, DOI 10.1002/gepi.21899; Pan W, 2011, GENET EPIDEMIOL, V35, P211, DOI 10.1002/gepi.20567; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schaid DJ, 2012, GENET EPIDEMIOL, V36, P3, DOI 10.1002/gepi.20632; Strober W, 2014, IMMUNOL REV, V260, P249, DOI 10.1111/imr.12193; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Tzeng JY, 2011, AM J HUM GENET, V89, P277, DOI 10.1016/j.ajhg.2011.07.007; Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070676; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhang QY, 2011, GENET EPIDEMIOL, V35, P679, DOI 10.1002/gepi.20618; Zhou YH, 2013, BIOSTATISTICS, V14, P573, DOI 10.1093/biostatistics/kxt004	44	45	46	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					86	98		10.1016/j.ajhg.2015.05.018	http://dx.doi.org/10.1016/j.ajhg.2015.05.018			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26119817	Bronze, Green Published			2022-12-18	WOS:000358189500008
J	Lin, DY; Tao, R; Kalsbeek, WD; Zeng, DL; Gonzalez, F; Fernandez-Rhodes, L; Graff, M; Koch, GG; North, KE; Heiss, G				Lin, Dan-Yu; Tao, Ran; Kalsbeek, William D.; Zeng, Donglin; Gonzalez, Franklyn, II; Fernandez-Rhodes, Lindsay; Graff, Mariaelisa; Koch, Gary G.; North, Kari E.; Heiss, Gerardo			Genetic Association Analysis under Complex Survey Sampling: The Hispanic Community Health Study/Study of Latinos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; PROSPECTIVE COHORT; VARYING PROBABILITIES; FINITE POPULATION; ASYMPTOTIC THEORY; DESIGN; RARE; ARCHITECTURE; ENVIRONMENT; SELECTION	The cohort design allows investigators to explore the genetic basis of a variety of diseases and traits in a single study while avoiding major weaknesses of the case-control design. Most cohort studies employ multistage cluster sampling with unequal probabilities to conveniently select participants with desired characteristics, and participants from different clusters might be genetically related. Analysis that ignores the complex sampling design can yield biased estimation of the genetic association and inflation of the type I error. Herein, we develop weighted estimators that reflect unequal selection probabilities and differential nonresponse rates, and we derive variance estimators that properly account for the sampling design and the potential relatedness of participants in different sampling units. We compare, both analytically and numerically, the performance of the proposed weighted estimators with unweighted estimators that disregard the sampling design. We demonstrate the usefulness of the proposed methods through analysis of MetaboChip data in the Hispanic Community Health Study/Study of Latinos, which is the largest health study of the Hispanic/Latino population in the United States aimed at identifying risk factors for various diseases and determining the role of genes and environment in the occurrence of diseases. We provide guidelines on the use of weighted and unweighted estimators, as well as the relevant software.	[Lin, Dan-Yu; Tao, Ran; Kalsbeek, William D.; Zeng, Donglin; Gonzalez, Franklyn, II; Koch, Gary G.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Fernandez-Rhodes, Lindsay; Graff, Mariaelisa; North, Kari E.; Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu		Fernandez-Rhodes, Lindsay/0000-0001-6985-423X	NIH [R01CA082659, R37GM047845, U01HG004803]; National Heart, Lung, and Blood Institute (NHLBI) [HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01-HC65236]; San Diego State University [N01-HC65237]; HCHS/SOL; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA142538, R01CA082659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234, T32HL007055, U01HL065233] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004803, U01HG007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047845] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; HCHS/SOL; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH awards R01CA082659 (D.-Y.L., R.T., D.Z.), R37GM047845 (D.-Y.L., D.Z.), and U01HG004803 (D.-Y.L., R.T., L.F.-R., M.G., K.E.N., G.H.). The authors thank the staff and participants of the HCHS/SOL for their important contributions. The HCHS/SOL was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, and NIH Institution-Office of Dietary Supplements.	Allison DB, 1997, AM J HUM GENET, V60, P676; Barnett IJ, 2013, GENET EPIDEMIOL, V37, P142, DOI 10.1002/gepi.21699; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Chen HY, 2011, GENET EPIDEMIOL, V35, P823, DOI 10.1002/gepi.20631; Chen ZH, 2005, AM J HUM GENET, V77, P661, DOI 10.1086/491658; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Fowler JH, 2011, P NATL ACAD SCI USA, V108, P1993, DOI 10.1073/pnas.1011687108; Guttmacher AE, 2013, NEW ENGL J MED, V369, P1873, DOI 10.1056/NEJMp1311150; HAJEK J, 1964, ANN MATH STAT, V35, P1491, DOI 10.1214/aoms/1177700375; Harris KM, 2013, TWIN RES HUM GENET, V16, P391, DOI 10.1017/thg.2012.137; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; HuYjek J., 1960, PUBL MATH I HUNG, V5, P361; Johnson C.L., 2014, VITAL HLTH STAT, V162, P1; Korn EL, 2011, ANAL HLTH SURVEYS; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Li DL, 2011, GENET EPIDEMIOL, V35, P790, DOI 10.1002/gepi.20628; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin DY, 2013, P NATL ACAD SCI USA, V110, P12247, DOI 10.1073/pnas.1221713110; Lin DY, 2000, BIOMETRIKA, V87, P37, DOI 10.1093/biomet/87.1.37; Little RJ, 2004, J AM STAT ASSOC, V99, P546, DOI 10.1198/016214504000000467; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Page GP, 1999, AM J HUM GENET, V64, P1194, DOI 10.1086/302331; Pfeffermann D., 1999, SANKHYA SER B, V61, P166; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROSEN B, 1972, ANN MATH STAT, V43, P373, DOI 10.1214/aoms/1177692620; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang XF, 2013, GENET EPIDEMIOL, V37, P778, DOI 10.1002/gepi.21763; Xiong MM, 2002, HUM HERED, V53, P158, DOI 10.1159/000064978	36	45	45	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					675	688		10.1016/j.ajhg.2014.11.005	http://dx.doi.org/10.1016/j.ajhg.2014.11.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25480034	Green Published, Bronze			2022-12-18	WOS:000346623100004
J	Chen, ES; Gigek, CO; Rosenfeld, JA; Diallo, AB; Maussion, G; Chen, GG; Vaillancourt, K; Lopez, JP; Crapper, L; Poujol, R; Shaffer, LG; Bourque, G; Ernst, C				Chen, Elizabeth S.; Gigek, Carolina O.; Rosenfeld, Jill A.; Diallo, Alpha B.; Maussion, Gilles; Chen, Gary G.; Vaillancourt, Kathryn; Lopez, Juan P.; Crapper, Liam; Poujol, Raphael; Shaffer, Lisa G.; Bourque, Guillaume; Ernst, Carl			Molecular Convergence of Neurodevelopmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; COPY NUMBER VARIATION; INTELLECTUAL DISABILITY; DIAGNOSTIC BOUNDARIES; DEVELOPMENTAL DELAY; GENETIC-VARIATION; DNA METHYLATION; HUMAN GENOME; CELLS; COMPLEX	Neurodevelopmental disorders (NDDs) are caused by mutations in diverse genes involved in different cellular functions, although there can be crosstalk, or convergence, between molecular pathways affected by different NDDs. To assess molecular convergence, we generated human neural progenitor cell models of 9q34 deletion syndrome, caused by haploinsufficiency of EHMT1, and 18q21 deletion syndrome, caused by haploinsufficiency of TCF4. Using next-generation RNA sequencing, methylation sequencing, chromatin immunoprecipitation sequencing, and whole-genome miRNA analysis, we identified several levels of convergence. We found mRNA and miRNA expression patterns that were more characteristic of differentiating cells than of proliferating cells, and we identified CpG clusters that had similar methylation states in both models of reduced gene dosage. There was significant overlap of gene targets of TCF4 and EHMT1, whereby 8.3% of TCF4 gene targets and 4.2% of EHMT1 gene targets were identical. These data suggest that 18q21 and 9q34 deletion syndromes show significant molecular convergence but distinct expression and methylation profiles. Common intersection points might highlight the most salient features of disease and provide avenues for similar treatments for NDDs caused by different genetic mutations.	[Chen, Elizabeth S.; Gigek, Carolina O.; Diallo, Alpha B.; Maussion, Gilles; Chen, Gary G.; Vaillancourt, Kathryn; Crapper, Liam; Poujol, Raphael; Ernst, Carl] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada; [Chen, Elizabeth S.; Gigek, Carolina O.; Diallo, Alpha B.; Maussion, Gilles; Chen, Gary G.; Vaillancourt, Kathryn; Lopez, Juan P.; Crapper, Liam; Poujol, Raphael; Ernst, Carl] Douglas Hosp, Res Inst, McGill Grp Suicide Studies, Montreal, PQ H4H 1R3, Canada; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Lopez, Juan P.; Bourque, Guillaume; Ernst, Carl] McGill Univ, Dept Human Genet, Montreal, PQ H4H 1R3, Canada; [Shaffer, Lisa G.] Genet Vet Sci Inc, Paw Print Genet, Spokane, WA 99202 USA; [Bourque, Guillaume] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Bourque, Guillaume] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada	McGill University; McGill University; McGill University; McGill University	Ernst, C (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada.	carl.ernst@mcgill.ca	Bourque, Guillaume/AFR-2927-2022; Maussion, Gilles/AAA-2027-2021; Chen, Elizabeth/G-1598-2012; Chen, Elizabeth Suchi/CAF-4285-2022; Lopez, Juan Pablo/AAM-5727-2021; Lopez, Juan Pablo/ABF-2377-2020	Bourque, Guillaume/0000-0002-3933-9656; Maussion, Gilles/0000-0001-5785-6238; Chen, Elizabeth/0000-0002-3573-0164; Chen, Elizabeth Suchi/0000-0002-3573-0164; Lopez, Juan Pablo/0000-0002-5812-4220; Gigek, Carolina/0000-0003-4857-687X	Scottish Rite Charitable Foundation; Banting Foundation; Canada Research Chairs program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico scholarship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Canadian Institute of Health Research; Fonds de Recherche de Quebec Sante	Scottish Rite Charitable Foundation; Banting Foundation; Canada Research Chairs program(Canada Research Chairs); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico scholarship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche de Quebec Sante	This work was funded by a grant from the Scottish Rite Charitable Foundation and the Banting Foundation to C.E., who is supported by the Canada Research Chairs program. C.O.G. is supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico scholarship, E.S.C. is supported by a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, K.V. and J.P.L. are supported by the Canadian Institute of Health Research, and L.C. is supported by the Fonds de Recherche de Quebec Sante. We are grateful to Maria Antonietta Davoli and Naguib Mechawar for help and advice on performing fluorescent microscopy and microscopy analysis.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Balemans MCM, 2014, DEV BIOL, V386, P395, DOI 10.1016/j.ydbio.2013.12.016; Chen GG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-290; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Deng ZQ, 2013, J BIOL CHEM, V288, P319, DOI 10.1074/jbc.M112.418830; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Ernst C, 2008, J NEUROSCI METH, V174, P123, DOI 10.1016/j.jneumeth.2008.06.027; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Korzh Vladimir P., 1994, Current Opinion in Neurobiology, V4, P21, DOI 10.1016/0959-4388(94)90027-2; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Vinas JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060937; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Qu QH, 2013, MOL CELL BIOL, V33, P2551, DOI 10.1128/MCB.00325-13; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Xu HY, 2011, HUM MUTAT, V32, P1341, DOI 10.1002/humu.21601	42	45	47	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					490	508		10.1016/j.ajhg.2014.09.013	http://dx.doi.org/10.1016/j.ajhg.2014.09.013			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25307298	Green Published, Bronze			2022-12-18	WOS:000344845000002
J	Duggan, AT; Evans, B; Friedlaender, FR; Friedlaender, JS; Koki, G; Merriwether, DA; Kayser, M; Stoneking, M				Duggan, Ana T.; Evans, Bethwyn; Friedlaender, Frangoise R.; Friedlaender, Jonathan S.; Koki, George; Merriwether, D. Andrew; Kayser, Manfred; Stoneking, Mark			Maternal History of Oceania from Complete mtDNA Genomes: Contrasting Ancient Diversity with Recent Homogenization Due to the Austronesian Expansion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; EVOLUTIONARY HISTORY; LATE COLONIZATION; HUMAN OCCUPATION; SOLOMON-ISLANDS; GLOBIN GENES; SANTA-CRUZ; PACIFIC; POPULATION; POLYNESIANS	Archaeology, linguistics, and existing genetic studies indicate that Oceania was settled by two major waves of migration. The first migration took place approximately 40 thousand years ago and these migrants, Papuans, colonized much of Near Oceania. Approximately 3.5 thousand years ago, a second expansion of Austronesian-speakers arrived in Near Oceania and the descendants of these people spread to the far corners of the Pacific, colonizing Remote Oceania. To assess the female contribution of these two human expansions to modern populations and to investigate the potential impact of other migrations, we obtained 1,331 whole mitochondrial genome sequences from 34 populations spanning both Near and Remote Oceania. Our results quantify the magnitude of the Austronesian expansion and demonstrate the homogenizing effect of this expansion on almost all studied populations. With regards to Papuan influence, autochthonous haplogroups support the hypothesis of a long history in Near Oceania, with some lineages suggesting a time depth of 60 thousand years, and offer insight into historical interpopulation dynamics. Santa Cruz, a population located in Remote Oceania, is an anomaly with extreme frequencies of autochthonous haplogroups of Near Oceanian origin; simulations to investigate whether this might reflect a pre-Austronesian versus Austronesian settlement of the island failed to provide unequivocal support for either scenario.	[Duggan, Ana T.; Stoneking, Mark] Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Evans, Bethwyn] Australian Natl Univ, Coll Asia & Pacific, Canberra, ACT 0200, Australia; [Friedlaender, Frangoise R.; Friedlaender, Jonathan S.] Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA; [Koki, George] Inst Med Res, Goroka 441, Papua N Guinea; [Merriwether, D. Andrew] SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; [Kayser, Manfred] Erasmus MC Univ, Med Ctr Rotterdam, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands	Max Planck Society; Australian National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; PNG Institute Of Medical Research; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Erasmus University Rotterdam; Erasmus MC	Stoneking, M (corresponding author), Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	stoneking@eva.mpg.de	Duggan, Ana T./G-8839-2016	Duggan, Ana/0000-0002-2582-2954	Max Planck Society; Wenner-Gren Foundation for Anthropological Research; National Science Foundation; National Geographic Society	Max Planck Society(Max Planck SocietyFoundation CELLEX); Wenner-Gren Foundation for Anthropological Research; National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society)	We thank all sample donors for contributing to this study and the numerous individuals in Bougainville who assisted with the sample collection. We thank the Sequencing Group within the Evolutionary Genetics Department for expert production of the sequences, and Gabriel Renaud and Udo Stenzel for their assistance with the HiSeq data. We thank Chiara Barbieri, Sebastian Lippold, and Sebastian Zollner for helpful discussions and suggestions. We thank Laura Banuelos, Torsten Blass, Alexander Hubner, and Roland Schroder for technical assistance. We thank Peter Sheppard and David Roe for sharing their knowledge of Near Oceanian archaeology. We thank Brigitte Pakendorf for helpful comments on the manuscript. This research was supported by the Max Planck Society, the Wenner-Gren Foundation for Anthropological Research, the National Science Foundation, and the National Geographic Society.	Athens J. S., 2002, ARCHAEOL OCEAN, V37, P57, DOI DOI 10.1002/j.1834-4453.2002.tb00507.x; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbieri C, 2012, MOL BIOL EVOL, V29, P1213, DOI 10.1093/molbev/msr291; Bellwood P., 1978, MANS CONQUEST PACIFI; Benton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035026; BLUST R, 1995, J WORLD PREHIST, V9, P453, DOI 10.1007/BF02221119; Cox MP, 2012, P ROY SOC B-BIOL SCI, V279, P2761, DOI 10.1098/rspb.2012.0012; Delfin F, 2014, EUR J HUM GENET, V22, P228, DOI 10.1038/ejhg.2013.122; Delfin F, 2012, MOL BIOL EVOL, V29, P545, DOI 10.1093/molbev/msr186; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fredricksen C., 1993, SAHUL REV, V24, P144; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Friedlaender JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000248; Friedlaender JS, 2002, HUM BIOL, V74, P453, DOI 10.1353/hub.2002.0029; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Green R.C., 1995, NZ J ARCHAEOLOGY, V17, P5; Green RC, 2008, ARCHAEOL OCEAN, V43, P49, DOI 10.1002/j.1834-4453.2008.tb00030.x; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Gunnarsdottir ED, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1235; Hall T.A., 1999, NUCLC ACIDS S, V41, P95, DOI citeulike-article-id:691774; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hogbin HI, 1940, J POLYNESIAN SOC, V49, P199; Hogg AG, 2003, ANTIQUITY, V77, P116, DOI 10.1017/S0003598X00061408; Hunley K., 2007, GENES LANGUAGE CULTU, P141; Hunt TL, 2006, SCIENCE, V311, P1603, DOI 10.1126/science.1121879; Hurles ME, 2002, GENETICS, V160, P289; Jinam TA, 2012, MOL BIOL EVOL, V29, P3513, DOI 10.1093/molbev/mss169; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kirch P.V., 2017, ROAD WINDS ARCHAEOLO; Kirch PV, 2010, ANNU REV ANTHROPOL, V39, P131, DOI 10.1146/annurev.anthro.012809.104936; KIRCH PV, 1988, RADIOCARBON, V30, P161, DOI 10.1017/S0033822200044106; KIRCH PV, 1984, J PAC HIST, V19, P224, DOI 10.1080/00223348408572496; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Leavesley M.G., 2004, ANTIQUITY, V78, P318; Leavesley MG., 2002, AUST ARCHAEOL, V54, P55, DOI [10.1080/03122417.2002.11682070, DOI 10.1080/03122417.2002.11682070]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lynch J., 2002, OCEANIC LANGUAGES; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; MELTON T, 1995, AM J HUM GENET, V57, P403; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Meyer M, 2010, ILLUMINA SEQUENCING; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Pawley A., 2007, POPULATION GENETICS, P36; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Razafindrazaka H, 2010, EUR J HUM GENET, V18, P575, DOI 10.1038/ejhg.2009.222; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Roe D., 1993, THESIS AUSTR NATL U; Ross M, 2007, OCEAN LINGUIST, V46, P456; Ross Malcolm, 1988, PROTOOCEANIC AUSTRON; Scheinfeldt L, 2006, MOL BIOL EVOL, V23, P1628, DOI 10.1093/molbev/msl028; Sheppard PJ, 2006, J POLYNESIAN SOC, V115, P47; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; Specht J., 1997, ASIAN PERSPECT, V36, P175; SPRIGGS M, 1993, ANTIQUITY, V67, P200, DOI 10.1017/S0003598X00045324; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Summerhayes Glenn R., 2001, ARCHAEOL OCEAN, V36, P53, DOI DOI 10.1002/J.1834-4453.2001.TB00478.X; SUMMERHAYES GR, 2007, GENES LANGUAGE CULTU, P10; SYKES B, 1995, AM J HUM GENET, V57, P1463; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; TRENT RJ, 1986, AM J HUM GENET, V39, P350; TRENT RJ, 1988, AM J HUM GENET, V42, P601; Tryon D. T., 1983, SOLOMON ISLANDS LANG; Tumonggor MK, 2013, J HUM GENET, V58, P165, DOI 10.1038/jhg.2012.154; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Walker JA, 2005, ANAL BIOCHEM, V337, P89, DOI 10.1016/j.ab.2004.09.036; Walter R., 2009, LAPITA ANCESTORS DES, P35; Whyte ALH, 2005, HUM BIOL, V77, P157, DOI 10.1353/hub.2005.0045; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WICKLER S, 1988, ANTIQUITY, V62, P703, DOI 10.1017/S0003598X00075104; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040	91	45	45	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					721	733		10.1016/j.ajhg.2014.03.014	http://dx.doi.org/10.1016/j.ajhg.2014.03.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	AG5VB	24726474	Green Published, Bronze			2022-12-18	WOS:000335485700006
J	Gonzalez, JR; Caceres, A; Esko, T; Cusco, I; Puig, M; Esnaola, M; Reina, J; Siroux, V; Bouzigon, E; Nadif, R; Reinmaa, E; Milani, L; Bustamante, M; Jarvis, D; Anto, JM; Sunyer, J; Demenais, F; Kogevinas, M; Metspalu, A; Caceres, M; Perez-Jurado, LA				Gonzalez, Juan R.; Caceres, Alejandro; Esko, Tonu; Cusco, Ivon; Puig, Marta; Esnaola, Mikel; Reina, Judith; Siroux, Valerie; Bouzigon, Emmanuelle; Nadif, Rachel; Reinmaa, Eva; Milani, Lili; Bustamante, Mariona; Jarvis, Deborah; Anto, Josep M.; Sunyer, Jordi; Demenais, Florence; Kogevinas, Manolis; Metspalu, Andres; Caceres, Mario; Perez-Jurado, Luis A.			A Common 16p11.2 Inversion Underlies the Joint Susceptibility to Asthma and Obesity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							I INTERFERON; ASSOCIATION; DELETIONS; LOCI; HYPERRESPONSIVENESS; IDENTIFICATION; EXPRESSION; GENETICS; SEQUENCE; ORIGIN	The prevalence of asthma and obesity is increasing worldwide, and obesity is a well-documented risk factor for asthma. The mechanisms underlying this association and parallel time trends remain largely unknown but genetic factors may be involved. Here, we report on a common similar to 0.45 Mb genomic inversion at 16p11.2 that can be accurately genotyped via SNP array data. We show that the inversion allele protects against the joint occurrence of asthma and obesity in five large independent studies (combined sample size of 317 cases and 543 controls drawn from a total of 5,809 samples; combined OR = 0.48, p = 5.5 3 x 10(-6)). Allele frequencies show remarkable worldwide population stratification, ranging from 10% in East Africa to 49% in Northern Europe, consistent with discordant and extreme genetic drifts or adaptive selections after human migration out of Africa. Inversion alleles strongly correlate with expression levels of neighboring genes, especially TUFM (p = 3.0 x 10(-40)) that encodes a mitochondrial protein regulator of energy balance and inhibitor of type 1 interferon, and other candidates for asthma (IL27) and obesity (APOB48R and SH2B1). Therefore, by affecting gene expression, the similar to 0.45 Mb 16p11.2 inversion provides a genetic basis for the joint susceptibility to asthma and obesity, with a population attributable risk of 39.7%. Differential mitochondrial function and basal energy balance of inversion alleles might also underlie the potential selection signature that led to their uneven distribution in world populations.	[Gonzalez, Juan R.; Caceres, Alejandro; Esnaola, Mikel; Bustamante, Mariona; Anto, Josep M.; Sunyer, Jordi; Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain; [Gonzalez, Juan R.; Caceres, Alejandro; Cusco, Ivon; Esnaola, Mikel; Reina, Judith; Bustamante, Mariona; Jarvis, Deborah; Perez-Jurado, Luis A.] Hosp Mar Res Inst, IMIM, Barcelona 08003, Spain; [Gonzalez, Juan R.; Esnaola, Mikel; Kogevinas, Manolis] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona 08003, Spain; [Gonzalez, Juan R.; Sunyer, Jordi] Univ Autonoma Barcelona, Dept Math, Bellaterra 08193, Barcelona, Spain; [Esko, Tonu; Reinmaa, Eva; Milani, Lili; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Reinmaa, Eva; Milani, Lili; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Cusco, Ivon; Reina, Judith; Anto, Josep M.; Sunyer, Jordi; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Cusco, Ivon; Reina, Judith; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona 08003, Spain; [Puig, Marta; Caceres, Mario] Univ Auto noma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Siroux, Valerie] UJF, INSERM, Inst Albert Bonniot, U823, F-38042 Grenoble, France; [Siroux, Valerie] Univ Grenoble 1, F-38041 Grenoble, France; [Bouzigon, Emmanuelle] INSERM, Genet Variat Human Dis Unit, UMRS 946, F-75010 Paris, France; [Bouzigon, Emmanuelle; Demenais, Florence] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, F-75010 Paris, France; [Nadif, Rachel] INSERM, CESP, Ctr Res Epidemiol & Populat Hlth, Resp & Environm Epidemiol Team,U1018, F-94807 Villejuif, France; [Nadif, Rachel] Univ Paris Sud 11, UMRS 1018, F-94807 Villejuif, France; [Bustamante, Mariona] Ctr Genom Regulat CRG, Genes & Dis Grp, Barcelona 08003, Spain; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens 11521, Greece; [Caceres, Mario] ICREA, Barcelona 08010, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Tartu; University of Tartu; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Imperial College London; National & Kapodistrian University of Athens; ICREA	Gonzalez, JR (corresponding author), Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain.	jrgonzalez@creal.cat; luis.perez@upf.edu	Milani, Lili/C-8759-2011; Bustamante, Mariona/M-7277-2015; Puig, Marta/F-7885-2016; Milani, Lili/N-1097-2019; Pérez Jurado, Luis Alberto/M-7706-2015; Nadif, Rachel/R-2876-2016; Cusco, I/H-2096-2014; Bouzigon, Emmanuelle/L-2766-2017; Kogevinas, Manolis/C-3918-2017; Gonzalez, Juan R/B-7860-2018; Demenais, Florence/G-3298-2013; Sunyer, Jordi/G-6909-2014; Caceres, Alejandro/ABF-4180-2021; Cáceres, Mario/A-6379-2009; Cusco, Ivon/AAF-4662-2021; Bustamante, Mariona/ABB-9142-2021; siroux, valerie/N-1865-2013; Anto, J M/H-2676-2014	Milani, Lili/0000-0002-5323-3102; Bustamante, Mariona/0000-0003-0127-2860; Puig, Marta/0000-0002-4439-6372; Milani, Lili/0000-0002-5323-3102; Nadif, Rachel/0000-0003-4938-9339; Cusco, I/0000-0003-2104-9332; Bouzigon, Emmanuelle/0000-0001-5756-4286; Kogevinas, Manolis/0000-0002-9605-0461; Gonzalez, Juan R/0000-0003-3267-2146; Demenais, Florence/0000-0001-8361-0936; Sunyer, Jordi/0000-0002-2602-4110; Cáceres, Mario/0000-0002-7736-3251; Cusco, Ivon/0000-0003-2104-9332; Bustamante, Mariona/0000-0003-0127-2860; siroux, valerie/0000-0001-7329-7237; Anto, J M/0000-0002-4736-8529; Caceres, Alejandro/0000-0001-8551-6695; Jarvis, Deborah/0000-0002-1753-3896	Spanish Ministry of Science and Innovation [MTM2008-02457]; Statistical Genetics Network - GENOMET [MTM2010-09526-E]; European Research Council (ERC) [243212-INVFEST]; Spanish Ministry of Science and Innovation-ISCIII-FEDER [FIS PI10/2512, PI13/02481]; Catalan Department of Economy and Knowledge [2009SGR1274]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Statistical Genetics Network - GENOMET; European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation-ISCIII-FEDER; Catalan Department of Economy and Knowledge; ICREA(ICREA)	We thank David Izquierdo and Raquel Flores for technical help and Joel Martin for kindly providing the entire sequence of the EIFVar2 haplotype. Work was supported by the Spanish Ministry of Science and Innovation (MTM2008-02457) and Statistical Genetics Network - GENOMET (MTM2010-09526-E) to J.R.G., the European Research Council (ERC) Starting Grant (243212-INVFEST) to M. C., and the Spanish Ministry of Science and Innovation-ISCIII-FEDER (FIS PI10/2512 and PI13/02481) and the Catalan Department of Economy and Knowledge (2009SGR1274 and ICREA Academia) to L.A.P.-J. Supplemental Data contains detailed information about acknowledgements of EGCUT, ECRHS, EGEA, and dbGAP studies.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Bartlett NW, 2012, EMBO MOL MED, V4, P1244, DOI 10.1002/emmm.201201650; Belostotsky R, 2012, RNA BIOL, V9, P33, DOI 10.4161/rna.9.1.18009; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Beuther DA, 2010, CURR OPIN PULM MED, V16, P64, DOI 10.1097/MCP.0b013e3283338fa7; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Caceres A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-28; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; Chae SC, 2007, J HUM GENET, V52, P355, DOI 10.1007/s10038-007-0123-8; Chen Jie, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P521; Chinn S, 2006, EUR RESPIR J, V28, P763, DOI 10.1183/09031936.06.00150505; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gonzalez JR, 2008, GENET EPIDEMIOL, V32, P246, DOI 10.1002/gepi.20299; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Greenberg H, 2012, CURR OPIN PULM MED, V18, P57, DOI 10.1097/MCP.0b013e32834d098e; Guha S, 2013, JAMA PSYCHIAT, V70, P253, DOI 10.1001/2013.jamapsychiatry.71; Gutierrez-Aguilar R, 2012, OBESITY, V20, P306, DOI 10.1038/oby.2011.236; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; KAUFFMANN F, 1995, CLIN EXP ALLERGY, V25, P19, DOI 10.1111/j.1365-2222.1995.tb00413.x; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Leonard WR, 2002, AM J HUM BIOL, V14, P609, DOI 10.1002/ajhb.10072; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040224; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Montanari A, 2013, GENE, V527, P1, DOI 10.1016/j.gene.2013.05.042; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Varela LM, 2011, AM J CLIN NUTR, V93, P918, DOI 10.3945/ajcn.110.007765; Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323	44	45	47	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					361	372		10.1016/j.ajhg.2014.01.015	http://dx.doi.org/10.1016/j.ajhg.2014.01.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24560518	Bronze, Green Published			2022-12-18	WOS:000332611400010
J	Akizu, N; Silhavy, JL; Rosti, RO; Scott, E; Fenstermaker, AG; Schroth, J; Zaki, MS; Sanchez, H; Gupta, N; Kabra, M; Kara, M; Ben-Omran, T; Rosti, B; Guemez-Gamboa, A; Spencer, E; Pan, R; Cai, N; Abdellateef, M; Gabriel, S; Halbritter, J; Hildebrandt, F; van Bokhoven, H; Gunel, M; Gleeson, JG				Akizu, Naiara; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Scott, Eric; Fenstermaker, Ali G.; Schroth, Jana; Zaki, Maha S.; Sanchez, Henry; Gupta, Neerja; Kabra, Madhulika; Kara, Majdi; Ben-Omran, Tawfeg; Rosti, Basak; Guemez-Gamboa, Alicia; Spencer, Emily; Pan, Roger; Cai, Na; Abdellateef, Mostafa; Gabriel, Stacey; Halbritter, Jan; Hildebrandt, Friedhelm; van Bokhoven, Hans; Gunel, Murat; Gleeson, Joseph G.			Mutations in CSPP1 Lead to Classical Joubert Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISORDERS; CILIA; ORGANIZATION; ARCHITECTURE; SPINDLE; CELLS	Joubert syndrome and related disorders (JSRDs) are genetically heterogeneous and characterized by a distinctive mid-hindbrain malformation. Causative mutations lead to primary cilia dysfunction, which often results in variable involvement of other organs such as the liver, retina, and kidney. We identified predicted null mutations in CSPP1 in six individuals affected by classical JSRDs. CSPP1 encodes a protein localized to centrosomes and spindle poles, as well as to the primary cilium. Despite the known interaction between CSPP1 and nephronophthisis-associated proteins, none of the affected individuals in our cohort presented with kidney disease, and further, screening of a large cohort of individuals with nephronophthisis demonstrated no mutations. CSPP1 is broadly expressed in neural tissue, and its encoded protein localizes to the primary cilium in an in vitro model of human neurogenesis. Here, we show abrogated protein levels and ciliogenesis in affected fibroblasts. Our data thus suggest that CSPP1 is involved in neural-specific functions of primary cilia.	[Akizu, Naiara; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Scott, Eric; Fenstermaker, Ali G.; Schroth, Jana; Rosti, Basak; Guemez-Gamboa, Alicia; Spencer, Emily; Pan, Roger; Cai, Na; Abdellateef, Mostafa; Gleeson, Joseph G.] Univ Calif San Diego, Inst Genom Med, Neurogenet Lab, San Diego, CA 92093 USA; [Akizu, Naiara; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Scott, Eric; Fenstermaker, Ali G.; Schroth, Jana; Rosti, Basak; Guemez-Gamboa, Alicia; Spencer, Emily; Pan, Roger; Cai, Na; Abdellateef, Mostafa; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Akizu, Naiara; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Scott, Eric; Fenstermaker, Ali G.; Schroth, Jana; Rosti, Basak; Guemez-Gamboa, Alicia; Spencer, Emily; Pan, Roger; Cai, Na; Abdellateef, Mostafa; Gleeson, Joseph G.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Akizu, Naiara; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Scott, Eric; Fenstermaker, Ali G.; Schroth, Jana; Rosti, Basak; Guemez-Gamboa, Alicia; Spencer, Emily; Pan, Roger; Cai, Na; Abdellateef, Mostafa; Halbritter, Jan; Hildebrandt, Friedhelm; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo 12311, Egypt; [Sanchez, Henry] Palo Alto Med Fdn, Dept Pediat, Fremont, CA 94538 USA; [Gupta, Neerja; Kabra, Madhulika] All India Inst Med Sci, Div Genet, Dept Pediat, New Delhi 110029, India; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha 3050, Qatar; [Gabriel, Stacey] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Halbritter, Jan; Hildebrandt, Friedhelm] Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Halbritter, Jan; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston, MA 02115 USA; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, Yale Program Neurogenet, New Haven, CT 06510 USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, Yale Program Neurogenet, New Haven, CT 06510 USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Genet, Yale Program Neurogenet, New Haven, CT 06510 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Palo Alto Medical Foundation Research Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; Hamad Medical Corporation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Radboud University Nijmegen; Yale University; Yale University; Yale University	Gleeson, JG (corresponding author), Univ Calif San Diego, Inst Genom Med, Neurogenet Lab, San Diego, CA 92093 USA.	jogleeson@ucsd.edu	Zaki, Maha S/B-9361-2013; Gupta, Neerja/X-9960-2019; Wang, Guilin/G-8794-2018; Bokhoven, J.H.L.M. van van/H-8015-2014	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Zaki, Maha/0000-0001-7840-0002; kabra, madhulika/0000-0003-3315-9782; Guemez-Gamboa, Alicia/0000-0001-6890-4661; , NeerjaG/0000-0001-9640-4728; Spencer, Emily/0000-0003-2650-4357	National Institutes of Health [R01NS041537, R01NS048453, R01NS052455, P01HD070494, P30NS047101, DK068306]; Howard Hughes Medical Institute; California Institute of Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, P30DK079310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, R01NS041537, R01NS048453, P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the affected children and their families for their invaluable contributions to this study, supported by National Institutes of Health grants R01NS041537, R01NS048453, R01NS052455, P01HD070494, and P30NS047101 (J.G.G.) and DK068306 (F.H.), the Howard Hughes Medical Institute (J.G.G. and F.H.), and the California Institute of Regenerative Medicine (N.A.). We thank the Broad Institute (U54HG003067 to E. Lander), the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton and M. Gunel) for sequencing support, T. Caspary for ARL13B antibody, and J. Santini at the University of California, San Diego Neuroscience Microscopy Core. CSPP1 has been designated as JBTS21 by the HUGO Gene Nomenclature Committee.	Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Kroes HY, 2010, INT J PEDIATR OTORHI, V74, P1034, DOI 10.1016/j.ijporl.2010.05.034; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Patzke S, 2005, ONCOGENE, V24, P1159, DOI 10.1038/sj.onc.1208267; Patzke S, 2006, J CELL PHYSIOL, V209, P199, DOI 10.1002/jcp.20725; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sattar S, 2011, DEV MED CHILD NEUROL, V53, P793, DOI 10.1111/j.1469-8749.2011.04021.x; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003	17	45	50	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					80	86		10.1016/j.ajhg.2013.11.015	http://dx.doi.org/10.1016/j.ajhg.2013.11.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360807	Green Published, Bronze			2022-12-18	WOS:000329888400008
J	Tu, X; Nie, SF; Liao, YH; Zhang, HS; Fan, Q; Xu, CQ; Bai, Y; Wang, F; Ren, X; Tang, TT; Xia, N; Li, SS; Huang, Y; Liu, J; Yang, Q; Zhao, YY; Lv, QL; Li, QX; Li, Y; Xia, YL; Qian, J; Li, B; Wu, G; Wu, YX; Yang, Y; Wang, QK; Cheng, X				Tu, Xin; Nie, Shaofang; Liao, Yuhua; Zhang, Hongsong; Fan, Qian; Xu, Chengqi; Bai, Ying; Wang, Fan; Ren, Xiang; Tang, Tingting; Xia, Ni; Li, Sisi; Huang, Yuan; Liu, Juan; Yang, Qing; Zhao, Yuanyuan; Lv, Qiulun; Li, Qingxian; Li, Yue; Xia, Yunlong; Qian, Jin; Li, Bin; Wu, Gang; Wu, Yanxia; Yang, Yan; Wang, Qing K.; Cheng, Xiang			The IL-33-ST2L Pathway Is Associated with Coronary Artery Disease in a Chinese Han Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; SUSCEPTIBILITY LOCI; ENDOTHELIAL-CELLS; HEART-DISEASE; MYOCARDIAL-INFARCTION; HUMAN BASOPHILS; IL-1 FAMILY; MAST-CELLS; ST2 GENE	The effects of interleukin-33 (IL-33) on the immune system have been clearly demonstrated; however, in cardiovascular diseases, especially in coronary artery disease (CAD), these effects have not yet been clarified. In this study, we investigate the genetic role of the IL-33-ST2L pathway in CAD. We performed three-stage case-control association analyses on a total of 4,521 individuals with CAD and 4,809 controls via tag SNPs in the genes encoding IL-33 and ST2L-IL-1RL1. One tag SNP in each gene was significantly associated with CAD (rs7025417(T) in IL33, p(adj) = 1.19 x 10(-28), OR = 1.39, 95% CI: 1.31-1.47; rs11685424(G) in IL1RL1, p(adj) = 6.93 x 10(-30), OR = 1.40, 95% CI: 1.32-1.48). Combining significant variants in two genes, the risk for CAD increased nearly 5-fold (p(adj) = 8.90 x 10(-21), OR = 4.98, 95% CI: 3.56-6.97). Traditional risk factors for CAD were adjusted for the association studies by SPSS with logistic regression analysis. With the two variants above, both located within the gene promoter regions, reporter gene analysis indicated that the rs7025417 C>T and rs11685424 A>G changes resulted in altered regulation of IL33 and IL1RL1 gene expression, respectively (p < 0.005). Further studies revealed that the rs7025417 genotype was significantly associated with plasma IL-33 levels in the detectable subjects (n = 227, R-2 = 0.276, p = 1.77 x 10(-17)): the level of IL-33 protein increased with the number of rs7025417 risk (T) alleles. Based on genetic evidence in humans, the IL-33-ST2L pathway appears to have a causal role in the development of CAD, highlighting this pathway as a valuable target for the prevention and treatment of CAD.	[Tu, Xin; Xu, Chengqi; Bai, Ying; Ren, Xiang; Li, Sisi; Huang, Yuan; Yang, Qing; Zhao, Yuanyuan; Lv, Qiulun; Wang, Qing K.] Huazhong Univ Sci & Technol, Cardio Inst X, Ctr Human Genome Res,Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Nie, Shaofang; Liao, Yuhua; Zhang, Hongsong; Fan, Qian; Tang, Tingting; Xia, Ni; Liu, Juan; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Lab Cardiovasc Immunol,Inst Cardiol, Wuhan 430000, Peoples R China; [Wang, Fan] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Li, Qingxian] Affiliated Hosp, Jining Med Coll, Dept Cardiol, Jining 272000, Peoples R China; [Li, Yue] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Peoples R China; [Xia, Yunlong] Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Peoples R China; [Qian, Jin] Suizhou Cent Hosp, Dept Cardiol, Suizhou 441300, Peoples R China; [Li, Bin] Xiangyang Cent Hosp, Dept Cardiol, Xiangyang 441021, Peoples R China; [Wu, Gang] Wuhan Univ, Renmin Hosp, Wuhan 430060, Peoples R China; [Wu, Yanxia] Wuhan 1 Hosp, Wuhan 430032, Peoples R China; [Yang, Yan] Wuhan Asia Heart Hosp, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Yale University; Jining Medical University; Harbin Medical University; Dalian Medical University; Wuhan University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Cardio Inst X, Ctr Human Genome Res,Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China.	qkwang@mail.hust.edu.cn; nathancx@mail.hust.edu.cn	饭, 蔡/AAI-5850-2020; Zhang, Hongsong/AGH-4158-2022; Lu, Qiulun/A-7073-2018; Zhao, Yuanyuan/AAY-6670-2021; Wu, yanxia/HGA-0318-2022	Zhang, Hongsong/0000-0003-4251-7609; Zhao, Yuanyuan/0000-0003-0217-3290; WANG, FAN/0000-0001-9806-5037; Xu, Chengqi/0000-0002-4269-6830	National Basic Research Program of China (973 Program) [2013CB531103, 2012CB517800]; National Natural Science Foundation of China [81222002, 81170303, 81070106, 81270163]; Program for New Century Excellent Talents at the University of China [NCET-09-0380, NCET-11-0181]; Hubei Province Natural Science Key Program [2008CDA047]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents at the University of China(Program for New Century Excellent Talents in University (NCET)); Hubei Province Natural Science Key Program	This work was supported by grants from the National Basic Research Program of China (973 Program: 2013CB531103 and 2012CB517800), the National Natural Science Foundation of China (No. 81222002, 81170303, 81070106, and 81270163), the Program for New Century Excellent Talents at the University of China (NCET-09-0380 and NCET-11-0181), and a Hubei Province Natural Science Key Program (2008CDA047).	Aoki S, 2010, MOL CELL BIOCHEM, V335, P75, DOI 10.1007/s11010-009-0244-9; Blagodatskikh KA, 2010, MOL BIOL+, V44, P741, DOI 10.1134/S0026893310050092; Chen YC, 2011, CLIN BIOCHEM, V44, P1041, DOI 10.1016/j.clinbiochem.2011.06.010; Cheng XA, 2011, DIABETES, V60, P680, DOI 10.2337/db10-0185; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Erdmann J, 2011, EUR HEART J, V32, P158, DOI 10.1093/eurheartj/ehq405; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Prins BP, 2012, ATHEROSCLEROSIS, V225, P1, DOI 10.1016/j.atherosclerosis.2012.05.015; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sedhom M.A., 2012, GUT, DOI DOI 10.1136/GUTJN1-2011-301785; Shi LS, 2009, HUM GENET, V126, P843, DOI 10.1007/s00439-009-0737-3; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; Tsapaki A, 2010, J THROMB THROMBOLYS, V30, P365, DOI 10.1007/s11239-010-0496-y; Valent P, 2009, BLOOD, V113, P1396, DOI 10.1182/blood-2008-11-189811; van Minkelen R, 2009, ATHEROSCLEROSIS, V203, P201, DOI 10.1016/j.atherosclerosis.2008.06.029; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Xu CQ, 2010, STROKE, V41, P1587, DOI 10.1161/STROKEAHA.110.583096; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zdravkovic S, 2007, EUR J HUM GENET, V15, P872, DOI 10.1038/sj.ejhg.5201846; Zhang XL, 2011, CLIN CHIM ACTA, V412, P327, DOI 10.1016/j.cca.2010.10.027	51	45	52	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					652	660		10.1016/j.ajhg.2013.08.009	http://dx.doi.org/10.1016/j.ajhg.2013.08.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24075188	Green Published, Bronze			2022-12-18	WOS:000326305600007
J	Gaignard, P; Menezes, M; Schiff, M; Bayot, A; Rak, M; de Baulny, HO; Su, CH; Gilleron, M; Lombes, A; Abida, H; Tzagoloff, A; Riley, L; Cooper, ST; Mina, K; Sivadorai, P; Davis, MR; Allcock, RJN; Kresoje, N; Laing, NG; Thorburn, DR; Slama, A; Christodoulou, J; Rustin, P				Gaignard, Pauline; Menezes, Minal; Schiff, Manuel; Bayot, Aurelien; Rak, Malgorzata; de Baulny, Helene Ogler; Su, Chen-Hsien; Gilleron, Mylene; Lombes, Anne; Abida, Heni; Tzagoloff, Alexander; Riley, Lisa; Cooper, Sandra T.; Mina, Kym; Sivadorai, Padma; Davis, Mark R.; Allcock, Richard J. N.; Kresoje, Nina; Laing, Nigel G.; Thorburn, David R.; Slama, Abdelhamid; Christodoulou, John; Rustin, Pierre			Mutations in CYC1, Encoding Cytochrome c(1) Subunit of Respiratory Chain Complex III, Cause Insulin-Responsive Hyperglycemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BC(1) COMPLEX; DEFICIENCY; MITOCHONDRIA; BCS1L; GENE	Many individuals with abnormalities of mitochondrial respiratory chain complex III remain genetically undefined. Here, we report mutations (c.288G>T [p.Trp96Cys] and c.643C>T [p.Leu215Phe]) in CYC1, encoding the cytochrome c(1) subunit of complex III, in two unrelated children presenting with recurrent episodes of ketoacidosis and insulin-responsive hyperglycemia. Cytochrome c(1), the heme-containing component of complex III, mediates the transfer of electrons from the Rieske iron-sulfur protein to cytochrome c. Cytochrome c(1) is present at reduced levels in the skeletal muscle and skin fibroblasts of affected individuals. Moreover, studies on yeast mutants and affected individuals' fibroblasts have shown that exogenous expression of wild-type CYC1 rescues complex III activity, demonstrating the deleterious effect of each mutation on cytochrome c(1) stability and complex III activity.	[Gaignard, Pauline; Slama, Abdelhamid] Hop Bicetre, AP HP, Lab Biochim, F-94275 Le Kremlin Bicetre, France; [Menezes, Minal; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat, Camperdown, NSW 2006, Australia; [Schiff, Manuel; Bayot, Aurelien; Rak, Malgorzata; Rustin, Pierre] Hop Robert Debre, Inst Natl Sante & Rech Med Unite Mixte Rech 676, F-75019 Paris, France; [Schiff, Manuel; Bayot, Aurelien; Rak, Malgorzata; Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, F-75019 Paris, France; [Schiff, Manuel; de Baulny, Helene Ogler] Hop Robert Debre, AP HP, Reference Ctr Inherited Metab Dis, F-75019 Paris, France; [Su, Chen-Hsien; Abida, Heni; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Gilleron, Mylene; Lombes, Anne] Inst Cochin, Inst Natl Sante & Rech Med Unite Mixte 1016, F-75014 Paris, France; [Gilleron, Mylene; Lombes, Anne] Hop La Pitie Salpetriere, AP HP, Serv Biochim Metabol, F-75651 Paris, France; [Gilleron, Mylene; Lombes, Anne] Hop La Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, F-75651 Paris, France; [Riley, Lisa; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Westmead, NSW 2145, Australia; [Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW 2145, Australia; [Mina, Kym] Royal Perth Hosp, Dept Mol Genet, PathWest Lab Med WA, Perth, WA 6000, Australia; [Mina, Kym; Allcock, Richard J. N.; Kresoje, Nina] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Sivadorai, Padma; Davis, Mark R.] Royal Perth Hosp, PathWest Lab Med WA, Dept Anatom Pathol, Neurogenet Lab, Perth, WA 6000, Australia; [Allcock, Richard J. N.; Kresoje, Nina] Univ Western Australia, Lotterywest State Biomed Facil Genom, Nedlands, WA 6009, Australia; [Kresoje, Nina] Royal Perth Hosp, PathWest Lab Med WA, Dept Clin Immunol, Perth, WA 6000, Australia; [Laing, Nigel G.] Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia; [Laing, Nigel G.] Queen Elizabeth II Med Ctr, Westem Australian Inst Med Res, Nedlands, WA 6009, Australia; [Thorburn, David R.] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Thorburn, David R.] Royal Childrens Hosp, Melbourne, Vic 3052, Australia; [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Christodoulou, John] Univ Sydney, Sydney Med Sch, Camperdown, NSW 2006, Australia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Sydney; University of Sydney; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney	Rustin, P (corresponding author), Hop Robert Debre, Inst Natl Sante & Rech Med Unite Mixte Rech 676, 48 Blvd Serurier, F-75019 Paris, France.	pierre.rustin@inserm.fr	Christodoulou, John/M-3628-2019; Christodoulou, John/E-5866-2015; Lombes, Anne/G-4684-2014; Schiff, Manuel/G-3596-2017; Thorburn, David R/G-6266-2013	Christodoulou, John/0000-0002-8431-0641; Lombes, Anne/0000-0002-9064-0399; Schiff, Manuel/0000-0001-8272-232X; Cooper, Sandra/0000-0002-7314-5097; Laing, Nigel/0000-0001-5111-3732; thorburn, david/0000-0002-7725-9470; Bayot, Aurelien/0000-0001-7236-9948; Gaignard, Pauline/0000-0002-9520-2013	Association contre les Maladies Mitochondria les, Action Remy; Agence Nationale de la Recherche; National Institutes of Health [HL02274]; Australian National Health and Medical Research Council (NHMRC) [1026891]; Australian Mitochondrial Disease Foundation (AMDF); AMDF; NHMRC [1002147, 1022707, 1022896, 1023619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER	Association contre les Maladies Mitochondria les, Action Remy; Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Mitochondrial Disease Foundation (AMDF); AMDF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Alison Compton and Justine Marum for Sequenom analysis and Wendy Salter for enzyme assays. This research was supported by Association contre les Maladies Mitochondria les, Action Remy (A.S. and P.R.), Agence Nationale de la Recherche grants to P.R., National Institutes of Health grant HL02274 to A.T., Australian National Health and Medical Research Council (NHMRC) grant 1026891 to S.C. and J.C., an Australian Mitochondrial Disease Foundation (AMDF) PhD Scholarship to M.M., and AMDF funding support to M.D. and N.G.L. N.G.L. was supported by NHMRC Principal Research Fellowship 1002147 and project grant 1022707. D.R.T. was supported by NHMRC Principal Research Fellowship 1022896 and project grant 1023619. We also gratefully acknowledge donations to J.C. by the Crane and Perkins families.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Miyake N, 2013, HUM MUTAT, V34, P446, DOI 10.1002/humu.22257; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773	15	45	47	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					384	389		10.1016/j.ajhg.2013.06.015	http://dx.doi.org/10.1016/j.ajhg.2013.06.015			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23910460	Bronze, Green Published			2022-12-18	WOS:000323186200018
J	Hatoum, IJ; Greenawalt, DM; Cotsapas, C; Daly, MJ; Reitman, ML; Kaplan, LM				Hatoum, Ida J.; Greenawalt, Danielle M.; Cotsapas, Chris; Daly, Mark J.; Reitman, Marc L.; Kaplan, Lee M.			Weight Loss after Gastric Bypass Is Associated with a Variant at 15q26.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; ENERGY-EXPENDITURE; RISK-FACTORS; BILE; INDIVIDUALS; OVERWEIGHT; SURGERY; OBESITY	The amount of weight loss attained after Roux-en-Y gastric bypass (RYGB) surgery follows a wide and normal distribution, and recent evidence indicates that this weight loss is due to physiological, rather than mechanical, mechanisms. To identify potential genetic factors associated with weight loss after RYGB, we performed a genome-wide association study (GWAS) of 693 individuals undergoing RYGB and then replicated this analysis in an independent population of 327 individuals undergoing RYGB. We found that a 15q26.1 locus near ST8SIA2 and SLCO3A1 was significantly associated with weight loss after RYGB. Expression of ST8SIA2 in omental fat of these individuals at baseline was significantly associated with weight loss after RYGB. Gene expression analysis in RYGB and weight-matched, sham-operated (WMS) mice revealed that expression of St8sia2 and Slco3a1 was significantly altered in metabolically active tissues in RYGB-treated compared to WMS mice. These findings provide strong evidence for specific genetic influences on weight loss after RYGB and underscore the biological nature of the response to RYGB.	[Hatoum, Ida J.; Kaplan, Lee M.] Massachusetts Gen Hosp, Obes Metab & Nutr Inst, Boston, MA 02114 USA; [Hatoum, Ida J.; Kaplan, Lee M.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Hatoum, Ida J.; Cotsapas, Chris; Daly, Mark J.; Kaplan, Lee M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Greenawalt, Danielle M.] Merck Res Labs, Dept Genet, Boston, MA 02115 USA; [Cotsapas, Chris; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cotsapas, Chris; Daly, Mark J.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Reitman, Marc L.] Merck Res Labs, Clin Pharmacol, Rahway, NJ 07065 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Merck & Company	Kaplan, LM (corresponding author), Massachusetts Gen Hosp, Obes Metab & Nutr Inst, Boston, MA 02114 USA.	lmkaplan@partners.org	Reitman, Marc/B-4448-2013; Daly, Mark J/B-2453-2017	Reitman, Marc/0000-0002-0426-9475; Daly, Mark J/0000-0002-0949-8752; Cotsapas, Chris/0000-0002-7772-5910	National Institutes of Health [DK093257, DK088661, DK090956]; Merck Research Laboratories; Ethicon Endo-Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK088661, RC4DK090956, F32DK093257, ZIADK075057, ZIADK075062, P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Ethicon Endo-Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Shubhra Kashyap and Melissa Paziuk for their expert technical assistance, Harveen Dhillon Natarajan and Nadia Ahmad for their help with the animal studies, and Rahul Deo for his invaluable statistical expertise. This work was supported by National Institutes of Health grants DK093257 (I.J.H.), DK088661 (L.M.K.), and DK090956 (L.M.K.) and by research grants from Merck Research Laboratories (L.M.K.) and Ethicon Endo-Surgery (L.M.K.). D.M.G. reports employment by Merck Research Laboratories. M.L.R. reports former employment by Merck Research Laboratories.	Adachi H, 2003, AM J PHYSIOL-RENAL, V285, pF1188, DOI 10.1152/ajprenal.00402.2002; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Bray GA, 2008, ENDOCRIN METAB CLIN, V37, P923, DOI 10.1016/j.ecl.2008.08.004; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hatoum IJ, 2012, J CLIN ENDOCR METAB, V97, pE1023, DOI 10.1210/jc.2011-3432; Hatoum IJ, 2011, J CLIN ENDOCR METAB, V96, pE1630, DOI 10.1210/jc.2011-1130; Hatoum IJ, 2009, OBESITY, V17, P92, DOI 10.1038/oby.2008.507; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Libra A, 2006, J PHARMACOL EXP THER, V319, P809, DOI 10.1124/jpet.106.106591; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McAuley EZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038172; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Ochner CN, 2011, ANN SURG, V253, P502, DOI 10.1097/SLA.0b013e318203a289; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sarahan KA, 2011, PHYSIOL GENOMICS, V43, P1049, DOI 10.1152/physiolgenomics.00134.2010; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Vazza G, 2007, MOL PSYCHIATR, V12, P87, DOI 10.1038/sj.mp.4001895; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Yakata K, 2011, J STRUCT BIOL, V174, P315, DOI 10.1016/j.jsb.2011.01.003	35	45	48	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					827	834		10.1016/j.ajhg.2013.04.009	http://dx.doi.org/10.1016/j.ajhg.2013.04.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643386	Bronze, Green Published			2022-12-18	WOS:000318582800018
J	Lin, ZM; Chen, Q; Shi, L; Lee, MY; Giehl, KA; Tang, ZL; Wang, HJ; Zhang, J; Yin, JH; Wu, LS; Xiao, R; Liu, XZ; Dai, LL; Zhu, XJ; Li, RY; Betz, RC; Zhang, X; Yang, Y				Lin, Zhimiao; Chen, Quan; Shi, Lei; Lee, Mingyang; Giehl, Kathrin A.; Tang, Zhanli; Wang, Huijun; Zhang, Jie; Yin, Jinghua; Wu, Lingshen; Xiao, Ruo; Liu, Xuanzhu; Dai, Lanlan; Zhu, Xuejun; Li, Ruoyu; Betz, Regina C.; Zhang, Xue; Yang, Yong			Loss-of-Function Mutations in HOXC13 Cause Pure Hair and Nail Ectodermal Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; EXPRESSION; FOLLICLE; MULTIPLE; KERATINS; DEFECTS; MATRIX; GROWTH	Pure hair and nail ectodermal dysplasia (PHNED) is a congenital condition characterized by hypotrichosis and nail dystrophy. Autosomal-recessive PHNED has previously been mapped to chromosomal region 12q12-q14.1, which contains the type II hair keratin and HOXC clusters. Hoxc13-null mice are known to develop hair and nail defects very similar to those seen in human PHNED. We performed whole-exome sequencing in a consanguineous Chinese family affected by PHNED and identified a homozygous nonsense mutation (c.390C>A [p.Tyr130*]) in HOXC13 in all affected individuals. In an additional affected female from a consanguineous Afghan family, we found a 27.6 kb homozygous microdeletion involving the first exon of HOXC13. We examined HOXC13 expression in scalp specimen obtained from the index individual of the Chinese family and detected dramatically reduced mRNA levels in skin tissue and nearly absent protein staining in hair follicles, suggesting a mechanism of nonsense-mediated mRNA decay. We also observed markedly decreased expression of four HOXC13 target genes in the specimen. Taken together, our results demonstrate that loss-of-function mutations in HOXC13 cause autosomal-recessive PHNED and further highlight the importance of HOXC13 in hair and nail development.	[Shi, Lei; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China; [Shi, Lei; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Lin, Zhimiao; Chen, Quan; Lee, Mingyang; Wang, Huijun; Zhang, Jie; Yin, Jinghua; Wu, Lingshen; Zhu, Xuejun; Li, Ruoyu; Yang, Yong] Peking Univ, Hosp 1, Dept Dermatol, Beijing 100034, Peoples R China; [Shi, Lei; Zhang, Xue] Peking Union Med Coll, Beijing 100005, Peoples R China; [Giehl, Kathrin A.] Univ Munich, Dept Dermatol, D-80337 Munich, Germany; [Tang, Zhanli] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Dermatol, Qingdao 266003, Peoples R China; [Xiao, Ruo; Liu, Xuanzhu; Dai, Lanlan] Beijing Genom Inst Shenzhen, Dept Mendelian Disorder Res, Shenzhen 518083, Peoples R China; [Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Yang, Yong] Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Munich; Qingdao University; Beijing Genomics Institute (BGI); University of Bonn	Zhang, X (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China.	xuezhang@pumc.edu.cn; dryongyang@bjmu.edu.cn	wang, hui/GRS-4730-2022; Betz, Regina C/E-8591-2011	Betz, Regina C/0000-0001-5024-3623; Chen, Quan/0000-0002-2094-9868	National Natural Science Foundation of China [81071289]; Program for Changjiang Scholars and Innovative Research Team in University [LRT1006]; German Research foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); German Research foundation(German Research Foundation (DFG))	We are grateful to the family members for participation in this study. This work was mainly supported by the National Natural Science Foundation of China (81071289 to Y.Y.) and the Program for Changjiang Scholars and Innovative Research Team in University (LRT1006 to X. Z.). R.C.B. is a recipient of a Heisenberg Professorship of the German Research foundation. K.A.G. would like to thank Professor Hans Wolff for his clinical support.	Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; Barbareschi M, 1997, AM J MED GENET, V72, P91, DOI 10.1002/(SICI)1096-8628(19971003)72:1<91::AID-AJMG19>3.0.CO;2-P; Bazzi H, 2009, DIFFERENTIATION, V78, P292, DOI 10.1016/j.diff.2009.06.004; CALZAVARAPINTON P, 1991, DERMATOLOGICA, V182, P184, DOI 10.1159/000247779; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Godwin AR, 1999, J INVEST DERM SYMP P, V4, P244, DOI 10.1038/sj.jidsp.5640221; Harrison Shannon, 2004, Australas J Dermatol, V45, P103, DOI 10.1111/j.1440-0960.2004.00055.x; Imbeaud S, 1996, HUM MOL GENET, V5, P1269, DOI 10.1093/hmg/5.9.1269; Irvine AD, 2009, AM J MED GENET A, V149A, P1970, DOI 10.1002/ajmg.a.32852; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Naeem M, 2007, CLIN EXP DERMATOL, V32, P502, DOI 10.1111/j.1365-2230.2007.02413.x; Naeem M, 2006, J MED GENET, V43, P274, DOI 10.1136/jmg.2005.033381; Naeem M, 2006, BRIT J DERMATOL, V155, P1184, DOI 10.1111/j.1365-2133.2006.07509.x; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Park HL, 2000, DEVELOPMENT, V127, P1593; Perrin C, 2004, BRIT J DERMATOL, V151, P362, DOI 10.1111/j.1365-2133.2004.06108.x; Peterson RL, 2005, J INVEST DERM SYMP P, V10, P238, DOI 10.1111/j.1087-0024.2005.10114.x; Pick L, 2012, ANN NY ACAD SCI, V1256, P15, DOI 10.1111/j.1749-6632.2011.06385.x; PINHEIRO M, 1992, CLIN GENET, V41, P296; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Rasool M, 2010, EUR J DERMATOL, V20, P443, DOI 10.1684/ejd.2010.0962; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Visinoni AF, 2009, AM J MED GENET A, V149A, P1980, DOI 10.1002/ajmg.a.32864; Webb BD, 2012, AM J HUM GENET, V91, P171, DOI 10.1016/j.ajhg.2012.05.018; Zhao XL, 2007, AM J HUM GENET, V80, P361, DOI 10.1086/511387	36	45	50	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					906	911		10.1016/j.ajhg.2012.08.029	http://dx.doi.org/10.1016/j.ajhg.2012.08.029			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23063621	Bronze, Green Published			2022-12-18	WOS:000311011400013
J	Giehl, KA; Eckstein, GN; Pasternack, SM; Praetzel-Wunder, S; Ruzicka, T; Lichtner, P; Seidl, K; Rogers, M; Graf, E; Langbein, L; Braun-Falco, M; Betz, RC; Strom, TM				Giehl, Kathrin A.; Eckstein, Gertrud N.; Pasternack, Sandra M.; Praetzel-Wunder, Silke; Ruzicka, Thomas; Lichtner, Peter; Seidl, Kerstin; Rogers, Mike; Graf, Elisabeth; Langbein, Lutz; Braun-Falco, Markus; Betz, Regina C.; Strom, Tim M.			Nonsense Mutations in AAGAB Cause Punctate Palmoplantar Keratoderma Type Buschke-Fischer-Brauer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYTIC HYPERKERATOSIS; IDENTIFICATION; LOCUS; FAMILIES; KERATINS; DISEASES; PROTEIN; GENE	Punctate palmoplantar keratodermas (PPKPs) are rare autosomal-dominant inherited skin diseases that are characterized by multiple hyperkeratotic plaques distributed on the palms and soles. To date, two different loci in chromosomal regions 15q22-15q24 and 8q24.13-8q24.21 have been reported. Pathogenic mutations, however, have yet to be identified. In order to elucidate the genetic cause of PPKP type Buschke-Fischer-Brauer (PPKP1), we performed exome sequencing in five affected individuals from three families, and we identified in chromosomal region 15q22.33-q23 two heterozygous nonsense mutations-c.370C>T (p.Arg124(star)) and c.481C>T (p.Arg161(star))-in AAGAB in all affected individuals. Using immunoblot analysis, we showed that both mutations result in premature termination of translation and truncated protein products. Analyses of mRNA of affected individuals revealed that the disease allele is either not detectable or only detectable at low levels. To assess the consequences of the mutations in skin, we performed immunofluorescence analyses. Notably, the amount of granular staining in the keratinocytes of affected individuals was lower in the cytoplasm but higher around the nucleus than it was in the keratinocytes of control individuals. AAGAB encodes the alpha-and gamma-adaptin-binding protein p34 and might play a role in membrane traffic as a chaperone. The identification of mutations, along with the results from additional studies, defines the genetic basis of PPKP1 and provides evidence that AAGAB plays an important role in skin integrity.	[Giehl, Kathrin A.; Ruzicka, Thomas; Seidl, Kerstin; Braun-Falco, Markus] Univ Munich, Dept Dermatol, Ctr Rare & Genet Skin Dis, D-80337 Munich, Germany; [Eckstein, Gertrud N.; Lichtner, Peter; Graf, Elisabeth; Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Pasternack, Sandra M.; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Praetzel-Wunder, Silke; Rogers, Mike; Langbein, Lutz] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich	Giehl, KA (corresponding author), Univ Munich, Dept Dermatol, Ctr Rare & Genet Skin Dis, D-80337 Munich, Germany.	kathrin.giehl@med.uni-muenchen.de	Betz, Regina C/E-8591-2011; Rogers, Michael A./J-9803-2012	Betz, Regina C/0000-0001-5024-3623; Rogers, Michael A./0000-0002-3728-2107	Wilhelm Sander-Stiftung, Munich; BGF; German Ministry of Education and Research [01GS08160, 01GR0802]; European Commission [261123]	Wilhelm Sander-Stiftung, Munich; BGF; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank the individuals and their families for their participation in this study. We also thank R. Feldmann for technical assistance and J. Schweizer for helpful discussion. The work was supported by grants of the Wilhelm Sander-Stiftung, Munich (to L.L.), a scholarship for Excellence of the BGF (to KG.), the German Ministry of Education and Research (01GS08160 and 01GR0802), and the European Commission 7th Framework Program (261123, GEUVADIS). R.C.B. is recipient of a Heisenberg Professorship from the German Research Foundation.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bchetnia M, 2009, J DERMATOL SCI, V54, P54, DOI 10.1016/j.jdermsci.2008.11.008; BENNION SD, 1984, J AM ACAD DERMATOL, V10, P587, DOI 10.1016/S0190-9622(84)80262-5; Bergman R, 2008, AM J DERMATOPATH, V30, P101, DOI 10.1097/DAD.0b013e3181614898; Brauer A, 1913, ARCH DERMATOL SYPH-G, V114, P211; Braun-Falco M, 2009, J DTSCH DERMATOL GES, V7, P971, DOI 10.1111/j.1610-0387.2009.07058.x; Buschke A, 1910, IKONOGRAPHIA DERMATO, V51, P183; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; Dereure O, 2010, ANN DERMATOL VENER, V137, P423, DOI 10.1016/j.annder.2010.03.018; El Amri I, 2010, ANN DERMATOL VENER, V137, P269, DOI 10.1016/j.annder.2010.02.002; Emmert S, 2003, EUR J DERMATOL, V13, P16; Ena P, 1986, G Ital Dermatol Venereol, V121, P45; Gao M, 2005, BRIT J DERMATOL, V152, P874, DOI 10.1111/j.1365-2133.2005.06488.x; Joh GY, 1997, J INVEST DERMATOL, V108, P357, DOI 10.1111/1523-1747.ep12286491; Kelsell DP, 1999, MOL MED TODAY, V5, P107, DOI 10.1016/S1357-4310(98)01428-2; Korge BP, 1996, J MOL MED-JMM, V74, P59; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Mamai O, 2012, J DERMATOL SCI, V67, P210, DOI 10.1016/j.jdermsci.2012.06.011; Martinez-Mir A, 2003, J MED GENET, V40, P872, DOI 10.1136/jmg.40.12.872; Math A, 2006, EUR J DERMATOL, V16, P507, DOI 10.1684/ejd.2006.0022; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; STANIMIROVIC A, 1993, J AM ACAD DERMATOL, V29, P435, DOI 10.1016/0190-9622(93)70207-A; Stevens HP, 1996, BRIT J DERMATOL, V134, P720, DOI 10.1111/j.1365-2133.1996.tb06978.x; Uitto J, 2007, EXP CELL RES, V313, P1995, DOI 10.1016/j.yexcr.2007.03.029; Zhang XJ, 2004, J INVEST DERMATOL, V122, P1121, DOI 10.1111/j.0022-202X.2004.22507.x	26	45	50	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					754	759		10.1016/j.ajhg.2012.08.024	http://dx.doi.org/10.1016/j.ajhg.2012.08.024			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23000146	Green Published, Bronze			2022-12-18	WOS:000309568500018
J	Kim, HG; Kim, HT; Leach, NT; Lan, F; Ullmann, R; Silahtaroglu, A; Kurth, I; Nowka, A; Seong, IS; Shen, YP; Talkowski, ME; Ruderfer, D; Lee, JH; Glotzbach, C; Ha, K; Kjaergaard, S; Levin, AV; Romeike, BF; Kleefstra, T; Bartsch, O; Elsea, SH; Jabs, EW; MacDonald, ME; Harris, DJ; Quade, BJ; Ropers, HH; Shaffer, LG; Kutsche, K; Layman, LC; Tommerup, N; Kalscheuer, VM; Shi, Y; Morton, CC; Kim, CH; Gusella, JF				Kim, Hyung-Goo; Kim, Hyun-Taek; Leach, Natalia T.; Lan, Fei; Ullmann, Reinhard; Silahtaroglu, Asli; Kurth, Ingo; Nowka, Anja; Seong, Ihn Sik; Shen, Yiping; Talkowski, Michael E.; Ruderfer, Douglas; Lee, Ji-Hyun; Glotzbach, Caron; Ha, Kyungsoo; Kjaergaard, Susanne; Levin, Alex V.; Romeike, Bernd F.; Kleefstra, Tjitske; Bartsch, Oliver; Elsea, Sarah H.; Jabs, Ethylin Wang; MacDonald, Marcy E.; Harris, David J.; Quade, Bradley J.; Ropers, Hans-Hilger; Shaffer, Lisa G.; Kutsche, Kerstin; Layman, Lawrence C.; Tommerup, Niels; Kalscheuer, Vera M.; Shi, Yang; Morton, Cynthia C.; Kim, Cheol-Hee; Gusella, James F.			Translocations Disrupting PHF21A in the Potocki-Shaffer-Syndrome Region Are Associated with Intellectual Disability and Craniofacial Anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-DELETION SYNDROME; BALANCED CHROMOSOME REARRANGEMENTS; CHROMATIN-REMODELING COMPLEX; ENLARGED PARIETAL FORAMINA; LINKED MENTAL-RETARDATION; OF-FUNCTION MUTATIONS; COFFIN-SIRIS SYNDROME; BRAF-HDAC COMPLEX; MULTIPLE EXOSTOSES	Potocki-Shaffer syndrome (PSS) is a contiguous gene disorder due to the interstitial deletion of band p11.2 of chromosome 11 and is characterized by multiple exostoses, parietal foramina, intellectual disability (ID), and craniofacial anomalies (CFAs). Despite the identification of individual genes responsible for multiple exostoses and parietal foramina in PSS, the identity of the gene(s) associated with the ID and CFA phenotypes has remained elusive. Through characterization of independent subjects with balanced translocations and supportive comparative deletion mapping of PSS subjects, we have uncovered evidence that the ID and CFA phenotypes are both caused by haploinsufficiency of a single gene, PHF21A, at 11p11.2. PHF21A encodes a plant homeodomain finger protein whose murine and zebrafish orthologs are both expressed in a manner consistent with a function in neurofacial and craniofacial development, and suppression of the latter led to both craniofacial abnormalities and neuronal apoptosis. Along with lysine-specific demethylase 1 (LSD1), PHF21A, also known as BHC80, is a component of the BRAF-histone deacetylase complex that represses target-gene transcription. In lymphoblastoid cell lines from two translocation subjects in whom PHF21A was directly disrupted by the respective breakpoints, we observed derepression of the neuronal gene SCN3A and reduced LSD1 occupancy at the SCN3A promoter, supporting a direct functional consequence of PHF21A haploinsufficiency on transcriptional regulation. Our finding that disruption of PHF21A by translocations in the PSS region is associated with ID adds to the growing list of ID-associated genes that emphasize the critical role of transcriptional regulation and chromatin remodeling in normal brain development and cognitive function.	[Kim, Hyung-Goo; Seong, Ihn Sik; Shen, Yiping; Talkowski, Michael E.; Ruderfer, Douglas; Lee, Ji-Hyun; MacDonald, Marcy E.; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kim, Hyung-Goo; Layman, Lawrence C.] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Kim, Hyung-Goo; Ullmann, Reinhard; Ropers, Hans-Hilger; Kalscheuer, Vera M.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Kim, Hyun-Taek; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Leach, Natalia T.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Leach, Natalia T.; Quade, Bradley J.; Morton, Cynthia C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lan, Fei; Shen, Yiping; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lan, Fei] Constellat Pharmaceut, Dept Biol, Cambridge, MA 02142 USA; [Silahtaroglu, Asli; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark; [Kurth, Ingo] Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Kurth, Ingo; Nowka, Anja; Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20249 Hamburg, Germany; [Seong, Ihn Sik; Talkowski, Michael E.; MacDonald, Marcy E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Shen, Yiping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China; [Talkowski, Michael E.; Ruderfer, Douglas; MacDonald, Marcy E.; Morton, Cynthia C.; Gusella, James F.] Program Med & Populat Genet, Cambridge, MA 02114 USA; [Glotzbach, Caron; Shaffer, Lisa G.] PerkinElmer, Signature Genom Labs, Spokane, WA 99207 USA; [Ha, Kyungsoo] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA; [Kjaergaard, Susanne] Rigshosp, Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Levin, Alex V.] Thomas Jefferson Univ, Wills Eye Inst, Philadelphia, PA 19107 USA; [Romeike, Bernd F.] Univ Jena, Dept Neuropathol, D-07747 Jena, Germany; [Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 Nijmegen, Netherlands; [Bartsch, Oliver] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55101 Mainz, Germany; [Elsea, Sarah H.] Virginia Commonwealth Univ, Sch Med, Dept Pediat, Richmond, VA 23298 USA; [Elsea, Sarah H.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Jabs, Ethylin Wang] Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; [Harris, David J.] Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; [Quade, Bradley J.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; University System of Georgia; Augusta University; Max Planck Society; Chungnam National University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Copenhagen; Friedrich Schiller University of Jena; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University; University System of Georgia; Augusta University; Rigshospitalet; University of Copenhagen; Jefferson University; Friedrich Schiller University of Jena; Radboud University Nijmegen; Johannes Gutenberg University of Mainz; Virginia Commonwealth University; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kim, HG (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	hkim@chgr.mgh.harvard.edu	Ruderfer, Douglas M/M-5795-2016; Romeike, Bernd/K-8516-2019; Silahtaroglu, Asli/X-1974-2019; Kim, Cheol-Hee/F-6278-2013; Tommerup, Niels/T-8776-2017; Bartsch, Oliver/ABE-2681-2020; Kleefstra, Tjitske/G-2619-2012; , PD Dr. med. Bernd FM Romeike/Q-2600-2019	Ruderfer, Douglas M/0000-0002-2365-386X; Silahtaroglu, Asli/0000-0001-6181-2705; Tommerup, Niels/0000-0003-2304-0112; , PD Dr. med. Bernd FM Romeike/0000-0002-9693-3870; Kurth, Ingo/0000-0002-5642-8378; Jabs, Ethylin/0000-0001-8983-5466; Kim, Cheol-Hee/0000-0002-3019-0699; Talkowski, Michael/0000-0003-2889-0992; Elsea, Sarah/0000-0002-1400-8519; Kalscheuer, Vera/0000-0001-6898-3259	Next-Generation BioGreen 21 Program, Republic of Korea [PJ00812701]; Deutsche Forschungsgemeinschaft [KU 1240/5-1]; Danish National Research Foundation; Lundbeck Foundation; National Institutes of Health [NCI118487, RO1 GM071004]; United States Public Health Service [GM061354, HD065286]; European Union [241995]; German Federal Ministry of Education and Research through the German Mental Retardation Network [01GS08161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, P01GM061354] Funding Source: NIH RePORTER; Lundbeck Foundation [R67-2010-6206] Funding Source: researchfish	Next-Generation BioGreen 21 Program, Republic of Korea; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); European Union(European Commission); German Federal Ministry of Education and Research through the German Mental Retardation Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden)	We are grateful to DGAP012 and MCN1762, as well as their family members, for their cooperation and participation in this study. We are also indebted to Amy Bosco, Heather L. Ferguson, and Chantal Kelly for obtaining informed consent and clinical information; to Joanne Sutherland, genetic counselor at the Hospital for Sick Children, Toronto, for her assistance in obtaining samples; to Shigeki Iwase and Tadashi Baba for the PHF21A antibody; to Mary Anne Anderson and Tammy Gillis in the Center for Human Genetic Research Tissue Culture Facility and Genomics Resource for technical assistance; to Ian Krantz, Stephanie Seminara, and Simeon A. Boyadjiev for providing samples of affected individuals; and to Ines Muller and Corinna Menzel for technical assistance. This work was supported by a grant from the Next-Generation BioGreen 21 Program (PJ00812701 to C.H.K.), Republic of Korea, a grant from the Deutsche Forschungsgemeinschaft (KU 1240/5-1 to K.K.), the Danish National Research Foundation (N.T.), the Lundbeck Foundation (N.T. and A.S.), National Institutes of Health grants NCI118487 (to Y.S.) and RO1 GM071004 (to Y.S.), and United States Public Health Service grants GM061354 (Developmental Genome Anatomy Project to C.C.M. and J.F.G.) and HD065286 (to J.F.G.). Part of this work was financed by the European Union's Seventh Framework Program under grant agreement number 241995, project GENCODYS, and the German Federal Ministry of Education and Research through the German Mental Retardation Network (grant 01GS08161 to H.H.R.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Arkesteijn G, 1999, CYTOMETRY, V35, P117, DOI 10.1002/(SICI)1097-0320(19990201)35:2<117::AID-CYTO2>3.0.CO;2-L; Bartsch O, 2005, HUM GENET, V117, P485, DOI 10.1007/s00439-005-1331-y; Bartsch O, 1996, AM J HUM GENET, V58, P734; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dollfus H, 1998, AM J OPHTHALMOL, V125, P397, DOI 10.1016/S0002-9394(99)80157-3; Fantes JA, 2008, AM J HUM GENET, V82, P916, DOI 10.1016/j.ajhg.2008.02.007; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gecz J, 2004, FRONT BIOSCI, V9, P1, DOI 10.2741/1199; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Halgren C, 2011, CLIN GENET; Hall CR, 2001, CLIN GENET, V60, P356, DOI 10.1034/j.1399-0004.2001.600506.x; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Iwase S, 2006, FEBS LETT, V580, P3129, DOI 10.1016/j.febslet.2006.04.065; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Kleefstra T, 2005, J MED GENET, V42, P299, DOI 10.1136/jmg.2004.028464; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, HUM GENET, V99, P32; Mavrogiannis LA, 2006, EUR J HUM GENET, V14, P151, DOI 10.1038/sj.ejhg.5201526; Mavrogiannis LA, 2001, NAT GENET, V27, P17, DOI 10.1038/83703; Miller DT, 2008, CURR PROTOC HUM GENE, V58; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Pasillas MP, 2011, HUM MUTAT, V32, P292, DOI 10.1002/humu.21424; Potocki L, 1996, AM J MED GENET, V62, P319, DOI 10.1002/(SICI)1096-8628(19960329)62:3<319::AID-AJMG22>3.0.CO;2-M; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Romeike BFM, 2007, CLIN NEUROPATHOL, V26, P1; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Scheer MP, 2000, GENOMICS, V63, P123, DOI 10.1006/geno.1999.6027; Schilling TF, 1996, DEVELOPMENT, V123, P329; SHAFFER LG, 1993, AM J MED GENET, V45, P581, DOI 10.1002/ajmg.1320450512; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wakui K, 2005, EUR J HUM GENET, V13, P528, DOI 10.1038/sj.ejhg.5201366; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Wu YQ, 2000, AM J HUM GENET, V67, P1327; Wuyts W, 2004, EUR J HUM GENET, V12, P400, DOI 10.1038/sj.ejhg.5201163; Wuyts W, 1999, EUR J HUM GENET, V7, P579, DOI 10.1038/sj.ejhg.5200339; Wuyts W, 2000, J MED GENET, V37, P916, DOI 10.1136/jmg.37.12.916; Yamamoto T, 2001, J Med Genet, V38, pE5, DOI 10.1136/jmg.38.2.e5	74	45	45	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					56	72		10.1016/j.ajhg.2012.05.005	http://dx.doi.org/10.1016/j.ajhg.2012.05.005			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22770980	Green Published, Bronze			2022-12-18	WOS:000306445000005
J	Tanaka, A; Weinel, S; Nagy, N; O'Driscoll, M; Lai-Cheong, JE; Kulp-Shorten, CL; Knable, A; Carpenter, G; Fisher, SA; Hiragun, M; Yanase, Y; Hide, M; Callen, J; McGrath, JA				Tanaka, Akio; Weinel, Sarah; Nagy, Nikoletta; O'Driscoll, Mark; Lai-Cheong, Joey E.; Kulp-Shorten, Carol L.; Knable, Alfred; Carpenter, Gillian; Fisher, Sheila A.; Hiragun, Makiko; Yanase, Yuhki; Hide, Michihiro; Callen, Jeffrey; McGrath, John A.			Germ line Mutation in ATR in Autosomal-Dominant Oropharyngeal Cancer Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY EMBRYONIC LETHALITY; ATAXIA-TELANGIECTASIA; TUMOR-SUPPRESSOR; FANCONI-ANEMIA; GENE ATR; BREAST; REPAIR; LEADS; HAPLOINSUFFICIENT; SUSCEPTIBILITY	ATR (ataxia telangiectasia and Rad3 related) is an essential regulator of genome integrity. It controls and coordinates DNA-replication origin firing, replication-fork stability, cell-cycle checkpoints, and DNA repair. Previously, autosomal-recessive loss-of-function mutations in ATR have been demonstrated in Seckel syndrome, a developmental disorder. Here, however, we report on a different kind of genetic disorder that is due to functionally compromised ATR activity, which translates into an autosomal-dominant inherited disease. The condition affects 24 individuals in a five-generation pedigree and comprises oropharyngeal cancer, skin telangiectases, and mild developmental anomalies of the hair, teeth, and nails. We mapped the disorder to a similar to 16.8 cM interval in chromosomal region 3q22-24, and by sequencing candidate genes, we found that ATR contained a heterozygous missense mutation (c.6431A>G [p.Gln2144Arg] that segregated with the disease. The mutation occurs within the FAT (MAP, ATM, and TRRAP) domain-which can activate p53-of ATR. The mutation did not lead to a reduction in ATR expression, but cultured fibroblasts showed lower p53 levels after activation of AIR with hydroxyurea than did normal control fibroblasts. Moreover, loss of heterozygosity for the ATR locus was noted in oropharyngeal-tumor tissue. Collectively, the clinicopathological and molecular findings point to a cancer syndrome and provide evidence implicating a germline mutation in ATR and susceptibility to malignancy in humans.	[Tanaka, Akio; Nagy, Nikoletta; Lai-Cheong, Joey E.; McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Tanaka, Akio; Hiragun, Makiko; Yanase, Yuhki; Hide, Michihiro] Hiroshima Univ, Dept Dermatol, Grad Sch Biomed Sci, Hiroshima 7348551, Japan; [Weinel, Sarah; Kulp-Shorten, Carol L.; Knable, Alfred; Callen, Jeffrey] Univ Louisville, Div Dermatol, Dept Med, Sch Med, Louisville, KY 40202 USA; [O'Driscoll, Mark; Carpenter, Gillian] Univ Sussex, Human DNA Damage Response Disorders Grp, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Fisher, Sheila A.] Kings Coll London, Dept Med & Mol Genet, Sch Med, London SE1 9RT, England	University of London; King's College London; Hiroshima University; University of Louisville; University of Sussex; University of London; King's College London	McGrath, JA (corresponding author), Kings Coll London, St Johns Inst Dermatol, Guys Campus, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	Yanase, Yuhki/U-6082-2017; Nagy, Nikoletta/AAJ-6631-2020; McGrath, John/N-3529-2019; Hide, Michihiro/H-2519-2019; McGrath, John/D-6824-2012	Nagy, Nikoletta/0000-0001-8576-7953; Hide, Michihiro/0000-0002-1569-6034; Tanaka, Akio/0000-0002-5354-7064; O'Driscoll, Mark/0000-0003-2765-316X; McGrath, John/0000-0002-3708-9964	Medical Research Council; UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; CRUK	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; CRUK(Cancer Research UK)	We thank P. Green, T. Techanukul, and C. Mathew for discussions. We also thank S. Clements and N. Almaani for technical assistance. M.O. is a Cancer Research UK (CRUK) Senior Cancer Research fellow, supported by CRUK and the Medical Research Council. We acknowledge financial support from the UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Services (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Blackford AN, 2008, J VIROL, V82, P7640, DOI 10.1128/JVI.00170-08; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Menoyo A, 2001, CANCER RES, V61, P7727; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; O'Driscoll M, 2009, DNA REPAIR, V8, P1333, DOI 10.1016/j.dnarep.2009.09.001; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Poehlmann A, 2010, PATHOL RES PRACT, V206, P591, DOI 10.1016/j.prp.2010.06.006; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; Thompson LH, 2005, NAT GENET, V37, P921, DOI 10.1038/ng0905-921; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137	34	45	47	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					511	517		10.1016/j.ajhg.2012.01.007	http://dx.doi.org/10.1016/j.ajhg.2012.01.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22341969	Green Published, Bronze			2022-12-18	WOS:000301762800017
J	Jones, MA; Ng, BG; Bhide, S; Chin, E; Rhodenizer, D; He, P; Losfeld, ME; He, M; Raymond, K; Berry, G; Freeze, HH; Hegdel, MR				Jones, Melanie A.; Ng, Bobby G.; Bhide, Shruti; Chin, Ephrem; Rhodenizer, Devin; He, Ping; Losfeld, Marie-Estelle; He, Miao; Raymond, Kimiyo; Berry, Gerard; Freeze, Hudson H.; Hegdel, Madhuri R.			DDOST Mutations Identified by Whole-Exome Sequencing Are Implicated in Congenital Disorders of Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IA CDG-IA; OLIGOSACCHARYL TRANSFERASE; YEAST; SUBUNIT	Congenital disorders of glycosylation (CDG) are inherited autosomal-recessive diseases that impair N-glycosylation. Approximately 20% of patients do not survive beyond the age of 5 years old as a result of widespread organ dysfunction. Although most patients receive a CDG diagnosis based on abnormal glycosylation of transferrin, this test cannot provide a genetic diagnosis; indeed, many patients with abnormal transferrin do not have mutations in any known CDG genes. Here, we combined biochemical analysis with whole-exome sequencing (WES) to identify the genetic defect in an untyped CDG patient, and we found a 22 bp deletion and a missense mutation in DDOST; whose product is a component of the oligosaccharyltransferase complex that transfers the glycan chain from a lipid carrier to nascent proteins in the endoplasmic reticulum lumen. Biochemical analysis with three biomarkers revealed that N-glycosylation was decreased in the patient's fibroblasts. Complementation with wild-type-DDOST cDNA in patient fibroblasts restored glycosylation, indicating that the mutations were pathological. Our results highlight the power of combining WES and biochemical studies, including a glyco-complementation system, for identifying and confirming the defective gene in an untyped CDG patient. This approach will be very useful for uncovering other types of CDG as well.	[Jones, Melanie A.; Bhide, Shruti; Chin, Ephrem; Rhodenizer, Devin; He, Miao; Hegdel, Madhuri R.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Ng, Bobby G.; He, Ping; Losfeld, Marie-Estelle; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Genet Dis Program, La Jolla, CA 92037 USA; [Raymond, Kimiyo] Mayo Clin, Coll Med, Biochem Genet Lab, Rochester, MN 55905 USA; [Berry, Gerard] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02115 USA	Emory University; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School	Hegdel, MR (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	mhegde@emory.edu		Berry, Gerard/0000-0001-5299-3313; Freeze, Hudson/0000-0001-6316-0501	Rocket Fund; Sanford-Burnham Professorship [R01 DK55615, AHA 11POST7580057, 1RC1NS 069541-01, MDA138896];  [T32 MH087977]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087977] Funding Source: NIH RePORTER	Rocket Fund; Sanford-Burnham Professorship; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank the patient and his family for participating in this study. This work was supported by T32 MH087977, The Rocket Fund, the Sanford-Burnham Professorship (H.H.F.), R01 DK55615, AHA 11POST7580057, 1RC1NS 069541-01, and MDA138896. We would also like to thank Caroline Wilson and Zachary Thompson for technical assistance.	Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; Footitt EJ, 2009, J INHERIT METAB DIS; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fujita N, 2008, FEBS J, V275, P788, DOI 10.1111/j.1742-4658.2008.06246.x; HEESEN ST, 1992, EMBO J, V11, P2071, DOI 10.1002/j.1460-2075.1992.tb05265.x; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Jones MA, 2011, GENET MED, V13, P921, DOI 10.1097/GIM.0b013e318226fbf2; Karaoglu D, 1997, J BIOL CHEM, V272, P32513, DOI 10.1074/jbc.272.51.32513; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kjaergaard S, 2001, ARCH DIS CHILD, V85, P236, DOI 10.1136/adc.85.3.236; Lennarz WJ, 2007, ACTA BIOCHIM POL, V54, P673, DOI 10.18388/abp.2007_3131; Matthijs G, 2000, HUM MUTAT, V16, P386, DOI 10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Nishikawa A, 2001, BIOCHEM J, V355, P245, DOI 10.1042/0264-6021:3550245; Schachter H, 2009, BBA-MOL BASIS DIS, V1792, P925, DOI 10.1016/j.bbadis.2008.11.002; Tai VWF, 2001, J ORG CHEM, V66, P6217, DOI 10.1021/jo0100345; Vleugels W, 2009, BIOCHEM BIOPH RES CO, V390, P769, DOI 10.1016/j.bbrc.2009.10.047; Vleugels W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/humu.21085; Yamagata T, 1997, GENOMICS, V45, P535, DOI 10.1006/geno.1997.4966	23	45	48	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					363	368		10.1016/j.ajhg.2011.12.024	http://dx.doi.org/10.1016/j.ajhg.2011.12.024			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22305527	Green Published, Bronze			2022-12-18	WOS:000300742200019
J	Roach, JC; Glusman, G; Hubley, R; Montsaroff, SZ; Holloway, AK; Mauldin, DE; Srivastava, D; Garg, V; Pollard, KS; Galas, DJ; Hood, L; Smit, AFA				Roach, Jared C.; Glusman, Gustavo; Hubley, Robert; Montsaroff, Stephen Z.; Holloway, Alisha K.; Mauldin, Denise E.; Srivastava, Deepak; Garg, Vidu; Pollard, Katherine S.; Galas, David J.; Hood, Leroy; Smit, Arian F. A.			Chromosomal Haplotypes by Genetic Phasing of Human Families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALGORITHMS	Assignment of alleles to haplotypes for nearly all the variants on all chromosomes can be performed by genetic analysis of a nuclear family with three or more children. Whole-genome sequence data enable deterministic phasing of nearly all sequenced alleles by permitting assignment of recombinations to precise chromosomal positions and specific meioses. We demonstrate this process of genetic phasing on two families each with four children. We generate haplotypes for all of the children and their parents; these haplotypes span all genotyped positions, including rare variants. Misassignments of phase between variants (switch errors) are nearly absent. Our algorithm can also produce multimegabase haplotypes for nuclear families with just two children and can handle families with missing individuals. We implement our algorithm in a suite of software scripts (Haploscribe). Haplotypes and family genome sequences will become increasingly important for personalized medicine and for fundamental biology.	[Roach, Jared C.; Glusman, Gustavo; Hubley, Robert; Montsaroff, Stephen Z.; Mauldin, Denise E.; Galas, David J.; Hood, Leroy; Smit, Arian F. A.] Inst Syst Biol, Seattle, WA 98109 USA; [Holloway, Alisha K.; Srivastava, Deepak; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Garg, Vidu] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Garg, Vidu] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Galas, David J.; Hood, Leroy] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-1511 Luxembourg, Luxembourg	Institute for Systems Biology (ISB); University of California System; University of California San Francisco; The J David Gladstone Institutes; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Luxembourg	Roach, JC (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	genetics@strategicgenomics.com	Garg, Vidu/D-8240-2012; Holloway, Alisha/H-9574-2013; Garg, Vidu/E-3101-2011	Garg, Vidu/0000-0002-3778-5927; Holloway, Alisha/0000-0001-9810-389X; Glusman, Gustavo/0000-0001-8060-5955	Center for Systems Biology [GM076547, RO1GM081083]; University of Luxembourg Institute for Systems Biology Program; National Heart, Lung, and Blood Institute; National Institutes of Health; Gladstone Institutes; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081083, P50GM076547] Funding Source: NIH RePORTER	Center for Systems Biology; University of Luxembourg Institute for Systems Biology Program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Center for Systems Biology P50 grant GM076547 (National Institutes of Health) to L.H.; RO1GM081083 (National Institutes of Health) to A.F.A.S. and G.G.; the University of Luxembourg Institute for Systems Biology Program. D.S. was supported by grants from the National Heart, Lung, and Blood Institute and the National Institutes of Health. K.S.P., A.K.H., and D.S. were supported by institutional support from Gladstone Institutes. CGI provided data for the CEPH pedigree. Mary Brunkow, Rich Gelinas, and Lee Rowen provided project management and assistance with the manuscript.	Boysen C, 1997, GENOME RES, V7, P330, DOI 10.1101/gr.7.4.330; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HOBBS F, 2005, CENSR24 US CENS BUR; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI X, 2010, THESIS CASE W RESERV; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lippert Ross, 2002, Brief Bioinform, V3, P23, DOI 10.1093/bib/3.1.23; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg2939; Niu TH, 2004, GENET EPIDEMIOL, V27, P334, DOI 10.1002/gepi.20024; Qian DJ, 2002, AM J HUM GENET, V70, P1434, DOI 10.1086/340610; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Shih MC, 2001, STAT METHODS MED RES, V10, P27, DOI 10.1191/096228001671737777; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Thompson E.A., 2000, STAT INFERENCE GENET; Waggoner Darrel, 2007, Semin Pediatr Neurol, V14, P7, DOI 10.1016/j.spen.2006.11.004; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356; WHOLE GENOME SEQUENC	24	45	47	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					382	397		10.1016/j.ajhg.2011.07.023	http://dx.doi.org/10.1016/j.ajhg.2011.07.023			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21855840	Bronze, Green Published			2022-12-18	WOS:000294939800003
J	Liu, DJJ; Leal, SM				Liu, Dajiang J.; Leal, Suzanne M.			Replication Strategies for Rare Variant Complex Trait Association Studies via Next-Generation Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPING ERRORS; COMMON DISEASES; HUMAN GENOME; MUTATIONS; POPULATION; SUSCEPTIBILITY; PROBABILITY; CONTRIBUTE; DISCOVERY; SELECTION	There is solid evidence that complex traits can be caused by rare variants. Next-generation sequencing technologies are powerful tools for mapping rare variants. Confirmation of significant findings in stage 1 through replication in an independent stage 2 sample is necessary for association studies. For gene-based mapping of rare variants, two replication strategies are possible: (1) variant-based replication, wherein only variants from nucleotide sites uncovered in stage 1 are genotyped and followed-up and (2) sequence-based replication, wherein the gene region is sequenced in the replication sample and both known and novel variants are tested. The efficiency of the two strategies is dependent on the proportions of causative variants discovered in stage 1 and sequencing/genotyping errors. With rigorous population genetic and phenotypic models, it is demonstrated that sequence-based replication is consistently more powerful. However, the power gain is small (1) for large-scale studies with thousands of individuals, because a large fraction of causative variant sites can be observed and (2) for small- to medium-scale studies with a few hundred samples, because a large proportion of the locus population attributable risk can be explained by the uncovered variants. Therefore, genotyping can be a temporal solution for replicating genetic studies if stage 1 and 2 samples are drawn from the same population. However, sequence-based replication is advantageous if the stage 1 sample is small or novel variants discovery is also of interest. It is shown that currently attainable levels of sequencing error only minimally affect the comparison, and the advantage of sequence-based replication remains.	[Liu, Dajiang J.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Liu, Dajiang J.; Leal, Suzanne M.] Rice Univ, Dept Stat, Houston, TX 77005 USA	Baylor College of Medicine; Rice University	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	sleal@bcm.edu		Liu, Dajiang/0000-0001-6553-858X	National Institutes of Health [R01-DCO3594, 1RC2HL102926, RL1HL092550, EIA-0216467]; Gulf Coast Consortia (NIH) [5 R90 DK071505-04]; Shared University Grid at Rice; Rice University; Sun Microsystems; Sigma Solutions, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gulf Coast Consortia (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared University Grid at Rice; Rice University; Sun Microsystems; Sigma Solutions, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research is supported by National Institutes of Health grant R01-DCO3594 and 1RC2HL102926 (S.M.L.). D.J.L. is partially supported by a training fellowship from the Keck Center Pharmacoinformatics Training Program of the Gulf Coast Consortia (NIH Grant No. 5 R90 DK071505-04). We would like to thank Drs. Jonathan Cohen and Helen Hobbs for providing us with data from the Dallas Heart Study on the ANGTPL family genes, which was supported by National Institute of Health grant RL1HL092550 (J. Cohen). The authors would also like to thank Drs. John W. Belmont, Hua Chen, Xiang Qin, and Fuli Yu for illuminating discussions on this work. Computation for this research was supported in part by the Shared University Grid at Rice funded by NSF under Grant EIA-0216467, and a partnership between Rice University, Sun Microsystems, and Sigma Solutions, Inc.	[Anonymous], ONLINE MENDELIAN INH; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Ionita-Laza I, 2009, P NATL ACAD SCI USA, V106, P5008, DOI 10.1073/pnas.0807815106; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kerem B, 1997, GENET TEST, V1, P35, DOI 10.1089/gte.1997.1.35; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Scheet P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000147; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058	40	45	45	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					790	801		10.1016/j.ajhg.2010.10.025	http://dx.doi.org/10.1016/j.ajhg.2010.10.025			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129725	Green Published, Bronze			2022-12-18	WOS:000285564600005
J	Dahlqvist, J; Klar, J; Tiwari, N; Schuster, J; Torma, H; Badhai, J; Pujol, R; van Steensel, MAM; Brinkhuizen, T; Gijezen, L; Chaves, A; Tadini, G; Vahlquist, A; Dahl, N				Dahlqvist, Johanna; Klar, Joakim; Tiwari, Neha; Schuster, Jens; Torma, Hans; Badhai, Jitendra; Pujol, Ramon; van Steensel, Maurice A. M.; Brinkhuizen, Tjinta; Gijezen, Lieke; Chaves, Antonio; Tadini, Gianluca; Vahlquist, Anders; Dahl, Niklas			A Single-Nucleotide Deletion in the POMP 5 ' UTR Causes a Transcriptional Switch and Altered Epidermal Proteasome Distribution in KLICK Genodermatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; OPEN READING FRAMES; MESSENGER-RNA; 20S PROTEASOME; LAMELLAR ICHTHYOSIS; VOHWINKELS-SYNDROME; PROTEIN; KERATINOCYTES; KERATODERMA; BETA	KLICK syndrome is a rare autosomal-recessive skin disorder characterized by palmoplantar keratoderrna, linear hyperkeratotic papules, and ichthyosiform scaling. In order to establish the genetic cause of this disorder, we collected DNA samples from eight European prohands. Using high-density genome-wide SNP analysis, we identified a 1.5 Mb homozygous candidate region on chromosome 13q. Sequence analysis of the ten annotated genes in the candidate region revealed homozygosity for a single-nucleotide deletion at position c.-95 in the proteasome maturation protein (POMP) gene, in all probands. The deletion is included in POMP transcript variants with long 5' untranslated regions (UTRs) and was associated with a marked increase of these transcript variants in keratinocytes from KLICK patients. POMP is a ubiquitously expressed protein and functions as a chaperone for proteasome maturation. Immunohistochemical analysis of skin biopsies from KLICK patients revealed an altered epidermal distribution of POMP, the proteasome subunit proteins alpha 7 and beta 5, and the ER stress marker CHOP. Our results suggest that KLICK syndrome is caused by a single-nucleotide deletion in the 5' UTR of POMP resulting in altered distribution of POMP in epidermis and a perturbed formation of the outermost layers of the skin. These findings imply that the proteasome has a prominent role in the terminal differentiation of human epidermis.	[Dahlqvist, Johanna; Klar, Joakim; Schuster, Jens; Badhai, Jitendra; Dahl, Niklas] Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Dahlqvist, Johanna; Klar, Joakim; Schuster, Jens; Torma, Hans; Badhai, Jitendra; Vahlquist, Anders; Dahl, Niklas] Univ Hosp, S-75185 Uppsala, Sweden; [Tiwari, Neha] Univ Basel, Dept Biomed, Inst Biochem & Genet, CH-4058 Basel, Switzerland; [Torma, Hans; Vahlquist, Anders] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Pujol, Ramon] Hosp del Mar IMAS, Dept Dermatol, Barcelona 08003, Spain; [van Steensel, Maurice A. M.; Brinkhuizen, Tjinta; Gijezen, Lieke] Univ Maastricht, Dept Dermatol, Univ Hosp Maastricht, NL-6202 Maastricht, Netherlands; [van Steensel, Maurice A. M.; Brinkhuizen, Tjinta; Gijezen, Lieke] Univ Maastricht, GROW Sch Oncol & Dev Biol, NL-6202 Maastricht, Netherlands; [Chaves, Antonio] Univ Hosp Infanta Cristina, Dept Dermatol, Badajoz 06006, Spain; [Tadini, Gianluca] IRCCS, Inst Dermatol Sci, Fdn Osped Maggiore Policlin, I-20132 Milan, Italy	Uppsala University; Uppsala University; Uppsala University Hospital; University of Basel; Uppsala University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Maastricht University; Maastricht University; IRCCS Ca Granda Ospedale Maggiore Policlinico	Dahl, N (corresponding author), Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden.	niklas.dahl@genpat.uu.se	Törmä, Hans/F-8152-2011; Schuster, Jens/D-2005-2010; Klar, Joakim/H-2900-2019; van Steensel, Maurice A.M./V-3852-2019	Törmä, Hans/0000-0002-3617-8551; Schuster, Jens/0000-0002-4383-9880; Klar, Joakim/0000-0003-4185-7409; PUJOL, RAMON M/0000-0002-5622-6055; Tiwari, Neha/0000-0001-7931-4085; Badhai, Jitendra/0000-0002-9526-3748; van Steensel, Maurice/0000-0002-7507-2442	Swedish Research Council; T. and R. Soderberg's fund; E. Welander foundation; Uppsala University and Uppsala University Hospital; Foundation for Ichthyosis and Related Skin Types; GROW school for oncology and developmental biology; Dutch Cancer Fund [UM2009-4352]	Swedish Research Council(Swedish Research CouncilEuropean Commission); T. and R. Soderberg's fund; E. Welander foundation; Uppsala University and Uppsala University Hospital; Foundation for Ichthyosis and Related Skin Types; GROW school for oncology and developmental biology; Dutch Cancer Fund	We thank all patients and their families for participating by providing blood and tissue samples. We thank Inger Pihl-Lundin for substantial immunohistochemical work and Fuad Bahram, Kasper Rouschop, and Miriam Kamps for technical support and valuable discussions. We are grateful to Torbjorn Egelrud and Arne Pettersson for collection of patient samples. This work was supported by the Swedish Research Council, T. and R. Soderberg's fund, E. Welander foundation, Uppsala University and Uppsala University Hospital, Foundation for Ichthyosis and Related Skin Types, the GROW school for oncology and developmental biology and the Dutch Cancer Fund (KWF UM2009-4352).	Badhai J, 2009, FEBS LETT, V583, P2049, DOI 10.1016/j.febslet.2009.05.023; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Chaves AJ, 2006, ACTAS DERMO-SIFILOGR, V97, P342, DOI 10.1016/S0001-7310(06)73415-9; Chondrogianni N, 2007, EXP GERONTOL, V42, P899, DOI 10.1016/j.exger.2007.01.012; Dahlqvist J, 2007, J MED GENET, V44, P615, DOI 10.1136/jmg.2007.050542; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Forte GI, 2009, MOL IMMUNOL, V46, P2161, DOI 10.1016/j.molimm.2009.04.034; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Gibson DFC, 1996, J INVEST DERMATOL, V106, P154, DOI 10.1111/1523-1747.ep12329856; Griffin Thomas A., 2000, Molecular Cell Biology Research Communications, V3, P212, DOI 10.1006/mcbr.2000.0213; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Ord T, 2009, GENE, V444, P24, DOI 10.1016/j.gene.2009.06.001; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; PUJOL RM, 1989, ARCH DERMATOL, V125, P103, DOI 10.1001/archderm.125.1.103; Richard G, 2002, AM J HUM GENET, V70, P1341, DOI 10.1086/339986; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Schmuth Matthias, 2007, Adv Dermatol, V23, P231, DOI 10.1016/j.yadr.2007.07.011; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Smith L, 2009, J CELL MOL MED; Strahle U, 2008, BRAIN RES BULL, V75, P225, DOI 10.1016/j.brainresbull.2007.11.010; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Tanemura M, 2009, TRANSPL P, V41, P334, DOI 10.1016/j.transproceed.2008.10.032; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Vahlquist A, 1997, ACTA DERM-VENEREOL, V77, P225; Van de Water N, 2008, HEMOGLOBIN, V32, P247, DOI 10.1080/03630260701798375; van Steensel MAM, 2005, BRIT J DERMATOL, V152, P155, DOI 10.1111/J.1365-2133.2005.06319.X; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	45	48	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					596	603		10.1016/j.ajhg.2010.02.018	http://dx.doi.org/10.1016/j.ajhg.2010.02.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20226437	Bronze, Green Published			2022-12-18	WOS:000276716800010
J	Schraders, M; Lee, K; Oostrik, J; Huygen, PLM; Ali, G; Hoefsloot, LH; Veltman, JA; Cremers, FPM; Basit, S; Ansar, M; Cremers, CWRJ; Kunst, HPM; Ahmad, W; Admiraal, RJC; Leal, SM; Kremer, H				Schraders, Margit; Lee, Kwanghyuk; Oostrik, Jaap; Huygen, Patrick L. M.; Ali, Ghazanfar; Hoefsloot, Lies H.; Veltman, Joris A.; Cremers, Frans P. M.; Basit, Sulman; Ansar, Muhammad; Cremers, Cor W. R. J.; Kunst, Henricus P. M.; Ahmad, Wasim; Admiraal, Ronald J. C.; Leal, Suzanne M.; Kremer, Hannie			Homozygosity Mapping Reveals Mutations of GRXCR1 as a Cause of Autosomal-Recessive Nonsyndromic Hearing Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; HAIR-CELLS; PREDICTION; GENE; GLUTATHIONYLATION; IDENTIFICATION; PIROUETTE; DOMINANT; PROGRAM; EYES	We identified overlapping homozygous regions within the DFNB25 locus in two Dutch and ten Pakistani families with sensorineural autosomal-recessive nonsyndromic hearing impairment (arNSHI). Only one of the families, W98-053, was not consanguineous, and its sibship pointed toward a reduced critical region of 0.9 Mb. This region contained the GRXCR1 gene, and the orthologous mouse gene was described to be mutated in the pirouette (pi) mutant with resulting hearing loss and circling behavior. Sequence analysis of the GRXCR1 gene in hearing-impaired family members revealed splice-site mutations in two Dutch families and a missense and nonsense mutation, respectively, in two Pakistani families. The splice-site mutations are predicted to cause frameshifts and premature stop codons. In family W98-053, this could be confirmed by cDNA analysis. GRXCR1 is predicted to contain a GRX-like domain. GRX domains are involved in reversible S-glutathionylation of proteins and thereby in the modulation of activity and/or localization of these proteins. The missense mutation is located in this domain, whereas the nonsense and splice-site mutations may result in complete or partial absence of the GRX-like domain or of the complete protein. Hearing loss in patients with GRXCR1 mutations is congenital and is moderate to profound. Progression of the hearing loss was observed in family W98-053. Vestibular dysfunction was observed in some but not all affected individuals. Quantitative analysis of GRXCR1 transcripts in fetal and adult human tissues revealed a preferential expression of the gene in fetal cochlea, which may explain the nonsyndromic nature of the hearing impairment.	[Schraders, Margit; Oostrik, Jaap; Huygen, Patrick L. M.; Cremers, Cor W. R. J.; Kunst, Henricus P. M.; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Otorhinolaryngol Head & Neck Surg, NL-6525 GA Nijmegen, Netherlands; [Hoefsloot, Lies H.; Veltman, Joris A.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Veltman, Joris A.; Cremers, Frans P. M.; Kremer, Hannie] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ali, Ghazanfar; Basit, Sulman; Ansar, Muhammad; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Baylor College of Medicine; Quaid I Azam University	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Otorhinolaryngol Head & Neck Surg, NL-6525 GA Nijmegen, Netherlands.	h.kremer@antrg.umcn.nl	Admiraal, R.J.C./L-4171-2015; Huygen, P.L.M./L-4401-2015; Kremer, Hannie/F-5126-2010; Cremers, Frans/A-5625-2014; Schraders, Margit/A-1607-2016; Basit, Sulman/F-6395-2015; Ali, Ghazanfar/J-9971-2012; Kunst, Henricus P.M./J-6456-2012; Ansar, Muhammad/F-4808-2015; Basit, Sulman/AAY-9763-2021; Cremers, C.W.R.J./L-4254-2015; Oostrik, Jaap/A-1703-2016; Ahmad, Wasim/GSD-8904-2022; Veltman, Joris A/F-5128-2010; Basit, Sulman/Q-7939-2018; Ansar, Muhammad/H-5967-2011; Basit, Sulman/B-2947-2013; Ahmad, Wasim/E-9713-2015; Ali, Ghazanfar/L-9277-2019	Kremer, Hannie/0000-0002-0841-8693; Cremers, Frans/0000-0002-4954-5592; Kunst, Henricus P.M./0000-0003-1162-6394; Basit, Sulman/0000-0003-4294-6825; Veltman, Joris A/0000-0002-3218-8250; Basit, Sulman/0000-0003-4294-6825; Ansar, Muhammad/0000-0001-5891-7063; Ali, Ghazanfar/0000-0002-6172-9503; Lee, Kwanghyuk/0000-0001-7781-9696; Lee, Kwanghyuk/0000-0003-1389-1220	RNID [GR36]; Fonds NutsOhra [SNO-T-0702-102]; EUROHEAR [LSHG-CT-2004-512063]; The Janivo Stichting; The Heinsius Houbolt Foundation; Higher Education Commission (HEC) of the Government of Pakistan; National Institutes of Health (NTH)-National Institute of Deafness and Other Communication Disorders [DC03594]; NTH [N01-HG-65403]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003594, R01DC003594] Funding Source: NIH RePORTER	RNID; Fonds NutsOhra; EUROHEAR; The Janivo Stichting; The Heinsius Houbolt Foundation; Higher Education Commission (HEC) of the Government of Pakistan; National Institutes of Health (NTH)-National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NTH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Saskia van der Velde-Visser, Christel Beumer, and Suzanne Keijzers-Vloet for excellent technical assistance and A. Beynon and K.P. Krommenhoek for evaluation of vestibular function. This work was financially Supported by RNID (grant GR36 to H.K.), Fonds NutsOhra (project SNO-T-0702-102 to H.K.), EUROHEAR (contract no. LSHG-CT-2004-512063 to H.K. and C.C.), The Janivo Stichting, The Heinsius Houbolt Foundation (to H.K.), the Higher Education Commission (HEC) of the Government of Pakistan (to W.A.), and the National Institutes of Health (NTH)-National Institute of Deafness and Other Communication Disorders (grant DC03594 to S.M.L.). Genotyping services were provided by the Center for Inherited Disease Research (CIDR) to S.M.L. CIDR is fully funded through a federal contract from the NTH to Johns Hopkins University, contract no. N01-HG-65403.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Beyer LA, 2000, J NEUROCYTOL, V29, P227, DOI 10.1023/A:1026515619443; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dayhoff M., 1978, ATLAS PROTEIN SEQ ST, V5; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Erven A, 2002, EUR J NEUROSCI, V16, P1433, DOI 10.1046/j.1460-9568.2002.02213.x; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Kunst H, 1999, AUDIOLOGY, V38, P165; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luijendijk MWJ, 2003, GENOMICS, V82, P480, DOI 10.1016/S0888-7543(03)00150-2; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Odeh H, 2004, AUDIOL NEURO-OTOL, V9, P303, DOI 10.1159/000080701; Odeh H, 2010, AM J HUM GENET, V86, P148, DOI 10.1016/j.ajhg.2010.01.016; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tranebjaerg L, 2008, INT J AUDIOL, V47, P535, DOI 10.1080/14992020802249259; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEEKS DE, 1995, AM J HUM GENET, V56, P1506	40	45	48	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					138	147		10.1016/j.ajhg.2009.12.017	http://dx.doi.org/10.1016/j.ajhg.2009.12.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137778	Bronze, Green Published			2022-12-18	WOS:000274637200004
J	Lahiry, P; Wang, J; Robinson, JF; Turowec, JP; Litchfield, DW; Lanktree, MB; Gloor, GB; Puffenberger, EG; Strauss, KA; Martens, MB; Ramsay, DA; Rupar, CA; Siu, V; Hegele, RA				Lahiry, Piya; Wang, Jian; Robinson, John F.; Turowec, Jacob P.; Litchfield, David W.; Lanktree, Matthew B.; Gloor, Gregory B.; Puffenberger, Erik G.; Strauss, Kevin A.; Martens, Mildred B.; Ramsay, David A.; Rupar, C. Anthony; Siu, Victoria; Hegele, Robert A.			A Multiplex Human Syndrome Implicates a Key Role for Intestinal Cell Kinase in Development of Central Nervous, Skeletal, and Endocrine Systems	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIB-POLYDACTYLY SYNDROME; HYDROLETHALUS SYNDROME; PROTEIN; IDENTIFICATION; MUTATIONS; MAJEWSKI; GENE; INHIBITORS; REGION	Six infants in an Old Order Amish pedigree were observed to be affected with endocrine-cerebro-osteodysplasia (ECO). ECO is a previously unidentified neonatal lethal recessive disorder with multiple anomalies involving the endocrine, cerebral, and skeletal systems. Autozygosity mapping and sequencing identified a previously unknown missense mutation, R272Q, in ICK, encoding intestinal cell kinase (ICK). Our results established that R272 is conserved across species and among ethnicities, and three-dimensional analysis of the protein structure suggests protein instability due to the R272Q mutation. We also demonstrate that the R272Q mutant fails to localize at the nucleus and has diminished kinase activity. These findings suggest that ICK plays a key role in the development of	[Lahiry, Piya; Turowec, Jacob P.; Litchfield, David W.; Lanktree, Matthew B.; Gloor, Gregory B.; Rupar, C. Anthony; Siu, Victoria; Hegele, Robert A.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Lahiry, Piya; Wang, Jian; Robinson, John F.; Lanktree, Matthew B.; Hegele, Robert A.] Robarts Res Inst, London, ON N6A 5K8, Canada; [Puffenberger, Erik G.; Strauss, Kevin A.] Clin Special Children, Strasburg, PA 17579 USA; [Martens, Mildred B.; Ramsay, David A.] Univ Western Ontario Hosp, Dept Pathol, London Hlth Sci Ctr, London, ON N6A 5A5, Canada; [Rupar, C. Anthony; Siu, Victoria] London Hlth Sci Ctr, Med Genet Program, London, ON N6C 2V5, Canada; [Rupar, C. Anthony; Siu, Victoria] Childrens Hlth Res Inst, London, ON N6C 2V5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); London Health Sciences Centre	Hegele, RA (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	hegele@robarts.ca	Lanktree, Matthew Bruce/I-9790-2019; Hegele, Robert/AAF-6482-2020; Gloor, Greg B/D-1671-2013; Hegele, Robert/G-3301-2011; Litchfield, David/E-4636-2015	Lanktree, Matthew Bruce/0000-0002-5750-6286; Hegele, Robert/0000-0003-2861-5325; Litchfield, David/0000-0002-2425-6620; Gloor, Gregory/0000-0001-5803-3380; Puffenberger, Erik/0000-0002-6388-9148	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research (CIHR) [CTP-79853, MOP-37854]; Ontario Genomics Institute; Children's Health Research Institute; Lawson Health Research Institute; Garrod Association	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Children's Health Research Institute; Lawson Health Research Institute; Garrod Association	We acknowledge the generous cooperation of the families participating in this study. We acknowledge the excellent technical assistance of Rebecca Provost, Rachel Rollings, Caroline O'Neil, and Roger Dewar. R.A.H. is a Career Investigator of the Heart and Stroke Foundation of Ontario and holds the Edith Schulich Vinet Canada Research Chair (Tier 1) in Human Genetics and the Jacob J. Wolfe Distinguished Medical Research Chair. P.L. was supported by the Canadian Institutes of Health Research (CIHR) Scriver Family MD/PhD studentship award and the HSFO Vascular Training Program. This work was supported by a team grant from the CIHR (CTP-79853, MOP-37854), the Heart and Stroke Foundation of Ontario, Genome Canada through the Ontario Genomics Institute, and grants from the Children's Health Research Institute, the Lawson Health Research Institute, and the Garrod Association.	Abe S, 1995, ONCOGENE, V11, P2187; BOLEN JB, 1995, CURR OPIN IMMUNOL, V7, P306, DOI 10.1016/0952-7915(95)80103-0; Budhiraja S, 2008, FUND CLIN PHARMACOL, V22, P231, DOI 10.1111/j.1472-8206.2008.00583.x; CHEN H, 1980, AM J MED GENET, V7, P215, DOI 10.1002/ajmg.1320070214; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano W. L, 2002, PYMOL MOL GENETICS G; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; DINCSOY MY, 1995, AM J MED GENET, V56, P317, DOI 10.1002/ajmg.1320560321; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; HIGGINS D, 2007, CLUSTAL MULTIPLE SEQ; Hostetler JohnA., 1993, AMISH SOC, VFourth, DOI 10.2307/539066; Hurst JA, 2005, SEMIN FETAL NEONAT M, V10, P233, DOI 10.1016/j.siny.2004.12.001; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lew J, 2003, BIOCHEMISTRY-US, V42, P849, DOI 10.1021/bi0269761; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MOORE KL, 1977, DEV HUMAN; NERI G, 1995, AM J MED GENET, V59, P365, DOI 10.1002/ajmg.1320590317; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Norgard M, 1996, PRENATAL DIAG, V16, P173, DOI 10.1002/(SICI)1097-0223(199602)16:2<173::AID-PD821>3.0.CO;2-I; Peltonen L, 1997, GENOME RES, V7, P765, DOI 10.1101/gr.7.8.765; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rosing B, 2008, ULTRASOUND OBST GYN, V31, P457, DOI 10.1002/uog.5285; SALONEN R, 1981, CLIN GENET, V19, P321; SCHULZEGAHMEN U, 1995, PROTEINS, V22, P378, DOI 10.1002/prot.340220408; SHARMA AK, 1992, AM J MED GENET, V43, P949, DOI 10.1002/ajmg.1320430609; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; URIOSTE M, 1994, AM J MED GENET, V49, P94, DOI 10.1002/ajmg.1320490118; Visapaa I, 1999, AM J HUM GENET, V65, P1086, DOI 10.1086/302603; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Yang T, 2002, BIOMOL ENG, V19, P1, DOI 10.1016/S1389-0344(02)00002-3; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	40	45	47	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					134	147		10.1016/j.ajhg.2008.12.017	http://dx.doi.org/10.1016/j.ajhg.2008.12.017			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19185282	Green Published, Bronze			2022-12-18	WOS:000263799700005
J	Clarke, GM; Carter, KW; Palmer, LJ; Morris, AP; Cardon, LR				Clarke, Geraldine M.; Carter, Kim W.; Palmer, Lyle J.; Morris, Andrew P.; Cardon, Lon R.			Fine mapping versus replication in whole-genome association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; GENETIC EPIDEMIOLOGY; COMMON DISEASES; BREAST-CANCER; RISK; SUSCEPTIBILITY; LOCI; PERSPECTIVES; VARIANT; HAPMAP	Association replication studies have a poor track record and, even when successful, often claim association with different markers, alleles, and phenotypes than those reported in the primary study. It is unknown whether these outcomes reflect genuine associations or false-positive results. A greater understanding of these observations is essential for genomewide association (GWA) studies, since they have the potential to identify multiple new associations that that will require external validation. Theoretically, a repeat association with precisely the same variant in an independent sample is the gold standard for replication, but testing additional variants is commonplace in replication studies. Finding different associated SNPs within the same gene or region as that originally identified is often reported as confirmatory evidence. Here, we compare the probability of replicating a gene or region under two commonly used marker-selection strategies: an "exact" approach that involves only the originally significant markers and a "local" approach that involves both the originally significant markers and others in the same region. When a region of high intermarker linkage disequilibrium is tested to replicate an initial finding that is only weak association with disease, the local approach is a good strategy. Otherwise, the most powerful and efficient strategy for replication involves testing only the initially identified variants. Association with a marker other than that originally identified can occur frequently, even in the presence of real effects in a low-powered replication study, and instances of such association increase as the number of included variants increases. Our results provide a basis for the design and interpretation of GWA replication studies and point to the importance of a clear distinction between fine mapping and replication after GWA.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Western Australia Inst Med Res, Ctr Genet Epidemiol, Nedlands, WA, Australia; Univ Western Australia, UWA Ctr Med Res, Perth, WA 6009, Australia	University of Oxford; Wellcome Centre for Human Genetics; University of Western Australia	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk	Palmer, Lyle John/N-1948-2019; Palmer, Lyle John/K-3196-2014	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055	Wellcome Trust [081682] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GLESER LJ, 1985, J ROY STAT SOC B MET, V47, P459; Greenland S, 2007, INT J EPIDEMIOL, V36, P195, DOI 10.1093/ije/dyl289; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ober C, 2005, J ALLERGY CLIN IMMUN, V116, P274, DOI 10.1016/j.jaci.2005.04.039; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Smyth LJC, 2006, INT J CANCER, V119, P1638, DOI 10.1002/ijc.22018; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	34	45	46	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					995	1005		10.1086/521952	http://dx.doi.org/10.1086/521952			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924341	Green Published, Bronze			2022-12-18	WOS:000250480900011
J	Huang, BE; Lin, DY				Huang, B. E.; Lin, D. Y.			Efficient association mapping of quantitative trait loci with selective genotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION; POWER	Selective genotyping (i.e., genotyping only those individuals with extreme phenotypes) can greatly improve the power to detect and map quantitative trait loci in genetic association studies. Because selection depends on the phenotype, the resulting data cannot be properly analyzed by standard statistical methods. We provide appropriate likelihoods for assessing the effects of genotypes and haplotypes on quantitative traits under selective- genotyping designs. We demonstrate that the likelihood-based methods are highly effective in identifying causal variants and are substantially more powerful than existing methods.	Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, McGavran Greenberg Hall,CB 7420, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu	Huang, Bevan/A-5949-2009	Huang, Bevan/0000-0002-1981-5838	NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA106209] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen ZH, 2005, AM J HUM GENET, V77, P661, DOI 10.1086/491658; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Laitinen T, 1997, HUM MOL GENET, V6, P2069, DOI 10.1093/hmg/6.12.2069; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Slatkin M, 1999, AM J HUM GENET, V64, P1765, DOI 10.1086/302413; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Wallace C, 2006, AM J HUM GENET, V78, P498, DOI 10.1086/500562; Xiong MM, 2002, HUM HERED, V53, P158, DOI 10.1159/000064978	11	45	47	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					567	576		10.1086/512727	http://dx.doi.org/10.1086/512727			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273979	Green Published, Bronze			2022-12-18	WOS:000244403300019
J	Lenski, C; Kooy, RF; Reyniers, E; Loessner, D; Wanders, RJA; Winnepenninckx, B; Hellebrand, H; Engert, S; Schwartz, CE; Meindl, A; Ramser, J				Lenski, Claus; Kooy, R. Frank; Reyniers, Edwin; Loessner, Daniela; Wanders, Ronald J. A.; Winnepenninckx, Birgitta; Hellebrand, Heide; Engert, Stefanie; Schwartz, Charles E.; Meindl, Alfons; Ramser, Juliane			The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; DEHYDROGENASE	Recently, we defined a new syndromic form of X-linked mental retardation in a 4-generation family with a unique clinical phenotype characterized by mild mental retardation, choreoathetosis, and abnormal behavior (MRXS10). Linkage analysis in this family revealed a candidate region of 13.4 Mb between markers DXS1201 and DXS991 on Xp11; therefore, mutation analysis was performed by direct sequencing in most of the 135 annotated genes located in the region. The gene (HADH2) encoding L-3-hydroxyacyl-CoA dehydrogenase II displayed a sequence alteration (c.574 C -> A; p.R192R) in all patients and carrier females that was absent in unaffected male family members and could not be found in 2,500 control X chromosomes, including in those of 500 healthy males. The silent C -> A substitution is located in exon 5 and was shown by western blot to reduce the amount of HADH2 protein by 60%-70% in the patient. Quantitative in vivo and in vitro expression studies revealed a ratio of splicing transcript amounts different from those normally seen in controls. Apparently, the reduced expression of the wild-type fragment, which results in the decreased protein expression, rather than the increased amount of aberrant splicing fragments of the HADH2 gene, is pathogenic. Our data therefore strongly suggest that reduced expression of the HADH2 protein causes MRXS10, a phenotype different from that caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, which is a neurodegenerative disorder caused by missense mutations in this multifunctional protein.	Tech Univ Munich, Dept Obstet & Gynecol, D-8000 Munich, Germany; Univ Munich, Dept Med Genet, Munich, Germany; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA	Technical University of Munich; University of Munich; University of Antwerp; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Greenwood Genetic Center	Meindl, A (corresponding author), Tech Univ Munich, Dept Obstet & Gynecol, D-8000 Munich, Germany.	alfons.meindl@lrz.tu-muenchen.de	Kooy, Frank/F-5276-2014; Loessner, Daniela/L-2265-2017	Kooy, Frank/0000-0003-2024-0485; Loessner, Daniela/0000-0001-5891-3441	NICHD NIH HHS [R01 HD026202, HD26202] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Reyniers E, 1999, AM J HUM GENET, V65, P1406, DOI 10.1086/302638; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Stevenson RE, 2005, CURR OPIN PEDIATR, V17, P720, DOI 10.1097/01.mop.0000184290.57525.fb; Stevenson RE, 2002, CYTOGENET GENOME RES, V99, P265, DOI 10.1159/000071603; Tien K, 2004, ANN NEUROL, V56, P51, DOI 10.1002/ana.20133; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229	13	45	50	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					372	377		10.1086/511527	http://dx.doi.org/10.1086/511527			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236142	Green Published, Bronze			2022-12-18	WOS:000243729500017
J	Wilch, E; Zhu, M; Burkhart, KB; Regier, M; Elfenbein, JL; Fisher, RA; Friderici, KH				Wilch, Ellen; Zhu, Mei; Burkhart, Kirk B.; Regier, Martha; Elfenbein, Jill L.; Fisher, Rachel A.; Friderici, Karen H.			Expression of GJB2 and GJB6 is reduced in a novel DFNB1 allele	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CONNEXIN26 GENE; HEARING IMPAIRMENT; GAP-JUNCTIONS; INNER-EAR; MUTATIONS; DEAFNESS; DEL(GJB6-D13S1830); MULTICENTER; PROMOTER; COCHLEA	In a large kindred of German descent, we found a novel allele that segregates with deafness when present in trans with the 35delG allele of GJB2. Qualitative polymerase chain reaction - based allele-specific expression assays showed that expression of both GJB2 and GJB6 from the novel allele is dramatically reduced. This is the first evidence of a deafness-associated regulatory mutation of GJB2 and of potential coregulation of GJB2 and GJB6.	Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Audiol & Speech Sci, E Lansing, MI 48824 USA; Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Friderici, KH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 5163 Biomed Phys Sci Bldg, E Lansing, MI 48824 USA.	frideric@msu.edu			NIDCD NIH HHS [R01 DC004568, DC004568] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004568] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Common JEA, 2005, CLIN EXP DERMATOL, V30, P688, DOI 10.1111/j.1365-2230.2005.01878.x; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Essenfelder GM, 2005, GENE, V350, P33, DOI 10.1016/j.gene.2004.12.048; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Forge A, 2003, CELL COMMUN ADHES, V10, P341, DOI 10.1080/cac.10.4-6.341.346; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Kiang DT, 1997, GENE, V199, P165, DOI 10.1016/S0378-1119(97)00365-X; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Tu ZJ, 1998, BBA-GENE STRUCT EXPR, V1443, P169, DOI 10.1016/S0167-4781(98)00212-7; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wilcox SA, 2000, MOL DIAGN, V5, P75, DOI 10.2165/00066982-200005010-00015	18	45	48	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					174	179		10.1086/505333	http://dx.doi.org/10.1086/505333			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773579	Green Published, Bronze			2022-12-18	WOS:000238341200020
J	De Temmerman, N; Sermon, K; Seneca, S; De Rycke, M; Hilven, P; Lissens, W; Van Steirteghem, A; Liebaers, I				De Temmerman, N; Sermon, K; Seneca, S; De Rycke, M; Hilven, P; Lissens, W; Van Steirteghem, A; Liebaers, I			Intergenerational instability of the expanded CTG repeat in the DMPK gene: Studies in human gametes and preimplantation embryos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; SOMATIC MOSAICISM; (CTG)(N) REPEAT; EXPANSION; DISEASE; DNA; MUTATIONS	The CTG repeat at the 3' untranslated region of the dystrophia myotonica protein kinase ( DMPK) gene shows marked intergenerational and somatic instability in patients with myotonic dystrophy (DM1), when the repeat is expanded to more than similar to55 repeats. Intensive research has yielded some insights into the timing and mechanism of these intergenerational changes: ( 1) increases in expansion sizes occur during gametogenesis but probably not during meiosis, (2) the marked somatic mosaicism becomes apparent from the 2nd trimester of development onward and increases during adult life, and ( 3) DNA repair mechanisms are involved. We have performed preimplantation genetic diagnosis for DM1 since 1995, which has given us the unique opportunity to study the expanded CTG repeat in affected embryos and in gametes from affected patients. We were able to demonstrate significant increases in the number of repeats in embryos from female patients with DM1 and in their immature and mature oocytes, whereas, in spermatozoa and embryos from male patients with DM1, smaller increases were detected. These data are in concordance with data on other tissues from adults and fetuses and fill a gap in our knowledge of the behavior of CTG triplet expansions in DM1.	Free Univ Brussels, Res Ctr Reprod & Genet, B-1090 Brussels, Belgium; Free Univ Brussels, Dutch Speaking Brussels Free Univ, Sch Med, B-1090 Brussels, Belgium; Free Univ Brussels, Univ Hosp, Ctr Med Genet, B-1090 Brussels, Belgium; Free Univ Brussels, Univ Hosp, Ctr Reprod Med, B-1090 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Sermon, K (corresponding author), Free Univ Brussels, Res Ctr Reprod & Genet, Laarbeeklaan 101, B-1090 Brussels, Belgium.	karen.sermon@az.vub.ac.be	Lissens, Willy/B-2892-2013	Lissens, Willy/0000-0003-3875-9955; De Rycke, Martine/0000-0001-7861-9426; Sermon, Karen/0000-0002-2311-9034; Seneca, Sara/0000-0002-0853-9890				BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Harper PS, 2001, METABOLIC MOL BASIS, P5525; JANSEN G, 1994, AM J HUM GENET, V54, P575; Kaytor MD, 1997, HUM MOL GENET, V6, P2135, DOI 10.1093/hmg/6.12.2135; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Martorell L, 2000, EUR J HUM GENET, V8, P423, DOI 10.1038/sj.ejhg.5200478; Martorell L, 1997, HUM MOL GENET, V6, P877, DOI 10.1093/hmg/6.6.877; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 2003, TRENDS MOL MED, V9, P490, DOI 10.1016/j.molmed.2003.09.006; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Sambrook J, 2001, MOL CLONING LAB MANU; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Sermon K, 2001, MOL CELL ENDOCRINOL, V183, pS77, DOI 10.1016/S0303-7207(01)00572-X; Sinden RR, 2002, J BIOSCIENCES, V27, P53, DOI 10.1007/BF02703683; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; WONG LJC, 1995, AM J HUM GENET, V56, P114; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523; Yoon SR, 2003, P NATL ACAD SCI USA, V100, P8834, DOI 10.1073/pnas.1331390100	20	45	45	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					325	329						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15185171				2022-12-18	WOS:000222702000017
J	Maniatis, N; Collins, A; Gibson, J; Zhang, WH; Tapper, W; Morton, NE				Maniatis, N; Collins, A; Gibson, J; Zhang, WH; Tapper, W; Morton, NE			Positional cloning by linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELIC ASSOCIATION; COMPLEX INHERITANCE; LD MAPS; RECOMBINATION; LIKELIHOOD; DISEASE; TRAITS; FUTURE	Recently, metric linkage disequilibrium (LD) maps that assign an LD unit (LDU) location for each marker have been developed (Maniatis et al. 2002). Here we present a multiple pairwise method for positional cloning by LD within a composite likelihood framework and investigate the operating characteristics of maps in physical units (kb) and LDU for two bodies of data (Daly et al. 2001; Jeffreys et al. 2001) on which current ideas of blocks are based. False-negative indications of a disease locus (type II error) were examined by selecting one single-nucleotide polymorphism ( SNP) at a time as causal and taking its allelic count ( 0, 1, or 2, for the three genotypes) as a pseudophenotype, Y. By use of regression and correlation, association between every pseudophenotype and the allelic count of each SNP locus ( X) was based on an adaptation of the Malecot model, which includes a parameter for location of the putative gene. By expressing locations in kb or LDU, greater power for localization was observed when the LDU map was fitted. The efficiency of the kb map, relative to the LDU map, to describe LD varied from a maximum of 0.87 to a minimum of 0.36, with a mean of 0.62. False-positive indications of a disease locus ( type I error) were examined by simulating an unlinked causal SNP and the allele count was used as a pseudophenotype. The type I error was in good agreement with Wald's likelihood theorem for both metrics and all models that were tested. Unlike tests that select only the most significant marker, haplotype, or haploset, these methods are robust to large numbers of markers in a candidate region. Contrary to predictions from tagging SNPs that retain haplotype diversity, the sample with smaller size but greater SNP density gave less error. The locations of causal SNPs were estimated with the same precision in blocks and steps, suggesting that block definition may be less useful than anticipated for mapping a causal SNP. These results provide a guide to efficient positional cloning by SNPs and a benchmark against which the power of positional cloning by haplotype-based alternatives may be measured.	Univ Southampton, Southampton Gen Hosp, Div Human Genet, Southampton SO16 6YD, Hants, England	University of Southampton	Maniatis, N (corresponding author), Univ Southampton, Southampton Gen Hosp, Div Human Genet, Duthie Bldg,MP 808, Southampton SO16 6YD, Hants, England.	N.Maniatis@soton.ac.uk	Collins, Andrew/A-6595-2010; Collins, Andrew/S-2196-2019; Gibson, Jane/I-1630-2012	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Gibson, Jane/0000-0002-0973-8285; Tapper, William/0000-0002-5896-1889; Maniatis, Nikolas/0000-0002-6567-5936				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; ABRAMOWITZ M., 1965, HDB MATH FUNCTIONS; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Collins A, 1998, P NATL ACAD SCI USA, V95, P1741, DOI 10.1073/pnas.95.4.1741; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; KIMURA M, 1973, GENETICS, V75, P199; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lonjou C, 2003, P NATL ACAD SCI USA, V100, P6069, DOI 10.1073/pnas.1031521100; Lonjou C, 1998, P NATL ACAD SCI USA, V95, P11366, DOI 10.1073/pnas.95.19.11366; Lonjou C, 1998, HUM HERED, V48, P333, DOI 10.1159/000022825; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Morton NE, 2001, P NATL ACAD SCI USA, V98, P5217, DOI 10.1073/pnas.091062198; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shete S, 2003, ANN HUM GENET, V67, P189, DOI 10.1046/j.1469-1809.2003.00025.x; Tapper WJ, 2003, ANN HUM GENET, V67, P487, DOI 10.1046/j.1469-1809.2003.00050.x; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Wald A., 1947, SEQUENTIAL ANAL; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Zhang WH, 2002, P NATL ACAD SCI USA, V99, P17004, DOI 10.1073/pnas.012672899	32	45	46	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					846	855		10.1086/383589	http://dx.doi.org/10.1086/383589			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15048619	Bronze, Green Published			2022-12-18	WOS:000220926100006
J	Li, C; Scott, LJ; Boehnke, M				Li, C; Scott, LJ; Boehnke, M			Assessing whether an allele can account in part for a linkage signal: The Genotype-IBD Sharing Test (GIST)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIABETES-MELLITUS; GENE; DISEASE; REPEAT	To fine map genes, investigators often test for disease-marker association in chromosomal regions with evidence for linkage. Given a marker allele tentatively associated with disease, one would ask if this allele, or one in linkage disequilibrium (LD) with it, could account in part for the observed linkage signal. This question can be addressed by determining if families selected on the basis of the presence of the tentatively associated allele show stronger evidence of linkage as measured by increased allele sharing identical by descent (IBD) by affected family members. However, common selection strategies can be biased for or against linkage in the marker region, even given no disease-marker association. We define unbiased selection schemes and extend the definition to allow weighted selection on the basis of all genotyped family members. For affected-sibship data, we describe three genotype-based weight variables, corresponding to dominant, recessive, and additive models. We then introduce a test for association of a family weight variable with excess IBD sharing. This test allows us to determine if the linkage signal in a region can be attributed in part to the presence of a marker allele, either because of direct involvement in disease etiology or because of LD with a predisposing genetic variant. For samples of 500 affected sib pairs, the tests are powerful in detection of genotype-IBD sharing association, even for disease models with sib relative risk as low as lambda(s) = 1.1, or when evidence for linkage is absent because of sampling variation. This makes our method a new tool for detecting linkage as well as association, especially in regions harboring a candidate gene. We have implemented these methods in the software package GIST (Genotype-IBD Sharing Test).	Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan	Li, C (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, 519 Light Hall, Nashville, TN 37232 USA.	chun.li@vanderbilt.edu	Li, Chun/R-1095-2019; Li, Chun/B-8388-2012	Li, Chun/0000-0002-8819-2443; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, R29HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062370, R01DK062370, U01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015465] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000376, HG00376, N01-HG-15465] Funding Source: Medline; NIDDK NIH HHS [DK62370, R56 DK062370, R01 DK062370, U01 DK062370] Funding Source: Medline; NIEHS NIH HHS [N01HG15465] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ferguson T. S., 1996, COURSE LARGE SAMPLE; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hollander M., 1999, NONPARAMETRIC STAT M; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; KELLERMCNULTY S, 1987, AM STAT, V41, P40, DOI 10.2307/2684317; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Sengul H, 2001, AM J HUM GENET, V69, P179, DOI 10.1086/321264; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun L, 2002, AM J HUM GENET, V70, P399, DOI 10.1086/338660; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yamada T, 1996, POLYM REACT ENG, V4, P1	15	45	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					418	431		10.1086/381712	http://dx.doi.org/10.1086/381712			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14872409	Green Published, Bronze			2022-12-18	WOS:000220118500009
J	Gorlov, IP; Gorlova, OY; Frazier, ML; Amos, CI				Gorlov, IP; Gorlova, OY; Frazier, ML; Amos, CI			Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; PROTEIN; DATABASE	There is a critical need to understand why missense mutations are deleterious. The deleterious effects of missense mutations are commonly attributed to their impact on primary amino acid sequence and protein structure. However, several recent studies have shown that some missense mutations are deleterious because they disturb cis-acting splicing elements-so-called "exonic splicing enhancers" (ESEs). It is not clear whether the ESE-related deleterious effects of missense mutations are common. We have evaluated colocalization of pathogenic missense mutations (found in affected individuals) with high-score ESE motifs in the human mismatch-repair genes hMSH2 and hMLH1. We found that pathogenic missense mutations in the hMSH2 and hMLH1 genes are located in ESE sites significantly more frequently than expected. Pathogenic missense mutations also tended to decrease ESE scores, thus leading to a higher propensity for splicing defects. In contrast, nonpathogenic missense mutations (polymorphisms found in unaffected individuals) and nonsense mutations are distributed randomly in relation to ESE sites. Comparison of the observed and expected frequencies of missense mutations in ESE sites shows that pathogenic effects of greater than or equal to20% of mutations in hMSH2 result from disruption of ESE sites and disturbed splicing. Similarly, pathogenic effects of greater than or equal to16% of missense mutations in the hMLH1 gene are ESE related. The colocalization of pathogenic missense mutations with ESE sites strongly suggests that their pathogenic effects are splicing related.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Amos, CI (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Box 189,1515 Holcombe Blvd, Houston, TX 77030 USA.				NCI NIH HHS [R25 CA57730, P30 CA016672, CA16672, CA70759, R25 CA057730, R01 CA070759] Funding Source: Medline; NHGRI NIH HHS [HG02275, R01 HG002275] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA070759, R25CA057730] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Fackenthal JD, 2002, AM J HUM GENET, V71, P625, DOI 10.1086/342192; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Martin ACR, 2002, HUM MUTAT, V19, P149, DOI 10.1002/humu.10032; Moseley CT, 2002, J CLIN ENDOCR METAB, V87, P847, DOI 10.1210/jc.87.2.847; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Pollard AJ, 2002, J BIOL CHEM, V277, P15241, DOI 10.1074/jbc.M109046200; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293	17	45	47	1	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1157	1161		10.1086/378819	http://dx.doi.org/10.1086/378819			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14526391	Green Published, Bronze			2022-12-18	WOS:000186493400016
J	Binzak, BA; Wevers, RA; Moolenaar, SH; Lee, YM; Hwu, WL; Poggi-Bach, J; Engelki, UFH; Hoard, HM; Vockley, JG; Vockley, J				Binzak, BA; Wevers, RA; Moolenaar, SH; Lee, YM; Hwu, WL; Poggi-Bach, J; Engelki, UFH; Hoard, HM; Vockley, JG; Vockley, J			Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAT-LIVER MITOCHONDRIA; FOLATE-BINDING PROTEINS; SARCOSINE DEHYDROGENASE; ENZYMATIC-PROPERTIES; COA DEHYDROGENASE; IDENTIFICATION; SPECTROSCOPY; FLAVOPROTEIN; ACID	Dimethylglycine dehydrogenase (DMGDH) (E.C. number 1.5.99.2) is a mitochondrial matrix enzyme involved in the metabolism of choline, converting dimethylglycine to sarcosine. Sarcosine is then transformed to glycine by sarcosine dehydrogenase (E.C. number 1.5.99.1). Both enzymes use flavin adenine dinucleotide and folate in their reaction mechanisms. We have identified a 38-year-old man who has a lifelong condition of fishlike body odor and chronic muscle fatigue, accompanied by elevated levels of the muscle form of creatine kinase in serum. Biochemical analysis of the patient's serum and urine, using H-1-nuclear magnetic resonance NMR spectroscopy, revealed that his levels of dimethylglycine were much higher than control values. The cDNA and the genomic DNA for human DMGDH (hDMGDH) were then cloned, and a homozygous A-->G substitution (326 A-->G) was identified in both the cDNA and genomic DNA of the patient. This mutation changes a His to an Arg (H109R). Expression analysis of the mutant cDNA indicates that this mutation inactivates the enzyme. We therefore confirm that the patient described here represents the first reported case of a new inborn error of metabolism, DMGDH deficiency.	Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Nijmegen Hosp, Inst Neurol, NL-6500 HB Nijmegen, Netherlands; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; Natl Taiwan Univ, Coll Med, Inst Biochem Sci, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Dept Pediat & Med Genet, Taipei, Taiwan; Hop Bicetre AP HP, Lab Biochim 1, Paris, France; SmithKline Beecham, Philadelphia, PA USA	Mayo Clinic; Mayo Clinic; Radboud University Nijmegen; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; GlaxoSmithKline	Vockley, J (corresponding author), Mayo Clin & Mayo Fdn, Dept Med Genet, 200 1st St SW, Rochester, MN 55905 USA.		Vockley, Jerry/B-5210-2016; Vockley, Jerry/AAF-8523-2020; Wevers, Ron A./H-8116-2014	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Wevers, Ron A./0000-0003-2278-9746; HWU, WUH-LIANG/0000-0001-6690-4879	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045482] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK45482, R01 DK045482] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Bergeron F, 1998, EUR J BIOCHEM, V257, P556, DOI 10.1046/j.1432-1327.1998.2570556.x; Binzak B, 1998, BBA-PROTEIN STRUCT M, V1382, P137, DOI 10.1016/S0167-4838(97)00161-1; Binzak BA, 2000, MOL GENET METAB, V69, P181, DOI 10.1006/mgme.2000.2980; COOK RJ, 1984, J BIOL CHEM, V259, P2475; COOK RJ, 1985, J BIOL CHEM, V260, P2998; DUDMAN NPB, 1993, ARTERIOSCLER THROMB, V13, P1253, DOI 10.1161/01.ATV.13.9.1253; FRISELL WR, 1962, J BIOL CHEM, V237, P94; GERRITSEN T, 1966, NEW ENGL J MED, V275, P66, DOI 10.1056/NEJM196607142750202; Gerritsen T, 1972, Helv Paediatr Acta, V21, P33; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HOSKINS DD, 1961, J BIOL CHEM, V236, P177; LANG H, 1994, BIOCHEM J, V299, P393, DOI 10.1042/bj2990393; LANG H, 1991, EUR J BIOCHEM, V198, P793, DOI 10.1111/j.1432-1033.1991.tb16083.x; MACKENZIE CG, 1958, J BIOL CHEM, V232, P417; MACKENZIE CG, 1956, J BIOL CHEM, V222, P145; MALEY GF, 1982, ARCH BIOCHEM BIOPHYS, V216, P551, DOI 10.1016/0003-9861(82)90244-2; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; Moolenaar SH, 1999, CLIN CHEM, V45, P459; Otto A, 1996, J BIOL CHEM, V271, P9823, DOI 10.1074/jbc.271.16.9823; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; SCOTT CR, 1995, METABOLIC MOL BASES, P1329; STEENKAMP DJ, 1982, BIOCHEM J, V203, P707, DOI 10.1042/bj2030707; STRONG WB, 1989, BIOCHEMISTRY-US, V28, P106, DOI 10.1021/bi00427a016; WAGNER C, 1984, ARCH BIOCHEM BIOPHYS, V233, P457, DOI 10.1016/0003-9861(84)90467-3; WEVERS RA, 1994, CLIN CHEM, V40, P1245; WITTWER AJ, 1980, P NATL ACAD SCI-BIOL, V77, P4484, DOI 10.1073/pnas.77.8.4484; WITTWER AJ, 1981, J BIOL CHEM, V256, P4109; WITTWER AJ, 1981, J BIOL CHEM, V256, P4102	29	45	49	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					839	847		10.1086/319520	http://dx.doi.org/10.1086/319520			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11231903	Bronze, Green Published			2022-12-18	WOS:000167666000005
J	Downey, LM; Keen, TJ; Roberts, E; Mansfield, DC; Bamashmus, M; Inglehearn, CF				Downey, LM; Keen, TJ; Roberts, E; Mansfield, DC; Bamashmus, M; Inglehearn, CF			A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORRIE DISEASE GENE; LINKAGE ANALYSIS; RETINOPATHY; PREMATURITY; MUTATIONS	We report a new locus for familial exudative vitreoretinopathy (FEVR), on chromosome 11p12-13 in a large autosomal dominant pedigree. Statistically significant linkage was achieved across a 14-cM interval flanked by markers GATA34E08 and D11S4102, with a maximum multipoint LOD score of 6.6 at D11S2010. FEVR is a disease characterized by the failure of development of peripheral retinal blood vessels, and it is difficult to diagnose clinically because of the wide spectrum of fundus abnormalities associated with it. The identification of a new locus is important for genetic counseling and potentiates further studies aimed toward the identification of a gene with an important role in angiogenesis within neuroepithelial tissues. Such a gene may also have a role in the genetic predisposition to retinopathy of prematurity, a sporadic disorder with many clinical similarities to FEVR.	Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Inverclyde Royal Hosp, Dept Ophthalmol, Greenock, England	Saint James's University Hospital; University of Leeds	Inglehearn, CF (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.		Inglehearn, Chris/GYD-9783-2022	BAMASHMUS, MAHFOUTH/0000-0002-2219-5983				Bamashmus MA, 2000, BRIT J OPHTHALMOL, V84, P358, DOI 10.1136/bjo.84.4.358; Benson W E, 1995, Trans Am Ophthalmol Soc, V93, P473; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; CHEN ZY, 1993, GENOMICS, V16, P533, DOI 10.1006/geno.1993.1224; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; de Crecchio G, 1998, CLIN GENET, V54, P315, DOI 10.1034/j.1399-0004.1998.5440409.x; FULLWOOD P, 1993, BRIT J OPHTHALMOL, V77, P168, DOI 10.1136/bjo.77.3.168; GIBSON DL, 1989, PEDIATRICS, V83, P486; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; LI Y, 1992, AM J HUM GENET, V51, P749; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; MIYAKUBO H, 1984, OPHTHALMOLOGY, V91, P1524; MULLER B, 1994, GENOMICS, V20, P317, DOI 10.1006/geno.1994.1176; OBER RR, 1980, BRIT J OPHTHALMOL, V64, P112, DOI 10.1136/bjo.64.2.112; Saunders RA, 1997, ARCH OPHTHALMOL-CHIC, V115, P604, DOI 10.1001/archopht.1997.01100150606005; SHASTRY BS, 1995, GENOMICS, V27, P341, DOI 10.1006/geno.1995.1052; Shastry BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P651, DOI 10.1001/archopht.1997.01100150653015	17	45	48	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					778	781		10.1086/318790	http://dx.doi.org/10.1086/318790			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179025	Green Published, Bronze			2022-12-18	WOS:000166994200022
J	Su, LK; Barnes, CJ; Yao, WZ; Qi, Y; Lynch, PM; Steinbach, G				Su, LK; Barnes, CJ; Yao, WZ; Qi, Y; Lynch, PM; Steinbach, G			Inactivation of germline mutant APC alleles by attenuated somatic mutations: A molecular genetic mechanism for attenuated familial adenomatous polyposis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN; COLORECTAL-CANCER; COLI GENE; FUNCTIONAL INTERACTION; IDENTIFICATION; GSK3-BETA; FAP; CHROMOSOME-5Q21; TUMORIGENESIS	Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in familial adenomatous polyposis (FAP). Patients with FAP typically develop hundreds to thousands of benign colorectal tumors and early-onset colorectal cancer. A subset of germline APC mutations results in an attenuated FAP (AFAP) phenotype, in which patients develop fewer tumors and develop them at an older age. Although a genotype-phenotype correlation between the locations of APC germline mutations and the development of AFAP has been well documented, the mechanism for AFAP has not been well defined. We investigated the mechanism for AFAP in patients carrying a mutant APC allele (APC(AS9)) that has a mutation in the alternatively spliced region of exon 9. APC(AS9) was found to down-regulate beta-catenin-regulated transcription, the major tumor-suppressor function of APC, as did the wildtype APC. Mutation analysis showed that both APC(AS9) and the wild-type APC alleles were somatically mutated in most colorectal tumors from these patients. Functional analysis showed that 4666insA, a common somatic mutation in APC(AS9) in these tumors, did not inactivate the wild-type APC. Our results indicate that carriers of APC(AS9) develop fewer colorectal tumors than do typical patients with FAP because somatic inactivation of both APC alleles is necessary for colorectal tumorigenesis. However, these patients develop colorectal tumors more frequently than does the general population because APC(AS9) is inactivated by mutations that do not inactivate the wild-type APC.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Oncol & Digest Dis, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Div Canc Prevent, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Su, LK (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Box 79, Houston, TX 77030 USA.	lsu@notes.mdacc.tmc.edu		Steinbach, Gideon/0000-0001-7597-0544	NCI NIH HHS [P30 CA016672, N01-CN-65118-MAO, CA70371, CA16672] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN065118] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R29CA070371, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brensinger JD, 1998, GUT, V43, P548, DOI 10.1136/gut.43.4.548; CHENG H, 1984, GASTROENTEROLOGY, V86, P78; Dashwood RH, 1998, CANCER RES, V58, P1127; Friedl W, 1996, HUM GENET, V97, P579; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gryfe R, 1999, AM J HUM GENET, V64, P378, DOI 10.1086/302262; Gryfe R, 1998, CANCER RES, V58, P4040; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KNUDSON AG, 1985, CANCER RES, V45, P1437; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LYNCH HT, 1992, DIS COLON RECTUM, V35, P411, DOI 10.1007/BF02049396; LYNCH HT, 1995, CANCER, V76, P2427, DOI 10.1002/1097-0142(19951215)76:12<2427::AID-CNCR2820761205>3.0.CO;2-B; MIYAKI M, 1994, CANCER RES, V54, P3011; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Nagase Hiroki, 1992, Human Mutation, V1, P467, DOI 10.1002/humu.1380010603; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SAMOWITZ WS, 1995, CANCER RES, V55, P3732; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Soravia C, 1998, AM J HUM GENET, V62, P1290, DOI 10.1086/301883; Sparks AB, 1998, CANCER RES, V58, P1130; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Spirio LN, 1998, NAT GENET, V20, P385, DOI 10.1038/3865; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Su LK, 2000, HUM GENET, V106, P101, DOI 10.1007/s004390051016; Takahashi M, 1998, CANCER RES, V58, P42; VANDERLUIJT RB, 1995, HUM GENET, V96, P705, DOI 10.1007/BF00210303; vanderLuijt RB, 1996, HUM GENET, V98, P727, DOI 10.1007/s004390050293; Walon C, 1997, HUM GENET, V100, P601, DOI 10.1007/s004390050560; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	46	45	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					582	590		10.1086/303058	http://dx.doi.org/10.1086/303058			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10924409	Green Published, Bronze			2022-12-18	WOS:000089002300005
J	Varley, H; Di, SJ; Scherer, SW; Royle, NJ				Varley, H; Di, SJ; Scherer, SW; Royle, NJ			Characterization of terminal deletions at 7q32 and 22q13.3 healed by de novo telomere addition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR CHARACTERIZATION; JACOBSEN-SYNDROME; MENTAL-RETARDATION; PRIMER SPECIFICITY; HUMAN-CHROMOSOMES; DNA-SEQUENCE; REPEAT; TETRAHYMENA; YEAST; RNA	We have developed a strategy for the isolation of terminal deletion breakpoints from any chromosome that has been healed by de novo addition of a telomere repeat array. Breakpoints at 7q32 and 22q13.3 have been isolated and characterized in two patients (patients FB336R and AJ). Both truncated chromosomes have been healed by the addition of a novel telomere, with such an addition possibly mediated by the enzyme telomerase. The breakpoint at 7q32 in patient FB336R shows a structure similar to that of breakpoints on other chromosomes that have been healed in this way. However, the breakpoint at 22q13.3 in patient AJ has 10 nucleotides of unknown origin inserted between the sequence unique to chromosome 22q and the start of the telomere repeat array. This unusual structure is suggestive of a multistep healing event resulting in de novo telomere addition at this breakpoint, and possible mechanisms are discussed.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Cell Works Inc, Canc Res Lab, Baltimore, MD USA; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada	University of Leicester; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Royle, NJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Scherer, Stephen W./B-3785-2013	Scherer, Stephen W./0000-0002-8326-1999; Royle, Nicola/0000-0003-1174-6329				ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baird DM, 2000, AM J HUM GENET, V66, P235, DOI 10.1086/302721; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; BULUWELA L, 1989, NUCLEIC ACIDS RES, V17, P452, DOI 10.1093/nar/17.1.452; CHENG JF, 1991, NUCLEIC ACIDS RES, V19, P149, DOI 10.1093/nar/19.1.149; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Flint J, 1996, HUM MOL GENET, V5, P1163, DOI 10.1093/hmg/5.8.1163; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; FLINT J, 1994, AM J HUM GENET, V55, P505; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Gilley D, 1996, MOL CELL BIOL, V16, P66; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; HARRINGTON LA, 1991, NATURE, V353, P451, DOI 10.1038/353451a0; Jacobsen P, 1973, Ugeskr Laeger, V135, P17; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KOCH JE, 1989, CHROMOSOMA, V98, P259, DOI 10.1007/BF00327311; May CA, 1996, HUM MOL GENET, V5, P1823, DOI 10.1093/hmg/5.11.1823; McClintock B, 1941, GENETICS, V26, P234; Michaelis RC, 1998, AM J MED GENET, V76, P222, DOI 10.1002/(SICI)1096-8628(19980319)76:3<222::AID-AJMG5>3.0.CO;2-S; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Muller H.J., 1938, COLLECTING NET, V13, P181; NESSLINGER NJ, 1994, AM J HUM GENET, V54, P464; ROYLE NJ, 1992, P ROY SOC B-BIOL SCI, V247, P57, DOI 10.1098/rspb.1992.0009; ROYLE NJ, 1994, NAT GENET, V6, P52, DOI 10.1038/ng0194-52; Sambrook J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHINZEL A, 1977, J MED GENET, V14, P438, DOI 10.1136/jmg.14.6.438; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Tunnacliffe A, 1999, GENOME RES, V9, P44; VOULLAIRE LE, 1987, HUM GENET, V76, P202, DOI 10.1007/BF00284923; Wong ACC, 1997, AM J HUM GENET, V60, P113; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; Wright WE, 1996, DEV GENET, V18, P173; YU GL, 1991, CELL, V67, P823, DOI 10.1016/0092-8674(91)90077-C; ZAKIAN VA, 1990, TRENDS GENET, V6, P12, DOI 10.1016/0168-9525(90)90043-6	51	45	46	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					610	622		10.1086/303050	http://dx.doi.org/10.1086/303050			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10924407	Green Published, Bronze			2022-12-18	WOS:000089002300008
J	Hinek, A; Zhang, SQ; Smith, AC; Callahan, JW				Hinek, A; Zhang, SQ; Smith, AC; Callahan, JW			Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; ELASTIN/LAMININ-BINDING-PROTEIN; MUCOPOLYSACCHARIDOSIS-IV-B; CHONDROITIN SULFATE; GM1 GANGLIOSIDOSIS; DUCTUS-ARTERIOSUS; MESSENGER-RNA; TROPOELASTIN; MICROFIBRILS; FIBRILLIN	We have previously shown that intracellular trafficking and extracellular assembly of tropoelastin into elastic fibers is facilitated by the 67-kD elastin-binding protein identical to an enzymatically inactive, alternatively spliced variant of beta-galactosidase (S-Gal). In the present study, we investigated elastic-fiber assembly in cultures of dermal fibroblasts from patients with either Morquio B disease or GM1-gangliosidosis who bore different mutations of the P-galactosidase gene. We found that fibroblasts taken from patients with an adult form of GM1-gangliosidosis and from patients with an infantile form, carrying a missense mutations in the beta-galactosidase gene-mutations that caused deficiency in lysosomal beta-galactosidase but not. in S-Gal-assembled normal elastic fibers. In contrast, fibroblasts from two cases of infantile GM1-gangliosidosis that bear nonsense mutations of the beta-galactosidase gene, as well as fibroblasts from four patients with Morquio B who had mutations causing deficiency in both forms of beta-galactosidase, did not assemble elastic fibers. We also demonstrated that S-Gal-deficient fibroblasts from patients with either GM1-gangliosidosis or Morquio B can acquire the S-Gal protein, produced by coculturing of Chinese hamster ovary cells permanently transected with S-Gal cDNA, resulting in improved deposition of elastic fibers. The present study provides a novel and natural model validating functional roles of S-Gal in elastogenesis and elucidates an association between impaired elastogenesis and the development of connective-tissue disorders in patients with Morquio B disease and in patients with an infantile form of GM1-gangliosidosis.	Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Struct Biol & Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Hinek, A (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Smith, Adam/GPS-8322-2022; Smith, Adam/N-1935-2017; Hinek, Aleksander/V-8790-2019	Smith, Adam/0000-0001-9927-4914; 				ALROY J, 1995, VIRCHOWS ARCH, V426, P141; ALROY J, 1992, AM J PATHOL, V140, P675; ARBISSER AI, 1977, AM J MED GENET, V1, P195, DOI 10.1002/ajmg.1320010205; BENSON F, 1976, POSTGRAD MED J, V52, P159; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; CHARROW J, 1986, J PEDIATR-US, V108, P729, DOI 10.1016/S0022-3476(86)81054-X; CHRISTIANO AM, 1994, J INVEST DERMATOL, V103, pS53, DOI 10.1111/1523-1747.ep12399044; CLEARY EG, 1967, J CELL BIOL, V33, P469, DOI 10.1083/jcb.33.3.469; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DAGROSA RM, 1992, BIOCHEM J, V285, P833, DOI 10.1042/bj2850833; Dangel JH, 1998, EUR J PEDIATR, V157, P534, DOI 10.1007/s004310050872; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FACTOR SM, 1978, VIRCHOWS ARCH A, V379, P1, DOI 10.1007/BF00432778; Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096; GIUGLIANI R, 1987, CLIN GENET, V32, P313; GROEBE H, 1980, AM J HUM GENET, V32, P258; HADLEY RN, 1971, AM J CLIN PATHOL, V55, P237; Haust M D, 1987, Am J Cardiovasc Pathol, V1, P231; Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1992, EXP CELL RES, V203, P344, DOI 10.1016/0014-4827(92)90008-V; HINEK A, 1993, J BIOL CHEM, V268, P1405; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hinek A, 1996, BIOL CHEM, V377, P471; HOLZENBERGER M, 1993, ANAT EMBRYOL, V188, P481; HURLE JM, 1994, J CELL SCI, V107, P2623; KAGAN HM, 1986, J CELL BIOL, V103, P1121, DOI 10.1083/jcb.103.3.1121; Kielty CM, 1996, FEBS LETT, V386, P169, DOI 10.1016/0014-5793(96)00423-1; KIELTY CM, 1995, INT J BIOCHEM CELL B, V27, P747, DOI 10.1016/1357-2725(95)00028-N; KOHLSCHUTTER A, 1982, EUR J PEDIATR, V139, P75, DOI 10.1007/BF00442086; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Mecham R.P., 1991, CELL BIOL EXTRACELLU, V2nd, P79; MECHAM RP, 1988, BIOCHEM BIOPH RES CO, V151, P822, DOI 10.1016/S0006-291X(88)80355-3; MECHAM RP, 1991, J CELL BIOL, V113, P187, DOI 10.1083/jcb.113.1.187; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; MORREAU H, 1989, J BIOL CHEM, V264, P20655; Morrone A, 2000, HUM MUTAT, V15, P354, DOI 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.3.CO;2-C; MUTOH T, 1988, BIOCHIM BIOPHYS ACTA, V964, P244, DOI 10.1016/0304-4165(88)90172-9; MUTOH T, 1986, NEUROLOGY, V36, P1237, DOI 10.1212/WNL.36.9.1237; OkamuraOho Y, 1996, BIOCHEM J, V313, P787, DOI 10.1042/bj3130787; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; Oshima M., 1995, METABOLIC MOL BASES, V2, P2785; PasqualiRonchetti I, 1997, MICROSC RES TECHNIQ, V38, P428, DOI 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; PROSSER IW, 1991, CONNECT TISSUE RES, V25, P265, DOI 10.3109/03008209109029162; ROSENBERG H, 1985, J PEDIATR-US, V106, P78, DOI 10.1016/S0022-3476(85)80472-8; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004; SAUNDERS NA, 1985, BIOCHEM J, V230, P217, DOI 10.1042/bj2300217; SELMIN O, 1991, MATRIX, V11, P347, DOI 10.1016/S0934-8832(11)80206-4; SINGH MB, 1984, HISTOCHEM J, V16, P1273, DOI 10.1007/BF01003726; SKOMOROWSKI MA, 1999, J INHERIT METAB D S1, V22, P131; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; VANDERHORST GTJ, 1983, AM J MED GENET, V16, P261, DOI 10.1002/ajmg.1320160215; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; YAMAMOTO Y, 1990, DNA CELL BIOL, V9, P119, DOI 10.1089/dna.1990.9.119; ZHANG SQ, 1994, BIOCHEM J, V304, P281, DOI 10.1042/bj3040281	66	45	53	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					23	36		10.1086/302968	http://dx.doi.org/10.1086/302968			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10841810	Bronze, Green Published			2022-12-18	WOS:000088926900006
J	Murray, A; Ennis, S; Morton, N				Murray, A; Ennis, S; Morton, N			No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Southampton Univ Hosp Trust, Human Genet Res Div, Southampton, Hants, England	Salisbury District Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Murray, A (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.			Murray, Anna/0000-0002-2351-2522				Hundscheid RDL, 2000, AM J HUM GENET, V66, P413, DOI 10.1086/302774; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; MURRAY A, IN PRESS EUR J HUM G	4	45	45	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					253	254		10.1086/302963	http://dx.doi.org/10.1086/302963			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10848495	Green Published, Bronze			2022-12-18	WOS:000088926900030
J	Gaudet, D; Arsenault, S; Perusse, L; Vohl, MC; St-Pierre, J; Bergeron, J; Despres, JP; Dewar, K; Daly, MJ; Hudson, T; Rioux, JD				Gaudet, D; Arsenault, S; Perusse, L; Vohl, MC; St-Pierre, J; Bergeron, J; Despres, JP; Dewar, K; Daly, MJ; Hudson, T; Rioux, JD			Glycerol as a correlate of impaired glucose tolerance: Dissection of a complex system by use of a simple genetic trait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KINASE GENE; ADIPOSE-TISSUE; DEFICIENCY; METABOLISM; XP21; PHARMACOKINETICS; MUTATIONS; SECRETION; FAT	Glycerol kinase (GK) represents the primary entry of glycerol into glucose and triglyceride metabolism. Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease. The relationship between glycerol and the risk of IGT, however, is poorly understood. We therefore undertook the study of fasting plasma glycerol levels in a cohort of 1,056 unrelated men and women of French-Canadian descent. Family screening in the initial cohort identified 18 men from five families with severe hyperglycerolemia (values above 2.0 mmol/liter) and demonstrated an X-linked pattern of inheritance. Linkage analysis of the data from 12 microsatellite markers surrounding the Xp21.3 GK gene resulted in a peak LOD score of 3.46, centered around marker DXS8039. In addition, since all of the families originated in a population with a proven founder effect-the Saguenay Lac-St.-Jean region of Quebec-a common disease haplotype was sought. Indeed, a six-marker haplotype extending over a region of 5.5 cM was observed in all families. Resequencing of the GK gene in family members led to the discovery of a N288D missense mutation in exon 10, which resulted in the substitution of a highly conserved asparagine residue by a negatively charged aspartic acid. Although patients with the N288D mutation suffered from severe hyperglycerolemia, they were apparently otherwise healthy. The phenotypic analysis of the family members, however, showed that glycerol levels correlated with impaired glucose metabolism and body-fat distribution. We subsequently noted a substantial variation in glycerolemia in subjects of the initial cohort with normal plasma glycerol levels and demonstrated that this variance showed significant family resemblance. These results suggest a potentially important genetic connection between fasting glycerolemia and glucose homeostasis, not only in this X-linked deficiency but, potentially, in individuals within the "normal" range of plasma glycerol concentrations.	Chicoutimi Hosp, Lipid Clin, Lipid Res Grp, 305 St Vallier St, Chicoutimi, PQ, Canada; Univ Laval, Phys Act Sci Lab, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Lipid Res Ctr, Quebec City, PQ G1K 7P4, Canada; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; McGill Univ, Montreal Gen Hosp, Inst Res, Montreal, PQ H3G 1A4, Canada	Laval University; Laval University; Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University	Gaudet, D (corresponding author), Chicoutimi Hosp, Lipid Clin, Lipid Res Grp, 305 St Vallier St, Chicoutimi, PQ, Canada.	dgaudet@saglac.qc.ca; rioux@genome.wi.mit.edu	Perusse, Louis/A-3444-2012; Daly, Mark J/B-2453-2017; Vohl, Marie-Claude/AAQ-1378-2021; Rioux, John D/A-9599-2015	Perusse, Louis/0000-0001-6440-9698; Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Vohl, Marie-Claude/0000-0002-7017-5848				BABA H, 1995, NUTRITION, V11, P149; Baumgartner R N, 1990, Exerc Sport Sci Rev, V18, P193; Blomquist HK, 1996, CLIN GENET, V50, P375; BOGARDUS C, 1986, NEW ENGL J MED, V315, P96, DOI 10.1056/NEJM198607103150205; Catron LF, 1929, J BIOL CHEM, V84, P553; CHAKRABARTY K, 1984, INT J OBESITY, V8, P609; DAVIES KE, 1988, AM J MED GENET, V29, P557, DOI 10.1002/ajmg.1320290313; DESBUQUOIS B, 1971, J CLIN ENDOCR METAB, V33, P732, DOI 10.1210/jcem-33-5-732; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; FRANK MSB, 1981, PHARMACOTHERAPY, V1, P147; Gavin JR, 1997, DIABETES CARE, V20, P1183; GRADIE MI, 1988, AM J PHYS ANTHROPOL, V77, P321, DOI 10.1002/ajpa.1330770305; GUO WW, 1993, NAT GENET, V4, P367, DOI 10.1038/ng0893-367; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Huq AHMM, 1997, HUM MOL GENET, V6, P1803, DOI 10.1093/hmg/6.11.1803; JANSSON PA, 1992, J CLIN INVEST, V89, P1610, DOI 10.1172/JCI115756; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LOHMAN T, 1988, AIRL VA CONS C HUM K; McCabe ER, 1995, METABOLIC BASIS INHE, P1631; MCCABE ERB, 1994, J BIOENERG BIOMEMBR, V26, P317, DOI 10.1007/BF00763103; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; Noel RJ, 1997, J BIOL CHEM, V272, P18621, DOI 10.1074/jbc.272.30.18621; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3270, DOI 10.1161/01.ATV.17.11.3270; PETTIGREW DW, 1988, J BIOL CHEM, V263, P135; Pettigrew DW, 1998, ARCH BIOCHEM BIOPHYS, V349, P236, DOI 10.1006/abbi.1997.0444; RICHTERICH R, 1971, SCHWEIZ MED WSCHR, V101, P615; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; ROGNSTAD R, 1974, BIOCHEM J, V140, P249, DOI 10.1042/bj1400249; Romero NB, 1997, NEUROMUSCULAR DISORD, V7, P499, DOI 10.1016/S0960-8966(97)00114-4; ROSE CI, 1978, J CLIN INVEST, V61, P163, DOI 10.1172/JCI108914; SARGENT CA, 1994, HUM MOL GENET, V3, P1317, DOI 10.1093/hmg/3.8.1317; Sjarif DR, 1998, J MED GENET, V35, P650, DOI 10.1136/jmg.35.8.650; SOMMER S, 1993, ARZNEIMITTEL-FORSCH, V43-2, P744; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Walker AP, 1996, AM J HUM GENET, V58, P1205; WALKER AP, 1993, HUM MOL GENET, V2, P107, DOI 10.1093/hmg/2.2.107; *WHO STUD GROUP DI, 1985, WHO TECHN REP SER, V727; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; YILMAZ MT, 1987, MOL CELL ENDOCRINOL, V52, P251, DOI 10.1016/0303-7207(87)90051-7	40	45	50	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1558	1568		10.1086/302903	http://dx.doi.org/10.1086/302903			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10736265	Green Published, Bronze			2022-12-18	WOS:000088373700010
J	Kumar, S; Deffenbacher, K; Marres, HAM; Cremers, CWRJ; Kimberling, WJ				Kumar, S; Deffenbacher, K; Marres, HAM; Cremers, CWRJ; Kimberling, WJ			Genomewide search and genetic localization of a second gene associated with autosomal dominant branchio-oto-renal syndrome: Clinical and genetic implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOR SYNDROME; HEARING-LOSS; BRANCHIOOCULOFACIAL SYNDROME; EAR PITS; ANOMALIES; LINKAGE; CHROMOSOME-8Q; INHERITANCE; DYSPLASIA; FAMILY	Branchio-oto-renal (BOR) syndrome is characterized by ear malformations, cervical fistulas, hearing loss, and renal anomalies. It is an autosomal dominant disorder with variable clinical manifestations. The most common features of BOR syndrome are branchial, hearing, and renal anomalies. However, many affected subjects have been observed with branchial-cleft anomalies and hearing loss but without renal anomalies, a condition called "branchio-otic" (BO) syndrome. It is logical to question whether the BOR and BO syndromes are allelic or whether they represent distinct genetic entities. We identified a very large extended family whose members had branchial and hearing anomalies associated with commissural lip pits that segregated in an autosomal dominant fashion. Using a genomewide search strategy, we identified genetic linkage, with a maximum LOD score of 4.81 at recombination fraction 0, between the BO phenotype and polymorphic marker D1S2757 in the genetic region of chromosome 1q31. This is the first report of linkage for a second gene associated with BOR syndrome. The findings have important clinical implications and will provide insight into the genetic basis of BOR syndrome.	Boys Town Natl Res Hosp, Dept Genet, Ctr Hereditary & Commun Disorders, Omaha, NE 68131 USA; Univ Nijmegen Hosp, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands	Boys Town National Research Hospital; Radboud University Nijmegen	Kumar, S (corresponding author), Boys Town Natl Res Hosp, Dept Genet, Ctr Hereditary & Commun Disorders, 555 N 30th St, Omaha, NE 68131 USA.	Kumar@boystown.org	Marres, H.A.M./H-8071-2014; Cremers, C.W.R.J./L-4254-2015		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER; NIDCD NIH HHS [P01DC01813] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; ASHERSON FM, 1834, FISTULIS COLLII CONG; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CREMERS CWRJ, 1980, INT J PEDIATR OTORHI, V2, P309, DOI 10.1016/0165-5876(80)90036-1; FITCH N, 1976, AM J DIS CHILD, V130, P1356, DOI 10.1001/archpedi.1976.02120130062012; FOURMAN P, 1955, BMJ-BRIT MED J, V2, P1354, DOI 10.1136/bmj.2.4952.1354; FRASER FC, 1978, AM J MED GENET, V2, P241, DOI 10.1002/ajmg.1320020305; FRASER FC, 1983, AM J MED GENET, V14, P473, DOI 10.1002/ajmg.1320140311; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; HEIMLER A, 1986, AM J MED GENET, V25, P15, DOI 10.1002/ajmg.1320250104; Heusinger C., 1864, VIRCHOWS ARCH, V29, P358, DOI [10.1007/BF01937182, DOI 10.1007/BF01937182]; Kumar S, 1997, GENET TEST, V1, P243, DOI 10.1089/gte.1997.1.243; KUMAR S, 1992, HUM MOL GENET, V1, P491, DOI 10.1093/hmg/1.7.491; Kumar S, 1998, HUM MUTAT, V11, P443, DOI 10.1002/(SICI)1098-1004(1998)11:6<443::AID-HUMU4>3.3.CO;2-J; Kumar S, 1996, GENOMICS, V31, P71, DOI 10.1006/geno.1996.0011; Kumar S, 1998, AM J MED GENET, V76, P395, DOI 10.1002/(SICI)1096-8628(19980413)76:5<395::AID-AJMG6>3.3.CO;2-5; LIN AE, 1995, AM J MED GENET, V56, P42, DOI 10.1002/ajmg.1320560112; MARRES HAM, 1994, J LARYNGOL OTOL, V108, P13, DOI 10.1017/S002221510012571X; MCCOOL M, 1994, AM J MED GENET, V49, P414, DOI 10.1002/ajmg.1320490413; MELNICK M, 1978, CLIN GENET, V13, P425; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Paget J, 1878, Med Chir Trans, V61, P41; PENNIE BH, 1992, INT J PEDIATR OTORHI, V23, P269, DOI 10.1016/0165-5876(92)90109-3; PRECECHTEL A, 1927, ACTA OTO-LARYNGOL, V11, P23; PREISCH JW, 1985, CLIN GENET, V27, P506; SANDER W, 1995, ADV STR ORG, V4, P1; SMITH RJH, 1992, GENOMICS, V14, P841, DOI 10.1016/S0888-7543(05)80102-8; Stratakis CA, 1998, AM J MED GENET, V79, P209, DOI 10.1002/(SICI)1096-8628(19980923)79:3<209::AID-AJMG12>3.3.CO;2-D	28	45	53	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1715	1720		10.1086/302890	http://dx.doi.org/10.1086/302890			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762556	Bronze, Green Published			2022-12-18	WOS:000088373700028
J	Lam, JC; Roeder, K; Devlin, B				Lam, JC; Roeder, K; Devlin, B			Haplotype fine mapping by evolutionary trees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; DISEASE GENES; HEREDITARY HEMOCHROMATOSIS; DIASTROPHIC DYSPLASIA; FOUNDER POPULATIONS; POSITIONAL CLONING; MUTATION-RATES; MARKER LOCI; LIKELIHOOD; FINLAND	To refine the location of a disease gene within the bounds provided by linkage analysis, many scientists use the pattern of linkage disequilibrium between the disease allele and alleles at nearby markers. We describe a method that seeks to refine location by analysis of "disease" and "normal" haplotypes, thereby using multivariate information about linkage disequilibrium. Under the assumption that the disease mutation occurs in a specific gap between adjacent markers, the method first combines parsimony and likelihood to build an evolutionary tree of disease haplotypes, with each node (haplotype) separated, by a single mutational or recombinational step, from its parent. If required, latent nodes (unobserved haplotypes) are incorporated to complete the tree. Once the tree is built, its likelihood is computed from probabilities of mutation and recombination. When each gap between adjacent markers is evaluated in this fashion and these results are combined with prior information, they yield a posterior probability distribution to guide the search for the disease mutation. We show, by evolutionary simulations, that an implementation of these methods, called "FineMap," yields substantial refinement and excellent coverage for the true location of the disease mutation. Moreover, by analysis of hereditary hemochromatosis haplotypes, we show that FineMap can be robust to genetic heterogeneity.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Devlin, B (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 3811 Ohara St, Pittsburgh, PA 15213 USA.	roeder@stat.cmu.edu; devlinbj@msx.upmc.edu		Roeder, Kathryn/0000-0002-8869-6254	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, P01MH056193, R01MH057881] Funding Source: NIH RePORTER; NIMH NIH HHS [P01 MH056193, MH56193, R37 MH057881, R01 MH057881, MH57881] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baysal BE, 1999, HUM GENET, V104, P219, DOI 10.1007/s004390050939; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davison AC, 1997, BOOTSTRAP METHODS TH; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; DONNELLY P, 1986, THEOR POPUL BIOL, V30, P271, DOI 10.1016/0040-5809(86)90037-7; ELANDTJOHNSON RC, PROBABILITY MODELS S; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; GOOD IJ, 1971, BIOMETRIKA, V58, P255, DOI 10.2307/2334515; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Jobson J. D., 1991, APPL MULTIVARIATE DA; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KINGMAN JFC, 1982, APPL PROBABILITY TRU, V82, P27; Lange K., 1997, MATH STAT METHODS GE; Lee P.M., 1990, J AM STAT ASSOC, V85, P128; Liu JS, 1999, J AM STAT ASSOC, V94, P1, DOI 10.2307/2669673; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Slatkin M, 1996, GENETICS, V143, P579; SMITH JC, 1990, J FORENSIC SCI SOC, V30, P19, DOI 10.1016/S0015-7368(90)73298-7; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Thomas W, 1998, HUM GENET, V102, P517, DOI 10.1007/s004390050734; vanSchothorst EM, 1996, EUR J HUM GENET, V4, P267; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weiss Mark Allen, 1996, ALGORITHMS DATA STRU; XIE X, 1993, AM J HUM GENET, V53, P1107	35	45	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					659	673		10.1086/302756	http://dx.doi.org/10.1086/302756			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677324	Green Published, Bronze			2022-12-18	WOS:000088373100031
J	Brzustowicz, LM; Farrell, S; Khan, MB; Weksberg, R				Brzustowicz, LM; Farrell, S; Khan, MB; Weksberg, R			Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; GENETIC-MAP; GPC3; GLYPICAN; XQ26	Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked overgrowth syndrome with associated visceral and skeletal abnormalities. Alterations in the glypican-3 gene (GPC3), which is located on Xq26, have been implicated in the etiology of relatively milder cases of this disorder. Not all individuals with SGBS have demonstrated disruptions of the GPC3 locus, which raises the possibility that other loci on the X chromosome could be responsible for some cases of this syndrome. We have previously described a large family with a severe form of SGBS that is characterized by multiple anomalies, hydrops fetalis, and death within the first 8 wk of life. Using 25 simple tandem-repeat polymorphism markers spanning the X chromosome, we have localized the gene for this disorder to an similar to 6-Mb region of Xp22, with a maximum LOD score of 3.31 and with LOD scores < - 2.0 for all of Xq. These results demonstrate that neither the GPC3 gene nor other genes on Xq26 are responsible for all cases of SGBS and that a second SGBS locus resides on Xp22.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Credit Valley Hosp, Toronto, ON, Canada; Hosp Sick Children, Dept Paediat, Toronto, ON, Canada; Hosp Sick Children, Dept Genet, Toronto, ON, Canada; Univ Toronto, Dept Paediat, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toronto; Trillium Health Partners; Credit Valley Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Brzustowicz, LM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001392] Funding Source: NIH RePORTER; NIMH NIH HHS [K08 MH01392] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; Huber R, 1998, GENE, V225, P9, DOI 10.1016/S0378-1119(98)00549-6; HUGHESBENZIE RM, 1992, AM J MED GENET, V43, P428, DOI 10.1002/ajmg.1320430165; IRELAND M, 1993, P GREENW GEN CTR, V12, P41; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Li M, 1998, CLIN GENET, V53, P165; Lindsay S, 1997, J MED GENET, V34, P480, DOI 10.1136/jmg.34.6.480; Neri G, 1998, AM J MED GENET, V79, P279, DOI 10.1002/(SICI)1096-8628(19981002)79:4<279::AID-AJMG9>3.0.CO;2-H; OPITZ JM, 1988, AM J MED GENET, V30, P301, DOI 10.1002/ajmg.1320300131; OPITZ JM, 1984, AM J MED GENET, V17, P359, DOI 10.1002/ajmg.1320170129; ORTH U, 1994, AM J MED GENET, V50, P388, DOI 10.1002/ajmg.1320500423; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Simpson J L, 1975, Birth Defects Orig Artic Ser, V11, P18; TERESPOLSKY D, 1995, AM J MED GENET, V59, P329, DOI 10.1002/ajmg.1320590310; Veugelers M, 1998, GENOMICS, V53, P1, DOI 10.1006/geno.1998.5465; XUAN JY, 1994, HUM MOL GENET, V3, P133, DOI 10.1093/hmg/3.1.133	19	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					779	783		10.1086/302527	http://dx.doi.org/10.1086/302527			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441586	Green Published, Bronze			2022-12-18	WOS:000082426400024
J	Kirk, R; Furlong, RA; Amos, W; Cooper, G; Rubinsztein, JS; Walsh, C; Paykel, ES; Rubinsztein, DC				Kirk, R; Furlong, RA; Amos, W; Cooper, G; Rubinsztein, JS; Walsh, C; Paykel, ES; Rubinsztein, DC			Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION; GENOME; IDENTIFICATION; PSYCHOSES; SEQUENCE	Previous reports of preferential transmission of bipolar affective disorder (BP) from the maternal versus the paternal lines in families suggested that this disorder may be caused by mitochondrial DNA mutations. We have sequenced the mitochondrial genome in 25 BP patients with family histories of psychiatric disorder that suggest matrilineal inheritance. No polymorphism identified more than once in this sequencing showed any significant association with BP in association studies using 94 cases and 94 controls. To determine whether our BP sample showed evidence of selection against the maternal lineage, we determined genetic distances between all possible pairwise comparisons within the BP and control groups, based on multilocus mitochondrial polymorphism haplotypes. These analyses revealed fewer closely related haplotypes in the BP group than in the matched control group, suggesting selection against maternal lineages in this disease. Such selection is compatible with recurrent mitochondrial mutations, which are associated with slightly decreased fitness. Although such mismatch distribution comparisons have been used previously for analyses of population histories, this is, as far as we are aware, the first report of this method being used to study disease.	Univ Cambridge, Dept Med Genet, Cambridge, England; Univ Cambridge, Dept Zool, Cambridge, England; Univ Cambridge, Dept Psychiat, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Wellcome MRC Bldg, Cambridge CB2 2XY, England.		Rubinsztein, David C/C-3472-2011					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANGST J, 1980, HUM GENET, V55, P237, DOI 10.1007/BF00291773; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DUNNER DL, 1975, ARCH GEN PSYCHIAT, V32, P1134; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Gershon Elliot S., 1990, MANIC DEPRESSIVE ILL, P373; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; GIGOROIUSERBANE.M, 1998, AM J MED GENET, V81, P397; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GOETZL V, 1974, ARCH GEN PSYCHIAT, V31, P665; HELZER JE, 1974, ARCH GEN PSYCHIAT, V31, P73; Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7; Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; REICH T, 1969, AM J PSYCHIAT, V125, P1358, DOI 10.1176/ajp.125.10.1358; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosanoff AJ, 1935, AM J PSYCHIAT, V91, P725, DOI 10.1176/ajp.91.4.725; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SLATKIN M, 1991, GENETICS, V129, P555; SMERALDI E, 1977, ACTA PSYCHIAT SCAND, V56, P382, DOI 10.1111/j.1600-0447.1977.tb06679.x; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; TRZEBIATOWSKATRZECIAK O, 1977, BRIT J PSYCHIAT, V131, P478, DOI 10.1192/bjp.131.5.478; VOGEL HP, 1979, ACTA PSYCHIAT SCAND, V60, P483, DOI 10.1111/j.1600-0447.1979.tb00558.x	27	45	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					508	518		10.1086/302507	http://dx.doi.org/10.1086/302507			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417293	Green Published, Bronze			2022-12-18	WOS:000081836900026
J	Torra, R; Badenas, C; San Millan, JL; Perez-Oller, L; Estivill, X; Darnell, A				Torra, R; Badenas, C; San Millan, JL; Perez-Oller, L; Estivill, X; Darnell, A			A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2ND GENE; EPITHELIAL-CELLS; PKD2 GENE; LOCALIZATION; MUTATIONS; PROTEIN; ADULT; LOCUS; DNA; EXPRESSION	Autosomal dominant polycystic kidney disease (ADPKD) is genetically heterogeneous, with at least three chromosomal loci (PKD1, PKD2, and PKD3) that account for the disease. Mutations in the PKD2 gene, on the long arm of chromosome 4, are expected to be responsible for similar to 15% of cases of ADPKD. Although ADPKD is a systemic disease, it shows a focal expression, because <1% of nephrons become cystic. A feasible explanation for the focal nature of events in PKD1, proposed on the basis of the two-hit theory, suggests that cystogenesis results from the inactivation of the normal copy of the PKD1 gene by a second somatic mutation. The aim of this study is to demonstrate that somatic mutations are present in renal cysts from a PKD2 kidney. We have studied 30 renal cysts from a patient with PKD2 in which the germline mutation was shown to be a deletion that encompassed most of the disease gene. Loss-of-heterozygosity (LOH) studies showed loss of the wildtype allele in 10% of cysts. Screening of six exons of the gene by SSCP detected eight different somatic mutations, all of them expected to produce truncated proteins. Overall, greater than or equal to 37% of the cysts studied presented somatic mutations. No LOH for the PKD1 gene or locus D3S1478 were observed in those cysts, which demonstrates that somatic alterations are specific. We have identified second-hit mutations in human PKD2 cysts, which suggests that this mechanism could be a crucial event in the development of cystogenesis in human ADPKD-type 2.	Univ Barcelona, Hosp Clin, Dept Nephrol, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; Univ Barcelona, Hosp Clin, Dept Genet, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; Hosp Ramon y Cajal, Dept Mol Genet, E-28034 Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario Ramon y Cajal	Torra, R (corresponding author), Univ Barcelona, Hosp Clin, Dept Nephrol, Inst Invest Biomed August Pi & Sunyer, Villarroel 170, E-08036 Barcelona, Spain.		San-Millán, José L./F-9944-2015; Estivill, Xavier/E-2957-2012; Badenas, Celia/ABH-5480-2020; Torra, Roser/A-9983-2008; Estivill, Xavier/A-3125-2013	Badenas, Celia/0000-0002-0621-0477; Torra, Roser/0000-0001-8714-2332; Estivill, Xavier/0000-0002-0723-2256				BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; IbraghimovBeskrovnaya O, 1997, P NATL ACAD SCI USA, V94, P6397, DOI 10.1073/pnas.94.12.6397; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Martin GM, 1996, HUM MOL GENET, V5, P215, DOI 10.1093/hmg/5.2.215; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; Pei Y, 1998, J AM SOC NEPHROL, V9, P1853; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; Torra R, 1996, J AM SOC NEPHROL, V7, P2142; TORRA R, IN PRESS KIDNEY INT; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Veldhuisen B, 1997, AM J HUM GENET, V61, P547, DOI 10.1086/515497; Viribay M, 1997, HUM GENET, V101, P229, DOI 10.1007/s004390050621; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WARD CJ, 1994, CELL, V77, P881; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; WRIGHT GD, 1993, NEPHROL DIAL TRANSPL, V8, P491, DOI 10.1093/ndt/8.6.491; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xenophontos S, 1997, HUM MOL GENET, V6, P949, DOI 10.1093/hmg/6.6.949; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	39	45	45	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					345	352		10.1086/302501	http://dx.doi.org/10.1086/302501			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417277	Green Published, Bronze			2022-12-18	WOS:000081836900010
J	Sprecher, E; Bergman, R; Szargel, R; Friedman-Birnbaum, R; Cohen, N				Sprecher, E; Bergman, R; Szargel, R; Friedman-Birnbaum, R; Cohen, N			Identification of a genetic defect in the hairless gene in atrichia with papular lesions: Evidence for phenotypic heterogeneity among inherited atrichias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNIVERSAL CONGENITAL ALOPECIA; MUTATION; MONILETHRIX; HHB6; EXPRESSION; DOMAIN	Recently, we showed that atrichia with papular lesions (APL), a rare inherited form of alopecia, is transmitted as an autosomal recessive trait in a large inbred kindred of Israeli-Arab origin. Furthermore, we mapped the APL locus to a 5-cM region of chromosome 8p12 in this family. The human "hairless" gene is a candidate target gene for the disease mutation because it maps to the APL locus and because it was recently found to be mutated in a related but clinically distinct form of alopecia known as "alopecia universalis" or "congenital alopecia." In the present study, the coding sequence of the hairless gene was compared by reverse transcription-PCR in fibroblast cell lines derived from an affected patient and an unrelated individual. We identified a single-base deletion (3434delC) in the hairless gene that cosegregated with the disease phenotype in the family. This deletion is predicted to cause a frameshift mutation in the highly conserved C-terminal part of the hairless protein, a region putatively involved in the transcription factor activity of the hairless gene product. The present results are indicative of phenotypic heterogeneity in inherited atrichias caused by mutations in the hairless gene, suggesting different roles for the regions mutated in APL and in other forms of congenital atrichia during hair development.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Tamkin Human Mol Genet Res Facil, Dept Genet, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Rambam Med Ctr, Dept Dermatol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Cohen, N (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Tamkin Human Mol Genet Res Facil, Dept Genet, POB 9649, IL-31096 Haifa, Israel.							AHMAD M, 1993, AM J MED GENET, V46, P369, DOI 10.1002/ajmg.1320460405; Ahmad W, 1998, AM J HUM GENET, V63, P984, DOI 10.1086/302069; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Bertolino A, 1993, DERMATOLOGY GEN MED, P671; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Czarnecki N, 1980, Z Hautkr, V55, P210; DAMSTE J, 1954, DERMATOLOGICA, V108, P114; del Castillo V, 1974, Int J Dermatol, V13, P261; DELPRAT A, 1994, ANN DERMATOL VENER, V121, P802; ISCHII Y, 1979, J DERMATOL, V6, P111; KANZLER MH, 1986, ARCH DERMATOL, V122, P565, DOI 10.1001/archderm.122.5.565; KENUE RK, 1994, DERMATOLOGY, V188, P72, DOI 10.1159/000247092; Korge BP, 1998, J INVEST DERMATOL, V111, P896, DOI 10.1046/j.1523-1747.1998.00362.x; LOEWENTHAL L, 1961, DERMATOLOGICA, V122, P85, DOI 10.1159/000255187; MISCIALI C, 1992, DERMATOLOGY, V185, P284, DOI 10.1159/000247470; Nothen MM, 1998, AM J HUM GENET, V62, P386, DOI 10.1086/301717; SAMBROOK J, 1989, MOL CLONING LABORATO, V2, P16; Sprecher E, 1998, AM J MED GENET, V80, P546, DOI 10.1002/(SICI)1096-8628(19981228)80:5<546::AID-AJMG28>3.0.CO;2-I; Thompson CC, 1997, P NATL ACAD SCI USA, V94, P8527, DOI 10.1073/pnas.94.16.8527; Winter H, 1997, HUM GENET, V101, P165, DOI 10.1007/s004390050607; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; Zlotogorski A, 1998, HUM GENET, V103, P400, DOI 10.1007/s004390050840; Zlotogorski A, 1998, EXP DERMATOL, V7, P268	24	45	48	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1323	1329		10.1086/302368	http://dx.doi.org/10.1086/302368			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205263	Green Published, Bronze			2022-12-18	WOS:000080093000010
J	Howell, N; Mackey, DA				Howell, N; Mackey, DA			Low-penetrance branches in matrilineal pedigrees with leber hereditary optic neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA MUTATIONS; TISSUE DISTRIBUTION; MTDNA MUTATIONS; 11778-MUTATION; AUSTRALIA; GENE		Univ Texas, Med Branch, Dept Radiat Oncol, Biol Div 0656, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA; Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas, Australia	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Melbourne; University of Melbourne; University of Tasmania	Howell, N (corresponding author), Univ Texas, Med Branch, Dept Radiat Oncol, Biol Div 0656, Galveston, TX 77555 USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709	NEI NIH HHS [EY10758] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010758] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Brown MD, 1997, AM J HUM GENET, V60, P381; El Meziane A, 1998, NAT GENET, V18, P350; HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721; Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1994, AM J HUM GENET, V55, P203; HOWELL N, 1993, GENETICS, V133, P133; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1994, CLIN NEUROSCI, V2, P146; Juvonen V, 1997, HUM MUTAT, V9, P412, DOI 10.1002/(SICI)1098-1004(1997)9:5<412::AID-HUMU6>3.3.CO;2-Q; Leber T., 1871, GRAEFES ARCH OPHTHAL, V17, P249, DOI 10.1007/BF01694557; MACKEY D, 1994, AM J OPHTHALMOL, V117, P817, DOI 10.1016/S0002-9394(14)70337-X; Mackey D, 1998, AM J HUM GENET, V62, P492, DOI 10.1086/301731; Mackey DA, 1996, AM J HUM GENET, V59, P481; MACKEY DA, 1994, CLIN NEUROSCI, V2, P162; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Torroni A, 1997, AM J HUM GENET, V60, P1107; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1	25	45	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1220	1224		10.1086/302049	http://dx.doi.org/10.1086/302049			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9867707	Green Published, Bronze			2022-12-18	WOS:000076577800036
J	Howell, N; Bogolin, C; Jamieson, R; Marenda, DR; Mackey, DA				Howell, N; Bogolin, C; Jamieson, R; Marenda, DR; Mackey, DA			mtDNA mutations that cause optic neuropathy: How do we know?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA MUTATION; PHYLOGENETIC ANALYSIS; ALZHEIMER-DISEASE; POINT MUTATION; INCREASED RISK; DYSTONIA; GENOME; GENE; PEDIGREES; SEQUENCE		Univ Texas, Med Branch, Dept Radiat Oncol, Dept Human Biol Chem & Genet,Div Biol 0656, Galveston, TX 77555 USA; New Childrens Hosp, Dept Clin Genet, Sydney, NSW, Australia; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Univ Tasmania, Menzies Ctr, Hobart, Tas, Australia	University of Texas System; University of Texas Medical Branch Galveston; University of Sydney; University of Iowa; University of Melbourne; University of Melbourne; University of Tasmania	Howell, N (corresponding author), Univ Texas, Med Branch, Dept Radiat Oncol, Dept Human Biol Chem & Genet,Div Biol 0656, Galveston, TX 77555 USA.		Jamieson, Robyn/M-5161-2019; Mackey, David A/H-5340-2014	Jamieson, Robyn/0000-0002-7285-0253; Mackey, David A/0000-0001-7914-4709	NEI NIH HHS [R01 EY10758] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010758] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Brown J, 1997, ARCH OPHTHALMOL-CHIC, V115, P95, DOI 10.1001/archopht.1997.01100150097016; BROWN MD, 1994, CLIN NEUROSCI, V2, P138; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; DeVries DD, 1996, AM J HUM GENET, V58, P703; Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254; Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1994, AM J HUM GENET, V55, P219; HOWELL N, 1992, AM J HUM GENET, V50, P1333; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Hutchin TP, 1997, GENETICS, V145, P771; JOHNS DR, 1994, CLIN NEUROSCI, V2, P146; Johnston RL, 1997, ARCH OPHTHALMOL-CHIC, V115, P100, DOI 10.1001/archopht.1997.01100150102017; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177; LeoKottler B, 1996, GER J OPHTHALMOL, V5, P233; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Mackey DA, 1996, AM J HUM GENET, V59, P481; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; Tysoe C, 1996, J MED GENET, V33, P1002, DOI 10.1136/jmg.33.12.1002; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1995, HUMAN GENE MAPPING 1, P910; Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660	31	45	46	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					196	202		10.1086/301675	http://dx.doi.org/10.1086/301675			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443868	Green Published, Bronze			2022-12-18	WOS:000072127900027
J	Kikawa, Y; Inuzuka, M; Jin, BY; Kaji, S; Koga, J; Yamamoto, Y; Fujisawa, K; Hata, I; Nakai, A; Shigematsu, Y; Mizunuma, H; Taketo, A; Mayumi, M; Sudo, M				Kikawa, Y; Inuzuka, M; Jin, BY; Kaji, S; Koga, J; Yamamoto, Y; Fujisawa, K; Hata, I; Nakai, A; Shigematsu, Y; Mizunuma, H; Taketo, A; Mayumi, M; Sudo, M			Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUKOCYTE ENZYME-ACTIVITY; FRUCTOSE-1,6-DIPHOSPHATASE DEFICIENCY; LIVER FRUCTOSE-1,6-BISPHOSPHATASE; FRUCTOSE 1,6-BISPHOSPHATASE; BIOCHEMICAL OBSERVATIONS; ESCHERICHIA-COLI; CDNA; HETEROZYGOTES; MUTAGENESIS; EXPRESSION	Fructose-1,6-bisphosphatase (FBPase) deficiency is an autosomal recessive inherited disorder and may cause sudden unexpected infant-death. We reported the first case of molecular diagnosis of FBPase deficiency, using cultured monocytes as a source for FBPase mRNA. In the present study, we confirmed the presence of the same genetic mutation in this patient by amplifying genomic DNA. Molecular analysis was also performed to diagnose another 12 Japanese patients with FBPase deficiency. Four mutations responsible for FBPase deficiency were identified in 10 patients from 8 unrelated families among a total of 13 patients from 11 unrelated families; no mutation was found in the remaining 3 patients from 3 unrelated families. The identified mutations included the mutation reported earlier, with an insertion of one G residue at base 961 in exon 7 (960/961insG) (10 alleles, including 2 alleles in the Japanese family from our previous report [46% of the 22 mutant alleles]), and three novel mutations-a G-->A transition at base 490 in exon 4 (G164S) (3 alleles [14%]), a C-->A transversion at base 530 in exon 4 (A177D) (1 allele [4%]), and a G-->T transversion at base 88 in exon 1 (E30X) (2 alleles [9%]). FBPase proteins with G164S or A177D mutations were enzymatically inactive when purified from E. coli,Another new mutation, a T-->C transition at base 974 in exon 7 (V325A), was found in the same allele with the G164S mutation in one family (one allele) but was not responsible for FBPase deficiency. Our results indicate that the insertion of one G residue at base 961 was associated with a preferential disease-causing alternation in 13 Japanese patients. Our results also indicate accurate carrier detection in eight families (73%) of 11 Japanese patients with FBPase deficiency, in whom mutations in both alleles were identified.	FUKUI MED SCH,DEPT BIOCHEM,MATSUOKA,FUKUI 91011,JAPAN; JCR PHARMACEUT CO LTD,BIOTECHNOL RES LABS,NISHI KU,KOBE,HYOGO,JAPAN; AKITA UNIV,COLL ALLIED MED SCI,DEPT BIOCHEM,AKITA 010,JAPAN	University of Fukui; Akita University	Kikawa, Y (corresponding author), FUKUI MED SCH,DEPT PEDIAT,MATSUOKA,FUKUI 91011,JAPAN.							BAKER L, 1970, LANCET, V7662, P13; BESLEY GTN, 1994, J INHERIT METAB DIS, V17, P333, DOI 10.1007/BF00711822; BUHRDEL P, 1990, EUR J PEDIATR, V149, P574; BURLINA AB, 1990, J INHERIT METAB DIS, V13, P263, DOI 10.1007/BF01799368; COOPER DN, 1991, HUM GENET, V87, P409; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; ELMAGHRABI MR, 1995, GENOMICS, V27, P520, DOI 10.1006/geno.1995.1085; ELMAGHRABI MR, 1988, P NATL ACAD SCI USA, V85, P8430, DOI 10.1073/pnas.85.22.8430; ELMAGHRABI MR, 1993, J BIOL CHEM, V268, P9466; EMERY JL, 1988, LANCET, V8601, P29; GITZELMANN R, 1995, METABOLIC BASIS INHE, V1, P416; HENGMING K, 1989, J MOL BIOL, V212, P513; HOMMES FA, 1985, J INHERIT METAB DIS, V8, P169, DOI 10.1007/BF01805428; ITO M, 1984, CLIN CHIM ACTA, V141, P27; KIKAWA Y, 1994, BIOCHEM BIOPH RES CO, V199, P687, DOI 10.1006/bbrc.1994.1283; KIKAWA Y, 1993, CLIN CHIM ACTA, V215, P81, DOI 10.1016/0009-8981(93)90251-X; KIKAWA Y, 1995, BIOCHEM BIOPH RES CO, V210, P797, DOI 10.1006/bbrc.1995.1729; KINUGASA A, 1979, PEDIATR RES, V13, P1361, DOI 10.1203/00006450-197912000-00012; LIANG JY, 1993, P NATL ACAD SCI USA, V90, P2132, DOI 10.1073/pnas.90.6.2132; Maniatis T, 1989, DECONTAMINATION DILU; MIZUNUMA H, 1986, J BIOCHEM-TOKYO, V99, P1781, DOI 10.1093/oxfordjournals.jbchem.a135656; NAGAI T, 1992, J INHERIT METAB DIS, V15, P720, DOI 10.1007/BF01800012; NAKAI A, 1993, J INHERIT METAB DIS, V16, P408, DOI 10.1007/BF00710290; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROGERS DT, 1988, J BIOL CHEM, V263, P6051; SCHRIJVER J, 1975, NEW ENGL J MED, V292, P1298; SHIN YS, 1993, CLIN INVESTIGATOR, V71, P115; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4	28	45	55	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					852	861		10.1086/514875	http://dx.doi.org/10.1086/514875			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382095	Green Published, Bronze			2022-12-18	WOS:A1997YA59100011
J	Scozzari, R; Cruciani, F; Malaspina, P; Santolamazza, P; Ciminelli, BM; Torroni, A; Modiano, D; Wallace, DC; Kidd, KK; Olckers, A; Moral, P; Terrenato, L; Akar, N; Qamar, R; Mansoor, A; Mehdi, SQ; Meloni, G; Vona, G; Cole, DEC; Cai, WW; Novelletto, A				Scozzari, R; Cruciani, F; Malaspina, P; Santolamazza, P; Ciminelli, BM; Torroni, A; Modiano, D; Wallace, DC; Kidd, KK; Olckers, A; Moral, P; Terrenato, L; Akar, N; Qamar, R; Mansoor, A; Mehdi, SQ; Meloni, G; Vona, G; Cole, DEC; Cai, WW; Novelletto, A			Differential structuring of human populations for homologous X and Y microsatellite loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; RECENT AFRICAN ORIGIN; TANDEM REPEAT LOCI; HUMAN-EVOLUTION; SEQUENCE POLYMORPHISM; HIGH-RESOLUTION; MUTATION-RATE; GENETIC-MAP; CHROMOSOME; HAPLOTYPES	The global pattern of variation at the homologous microsatellite loci DYS413 (Yq11) and DXS8174 and DXS8175 (Xp22) was analyzed by examination of 30 world populations from four continents, accounting for more than 1,100 chromosomes per locus. The data showed discordant patterns of among-and within-population gene diversity for the Y-linked and the X-linked microsatellites. For the Y-linked polymorphism, all groups of populations displayed high F-ST values (the correlation between random haplotypes within subpopulations, relative to haplotypes of the total population) and showed a general trend for the haplotypes to cluster in a population-specific way. This was especially true for sub-Saharan African populations. The data also indicated that a large fraction of the variation among populations was due to the accumulation of new variants associated with the radiation process. Europeans exhibited the highest level of within-population haplotype diversity, whereas sub-Saharan Africans showed the lowest. In contrast, data for the two X-linked polymorphisms were concordant in showing lower F-ST values, as compared with those for DYS413, but higher within-population variances, for African versus non-African populations. Whereas the results for the X-linked loci agreed with a model of greater antiquity for the African populations, those for DYS413 showed a confounding pattern that is apparently at odds with such a model. Possible factors involved in this differential structuring for homologous X and Y microsatellite polymorphisms are discussed.	UNIV ROMA LA SAPIENZA,IST PARASSITOL,FDN PASTEUR CENCI BOLOGNETTI,I-00185 ROME,ITALY; UNIV ROMA TOR VERGATA,DIPARTIMENTO BIOL,ROME,ITALY; EMORY UNIV,DEPT MED & MOL GENET,ATLANTA,GA 30322; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; UNIV PRETORIA,DEPT HUMAN GENET,ZA-0002 PRETORIA,SOUTH AFRICA; UNIV BARCELONA,DEPT ANIM BIOL,BARCELONA,SPAIN; ANKARA UNIV,PEDIAT MOL PATHOL UNIT,TR-06100 ANKARA,TURKEY; AQ KHAN RES LABS,ISLAMABAD,PAKISTAN; UNIV SASSARI,CLIN PEDIAT A FILIA,I-07100 SASSARI,ITALY; UNIV CAGLIARI,DIPARTIMENTO BIOL SPERIMENTALE,SEZ SCI ANTROPOL,CAGLIARI,ITALY; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT MED,TORONTO,ON,CANADA; UNIV TORONTO,DEPT GENET,TORONTO,ON,CANADA; CNR,IST INT GENET & BIOFIS,I-80125 NAPLES,ITALY	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Rome Tor Vergata; Emory University; Yale University; University of Pretoria; University of Barcelona; Ankara University; University of Sassari; University of Cagliari; University of Toronto; University of Toronto; University of Toronto; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Scozzari, R (corresponding author), UNIV ROMA LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOL,P ALDO MORO 5,I-00185 ROME,ITALY.		Olckers, Antonel/AAW-8903-2020; Cruciani, Fulvio/G-6105-2012; Akar, Nejat/H-2949-2019; Mehdi, Syed Qasim/L-2385-2015; qamar, raheel/D-4543-2012; Qamar, Raheel/G-3355-2015; Moral, Pedro/K-9587-2014; Torroni, Antonio/E-1557-2011; Meloni, Gianfranco G.F./E-9426-2012; Malaspina, Patrizia/G-7772-2017	Olckers, Antonel/0000-0002-4974-5666; Moral, Pedro/0000-0001-5072-5892; Torroni, Antonio/0000-0002-4163-4478; Meloni, Gianfranco G.F./0000-0002-0604-8924; Cruciani, Fulvio/0000-0002-6900-024X; Malaspina, Patrizia/0000-0002-0067-369X; Novelletto, Andrea/0000-0002-1146-7680				Andreassen R, 1996, AM J HUM GENET, V59, P360; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; BENERECETTI ASS, 1996, AM J HUM GENET S, V3, P15; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; CAI WW, 1994, HUM HERED, V44, P279, DOI 10.1159/000154230; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Ciminelli BM, 1995, J MOL EVOL, V41, P966; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; DEKA R, 1995, ELECTROPHORESIS, V16, P1659, DOI 10.1002/elps.11501601275; DEKA R, 1995, AM J HUM GENET, V56, P461; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EXCOFFIER L, 1992, GENETICS, V131, P479; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FIGUS A, 1995, AM J HUM GENET, V57, P1318; Freimer NB, 1996, CIBA F SYMP, V197, P51; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grimes BF, 1992, ETHNOLOGUE LANGUAGES; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; JORDE LB, 1995, AM J HUM GENET, V57, P523; KIDD JR, 1991, HUM BIOL, V63, P775; KIDD KK, 1996, MOL BIOL HUMAN DIVER, P242; KONOTEYAHULU FID, 1980, BRIT MED J, V281, P1700, DOI 10.1136/bmj.281.6256.1700; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; LONG JC, 1986, GENETICS, V112, P629; Lucotte G, 1996, J MOL EVOL, V42, P472; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; Malaspina P, 1997, J MOL EVOL, V44, P652; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Meroni G, 1996, HUM MOL GENET, V5, P423, DOI 10.1093/hmg/5.4.423; Michalakis Y, 1996, GENETICS, V142, P1061; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; Nei M., 1987, MOL EVOLUTIONARY GEN; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rogers AR, 1996, AM J HUM GENET, V58, P1033; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; Scozzari R, 1997, AM J HUM GENET, V60, P241; Scozzari R, 1996, HUM BIOL, V68, P315; Semino O, 1996, AM J HUM GENET, V59, P964; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; SLATKIN M, 1995, GENETICS, V139, P457; SPURDLE A, 1992, HUM MOL GENET, V1, P169, DOI 10.1093/hmg/1.3.169; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TERRENATO L, 1979, ANN HUM GENET, V42, P391, DOI 10.1111/j.1469-1809.1979.tb00671.x; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TORRONI A, 1990, ANN HUM GENET, V54, P287; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zerjal T, 1997, AM J HUM GENET, V60, P1174	67	45	48	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					719	733		10.1086/515500	http://dx.doi.org/10.1086/515500			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326337	hybrid, Green Submitted, Green Published			2022-12-18	WOS:A1997XY52300029
J	Bidooki, SK; Johnson, MA; ChrzanowskaLightowlers, Z; Bindoff, LA; Lightowlers, RN				Bidooki, SK; Johnson, MA; ChrzanowskaLightowlers, Z; Bindoff, LA; Lightowlers, RN			Intracellular mitochondrial triplasmy in a patient with two heteroplasmic base changes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN; PROTEIN-SYNTHESIS; DNA; MUTATION; DEFECTS; MUSCLE; ADVANTAGE; GENOMES; FIBERS; MERRF	We report the clinical, biochemical, and genetic investigation of a patient with a severe mitochondrial encephalomyopathy. Genetic studies identified a novel, heteroplasmic tRNA mutation at nt 10010. This T-->C transition is located in the DHU loop of mitochondrial tRNA(Gly). In skeletal muscle, it was present at lower levels in cytochrome c oxidase (COX)-normal (87.2% +/- 11%) compared with COX-deficient fibers (97.3% +/- 2.6%); it was found in skin fibroblasts and blood cells, but at lower levels of heteroplasmy (15% +/- 6% and 17% +/- 10%, respectively). A second, heteroplasmic transition (A-->G), at nt 5656, showed a different distribution than the tRNA(Gly) mutation, with very low levels in skeletal muscle (<3%) but higher levels in blood (22.7% +/- 3%) and skin fibroblasts (21% +/- 2%). These transitions were followed both in vivo, by repeat biopsy and blood sampling, and in vitro, by establishing primary cultures of myoblasts and skin fibroblasts, Repeat muscle biopsy showed a dramatic increase in COX-deficient fibers, but not of the tRNA(Gly) mutation. Indeed, no significant change in heteroplasmy was measured for either substitution in muscle or blood. In vitro analysis gave very different results. The T10010C was not found in cultured myoblasts, even at early passage. In uncloned fibroblasts, the T10010C was stable (similar to 10%) for several passages but then gradually was lost. In contrast, the A5656G rose progressively from 27% to 91%, In cloned fibroblasts, different combinations of both base-pair changes and wild type could be identified, confirming the presence of clonal, intracellular triplasmy.	MIDDLESBROUGH GEN HOSP,DEPT NEUROL,MIDDLESBROUGH TS5 5AZ,CLEVELAND,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT NEUROL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT NEUROBIOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND	Newcastle University - UK; Newcastle University - UK				Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152; Bindoff, Laurence/0000-0003-0988-276X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BENDALL KE, 1995, AM J HUM GENET, V57, P248; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BOULET L, 1992, AM J HUM GENET, V51, P1187; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835; Howell N, 1996, AM J HUM GENET, V59, P501; JACKSON MJ, 1994, DIABETES CARE, V17, P728, DOI 10.2337/diacare.17.7.728; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106; KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LOWERSON SA, 1992, ANAL BIOCHEM, V205, P372, DOI 10.1016/0003-2697(92)90453-E; MORTEN KJ, 1995, HUM MOL GENET, V4, P1689; Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612; Schultz E, 1993, Mol Cell Biol Hum Dis Ser, V3, P190; Thomas AW, 1996, J MED GENET, V33, P253, DOI 10.1136/jmg.33.3.253; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weber K, 1997, AM J HUM GENET, V60, P373; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	27	45	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1430	1438		10.1086/515460	http://dx.doi.org/10.1086/515460			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199564	Bronze, Green Published			2022-12-18	WOS:A1997XE29400021
J	Putnam, EA; Park, ES; Aalfs, CM; Hennekam, RCM; Milewicz, DM				Putnam, EA; Park, ES; Aalfs, CM; Hennekam, RCM; Milewicz, DM			Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL MARFAN-SYNDROME; FIBRILLIN GENES; MISSENSE MUTATION; MESSENGER-RNA; SEQUENCE; IDENTIFICATION; POLYMORPHISMS; ERYTHROCYTES; EXPRESSION; DIAGNOSIS	Congenital contractural arachnodactyly (CCA) is an autosomal dominant disorder that is phenotypically related to the Marfan syndrome. CCA has recently been shown to result from mutations in the FBN2 gene, which encodes an elastin-associated microfibrillar protein called fibrillin-2. Two siblings are reported here with classic manifestations of CCA with unaffected parents. Analysis of the FBN2 cDNA from dermal fibroblasts from one of the affected siblings revealed a heterozygous exon splicing error deleting nt 3722-3844 of the FBN2 mRNA. This cDNA deletion resulted in selective removal of one of the 43 calcium-binding EGF-like domains of the fibrillin-2 protein. Analysis of the FBN2 gene in the affected siblings' DNA indicated that the splicing error resulted from an A-to-G transition 15 nt upstream from the 3' splice site of the intron. The genomic mutation resulting in the splicing error alters a putative branch point sequence important for lariat formation, an intermediate structure of normal splicing. The mutation was detectable in DNA from the father's hair bulbs and buccal cells but not his white blood cell DNA, indicating that the father was a somatic mosaic. Analysis of transcript levels by use of dermal fibroblasts from the proband demonstrated that the FBN2 allele containing the exon deletion was expressed at a higher level than the allele inherited from the mother. These results indicate that FBN2 exon splicing errors are a cause of CCA, furthering the understanding of the molecular basis of this disorder. In addition, the demonstration of gonadal mosaicism in the FBN2 gene is important for accurate genetic counseling of families with sporadic cases of CCA. Finally, the preferential expression of the mutated FBN2 allele in dermal fibroblasts may have implications for understanding the pathogenesis and rarity of CCA.	UNIV TEXAS,SCH MED,DEPT INTERNAL MED,HOUSTON,TX 77030; ST LUKES HOSP,TEXAS HEART INST,DIV CARDIOVASC RES,HOUSTON,TX; UNIV AMSTERDAM,ACAD MED CTR,DEPT PEDIAT,FAC MED,NL-1105 AZ AMSTERDAM,NETHERLANDS	University of Texas System; Texas Heart Institute; University of Amsterdam; Academic Medical Center Amsterdam								ARROYO MAR, 1985, CLIN GENET, V27, P570; BEALS RK, 1971, J BONE JOINT SURG AM, VA 53, P987, DOI 10.2106/00004623-197153050-00013; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BIDDINGER AL, 1993, HUM MOL GENET, V2, P1323, DOI 10.1093/hmg/2.8.1323; BYERS PH, 1995, METABOLIC MOL BASES, P4029; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHN DH, 1990, AM J HUM GENET, V46, P591; Cooper D. N., 1993, HUMAN GENE MUTATION; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; CURRARINO G, 1986, AM J MED GENET, V25, P763, DOI 10.1002/ajmg.1320250414; DELEMARREVANDEW.A, 1980, NED TIJDSCR GENEESKD, V124, P348; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELDADAH ZA, 1995, NAT MED, V1, P798, DOI 10.1038/nm0895-798; GODFREY M, 1990, AM J HUM GENET, V46, P661; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LI X, 1995, MAMM GENOME, V6, P42, DOI 10.1007/BF00350892; MILEWICZ DM, 1993, AM J HUM GENET, V53, P62; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; RUSKIN B, 1985, CELL, V41, P833, DOI 10.1016/S0092-8674(85)80064-7; RUSKIN B, 1985, NATURE, V317, P732, DOI 10.1038/317732a0; Sambrook J, 1989, MOL CLONING LAB MANU; VILJOEN D, 1991, CLIN GENET, V39, P181; WANG M, 1995, HUM MOL GENET, V4, P607, DOI 10.1093/hmg/4.4.607; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILSON JG, 1986, J EXP MED, V164, P50, DOI 10.1084/jem.164.1.50; WILSON JG, 1982, NEW ENGL J MED, V307, P981, DOI 10.1056/NEJM198210143071604; WONG WW, 1989, J EXP MED, V169, P847, DOI 10.1084/jem.169.3.847; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	38	45	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					818	827						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106527				2022-12-18	WOS:A1997WT61400010
J	Valdes, AM; McWeeney, S; Thomson, G				Valdes, AM; McWeeney, S; Thomson, G			HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: Application of the haplotype method	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENETIC-DISORDERS; T-CELL CLONES; DISEASE ASSOCIATIONS; BETA-CHAIN; SUSCEPTIBILITY; COMPLEX; ALLELES; IDDM; LOCI; POSITION-57	Insulin-dependent diabetes mellitus (IDDM) HLA class II DRB1-DQA1-DQB1 data from four populations (Norwegian, Sardinian, Mexican American, and Taiwanese) have been analyzed to detect the amino acids involved in the disease process. The combination of sites DRB1#67 and 86; DQA1#47; and DQB1#9, 26, 57, and 70 predicts the IDDM component in these four populations, when the results and criteria of the haplotype method for amino acids, developed in the companion paper in this issue of the Journal, are used. The following sites, either individually, or in various combinations, previously have been suggested as IDDM components: DRB1#57, 70, 71, and 86; DQA1#52; and DQB1#13, 45, and 57 (DQB1#13 and 45 correlates 100% with DQB1#9 and 26). We propose that DQA1#47 is a better predictor of IDDM than is the previously suggested DQA1#52, and we add DRB1#67 and DQB1#70 to the HLA DR-DQ IDDM amino acids. We do not claim to have identified all HLA DR-DQ amino acids - or highly correlated sites - involved in IDDM. The frequencies and predisposing/protective effects of the haplotypes defined by these seven sites have been compared, and the effects on IDDM are consistent across the populations. The strongest susceptible effects came from haplotypes DRB1*0301/DQA1*0501/DQB1*0201 and DRB1*0401-5-7-8/DQA1*0301/DQB1*0302. The number of strong protective haplotypes observed was larger than the number of susceptible ones; some of the predisposing haplotypes were present in only one or two populations. Although the sites under consideration do not necessarily have a functional involvement in IDDM, they should be highly associated with such sites and should prove to be useful in risk assessment.	UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley				Valdes, Ana M./0000-0003-1141-4471	NICHD NIH HHS [HD12731] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AWATA T, 1990, DIABETES, V39, P266, DOI 10.2337/diabetes.39.2.266; CAHILL GF, 1981, NEW ENGL J MED, V304, P1454, DOI 10.1056/NEJM198106113042403; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; CUCCA F, 1996, HLA MHC GENES MOL FU, P383; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; DURINOVICBELLO I, 1994, DIABETES, V43, P1318, DOI 10.2337/diabetes.43.11.1318; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; HAMAGUCHI K, 1991, P 11 INT HIST WORKSH, V1, P488; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HarfouchHammoud E, 1996, J AUTOIMMUN, V9, P411, DOI 10.1006/jaut.1996.0056; HU CY, 1993, HUM IMMUNOL, V38, P105, DOI 10.1016/0198-8859(93)90526-7; Huang HS, 1995, HUM IMMUNOL, V44, P210, DOI 10.1016/0198-8859(95)00108-5; IMANISHI T, 1992, P 11 INT HIST WORKSH, V1, P1065; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; KHALIL I, 1990, J CLIN INVEST, V85, P1315, DOI 10.1172/JCI114569; Krolewski A.S., 1985, JOSLINS DIABETES MEL, P12; MIJOVIC CG, 1991, GENETICS DIABETES 1, P321; NEPOM GT, 1990, DIABETES, V39, P1153, DOI 10.2337/diabetes.39.10.1153; Noble JA, 1996, AM J HUM GENET, V59, P1134; Owerbach D, 1996, DIABETES, V45, P544, DOI 10.2337/diabetes.45.5.544; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; RONNINGEN KS, 1991, TISSUE ANTIGENS, V37, P105, DOI 10.1111/j.1399-0039.1991.tb01854.x; Salamon H, 1996, J COMPUT BIOL, V3, P407, DOI 10.1089/cmb.1996.3.407; SANJEEVI CB, 1995, DIABETES, V44, P125, DOI 10.2337/diabetes.44.1.125; SERJEANTSON SW, 1991, GENETICS DIABETES 1, P299; SHEEHY MJ, 1992, DIABETES, V41, P123, DOI 10.2337/diabetes.41.2.123; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; TAIT BD, 1995, EUR J IMMUNOGENET, V22, P289, DOI 10.1111/j.1744-313X.1995.tb00245.x; TAIT BD, 1991, GENETICS DIABETES 1, P211; THOMSON G, 1995, AM J HUM GENET, V57, P474; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1991, GENETICS DIABETES 1, P247; THOMSON G, IN PRESS DIABETES RE; THORSBY E, 1993, DIABETOLOGIA, V36, P371, DOI 10.1007/BF00402270; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560; TODD JA, 1991, RES IMMUNOL, V142, P483, DOI 10.1016/0923-2494(91)90051-J; VALDES AM, 1997, AM J HUM GENET, V59, P703; VICARIO JL, 1992, DIABETOLOGIA, V35, P475, DOI 10.1007/BF02342447; WINTER WE, 1992, DIABETES FORECAS MAY, P35; YAMANAKA K, 1992, HUM IMMUNOL, V33, P57, DOI 10.1016/0198-8859(92)90052-O; Yasunaga S, 1996, TISSUE ANTIGENS, V47, P37, DOI 10.1111/j.1399-0039.1996.tb02512.x; [No title captured]	49	45	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					717	728						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042932				2022-12-18	WOS:A1997WK40300029
J	Goddard, KAB; Yu, CE; Oshima, J; Miki, T; Nakura, J; Piussan, C; Martin, GM; Schellenberg, GD; Wijsman, EM; Brown, WT; Burg, G; Cerimele, D; Cottini, F; Epstein, CJ; Fischer, W; Fraccaro, M; Fujiwara, Y; Fukuchi, KI; Hiwada, K; Hoehn, H; Hosokawa, Y; Hurlimann, AF; Ishawata, H; Kamino, K; Kihara, K; Kiso, S; Lin, Y; Maeda, T; Matthews, J; Matsumura, T; McKay, JE; Melaragno, MI; Mitsuda, M; Motulsky, AG; Murakami, T; Murano, S; Niikawa, N; Poot, M; Ogihara, T; Rizzo, M; Saida, T; Scappaticci, S; Tannok, TCA; Tamaki, S; Utsu, N; Uyeno, B; Wakayama, A; Yanagawa, M; Yevich, II; Yoshida, S; Zigrang, W				Goddard, KAB; Yu, CE; Oshima, J; Miki, T; Nakura, J; Piussan, C; Martin, GM; Schellenberg, GD; Wijsman, EM; Brown, WT; Burg, G; Cerimele, D; Cottini, F; Epstein, CJ; Fischer, W; Fraccaro, M; Fujiwara, Y; Fukuchi, KI; Hiwada, K; Hoehn, H; Hosokawa, Y; Hurlimann, AF; Ishawata, H; Kamino, K; Kihara, K; Kiso, S; Lin, Y; Maeda, T; Matthews, J; Matsumura, T; McKay, JE; Melaragno, MI; Mitsuda, M; Motulsky, AG; Murakami, T; Murano, S; Niikawa, N; Poot, M; Ogihara, T; Rizzo, M; Saida, T; Scappaticci, S; Tannok, TCA; Tamaki, S; Utsu, N; Uyeno, B; Wakayama, A; Yanagawa, M; Yevich, II; Yoshida, S; Zigrang, W			Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: Lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAMETIC DISEQUILIBRIUM; MULTIPLE ALLELES; POLYMORPHISMS	Werner syndrome (WS) is an autosomal recessive disorder characterized by premature onset of a number of age-related diseases, The gene for WS, WRN, has been mapped to the 8p 11.1-21.1 region with further localization through linkage disequilibrium mapping. Here we present the results of linkage disequilibrium and ancestral haplotype analyses of 35 markers to further refine the location of WRN. We identified an interval in this region in which 14 of 18 markers tested show significant evidence of linkage disequilibrium in at least one of the two populations tested, Analysis of extended and partial haplotypes covering 21 of the markers studied supports the existence of both obligate and probable ancestral recombinant events which localize WRN almost certainly to the interval between D8S2196 and D8S2186, and most likely to the narrower interval between D8S2168 and D8S2186. These haplotype analyses also suggest that there are multiple WRN mutations in each of the two populations under study, We also present a comparison of approaches to performing disequilibrium tests with multiallelic markers, and show that some commonly used approximations for such tests perform poorly in comparison to exact probability tests. Finally, we discuss some of the difficulties introduced by the high mutation rate at microsatellite markers which influence our ability to use ancestral haplotype analysis to localize disease genes.	UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PHARMACOL & NEUROL, SEATTLE, WA 98195 USA; VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, SEATTLE, WA USA; OSAKA UNIV, SCH MED, DEPT GERIATR MED, OSAKA 553, JAPAN; UNIV AMIENS, AMIENS, FRANCE	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Osaka University; Picardie Universites; Universite de Picardie Jules Verne (UPJV)			Brown, William/GXN-2777-2022; Melaragno, Maria Isabel/W-8714-2019; Poot, Martin/F-9427-2010; Melaragno, Maria I/F-9013-2012		NATIONAL INSTITUTE ON AGING [R37AG008303, R01AG012019] Funding Source: NIH RePORTER; NIA NIH HHS [AG12019, AG08303] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; [Anonymous], 1992, Science, V258, P67; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; ELLIS NA, 1994, AM J HUM GENET, V55, P453; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEALE SM, 1995, CELL, V83, P539, DOI 10.1016/0092-8674(95)90093-4; HEDRICK PW, 1987, GENETICS, V117, P331; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1994, AM J HUM GENET, V54, P705; HUDSON RR, 1985, GENETICS, V109, P611; JORDE LB, 1994, AM J HUM GENET, V54, P884; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIHARA K, 1994, JPN J HUM GENET, V39, P403, DOI 10.1007/BF01892385; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LEWONTIN RC, 1988, GENETICS, V120, P849; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MARTIN GM, 1970, LAB INVEST, V23, P86; NAKURA J, 1994, GENOMICS, V23, P600, DOI 10.1006/geno.1994.1548; NAKURA J, 1993, GERONTOLOGY, V39, P11; OLSON JM, 1994, AM J HUM GENET, V55, P574; OSHIMA J, 1994, GENOMICS, V23, P100, DOI 10.1006/geno.1994.1464; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; *SAS I, 1990, FREQ PROC SAS PROC G; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHELLENBERG GD, 1992, LANCET, V339, P1002, DOI 10.1016/0140-6736(92)91590-5; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Sirugo G., 1993, European Journal of Human Genetics, V1, P133; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THOMAS W, 1993, GENOMICS, V16, P685, DOI 10.1006/geno.1993.1248; TOMFOHRDE J, 1992, GENOMICS, V14, P144, DOI 10.1016/S0888-7543(05)80297-6; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEIR BS, 1978, GENETICS, V88, P633; WEIR BS, 1992, GENETICS, V130, P873; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Weir BS, 1990, GENETIC DATA ANAL; YE L, 1995, GENOMICS, V28, P566, DOI 10.1006/geno.1995.1189; YU CE, 1994, AM J HUM GENET, V55, P356; ZAHN LM, 1995, GENOMICS, V28, P140, DOI 10.1006/geno.1995.1124; ZOUROS E, 1977, GENETICS, V85, P543	51	45	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1286	1302						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651307				2022-12-18	WOS:A1996UM27100023
J	ANDERSON, KL; BAIRD, L; LEWIS, RA; CHINAULT, AC; OTTERUD, B; LEPPERT, M; LUPSKI, JR				ANDERSON, KL; BAIRD, L; LEWIS, RA; CHINAULT, AC; OTTERUD, B; LEPPERT, M; LUPSKI, JR			A YAC CONTIG ENCOMPASSING THE RECESSIVE STARGARDT DISEASE GENE (STGD) ON CHROMOSOME 1P	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; FUNDUS-FLAVIMACULATUS; HUMAN GENOME; MACULAR DYSTROPHY; CLONES; MACULOPATHY; LIBRARY; LINKAGE; FAMILY; LOCUS	Stargardt disease (STGD) and fundus flavimaculatus are infrequent autosomal recessive conditions characterized by a juvenile macular dystrophy and variable degrees of peripheral retinal changes. Linkage analysis performed in 47 STGD/fundus flavimaculatus families demonstrated significant linkage to 13 polymorphic DNA markers on chromosome 1p. The maximum combined two-point lod score was 32.7 (maximum recombination fraction [theta(max)] = .006) with the polymorphic marker D1S188. Our data demonstrate that STGD and fundus flavimaculatus are the same disorder clinically and genetically and provide further evidence for genetic homogeneity of this phenotype. Analysis of recombination events on disease chromosomes placed the STGD gene within a 4-cM interval between markers D1S435 and D1S236. A physical map was constructed of a YAC contig flanking STGD, from markers D1S500 to D1S495, and includes the critical interval delineated by historical recombinants. This contig spans similar to 31 cM, with one gap (3-5 cM) that is outside the 4-cM critical region. Localization of STGD to a single YAC contig will facilitate its positional cloning.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT; UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah								AMALRIC P, 1969, B MEM SOC FR OPHTALM, V81, P537; ANMARKRUD N, 1979, ACTA OPHTHALMOL, V57, P172; BATTEN RD, 1897, T OPHTHAL SOC UK, V17, P48; BELLANNECHANTEL.C, 1992, CELL, V70, P1059; BIRCH J, 1979, CONGENITAL ACQUIRED, P263; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Bither P P, 1988, J Am Optom Assoc, V59, P112; BONNET P, 1943, J FR OPHTHALMOL, V2, P336; BONNIN P, 1976, INT S FLUORESCEIN AN, P461; Bowcock Anne, 1992, Human Molecular Genetics, V1, P138, DOI 10.1093/hmg/1.2.138; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; CIBIS GW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1785; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COHEN SY, 1993, RETINA-J RET VIT DIS, V13, P312; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; ERNEST JT, 1966, AM J OPHTHALMOL, V62, P1; FIORE C, 1980, Bollettino di Oculistica, V59, P447; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Franceschetti A, 1965, Arch Ophtalmol Rev Gen Ophtalmol, V25, P505; Franceschetti A, 1965, Trans Am Acad Ophthalmol Otolaryngol, V69, P1048; Franceschetti A., 1963, ENTWICKLUNG FORTSCHR, P107; FRANCOIS P, 1975, ARCH OPHTALMOL-PARIS, V35, P817; GASS JDM, 1987, STEREOSCOPIC ATLAS M, P256; GERBER S, 1995, AM J HUM GENET, V56, P396; GLENN AM, 1994, RETINA-J RET VIT DIS, V14, P27, DOI 10.1097/00006982-199401000-00006; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREEN WR, 1985, OPHTHALMIC PATHOLOGY, V2, P1210; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HADDEN OB, 1976, AM J OPHTHALMOL, V82, P527, DOI 10.1016/0002-9394(76)90539-0; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; HEHER KL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1495, DOI 10.1001/archopht.1993.01090110061024; IRVINE AR, 1972, BRIT J OPHTHALMOL, V56, P817, DOI 10.1136/bjo.56.11.817; JACKSON E, 1905, T AM OPHTHAL SOC, V10, P150; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; KLEIN BA, 1967, AM J OPHTHALMOL, V64, P3; KRILL AE, 1977, KRILLS HEREDITARY RE, P739; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; Lang W., 1885, T OPHTHAL SOC UK, V5, P140; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; LOPEZ PF, 1990, OPHTHALMOLOGY, V97, P798; MAGOVCEVIC I, 1995, GENOMICS, V25, P288, DOI 10.1016/0888-7543(95)80139-D; MANSOUR AM, 1992, OPHTHALMOLOGICA, V205, P138, DOI 10.1159/000310329; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MCDONNELL PJ, 1986, OPHTHALMOLOGY, V93, P116; Mckusick V.A., 1994, MENDELIAN INHERITANC; MOLONEY JBM, 1983, AM J OPHTHALMOL, V96, P57, DOI 10.1016/0002-9394(83)90455-5; MORRIS TA, 1993, GENOMICS, V17, P442, DOI 10.1006/geno.1993.1345; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEAME H, 1944, T OPHTHAL SOC UK, V64, P212; NOBLE KG, 1979, ARCH OPHTHALMOL-CHIC, V97, P1281; OATMAN EL, 1907, ARCH OPHTHALMOL-CHIC, V36, P554; OTT J, 1991, ANAL HUMAN GENETIC L, P14; ROSEHR K, 1954, KLIN MONATSBL AUGENH, V124, P171; SORSBY A, 1955, Br J Ophthalmol, V39, P385, DOI 10.1136/bjo.39.7.385; Stargardt K, 1917, ARCH PSYCHIAT NERVEN, V58, P852, DOI 10.1007/BF02036429; STARGARDT K, 1925, KLIN MONATSBL AUGENH, V75, P246; STARGARDT K, 1913, Z AUGENHEILKD, V30, P95; STARGARDT K, 1916, Z AUGENHEILKD, V35, P249; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STEINMETZ RL, 1991, OPHTHALMOLOGY, V98, P953; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Turut P, 1975, Bull Soc Ophtalmol Fr, V75, P309; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035; 1995, AM J HUM GENET, V57, P619; 1904, CLIN OPHTHALMOL, V10, P125	74	45	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1351	1363						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533764				2022-12-18	WOS:A1995TE65500012
J	KOIVISTO, UM; VIIKARI, JS; KONTULA, K				KOIVISTO, UM; VIIKARI, JS; KONTULA, K			MOLECULAR CHARACTERIZATION OF MINOR GENE REARRANGEMENTS IN FINNISH PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - IDENTIFICATION OF 2 COMMON MISSENSE MUTATIONS (GLY823-]ASP AND LEU380-]HIS) AND 8 RARE MUTATIONS OF THE LDL RECEPTOR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; POLYMERASE CHAIN-REACTION; NONSENSE MUTATION; DELETION; FINLAND; FH; PREVALENCE; JEWS	Two deletions of the low-density lipoprotein (LDL) receptor gene were previously shown to account for about two thirds of all mutations causing familial hypercholesterolemia (FH) in Finland. We screened the DNA samples from a cohort representing the remaining 30% of Finnish heterozygous FH patients by amplifying all the 18 exons of the receptor gene by PCR and searching for DNA variations with the SSCP technique. Ten novel mutations were identified, comprising two nonsense and seven missense mutations as well as one frameshift mutation caused by a 13-bp deletion. A single nucleotide change, substituting adenine for guanidine at position 2533 and resulting in an amino acid change of glycine to aspartic acid at codon 823, was found in DNA samples from 14 unrelated FH probands. This mutation (FH-Turku) affects the sequence encoding the putative basolateral sorting signal of the LDL receptor protein; however, the exact functional consequences of this mutation are yet to be examined. The PH-Turku gene and another point mutation (Leu380-->His or FH-Pori) together account for similar to 8% of the FH-causing genes in Finland and are particularly common among FH patients from the southwestern part of the country (combined, 30%). Primer-introduced restriction analysis was applied for convenient assay of the FH-Turku and FH-Pori point mutations. In conclusion, this paper demonstrates the unique genetic background of FH in Finland and describes a commonly occurring FH gene with a missense mutation closest to the C terminus thus far reported.	HELSINKI UNIV, DEPT MED, SF-00014 HELSINKI, FINLAND; TURKU UNIV, DEPT INTERNAL MED, TURKU, FINLAND	University of Helsinki; University of Turku	KOIVISTO, UM (corresponding author), HELSINKI UNIV, INST BIOTECHNOL, POB 45, SF-00014 HELSINKI, FINLAND.							AALTOSETALA K, 1989, J CLIN INVEST, V84, P499, DOI 10.1172/JCI114192; AALTOSETALA K, 1992, J INTERN MED, V231, P227, DOI 10.1111/j.1365-2796.1992.tb00528.x; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; DEFESCHE JC, 1992, CLIN GENET, V42, P273; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GUDNASON V, 1993, ARTERIOSCLER THROMB, V13, P56, DOI 10.1161/01.ATV.13.1.56; HAMALAINEN T, 1990, ATHEROSCLEROSIS, V82, P177, DOI 10.1016/0021-9150(90)90038-K; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HUURRE M, 1990, 9000 VUOTTA SUOMEN E; Jacobson D R, 1991, PCR Methods Appl, V1, P146; KINGUNDERWOOD L, 1991, CLIN GENET, V40, P17; KOIVISTO PVI, 1993, ARTERIOSCLER THROMB, V13, P1680, DOI 10.1161/01.ATV.13.11.1680; KOIVISTO UM, 1993, J LIPID RES, V34, P269; KOIVISTO UM, 1992, J CLIN INVEST, V90, P219, DOI 10.1172/JCI115839; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; KONTULA K, 1992, ANN MED, V24, P363, DOI 10.3109/07853899209147838; LANDSBERGER D, 1992, AM J HUM GENET, V50, P427; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEITERSDORF E, 1993, HUM GENET, V91, P141, DOI 10.1007/BF00222714; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; LEITERSDORF E, 1990, J CLIN INVEST, V85, P1014, DOI 10.1172/JCI114531; LEREN TP, 1994, ATHEROSCLEROSIS, V111, P175, DOI 10.1016/0021-9150(94)90091-4; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MEINER V, 1991, AM J HUM GENET, V49, P443; NORIO R, 1973, ANN CLIN RES, V5, P109; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RODNINGEN OK, 1992, CLIN GENET, V42, P288; SCHUSTER H, 1994, CLIN INVESTIGATOR, V72, P898; TOP B, 1990, ATHEROSCLEROSIS, V83, P127, DOI 10.1016/0021-9150(90)90158-F; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39	32	45	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					789	797						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573037				2022-12-18	WOS:A1995RV79300007
J	KOEBERL, DD; MCGILLIVRAY, B; SYBERT, VP				KOEBERL, DD; MCGILLIVRAY, B; SYBERT, VP			PRENATAL-DIAGNOSIS OF 45,X/46,XX MOSAICISM AND 45,X - IMPLICATIONS FOR POSTNATAL OUTCOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERUM GONADOTROPIN CONCENTRATIONS; INFANCY; AGE	The prognosis for 45,X/46,XX mosaicism diagnosed prenatally has yet to be established. We report our experience with 12 patients in whom prenatal diagnosis of 45,X/46,XX mosaicism was detected by amniocentesis for advanced maternal age or decreased maternal serum alpha-fete protein and compared them with 41 45,X/46,XX patients diagnosed postnatally. The girls in the prenatal group range in age from 3 mo to 10 years. All have had normal linear growth. Four had structural anomalies including: ASD (n = 1); ptosis and esotropia (n = 1); labial fusion (n = 1); and urogenital sinus, dysplastic kidneys, and hydrometrocolpos (n = 1). Gonadotropins were measured in seven; one had elevated luteinizing hormone/FSH at 3 mo of age. One has developmental delay and seizures as well as ophthalmologic abnormalities, None would have warranted karyotyping for clinical suspicion of Turner syndrome. The prevalence of 45,X/46,XX mosaicism is 10-fold higher among amniocenteses than in series of postnatally diagnosed individuals with Turner syndrome, which suggests that most individuals with this karyotype escape detection and that an ascertainment bias exists toward those with clinically evident abnormalities. The phenomenon of a milder phenotype for the prenatal group is similar to that observed for 45,X/46,XY diagnosed prenatally. Prenatal counseling for 45,X/46,XX in the absence of such ultrasound abnormalities as hydrops fetalis should take into account the expectation of a milder phenotype (except, possibly, with respect to developmental delay) than that of patients ascertained postnatally. The same does not hold true for 45,X diagnosed prenatally.	CHILDRENS HOSP & MED CTR,DIV DERMATOL,SEATTLE,WA 98905; UNIV BRITISH COLUMBIA,VANCOUVER,BC,CANADA; UNIV WASHINGTON,SCH MED,DEPT MED,DIV MED GENET,SEATTLE,WA 98195	Seattle Children's Hospital; University of British Columbia; University of Washington; University of Washington Seattle								Altman DG, 1991, PRACTICAL STATISTICS; CHANG HJ, 1990, AM J HUM GENET, V46, P156; CONTE FA, 1980, J CLIN ENDOCR METAB, V50, P163, DOI 10.1210/jcem-50-1-163; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; HSU LYF, 1989, PRENATAL DIAG, V9, P31, DOI 10.1002/pd.1970090106; KULKARNI R, 1989, PRENATAL DIAG, V9, P439, DOI 10.1002/pd.1970090610; LIPPE B, 1991, ENDOCRIN METAB CLIN, V20, P121, DOI 10.1016/S0889-8529(18)30284-6; LIPPE B, 1993, BASIC CLIN APPROACH, P117; WARBURTON D, 1980, LANCET, V1, P167; WHEELER M, 1988, AM J MED GENET, V29, P565, DOI 10.1002/ajmg.1320290314; WILSON MG, 1989, AM J MED GENET, V32, P506, DOI 10.1002/ajmg.1320320417; WINTER JSD, 1975, J CLIN ENDOCR METAB, V40, P545, DOI 10.1210/jcem-40-4-545; WINTER JSD, 1972, J CLIN ENDOCR METAB, V35, P561, DOI 10.1210/jcem-35-4-561	14	45	49	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					661	666						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668295				2022-12-18	WOS:A1995RR60500016
J	PAULS, DL; OTT, J; PAUL, SM; ALLEN, CR; FANN, CSJ; CARULLI, JP; FALLS, KM; BOUTHILLIER, CA; GRAVIUS, TC; KEITH, TP; EGELAND, JA; GINNS, EI				PAULS, DL; OTT, J; PAUL, SM; ALLEN, CR; FANN, CSJ; CARULLI, JP; FALLS, KM; BOUTHILLIER, CA; GRAVIUS, TC; KEITH, TP; EGELAND, JA; GINNS, EI			LINKAGE ANALYSES OF CHROMOSOME-18 MARKERS DO NOT IDENTIFY A MAJOR SUSCEPTIBILITY LOCUS FOR BIPOLAR AFFECTIVE-DISORDER IN THE OLD-ORDER AMISH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; SEGREGATION ANALYSIS; DNA MARKERS; TRANSMISSION; GENOME; SEARCH; INHERITANCE; RELIABILITY; FAMILY; MAP	Previously reported linkage of bipolar affective disorder to DNA markers in the pericentromeric region of chromosome 18 was reexamined in a larger homogeneous sample of Old Order Amish families. Four markers (D18S21, D18S53, D18S44, and D18S40) were examined in three kindreds containing 31 bipolar I (BP I) individuals. Although linkage findings were replicated in the one previously studied Amish pedigree containing four BP I individuals, linkage to this region was excluded in the larger sample. If a susceptibility locus for bipolar disorder is located in this region of chromosome 18, it is of minor significance in this population.	NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY; COLUMBIA UNIV,NEW YORK,NY; NIMH,IRP,CLIN NEUROSCI BRANCH,BETHESDA,MD 20892; ELI LILLY & CO,LILLY RES LABS,INDIANAPOLIS,IN 46285; UNIV MIAMI,DEPT PSYCHIAT,MIAMI,FL 33152; GENOME THERAPEUT CORP,WALTHAM,MA	New York State Psychiatry Institute; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Eli Lilly; University of Miami	PAULS, DL (corresponding author), YALE UNIV,SCH MED,CTR CHILD STUDY,230 S FRONTAGE RD,NEW HAVEN,CT 06510, USA.		Fann, Cathy SJ/F-9410-2010; Paul, Steve/ABE-5400-2020	Fann, Cathy SJ/0000-0001-9025-2276; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH028287, R01MH044292, R37MH044292] Funding Source: NIH RePORTER; NIMH NIH HHS [MH28287, MH44292, MH-00508] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALEYWILSON JE, 1989, SAGE STATISTICAL ANA; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BARONDES SH, 1992, J PSYCHIAT RES, V26, P299, DOI 10.1016/0022-3956(92)90036-N; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BUCHER KD, 1981, J PSYCHIAT RES, V16, P65, DOI 10.1016/0022-3956(81)90014-5; BUCHER KD, 1981, J PSYCHIATR RES, V16, P53, DOI 10.1016/0022-3956(81)90013-3; COON H, 1993, AM J HUM GENET, V52, P1234; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; EGELAND JA, 1992, NIH932944 US DEP HLT, P386; Egeland Janice A., 1990, Psychiatric Genetics, V1, P5; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GEJMAN PV, 1993, NEUROPSYCHOPHARMACOL, V9, P31, DOI 10.1038/npp.1993.40; GINNS EI, 1992, J PSYCHIAT RES, V26, P305, DOI 10.1016/0022-3956(92)90037-O; HEBEBRAND J, 1992, HUM GENET, V90, P289; HOSTETTER AM, 1983, AM J PSYCHIAT, V140, P62; KEITH T, 1991, AM J HUM GENET, V49, P346; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LECKMAN JF, 1977, J PSYCHIAT RES, V13, P237, DOI 10.1016/S0022-3956(77)90019-X; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MELONI R, 1993, PSYCHIAT GENET, V3, P121; NURNBERGER J, 1993, PSYCHIAT GENET, V3, P207; Ott J., 1991, ANAL HUMAN GENETIC L; PAULS DL, 1991, GENOMICS, V11, P730, DOI 10.1016/0888-7543(91)90081-O; PAULS DL, IN PRESS AM J MED GE; PEKKARINEN P, 1994, AM J HUM GENET S, V35, P133; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; RISCH N, 1986, J PSYCHIAT RES, V20, P275, DOI 10.1016/0022-3956(86)90031-2; SHAM PC, 1991, PSYCHIAT GENET, V2, P175, DOI DOI 10.1097/00041444-199203000-00002; Spence MA, 1993, PSYCHIAT GENET, V3, P143; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; TSUANG MT, 1985, J PSYCHIAT RES, V19, P23, DOI 10.1016/0022-3956(85)90065-2; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	39	45	50	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					636	643						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668292				2022-12-18	WOS:A1995RR60500013
J	REISH, O; TOWNSEND, D; BERRY, SA; TSAI, MY; KING, RA				REISH, O; TOWNSEND, D; BERRY, SA; TSAI, MY; KING, RA			TYROSINASE INHIBITION DUE TO INTERACTION OF HOMOCYST(E)INE WITH COPPER - THE MECHANISM FOR REVERSIBLE HYPOPIGMENTATION IN HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Deficiency of cystathionine B-synthase (CBS) is a genetic disorder of transsulfuration resulting in elevated plasma homocyst(e)ine and methionine and decreased cysteine. Affected patients have multisystem involvement, which may include light skin and hair. Reversible hypopigmentation in treated homocystinuric patients has been infrequently reported, and the mechanism is undefined. Two CBS-deficient homocystinuric patients manifested darkening of their hypopigmented hair following treatment that decreased plasma homocyst(e)ine. We hypothesized that homocyst(e)ine inhibits tyrosinase, the major pigment enzyme. The activity of tyrosinase extracted from pigmented human melanoma cells (MNT-1) that were grown in the presence of homocysteine was reduced in comparison to that extracted from cells grown without homocysteine. Copper sulfate restored homocyst(e)ine-inhibited tyrosinase activity when added to the culture cell media at a proportion of 1.25 mol of copper sulfate per 1 mol of DL-homocysteine. Holo-tyrosinase activity was inhibited by adding DL-homocysteine to the assay reaction mixture, and the addition of copper sulfate to the reaction mixture prevented this inhibition. Other tested compounds, L-cystine and betaine did not affect tyrosinase activity. Our data suggest that reversible hypopigmentation in homocystinuria is the result of tyrosinase inhibition by homocyst(e)ine and that the probable mechanism of this inhibition is the interaction of homocyst(e)ine with copper at the active site of tyrosinase.	UNIV MINNESOTA, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT MED, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Tsai, Michael/0000-0001-7553-3408; reish, orit/0000-0002-9483-238X; Berry, Susan/0000-0001-7970-688X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022167] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 22167] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBER GW, 1969, J PEDIATR, V75, P463, DOI 10.1016/S0022-3476(69)80274-X; BRATTSTROM L, 1988, METABOLISM, V37, P175, DOI 10.1016/S0026-0495(98)90014-2; CARSON NAJ, 1965, J PEDIATR-US, V66, P565, DOI 10.1016/S0022-3476(65)80121-4; CLEFFMANN G, 1963, ANN NY ACAD SCI, V100, P749, DOI 10.1111/j.1749-6632.1963.tb42888.x; DUDMAN NPB, 1983, CLIN CHIM ACTA, V127, P105, DOI 10.1016/0009-8981(83)90080-3; GANGE RW, 1986, DERMATOL CLIN, V4, P189, DOI 10.1016/S0733-8635(18)30821-0; GUBLER CJ, 1956, JAMA-J AM MED ASSOC, V161, P530, DOI 10.1001/jama.1956.62970060011010; KANG AH, 1973, J CLIN INVEST, V52, P2571, DOI 10.1172/JCI107449; King R., 1995, METABOLIC MOL BASES, P4353; LERNER AB, 1950, J BIOL CHEM, V187, P793; LEVENE CI, 1992, INT J EXP PATHOL, V73, P613; LINDBERG KA, 1976, CLIN RES, V24, pA265; MARSTON HR, 1952, PHYSIOL REV, V32, P66, DOI 10.1152/physrev.1952.32.1.66; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1985, AM J HUM GENET, V37, P1; NORDSTROM M, 1992, ATHEROSCLEROSIS, V94, P213, DOI 10.1016/0021-9150(92)90246-D; SHELLEY WB, 1972, ARCH DERMATOL, V106, P228, DOI 10.1001/archderm.106.2.228; TOWNSEND D, 1984, ANAL BIOCHEM, V139, P345, DOI 10.1016/0003-2697(84)90015-0; WILCKEN DEL, 1983, NEW ENGL J MED, V309, P448, DOI 10.1056/NEJM198308253090802; Witkop C J Jr, 1985, Clin Dermatol, V3, P70; YOSHIDA Y, 1992, ACTA NEUROL SCAND, V86, P490, DOI 10.1111/j.1600-0404.1992.tb05130.x	21	45	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					127	132						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611281				2022-12-18	WOS:A1995RE62900016
J	HUFF, V; JAFFE, N; SAUNDERS, GF; STRONG, LC; VILLALBA, F; RUTESHOUSER, EC				HUFF, V; JAFFE, N; SAUNDERS, GF; STRONG, LC; VILLALBA, F; RUTESHOUSER, EC			WTI EXON-I DELETION/INSERTION MUTATIONS IN WILMS-TUMOR PATIENTS, ASSOCIATED WITH DINUCLEOTIDE AND TRINUCLEOTIDE REPEATS AND DELETION HOTSPOT CONSENSUS SEQUENCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; GENETIC-DISEASE; SUPPRESSOR WT1; DNA-SEQUENCE; CGG REPEAT; INSTABILITY; MECHANISMS; LOCUS; CHROMOSOME-11; MUTAGENESIS	The WT1 gene is known to play a role in at least some cases of Wilms tumor (WT). The first exon of the gene is highly GC rich and contains many short tandem di- and trinucleotide repeats, interrupted direct repeats, and CCTG (CAGG) motifs that have been identified as hotspots for DNA deletions. We have analyzed 80 WT patient samples for mutations in the first exon of WT1, either by SSCP analysis of the first 131 bp of the coding portion of WT1 exon 1 or by size analysis of a PCR product encompassing the coding region of exon 1 in addition to flanking noncoding regions. We report here the occurrence of somatic and germ-line deletion and insertion mutations in this portion of the gene in four WT patients. The mutations are flanked by short direct repeats, and the breakpoints are within 5 nt of a CCTG (CAGG) sequence. These data suggest that a distinctive mutational mechanism, previously unrecognized for this gene, is important for the generation of DNA mutations at the WT1 locus.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	HUFF, V (corresponding author), UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT EXPTL PEDIAT,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NCI NIH HHS [CA60114, CA34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA060114, P01CA034936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; COOPER DN, 1991, HUM GENET, V87, P409; DAO DD, 1987, AM J HUM GENET, V41, P202; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; GESSLER M, 1994, HUM MUTAT, V3, P212, DOI 10.1002/humu.1380030307; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HUFF V, 1991, AM J HUM GENET, V48, P997; HUFF V, 1991, AM J HUM GENET, V49, P44; HUFF V, 1988, NATURE, V377, P378; JEGO N, 1993, ONCOGENE, V8, P209; KRAWCZAK M, 1991, HUM GENET, V86, P425; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; SINGER BS, 1988, J MOL BIOL, V202, P233, DOI 10.1016/0022-2836(88)90454-8; STEINMETZ M, 1987, TRENDS GENET, V3, P7, DOI 10.1016/0168-9525(87)90154-5; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VARANASI R, 1994, P NATL ACAD SCI USA, V91, P3554, DOI 10.1073/pnas.91.9.3554; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7	33	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					84	90						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825606				2022-12-18	WOS:A1995QC10100011
J	HALLMAYER, J; PINTADO, E; LOTSPEICH, L; SPIKER, D; MCMAHON, W; PETERSEN, PB; NICHOLAS, P; PINGREE, C; KRAEMER, HC; WONG, DL; RITVO, E; LIN, A; HEBERT, J; CAVALLISFORZA, LL; CIARANELLO, RD				HALLMAYER, J; PINTADO, E; LOTSPEICH, L; SPIKER, D; MCMAHON, W; PETERSEN, PB; NICHOLAS, P; PINGREE, C; KRAEMER, HC; WONG, DL; RITVO, E; LIN, A; HEBERT, J; CAVALLISFORZA, LL; CIARANELLO, RD			MOLECULAR ANALYSIS AND TEST OF LINKAGE BETWEEN THE FMR-I GENE AND INFANTILE-AUTISM IN MULTIPLEX FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION; DNA; AMPLIFICATION; FRAGMENTS; INTERVIEW; DIAGNOSIS; BEHAVIOR; GENOME; REGION	Approximately 2%-5% of autistic children show cytogenetic evidence of the fragile X syndrome. This report tests whether infantile autism in multiplex autism families arises from an unusual manifestion of the fragile X syndrome. This could arise either by expansion of the (CGG)n trinucleotide repeat in FMR-1 or from a mutation elsewhere in the gene. We studied 35 families that met stringent criteria for multiplex autism. Amplification of the trinucleotide repeat and analysis of methylation status were performed in 79 autistic children and in 31 of their unaffected siblings, by Southern blot analysis. No examples of amplified repeats were seen in the autistic or control children or in their parents or grandparents. We next examined the hypothesis that there was a mutation elsewhere in the FMR-1 gene, by linkage analysis in 32 of these families. We tested four different dominant models and a recessive model. Linkage to FMR-1 could be excluded (lod score between -24 and -62) in all models by using probes DXS548, FRAXAC1, and FRAXAC2 and the CGG repeat itself. Tests for heterogeneity in this sample were negative, and the occurrence of positive lod scores in this data set could be attributed to chance. Analysis of the data by the affected-sib method also did not show evidence for linkage of any marker to autism. These results enable us to reject the hypothesis that multiplex autism arises from expansion of the (CGG)n trinucieotide repeat in FMR-1. Further, because the overall lod scores for all probes in all models tested were highly negative, linkage to FMR-1 can also be ruled out in multiplex autistic families.	STANFORD UNIV,SCH MED,MED CTR,DEPT PSYCHIAT & BEHAV SCI,AUTISM GENET PROGRAM,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT PSYCHIAT,NANCY PRITZKER LAB DEV & MOLEC NEURBIOL,STANFORD,CA 94305; UNIV UTAH,DEPT PSYCHIAT,SALT LAKE CITY,UT 84112; CHILDRENS BEHAV THERAPY UNIT,SALT LAKE CITY,UT; UNIV CALIF LOS ANGELES,SCH MED,INST NEUROPSYCHIAT,DEPT PSYCHIAT,LOS ANGELES,CA 90024	Stanford University; Stanford University; Stanford University; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				Pintado, Elizabeth/0000-0002-5237-5045	NIMH NIH HHS [MH39437, MH 00219] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH000219, P01MH039437] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON MA, 1984, IN VITRO, V11, P856; BOLTON P, 1990, International Review of Psychiatry, V2, P67, DOI 10.3109/09540269009028273; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; EINFELD S, 1992, AM J MED GENET, V43, P56; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCH GS, 1992, AM J MED GENET, V43, P47, DOI 10.1002/ajmg.1320430107; FOLSTEIN SE, 1991, PEDIATRICS, V87, P767; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; JORDE LB, 1991, AM J HUM GENET, V49, P932; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Lotspeich Linda J., 1993, V35, P87; MACPHERSON JN, 1992, J MED GENET, V29, P802, DOI 10.1136/jmg.29.11.802; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OTT J, 1991, ANAL HUMAN GENETIC L, P203; PAYTON JB, 1989, J AM ACAD CHILD PSY, V28, P417, DOI 10.1097/00004583-198905000-00019; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P825, DOI 10.1097/00004583-199109000-00020; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; ROUSSEAU F, 1992, AM J MED GENET, V43, P197, DOI 10.1002/ajmg.1320430133; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; SMALLEY SL, 1991, PSYCHIAT CLIN N AM, V14, P125; SNOW K, 1993, AM J HUM GENET, V53, P1217; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; STEFFEN D, 1978, CELL, V15, P1003, DOI 10.1016/0092-8674(78)90284-2; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; TARLETON J, 1992, J MED GENET, V29, P919, DOI 10.1136/jmg.29.12.919; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB TP, 1986, J MED GENET, V23, P396, DOI 10.1136/jmg.23.5.396; WEHNERT M, 1993, HUM MOL GENET, V2, P1503, DOI 10.1093/hmg/2.9.1503; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	35	45	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					951	959						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	QB682	7977358				2022-12-18	WOS:A1994QB68200015
J	ROWELL, S; NEWMAN, B; BOYD, J; KING, MC				ROWELL, S; NEWMAN, B; BOYD, J; KING, MC			INHERITED PREDISPOSITION TO BREAST AND OVARIAN-CANCER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							FAMILIAL BREAST; ALLELIC LOSS; LINKAGE; CHROMOSOME-17Q21; REGION		UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, BERKELEY, CA 94720 USA; UNIV N CAROLINA, SCH PUBL HLTH, DEPT EPIDEMIOL, CHAPEL HILL, NC USA; UNIV PENN, DEPT OBSTET & GYNECOL, PHILADELPHIA, PA 19104 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania				King, Mary-Claire/0000-0001-9426-1743				ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1993, AM J HUM GENET, V53, P787; CLIBY W, 1993, CANCER RES, V53, P2393; CROPP CS, 1993, CANCER RES, V53, P5617; DUROCHR F, 1994, COLD SPRING HARB SYM, V59, P49; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Futreal P. A., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P610; FUTREAL PA, 1992, CANCER RES, V52, P2624; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HENDERSON BE, 1991, SCIENCE, V254, P1131, DOI 10.1126/science.1957166; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARGARITTE P, 1992, AM J HUM GENET, V50, P1231; MCGREGOR DH, 1977, J NATL CANCER I, V59, P799, DOI 10.1093/jnci/59.3.799; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OSTERMEYER EA, 1994, COLD SPRING HARB SYM, V59, P523, DOI 10.1101/SQB.1994.059.01.058; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; RIES LAG, 1990, NIH902789 US DEP HLT; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; SAITO H, 1993, CANCER RES, V53, P3382; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; STEICHENGERSDORF E, 1994, AM J HUM GENET, V55, P870; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; WEBER BL, 1994, COLD SPRING HARB SYM, V59, P531, DOI 10.1101/SQB.1994.059.01.059; WOOSTER R, 1992, NAT GENET, V2, P132, DOI 10.1038/ng1092-132; YANGFENG TL, 1993, INT J CANCER, V54, P546, DOI 10.1002/ijc.2910540405; 1994, JAMA-J AM MED ASSOC, V271, P785	32	45	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					861	865						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977346				2022-12-18	WOS:A1994QB68200002
J	KEATS, BJB; NOURI, N; PELIAS, MZ; DEININGER, PL; LITT, M				KEATS, BJB; NOURI, N; PELIAS, MZ; DEININGER, PL; LITT, M			TIGHTLY LINKED FLANKING MICROSATELLITE MARKERS FOR THE USHER SYNDROME TYPE-I LOCUS ON THE SHORT ARM OF CHROMOSOME-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAPPED GENES; LINKAGE; COMMITTEE	Usher syndrome type I is an autosomal recessive disease characterized by profound congenital hearing impairment and vestibular dysfunction followed by the onset of progressive pigmentary retinopathy in childhood or early adolescence. A locus (USH1C) for one form of this disease was previously assigned to the short arm of chromosome 11 through linkage studies in the Acadian population of southwestern Louisiana. Linkage analyses of a set of microsatellite markers in 27 Acadian families provide evidence that USH1C lies between D11S861 and D11S928. Three markers (D11S419, D11S921, and D11S899) that lie between the flanking markers show no recombination with USH1C, and all 54 chromosomes with the abnormal allele at the disease locus have identical alleles for D11S419 and D11S921. This haplotype was found on only 10 of 50 chromosomes with the normal allele at the disease locus, suggesting a strong founder effect. Of the 54 chromosomes with the abnormal allele, 12 had a divergent allele at D11S899. These results suggest that USH1C is in the 2-3-cM interval between D11S861 and D11S899.	LOUISIANA STATE UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,NEW ORLEANS,LA; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR	Louisiana State University System; Oregon Health & Science University	KEATS, BJB (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,1901 PERDIDO ST,NEW ORLEANS,LA 70112, USA.			Deininger, Prescott/0000-0002-1067-3028	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00022] Funding Source: Medline; NIDCD NIH HHS [DC00379] Funding Source: Medline; NIGMS NIH HHS [GM28356] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARRONG SD, 1992, ARCH OPHTHALMOL-CHIC, V110, P706, DOI 10.1001/archopht.1992.01080170128040; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KEATS BJB, 1992, GENOMICS, V14, P707, DOI 10.1016/S0888-7543(05)80172-7; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; MCALPINE PJ, 1991, CYTOGENET CELL GENET, V58, P5, DOI 10.1159/000133160; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; SMITH RJH, 1992, AM J MED GENET, V43, P964, DOI 10.1002/ajmg.1320430612; SMITH RJH, IN PRESS AM J MED GE; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; 1992, STATISTICAL ANAL GEN	16	45	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					681	686						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128966				2022-12-18	WOS:A1994NC83600013
J	OEHLMANN, R; SUMMERVILLE, GP; YEH, G; WEAVER, EJ; JIMENEZ, SA; KNOWLTON, RG				OEHLMANN, R; SUMMERVILLE, GP; YEH, G; WEAVER, EJ; JIMENEZ, SA; KNOWLTON, RG			GENETIC-LINKAGE MAPPING OF MULTIPLE EPIPHYSEAL DYSPLASIA TO THE PERICENTROMERIC REGION OF CHROMOSOME-19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; POLYMORPHISMS; MAP	Multiple epiphyseal dysplasia (MED) is an inherited chondrodystrophy that results in deformity of articular surfaces and in subsequent degenerative joint disease. The disease is inherited as an autosomal dominant trait with high penetrance. An MED mutation has been mapped by genetic linkage analysis of DNA polymorphisms in a single large pedigree. Close linkage of MED to 130 tested chromosomal markers was ruled out by discordant inheritance patterns. However, strong evidence for linkage of MED to markers in the pericentromeric region of chromosome 19 was obtained. The most closely linked marker was D19S215, with a maximum LOD score of 6.37 at 0 = .05. Multipoint linkage analysis indicated that MED is located between D19S212 and D19S215, a map interval of 1.7 cM. Discovery of the map location of MED in this family will facilitate identification of the mutant gene. The closely linked DNA polymorphisms will also provide the means to determine whether other inherited chondrodystrophies have underlying defects in the same gene.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,233 S 10TH ST,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT MED,PHILADELPHIA,PA 19107	Jefferson University; Jefferson University				Jimenez, Sergio/0000-0001-5213-1203	NIAMS NIH HHS [AR39740] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039740] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARRIE H, 1958, BRIT MED J, V2, P133, DOI 10.1136/bmj.2.5089.133; Barrington-Ward LE, 1912, LANCET, V1, P157; BEIGHTON P, 1992, AM J MED GENET, V42, P431, DOI 10.1002/ajmg.1320420406; BRIGGS MD, IN PRESS GENOMICS, V19; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HECHT JT, 1991, NUCLEIC ACIDS RES, V19, P6666, DOI 10.1093/nar/19.23.6666; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HULVEY JT, 1969, AMER J ROENTGENOL RA, V106, P170, DOI 10.2214/ajr.106.1.170; HUNT DD, 1967, J BONE JOINT SURG AM, VA 49, P1611, DOI 10.2106/00004623-196749080-00014; JACKSON WPU, 1954, ARCH INTERN MED, V94, P886, DOI 10.1001/archinte.1954.00250060020002; KNOWLTON RG, 1989, AM J HUM GENET, V45, P681; KORENBERG JR, 1993, GENOMICS, V16, P546, DOI 10.1006/geno.1993.1228; KORKKO J, 1993, AM J HUM GENET, V53, P55; Kozlowski K, 1967, Clin Radiol, V18, P330, DOI 10.1016/S0009-9260(67)80083-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAUDSLEY RH, 1955, J BONE JOINT SURG BR, V37, P228, DOI 10.1302/0301-620X.37B2.228; Ribbing S, 1937, ACTA RADIOL S, V34, P1; SHEPHARD E, 1956, J BONE JOINT SURG BR, V38, P458, DOI 10.1302/0301-620X.38B2.458; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1984, J BONE JOINT SURG AM, V66A, P817, DOI 10.2106/00004623-198466060-00002; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; WEAVER EJ, 1993, AM J MED GENET, V45, P345, DOI 10.1002/ajmg.1320450312; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	29	45	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					3	10						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279467				2022-12-18	WOS:A1994MQ70000002
J	CAO, Z; NATOWICZ, MR; KABACK, MM; LIMSTEELE, JST; PRENCE, EM; BROWN, D; CHABOT, T; TRIGGSRAINE, BL				CAO, Z; NATOWICZ, MR; KABACK, MM; LIMSTEELE, JST; PRENCE, EM; BROWN, D; CHABOT, T; TRIGGSRAINE, BL			A SECOND MUTATION ASSOCIATED WITH APPARENT BETA-HEXOSAMINIDASE-A PSEUDODEFICIENCY - IDENTIFICATION AND FREQUENCY ESTIMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAY-SACHS DISEASE; ADULT GM2 GANGLIOSIDOSIS; ASHKENAZI-JEWISH; ALPHA-CHAIN; N-ACETYLHEXOSAMINIDASE; SEQUENCE-ANALYSIS; MOLECULAR-BASIS; A DEFICIENCY; HUMAN ENZYME; SPLICE SITE	Deficient activity of beta-hexosaminidase A (Hex A), resulting from mutations in the HEXA gene, typically causes Tay-Sachs disease. However, healthy individuals lacking Hex A activity against synthetic substrates (i.e., individuals who are pseudodeficient) have been described. Recently, an apparently benign C-739-to-T (Arg247Trp) mutation was found among individuals with Hex A levels indistinguishable from those of carriers of Tay-Sachs disease. This allele, when in compound heterozygosity with a second ''disease-causing'' allele, results in Hex A pseudodeficiency. We examined the HEXA gene of a healthy 42-year-old who was Hex A deficient but did not have the C-739-to-T mutation. The HEXA exons were PCR amplified, and the products were analyzed for mutations by using restriction-enzyme digestion or single-strand gel electrophoresis. A G(805)-to-A (Gly269Ser) mutation associated with adult-onset G(M2) gangliosidosis was found on one chromosome. A new mutation, C-745-to-T (Arg243Trp), was identified on the second chromosome. This mutation was detected in an additional 4/63 (6%) non-Jewish and 0/218 Ashkenazi Jewish enzyme-defined carriers. Although the Arg249Trp change may result in a late-onset form of G,, gangliosidosis, any phenotype must be very mild. This new mutation and the benign C-739-to-T mutation together account for approximately 38% of non-Jewish enzyme-defined carriers. Because carriers of the C-739-to-T and C-745-to-T mutations cannot be differentiated from carriers of disease-causing alleles by using the classical biochemical screening approaches, DNA-based analyses for these mutations should be offered for non-Jewish enzyme-defined heterozygotes, before definitive counseling is provided.	UNIV MANITOBA,DEPT BIOCHEM & MOLEC BIOL,WINNIPEG R3E 0W3,MB,CANADA; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,WALTHAM,MA; HARVARD UNIV,SCH MED,BOSTON,MA; CHILDRENS HOSP SAN DIEGO,SAN DIEGO,CA; UNIV CALIF SAN DEIGO,SCH MED,DEPT PEDIAT,SAN DIEGO,CA	University of Manitoba; Harvard University; Harvard Medical School; University of California System; University of California San Diego			Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779				Akerman B. R., 1992, Human Mutation, V1, P303, DOI 10.1002/humu.1380010407; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BAPAT B, 1988, FEBS LETT, V237, P191, DOI 10.1016/0014-5793(88)80199-6; BECCARI T, 1992, BIOCHEM J, V285, P593, DOI 10.1042/bj2850593; GRAHAM TR, 1988, J BIOL CHEM, V263, P16823; GREBNER EE, 1986, AM J HUM GENET, V38, P505; GREBNER EE, 1991, AM J HUM GENET, V48, P604; GREENBERG DA, 1982, AM J HUM GENET, V34, P444; HOAR DI, 1984, PRENATAL DIAG, V4, P241, DOI 10.1002/pd.1970040402; KABACK MM, 1972, METHOD ENZYMOL, V28, P862; KABACK MM, 1978, PEDIATR RES, V12, pA530; KABACK MM, 1993, MOL BIOL LYSOSOMAL D, P43; KABACK MM, 1977, TAYSACHS DISEASE SCR; KELLY TE, 1976, CLIN GENET, V9, P540; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; KYTZIA HJ, 1985, J BIOL CHEM, V260, P7568; LANDELS EC, 1991, J MED GENET, V28, P177, DOI 10.1136/jmg.28.3.177; LANDELS EC, 1992, J MED GENET, V29, P563, DOI 10.1136/jmg.29.8.563; Mules Emilie H., 1992, Human Mutation, V1, P298, DOI 10.1002/humu.1380010406; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; NAVON R, 1986, AM J MED GENET, V24, P179, DOI 10.1002/ajmg.1320240123; NAVON R, 1990, AM J HUM GENET, V46, P817; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEOTE K, 1991, ADV NEUROL, V56, P189; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OBRIEN JS, 1978, AM J HUM GENET, V30, P602; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; OTITA M, 1989, GENOMICS, V5, P874; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PRENCE EM, IN PRESS CLIN CHEM; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SOTOGIL RW, 1989, J BIOL CHEM, V264, P14778; THOMAS GH, 1982, PEDIATR RES, V16, P232, DOI 10.1203/00006450-198203000-00014; TOMCZAK J, 1993, AM J HUM GENET, V53, P537; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; TRIGGSRAINE BL, 1992, AM J HUM GENET, V51, P793; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	45	45	46	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1198	1205						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	7902672				2022-12-18	WOS:A1993MJ81800006
J	MILATOVICH, A; KITAMURA, T; MIYAJIMA, A; FRANCKE, U				MILATOVICH, A; KITAMURA, T; MIYAJIMA, A; FRANCKE, U			GENE FOR THE ALPHA-SUBUNIT OF THE HUMAN INTERLEUKIN-3 RECEPTOR (IL3RA) LOCALIZED TO THE X-Y PSEUDOAUTOSOMAL REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GM-CSF RECEPTOR; COLONY-STIMULATING FACTOR; BETA-CHAIN GENE; TURNER SYNDROME; CYTOKINE RECEPTORS; MOLECULAR-CLONING; LEUKEMIA-CELLS; 2ND SUBUNIT; CHROMOSOME; EXPRESSION	Interleukin-3 (IL3) and granulocyte/macrophage colony-stimulating factor (CSF2) stimulate proliferation and differentiation of various hemopoietic cell types. As is characteristic of the cytokine receptor family, the receptors for these proteins comprise alpha- and beta-subunits. While IL3 and CSF2 receptors each have unique alpha-subunits, they share a common beta-subunit. By Southern analysis of somatic cell hybrid panels, pulsed-field gel electrophoresis (PFGE), and fluorescence chromosomal in situ hybridization, we have mapped the cloned sequence for the IL3 receptor alpha (IL3RA) to the X-Y pseudoautosomal region at bands Xp22.3 and Yp11.3, near the gene for the alpha-subunit of the CSF2 receptor (CSF2RA). The CSF2RA and IL3RA genes arc so close that their order could not bc determined by two-color interphase in situ hybridization. They share PFGE fragments generated by different restriction enzymes down to the 50-100-kb size range. Pseudoautosomal inheritance was demonstrated by an EcoRI RFLP detected with the IL3RA cDNA probe.	STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305; DNAX RES INST MOLEC & CELLULAR BIOL INC,MOLEC & CELLULAR BIOL RES INST,DEPT MOLEC BIOL,PALO ALTO,CA	Howard Hughes Medical Institute; Stanford University; Stanford University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.			Kitamura, Toshio/AAA-2071-2021		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008404] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00298] Funding Source: Medline; NIGMS NIH HHS [T32 GM08404] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BARDY PG, 1992, LEUKEMIA, V6, P893; BUDEL LM, 1990, BLOOD, V75, P1439; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; GESNER TG, 1988, J CELL PHYSIOL, V136, P493, DOI 10.1002/jcp.1041360314; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; JUST W, 1992, HUM GENET, V89, P240; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KUWAKI T, 1989, BIOCHEM BIOPH RES CO, V161, P16, DOI 10.1016/0006-291X(89)91553-2; LEHRACH H., 1990, GENOME ANAL, P39; LIPPE B, 1991, ENDOCRIN METAB CLIN, V20, P121, DOI 10.1016/S0889-8529(18)30284-6; MASSA G, 1992, EUR J PEDIATR, V151, P893, DOI 10.1007/BF01954124; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; METCALF D, 1986, BLOOD, V67, P257; MILATOVICH A, 1991, GENOMICS, V11, P1040, DOI 10.1016/0888-7543(91)90030-I; Milatovich Athena, 1992, Human Molecular Genetics, V1, P681, DOI 10.1093/hmg/1.9.681; MITELMAN F, 1991, CATALOG CHROMOSOME A; MIYAJIMA A, 1992, TRENDS BIOCHEM SCI, V17, P378, DOI 10.1016/0968-0004(92)90004-S; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; NUSBAUM NJ, 1992, MED HYPOTHESES, V39, P156, DOI 10.1016/0306-9877(92)90178-F; PARK LS, 1989, BLOOD, V74, P56; RAPPOLD G, 1992, GENOMICS, V14, P455, DOI 10.1016/S0888-7543(05)80241-1; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SCHIEBEL K, 1993, NAT GENET, V3, P82, DOI 10.1038/ng0193-82; SCHRADER JW, 1986, ANNU REV IMMUNOL, V4, P205, DOI 10.1146/annurev.iy.04.040186.001225; SHEN Y, 1992, CYTOGENET CELL GENET, V61, P175, DOI 10.1159/000133401; SLIM R, 1993, GENOMICS, V16, P691, DOI 10.1006/geno.1993.1249; TAKAKI S, 1991, EMBO J, V10, P2833, DOI 10.1002/j.1460-2075.1991.tb07832.x; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TEMTAMY SA, 1992, CLIN GENET, V41, P147; THERMAN E, 1990, HUM GENET, V85, P175; WASMUTH JJ, 1991, CYTOGENET CELL GENET, V58, P261, DOI 10.1159/000133165; YI HF, 1993, HUM MOL GENET, V2, P127, DOI 10.1093/hmg/2.2.127	46	45	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1146	1153						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213838				2022-12-18	WOS:A1993MC33300019
J	MILEWICZ, DM; WITZ, AM; SMITH, ACM; MANCHESTER, DK; WALDSTEIN, G; BYERS, PH				MILEWICZ, DM; WITZ, AM; SMITH, ACM; MANCHESTER, DK; WALDSTEIN, G; BYERS, PH			PARENTAL SOMATIC AND GERM-LINE MOSAICISM FOR A MULTIEXON DELETION WITH UNUSUAL END-POINTS IN A TYPE-III COLLAGEN (COL3A1) ALLELE PRODUCES EHLERS-DANLOS SYNDROME TYPE-IV IN THE HETEROZYGOUS OFFSPRING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; LETHAL OSTEOGENESIS IMPERFECTA; SINGLE BASE MUTATION; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; PROCOLLAGEN GENE COL3A1; 3 AFFECTED SIBLINGS; INTRAGENIC DELETION; GONADAL MOSAICISM; AORTIC-ANEURYSMS; CROUZON SYNDROME	Ehlers-Danlos syndrome (EDS) type IV is a dominantly inherited disorder that results from mutations in the type III collagen gene (COL3A1). We studied the structure of the COL3A1 gene of an individual with EDS type IV and that of her phenotypically normal parents. The proband was heterozygous for a 2-kb deletion in COL3A1, while her father was mosaic for the same deletion in somatic and germ cells. In fibroblasts from the father, approximately two-fifths of the COL3A1 alleles carried the deletion, but only 10%,of the COL3A1 alleles in white blood cells were of the mutant species. The deletion in the mutant allele extended from intron 7 into intron 11. There was a 12-bp direct repeat in intron 7 and intron 11, the latter about 60 bp 5' to the junction. At the breakpoint there was a duplication of 10 bp from intron 11 separated by an insertion of 4 bp contained within the duplicated sequence. The father was mosaic for the deletion so that the gene rearrangement occurred during his early embryonic development prior to lineage allocation. These findings suggest that at least some of the deletions seen in human genes may occur during replication, rather than as a consequence of meiotic crossing-over, and that they thus have a risk for recurrence when observed de novo.	UNIV WASHINGTON,DEPT PATHOL,SM-30,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; CHILDRENS HOSP,DIV GENET SERV,DENVER,CO 80218; CHILDRENS HOSP,DEPT PATHOL,DENVER,CO 80218	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Colorado; Children's Hospital Colorado				Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR21557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; ALLANSON JE, 1986, CLIN GENET, V29, P429; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BALLABIO A, 1989, GENOMICS, V4, P36, DOI 10.1016/0888-7543(89)90311-X; BARSH GS, 1985, P NATL ACAD SCI USA, V82, P2870, DOI 10.1073/pnas.82.9.2870; Beighton PH, 1970, EHLERS DANLOS SYNDRO; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BRADLEY TB, 1980, JOHNS HOPKINS MED J, V146, P236; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; CHEN SH, 1990, AM J HUM GENET, V47, P1020; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHU ML, 1985, J BIOL CHEM, V260, P691; COHN DH, 1990, AM J HUM GENET, V46, P591; COLE WG, 1990, J BIOL CHEM, V265, P17070; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DAVID TJ, 1972, J MED GENET, V9, P316, DOI 10.1136/jmg.9.3.316; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; EDWARDS JH, 1986, J MED GENET, V23, P521, DOI 10.1136/jmg.23.6.521; FRYNS JP, 1983, CLIN GENET, V24, P156; GITSCHIER J, 1989, LANCET, V1, P273; HALL JG, 1988, AM J HUM GENET, V43, P355; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HARTL DL, 1971, AM J HUM GENET, V24, P124; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; HIGUCHI M, 1988, MOL BIOL MED, V5, P23; JOHNSON PH, 1992, J INHERIT METAB DIS, V15, P426, DOI 10.1007/BF02435995; KONTUSAARI S, 1990, J CLIN INVEST, V86, P1465, DOI 10.1172/JCI114863; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KONTUSAARI S, 1992, AM J HUM GENET, V51, P497; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LEBO RV, 1990, AM J MED GENET, V37, P187, DOI 10.1002/ajmg.1320370206; LEE B, 1991, J BIOL CHEM, V266, P5256; LEE B, 1991, AM J HUM GENET, V48, P511; LEGIUS E, 1990, CLIN GENET, V38, P155; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; MADDALENA A, 1988, NEW ENGL J MED, V319, P999, DOI 10.1056/NEJM198810133191507; Maniatis T., 1982, MOL CLONING; MURRAY EW, 1992, AM J HUM GENET, V50, P199; NAVARRETE C, 1991, CLIN GENET, V40, P29; POPE FM, 1988, CLIN EXP DERMATOL, V13, P285, DOI 10.1111/j.1365-2230.1988.tb00709.x; RICHARDS AJ, 1992, HUM GENET, V88, P325, DOI 10.1007/BF00197268; RICHARDS AJ, 1991, J MED GENET, V28, P458, DOI 10.1136/jmg.28.7.458; ROLLNICK BR, 1988, CLIN GENET, V33, P145; RUDD NL, 1983, LANCET, V1, P50; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO LJ, 1989, P NATL ACAD SCI USA, V86, P8477, DOI 10.1073/pnas.86.21.8477; SOLERA J, 1992, AM J HUM GENET, V50, P434; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; TROMP G, 1989, J BIOL CHEM, V264, P1349; TROMP G, 1989, J BIOL CHEM, V264, P19313; TSIPOURAS P, 1986, HUM GENET, V74, P41; VISSING H, 1991, J BIOL CHEM, V266, P5244; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; WEINREB A, 1990, J BIOL CHEM, V265, P1352; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; WILLING MC, 1988, J BIOL CHEM, V263, P8398; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677	69	45	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					62	70						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317500				2022-12-18	WOS:A1993LJ38500009
J	SMITH, SA; EASTON, DF; FORD, D; PETO, J; ANDERSON, K; AVERILL, D; STRATTON, M; PONDER, M; PYE, C; PONDER, BAJ				SMITH, SA; EASTON, DF; FORD, D; PETO, J; ANDERSON, K; AVERILL, D; STRATTON, M; PONDER, M; PYE, C; PONDER, BAJ			GENETIC-HETEROGENEITY AND LOCALIZATION OF A FAMILIAL BREAST-OVARIAN CANCER GENE ON CHROMOSOME 17Q12-Q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS	In a study of 31 breast cancer families and 12 breast-ovarian cancer families, we have obtained clear evidence of linkage to markers on chromosome 17q in the families with ovarian cancer (maximum lod score 3.34 at theta = .04) but only weak evidence in those without ovarian cancer. Recombinant events indicate that the gene lies between D17S588 and D17S250.	UNIV CAMBRIDGE,DEPT PATHOL,CANC RES CAMPAIGN HUMAN CANC GENET RES GRP,TENNIS COURT RD,CAMBRIDGE CB2 1QP,ENGLAND; INST CANC RES,EPIDEMIOL SECT,SUTTON SM2 5PX,SURREY,ENGLAND; INST CANC RES,MOLEC CARCINOGENESIS SECT,SUTTON SM2 5PX,SURREY,ENGLAND	University of Cambridge; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK								EASTON DF, 1993, AM J HUM GENET, V52, P678; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NAROD SA, 1991, LANCET, V338, P82; OTT J, 1985, ANAL HUMAN GENETIC L; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; Smith CAB, 1961, P SEC INT C HUM GENE, V1, P212; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	9	45	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					767	776						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460642				2022-12-18	WOS:A1993KY05900016
J	FISHER, CW; FISHER, CR; CHUANG, JL; LAU, KS; CHUANG, DT; COX, RP				FISHER, CW; FISHER, CR; CHUANG, JL; LAU, KS; CHUANG, DT; COX, RP			OCCURRENCE OF A 2-BP (AT) DELETION ALLELE AND A NONSENSE (G-TO-T) MUTANT ALLELE AT THE E2 (DBT) LOCUS OF 6 PATIENTS WITH MAPLE SYRUP URINE DISEASE - MULTIPLE-EXON SKIPPING AS A SECONDARY EFFECT OF THE MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID DEHYDROGENASE COMPLEX; DIHYDROLIPOYL TRANSACYLASE COMPONENT; BRANCHED-CHAIN ACYLTRANSFERASE; MESSENGER-RNA; BOVINE LIVER; SUBUNIT STRUCTURE; LIPOYL-BEARING; CORE DOMAIN; CDNA; GENE	We have identified two novel mutant alleles in the transacylase (E2) gene of the human branched-chain alpha-keto acid dehydrogenase (BCKAD) complex in 6 of 38 patients with maple syrup urine disease (MSUD). One mutation, a 2-bp (AT) deletion in exon 2 of the E2 gene, causes a frameshift downstream of residue (-26) in the mitochondrial targeting presequence. The second mutation, a G-to-T transversion in exon 6 of the E2 gene, produces a premature stop codon at Glu-163 (E163*). Transfection of constructs harboring the E163* mutation into an E2-deficient MSUD cell line produced a truncated E2 subunit. However, this mutant E2 chain is unable to assemble into a 24-mer cubic structure and is degraded in the cell. The 2-bp (AT) deletion and the E163* mutant alleles occur in either the homozygous or compound-heterozygous state in the 6 of 38 unrelated MSUD patients studied. Moreover, an array of precise single- and multiple-exon deletions were observed in many amplified E2 mutant cDNAs. The latter results appear to represent secondary effects on RNA processing that are associated with the MSUD mutations at the E2 locus.	UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,5323 HARRY HINES BLVD,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75230	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIDDK NIH HHS [DK-26758] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Battey, 1986, BASIC METHODS MOL BI; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUANG DT, 1981, BIOCHEM J, V200, P59, DOI 10.1042/bj2000059; CHUANG DT, 1985, J BIOL CHEM, V260, P3779; DANNER DJ, 1989, METABOLIC BASIS INHE, V1, P671; EISENSTEIN RS, 1991, J INHERIT METAB DIS, V14, P37, DOI 10.1007/BF01804386; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER CR, 1991, J CLIN INVEST, V88, P1034, DOI 10.1172/JCI115363; FISHER CW, 1989, J BIOL CHEM, V264, P3448; FISHER CW, 1991, BIOCHEM BIOPH RES CO, V174, P804, DOI 10.1016/0006-291X(91)91489-Y; GRIFFIN TA, 1988, J BIOL CHEM, V263, P14008; HARRISON B, 1986, ANAL BIOCHEM, V158, P307, DOI 10.1016/0003-2697(86)90555-5; HERRING WJ, 1991, AM J HUM GENET, V48, P342; HU CWC, 1986, J BIOL CHEM, V261, P343; LAU KS, 1988, BIOCHEMISTRY-US, V27, P1972, DOI 10.1021/bi00406a025; LAU KS, 1992, J BIOL CHEM, V267, P24090; MARGOLSKEE RF, 1988, MOL CELL BIOL, V8, P2837, DOI 10.1128/MCB.8.7.2837; MATSUO M, 1992, BIOCHEM BIOPH RES CO, V182, P495, DOI 10.1016/0006-291X(92)91759-J; MENKES JH, 1954, PEDIATRICS, V14, P462; MILES JS, 1987, BIOCHEM J, V245, P869, DOI 10.1042/bj2450869; MITSUBUCHI H, 1991, J CLIN INVEST, V87, P1207, DOI 10.1172/JCI115120; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; RANDLE PJ, 1984, ENZYME REGULATION RE, P1; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROCHE TE, 1972, BIOCHEM BIOPH RES CO, V8, P840; SOMASEKHAR MB, 1985, NUCLEIC ACIDS RES, V13, P5591, DOI 10.1093/nar/13.15.5591; WYNN RM, 1992, J BIOL CHEM, V267, P1881; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZNEIMER SM, 1991, GENOMICS, V10, P740, DOI 10.1016/0888-7543(91)90458-Q	30	45	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					414	424						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430702				2022-12-18	WOS:A1993KN27500020
J	RYAN, SG; DIXON, MJ; NIGRO, MA; KELTS, KA; MARKAND, ON; TERRY, JC; SHIANG, R; WASMUTH, JJ; OCONNELL, P				RYAN, SG; DIXON, MJ; NIGRO, MA; KELTS, KA; MARKAND, ON; TERRY, JC; SHIANG, R; WASMUTH, JJ; OCONNELL, P			GENETIC AND RADIATION HYBRID MAPPING OF THE HYPEREKPLEXIA REGION ON CHROMOSOME 5Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STIFF-MAN SYNDROME; STARTLE DISEASE; DNA POLYMORPHISMS; RECEPTOR GENES; LOCALIZATION; HYPEREXPLEXIA; CDNAS; FMS; SELECTION; DISORDER	Hyperekplexia, or startle disease (STHE), is an autosomal dominant neurologic disorder characterized by muscular rigidity of central nervous system origin, particularly in the neonatal period, and by an exaggerated startle response to sudden, unexpected acoustic or tactile stimuli. STHE responds dramatically to the benzodiazepine drug clonazepam, which acts at gamma-aminobutyric acid type A (GABA-A) receptors. The STHE locus (STHE) was recently assigned to chromosome 5q, on the basis of tight linkage to the colony-stimulating factor 1-receptor (CSF1-R) locus in a single large family. We performed linkage analysis in the original and three additional STHE pedigrees with eight chromosome 5q microsatellite markers and placed several of the most closely linked markers on an existing radiation hybrid (RH) map of the region. The results provide strong evidence for genetic locus homogeneity and assign STHE to a 5.9-cM interval defined by CSF1-R and D5S379, which are separated by an RH map distance of 74 centirays (roughly 2.2-3.7 Mb). Two polymorphic markers (D5S119 and D5S209) lie within this region, but they could not be ordered with respect to STHE. RH mapping eliminated the candidate genes GABRA1 and GABRG2, which encode GABA-A receptor components, by showing that they are telomeric to the target region.	UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284; UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PL,LANCS,ENGLAND; WAYNE STATE UNIV,SCH MED,DEPT PEDIAT,DETROIT,MI 48201; INDIANA UNIV,SCH MED,DEPT NEUROL,INDIANAPOLIS,IN 46202; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	University of Texas System; University of Texas Health San Antonio; University of Manchester; Wayne State University; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Irvine	RYAN, SG (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000320] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00320] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDERMANN F, 1980, BRAIN, V103, P985, DOI 10.1093/brain/103.4.985; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BROWN P, 1991, BRAIN, V114, P1903, DOI 10.1093/brain/114.4.1903; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DANA SL, 1985, SOMAT CELL MOLEC GEN, V11, P625, DOI 10.1007/BF01534727; DOOLEY JM, 1989, PEDIATR NEUROL, V5, P126, DOI 10.1016/0887-8994(89)90041-6; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GROFFEN J, 1983, NUCLEIC ACIDS RES, V11, P6331, DOI 10.1093/nar/11.18.6331; HAYASHI T, 1991, AM J MED GENET, V40, P138, DOI 10.1002/ajmg.1320400203; KELTS KA, 1988, ANN NEUROL, V24, P309; KIRSTEIN L, 1958, ACTA PSYCH NEUROL, V33, P471, DOI 10.1111/j.1600-0447.1958.tb03533.x; KLEIN R, 1972, AM J DIS CHILD, V124, P730, DOI 10.1001/archpedi.1972.02110170108018; KURCZYNSKI TW, 1983, ARCH NEUROL-CHICAGO, V40, P246, DOI 10.1001/archneur.1983.04050040076015; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBEAU MM, 1986, SCIENCE, V231, P984, DOI 10.1126/science.3484837; LINGAM S, 1981, AM J DIS CHILD, V135, P909, DOI 10.1001/archpedi.1981.02130340021008; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MAISON FG, 1990, MUSCLE NERVE, V13, P877; MARKAND ON, 1984, ARCH NEUROL-CHICAGO, V41, P71, DOI 10.1001/archneur.1984.04050130077028; MATSUMOTO J, 1992, ANN NEUROL, V32, P41, DOI 10.1002/ana.410320108; MORLEY DJ, 1982, CLIN GENET, V21, P388; MOSS SJ, 1991, NEUROSCI LETT, V123, P265, DOI 10.1016/0304-3940(91)90947-R; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NIGRO MA, 1992, PEDIATR NEUROL, V8, P221, DOI 10.1016/0887-8994(92)90073-8; OTT J, 1978, ANN HUM GENET, V42, P225; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P1160, DOI 10.1093/nar/19.5.1160-a; PUCKETT C, 1991, P NATL ACAD SCI USA, V88, P7557, DOI 10.1073/pnas.88.17.7557; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; SABL JF, 1992, AM J HUM GENET, V50, P1171; Sambrook J., 1989, MOL CLONING LAB MANU; SANDER JE, 1980, ANN NEUROL, V8, P195, DOI 10.1002/ana.410080212; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPEER MC, 1992, AM J HUM GENET, V50, P1211; STEPHENSON JBP, 1980, ARCH DIS CHILD, V55, P907; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; SUNUHARA RK, 1990, NATURE, V347, P80; VILLARREAL XC, 1989, BIOCHEMISTRY-US, V28, P6483, DOI 10.1021/bi00441a049; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WARRINGTON JA, 1991, GENOMICS, V11, P701, DOI 10.1016/0888-7543(91)90078-S; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516	45	45	46	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1334	1343						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1334371				2022-12-18	WOS:A1992KC99500015
J	GORSKI, SM; ADAMS, KJ; BIRCH, PH; FRIEDMAN, JM; GOODFELLOW, PJ				GORSKI, SM; ADAMS, KJ; BIRCH, PH; FRIEDMAN, JM; GOODFELLOW, PJ			THE GENE RESPONSIBLE FOR X-LINKED CLEFT-PALATE (CPX) IN A BRITISH-COLUMBIA NATIVE KINDRED IS LOCALIZED BETWEEN PGK1 AND DXYS1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MENTAL-RETARDATION; CHROMOSOME; CHOROIDEREMIA; DELETION; COMMITTEE; FAMILY; DEAFNESS; HUMANS; XQ21	Human craniofacial malformations are a class of common congenital anomalies in which the etiology is heterogeneous and often poorly understood. To better delineate the molecular basis of craniofacial development, we have undertaken a series of experiments directed toward the isolation of a gene involved in human secondary palate formation. DNA marker linkage studies have been performed in a large British Columbia (B.C.) Native family in which cleft palate segregates as an X-linked trait. We have examined 62 family members, including 15 affected males and 8 obligate carrier females. A previous clinical description of the clefting defect in this kindred included submucous cleft palate and bifid or absent uvula. Our recent reevaluation of the family has indicated that ankyloglossia (tongue-tic) is also a feature of X-linked cleft palate in some of the affected males and carrier females. Ankyloglossia has previously been associated with X-linked cleft palate in an Icelandic kindred in which a gene responsible for cleft palate (CPX) was assigned to the Xq21.3-q22 region between DXYS12 and DXS17. For the B.C. kindred reported here, we have mapped the gene responsible for cleft palate and/or ankyloglossia to a more proximal position on the X chromosome. No recombination was observed between B.C. CPX and the DNA marker DXS72 (peak lod score [Z(max)] = 7.44 at recombination fraction [theta] = .0) localized to Xq21.1. Recombination was observed between CPX and PGK1(Z(max) = 7.35 at theta = .03) and between CPX and DXYS1 (Z(max) = 5.59 at theta = .04). These recombination events localize B.C. CPX between PGK1 and DXYS1 in the Xq13-q21.31 region.	UNIV BRITISH COLUMBIA,DEPT MED,226 WESBROOK BLDG,6174 UNIV BLVD,VANCOUVER V6T 1Z3,BC,CANADA	University of British Columbia			Gorski, Sharon M/E-9375-2012	Gorski, Sharon M/0000-0002-3821-8289; Birch, Patricia/0000-0003-3831-2344; Friedman, Jan/0000-0002-7482-9570				BIXLER D, 1987, AM J MED GENET, V28, P503, DOI 10.1002/ajmg.1320280229; BJORNSSON A, 1989, CLEFT PALATE J, V26, P3; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; DIEWERT VM, 1981, TERATOLOGY, V24, P149, DOI 10.1002/tera.1420240206; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER FC, 1980, CURRENT RES TRENDS P, P357; Haldane JBS, 1919, J GENET, V8, P299; HALL B D, 1987, American Journal of Medical Genetics, V26, P239, DOI 10.1002/ajmg.1320260140; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; IVENS A, 1988, HUM GENET, V78, P356, DOI 10.1007/BF00291735; JENKINS M, 1980, HUM GENET, V53, P341, DOI 10.1007/BF00287053; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KEATS BJB, 1990, CYTOGENET CELL GENET, V55, P387, DOI 10.1159/000133023; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LECK I, 1984, BRIT MED BULL, V40, P390, DOI 10.1093/oxfordjournals.bmb.a072010; LOWRY R B, 1971, Birth Defects Original Article Series, V7, P76; LOWRY RB, 1970, PEDIATRICS, V46, P123; LOWRY RB, 1989, CAN MED ASSOC J, V140, P1167; LOWRY RB, 1973, CAN MED ASSOC J, V109, P995; LUTY JA, 1990, AM J HUM GENET, V46, P776; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Maniatis T, 1989, DECONTAMINATION DILU; MCWILLIAMS BJ, 1991, CLEFT PALATE CRANIOF, V628, P247; MELNICK M, 1980, ETIOLOGY CLEFT LIP C; MERRY DE, 1989, AM J HUM GENET, V45, P530; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MOORE GE, 1990, CLEFT PALATE J, V27, P131, DOI 10.1597/1545-1569(1990)027<0131:XCGIIT>2.3.CO;2; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; PUCK JM, 1991, CYTOGENET CELL GENET, V58, P2082; ROLLNICK BR, 1986, AM J MED GENET, V24, P465, DOI 10.1002/ajmg.1320240309; RUSHTON AR, 1979, HUM GENET, V48, P179, DOI 10.1007/BF00286901; Sperber G. H, 1989, CRANIOFACIAL EMBRYOL; TABOR A, 1983, HUM GENET, V64, P196, DOI 10.1007/BF00327127; WEATHERL.RC, 1972, PLAST RECONSTR SURG, V49, P297, DOI 10.1097/00006534-197203000-00010; WILLIAMSON R, 1990, CYTOGENET CELL GENET, V55, P457, DOI 10.1159/000133027	38	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1129	1136						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570839				2022-12-18	WOS:A1992HR47300028
J	LARSSON, NG; EIKEN, HG; BOMAN, H; HOLME, E; OLDFORS, A; TULINIUS, MH				LARSSON, NG; EIKEN, HG; BOMAN, H; HOLME, E; OLDFORS, A; TULINIUS, MH			LACK OF TRANSMISSION OF DELETED MTDNA FROM A WOMAN WITH KEARNS-SAYRE SYNDROME TO HER CHILD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DELETIONS; TISSUE DISTRIBUTION; SEGREGATION; MUTATION; DISEASE	We have investigated the daughter of a woman with Kearns-Sayre syndrome. The woman had a high percentage of deleted mtDNA in muscle, but no deleted mtDNA was detected in fibroblasts, bone marrow, and peripheral blood cells by Southern blot analysis. With PCR, analytical sensitivity was significantly increased, and deleted mtDNA was detected in all examined tissues from this patient. The patient had healthy parents and nine healthy siblings. No deleted mtDNA was detected in blood from the mother of the patient. The patient had an uneventful pregnancy and delivered at term. Deleted mtDNA could not be detected in placenta by Southern blot analysis. With PCR, deleted mtDNA was detected in the majority of placental specimens. This finding may, however, be due to contamination with maternal DNA. The patient's daughter was healthy at age 5 mo, and morphologic examination of muscle was normal. No transmission of deleted mtDNA to the daughter could be detected by Southern blot and PCR analysis of peripheral blood cells, bone marrow, fibroblasts, and muscle. The presence of deleted mtDNA was excluded at a fractional level of less than 1:100,000 in all examined tissues from the daughter.	GOTHENBURG UNIV,DEPT CLIN CHEM,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT PATHOL,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT PEDIAT,S-41124 GOTHENBURG,SWEDEN; UNIV BERGEN,DEPT MED GENET,N-5014 BERGEN,NORWAY	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Bergen			Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Eiken, Hans Geir/0000-0002-5368-3648; Oldfors, Anders/0000-0002-5758-7397				ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; MCSHANE MA, 1991, AM J HUM GENET, V48, P39; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; POULTON J, 1991, AM J HUM GENET, V48, P649; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; ROWLAND LP, 1988, NEUROLOGY, V38, P1399, DOI 10.1212/WNL.38.9.1399; SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6; VILKKI J, 1990, AM J HUM GENET, V47, P95; ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118	14	45	47	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					360	363						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734716				2022-12-18	WOS:A1992HD00100011
J	RYYNANEN, M; KNOWLTON, RG; UITTO, J				RYYNANEN, M; KNOWLTON, RG; UITTO, J			MAPPING OF EPIDERMOLYSIS-BULLOSA SIMPLEX MUTATION TO CHROMOSOME-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENE COL2A1; LINKAGE ANALYSIS; KERATIN GENES; MARKERS; FAMILY; LOCUS	Epidermolysis bullosa simplex (EBS) is a dominantly inherited genodermatosis characterized by intraepidermal blister formation. Recent reports have suggested that EBS mutations may relate to keratin abnormalities. In this study, we conducted RFLP analyses to test the hypothesis that EBS is linked to one of the keratin gene clusters on chromosome 12 or chromosome 17. Although these keratin gene loci are not defined by RFLPs, several mapped RFLPs in the same chromosomal regions could be tested for linkage. A large EBS family with 14 affected and 12 unaffected individuals in three generations was analyzed for RFLP inheritance. Within this family there was no evidence for linkage of the EBS mutation to markers on chromosome 17q. However, there was evidence for close linkage to D12S17 located on chromosome 12q, with a maximum LOD score of 5.55 at theta = 0. Mapping of this mutation to chromosome 12 defines an EBS locus distinct from both EBS1 (Ogna) and EBS2 (Koebner), which are on chromosomes 8 and 1, respectively. Further mapping will determine whether this EBS locus on chromosome 12 resides within the keratin gene cluster at 12q11-q13.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL,DEPT DERMATOL,1020 LOCUST ST, ROOM M-46 JAH, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON INST MOLEC MED, MOLEC DERMATOL SECT, PHILADELPHIA, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University					NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BADER BL, 1988, EUR J CELL BIOL, V47, P300; BARLETTA C, 1990, CYTOGENET CELL GENET, V54, P148, DOI 10.1159/000132979; BONIFAS JM, 1991, J INVEST DERMATOL, V96, P550; BRIGGAMAN RA, 1985, J INVEST DERMATOL, V84, P371, DOI 10.1111/1523-1747.ep12265450; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; Gedde-Dahl T Jr, 1981, Acta Derm Venereol Suppl (Stockh), V95, P74; HUMPHRIES M, 1990, J INVEST DERMATOL, V95, P568, DOI 10.1111/1523-1747.ep12505546; HUMPHRIES MM, 1990, GENOMICS, V7, P377, DOI 10.1016/0888-7543(90)90171-P; ITO M, 1991, ARCH DERMATOL, V127, P367, DOI 10.1001/archderm.127.3.367; KERO M, 1984, ACTA DERM-VENEREOL, P1; KNOWLTON RG, 1989, AM J HUM GENET, V45, P681; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAW ML, 1986, ANN HUM GENET, V50, P131, DOI 10.1111/j.1469-1809.1986.tb01031.x; LESSIN SR, 1988, J INVEST DERMATOL, V91, P572, DOI 10.1111/1523-1747.ep12477087; McKusick VA, 1990, MENDELIAN INHERITANC; MULLEY JC, 1984, AM J MED GENET, V19, P573, DOI 10.1002/ajmg.1320190320; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P779, DOI 10.1093/nar/16.2.779; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OLAISEN B, 1973, HUM HERED, V23, P189, DOI 10.1159/000152573; OTT J, 1974, AM J HUM GENET, V26, P566; POPESCU NC, 1989, HUM GENET, V82, P109, DOI 10.1007/BF00284039; ROMANO V, 1988, CYTOGENET CELL GENET, V48, P148, DOI 10.1159/000132612; ROPERS HH, 1989, CYTOGENET CELL GENET, V51, P259, DOI 10.1159/000132794; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; TAKAHASHI E, 1990, HUM GENET, V86, P14; TSUI LC, 1985, CYTOGENET CELL GENET, V40, P764; UITTO J, 1989, J INVEST DERMATOL, V92, pS61, DOI 10.1111/1523-1747.ep13075039; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WASEEM A, 1990, GENOMICS, V7, P188, DOI 10.1016/0888-7543(90)90540-B; WEAVER EJ, 1989, CYTOGENET CELL GENET, V51, P1103	31	45	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					978	984						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1718160				2022-12-18	WOS:A1991GM87300009
J	COLEMAN, M; BHATTACHARYA, S; LINDSAY, S; WRIGHT, A; JAY, M; LITT, M; CRAIG, I; DAVIES, K				COLEMAN, M; BHATTACHARYA, S; LINDSAY, S; WRIGHT, A; JAY, M; LITT, M; CRAIG, I; DAVIES, K			LOCALIZATION OF THE MICROSATELLITE PROBE DXS426 BETWEEN DXS7 AND DXS255 ON XP AND LINKAGE TO X-LINKED RETINITIS-PIGMENTOSA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OXFORD,INST MOLEC GENET,OXFORD,ENGLAND; UNIV OXFORD,DEPT GENET,OXFORD,ENGLAND; UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; MRC,HUMAN GENET UNIT,EDINBURGH,SCOTLAND; MOORFIELDS EYE HOSP,LONDON WC1V 7AN,ENGLAND; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MED GENET,PORTLAND,OR 97201	University of Oxford; University of Oxford; Newcastle University - UK; University of Edinburgh; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Oregon Health & Science University			Craig, Ian/AAF-9167-2019	Lindsay, Susan/0000-0003-2980-4582; Craig, Ian/0000-0002-4063-1005	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARDEN GB, 1983, BRIT J OPHTHALMOL, V67, P419, DOI 10.1136/bjo.67.7.419; BERSON EL, 1979, AM J OPHTHALMOL, V87, P460, DOI 10.1016/0002-9394(79)90231-9; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; CHEN JD, 1989, CLIN GENET, V35, P338; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; FORREST SM, 1987, CYTOGENET CELL GENET, V46, P615; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRIEDRICH U, 1985, HUM GENET, V71, P93; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; INGLE C, 1985, AM J HUM GENET, V37, P451; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LITT M, 1989, AM J HUM GENET, V44, P397; LUTY JA, 1989, CYTOGENET CELL GENET, V51, P1036; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MEITINGER T, 1989, HUM GENET, V81, P283; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; OTT J, 1974, AM J HUM GENET, V26, P588; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; WEBER JL, 1989, AM J HUM GENET, V44, P388; WRIGHT AF, 1983, T OPHTHAL SOC UK, V103, P467; WRIGHT AF, 1987, AM J HUM GENET, V41, P635	23	45	45	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					935	940						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	2239970				2022-12-18	WOS:A1990EK40000008
J	SHIELDS, ED; SCRIVER, CR; READE, T; FUJIWARA, TM; MORGAN, K; CIAMPI, A; SCHWARTZ, S				SHIELDS, ED; SCRIVER, CR; READE, T; FUJIWARA, TM; MORGAN, K; CIAMPI, A; SCHWARTZ, S			X-LINKED HYPOPHOSPHATEMIA - THE MUTANT-GENE IS EXPRESSED IN TEETH AS WELL AS IN KIDNEY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,FAC DENT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,FAC MED,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,FAC SCI,DEPT BIOL,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,FAC MED,DEPT EPIDEMIOL & BIOSTAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MONTREAL CHILDRENS HOSP,CTR HUMAN GENET,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,MONTREAL H3H 1P3,QUEBEC,CANADA; MONTREAL CHILDRENS HOSP,DEPT DENT,MONTREAL H3H 1P3,QUEBEC,CANADA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University								BELL CL, 1988, AM J HUM GENET, V43, P293; BERKMAN M D, 1971, Birth Defects Original Article Series, V7, P204; BHAKDINARONK A, 1981, ORAL SURG ORAL MED O, V51, P100, DOI 10.1016/0030-4220(81)90132-8; Bodecker CF., 1925, DENT COSMOS, V67, P543; BONEH A, 1987, AM J MED GENET, V27, P997, DOI 10.1002/ajmg.1320270434; BURNETT CH, 1964, AM J MED, V36, P222, DOI 10.1016/0002-9343(64)90085-3; COSTA T, 1981, J CLIN ENDOCR METAB, V52, P463, DOI 10.1210/jcem-52-3-463; COUVE E, 1986, ARCH ORAL BIOL, V31, P643, DOI 10.1016/0003-9969(86)90093-2; DEJONGE TE, 1950, PARONDONTOLOGIE, V93, P83; EDWARDS JH, 1989, ANN HUM GENET, V53, P33, DOI 10.1111/j.1469-1809.1989.tb01120.x; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; FRAME B, 1965, AM J MED, V38, P134, DOI 10.1016/0002-9343(65)90167-1; Fraser D, 1982, J Int Assoc Dent Child, V13, P1; FROST H M, 1958, Henry Ford Hosp Med Bull, V6, P300; GLORIEUX F, 1972, SCIENCE, V175, P997, DOI 10.1126/science.175.4025.997; GLORIEUX FH, 1972, NEW ENGL J MED, V287, P481, DOI 10.1056/NEJM197209072871003; GLORIEUX FH, 1987, CALCIUM REGULATION B, P227; GREENBERG BG, 1960, J CLIN ENDOCR METAB, V20, P364, DOI 10.1210/jcem-20-3-364; Jones S. J., 1984, DENTIN DENTINOGENESI, P81; KARJALAINEN S, 1984, DENTIN DENTINOGENESI, V2, P107; KAY MA, 1985, MINER ELECTROL METAB, V11, P374; KRUSE K, 1982, ARCH DIS CHILD, V57, P217, DOI 10.1136/adc.57.3.217; LUGINBUHL R, 1987, SAS STAT GUIDE PERSO; LUOSTARINEN V, 1971, P FINN DENT SOC S2, V67, P3; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P443, DOI 10.1007/BF02405074; MCNAIR SL, 1969, NEW ENGL J MED, V281, P511, DOI 10.1056/NEJM196909042811001; NIKIFORUK G, 1979, METAB BONE DIS RELAT, V2, P17, DOI 10.1016/0221-8747(79)90014-6; PHILIPPAS GG, 1966, J DENT RES, V45, P778, DOI 10.1177/00220345660450034701; Rasmussen H, 1989, METABOLIC BASIS INHE, P2581; SCHWARTZ S, 1988, ORAL SURG ORAL MED O, V66, P310, DOI 10.1016/0030-4220(88)90237-X; SCRIVER C R, 1988, American Journal of Human Genetics, V43, pA14; SCRIVER CR, 1981, ARCH DIS CHILD, V56, P203, DOI 10.1136/adc.56.3.203; SCRIVER CR, 1907, AM J MED GENET, V1, P101; SOFAER JA, 1982, ARCH ORAL BIOL, V27, P701, DOI 10.1016/0003-9969(82)90196-0; STEENDIJK R, 1965, NATURE, V207, P426, DOI 10.1038/207426a0; STICKLER GB, 1969, ACTA PAEDIATR SCAND, V58, P213, DOI 10.1111/j.1651-2227.1969.tb04709.x; TENENHOUSE HS, 1978, KIDNEY INT, V14, P236, DOI 10.1038/ki.1978.115; TENENHOUSE HS, 1985, ENDOCRINOLOGY, V117, P1719, DOI 10.1210/endo-117-5-1719; THAKKER RV, 1987, J MED GENET, V24, P756, DOI 10.1136/jmg.24.12.756; TRACY WE, 1971, ORAL SURG ORAL MED O, V32, P38, DOI 10.1016/0030-4220(71)90248-9; WINTERS RW, 1958, MEDICINE, V37, P97, DOI 10.1097/00005792-195805000-00001; WITKOP CJ, 1967, ORAL SURG ORAL MED O, V23, P174, DOI 10.1016/0030-4220(67)90092-8	43	45	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					434	442						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2155529				2022-12-18	WOS:A1990CT66800005
J	VANDERSPEK, JC; WYANDT, HE; SKARE, JC; MILUNSKY, A; OPPENHEIM, FG; TROXLER, RF				VANDERSPEK, JC; WYANDT, HE; SKARE, JC; MILUNSKY, A; OPPENHEIM, FG; TROXLER, RF			LOCALIZATION OF THE GENES FOR HISTATINS TO HUMAN CHROMOSOME-4Q13 AND TISSUE DISTRIBUTION OF THE MESSENGER-RNAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BOSTON UNIV,SCH MED,DEPT BIOCHEM,80 E CONCORD ST,BOSTON,MA 02118; BOSTON UNIV,SCH MED,CTR HUMAN GENET,BOSTON,MA 02118; GOLDMAN SCH GRAD DENT,DEPT ORAL BIOL,BOSTON,MA	Boston University; Boston University				Milunsky, Aubrey/0000-0003-2114-4823	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005672, R37DE005672] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE 05672, DE 07652] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 1985, INT SYSTEM HUMAN CYT; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALL SP, 1982, ANN HUM GENET, V46, P35, DOI 10.1111/j.1469-1809.1982.tb00693.x; Bixler D., 1976, ORAL FACIAL GENETICS, P227; BOACKLE RJ, 1980, BIOL BASIS DENTAL CA, P113; BOUGHMAN JA, 1986, J CRAN GENET DEV BIO, V6, P341; BOUGHMAN JA, 1987, J PERIODONTOL, V59, P332; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CONNEALLY PM, 1984, CYTOGENET CELL GENET, V37, P438; DAVIS LG, 1986, BASIC METHODS MOL BI, P62; DICKINSON DP, 1987, BIOCHEM BIOPH RES CO, V149, P784, DOI 10.1016/0006-291X(87)90436-0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOX PC, 1988, J AM DENT ASSOC, V116, P635, DOI 10.14219/jada.archive.1988.0002; HAY DI, 1973, ARCH ORAL BIOL, V18, P1517, DOI 10.1016/0003-9969(73)90127-1; HAY DI, 1984, J DENT RES, V63, P857, DOI 10.1177/00220345840630060901; HAY DI, 1975, ARCH ORAL BIOL, V20, P553, DOI 10.1016/0003-9969(75)90073-4; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KRILL DB, 1986, J PERIODONTOL, V58, P1; LPPENHEIM FG, 1986, J BIOL CHEM, V263, P7472; MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984; OPPENHEIM FG, 1987, J DENT RES, V66, P462, DOI 10.1177/00220345870660021301; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; SABATINI L M, 1988, American Journal of Human Genetics, V43, pA199; SABATINI LM, 1987, AM J HUM GENET, V41, P1048; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; YUNIS JJ, 1974, HUMAN CHROMOSOMAL ME	28	45	49	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					381	387						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2773933				2022-12-18	WOS:A1989AN87900007
J	BROOKS, BA; MCBRIDE, OW; DOLPHIN, CT; FARRALL, M; SCAMBLER, PJ; GONZALEZ, FJ; IDLE, JR				BROOKS, BA; MCBRIDE, OW; DOLPHIN, CT; FARRALL, M; SCAMBLER, PJ; GONZALEZ, FJ; IDLE, JR			THE GENE CYP3 ENCODING P450PCNI (NIFEDIPINE OXIDASE) IS TIGHTLY LINKED TO THE GENE COLIA2 ENCODING COLLAGEN TYPE-I-ALPHA ON 7Q21-Q22.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,DEPT PHARMACOL & TOXICOL,LONDON W2 1PG,ENGLAND; NCI,BIOCHEM LABS,BETHESDA,MD 20205; NCI,MOLEC CARCINOGENESIS LABS,BETHESDA,MD 20205	Imperial College London; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020; Idle, Jeff/B-1152-2012	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Idle, Jeff/0000-0002-6143-1520	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AYESH R, 1985, MICROSOMES DRUG OXID, P340; AYESH R, 1984, NATURE, V311, P167; BEAUNE PH, 1986, P NATL ACAD SCI USA, V83, P8064, DOI 10.1073/pnas.83.21.8064; BOOBIS AR, 1985, MICROSOMES DRUG OXID; CAPORASO N, 1987, P AN M AM SOC CLIN, V6, P229; DAYER P, 1987, BIOCHEM PHARMACOL, V36, P4145, DOI 10.1016/0006-2952(87)90573-9; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; EICHELBAUM M, 1984, FED PROC, V43, P2298; EVANS DAP, 1980, J MED GENET, V17, P102, DOI 10.1136/jmg.17.2.102; EVANS DAP, 1983, J MED GENET, V20, P321, DOI 10.1136/jmg.20.5.321; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GONZALEZ FJ, 1988, DNA-J MOLEC CELL BIO, V7, P79, DOI 10.1089/dna.1988.7.79; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969; IDLE JR, 1979, DRUG METAB REV, V9, P301, DOI 10.3109/03602537908993896; IDLE JR, 1983, BR MED J, V286, P178; IDLE JR, 1984, 2ND P WORLD C CLIN P, P148; KAISARY A, 1987, CANCER RES, V47, P5488; KLEINBLOESEM CH, 1984, BIOCHEM PHARMACOL, V33, P3721, DOI 10.1016/0006-2952(84)90165-5; KUPFER A, 1983, SEMIN LIVER DIS, V3, P341, DOI 10.1055/s-2008-1040786; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, AM J HUM GENET, V42, P38; MAHGOUB A, 1977, LANCET, V2, P548; MOLOWA DT, 1986, P NATL ACAD SCI USA, V83, P5311, DOI 10.1073/pnas.83.14.5311; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; SCHELLENS JHM, 1986, ACTA PHARM TOXICOL S, V5, P656; SPENCE MA, IN PRESS CYTOGENET C; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	29	45	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					280	284						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2901225				2022-12-18	WOS:A1988P884100008
J	JORDE, LB; LATHROP, GM				JORDE, LB; LATHROP, GM			A TEST OF THE HETEROZYGOTE-ADVANTAGE HYPOTHESIS IN CYSTIC-FIBROSIS CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	JORDE, LB (corresponding author), UNIV UTAH,SCH MED,DEPT HUMAN GENET,501 WINTROBE BLDG,50 N MED DR,SALT LAKE CITY,UT 84132, USA.							ANDERSON CM, 1966, MOD PROBL PEDIATR, V10, P381; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BOWCOCK AM, 1986, AM J HUM GENET, V39, P699; BRASS W, 1958, B INT STATIST INST, V36, P165; BURDICK AB, 1977, HUM HERED, V27, P366, DOI 10.1159/000152892; CASSANO WF, 1985, MED HYPOTHESES, V18, P51, DOI 10.1016/0306-9877(85)90119-7; CONNEALLY PM, 1973, TEX REP BIOL MED, V31, P639; CRAWFURD MD, 1972, HEREDITY, V29, P126; DANKS DM, 1984, AM J HUM GENET, V36, P1401; DANKS DM, 1965, ANN HUM GENET, V28, P323, DOI 10.1111/j.1469-1809.1965.tb00489.x; DANKS DM, 1983, AM J HUM GENET, V35, P838; EDWARDS JH, 1977, ARCH DIS CHILD, V52, P343, DOI 10.1136/adc.52.5.343; GEDSCHOLD J, 1987, HUM GENET, V75, P277, DOI 10.1007/BF00281074; GOODMAN HO, 1952, AM J HUM GENET, V4, P59; HALLETT WY, 1965, AM REV RESPIR DIS, V92, P714; HARRIS CJ, 1983, TXB CYSTIC FIBROSIS, P1; HOLLANDER DH, 1982, MED HYPOTHESES, V8, P191, DOI 10.1016/0306-9877(82)90102-5; KLINGER K, 1986, NUCLEIC ACIDS RES, V14, P8681, DOI 10.1093/nar/14.21.8681; KNUDSON AG, 1967, AM J HUM GENET, V19, P388; LANDER ES, 1986, AM J HUM GENET, V39, P282; MAYO O, 1970, ANN HUM GENET, V33, P307, DOI 10.1111/j.1469-1809.1970.tb01655.x; MEINDL RS, 1987, AM J PHYS ANTHROPOL, V74, P39, DOI 10.1002/ajpa.1330740104; PRITCHARD DJ, 1983, ARCH DIS CHILD, V58, P290, DOI 10.1136/adc.58.4.290; ROMEO G, 1986, AM J HUM GENET, V39, P283; ROMEO G, 1985, AM J HUM GENET, V37, P338; SCHAAP T, 1976, CYSTIC FIBROSIS PROJ, P291; SCHMIDTKE J, 1987, HUM GENET, V76, P337, DOI 10.1007/BF00272441; SHIER WT, 1979, MED HYPOTHESES, V5, P661, DOI 10.1016/0306-9877(79)90087-2; Siegel S, 1956, NONPARAMETRIC STATIS; Skolnick MH, 1980, BANBURY REPORT, P285, DOI DOI 10.1111/J.1365-2796.2006.01657.X; Sokal R.R., 1981, BIOMETRY PRINCIPLES; STEINBERG AG, 1960, AM J HUM GENET, V12, P416; STUART AB, 1974, LANCET, V2, P1521; SUPER M, 1979, CLIN GENET, V16, P65, DOI 10.1111/j.1399-0004.1979.tb00853.x; TENKATE LP, 1977, ANN HUM GENET, V40, P287; VITALE E, 1986, AM J HUM GENET, V39, P832; WATKINS PC, 1986, AM J HUM GENET, V39, P735; WHITE R, 1986, SCIENCE, V234, P1054, DOI 10.1126/science.3465037; WRIGHT SW, 1968, AM J HUM GENET, V20, P157; [No title captured]	40	45	45	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					808	815						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	3369446				2022-12-18	WOS:A1988N519700002
J	STOCKS, J; PAUL, H; GALTON, D				STOCKS, J; PAUL, H; GALTON, D			HAPLOTYPES IDENTIFIED BY DNA RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN THE A-1 C-III A-IV GENE REGION AND HYPERTRIGLYCERIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											STOCKS, J (corresponding author), ST BARTHOLOMEWS HOSP, DIABET & LIPID LAB, 51-53 BARTS CLOSE, LONDON EC1A 7BE, ENGLAND.		Harmatz, Paul/AAY-5866-2020	Harmatz, Paul/0000-0001-5603-2085				ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; FERNS GAA, 1985, LANCET, V2, P300; FIELDING CJ, 1972, BIOCHIM BIOPHYS ACTA, V270, P513, DOI 10.1016/0005-2760(72)90116-6; GALTON DJ, 1982, CLIN BIOCHEM REV, V3, P377; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KARATHANASIS SK, 1983, NATURE, V304, P371, DOI 10.1038/304371a0; KARATHANASIS SK, 1986, P NATL ACAD SCI USA, V82, P6347; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; PAUL H, 1987, HUM GENET, V75, P264, DOI 10.1007/BF00281071; PROTTER AA, 1984, DNA-J MOLEC CELL BIO, V3, P449, DOI 10.1089/dna.1.1984.3.449; REES A, 1985, ATHEROSCLEROSIS, V58, P269, DOI 10.1016/0021-9150(85)90072-3; REES A, 1986, HUM GENET, V72, P168; REES A, 1985, J CLIN INVEST, V76, P1090, DOI 10.1172/JCI112062; REES A, 1983, LANCET, V1, P444; SCOTT J, 1985, HUM GENET, V71, P144; SCOTT J, 1985, LANCET, V1, P771; SEILHAMER JJ, 1984, DNA-J MOLEC CELL BIO, V3, P309, DOI 10.1089/dna.1.1984.3.309; SHARPE CR, 1984, NUCLEIC ACIDS RES, V12, P3917, DOI 10.1093/nar/12.9.3917; SHARPE CR, 1985, THESIS U OXFORD; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WAINSCOAT JS, 1984, LANCET, V2, P1299; WEISGRABER KH, 1980, J CLIN INVEST, V66, P901, DOI 10.1172/JCI109957	25	45	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					106	118						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	2887109				2022-12-18	WOS:A1987J757500002
J	YANGFENG, TL; OPDENAKKER, G; VOLCKAERT, G; FRANCKE, U				YANGFENG, TL; OPDENAKKER, G; VOLCKAERT, G; FRANCKE, U			HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE LOCATED NEAR CHROMOSOMAL BREAKPOINT IN MYELOPROLIFERATIVE DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CATHOLIC UNIV LEUVEN,REGA INST MED RES,B-3000 LOUVAIN,BELGIUM	KU Leuven	YANGFENG, TL (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,POB 3333,NEW HAVEN,CT 06510, USA.		Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017	Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294	NIGMS NIH HHS [GM26105, GM-07439] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHINOFUSE H, 1984, P SOC EXP BIOL MED, V176, P109; ASTRUP T, 1966, FED PROC, V25, P42; BACHMANN F, 1984, SEMIN THROMB HEMOST, V10, P6, DOI 10.1055/s-2007-1004403; BANYAI L, 1983, FEBS LETT, V163, P37, DOI 10.1016/0014-5793(83)81157-0; BASS EB, 1983, ANN INTERN MED, V99, P192, DOI 10.7326/0003-4819-99-2-192; BASS F, 1984, HUM GENET, V67, P301; BENHAM FJ, 1985, MOL BIOL MED, V2, P251; BERGMANN SR, 1983, SCIENCE, V220, P1181; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; BUNNING RAD, 1985, OCT EMBO WORKSH PLAS; COLLEN D, 1984, CIRCULATION, V70, P1012, DOI 10.1161/01.CIR.70.6.1012; COLLEN D, 1982, THROMB HAEMOSTASIS, V48, P294; DEMARTINVILLE B, 1982, AM J HUM GENET, V34, P216; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FREIDHOFF F, 1983, CANCER GENET CYTOGEN, V9, P391; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HARRIS TJR, 1986, BIOL MED; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; KIMBERLING WJ, 1975, AM J HUM GENET, V27, P586; KUCHERLAPATI R, 1978, CELL, V15, P1331, DOI 10.1016/0092-8674(78)90058-2; LEWIS JP, 1983, AM J PEDIAT HEMATOL, V5, P265; MATSUO O, 1981, NATURE, V291, P591; MUNKE M, 1983, EUR J PEDIATR, V141, P8, DOI 10.1007/BF00445661; NOWAKOWSKI H, 1961, RECENT PROG HORM RES, V17, P53; NY T, 1984, P NATL ACAD SCI-BIOL, V81, P5355, DOI 10.1073/pnas.81.17.5355; OPDENAKKER G, 1982, EUR J BIOCHEM, V121, P269, DOI 10.1111/j.1432-1033.1982.tb05781.x; OPDENAKKER G, 1983, EUR J BIOCHEM, V131, P481, DOI 10.1111/j.1432-1033.1983.tb07287.x; OPDENAKKER G, 1985, BIOCHEM J, V231, P309, DOI 10.1042/bj2310309; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; PELTZ SW, 1983, ENDOCRINOLOGY, V112, P890, DOI 10.1210/endo-112-3-890; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; RAJPUT B, 1985, SCIENCE, V230, P672, DOI 10.1126/science.3840278; REICH E, 1978, BIOL MARKERS NEOPLAS, P491; RIJKEN DC, 1981, J BIOL CHEM, V256, P7035; SANTEN RJ, 1973, J CLIN ENDOCR METAB, V36, P47, DOI 10.1210/jcem-36-1-47; SCOTT RW, 1984, NATURE, V310, P562, DOI 10.1038/310562a0; Southern E, 1979, Methods Enzymol, V68, P152; The Thrombolysis In Myocardial Infarction (TIMI) trial, 1985, N ENGL J MED, V312, P932; TRIPPUTI P, 1985, P NATL ACAD SCI USA, V82, P4448, DOI 10.1073/pnas.82.13.4448; VANDEWERF F, 1984, CIRCULATION, V69, P605, DOI 10.1161/01.CIR.69.3.605; VANDEWERF F, 1984, NEW ENGL J MED, V310, P609; WEIMAR W, 1981, LANCET, V2, P1018; WIGLER M, 1976, NATURE, V259, P232, DOI 10.1038/259232a0; Wilson E L, 1985, Haematol Blood Transfus, V29, P197; WILSON EL, 1983, BLOOD, V61, P568; YANGFENG TL, 1986, SOMAT CELL MOLEC GEN, V12, P95, DOI 10.1007/BF01560732; 1985, BIRTH DEFECTS ORIG A, V21	49	45	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					79	87						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3092643				2022-12-18	WOS:A1986D961500007
J	HUEBNER, K; ISOBE, M; GASSON, JC; GOLDE, DW; CROCE, CM				HUEBNER, K; ISOBE, M; GASSON, JC; GOLDE, DW; CROCE, CM			LOCALIZATION OF THE GENE ENCODING HUMAN ERYTHROID-POTENTIATING ACTIVITY TO CHROMOSOME REGION XP11.1-]XP11.4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	HUEBNER, K (corresponding author), WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104, USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NCI NIH HHS [CA-16685, CA-21124, CA-10805] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA021124, R01CA016685] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CROCE CM, 1985, SCIENCE, V227, P1044, DOI 10.1126/science.3919442; CROCE CM, 1974, NATURE, V249, P839, DOI 10.1038/249839a0; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DANKS DM, 1971, LANCET, V2, P1089; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; ERIKSON J, 1985, SCIENCE, V229, P784, DOI 10.1126/science.3875152; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; GASSON JC, 1985, STEM CELL PHYSL, P95; GOLDE DW, 1980, P NATL ACAD SCI US, V77, P590; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HUEBNER K, 1985, P NATL ACAD SCI USA, V82, P3790, DOI 10.1073/pnas.82.11.3790; IHLE JN, 1983, J IMMUNOL, V131, P282; ISOBE M, 1985, P NATL ACAD SCI USA, V82, P5836, DOI 10.1073/pnas.82.17.5836; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MENKES JH, 1962, PEDIATRICS, V29, P764; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P6339, DOI 10.1073/pnas.78.10.6339; OBRIEN SJ, 1984, GENETIC MAPS, V3; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROPERS HH, 1983, HUM GENET, V65, P53, DOI 10.1007/BF00285028; ROWE DW, 1974, J EXP MED, V139, P180, DOI 10.1084/jem.139.1.180; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WESTBROOK CA, 1984, J BIOL CHEM, V259, P9992; WIENKER TF, 1983, HUM GENET, V65, P72, DOI 10.1007/BF00285032	24	45	45	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					819	826						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3460333				2022-12-18	WOS:A1986D392200004
J	SHIMIZU, K; HARANO, T; HARANO, K; MIWA, S; AMENOMORI, Y; OHBA, Y; KUTLAR, F; HUISMAN, THJ				SHIMIZU, K; HARANO, T; HARANO, K; MIWA, S; AMENOMORI, Y; OHBA, Y; KUTLAR, F; HUISMAN, THJ			ABNORMAL ARRANGEMENTS IN THE ALPHA-GLOBIN AND GAMMA-GLOBIN GENE CLUSTERS IN A RELATIVELY LARGE GROUP OF JAPANESE NEWBORNS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MED COLL GEORGIA, DEPT CELL & MOLEC BIOL, AUGUSTA, GA 30912 USA; KAWASAKI MED SCH, DEPT BIOCHEM & CHEM PATHOL, KURASHIKI, OKAYAMA 70101, JAPAN; UNIV TOKYO, INST MED SCI, TOKYO 113, JAPAN; YAMAGUCHI UNIV, SCH MED, DEPT CLIN PATHOL, UBE, YAMAGUCHI 755, JAPAN; JAPAN RED CROSS MED CTR, DEPT OBSTET, TOKYO, JAPAN	University System of Georgia; Augusta University; Kawasaki Medical School; University of Tokyo; Yamaguchi University; Japanese Red Cross Medical Center					NHLBI NIH HHS [HLB-05168, HLB-15158] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKSOY M, 1985, AM J HEMATOL, V20, P7, DOI 10.1002/ajh.2830200103; CHEN SS, 1985, HEMOGLOBIN, V9, P25, DOI 10.3109/03630268508996979; EMBURY SH, 1979, J CLIN INVEST, V63, P1307, DOI 10.1172/JCI109426; FELICE AE, 1984, BLOOD, V63, P1253; FUYUNO K, 1981, HEMOGLOBIN, V5, P139, DOI 10.3109/03630268108996920; GILMAN JG, 1984, BLOOD, V64, P452; GILMAN JG, 1984, BRIT J HAEMATOL, V56, P339, DOI 10.1111/j.1365-2141.1984.tb03961.x; GILMAN JG, 1985, BLOOD; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; HARANO T, 1985, BRIT J HAEMATOL, V59, P333, DOI 10.1111/j.1365-2141.1985.tb02998.x; HARANO T, 1985, AM J HEMATOL, V19, P349, DOI 10.1002/ajh.2830190405; HARANO T, 1984, HEMOGLOBIN, V8, P549, DOI 10.3109/03630268408991741; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; HUISMAN THJ, 1981, BLOOD, V57, P75; HUISMAN THJ, 1983, AM J HEMATOL, V14, P133, DOI 10.1002/ajh.2830140205; HUISMAN THJ, 1977, NATURE, V265, P63, DOI 10.1038/265063a0; HUISMAN THJ, 1981, BLOOD, V58, P491; HUISMAN THJ, 1981, ADV HEMOGLOBIN ANAL, P23; Huisman THJ, 1977, HEMOGLOBINOPATHIES T; HUISMAN THJ, 1983, U CHICAGO SICKLE CEL, V4, P119; IMAMURA T, 1980, HEMOGLOBIN, V4, P409, DOI 10.3109/03630268008996221; KUTLAR A, 1984, BIOCHEM GENET, V22, P21, DOI 10.1007/BF00499284; LIEINJO LE, 1982, BLOOD, V59, P370; NAKATSUJI T, 1984, AM J HEMATOL, V16, P189, DOI 10.1002/ajh.2830160212; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; POWERS PA, 1984, NUCLEIC ACIDS RES, V12, P7023, DOI 10.1093/nar/12.18.7023; SCHROEDER WA, 1972, NATURE-NEW BIOL, V240, P273, DOI 10.1038/newbio240273a0; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; SHELTON JB, 1979, HEMOGLOBIN, V3, P353, DOI 10.3109/03630267908997540; SHELTON JB, 1984, J LIQ CHROMATOGR, V7, P1969, DOI 10.1080/01483918408068849; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; SHIBATA S, 1980, HEMOGLOBIN, V4, P395, DOI 10.3109/03630268008996220; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SUKUMARAN PK, 1983, NUCLEIC ACIDS RES, V11, P4635; TRENT RJ, 1981, NUCLEIC ACIDS RES, V9, P6723, DOI 10.1093/nar/9.24.6723; TRENT RJ, 1981, BRIT J HAEMATOL, V49, P149, DOI 10.1111/j.1365-2141.1981.tb07207.x; ZENG YT, 1985, AM J HEMATOL, V18, P235, DOI 10.1002/ajh.2830180303	37	45	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1986	38	1					45	58						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AYP17	2418679				2022-12-18	WOS:A1986AYP1700005
J	KHOURY, MJ; ERICKSON, JD; JAMES, LM				KHOURY, MJ; ERICKSON, JD; JAMES, LM			PATERNAL EFFECTS ON THE HUMAN SEX-RATIO AT BIRTH - EVIDENCE FROM INTERRACIAL CROSSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR DIS CONTROL, CTR ENVIRONM HLTH, DIV CHRON DIS, BIRTH DEFECTS BRANCH, ATLANTA, GA 30333 USA	Centers for Disease Control & Prevention - USA								Bulmer M. G., 1970, BIOL TWINNING MAN; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; Ciocco A., 1938, HUM BIOL, V10, P36; ERICKSON JD, 1976, ANN HUM GENET, V40, P205, DOI 10.1111/j.1469-1809.1976.tb00182.x; GUERRERO R, 1974, NEW ENGL J MED, V291, P1056, DOI 10.1056/NEJM197411142912004; HARLAP S, 1979, NEW ENGL J MED, V300, P1445, DOI 10.1056/NEJM197906283002601; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; JACOBS PA, 1972, GENETICS SPERMATOZOO, P346; JAMES WH, 1980, LANCET, V1, P1124; MANTEL N, 1959, J NATL CANCER I, V22, P719; MILLER OJ, 1982, CYTOGENET CELL GENET, V32, P179, DOI 10.1159/000131697; MORTON NE, 1967, MONOGRAPH HUMAN GENE, V3; NEEL JV, 1956, NATIONAL RES COUNCIL; PATIL SR, 1977, HUM GENET, V35, P233, DOI 10.1007/BF00393975; Porter IH, 1980, HUMAN EMBRYONIC FETA; Stern Curt, 1973, PRINCIPLES HUMAN GEN; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; TEITELBAUM MS, 1971, AM J HUM GENET, V23, P271; VERMA RS, 1982, J MED GENET, V19, P297, DOI 10.1136/jmg.19.4.297; VERP MS, 1983, AM J OBSTET GYNECOL, V145, P433, DOI 10.1016/0002-9378(83)90313-7; Waxweiler R. J., 1981, BIRTH DEFECTS 4 CORN, P37; WIESE WH, 1981, RAD HAZARDS MINING, P605; 1981, VITAL STATISTICS 3A; 1978, DHEW PHS781108 NCHS	24	45	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1103	1111						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6496474				2022-12-18	WOS:A1984TS30200015
J	NIIKAWA, N; KAJII, T				NIIKAWA, N; KAJII, T			THE ORIGIN OF MOSAIC DOWN SYNDROME - 4 CASES WITH CHROMOSOME MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YAMAGUCHI UNIV,SCH MED,DEPT PEDIAT,UBE,YAMAGUCHI 755,JAPAN	Yamaguchi University	NIIKAWA, N (corresponding author), HOKKAIDO UNIV,SCH MED,DEPT PEDIAT,SAPPORO,HOKKAIDO 060,JAPAN.							ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FORD CE, 1981, TRISOMY 21, P103; HARRIS DJ, 1982, AM J HUM GENET, V34, P125; HASSOLD T, 1982, HUM GENET, V61, P31, DOI 10.1007/BF00291327; KAJII T, 1977, CYTOGENET CELL GENET, V18, P109, DOI 10.1159/000130756; MAGENIS RE, 1981, TRISOMY 21 RES PERSP, P77; NIIKAWA N, 1975, HUMANGENETIK, V30, P83, DOI 10.1007/BF00273636; NIIKAWA N, 1977, HUM GENET, V40, P73; RICHARDS BW, 1974, J MENT DEFIC RES, V18, P199; SMITH GF, 1976, DOWNS ANOMALY, P169; TAYLOR AI, 1968, NATURE, V219, P1028, DOI 10.1038/2191028a0; TAYLOR AI, 1970, NATURE, V227, P163, DOI 10.1038/227163a0; WERNER W, 1982, HUM GENET, V60, P202, DOI 10.1007/BF00569714	13	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					123	130						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6230008				2022-12-18	WOS:A1984SC43000011
J	FERRELL, RE; HITTNER, HM; ANTOSZYK, JH				FERRELL, RE; HITTNER, HM; ANTOSZYK, JH			LINKAGE OF ATYPICAL VITELLIFORM MACULAR DYSTROPHY (VMD-1) TO THE SOLUBLE GLUTAMATE PYRUVATE TRANSAMINASE (GPT1) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,CULLEN EYE INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	FERRELL, RE (corresponding author), UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025, USA.				NEI NIH HHS [EY-03430] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Deutman, 1971, HEREDITARY DYSTROPHI, P198; FERRELL RE, 1980, AM J HUM GENET, V32, P92; HITTNER HM, 1982, J PEDIAT OPHTH STRAB, V19, P40; HITTNER HM, UNPUB ATYPICAL VITEL; KEATS BJB, 1979, SOURCE BOOK LINKAGE; KOBRIN JL, 1981, MACULAR DISEASE, V21, P167; KRILL AE, 1977, HEREDITARY RETINAL C, V2, P665; MAGENIS E, 1979, CYTOGENET CELL GENET, V24, P180; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1978, CYTOGENET CELL GENET, V22, P15, DOI 10.1159/000130916; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1976, AM J HUM GENET, V28, P528; POVEY S, 1979, CYTOGENET CELL GENET, V25, P199; WIJNEN LMM, 1982, CYTOGENET CELL GENET, V32, P327	14	45	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					78	84						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6823974				2022-12-18	WOS:A1983QB70300008
J	KLINE, J; LEVIN, B; SHROUT, P; STEIN, Z; SUSSER, M; WARBURTON, D				KLINE, J; LEVIN, B; SHROUT, P; STEIN, Z; SUSSER, M; WARBURTON, D			MATERNAL SMOKING AND TRISOMY AMONG SPONTANEOUSLY ABORTED CONCEPTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10032; COLUMBIA UNIV,SCH PUBL HLTH,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT HUMAN GENET & DEV,NEW YORK,NY 10032	New York State Psychiatry Institute; Columbia University; Columbia University	KLINE, J (corresponding author), COLUMBIA UNIV,SERGIEVSKY CTR,NEW YORK,NY 10032, USA.				NICHD NIH HHS [1-R01-HD-12207, 1R01-HD-08838] Funding Source: Medline; NIDA NIH HHS [1-R01-DA-02090] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALBERMAN E, 1972, ANN HUM GENET, V36, P185, DOI 10.1111/j.1469-1809.1972.tb00768.x; ALBERMAN E, 1972, ANN HUM GENET, V36, P195, DOI 10.1111/j.1469-1809.1972.tb00769.x; BRESLOW NE, 1978, AM J EPIDEMIOL, V108, P299, DOI 10.1093/oxfordjournals.aje.a112623; ERICKSON JD, 1979, AM J HUM GENET, V31, P489; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; Harlap S, 1979, Lancet, V1, P1342; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; HOOK EB, 1981, AM J HUM GENET, V33, P123; JICK H, 1977, LANCET, V1, P1354; JICK H, 1981, JAMA-J AM MED ASSOC, V245, P1329, DOI 10.1001/jama.245.13.1329; KAUFMAN DW, 1980, AM J PUBLIC HEALTH, V70, P420, DOI 10.2105/AJPH.70.4.420; Kline J, 1980, HUMAN EMBRYONIC FETA, P225; KLINE J, 1981, FRONTIERS KNOWLEDGE, V2, P131; LEVIN B, 1980, B05 COL U SCH PUBL H; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; STARK CR, 1977, POPULATION CYTOGENET, P275; STEIN Z, 1975, AM J EPIDEMIOL, V102, P275, DOI 10.1093/oxfordjournals.aje.a112163; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x; STENE J, 1981, ANN HUM GENET, V59, P119; UCHIDA IA, 1974, NATURE, V250, P601, DOI 10.1038/250601a0; UCHIDA IA, 1977, POPULATION CYTOGENET, P285	21	45	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					421	431						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6859038				2022-12-18	WOS:A1983QS16000007
J	ALVESALO, L; PORTIN, P				ALVESALO, L; PORTIN, P			47,XXY MALES - SEX-CHROMOSOMES AND TOOTH SIZE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV KUOPIO,DEPT DENT,SF-70101 KUOPIO 10,FINLAND; UNIV TURKU,DEPT GENET,SF-20500 TURKU 50,FINLAND	University of Eastern Finland; University of Turku	ALVESALO, L (corresponding author), UNIV TURKU,INST DENT,SF-20500 TURKU 50,FINLAND.							ALVESALO L, 1979, ANN HUM GENET, V43, P97, DOI 10.1111/j.1469-1809.1979.tb02001.x; ALVESALO L, 1980, AM J HUM GENET, V32, P736; ALVESALO L, 1975, AM J HUM GENET, V27, P53; ALVESALO L, 1977, AM J HUM GENET, V29, P486; GARN SM, 1968, ARCH ORAL BIOL, V13, P129, DOI 10.1016/0003-9969(68)90043-5; KARI M, J DENT RES; LUNT RC, 1974, J AM DENT ASSOC, V89, P599, DOI 10.14219/jada.archive.1974.0446; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; [No title captured]	9	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					955	959						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964	7446531				2022-12-18	WOS:A1980KT96400017
J	ELLIS, WS; STARMER, WT				ELLIS, WS; STARMER, WT			INBREEDING AS MEASURED BY ISONYMY, PEDIGREES, AND POPULATION-SIZE IN TORBEL, SWITZERLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SYRACUSE UNIV,DEPT BIOL,SYRACUSE,NY 13210	Syracuse University	ELLIS, WS (corresponding author), UNIV ARIZONA,DEPT ANTHROPOL,TUCSON,AZ 85721, USA.							Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; CROW JF, UNPUBLISHED; Crow JF, 1971, INTRO POPULATION GEN; Darwin G., 1875, J STAT SOC, V38, P153; ELLIS WS, 1976, SOC BIOL, V23, P158, DOI 10.1080/19485565.1976.9988221; FRIEDL J, 1974, HUM BIOL, V46, P699; HUSSELS I, 1969, HUM BIOL, V41, P469; Jacquard A., 1974, GENETIC STRUCTURE PO; KNODEL J, 1973, RADHAKAMAL MUKERJEE; KUCHEMANN CF, 1967, HUM BIOL, V39, P251; LASKER GW, 1972, HUM BIOL, V44, P351; MACCLUER JW, 1967, AM J HUM GENET, V19, P189; MORTON NE, 1970, HUM BIOL, V42, P65; NETTING RMC, 1976, HUM ECOL, V4, P135, DOI 10.1007/BF01531217; ROBERTS DF, 1974, ANN HUM BIOL, V1, P392; Swedlund AC, 1975, B EUGEN SOC, V7, P67; YASUDA N, 1971, AM J HUM GENET, V23, P303	18	45	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	4					366	376						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FP353	362911				2022-12-18	WOS:A1978FP35300005
J	BOYER, SH; MARGOLET, L; BOYER, ML; HUISMAN, THJ; SCHROEDER, WA; WOOD, WG; WEATHERALL, DJ; CLEGG, JB; CARTNER, R				BOYER, SH; MARGOLET, L; BOYER, ML; HUISMAN, THJ; SCHROEDER, WA; WOOD, WG; WEATHERALL, DJ; CLEGG, JB; CARTNER, R			INHERITANCE OF F CELL FREQUENCY IN HETEROCELLULAR HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN - EXAMPLE OF ALLELIC EXCLUSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV HOSP,SCH MED,DEPT MED,DIV MED GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,SCH MED,HOWARD HUGHES MED INST BIOCHEM GENET LAB,BALTIMORE,MD 21205; MED COLL GEORGIA,CTR SICKLE CELL,AUGUSTA,GA 30902; MED COLL GEORGIA,PROT CHEM LAB,AUGUSTA,GA 30902; CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125; RADCLIFFE INFIRM,NUFFIELD DEPT CLIN MED,OXFORD OX2 6HE,ENGLAND; VET ADM HOSP,AUGUSTA,GA 30902; SUNDERLAND GRP HOSP,CENT LAB,SUNDERLAND,ENGLAND	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Georgia; Augusta University; University System of Georgia; Augusta University; California Institute of Technology; Radcliffe Infirmary; University of Oxford								BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; BOYER SH, 1975, JOHNS HOPKINS MED J, V137, P105; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; BOYER SH, 1974, ANN NY ACAD SCI, V241, P699, DOI 10.1111/j.1749-6632.1974.tb21925.x; BROWN DD, 1969, ANNU REV GENET, V3, P127, DOI 10.1146/annurev.ge.03.120169.001015; CHUDWIN DS, 1974, CLIN CHIM ACTA, V50, P413, DOI 10.1016/0009-8981(74)90161-2; DAN M, 1967, EXP CELL RES, V46, P596, DOI 10.1016/0014-4827(67)90385-0; DOZY AM, 1968, J CHROMATOGR, V32, P723, DOI 10.1016/S0021-9673(01)80551-3; EFREMOV CD, 1974, J LAB CLIN MED, V83, P657; FORGET BG, 1976, CELL, V7, P323, DOI 10.1016/0092-8674(76)90161-6; FRIEDMAN S, 1973, J CLIN INVEST, V52, P1543; FRIEDMAN S, 1976, NATURE, V259, P137; GITLIN D, 1968, BLOOD, V32, P796, DOI 10.1182/blood.V32.5.796.796; HORTON BF, 1965, ACTA HAEMATOL-BASEL, V33, P312, DOI 10.1159/000209541; HOSOI T, 1965, EXP CELL RES, V37, P680, DOI 10.1016/0014-4827(65)90215-6; HUISMAN THJ, 1975, AM J HUM GENET, V27, P765; HUISMAN THJ, 1974, ANN NY ACAD SCI, V232, P107, DOI 10.1111/j.1749-6632.1974.tb20576.x; HUISMAN THJ, 1970, BLOOD-J HEMATOL, V36, P1; HUISMAN THJ, 1974, P INT S ABNORMAL HEM, P95; KAN YW, 1975, NATURE, V258, P162, DOI 10.1038/258162a0; KATSURA S, IN PRESS; KATSURA SYUSAKU, 1964, YOKOHAMA MED BULL, V15, P117; KLEIHAUER E, 1957, KLIN WOCHENSCHR, V35, P637, DOI 10.1007/BF01481043; KNOXMACA.HH, 1973, BRIT MED J, V3, P150, DOI 10.1136/bmj.3.5872.150; KOHN J, 1972, J CLIN PATHOL, V25, P830, DOI 10.1136/jcp.25.9.830; MAKLER MT, 1974, BRIT J HAEMATOL, V26, P519, DOI 10.1111/j.1365-2141.1974.tb00495.x; MARTI HR, 1963, NORMALE ANORMALE MEN; PEMBREY ME, 1972, J CLIN PATHOL, V25, P738, DOI 10.1136/jcp.25.8.738; RINGELHANN B, 1970, ACTA HAEMATOL-BASEL, V43, P100, DOI 10.1159/000208719; SCHROEDER WA, 1970, ANAL BIOCHEM, V35, P235, DOI 10.1016/0003-2697(70)90030-8; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; SIEGEL W, 1970, ANN INTERN MED, V72, P533, DOI 10.7326/0003-4819-72-4-533; SOFRONIADOU K, 1975, BRIT J HAEMATOL, V29, P137, DOI 10.1111/j.1365-2141.1975.tb01807.x; STAMATOYANNOPOULOS G, 1975, BLOOD, V46, P683; SUKUMARAN PK, 1972, BRIT J HAEMATOL, V23, P403, DOI 10.1111/j.1365-2141.1972.tb07075.x; TAKI K, IN PRESS; WEATHERALL DJ, 1975, BRIT J HAEMATOL, V29, P205, DOI 10.1111/j.1365-2141.1975.tb01815.x; Weatherall DJ, 1972, THALASSEMIA SYNDROME; WHEELER JT, 1961, B JOHNS HOPKINS HOSP, V109, P217; WOOD WG, 1975, BLOOD, V46, P671	40	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					256	271						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	868872				2022-12-18	WOS:A1977DG79400005
J	PALMER, CG; CHRISTIAN, JC; MERRITT, AD				PALMER, CG; CHRISTIAN, JC; MERRITT, AD			PARTIAL TRISOMY 1 DUE TO A SHIFT AND PROBABLE LOCATION OF DUFFY (FY) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis								EBBIN AJ, 1971, J MED GENET, V8, P536, DOI 10.1136/jmg.8.4.536; Feingold M, 1974, Birth Defects Orig Artic Ser, V10, P1; FRIEDRICH U, 1974, HUMANGENETIK, V21, P133, DOI 10.1007/BF00281032; GARRETT JH, 1975, CLIN GENET, V8, P341; KOIVISTO M, 1975, ACTA PAEDIATR SCAND, V65, P513; MAGANIAS NH, 1967, ARCH INTERN MED, V119, P297; MARSH WL, 1974, SCIENCE, V183, P966, DOI 10.1126/science.183.4128.966; MERRITT AD, 1977, ADV HUMAN GENETICS, V8; MEYERS DA, 1977, THESIS INDIANA U; NEU RL, 1973, CLIN GENET, V4, P474; NORWOOD TH, 1974, HUMANGENETIK, V25, P79; Rivas M L, 1975, Birth Defects Orig Artic Ser, V11, P239; SMITH DW, 1976, RECOGNIZABLE PATTERN; VANDENBE.H, 1973, HUMANGENETIK, V18, P225	14	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	4					371	377						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN459	879169				2022-12-18	WOS:A1977DN45900006
J	ROPERS, HH; WIENKER, TF; GRIMM, T; SCHROETTER, K; BENDER, K				ROPERS, HH; WIENKER, TF; GRIMM, T; SCHROETTER, K; BENDER, K			EVIDENCE FOR PREFERENTIAL X-CHROMOSOME INACTIVATION IN A FAMILY WITH FABRY DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV FREIBURG,INST HUMAN GENET,D-7800 FREIBURG,FED REP GER	University of Freiburg								ALBERTINI RJ, 1974, BIOCH GENET, V11, P379; COMINGS D, 1975, AM J HUM GENET, V27, P430; DREWS U, 1974, CELL, V1, P3, DOI 10.1016/0092-8674(74)90148-2; FELLOUS M, 1975, CYTOGENET CELL GENET, V14, P193; Gartler S M, 1976, Adv Hum Genet, V7, P99; GRIMM T, 1976, HUM GENET, V32, P329, DOI 10.1007/BF00295824; JOHNSTON AW, 1969, ANN HUM GENET, V32, P369, DOI 10.1111/j.1469-1809.1969.tb00088.x; LANGENBECK U, 1975, HUMANGENETIK, V27, P315; LUSIS AJ, 1975, CELL, V6, P371, DOI 10.1016/0092-8674(75)90186-5; MCDONALD JA, 1972, BIOCHEM GENET, V6, P21, DOI 10.1007/BF00485961; MOSER H, 1974, CLIN GENET, V5, P271; NESBITT MN, 1971, DEV BIOL, V26, P252, DOI 10.1016/0012-1606(71)90125-4; NESBITT MN, 1971, ANNU REV GENET, V5, P143, DOI 10.1146/annurev.ge.05.120171.001043; OPITZ JM, 1965, AM J HUM GENET, V17, P325; PEARSON P L, 1974, Birth Defects Original Article Series, V10, P136; RIETRA PJG, 1976, THESIS U AMSTERDAM, P94; ROMEO G, 1975, BIOCHEM GENET, V13, P615, DOI 10.1007/BF00484919; ROPERS HH, 1975, HUMANGENETIK, V26, P117; Sweeley C.C., 1972, METABOLIC BASIS INHE, P663	19	45	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	4					361	370						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN459	406783				2022-12-18	WOS:A1977DN45900005
J	COREY, LA; KANG, KW; CHRISTIAN, JC; NORTON, JA; HARRIS, RE; NANCE, WE				COREY, LA; KANG, KW; CHRISTIAN, JC; NORTON, JA; HARRIS, RE; NANCE, WE			EFFECTS OF CHORION TYPE ON VARIATION IN CORD BLOOD CHOLESTEROL OF MONOZYGOTIC TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46202; CREIGHTON UNIV,SCH MED,DEPT PUBL HLTH & PREVENT MED,OMAHA,NB 68178; MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Creighton University; Virginia Commonwealth University								ABELL LL, 1952, J BIOL CHEM, V195, P357; CHRISTIAN J, 1974, CLIN RES, V22, pA327; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1975, J AM OIL CHEM SOC, V52, pA123; CHRISTIAN JHB, IN PRESS; COCHRAN WG, 1951, BIOMETRICS, V7, P17, DOI 10.2307/3001601; DARMADY JM, 1972, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5815.685; GAYLOR DW, 1969, TECHNOMETRICS, V11, P691, DOI 10.2307/1266893; GOTTLIEB A, 1952, DAPIM REFRIUM, V21, P254; HASEMAN JK, 1970, BEHAV GENET, V1, P11, DOI 10.1007/BF01067367; JENSEN J, 1965, J LIPID RES, V6, P193; KEMPTHORNE O, 1961, AM J HUM GENET, V13, P320; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SHCHEKOCHIKHINA LK, 1968, VOP ANTROPOL, V26, P115; SING CF, 1975, AM J HUM GENET, V27, P333; Snedecor G.W., 1980, STAT METHODS, V7; Strong S.J, 1967, PLACENTA TWIN PREGNA	17	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					433	441						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CH661	988747				2022-12-18	WOS:A1976CH66100001
J	NG, WG; DONNELL, GN; KOCH, R; BERGREN, WR				NG, WG; DONNELL, GN; KOCH, R; BERGREN, WR			BIOCHEMICAL AND GENETIC STUDIES OF PLASMA AND LEUKOCYTE ALPHA-L-FUCOSIDASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SO CALIF,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; CHILDRENS HOSP LOS ANGELES,LOS ANGELES,CA	University of Southern California; Children's Hospital Los Angeles								ALHADEFF JA, 1974, CLIN CHIM ACTA, V57, P307, DOI 10.1016/0009-8981(74)90412-4; BORRONE C, 1974, J PEDIATR-US, V84, P727, DOI 10.1016/S0022-3476(74)80019-3; DURAD P, 1971, HELV PAEDIATR ACTA, V26, P19; DURAND P, 1968, LANCET, V1, P1198; DURAND P, 1969, J PEDIATR, V75, P665, DOI 10.1016/S0022-3476(69)80464-6; DURAND P, 1972, GLYCOLIPIDS GLYCOPRO, P293; GATTI R, 1973, LANCET, V2, P1024; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; KOUSSEFF BG, 1973, LANCET, V2, P1387; LOEB H, 1969, HELV PAEDIATR ACTA, V36, P519; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASTUDA I, 1973, CLIN CHIM ACTA, V48, P9; NG WG, 1973, ANN HUM GENET, V37, P1, DOI 10.1111/j.1469-1809.1973.tb01808.x; NG WG, 1973, PEDIATR RES, V7, P391; NG WG, 1973, 13TH INT C GEN BERK; NG WG, 1974, BIRTH DEFECTS OAS; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OCKERMAN PA, 1968, ACTA PAEDIATR SCAND, V57, P281, DOI 10.1111/j.1651-2227.1968.tb07292.x; PATEL V, 1972, SCIENCE, V176, P426, DOI 10.1126/science.176.4033.426; TURNER BM, 1974, CLIN CHIM ACTA, V57, P29, DOI 10.1016/0009-8981(74)90174-0; VANHOOF F, 1968, LANCET, V1, P1198; WOOD S, 1975, CLIN CHIM ACTA, V58, P251, DOI 10.1016/0009-8981(75)90444-1; ZIELKE K, 1972, J LAB CLIN MED, V79, P164; ZIELKE K, 1972, J EXP MED, V136, P197, DOI 10.1084/jem.136.1.197	24	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					42	50						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	1247019				2022-12-18	WOS:A1976BC88800006
J	DAY, N; HOLMES, LB				DAY, N; HOLMES, LB			INCIDENCE OF GENETIC DISEASE IN A UNIVERSITY HOSPITAL POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP,CHILDRENS SERV,GENET UNIT,BOSTON,MA 02114; HARVARD UNIV,MED SCH,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School								BROWN WT, 1972, SURGERY, V72, P756; BURGER RH, 1972, J UROLOGY, V108, P249, DOI 10.1016/S0022-5347(17)60702-X; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1956, GREAT ORMOND STREET, V11, P65; DEMYER W, 1972, NEUROLOGY, V22, P634, DOI 10.1212/WNL.22.6.634; LANG DJ, 1966, PEDIATRICS, V38, P913; LANZKOWSKY P, 1965, J PEDIATR-US, V67, P826, DOI 10.1016/S0022-3476(65)80373-0; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; LUBS ML, 1972, J PEDIATR-US, V80, P26, DOI 10.1016/S0022-3476(72)80448-7; MCKUSICK VA, 1971, MENDELIAN INHERITANC; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; REFSUM S, 1968, HDB CLINICAL NEUROLO, V5; REISS JA, 1972, J PEDIATR-US, V80, P655, DOI 10.1016/S0022-3476(72)80069-6; RIMOIN DL, 1971, MED CLIN N AM, V55, P807, DOI 10.1016/S0025-7125(16)32477-4; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; SIBINGA MS, 1971, PEDIATRICS, V48, P216; Smith D.W., 1970, RECOGNIZABLE PATTERN; SMITH DW, 1970, J PEDIATR-US, V76, P653, DOI 10.1016/S0022-3476(70)80282-7; STEVENSON ALAN CARRUTH, 1959, RADIATION RES SUPPL, V1, P306, DOI 10.2307/3583647; WATSON W, 1972, ARCH DERMATOL, V105, P197, DOI 10.1001/archderm.105.2.197; WEINER B, 1949, J HERED, V40, P219; WELSH JD, 1967, ARCH INTERN MED, V120, P261, DOI 10.1001/archinte.1967.00300030003003; 1969, WHO416 TECH REP	23	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					237	246						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704856				2022-12-18	WOS:A1973P918200003
J	KHAN, PM; WESTERVELD, A; GRZESCHIK, KH; DEYS, BF; GARSON, OM; SINISCALCO, M				KHAN, PM; WESTERVELD, A; GRZESCHIK, KH; DEYS, BF; GARSON, OM; SINISCALCO, M			X-LINKAGE OF HUMAN PHOSPHOGLYCERATE KINASE CONFIRMED IN MAN-MOUSE AND MAN-CHINESE HAMSTER SOMATIC CELL HYBRIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALBERTINI RJ, 1970, SCIENCE, V169, P482, DOI 10.1126/science.169.3944.482; BLANCHAER MC, 1955, AM J PHYSIOL, V181, P602, DOI 10.1152/ajplegacy.1955.181.3.602; BOONE CM, 1969, BIOCHEM GENET, V3, P119, DOI 10.1007/BF00520348; CHEN SH, 1971, AM J HUM GENET, V23, P87; HARRIS H, 1965, NATURE, V205, P640, DOI 10.1038/205640a0; KLEBE RJ, 1970, J CELL BIOL, V45, P74, DOI 10.1083/jcb.45.1.74; LITTLEFIELD JW, 1963, P NATL ACAD SCI USA, V50, P568, DOI 10.1073/pnas.50.3.568; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MEERAKHAN P, IN PRESS; MILLER OJ, 1971, P NATL ACAD SCI USA, V68, P116, DOI 10.1073/pnas.68.1.116; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; Ruddle F. H., 1970, Symposia of the International Society for Cell Biology, V9, P233; SHIN SI, 1971, BIOCHEM GENET, V5, P91, DOI 10.1007/BF00485734; SINISCALCO M, 1969, P NATL ACAD SCI USA, V62, P793, DOI 10.1073/pnas.62.3.793; Siniscalco M, 1970, S INT SOC CELL BIOL, V9, P205; SINISCALCO M, TO BE PUBLISHED; VALENTINE WN, 1969, NEW ENGL J MED, V280, P528, DOI 10.1056/NEJM196903062801003; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; WESTERVELD A, IN PRESS	20	45	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	6					614	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2014	5132070				2022-12-18	WOS:A1971L201400009
J	WARBURTON, D; NAYLOR, AF				WARBURTON, D; NAYLOR, AF			EFFECT OF PARITY ON PLACENTAL WEIGHT AND BIRTH WEIGHT - IMMUNOLOGICAL PHENOMENON - REPORT OF COLLABORATIVE STUDY OF CEREBRAL PALSY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALEXANDER G, 1964, J REPROD FERTIL, V7, P307, DOI 10.1530/jrf.0.0070307; BACH FH, 1968, SCIENCE, V159, P1196, DOI 10.1126/science.159.3820.1196; BEISCHER NA, 1968, AM J OBSTET GYNECOL, V101, P801, DOI 10.1016/0002-9378(68)90036-7; BERENDES H, 1966, RESEARCH METHODOLOGY; BILLINGHAM RE, 1964, NEW ENGL J MED, V270, P720, DOI 10.1056/NEJM196404022701406; BILLINGHAM RE, 1964, NEW ENGL J MED, V270, P667, DOI 10.1056/NEJM196403262701306; BILLINGTON WD, 1964, NATURE, V202, P317, DOI 10.1038/202317a0; Brain P, 1968, Med J Aust, V1, P1046; BROADHUR.PL, 1965, FOLIA PRIMATOL, V3, P201, DOI 10.1159/000155029; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; CURRIE GA, 1968, P ROY SOC MED, V61, P1206, DOI 10.1177/003591576806111P204; DANFORTH DN, 1966, TEXTBOOK OBSTETRICS; FREDA VJ, 1965, AM J OBSTET GYNECOL, V92, P341; FRIEDMAN EA, 1969, OBSTET GYNECOL, V33, P404; Gleason RE, 1967, TRANSPLANTATION, V5, P343, DOI [10.1097/00007890-196703000-00046, DOI 10.1097/00007890-196703000-00046]; HULL PETER, 1966, GENETICS, V54, P1049; JAMES DA, 1967, J REPROD FERTIL, V14, P265, DOI 10.1530/jrf.0.0140265; JAMES DA, 1965, NATURE, V205, P613, DOI 10.1038/205613a0; JAYANT K, 1966, ANN HUM GENET, V29, P367, DOI 10.1111/j.1469-1809.1966.tb00533.x; JEFFCOATE TNA, 1959, AM J OBSTET GYNECOL, V77, P475, DOI 10.1016/S0002-9378(16)36717-5; JENSEN KG, 1962, VOX SANG, V7, P454, DOI 10.1111/j.1423-0410.1962.tb03277.x; JONES WR, 1968, NATURE, V218, P480, DOI 10.1038/218480a0; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; KLOOSTERMAN G J, 1954, Gynaecologia, V138, P529; McKeown T, 1951, BR J SOC MED, V5, P98; MCLAREN A, 1965, J REPROD FERTIL, V9, P79, DOI 10.1530/jrf.0.0090079; MORTON NE, 1955, ANN HUM GENET, V20, P125; NAEYE RL, 1966, AM J OBSTET GYNECOL, V95, P276, DOI 10.1016/0002-9378(66)90180-3; NAYLOR AF, 1967, ANN HUM GENET, V31, P71, DOI 10.1111/j.1469-1809.1967.tb02021.x; NORTH AF, 1966, PEDIATRICS, V38, P1013; OSULLIVA.JB, 1965, AM J OBSTET GYNECOL, V92, P1023, DOI 10.1016/0002-9378(65)90739-8; PENROSE LS, 1961, RECENT ADV HUMAN GEN, P56; PITKANEN H, 1949, Ann Chir Gynaecol Fenn Suppl, V38, P356; ROBSON EB, 1955, ANN HUM GENET, V19, P262, DOI 10.1111/j.1469-1809.1955.tb01352.x; SEDLIS A, 1967, DEV MED CHILD NEUROL, V9, P160; SNEDECOR GW, 1946, STATISTICAL METHODS, P289; WARBURTON FE, 1968, HEREDITY, V23, P151, DOI 10.1038/hdy.1968.17	37	45	45	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					41	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581980				2022-12-18	WOS:A1971I619000005
J	GERSHOWITZ, H; LAYRISSE, M; LAYRISSE, Z; NEEL, JV; BREWER, C; CHAGNON, N; AYRES, M				GERSHOWITZ, H; LAYRISSE, M; LAYRISSE, Z; NEEL, JV; BREWER, C; CHAGNON, N; AYRES, M			GENE FREQUENCIES AND MICRODIFFERENTIATION AMONG MAKIRITARE INDIANS .1. 11 BLOOD GROUP SYSTEMS AND ABH-LE SECRETOR TRAITS - A NOTE ON RH GENE FREQUENCY DETERMINATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; ARENDS T, 1962, 8 P C INT SOC BLOOD, P379; ARENDS T, 1964, 10 P C INT SOC BLOOD, P405; ARENDS T, 1967, 9 P C INT SOC BLOOD, P463; BARANDIARAN DD, 1966, ANTROPOLOGICA, P1; BOYD WC, 1963, SCIENCE, V140, P1057, DOI 10.1126/science.140.3571.1057; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; CIRVIEUX JMS, 1968, REV CULTURA U ORIENT, V1, P30; CRUXENT JM, 1953, B INDIGENA VENEZOLAN, V3, P325; ESCORIAZA DD, 1959, ANTROPOLOGICA, V10, P61; FRANCISCO HJ, 1965, NATURE, V28, P2; FUCHS H, 1964, AM INDIGENA, V24, P171; FUCHS H, 1962, FOLIA ANTROPOLOGICA, P27; FUCHS H, 1962, AM INDIGENA, V22, P169; GALLANGO ML, 1963, HUM BIOL, V35, P361; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; KOCHGRUNBERG T, 1917, ROROIMA ORINOCO ERGE, V1; LAYRISSE M, 1963, HUM BIOL, V35, P140; LAYRISSE M, 1966, 13 CAR I CAR ANTR SO; Mourant A., 1954, DISTRIBUTION HUMAN B; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JAMES V., 1967, JAP J HUM GENET, V12, P1; NEEL JV, 1967, AM J HUM GENET, V19, P554; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1964, COLD SPRING HARB SYM, V29, P85, DOI 10.1101/SQB.1964.029.01.014; NEEL JV, 1969, 12 P INT C GEN TOK, V3, P389; NOTHOMB HJF, 1968, ORIENTE MED, V1, P91; POST RH, 1968, 165 PAN AM HEALTH OR, P141; REED TE, 1968, AM J HUM GENET, V20, P579; SALZANO FM, 1964, AM J HUM GENET, V16, P301; WILBERT J, 1963, INDIOS REGION ORINOC	31	45	45	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					515	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H6097	4995845				2022-12-18	WOS:A1970H609700003
J	PLATO, CC; REED, DM; ELIZAN, TS; KURLAND, LT				PLATO, CC; REED, DM; ELIZAN, TS; KURLAND, LT			AMYOTROPHIC LATERAL SCLEROSIS/PARKINSONISM-DEMENTIA COMPLEX OF GUAM .4. FAMILIAL AND GENETIC INVESTIGATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARNOLD A, 1953, J NERV MENT DIS, V117, P135, DOI 10.1097/00005053-195311720-00005; DIXON WJ, 1957, INTRODUCTION STATIST, P280; ELIZAN TS, 1966, ARCH NEUROL-CHICAGO, V14, P356, DOI 10.1001/archneur.1966.00470100012002; HABERLANDT W F, 1959, Acta Genet Med Gemellol (Roma), V8, P369; Haberlandt W. F., 1964, AMYOTROPHISCHE LATER; HIRANO A, 1961, BRAIN, V84, P642, DOI 10.1093/brain/84.4.642; HIRANO A, 1961, BRAIN, V84, P662, DOI 10.1093/brain/84.4.662; HIRANO A, 1966, ARCH NEUROL-CHICAGO, V15, P35, DOI 10.1001/archneur.1966.00470130039004; KOERNER DR, 1952, ANN INTERN MED, V37, P1204, DOI 10.7326/0003-4819-37-6-1204; KROOTH R, 1959, AMYOTROPHIC LATERAL; KURLAND LT, 1955, NEUROLOGY, V5, P182, DOI 10.1212/WNL.5.3.182; KURLAND LT, 1954, NEUROLOGY, V4, P438, DOI 10.1212/WNL.4.6.438; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; KURLAND LT, 1954, NEUROLOGY, V4, P355, DOI 10.1212/WNL.4.5.355; KURLAND LT, 1965, 1163 US PUBL HEALTH; MULDER D W, 1954, U S Armed Forces Med J, V5, P1724; PLATO CC, IN PRESS; REED D, 1966, AM J EPIDEMIOL, V83, P54, DOI 10.1093/oxfordjournals.aje.a120570; TILLEMA S, 1953, Doc Med Geogr Trop, V5, P366	19	45	46	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	5					617	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	99950	6050736				2022-12-18	WOS:A19679995000002
J	BOWMAN, HS; MCKUSICK, VA; DRONAMRA.KR				BOWMAN, HS; MCKUSICK, VA; DRONAMRA.KR			PYRUVATE KINASE DEFICIENT HEMOLYTIC ANEMIA IN AN AMISH ISOLATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOWMAN HS, 1963, ANN INTERN MED, V58, P567, DOI 10.7326/0003-4819-58-4-567; HOSTETLER JA, 1951, THESIS PENNSYLVANIA; HOSTETLER JA, 1948, MENNONITE QUART REV, V22, P227; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; Murdock GPM, 1949, SOCIAL STRUCTURE; OSKI FA, 1963, NEW ENGL J MED, V269, P763, DOI 10.1056/NEJM196310102691501; SELWYN JG, 1954, BLOOD, V9, P414, DOI 10.1182/blood.V9.5.414.414; TANAKA KR, 1962, BLOOD, V19, P267, DOI 10.1182/blood.V19.3.267.267; TANAKA KR, 1961, BLOOD, V18, P784	10	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	61289	14255553				2022-12-18	WOS:A19656128900001
J	SHIM, BS; BEARN, AG				SHIM, BS; BEARN, AG			DISTRIBUTION OF HAPTOGLOBIN SUBTYPES IN VARIOUS POPULATIONS INCLUDING SUBTYPE PATTERNS IN SOME NONHUMAN PRIMATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARNICOT NA, 1960, ANN HUM GENET, V24, P171; BLACKWELL RQ, 1963, NATURE, V197, P503, DOI 10.1038/197503a0; CONNELL GE, 1962, NATURE, V193, P505, DOI 10.1038/193505a0; DIXON GH, 1962, FED PROC, V21, P408; FLORY LL, 1963, NATURE, V197, P577, DOI 10.1038/197577a0; GIBLETT ELOISE R., 1963, NATURE, V197, P576, DOI 10.1038/197576a0; HARRIS H, 1959, S BIOCHEMISTRY HUMAN, P151; KIM HC, 1961, THESIS CATHOLIC MED, V5, P1; KIRK RL, 1961, ACTA GENET STAT MED, V11, P97; KIRK RL, CITED INDIRECTLY; MATSUNAGA E, 1960, NATURE, V186, P320, DOI 10.1038/186320a0; NAGEL R, 1963, NATURE, V197, P187, DOI 10.1038/197187a0; NANCE WE, 1963, NATURE, V198, P869, DOI 10.1038/198869a0; PARKER WC, 1961, ANN HUM GENET, V25, P227; PARKER WC, 1963, DISSERTATION ROCKEFE; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1962, AM J HUM GENET, V14, P14; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; WOLSTENHOLME GEW, 1959, S BIOCHEMISTRY HUMAN, P151; YAMAGUCHI M, 1961, Fukuoka Igaku Zasshi, V52, P763	21	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					477	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250428				2022-12-18	WOS:A19642974A00008
J	PARKER, WC; BEARN, AG				PARKER, WC; BEARN, AG			CONTROL GENE MUTATION AS A POSSIBLE EXPLANATION OF CERTAIN HAPTOGLOBIN PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1959, NATURE, V183, P1312, DOI 10.1038/1831312a0; ALY FW, 1962, NATURE, V194, P1091, DOI 10.1038/1941091a0; BARNICOT NA, 1960, ANN HUM GENET, V24, P171; Bennhold H., 1954, VERH DTSCH GES INN M, V60, P630; BLUMBERG BS, 1959, ANN HUM GENET, V23, P349, DOI 10.1111/j.1469-1809.1959.tb01478.x; CEPPELLINI R, IN PRESS; CLEVE H, 1961, ANN NY ACAD SCI, V94, P218, DOI 10.1111/j.1749-6632.1961.tb35543.x; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; EDELMAN GM, 1962, P NATL ACAD SCI USA, V48, P1035, DOI 10.1073/pnas.48.6.1035; FREDRICKSON D, 1961, ANN INTERN MED, V55, P1016, DOI 10.7326/0003-4819-55-6-1016; GALATIUSJENSEN F, 1960, HAPTOGLOBINS GENETIC; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P248; GIBLETT ER, 1959, NATURE, V183, P192, DOI 10.1038/183192a0; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; GIBLETT ER, 1959, CIBA F S BIOCHEMISTR, P179; GIBLETT ER, 1961, P C GENETIC POLYMORP, P132; GIBLETT ER, PERSONAL COMMUNICATI; GORINI L, 1961, S QUANT BIOL, V26, P173; GRUBB R., 1956, ACTA PATHOL ET MICROBIOL SCAND, V39, P390; HARRIS H, 1958, NATURE, V182, P1324, DOI 10.1038/1821324b0; HARRIS H, 1959, CIBA F S BIOCHEMISTR, P151; HEILMEYER L, 1961, DEUT MED WOCHENSCHR, V86, P1745, DOI 10.1055/s-0028-1113001; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; INGRAM VM, 1961, NATURE, V189, P704, DOI 10.1038/189704a0; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; KIRK RL, 1961, ACTA GENET STAT MED, V11, P97; KNEDEL M, 1957, Blut, V3, P129, DOI 10.1007/BF01630687; KORNGOLD L, 1963, FED PROC, V22, P264; MAAS WK, 1961, S QUANT BIOL, V26, P183; MONOD J, 1961, S QUANT BIOL, V26, P389; MOTULSKY AG, 1962, NATURE, V194, P607, DOI 10.1038/194607b0; NEEL JV, 1961, BLOOD, V18, P769, DOI 10.1182/blood.V18.6.769.769; NOVITSKI E, 1946, GENETICS, V31, P508; NOVITSKI E, 1961, GENETICS, V46, P711; PARKER WC, 1961, ANN HUM GENET, V25, P227; PARKER WC, 1963, THESIS ROCKEFELLER I; PARKER WC, 1963, AMER J MED; SALT HB, 1960, LANCET, V2, P325; SCHACHT LE, 1961, 2 P INT C HUM GEN RO; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1962, AM J HUM GENET, V14, P14; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9; SMITHIES O, 1960, GENETICS GENETIC INF, P133; STEINBERG A, 1961, AM J HUM GENET, V13, P355; SUTTON H E, 1959, Ann Hum Genet, V23, P175; THOMPSON PE, 1962, GENETICS, V47, P337; VOGEL HJ, 1961, S QUANT BIOL, V26, P163; Zuckerkandl E., 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; [No title captured]	52	45	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	2					159	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2970A	13941504				2022-12-18	WOS:A19632970A00007
J	DUNN, LC				DUNN, LC			CROSS CURRENTS IN HISTORY OF HUMAN GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Barthelmess A., 1952, VERERBUNGSWISSENSCHA; BATESON B, 1928, FRS NATURALIST; BATESON W, 1919, EUGEN REV, V11; BATESON W, 1901, 19021909 ROY SOC EV; Bernstein, 1924, KLIN WOCHENSCHR, V33, P1495; Brewer H, 1935, EUGEN REV, V27, P121; CHESTERTON GK, 1922, EUGENICS EVILS LONDO; DAVENPORT CB, 1914, 11 B COLD SPRING HAR; DAVIES SP, 1923, THESIS COLUMBIA U; DUGDALE RL, 1874, JUKES STUDY CRIME PA; FLORINSKY WM, 1866, VERVOLLKOMMUNG ENTAR; GALTON F, CITED INDIRECTLY; GARROD, LANCET, V2, P1708; GARROD, 1868, LANCET, V2, P1768; GARROD, 1901, LANCET; Garrod AE, 1908, LANCET, V2, P214; Garrod AE, 1908, LANCET, V2, P142; Garrod AE, 1908, LANCET, V2, P1; Garrod AE, 1908, LANCET, V2, P73; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; HERON D, 1913, 7 QUEST DAY FRAY; HOGBEN L, 1931, GENETICS PRINCIPLES; HOGBEN LT, 1933, NATURE NURTURE LONDO; JENNINGS HS, 1925, PROMETHEUS BIOLOGY A; JORAVSKY, 1961, ANTROPOGENETIKA MED, V5, P3; Joravsky David., 2009, SOVIET MARXISM NATUR; KOLTZOFF N, 1925, ARCH RASSEN GESELSCH, V17, P96; MULLER H. J., 1959, PERSPECTIVES IN BIOL AND MED, V3, P1; MULLER HJ, 1950, AM J HUM GENET, V2, P111; MULLER HJ, 1935, OUT NIGHT BIOLOGISTS; MULLER HJ, 1935, OUT NIGHT; PEARL R, 1928, 5 P INT C GEN BERL, V1, P260; Pearson K, 1904, PHILOS T R SOC LOND, V203, P53, DOI 10.1098/rsta.1904.0015; PEARSON K, LANCET, V2, P1615; PEARSON K, 1914, LIFE LETTERS LABORS, V1; Penrose LS, 1932, J GENET, V25, P407, DOI 10.1007/BF02984599; SEREBROVSKY AA, CITED INDIRECTLY; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; VERSCHUER OV, 1959, GENETIK MENSCHEN; VERSCHUER V, 1937, ERBARZT, P97; VERSCHUER V, 1941, LEITFADEN PASSENHYGI; Weinberg W., 1908, JAHRESHEFTE VEREINS, V64, P369; WEISSENBERG S, 1926, ARCH RASSENB, V18, P81; WRIGHT S., 1959, PERSPECTIVES IN BIOL AND MED, V3, P107	44	45	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2966A	13888510				2022-12-18	WOS:A19622966A00002
J	WHITTAKER, DL; COPELAND, DL; GRAHAM, JB				WHITTAKER, DL; COPELAND, DL; GRAHAM, JB			LINKAGE OF COLOR BLINDNESS TO HEMOPHILIAS A AND B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAM A, 1961, NATURE, V189, P686, DOI 10.1038/189686a0; AGGELER PM, 1952, P SOC EXP BIOL MED, V79, P692; BARROW EM, 1960, J LAB CLIN MED, V55, P936; BIGGS R, 1952, BRIT MED J, V2, P1378, DOI 10.1136/bmj.2.4799.1378; BRINKHOUS KM, 1954, BLOOD, V9, P254, DOI 10.1182/blood.V9.3.254.254; BRINKHOUS KM, 1950, SCIENCE, V111, P723, DOI 10.1126/science.111.2896.723; FIELD RA, 1946, CORNELL VET, V36, P285; GRAHAM JB, 1956, AM J HUM GENET, V8, P63; GRAHAM JB, 1949, J EXP MED, V90, P97, DOI 10.1084/jem.90.2.97; GRAHAM JB, 1953, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.4827.97-a; GRAHAM JB, 1957, HEMOPHILIA HEMOPHILI; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HUTT FB, 1948, J HERED, V39, P1; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; MANN JD, 1962, LANCET, V1, P8; MUSTARD JF, 1960, BRIT J HAEMATOL, V6, P259, DOI 10.1111/j.1365-2141.1960.tb06241.x; NYE SW, 1962, AM J MED SCI, V243, P279, DOI 10.1097/00000441-196203000-00002; RACE RR, PERSONAL COMMUNICATI; RENWICK JH, 1961, ADVANCES HUMAN GENET; RODMAN NF, 1958, AM J CLIN PATHOL, V29, P525; SJOLIN KE, 1961, HEMOPHILIC DISEASES; WIENER AS, 1953, BRIT MED J, V1, P559, DOI 10.1136/bmj.1.4809.559-c	22	45	45	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					149	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	14006651				2022-12-18	WOS:A19622963A00011
J	Deng, JW; Yu, JX; Li, PD; Luan, XH; Cao, L; Zhao, J; Yu, M; Zhang, W; Lv, H; Xie, ZY; Meng, LC; Zheng, YM; Zhao, YW; Gang, Q; Wang, QQ; Liu, J; Zhu, M; Guo, XY; Su, YN; Liang, Y; Liang, F; Hayashi, T; Maeda, MH; Sato, T; Ura, S; Oya, Y; Ogasawara, M; Iida, A; Nishino, I; Zhou, C; Yan, CZ; Yuan, Y; Hong, DJ; Wang, ZX				Deng, Jianwen; Yu, Jiaxi; Li, Pidong; Luan, Xinghua; Cao, Li; Zhao, Juan; Yu, Meng; Zhang, Wei; Lv, He; Xie, Zhiying; Meng, LingChao; Zheng, Yiming; Zhao, Yawen; Gang, Qiang; Wang, Qingqing; Liu, Jing; Zhu, Min; Guo, Xueyu; Su, Yanan; Liang, Yu; Liang, Fan; Hayashi, Tomohiro; Maeda, Meiko Hashimoto; Sato, Tatsuro; Ura, Shigehisa; Oya, Yasushi; Ogasawara, Masashi; Iida, Aritoshi; Nishino, Ichizo; Zhou, Chang; Yan, Chuanzhu; Yuan, Yun; Hong, Daojun; Wang, Zhaoxia			Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISTINCT; PROTEIN; TRANSCRIPTION; TRANSLATION; METHYLATION; FEATURES; DISEASE; GENE	Oculopharyngodistal myopathy (OPDM) is an adult-onset inherited neuromuscular disorder characterized by progressive ptosis, external ophthalmoplegia, and weakness of the masseter, facial, pharyngeal, and distal limb muscles. The myopathological features are presence of rimmed vacuoles (RVs) in the muscle fibers and myopathic changes of differing severity. Inheritance is variable, with either putative autosomal-dominant or autosomal-recessive pattern. Here, using a comprehensive strategy combining whole-genome sequencing (WGS), long-read whole-genome sequencing (LRS), linkage analysis, repeat-primed polymerase chain reaction (RP-PCR), and fluorescence amplicon length analysis polymerase chain reaction (AL-PCR), we identified an abnormal GGC repeat expansion in the 50 UTR of GIPC1 in one out of four families and three sporadic case subjects from a Chinese OPDM cohort. Expanded GGC repeats were further confirmed as the cause of OPDM in an additional 2 out of 4 families and 6 out of 13 sporadic Chinese individuals with OPDM, as well as 7 out of 194 unrelated Japanese individuals with OPDM. Methylation, qRT-PCR, and western blot analysis indicated that GIPC1 mRNA levels were increased while protein levels were unaltered in OPDM-affected individuals. RNA sequencing indicated p53 signaling, vascular smooth muscle contraction, ubiquitin-mediated proteolysis, and ribosome pathways were involved in the pathogenic mechanisms of OPDM-affected individuals with GGC repeat expansion in GIPC1. This study provides further evidence that OPDM is associated with GGC repeat expansions in distinct genes and highly suggests that expanded GGC repeat units are essential in the pathogenesis of OPDM, regardless of the genes in which the expanded repeats are located.	[Deng, Jianwen; Yu, Jiaxi; Zhao, Juan; Yu, Meng; Zhang, Wei; Lv, He; Xie, Zhiying; Meng, LingChao; Zheng, Yiming; Zhao, Yawen; Gang, Qiang; Wang, Qingqing; Liu, Jing; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, Beijing 100034, Peoples R China; [Li, Pidong; Guo, Xueyu; Su, Yanan; Liang, Yu; Liang, Fan] Grand Biosci, Beijing 101312, Peoples R China; [Luan, Xinghua; Cao, Li] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Neurol, Sch Med, Shanghai 200025, Peoples R China; [Luan, Xinghua; Cao, Li] Shanghai Jiao Tong Univ, Rui Jin Hosp North, Sch Med, Shanghai 200025, Peoples R China; [Zhu, Min; Hong, Daojun] Nanchang Univ, Dept Neurol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China; [Hayashi, Tomohiro] Toyama Univ Hosp, Dept Neurol, Toyama 9300194, Japan; [Maeda, Meiko Hashimoto] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Neurol, Tokyo 1058470, Japan; [Sato, Tatsuro] Hakodate Med Assoc Hosp, Dept Neurol, Hakodate, Hokkaido 0418522, Japan; [Ura, Shigehisa] Japanese Red Cross Asahikawa Hosp, Dept Neurol, Asahikawa, Hokkaido 0708530, Japan; [Oya, Yasushi] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo 1878551, Japan; [Iida, Aritoshi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Dept Clin Genome Anal, Tokyo 1878551, Japan; [Ogasawara, Masashi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878551, Japan; [Zhou, Chang] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Jinan 250012, Peoples R China; [Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Peoples R China; [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Peoples R China; [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Peoples R China	Peking University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanchang University; University of Toyama; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shandong University; Shandong University; Shandong University; Shandong University	Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, Beijing 100034, Peoples R China.; Hong, DJ (corresponding author), Nanchang Univ, Dept Neurol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.	hongdaojun@hotmail.com; drwangzx@163.com	Liang, Fan/HGA-0248-2022; Zheng, Yiming/AFQ-9684-2022; Iida, Aritoshi/CAA-1373-2022	Iida, Aritoshi/0000-0001-7538-1651; Deng, Jianwen/0000-0003-1206-1778; Li, Pidong/0000-0001-8509-4648; Yu, Jiaxi/0000-0002-6458-5226; Ogasawara, Masashi/0000-0001-6766-4029; Zheng, Yiming/0000-0001-7993-3054; Xie, Zhiying/0000-0003-2102-6026	National Natural Science Foundation of China [81571219]; Double thousand talents program of Jiangxi province; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [29-4, 30-9]; AMED [JP19ek0109285h0003]; Institute of Advanced Medical Sciences, Tokushima University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Double thousand talents program of Jiangxi province; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); AMED; Institute of Advanced Medical Sciences, Tokushima University	We appreciated the cooperation of the individuals and their families. We are grateful to Dr. Nicolas Charlet-Berguerand for helpful suggestions. We thank Dr. Wanjin Chen for the help on linkage analysis. The work was supported by the National Natural Science Foundation of China (No. 81571219 to Z.W.), Double thousand talents program of Jiangxi province (to D.H.), Intramural Research Grant (29-4 to I.N.; 30-9 to A.I.) for Neurological and Psychiatric Disorders of NCNP, and AMED under grant number JP19ek0109285h0003 and Joint Usage and Joint Research Programs, the Institute of Advanced Medical Sciences, Tokushima University (2019, A9 to A.I.).	AMATO AA, 1995, MUSCLE NERVE, V18, P842, DOI 10.1002/mus.880180807; Anders S, 2013, DIFFERENTIAL EXPRESS, P22, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Carretero-Ortega J, 2019, ELIFE, V8, DOI 10.7554/eLife.30454; Chourabi M, 2018, J INVEST DERMATOL, V138, P291, DOI 10.1016/j.jid.2017.08.045; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Deng JW, 2019, J MED GENET, V56, P758, DOI 10.1136/jmedgenet-2019-106268; Deng JW, 2018, P NATL ACAD SCI USA, V115, pE9678, DOI 10.1073/pnas.1806655115; Deng JW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005357; Durmus H, 2011, NEUROLOGY, V76, P227, DOI 10.1212/WNL.0b013e318207b043; Fernandes F, 2014, BIOINFORMATICS, V30, P464, DOI 10.1093/bioinformatics/btt706; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Glineburg MR, 2018, BRAIN RES, V1693, P43, DOI 10.1016/j.brainres.2018.02.006; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Hagerman P, 2013, ACTA NEUROPATHOL, V126, P1, DOI 10.1007/s00401-013-1138-1; Hartmann H, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800070; Ishiura H, 2019, NAT GENET, V51, P1222, DOI 10.1038/s41588-019-0458-z; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Kong HE, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00128; Lacroix AJ, 2019, AM J HUM GENET, V104, P35, DOI 10.1016/j.ajhg.2018.11.005; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li M, 2019, GENET MED, V21, P2744, DOI 10.1038/s41436-019-0594-y; Liu Q, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0456-7; Lu H, 2008, NEUROPATHOLOGY, V28, P599, DOI 10.1111/j.1440-1789.2008.00924.x; [鲁向辉 Lu Xianghui], 2012, [中华神经科杂志, Chinese Journal of Neurology], V45, P557; Mignarri A, 2012, NEUROMUSCULAR DISORD, V22, P759, DOI 10.1016/j.nmd.2012.03.010; Minami N, 2001, NEUROMUSCULAR DISORD, V11, P699, DOI 10.1016/S0960-8966(01)00227-9; Mitsuhashi S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1667-6; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pinto BS, 2017, MOL CELL, V68, P479, DOI 10.1016/j.molcel.2017.09.033; Pulst SM, 1999, ARCH NEUROL-CHICAGO, V56, P667, DOI 10.1001/archneur.56.6.667; SATOYOSHI E, 1977, ARCH NEUROL-CHICAGO, V34, P89, DOI 10.1001/archneur.1977.00500140043007; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Sone J, 2019, NAT GENET, V51, P1215, DOI 10.1038/s41588-019-0459-y; Tang HB, 2017, AM J HUM GENET, V101, P700, DOI 10.1016/j.ajhg.2017.09.013; Tian Y, 2019, AM J HUM GENET, V105, P166, DOI 10.1016/j.ajhg.2019.05.013; Tsai EA, 2016, J PERS MED, V6, DOI 10.3390/jpm6010012; Uyama E, 1998, NEUROMUSCULAR DISORD, V8, P119, DOI 10.1016/S0960-8966(98)00002-9; van der Sluijs BM, 2004, J NEUROL NEUROSUR PS, V75, P1499, DOI 10.1136/jnnp.2003.025072; Vittonatto Elisa, 2017, Acta Myol, V36, P191; Wagner M, 2012, NEUROMUSCULAR DISORD, V22, pS31; Wang L, 2010, MOL CANCER RES, V8, P1591, DOI 10.1158/1541-7786.MCR-10-0209; Zhao J., 2015, PLOS ONE, V10; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	50	44	46	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2020	106	6					793	804		10.1016/j.ajhg.2020.04.011	http://dx.doi.org/10.1016/j.ajhg.2020.04.011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LW4IW	32413282	Bronze, Green Published			2022-12-18	WOS:000539109000007
J	Aldinger, KA; Timms, AE; Thomson, Z; Mirzaa, GM; Bennett, JT; Rosenberg, AB; Roco, CM; Hirano, M; Abidi, F; Haldipur, P; Cheng, CV; Collins, S; Park, K; Zeiger, J; Overmann, LM; Alkuraya, FS; Biesecker, LG; Braddock, SR; Cathey, S; Cho, MT; Chung, BHY; Everman, DB; Zarate, YA; Jones, JR; Schwartz, CE; Goldstein, A; Hopkin, RJ; Krantz, ID; Ladda, RL; Leppig, KA; McGillivray, BC; Sell, S; Wusik, K; Gleeson, JG; Nickerson, DA; Bamshad, MJ; Gerrelli, D; Lisgo, SN; Seelig, G; Ishak, GE; Barkovich, AJ; Curry, CJ; Glass, IA; Millen, KJ; Doherty, D; Dobyns, WB				Aldinger, Kimberly A.; Timms, Andrew E.; Thomson, Zachary; Mirzaa, Ghayda M.; Bennett, James T.; Rosenberg, Alexander B.; Roco, Charles M.; Hirano, Matthew; Abidi, Fatima; Haldipur, Parthiv; Cheng, Chi, V; Collins, Sarah; Park, Kaylee; Zeiger, Jordan; Overmann, Lynne M.; Alkuraya, Fowzan S.; Biesecker, Leslie G.; Braddock, Stephen R.; Cathey, Sara; Cho, Megan T.; Chung, Brian H. Y.; Everman, David B.; Zarate, Yuri A.; Jones, Julie R.; Schwartz, Charles E.; Goldstein, Amy; Hopkin, Robert J.; Krantz, Ian D.; Ladda, Roger L.; Leppig, Kathleen A.; McGillivray, Barbara C.; Sell, Susan; Wusik, Katherine; Gleeson, Joseph G.; Nickerson, Deborah A.; Bamshad, Michael J.; Gerrelli, Dianne; Lisgo, Steven N.; Seelig, Georg; Ishak, Gisele E.; Barkovich, A. James; Curry, Cynthia J.; Glass, Ian A.; Millen, Kathleen J.; Doherty, Dan; Dobyns, William B.			Redefining the Etiologic Landscape of Cerebellar Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DANDY-WALKER MALFORMATION; HEMORRHAGE; HETEROTOPIA; MUTATION	Cerebellar malformations are diverse congenital anomalies frequently associated with developmental disability. Although genetic and prenatal non-genetic causes have been described, no systematic analysis has been performed. Here, we present a large-exome sequencing study of Dandy-Walker malformation (DWM) and cerebellar hypoplasia (CBLH). We performed exome sequencing in 282 individuals from 100 families with DWM or CBLH, and we established a molecular diagnosis in 36 of 100 families, with a significantly higher yield for CBLH (51%) than for DWM (16%). The 41 variants impact 27 neurodevelopmental-disorder-associated genes, thus demonstrating that CBLH and DWM are often features of monogenic neurodevelopmental disorders. Though only seven monogenic causes (19%) were identified in more than one individual, neuroimaging review of 131 additional individuals confirmed cerebellar abnormalities in 23 of 27 genetic disorders (85%). Prenatal risk factors were frequently found among individuals without a genetic diagnosis (30 of 64 individuals [47%]). Single-cell RNA sequencing of prenatal human cerebellar tissue revealed gene enrichment in neuronal and vascular cell types; this suggests that defective vasculogenesis may disrupt cerebellar development. Further, de novo gain-of-function variants in PDGFRB, a tyrosine kinase receptor essential for vascular progenitor signaling, were associated with CBLH, and this discovery links genetic and non-genetic etiologies. Our results suggest that genetic defects impact specific cerebellar cell types and implicate abnormal vascular development as a mechanism for cerebellar malformations. We also confirmed a major contribution for non-genetic prenatal factors in individuals with cerebellar abnormalities, substantially influencing diagnostic evaluation and counseling regarding recurrence risk and prognosis.	[Aldinger, Kimberly A.; Thomson, Zachary; Mirzaa, Ghayda M.; Haldipur, Parthiv; Cheng, Chi, V; Collins, Sarah; Park, Kaylee; Zeiger, Jordan; Ishak, Gisele E.; Glass, Ian A.; Millen, Kathleen J.; Doherty, Dan; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Timms, Andrew E.; Bennett, James T.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Mirzaa, Ghayda M.; Bennett, James T.; Bamshad, Michael J.; Glass, Ian A.; Millen, Kathleen J.; Doherty, Dan; Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Rosenberg, Alexander B.; Hirano, Matthew; Seelig, Georg] Univ Washington, Dept Elect Engn, Seattle, WA 98105 USA; [Roco, Charles M.] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA; [Abidi, Fatima; Cathey, Sara; Everman, David B.; Jones, Julie R.; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Overmann, Lynne M.; Lisgo, Steven N.] Newcastle Univ, Int Ctr Life, Inst Genet Med, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Alkuraya, Fowzan S.; Ladda, Roger L.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Res Ctr, Riyadh 11211, Saudi Arabia; [Biesecker, Leslie G.] Natl Human Genome Res Inst, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Braddock, Stephen R.] St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA; [Cho, Megan T.] GeneDx, Gaithersburg, MD 20877 USA; [Chung, Brian H. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Peoples R China; [Zarate, Yuri A.] Univ Arkansas Med Sci, Sect Genet & Metab, Little Rock, AR 72202 USA; [Goldstein, Amy] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Mitochondrial Med Frontier Program, Philadelphia, PA 19104 USA; [Goldstein, Amy; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Hopkin, Robert J.] Cincinnati Childrens Hosp, Dept Pediat, Div Human Genet, Med Ctr, Cincinnati, OH 45229 USA; [Hopkin, Robert J.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; [Sell, Susan] Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA 17033 USA; [Ladda, Roger L.] Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA; [Leppig, Kathleen A.] Kaiser Permanente Washington, Genet Serv, Seattle, WA 98112 USA; [McGillivray, Barbara C.] Childrens & Womens Hlth Ctr British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Wusik, Katherine] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Ctr Mendelian Genom, Seattle, WA 98195 USA; [Gerrelli, Dianne] UCL, Inst Child Hlth, London WC1N 1EH, England; [Seelig, Georg] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Ishak, Gisele E.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Curry, Cynthia J.] Univ Calif San Francisco, Dept Pediat, Genet Med, Fresno, CA 93701 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98105 USA	Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Greenwood Genetic Center; Newcastle University - UK; King Faisal Specialist Hospital & Research Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Saint Louis University; University of Hong Kong; University of Arkansas System; University of Arkansas Medical Sciences; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Kaiser Permanente; BC Women's Hospital & Health Centre; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; University College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of Washington; University of Washington Seattle	Dobyns, WB (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.; Dobyns, WB (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98105 USA.; Dobyns, WB (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98105 USA.	wbd@uw.edu	Dobyns, William Brian/ABC-6525-2021; Haldipur, Parthiv/ABH-8875-2020; Dobyns, William/AAI-2768-2020; Braddock, Stephen/AAL-1667-2021; Aldinger, Kimberly/ABB-1561-2020	Dobyns, William/0000-0002-7681-2844; Aldinger, Kimberly/0000-0002-5406-8911; Hopkin, Robert/0000-0003-0770-5516; Millen, Kathleen/0000-0001-9978-675X; HALDIPUR, PARTHIV/0000-0003-2865-8683; Lisgo, Steven/0000-0001-5186-3971; Zeiger, Jordan/0000-0002-0429-2122; Thomson, Zachary/0000-0002-3861-9998	National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS); National Institute of Child Health and Human Development (NICHD) [5R01NS050375, R01NS095733, K08NS092898, R24HD000836]; National Human Genome Research Institute (NHGRI) [U54HG006493]; University of Washington Intellectual and Developmental Disabilities Research Center (IDDRC) Genetics Core - NICHD [U54HG006493]; Dandy-Walker Alliance; Philly Baer Foundation; Intramural Research Program of the NHGRI [HG200328]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359, ZIAHG200328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050375, R01NS095733, K08NS092898] Funding Source: NIH RePORTER; MRC [MR/R006237/1] Funding Source: UKRI	National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Washington Intellectual and Developmental Disabilities Research Center (IDDRC) Genetics Core - NICHD; Dandy-Walker Alliance; Philly Baer Foundation; Intramural Research Program of the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the children as well as their families and referring physicians for their important contributions to our ongoing work on cerebellar disorders. This study was funded by the National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) or National Institute of Child Health and Human Development (NICHD) grant numbers 5R01NS050375 to W.B.D, R01NS095733 to K.J.M., K08NS092898 to G.M.M., and R24HD000836 to I.A.G. The University of Washington Center for Mendelian Genomics provided sequencing and data analysis, supported by National Human Genome Research Institute (NHGRI) grant number U54HG006493 to D.A.N. and M.J.B., and the University of Washington Intellectual and Developmental Disabilities Research Center (IDDRC) Genetics Core, supported by NICHD grant number U54HG006493, provided support to D.D. Additional funding was provided by The Dandy-Walker Alliance and The Philly Baer Foundation. L.G.B. was supported by grant number HG200328 from the Intramural Research Program of the NHGRI. Human fetal material was provided, in part, by the Joint Medical Research Council and Wellcome (MR/R006237/1) Human Developmental Biology Resource. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources. Please note that the authors cite OMIM according to journal editorial policy but do not endorse the referenced OMIM data.	Adamsbaum C, 2005, PEDIATR RADIOL, V35, P124, DOI 10.1007/s00247-004-1316-3; Aldinger KA, 2016, SEMIN FETAL NEONAT M, V21, P321, DOI 10.1016/j.siny.2016.04.008; Aldinger KA, 2016, J MED GENET, V53, P427, DOI 10.1136/jmedgenet-2015-103476; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P290; BARKOVICH AJ, 1989, AM J ROENTGENOL, V153, P1289, DOI 10.2214/ajr.153.6.1289; BENDA CE, 1954, J NEUROPATH EXP NEUR, V13, P14, DOI 10.1093/jnen/13.1.14; Bernardo S, 2015, PRENATAL DIAG, V35, P1358, DOI 10.1002/pd.4705; Boltshauseur E, 1996, NEUROPEDIATRICS, V27, P50, DOI 10.1055/s-2007-973748; Cappellacci S, 2006, AM J MED GENET A, V140A, P1203, DOI 10.1002/ajmg.a.31219; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Dandy WE, 1914, AM J DIS CHILD, V8, P406; ECCLES D, 2005, J MED GENET, V42, DOI DOI 10.1136/JMG.2004.028084; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gerrelli D, 2015, DEVELOPMENT, V142, P3073, DOI 10.1242/dev.122820; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Gripp KW, 2012, AM J MED GENET A, V158A, P2106, DOI 10.1002/ajmg.a.35449; Heinzen EL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007281; Hintz SR, 2015, PEDIATRICS, V135, pE32, DOI 10.1542/peds.2014-0898; Howley MM, 2018, BIRTH DEFECTS RES, V110, P1419, DOI 10.1002/bdr2.1388; Johnston JJ, 2015, AM J HUM GENET, V97, P465, DOI 10.1016/j.ajhg.2015.07.009; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kontopoulos EV, 2008, J MATERN-FETAL NEO M, V21, P839, DOI 10.1080/14767050802302967; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Li DZ, 2009, FETAL DIAGN THER, V25, P141, DOI 10.1159/000207556; Limperopoulos C, 2005, PEDIATRICS, V116, P717, DOI 10.1542/peds.2005-0556; Limperopoulos C, 2005, PEDIATRICS, V115, P688, DOI 10.1542/peds.2004-1169; Limperopoulos C, 2010, SEMIN PEDIATR NEUROL, V17, P75, DOI 10.1016/j.spen.2010.02.015; Limperopoulos C, 2009, PEDIATR NEUROL, V41, P1, DOI 10.1016/j.pediatrneurol.2009.02.007; Martignetti JA, 2013, AM J HUM GENET, V92, P1001, DOI 10.1016/j.ajhg.2013.04.024; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Pichiecchio A, 2016, EUR J PAEDIATR NEURO, V20, P188, DOI 10.1016/j.ejpn.2015.09.009; Pinchefsky EF, 2019, DEV MED CHILD NEUROL, V61, P350, DOI 10.1111/dmcn.14059; Pisano T, 2012, NEUROLOGY, V79, P1244, DOI 10.1212/WNL.0b013e31826aac88; Pond D, 2018, GENET MED, V20, P142, DOI 10.1038/gim.2017.104; Poretti A, 2009, NEUROPEDIATRICS, V40, P228, DOI 10.1055/s-0030-1248265; Poretti A, 2010, DEV MED CHILD NEUROL, V52, P718, DOI 10.1111/j.1469-8749.2009.03522.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Rossi M, 2017, PEDIATR NEUROL, V70, P34, DOI 10.1016/j.pediatrneurol.2017.01.033; Shiohama T, 2017, CASE REP PEDIAT, V2017, DOI 10.1155/2017/3861608; Snoeijen-Schouwenaars FM, 2019, EPILEPSIA, V60, P155, DOI 10.1111/epi.14618; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Steggerda SJ, 2013, CEREBELLUM, V12, P794, DOI 10.1007/s12311-013-0487-6; Taggart JK, 1942, ARCH NEURO PSYCHIATR, V48, P583, DOI 10.1001/archneurpsyc.1942.02290100083008; Tam EWY, 2011, J PEDIATR-US, V158, P245, DOI 10.1016/j.jpeds.2010.07.049; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Zarate YA, 2019, AM J MED GENET A, V179, P1047, DOI 10.1002/ajmg.a.61145	48	44	44	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					606	615		10.1016/j.ajhg.2019.07.019	http://dx.doi.org/10.1016/j.ajhg.2019.07.019			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31474318	Bronze, Green Published			2022-12-18	WOS:000484435700013
J	Bustamante-Marin, XM; Yin, WN; Sears, PR; Werner, ME; Brotslaw, EJ; Mitchell, BJ; Jania, CM; Zeman, KL; Rogers, TD; Herring, LE; Refabert, L; Thomas, L; Amselem, S; Escudier, E; Legendre, M; Grubb, BR; Knowles, MR; Zariwala, MA; Ostrowski, LE				Bustamante-Marin, Ximena M.; Yin, Wei-Ning; Sears, Patrick R.; Werner, Michael E.; Brotslaw, Eva J.; Mitchell, Brian J.; Jania, Corey M.; Zeman, Kirby L.; Rogers, Troy D.; Herring, Laura E.; Refabert, Luc; Thomas, Lucie; Amselem, Serge; Escudier, Estelle; Legendre, Marie; Grubb, Barbara R.; Knowles, Michael R.; Zariwala, Maimoona A.; Ostrowski, Lawrence E.			Lack of GAS2L2 Causes PCD by Impairing Cilia Orientation and Mucociliary Clearance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NITRIC-OXIDE MEASUREMENT; PLANAR CELL POLARITY; REAL-TIME PCR; EPITHELIAL-CELLS; INTRAFLAGELLAR TRANSPORT; HOUSEKEEPING GENES; BINDING PROTEIN; BODY ASYMMETRY; BEAT PATTERN; BASAL BODIES	Primary ciliary dyskinesia (PCD) is a genetic disorder in which impaired ciliary function leads to chronic airway disease. Exome sequencing of a PCD subject identified an apparent homozygous frameshift variant, c.887_890delTAAG (p.Val296Glyfs*13), in exon 5; this frameshift introduces a stop codon in amino acid 308 of the growth arrest-specific protein 2-like 2 (GAS2L2). Further genetic screening of unrelated PCD subjects identified a second proband with a compound heterozygous variant carrying the identical frameshift variant and a large deletion (c.867_*343+1207del; p.?) starting in exon 5. Both individuals had clinical features of PCD but normal ciliary axoneme structure. In this research, using human nasal cells, mouse models, and X. laevis embryos, we show that GAS2L2 is abundant at the apical surface of ciliated cells, where it localizes with basal bodies, basal feet, rootlets, and actin filaments. Cultured GAS2L2-deficient nasal epithelial cells from one of the affected individuals showed defects in ciliary orientation and had an asynchronous and hyperkinetic (GAS2L2-deficient = 19.8 Hz versus control = 15.8 Hz) ciliary-beat pattern. These results were recapitulated in Gas2l2(-/-) mouse tracheal epithelial cell (mTEC) cultures and in X. laevis embryos treated with Gas2l2 morpholinos. In mice, the absence of Gas2l2 caused neonatal death, and the conditional deletion of Gas2l2 impaired mucociliary clearance (MCC) and led to mucus accumulation. These results show that a pathogenic variant in GAS2L2 causes a genetic defect in ciliary orientation and impairs MCC and results in PCD.	[Bustamante-Marin, Ximena M.; Yin, Wei-Ning; Sears, Patrick R.; Rogers, Troy D.; Grubb, Barbara R.; Knowles, Michael R.; Ostrowski, Lawrence E.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Werner, Michael E.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Brotslaw, Eva J.; Mitchell, Brian J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jania, Corey M.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27599 USA; [Zeman, Kirby L.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27599 USA; [Herring, Laura E.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Refabert, Luc] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, F-75015 Paris, France; [Thomas, Lucie; Amselem, Serge; Escudier, Estelle; Legendre, Marie] Sorbonne Univ, Hop Trousseau, AP HP, INSERM,Childhood Genet Disorders,Dept Genet Med, F-75012 Paris, France; [Zariwala, Maimoona A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill	Ostrowski, LE (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA.; Zariwala, MA (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	maimoona_zariwala@med.unc.edu; ostro@med.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , BRIC Small Animal Imaging Facility/AEV-1023-2022; Legendre, Marie/AAD-7018-2021; , Proteomics Core UNC/AFQ-7201-2022	, BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Legendre, Marie/0000-0003-2178-0846; Bustamante Marin, Ximena/0000-0002-8534-3103; Brotslaw, Eva/0000-0002-1791-8411; THOMAS, Lucie/0000-0001-6998-590X	University of Washington School of Medicine (National Institutes of Health) [NHI]/National Human Genome Research Institute [NHGRI]) [U54HG0006493]; Seattle GO Sequencing Project [HL-102926]; RS & G at Northwest Genomics Center at the University of Washington (NIH-National Heart, Lung, and Blood Institute [NHLBI]) [HHSN268201100037]; National Cancer Institute cancer core grant [P30-CA016086-40]; National Institute of General Medical Sciences at the NIH [R01GM089970]; Office of Rare Diseases Research [5U54HL096458]; NHLBI at the NIH; NIH-NHLBI [R01HL071798, R01HL117836]; National Center for Advancing Translational Sciences at the NIH [UL1 TR000083]; Fondation pour la Recherche Medicale [DEQ20120323689]; Institut National de la Sante et de la Recherche Medicale (INSERM) [ANR-10-COHO-003]; Legs Poix grant from the Chancellerie des Universites of Sorbonne Universite;  [BOUCHE15R0];  [P30DK065988]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071798, R01HL117836, U54HL096458] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089970] Funding Source: NIH RePORTER	University of Washington School of Medicine (National Institutes of Health) [NHI]/National Human Genome Research Institute [NHGRI]); Seattle GO Sequencing Project; RS & G at Northwest Genomics Center at the University of Washington (NIH-National Heart, Lung, and Blood Institute [NHLBI]); National Cancer Institute cancer core grant; National Institute of General Medical Sciences at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Rare Diseases Research; NHLBI at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences at the NIH; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Legs Poix grant from the Chancellerie des Universites of Sorbonne Universite; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the PCD subjects and family members for their participation and thank the US PCD Foundation and the investigators and coordinators of the Genetic Disorders of Mucociliary Clearance Consortium, part of the Rare Disease Clinical Research Network. We thank Jay Shendure, Deborah Nickerson, and Michael Bamshad from University of Washington School of Medicine (National Institutes of Health [NHI]/National Human Genome Research Institute [NHGRI] U54HG0006493), Seattle GO Sequencing Project (HL-102926), RS & G at Northwest Genomics Center at the University of Washington (NIH-National Heart, Lung, and Blood Institute [NHLBI] HHSN268201100037); Shrikant Mane, Francesc Lopez-Giraldez, and Weilai Dong from the Yale Center (UM1 HG006504) for whole-exome sequencing and bioinformatics support; Kimberly Burns for histology and electron-microscopy support; Whitney Wolf and Lu Huang for technical assistance; Hong Dang for bioinformatics assistance; Robert Tarran for providing the Leica Sp8 confocal and GSD microscopes; Michael Chua and Tony Perdue for assistance with confocal imaging; Frank Conlon and Panna Tandon for providing Xenopus laevis oocytes; Uma Nagarajan and Amy Kiatthanapaiboon for providing samples of human fallopian -tube total RNA; Julie Kimbell for assistance with Mimics Research 18.0; and Scott H. Randell and the UNC Cell Culture Core for providing human airway cells. The UNC Cell Core Facility is supported by BOUCHE15R0 and P30DK065988 grants. The UNC Proteomics Core Facility is supported in part by P30 CA016086. The Small Animal Imaging Facility at the UNC Biomedical Imaging Research Center is supported in part by a National Cancer Institute cancer core grant, P30-CA016086-40. Funding support for this research was provided to B.J.M. by R01GM089970 from the National Institute of General Medical Sciences at the NIH; to M.R.K and M.A.Z by grant 5U54HL096458 from the Office of Rare Diseases Research and NHLBI at the NIH; to M.R.K., L.E.O., and M.A.Z. by NIH-NHLBI grant R01HL071798; to LEO., M.A.Z., and M.R.K by NIH-NHLBI grant R01HL117836; and to the University of North Carolina at Chapel Hill by grant UL1 TR000083 from the National Center for Advancing Translational Sciences at the NIH. Work by S.A., E.E., M.L., and L.T. is supported by the Fondation pour la Recherche Medicale grant DEQ20120323689, by Institut National de la Sante et de la Recherche Medicale (INSERM) grant ANR-10-COHO-003, and the Legs Poix grant from the Chancellerie des Universites of Sorbonne Universite.	Au FKC, 2017, DEV CELL, V40, P81, DOI 10.1016/j.devcel.2016.11.019; Batschelet E., 1981, MATH BIOL, V24, P371; BAUM GL, 1990, CHEST, V98, P608, DOI 10.1378/chest.98.3.608; Beydon N, 2015, PEDIATR PULM, V50, P1374, DOI 10.1002/ppul.23167; Blackburn K, 2017, J PROTEOME RES, V16, P1579, DOI 10.1021/acs.jproteome.6b00972; Bonnefoy S, 2018, AM J HUM GENET, V103, P727, DOI 10.1016/j.ajhg.2018.10.003; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; Bukowy-Bieryllo Z, 2013, PEDIATR PULM, V48, P352, DOI 10.1002/ppul.22632; Bustamante-Marin X. M., 2017, COLD SPRING HARB PER, V9, P9; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Clare DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5888; Collavin L, 1998, GENOMICS, V48, P265, DOI 10.1006/geno.1997.5172; Dabholkar YG, 2014, INDIAN J OTOLARYNGOL, V66, P92, DOI 10.1007/s12070-013-0689-8; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Desmond JC, 2007, LEUKEMIA, V21, P1026, DOI 10.1038/sj.leu.2404611; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Edelbusch C, 2017, HUM MUTAT, V38, P964, DOI 10.1002/humu.23261; El Khouri E, 2016, AM J HUM GENET, V99, P489, DOI 10.1016/j.ajhg.2016.06.022; Fassad MR, 2018, AM J HUM GENET, V102, P956, DOI 10.1016/j.ajhg.2018.03.024; Finn R, 2014, NEUROSCIENCE, V277, P552, DOI 10.1016/j.neuroscience.2014.07.029; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gamper I, 2009, EXP HEMATOL, V37, P539, DOI 10.1016/j.exphem.2009.02.002; Gentzsch M, 2017, AM J RESP CELL MOL, V56, P568, DOI 10.1165/rcmb.2016-0276MA; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; Grubb BR, 2016, AM J PHYSIOL-LUNG C, V310, pL860, DOI 10.1152/ajplung.00015.2016; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hoben IM, 2018, AM J HUM GENET, V102, P973, DOI 10.1016/j.ajhg.2018.03.025; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Hua XY, 2010, J APPL PHYSIOL, V108, P189, DOI 10.1152/japplphysiol.00669.2009; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Knowles MR, 2016, CLIN CHEST MED, V37, P449, DOI 10.1016/j.ccm.2016.04.008; Knowles MR, 2014, AM J RESP CRIT CARE, V189, P707, DOI 10.1164/rccm.201311-2047OC; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Leigh Margaret W, 2013, Ann Am Thorac Soc, V10, P574, DOI 10.1513/AnnalsATS.201305-110OC; LEIGH MW, 1992, CHEST, V101, pS16, DOI 10.1378/chest.101.3_Supplement.16S; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lundberg JO, 2008, ANAT REC, V291, P1479, DOI 10.1002/ar.20782; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; MONCADA S, 1991, PHARMACOL REV, V43, P109; Muller L, 2013, JOVE-J VIS EXP, DOI 10.3791/50646; Muthusamy N, 2014, GENESIS, V52, P350, DOI 10.1002/dvg.22753; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Noone PG, 1999, AM J RESP CRIT CARE, V160, P144, DOI 10.1164/ajrccm.160.1.9806146; Olbrich H, 2015, AM J HUM GENET, V97, P546, DOI 10.1016/j.ajhg.2015.08.012; Olcese C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14279; Ostrowski LE, 2014, GENE THER, V21, P253, DOI 10.1038/gt.2013.79; Ostrowski LE, 2010, AM J RESP CELL MOL, V43, P55, DOI 10.1165/rcmb.2009-0118OC; Paff T, 2017, AM J HUM GENET, V100, P160, DOI 10.1016/j.ajhg.2016.11.019; Raidt J, 2014, EUR RESPIR J, V44, P1579, DOI 10.1183/09031936.00052014; RAYNER CFJ, 1995, AM J RESP CRIT CARE, V151, P800; Rayner CFJ, 1996, AM J RESP CRIT CARE, V153, P1123, DOI 10.1164/ajrccm.153.3.8630555; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Runer T, 1998, ANN OTO RHINOL LARYN, V107, P40, DOI 10.1177/000348949810700108; RUTLAND J, 1990, NEW ENGL J MED, V323, P1681, DOI 10.1056/NEJM199012133232406; RUTMAN A, 1993, THORAX, V48, P770, DOI 10.1136/thx.48.7.770; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Sears PR, 2015, AM J PHYSIOL-LUNG C, V309, pL99, DOI 10.1152/ajplung.00024.2015; Shapiro AJ, 2016, PEDIATR PULM, V51, P115, DOI 10.1002/ppul.23304; Sharaby Y, 2014, DEV BIOL, V394, P305, DOI 10.1016/j.ydbio.2014.08.006; Sive HL, 2000, EARLY DEV XENOPUS LA; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stroud MJ, 2014, J CELL SCI, V127, P2672, DOI 10.1242/jcs.140558; Stroud MJ, 2011, J BIOL CHEM, V286, P24987, DOI 10.1074/jbc.M111.242263; Vertii Anastassiia, 2016, Cilia, V5, P13, DOI 10.1186/s13630-016-0030-8; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; Wallmeier J, 2016, AM J HUM GENET, V99, P460, DOI 10.1016/j.ajhg.2016.06.014; Werner ME, 2013, METHOD ENZYMOL, V525, P191, DOI 10.1016/B978-0-12-397944-5.00010-9; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Wolter P, 2012, J CELL SCI, V125, P2393, DOI 10.1242/jcs.097253; Wu YC, 2013, BBA-MOL CELL RES, V1833, P3145, DOI 10.1016/j.bbamcr.2013.08.009; Xiao X, 2016, MED IMAGE ANAL, V32, P157, DOI 10.1016/j.media.2016.03.007; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; York JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep34956; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zariwala M. A., 2007, GENEREVIEWS; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024698; Zhou HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086195	85	44	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2019	104	2					229	245		10.1016/j.ajhg.2018.12.009	http://dx.doi.org/10.1016/j.ajhg.2018.12.009			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL2SW	30665704	Green Published, Bronze			2022-12-18	WOS:000458557800005
J	Evans, DGR; van Veen, EM; Byers, HJ; Wallace, AJ; Ellingford, JM; Beaman, G; Santoyo-Lopez, J; Aitman, TJ; Eccles, DM; Lalloo, FI; Smith, MJ; Newman, WG				Evans, D. Gareth R.; van Veen, Elke M.; Byers, Helen J.; Wallace, Andrew J.; Ellingford, Jamie M.; Beaman, Glenda; Santoyo-Lopez, Javier; Aitman, Timothy J.; Eccles, Diana M.; Lalloo, Fiona I.; Smith, Miriam J.; Newman, William G.			A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROMOTER HYPERMETHYLATION; SPORADIC BREAST; EPIGENETIC INACTIVATION; SCORING SYSTEM; FAMILIES; RISK; SENSITIVITY; TUMORS; MLH1	Pathogenic variants in BRCA1 or BRCA2 are identified in similar to 20% of families with multiple individuals affected by early-onset breast and/or ovarian cancer. Extensive searches for additional highly penetrant genes or alternative mutational mechanisms altering BRCA1 or BRCA2 have not explained the missing heritability. Here, we report a dominantly inherited 5' UTR variant associated with epigenetic BRCA1 silencing due to promoter hypermethylation in two families affected by breast and ovarian cancer. BRCA1 promoter methylation of ten CpG dinucleotides in families who are affected by breast and/or ovarian cancer but do not have germline BRCA1 or BRCA2 pathogenic variants was assessed by pyrosequencing and clonal bisulfite sequencing. RNA and DNA sequencing of BRCA1 from lymphocytes was undertaken to establish allelic expression and the presence of germline variants. BRCA1 promoter hypermethylation was identified in 2 of 49 families in which multiple women are affected by grade 3 breast cancer or high-grade serous ovarian cancer. Soma-wide BRCA1 promoter hypermethylation was confirmed in blood, buccal mucosa, and hair follicles. Pyrosequencing showed that DNA was similar to 50% methylated, consistent with the silencing of one allele, which was confirmed by clonal bisulfite sequencing. RNA sequencing revealed the allelic loss of BRCA1 expression in both families and that this loss of expression segregated with the heterozygous variant c. -107A>T in the BRCA1 5' UTR. Our results establish a mechanism whereby familial breast and ovarian cancer is caused by an in cis 5' UTR variant associated with epigenetic silencing of the BRCA1 promoter in two independent families. We propose that methylation analyses be undertaken to establish the frequency of this mechanism in families affected by early-onset breast and/or ovarian cancer without a BRCA1 or BRCA2 pathogenic variant.	[Evans, D. Gareth R.; van Veen, Elke M.; Byers, Helen J.; Ellingford, Jamie M.; Beaman, Glenda; Smith, Miriam J.; Newman, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Fac Biol Med & Hlth,Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Evans, D. Gareth R.] Univ Hosp South Manchester, Prevent Breast Canc Ctr, Manchester M23 9LT, Lancs, England; [Evans, D. Gareth R.] Univ Hosp South Manchester, Nightingale Breast Screening Ctr, Manchester M23 9LT, Lancs, England; [Evans, D. Gareth R.] Christie NHS Fdn Trust, Manchester M20 4BX, Lancs, England; [Evans, D. Gareth R.; Newman, William G.] Univ Manchester, Manchester Canc Res Ctr, Manchester Breast Ctr, Manchester M20 4BX, Lancs, England; [van Veen, Elke M.; Byers, Helen J.; Wallace, Andrew J.; Ellingford, Jamie M.; Beaman, Glenda; Lalloo, Fiona I.; Smith, Miriam J.; Newman, William G.] St Marys Hosp, Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Santoyo-Lopez, Javier; Aitman, Timothy J.] Univ Edinburgh, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Santoyo-Lopez, Javier; Aitman, Timothy J.] Univ Edinburgh, Edinburgh Genom, Edinburgh EH4 2XU, Midlothian, Scotland; [Eccles, Diana M.] Univ Southampton, Fac Med, Canc Sci Acad Unit, Southampton S016 6YD, Hants, England; [Eccles, Diana M.] Univ Southampton, Fac Med, Southampton Clin Trials Unit, Southampton S016 6YD, Hants, England; [Eccles, Diana M.] Univ Hosp Southampton Fdn Trust, Southampton S016 6YD, Hants, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; Christie NHS Foundation Trust; University of Manchester; University of Manchester; University of Edinburgh; University of Edinburgh; University of Southampton; University of Southampton	Evans, DGR; Newman, WG (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Fac Biol Med & Hlth,Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England.; Evans, DGR (corresponding author), Univ Hosp South Manchester, Prevent Breast Canc Ctr, Manchester M23 9LT, Lancs, England.; Evans, DGR (corresponding author), Univ Hosp South Manchester, Nightingale Breast Screening Ctr, Manchester M23 9LT, Lancs, England.; Evans, DGR (corresponding author), Christie NHS Fdn Trust, Manchester M20 4BX, Lancs, England.; Evans, DGR; Newman, WG (corresponding author), Univ Manchester, Manchester Canc Res Ctr, Manchester Breast Ctr, Manchester M20 4BX, Lancs, England.; Newman, WG (corresponding author), St Marys Hosp, Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England.	gareth.evans@mft.nhs.uk; william.newman@manchester.ac.uk	Evans, D Gareth/AAB-4308-2022; van Veen, Elke/ABA-3250-2021; Eccles, Diana/K-6327-2019; Santoyo-Lopez, Javier/C-9714-2012; Santoyo-Lopez, Javier/AHE-5002-2022; Ellingford, Jamie M/AAZ-7474-2020	Evans, D Gareth/0000-0002-8482-5784; van Veen, Elke/0000-0001-8618-2332; Eccles, Diana/0000-0002-9935-3169; Santoyo-Lopez, Javier/0000-0003-1988-5059; Santoyo-Lopez, Javier/0000-0003-1988-5059; Ellingford, Jamie M/0000-0003-1137-9768; Newman, William/0000-0002-6382-4678; Aitman, Timothy/0000-0002-7875-4502	Prevent Breast Cancer [GA 12-006, GA 15-002]; Manchester NIHR Biomedical Research Centre [IS-BRC-1215-20007]; NIHR [NF-SI-0513-10076]; Health Education England Genomics Education Programme (HEE GEP); MRC [MR/N005902/1, MC_PC_15080] Funding Source: UKRI	Prevent Breast Cancer; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Health Education England Genomics Education Programme (HEE GEP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the family members for their participation and co-operation. This work was funded by Prevent Breast Cancer (GA 12-006 and GA 15-002) and the Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007). D.G.R.E. is an NIHR Senior Investigator (NF-SI-0513-10076). J.M.E. is funded by a postdoctoral research fellowship from the Health Education England Genomics Education Programme (HEE GEP). The views expressed in this publication are those of the authors and not necessarily those of the HEE GEP. No funding bodies had a role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. D.G.R.E. and E.M.v.V. had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All tested individuals gave consent to present their personal information in this manuscript. We thank Jeanette Rothwell for sample collection and Natasha Leo for technical assistance, as well as the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Byers H, 2016, EUR J HUM GENET, V24, P1591, DOI 10.1038/ejhg.2016.57; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Eccles SA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3493; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Evans DG, 2017, J MED GENET, V54, P674, DOI 10.1136/jmedgenet-2017-104584; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Frosk P, 2007, GENET TEST, V11, P208, DOI 10.1089/gte.2006.0518; Hansmann T, 2012, HUM MOL GENET, V21, P4669, DOI 10.1093/hmg/dds308; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hitchins MP, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc4001; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morak M, 2018, J MED GENET, V55, P240, DOI 10.1136/jmedgenet-2017-104744; Moran A, 2012, FAM CANCER, V11, P235, DOI 10.1007/s10689-011-9506-2; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sloane MA, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0207-4; Stefansson OA, 2012, EPIGENETICS-US, V7, P1225, DOI 10.4161/epi.22561; Tapia T, 2008, EPIGENETICS-US, V3, P157, DOI 10.4161/epi.3.3.6387; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Yamashita N, 2015, CLIN BREAST CANCER, V15, P498, DOI 10.1016/j.clbc.2015.06.009	28	44	44	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					213	220		10.1016/j.ajhg.2018.07.002	http://dx.doi.org/10.1016/j.ajhg.2018.07.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30075112	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000440563700004
J	Raraigh, KS; Han, ST; Davis, E; Evans, TA; Pellicore, MJ; McCague, AF; Joynt, AT; Lu, ZZ; Atalar, M; Sharma, N; Sheridan, MB; Sosnay, PR; Cutting, GR				Raraigh, Karen S.; Han, Sangwoo T.; Davis, Emily; Evans, Taylor A.; Pellicore, Matthew J.; McCague, Allison F.; Joynt, Anya T.; Lu, Zhongzhou; Atalar, Melis; Sharma, Neeraj; Sheridan, Molly B.; Sosnay, Patrick R.; Cutting, Garry R.			Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; SEQUENCE VARIANTS; MESSENGER-RNA; GENE-TRANSFER; CFTR; MUTATIONS; DELTA-F508; DISEASE; PATHOGENICITY	Missense DNA variants have variable effects upon protein function. Consequently, interpreting their pathogenicity is challenging, especially when they are associated with disease variability. To determine the degree to which functional assays inform interpretation, we analyzed 48 CFTR missense variants associated with variable expressivity of cystic fibrosis (CF). We assessed function in a native isogenic context by evaluating CFTR mutants that were stably expressed in the genome of a human airway cell line devoid of endogenous CFTR expression. 21 of 29 variants associated with full expressivity of the CF phenotype generated < 10% wild-type CFTR (WT-CFTR) function, a conservative threshold for the development of life-limiting CF lung disease, and five variants had moderately decreased function (10% to similar to 25% WT-CFTR). The remaining three variants in this group unexpectedly had > 25% WT-CFTR function; two were higher than 75% WT-CFTR. As expected, 14 of 19 variants associated with partial expressivity of CF had > 25% WT-CFTR function; however, four had minimal to no effect on CFTR function (> 75% WT-CFTR). Thus, 6 of 48 (13%) missense variants believed to be disease causing did not alter CFTR function. Functional studies substantially refined pathogenicity assignment with expert annotation and criteria from the American College of Medical Genetics and Genomics and Association for Molecular Pathology. However, four algorithms (CADD, REVEL, SIFT, and PolyPhen-2) could not differentiate between variants that caused severe, moderate, or minimal reduction in function. In the setting of variable expressivity, these results indicate that functional assays are essential for accurate interpretation of missense variants and that current prediction tools should be used with caution.	[Raraigh, Karen S.; Han, Sangwoo T.; Davis, Emily; Evans, Taylor A.; Pellicore, Matthew J.; McCague, Allison F.; Joynt, Anya T.; Lu, Zhongzhou; Atalar, Melis; Sharma, Neeraj; Sheridan, Molly B.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Sosnay, Patrick R.] Johns Hopkins Univ, Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	gcutting@jhmi.edu	Davis-Marcisak, Emily/X-1046-2019; Han, Sangwoo/E-4578-2018	Davis-Marcisak, Emily/0000-0001-8624-1013; Pellicore, Matthew/0000-0002-6792-0456; Han, Sangwoo/0000-0002-5876-704X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK044003] Funding Source: Medline; NIGMS NIH HHS [T32 GM007814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Awatade NT, 2015, EBIOMEDICINE, V2, P147, DOI 10.1016/j.ebiom.2014.12.005; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Bombieri C, 2015, SEMIN RESP CRIT CARE, V36, P180, DOI 10.1055/s-0035-1547318; Bromberg Y, 2013, P NATL ACAD SCI USA, V110, P14255, DOI 10.1073/pnas.1216613110; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Castellana S, 2013, BRIEF BIOINFORM, V14, P448, DOI 10.1093/bib/bbt013; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Chakravorty S, 2017, ANNU REV GENOM HUM G, V18, P229, DOI 10.1146/annurev-genom-083115-022545; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; Claustres M, 2017, HUM MUTAT, V38, P1297, DOI 10.1002/humu.23276; Dannhoffer L, 2009, AM J RESP CELL MOL, V40, P717, DOI 10.1165/rcmb.2008-0018OC; DESGEORGES M, 1994, AM J HUM GENET, V54, P384; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Farinha CM, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.152; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; Feuillet-Fieux MN, 2011, RHINOLOGY, V49, P347, DOI 10.4193/Rhino10.225; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Ghosh R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1353-5; GOLDMAN MJ, 1995, NAT GENET, V9, P126, DOI 10.1038/ng0295-126; Gottschalk LB, 2016, J CYST FIBROS, V15, P285, DOI 10.1016/j.jcf.2015.11.010; Greunert D. C, 1989, J CELL BIOL, V107, p140A; Guidugli L, 2018, AM J HUM GENET, V102; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Harrison SM, 2017, GENET MED, V19, P1096, DOI 10.1038/gim.2017.14; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Ipe J, 2017, CTS-CLIN TRANSL SCI, V10, P67, DOI 10.1111/cts.12440; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Kalin N, 1992, Hum Mutat, V1, P204, DOI 10.1002/humu.1380010305; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Knowles MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009548; KOBAYASHI K, 1990, AM J HUM GENET, V47, P611; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; LaRusch J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004376; Lee M, 2017, AM J HUM GENET, V100, P751, DOI 10.1016/j.ajhg.2017.04.001; Leong IUS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0176-z; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Marion H, 2015, J CYST FIBROS, V14, P305, DOI 10.1016/j.jcf.2014.11.001; Masica DL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004725; Masica DL, 2015, HUM MOL GENET, V24, P1908, DOI 10.1093/hmg/ddu607; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Moskowitz SM, 2008, GENET MED, V10, P851, DOI 10.1097/GIM.0b013e31818e55a2; Pranke IM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07504-1; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritchie GRS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0087-1; Salinas DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155624; SAVOV A, 1995, HUM MOL GENET, V4, P1169, DOI 10.1093/hmg/4.7.1169; Schaedel C, 1998, CLIN GENET, V53, P383; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stanton BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127742; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Sunyaev SR, 2012, HUM MOL GENET, V21, pR10, DOI 10.1093/hmg/dds385; Tang HM, 2016, GENETICS, V203, P635, DOI 10.1534/genetics.116.190033; Tang Rongying, 2016, Advances in Bioinformatics, V2016, P5614058, DOI 10.1155/2016/5614058; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Tsui LC., 2011, CYSTIC FIBROSIS MUTA; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Woods NT, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.1; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Young DL, 2015, MOL BIOL CELL, V26, P3904, DOI 10.1091/mbc.E15-03-0153; Zhang L.J., 2009, ETHYLENE IND, V25, P7, DOI DOI 10.1371/J0URNAL.PBI0.1000155; Zlotogora J, 2003, GENET MED, V5, P347, DOI 10.1097/01.GIM.0000086478.87623.69	68	44	44	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1062	1077		10.1016/j.ajhg.2018.04.003	http://dx.doi.org/10.1016/j.ajhg.2018.04.003			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29805046	Bronze, Green Published			2022-12-18	WOS:000434946200005
J	Xu, MC; Xie, YJ; Abouzeid, H; Gordon, CT; Fiorentino, A; Sun, ZX; Lehman, A; Osman, IS; Dharmat, R; Riveiro-Alvarez, R; Bapst-Wicht, L; Babino, D; Arno, G; Busetto, V; Zhao, L; Li, H; Lopez-Martinez, MA; Azevedo, LF; Hubert, L; Pontikos, N; Eblimit, A; Lorda-Sanchez, I; Kheir, V; Plagnol, V; Oufadem, M; Soens, ZT; Yang, LZ; Bole-Feysot, C; Pfundt, R; Allaman-Pillet, N; Nitschke, P; Cheetham, ME; Lyonnet, S; Agrawal, SA; Li, HJ; Pinton, G; Michaelides, M; Besmond, C; Li, YM; Yuan, ZS; von Lintig, J; Webster, AR; Le Hir, H; Stoilov, P; Amiel, J; Hardcastle, AJ; Ayuso, C; Sui, RF; Chen, R; Allikmets, R; Schorderet, DF				Xu, Mingchu; Xie, Yajing (Angela); Abouzeid, Hana; Gordon, Christopher T.; Fiorentino, Alessia; Sun, Zixi; Lehman, Anna; Osman, Ihab S.; Dharmat, Rachayata; Riveiro-Alvarez, Rosa; Bapst-Wicht, Linda; Babino, Darwin; Arno, Gavin; Busetto, Virginia; Zhao, Li; Li, Hui; Lopez-Martinez, Miguel A.; Azevedo, Liliana F.; Hubert, Laurence; Pontikos, Nikolas; Eblimit, Aiden; Lorda-Sanchez, Isabel; Kheir, Valeria; Plagnol, Vincent; Oufadem, Myriam; Soens, Zachry T.; Yang, Lizhu; Bole-Feysot, Christine; Pfundt, Rolph; Allaman-Pillet, Nathalie; Nitschke, Patrick; Cheetham, Michael E.; Lyonnet, Stanislas; Agrawal, Smriti A.; Li, Huajin; Pinton, Gaetan; Michaelides, Michel; Besmond, Claude; Li, Yumei; Yuan, Zhisheng; von Lintig, Johannes; Webster, Andrew R.; Le Hir, Herve; Stoilov, Peter; Amiel, Jeanne; Hardcastle, Alison J.; Ayuso, Carmen; Sui, Ruifang; Chen, Rui; Allikmets, Rando; Schorderet, Daniel F.		UK Inherited Retinal Dystrophy Con	Mutations in the Spliceosome Component CWC27 Cause Retinal Degeneration with or without Additional Developmental Anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; SACCHAROMYCES-CEREVISIAE GENOME; MESSENGER-RNA; PHOTORECEPTOR DEGENERATION; SEQUENCING DATA; CYTOPLASMIC TRANSLATION; PROTEOMIC ANALYSIS; GENE; COMPLEX; HAPLOINSUFFICIENCY	Pre-mRNA splicing factors play a fundamental role in regulating transcript diversity both temporally and spatially. Genetic defects in several spliceosome components have been linked to a set of non-overlapping spliceosomopathy phenotypes in humans, among which skeletal developmental defects and non-syndromic retinitis pigmentosa (RP) are frequent findings. Here we report that defects in spliceosome-associated protein CWC27 are associated with a spectrum of disease phenotypes ranging from isolated RP to severe syndromic forms. By whole-exome sequencing, recessive protein-truncating mutations in CWC27 were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects. Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype. Our study describes a retinal dystrophy-related phenotype spectrum as well as its genetic etiology and highlights the complexity of the spliceosomal gene network.	[Xu, Mingchu; Dharmat, Rachayata; Zhao, Li; Eblimit, Aiden; Soens, Zachry T.; Agrawal, Smriti A.; Li, Yumei; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xu, Mingchu; Dharmat, Rachayata; Zhao, Li; Eblimit, Aiden; Soens, Zachry T.; Agrawal, Smriti A.; Li, Yumei; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Xie, Yajing (Angela); Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Abouzeid, Hana; Bapst-Wicht, Linda; Azevedo, Liliana F.; Kheir, Valeria; Allaman-Pillet, Nathalie; Pinton, Gaetan; Schorderet, Daniel F.] Inst Res Ophthalmol, CH-1950 Sion, Switzerland; [Gordon, Christopher T.; Busetto, Virginia; Oufadem, Myriam; Lyonnet, Stanislas; Amiel, Jeanne] Inst Natl Sante & Recherche Med INSERM, Inst Imagine, Lab Embryol & Genet Congenital Malformat, UMR 1163, F-75015 Paris, France; [Gordon, Christopher T.; Hubert, Laurence; Oufadem, Myriam; Nitschke, Patrick; Lyonnet, Stanislas; Besmond, Claude] Paris Descartes Sorbonne Paris Cite Univ, Inst Imagine, F-75015 Paris, France; [Fiorentino, Alessia; Arno, Gavin; Pontikos, Nikolas; Cheetham, Michael E.; Michaelides, Michel; Webster, Andrew R.; Hardcastle, Alison J.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Sun, Zixi; Li, Hui; Yang, Lizhu; Li, Huajin; Sui, Ruifang] Chinese Acad Med Sci, Peking Union Med ical Coll Hosp, Peking Union Med Coll, Dept Ophthalmol, Beijing 100730, Peoples R China; [Lehman, Anna] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Osman, Ihab S.] Cairo Univ, Dept Ophthalmol, Cairo 11562, Egypt; [Riveiro-Alvarez, Rosa; Lopez-Martinez, Miguel A.; Lorda-Sanchez, Isabel; Ayuso, Carmen] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Dept Genet, Madrid 28040, Spain; [Riveiro-Alvarez, Rosa; Lopez-Martinez, Miguel A.; Lorda-Sanchez, Isabel; Ayuso, Carmen] Inst Salud Carlos III CIBERER ISCIII, Ctr Invest Biomed Red Fermedades Raras, Madrid 28029, Spain; [Babino, Darwin; von Lintig, Johannes] Case Western Reserve Univ Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Arno, Gavin; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Busetto, Virginia; Le Hir, Herve] PSL Res Univ, CNRS UMR 8197, Inst Biol IENS IBENS, INSERM U1024,Ecole Normale Super, F-75005 Paris, France; [Zhao, Li] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Hubert, Laurence; Besmond, Claude] Inst Imagine, Translat Genet, INSERM UMR 1163, F-75015 Paris, France; [Pontikos, Nikolas; Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Bole-Feysot, Christine] Inst Imagine, Genom Platform, INSERM UMR 1163, F-75015 Paris, France; [Pfundt, Rolph] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6525 Nijmegen, Netherlands; [Nitschke, Patrick] Inst Imagine, Bioinformat Platform, INSERM UMR 1163, F-75015 Paris, France; [Lyonnet, Stanislas; Amiel, Jeanne] Assistance Publ Hop Paris, Serv Genet, Hop Necker Enfants Malades, F-75015 Paris, France; [Stoilov, Peter] Univ Virginia, Dept Biochem & Canc Inst, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Schorderet, Daniel F.] Univ Lausanne & Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland	Baylor College of Medicine; Baylor College of Medicine; Columbia University; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of British Columbia; Egyptian Knowledge Bank (EKB); Cairo University; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Case Western Reserve University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Texas System; UTMD Anderson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Virginia; Columbia University	Chen, R (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Chen, R (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Allikmets, R (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA.; Allikmets, R (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	ruichen@bcm.edu; rla22@cumc.columbia.edu	Xu, Mingchu/J-9369-2019; ABOUZEID, HANA/AFR-1918-2022; Pfundt, Rolph/L-4576-2015; Fiorentino, Alessia/ABC-3638-2020; Gordon, Chris/F-1267-2017; amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022; Dharmat, Rachayata/J-4627-2019; Lehman, Anna/R-6706-2017; BESMOND, Claude/L-8451-2018; Pontikos, Nikolas/U-3642-2018; Allikmets, Rando/ABD-4533-2021; Lyonnet, Stanislas/H-5483-2017; Poulter, James/A-8190-2013; Black, Graeme/K-7374-2015	ABOUZEID, HANA/0000-0003-3915-3285; Gordon, Chris/0000-0002-9300-8399; amiel, jeanne/0000-0001-5973-4728; Dharmat, Rachayata/0000-0001-6969-4459; Lehman, Anna/0000-0003-0636-123X; BESMOND, Claude/0000-0001-9073-8225; Pontikos, Nikolas/0000-0003-1782-4711; Lyonnet, Stanislas/0000-0001-5426-9417; Taylor, Rachel/0000-0002-1235-4303; Poulter, James/0000-0003-2048-5693; Black, Graeme/0000-0001-8727-6592; Cheetham, Michael/0000-0001-6429-654X; Michaelides, Michel/0000-0002-1552-7046; von Lintig, Johannes/0000-0002-2079-2143; Fiorentino, Alessia/0000-0002-1403-4581; Busetto, Virginia/0000-0001-6886-3820; Ayuso, Carmen/0000-0002-9242-7065; Hardcastle, Alison/0000-0002-0038-6770; Le Hir, Herve/0000-0001-7964-9221; Toomes, Carmel/0000-0001-8373-9545	RP Fighting Blindness (UK); Fight for Sight; Moorfields Eye Charity; Moorfields Special Trustees; Foundation Fighting Blindness [CD-CL-0711-0518-UCL, BR-GE-0613-0618-BCM, CD-CL-0808-0470-PUMCH, CD-CL-0214-0631-PUMCH]; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; National Health Service Foundation Trust; UCL Institute of Ophthalmology; National Eye Institute [R01EY022356, R01EY018571, EY002520, R01EY020551, EY021163, EY019861, EY019007]; Retinal Research Foundation; NIH [1S10RR026550]; Agence Nationale de la Recherche [ANR-10-IAHU-01]; Research to Prevent Blindness (New York, NY); Ministry of Science and Technology of the People's Republic of China [2010DFB33430]; National Natural Science Foundation of China [81470669]; Beijing Natural Science Foundation [7152116]; Spanish ISCIII, Madrid, Spain [PI13/0226]; ONCE;  [ANR-10-LABX-54];  [ANR-11-IDEX-0001-02]; Medical Research Council [1125070] Funding Source: researchfish; National Institute for Health Research [CL-2017-06-001, ACF-2013-06-009] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020551, P30EY019007, R01EY018571, R01EY022356, P30EY002520, R24EY019861, R01EY021163] Funding Source: NIH RePORTER	RP Fighting Blindness (UK); Fight for Sight; Moorfields Eye Charity; Moorfields Special Trustees; Foundation Fighting Blindness(European Commission); National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; National Health Service Foundation Trust; UCL Institute of Ophthalmology; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retinal Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Spanish ISCIII, Madrid, Spain; ONCE; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the affected individuals and their family members for participating in our study. This work was supported by grants from RP Fighting Blindness (UK), Fight for Sight, Moorfields Eye Charity, Moorfields Special Trustees, Foundation Fighting Blindness (CD-CL-0711-0518-UCL), the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital, National Health Service Foundation Trust, and UCL Institute of Ophthalmology (A.J.H., M.E.C., M.M., and A.R.W.), grants from National Eye Institute (R01EY022356, R01EY018571, EY002520), Retinal Research Foundation, Foundation Fighting Blindness (BR-GE-0613-0618-BCM), and NIH shared instrument grant 1S10RR026550 to R.C., grants from National Eye Institute (R01EY020551) to J.v.L., funding from the Agence Nationale de la Recherche (ANR-10-IAHU-01, CranioRespiro) to S.L., C.T.G., and J.A., grants ANR-10-LABX-54 MEMOLIFE and ANR-11-IDEX-0001-02 PSL* Research University to V.B. and H.L.H., grants from National Eye Institute (EY021163, EY019861, and EY019007 Core Support for Vision Research) and unrestricted funds from Research to Prevent Blindness (New York, NY) to R.A., grants from the Foundation Fighting Blindness (CD-CL-0808-0470-PUMCH and CD-CL-0214-0631-PUMCH), the Ministry of Science and Technology of the People's Republic of China (grant 2010DFB33430), National Natural Science Foundation of China (81470669), and Beijing Natural Science Foundation (7152116) to R.S., and grants PI13/0226 from Spanish ISCIII, Madrid, Spain and ONCE. We also thank Blanca Garcia-Sandoval from Department of Ophthalmology of IIS-FJD, Madrid, Spain for help on this project.	Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Bujakowska K, 2009, INVEST OPHTH VIS SCI, V50, P5927, DOI 10.1167/iovs.08-3275; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chen X, 2014, HUM MOL GENET, V23, P2926, DOI 10.1093/hmg/ddu005; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Favaro FP, 2014, AM J HUM GENET, V94, P120, DOI 10.1016/j.ajhg.2013.11.020; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Graziotto JJ, 2008, INVEST OPHTH VIS SCI, V49, P3830, DOI 10.1167/iovs.07-1483; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Ingelfinger D, 2003, NUCLEIC ACIDS RES, V31, P4791, DOI 10.1093/nar/gkg660; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Lehalle D, 2015, CLIN GENET, V88, P405, DOI 10.1111/cge.12596; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorda-Sanchez I, 1999, Ophthalmic Genet, V20, P127, DOI 10.1076/opge.20.2.127.2289; Lynch DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5483; Marcelli Fabienne, 2012, Curr Protoc Mouse Biol, V2, P207, DOI 10.1002/9780470942390.mo110177; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Mordes D, 2006, MOL VIS, V12, P1259; Murphy D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006256; Ohrt T, 2012, RNA, V18, P1244, DOI 10.1261/rna.033316.112; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Salvo J, 2015, INVEST OPHTH VIS SCI, V56, P1937, DOI 10.1167/iovs.14-16065; Tajiguli A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21384; Tanackovic G, 2011, AM J HUM GENET, V88, P643, DOI 10.1016/j.ajhg.2011.04.008; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Ulrich A, 2014, ACTA CRYSTALLOGR D, V70, P3110, DOI 10.1107/S1399004714021695; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wan J, 2011, NUCLEIC ACIDS RES, V39, P7920, DOI 10.1093/nar/gkr545; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wieczorek D, 2014, AM J HUM GENET, V95, P698, DOI 10.1016/j.ajhg.2014.10.014; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Xu MC, 2015, INVEST OPHTH VIS SCI, V56, P3889, DOI 10.1167/iovs.15-16778; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	56	44	45	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					592	604		10.1016/j.ajhg.2017.02.008	http://dx.doi.org/10.1016/j.ajhg.2017.02.008			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28285769	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-18	WOS:000398389600003
J	Ye, JC; Tucker, NR; Weng, LC; Clauss, S; Lubitz, SA; Ellinor, PT				Ye, Jiangchuan; Tucker, Nathan R.; Weng, Lu-Chen; Clauss, Sebastian; Lubitz, Steven A.; Ellinor, Patrick T.			A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AP-2 TRANSCRIPTION FACTORS; RISK; GENE; PATHWAY; LOCUS; CARDIOMYOCYTE; ENHANCERS; APOPTOSIS; DATABASE; CITED2	The most significantly associated genetic locus for atrial fibrillation (AF) is in chromosomal region 4q25, where four independent association signals have been identified. Although model-system studies suggest that altered PITX2c expression might underlie the association, the link between specific variants and the direction of effect on gene expression remains unknown for all four signals. In the present study, we analyzed the AF-associated region most proximal to PITX2 at 4q25. First, we identified candidate regulatory variants that might confer AF risk through a combination of mammalian conservation, DNase hypersensitivity, and histone modification from ENCODE and the Roadmap Epigenomics Project, as well as through in vivo analysis of enhancer activity in embryonic zebrafish. Within candidate regions, we then identified a single associated SNP, rs2595104, which displayed dramatically reduced enhancer activity with the AF risk allele. CRISPR-Cas9-mediated deletion of the rs2595104 region and editing of the rs2595104 risk allele in human stem-cell-derived cardiomyocytes resulted in diminished PITX2c expression in comparison to that of the non-risk allele. This differential activity was mediated by activating enhancer binding protein 2 alpha (TFAP2a), which bound robustly to the non-risk allele at rs2595104, but not to the risk allele, in cardiomyocytes. In sum, we found that the AF-associated SNP rs2595104 altered PITX2c expression via interaction with TFAP2a. Such a pathway could ultimately contribute to AF susceptibility at the PITX2 locus associated with AF.	[Ye, Jiangchuan; Tucker, Nathan R.; Weng, Lu-Chen; Clauss, Sebastian; Lubitz, Steven A.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Ye, Jiangchuan; Tucker, Nathan R.; Weng, Lu-Chen; Clauss, Sebastian; Lubitz, Steven A.; Ellinor, Patrick T.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ellinor, PT (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.; Ellinor, PT (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.	ellinor@mgh.harvard.edu	Clauss, Sebastian/HDL-7189-2022	Clauss, Sebastian/0000-0002-5675-6128; Ellinor, Patrick/0000-0002-2067-0533; Tucker, Nathan/0000-0002-5071-4218	NIH [T32HL007208, 1RO1HL092577, 1K24HL105780]; European Union [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK); Doris Duke Charitable Foundation Clinical Scientist Development Award [2014105]; NIH NHLBI Career Development Award [K23HL114724]; American Heart Association [13EIA14220013]; Fondation Leducq [14CVD01]; Broad Institute from Bayer HealthCare; George L. Nardi, MD, Memorial Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL105780, T32HL007208, K23HL114724, R01HL092577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); German Centre for Cardiovascular Research (DZHK); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); NIH NHLBI Career Development Award; American Heart Association(American Heart Association); Fondation Leducq(Leducq Foundation); Broad Institute from Bayer HealthCare; George L. Nardi, MD, Memorial Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	N.R.T. was supported by an institutional training grant from the NIH (T32HL007208) and by the George L. Nardi, MD, Memorial Research Fund. S.C. received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency grant agreement PIOF-GA-2012-328352 and was supported by the German Centre for Cardiovascular Research (DZHK) (81X2600210 and 81X2600204). S.A.L. was supported by a Doris Duke Charitable Foundation Clinical Scientist Development Award (2014105) and an NIH NHLBI Career Development Award (K23HL114724). This work was supported by grants from the NIH to P.T.E. (1RO1HL092577 and 1K24HL105780). P.T.E. was also supported by an Established Investigator Award from the American Heart Association (13EIA14220013) and by the Fondation Leducq (14CVD01). P.T.E. is the principal investigator on a grant at the Broad Institute from Bayer HealthCare.	Aguirre LA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0138-0; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Campione M, 1999, DEVELOPMENT, V126, P1225; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gore-Panter SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086245; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Hammer S, 2008, J CELL BIOCHEM, V104, P1022, DOI 10.1002/jcb.21686; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Kapoor A, 2014, AM J HUM GENET, V94, P854, DOI 10.1016/j.ajhg.2014.05.001; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lubitz SA, 2014, J AM COLL CARDIOL, V63, P1200, DOI 10.1016/j.jacc.2013.12.015; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Martin RIR, 2015, J MOL CELL CARDIOL, V85, P207, DOI 10.1016/j.yjmcc.2015.06.005; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Muller FU, 2004, CELL DEATH DIFFER, V11, P485, DOI 10.1038/sj.cdd.4401383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nakajima M, 2016, AM J HUM GENET, V99, P202, DOI 10.1016/j.ajhg.2016.05.018; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Scheinman MM, 2000, J AM COLL CARDIOL, V35, P1687, DOI 10.1016/S0735-1097(00)00589-1; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tao Y, 2014, CIRC-CARDIOVASC GENE, V7, P23, DOI 10.1161/CIRCGENETICS.113.000259; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; van den Boogaard M, 2014, J CLIN INVEST, V124, P1844, DOI 10.1172/JCI73140; Wenke AK, 2010, FEBS J, V277, P894, DOI 10.1111/j.1742-4658.2009.07509.x; Wu H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004610	48	44	47	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1281	1291		10.1016/j.ajhg.2016.10.001	http://dx.doi.org/10.1016/j.ajhg.2016.10.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27866707	Bronze, Green Published			2022-12-18	WOS:000389148600004
J	Shashi, V; Pena, LDM; Kim, K; Burton, B; Hempel, M; Schoch, K; Walkiewicz, M; McLaughlin, HM; Cho, M; Stong, N; Hickey, SE; Shuss, CM; Freemark, MS; Bellet, JS; Keels, MA; Bonner, MJ; El-Dairi, M; Butler, M; Kranz, PG; Stumpel, CTRM; Klinkenberg, S; Oberndorff, K; Alawi, M; Santer, R; Petrovski, S; Kuismin, O; Korpi-Heikkila, S; Pietilainen, O; Aarno, P; Kurki, MI; Hoischen, A; Need, AC; Goldstein, DB; Kortum, F				Shashi, Vandana; Pena, Loren D. M.; Kim, Katherine; Burton, Barbara; Hempel, Maja; Schoch, Kelly; Walkiewicz, Magdalena; McLaughlin, Heather M.; Cho, Megan; Stong, Nicholas; Hickey, Scott E.; Shuss, Christine M.; Freemark, Michael S.; Bellet, Jane S.; Keels, Martha Ann; Bonner, Melanie J.; El-Dairi, Maysantoine; Butler, Megan; Kranz, Peter G.; Stumpel, Constance T. R. M.; Klinkenberg, Sylvia; Oberndorff, Karin; Alawi, Malik; Santer, Rene; Petrovski, Slave; Kuismin, Outi; Korpi-Heikkila, Satu; Pietilainen, Olli; Aarno, Palotie; Kurki, Mitja I.; Hoischen, Alexander; Need, Anna C.; Goldstein, David B.; Kortuem, Fanny		Undiagnosed Dis Network	De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOHRING-OPITZ SYNDROME; INTELLECTUAL DISABILITY; RECIPROCAL REGULATION; MUTATIONS; GENES; GENOMICS; HOMOLOG; FAMILY	The ASXL genes (ASXL1, ASXL2, and ASXL3) participate in body patterning during embryogenesis and encode proteins involved in epigenetic regulation and assembly of transcription factors to specific genomic loci. Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features. ASXL2 has not yet been associated with a human Mendelian disorder. In this study, we performed whole-exome sequencing in six unrelated probands with developmental delay, macrocephaly, and dysmorphic features. All six had de novo truncating variants in ASXL2. A careful review enabled the recognition of a specific phenotype consisting of macrocephaly, prominent eyes, arched eyebrows, hypertelorism, a glabellar nevus flammeus, neonatal feeding difficulties, hypotonia, and developmental disabilities. Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities. We were also able to demonstrate with mRNA studies that these variants are likely to exert a dominant-negative effect, given that both alleles are expressed in blood and the mutated ASXL2 transcripts escape nonsense-mediated decay. In conclusion, de novo truncating variants in ASXL2 underlie a neurodevelopmental syndrome with a clinically recognizable phenotype. This report expands the germline disorders that are linked to the ASXL genes.	[Shashi, Vandana; Pena, Loren D. M.; Schoch, Kelly] Duke Hlth, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Kim, Katherine; Burton, Barbara] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Hempel, Maja; Kortuem, Fanny] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Walkiewicz, Magdalena] Baylor Coll Med, Houston, TX 77030 USA; [McLaughlin, Heather M.; Cho, Megan] GeneDx, Gaithersburg, MD 20877 USA; [Stong, Nicholas; Petrovski, Slave; Goldstein, David B.] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Hickey, Scott E.; Shuss, Christine M.] Nationwide Childrens Hosp, Div Mol & Human Genet, Columbus, OH 43082 USA; [Undiagnosed Dis Network] NIH, Common Fund, Bldg 10, Bethesda, MD 20892 USA; [Freemark, Michael S.] Duke Hlth, Dept Pediat, Div Endocrinol & Diabet, Durham, NC 27710 USA; [Bellet, Jane S.; Keels, Martha Ann] Duke Hlth, Dept Pediat, Durham, NC 27710 USA; [Bellet, Jane S.] Duke Hlth, Dept Dermatol, Durham, NC 27710 USA; [Keels, Martha Ann] Duke Hlth, Dept Surg, Durham, NC 27710 USA; [Bonner, Melanie J.] Duke Hlth, Psychiat & Behav Sci, Durham, NC 27710 USA; [El-Dairi, Maysantoine] Duke Hlth, Duke Eye Ctr, Durham, NC 27710 USA; [Butler, Megan] Duke Hlth, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Durham, NC 27710 USA; [Kranz, Peter G.] Duke Hlth, Dept Radiol, Div Neuroradiol, Durham, NC 27710 USA; [Stumpel, Constance T. R. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Stumpel, Constance T. R. M.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, NL-6202 AZ Maastricht, Netherlands; [Klinkenberg, Sylvia] Maastricht Univ, Med Ctr, Dept Neurol, NL-6202 AZ Maastricht, Netherlands; [Oberndorff, Karin] Zuyderland Med Ctr, Dept Pediat, NL-6162 BG Sittard, Netherlands; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Hamburg, Ctr Bioinformat, D-20246 Hamburg, Germany; [Alawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom, D-20246 Hamburg, Germany; [Santer, Rene] Univ Med Ctr Hamburg Eppendorf, Dept Paediat, D-20246 Hamburg, Germany; [Petrovski, Slave] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic 3050, Australia; [Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; [Kuismin, Outi] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu 90014, Finland; [Kuismin, Outi] Univ Oulu, Oulu 90014, Finland; [Kuismin, Outi] Oulu Univ Hosp, Dept Clin Genet, Oulu 90029, Finland; [Kuismin, Outi; Aarno, Palotie] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Korpi-Heikkila, Satu] Ctr Intellectual Disabil Care, Northern Ostrobothnia Hosp Dist, Oulu 90220, Finland; [Pietilainen, Olli; Aarno, Palotie] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Pietilainen, Olli] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Aarno, Palotie] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Aarno, Palotie; Kurki, Mitja I.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Aarno, Palotie; Kurki, Mitja I.] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Aarno, Palotie] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kurki, Mitja I.] Broad Inst MIT & Harvard, Genet Anal Platform, Cambridge, MA 02142 USA; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Need, Anna C.] Imperial Coll London, Dept Med, Div Brain Sci, London W12 0NN, England	Ann & Robert H. Lurie Children's Hospital of Chicago; University of Hamburg; University Medical Center Hamburg-Eppendorf; Baylor College of Medicine; Columbia University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; Duke University; Maastricht University; Maastricht University; Maastricht University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Imperial College London	Shashi, V (corresponding author), Duke Hlth, Dept Pediat, Div Med Genet, Durham, NC 27710 USA.	vandana.shashi@duke.edu	Yamamoto, Shinya/ABB-2837-2021; , Malik/AAB-7437-2021; Goldstein, David/AAY-8125-2020; Graham, Brett/R-8685-2018; Wangler, Michael/H-6368-2019; Kurki, Mitja/GWM-5671-2022; Hoischen, Alexander/D-1282-2013; Hoischen, Alexander/AGF-7293-2022; Kranz, Peter G/B-2471-2016; Stong, Nicholas/ABB-7516-2021	Yamamoto, Shinya/0000-0003-2172-8036; , Malik/0000-0002-5993-7709; Graham, Brett/0000-0001-8451-8154; Wangler, Michael/0000-0001-5245-5910; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Kranz, Peter G/0000-0001-5410-7135; Hackbarth, Mary/0000-0003-1325-3165; Wheeler, Matthew/0000-0001-8721-3022; Holm, Ingrid/0000-0003-4712-8821; Kuismin, Outi/0000-0002-0157-8985; Iglesias, Brenda/0000-0002-7158-7975; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Fisher, Paul/0000-0002-1196-1590; Bellen, Hugo/0000-0001-5992-5989; orange, jordan/0000-0001-7117-7725; Palotie, Aarno/0000-0002-2527-5874; Sweetser, David/0000-0002-1621-3284; Stong, Nicholas/0000-0002-0678-637X; Brown, Donna/0000-0002-8805-7225; Macnamara, Ellen/0000-0002-9418-3287; Levy, Shawn/0000-0002-1369-5740	Undiagnosed Diseases Network [1U01HG007672-01]; Deutsche Forschungsgemeinschaft [KO 4576/1-1]; Pairnomix LLC; Sanofi- Genzyme; Shire; Biomarin; Ultragenyx; Alexion; Armagen; ReGenX Bio; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007943, U01HG007674, U01HG007672, U01HG007708] Funding Source: NIH RePORTER	Undiagnosed Diseases Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pairnomix LLC; Sanofi- Genzyme; Shire; Biomarin; Ultragenyx; Alexion; Armagen; ReGenX Bio; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to the inidividuals and their families who contributed to this study and allowed us to publish their information and pictures. We thank I. Jantke for skillful technical assistance. This work was supported by the Undiagnosed Diseases Network (1U01HG007672-01 to V.S.) and the Deutsche Forschungsgemeinschaft (KO 4576/1-1 to F.K.). The authors disclose the following: the Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular testing offered at the Baylor Genetics Laboratories (M.W.); D.B.G. has received consultancy fees and has equity ownership in Pairnomix LLC; H.M.M. and M.C. are employees of GeneDx; B.B. has received honoraria, consulting fees, or funding for clinical trials from Sanofi- Genzyme, Shire, Biomarin, Ultragenyx, Alexion, Armagen, and ReGenX Bio; and E.A.A. from the Undiagnosed Diseases Network is a co-founder of Personalis Inc.	Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Balasubramani A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8307; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Bohring A, 1999, AM J MED GENET, V85, P438, DOI 10.1002/(SICI)1096-8628(19990827)85:5<438::AID-AJMG2>3.0.CO;2-A; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brunner HG, 2000, AM J MED GENET, V92, P366, DOI 10.1002/1096-8628(20000619)92:5<366::AID-AJMG15>3.0.CO;2-U; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Fisher CL, 2003, GENE, V306, P115, DOI 10.1016/S0378-1119(03)00430-X; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Izawa T, 2015, CELL REP, V11, P1625, DOI 10.1016/j.celrep.2015.05.019; Katoh M, 2004, INT J ONCOL, V24, P1617; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Katoh M, 2015, EXPERT REV PROTEOMIC, V12, P317, DOI 10.1586/14789450.2015.1033409; Khan FF, 2014, BIOCHEM BIOPH RES CO, V451, P101, DOI 10.1016/j.bbrc.2014.07.080; Lai HL, 2012, J MOL CELL CARDIOL, V53, P734, DOI 10.1016/j.yjmcc.2012.08.014; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Metzeler KH, 2014, BLOOD, V124, P1382, DOI 10.1182/blood-2014-07-586073; Park UH, 2014, BIOCHEM BIOPH RES CO, V443, P489, DOI 10.1016/j.bbrc.2013.11.124; Park UH, 2011, J BIOL CHEM, V286, P1354, DOI 10.1074/jbc.M110.177816; Ramocki MB, 2003, EUR J HUM GENET, V11, P527, DOI 10.1038/sj.ejhg.5200995; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ropers HH, 2015, EUR J MED GENET, V58, P715, DOI 10.1016/j.ejmg.2015.10.007; Russell B, 2015, AM J MED GENET A, V167, P2122, DOI 10.1002/ajmg.a.37131; Russell B, 2013, GENOME MED, V5, DOI 10.1186/gm420; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Ware J.S., 2015, CURR PROTOC HUM GENE, V87, P1; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	33	44	45	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					991	999		10.1016/j.ajhg.2016.08.017	http://dx.doi.org/10.1016/j.ajhg.2016.08.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27693232	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000385333700020
J	Wade, EM; Daniel, PB; Jenkins, ZA; McInerney-Leo, A; Leo, P; Morgan, T; Addor, MC; Ades, LC; Bertola, D; Bohring, A; Carter, E; Cho, TJ; Duba, HC; Fletcher, E; Kim, CA; Krakow, D; Morava, E; Neuhann, T; Superti-Furga, A; Veenstra-Knol, I; Wieczorek, D; Wilson, LC; Hennekam, RCM; Sutherland-Smith, AJ; Strom, TM; Wilkie, AOM; Brown, MA; Duncan, EL; Markie, DM; Robertson, SP				Wade, Emma M.; Daniel, Philip B.; Jenkins, Zandra A.; McInerney-Leo, Aideen; Leo, Paul; Morgan, Tim; Addor, Marie Claude; Ades, Lesley C.; Bertola, Debora; Bohring, Axel; Carter, Erin; Cho, Tae-Joon; Duba, Hans-Christoph; Fletcher, Elaine; Kim, Chong A.; Krakow, Deborah; Morava, Eva; Neuhann, Teresa; Superti-Furga, Andrea; Veenstra-Knol, Irma; Wieczorek, Dagmar; Wilson, Louise C.; Hennekam, Raoul C. M.; Sutherland-Smith, Andrew J.; Strom, Tim M.; Wilkie, Andrew O. M.; Brown, Matthew A.; Duncan, Emma L.; Markie, David M.; Robertson, Stephen P.			Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; PROTEIN-KINASE PATHWAYS; OSTEOCLAST DIFFERENTIATION; PROLINE HYDROXYLATION; HIF-ALPHA; FILAMIN-A; ACTIVATION; GROWTH; TAB2; BINDING	Frontometaphyseal dysplasia (FMD) is a progressive sclerosing skeletal dysplasia affecting the long bones and skull. The cause of FMD in some individuals is gain-of-function mutations in FLNA, although how these mutations result in a hyperostotic phenotype remains unknown. Approximately one half of individuals with FMD have no identified mutation in FLNA and are phenotypically very similar to individuals with FLNA mutations, except for an increased tendency to form keloid scars. Using whole-exome sequencing and targeted Sanger sequencing in 19 FMD-affected individuals with no identifiable FLNA mutation, we identified mutations in two genes-MAP3K7, encoding transforming growth factor beta (TGF-beta)-activated kinase (TAK1), and TAB2, encoding TAK1-associated binding protein 2 (TAB2). Four mutations were found in MAP3K7, including one highly recurrent (n = 15) de novo mutation (c.1454C>T [p.Pro485Leu]) proximal to the coiled-coil domain of TAK1 and three missense mutations affecting the kinase domain (c.208G>C[p.Glu70Gln], c.299T>A[p.Val100Glu], and c.502G>C [p.Gly168Arg]). Notably, the subjects with the latter three mutations had a milder FMD phenotype. An additional de novo mutation was found in TAB2 (c.1705G>A, p.Glu569Lys). The recurrent mutation does not destabilize TAK1, or impair its ability to homodimerize or bind TAB2, but it does increase TAK1 autophosphorylation and alter the activity of more than one signaling pathway regulated by the TAK1 kinase complex. These findings show that dysregulation of the TAK1 complex produces a close phenocopy of FMD caused by FLNA mutations. Furthermore, they suggest that the pathogenesis of some of the filaminopathies caused by FLNA mutations might be mediated by misregulation of signaling coordinated through the TAK1 signaling complex.	[Wade, Emma M.; Daniel, Philip B.; Jenkins, Zandra A.; Morgan, Tim; Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin 9016, New Zealand; [McInerney-Leo, Aideen; Leo, Paul; Brown, Matthew A.; Duncan, Emma L.] Royal Brisbane & Womens Hosp, Herston, Qld 4029, Australia; [Addor, Marie Claude] CHU Vaudois, Serv Genet Med Maternite, CH-1011 Lausanne, Switzerland; [Ades, Lesley C.] Univ Sydney, Childrens Hosp, Dept Clin Genet, Discipline Pediat & Child Hlth, Sydney, NSW 2145, Australia; [Bertola, Debora; Kim, Chong A.] Hosp Clin Fac Med, Genet Unit Inst Crianca, BR-05403000 Sao Paulo, Brazil; [Bohring, Axel] Univ Munster, Inst Humangenetik, D-48149 Munster, Germany; [Carter, Erin] Hosp Special Surg, Kathryn & Alan C Greenberg Ctr Skeletal Dysplasia, New York, NY 10021 USA; [Cho, Tae-Joon] Seoul Natl Univ Childrens Hosp, Div Pediat Orthoped, 28 Seoul, South Korea; [Duba, Hans-Christoph] Kepler Univ, Med Campus 4, Zentrum Med Genetik Linz, Krankenhausstrasse 26-30, A-4020 Linz, Austria; [Fletcher, Elaine] Western Gen Hosp, South East Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Krakow, Deborah] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Morava, Eva] Tulane Univ, Sch Med, Hayward Genet Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Neuhann, Teresa] MGZ Med Genet Ctr, D-80335 Munich, Germany; [Superti-Furga, Andrea] Univ Lausanne, CHUV, Dept Pediat, CH-1015 Lausanne, Switzerland; [Veenstra-Knol, Irma] Univ Groningen, Univ Med Ctr Groningen, NL-9713 Groningen, Netherlands; [Wieczorek, Dagmar] Heinrich Heine Univ, Inst Human Genet, D-40225 Dusseldorf, Germany; [Wilson, Louise C.] Great Ormond St Hosp Children NHS Fdn Trust, Clin Genet Unit, London WC1N 3JH, England; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 Amsterdam, Netherlands; [Sutherland-Smith, Andrew J.] Massey Univ, Inst Fundamental Sci, Palmerston North 4474, New Zealand; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Humangenetik, D-85764 Munich, Germany; [Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp Headington, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Markie, David M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9016, New Zealand	University of Otago; Royal Brisbane & Women's Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Sydney; University of Munster; Seoul National University (SNU); Seoul National University Hospital; Johannes Kepler University Linz; University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tulane University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Groningen; Heinrich Heine University Dusseldorf; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Massey University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; University of Otago	Robertson, SP (corresponding author), Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin 9016, New Zealand.	stephen.robertson@otago.ac.nz	superti-furga, andrea/E-9162-2015; Brown, Matthew A/E-5749-2010; McInerney-Leo, Aideen M/D-8302-2016; Wade, Emma Mary/AAT-1035-2020; McInerney-Leo, Aideen M/E-1788-2018; Markie, David/I-7893-2019; Wieczorek, Dagmar/AAU-6008-2021; Wilkie, Andrew/AAC-3820-2020; Bertola, Débora/I-5120-2016; Leo, Paul/R-4464-2019; Krakow, Deborah/B-5778-2009; Sutherland-Smith, Andrew/F-1813-2011; Duncan, Emma/L-1224-2013	superti-furga, andrea/0000-0002-3543-7531; Brown, Matthew A/0000-0003-0538-8211; McInerney-Leo, Aideen M/0000-0002-0059-5732; Wieczorek, Dagmar/0000-0003-2812-6492; Wilkie, Andrew/0000-0002-2972-5481; Bertola, Débora/0000-0002-4701-6777; Krakow, Deborah/0000-0001-9906-4968; Sutherland-Smith, Andrew/0000-0001-9485-1428; Robertson, Stephen/0000-0002-5181-7809; Kim, Chong/0000-0002-1754-1300; Cho, Tae-Joon/0000-0001-8514-377X; Wade, Emma M/0000-0003-2990-0232; Markie, David/0000-0001-5452-9194; Duncan, Emma/0000-0002-8143-4403	Marsden Fund; Cure Kids; Otago University; University of Queensland; National Health and Medical Research Council	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Cure Kids; Otago University; University of Queensland(University of Queensland); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors would like to thank the participating families and J. Weissenbach for diagnostic expertise. We thank K. Matsumoto for the kind gift of the TAB1 construct. The work was supported by funding from the Marsden Fund (S.P.R. and M.A.B.) and Cure Kids (S.P.R.). E.W. is supported by an Otago University postgraduate research scholarship, and A.M.L. is supported by a University of Queensland postgraduate scholarship (Australian Postgraduate Award). M.A.B. is funded by a National Health and Medical Research Council senior principal research fellowship.	Akiyama S, 2004, J BIOL CHEM, V279, P36616, DOI 10.1074/jbc.M406610200; Atwal PS, 2016, AM J MED GENET A, V170, P891, DOI 10.1002/ajmg.a.37491; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Basart H, 2015, AM J MED GENET A, V167, P1215, DOI 10.1002/ajmg.a.37044; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Bray I, 2006, J EPIDEMIOL COMMUN H, V60, P851, DOI 10.1136/jech.2005.045179; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Dempsey CE, 2000, BBA-GENE STRUCT EXPR, V1517, P46, DOI 10.1016/S0167-4781(00)00258-X; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; FITZSIMMONS JS, 1982, CLIN GENET, V22, P195; Foley C, 2010, MOL SYNDROMOL, V1, P121, DOI 10.1159/000320184; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Klein OD, 2007, CLIN GENET, V71, P260, DOI 10.1111/j.1399-0004.2007.00757.x; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lah M, 2016, AM J MED GENET A, V170, P881, DOI 10.1002/ajmg.a.37567; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; Medina MT, 2008, NEUROLOGY, V70, P2137, DOI 10.1212/01.wnl.0000313149.73035.99; Morava E, 2003, AM J MED GENET A, V116A, P272, DOI 10.1002/ajmg.a.10831; Ouyang C, 2014, J BIOL CHEM, V289, P24226, DOI 10.1074/jbc.M114.559963; Qi B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07158; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2006, AM J MED GENET A, V140A, P1726, DOI 10.1002/ajmg.a.31322; Robertson SP, 2007, EUR J HUM GENET, V15, P3, DOI 10.1038/sj.ejhg.5201654; Sakurai H, 1998, BIOCHEM BIOPH RES CO, V243, P545, DOI 10.1006/bbrc.1998.8124; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Stogmann E, 2006, NEUROLOGY, V67, P2029, DOI 10.1212/01.wnl.0000250254.67042.1b; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Thienpont B, 2010, AM J HUM GENET, V86, P839, DOI 10.1016/j.ajhg.2010.04.011; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zenker M, 2006, AM J MED GENET A, V140A, P1069, DOI 10.1002/ajmg.a.31213	62	44	47	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					392	406		10.1016/j.ajhg.2016.05.024	http://dx.doi.org/10.1016/j.ajhg.2016.05.024			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27426733	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000381617200010
J	Alston, CL; Compton, AG; Formosa, LE; Strecker, V; Olahova, M; Haack, TB; Smet, J; Stouffs, K; Diakumis, P; Ciara, E; Cassiman, D; Romain, N; Yarham, JW; He, LP; De Paepe, B; Vanlander, AV; Seneca, S; Feichtinger, RG; Poski, R; Rokicki, D; Pronicka, E; Haller, RG; Van Hove, JLK; Bahlo, M; Mayr, JA; Van Coster, R; Prokisch, H; Wittig, I; Ryan, MT; Thorburn, DR; Taylor, RW				Alston, Charlotte L.; Compton, Alison G.; Formosa, Luke E.; Strecker, Valentina; Olahova, Monika; Haack, Tobias B.; Smet, Joel; Stouffs, Katrien; Diakumis, Peter; Ciara, Elzbieta; Cassiman, David; Romain, Nadine; Yarham, John W.; He, Langping; De Paepe, Boel; Vanlander, Arnaud V.; Seneca, Sara; Feichtinger, Rene G.; Poski, Rafal; Rokicki, Dariusz; Pronicka, Ewa; Haller, Ronald G.; Van Hove, Johan L. K.; Bahlo, Melanie; Mayr, Johannes A.; Van Coster, Rudy; Prokisch, Holger; Wittig, Ilka; Ryan, Michael T.; Thorburn, David R.; Taylor, Robert W.			Biallelic Mutations in TMEM126B Cause Severe Complex I Deficiency with a Variable Clinical Phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL COMPLEX; RESPIRATORY-CHAIN; ASSEMBLY FACTOR; DISEASE; PROTEIN; QUANTIFICATION; ASSOCIATION; PREDICTION; COMPONENT; DEFECTS	Complex I deficiency is the most common biochemical phenotype observed in individuals with mitochondrial disease. With 44 structural subunits and over 10 assembly factors, it is unsurprising that complex I deficiency is associated with clinical and genetic heterogeneity. Massively parallel sequencing (MPS) technologies including custom, targeted gene panels or unbiased whole-exome sequencing (WES) are hugely powerful in identifying the underlying genetic defect in a clinical diagnostic setting, yet many individuals remain without a genetic diagnosis. These individuals might harbor mutations in poorly understood or uncharacterized genes, and their diagnosis relies upon characterization of these orphan genes. Complexome profiling recently identified TMEM126B as a component of the mitochondrial complex I assembly complex alongside proteins ACAD9, ECSIT, NDUFAF1, and TIMMDC1. Here, we describe the clinical, biochemical, and molecular findings in six cases of mitochondrial disease from four unrelated families affected by biallelic (c.635G > T [p.Gly212Val] and/or c.401delA [p.Asn134Ilefs*2]) TMEM126B variants. We provide functional evidence to support the pathogenicity of these TMEM126B variants, including evidence of founder effects for both variants, and establish defects within this gene as a cause of complex I deficiency in association with either pure myopathy in adulthood or, in one individual, a severe multisystem presentation (chronic renal failure and cardiomyopathy) in infancy. Functional experimentation including viral rescue and complexome profiling of subject cell lines has confirmed TMEM126B as the tenth complex I assembly factor associated with human disease and validates the importance of both genome-wide sequencing and proteomic approaches in characterizing disease-associated genes whose physiological roles have been previously undetermined.	[Alston, Charlotte L.; Olahova, Monika; Yarham, John W.; He, Langping; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurol Sci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Compton, Alison G.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Compton, Alison G.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Formosa, Luke E.; Ryan, Michael T.] Monash Univ, Monash Biomedicine Discovery Inst, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3800, Australia; [Strecker, Valentina] Goethe Univ, Funct Prote, SFB 815 Core Unit, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Haack, Tobias B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Prokisch, Holger] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Pintelaan 185, B-9000 Ghent, Belgium; [Smet, Joel; De Paepe, Boel; Vanlander, Arnaud V.; Van Coster, Rudy] Vrije Univ Brussel, Res Grp Reprod & Genet, UZ Brussel, Ctr Med Genet, B-1090 Brussels, Belgium; [Stouffs, Katrien; Seneca, Sara] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Melbourne, Vic 3052, Australia; [Diakumis, Peter; Bahlo, Melanie] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [Ciara, Elzbieta; Pronicka, Ewa] Metab Ctr Univ Hosp, B-3000 Leuven, Belgium; [Cassiman, David; Van Hove, Johan L. K.] Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA; [Romain, Nadine; Haller, Ronald G.] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Feichtinger, Rene G.; Mayr, Johannes A.] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Poski, Rafal] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland; [Rokicki, Dariusz; Pronicka, Ewa] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Haller, Ronald G.] Univ Colorado Aurora, Dept Pediat, Aurora, CO 80045 USA; [Van Hove, Johan L. K.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Bahlo, Melanie] Goethe Univ, Cluster Excellence Macromolecular Complexes, D-60438 Frankfurt, Germany; [Wittig, Ilka] Partner Site RheinMain, German Ctr Cardiovasc Res, D-60590 Frankfurt, Germany	Newcastle University - UK; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; Goethe University Frankfurt; Technical University of Munich; Ghent University; Ghent University Hospital; University Hospital Brussels; Vrije Universiteit Brussel; Children's Memorial Health Institute; Paracelsus Private Medical University; Medical University of Warsaw; Children's Memorial Health Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Melbourne; Goethe University Frankfurt; German Centre for Cardiovascular Research	Thorburn, DR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia.	david.thorburn@mcri.edu.au; robert.taylor@ncl.ac.uk	Stouffs, Katrien/L-5982-2015; Ryan, Michael/X-2152-2019; Arnaud, Vanlander/ABB-5978-2021; De Paepe, Boel/B-7548-2013; Alston, Charlotte/ABG-9602-2020; Ryan, Michael T/C-6673-2011; Thorburn, David R/G-6266-2013; Cassiman, David/H-6813-2014	Stouffs, Katrien/0000-0001-8164-5692; Ryan, Michael/0000-0003-2586-8829; De Paepe, Boel/0000-0001-9403-4401; Alston, Charlotte/0000-0003-2095-5464; Ryan, Michael T/0000-0003-2586-8829; thorburn, david/0000-0002-7725-9470; Formosa, Luke/0000-0002-7740-6151; Bahlo, Melanie/0000-0001-5132-0774; Ciara, Elzbieta/0000-0002-1065-7968; Cassiman, David/0000-0002-6154-0970; Ploski, Rafal/0000-0001-6286-5526; Diakumis, Peter/0000-0002-7502-7545; Compton, Alison/0000-0002-2725-7055; Romain, Nadine/0000-0003-2492-549X; Pronicka, Ewa/0000-0002-5705-4814; Seneca, Sara/0000-0002-0853-9890; Rokicki, Dariusz/0000-0002-9736-2838; Prokisch, Holger/0000-0003-2379-6286; Mayr, Johannes/0000-0001-6970-336X	National Institute for Health Research (NIHR) [NIHR-HCS-D12-03-04]; Federal Ministry of Education and Research (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; Ghent University [BOF 01DI2714]; Belgian Fund for Scientific Research [3G020010]; Association Belge contre les Maladies Neuro-Musculaires; Fonds voor Wetenschappelijk Onderzoek [G.0.200]; Children's Memorial Health Institute [S136/13]; NIH [RO1-ARO50597]; Paracelsus Medical University [E-12/15/076-MAY]; European Commission FP7-PEOPLE-ITN MEET Project (GA) [317433]; BMBF through the German Network for Mitochondrial Disorders [01GM1113C, 01GM1113B]; E-Rare project GENOMIT [01GM1207]; Deutsche Forschungsgemeinschaft [SFB 815/Z1]; Australian National Health and Medical Research Council (NHMRC) [1102896, 1102971]; NHMRC [1054618, 1068409, 1068056]; Victorian Government's Operational Infrastructure Support Program; Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" service; Lily Foundation; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Federal Ministry of Education and Research (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); Ghent University(Ghent University); Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Association Belge contre les Maladies Neuro-Musculaires; Fonds voor Wetenschappelijk Onderzoek(FWO); Children's Memorial Health Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paracelsus Medical University; European Commission FP7-PEOPLE-ITN MEET Project (GA); BMBF through the German Network for Mitochondrial Disorders(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Wellcome Trust Strategic Award(Wellcome Trust); MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" service; Lily Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a National Institute for Health Research (NIHR) doctoral fellowship (NIHR-HCS-D12-03-04 to C.L.A.), the Federal Ministry of Education and Research (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C to T.B.H.), Ghent University (BOF 01DI2714 to A.V.V.), the Belgian Fund for Scientific Research (3G020010 to J.S., B.D.P., and R.V.C.), the Association Belge contre les Maladies Neuro-Musculaires and Fonds voor Wetenschappelijk Onderzoek G.0.200 (to S.S.), the Children's Memorial Health Institute (S136/13 to E.P.), the NIH (RO1-ARO50597 to R.G.H.), Paracelsus Medical University (E-12/15/076-MAY to J.A.M.), the European Commission FP7-PEOPLE-ITN MEET Project (GA no. 317433 to H.P.), the BMBF through the German Network for Mitochondrial Disorders (01GM1113C to H.P. and 01GM1113B to I.W.), the E-Rare project GENOMIT (01GM1207 to H.P.), the Deutsche Forschungsgemeinschaft (SFB 815/Z1 to I.W.), Australian National Health and Medical Research Council (NHMRC) Principal and Senior Research Fellowships (1102896 to D.R.T. and 1102971 to M.B.), NHMRC grants (1054618 to M.B., 1068409 to D.R.T. and A.G.C., and 1068056 to M.T.R.), the Victorian Government's Operational Infrastructure Support Program (D.R.T., A.G.C., and M.B.), a Wellcome Trust Strategic Award (096919/Z/11/Z to R.W.T.), the MRC Centre for Neuromuscular Diseases (G0601943 to R.W.T.), the UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" service (to R.W.T.), and the Lily Foundation (to R.W.T.). The views expressed are those of the authors and not necessarily of the NHS, NIHR, or the Department of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Formosa LE, 2015, HUM MOL GENET, V24, P2952, DOI 10.1093/hmg/ddv058; Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Herzer M, 2010, NEUROPEDIATRICS, V41, P30, DOI 10.1055/s-0030-1255062; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Prior KK, 2016, J BIOL CHEM, V291, P7045, DOI 10.1074/jbc.M115.710772; RICHARDS AJ, 1991, J MED GENET, V28, P458, DOI 10.1136/jmg.28.7.458; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002; Vanlander AV, 2015, HUM MUTAT, V36, P222, DOI 10.1002/humu.22728; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	38	44	45	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					217	227		10.1016/j.ajhg.2016.05.021	http://dx.doi.org/10.1016/j.ajhg.2016.05.021			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27374774	Green Published, hybrid			2022-12-18	WOS:000381616600019
J	Vukcevic, D; Traherne, JA; Naess, S; Ellinghaus, E; Kamatani, Y; Dilthey, A; Lathrop, M; Karlsen, TH; Franke, A; Moffatt, M; Cookson, W; Trowsdale, J; McVean, G; Sawcer, S; Leslie, S				Vukcevic, Damjan; Traherne, James A.; Naess, Sigrid; Ellinghaus, Eva; Kamatani, Yoichiro; Dilthey, Alexander; Lathrop, Mark; Karlsen, Tom H.; Franke, Andre; Moffatt, Miriam; Cookson, William; Trowsdale, John; McVean, Gil; Sawcer, Stephen; Leslie, Stephen			Imputation of KIR Types from SNP Variation Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASSICAL HLA ALLELES; DISEASE; LIGANDS; RISK; LOCI	Large population studies of immune system genes are essential for characterizing their role in diseases, including autoimmune conditions. Of key interest are a group of genes encoding the killer cell immunoglobulin-like receptors (KIRs), which have known and hypothesized roles in autoimmune diseases, resistance to viruses, reproductive conditions, and cancer. These genes are highly polymorphic, which makes typing expensive and time consuming. Consequently, despite their importance, KIRs have been little studied in large cohorts. Statistical imputation methods developed for other complex loci (e.g., human leukocyte antigen [HLA]) on the basis of SNP data provide an inexpensive high-throughput alternative to direct laboratory typing of these loci and have enabled important findings and insights for many diseases. We present KIR*IMP, a method for imputation of KIR copy number. We show that KIR*IMP is highly accurate and thus allows the study of KIRs in large cohorts and enables detailed investigation of the role of KIRs in human disease.	[Vukcevic, Damjan; Leslie, Stephen] Murdoch Childrens Res Inst, Stat Genet, Parkville, Vic 3052, Australia; [Vukcevic, Damjan; Leslie, Stephen] Univ Melbourne, Sch Math & Stat, Parkville, Vic 3010, Australia; [Traherne, James A.; Trowsdale, John] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Traherne, James A.; Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Naess, Sigrid; Karlsen, Tom H.] Univ Oslo, Hosp Rikshosp, Internal Med Res Inst, Dept Canc Med Surg & Transplantat, N-0424 Oslo, Norway; [Naess, Sigrid] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Surg & Transplantat, N-0424 Oslo, Norway; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Kamatani, Yoichiro; Lathrop, Mark] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Kamatani, Yoichiro] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Dilthey, Alexander; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford 0X3 7BN, England; [Lathrop, Mark] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Karlsen, Tom H.] Univ Oslo, KG Jebsen Inflammat Res Ctr, Inst Clin Med, N-0318 Oslo, Norway; [Moffatt, Miriam; Cookson, William] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Sawcer, Stephen] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England	Murdoch Children's Research Institute; University of Melbourne; University of Cambridge; University of Cambridge; University of Oslo; National Hospital Norway; University of Oslo; University of Kiel; Foundation Jean Dausset-CEPH; RIKEN; University of Oxford; Wellcome Centre for Human Genetics; McGill University; University of Oslo; Imperial College London; University of Cambridge	Leslie, S (corresponding author), Murdoch Childrens Res Inst, Stat Genet, Parkville, Vic 3052, Australia.	stephen.leslie@mcri.edu.au	Ellinghaus, Eva/E-6490-2012; Cookson, William/HHC-1790-2022; Kamatani, Yoichiro/N-5513-2015; Franke, Andre/B-2151-2010	Ellinghaus, Eva/0000-0003-2914-3382; Franke, Andre/0000-0003-1530-5811; Sawcer, Stephen/0000-0001-7685-0974; Vukcevic, Damjan/0000-0001-7780-9586	Australian National Health and Medical Research Council (NHMRC) [1053756]; Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government of Australia [VR0240]; UK Multiple Sclerosis Society [894/08]; German Ministry of Education and Research (BMBF); Peter Hans Hofschneider Professorship of the "Stiftung Experimentelle Biomedizin" in Zurich; Wellcome Trust; Medical Research Council (MRC); National Institute of Health Cambridge Biomedical Research Centre; Victorian Government's Operational Infrastructure Support Program; MRC [G0901682] Funding Source: UKRI; Medical Research Council [G0901682] Funding Source: researchfish	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government of Australia; UK Multiple Sclerosis Society; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Peter Hans Hofschneider Professorship of the "Stiftung Experimentelle Biomedizin" in Zurich; Wellcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Cambridge Biomedical Research Centre; Victorian Government's Operational Infrastructure Support Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank Chris Johnson, Wei Jiang, and Jyothi Jayaraman for their contributions to developing the lab-based KIR typing process and data generation, Sandra Maksimovic for assisting with the web-based implementation, Bente Woldseth for technical assistance, and Johannes Hov for helpful discussions. This work was supported by Australian National Health and Medical Research Council (NHMRC) Career Development Fellowship ID 1053756 (S.L.), Victorian Life Sciences Computation Initiative (VLSCI) grant VR0240 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government of Australia (S.L.), UK Multiple Sclerosis Society grant 894/08 (S.S.), the German Ministry of Education and Research (BMBF) program e:Med sysINFLAME (A.F.), the Peter Hans Hofschneider Professorship of the "Stiftung Experimentelle Biomedizin" in Zurich (A.F.), and the Wellcome Trust and Medical Research Council (MRC) with partial funding from the National Institute of Health Cambridge Biomedical Research Centre (J.T. and J.A.T.). Research at the Murdoch Childrens Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program, and further infrastructure support was provided by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at Interfaces." S.L., G.M., and A.D. are founders and partners in Peptide Groove LLP.	Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bryll R, 2003, PATTERN RECOGN, V36, P1291, DOI 10.1016/S0031-3203(02)00121-8; Carrington M, 2003, THE KIR GENE CLUSTER; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hollenbach JA, 2012, IMMUNOGENETICS, V64, P719, DOI 10.1007/s00251-012-0629-x; Hosking FJ, 2011, BLOOD, V117, P1633, DOI 10.1182/blood-2010-08-301598; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Marsh SGE, 2003, EUR J IMMUNOGENET, V30, P229, DOI 10.1046/j.1365-2370.2003.00383.x; Norman PJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003938; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Pontikos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-274; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Velardi A, 2008, CURR OPIN IMMUNOL, V20, P581, DOI 10.1016/j.coi.2008.07.004; Vukcevic D, 2011, GENET EPIDEMIOL, V35, P278, DOI 10.1002/gepi.20576; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	37	44	44	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					593	607		10.1016/j.ajhg.2015.09.005	http://dx.doi.org/10.1016/j.ajhg.2015.09.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26430804	hybrid, Green Published			2022-12-18	WOS:000362617300009
J	Law, R; Dixon-Saazar, T; Jerber, J; Cai, N; Abbasi, AA; Zaki, MS; Mittal, K; Gabriel, SB; Rafiq, MA; Khan, V; Nguyen, M; Ali, G; Copeland, B; Scott, E; Vasli, N; Mikhailov, A; Khan, MN; Andrade, DM; Ayaz, M; Ansar, M; Ayub, M; Vincent, JB; Gleeson, JG				Law, Rosalind; Dixon-Saazar, Tracy; Jerber, Julie; Cai, Na; Abbasi, Ansar A.; Zaki, Maha S.; Mittal, Kirti; Gabriel, Stacey B.; Rafiq, Muhammad Arshad; Khan, Valeed; Nguyen, Maria; Ali, Ghazanfar; Copeland, Brett; Scott, Eric; Vasli, Nasim; Mikhailov, Anna; Khan, Muhammad Nasim; Andrade, Danielle M.; Ayaz, Muhammad; Ansar, Muhammad; Ayub, Muhammad; Vincent, John B.; Gleeson, Joseph G.			Biallelic Truncating Mutations in FMN2, Encoding the Actin-Regulatory Protein Formin 2, Cause Nonsyndromic Autosomal-Recessive Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; DELETION; DEFICITS; NEURONS; CELLS; MICE	Dendritic spines represent the major site of neuronal activity in the brain; they serve as the receiving point for neurotransmitters and undergo rapid activity-dependent morphological changes that correlate with learning and memory. Using a combination of homozygosity mapping and next-generation sequencing in two consanguineous families affected by nonsyndromic autosomal-recessive intellectual disability, we identified truncating mutations in formin 2 (FMN2), encoding a protein that belongs to the formin family of actin cytoskeleton nucleation factors and is highly expressed in the maturing brain. We found that FMN2 localizes to punctae along dendrites and that germline inactivation of mouse Fmn2 resulted in animals with decreased spine density; such mice were previously demonstrated to have a conditioned fear-learning defect. Furthermore, patient neural cells derived from induced pluripotent stem cells showed correlated decreased synaptic density. Thus, FMN2 mutations link intellectual disability either directly or indirectly to the regulation of actin-mediated synaptic spine density.	[Law, Rosalind; Mittal, Kirti; Rafiq, Muhammad Arshad; Vasli, Nasim; Mikhailov, Anna; Vincent, John B.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5T 1R8, Canada; [Dixon-Saazar, Tracy; Jerber, Julie; Cai, Na; Nguyen, Maria; Copeland, Brett; Scott, Eric; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Dixon-Saazar, Tracy; Jerber, Julie; Cai, Na; Nguyen, Maria; Copeland, Brett; Scott, Eric; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Abbasi, Ansar A.] Univ Azad Jammu & Kashmir, Dept Zool, Muzaffarabad 13100, Pakistan; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo 12311, Egypt; [Gabriel, Stacey B.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Khan, Valeed; Ansar, Muhammad] Quaid I Azam Univ, Dept Biochem, Islamabad 45320, Pakistan; [Ali, Ghazanfar; Khan, Muhammad Nasim] Univ Azad Jammu & Kashmir, Dept Biotechnol, Muzaffarabad 13100, Pakistan; [Andrade, Danielle M.] Univ Toronto, Div Neurol, Dept Med, Toronto, ON M5S 2J7, Canada; [Andrade, Danielle M.] Toronto Western Res Inst, Krembil Neurosci Ctr, Toronto, ON M5S 2J7, Canada; [Ayaz, Muhammad; Ayub, Muhammad] Lahore Inst Res & Dev, Lahore 51000, Pakistan; [Ayub, Muhammad] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Vincent, John B.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Azad Jammu & Kashmir; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Quaid I Azam University; University of Azad Jammu & Kashmir; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Queens University - Canada; University of Toronto; University of Toronto	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5T 1R8, Canada.	john.vincent@camh.ca; jogleeson@rockefeller.edu	Ali, Ghazanfar/L-9277-2019; Ansar, Muhammad/F-4808-2015; Zaki, Maha S/B-9361-2013; Ansar, Muhammad/H-5967-2011	Ali, Ghazanfar/0000-0002-6172-9503; Ansar, Muhammad/0000-0001-5891-7063; Copeland, Brett/0000-0003-2933-6061; Andrade, Danielle/0000-0003-0953-2698; Zaki, Maha/0000-0001-7840-0002	National Institutes of Health [R01NS041537, R01NS048453, R01NS052455, P01HD070494, P30NS047101]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; California Institute of Regenerative Medicine; Canadian Institutes of Health Research [MOP-102758]; Pakistan Higher Education Commission (HEC); Broad Institute [U54HG003067]; Yale Center for Mendelian Disorders grant [U54HG006504]; Consortium for Autosomal Recessive Intellectual Disability (CARID); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, P30NS047101, R01NS052455, R01NS048453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pakistan Higher Education Commission (HEC)(Higher Education Commission of Pakistan); Broad Institute; Yale Center for Mendelian Disorders grant; Consortium for Autosomal Recessive Intellectual Disability (CARID); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the study participants and their families for their invaluable contributions to this study. This work was supported by National Institutes of Health grants R01NS041537, R01NS048453, R01NS052455, P01HD070494, and P30NS047101, the Simons Foundation Autism Research Initiative, the Howard Hughes Medical Institute (J.G.G.), the California Institute of Regenerative Medicine, the Canadian Institutes of Health Research (grant MOP-102758 to J.B.V.), and the Pakistan Higher Education Commission (HEC, A.A.A.). We thank the Broad Institute (grant U54HG003067 to E. Lander), the Yale Center for Mendelian Disorders grant (U54HG006504 to R. Lifton and M. Gunel) for sequencing support, the Consortium for Autosomal Recessive Intellectual Disability (CARID) for supporting ascertainment, and Katie Hsiao (Nathanial Heintz lab) for sharing hippocampal cultures.	Almuqbil M, 2013, EUR J MED GENET, V56, P686, DOI 10.1016/j.ejmg.2013.10.003; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Charfi C, 2011, BLOOD, V117, P1899, DOI 10.1182/blood-2010-10-311001; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimitrov BI, 2010, J MED GENET, V47, P569, DOI 10.1136/jmg.2009.073833; Ercan-Sencicek A.G., 2014, EUR J HUM GENET; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; HUTTENLOCHER PR, 1991, PEDIATR NEUROL, V7, P79, DOI 10.1016/0887-8994(91)90001-2; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Musante L, 2014, TRENDS GENET, V30, P32, DOI 10.1016/j.tig.2013.09.008; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Perrone MD, 2012, EUR J MED GENET, V55, P117, DOI 10.1016/j.ejmg.2011.11.004; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Strachan T, 1999, HUMAN MOL GENETICS; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185	31	44	45	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					721	728		10.1016/j.ajhg.2014.10.016	http://dx.doi.org/10.1016/j.ajhg.2014.10.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25480035	Green Published, Bronze			2022-12-18	WOS:000346623100008
J	Lim, SC; Smith, KR; Stroud, DA; Compton, AG; Tucker, EJ; Dasvarma, A; Gandolfo, LC; Marum, JE; McKenzie, M; Peters, HL; Mowat, D; Procopis, PG; Wilcken, B; Christodoulou, J; Brown, GK; Ryan, MT; Bahlo, M; Thorburn, DR				Lim, Sze Chern; Smith, Katherine R.; Stroud, David A.; Compton, Alison G.; Tucker, Elena J.; Dasvarma, Ayan; Gandolfo, Luke C.; Marum, Justine E.; McKenzie, Matthew; Peters, Heidi L.; Mowat, David; Procopis, Peter G.; Wilcken, Bridget; Christodoulou, John; Brown, Garry K.; Ryan, Michael T.; Bahlo, Melanie; Thorburn, David R.			A Founder Mutation in PET100 Causes Isolated Complex IV Deficiency in Lebanese Individuals with Leigh Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; PROGRESSIVE MYOCLONUS EPILEPSY; DNA-SEQUENCING DATA; MITOCHONDRIAL PROTEINS; SACCHAROMYCES-CEREVISIAE; INBREEDING COEFFICIENT; HIGH-THROUGHPUT; COX I; GENE; CHAIN	Leigh syndrome (LS) is a severe neurodegenerative disorder with characteristic bilateral lesions, typically in the brainstem and basal ganglia. It usually presents in infancy and is genetically heterogeneous, but most individuals with mitochondrial complex IV (or cytochrome c oxidase) deficiency have mutations in the biogenesis factor SURF1. We studied eight complex IV-deficient LS individuals from six families of Lebanese origin. They differed from individuals with SURF1 mutations in having seizures as a prominent feature. Complementation analysis suggested they had mutation(s) in the same gene but targeted massively parallel sequencing (MPS) of 1,034 genes encoding known mitochondrial proteins failed to identify a likely candidate. Linkage and haplotype analyses mapped the location of the gene to chromosome 19 and targeted MPS of the linkage region identified a homozygous c.3G>C (p.Met1?) mutation in C19orf79. Abolishing the initiation codon could potentially still allow initiation at a downstream methionine residue but we showed that this would not result in a functional protein. We confirmed that mutation of this gene was causative by lentiviral-mediated phenotypic correction. C19orf79 was recently renamed PET100 and predicted to encode a complex IV biogenesis factor. We showed that it is located in the mitochondrial inner membrane and forms a similar to 300 kDa subcomplex with complex IV subunits. Previous proteomic analyses of mitochondria had overlooked PET100 because its small size was below the cutoff for annotating bona fide proteins. The mutation was estimated to have arisen at least 520 years ago, explaining how the families could have different religions and different geographic origins within Lebanon.	[Lim, Sze Chern; Compton, Alison G.; Tucker, Elena J.; Dasvarma, Ayan; Marum, Justine E.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Lim, Sze Chern; Compton, Alison G.; Tucker, Elena J.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Smith, Katherine R.; Gandolfo, Luke C.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Smith, Katherine R.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Stroud, David A.; Ryan, Michael T.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia; [Gandolfo, Luke C.; Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3052, Australia; [McKenzie, Matthew] Monash Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia; [Peters, Heidi L.; Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Mowat, David] Univ NSW, Dept Med Genet, Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Sydney, NSW 2031, Australia; [Procopis, Peter G.] Childrens Hosp Westmead, Dept Neurol, Westmead, NSW 2145, Australia; [Procopis, Peter G.; Wilcken, Bridget; Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Christodoulou, John] Childrens Hosp Westmead, Genet Metab Disorders Res Unit, Sydney, NSW 2145, Australia; [Christodoulou, John] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia; [Brown, Garry K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; University of Melbourne; Royal Children's Hospital Melbourne; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Oxford	Thorburn, DR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	david.thorburn@mcri.edu.au	Ryan, Michael T/C-6673-2011; Christodoulou, John/M-3628-2019; peters, heidi/GWD-0358-2022; Lim, Sze Chern/I-6763-2013; Stroud, David A/B-4929-2016; Christodoulou, John/E-5866-2015; Ryan, Michael/X-2152-2019; McKenzie, Matthew/H-4926-2019; Stroud, David Arthur/HGB-4331-2022; Thorburn, David R/G-6266-2013	Ryan, Michael T/0000-0003-2586-8829; Christodoulou, John/0000-0002-8431-0641; Lim, Sze Chern/0000-0003-0312-9937; Stroud, David A/0000-0002-2048-3383; Ryan, Michael/0000-0003-2586-8829; McKenzie, Matthew/0000-0001-7508-1800; Stroud, David Arthur/0000-0002-2048-3383; thorburn, david/0000-0002-7725-9470; Bahlo, Melanie/0000-0001-5132-0774; Compton, Alison/0000-0002-2725-7055; Peters, Heidi/0000-0001-7189-5874; Tucker, Elena/0000-0002-6380-5100	Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Australian National Health and Medical Research Council; Independent Research Institute Infrastructure Support Scheme; Melbourne Research Scholarship; Australian Research Council; Pratt Foundation scholarship; James and Vera Lawson Trust; Victorian Government's Operational Infrastructure Support Program	Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Independent Research Institute Infrastructure Support Scheme; Melbourne Research Scholarship; Australian Research Council(Australian Research Council); Pratt Foundation scholarship; James and Vera Lawson Trust; Victorian Government's Operational Infrastructure Support Program	We thank C. Zetzer, K. Reed, H. Dahl, and S. White for assisting with complementation and linkage analyses and S. Tregoning, W. Salter, K. Canavan, S. Smith, and W. Hutchison for technical assistance with cell culture, enzyme, and molecular analyses. A. Boneh, M. Nash, A. Mansour, and G. Wise are thanked for referral of affected individuals or clinical review. We thank the subjects and their families for their involvement and V.K. Mootha and S.E. Calvo for their collaboration by sequencing known MitoExorne genes and for helpful discussion. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). This work was supported by the Australian National Health and Medical Research Council via Project (M.T.R., D.R.T.) and Program (M.B.) grants, a Career Development Fellowship (M.McK.), a Principal Research Fellowship (D.R.T.), and the Independent Research Institute Infrastructure Support Scheme (M.B., K.R.S.). Other support came from a Melbourne Research Scholarship (S.C.L.), a Future Fellowship from the Australian Research Council (M.B.), a Pratt Foundation scholarship (K.R.S.), the James and Vera Lawson Trust (M.McK.) and the Victorian Government's Operational Infrastructure Support Program (D.R.T., M.McK., M.B., and K.R.S.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200; Church C, 1996, J BIOL CHEM, V271, P18499, DOI 10.1074/jbc.271.31.18499; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colombo R., 2008, HDB HUMAN MOL EVOLUT, P138; Corbett MA, 2011, AM J HUM GENET, V88, P657, DOI 10.1016/j.ajhg.2011.04.011; Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169; Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hong YS, 1996, HUM MOL GENET, V5, P1925, DOI 10.1093/hmg/5.12.1925; Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002; Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lomax LB, 2013, BRAIN, V136, P1146, DOI 10.1093/brain/awt021; MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Oquendo CE, 2004, J MED GENET, V41, P540, DOI 10.1136/jmg.2003.017426; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Stiburek L, 2006, PHYSIOL RES, V55, pS27, DOI 10.33549/physiolres.930000.55.S2.27; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Yeap YYC, 2010, BIOCHEM J, V430, P345, DOI 10.1042/BJ20100425; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	71	44	44	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					209	222		10.1016/j.ajhg.2013.12.015	http://dx.doi.org/10.1016/j.ajhg.2013.12.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24462369	Green Published, Bronze			2022-12-18	WOS:000331419500005
J	Ayub, Q; Yngvadottir, B; Chen, Y; Xue, YL; Hu, M; Vernes, SC; Fisher, SE; Tyler-Smith, C				Ayub, Qasim; Yngvadottir, Bryndis; Chen, Yuan; Xue, Yali; Hu, Min; Vernes, Sonja C.; Fisher, Simon E.; Tyler-Smith, Chris			FOXP2 Targets Show Evidence of Positive Selection in European Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LANGUAGE DISORDERS; GENE; SPEECH; DEFICITS; IDENTIFICATION; POLYMORPHISMS; ASSOCIATION; EXPRESSION; EVOLUTION; DISEASE	Forkhead box P2 (FOXP2) is a highly conserved transcription factor that has been implicated in human speech and language disorders and plays important roles in the plasticity of the developing brain. The pattern of nudeotide polymorphisms in FOXP2 in modem populations suggests that it has been the target of positive (Darwinian) selection during recent human evolution. In our study, we searched for evidence of selection that might have followed FOXP2 adaptations in modern humans. We examined whether or not putative FOXP2 targets identified by chromatin-immunoprecipitation genomic screening show evidence of positive selection. We developed an algorithm that, for any given gene list, systematically generates matched lists of control genes from the Ensembl database, collates summary statistics for three frequency-spectrum-based neutrality tests from the low-coverage resequencing data of the 1000 Genomes Project, and determines whether these statistics are significantly different between the given gene targets and the set of controls. Overall, there was strong evidence of selection of FOXP2 targets in Europeans, but not in the Han Chinese, Japanese, or Yomba populations. Significant outliers included several genes linked to cellular movement, reproduction, development, and immune cell trafficking, and 13 of these constituted a significant network associated with cardiac arteriopathy. Strong signals of selection were observed for CNTNAP2 and RBFOX1, key neurally expressed genes that have been consistently identified as direct FOXP2 targets in multiple studies and that have themselves been associated with neurodevelopmental disorders involving language dysfunction.	[Ayub, Qasim; Yngvadottir, Bryndis; Chen, Yuan; Xue, Yali; Hu, Min; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Vernes, Sonja C.; Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, NL-6525 XD Nijmegen, Netherlands; [Vernes, Sonja C.; Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands	Wellcome Trust Sanger Institute; Max Planck Society; Radboud University Nijmegen	Ayub, Q (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	qa1@sanger.ac.uk	Vernes, Sonja/E-8454-2012; Fisher, Simon E./E-9130-2012	Vernes, Sonja/0000-0003-0305-4584; Fisher, Simon E./0000-0002-3132-1996; Ayub, Qasim/0000-0003-3291-0917	Wellcome Trust [098051]; Max Planck Society	Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank Daniel MacArthur and Eleftheria Zeggini for helpful discussions, G. Achaz for providing the code for the Y test statistic, and two anonymous reviewers for useful comments. This work was supported by the Wellcome Trust (098051) and the Max Planck Society.	Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BIEDLER JL, 1973, CANCER RES, V33, P2643; Chen Q, 2003, AM J HUM GENET, V72, P13, DOI 10.1086/345312; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fay JC, 2000, GENETICS, V155, P1405; Fisher R., 1954, OLIVER BOYD, DOI DOI 10.1007/BF01603396; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fukumura K, 2007, NUCLEIC ACIDS RES, V35, P5303, DOI 10.1093/nar/gkm569; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Hu M, 2012, HUM GENET, V131, P665, DOI 10.1007/s00439-011-1111-9; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Lu BS, 2003, J BIOL CHEM, V278, P16289, DOI 10.1074/jbc.M211023200; Lu HQ, 2006, PROTEIN EXPRES PURIF, V46, P92, DOI 10.1016/j.pep.2005.07.021; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Ptak SE, 2009, MOL BIOL EVOL, V26, P2181, DOI 10.1093/molbev/msp143; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Sokal R. R., 2012, BIOMETRY; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; TAJIMA F, 1989, GENETICS, V123, P585; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Wilson R., 2012, MOL CELL PROTEOMICS, V11.1, DOI DOI 10.1074/MCP.M111.014159; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	42	44	46	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					696	706		10.1016/j.ajhg.2013.03.019	http://dx.doi.org/10.1016/j.ajhg.2013.03.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23602712	Green Published, hybrid			2022-12-18	WOS:000318582800006
J	Webb, BD; Shaaban, S; Gaspar, H; Cunha, LF; Schubert, CR; Hao, K; Robson, CD; Chan, WM; Andrews, C; MacKinnon, S; Oystreck, DT; Hunter, DG; Iacovelli, AJ; Ye, XQ; Camminady, A; Engle, EC; Jabs, EW				Webb, Bryn D.; Shaaban, Sherin; Gaspar, Harald; Cunha, Luis F.; Schubert, Christian R.; Hao, Ke; Robson, Caroline D.; Chan, Wai-Man; Andrews, Caroline; MacKinnon, Sarah; Oystreck, Darren T.; Hunter, David G.; Iacovelli, Anthony J.; Ye, Xiaoqian; Camminady, Anne; Engle, Elizabeth C.; Jabs, Ethylin Wang			HOXB1 Founder Mutation in Humans Recapitulates the Phenotype of Hoxb1(-/-) Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRANIAL DYSINNERVATION DISORDERS; COOPERATIVE DNA-BINDING; MOBIUS-SYNDROME; VERTEBRATE DEVELOPMENT; OLIVOCOCHLEAR REFLEX; HOMEODOMAIN PROTEINS; NEURONAL CIRCUITRY; ACOUSTIC INJURY; MOTOR-NEURONS; AXON GUIDANCE	Members of the highly conserved homeobox (HOX) gene family encode transcription factors that confer cellular and tissue identities along the antero-posterior axis of mice and humans. We have identified a founder homozygous missense mutation in HOXB1 in two families from a conservative German American population. The resulting phenotype includes bilateral facial palsy, hearing loss, and strabismus and correlates extensively with the previously reported Hoxb1(-/-) mouse phenotype. The missense variant is predicted to result in the substitution of a cysteine for an arginine at amino acid residue 207 (Arg207Cys), which corresponds to the highly conserved Arg5 of the homeodomain. Arg5 interacts with thymine in the minor groove of DNA through hydrogen bonding and electrostatic attraction. Molecular modeling and an in vitro DNA-protein binding assay predict that the mutation would disrupt these interactions, destabilize the HOXB1:PBX1:DNA complex, and alter HOXB1 transcriptional activity.	[Shaaban, Sherin; Chan, Wai-Man; Andrews, Caroline; Engle, Elizabeth C.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Webb, Bryn D.; Gaspar, Harald; Cunha, Luis F.; Hao, Ke; Iacovelli, Anthony J.; Ye, Xiaoqian; Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Webb, Bryn D.; Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Engle, Elizabeth C.] Boston Childrens Hosp, Dept Med Genet, Boston, MA 02115 USA; [MacKinnon, Sarah; Hunter, David G.; Engle, Elizabeth C.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Robson, Caroline D.] Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Andrews, Caroline; Engle, Elizabeth C.] Boston Childrens Hosp, FB Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Chan, Wai-Man; Engle, Elizabeth C.] Boston Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Schubert, Christian R.; Engle, Elizabeth C.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Shaaban, Sherin; Schubert, Christian R.; Andrews, Caroline; Engle, Elizabeth C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hunter, David G.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Schubert, Christian R.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Shaaban, Sherin] Mansoura Univ, Dept Ophthalmol, Daqahlia 35516, Egypt; [Shaaban, Sherin] Dubai Harvard Fdn Med Res, Boston, MA 02115 USA; [Gaspar, Harald; Camminady, Anne] Univ Klinikum Heidelberg, Inst Humangenet, D-69120 Heidelberg, Germany; [Cunha, Luis F.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Schubert, Christian R.] MIT, Harvard Mit Div Hlth Sci & Technol, Elect Res Lab, Cambridge, MA 02139 USA; [Schubert, Christian R.] MIT, Harvard Mit Div Hlth Sci & Technol, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Chan, Wai-Man; Andrews, Caroline; Engle, Elizabeth C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Oystreck, Darren T.] King Saud Univ, Dept Ophthalmol, Coll Med, Riyadh 11411, Saudi Arabia; [Oystreck, Darren T.] Univ Stellenbosch, Fac Hlth Sci, Div Ophthalmol, ZA-7505 Tygerberg, South Africa; [Engle, Elizabeth C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21205 USA; [Gaspar, Harald] Univ Med Ctr Freiburg, Inst Human Genet, Freiburg, Germany	Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Egyptian Knowledge Bank (EKB); Mansoura University; Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; King Saud University; Stellenbosch University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Freiburg	Engle, EC (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	elizabeth.engle@childrens.harvard.edu; ethylin.jabs@mssm.edu	Oystreck, Darren T/Q-6135-2017	Oystreck, Darren T/0000-0001-6974-1091; Jabs, Ethylin/0000-0001-8983-5466; Hunter, David/0000-0002-4587-4794; Robson, Caroline/0000-0001-5592-249X	Moebius Syndrome Foundation; Children's Hospital Ophthalmology Foundation; National Human Genome Research Institute [U54 HG003067]; Swiss National Science Foundation; National Institutes of Health [U54 HG003067, R01 EY15298, R01 HD018655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015298] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Moebius Syndrome Foundation; Children's Hospital Ophthalmology Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to all individuals who generously participated in this study. We especially thank the Moebius Syndrome Foundation and the Children's Hospital Ophthalmology Foundation for their support. We are grateful to the Broad Institute for generating high-quality sequence data supported by funds from the National Human Genome Research Institute (grant #U54 HG003067, Eric Lander, PI). We would also like to thank Robert Cullen for his help with clinical assessment of family A. We appreciate Mihaly Mezei of Mount Sinai School of Medicine for his advice and guidance with protein modeling. Vincenzo Zappavigna of University of Modena and Reggio Emilia, Italy and Mark Featherstone of Nanyang Technological University, Singapore generously provided us with pAdML-ARE, pAdML, pSG-HOXB1, and pSG-PBX1A vectors. Kari Hemminki of the German Cancer Research Center, Heidelberg, Germany supplied us with German control DNAs. This research was supported in part by the Swiss National Science Foundation and National Institutes of Health (grants R01 EY15298, R01 HD018655, R01 HD018655, and U54 HG003067). E.C.E. is a Howard Hughes Medical Institute Investigator.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alrashdi IS, 2010, CLIN DYSMORPHOL, V19, P198, DOI 10.1097/MCD.0b013e32832b7700; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arenkiel BR, 2004, GENE DEV, V18, P1539, DOI 10.1101/gad.1207204; Arenkiel BR, 2003, DEV DYNAM, V227, P379, DOI 10.1002/dvdy.10323; Bogart KR, 2010, CLEFT PALATE-CRAN J, V47, P134, DOI 10.1597/08-257.1; Briscoe J, 2004, GENE DEV, V18, P1643, DOI 10.1101/gad.1227004; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Faiella Antonio, 1998, Human Mutation, V12, P363; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gavalas A, 2003, DEVELOPMENT, V130, P5663, DOI 10.1242/dev.00802; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gavalas A, 1998, DEVELOPMENT, V125, P1123; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Goddard JM, 1996, DEVELOPMENT, V122, P3217; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Gutowski N J, 2003, Neuromuscul Disord, V13, P573, DOI 10.1016/S0960-8966(03)00043-9; Ishioka A, 2011, DEV BIOL, V350, P154, DOI 10.1016/j.ydbio.2010.10.011; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; Kremer H, 1996, HUM MOL GENET, V5, P1367, DOI 10.1093/hmg/5.9.1367; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miller G, 2007, SCIENCE, V316, P826, DOI 10.1126/science.316.5826.826; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Oystreck DT, 2011, J NEURO-OPHTHALMOL, V31, P69, DOI 10.1097/WNO.0b013e31820d0756; Phelan ML, 1997, J BIOL CHEM, V272, P8635, DOI 10.1074/jbc.272.13.8635; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rossel M, 1999, DEVELOPMENT, V126, P5027; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Traboulsi EI, 2007, J AAPOS, V11, P215, DOI 10.1016/j.jaapos.2007.04.007; Vallette-Kasic S, 2001, MOL ENDOCRINOL, V15, P411, DOI 10.1210/me.15.3.411; Verzijl HTFM, 2003, NEUROLOGY, V61, P327, DOI 10.1212/01.WNL.0000076484.91275.CD; Verzijl HTFM, 1999, AM J HUM GENET, V65, P752, DOI 10.1086/302539; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Yamada S, 1999, DIABETES, V48, P645, DOI 10.2337/diabetes.48.3.645	52	44	47	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					171	179		10.1016/j.ajhg.2012.05.018	http://dx.doi.org/10.1016/j.ajhg.2012.05.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22770981	Green Published, Bronze			2022-12-18	WOS:000306445000015
J	Frojmark, AS; Schuster, J; Sobol, M; Entesarian, M; Kilander, MBC; Gabrikova, D; Nawaz, S; Baig, SM; Schulte, G; Klar, J; Dahl, N				Frojmark, Anne-Sophie; Schuster, Jens; Sobol, Maria; Entesarian, Miriam; Kilander, Michaela B. C.; Gabrikova, Dana; Nawaz, Sadia; Baig, Shahid M.; Schulte, Gunnar; Klar, Joakim; Dahl, Niklas			Mutations in Frizzled 6 Cause Isolated Autosomal-Recessive Nail Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-CATENIN; DIFFERENTIATION; REGULATOR; POLARITY; PATHWAY; WNT10A; AER	Inherited and isolated nail malformations are rare and heterogeneous conditions. We identified two consanguineous pedigrees in which some family members were affected by isolated nail dysplasia that suggested an autosomal-recessive inheritance pattern and was characterized by claw-shaped nails, onychauxis, and onycholysis. Genome-wide SNP array analysis of affected individuals from both families showed an overlapping and homozygous region of 800 kb on the long arm of chromosome 8. The candidate region spans eight genes, and DNA sequence analysis revealed homozygous nonsense and missense mutations in FZD(6), the gene encoding Frizzled 6. FZD(6) belongs to a family of highly conserved membrane-bound WNT receptors involved in developmental processes and differentiation through several signaling pathways. We expressed the FZD(6) missense mutation and observed a quantitative shift in subcellular distribution from the plasma membrane to the lysosomes, where the receptor is inaccessible for signaling and presumably degraded. Analysis of human fibroblasts homozygous for the nonsense mutation showed an aberrant response to both WNT-3A and WNT-5A stimulation; this response was consistent with an effect on both canonical and noncanonical WNT-FZD signaling. A detailed analysis of the Fzd(6)(-/-) mice, previously shown to have an altered hair pattern, showed malformed claws predominantly of the hind limbs. Furthermore, a transient Fdz6 mIZNA expression was observed in the epidermis of the digital tips at embryonic day 16.5 during early claw morphogenesis. Thus, our combined results show that FZD6 mutations can result in severe defects in nail and claw formation through reduced or abolished membranous FZD(6) levels and several nonfunctional WNT-FZD pathways.	[Frojmark, Anne-Sophie; Schuster, Jens; Sobol, Maria; Entesarian, Miriam; Gabrikova, Dana; Klar, Joakim; Dahl, Niklas] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Frojmark, Anne-Sophie; Schuster, Jens; Sobol, Maria; Entesarian, Miriam; Gabrikova, Dana; Klar, Joakim; Dahl, Niklas] Uppsala Univ, Sci Life Lab, S-75185 Uppsala, Sweden; [Sobol, Maria] Natl Tams Shevchenko Univ Kyiv, Dept Gen & Mol Genet, UA-03680 Kiev, Ukraine; [Kilander, Michaela B. C.; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, S-17176 Stockholm, Sweden; [Nawaz, Sadia; Baig, Shahid M.] NIBGE, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad 38000, Pakistan; [Schuster, Jens; Sobol, Maria; Entesarian, Miriam] Karolinska Univ Hosp, Ctr Mol Med, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden	Uppsala University; Uppsala University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Karolinska Institutet; Pakistan Institute of Engineering & Applied Science; Karolinska Institutet; Karolinska University Hospital	Dahl, N (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.	niklas.dahl@igp.uu.se	Schuster, Jens/D-2005-2010; Klar, Joakim/H-2900-2019; Baig, Shahid Mahmood/I-7309-2015; Sobol, Maria/AAA-5738-2019; BAig, Shahid Mahmood/AAS-8365-2020	Schuster, Jens/0000-0002-4383-9880; Klar, Joakim/0000-0003-4185-7409; Schulte, Gunnar/0000-0002-2700-7013; Kilander, Michaela/0000-0001-5166-4614; Dojcakova, Dana/0000-0003-1637-5002	Swedish Research Council [K2010-66X-10829-17-3, K2008-68P-20810-01-4, K2008-68X-20805-01-4]; Swedish Links, Asia [348-2008-6069]; Indevelops fund; Thureus fund; Uppsala University Hospital; Uppsala University; Science for Life Laboratory; Karolinska Institutet; Swedish Society for Medical Research; Swedish Institute; Swedish Cancer Society [CAN 2008/539]; Knut and Alice Wallenberg Foundation [KAW2008.0149]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Links, Asia; Indevelops fund; Thureus fund; Uppsala University Hospital; Uppsala University; Science for Life Laboratory; Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; Swedish Institute; Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank all family members who participated in this study. Mice targeted for Fzd6 were generously shared by Jeremy Nathans, Howard Hughes Medical Institute and Johns Hopkins University. Wnt producing 3T3 fibroblast lines were a gift from Peter Mark, Universitatklinikum Rostock. This work was supported by grants from the Swedish Research Council (K2010-66X-10829-17-3) and Swedish Links, Asia (348-2008-6069), the Indevelops fund, Thureus fund, Uppsala University Hospital, Uppsala University, and the Science for Life Laboratory. M.B.C.K. was supported by the Karolinska Institutet's Keratitis, Ichthyosis, and Neurosensory Deafness Syndrome program; J.K. was supported by the Swedish Society for Medical Research, and M.S. was supported by the Swedish Institute. Work in the laboratory of G.S. was supported by the Swedish Research Council (K2008-68P-20810-01-4, K2008-68X-20805-01-4), Swedish Cancer Society (CAN 2008/539), and the Knut and Alice Wallenberg Foundation (KAW2008.0149).	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Entesarian M, 2009, AM J MED GENET A, V149A, P380, DOI 10.1002/ajmg.a.32663; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hamm H, 2000, ARCH DERMATOL, V136, P1239, DOI 10.1001/archderm.136.10.1239; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Nikolova T, 2007, DIFFERENTIATION, V75, P100, DOI 10.1111/j.1432-0436.2006.00119.x; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Revet I, 2010, CANCER LETT, V289, P195, DOI 10.1016/j.canlet.2009.08.019; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schuster J, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-58; Seitz CS, 2005, BRIT J DERMATOL, V152, P1339, DOI 10.1111/j.1365-2133.2005.06509.x; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Soshnikova N, 2003, GENE DEV, V17, P1963, DOI 10.1101/gad.263003; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	36	44	48	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					852	860		10.1016/j.ajhg.2011.05.013	http://dx.doi.org/10.1016/j.ajhg.2011.05.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21665003	Bronze, Green Published			2022-12-18	WOS:000291768500018
J	Shaheen, R; Al-Owain, M; Sakati, N; Alzayed, ZS; Alkuraya, FS				Shaheen, Ranad; Al-Owain, Mohammed; Sakati, Nadia; Alzayed, Zayed S.; Alkuraya, Fowzan S.			FKBP10 and Bruck Syndrome: Phenotypic Heterogeneity or Call for Reclassification?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TELOPEPTIDE LYSYL HYDROXYLASE		[Shaheen, Ranad; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Al-Owain, Mohammed] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Al-Owain, Mohammed; Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia; [Sakati, Nadia] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; [Alzayed, Zayed S.] King Faisal Specialist Hosp & Res Ctr, Dept Orthoped, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital; King Saud University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Alkuraya, Fowzan S./A-1542-2009	Alkuraya, Fowzan S./0000-0003-4158-341X; SHAHEEN, RANAD/0000-0002-2590-1759				Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Andiran N, 2008, PEDIATR INT, V50, P836, DOI 10.1111/j.1442-200X.2008.02752.x; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; VILJOEN D, 1989, CLIN GENET, V36, P122	9	44	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					306	307		10.1016/j.ajhg.2010.05.020	http://dx.doi.org/10.1016/j.ajhg.2010.05.020			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20696291	Green Published, Bronze			2022-12-18	WOS:000281107000016
J	Li, Y; Pohl, E; Boulouiz, R; Schraders, M; Nurnberg, G; Charif, M; Admiraal, RJC; von Ameln, S; Baessmann, I; Kandil, M; Veltman, JA; Nurnberg, P; Kubisch, C; Barakat, A; Kremer, H; Wolinik, B				Li, Yun; Pohl, Esther; Boulouiz, Redouane; Schraders, Margit; Nuernberg, Gudrun; Charif, Majida; Admiraal, Ronald J. C.; von Ameln, Simon; Baessmann, Ingelore; Kandil, Mostafa; Veltman, Joris A.; Nuernberg, Peter; Kubisch, Christian; Barakat, Abdelhamid; Kremer, Hannie; Wolinik, Bernd			Mutations in TPRN Cause a Progressive Form of Autosomal-Recessive Nonsyndromic Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; GENETICS; MODELS	We performed genome-wide homozygosity mapping in a large consanguineous family from Morocco and mapped the autosomal-recessive nonsyndromic hearing loss (ARNSHL) in this family to the DFNB79 locus on chromosome 9q34. By sequencing of 62 positional candidate genes of the critical region, we identified a causative homozygous 11 bp deletion, c.42_52del, in the TPRN gene in all seven affected individuals. The deletion is located in exon 1 and results in a frameshift and premature protein truncation (p.Gly15AlafsX150). Interestingly, the deleted sequence is part of a repetitive and CG-rich motive predicted to be prone to structural aberrations during crossover fort-nation. We identified another family with progressive ARNSHL linked to this locus, whose affected members were shown to carry a causative 1 bp deletion (c.1347delG) in exon 1 of TPRN. The function of the encoded protein, taperin, is unknown; yet, partial homology to the actin-caping protein phostensin suggests a role in actin dynamics.	[Li, Yun; Pohl, Esther; von Ameln, Simon; Nuernberg, Peter; Kubisch, Christian; Wolinik, Bernd] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Li, Yun; Pohl, Esther; von Ameln, Simon; Kubisch, Christian; Wolinik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Boulouiz, Redouane; Charif, Majida; Barakat, Abdelhamid] Inst Pasteur Maroc, Dept Genet, Casablanca 20100, Morocco; [Schraders, Margit; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, NL-6525 GA Nijmegen, Netherlands; [Schraders, Margit; Veltman, Joris A.; Kremer, Hannie] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Schraders, Margit; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Nuernberg, Gudrun; Baessmann, Ingelore; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter; Kubisch, Christian; Wolinik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Kandil, Mostafa] Fac Sci, Lab Sci Anthropogenet & Pathol, El Jadida 24000, Morocco; [Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands	University of Cologne; University of Cologne; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Cologne; University of Cologne; Chouaib Doukkali University of El Jadida; Radboud University Nijmegen	Wolinik, B (corresponding author), Univ Cologne, CMMC, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de	Schraders, Margit/A-1607-2016; Admiraal, R.J.C./L-4171-2015; Veltman, Joris A/F-5128-2010; Wollnik, Bernd/GRY-6062-2022; Kremer, Hannie/F-5126-2010; Kubisch, Christian/F-1893-2011	Veltman, Joris A/0000-0002-3218-8250; Wollnik, Bernd/0000-0003-2589-0364; Kremer, Hannie/0000-0002-0841-8693; Kubisch, Christian/0000-0003-4220-0978; von Ameln, Simon/0000-0002-2242-3165; BOULOUIZ, Redouane/0000-0003-4430-3612	European Commission [LSHG-CT-20054-512063]; German Federal Ministry of Education and Research (BMBF) [01GM0801]; RNID [GR36]; Fonds NutsOhra [SNO-T-0702-102]; Janivo Stichting; Heinsius Houbolt Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); RNID; Fonds NutsOhra; Janivo Stichting; Heinsius Houbolt Foundation	We thank all family members who participated in this study. We also thank Michaela Thoenes, Esther Milz, and Nicole Weegerink for preparing the figures of the audiograms and the longitudinal linear regression analysis and Karin Boss for critically reading the manuscript. This work was supported by the European Commission FP6 Integrated Project EUROHEAR (LSHG-CT-20054-512063 to C.K., H.K., and B.W.), by a German Federal Ministry of Education and Research (BMBF) grant under the E-RARE network CRA-NIRARE consortium (01GM0801 to B.W.), by the RNID (GR36 to H.K.), by Fonds NutsOhra (project SNO-T-0702-102 to H.K.), and by grants from the Janivo Stichting (to H.K.), and the Heinsius Houbolt Foundation (to H.K.).	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Boulouiz R, 2008, AM J MED GENET A, V146A, P3086, DOI 10.1002/ajmg.a.32525; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Costantini M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005972; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Khan SY, 2010, EUR J HUM GENET, V18, P125, DOI 10.1038/ejhg.2009.121; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lai NS, 2009, BIOCHEM BIOPH RES CO, V387, P676, DOI 10.1016/j.bbrc.2009.07.086; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Mehl AL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e7; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699	21	44	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					479	484		10.1016/j.ajhg.2010.02.003	http://dx.doi.org/10.1016/j.ajhg.2010.02.003			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20170898	Green Published, Bronze			2022-12-18	WOS:000275678800020
J	Wang, ZQ; Si, LZ; Tang, Q; Lin, DB; Fu, ZJ; Zhang, J; Cui, B; Zhu, YF; Kong, XH; Deng, M; Xia, Y; Xu, H; Le, WD; Hu, LD; Kong, XY				Wang, Zhi-Qiang; Si, Lizhen; Tang, Quan; Lin, Debao; Fu, Zhangjie; Zhang, Jing; Cui, Bin; Zhu, Yufei; Kong, Xianghua; Deng, Min; Xia, Yu; Xu, Heng; Le, Weidong; Hu, Landian; Kong, Xiangyin			Gain-of-Function Mutation of KIT Ligand on Melanin Synthesis Causes Familial Progressive Hyperpigmentation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEM-CELL FACTOR; DYSCHROMATOSIS SYMMETRICA HEREDITARIA; C-KIT; HUMAN MELANOCYTES; GROWTH-FACTOR; CUTANEOUS MASTOCYTOSIS; MESSENGER-RNA; EXPRESSION; LOCUS; GENE	Familial progressive hyperpigmentation (FPH) is an autosomal-dominantly inherited disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age. The genetic basis for FPH remains unknown. In this study, a six-generation Chinese family with FPH was subjected to a genome-wide scan for linkage analysis. Two-point linkage analysis mapped the locus for FPH at chromosome 12q21.31-q23.1, with a maximum two-point LOD score of 4.35 (circle divide = 0.00) at D12S81. Haplotype analysis confined the locus within an interval of 9.09 cM, flanked by the markers D12S1667 and D12S2081. Mutation profiling of positional candidate genes detected a heterozygous transversion (c. 107A -> G) in exon 2 of the KIT ligand (KITLG) gene, predicted to result in the substitution of a serine residue for an asparagine residue at codon 36 (p.N -> S). This mutant "G" allele cosegregated perfectly with affected, but not with unaffected, members of the FPH family. Function analysis of the soluble form of sKITLG revealed that mutant sKITLGN36S increased the content of the melanin by 109% compared with the wild-type sKITLG in human A375 melanoma cells. Consistent with this result, the tyrosinase activity was significantly increased by mutant sKITLGN36S compared to wild-type control. To our knowledge, these data provided the first genetic evidence that the FPH disease is caused by the KITLGN36S mutation, which has a gain-of-function effect on the melanin synthesis and opens a new avenue for exploration of the genetic mechanism of FPH.	[Wang, Zhi-Qiang; Si, Lizhen; Tang, Quan; Fu, Zhangjie; Zhang, Jing; Cui, Bin; Zhu, Yufei; Deng, Min; Xia, Yu; Xu, Heng; Le, Weidong; Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China; [Wang, Zhi-Qiang; Si, Lizhen; Tang, Quan; Fu, Zhangjie; Zhang, Jing; Cui, Bin; Zhu, Yufei; Deng, Min; Xia, Yu; Xu, Heng; Le, Weidong; Hu, Landian; Kong, Xiangyin] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Lin, Debao] Guiyang Med Coll, Dept Dermatol, Guiyang 550001, Guizhou, Peoples R China; [Kong, Xianghua] Affiliated Hosp Binzhou Med Coll, Clin Lab, Binzhou 256603, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Guizhou Medical University; Binzhou Medical University	Kong, XY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China.	xykong@sibs.ac.cn	Xu, Heng/AAS-3465-2021	Xu, Heng/0000-0002-7748-2621	National High Technology Research and Development Program of China [2006AA02Z330, 2006AA02A301]; National Basic Research Program of China [2007CB512202, 2007CB512100, 2004CB518603]; National Natural Science Foundation of China, Key Program [30530450]; Knowledge Innovation Program of the Chinese Academy of Sciences; E-Institutes of Shanghai Municipal Education Commission	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China, Key Program(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); E-Institutes of Shanghai Municipal Education Commission	We thank all members of the TPT-PS family for participation in this study, and we thank Donghua Chen, Minhuajin, and Jianqun Wang for their support. This work is supported by the National High Technology Research and Development Program of China (2006AA02Z330, 2006AA02A301), the National Basic Research Program of China (2007CB512202, 2007CB512100, 2004CB518603), the National Natural Science Foundation of China, Key Program (30530450), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCXI-YW-R-74), and the E-Institutes of Shanghai Municipal Education Commission.	ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; Bellet JS, 2003, CUTIS, V71, P149; CHERNOSKY ME, 1971, ARCH DERMATOL, V103, P581, DOI 10.1001/archderm.103.6.581; CHUI DHK, 1976, DEV BIOL, V49, P300, DOI 10.1016/0012-1606(76)90277-3; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; FUNASAKA Y, 1992, MOL BIOL CELL, V3, P197, DOI 10.1091/mbc.3.2.197; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; GRICHNIK JM, 1995, J AM ACAD DERMATOL, V33, P577, DOI 10.1016/0190-9622(95)91274-6; HALABAN R, 1993, ANN NY ACAD SCI, V680, P290, DOI 10.1111/j.1749-6632.1993.tb19691.x; HAMANN K, 1995, BRIT J DERMATOL, V133, P203, DOI 10.1111/j.1365-2133.1995.tb02616.x; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Huang YH, 2008, J DERMATOL SCI, V49, P115, DOI 10.1016/j.jdermsci.2007.07.008; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LING DB, 1991, BRIT J DERMATOL, V125, P607; LUO D, 1995, MELANOMA RES, V5, P303, DOI 10.1097/00008390-199510000-00002; MANOVA K, 1992, J NEUROSCI, V12, P4663; Miyamoto T, 1997, ATHEROSCLEROSIS, V129, P207, DOI 10.1016/S0021-9150(96)06043-1; Miyamura Y, 2003, AM J HUM GENET, V73, P693, DOI 10.1086/378209; MORITA E, 1994, ARCH DERMATOL RES, V286, P273, DOI 10.1007/BF00387600; Parichy DM, 1999, DEV GENES EVOL, V209, P349, DOI 10.1007/s004270050263; POOLE TW, 1979, DEV BIOL, V72, P398, DOI 10.1016/0012-1606(79)90130-1; Rajaraman S, 2002, GENETICS, V162, P341; REBORA A, 1989, Archives of Dermatology, V125, P1442, DOI 10.1001/archderm.125.10.1442; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sriwiriyanont P, 2006, LAB INVEST, V86, P1115, DOI 10.1038/labinvest.3700469; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Stuhrmann M, 2008, CLIN GENET, V73, P566, DOI 10.1111/j.1399-0004.2008.01000.x; SUENAGA M, 1952, Tohoku J Exp Med, V55, P373; Tsuchiya T, 2008, BIOL PHARM BULL, V31, P1618, DOI 10.1248/bpb.31.1618; Wehrle-Haller B, 2001, DEV BIOL, V232, P471, DOI 10.1006/dbio.2001.0167; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Zanardo L, 2004, ACTA DERM-VENEREOL, V84, P57, DOI 10.1080/00015550310005780; Zhang C, 2006, EUR J DERMATOL, V16, P246; Zhang XJ, 2003, J INVEST DERMATOL, V120, P776, DOI 10.1046/j.1523-1747.2003.12130.x	40	44	45	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					672	677		10.1016/j.ajhg.2009.03.019	http://dx.doi.org/10.1016/j.ajhg.2009.03.019			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19375057	Green Published, Bronze			2022-12-18	WOS:000266338800012
J	Huyghe, JR; Van Laer, L; Hendrickx, JJ; Fransen, E; Demeester, K; Topsakal, V; Kunst, S; Manninen, M; Jensen, M; Bonaconsa, A; Mazzoli, M; Baur, M; Hannula, S; Maki-Torkko, E; Espeso, A; Van Eyken, E; Flaquer, A; Becker, C; Stephens, D; Sorri, M; Orzan, E; Bille, M; Parving, A; Pyykko, I; Cremers, CWRJ; Kremer, H; Van de Heyning, PH; Wienker, TE; Nurnberg, P; Pfister, M; Van Camp, G				Huyghe, Jeroen R.; Van Laer, Lut; Hendrickx, Jan-Jaap; Fransen, Erik; Demeester, Kelly; Topsakal, Vedat; Kunst, Sylvia; Manninen, Minna; Jensen, Mona; Bonaconsa, Amanda; Mazzoli, Manuela; Baur, Manuela; Hannula, Samuli; Maki-Torkko, Elina; Espeso, Angeles; Van Eyken, Els; Flaquer, Antonia; Becker, Christian; Stephens, Dafydd; Sorri, Martti; Orzan, Eva; Bille, Michael; Parving, Agnete; Pyykko, Ilmari; Cremers, Cor W. R. J.; Kremer, Hannie; Van de Heyning, Paul H.; Wienker, Thomas E.; Nuernberg, Peter; Pfister, Markus; Van Camp, Guy			Genome-wide SNP-based linkage scan identifies a locus on 8q24 for an age-related hearing impairment trait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MONTE-CARLO PROCEDURES; EMPIRICAL P-VALUES; ENVIRONMENTAL-INFLUENCES; GENETIC ASSOCIATIONS; PRESBYCUSIS; THRESHOLDS; VARIANTS; DISEASES; TESTS; MAPS	Age-related hearing impairment (ARHI), or presbycusis, is a very common multifactorial disorder. Despite the knowledge that genetics play an important role in the etiology of human ARHI as revealed by heritability studies, to date, its precise genetic determinants remain elusive. Here we report the results of a cross-sectional family-based genetic study employing audiometric data. By using principal component analysis, we were able to reduce the dimensionality of this multivariate phenotype while capturing most of the variation and retaining biologically important features of the audiograms. We conducted a genome-wide association as well as a linkage scan with high-density SNP microarrays. Because of the presence of genetic population substructure, association testing was stratified after which evidence was combined by meta-analysis. No association signals reaching genome-wide significance were detected. Linkage analysis identified a linkage peak on 8q24.13-q24.22 for a trait correlated to audiogram shape. The signal reached genome-wide significance, as assessed by simulations. This finding represents the first locus for an ARHI trait.	[Huyghe, Jeroen R.; Van Laer, Lut; Fransen, Erik; Van Eyken, Els; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Hendrickx, Jan-Jaap; Demeester, Kelly; Topsakal, Vedat; Van de Heyning, Paul H.] Univ Antwerp Hosp, Dept Otorhinolaryngol, B-2650 Antwerp, Belgium; [Hendrickx, Jan-Jaap; Kunst, Sylvia; Cremers, Cor W. R. J.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Manninen, Minna; Pyykko, Ilmari] Univ Tampere, Dept Otorhinolaryngol, FIN-33014 Tampere, Finland; [Jensen, Mona; Bille, Michael; Parving, Agnete] Bispebjerg Hosp, Dept Audiol, DK-2400 Copenhagen, Denmark; [Bonaconsa, Amanda; Mazzoli, Manuela; Orzan, Eva] Univ Hosp Padova, Dept Otosurg, I-35128 Padua, Italy; [Baur, Manuela; Pfister, Markus] Univ Tubingen, Dept Otorhinolaryngol, D-72074 Tubingen, Germany; [Hannula, Samuli; Maki-Torkko, Elina; Sorri, Martti] Univ Oulu, Dept Otorhinolaryngol, FIN-90220 Oulu, Finland; [Espeso, Angeles; Stephens, Dafydd] Cardiff Univ, Welsh Hearing Inst, Cardiff CF4 4XW, S Glam, Wales; [Flaquer, Antonia; Wienker, Thomas E.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; [Becker, Christian; Nuernberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Becker, Christian; Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, CECAD, D-50674 Cologne, Germany; [Kremer, Hannie] Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	University of Antwerp; University of Antwerp; Radboud University Nijmegen; Tampere University; University of Copenhagen; Bispebjerg Hospital; University of Padua; Azienda Ospedaliera - Universita di Padova; Eberhard Karls University of Tubingen; University of Oulu; Cardiff University; University of Bonn; University of Cologne; University of Cologne; University of Cologne; Radboud University Nijmegen	Van Camp, G (corresponding author), Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium.	guy.vancamp@ua.ac.be	Kremer, Hannie/F-5126-2010; Fransen, Erik/C-4102-2015; Heyning, Paul H Vande/I-8278-2017; Van Camp, Guy/F-3386-2013; Mäki-Torkko, Elina/AAD-5074-2021; Orzan, Eva/AAC-7814-2022; Hendrickx, Jan-Jaap/AAD-2223-2021; Cremers, C.W.R.J./L-4254-2015	Kremer, Hannie/0000-0002-0841-8693; Fransen, Erik/0000-0001-7785-4790; Heyning, Paul H Vande/0000-0002-8424-3717; Van Camp, Guy/0000-0001-5105-9000; Orzan, Eva/0000-0001-7465-1066; Espeso, Angeles/0000-0003-3186-9529; Topsakal, Vedat/0000-0003-0416-4005	European Community [QLRT2001-00331]; the University of Antwerp; National Genome Research Network [01GR0416]; Medical Research Council [G9810900] Funding Source: researchfish; MRC [G9810900] Funding Source: UKRI	European Community(European Commission); the University of Antwerp; National Genome Research Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the families and the staff from all the collecting centers for their cooperation. J.R.H. wishes to thank GoncaloAbecasis for kindly providing help with MERLIN and for providing valuable suggestions for the analysis. This work was financially supported by the European Community (5th Framework project QLRT2001-00331), the University of Antwerp (TOP project), and the German Federal Ministry of Education and Research through the National Genome Research Network (grant 01GR0416 to P.N.).	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Christensen K, 2001, J AM GERIATR SOC, V49, P1512, DOI 10.1046/j.1532-5415.2001.4911245.x; DeStefano AL, 2003, ARCH OTOLARYNGOL, V129, P285, DOI 10.1001/archotol.129.3.285; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Falconer D.S., 1997, INTRO QUANTITATIVE G, VFourth; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Garringer HJ, 2006, ARCH OTOLARYNGOL, V132, P506, DOI 10.1001/archotol.132.5.506; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Karlsson KK, 1997, EAR HEARING, V18, P114, DOI 10.1097/00003446-199704000-00003; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; North BV, 2003, AM J HUM GENET, V72, P498, DOI 10.1086/346173; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Ohlemiller Kevin K, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P439, DOI 10.1097/01.moo.0000134450.99615.22; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Viljanen A, 2007, J GERONTOL A-BIOL, V62, P447, DOI 10.1093/gerona/62.4.447; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	32	44	48	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					401	407		10.1016/j.ajhg.2008.08.002	http://dx.doi.org/10.1016/j.ajhg.2008.08.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18760390	Green Published, Bronze			2022-12-18	WOS:000259307200010
J	Assie, G; LaFramboise, T; Platzer, P; Bertherat, J; Stratakis, CA; Eng, C				Assie, Guillaume; LaFramboise, Thomas; Platzer, Petra; Bertherat, Jerome; Stratakis, Constantine A.; Eng, Charis			SNP Arrays in heterogeneous tissue: Highly accurate collection of both germline and somatic genetic information from unpaired single tumor samples	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ANALYSIS; NUCLEOTIDE POLYMORPHISM-LOSS; COPY NUMBER ALTERATION; UNIPARENTAL DISOMY; CHROMOSOMAL INSTABILITY; ALLELIC IMBALANCES; HETEROZYGOSITY; REVEALS; CANCER; MICRODELETIONS	SNP arrays provide reliable genotypes and can detect chromosomal aberrations at a high resolution. However, tissue heterogeneity is currently a major limitation for somatic tissue analysis. We have developed SOMATICs, an original program for accurate analysis of heterogeneous tissue samples. Fifty-four samples (42 tumors and 12 normal tissues) were processed through Illumina Beadarrays and then analyzed with SOMATICs. We demonstrate that tissue heterogeneity-related limitations not only can be overcome but can also be turned into an advantage. First, admixture of normal cells with tumor can be used as an internal reference, thereby enabling highly sensitive detection of somatic deletions without having corresponding normal tissue. Second, the presence of normal cells allows for discrimination of somatic from germline aberrations, and the proportion of cells in the tissue sample that are harboring the somatic events can be assessed. Third, relatively early versus late somatic events can also be distinguished, assuming that late events occur only in subsets of cancer cells. Finally, admixture by normal cells allows inference of germline genotypes from a cancer sample. All this information can be obtained from any cancer sample containing a proportion of 40-75% of cancer cells. SOMATICs is a ready-to-use open-source program that integrates all of these features into a simple format, comprehensively describing each chromosomal event.	[Assie, Guillaume; LaFramboise, Thomas; Platzer, Petra; Eng, Charis] Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA; [LaFramboise, Thomas; Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Bertherat, Jerome] INSERM, U567, Inst Cochin, F-75014 Paris, France; [Bertherat, Jerome] Hop Cochin, Dept Endocrinol, F-75014 Paris, France; [Stratakis, Constantine A.] NICHHD, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Eng, C (corresponding author), Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	engc@ccf.org	Stratakis, Constantine A./AAP-4745-2020	BERTHERAT, Jerome/0000-0003-2551-3008; Eng, Charis/0000-0002-3693-5145; Assie, Guillaume/0000-0001-9590-0906	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000642, Z01HD000642] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Calhoun ES, 2006, CANCER RES, V66, P7920, DOI 10.1158/0008-5472.CAN-06-0721; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Dumur CI, 2003, GENOMICS, V81, P260, DOI 10.1016/S0888-7543(03)00020-X; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; Fitzgibbon J, 2007, LEUKEMIA, V21, P1514, DOI 10.1038/sj.leu.2404696; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hu N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-299; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Irving JAE, 2005, CANCER RES, V65, P3053, DOI 10.1158/0008-5472.CAN-04-2604; Kloth JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-53; Koed K, 2005, CANCER RES, V65, P34; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; LIN M, 2004, IN PRESS BIOINFORMAT; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Liu WN, 2006, GENE CHROMOSOME CANC, V45, P1018, DOI 10.1002/gcc.20369; MAECHLER M, 2007, HARTIGANS DIP TEST S; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Oliphant A, 2002, BIOTECHNIQUES, P56; Pasini B, 2008, EUR J HUM GENET, V16, P79, DOI 10.1038/sj.ejhg.5201904; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Polzehl J, 2000, J R STAT SOC B, V62, P335, DOI 10.1111/1467-9868.00235; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Torring N, 2007, BRIT J CANCER, V96, P499, DOI 10.1038/sj.bjc.6603476; Wang ZGC, 2006, BREAST CANCER RES TR, V97, P301, DOI 10.1007/s10549-005-9124-5; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yu YT, 2007, LAB INVEST, V87, P430, DOI 10.1038/labinvest.3700536	40	44	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					903	915		10.1016/j.ajhg.2008.01.012	http://dx.doi.org/10.1016/j.ajhg.2008.01.012			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18355774	Green Published, Bronze			2022-12-18	WOS:000255103900009
J	Mabuchi, A; Nakamura, S; Takatori, Y; Ikegawa, S				Mabuchi, Akihiko; Nakamura, Shigeru; Takatori, Yoshio; Ikegawa, Shiro			Familial osteoarthritis of the hip joint associated with acetabular dysplasia maps to chromosome 13q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; CHONDROGENESIS; PREVALENCE; JAPANESE; REGION; WOMEN	Genetic factors have been implicated in osteoarthritis ( OA), particularly in OA of the hip joint ( hip OA). Several instances of familial hip OA that show distinctive modes of inheritance but that differ from chondrodysplasia have been reported. Here, we report the characterization of a large Japanese family with an inherited disease of the hip that is indistinguishable from common hip OA, as evidenced by clinical symptoms and radiographs of the joint. This family contained eight patients in 4 generations. Affected individuals develop pain in the hip joint during adolescence, and the disease progresses to severe crippling before age 60 years. Patients generally are in good health, height is not reduced, and there is no extraskeletal involvement suggestive of chondrodysplasia. The skeletal change is bilateral acetabular dysplasia followed by OA, which occurs after age similar to 40 years and is indistinguishable from idiopathic nonfamilial dysplastic hip OA. This trait shows autosomal dominant inheritance, with a considerably consistent phenotype. Genomewide screening revealed linkage at chromosome 13q22, and haplotype analysis narrowed the locus to a 6.0-cM interval between markers D13S1296 and D13S162, with a maximal multipoint LOD score of 3.57. The family described here represents a novel genetic entity as a monogenic form of hip OA. Its further characterization can aid in elucidating the etiology and pathogenesis of a common idiopathic form of OA.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Dept Orthoped Surg, Tokyo, Japan; Teikyo Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan	RIKEN; University of Tokyo; Teikyo University	Nakamura, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 5-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147				ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; Beals RK, 2003, CLIN ORTHOP RELAT R, P109, DOI 10.1097/01.blo.0000043052.62337.66; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; Chitnavis J, 1997, J BONE JOINT SURG BR, V79B, P660, DOI 10.1302/0301-620X.79B4.7437; CILLIERS HJ, 1990, AM J MED GENET, V36, P386, DOI 10.1002/ajmg.1320360403; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20; Ingvarsson T, 2001, ARTHRITIS RHEUM-US, V44, P2548, DOI 10.1002/1529-0131(200111)44:11<2548::AID-ART435>3.0.CO;2-S; Inoue K, 2000, RHEUMATOLOGY, V39, P745, DOI 10.1093/rheumatology/39.7.745; Lane NE, 2000, ARTHRITIS RHEUM-US, V43, P400, DOI 10.1002/1529-0131(200002)43:2<400::AID-ANR21>3.0.CO;2-D; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINDBERG H, 1986, CLIN ORTHOP RELAT R, P273; Loughlin J, 2000, RHEUMATOLOGY, V39, P377, DOI 10.1093/rheumatology/39.4.377; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569; MARDON G, 1994, DEVELOPMENT, V120, P3473; MASSIE WK, 1950, J BONE JOINT SURG AM, V32-A, P519, DOI 10.2106/00004623-195032030-00005; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; MURRAY RO, 1965, BRIT J RADIOL, V38, P810, DOI 10.1259/0007-1285-38-455-810; Mustafa Z, 2000, RHEUMATOLOGY, V39, P299, DOI 10.1093/rheumatology/39.3.299; NAKAMURA S, 1989, CLIN ORTHOP RELAT R, P190; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; Saito M, 2002, J HUM GENET, V47, P377, DOI 10.1007/s100380200054; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHARP IK, 1961, J BONE JOINT SURG BR, V43, P268, DOI 10.1302/0301-620X.43B2.268; Sobel E, 1996, AM J HUM GENET, V58, P1323; SOLOMON L, 1976, J BONE JOINT SURG BR, V58, P176, DOI 10.1302/0301-620X.58B2.932079; TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352; Wiberg G., 1939, ACTA CHIR SCAND, V83, P1; Wynne-Davies R, 1970, J Bone Joint Surg Br, V52, P704	30	44	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					163	168		10.1086/505088	http://dx.doi.org/10.1086/505088			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773577	Bronze, Green Published			2022-12-18	WOS:000238341200018
J	Chen, JJ; Huang, W; Gui, JP; Yang, S; Zhou, FS; Xiong, QG; Wu, HB; Cui, Y; Gao, M; Li, W; Li, JX; Yan, KL; Yuan, WT; Xu, SJ; Liu, JJ; Zhang, XJ				Chen, JJ; Huang, W; Gui, JP; Yang, S; Zhou, FS; Xiong, QG; Wu, HB; Cui, Y; Gao, M; Li, W; Li, JX; Yan, KL; Yuan, WT; Xu, SJ; Liu, JJ; Zhang, XJ			A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC EPIDEMIOLOGY; SUSCEPTIBILITY LOCUS; ASSOCIATION; POLYMORPHISMS; CONFIRMATION; PATHOGENESIS; ALLELES; SLEV1; AIS1; WIDE	Generalized vitiligo is a common, autoimmune, familial-clustering depigmentary disorder of the skin and hair that results from selective destruction of melanocytes. Generalized vitiligo is likely a heterogeneous disease, with five susceptibility loci reported so far-on chromosomes 1p31, 6p21, 7q, 8p, and 17p13-in white populations. To investigate vitiligo susceptibility loci in the Chinese population, we performed a genomewide linkage analysis in 57 multiplex Chinese families, each with at least two affected siblings, and we identified interesting linkage evidence on 1p36, 4q13-q21, 6p21-p22, 6q24-q25, 14q12-q13, and 22q12. Subsequently, to extract more linkage information, we investigated our initial genomewide linkage findings in a follow-up analysis of 49 new families and additional markers. Our initial genomewide linkage analysis and our subsequent follow-up analysis have identified a novel linkage to vitiligo on 4q13-q21, with highly significant linkage evidence (a nonparametic LOD score of 4.62 [P = .000003] and a heterogeneity LOD score of 4.01, under a recessive inheritance model), suggesting that 4q13-q21 likely harbors a major susceptibility locus for vitiligo in the Chinese population. We observed a minimal overlap between the linkage results of our current genomewide analysis in the Chinese population and the results of previous analyses in white populations, and we thus hypothesize that, as a polygenic disorder, vitiligo may be associated with great genetic heterogeneity and a substantial difference in its genetic basis between ethnic populations.	Anhui Med Univ, Inst Dermatol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; Anhui Med Univ, Dept Dermatol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; Key Lab Genome Res, Hefei, Anhui, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai, Peoples R China; Railway Hosp, Vitiligo Clin, Xiangfan, Hubei, Peoples R China; Genome Inst Singapore, Singapore, Singapore	Anhui Medical University; Anhui Medical University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zhang, XJ (corresponding author), Anhui Med Univ, Inst Dermatol, 69 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	ayzxj@mail.hf.ah.cn	chen, jianjun/AAG-7572-2019; Chen, Gang/G-2722-2010; Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Alkhateeb A, 2002, HUM MOL GENET, V11, P661, DOI 10.1093/hmg/11.6.661; Arcos-Burgos M, 2002, HUM GENET, V110, P334, DOI 10.1007/s00439-002-0687-5; Blomhoff A, 2005, PIGM CELL RES, V18, P55, DOI 10.1111/j.1600-0749.2004.00196.x; BOLOGNIA JL, 1998, PIGMENTARY SYSTEM, P513; Bowcock AM, 2004, J INVEST DERMATOL, V122, pXV, DOI 10.1111/j.0022-202X.2004.22627.x; CARNEVALE A, 1980, REV INVEST CLIN, V32, P37; Casp CB, 2003, GENES IMMUN, V4, P492, DOI 10.1038/sj.gene.6364016; Casp CB, 2002, PIGM CELL RES, V15, P62, DOI 10.1034/j.1600-0749.2002.00057.x; Cho S, 2000, PEDIATR DERMATOL, V17, P189, DOI 10.1046/j.1525-1470.2000.01749.x; DAS S K, 1985, Genetic Epidemiology, V2, P255, DOI 10.1002/gepi.1370020303; de Vijlder HC, 2004, PIGM CELL RES, V17, P270, DOI 10.1111/j.1600-0749.2004.00145.x; Fain PR, 2003, AM J HUM GENET, V72, P1560, DOI 10.1086/375451; GOUDIE BM, 1983, SCOT MED J, V28, P338, DOI 10.1177/003693308302800405; Gudjonsson JE, 2004, CLIN EXP IMMUNOL, V135, P1, DOI 10.1111/j.1365-2249.2004.02310.x; HAFEZ M, 1983, ACTA DERM-VENEREOL, V63, P249; HANN SK, 2000, VITILIGO COMPREHENSI; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Jin SY, 2004, PIGM CELL RES, V17, P84, DOI 10.1046/j.1600-0749.2003.00105.x; Kemp EH, 1999, BRIT J DERMATOL, V140, P73; Kovacs SO, 1998, J AM ACAD DERMATOL, V38, P647, DOI 10.1016/S0190-9622(98)70194-X; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Le Poole IC, 2004, J INVEST DERM SYMP P, V9, P68, DOI 10.1111/j.1087-0024.2004.00825.x; MAJUMDER PP, 1993, ARCH DERMATOL, V129, P994, DOI 10.1001/archderm.129.8.994; MEHTA NR, 1973, INDIAN J MED RES, V61, P145; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Na GY, 2003, PIGM CELL RES, V16, P383, DOI 10.1034/j.1600-0749.2003.00062.x; NATH SK, 1994, AM J HUM GENET, V55, P981; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Sagoo GS, 2004, J INVEST DERMATOL, V122, P1401, DOI 10.1111/j.0022-202X.2004.22607.x; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Tastan HB, 2004, PIGM CELL RES, V17, P181, DOI 10.1111/j.1600-0749.2004.00141.x; VENNEKER GT, 1992, J INVEST DERMATOL, V99, P853, DOI 10.1111/1523-1747.ep12614826; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Zamani M, 2001, BRIT J DERMATOL, V145, P90, DOI 10.1046/j.1365-2133.2001.04288.x; Zhang XJ, 2004, J AM ACAD DERMATOL, V51, P383, DOI 10.1016/j.jaad.2003.12.044; Zhang XJ, 2004, J DERMATOL SCI, V35, P165, DOI 10.1016/j.jdermsci.2004.05.003; Zhang XJ, 2002, J INVEST DERMATOL, V119, P1361, DOI 10.1046/j.1523-1747.2002.19612.x; 徐元勇, 2002, [中华皮肤科杂志, Chinese Journa of Dermatology], V35, P406	46	44	46	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1057	1065		10.1086/430279	http://dx.doi.org/10.1086/430279			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15809929	Green Published, Bronze			2022-12-18	WOS:000229047900011
J	Kenealy, SJ; Babron, MC; Bradford, Y; Schnetz-Boutaud, N; Haines, JL; Rimmler, JB; Schmidt, S; Pericak-Vance, MA; Barcellos, LF; Lincoln, RR; Oksenberg, JR; Hauser, SL; Clanet, M; Brassat, D; Edan, G; Yaouanq, J; Semana, G; Cournu-Rebeix, I; Lyon-Caen, O; Fontaine, B				Kenealy, SJ; Babron, MC; Bradford, Y; Schnetz-Boutaud, N; Haines, JL; Rimmler, JB; Schmidt, S; Pericak-Vance, MA; Barcellos, LF; Lincoln, RR; Oksenberg, JR; Hauser, SL; Clanet, M; Brassat, D; Edan, G; Yaouanq, J; Semana, G; Cournu-Rebeix, I; Lyon-Caen, O; Fontaine, B		American-French Multiple Sclerosis	A second-generation genomic screen for multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOE EPSILON-4 ALLELE; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCI; CELIAC-DISEASE; WIDE SCREEN; SIB-PAIRS; FAMILIES; PROGRESSION; HETEROGENEITY; ASSOCIATION	Multiple sclerosis (MS) is a debilitating neuroimmunological and neurodegenerative disorder. Despite substantial evidence for polygenic inheritance of the disease, the major histocompatibility complex is the only region that clearly and consistently demonstrates linkage and association in MS studies. The goal of this study was to identify additional chromosomal regions that harbor susceptibility genes for MS. With a panel of 390 microsatellite markers genotyped in 245 U. S. and French multiplex families (456 affected relative pairs), this is the largest genomic screen for MS conducted to date. Four regions met both of our primary criteria for further interest (heterogeneity LOD [HLOD] and Z scores >2.0): 1q (HLOD = 2.17; Z = 3.38), 6p (HLOD = 4.21; Z = 2.26), 9q (HLOD; Z = 2.71), and 16p (HLOD = 2.64; Z = 2.05). Two additional regions met only the Z score criterion: 3q (Z = 2.39) and 5q (Z = 2.17). Further examination of the data by country (United States vs. France) identified one additional region demonstrating suggestive linkage in the U. S. subset (18p [HLOD = 2.39]) and two additional regions generating suggestive linkage in the French subset (1p [HLOD = 2.08] and 22q [HLOD = 2.06]). Examination of the data by human leukocyte antigen (HLA)-DR2 stratification identified four additional regions demonstrating suggestive linkage: 2q (HLOD = 3.09 in the U. S. DR2 - families), 6q (HLOD = 3.10 in the French DR2 - families), 13q (HLOD = 2.32 in all DR2+ families and HLOD = 2.17 in the U. S. DR2+ families), and 16q (HLOD = 2.32 in all DR2+ families and HLOD = 2.13 in the U. S. DR2+ families). These data suggest several regions that warrant further investigation in the search for MS susceptibility genes.	Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; INSERM, U535, Villejuif, France; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; INSERM, U563, F-75654 Paris 13, France; CHRU Purpan, Neurol Federat, Toulouse, France; Univ Toulouse 3, F-31062 Toulouse, France; CHRU Pontchaillou, Rennes, France; Univ Rennes, Rennes, France; INSERM, U546, F-75654 Paris 13, France; Grp Hosp Pitie Salpetriere, Neurol Federat, F-75634 Paris, France; Univ Paris 06, Paris, France	Vanderbilt University; Institut National de la Sante et de la Recherche Medicale (Inserm); Duke University; University of California System; University of California San Francisco; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Rennes; Universite de Rennes 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Haines, JL (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, 519 Light Hall, Nashville, TN 37232 USA.	jonathan@chgr.mc.vanderbilt.edu	Hauser, Stephen L/J-2978-2016; Donley, Elizabeth/O-4916-2019; Haines, Jonathan/C-3374-2012; Edan, Gilles/AAI-5944-2020; Brassat, David/L-2173-2014	Donley, Elizabeth/0000-0002-3439-4322; Haines, Jonathan/0000-0002-4351-4728; Babron, Marie-Claude/0000-0002-4100-0299	NINDS NIH HHS [NS32830, NS26799, R01 NS026799, R01 NS032830] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS032830] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akesson E, 2002, GENES IMMUN, V3, P279, DOI 10.1038/sj.gene.6363866; Ban M, 2002, GENES IMMUN, V3, P464, DOI 10.1038/sj.gene.6363910; Barcellos LF, 2002, BRAIN, V125, P150; Broadley S, 2001, GENES IMMUN, V2, P205, DOI 10.1038/sj.gene.6363758; Chapman J, 1999, ARCH NEUROL-CHICAGO, V56, P1484, DOI 10.1001/archneur.56.12.1484; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; Coraddu F, 2001, EUR J HUM GENET, V9, P621, DOI 10.1038/sj.ejhg.5200680; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dyment DA, 2004, HUM MOL GENET, V13, P1005, DOI 10.1093/hmg/ddh123; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Enzinger C, 2004, ANN NEUROL, V55, P563, DOI 10.1002/ana.20027; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Eraksoy M, 2003, J NEUROIMMUNOL, V143, P17, DOI 10.1016/j.jneuroim.2003.08.006; Evangelou N, 1999, J NEUROL NEUROSUR PS, V67, P203, DOI 10.1136/jnnp.67.2.203; Fazekas F, 2000, J NEUROL NEUROSUR PS, V69, P25, DOI 10.1136/jnnp.69.1.25; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Goedde R, 2002, HUM GENET, V111, P270, DOI 10.1007/s00439-002-0801-8; GOODKIN DE, 1991, ARCH NEUROL-CHICAGO, V48, P805, DOI 10.1001/archneur.1991.00530200041016; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 2002, HUM MOL GENET, V11, P2251; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hensiek AE, 2003, J NEUROIMMUNOL, V143, P25, DOI 10.1016/j.jneuroim.2003.08.007; Hogh P, 2000, MULT SCLER J, V6, P226, DOI 10.1191/135245800678827851; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Laaksonen M, 2003, J NEUROIMMUNOL, V143, P70, DOI 10.1016/j.jneuroim.2003.08.014; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Naluai AT, 2001, EUR J HUM GENET, V9, P938, DOI 10.1038/sj.ejhg.5200752; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1986, AM J HUM GENET, V39, P159; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Roth MP, 1999, J IMMUNOL, V162, P1917; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer S, 2002, BRAIN, V125, P1337, DOI 10.1093/brain/awf143; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schmidt S, 2002, AM J HUM GENET, V70, P708, DOI 10.1086/339269; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Vance Jeffery M., 1998, P201; Yaouanq J, 1997, SCIENCE, V276, P664	45	44	48	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1070	1078		10.1086/426459	http://dx.doi.org/10.1086/426459			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15494893	Green Published, Bronze			2022-12-18	WOS:000224866400011
J	Jordanova, A; Thomas, FP; Guergueltcheva, V; Tourney, I; Gondim, FAA; Ishpekova, B; De Vriendt, E; Jacobs, A; Litvinenko, I; Ivanova, N; Buzhov, B; De Jonghe, P; Kremensky, I; Timmerman, V				Jordanova, A; Thomas, FP; Guergueltcheva, V; Tourney, I; Gondim, FAA; Ishpekova, B; De Vriendt, E; Jacobs, A; Litvinenko, I; Ivanova, N; Buzhov, B; De Jonghe, P; Kremensky, I; Timmerman, V			Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFERENTIATION-ASSOCIATED PROTEIN-1; DISEASE TYPE-2; CLINICAL-FEATURES; HEREDITARY MOTOR; GENE; MUTATIONS; NEUROPATHY; GDAP1; LOCALIZATION; DUPLICATION	Dominant intermediate Charcot-Marie-Tooth (DI-CMT) neuropathy is a genetic and phenotypic variant of classical CMT, characterized by intermediate nerve conduction velocities and histological evidence of both axonal and demyelinating features. We report two unrelated families with intermediate CMT linked to a novel locus on chromosome 1p34-p35 (DI-CMTC). The combined haplotype analysis in both families localized the DI-CMTC gene within a 6.3-cM linkage interval flanked by markers D1S2787 and DIS2830. The functional and positional candidate genes, Syndecan 3 (SDC3), and lysosomal-associated multispanning membrane protein 5 (LAPTM5) were excluded for pathogenic mutations.	Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Flanders Interuniv Inst Biotechnol, Dept Mol Genet, Antwerp, Belgium; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Med Univ Sofia, Dept Pediat, Sofia, Bulgaria; St Louis Univ, Dept Neurol, St Louis, MO 63103 USA; St Louis VA Med Ctr, Inst Mol Virol, Dept Mol Microbiol & Immunol, St Louis, MO USA	University of Antwerp; Medical University Sofia; Medical University Sofia; Medical University Sofia; Saint Louis University	Timmerman, V (corresponding author), Univ Antwerp, Mol Genet Dept VIB8, Peripheral Neuropathy Grp, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Jordanova, Albena/H-8323-2015; Litvinenko, Ivan/GQZ-3185-2022; de Assis Gondim, Francisco/J-1463-2014; Thomas, Florian P/AAL-3813-2020; Timmerman, Vincent/O-7283-2019	Jordanova, Albena/0000-0002-3833-3754; de Assis Gondim, Francisco/0000-0002-8957-5796; Timmerman, Vincent/0000-0002-2162-0933; Thomas, Florian P/0000-0002-6103-4138				Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; BENOTHMANE K, 1993, GENOMICS, V17, P370; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Birouk N, 1998, NEUROLOGY, V50, P1074, DOI 10.1212/WNL.50.4.1074; Boerkoel CF, 2003, ANN NEUROL, V53, P400, DOI 10.1002/ana.10505; Carey DJ, 1996, PERSPECT DEV NEUROBI, V3, P331; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; DAVIS CJF, 1978, J GENET HUM, V26, P311; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; Dyck P, 1993, PERIPHERAL NEUROPATH; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Ismailov SM, 2001, EUR J HUM GENET, V9, P646, DOI 10.1038/sj.ejhg.5200686; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mastaglia FL, 1999, J NEUROL NEUROSUR PS, V67, P174, DOI 10.1136/jnnp.67.2.174; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Muglia M, 2001, NEUROLOGY, V56, P100, DOI 10.1212/WNL.56.1.100; Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PATEL P, 1991, J INT BUS STUD, V22, P1, DOI 10.1057/palgrave.jibs.8490289; Pericak-Vance MA, 1997, NEUROGENETICS, V1, P89, DOI 10.1007/s100480050013; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Saito M, 1997, NEUROLOGY, V49, P1630, DOI 10.1212/WNL.49.6.1630; Senderek J, 2003, BRAIN, V126, P642, DOI 10.1093/brain/awg068; SKRE H, 1974, CLIN GENET, V6, P98; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	45	44	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1423	1430		10.1086/379792	http://dx.doi.org/10.1086/379792			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14606043	Bronze, Green Published			2022-12-18	WOS:000187491100016
J	Schork, NJ				Schork, NJ			Power calculations for genetic association studies using estimated probability distributions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GAMETIC DISEQUILIBRIUM; GENOMIC CONTROL; POPULATIONS; BRISTLES; LOCI	The determination of the power of-or of an appropriate sample size for-genetic association studies that exploit linkage disequilibrium requires many assumptions. Some of the more important assumptions include the linkage-disequilibrium strength among alleles at the observed marker-locus sites and a potential trait-influencing locus, the frequencies of the marker locus and trait-influencing alleles, and the ultimate density of the marker locus "map" (i.e., the number of bases between marker loci) necessary in order to identify, with some confidence, trait-influencing alleles. I consider an approach to assessment of the power and sample-size requirements of genetic case-control association study designs that makes use of empirically derived estimates of the distributions of important parameters often assumed to take on arbitrary values. My proposed methodology is extremely general and flexible and ultimately can provide realistic answers to questions such as "How many markers and/or how many individuals might it take to identify, with confidence, a disease gene, via linkage-disequilibrium and association methods from a candidate region or whole genome perspective?" I showcase aspects of the proposed methodology, using information abstracted from the literature.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Schork, NJ (corresponding author), Univ Calif San Diego, Dept Psychiat, 2062 Basic Sci Bldg,9500 Gilman Drive, La Jolla, CA 92093 USA.			Schork, Nicholas/0000-0003-0920-5013	NHLBI NIH HHS [HL 54998-01, HL 69758-01, HL 94011, U01 HL069758, P50 HL054998] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054998, U01HL069758] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; LEWONTIN RC, 1988, GENETICS, V120, P849; Mackay TFC, 1996, BIOESSAYS, V18, P113, DOI 10.1002/bies.950180207; MACKAY TFC, 1995, TRENDS GENET, V11, P464, DOI 10.1016/S0168-9525(00)89154-4; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schlesselman James J., 1982, CASE CONTROL STUDIES; Schork NJ, 2000, AM J HUM GENET, V67, P1208, DOI 10.1086/321201; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Silverman B.W., 1986, DENSITY ESTIMATION S; TAYLOR CC, 1989, BIOMETRIKA, V76, P705; Zapata C, 2000, EVOLUTION, V54, P1809, DOI 10.1111/j.0014-3820.2000.tb00711.x	18	44	45	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1480	1489		10.1086/340788	http://dx.doi.org/10.1086/340788			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992254	Green Published, Bronze			2022-12-18	WOS:000175445700009
J	Wiltshire, S; Frayling, TM; Hattersley, AT; Hitman, GA; Walker, M; Levy, JC; O'Rahilly, S; Groves, CJ; Menzel, S; Cardon, LR; McCarthy, MI				Wiltshire, S; Frayling, TM; Hattersley, AT; Hitman, GA; Walker, M; Levy, JC; O'Rahilly, S; Groves, CJ; Menzel, S; Cardon, LR; McCarthy, MI			Evidence for linkage of stature to chromosome 3p26 in a large UK family data set ascertained for type 2 diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT; SIB PAIRS; LOCUS; REPLICATION; PEDIGREES	We have analyzed data from 573 pedigrees from the United Kingdom for evidence for linkage to loci influencing adult stature. Our data set comprised 1,214 diabetic and 163 nondiabetic siblings for whom height data were available. We used variance-components analysis implemented in GENEHUNTER 2 and a modification of the Haseman-Elston regression method, HE-COM. We found evidence for a locus on 3p26 (LOD score 3.17) influencing height in this adult sample, with less-significant evidence for loci on chromosomes 7, 10, 15, 17, 19, and 20. Our findings extend similar recent studies in Scandinavian and Quebecois populations, adding further evidence that height is indeed under the control of multiple genes.	Univ London Imperial Coll Sci & Technol, Genet & Gen Res Inst, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, Div Med, London, England; Barts & London Queen Marys Sch Med & Dent, Dept Diabet & Metab Med, London, England; Univ Oxford, Radcliffe Infirm, Wellcome Trust Ctr Human Genet, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX2 6HE, England; Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Diabet & Vasc Med, Exeter, Devon, England; Newcastle Univ, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England	Imperial College London; Imperial College London; University of London; Queen Mary University London; Radcliffe Infirmary; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; University of Exeter; Newcastle University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	McCarthy, MI (corresponding author), Univ London Imperial Coll Sci & Technol, Genet & Gen Res Inst, Hammersmith Campus, London W12 0NN, England.	m.mccarthy@ic.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Menzel, Stephan/U-6906-2019; McCarthy, Mark/M-3763-2015	O'Rahilly, Stephen/0000-0003-2199-4449; Levy, Jonathan/0000-0002-9486-1885; McCarthy, Mark/0000-0002-4393-0510; Hattersley, Andrew/0000-0001-5620-473X; Menzel, Stephan/0000-0002-1590-9108				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dolan CV, 1999, AM J HUM GENET, V64, P268, DOI 10.1086/302189; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; ERENS B, 2001, HLTH SURVEY ENGLAND; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lessem JL, 2001, BIOINFORMATICS, V17, P371, DOI 10.1093/bioinformatics/17.4.371; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Sham PC, 2000, GENET EPIDEMIOL, V19, pS22, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI4>3.0.CO;2-S; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; WILTSHIRE S, 2001, AM J HUM GENET, V69, P922	18	44	49	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					543	546		10.1086/338760	http://dx.doi.org/10.1086/338760			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11753821	Green Published, Bronze			2022-12-18	WOS:000173254300026
J	Eden, ER; Naoumova, RP; Burden, JJ; McCarthy, MI; Soutar, AK				Eden, ER; Naoumova, RP; Burden, JJ; McCarthy, MI; Soutar, AK			Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LDL-RECEPTOR GENE; MUTATIONS; TRAITS; LOCUS; CHINA; MAP	Familial hypercholesterolemia (FH) is a common inherited disorder of metabolism characterized clinically by high levels of low-density lipoprotein (LDL) in plasma owing to reduced catabolism. This leads to accelerated atherosclerosis and thus to an increased risk of coronary heart disease. FH is usually caused by defects in the gene for either the LDL receptor or apolipoprotein B (apoB), the ligand for the LDL receptor. Elsewhere, we have described two unrelated patients with phenotypic homozygous FH. Both patients were offspring of consanguineous unions, and linkage to either the gene for the LDL receptor or the gene for apoB was excluded in both. Their cells in culture do not degrade LDL, despite the presence of normal surface binding of LDL to the LDL receptor. This observation suggests that the patients may be homozygous for a defective gene that encodes a component of the internalization pathway. We first excluded linkage of the defect to known genes for proteins reported to be involved in internalization of receptors in clathrin-coated pits. We then performed genomewide homozygosity mapping. Genotyping of 500 polymorphic markers in three affected and seven unaffected members of the first pedigree showed that recessive hypercholesterolemia in this family is localized to a single chromosomal region on 1p36-p35. Genotyping of two affected and five unaffected members of the second pedigree provided further evidence of linkage to this locus, thereby mapping the disease-causing gene to a 12-cM region on chromosome 1p36-p35, with a combined LOD score of 5.3 in these unrelated families. Identification of the gene in this region may lead to new insights into the mechanisms of LDL receptor-mediated uptake of LDL by cells and may help to identify further genetic risk factors for premature atherosclerosis.	Hammersmith Hosp, Imperial Coll Sch Med, MRC, Ctr Clin Sci,Lipoprot Grp, London W12 ONN, England; Hammersmith Hosp, Imperial Coll Sch Med, MRC, Ctr Clin Sci,Mol Med Grp, London W12 ONN, England; Hammersmith Hosp, Imperial Coll Sch Med, Genet & Genom Inst, London W12 ONN, England; Hammersmith Hosp, Imperial Coll Sch Med, Div Med, London W12 ONN, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Soutar, AK (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, MRC, Ctr Clin Sci,Lipoprot Grp, Du Cane Rd, London W12 ONN, England.		Burden, Jemima/Q-1228-2017; McCarthy, Mark/M-3763-2015	Burden, Jemima/0000-0001-5894-7043; McCarthy, Mark/0000-0002-4393-0510; Eden, Emily/0000-0001-9352-5532				Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Day INM, 1997, HUM MUTAT, V10, P116; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EDEN E, 2000, ATHEROSCLEROSIS, V151, P300; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; Haddad L, 1999, J LIPID RES, V40, P1113; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Maniatis T., 1989, MOL CLONING LAB MANU; MISEREZ AR, 1995, ARTERIOSCL THROM VAS, V15, P1719, DOI 10.1161/01.ATV.15.10.1719; MYANT NB, 1993, ATHEROSCLEROSIS, V104, P1, DOI 10.1016/0021-9150(93)90171-P; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; Pimstone SN, 1998, ARTERIOSCL THROM VAS, V18, P309, DOI 10.1161/01.ATV.18.2.309; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SUN XM, 1994, ARTERIOSCLER THROMB, V14, P85, DOI 10.1161/01.ATV.14.1.85; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Varret M, 1999, AM J HUM GENET, V64, P1378, DOI 10.1086/302370; ZULIANI G, 1995, EUR J CLIN INVEST, V25, P322, DOI 10.1111/j.1365-2362.1995.tb01709.x	23	44	46	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					653	660		10.1086/318795	http://dx.doi.org/10.1086/318795			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179013	Green Published, Bronze			2022-12-18	WOS:000166994200010
J	Burton, PR; Palmer, LJ; Jacobs, K; Keen, KJ; Olson, JM; Elston, RC				Burton, PR; Palmer, LJ; Jacobs, K; Keen, KJ; Olson, JM; Elston, RC			Ascertainment adjustment: Where does if take US?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINEAR MIXED MODELS; PEDIGREE DATA	It is commonly assumed that the parameter estimates of a statistical genetics model that has been adjusted for ascertainment will estimate parameters in the general population from which the ascertained subpopulation was originally drawn. We show that this is true only in certain restricted circumstances. More generally, ascertainment-adjusted parameter estimates reflect parameters in the ascertained subpopulation. In many situations, this shift in perspective is immaterial: the parameters of interest are the same in the ascertained sample and in the population from which it was drawn, and it is therefore irrelevant to which population inferences are presumed to apply. In other circumstances, however, this is not so. This has important implications, particularly for studies investigating the etiology of complex diseases.	Univ Leicester, Genet Epidemiol Unit, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; TVW Telethon Inst Child Hlth Res, Div Biostat & Genet Epidemiol, Perth, WA, Australia; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Ctr, Cleveland, OH 44106 USA	University of Leicester; Telethon Kids Institute; University of Western Australia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; MetroHealth System	Burton, PR (corresponding author), Univ Leicester, Genet Epidemiol Unit, Dept Epidemiol & Publ Hlth, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.		Keen, Kevin J/D-5628-2013; Palmer, Lyle John/N-1948-2019; Palmer, Lyle John/K-3196-2014; Burton, Paul R/H-7527-2016	Keen, Kevin J/0000-0001-5695-0505; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; 	NCRR NIH HHS [RR0365] Funding Source: Medline; NHGRI NIH HHS [R29 HG001577, HG01577, R01 HG001577] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, R01 GM028356, GM28356] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001577, R29HG001577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; BURTON PR, 1994, STAT MED, V13, P1699, DOI 10.1002/sim.4780131702; Burton PR, 1999, GENET EPIDEMIOL, V17, P118, DOI 10.1002/(SICI)1098-2272(1999)17:2<118::AID-GEPI3>3.0.CO;2-V; CANNINGS C, 1977, CLIN GENET, V12, P208; ELSTON RC, 1995, AM J HUM GENET, V56, P15; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; GREENBERG DA, 1985, AM J MED GENET, V21, P357, DOI 10.1002/ajmg.1320210219; HODGE SE, 1988, AM J HUM GENET, V43, P364; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LI CC, 1968, AM J HUM GENET, V20, P61; LINDLEY DV, 1965, INTRO PROBABILITY 2; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; PFEIFFER R, 2000, INT SOC CLIN BIOST T; Spiegelhalter D. J., 2000, WINBUGS VERSION 1 3; VIELAND VJ, 1995, AM J HUM GENET, V56, P33	17	44	46	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1505	1514		10.1086/316899	http://dx.doi.org/10.1086/316899			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078478	Green Published, Bronze			2022-12-18	WOS:000165607600015
J	Stiburkova, B; Majewski, J; Sebesta, I; Zhang, WY; Ott, J; Kmoch, S				Stiburkova, B; Majewski, J; Sebesta, I; Zhang, WY; Ott, J; Kmoch, S			Familial juvenile hyperuricemic nephropathy: Localization of the gene on chromosome 16p11.2 - and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAMM-HORSFALL PROTEIN; MEDULLARY CYSTIC-DISEASE; HORMONE-BINDING PROTEIN; GOUTY NEPHROPATHY; KIDNEY-DISEASE; HYPER-URICEMIA; RENAL-DISEASE; IDENTIFICATION; LOCUS; HYPOTHYROIDISM	Familial juvenile hyperuricemic nephropathy (FJHN), is an autosomal dominant renal disease characterized by juvenile onset of hypcruricemia, gouty arthritis, and progressive renal failure at an early age. Using a genomewide linkage analysis in three Czech affected families, we have identified, on chromosome 16p11.2, a locus for FJHN and have found evidence for genetic heterogeneity and reduced penetrance of the disease. The maximum two-point LOD score calculated with allowance for heterogeneity (HLOD) was 4.70, obtained at recombination fraction 0, with marker D16S30SG; multipoint linkage analysis yielded a maximum HLOD score of 4.76 at the same location. Haplotype analysis defined a 10-cM candidate region between flanking markers D16S501 and D16S3113, exhibiting crossover events with the disease locus. The candidate interval contains several genes expressed in the kidney, two of which-uromodulin and NADP-regulated thyroid-hormone-binding protein-represent promising candidates for further analysis.	Inst Inherited Metab Disorders, Prague 12800 2, Czech Republic; Charles Univ, Sch Med 1, Dept Clin Biochem, Prague, Czech Republic; Hosp Prague, Gen Fac, Prague, Czech Republic; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	Charles University Prague; Rockefeller University	Kmoch, S (corresponding author), Inst Inherited Metab Disorders, Ke Karlovu 2, Prague 12800 2, Czech Republic.		Stiburkova, Blanka/N-8824-2013; Kmoch, Stanislav/C-1575-2010; Sebesta, Ivan/K-6484-2017	Stiburkova, Blanka/0000-0003-2465-1476; Kmoch, Stanislav/0000-0002-6239-707X; Sebesta, Ivan/0000-0002-0917-7967	NHGRI NIH HHS [HG00008] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CAMERON JS, 1993, PEDIATR NEPHROL, V7, P105, DOI 10.1007/BF00861588; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DUNCAN H, 1960, Q J MED, V29, P127; Fuchshuber A, 1998, NEPHROL DIAL TRANSPL, V13, P1955, DOI 10.1093/ndt/13.8.1955; Gokhale JA, 1996, UROL RES, V24, P201, DOI 10.1007/BF00295893; GREENER M, 1999, CELL MOL BIOL LETT, V4, P399; HOYER JR, 1979, KIDNEY INT, V16, P279, DOI 10.1038/ki.1979.130; IWAI N, 1994, HYPERTENSION, V23, P375, DOI 10.1161/01.HYP.23.3.375; KATZ AI, 1977, ANNU REV PHYSIOL, V39, P97, DOI 10.1146/annurev.ph.39.030177.000525; KLEIN I, 1984, ARCH INTERN MED, V144, P123, DOI 10.1001/archinte.144.1.123; Korom I, 1979, Orv Hetil, V120, P589; Lam P. W., 1995, Singapore Medical Journal, V36, P85; Lhotta K, 1998, NEPHRON, V79, P340, DOI 10.1159/000045060; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; McBride MB, 1997, J INHERIT METAB DIS, V20, P351, DOI 10.1023/A:1005365625778; McBride MB, 1998, PEDIATR NEPHROL, V12, P357, DOI 10.1007/s004670050466; MIRANDA ME, 1994, ADV EXP MED BIOL, V370, P61; Mooraki A, 1998, CLIN NEPHROL, V49, P59; MORO F, 1991, ADV EXP MED BIOL, V309, P199; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pavelka K Jr, 1996, Cas Lek Cesk, V135, P668; POOK MA, 1993, ANN HUM GENET, V57, P285, DOI 10.1111/j.1469-1809.1993.tb00902.x; PRIETO C, 1994, ADV EXP MED BIOL, V370, P65; PUIG JG, 1993, ARCH INTERN MED, V153, P357, DOI 10.1001/archinte.153.3.357; REITER L, 1995, AM J KIDNEY DIS, V25, P235; RESNICK JS, 1978, LAB INVEST, V38, P550; SAEKI A, 1995, NEPHRON, V70, P359, DOI 10.1159/000188618; SATO A, 1995, METABOLISM, V44, P207, DOI 10.1016/0026-0495(95)90266-X; Scolari F, 1999, AM J HUM GENET, V64, P1655, DOI 10.1086/302414; SEBESTA I, 1994, ADV EXP MED BIOL, V370, P73; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stavrou C, 1998, AM J MED GENET, V77, P149, DOI 10.1002/(SICI)1096-8628(19980501)77:2<149::AID-AJMG8>3.0.CO;2-N; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; THOMPSON GR, 1978, ARCH INTERN MED, V138, P1614, DOI 10.1001/archinte.138.11.1614; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728; Vie MP, 1996, ENDOCRINOLOGY, V137, P4563, DOI 10.1210/en.137.11.4563; WESTBERG NG, 1979, ACTA MED SCAND, V205, P163	37	44	47	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1989	1994		10.1086/302936	http://dx.doi.org/10.1086/302936			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10780922	Green Published, Bronze			2022-12-18	WOS:000088373800029
J	Shadel, GS				Shadel, GS			Yeast as a model for human mtDNA replication	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; HYPERSUPPRESSIVE PETITE; RNA-POLYMERASE; TRANSCRIPTION; MAINTENANCE; GENOME; NUCLEAR; RECOMBINATION		Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Shadel, GS (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.				NHLBI NIH HHS [R01 HL059655, HL-59655] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942; Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; FANGMAN WL, 1989, MOL CELL BIOL, V9, P1917, DOI 10.1128/MCB.9.5.1917; FANGMAN WL, 1990, MOL CELL BIOL, V10, P10, DOI 10.1128/MCB.10.1.10; FOURY F, 1989, J BIOL CHEM, V264, P20552; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391; GRIVELL LA, 1995, CRIT REV BIOCHEM MOL, V30, P121, DOI 10.3109/10409239509085141; Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Howell N, 1997, AM J HUM GENET, V61, P19, DOI 10.1086/513910; Knight SAB, 1999, AM J HUM GENET, V64, P365, DOI 10.1086/302270; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; LISOWSKY T, 1988, MOL GEN GENET, V214, P218, DOI 10.1007/BF00337714; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; REENAN RAG, 1992, GENETICS, V132, P975; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Van Dyck E, 1998, MOL CELL BIOL, V18, P2976, DOI 10.1128/MCB.18.5.2976; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493	40	44	47	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1230	1237		10.1086/302630	http://dx.doi.org/10.1086/302630			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521287	Bronze, Green Published			2022-12-18	WOS:000083531000003
J	Funke, B; Edelmann, L; McCain, N; Pandita, RK; Ferreira, J; Merscher, S; Zohouri, M; Cannizzaro, L; Shanske, A; Morrow, BE				Funke, B; Edelmann, L; McCain, N; Pandita, RK; Ferreira, J; Merscher, S; Zohouri, M; Cannizzaro, L; Shanske, A; Morrow, BE			Der(22) syndrome and velo-cardio-facial syndrome/DiGeorge syndrome share a 1.5-Mb region of overlap on chromosome 22q11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAT-EYE SYNDROME; DIGEORGE-SYNDROME; MOLECULAR DEFINITION; PROXIMAL 22Q; TRANSLOCATION; DELETIONS; GENE; DUPLICATION; IDENTIFICATION; MICRODELETIONS	Derivative 22 (der[22]) syndrome is a rare disorder associated with multiple congenital anomalies, including profound mental retardation, preauricular skin tags or pits, and conotruncal heart defects. It can occur in offspring of carriers of the constitutional t(11;22)(q23;q11) translocation, owing to a 3:1 meiotic malsegregation event resulting in partial trisomy of chromosomes 11 and 22. The trisomic region on chromosome 22 overlaps the region hemizygously deleted in another congenital anomaly disorder, velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS). Most patients with VCFS/DGS have a similar 3-Mb deletion, whereas some have a nested distal deletion endpoint resulting in a 1.5- Mb deletion, and a few rare patients have unique deletions. To define the interval on 22q11 containing the t(11;22) breakpoint, haplotype analysis and FISH mapping were performed for five patients with der(22) syndrome. Analysis of all the patients was consistent with 3:1 meiotic malsegregation in the t(11;22) carrier parent. FISH-mapping studies showed that the t(11;22) breakpoint occurred in the same interval as the 1.5-Mb distal deletion breakpoint for VCFS. The deletion breakpoint of one VCFS patient with an unbalanced t(18;22) translocation also occurred in the same region. Hamster-human somatic hybrid cell lines from a patient with der(22) syndrome and a patient with VCFS showed that the breakpoints occurred in an interval containing low-copy repeats, distal to RANBP1 and proximal to ZNF74. The presence of low-copy repetitive sequences may confer susceptibility to chromosome rearrangements. A 1.5-Mb region of overlap on 22q11 in both syndromes suggests the presence of dosage-dependent genes in this interval.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Obstet Gynecol, Div Reprod Genet, Bronx, NY 10461 USA; Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA; Montefiore Med Ctr, Ctr Congenital & Craniofacial Disorders, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	morrow@aecom.yu.edu	Ferreira, Jose Carlos P/E-3105-2016	Ferreira, Jose Carlos P/0000-0003-0517-8230; Merscher, Sandra/0000-0002-4757-7494; Morrow, Bernice/0000-0002-8076-4726	NCI NIH HHS [T32 CA09060] Funding Source: Medline; NICHD NIH HHS [P01 HD34980-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009060] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUBRY M, 1993, HUM MOL GENET, V2, P1583, DOI 10.1093/hmg/2.10.1583; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; Budarf ML, 1996, GENOMICS, V35, P275, DOI 10.1006/geno.1996.0358; CAREY AH, 1990, GENOMICS, V7, P299, DOI 10.1016/0888-7543(90)90161-M; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; COLLINS J, 1995, NATURE, V337, P367; Collins JE, 1997, GENOME RES, V7, P522, DOI 10.1101/gr.7.5.522; Di Matteo G, 1998, J BIOL CHEM, V273, P495, DOI 10.1074/jbc.273.1.495; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; EDELMANN L, IN PRESS AM J HUM GE; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; GUANTI G, 1981, J MED GENET, V18, P108, DOI 10.1136/jmg.18.2.108; HALFORD S, 1993, HUM MOL GENET, V2, P1577, DOI 10.1093/hmg/2.10.1577; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HERZOG R, 1991, BIOCHEMISTRY-US, V30, P1350, DOI 10.1021/bi00219a027; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KNOLL JHM, 1995, AM J MED GENET, V55, P221, DOI 10.1002/ajmg.1320550214; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; LIN AE, 1986, CLIN GENET, V29, P269; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; Luan XD, 1997, ONCOGENE, V15, P79, DOI 10.1038/sj.onc.1201164; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; MEARS AJ, 1994, AM J HUM GENET, V55, P134; MEARS AJ, 1995, AM J HUM GENET, V57, P667; MORROW B, 1995, AM J HUM GENET, V56, P1391; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; ODonnell H, 1997, AM J HUM GENET, V60, P1544; PRASHER VP, 1995, J MED GENET, V32, P306, DOI 10.1136/jmg.32.4.306; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SCHINZEL A, 1981, HUM GENET, V57, P148; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Smeets D, 1997, J MED GENET, V34, P18, DOI 10.1136/jmg.34.1.18; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; VANHOVE JLK, 1992, AM J MED GENET, V44, P24, DOI 10.1002/ajmg.1320440107; Wandstrat AE, 1998, AM J HUM GENET, V62, P925, DOI 10.1086/301777; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	48	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					747	758		10.1086/302284	http://dx.doi.org/10.1086/302284			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053009	Bronze, Green Published			2022-12-18	WOS:000079204700012
J	Cacurri, S; Piazzo, N; Deidda, G; Vigneti, E; Galluzzi, G; Colantoni, L; Merico, B; Ricci, E; Felicetti, L				Cacurri, S; Piazzo, N; Deidda, G; Vigneti, E; Galluzzi, G; Colantoni, L; Merico, B; Ricci, E; Felicetti, L			Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA REARRANGEMENTS; FSHD; 4Q35; FAMILIES; DELETIONS; REGION	Physical mapping and in situ hybridization experiments have shown that a duplicated locus with a structural organization similar to that of the 4q35 locus implicated in facioscapulohumeral muscular dystrophy is present in the subtelomeric portion of 10q. We performed sequence analysis of the p13E-11 probe and of the adjacent KpnI tandem-repeat unit derived from a 10qter cosmid clone and compared our results with those published, by other laboratories, for the 4q35 region.We found that the sequence homology range is 98%-100% and confirmed that the only difference that can be exploited for differentiation of the 10qter from the 4q35 alleles is the presence of an additional BlnI site within the 10qter KpnI repeat unit. In addition, we observed that the high degree of sequence homology does facilitate interchromosomal exchanges resulting in displacement of the whole set of BlnI-resistant or BlnI-sensitive KpnI repeats from one chromosome to the other. However, partial translocations escape detection if the latter simply relies on the hybridization pattern from double digestion with EcoRI/BlnI and with p13E-11 as a probe.We discovered that the restriction enzyme Tru9I cuts at both ends of the array of KpnI repeats of different chromosomal origins and allows the use of cloned KpnI sequences as a probe by eliminating other spurious fragments. This approach coupled with BlnI digestion permitted us to investigate the structural organization of BlnI-resistant and BlnI-sensitive units within translocated chromosomes of 4q35 and 10q26 origin. A priori, the possibility that partial translocations could play a role in the molecular mechanism of the disease cannot be excluded.	CNR, Ist Biol Cellulare, I-00137 Rome, Italy; Univ Roma Tor Vergata, Dipartimento Genet Umana, Rome, Italy; Univ Cattolica Sacro Cuore, Policlin Gemelli, Unione Italiana Lotta Distrofia Muscolare, Rome, Italy; Univ Cattolica Sacro Cuore, Policlin Gemelli, Ist Neurol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Felicetti, L (corresponding author), CNR, Ist Biol Cellulare, Viale Marx 43, I-00137 Rome, Italy.	luciano@biocell.irmkant.rm.cnr.it	Ricci, Enzo/AAC-4448-2020	DEIDDA, GIANCARLO/0000-0002-0828-5800; RICCI, Enzo/0000-0003-3092-3597	Telethon [668] Funding Source: Medline	Telethon(Fondazione Telethon)		BAKKER E, 1995, MUSCLE NERVE, pS39; CACURRI S, 1994, HUM GENET, V94, P367, DOI 10.1007/BF00201595; DEIDDA G, 1995, EUR J HUM GENET, V3, P155; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; DEIDDA GC, 1994, ANN NEUROL, V36, P117, DOI 10.1002/ana.410360128; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; HEWITT JE, 1997, SAT S AM AC NEUR BOS; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; LEE JH, 1995, MUSCLE NERVE, pS6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; PASSOSBUENO MR, 1993, HUM MOL GENET, V2, P557, DOI 10.1093/hmg/2.5.557; UPADHYAYA M, 1993, HUM MOL GENET, V2, P981, DOI 10.1093/hmg/2.7.981; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WEIFFENBACH B, 1993, NAT GENET, V4, P165, DOI 10.1038/ng0693-165; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; WIJMENGA C, 1994, GENOMICS, V19, P21, DOI 10.1006/geno.1994.1006; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567	19	44	49	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					181	190		10.1086/301906	http://dx.doi.org/10.1086/301906			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634507	Bronze, Green Published			2022-12-18	WOS:000074761000026
J	Liang, Y; Wang, AH; Probst, FJ; Arhya, IN; Barber, TD; Chen, KS; Deshmukh, D; Dolan, DF; Hinnant, JT; Carter, LE; Jain, PK; Lalwani, AK; Li, XYC; Lupski, JR; Moeljopawiro, S; Morell, R; Negrini, C; Wilcox, ER; Winata, S; Camper, SA; Friedman, TB				Liang, Y; Wang, AH; Probst, FJ; Arhya, IN; Barber, TD; Chen, KS; Deshmukh, D; Dolan, DF; Hinnant, JT; Carter, LE; Jain, PK; Lalwani, AK; Li, XYC; Lupski, JR; Moeljopawiro, S; Morell, R; Negrini, C; Wilcox, ER; Winata, S; Camper, SA; Friedman, TB			Genetic mapping refines DFNB3 to 17p11.2, suggests multiple alleles of DFNB3, and supports homology to the mouse model shaker-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS SYNDROME; SOMATIC-CELL HYBRIDS; RECESSIVE DEAFNESS; LOCALIZATION; MUTATION; CHROMOSOME-17; CLONING; REGION; MAPS; DNA	The nonsyndromic congenital recessive deafness gene, DFNB3, first identified in Bengkala, Bali, was mapped to a similar to 12-cM interval on chromosome 17. New short tandem repeats (STRs) and additional DNA samples were used to identify recombinants that constrain the DFNB3 interval to less than or similar to 6 cM on 17p11.2. Affected individuals from Bengkala and affected members of a family with hereditary deafness who were from Bila, a village neighboring Bengkala, were homozygous for the same alleles for six adjacent STRs in the DFNB3 region and were heterozygous for other distal markers, thus limiting DFNB3 to an similar to 3-cM interval. Nonsyndromic deafness segregating in two unrelated consanguineous Indian families, M21 and I-1924, were also linked to the DFNB3 region. Haplotype analysis indicates that the DFNB3 mutations in the three pedigrees most likely arose independently and suggests that DFNB3 makes a significant contribution to hereditary deafness worldwide. On the basis of conserved synteny, mouse deafness mutations shaker-2 (sh2) and sh2(J) are proposed as models of DFNB3. Genetic mapping has refined sh2 to a 0.6-cM interval of chromosome 11. Three homologous genes map within the sh2 and DFNB3 intervals, suggesting that sh2 is the homologue of DFNB3.	Natl Inst Deafness & Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Michigan State Univ, Dept Religious Studies, E Lansing, MI USA; Michigan State Univ, Grad Program Genet, E Lansing, MI USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; Udayana Univ, Fac Med, Dept Biochem, Denpasar, Indonesia; Udayana Univ, Fac Med, Dept Microscop Anat, Denpasar, Indonesia; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Rotary Deaf Sch, Ichalkaranji, India; Epstein Labs, Mol Oncol Lab, San Francisco, CA USA; Gadjah Mada Univ, Fac Biol, Biochem Lab, Yogyakarta, Indonesia; Gadjah Mada Univ, Interuniv Ctr Biotechnol, Yogyakarta, Indonesia	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Michigan State University; Michigan State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universitas Udayana; Universitas Udayana; Baylor College of Medicine; Gadjah Mada University; Gadjah Mada University	Friedman, TB (corresponding author), Natl Inst Deafness & Commun Disorders, Mol Genet Lab, NIH, 5 Res Court,Room 2A01, Rockville, MD 20850 USA.		Morell, Robert James/Q-2042-2019; Chen, Ken-Shiung/A-2204-2011	Camper, Sally/0000-0001-8556-3379; Morell, Robert/0000-0003-1537-7356	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000038, Z01DC000035, R01DC002407] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC02407, Z01 DC00035, Z01 DC00038] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BEESON D, 1990, ANN HUM GENET, V54, P199, DOI 10.1111/j.1469-1809.1990.tb00378.x; BLOCH KD, 1995, GENOMICS, V27, P526, DOI 10.1006/geno.1995.1086; Campbell HD, 1997, GENOMICS, V42, P46, DOI 10.1006/geno.1997.4709; CHEN H, 1995, GENOMICS, V27, P389, DOI 10.1006/geno.1995.1068; CHEN KS, 1995, AM J HUM GENET, V56, P175; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; CHEVILLARD C, 1993, HUM MOL GENET, V2, P1235, DOI 10.1093/hmg/2.8.1235; COOK SA, 1993, MOUSE GENOME, V91, P312; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DeLaurenzi V, 1996, NAT GENET, V12, P52; DEOL MS, 1954, J GENET, V52, P562, DOI 10.1007/BF02985081; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOBROVOLSKAIA-ZAVASDKAIA N., 1928, ARCH BIOL, V38, P457; Elsea SH, 1998, AM J MED GENET, V75, P104; ELSEA SH, 1995, AM J HUM GENET, V57, P1342; ESTRADA B, 1997, INFECT MED, V14, P239; FALCONER DS, 1953, J HERED, V44, P159, DOI 10.1093/oxfordjournals.jhered.a106383; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Hugnot JP, 1997, GENOMICS, V39, P113, DOI 10.1006/geno.1996.4450; KOCHER W, 1960, Z VEREBUNGSL, V91, P114, DOI 10.1007/BF00890005; Lansing John, 1991, PRIESTS PROGRAMMERS; Liang Y, 1997, GENE, V184, P163, DOI 10.1016/S0378-1119(96)00590-2; MICHIE DONALD, 1955, JOUR GENETICS, V53, P280, DOI 10.1007/BF02993982; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; Potocki L., 1996, American Journal of Human Genetics, V59, pA310; Probst FJ, 1997, AM J HUM GENET, V61, pA242; Saccone S, 1996, GENE, V174, P85, DOI 10.1016/0378-1119(96)00392-7; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; TOWNSENDNICHOLSON A, 1995, GENOMICS, V25, P605, DOI 10.1016/0888-7543(95)80074-V; Wakabayashi Y, 1997, BIOCHEM BIOPH RES CO, V234, P107, DOI 10.1006/bbrc.1997.6595; WatkinsChow DE, 1997, GENOMICS, V40, P114, DOI 10.1006/geno.1996.4532; WEBB GC, 1990, AM J HUM GENET, V46, P308; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wilgenbus KK, 1997, GENOMICS, V42, P1, DOI 10.1006/geno.1997.4707; WINATA S, 1995, J MED GENET, V32, P336, DOI 10.1136/jmg.32.5.336; Yamasoba T, 1997, HEARING RES, V112, P13, DOI 10.1016/S0378-5955(97)00092-0; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589	47	44	48	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					904	915		10.1086/301786	http://dx.doi.org/10.1086/301786			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529344	Green Published, Bronze			2022-12-18	WOS:000073514400022
J	Nothen, MM; Cichon, S; Vogt, IR; Hemmer, S; Kruse, R; Knapp, M; Holler, T; ul Haque, MF; Haque, S; Propping, P; Ahmad, M; Rietschel, M				Nothen, MM; Cichon, S; Vogt, IR; Hemmer, S; Kruse, R; Knapp, M; Holler, T; ul Haque, MF; Haque, S; Propping, P; Ahmad, M; Rietschel, M			A gene for universal congenital alopecia maps to chromosome 8p21-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; RECESSIVE INHERITANCE; LINKAGE ANALYSIS; ATRICHIA; HAIR; DISORDERS	Complete or partial congenital absence of hair (congenital alopecia) may occur either in isolation or with associated defects. The majority of families With isolated congenital alopecia has been reported to follow an autosomal-recessive mode of inheritance (MIM 203655). As yet, no gene has been linked to isolated congenital alopecia, nor has linkage been established to a specific region of the genome. In an attempt to map the gents for the autosomal recessive form of the disorder, we have performed generic linkage analysis on a large inbred Pakistani family in which affected persons show complete absence of hair development (universal congenital alopecia). We have analyzed individuals of this family, using >175 microsatellite polymorphic markers of the human genome. A maximum LOD score of 7.90 at a recombination fraction of 0 has been obtained with locus D8S258. Haplotype analysis of recombination events localized the disease to a 15-cM region between marker loci D8S261 and D8S1771. We have thus mapped the gene for this hereditary form of isolated congenital alopecia to a locus on chromosome 8p21-22 (ALUNC [alopecia universalis congenitalis]), this will aid future identification of the responsible gene, which will be extremely useful for the understanding of the biochemistry of hair development.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Inst Med Stat, D-53111 Bonn, Germany; Univ Bonn, Dept Psychiat, D-53111 Bonn, Germany; Quaid I Azam Univ, Dept Biol Sci, Islamabad, Pakistan; Cedars Sinai Res Inst, Ahmanson Dept Pediat, Los Angeles, CA USA	University of Bonn; University of Bonn; University of Bonn; Quaid I Azam University; Cedars Sinai Medical Center	Nothen, MM (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.	noethen@humgen.uni-bonn.de	Cichon, Sven/B-9618-2014	Cichon, Sven/0000-0002-9475-086X; Nothen, Markus/0000-0002-8770-2464				AHMAD M, 1993, AM J MED GENET, V46, P369, DOI 10.1002/ajmg.1320460405; ANDRES DA, 1993, GENOMICS, V18, P105, DOI 10.1006/geno.1993.1432; Anzai H, 1996, LANCET, V347, P337, DOI 10.1016/S0140-6736(96)90522-X; Baer T, 1907, ARCH DERMATOL SYPH-G, V84, P15, DOI 10.1007/BF01953895; BIRKE G, 1954, Arch Klin Exp Dermatol, V197, P322, DOI 10.1007/BF00361701; BIRNBAUM PS, 1987, DERMATOL CLIN, V5, P137, DOI 10.1016/S0733-8635(18)30771-X; BOOKSTEIN R, 1994, GENOMICS, V24, P317, DOI 10.1006/geno.1994.1622; CANTU JM, 1980, CLIN GENET, V17, P209; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FEINSTEIN A, 1987, J CRAN GENET DEV BIO, V7, P301; HEALY E, 1995, HUM MOL GENET, V4, P2399, DOI 10.1093/hmg/4.12.2399; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; KENUE RK, 1994, DERMATOLOGY, V188, P72, DOI 10.1159/000247092; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUNDBACK H, 1944, ACTA DERM-VENEREOL, V25, P189; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; PAJTAS J, 1950, Dermatologica, V101, P90; PHILPOTT MP, 1991, ANN NY ACAD SCI, V642, P148; PINHEIRO M, 1985, HUM HERED, V35, P53, DOI 10.1159/000153515; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SPIVAKKROIZMAN T, 1992, J BIOL CHEM, V267, P8056; TILLMAN WG, 1952, BRIT MED J, V2, P428, DOI 10.1136/bmj.2.4781.428; VOGT BR, 1988, PEDIATR DERMATOL, V5, P236, DOI 10.1111/j.1525-1470.1988.tb00894.x; Wang TW, 1996, SCIENCE, V271, P1120, DOI 10.1126/science.271.5252.1120; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4300, DOI 10.1093/nar/18.14.4300	27	44	48	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					386	390		10.1086/301717	http://dx.doi.org/10.1086/301717			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463324	Green Published, Bronze			2022-12-18	WOS:000072416000022
J	O'Quinn, JR; Hennekam, RCM; Jorde, LB; Bamshad, M				O'Quinn, JR; Hennekam, RCM; Jorde, LB; Bamshad, M			Syndromic ectrodactyly with severe limb, ectodermal, urogenital, and palatal defects maps to chromosome 19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ULNAR-MAMMARY SYNDROME; SPLIT FOOT LOCUS; EEC-SYNDROME; HAND; GENE; EXPRESSION; LINKAGE; BETA	Congenital limb malformations rank behind only congenital heart disease as the most common birth defects observed in infants. Finding genes that cause defects in human limb patterning should be straightforward but has been limited, in part, by the bewildering spectrum of phenotypes, which are difficult to separate into etiologically distinct disorders. One approach to the identification of relevant genes is to take advantage of unique extended kindreds in which a defect in limb patterning is segregating. Recently, a large Dutch family with ectrodactyly, ectodermal dysplasia, cleft palate, and urogenital defects (EEC) was described by Maas et al. We have studied this kindred and localized a gene causing EEC to a locus on chromosome 19, in a region defined by D19S894 and D19S416. A second extended kindred with EEC does not map to this locus, indicating that EEC is a genetically heterogeneous disorder. Growth and patterning of the limbs, teeth, hair, and genitourinary system are mediated in part by epithelial-mesenchyme inductive interactions. The identification of both the gene causing EEC and its mutation may further elucidate the general signals mediating inductive mechanisms.	Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT 84132 USA; Shriners Hosps Children, Intermt Unit, Salt Lake City, UT USA; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Inst Human Genet, NL-1105 AZ Amsterdam, Netherlands	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bamshad, M (corresponding author), Eccles Inst Human Genet, Bldg 533, Room 7200, Salt Lake City, UT 84112 USA.	mike@thor.med.utah.edu			NHGRI NIH HHS [5-P30-HG00199] Funding Source: Medline; PHS HHS [MO1-0064] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000199] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1996, AM J MED GENET, V65, P325, DOI 10.1002/(SICI)1096-8628(19961111)65:4<325::AID-AJMG15>3.0.CO;2-W; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BUSS PW, 1995, J MED GENET, V32, P716, DOI 10.1136/jmg.32.9.716; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRANCESCHINI P, 1992, AM J MED GENET, V44, P807, DOI 10.1002/ajmg.1320440618; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Hamel Ben, 1996, European Journal of Human Genetics, V4, P148; HAQUE MFU, 1993, HUM GENET, V91, P17; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maas SM, 1996, AM J MED GENET, V63, P472; MARTIN P, 1993, DEV GENET, V14, P225, DOI 10.1002/dvg.1020140309; MILLAN FA, 1991, DEVELOPMENT, V111, P131; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; PREUS M, 1973, CLIN GENET, V4, P369; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; STEIN J, 1995, AM J HUM GENET, V57, P257; STEIN J, 1997, AM J HUM GENET, V60, P1012; Temtamy SA, 1978, GENETICS HAND MALFOR; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Wyszynski DF, 1997, HUM GENET, V99, P22	26	44	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					130	135		10.1086/301687	http://dx.doi.org/10.1086/301687			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443880	Green Published, Bronze			2022-12-18	WOS:000072127900018
J	Qian, F; Germino, CG				Qian, F; Germino, CG			''Mistakes happen'': Somatic mutation and disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; GENE; PROTEIN; PKD1		JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV NEPHROL,BALTIMORE,MD 21205	Johns Hopkins University				Germino, Gregory/0000-0002-3609-5588	NIDDK NIH HHS [DK48006] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048006, R37DK048006] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bacallao RL, 1997, CURR OPIN NEPHROL HY, V6, P377; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; BESSLER M, 1994, LANCET, V343, P951, DOI 10.1016/S0140-6736(94)90068-X; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; CROSBY JL, 1993, AM J HUM GENET, V52, P866; *EUR POL KIDN DIS, 1994, CELL, V77, P881; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Ong ACM, 1997, LANCET, V349, P1039, DOI 10.1016/S0140-6736(05)62286-6; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SPRITZ RA, 1992, AM J HUM GENET, V51, P1058; Tischfield JA, 1997, AM J HUM GENET, V61, P995, DOI 10.1086/301617; Watnick TJ, 1997, HUM MOL GENET, V6, P1473, DOI 10.1093/hmg/6.9.1473; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	27	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1000	1005		10.1086/301618	http://dx.doi.org/10.1086/301618			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345111	Green Published, hybrid			2022-12-18	WOS:A1997YH01700003
J	Mackay, D; Ionides, A; Berry, V; Moore, A; Bhattacharya, S; Shiels, A				Mackay, D; Ionides, A; Berry, V; Moore, A; Bhattacharya, S; Shiels, A			A new locus for dominant ''zonular pulverulent'' cataract, on chromosome 13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL CATARACT; LINKAGE ANALYSIS; CRYSTALLIN GENE; MUTATIONS; DELETION; MEMBRANE; PROTEIN; MOUSE	Inherited cataract is a clinically and genetically heterogeneous disease that most often presents as a congenital autosomal dominant trait. Here we report the linkage of a new locus for dominant ''zonular pulverulent'' cataract (CZP) to chromosome 13. To map the CZP locus we performed molecular-genetic linkage analysis using microsatellite markers in a five-generation English pedigree. After exclusion of eight known loci and several candidate genes for autosomal dominant cataract, we obtained significantly positive LOD scores (Z) for markers D13S175 (maximum Z [Z(max)] = 4.06; maximum recombination frequency [theta(max)] = 0) and D13S1236 (Z(max) = 5.75, theta(max) = 0). Multipoint analysis gave Z(max) = 6.62 (theta(max) = 0) at marker D13S175. Haplotype data indicated that CZP probably lies in the centromeric region of chromosome 13, provocatively close to the gene for lens connexin4G.	MOORFIELDS EYE HOSP,LONDON,ENGLAND; INST OPHTHALMOL,DEPT MOL GENET,LONDON,ENGLAND	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London			Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Mackay, Donna/0000-0002-2499-1203	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; CHURCH RL, 1995, CURR EYE RES, V14, P215, DOI 10.3109/02713689509033517; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; FRANCOIS J, 1982, OPHTHALMOLOGICA, V184, P61, DOI 10.1159/000309186; Ionides ACW, 1997, HUM MOL GENET, V6, P47, DOI 10.1093/hmg/6.1.47; Kramer P, 1996, GENOMICS, V35, P539, DOI 10.1006/geno.1996.0395; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUND AM, 1992, CLIN GENET, V41, P65; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; Matsushima Y, 1996, GENOMICS, V36, P553, DOI 10.1006/geno.1996.0507; MAUMENEE IH, 1979, OPHTHALMOLOGY, V86, P1554; MCKUSICK VA, 1996, ONLINE FULL TEXT DAT; Merin S., 1991, INHERITED EYE DIS, P86; Mignon C, 1996, CYTOGENET CELL GENET, V72, P185, DOI 10.1159/000134183; Nettleship E., 1909, T OPHTHAL SOC UK, V29, P188; PADMA T, 1995, AM J HUM GENET, V57, P840; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; RICHARDS J, 1984, CYTOGENET CELL GENET, V37, P570; RODRIGUEZ IR, 1992, BIOCHIM BIOPHYS ACTA, V1180, P44, DOI 10.1016/0925-4439(92)90025-I; Rogaev EI, 1996, HUM MOL GENET, V5, P699, DOI 10.1093/hmg/5.5.699; RYSAVY FR, 1992, COMPUT APPL BIOSCI, V8, P149; SCHWARZ HJ, 1992, SOMAT CELL MOLEC GEN, V18, P351, DOI 10.1007/BF01235758; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212	34	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1474	1478		10.1086/515468	http://dx.doi.org/10.1086/515468			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199569	Bronze, Green Published			2022-12-18	WOS:A1997XE29400026
J	Bernasconi, F; Karaguzel, A; Celep, F; Keser, I; Luleci, G; Dutly, F; Schinzel, AA				Bernasconi, F; Karaguzel, A; Celep, F; Keser, I; Luleci, G; Dutly, F; Schinzel, AA			Normal phenotype with maternal isodisomy in a female with two isochromosomes: i(2p) and i(2q)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNIPARENTAL DISOMY; TRANSLOCATIONS; CHROMOSOME-2; ORIGIN; MAP	A 36-year-old normal healthy female was karyotyped because all of her five pregnancies had terminated in spontaneous abortions during the first 3 mo. Cytogenetic investigation disclosed a female karyotype with isochromosomes of 2p and 2q replacing the two normal chromosomes 2. Her husband and both of her parents had normal karyotypes. Molecular studies revealed maternal only inheritance for chromosome 2 markers. Reduction to homozygosity of all informative markers indicated that the isochromosomes derived from a single maternal chromosome 2. Except for the possibility of homozygosity for recessive mutations, maternal uniparental disomy 2 appears to have no adverse impact on the phenotype. Our data indicate that no maternally imprinted genes with major effect map to chromosome 2.	UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; KARADENIZ TECH UNIV,DEPT MED BIOL,TRABZON,TURKEY; AKDENIZ UNIV,DEPT MED GENET,ANTALYA,TURKEY	University of Zurich; Karadeniz Technical University; Akdeniz University			EYÜPOĞLU, Figen CELEP/AAS-5109-2020					ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; Bernard L. E., 1995, American Journal of Human Genetics, V57, pA51; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRISON K, 1995, AM J MED GENET, V58, P147, DOI 10.1002/ajmg.1320580211; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LINDENBAUM RH, 1991, AM J HUM GENET S, V49, pA285; LORDASANCHEZ I, 1991, AM J HUM GENET, V49, P1034; MULLER H, 1972, J MED GENET, V9, P462, DOI 10.1136/jmg.9.4.462; NIIKAWA N, 1983, HUM GENET, V63, P85, DOI 10.1007/BF00285407; OHAMA K, 1978, HUM GENET, V40, P221, DOI 10.1007/BF00272305; Pearsall RS, 1996, BIOCHEM BIOPH RES CO, V222, P171, DOI 10.1006/bbrc.1996.0716; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; SCHINZEL A, 1995, HUMAN GENETIC MAPPIN, P1017; Spinner N. B., 1994, American Journal of Human Genetics, V55, pA118; WILLIAMSON CM, 1995, GENET RES, V65, P83, DOI 10.1017/S0016672300033103	17	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1114	1118						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900241				2022-12-18	WOS:A1996VN90000020
J	PARK, WJ; BELLUS, GA; JABS, EW				PARK, WJ; BELLUS, GA; JABS, EW			MUTATIONS IN FIBROBLAST GROWTH-FACTOR RECEPTORS - PHENOTYPIC CONSEQUENCES DURING EUKARYOTIC DEVELOPMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							TYROSINE KINASE; FAMILY; EXPRESSION; DIVERSITY; GENE		JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21287	Johns Hopkins University				Bellus, Gary/0000-0001-7492-3324; Jabs, Ethylin/0000-0001-8983-5466	NIDCR NIH HHS [P50DE11131] Funding Source: Medline; NIGMS NIH HHS [T32GM07471] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007471] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Gospodarowicz D, 1990, Curr Top Dev Biol, V24, P57, DOI 10.1016/S0070-2153(08)60084-8; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MIMA T, 1995, P NATL ACAD SCI USA, V92, P467, DOI 10.1073/pnas.92.2.467; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PERRIMON N, 1993, CELL, V74, P219, DOI 10.1016/0092-8674(93)90412-J; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; PRESTON RA, 1995, MAR INT GEN WORKSH C; PRINOS P, 1995, PEDIATR RES, V37, pA151; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; REARDON W, 1995, MAR INT GEN WORKSH C; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TOMMERUP N, 1993, HUM MOL GENET, V2, P1571, DOI 10.1093/hmg/2.10.1571; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; WASMUTH J, 1995, MAR INT GEN WORKSH C; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WHITMAN M, 1989, ANNU REV CELL BIOL, V5, P93; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	45	44	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					748	754						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573032				2022-12-18	WOS:A1995RV79300002
J	TOMATSU, S; FUKUDA, S; COOPER, A; WRAITH, JE; REZVI, GMM; YAMAGISHI, A; YAMADA, N; KATO, Z; ISOGAI, K; SUKEGAWA, K; KONDO, N; SUZUKI, Y; SHIMOZAWA, N; ORII, T				TOMATSU, S; FUKUDA, S; COOPER, A; WRAITH, JE; REZVI, GMM; YAMAGISHI, A; YAMADA, N; KATO, Z; ISOGAI, K; SUKEGAWA, K; KONDO, N; SUZUKI, Y; SHIMOZAWA, N; ORII, T			MUCOPOLYSACCHARIDOSIS IVA - IDENTIFICATION OF A COMMON MISSENSE MUTATION 1113F IN THE N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MORQUIO-DISEASE; POINT MUTATIONS; DEFICIENCY; FIBROBLASTS; FORMS; MILD	Mucopolysaccharidosis IVA is an autosomal recessive lysosomal storage disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase. The recent isolation and characterization of cDNA and genomic sequences encoding GALNS has facilitated identification of the molecular lesions that cause MPS IVA. We identified a common missense mutation among Caucasian MPS IVA patients. The mutation was originally detected by SSCP, and successive sequencing revealed an A-->T transversion at nt 393. This substitution altered the isoleucine at position 113 to phenylalanine (I113F) in the 622 amino acid GALNS protein and was associated with a severe phenotype in a homozygote. Compound heterozygotes with one I113F-allele mutation have a wide range of clinical phenotypes. Transfection experiments in GALNS-deficient fibroblasts revealed that the mutation drastically reduces the enzyme activity of GALNS. Allele-specific oligonucleotide or SSCP analysis indicated that this mutation accounted for 22.5% (9/40) of unrelated MPS IVA chromosomes from 23 Caucasian patients, including 6 consanguineous cases. Of interest, the Ile 113-->Phe substitution occurred in only Caucasian MPS IVA patients and in none of the GALNS alleles of 20 Japanese patients. These findings identify a frequent missense mutation among MPS IVA patients of Caucasian ancestry, that results in severe MPS IVA when homoallelic, and will facilitate molecular diagnosis of most such patients and identification of heterozygous carriers. In addition to this common mutation, 10 different point mutations and 2 small deletions were detected, suggesting allelic heterogeneity in GALNS gene.	UNIV MANCHESTER,ROYAL MANCHESTER CHILDRENS HOSP,SCH MED,MANCHESTER,LANCS,ENGLAND	Royal Manchester Children's Hospital; University of Manchester	TOMATSU, S (corresponding author), GIFU UNIV,SCH MED,DEPT PEDIAT,40 TSUKASA MACHI,GIFU 500,JAPAN.		Kato, Zenichiro/E-8900-2010	Shimozawa, Nobuyuki/0000-0003-3040-5458				BAKER E, 1993, AM J HUM GENET, V52, P96; BECK M, 1986, CLIN GENET, V29, P325; FUJIMOTO A, 1983, AM J MED GENET, V18, P369; FUKUDA S, 1992, J CLIN INVEST, V90, P1049, DOI 10.1172/JCI115919; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; GLOSSL J, 1981, PEDIATR RES, V15, P976; HECHIT JT, 1984, AM J MED GENET, V15, P265; HORI T, 1995, GENOMICS, V26, P535, DOI 10.1016/0888-7543(95)80172-I; IWATA H, 1995, HUM GENET, V95, P257; LEVRAN O, 1991, P NATL ACAD SCI USA, V88, P3748, DOI 10.1073/pnas.88.9.3748; MASUNO M, 1993, GENOMICS, V16, P777, DOI 10.1006/geno.1993.1266; Matalon R, 1974, BIOCHEM BIOPH RES CO, V61, P709; Morquio L., 1929, B SOC PEDIAT PARIS, V27, P145; NAKASHIMA Y, 1994, GENOMICS, V20, P99, DOI 10.1006/geno.1994.1132; OGAWA T, 1995, HUM MOL GENET, V4, P341, DOI 10.1093/hmg/4.3.341; Orii T, 1981, CONNECT TISSUE RES, V13, P169; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; SCOTT HS, 1992, HUM GENET, V88, P701, DOI 10.1007/BF02265303; SUKEGAWA K, 1982, J INHERIT METAB DIS, V5, P231, DOI 10.1007/BF02179150; TOMATSU S, 1994, HUM MOL GENET, V3, P1208, DOI 10.1093/hmg/3.7.1208-a; TOMATSU S, 1995, HUM GENET, V95, P243; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; TOMATSU S, 1994, HUM MOL GENET, V3, P1427, DOI 10.1093/hmg/3.8.1427; TOMATSU S, 1995, HUM MOL GENET, V4, P741, DOI 10.1093/hmg/4.4.741; TOMATSU S, 1995, HUM GENET, V95, P376; Tomatsu S., 1992, American Journal of Human Genetics, V51, pA178; TOMATSU S, 1994, J INHERIT METAB DIS, V5, P169; TOMATSU S, IN PRESS HUM MUTAT; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; ZHANG ZF, 1993, AM J HUM GENET, V52, P1111	31	44	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					556	563						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668283				2022-12-18	WOS:A1995RR60500004
J	CHUN, K; MACKAY, N; PETROVABENEDICT, R; FEDERICO, A; FOIS, A; COLE, DEC; ROBERTSON, E; ROBINSON, BH				CHUN, K; MACKAY, N; PETROVABENEDICT, R; FEDERICO, A; FOIS, A; COLE, DEC; ROBERTSON, E; ROBINSON, BH			MUTATIONS IN THE X-LINKED E(1)ALPHA SUBUNIT OF PYRUVATE-DEHYDROGENASE - EXON SKIPPING, INSERTION OF DUPLICATE SEQUENCE, AND MISSENSE MUTATIONS LEADING TO THE DEFICIENCY OF THE PYRUVATE-DEHYDROGENASE COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E1-ALPHA SUBUNIT; LACTIC-ACIDOSIS; 4-NUCLEOTIDE INSERTION; NONSENSE MUTATION; 20-BP DELETION; MESSENGER-RNA; ALPHA-SUBUNIT; LOCUS DXS255; GENE; CHROMOSOME	Human pyruvate dehydrogenase (PDH)-complex deficiency is an inborn error of metabolism that is extremely heterogeneous in its presentation and clinical course. In a study of 14 patients (7 females and 7 males), we have found a mutation in the coding region of the E(1) alpha gene in all 14 patients. Two female patients had the same 7-bp deletion at nt 927; another female patient had a 3-bp deletion at nt 931. Another female patient was found to have a deletion of exon 6 in her cDNA. Two other female patients were found to have insertions, one of 13 bp at nt 981 and one of 46 bp at nucleotide 1078. Two male patients were found to have a 4-bp insertion at nucleotide 1163. The remaining six patients all had missense mutations. A male patient and a female patient both had an A1133G mutation. The other missense mutations were C214T, C615A, and C787G (two patients). Five of these mutations are novel mutations, five have been previously reported in other patients, and two were published observations in other patients in an Ela-mutation summary. In the four cases where parent DNA was available, only one mother was found to be a carrier of the same mutation as her child.	HOSP SICK CHILDREN, RES INST, TORONTO, ON M5G 1X8, CANADA; UNIV TORONTO, DEPT PAEDIAT, TORONTO, ON M5S 1A1, CANADA; UNIV TORONTO, DEPT BIOCHEM, TORONTO, ON, CANADA; UNIV SIENA, DEPT NEUROL, I-53100 SIENA, ITALY; UNIV SIENA, CHILDRENS HOSP, DEPT PAEDIAT, I-53100 SIENA, ITALY; DALHOUSIE UNIV, DEPT PATHOL, HALIFAX, NS, CANADA; DALHOUSIE UNIV, DEPT PAEDIAT, HALIFAX, NS, CANADA; IZAAK WALTON KILLAM HOSP CHILDREN, HALIFAX, NS B3J 3G9, CANADA; UNIV ADELAIDE, DEPT PAEDIAT, ADELAIDE, SA, AUSTRALIA; UNIV ADELAIDE, DEPT GENET, ADELAIDE, SA, AUSTRALIA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Siena; University of Siena; Dalhousie University; Dalhousie University; Dalhousie University; University of Adelaide; University of Adelaide				federico, antonio/0000-0002-5246-1621				AWATA H, 1994, J INHERIT METAB DIS, V17, P189, DOI 10.1007/BF00711616; BOURGERON T, 1992, BIOCHEM BIOPH RES CO, V186, P16, DOI 10.1016/S0006-291X(05)80769-7; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BROWN GK, 1989, ANN NY ACAD SCI, V573, P360, DOI 10.1111/j.1749-6632.1989.tb15011.x; BROWN GK, 1992, J INHERIT METAB DIS, V15, P625, DOI 10.1007/BF01799619; BROWN RM, 1993, J MED GENET, V30, P177, DOI 10.1136/jmg.30.3.177; BROWN RM, 1990, GENOMICS, V7, P215, DOI 10.1016/0888-7543(90)90543-4; CHUN K, 1991, AM J HUM GENET, V49, P414; CHUN K, 1993, HUM MOL GENET, V2, P449, DOI 10.1093/hmg/2.4.449; Dahl H.-H. M., 1992, Human Mutation, V1, P97, DOI 10.1002/humu.1380010203; DAHL HHM, 1994, HUM MUTAT, V3, P152, DOI 10.1002/humu.1380030210; DAHL HHM, 1990, AM J HUM GENET, V47, P286; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DEMEIRLEIR L, 1988, J BIOL CHEM, V263, P1991; DEMEIRLEIR LJ, 1991, J INHERIT METAB DIS, V14, P301, DOI 10.1007/BF01811687; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; ENDO H, 1991, J INHERIT METAB DIS, V14, P793, DOI 10.1007/BF01799952; ENDO H, 1989, AM J HUM GENET, V44, P358; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; FUKAO T, 1994, J CLIN INVEST, V93, P1035, DOI 10.1172/JCI117052; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; HANSEN LL, 1991, J INHERIT METAB DIS, V14, P140, DOI 10.1007/BF01800586; HANSEN LL, 1993, HUM MOL GENET, V2, P805, DOI 10.1093/hmg/2.6.805; HANSEN LL, 1994, HUM MOL GENET, V3, P1021, DOI 10.1093/hmg/3.6.1021; HAWKINS CF, 1989, FEBS LETT, V282, P209; HO L, 1989, ANN NY ACAD SCI, V573, P347, DOI 10.1111/j.1749-6632.1989.tb15010.x; ITO M, 1992, J INHERIT METAB DIS, V15, P848, DOI 10.1007/BF01800220; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; JAEGER JA, 1990, METHOD ENZYMOL, V183, P281; KERR DS, 1988, PEDIATR RES, V24, P95, DOI 10.1203/00006450-198807000-00022; KRAWCZAK M, 1992, HUM GENET, V90, P41; KRAWCZAK M, 1991, HUM GENET, V86, P425; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Maniatis T., 1982, MOL CLONING; MARAGOS C, 1989, J BIOL CHEM, V264, P12294; MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616; MATTHEWS PM, 1994, BRAIN, V117, P435, DOI 10.1093/brain/117.3.435; MATTHEWS PM, 1993, NEUROLOGY, V43, P2025, DOI 10.1212/WNL.43.10.2025; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; Randle P J, 1978, Biochem Soc Symp, P47; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; RICKETTS MH, 1987, P NATL ACAD SCI USA, V84, P3181, DOI 10.1073/pnas.84.10.3181; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROBINSON BH, 1989, ADV HUM GENET, V18, P151; ROBINSON BH, 1989, ANN NY ACAD SCI, V573, P337, DOI 10.1111/j.1749-6632.1989.tb15009.x; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1990, J CLIN INVEST, V85, P1821, DOI 10.1172/JCI114641; ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9; ROBINSON BH, 1993, FEBS LETT, V328, P99, DOI 10.1016/0014-5793(93)80973-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; TAKAKUBO F, 1993, HUM MOL GENET, V2, P473, DOI 10.1093/hmg/2.4.473; TAKAKUBO F, 1993, HUM MOL GENET, V2, P1961, DOI 10.1093/hmg/2.11.1961; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WEXLER ID, 1992, PEDIATR RES, V32, P169, DOI 10.1203/00006450-199208000-00009; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	61	44	46	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					558	569						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887409				2022-12-18	WOS:A1995QK91800002
J	DAHL, HHM				DAHL, HHM			PYRUVATE-DEHYDROGENASE E1-ALPHA DEFICIENCY - MALES AND FEMALES DIFFER YET AGAIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							X-CHROMOSOME INACTIVATION; E1-ALPHA SUBUNIT; LACTIC-ACIDOSIS; COMPLEX DEFICIENCY; 4-NUCLEOTIDE INSERTION; 20-BP DELETION; GENE; MUTATION; DEFECTS; FIBROBLASTS				DAHL, HHM (corresponding author), ROYAL CHILDRENS HOSP, MURDOCH INST, FLEMINGTON RD, MELBOURNE, VIC 3052, AUSTRALIA.							AWATA H, 1994, J INHERIT METAB DIS, V17, P189, DOI 10.1007/BF00711616; BROWN GK, 1987, J INHERIT METAB DIS, V10, P359, DOI 10.1007/BF01799978; BROWN GK, 1989, ANN NY ACAD SCI, V573, P360, DOI 10.1111/j.1749-6632.1989.tb15011.x; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603; BROWN GK, 1992, J INHERIT METAB DIS, V15, P625, DOI 10.1007/BF01799619; BROWN RM, 1993, J MED GENET, V30, P177, DOI 10.1136/jmg.30.3.177; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; BROWN RM, 1994, PRENATAL DIAG, V14, P435, DOI 10.1002/pd.1970140604; CHUN K, 1995, AM J HUM GENET, V56, P558; CHUN K, 1991, AM J HUM GENET, V49, P414; CHUN K, 1993, HUM MOL GENET, V2, P449, DOI 10.1093/hmg/2.4.449; Dahl H.-H. M., 1992, Human Mutation, V1, P97, DOI 10.1002/humu.1380010203; DAHL HHM, 1994, HUM MUTAT, V3, P152, DOI 10.1002/humu.1380030210; DAHL HHM, 1992, J INHERIT METAB DIS, V15, P835, DOI 10.1007/BF01800219; DAHL HHM, 1990, AM J HUM GENET, V47, P286; DEMEIRLEIR L, 1992, HUM GENET, V88, P649, DOI 10.1007/BF02265291; DEMEIRLEIR L, 1993, PEDIATR NEUROL, V9, P216, DOI 10.1016/0887-8994(93)90088-T; DEMEIRLEIR LJ, 1991, J INHERIT METAB DIS, V14, P301, DOI 10.1007/BF01811687; DEVIVO DC, 1991, MODERN PERSPECTIVES, P27; ENDO H, 1991, J INHERIT METAB DIS, V14, P793, DOI 10.1007/BF01799952; ENDO H, 1989, AM J HUM GENET, V44, P358; FUJII T, 1994, ANN NEUROL, V36, P83, DOI 10.1002/ana.410360116; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; HANSEN LL, 1991, J INHERIT METAB DIS, V14, P140, DOI 10.1007/BF01800586; HANSEN LL, 1993, HUM MOL GENET, V2, P805, DOI 10.1093/hmg/2.6.805; HANSEN LL, 1994, HUM MOL GENET, V3, P1021, DOI 10.1093/hmg/3.6.1021; HO L, 1989, ANN NY ACAD SCI, V573, P347, DOI 10.1111/j.1749-6632.1989.tb15010.x; ITO M, 1992, J INHERIT METAB DIS, V15, P848, DOI 10.1007/BF01800220; KERR DS, 1988, PEDIATR RES, V24, P95, DOI 10.1203/00006450-198807000-00022; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616; MATTHEWS PM, 1994, BRAIN, V117, P435, DOI 10.1093/brain/117.3.435; MATTHEWS PM, 1993, NEUROLOGY, V43, P2025, DOI 10.1212/WNL.43.10.2025; OLD SE, 1989, ANN NEUROL, V26, P746, DOI 10.1002/ana.410260610; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROBINSON BH, 1989, ANN NY ACAD SCI, V573, P337, DOI 10.1111/j.1749-6632.1989.tb15009.x; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1990, J CLIN INVEST, V85, P1821, DOI 10.1172/JCI114641; TAKAKUBO F, 1994, DEV BRAIN RES, V77, P63, DOI 10.1016/0165-3806(94)90214-3; TAKAKUBO F, 1993, HUM MOL GENET, V2, P473, DOI 10.1093/hmg/2.4.473; TAKAKUBO F, 1993, HUM MOL GENET, V2, P1961, DOI 10.1093/hmg/2.11.1961; WEXLER ID, 1992, PEDIATR RES, V32, P169, DOI 10.1203/00006450-199208000-00009; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336	46	44	45	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					553	557						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887408				2022-12-18	WOS:A1995QK91800001
J	THOMAS, GH				THOMAS, GH			PSEUDODEFICIENCIES OF LYSOSOMAL HYDROLASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARYLSULFATASE-A PSEUDODEFICIENCY; ALPHA-L-FUCOSIDASE; TAY-SACHS CARRIERS; METACHROMATIC LEUKODYSTROPHY; HEXOSAMINIDASE-A; BETA-HEXOSAMINIDASE; ENZYME-ACTIVITY; PRENATAL-DIAGNOSIS; NORMAL INDIVIDUALS; MOLECULAR-BASIS		JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	THOMAS, GH (corresponding author), KENNEDY KRIEGER INST,ROOM 503,707 N BROADWAY,BALTIMORE,MD 21205, USA.				NICHD NIH HHS [NICHD HD24605] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALHADEFF JA, 1978, BIOCHEM MED METAB B, V20, P357, DOI 10.1016/0006-2944(78)90083-2; BACH G, 1982, CLIN GENET, V21, P59; BALDINGER S, 1987, CLIN GENET, V31, P70; BARTH ML, 1993, HUM GENET, V91, P73; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BISHOP DF, 1981, AM J HUM GENET S, V33, P71; CAO Z, 1993, AM J HUM GENET, V53, P1198; CHABAS A, 1991, J INHERIT METAB DIS, V14, P908, DOI 10.1007/BF01800472; CLARKE JTR, 1971, NEW ENGL J MED, V284, P233, DOI 10.1056/NEJM197102042840503; DESNICK RJ, 1992, PRENATAL DIAG, V12, P357, DOI 10.1002/pd.1970120505; DLOTT B, 1990, J BIOL CHEM, V265, P17921; DREYFUS JC, 1977, AM J HUM GENET, V29, P287; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; DUBOIS G, 1977, AM J HUM GENET, V29, P191; FRANCIS GS, 1993, ANN NEUROL, V34, P212, DOI 10.1002/ana.410340218; GATTI R, 1985, PRENATAL DIAG, V5, P149, DOI 10.1002/pd.1970050209; GIESELMANN V, 1991, HUM GENET, V86, P251; GIESELMANN V, 1991, AM J HUM GENET, V49, P407; GIESELMANN V, 1989, P NATL ACAD SCI USA, V86, P9436, DOI 10.1073/pnas.86.23.9436; GIESELMANN V, 1991, DEV NEUROSCI-BASEL, V13, P222, DOI 10.1159/000112164; GREBNER EE, 1986, AM J HUM GENET, V38, P505; HERSKA M, 1987, AM J MED GENET, V26, P629, DOI 10.1002/ajmg.1320260318; HERZ B, 1984, HUM GENET, V66, P147, DOI 10.1007/BF00286589; HOHENSCHUTZ C, 1989, HUM GENET, V82, P45, DOI 10.1007/BF00288270; KAPPLER J, 1991, DEV NEUROSCI-BASEL, V13, P228, DOI 10.1159/000112165; KAPPLER J, 1991, HUM GENET, V86, P463; KAPPLER J, 1991, EUR J PEDIATR, V150, P287, DOI 10.1007/BF01955534; KELLY TE, 1976, CLIN GENET, V9, P540; KIHARA H, 1984, PEDIATR RES, V18, P1021, DOI 10.1203/00006450-198418100-00022; LI ZG, 1992, AM J MED GENET, V43, P976, DOI 10.1002/ajmg.1320430614; Mules Emilie H., 1992, Human Mutation, V1, P298, DOI 10.1002/humu.1380010406; NAVON R, 1986, AM J MED GENET, V24, P179, DOI 10.1002/ajmg.1320240123; NELSON PV, 1991, HUM GENET, V87, P87, DOI 10.1007/BF01213099; NISHIMOTO J, 1988, CLIN GENET, V33, P254; OBRIEN JS, 1978, AM J HUM GENET, V30, P602; PENZIEN JM, 1993, AM J HUM GENET, V52, P557; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; RAMAGE P, 1975, BIOCHIM BIOPHYS ACTA, V403, P473, DOI 10.1016/0005-2744(75)90075-3; SCHAAP T, 1981, AM J HUM GENET, V33, P531; SHEN N, 1993, AM J MED GENET, V45, P631, DOI 10.1002/ajmg.1320450523; TAYLOR HA, 1993, J INHERIT METAB DIS, V16, P1058, DOI 10.1007/BF00711533; THOMAS GH, 1982, PEDIATR RES, V16, P232, DOI 10.1203/00006450-198203000-00014; TOMCZAK J, 1993, AM J HUM GENET, V53, P537; TONNESEN T, 1983, ACTA PAEDIATR SCAND, V72, P175, DOI 10.1111/j.1651-2227.1983.tb09692.x; TRIGGSRAINE BL, 1992, AM J HUM GENET, V51, P793; TURNER BM, 1975, AM J HUM GENET, V27, P651; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; WAUTERS JG, 1992, BIOCHEM GENET, V30, P131, DOI 10.1007/BF02399704; WENGER DA, 1991, DEV NEUROSCI-BASEL, V13, P216, DOI 10.1159/000112163; WENGER DA, 1976, J PEDIATR-US, V88, P76, DOI 10.1016/S0022-3476(76)80732-9; WHITLEY CB, 1987, AM J MED GENET, V28, P233, DOI 10.1002/ajmg.1320280136; WILLEMS PJ, 1991, AM J MED GENET, V38, P111, DOI 10.1002/ajmg.1320380125; WOOD S, 1976, J LAB CLIN MED, V88, P469; ZLOTOGORA J, 1985, LANCET, V2, P1296; ZLOTOGORA J, 1983, AM J MED GENET, V14, P73, DOI 10.1002/ajmg.1320140112	56	44	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					934	940						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	7911004				2022-12-18	WOS:A1994NP05300002
J	BRZUSTOWICZ, LM; ALLITTO, BA; MATSEOANE, D; THEVE, R; MICHAUD, L; CHATKUPT, S; SUGARMAN, E; PENCHASZADEH, GK; SUSLAK, L; KOENIGSBERGER, MR; GILLIAM, TC; HANDELIN, BL				BRZUSTOWICZ, LM; ALLITTO, BA; MATSEOANE, D; THEVE, R; MICHAUD, L; CHATKUPT, S; SUGARMAN, E; PENCHASZADEH, GK; SUSLAK, L; KOENIGSBERGER, MR; GILLIAM, TC; HANDELIN, BL			PATERNAL ISODISOMY FOR CHROMOSOME-5 IN A CHILD WITH SPINAL MUSCULAR-ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; NORMAL DAUGHTER; LOCUS; TRANSLOCATION; TRANSMISSION; ASSOCIATION; MECHANISM; MOTHER; GENE	Paternal isodisomy for chromosome 5 was detected in a 2-year-old boy with type III spinal muscular atrophy (SMA), an autosomal recessive degenerative disorder of alpha motor neurons, known to map to 5q11.2-13.3. Examination of 17 short-sequence repeat polymorphisms spanning 5p15.1-15.3 to 5q33.3-qter produced no evidence of maternally inherited alleles. Cytogenetic analysis revealed a normal male karyotype, and FISH with probes closely flanking the SMA locus confirmed the presence of two copies of chromosome 5. No developmental abnormalities, other than those attributable to classical childhood-onset SMA, were present. While the absence of a maternally derived chromosome 5 could have produced the symptoms of SMA through the mechanism of genomic imprinting, the lack of more global developmental abnormalities would be unusual. Paternal transmission of two copies of a defective gene at the SMA locus seems to be the most likely cause of disease, but proof of this will have to await the identification of the SMA gene. While uniparental isodisomy is a rare event, it must be considered as a possible mechanism involved in SMA when conducting prenatal testing and counseling for this disorder.	COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY; INTEGRATED GENET INC,FRAMINGHAM,MA 01701; UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT NEUROSCI,NEWARK,NJ 07103; UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT PEDIAT,NEWARK,NJ 07103	Columbia University; New York State Psychiatry Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	BRZUSTOWICZ, LM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,UNIT 58,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029893] Funding Source: NIH RePORTER; NCRR NIH HHS [S07 RR05393] Funding Source: Medline; NINDS NIH HHS [R29 NS29893, 1R01 NS8877-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELDJORD C, 1992, BLOOD, V80, P287; BENNETT P, 1992, LANCET, V340, P1284, DOI 10.1016/0140-6736(92)92980-T; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; Brooke MH, 1985, CLIN VIEW NEUROMUSCU, P36; BRZUSTOWICZ LM, 1992, GENOMICS, V13, P991, DOI 10.1016/0888-7543(92)90012-H; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; DANIELS RJ, 1992, GENOMICS, V12, P335, DOI 10.1016/0888-7543(92)90382-3; DWORNICZAK B, 1992, LANCET, V340, P1285; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; GILLIAM TC, 1992, MOL GENETIC BASIS NE, P883; HALL JG, 1990, AM J HUM GENET, V46, P857; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; KLINGER K, 1992, AM J HUM GENET, V51, P55; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Maniatis T., 1982, MOL CLONING; MANKOO BS, 1991, NUCLEIC ACIDS RES, V19, P1963, DOI 10.1093/nar/19.8.1963-a; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MORRISON KE, 1992, AM J HUM GENET, V50, P520; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; PALMER CG, 1980, CLIN GENET, V17, P418; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEARN JH, 1973, BRAIN, V96, P463, DOI 10.1093/brain/96.3.463; PEARN JH, 1978, BRAIN, V101, P591, DOI 10.1093/brain/101.4.591; PENTAO L, 1992, AM J HUM GENET, V50, P690; SHERRINGTON R, 1991, AM J HUM GENET, V49, P966; SOARES VM, 1993, GENOMICS, V15, P365, DOI 10.1006/geno.1993.1069; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; VOSS R, 1989, AM J HUM GENET, V45, P373; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760; WILLATT LR, 1992, J MED GENET, V29, P742, DOI 10.1136/jmg.29.10.742	37	44	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					482	488						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116617				2022-12-18	WOS:A1994MZ15800011
J	HAGIWAR, Y; NISHIO, H; KITOH, Y; TAKESHIMA, Y; NARITA, N; WADA, H; YOKOYAMA, M; NAKAMURA, H; MATSUO, M				HAGIWAR, Y; NISHIO, H; KITOH, Y; TAKESHIMA, Y; NARITA, N; WADA, H; YOKOYAMA, M; NAKAMURA, H; MATSUO, M			A NOVEL POINT MUTATION (G(-1) TO T) IN A 5' SPLICE DONOR SITE OF INTRON-13 OF THE DYSTROPHIN GENE RESULTS IN EXON SKIPPING AND IS RESPONSIBLE FOR BECKER MUSCULAR-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; SYNDROME TYPE-VII; NONMUSCLE TISSUES; NONSENSE MUTATION; DUCHENNE; DELETION; PROTEIN; TRANSCRIPT; EXPRESSION; PATIENT	The mutations in one-third of Duchenne and Becker muscular dystrophy patients remain unknown, as they do not involve gross rearrangements of the dystrophin gene. We now report a defect in the splicing of precursor mRNA (pre-mRNA), resulting from a maternally inherited mutation of the dystrophin gene in a patient with Becker muscular dystrophy. This defect results from a G-to-T transversion at the terminal nucleotide of exon 13, within the 5' splice site of intron 13, and causes complete skipping of exon 13 during processing of dystrophin pre-mRNA. The predicted polypeptide encoded by the aberrant mRNA is a truncated dystrophin lacking 40 amino acids from the amino-proximal end of the rod domain. This is the first report of an intraexon point mutation that completely inactivates a 5' splice donor site in dystrophin pre-mRNA. Analysis of the genomic context of the G-1-to-T mutation at the 5' splice site supports the exon-definition model of pre-mRNA splicing and contributes to the understanding of splice-site selection.	KOBE UNIV,SCH MED,INT CTR MED RES,7-5-1 KUSUNOKICHO,KOBE 650,JAPAN; KOBE UNIV,SCH MED,DEPT PEDIAT,KOBE 650,JAPAN; KOBE UNIV,SCH MED,DEPT INTERNAL MED 1,KOBE 650,JAPAN	Kobe University; Kobe University; Kobe University								AKLI S, 1990, J BIOL CHEM, V265, P7324; ANDREWS LG, 1992, J BIOL CHEM, V267, P7834; BEGGS AH, 1990, HUM GENET, V86, P45; BERG LP, 1992, GENOMICS, V13, P1359, DOI 10.1016/0888-7543(92)90070-9; Blake Derek J., 1992, Human Molecular Genetics, V1, P103, DOI 10.1093/hmg/1.2.103; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; CHAMBERLAIN JS, 1991, PRC PROTOCOLS GUIDE, V10, P457; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLEMENS PR, 1992, NEUROLOGY, V42, P1775, DOI 10.1212/WNL.42.9.1775; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KILIMANN MW, 1992, HUM GENET, V89, P253; KITOH Y, 1992, AM J MED GENET, V42, P453, DOI 10.1002/ajmg.1320420408; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; MANIATIS T, 1991, SCIENCE, V251, P33, DOI 10.1126/science.1824726; MATSUO M, 1990, BIOCHEM BIOPH RES CO, V170, P963, DOI 10.1016/0006-291X(90)92185-3; MATSUO M, 1991, J CLIN INVEST, V87, P2127, DOI 10.1172/JCI115244; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NAKAJIMA T, 1991, J NEUROL, V238, P6, DOI 10.1007/BF00319701; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; NIGRO V, 1992, HUM MOL GENET, V1, P517, DOI 10.1093/hmg/1.7.517; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; PRIOR TW, 1993, HUM MOL GENET, V2, P311, DOI 10.1093/hmg/2.3.311; PRIOR TW, 1993, HUM MUTAT, V2, P192, DOI 10.1002/humu.1380020307; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; ROBERTS RG, 1993, HUM MOL GENET, V2, P75, DOI 10.1093/hmg/2.1.75; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; SAAD FA, 1993, HUM MUTAT, V2, P314, DOI 10.1002/humu.1380020413; Saad Fawzy, 1992, Human Molecular Genetics, V1, P345, DOI 10.1093/hmg/1.5.345; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHERRATT TG, 1992, BIOCHEM J, V287, P755, DOI 10.1042/bj2870755; VAINZOF M, 1993, HUM MOL GENET, V2, P39, DOI 10.1093/hmg/2.1.39; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; WEIL D, 1989, J BIOL CHEM, V264, P16804; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WINNARD AV, 1992, HUM MOL GENET, V1, P645, DOI 10.1093/hmg/1.8.645	47	44	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					53	61						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279470				2022-12-18	WOS:A1994MQ70000008
J	TSUJINO, S; SHANSKE, S; NONAKA, I; ETO, Y; MENDELL, JR; FENICHEL, GM; DIMAURO, S				TSUJINO, S; SHANSKE, S; NONAKA, I; ETO, Y; MENDELL, JR; FENICHEL, GM; DIMAURO, S			3 NEW MUTATIONS IN PATIENTS WITH MYOPHOSPHORYLASE DEFICIENCY (MCARDLE DISEASE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE CODON DELETION; GLYCOGEN-PHOSPHORYLASE; PROPIONIC ACIDEMIA; AMPLIFIED CDNA; GENE; IDENTIFICATION; RESOLUTION; CLEAVAGE; PROTEINS; SUBUNIT	We report three new mutations in patients with myophosphorylase deficiency (McArdle disease). A splice-junction mutation (G-to-A transition at the 5' end of intron 14) and a missense mutation (CTG to CCG at codon 291, changing an encoded leucine to a proline) were identified in Caucasian patients who were heterozygous for a common mutation reported elsewhere (CGA [Arg] to TGA [stop]) at codon 49. The splice-junction mutation destroyed the consensus sequence at the 5' splice site, and a cryptic splice site 67 bp upstream was recognized instead. As a result, there was a 67-bp deletion in the 3'-terminal region of exon 14 in the transcript, resulting in a frameshift with premature translation termination. A deletion of a single codon, 708/709 (TTC, specifying phenylalanine) was identified in Japanese patients. Two affected siblings were homozygotes, and their parents were heterozygotes. A third, unrelated patient was heterozygous for the same mutation, while the myophosphorylase gene on the other allele was only faintly expressed.	COLUMBIA PRESBYTERIAN MED CTR, COLL PHYS & SURG 4-420, DEPT NEUROL, NEW YORK, NY 10032 USA; MUSASHI HOSP, NATL CTR NEUROL & PSYCHIAT, TOKYO, JAPAN; JIKEI UNIV SCH MED, DEPT PEDIAT, DIV MED GENET & ENDOCRINOL, TOKYO 105, JAPAN; OHIO STATE UNIV HOSP, DEPT NEUROL, COLUMBUS, OH 43210 USA; VANDERBILT UNIV, DEPT NEUROL, NASHVILLE, TN 37240 USA	Columbia University; NewYork-Presbyterian Hospital; National Center for Neurology & Psychiatry - Japan; Jikei University; Ohio State University; Vanderbilt University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 11766] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; BARTRAM C, 1993, HUM MOL GENET, V2, P1291, DOI 10.1093/hmg/2.8.1291; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURKE J, 1987, PROTEINS, V2, P177, DOI 10.1002/prot.340020303; CURIEL DT, 1989, J BIOL CHEM, V264, P13938; DAVIDSON BL, 1989, J CLIN INVEST, V84, P342, DOI 10.1172/JCI114160; FRAIZER GC, 1989, AM J HUM GENET, V44, P894; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; HANSEN LL, 1991, J INHERIT METAB DIS, V14, P140, DOI 10.1007/BF01800586; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMHONWAH AM, 1990, GENOMICS, V8, P249, DOI 10.1016/0888-7543(90)90279-4; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; LEVRAN O, 1991, J CLIN INVEST, V88, P806, DOI 10.1172/JCI115380; LOCKYER JM, 1991, J BIOL CHEM, V266, P20262; MAEKAWA K, 1984, Acta Paediatrica Japonica, V26, P10; MCARDLE B, 1951, CLIN SCI, V10, P12; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; RABEN N, 1993, J BIOL CHEM, V268, P4963; SCHMID R, 1959, J CLIN INVEST, V38, P2044, DOI 10.1172/JCI103983; SHANSKE S, 1987, J BIOL CHEM, V262, P14612; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; SPRANG S, 1979, J MOL BIOL, V131, P523, DOI 10.1016/0022-2836(79)90006-8; TAHARA T, 1990, P NATL ACAD SCI USA, V87, P1372, DOI 10.1073/pnas.87.4.1372; TSUJINO S, 1993, NEW ENGL J MED, V329, P241, DOI 10.1056/NEJM199307223290404	30	44	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					44	52						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279469				2022-12-18	WOS:A1994MQ70000007
J	JUVONEN, V; VILKKI, J; AULA, P; NIKOSKELAINEN, E; SAVONTAUS, ML				JUVONEN, V; VILKKI, J; AULA, P; NIKOSKELAINEN, E; SAVONTAUS, ML			REEVALUATION OF THE LINKAGE OF AN OPTIC ATROPHY SUSCEPTIBILITY GENE TO X-CHROMOSOMAL MARKERS IN FINNISH FAMILIES WITH LEBER HEREDITARY OPTIC NEURORETINOPATHY (LHON)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NEUROPATHY; MUTATION; PEDIGREES		INST PLANT BREEDING,JOKIOINEN,FINLAND; UNIV TURKU,DEPT GENET,SF-20500 TURKU 50,FINLAND; UNIV TURKU,CENT HOSP,DEPT OPHTHALMOL,SF-20520 TURKU 52,FINLAND	University of Turku; University of Turku	JUVONEN, V (corresponding author), UNIV TURKU,DEPT MED GENET,SF-20500 TURKU 50,FINLAND.				NEI NIH HHS [1-RO EY409040-01] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLACK GCM, 1991, NUCLEIC ACIDS RES, V19, P689; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089; CHEN JD, 1989, HUM GENET, V82, P203, DOI 10.1007/BF00291154; CHEN JD, 1991, AM J HUM GENET, V49, P692; CHEN ZY, 1991, CYTOGENET CELL GENET, V58, P2059; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; KONRADI C, 1992, GENOMICS, V12, P176, DOI 10.1016/0888-7543(92)90426-S; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; SWEENEY MG, 1992, AM J HUM GENET, V51, P741; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VILKKI J, 1990, AM J HUM GENET, V47, P95; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	16	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					289	292						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317495				2022-12-18	WOS:A1993LJ38500032
J	MISEREZ, AR; SCHUSTER, H; CHIODETTI, N; KELLER, U				MISEREZ, AR; SCHUSTER, H; CHIODETTI, N; KELLER, U			POLYMORPHIC HAPLOTYPES AND RECOMBINATION RATES AT THE LDL RECEPTOR GENE LOCUS IN SUBJECTS WITH AND WITHOUT FAMILIAL HYPERCHOLESTEROLEMIA WHO ARE FROM DIFFERENT POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; FRAGMENT LENGTH POLYMORPHISMS; ALU-ALU RECOMBINATION; DNA POLYMORPHISM; NONUNIFORM RECOMBINATION; CLUSTER; MUTATION; EXONS; DISEQUILIBRIUM; ASSOCIATION	RFLPs at the low-density lipoprotein (LDL) receptor locus for TaqI, StuI, HincII, AvaII, ApaLI (5' and 3'), PvuII, and NcoI were studied in Swiss and German families with familial hypercholesterolemia (FH). A total of 1,104 LDL receptor alleles were analyzed using Southern blotting and new PCR-based techniques for detection of the TaqI, StuI, HincII, AvaII, NcoI RFLPs. Two hundred fifty-six independent haplotypes f rom 368 individuals of 61 unrelated Swiss families, as well as 114 independent haplotypes from 184 subjects of 25 unrelated German families, were constructed. In 76 families, clinical diagnosis of FH was confirmed by cosegregation analysis. Of the 43 unique haplotypes consisting of seven RFLPs detected in the Swiss and Germans, only 9 were common in both population samples. Analysis of linkage disequilibrium revealed nonrandom associations between several of the investigated RFLPs. ApaLI (5'), NcoI, PvuII, TaqI, and AvaII or HincII were particularly informative (cumulative informativeness .85). Relative frequencies, heterozygosity indexes, and PICs of the RFLPs from the Swiss and Germans were compared with values calculated from reported haplotype data for Italians, Icelanders, North American Caucasians, South African Caucasians, and Japanese. Pairwise comparisons of population samples by common RFLPs demonstrated unexpected differences even between geographically adjacent populations (e.g., the Swiss and Germans). Furthermore, genetic distances from the Germans to the other Caucasians were larger than to the Japanese. An unexpected lack of correlation between linkage disequilibria and physical distances was detected for the German and Japanese data, possibly because of nonuniform recombination with excessively high rates between exon 13 and intron 15. Hence, the present study revealed a striking variety of polymorphic haplotypes and heterogeneity of RFLP frequencies and recombination rates among the seven population samples.	UNIV HOSP BASEL, DEPT INTERNAL MED, CH-4031 BASEL, SWITZERLAND; UNIV MUNICH, MED POLIKLIN, W-8000 MUNICH 2, GERMANY	University of Basel; University of Munich	MISEREZ, AR (corresponding author), UNIV HOSP BASEL, DEPT RES, PETERSGRABER 4, CH-4031 BASEL, SWITZERLAND.		Miserez, André R./A-8581-2008					AALTOSETALA K, 1989, J CLIN INVEST, V84, P499, DOI 10.1172/JCI114192; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BLAND M, 1989, INTRO MED STATISTICS, P245; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRINK PA, 1987, HUM GENET, V77, P32, DOI 10.1007/BF00284709; BROWN MS, 1991, PRINCIPLES INTERNAL, P1814; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAKRAVARTI A, 1985, AM J HUM GENET, V37, P984; DAGA A, 1990, HUM GENET, V84, P412; Falconer D. S., 1989, Introduction to quantitative genetics.; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOBBS HH, 1988, J CLIN INVEST, V81, P909, DOI 10.1172/JCI113402; HOBBS HH, 1987, NUCLEIC ACIDS RES, V15, P379, DOI 10.1093/nar/15.1.379; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HORSTHEMKE B, 1987, EUR J BIOCHEM, V164, P77, DOI 10.1111/j.1432-1033.1987.tb10995.x; HUDSON RR, 1985, GENETICS, V111, P147; HUMPHRIES S, 1989, ARTERIOSCLEROSIS, V9, pI59; HUMPHRIES SE, 1985, LANCET, V1, P1003; INGRAM D, 1984, MATH METHODS MED, V1; KOTZE MJ, 1989, S AFR MED J, V76, P402; KOTZE MJ, 1989, J MED GENET, V26, P255, DOI 10.1136/jmg.26.4.255; KOTZE MJ, 1987, NUCLEIC ACIDS RES, V15, P376, DOI 10.1093/nar/15.1.376; KOTZE MJ, 1986, S AFR MED J, V70, P77; KOTZE MJ, 1989, S AFR MED J, V76, P399; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; LEITERSDORF E, 1988, NUCLEIC ACIDS RES, V16, P7215, DOI 10.1093/nar/16.14.7215; LEITERSDORF E, 1987, NUCLEIC ACIDS RES, V15, P2782, DOI 10.1093/nar/15.6.2782; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LEWONTIN RC, 1964, GENETICS, V49, P49; LITT M, 1986, AM J HUM GENET, V39, P166; MA YH, 1989, CLIN GENET, V36, P219; MANTEL N, 1967, CANCER RES, V27, P209; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEI M, 1982, EVOLUTIONARY BIOL, P1; OHTA T, 1969, GENETICS, V63, P229; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; SCHUSTER H, 1989, HUM GENET, V82, P69, DOI 10.1007/BF00288276; SCHUSTER H, 1992, ANAL BIOCHEM, V204, P22, DOI 10.1016/0003-2697(92)90133-R; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; SPENGEL FA, 1982, ANN NUTR METAB, V26, P240, DOI 10.1159/000176569; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; SVED J A, 1971, Theoretical Population Biology, V2, P125; TAYLOR R, 1989, J MED GENET, V26, P494, DOI 10.1136/jmg.26.8.494; TRECO D, 1985, MOL CELL BIOL, V5, P2029, DOI 10.1128/MCB.5.8.2029; WEIR BS, 1986, AM J HUM GENET, V38, P776; YAMAKAWA K, 1991, HUM GENET, V86, P445; YAMAKAWA K, 1987, NUCLEIC ACIDS RES, V15, P7659, DOI 10.1093/nar/15.18.7659; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; ZERBA KE, 1991, GENETICS, V129, P525	60	44	44	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					808	826						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8096361				2022-12-18	WOS:A1993KY05900022
J	MULLEY, JC; KOZMAN, HM; PHILLIPS, HA; GEDEON, AK; MCCURE, JA; ILES, DE; GREGG, RG; HOGAN, K; COUCH, FJ; MACLENNAN, DH; HAAN, EA				MULLEY, JC; KOZMAN, HM; PHILLIPS, HA; GEDEON, AK; MCCURE, JA; ILES, DE; GREGG, RG; HOGAN, K; COUCH, FJ; MACLENNAN, DH; HAAN, EA			REFINED GENETIC LOCALIZATION FOR CENTRAL CORE DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALIGNANT HYPERTHERMIA SUSCEPTIBILITY; DINUCLEOTIDE REPEAT POLYMORPHISM; RYANODINE RECEPTOR GENE; LINKAGE; LOCUS; CHROMOSOME-19; MUTATION	Central core disease (CCO) is an autosomal dominant myopathy clinically distinct from malignant hyperthermia (MHS). In a large kindred in which the gene for CCO is segregating, two-point linkage analysis gave a maximum lod score, between the central core disease locus (CCO) and the ryanodine receptor locus (RYR1), of 11.8, with no recombination. Mutation within RYR1 is responsible for MHS, and RYR1 is also a candidate locus for CCO. A combination of physical mapping using a radiation-induced human-hamster hybrid panel and of multipoint linkage analysis using the Centre d'Etude du Polymorphisme Humain families established the marker order and sex-average map distances (in centimorgans) on the background map as D19S75-(5.2)-D19S9-(3.4)-D19S191-(2.2)-RYR1-(1.7)-D19S190-(1.6)-D19S47-(2.0)-CYP2B. Recombination was observed between CCO and the markers flanking RYR1. These linkage data are consistent with the hypothesis that CCO and RYR1 are allelic. The most likely position for CCO is near RYR1, with a multipoint lod score of 11.4, in 19q13.1 between D19S191 and D19S190, within the same interval as MHS (RYR1).	ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET & EPIDEMIOL,ADELAIDE,SA 5006,AUSTRALIA; CATHOLIC UNIV NIJMEGEN,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS; UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT & HUMAN DEV,MADISON,WI 53706; UNIV TORONTO,BANTING & BEST DEPT MED RES,TORONTO M5S 1A1,ONTARIO,CANADA	Radboud University Nijmegen; University of Wisconsin System; University of Wisconsin Madison; University of Toronto	MULLEY, JC (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Gedeon, Agi/G-7890-2011	Gregg, Ronald/0000-0001-5805-224X				BYRNE E, 1982, J NEUROL SCI, V53, P77, DOI 10.1016/0022-510X(82)90081-8; COUCH FJ, 1991, NUCLEIC ACIDS RES, V19, P5094, DOI 10.1093/nar/19.18.5094; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; FAGERLUND T, 1992, CLIN GENET, V41, P270; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; HAAN EA, 1990, HUM GENET, V86, P187; HOGAN K, 1992, ANESTH ANALG, V75, P441; ILES DE, 1992, GENOMICS, V14, P749, DOI 10.1016/S0888-7543(05)80179-X; ILES DE, 1992, NUCLEIC ACIDS RES, V20, P1170; KAUSCH K, 1991, GENOMICS, V10, P765, DOI 10.1016/0888-7543(91)90461-M; KOZMAN HM, IN PRESS CYTOGENET C; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MULLEY JC, 1987, AM J MED GENET, V27, P435, DOI 10.1002/ajmg.1320270222; MULLEY JC, 1991, J MED GENET, V28, P448, DOI 10.1136/jmg.28.7.448; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4639, DOI 10.1093/nar/18.15.4639-a; WEBER JL, 1989, AM J HUM GENET, V44, P388	23	44	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					398	405						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430700				2022-12-18	WOS:A1993KN27500018
J	WILLEMS, PJ; VITS, L; RAEYMAEKERS, P; BEUTEN, J; COUCKE, P; HOLDEN, JJA; VAN BROECKHOVEN, C; WARREN, ST; SAGI, M; ROBINSON, D; DENNIS, N; FRIEDMAN, KJ; MAGNAY, D; LYONNET, S; WHITE, BN; WITTWER, BH; AYLSWORTH, AS; REICKE, S				WILLEMS, PJ; VITS, L; RAEYMAEKERS, P; BEUTEN, J; COUCKE, P; HOLDEN, JJA; VAN BROECKHOVEN, C; WARREN, ST; SAGI, M; ROBINSON, D; DENNIS, N; FRIEDMAN, KJ; MAGNAY, D; LYONNET, S; WHITE, BN; WITTWER, BH; AYLSWORTH, AS; REICKE, S			FURTHER LOCALIZATION OF X-LINKED HYDROCEPHALUS IN THE CHROMOSOMAL REGION-XQ28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL ADHESION MOLECULE; MASA SYNDROME; MENTAL-RETARDATION; LINKAGE ANALYSIS; SPASTIC PARAPLEGIA; PHYSICAL MAP; DXS52 LOCUS; DNA PROBES; GENE; XQ28	X-linked hydrocephalus (HSAS) is the most frequent genetic form of hydrocephalus. Clinical symptoms of HSAS include hydrocephalus, mental retardation, clasped thumbs, and spastic paraparesis. Recently we have assigned the HSAS gene to Xq28 by linkage analysis. In the present study we used a panel of 18 Xq27-q28 marker loci to further localize the HSAS gene in 13 HSAS families of different ethnic origins. Among the Xq27-q28 marker loci used, DXS52, DXS15, and F8C gave the highest combined lod scores, of 14.64, 6.53 and 6.33, respectively, at recombination fractions of .04, 0, and .05, respectively. Multipoint linkage analysis localizes the HSAS gene in the telomeric part of the Xq28 region, with a maximal lod score of 20.91 at 0.5 cM distal to DXS52. Several recombinations between the HSAS gene and the Xq28 markers DXS455, DXS304, DXS305, and DXS52 confirm that the HSAS locus is distal to DXS52. One crossover between HSAS and F8C suggests the HSAS gene to be proximal to F8C. Therefore, data from multipoint linkage analysis and the localization of key crossovers indicate that the HSAS gene is most likely located between DXS52 and F8C. This high-resolution genetic mapping places the HSAS locus within a region of <2 Mb in length, which is now amenable to positional cloning.	UNIV INSTELLING ANTWERP, DEPT NEUROGENET, B-2610 WILRIJK, BELGIUM; CYTOGENET & DNA RES LAB, ONGWANADA, KINGSTON, ONTARIO, CANADA; EMORY UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT BIOCHEM & PEDIAT, ATLANTA, GA 30322 USA; HADASSAH UNIV HOSP, DEPT HUMAN GENET, IL-91120 JERUSALEM, ISRAEL; WESSEX REG GENET LAB, SALISBURY, ENGLAND; SOUTHAMPTON GEN HOSP, DEPT CHILD HLTH, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND; UNIV N CAROLINA, DIV MOLEC PATHOL, CHAPEL HILL, NC 27514 USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27514 USA; UNIV N CAROLINA, BRAIN & DEV RES CTR, CHAPEL HILL, NC 27514 USA; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE TYNE NE1 7RU, TYNE & WEAR, ENGLAND; HOP NECKER ENFANTS MALAD, INSERM, U12, F-75730 PARIS 15, FRANCE; MCMASTER UNIV, HAMILTON L8S 4L8, ONTARIO, CANADA; PUBL HOSP, INST MED GENET, MAGDEBURG, GERMANY; UNIV SAARLAND, INST HUMAN GENET, W-6650 HOMBURG, GERMANY	University of Antwerp; Emory University; Howard Hughes Medical Institute; Hebrew University of Jerusalem; University of Southampton; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McMaster University; Saarland University	WILLEMS, PJ (corresponding author), UNIV INSTELLING ANTWERP, DEPT MED GENET, UNIV SPLEIN 1, B-2610 WILRIJK, BELGIUM.		Van Broeckhoven, Christine/M-7853-2019; Lyonnet, Stanislas/H-5483-2017; Warren, Stephen T/A-2498-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Lyonnet, Stanislas/0000-0001-5426-9417; 				BELL MV, 1989, HUM GENET, V82, P27, DOI 10.1007/BF00288266; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; BROWN WT, 1988, HUM GENET, V78, P201, DOI 10.1007/BF00291662; BURTON BK, 1979, CLIN GENET, V16, P47; CAILLAUD C, 1991, AM J HUM GENET, V49, P95; CASSIE R, 1977, J MED GENET, V14, P72, DOI 10.1136/jmg.14.1.72; DJABALI M, 1990, GENOMICS, V7, P587, DOI 10.1016/0888-7543(90)90203-7; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; FEY MF, 1990, HUM GENET, V84, P471; FRIED K, 1972, CLIN GENET, V3, P258; FRIEDMAN KJ, 1991, 23D P ANN MARCH DIM; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GAREIS FJ, 1984, AM J MED GENET, V17, P333, DOI 10.1002/ajmg.1320170126; HOLDEN JJA, 1990, AM J HUM GENET S, V47, pA183; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KENWRICK S, 1989, AM J HUM GENET, V45, P873; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEGIUS E, 1991, AM J MED GENET S, V49, pA1959; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MULLIGAN LM, 1987, AM J MED GENET, V26, P751, DOI 10.1002/ajmg.1320260334; OPITZ JM, 1965, J PEDIATR-US, V67, P713, DOI 10.1016/S0022-3476(65)80464-4; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; RENIER WO, 1982, CLIN NEUROL NEUROSUR, V84, P113, DOI 10.1016/0303-8467(82)90064-6; RIETSCHEL M, 1991, AM J MED GENET, V41, P10, DOI 10.1002/ajmg.1320410104; ROGERS JG, 1983, PRENATAL DIAG, V3, P269, DOI 10.1002/pd.1970030316; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SERVILLE F, IN PRESS EUR J PEDIA; TEEBI AS, 1988, AM J MED GENET, V31, P469, DOI 10.1002/ajmg.1320310228; VEENEMA H, 1987, J MED GENET, V24, P413, DOI 10.1136/jmg.24.7.413; WILLEMS P J, 1989, American Journal of Human Genetics, V45, pA167; WILLEMS PJ, 1988, AM J MED GENET, V31, P471, DOI 10.1002/ajmg.1320310229; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLEMS PJ, 1991, NUCLEIC ACIDS RES, V19, P5448, DOI 10.1093/nar/19.19.5448-a; WILLEMS PJ, IN PRESS HUM GENET; WINTER RM, 1989, HUM GENET, V82, P367; YEATMAN GW, 1984, AM J MED GENET, V17, P339, DOI 10.1002/ajmg.1320170127	42	44	44	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					307	315						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642232				2022-12-18	WOS:A1992JF77600010
J	DOLL, R; NATOWICZ, MR; SCHIFFMANN, R; SMITH, FI				DOLL, R; NATOWICZ, MR; SCHIFFMANN, R; SMITH, FI			MOLECULAR DIAGNOSTICS FOR MYELIN PROTEOLIPID PROTEIN GENE-MUTATIONS IN PELIZAEUS-MERZBACHER DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBRANE; DISORDER	Pelizaeus-Merzbacher disease (PMD) is a clinically heterogeneous, slowly progressive leukodystrophy. The recent detection of mutations in the myelin proteolipid protein (PLP) gene in several PMD patients offers the opportunity both to design DNA-based tests that would be useful in diagnosing a proportion of PMD cases and, in particular, to evaluate the diagnostic utility of single-strand conformation polymorphism (SSCP) analysis for this disease. A combination of SSCP analysis and direct sequencing of PCR-amplified DNA was used to screen for PLP mutations in 24 patients affected with leukodystrophies of unknown etiology. Two heretofore undescribed mutations in the PLP gene were identified, Asp202His in exon 4 and Gly73Arg in exon 3. The ease and efficiency of SSCP analysis in detecting new mutations support the utilization of this technique in screening for PLP mutations in patients with unexplained leukodystrophies.	EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, DIV BIOCHEM & MOLEC BIOL, 200 TRAPELO RD, WALTHAM, MA 02254 USA; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, DIV MED GENET, WALTHAM, MA 02254 USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA; HADASSAH UNIV, MED CTR, PEDIAT NEUROL UNIT, JERUSALEM, ISRAEL	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038381, R29DK038381] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38381] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baraitser M., 1990, GENETICS NEUROLOGICA; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hayashi K, 1991, PCR Methods Appl, V1, P34; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; HUDSON LD, 1989, J CELL BIOL, V109, P717, DOI 10.1083/jcb.109.2.717; LAURSEN RA, 1984, P NATL ACAD SCI-BIOL, V81, P2912, DOI 10.1073/pnas.81.9.2912; Maniatis T., 1982, MOL CLONING; NADON NL, 1990, DEVELOPMENT, V110, P529; NORMAN RM, 1966, J NEUROL NEUROSUR PS, V29, P521, DOI 10.1136/jnnp.29.6.521; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; SHAW SY, 1989, FEBS LETT, V250, P306, DOI 10.1016/0014-5793(89)80744-6; STOFFEL W, 1984, P NATL ACAD SCI-BIOL, V81, P5012, DOI 10.1073/pnas.81.16.5012; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; WEIMBS T, 1990, BIOL CHEM H-S, V371, P1175, DOI 10.1515/bchm3.1990.371.2.1175	23	44	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					161	169						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1376966				2022-12-18	WOS:A1992JA46700017
J	VANIER, MT; RODRIGUEZLAFRASSE, C; ROUSSON, R; MANDON, G; BOUE, J; CHOISET, A; FRANCEPEYRAT, M; DUMONTEL, C; JUGE, MC; PENTCHEV, PG; REVOL, A; LOUISOT, P				VANIER, MT; RODRIGUEZLAFRASSE, C; ROUSSON, R; MANDON, G; BOUE, J; CHOISET, A; FRANCEPEYRAT, M; DUMONTEL, C; JUGE, MC; PENTCHEV, PG; REVOL, A; LOUISOT, P			PRENATAL-DIAGNOSIS OF NIEMANN-PICK TYPE-C DISEASE - CURRENT STRATEGY FROM AN EXPERIENCE OF 37 PREGNANCIES AT RISK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY LIPOPROTEIN; CHORIONIC VILLI; CHOLESTEROL ESTERIFICATION; CULTURED FIBROBLASTS; CELLS; FETUS	Thirty-seven pregnancies at risk for Niemann-Pick type C disease were monitored by study of cultured amniotic fluid cells (8 cases) or chorionic villus cells (29 cases) in 23 couples over the period 1984-91. An early protocol combined determination of sphingomyelinase activity with electron microscopy. The current strategy, based on the demonstration of specific abnormalities in intracellular processing of exogenous cholesterol, combines the study of the early phase (first 6 h) of LDL-induced cholesteryl ester formation and the histochemical evaluation (filipin staining after 24 h of LDL uptake) of the LDL-induced accumulation of unesterified cholesterol. Thirteen fetuses were predicted to be affected. Confirmation of the diagnosis was made by study of cholesterol processing in fetal skin fibroblast cultures and/or by demonstration of a characteristic lipid storage in fetal liver, already present at 14 w gestation. Definition of the biochemical phenotype (classical, variant, or intermediate) of the index case, with regard to cholesterol-processing abnormalities, is an absolute prerequisite to adequate genetic counseling in a given family. Prenatal diagnosis has now proved a safe procedure in the predominant (approximately 85%) group of families with the classical phenotype.	LYON SUD UNIV HOSP,FDN GILLET MERIEUX,LYONS,FRANCE; DEBROUSSE HOSP,CELL CULTURE LAB,LYONS,FRANCE; ALEXIS CARREL MED SCH,LYONS,FRANCE; INSERM,U73,F-75005 PARIS,FRANCE; ST VINCENT DE PAUL HOSP,PARIS,FRANCE; PRENATAL DIAG CTR,LILLE,FRANCE; NINCDS,BETHESDA,MD 20892	CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	VANIER, MT (corresponding author), FAC MED LYON SUD,LYON SUD MED SCH,INSERM,U189,DEPT BIOCHEM,BP 12,F-69921 OULLINS,FRANCE.							ARGOFF CE, 1991, BIOCHIM BIOPHYS ACTA, V1096, P319, DOI 10.1016/0925-4439(91)90068-K; BRADY RO, 1983, METABOLIC BASIS INHE, P834; BUTLER JD, 1987, P NATL ACAD SCI USA, V84, P556, DOI 10.1073/pnas.84.2.556; CHARBONNE F, 1986, CR SOC BIOL, V180, P316; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HARZER K, 1978, ACTA NEUROCHIR, V43, P97; KANOUN N, 1989, ANN PEDIATR-PARIS, V36, P335; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; MANOCOCHIE IK, 1989, ARCH DIS CHILD, V64, P1391; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1986, J BIOL CHEM, V261, P6775; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; SACHS ES, 1988, TECHNIQUES CULTURE C, P377; SOKOL J, 1988, J BIOL CHEM, V263, P3411; SPENCE MW, 1989, METABOLIC BASIS INHE, P1655; VANIER MT, 1991, J INHERIT METAB DIS, V14, P580, DOI 10.1007/BF01797928; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; VANIER MT, 1985, CLIN GENET, V28, P348; VANIER MT, 1989, LANCET, V1, P1014; VANIER MT, 1986, ENZYMES LIPID METABO, P791; VANIER MT, 1988, LIPID STORAGE DISORD, P175; WENGER DA, 1978, AM J MED GENET, V2, P345, DOI 10.1002/ajmg.1320020405	26	44	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					111	122						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609791				2022-12-18	WOS:A1992JA46700012
J	MORRISON, KE; DANIELS, RJ; SUTHERS, GK; FLYNN, GA; FRANCIS, MJ; BUCKLE, VJ; DAVIES, KE				MORRISON, KE; DANIELS, RJ; SUTHERS, GK; FLYNN, GA; FRANCIS, MJ; BUCKLE, VJ; DAVIES, KE			HIGH-RESOLUTION GENETIC-MAP AROUND THE SPINAL MUSCULAR-ATROPHY (SMA) LOCUS ON CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; HUMANS	Although autosomal recessive spinal muscular atrophy (SMA) has been mapped to chromosome 5q12-q13, there is for this region no genetic map based on highly informative markers. In this study we present the mapping of two previously reported microsatellite markers in 40 CEPH and 31 SMA pedigrees. We also describe the isolation of a new microsatellite marker at the D5S112 locus. The most likely order of markers (with recombination fractions given in parentheses) is 5cen-D5S6-(.02)-D5S125-(.04)-(JK53CA1/2,D5S112)-(.04)-D5S39-qter. The relative order of D5S6, D5S112, and D5S39 was confirmed by in situ hybridization. Multipoint linkage analysis in 31 SMA families indicates that the SMA locus lies in the 6-cM interval between D5S6 and JK53CA1/2, D5S112.	UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,DEPT CLIN NEUROL,OXFORD OX3 9DU,ENGLAND	University of Oxford; University of Oxford				Morrison, Karen Elaine/0000-0003-0216-5717				BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; DANIELS RJ, IN PRESS GENOMICS; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dubowitz V., 1978, MUSCLE DISORDERS CHI, P146; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; HIRST MC, 1991, NUCLEIC ACIDS RES, V19, P3283, DOI 10.1093/nar/19.12.3283; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MANKOO BS, 1990, NUCLEIC ACIDS RES, V19, P1963; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; SHERRINGTON R, UNPUB MICROSATELLITE; SHETH P, 1991, AM J HUM GENET, V48, P764; WASMUTH JJ, IN PRESS CYTOGENET C; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z	19	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					520	527						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539593				2022-12-18	WOS:A1992HH97400010
J	RICHARDS, RI; SHEN, Y; HOLMAN, K; KOZMAN, H; HYLAND, VJ; MULLEY, JC; SUTHERLAND, GR				RICHARDS, RI; SHEN, Y; HOLMAN, K; KOZMAN, H; HYLAND, VJ; MULLEY, JC; SUTHERLAND, GR			FRAGILE-X SYNDROME - DIAGNOSIS USING HIGHLY POLYMORPHIC MICROSATELLITE MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA PROBES; CHROMOSOME; AMPLIFICATION; LINKAGE	We describe two highly polymorphic microsatellite AC repeat sequences, VK23AC and VK14AC, which are closely linked to the fragile X at Xq27.3. Both VK23AC (DXS297) and VK14AC (DXS292) are proximal to the fragile site. Two-point linkage analysis in 31 fragile X families gave (a) a recombination frequency of 1% (range 0.00%-4%) with a maximum lod score of 32.04 for DXS297 and (b) a recombination frequency of 7% (range of 3%-15%) with a maximum lod score of 12.87 for DXS292. Both of these polymorphisms are applicable to diagnosis by linkage in families with fragile X syndrome. A multipoint linkage map of genetic markers at Xq27.3 was constructed from genotyping these polymorphisms in the CEPH pedigrees. The DXS292 marker is in the DXS98-DXS297 interval and is 3 cM proximal to DXS297.			RICHARDS, RI (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Richards, Robert/ABE-6423-2020; Sutherland, Grant Robert/D-2606-2012	Hyland, Valentine/0000-0002-6814-2094; Richards, Robert Ian/0000-0002-5978-6453				CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; HOFKER MH, 1986, AM J HUM GENET, V39, P438; HYLAND VJ, 1989, HUM GENET, V83, P61, DOI 10.1007/BF00274150; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; LITT M, 1989, AM J HUM GENET, V44, P397; MULLEY J, 1988, AM J MED GENET, V30, P567, DOI 10.1002/ajmg.1320300158; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; RICHARDS RI, UNPUB HUMAN GLANDULA; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1990, CLIN GENET, V37, P2; SUTHERLAND GR, 1990, CLIN GENET, V37, P167; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; SUTHERS GK, 1991, AM J HUM GENET, V48, P460; WEBER JL, 1989, AM J HUM GENET, V44, P388	17	44	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1051	1057						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035525				2022-12-18	WOS:A1991FP09200004
J	ALITALO, T; KRUSE, TA; FORSIUS, H; ERIKSSON, AW; DELACHAPELLE, A				ALITALO, T; KRUSE, TA; FORSIUS, H; ERIKSSON, AW; DELACHAPELLE, A			LOCALIZATION OF THE ALAND ISLAND EYE DISEASE LOCUS TO THE PERICENTROMERIC REGION OF THE X-CHROMOSOME BY LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STATIONARY NIGHT BLINDNESS; FORSIUS-ERIKSSON SYNDROME; GENE; EXCLUSION; COMMITTEE; DELETION; DNA	Aland Island eye disease (AIED) is an X-chromosomal disorder characterized by reduced visual acuity, progressive axial myopia, regular astigmatism, latent nystagmus, foveal hypoplasia, defective dark adaptation, and fundus hypopigmentation. The syndrome was originally reported in 1964 in a family on the Aland Islands. To determine the localization of the AIED gene, linkage studies were performed in this family. A total of 37 polymorphisms, covering loci on the entire X chromosome, were used. By two-point analysis the strongest evidence for linkage was obtained between AIED and DXS255 (maximum lod score [Z(max)] 4.92 at maximum recombination fraction [theta-max].00). Marker loci DXS106, DXS159, and DXS1 also showed no recombination with AIED. Other positive lod scores at theta-max .00 were obtained with markers localized in the XY homologous region in Xq13-q21, but the numbers of informative meioses were small. Multilocus linkage analysis indicated that the most probable location of AIED is in the pericentromeric region between DXS7 and DXS72. These results rule out localizations of AIED more distal on Xp that have been proposed by others. Our data do not exclude the possibility that AIED and incomplete congenital stationary night blindness are caused by mutations in the same gene. This question should be resolved by careful clinical comparison of the disorders and ultimately by the molecular dissection of the genes themselves.	FOLKHALSAN INST GENET,HELSINKI,FINLAND; AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS,DENMARK; FREE UNIV AMSTERDAM,INST HUMAN GENET,1007 MC AMSTERDAM,NETHERLANDS	Aarhus University; Vrije Universiteit Amsterdam	ALITALO, T (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMANINKATU 3,SF-00290 HELSINKI 29,FINLAND.							ALITALO T, 1987, CLIN GENET, V32, P192; BECHHANSEN NT, 1990, HUM GENET, V84, P406; FARRER LA, 1987, AM J HUM GENET, V40, P329; FORSIUS H, 1964, Klin Monbl Augenheilkd, V144, P447; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GAL A, 1989, HUM GENET, V81, P315, DOI 10.1007/BF00283682; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KRILL AE, 1977, HEREDITARY RETINAL C, V2, P391; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MENDEL JL, 1989, CYTOGENET CELL GENET, V51, P384; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; ODONNELL FE, 1980, CLIN GENET, V17, P403; OTT J, 1986, HUM GENET, V74, P280; PILLERS DAM, 1990, AM J MED GENET, V36, P23, DOI 10.1002/ajmg.1320360106; PILLERS DM, 1989, CYTOGENET CELL GENET, V51, P1059; Race RR., 1975, BLOOD GROUPS MAN; VANDORP DB, 1985, CLIN GENET, V28, P526; VANVLIET AG, 1973, ACTA OPHTHALMOL, V51, P782; Waardenburg P J, 1970, J Med Genet, V7, P194, DOI 10.1136/jmg.7.3.194; WAARDENBURG PJ, 1969, PROGR NEUROOPHTHALMO, V2, P336; WAINWRIGHT B, 1986, J MED GENET, V23, P417, DOI 10.1136/jmg.23.5.417; WELEBER RG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1170, DOI 10.1001/archopht.1989.01070020236032	27	44	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					31	38						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985461				2022-12-18	WOS:A1991ET18800005
J	AMOS, CI; DAWSON, DV; ELSTON, RC				AMOS, CI; DAWSON, DV; ELSTON, RC			THE PROBABILISTIC DETERMINATION OF IDENTITY-BY-DESCENT SHARING FOR PAIRS OF RELATIVES FROM PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOWARD UNIV, CTR CANC, DIV BIOSTAT & EPIDEMIOL, WASHINGTON, DC 20059 USA; DUKE UNIV, MED CTR, DEPT COMMUNITY & FAMILY MED, DIV BIOMETRY & MED INFORMAT, DURHAM, NC 27710 USA; LOUISIANA STATE UNIV, MED CTR, DEPT BIOMETRY & GENET, NEW ORLEANS, LA 70112 USA	Howard University; Duke University; Louisiana State University System	AMOS, CI (corresponding author), NCI, FAMILY STUDIES SECT, 6130 EXECUT BLVD, SUITE 439, BETHESDA, MD 20892 USA.				NCI NIH HHS [CA14718] Funding Source: Medline; NIGMS NIH HHS [GM39573, GM28356] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R29GM039573, R01GM028356] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISHOP DT, 1990, AM J HUM GENET, V46, P254; CHEVALET C, 1971, Annales de Genetique et de Selection Animale, V3, P449, DOI 10.1186/1297-9686-3-4-449; CHEVALET C, 1984, GENET SEL EVOL, V16, P431, DOI 10.1186/1297-9686-16-4-431; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DEVRIES RRP, 1976, LANCET, V2, P1328; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FIMMERS R, 1989, MULTIPOINT MAPPING L, P123; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; GILLOIS M, 1966, ANN GENET-PARIS, V9, pG58; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; JACQUARD A, 1968, POPULATION, V23, P93, DOI 10.2307/1529060; LANGE K, 1986, AM J HUM GENET, V39, P148; PERICAKVANCE MA, 1986, NEUROLOGY, V36, P1418, DOI 10.1212/WNL.36.11.1418; RISCH N, 1990, AM J HUM GENET, V46, P242; SANDKUYL LA, 1989, PROG CLIN BIOL RES, V329, P117; SUAREZ B, 1982, AM J MED GENET, V12, P309, DOI 10.1002/ajmg.1320120309; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; THOMPSON EA, 1984, PEDIGREE ANAL HUMAN; THOMSON G, 1986, AM J HUM GENET, V39, P207; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEITKAMP LR, 1981, AM J HUM GENET, V33, P776; 1955, POPULATION GENETICS	25	44	46	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					842	853						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220824				2022-12-18	WOS:A1990EE94000012
J	ZIMRAN, A; GELBART, T; BEUTLER, E				ZIMRAN, A; GELBART, T; BEUTLER, E			LINKAGE OF THE PVULL POLYMORPHISM WITH THE COMMON JEWISH MUTATION FOR GAUCHER DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SCRIPPS CLIN & RES FDN,RES INST,10666 N TORREY PINES RD,LA JOLLA,CA 92037	Scripps Research Institute					NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK36639] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036639] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BEUTLER E, 1979, GENETIC DISEASES ASH, P157; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Maniatis T., 1982, MOL CLONING; MASUNO M, 1989, Acta Paediatrica Japonica, V31, P158; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SORGE J, 1985, P NATL ACAD SCI USA, V82, P5442, DOI 10.1073/pnas.82.16.5442; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	13	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					902	905						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971142				2022-12-18	WOS:A1990DD89600006
J	GODFREY, M; OLSON, S; BURGIO, RG; MARTINI, A; VALLI, M; CETTA, G; HORI, H; HOLLISTER, DW				GODFREY, M; OLSON, S; BURGIO, RG; MARTINI, A; VALLI, M; CETTA, G; HORI, H; HOLLISTER, DW			UNILATERAL MICROFIBRILLAR ABNORMALITIES IN A CASE OF ASYMMETRIC MARFAN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHRINERS HOSP CRIPPLED CHILDREN,PORTLAND,OR; OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201; UNIV PAVIA,DEPT PEDIAT,I-27100 PAVIA,ITALY; UNIV PAVIA,DEPT BIOCHEM,I-27100 PAVIA,ITALY	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Pavia; University of Pavia								APPEL A, 1979, J BIOL CHEM, V254, P2199; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BOUCEK RJ, 1981, NEW ENGL J MED, V305, P988, DOI 10.1056/NEJM198110223051705; BURGIO RG, 1988, AM J MED GENET, V30, P905, DOI 10.1002/ajmg.1320300405; BYERS PH, 1981, P NATL ACAD SCI-BIOL, V78, P7745, DOI 10.1073/pnas.78.12.7745; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; Cleary E.G., 1987, CONNECTIVE TISSUE DI, V12, P55; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; COTTAPEREIRA G, 1978, BIOL CELLULAIRE, V31, P297; COTTAPEREIRA G, 1976, J INVEST DERMATOL, V66, P143, DOI 10.1111/1523-1747.ep12481882; DALGLEISH R, 1987, J MED GENET, V24, P148, DOI 10.1136/jmg.24.3.148; FRANCIS MJO, 1974, CLIN SCI MOL MED, V51, P467; FRANCOMANO CA, 1988, AM J MED GENET, V29, P457, DOI 10.1002/ajmg.1320290233; FRYNS JP, 1986, CLIN GENET, V30, P324; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; GODFREY M, 1990, AM J HUM GENET, V46, P652; HARDEN DG, 1985, BIRTH DEFECTS ORIGIN, V21; HENRY WL, 1978, CIRCULATION, V57, P278, DOI 10.1161/01.CIR.57.2.278; HOLLISTER DW, 1985, BIOL CHEM PATHOLOGY, P449; HOLLISTER DW, UNPUB N ENGL J MED; HUTTUNEN K, 1989, AM J MED GENET, V32, P244; LAITINEN O, 1968, CLIN CHIM ACTA, V21, P21; LAMBERG SI, 1973, J CLIN INVEST, V52, P2428, DOI 10.1172/JCI107433; LOW FN, 1962, ANAT REC, V142, P131, DOI 10.1002/ar.1091420205; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; McKusick V.A., 1972, CLIN GENET; MECHAM RP, 1988, BIOCHEM BIOPH RES CO, V151, P822, DOI 10.1016/S0006-291X(88)80355-3; MULLER KP, 1987, EUR J CLIN INVEST, V17, P218, DOI 10.1111/j.1365-2362.1987.tb01239.x; OGILVIE DJ, 1987, AM J HUM GENET, V41, P1071; OLSON SB, 1986, AM J HUM GENET, V38, P235; OVERTON KM, 1976, AM J HUM GENET, V28, P417; PEREJDA AJ, 1985, J LAB CLIN MED, V106, P376; POOLE AR, 1980, J HISTOCHEM CYTOCHEM, V28, P621, DOI 10.1177/28.7.6156200; PRIEST RE, 1973, NATURE, V245, P264, DOI 10.1038/245264a0; PYERITZ RE, 1988, AM J HUM GENET, V43, P726; PYERITZ RE, 1986, AM FAM PHYSICIAN, V34, P83; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; PYERITZ RE, 1983, PRINCIPLES PRACTICE, P820; RAVIOLA G, 1971, INVEST OPHTH VISUAL, V10, P851; ROSENBLOOM J, 1984, LAB INVEST, V51, P605; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SARUK M, 1977, ARCH PATHOL LAB MED, V101, P74; SERAFINIFRACASSINI A, 1981, BIOCHEMISTRY-US, V20, P5424, DOI 10.1021/bi00522a011; STREETEN BW, 1983, INVEST OPHTH VIS SCI, V24, P119; SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5; TAKEBAYASHI S, 1988, ACTA PATHOL JAPON, V38, P1433; TSIPOURAS P, 1986, CLIN GENET, V30, P428	49	44	44	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					661	671						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2180285				2022-12-18	WOS:A1990CW54900005
J	BLANC, M; SANCHEZMAZAS, A; VANBLYENBURGH, NH; SEVIN, A; PISON, G; LANGANEY, A				BLANC, M; SANCHEZMAZAS, A; VANBLYENBURGH, NH; SEVIN, A; PISON, G; LANGANEY, A			INTERETHNIC GENETIC DIFFERENTIATION - GM POLYMORPHISM IN EASTERN SENEGAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV GENEVA,GENET & BIOMETRIE LAB,12 RUE GUSTAVE REVILLIOD,CH-1227 CAROUGE,SWITZERLAND; HOP PURPAN,CNSR,CTR HEMOTYPOL,TOULOUSE,FRANCE; CNRS,MUSEE HOMME,URA 49,F-75005 PARIS,FRANCE	University of Geneva; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS)				SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432				Ai Q, 1987, Gene Geogr, V1, P169; BOULOUX C, 1972, HUM BIOL, V44, P289; CAIN A. J., 1958, PROC ZOOL SOC LONDON, V131, P85; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; CHAVENTRE A, 1983, INED103 TRAV DOC; Dupire M., 1970, ORG SOCIALE PEULS; DUPIRE M, 1963, B MEM SOC ANTHRO PAR, V5, P233; Ehret Christopher, 1984, HUNTERS FARMERS, P26; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; FERRY MP, 1967, B MEM SOC ANTRH PARI, V5, P125; GERSHOWITZ H, 1978, AM J PHYS ANTRH, V49, P238; GESSAIN R, 1963, B MEM SOC ANTHRO PAR, V5, P5; GOMILA J, 1971, BEDIK BARRIERES CULT; Gower JC, 1967, STATISTICIAN, V17, P13, DOI DOI 10.2307/2987199; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; HIERNAUX J, 1976, ANN HUM BIOL, V3, P127, DOI 10.1080/03014467600001241; HUIZINGA J, 1969, P NED AKAD WET C, V71, P373; IMAIZUMI Y, 1970, ARCHAEOL PHYS ANTHR, V5, P219; JENKINS T, 1970, AM J PHYS ANTHROPOL, V32, P197, DOI 10.1002/ajpa.1330320206; LALOUEL JM, 1976, AM J PHYS ANTHROPOL, V45, P453, DOI 10.1002/ajpa.1330450307; LANGANEY A, 1973, HUM BIOL, V45, P137; LANGANEY A, 1972, HUM BIOL, V44, P475; LANGANEY A, 1978, ANTHROPOLOGIE, V82, P95; LANGANEY A, 1973, ANN GENET-PARIS, V16, P247; LANGANEY A, 1972, POPULATION, V1, P83; LANGANEY A, 1974, CAH ANTHR ECOL HUM, V2, P11; LANGANEY A, 1979, POPULATION, V4, P909; LEFRANC G, 1978, HUM GENET, V41, P197, DOI 10.1007/BF00273102; MATSUMOTO H, 1988, HUM GENET, V80, P207, DOI 10.1007/BF01790088; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MORTON NE, 1973, AM J HUM GENET, V25, P422; MORTON NE, 1973, AM J PHYS ANTHROPOL, V38, P709, DOI 10.1002/ajpa.1330380309; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; PELLEGRINI B, 1987, HYPOTHESES THEORIES; PISON G, 1982, INED99 TRAV DOC; SANCHEZMAZAS A, 1988, HUM GENET, V78, P161, DOI 10.1007/BF00278189; SANCHEZMAZAS A, 1986, THEORIA-SPAIN, V4, P143; SOKAL RR, 1988, AM J PHYS ANTHROPOL, V76, P337, DOI 10.1002/ajpa.1330760308; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; STEINBERG AG, 1975, AM J HUM GENET, V27, P528; STEINBERG AG, 1973, AM J PHYS ANTHROPOL, V39, P403, DOI 10.1002/ajpa.1330390308; VANLOGHEM E, 1978, J IMMUNOGENET, V5, P143; 1976, J IMMUNOGENET, V3, P357	43	44	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					383	392						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2105642				2022-12-18	WOS:A1990CM93800020
J	LANGE, K; MATTHYSSE, S				LANGE, K; MATTHYSSE, S			SIMULATION OF PEDIGREE GENOTYPES BY RANDOM-WALKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCLEAN HOSP, MAILMAN RES CTR, BELMONT, MA 02178 USA; HARVARD UNIV, SCH MED, DEPT PSYCHIAT, BOSTON, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	LANGE, K (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOMATH, LOS ANGELES, CA 90024 USA.				NCI NIH HHS [CA 16042] Funding Source: Medline; NIMH NIH HHS [MH 31154] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH031154] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1987, SIMULATED ANNEALING; BODER E, 1985, ATAXIA TELANGIECTASI, P1; Feller W., 1957, INTRO PROBABILITY TH, V1; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; HOLZMAN PS, 1988, ARCH GEN PSYCHIAT, V45, P641; JASPERS NGJ, 1985, ATAXIA TELANGIECTASI, P147; Kalos M.H., 1986, MONTE CARLO METHODS, V1; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LANGE K, 1988, PROGRAMS PEDIGREE AN; LEHMANN AR, 1982, ATAXIA TELANGIECTASI, P83; LUNDY M, 1986, MATH PROGRAM, V34, P111, DOI 10.1007/BF01582166; MATTHYSSE S, 1986, J PSYCHIAT RES, V20, P57, DOI 10.1016/0022-3956(86)90023-3; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Seneta E, 1981, NONNEGATIVE MATRICES; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; TSUANG MT, 1980, BRIT J PSYCHIAT, V137, P497, DOI 10.1192/bjp.137.6.497; WEEKS DE, IN PRESS IMAJ MATH A	20	44	44	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					959	970						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2589323				2022-12-18	WOS:A1989CF40300016
J	SHERMAN, SL; ASTON, CE; MORTON, NE; SPEISER, PW; NEW, MI				SHERMAN, SL; ASTON, CE; MORTON, NE; SPEISER, PW; NEW, MI			A SEGREGATION AND LINKAGE STUDY OF CLASSICAL AND NONCLASSICAL 21-HYDROXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MEM SLOAN KETTERING CANC CTR,DEPT EPIDEMIOL & BIOSTAT,DIV GENET EPIDEMIOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PEDIAT,DIV PEDIAT ENDOCRINOL,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 36295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DUPONT B, 1984, HISTOCOMPATIBILITY T, P660; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; MACLEAN CJ, 1984, COMPUT BIOMED RES, V17, P471, DOI 10.1016/0010-4809(84)90013-2; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MATTESON KJ, 1987, P NATL ACAD SCI USA, V84, P5858, DOI 10.1073/pnas.84.16.5858; NEW MI, 1979, J CLIN ENDOCR METAB, V48, P356, DOI 10.1210/jcem-48-2-356; NEW MI, 1983, J CLIN ENDOCR METAB, V57, P320, DOI 10.1210/jcem-57-2-320; NEW MI, 1984, ANNU REV MED, V35, P649, DOI 10.1146/annurev.me.35.020184.003245; POLLACK MS, 1981, AM J HUM GENET, V33, P540; SPEISER PW, 1985, AM J HUM GENET, V37, P650; WERKMEISTER JW, 1986, AM J HUM GENET, V39, P461; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089	12	44	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					830	838						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	3259403				2022-12-18	WOS:A1988N519700005
J	COX, NJ; BAKER, L; SPIELMAN, RS				COX, NJ; BAKER, L; SPIELMAN, RS			INSULIN-GENE SHARING IN SIB PAIRS WITH INSULIN-DEPENDENT DIABETES-MELLITUS - NO EVIDENCE FOR LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DIV ENDOCRINOL DIABET,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia					NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM019525, R01AM035047] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-240] Funding Source: Medline; NIADDK NIH HHS [AM-19525, AM-35047] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELL G I, 1985, American Journal of Human Genetics, V37, pA188; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CLERGETDARPOUX F, 1980, CLIN GENET, V18, P51; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DIZIER MH, 1986, TISSUE ANTIGENS, V27, P269; ELBEIN SC, 1985, DIABETES, V34, P1139, DOI 10.2337/diabetes.34.11.1139; FERNS GAA, 1986, J MED GENET, V23, P210, DOI 10.1136/jmg.23.3.210; GREEN A, 1985, Genetic Epidemiology, V2, P1, DOI 10.1002/gepi.1370020102; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; HODGE SE, 1983, AM J HUM GENET, V35, P1139; HOOVER ML, 1986, COLD SPRING HARB SYM, V51, P803, DOI 10.1101/SQB.1986.051.01.093; Li CC., 1955, POPULATION GENETICS; OWERBACH D, 1982, DIABETES, V31, P275, DOI 10.2337/diabetes.31.3.275; ROTWEIN PS, 1983, NEW ENGL J MED, V308, P65, DOI 10.1056/NEJM198301133080202; SCHERNTHANER G, 1984, METABOLISM, V33, P833, DOI 10.1016/0026-0495(84)90110-0; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; SUAREZ BK, 1979, CLIN GENET, V15, P126; SUAREZ BK, 1981, DIABETOLOGIA, V20, P524, DOI 10.1007/BF00252759; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84	25	44	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					167	172						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2892397				2022-12-18	WOS:A1988L869700022
J	OGILVIE, DJ; WORDSWORTH, BP; PRIESTLEY, LM; DALGLEISH, R; SCHMIDTKE, J; ZOLL, B; SYKES, BC				OGILVIE, DJ; WORDSWORTH, BP; PRIESTLEY, LM; DALGLEISH, R; SCHMIDTKE, J; ZOLL, B; SYKES, BC			SEGREGATION OF ALL 4 MAJOR FIBRILLAR COLLAGEN GENES IN THE MARFAN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OXFORD,NUFFIELD DEPT PATHOL,OXFORD,ENGLAND; UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND; INST HUMANGENET,GOTTINGEN,FED REP GER	University of Oxford; University of Leicester			Dalgleish, Raymond/I-6245-2019	Dalgleish, Raymond/0000-0001-7667-187X				BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; BOUCEK RJ, 1981, NEW ENGL J MED, V305, P988, DOI 10.1056/NEJM198110223051705; BYERS PH, 1981, P NATL ACAD SCI-BIOL, V78, P7745, DOI 10.1073/pnas.78.12.7745; DALGLEISH R, 1987, J MED GENET, V24, P148, DOI 10.1136/jmg.24.3.148; DALGLEISH R, 1985, NUCLEIC ACIDS RES, V13, P4609, DOI 10.1093/nar/13.12.4609; FALK CT, 1986, AM J HUM GENET, V38, P269; FRIED K, 1977, J MED GENET, V14, P359, DOI 10.1136/jmg.14.5.359; GROBLERRABIE AF, 1985, J MED GENET, V22, P182, DOI 10.1136/jmg.22.3.182; GROBLERRABIE AF, 1985, EMBO J, V4, P1745, DOI 10.1002/j.1460-2075.1985.tb03845.x; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; McKusick V. A., 1986, MENDELIAN INHERITANC; OGILVIE DJ, 1987, NUCLEIC ACIDS RES, V15, P4699, DOI 10.1093/nar/15.11.4699; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; PYERITZ RE, 1981, NEW ENGL J MED, V305, P1011, DOI 10.1056/NEJM198110223051711; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SYKES B, 1985, J MED GENET, V22, P187, DOI 10.1136/jmg.22.3.187; SYKES B, 1986, LANCET, V2, P69; SYKES B, 1985, BIOESSAYS, V3, P112, DOI 10.1002/bies.950030306; SYKES B, 1983, DIS MARKERS, V1, P141; SYKES BC, 1985, HUM GENET, V70, P35, DOI 10.1007/BF00389455; TSIPOURAS P, 1986, CLIN GENET, V30, P428; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; TSIPOURAS P, 1984, Pediatric Research, V18, p226A, DOI 10.1203/00006450-198404001-00800; WALLIS G, 1986, J MED GENET, V23, P411, DOI 10.1136/jmg.23.5.411	24	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1071	1082						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3479900				2022-12-18	WOS:A1987L298400010
J	GAL, A; WEBER, B; NERI, G; SERRA, A; MULLER, U; SCHEMPP, W; PAGE, DC				GAL, A; WEBER, B; NERI, G; SERRA, A; MULLER, U; SCHEMPP, W; PAGE, DC			A 45,X MALE WITH Y-SPECIFIC DNA TRANSLOCATED ONTO CHROMOSOME-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CATTOLICA SACRO CUORE, FAC MED A GEMELLI, IST GENET UMANA, I-00168 ROME, ITALY; UNIV FREIBURG, INST HUMAN GENET, D-7800 FREIBURG, FED REP GER; HARVARD UNIV, CHILDRENS HOSP, DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Freiburg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	GAL, A (corresponding author), UNIV BONN, INST HUMAN GENET, WILHELMSTR 31, D-5300 BONN, FED REP GER.			Weber, Bernhard H.F./0000-0002-8808-7723	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD020059] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20059] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON M, 1986, SCIENCE, V233, P786, DOI 10.1126/science.3738510; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; Buhler EM, 1985, Y CHROMOSOME B, P61; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; COX DR, 1985, CYTOGENET CELL GENET, V40, P206, DOI 10.1159/000132175; CURTO FL, 1974, AM J DIS CHILD, V128, P90, DOI 10.1001/archpedi.1974.02110260092018; DELACHAPELLE A, 1986, AM J HUM GENET, V38, P330; DISTECHE CM, 1986, HUM GENET, V74, P372, DOI 10.1007/BF00280488; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FORABOSCO A, 1977, CLIN GENET, V12, P97; FRACCARO M, 1966, ANN HUM GENET, V29, P281, DOI 10.1111/j.1469-1809.1966.tb00523.x; FRYNS JP, 1985, Y CHROMOSOME B, P151; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GAL A, 1985, 1ST M EUR SOC HUM RE; GANSHIRTAHLERT D, IN PRESS HUM GENET; GELDWERTH D, 1985, EMBO J, V4, P1739, DOI 10.1002/j.1460-2075.1985.tb03844.x; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; KOO GC, 1977, SCIENCE, V198, P940, DOI 10.1126/science.929180; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LAU YF, 1985, HUM GENET, V69, P102, DOI 10.1007/BF00293276; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MASERATI E, 1986, HUM GENET, V74, P126, DOI 10.1007/BF00282075; MULLER U, 1986, NUCLEIC ACIDS RES, V14, P1325, DOI 10.1093/nar/14.3.1325; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAGE DC, 1984, AM J HUM GENET, V36, P565; PAGE DC, 1985, NATURE, V315, P224, DOI 10.1038/315224a0; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Race RR., 1975, BLOOD GROUPS MAN; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHEMPP W, 1985, HUM GENET, V71, P150; SEIDEL H, 1981, CLIN GENET, V19, P290; SHEEHY RR, 1985, AM J HUM GENET, V37, pA342; SUBRT I, 1974, HUMANGENETIK, V23, P305, DOI 10.1007/BF00272514; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; TOLKSDORF M, 1980, EUR J PEDIATR, V133, P293, DOI 10.1007/BF00496093; TURLEAU C, 1980, HUM GENET, V53, P299, DOI 10.1007/BF00287044; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; VIGNETTI P, 1977, CLIN GENET, V12, P319; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7	41	44	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1987	40	6					477	488						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H9693	3473936				2022-12-18	WOS:A1987H969300001
J	NEWGARD, CB; FLETTERICK, RJ; ANDERSON, LA; LEBO, RV				NEWGARD, CB; FLETTERICK, RJ; ANDERSON, LA; LEBO, RV			THE POLYMORPHIC LOCUS FOR GLYCOGEN-STORAGE DISEASE-VI (LIVER-GLYCOGEN PHOSPHORYLASE) MAPS TO CHROMOSOME-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIADDK NIH HHS [AM32822] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM032822] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON L, 1986, MUSCLE NERVE, V9, P231; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BIRD AP, 1984, NATURE, V307, P503, DOI 10.1038/307503a0; CHAKRAVARTI A, 1985, AM J HUM GENET, V37, P984; Chang J C, 1982, Trans Assoc Am Physicians, V95, P71; DAEGELEN D, 1986, ANN NY ACAD SCI, V478, P272, DOI 10.1111/j.1749-6632.1986.tb15538.x; DAVID ES, 1986, BIOCHIM BIOPHYS ACTA, V880, P78, DOI 10.1016/0304-4165(86)90122-4; DREYFUS JC, 1974, ENZYME, V18, P60, DOI 10.1159/000459414; FEIR H, 1976, NEUROLOGY, V26, P963; Goossens M, 1981, Methods Enzymol, V76, P805; HERS H G, 1959, Rev Int Hepatol, V9, P35; HOGGE WA, 1985, PRENATAL DIAG, V5, P393, DOI 10.1002/pd.1970050605; HUG G, 1974, J LAB CLIN MED, V84, P26; HUG G, 1980, INHERITED DISORDERS, P327; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; JUNGERMANN K, 1983, ISOLATION CHARACTERI, P125; KOSTER JF, 1979, CLIN CHIM ACTA, V94, P229, DOI 10.1016/0009-8981(79)90069-X; KREBS EG, 1962, ADV ENZYMOL REL S BI, V24, P263; LEBO RV, 1987, CYTOMETRY, V8, P71, DOI 10.1002/cyto.990080111; LEBO RV, 1985, CYTOMETRY, V6, P478, DOI 10.1002/cyto.990060513; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; LEDERER B, 1976, BIOCHEM J, V159, P689, DOI 10.1042/bj1590689; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MCARDLE B, 1951, CLIN SCI, V10, P12; MCKUSICK VA, 1986, MENDELIAN INHERITANC, pR80; NAKANO K, 1986, FEBS LETT, V204, P283, DOI 10.1016/0014-5793(86)80829-8; NEWGARD CB, 1986, P NATL ACAD SCI USA, V83, P8132, DOI 10.1073/pnas.83.21.8132; ORKIN SH, 1984, ANNU REV GENET, V18, P131; SCHANE HP, 1965, ANAL BIOCHEM, V11, P371, DOI 10.1016/0003-2697(65)90025-4; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TOLAN DR, UNPUB EVOLUTIONARY I; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WOO SLC, 1984, PEDIATRICS, V74, P412; WOSILAIT WD, 1956, J BIOL CHEM, V218, P469	36	44	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1987	40	4					351	364						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H3196	2883891				2022-12-18	WOS:A1987H319600005
J	ZENGERLING, S; OLEK, K; TSUI, LC; GRZESCHIK, KH; RIORDAN, JR; BUCHWALD, M				ZENGERLING, S; OLEK, K; TSUI, LC; GRZESCHIK, KH; RIORDAN, JR; BUCHWALD, M			MAPPING OF DNA MARKERS LINKED TO THE CYSTIC-FIBROSIS LOCUS ON THE LONG ARM OF CHROMOSOME-7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV BONN,INST STRAHLENBIOL,D-5300 BONN,FED REP GER; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV MUNSTER,INST HUMAN GENET,D-4400 MUNSTER,FED REP GER; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Bonn; University of Toronto; University of Toronto; University of Toronto; University of Munster; University of Toronto			Tsui, Lap-chee/A-1081-2010		NIADDK NIH HHS [AM34944-02] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM034944] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTELS I, 1986, AM J HUM GENET, V38, P280; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BUCHWALD M, 1986, CYTOGENET CELL GENET, V41, P234, DOI 10.1159/000132235; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; EIBERG H, 1985, CLIN GENET, V28, P265; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; ISOBE M, 1985, SCIENCE, V228, P580, DOI 10.1126/science.3983641; JUNIEN C, 1982, AM J HUM GENET, V34, P381; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LEBEAU MM, 1985, CELL, V41, P335, DOI 10.1016/0092-8674(85)90086-8; MORTON CC, 1985, SCIENCE, V228, P582, DOI 10.1126/science.3983642; RETIEF E, 1985, HUM GENET, V69, P304, DOI 10.1007/BF00291646; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; SCAMBLER PJ, 1985, LANCET, V2, P1241; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; SCHMIEGELOW K, 1986, CLIN GENET, V29, P374; TRENT J, 1985, CYTOGENET CELL GENET, V40, P761; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; TSUI LC, 1987, IN PRESS COLD SPRING, V51; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0	24	44	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1987	40	3					228	236						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0854	3472464				2022-12-18	WOS:A1987H085400003
J	HOOK, EB; CROSS, PK				HOOK, EB; CROSS, PK			CIGARETTE-SMOKING AND DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	Albany Medical College	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR CHILD HLTH,ALBANY,NY 12237, USA.							HOOK EB, 1984, ANN HUM GENET, V48, P313, DOI 10.1111/j.1469-1809.1984.tb00845.x; HOOK EB, 1981, POPULATION BIOL ASPE, P389; HOOK EG, 1982, ADV BIOMEDICINE BEHA, P11; JOHNSON K, 1985, GENET EPIDEMIOL; KLINE J, 1983, AM J HUM GENET, V35, P421; KLINE J, 1981, FRONTIERS KNOWLEDGE, V2, P131	6	44	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1216	1224						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	2934980				2022-12-18	WOS:A1985AXE3600016
J	PINTOCISTERNAS, J; PINEDA, L; BARRAI, I				PINTOCISTERNAS, J; PINEDA, L; BARRAI, I			ESTIMATION OF INBREEDING BY ISONYMY IN IBEROAMERICAN POPULATIONS - AN EXTENSION OF THE METHOD OF CROW AND MANGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ZULIA,UNIDAD GENET MED,MARACAIBO,VENEZUELA; UNIV FERRARA,CATTEDRA GENET,IST ZOOL,I-44100 FERRARA,ITALY; NATL ACAD LINCEI,CTR INTERDISCIPLINARY,ROME,ITALY	University of Ferrara	PINTOCISTERNAS, J (corresponding author), INST VENEZOLANO INVEST CIENT,GENET HUMANA LAB,CARACAS 1010A,VENEZUELA.							ALLEN G, 1965, EUGEN QUART, V12, P181, DOI 10.1080/19485565.1965.9987629; BATHIA K, 1981, ANN HUM GENET, V45, P213; Bernstein F., 1925, Z ABSTAMMUNGS UND VE, V37, P237, DOI [DOI 10.1007/BF01763333, 10.1007/BF01763333]; CROW JF, 1983, HUM BIOL, V55, P383; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; Darwin G., 1875, J STAT SOC, V38, P153; FRIEDL J, 1974, HUM BIOL, V46, P699; LASKER GW, 1967, AM J HUM GENET, V20, P250; LAZO B, 1978, SOC BIOL, V25, P228, DOI 10.1080/19485565.1978.9988341; LAZO B, 1970, SOC BIOL, V17, P167, DOI 10.1080/19485565.1970.9987867; Malecot G, 1948, MATH HEREDITE; MARIN A, 1977, 1ER ACT C ESP ANTR B, P593; PINEDA L, 1984, UNPUB CONSANGUINITY; PINEDA L, 1982, ACTA CIENT VENEZ S1, V33, P211; PINEDA L, 1979, ACTA CIENT VENEZ S1, V30, P77; PINEDA L, 1979, 4 ACT C LAT AM GEN M, P68; PINTOCISTERNAS J, 1979, SOC BIOL, V26, P55, DOI 10.1080/19485565.1979.9988361; PINTOCISTERNAS J, 1981, ACTA CIENT VENEZ, V32, P262; PINTOCISTERNAS J, 1982, ACTA CIENT VENEZ  S1, V33, P210; SHAW RICHARD F., 1960, JOUR HEREDITY, V51, P221; Wright S., 1968, EVOLUTION GENETICS P, P373; YASUDA N, 1966, 3RD P INT C HUM GEN	22	44	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					373	385						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	3985012				2022-12-18	WOS:A1985AGY5900012
J	HOOK, EB; SCHREINEMACHERS, DM; WILLEY, AM; CROSS, PK				HOOK, EB; SCHREINEMACHERS, DM; WILLEY, AM; CROSS, PK			INHERITED STRUCTURAL CYTOGENETIC ABNORMALITIES DETECTED INCIDENTALLY IN FETUSES DIAGNOSED PRENATALLY - FREQUENCY, PARENTAL-AGE ASSOCIATIONS, SEX-RATIO TRENDS, AND COMPARISONS WITH RATES OF MUTANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208; UNION UNIV ALBANY MED COLL,DEPT OBSTET & GYNECOL,ALBANY,NY 12208; NEW YORK STATE DEPT HLTH,CTR LABS & RES,INST BIRTH DEFECTS,ALBANY,NY 12201	Albany Medical College; Albany Medical College; State University of New York (SUNY) System	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR MATERNAL & CHILD HLTH,ALBANY,NY 12237, USA.							BOUE J, 1982, PRENATAL DIAG, V2, P163, DOI 10.1002/pd.1970020304; HOOK EB, 1983, AM J HUM GENET, V35, P96; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1981, POPULATION BIOL ASPE, P389; Hook EB, 1977, POPULATION CYTOGENET, P63; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; Prescott G H, 1978, Birth Defects Orig Artic Ser, V14, P269; VANDYKE DL, 1983, AM J HUM GENET, V35, P301	8	44	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					422	443						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6711562				2022-12-18	WOS:A1984SM32400017
J	LEGRAND, L; LATHROP, GM; MARCELLIBARGE, A; DRYLL, A; BARDIN, T; DEBEYRE, N; POIRIER, JC; SCHMID, M; RYCKEWAERT, A; DAUSSET, J				LEGRAND, L; LATHROP, GM; MARCELLIBARGE, A; DRYLL, A; BARDIN, T; DEBEYRE, N; POIRIER, JC; SCHMID, M; RYCKEWAERT, A; DAUSSET, J			HLA-DR GENOTYPE RISKS IN SEROPOSITIVE RHEUMATOID-ARTHRITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MUSEE HOMME,ANTHROPOL LAB,PARIS,FRANCE; MUSEE HOMME,INSERM,PARIS,FRANCE; HOP LARIBOISIERE,RHUMATOL CLIN,F-75475 PARIS 10,FRANCE	Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	LEGRAND, L (corresponding author), HOP ST LOUIS,INSERM,U93,F-75475 PARIS 10,FRANCE.							ALARCON GS, 1981, ARTHRITIS RHEUM S303, V24; BARDIN T, 1982, ANN RHEUM DIS, V41, P599, DOI 10.1136/ard.41.6.599; BETUEL H, 1980, HISTOCOMPATIBILITY T, P668; BODMER WF, 1978, HISTOCOMPATIBILITY T, P219; BRACKERTZ D, 1980, ARTHRITIS RHEUM, V23, P656; BRITTON S, 1982, IMMUNOL TODAY, V5, P127; DEPPER JM, 1981, J IMMUNOL, V127, P1899; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; FALK CT, 1980, ANN HUM GENET, V43, P295; GIBOFSKY A, 1978, J EXP MED, V148, P1728, DOI 10.1084/jem.148.6.1728; JARAQUEMADA D, 1979, TRANSPLANT P, V11, P1306; KHAN MA, 1981, TISSUE ANTIGENS, V18, P136, DOI 10.1111/j.1399-0039.1981.tb01375.x; LATHROP GM, 1983, TISSUE ANTIGENS, V22, P160, DOI 10.1111/j.1399-0039.1983.tb01183.x; LIORCA G, 1981, REV RHUM MAL OSTEOAR, V48, P691; MCMICHAEL AJ, 1977, ARTHRITIS RHEUM, V20, P1037, DOI 10.1002/art.1780200501; NICHOL FE, 1981, LANCET, V1, P220; PANAYI GS, 1977, ANN RHEUM DIS, V36, P365, DOI 10.1136/ard.36.4.365; PANAYI GS, 1978, BMJ-BRIT MED J, V2, P1326, DOI 10.1136/bmj.2.6148.1326; PANAYI GS, 1981, 15 C INT RHUM RES 00; PELLEGRINO MA, 1975, CLIN IMMUNOL IMMUNOP, V3, P324, DOI 10.1016/0090-1229(75)90019-7; RAO CR, 1973, LINEAR STATISTICAL I; ROPES M W, 1958, Bull Rheum Dis, V9, P175; SCHERAK O, 1980, J RHEUMATOL, V7, P9; STASTNY P, 1974, TISSUE ANTIGENS, V4, P571; Stastny P., 1980, HISTOCOMPATIBDITY TE, P681; STROM H, 1981, TISSUE ANTIGENS, V18, P92, DOI 10.1111/j.1399-0039.1981.tb01370.x; SVEJGAARD A, 1981, ANN HUM GENET, V45, P299; THOMSEN M, 1979, TISSUE ANTIGENS, V13, P56; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102	30	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					690	699						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6428222				2022-12-18	WOS:A1984SY11900018
J	SATOH, C; NEEL, JV; YAMASHITA, A; GORIKI, K; FUJITA, M; HAMILTON, HB				SATOH, C; NEEL, JV; YAMASHITA, A; GORIKI, K; FUJITA, M; HAMILTON, HB			THE FREQUENCY AMONG JAPANESE OF HETEROZYGOTES FOR DEFICIENCY VARIANTS OF 11 ENZYMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RADIAT EFFECTS RES FDN,NAGASAKI 850,JAPAN; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109	Radiation Effects Research Foundation - Japan; University of Michigan System; University of Michigan	SATOH, C (corresponding author), RADIAT EFFECTS RES FDN,5-2 HIJIYAMA PK,HIROSHIMA 730,JAPAN.							AWA AA, 1983, JPN J HUM GENET; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; Beutler E, 1982, GLUTATHIONE RED CELL, V3 rd; FIELEK S, 1979, CLIN CHEM, V25, P384; FISHER RA, 1963, STATISTICAL METHODS; GORIKI K, UNPUB INHERITED HUMA; HAMILTON HB, 1961, J CLIN INVEST, V40, P2199, DOI 10.1172/JCI104446; ISHIDA Y, 1981, AM J HEMATOL, V10, P239, DOI 10.1002/ajh.2830100303; JOHNSON FM, 1981, GENETICS, V97, P113; JOHNSON FM, 1981, P NATL ACAD SCI-BIOL, V78, P3138, DOI 10.1073/pnas.78.5.3138; LANGLEY CH, 1981, GENETICS, V99, P151; MATSUBARA T, 1976, 16TH INT C HEM, P368; MIWA S, 1980, BRIT J HAEMATOL, V45, P575, DOI 10.1111/j.1365-2141.1980.tb07181.x; MIWA S, 1980, JPN J HUM GENET, V25, P83, DOI 10.1007/BF01873607; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5046, DOI 10.1073/pnas.78.8.5046; MOHRENWEISER HW, 1983, UTILIZATION MAMMALIA; MUKAI T, 1977, P NATL ACAD SCI USA, V74, P2514, DOI 10.1073/pnas.74.6.2514; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P4221, DOI 10.1073/pnas.77.7.4221; NEEL JV, 1956, NATIONAL ACADEMY SCI, V461; NEEL JV, 1979, GENETIC DAMAGE MAN C, P29; RACINE RR, 1980, ENVIRON MUTAGEN, V2, P167, DOI 10.1002/em.2860020209; SATOH C, UNPUB STUDIES GENETI; SATOH C, UNPUB FREQUENCY JAPA; SCHULL WJ, 1981, SCIENCE, V213, P1220, DOI 10.1126/science.7268429; SOARES ER, 1979, ENVIRON MUTAGEN, V1, P19, DOI 10.1002/em.2860010108; STANBURY JB, 1978, METABOLIC BASIS INHE; TAKAHARA S, 1960, J CLIN INVEST, V39, P610, DOI 10.1172/JCI104075; VALENTINE W, 1961, T ASSOC AM PHYSICIAN, V74, P100; VOELKER RA, 1980, P NATL ACAD SCI-BIOL, V77, P1091, DOI 10.1073/pnas.77.2.1091; VOELKER RA, 1980, GENETICS, V94, P961; 1967, BR J HAEMATOL, V13, P71	31	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					656	674						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6881142				2022-12-18	WOS:A1983RG73100012
J	HO, MW; POVEY, S; SWALLOW, D				HO, MW; POVEY, S; SWALLOW, D			LACTASE POLYMORPHISM IN ADULT BRITISH NATIVES - ESTIMATING ALLELE FREQUENCIES BY ENZYME ASSAYS IN AUTOPSY SAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LONDON UNIV COLL,MRC,GALTON LAB,HUMAN BIOCHEM GENET UNIT,LONDON WC1E 6BT,ENGLAND	University of London; University College London	HO, MW (corresponding author), OPEN UNIV,MILTON KEYNES MK7 6AA,BUCKS,ENGLAND.							AURICCHIO S, 1963, ENZYMOL BIOL CLIN, V3, P193, DOI 10.1159/000458059; DAHLQVIST A, 1977, POSTGRAD MED J, V53, P57; FERGUSON A, 1967, LANCET, V2, P188; GRAY GM, 1969, J CLIN INVEST, V48, P716, DOI 10.1172/JCI106029; Harris, 1976, HDB ENZYME ELECTROPH; KRETCHMER N, 1977, POSTGRAD MED J, V58, P65; LEBENTHAL E, 1974, GASTROENTEROLOGY, V67, P1107; LISKER R, 1975, AM J HUM GENET, V27, P662; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NEWCOMER AD, 1966, GASTROENTEROLOGY, V53, P881; PAIGEN K, 1979, ANNU REV GENET, V13, P417, DOI 10.1146/annurev.ge.13.120179.002221; PENA AS, 1973, DIGESTION, V8, P317, DOI 10.1159/000197331; PENARAMIREZ AS, 1971, THESIS OXFORD U; PROUDFOOT NJ, 1980, SCIENCE, V209, P1329, DOI 10.1126/science.6158093; ROSENSWE.NS, 1967, LANCET, V2, P777; ROSENSWEIG NS, 1971, AM J CLIN NUTR, V24, P65; SAHI T, 1974, Scandinavian Journal of Gastroenterology Supplement, V9, P1	17	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	4					650	657						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NY863	6808832				2022-12-18	WOS:A1982NY86300011
J	SHAFITZAGARDO, B; DEVINE, EA; SMITH, M; ARREDONDOVEGA, F; DESNICK, RJ				SHAFITZAGARDO, B; DEVINE, EA; SMITH, M; ARREDONDOVEGA, F; DESNICK, RJ			ASSIGNMENT OF THE GENE FOR ACID BETA-GLUCOSIDASE TO HUMAN CHROMOSOME-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SHAFITZAGARDO, B (corresponding author), CUNY MT SINAI SCH MED,DIV MED GENET,NEW YORK,NY 10029, USA.				NICHD NIH HHS [HD-07105] Funding Source: Medline; NIGMS NIH HHS [GM-25279] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERATIS NG, 1975, PEDIATR RES, V9, P475, DOI 10.1203/00006450-197505000-00003; BEUTLER E, 1975, J LAB CLIN MED, V85, P672; BEUTLER E, 1970, LANCET, V1, P612; BRADY RO, 1978, METABOLIC BASIS INHE, P731; BREG WR, 1972, STAIN TECHNOL, V47, P87, DOI 10.3109/10520297209116456; BRUNS GAP, 1979, BIOCHEM GENET, V17, P1031, DOI 10.1007/BF00504344; EICHMANN K, 1971, J EXP MED, V133, P424, DOI 10.1084/jem.133.3.424; FRIEND KK, 1976, EXP CELL RES, V99, P31, DOI 10.1016/0014-4827(76)90676-5; FURBISH FS, 1977, P NATL ACAD SCI USA, V74, P3560, DOI 10.1073/pnas.74.8.3560; GEORGE DL, 1977, SOMAT CELL GENET, V3, P629, DOI 10.1007/BF01539070; HAM RG, 1962, P SOC EXP BIOL MED, V111, P67; Harris, 1976, HDB ENZYME ELECTROPH; HO MW, 1973, BIOCHEM J, V136, P721, DOI 10.1042/bj1360721; HO MW, 1972, AM J HUM GENET, V24, P37; KHAN PM, 1978, CYTOGENET CELL GENET, V22, P212; KLEBE RJ, 1970, J CELL BIOL, V45, P74, DOI 10.1083/jcb.45.1.74; LITTLEFI.JW, 1966, EXP CELL RES, V41, P190, DOI 10.1016/0014-4827(66)90558-1; MUELLER OT, 1977, J BIOL CHEM, V252, P825; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; PENTCHEV PG, 1973, J BIOL CHEM, V248, P5256; PETERS SP, 1976, ARCH BIOCHEM BIOPHYS, V175, P569, DOI 10.1016/0003-9861(76)90547-6; POVEY S, 1976, ANN HUM GENET, V39, P413, DOI 10.1111/j.1469-1809.1976.tb00145.x; SHAFITZAGARDO B, 1980, BIOCHIM BIOPHYS ACTA, V614, P459, DOI 10.1016/0005-2744(80)90235-1; SHAFITZAGARDO B, UNPUBLISHED; SHIMIZU N, 1978, CYTOGENET CELL GENET, V22, P441, DOI 10.1159/000130992; SHOWS TB, 1979, SOMAT CELL GENET, V5, P147, DOI 10.1007/BF01539157; SMITH M, 1975, ANN HUM GENET, V39, P21, DOI 10.1111/j.1469-1809.1975.tb00104.x; SPARKES RS, 1978, CYTOGENET CELL GENET, V22, P226, DOI 10.1159/000130942; TURNER BM, 1977, BIOCHIM BIOPHYS ACTA, V480, P442, DOI 10.1016/0005-2744(77)90036-5; TURNER BM, 1978, AM J HUM GENET, V30, P346; VANSOMEREN H, 1974, HUMANGENETIK, V25, P189; VAUGHAN VL, 1976, SOMAT CELL GENET, V2, P537, DOI 10.1007/BF01542690	32	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					564	575						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	6455062				2022-12-18	WOS:A1981LZ34800010
J	FRASER, FC				FRASER, FC			EVOLUTION OF A PALATABLE MULTIFACTORIAL THRESHOLD MODEL - THE WILLIAM ALLAN MEMORIAL AWARD ADDRESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,DEPT BIOL,MONTREAL H3C 3G1,QUEBEC,CANADA; MCGILL UNIV,DEPT PAEDIAT,MONTREAL H3C 3G1,QUEBEC,CANADA; MONTREAL CHILDRENS HOSP,DEPT MED GENET,MONTREAL H3H 1P3,QUEBEC,CANADA	McGill University; McGill University; McGill University	FRASER, FC (corresponding author), MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3C 3G1,QUEBEC,CANADA.							BAXTER H, 1950, McGill Med J, V19, P245; BIDDLE FG, 1977, GENETICS, V85, P289; BIDDLE FG, 1978, TERATOLOGY, V18, P247, DOI 10.1002/tera.1420180210; BIDDLE FG, 1976, GENETICS, V84, P743; BONAITIPELIL C, 1974, J MED GENET, V11, P374, DOI 10.1136/jmg.11.4.374; BORNSTEIN S, 1970, TERATOLOGY, V3, P295, DOI 10.1002/tera.1420030403; CARTER C. O., 1965, PROGR MED GENET, V4, P59; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CHUNG CS, 1974, AM J HUM GENET, V26, P177; CLONINGER CR, 1979, AM J HUM GENET, V31, P366; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; CZEIZEL A, 1972, HUM HERED, V22, P405, DOI 10.1159/000152518; DAVIDSON JG, 1969, TERATOLOGY, V2, P371, DOI 10.1002/tera.1420020411; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; ELSTON RC, 1979, AM J HUM GENET, V31, P655; ELSTON RC, 1975, AM J HUM GENET, V27, P31; FALCONER DS, 1967, ANN HUM GENET, V31, P1; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FERGUSON MWJ, 1978, J ANAT, V126, P37; FITCH N, 1957, J EXP ZOOL, V136, P329, DOI 10.1002/jez.1401360208; FRASER F C, 1970, Journal of Medical Genetics, V7, P112, DOI 10.1136/jmg.7.2.112; FRASER F. CLARKE, 1961, PROGR MED GENET, V1, P38; FRASER FC, 1951, PEDIATRICS, V8, P527; FRASER FC, 1963, AM J HUM GENET, V15, P1; FRASER FC, 1956, EUGEN QUART, V3, P45, DOI 10.1080/19485565.1956.9987264; FRASER FC, 1954, J PEDIATR-US, V44, P85, DOI 10.1016/S0022-3476(54)80098-9; FRASER FC, 1970, AM J HUM GENET, V22, P336; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; FRASER FC, 1957, PEDIATRICS, V19, P782; FRASER FC, 1978, TERATOLOGY, V18, P123, DOI 10.1002/tera.1420180115; FRASER FC, 1967, NATURE, V214, P417, DOI 10.1038/214417a0; FRASER FC, 1963, 2ND P INT C HUM GEN, P1852; FRASER FC, 1964, CONGENITAL MALFORMAT, P277; FRASER FC, 1975, GENETICS MAN; FRASER FC, 1977, HDB TERATOLOGY, V1, P75; FRASER FC, 1965, TERATOLOGY PRINCIPLE, P21; FRASER FC, 1980, ETIOLOGY CLEFT LIP P; GOLDSTEIN M, 1965, J Med Genet, V2, P128, DOI 10.1136/jmg.2.2.128; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; INGALLS TH, 1950, AM J DIS CHILD, V80, P34; JURILOFF D, 1980, ETIOLOGY CLEFT LIP P; JURILOFF DM, 1976, TERATOLOGY, V14, P35, DOI 10.1002/tera.1420140106; JURILOFF DM, 1980, DEV PHARMACOLOGY THE, V1; KALTER H, 1954, GENETICS, V39, P185; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; LIPPMANHAND A, 1979, AM J MED GENET, V4, P51, DOI 10.1002/ajmg.1320040108; MELNICK M, 1978, TERATOLOGY, V18, P119, DOI 10.1002/tera.1420180114; MELNICK M, 1976, LANCET, P176; MILLER KK, 1977, TERATOLOGY, V16, P41, DOI 10.1002/tera.1420160107; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1976, 5TH P INT C HUM GEN, P236; NEWCOMBE HB, 1964, CONGENITAL MALFORMAT, P345; POLLARD DR, 1968, TERATOLOGY, V1, P335, DOI 10.1002/tera.1420010310; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; ROTTER JI, 1979, LANCET, V1, P1088; ROTTER JI, 1979, GENETIC ANAL COMMON, P135; SEEGMILLER RE, 1977, J EMBRYOL EXP MORPH, V38, P227; SHAH RM, 1979, ADV STUDY BIRTH DEFE, V1, P69; SING CF, 1979, GENETIC ANAL COMMON; SMITH C, 1970, ANN HUM GENET, V34, P85, DOI 10.1111/j.1469-1809.1970.tb00223.x; SPENCE MA, 1976, HUM HERED, V26, P327; TRASLER DG, 1968, TERATOLOGY, V1, P33, DOI 10.1002/tera.1420010106; TRASLER DG, 1963, DEV BIOL, V6, P45, DOI 10.1016/0012-1606(63)90004-6; TRASLER DG, 1956, SCIENCE, V124, P439, DOI 10.1126/science.124.3219.439; TRASLER DG, 1977, HDB TERATOLOGY, V2, P271; TRASLER DG, 1965, TERATOLOGY PRINCIPLE, P38; VEKEMANS M, 1979, AM J MED GENET, V4, P95, DOI 10.1002/ajmg.1320040111; VEKEMANS M, 1977, TERATOLOGY, V15, pA18; VEKEMANS M, UNPUBLISHED; VEKEMANS M, 1977, 5TH P INT C BIRTH DE, P66; VERRUSIO AC, 1968, SCIENCE, V160, P206, DOI 10.1126/science.160.3824.206; WALKER BE, 1956, J EMBRYOL EXP MORPH, V4, P176; WALKER BE, 1957, J EMBRYOL EXP MORPH, V5, P201; WARKANY J, 1954, HARVEY LECT, V48, P89; Warkany J, 1940, SCIENCE, V92, P383, DOI 10.1126/science.92.2391.383; Wright S, 1934, GENETICS, V19, P0506	79	44	44	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					796	813						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964	7446524				2022-12-18	WOS:A1980KT96400004
J	MIGEON, BR; DO, TT				MIGEON, BR; DO, TT			IN SEARCH OF NONRANDOM X-INACTIVATION - STUDIES OF FETAL MEMBRANES HETEROZYGOUS FOR GLUCOSE-6-PHOSPHATE-DEHYDROGENASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MIGEON, BR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.							BATTISTUZZI G, 1977, AM J HUM GENET, V29, P31; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; MIGEON BR, 1975, AM J HUM GENET, V27, P233; MIGEON BR, 1978, GENETIC MOSAICS CHIM; MONK M, 1978, DEV MAMMALS; NANCE WE, 1967, CLINICAL RESEARCH, V15, P66; ROPERS HH, 1978, HUM GENET, V43, P265, DOI 10.1007/BF00278833; SARKAR S, 1977, J MED GENET, V4, P250; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1978, GENETIC MOSAICS CHIM; WAKE N, 1976, NATURE, V262, P580, DOI 10.1038/262580a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; WEST JD, 1978, GENETIC MOSAICS CHIM	13	44	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	5					581	585						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HS030	507052				2022-12-18	WOS:A1979HS03000008
J	RAO, DC; KEATS, BJ; LALOUEL, JM; MORTON, NE; YEE, S				RAO, DC; KEATS, BJ; LALOUEL, JM; MORTON, NE; YEE, S			MAXIMUM-LIKELIHOOD MAP OF CHROMOSOME-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											RAO, DC (corresponding author), UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822, USA.							BERG K, 1974, CLIN GENET, V6, P147; BURGERHOUT WG, 1977, 4TH INT WORKSH HUM G; COOK PJL, 1974, ANN HUM GENET, V37, P261, DOI 10.1111/j.1469-1809.1974.tb01834.x; COOK PJL, 1978, 4TH WINN C INT WORKS, P375; GOSS SJ, 1977, J CELL SCI, V25, P39; GREENSTADT J, 1967, MATH COMPUT, V21, P360, DOI 10.2307/2003238; KAMARYT J, 1978, HUM GENET, V43, P205, DOI 10.1007/BF00293596; KEATS BJB, HUM GENET; KEATS BJB, 1979, SOURCE BOOK LINKAGE; LALOUEL JM, 1977, HEREDITY, V38, P61, DOI 10.1038/hdy.1977.8; LAWLEY DN, 1963, FACTOR ANAL STATISTI; MCKUSICK VA, 1978, CATALOGS AUTOSOMAL D; MEYERS DA, 1978, 4TH WINN C INT WORKS, P396; MORTON NE, 1977, HUM HERED, V27, P38, DOI 10.1159/000152850; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1976, HEREDITY, V37, P405, DOI 10.1038/hdy.1976.105; MORTON NE, 1978, 4TH WINN C INT WORKS, P15; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1978, AM J HUM GENET, V30, P516; STURT E, 1975, ANN HUM GENET, V39, P255, DOI 10.1111/j.1469-1809.1975.tb00127.x; WEITKAMP L R, 1974, Birth Defects Original Article Series, V10, P179; WILLIAMS WR, 1979, HUM GENET, V47, P297, DOI 10.1007/BF00321022; 1975, BIRTH DEFECTS OAS, V11	24	44	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	6					680	696						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HZ742	293128				2022-12-18	WOS:A1979HZ74200004
J	WEIL, J; EPSTEIN, CJ				WEIL, J; EPSTEIN, CJ			EFFECT OF TRISOMY-21 ON THE PATTERNS OF POLYPEPTIDE-SYNTHESIS IN HUMAN-FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	WEIL, J (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143, USA.							EPSTEIN CJ, 1977, NATURE, V267, P615, DOI 10.1038/267615a0; EPSTEIN LB, 1976, J INFECT DIS, V133, pA56, DOI 10.1093/infdis/133.Supplement_2.A56; FEASTER WW, 1977, AM J HUM GENET, V29, P563; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; HOEHN H, 1975, AM J HUM GENET, V27, P676; HSIA DYY, 1968, ANN NY ACAD SCI, V155, P716, DOI 10.1111/j.1749-6632.1968.tb55059.x; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; KRONE W, 1977, HEREDITAS, V86, P31; LEJEUNE J, 1977, HEREDITAS, V86, P9; MARTIN GM, 1974, HUM PATHOL, V5, P387, DOI 10.1016/S0046-8177(74)80019-5; MARTIN GM, 1970, LAB INVEST, V23, P86; MCDANIEL RG, 1970, CAN J GENET CYTOL, V12, P490, DOI 10.1139/g70-068; MCKUSICK VA, 1977, SCIENCE, V196, P390, DOI 10.1126/science.850784; MOORE EE, 1977, AM J HUM GENET, V29, P389; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OTTOLENGHI S, 1974, NATURE, V251, P389, DOI 10.1038/251389a0; ROHDE RA, 1965, CALIF MED, V103, P249; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; SUH HW, 1977, BIOCHEM GENET, V15, P611, DOI 10.1007/BF00484093; TAN YH, 1974, SCIENCE, V186, P61, DOI 10.1126/science.186.4158.61; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; TAYLOR JM, 1974, NATURE, V251, P392, DOI 10.1038/251392a0; YIELDING KL, 1967, NATURE, V214, P613, DOI 10.1038/214613a0; 1978, HUMAN GENETIC MUTANT	24	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	4					478	488						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HM222	158307				2022-12-18	WOS:A1979HM22200009
J	HAMERTON, JL; MOHANDAS, T; MCALPINE, PJ; DOUGLAS, GR				HAMERTON, JL; MOHANDAS, T; MCALPINE, PJ; DOUGLAS, GR			LOCALIZATION OF HUMAN GENE LOCI USING SPONTANEOUS CHROMOSOME REARRANGEMENTS IN HUMAN-CHINESE HAMSTER SOMATIC-CELL HYBRIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MANITOBA, DEPT PAEDIAT, DIV GENET, WINNIPEG, MANITOBA, CANADA	University of Manitoba			Douglas, George/V-8276-2019					BEERMANN W, 1972, DEV STUDIES GIANT CH, P1; BEUTLER E, 1972, AM J HUM GENET, V24, P237; BOONE C, 1972, P NATL ACAD SCI USA, V69, P510, DOI 10.1073/pnas.69.2.510; BURGERHOUT W, 1973, HUMANGENETIK, V20, P159, DOI 10.1007/BF00284852; CHEN SH, 1971, AM J HUM GENET, V23, P87; CHEN TR, 1973, AM J HUM GENET, V25, P200; CREAGAN R, 1973, CYTOGENET CELL GENET, V12, P187, DOI 10.1159/000130454; CREAGAN R P, 1974, Birth Defects Original Article Series, V10, P79; CREAGAN RP, 1974, AM J HUM GENET, V26, P604; DAVIDSON RG, 1967, NATURE, V215, P761, DOI 10.1038/215761a0; DAVIDSON RG, 1965, ANN HUM GENET, V29, P5, DOI 10.1111/j.1469-1809.1965.tb00497.x; DERKALOUSTIAN VM, 1969, BIOCHEM GENET, V3, P299, DOI 10.1007/BF00521145; DOUGLAS GR, 1973, P NATL ACAD SCI USA, V70, P2737, DOI 10.1073/pnas.70.10.2737; DOUGLAS GR, 1973, NOBEL S, V23, P170; FERGUSONSMITH MA, 1973, NATURE-NEW BIOL, V243, P271, DOI 10.1038/newbio243271a0; GEE P A, 1974, Birth Defects Original Article Series, V10, P89; GEE PA, 1974, CYTOGENET CELL GENET, V13, P437, DOI 10.1159/000130297; GERALD P S, 1974, Birth Defects Original Article Series, V10, P29; GERMAN J, 1973, SCIENCE, V182, P1261, DOI 10.1126/science.182.4118.1261; GRZESCHIK KH, 1972, P NATL ACAD SCI USA, V69, P69, DOI 10.1073/pnas.69.1.69; GRZESCHIK KH, 1973, HUMANGENETIK, V19, P1, DOI 10.1007/BF00295233; GRZESCHIK KH, 1972, NATURE-NEW BIOL, V240, P48, DOI 10.1038/newbio240048a0; HAMERTON JL, 1973, CYTOGENET CELL GENET, V12, P128, DOI 10.1159/000130447; HAMERTON JL, 1974, 2ND INT WORKSH HUM G; JONGSMA A, 1973, HUMANGENETIK, V20, P195, DOI 10.1007/BF00385730; KHAN PM, 1971, AM J HUM GENET, V23, P614; LEFEVRE G, 1974, ANNU REV GENET, V8, P51, DOI 10.1146/annurev.ge.08.120174.000411; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; MAYEDA K, 1974, AM J HUM GENET, V26, P59; MCALPINE P J, 1974, Birth Defects Original Article Series, V10, P128; MCKUSICK VA, 1971, MENDELIAN INHERITANC; Meera Khan P, 1971, Arch Biochem Biophys, V145, P470; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; PEARSON P L, 1974, Birth Defects Original Article Series, V10, P136; POVEY S, 1974, ANN HUM GENET, V38, P1, DOI 10.1111/j.1469-1809.1974.tb01987.x; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; RICCIUTI FC, 1973, GENETICS, V74, P661; RUDDLE FH, 1970, NATURE, V227, P251, DOI 10.1038/227251a0; RUDDLE FH, 1973, NATURE, V242, P165, DOI 10.1038/242165a0; RUDDLE FH, 1971, NATURE-NEW BIOL, V232, P69, DOI 10.1038/newbio232069a0; SANTACHI.AS, 1970, NATURE, V227, P248, DOI 10.1038/227248a0; SWALLOW DM, 1973, ANN HUM GENET, V37, P31, DOI 10.1111/j.1469-1809.1973.tb01812.x; WEITKAMP LR, 1969, ANN HUM GENET, V33, P53, DOI 10.1111/j.1469-1809.1969.tb01629.x; 1972, BIRTH DEFECTS OAS, V8	44	44	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					595	608						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	1172370				2022-12-18	WOS:A1975AR23900003
J	HAMAGUCHI, H				HAMAGUCHI, H			PURIFICATION AND SOME PROPERTIES OF 3 COMMON GENETIC TYPES OF HAPTOGLOBINS AND HEMOGLOBIN-HAPTOGLOBIN COMPLEXES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1957, BRIT MED J, V2, P1137, DOI 10.1136/bmj.2.5054.1137; BLACK JA, 1968, NATURE, V218, P736, DOI 10.1038/218736a0; BRUNORI A, 1968, J BIOL CHEM, V243, P2950; BUNN HF, 1968, J BIOL CHEM, V243, P465; CHIANCONE E, 1968, J MOL BIOL, V34, P347, DOI 10.1016/0022-2836(68)90258-1; CLEVE H, 1967, AM J HUM GENET, V19, P713; CONNELL GE, 1962, NATURE, V193, P505, DOI 10.1038/193505a0; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; GIBLETT ER, 1968, BIBL HAEMATOL, V29, P10; GORDON S, 1966, P SOC EXP BIOL MED, V121, P846; GORDON S, 1968, P SOC EXP BIOL MED, V127, P52; HAMAGUCH.H, 1967, P JPN ACAD, V43, P332, DOI 10.2183/pjab1945.43.332; HAMAGUCHI H, 1969, BIOCHEM BIOPH RES CO, V35, P6, DOI 10.1016/0006-291X(69)90475-6; HAMAGUCHI H, 1968, P JPN ACAD, V44, P733, DOI 10.2183/pjab1945.44.733; HAMAGUCHI H, 1967, P JPN ACAD, V43, P562, DOI 10.2183/pjab1945.43.562; HAMAGUCHI H, IN PRESS; HEIMBURGER N, 1964, CLIN CHIM ACTA, V10, P293, DOI 10.1016/0009-8981(64)90059-2; HERMANBOUSSIER G, 1960, B SOC CHIM BIOL, V42, P837; JAYLE MF, 1962, PROG HEMATOL, V3, P343; LATHEM W, 1959, J CLIN INVEST, V38, P474, DOI 10.1172/JCI103823; LAURELL CB, 1957, BLOOD, V12, P493, DOI 10.1182/blood.V12.6.493.493; Lemberg R, 1941, BIOCHEM J, V35, P328, DOI 10.1042/bj0350328; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURRAY RK, 1961, BLOOD, V17, P45, DOI 10.1182/blood.V17.1.45.45; NAGEL RL, 1966, J MOL BIOL, V22, P249, DOI 10.1016/0022-2836(66)90130-6; NAGEL RL, 1967, J BIOL CHEM, V242, P3428; NAITO SETSUYA, 1967, JAP J HUM GENET, V12, P177; NAKAJIMA H, 1963, J BIOL CHEM, V238, P3784; NYMAN M, 1960, SCAND J CLIN LAB INV, V12, P121; NYMAN M, 1959, SCAND J CLIN LAB S39, V11; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; SARKAR PK, 1966, P NATL ACAD SCI USA, V55, P981, DOI 10.1073/pnas.55.4.981; SHIM BS, 1965, NATURE, V207, P3428; SMITH H, 1962, NATURE, V193, P286, DOI 10.1038/193286a0; SMITH MJ, 1967, BIOCHIM BIOPHYS ACTA, V147, P324, DOI 10.1016/0005-2795(67)90410-2; SMITHIES O, 1955, NATURE, V176, P1265, DOI 10.1038/1761265a0; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1962, AM J HUM GENET, V14, P14; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1966, J MOL BIOL, V21, P213, DOI 10.1016/0022-2836(66)90092-1; WAKS M, 1966, ARCH BIOCHEM BIOPHYS, V113, P304, DOI 10.1016/0003-9861(66)90191-3; YPHANTIS DA, 1960, ANN NY ACAD SCI, V88, P586, DOI 10.1111/j.1749-6632.1960.tb20055.x	45	44	44	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	5					440	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7549	5822290				2022-12-18	WOS:A1969E754900004
J	SCHMICKE.R				SCHMICKE.R			CHROMOSOME ABERRATIONS IN LEUKOCYTES EXPOSED IN VITRO TO DIAGNOSTIC LEVELS OF X RAYS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AMAROSE AP, 1965, OBSTET GYNECOL, V25, P828; AULA P, 1964, LANCET, V1, P720; BENDER MA, 1962, P NATL ACAD SCI USA, V48, P522, DOI 10.1073/pnas.48.4.522; BENDER MA, 1964, ANN NY ACAD SCI, V114, P249; BENDER MA, 1963, RADIAT RES, V18, P389, DOI 10.2307/3571503; BENDER MA, 1962, RADIAT RES, V16, P44, DOI 10.2307/3571128; BENDER MA, 1962, EXP CELL RES, V27, P221, DOI 10.1016/0014-4827(62)90225-2; BENDER MA, 1964, SCINTILLATION SCANNI, P87; BLOOM AD, 1964, NEW ENGL J MED, V270, P1341, DOI 10.1056/NEJM196406182702504; BLOOM GE, 1966, NEW ENGL J MED, V274, P8, DOI 10.1056/NEJM196601062740102; BOYD E, 1961, LANCET, V1, P977; BUCKTON KE, 1962, LANCET, V2, P676; BUCKTON KE, 1964, NATURE, V202, P714, DOI 10.1038/202714a0; CONEN PE, 1961, BRIT MED J, V2, P1055, DOI 10.1136/bmj.2.5259.1055; CONEN PE, 1963, PEDIATRICS, V31, P72; GOODLIN RC, 1962, AMER J ROENTGENOL RA, V87, P555; HAMPAR B, 1961, NATURE, V192, P145, DOI 10.1038/192145a0; HARNDEN DG, 1964, AM J HUM GENET, V16, P204; KIOSSOGLOU KA, 1965, BLOOD-J HEMATOL, V25, P662, DOI 10.1182/blood.V25.5.662.662; LEA DE, 1956, ACTIONS RADIATIONS L, P189; LEA DE, 1942, TRADESCANTIA J GENET, V44, P216; MACINTYRE MN, 1962, J CLIN ENDOCR METAB, V22, P1171, DOI 10.1210/jcem-22-12-1171; MACKINNEY AA, 1962, BLOOD, V19, P349, DOI 10.1182/blood.V19.3.349.349; MIGEON BR, 1964, NATURE, V203, P1395, DOI 10.1038/2031395a0; MOORE JG, 1964, AM J OBSTET GYNECOL, V88, P985, DOI 10.1016/S0002-9378(16)35083-9; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NICHOLS WW, 1966, AM J HUM GENET, V18, P81; NICHOLS WW, 1962, HEREDITAS, V48, P367; NOFAL MM, 1964, J NUCL MED, V5, P840; NORMAN A, 1964, RADIAT RES, V23, P282, DOI 10.2307/3571608; NORMAN A, 1964, RADIOLOGY, V83, P108, DOI 10.1148/83.1.108; NOWELL PC, 1961, JNCI-J NATL CANCER I, V27, P1013; ONUKI Y, 1961, ANN NY ACAD SCI, V95, P882; PAVAN C, 1964, S MAMMALIAN CYTOG ED, P87; PEDERSEN B, 1964, ACTA PATHOL MIC SC, V61, P261, DOI 10.1111/apm.1964.61.2.261; SHAPIRO IM, 1963, INT J RADIAT BIOL RE, V6, P305, DOI 10.1080/09553006314550431; STEWART JS, 1961, LANCET, V1, P978; TOUGH IM, 1965, LANCET, V1, P684; TOUGH IM, 1960, LANCET, V2, P849; WOLFF S, 1963, RADIATIONINDUCED CHR, P11	40	44	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	88552	6019302				2022-12-18	WOS:A19678855200001
J	GRAHAM, JB; MCFALLS, VW; WINTERS, RW				GRAHAM, JB; MCFALLS, VW; WINTERS, RW			FAMILIAL HYPOPHOSPHATEMIA WITH VITAMIN-D-RESISTANT RICKETS .2. 3 ADDITIONAL KINDREDS OF THE SEX-LINKED DOMINANT TYPE WITH A GENETIC ANALYSIS OF FOUR SUCH FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Albright F, 1940, B JOHNS HOPKINS HOSP, V66, P7; Albright F, 1937, AM J DIS CHILD, V54, P529; Fanconi G, 1936, JAHRB KINDERHEILKD, V147, P299; GERSTENBERGER HJ, 1933, MONATSSCHR KINDERH, V56, P217; GREENBERG BG, J CLIN ENDOCR METAB; HALDANE JBS, 1948, ANN EUGENIC, V14, P117; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; MCCANCE RA, 1947, Q J MED, V16, P33; MITCHELL FN, 1957, AMA J DIS CHILD, V93, P385, DOI 10.1001/archpedi.1957.02060040387005; PARSONS LEONARD G., 1927, ARCH DIS CHILDHOOD, V2, P1; PARSONS LEONARD G., 1927, ARCH DIS CHILDHOOD, V2, P198; RATHBUN JC, 1948, AM J DIS CHILD, V75, P822, DOI 10.1001/archpedi.1948.02030020840003; SWANN GF, 1954, BRIT J RADIOL, V27, P623, DOI 10.1259/0007-1285-27-323-623; WINTERS RW, 1958, MEDICINE, V37, P97, DOI 10.1097/00005792-195805000-00001; WINTERS RW, 1957, T ASSOC AM PHYSICIAN, V70, P234; WINTERS RW, PEDIATRICS	16	44	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	4					311	332						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF076	13828798				2022-12-18	WOS:A1959WF07600003
J	METRAKOS, JD; FRASER, FC				METRAKOS, JD; FRASER, FC			EVIDENCE FOR A HEREDITARY FACTOR IN CHONDROECTODERMAL DYSPLASIA (ELLIS-VAN CREVELD SYNDROME)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CAFFEY J, 1952, AM J ROENTGENOL, V68, P875; DEBRE R, 1952, Arch Fr Pediatr, V9, P1055; DEBRE R, 1952, ARCH FRANC PEDIAT, V9, P65; DUNBAR JS, 1954, UNPUB; ELLIS RICHARD W. B., 1940, ARCH DIS CHILDHOOD [LONDON], V15, P65; FRASER FC, 1952, CAN MED ASSOC J, V66, P258; GALLAGHER EJ, 1953, ARCH DIS CHILD, V28, P14, DOI 10.1136/adc.28.137.14; GATTO I, 1951, Helv Paediatr Acta, V6, P437; KEIZER DPR, 1951, AMA AM J DIS CHILD, V82, P341, DOI 10.1001/archpedi.1951.02040040357008; LAMY M, 1952, PRECIS GENETIQUE MED; Macklin MT, 1938, J HERED, V29, P295, DOI 10.1093/oxfordjournals.jhered.a104522; MCINTOSH R, 1933, HOLTS DISEASES INFAN, P362; Stern C., 1949, PRINCIPLES HUMAN GEN; WELLER SDV, 1951, P ROY SOC MED, V44, P731	14	44	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	2					260	269						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB733	13158331				2022-12-18	WOS:A1954YB73300007
J	Depienne, C; Mandel, JL				Depienne, Christel; Mandel, Jean-Louis			30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							LINKED MENTAL-RETARDATION; CAG TRINUCLEOTIDE REPEAT; MACHADO-JOSEPH-DISEASE; MYOTONIC-DYSTROPHY; HEXANUCLEOTIDE REPEAT; FRIEDREICHS-ATAXIA; POLYGLUTAMINE EXPANSIONS; HUNTINGTONS-DISEASE; CEREBELLAR-ATAXIA; NONCODING REGION	Tandem repeats represent one of the most abundant class of variations in human genomes, which are polymorphic by nature and become highly unstable in a length-dependent manner. The expansion of repeat length across generations is a well-established process that results in human disorders mainly affecting the central nervous system. At least 50 disorders associated with expansion loci have been described to date, with half recognized only in the last ten years, as prior methodological difficulties limited their identification. These limitations still apply to the current widely used molecular diagnostic methods (exome or gene panels) and thus result in missed diagnosis detrimental to affected individuals and their families, especially for disorders that are very rare and/or clinically not recognizable. Most of these disorders have been identified through family-driven approaches and many others likely remain to be identified. The recent development of long-read technologies provides a unique opportunity to systematically investigate the contribution of tandem repeats and repeat expansions to the genetic architecture of human disorders. In this review, we summarize the current and most recent knowledge about the genetics of repeat expansion disorders and the diversity of their pathophysiological mechanisms and outline the perspectives of developing personalized treatments in the future.	[Depienne, Christel] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany; [Depienne, Christel] Sorbonne Univ, CNRS UMR 7225, Inserm U1127, UMR S 1127,Inst Cerveau & Moelle Epiniere ICM, F-75013 Paris, France; [Mandel, Jean-Louis] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Mandel, Jean-Louis] CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France; [Mandel, Jean-Louis] INSERM, U 1258, F-67400 Illkirch Graffenstaden, France; [Mandel, Jean-Louis] Univ Strasbourg, F-67400 Illkirch Graffenstaden, France; [Mandel, Jean-Louis] USIAS Univ Strasbourg, Inst Adv Study, F-67000 Strasbourg, France	University of Duisburg Essen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Depienne, C (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany.; Depienne, C (corresponding author), Sorbonne Univ, CNRS UMR 7225, Inserm U1127, UMR S 1127,Inst Cerveau & Moelle Epiniere ICM, F-75013 Paris, France.; Mandel, JL (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France.; Mandel, JL (corresponding author), CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France.; Mandel, JL (corresponding author), INSERM, U 1258, F-67400 Illkirch Graffenstaden, France.; Mandel, JL (corresponding author), Univ Strasbourg, F-67400 Illkirch Graffenstaden, France.; Mandel, JL (corresponding author), USIAS Univ Strasbourg, Inst Adv Study, F-67000 Strasbourg, France.	christel.depienne@uni-due.de; jlmandel@igbmc.fr		Depienne, Christel/0000-0002-7212-9554	University Hospital Essen; Deutsche Forschungsgemeinschaft (DFG); Tom-Wahlig-Stiftung (TWS); Deutsche Stiftung Neurologie (DSN); University of Strasbourg Institute of Advanced study (USIAS)	University Hospital Essen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tom-Wahlig-Stiftung (TWS); Deutsche Stiftung Neurologie (DSN); University of Strasbourg Institute of Advanced study (USIAS)	We thank the editors of the American Journal of Human Genetics and the three anonymous reviewers who made valuable contributions to the revision of this review. We also thank the University Hospital Essen, the Deutsche Forschungsgemeinschaft (DFG), the TomWahlig-Stiftung (TWS), the Deutsche Stiftung Neurologie (DSN), and the University of Strasbourg Institute of Advanced study (USIAS) for their financial support to the research studies conducted by the authors.	Acton RT, 2007, CLIN GENET, V72, P448, DOI 10.1111/j.1399-0004.2007.00883.x; Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Akcimen F, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01219; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Bampi GB, 2017, NEUROMOL MED, V19, P501, DOI 10.1007/s12017-017-8464-8; Banez-Coronel M, 2019, LAB INVEST, V99, P929, DOI 10.1038/s41374-019-0241-x; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bennett MF, 2020, EUR J HUM GENET, V28, P973, DOI 10.1038/s41431-020-0606-z; Bragg DC, 2017, P NATL ACAD SCI USA, V114, pE11020, DOI 10.1073/pnas.1712526114; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Buijsen RAM, 2016, HUM REPROD, V31, P158, DOI 10.1093/humrep/dev280; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cen ZD, 2019, MOVEMENT DISORD, V34, P1571, DOI 10.1002/mds.27832; Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db; Chen H, 2020, BRAIN, V143, DOI 10.1093/brain/awaa142; Chen ZY, 2020, CLIN GENET, V98, P274, DOI 10.1111/cge.13802; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; Colak D, 2014, SCIENCE, V343, P1002, DOI 10.1126/science.1245831; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; Corbett MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12671-y; Corral-Juan M, 2018, BRAIN, V141, P1981, DOI 10.1093/brain/awy137; Cortese A, 2020, BRAIN, V143, P480, DOI 10.1093/brain/awz418; Cortese A, 2019, NAT GENET, V51, P649, DOI 10.1038/s41588-019-0372-4; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Course MM, 2020, AM J HUM GENET, V107, P445, DOI 10.1016/j.ajhg.2020.07.004; Cumming SA, 2018, EUR J HUM GENET, V26, P1635, DOI 10.1038/s41431-018-0156-9; Dashnow H, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1505-2; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; De Roeck A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1856-3; De Roeck A, 2018, ACTA NEUROPATHOL, V135, P827, DOI 10.1007/s00401-018-1841-z; Dedic N, 2018, MOL PSYCHIATR, V23, P533, DOI 10.1038/mp.2017.133; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng JW, 2020, AM J HUM GENET, V106, P793, DOI 10.1016/j.ajhg.2020.04.011; Dewan R, 2021, NEURON, V109, DOI 10.1016/j.neuron.2020.11.005; Doi K, 2014, BIOINFORMATICS, V30, P815, DOI 10.1093/bioinformatics/btt647; Dolzhenko E, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02017-z; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Estevez-Fraga C, 2020, CURR OPIN NEUROL, V33, P508, DOI 10.1097/WCO.0000000000000835; Fang P, 2020, ANN CLIN TRANSL NEUR, V7, P517, DOI 10.1002/acn3.51021; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Florian RT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12763-9; Fotsing SF, 2019, NAT GENET, V51, P1652, DOI 10.1038/s41588-019-0521-9; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Goto S, 2005, ANN NEUROL, V58, P7, DOI 10.1002/ana.20513; Gousse G, 2018, ARCH PEDIATRIE, V25, P42, DOI 10.1016/j.arcped.2017.09.029; Grabczyk E, 2001, BRAIN RES BULL, V56, P367, DOI 10.1016/S0361-9230(01)00572-X; Grandi Fiorella C, 2013, Mob Genet Elements, V3, pe25674; Groh M, 2014, BIOCHEM SOC T, V42, P1123, DOI 10.1042/BST20140049; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Gymrek M, 2017, NAT GENET, V49, P1495, DOI 10.1038/ng.3952; Gymrek M, 2017, CURR OPIN GENET DEV, V44, P9, DOI 10.1016/j.gde.2017.01.012; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Ishiura H, 2019, NAT GENET, V51, P1222, DOI 10.1038/s41588-019-0458-z; Ishiura H, 2018, NAT GENET, V50, P581, DOI 10.1038/s41588-018-0067-2; Jacinto FV, 2020, J CELL MOL MED, V24, P3766, DOI 10.1111/jcmm.14916; Jiao B, 2020, NEUROBIOL AGING, V89, DOI 10.1016/j.neurobiolaging.2020.01.010; Jones L, 2017, LANCET NEUROL, V16, P88, DOI 10.1016/S1474-4422(16)30350-7; Joosten IBT, 2020, EUR J HUM GENET, V28, P956, DOI 10.1038/s41431-020-0601-4; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kay C, 2014, CLIN GENET, V86, P29, DOI 10.1111/cge.12385; Kim J, 2019, NEW ENGL J MED, V381, P1644, DOI 10.1056/NEJMoa1813279; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Kraus-Perrotta Cara, 2016, Cerebellum Ataxias, V3, P20; Lacroix AJ, 2019, AM J HUM GENET, V104, P35, DOI 10.1016/j.ajhg.2018.11.005; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Le Guennec K, 2016, NEUROLOGY, V86, P2134, DOI 10.1212/WNL.0000000000002627; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Loureiro JR, 2019, HUM MUTAT, V40, P404, DOI 10.1002/humu.23704; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Mantere T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00426; Margolis RL, 2001, ANN NEUROL, V50, P373, DOI 10.1002/ana.1124; Martins S, 2018, ADV EXP MED BIOL, V1049, P243, DOI 10.1007/978-3-319-71779-1_12; Matsuura T, 1999, J NEUROL, V246, P835, DOI 10.1007/s004150050464; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2004, AM J HUM GENET, V74, P1216, DOI 10.1086/421526; Mattioli F, 2020, AM J HUM GENET, V106, P438, DOI 10.1016/j.ajhg.2020.02.013; McGoldrick P, 2018, NEUROLOGY, V90, pE323, DOI 10.1212/WNL.0000000000004865; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Mitsuhashi S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1667-6; Mootha VV, 2015, INVEST OPHTH VIS SCI, V56, P2003, DOI 10.1167/iovs.14-16222; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Mor-Shaked H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00031; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Moulard B, 2002, HUM GENET, V111, P255, DOI 10.1007/s00439-002-0755-x; Mousavi N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz501; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nakamori M, 2020, NAT GENET, V52, P146, DOI 10.1038/s41588-019-0575-8; Nemeth AH, 1999, GENOMICS, V60, P320, DOI 10.1006/geno.1999.5929; Nguyen L, 2020, NEURON, V105, P645, DOI 10.1016/j.neuron.2019.11.007; Nolin SL, 2019, AM J MED GENET A, V179, P1148, DOI 10.1002/ajmg.a.61165; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Okubo M, 2019, ANN NEUROL, V86, P962, DOI 10.1002/ana.25586; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pearson CE, 1998, BIOCHEMISTRY-US, V37, P2701, DOI 10.1021/bi972546c; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rafehi H, 2019, AM J HUM GENET, V105, P151, DOI 10.1016/j.ajhg.2019.05.016; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohilla KJ, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0468-y; Rosario R, 2020, MOL HUM REPROD, V26, P727, DOI 10.1093/molehr/gaaa057; Ruggieri A, 2020, ACTA NEUROPATHOL, V140, P231, DOI 10.1007/s00401-020-02164-4; Santoro M, 2017, CLIN GENET, V92, P355, DOI 10.1111/cge.12954; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Satoh K, 2015, J BIOL CHEM, V290, P24152, DOI 10.1074/jbc.M115.655076; Seixas AI, 2017, AM J HUM GENET, V101, P87, DOI 10.1016/j.ajhg.2017.06.007; Sinden RR, 2007, FRONT BIOSCI-LANDMRK, V12, P4788, DOI 10.2741/2427; Smith BN, 2013, EUR J HUM GENET, V21, P102, DOI 10.1038/ejhg.2012.98; Sone J, 2019, NAT GENET, V51, P1215, DOI 10.1038/s41588-019-0459-y; Sone J, 2016, BRAIN, V139, P3170, DOI 10.1093/brain/aww249; Song JHT, 2018, AM J HUM GENET, V103, P421, DOI 10.1016/j.ajhg.2018.07.011; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Stoyas Colleen A, 2018, Handb Clin Neurol, V147, P143, DOI 10.1016/B978-0-444-63233-3.00011-7; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Sulovari A, 2019, P NATL ACAD SCI USA, V116, P23243, DOI 10.1073/pnas.1912175116; Sun QY, 2020, BRAIN, V143, P222, DOI 10.1093/brain/awz372; Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; Szmulewicz DJ, 2014, J VESTIBUL RES-EQUIL, V24, P465, DOI 10.3233/VES-140536; Tang HB, 2017, AM J HUM GENET, V101, P700, DOI 10.1016/j.ajhg.2017.09.013; Tankard RM, 2018, AM J HUM GENET, V103, P858, DOI 10.1016/j.ajhg.2018.10.015; Tian Y, 2019, AM J HUM GENET, V105, P166, DOI 10.1016/j.ajhg.2019.05.013; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Trost B, 2020, NATURE, V586, P80, DOI 10.1038/s41586-020-2579-z; Tsuchiya M, 2020, J HUM GENET, V65, P1143, DOI 10.1038/s10038-020-0807-x; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8; van den Ende T, 2018, TREMOR OTHER HYPERK, V8, DOI 10.7916/D85155WJ; van Kuilenburg ABP, 2019, NEW ENGL J MED, V380, P1433, DOI 10.1056/NEJMoa1806627; van Rootselaar AF, 2005, MOVEMENT DISORD, V20, P665, DOI 10.1002/mds.20413; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2020, ANN NEUROL, V88, P1132, DOI 10.1002/ana.25902; Weinhaeusel A, 2003, HUM MUTAT, V22, P404, DOI 10.1002/humu.10276; Westenberger A, 2019, ANN NEUROL, V85, P812, DOI 10.1002/ana.25488; Wild EJ, 2017, LANCET NEUROL, V16, P837, DOI 10.1016/S1474-4422(17)30280-6; Willems T, 2017, NAT METHODS, V14, P590, DOI [10.1038/NMETH.4267, 10.1038/nmeth.4267]; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; WONG LJC, 1995, AM J HUM GENET, V56, P114; Xi ZR, 2015, ACTA NEUROPATHOL, V129, P715, DOI 10.1007/s00401-015-1401-8; Yau WY, 2020, ANN NEUROL, V88, P641, DOI 10.1002/ana.25818; Yeetong P, 2019, BRAIN, V142, P3360, DOI 10.1093/brain/awz267; Zhu Q, 2020, NAT NEUROSCI, V23, P615, DOI 10.1038/s41593-020-0619-5; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu T, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033019; Zu T, 2017, NEURON, V95, P1292, DOI 10.1016/j.neuron.2017.08.039; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	164	43	43	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 6	2021	108	5					764	785		10.1016/j.ajhg.2021.03.011	http://dx.doi.org/10.1016/j.ajhg.2021.03.011		MAY 2021	22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SO3ST	33811808	Green Published, Bronze			2022-12-18	WOS:000658896700001
J	Biesecker, LG; Adam, MP; Alkuraya, FS; Amemiya, AR; Bamshad, MJ; Beck, AE; Bennett, JT; Bird, LM; Carey, JC; Chung, B; Clark, RD; Cox, TC; Curry, C; Dinulos, MBP; Dobyns, WB; Giampietro, PF; Girisha, KM; Glass, IA; Graham, JM; Gripp, KW; Haldeman-Englert, CR; Hall, BD; Innes, AM; Kalish, JM; Keppler-Noreuil, KM; Kosaki, K; Kozel, BA; Mirzaa, GM; Mulvihill, JJ; Nowaczyk, MJM; Pagon, RA; Retterer, K; Rope, AF; Sanchez-Lara, PA; Seaver, LH; Shieh, JT; Slavotinek, AM; Sobering, AK; Stevens, CA; Stevenson, DA; Tan, TY; Tan, WH; Tsai, AC; Weaver, DD; Williams, MS; Zackai, E; Zarate, YA				Biesecker, Leslie G.; Adam, Margaret P.; Alkuraya, Fowzan S.; Amemiya, Anne R.; Bamshad, Michael J.; Beck, Anita E.; Bennett, James T.; Bird, Lynne M.; Carey, John C.; Chung, Brian; Clark, Robin D.; Cox, Timothy C.; Curry, Cynthia; Dinulos, Mary Beth Palko; Dobyns, William B.; Giampietro, Philip F.; Girisha, Katta M.; Glass, Ian A.; Graham, John M., Jr.; Gripp, Karen W.; Haldeman-Englert, Chad R.; Hall, Bryan D.; Innes, A. Micheil; Kalish, Jennifer M.; Keppler-Noreuil, Kim M.; Kosaki, Kenjiro; Kozel, Beth A.; Mirzaa, Ghayda M.; Mulvihill, John J.; Nowaczyk, Malgorzata J. M.; Pagon, Roberta A.; Retterer, Kyle; Rope, Alan F.; Sanchez-Lara, Pedro A.; Seaver, Laurie H.; Shieh, Joseph T.; Slavotinek, Anne M.; Sobering, Andrew K.; Stevens, Cathy A.; Stevenson, David A.; Tan, Tiong Yang; Tan, Wen-Hann; Tsai, Anne C.; Weaver, David D.; Williams, Marc S.; Zackai, Elaine; Zarate, Yuri A.			A dyadic approach to the delineation of diagnostic entities in clinical genomics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENE	The delineation of disease entities is complex, yet recent advances in the molecular characterization of diseases provide opportunities to designate diseases in a biologically valid manner. Here, we have formalized an approach to the delineation of Mendelian genetic disorders that encompasses two distinct but inter-related concepts: (1) the gene that is mutated and (2) the phenotypic descriptor, preferably a recognizably distinct phenotype. We assert that only by a combinatorial or dyadic approach taking both of these attributes into account can a unitary, distinct genetic disorder be designated. We propose that all Mendelian disorders should be designated as "GENE-related phenotype descriptor" (e.g., "CFTR-related cystic fibrosis"). This approach to delineating and naming disorders reconciles the complexity of gene-to-phenotype relationships in a simple and clear manner yet communicates the complexity and nuance of these relationships.	[Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Adam, Margaret P.; Pagon, Roberta A.] Univ Washington, Dept Pediat, Div Genet Med, Sch Med, Seattle, WA 98105 USA; [Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Amemiya, Anne R.] Computercraft Corp, Mclean, VA 20005 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.; Mirzaa, Ghayda M.] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA; [Beck, Anita E.] Univ Washington, Pediat Genet Med Serv, Seattle, WA 98195 USA; [Beck, Anita E.] Seattle Childrens Hosp, Seattle, WA 98015 USA; [Bennett, James T.] Univ Washington, Ctr Dev Biol & Regenerat Med, Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Bennett, James T.] Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98101 USA; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92123 USA; [Bird, Lynne M.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Carey, John C.] Univ Utah, Dept Pediat, Sch Med, Salt Lake City, UT 84108 USA; [Chung, Brian] Univ Hong Kong, Hong Kong Childrens Hosp, Queen Mary Hosp, LKS Fac Med,Dept Paediat & Adolescent Med, Hong Kong, Peoples R China; [Clark, Robin D.] Loma Linda Univ, Dept Pediat, Div Med Genet, Sch Med, Loma Linda, CA 92354 USA; [Cox, Timothy C.] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64108 USA; [Cox, Timothy C.] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA; [Curry, Cynthia] Univ Calif Fresno, Dept Pediat, Genet Med, Fresno, CA 93701 USA; [Dinulos, Mary Beth Palko] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Pediat, Sect Genet & Child Dev, Lebanon, NH 03756 USA; [Dobyns, William B.] Univ Minnesota, Dept Pediat, Div Genet, Minneapolis, MN 55455 USA; [Giampietro, Philip F.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA; [Girisha, Katta M.] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Med Genet, Manipal 576104, Karnataka, India; [Glass, Ian A.] Univ Washington, Sch Med, Dept Pediat & Med, Seattle, WA 98195 USA; [Graham, John M., Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Graham, John M., Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Los Angeles, CA 90048 USA; [Gripp, Karen W.] AI DuPont Hosp Children Nemours, Dept Pediat, Div Med Genet, Wilmington, DE 19803 USA; [Haldeman-Englert, Chad R.] Mission Fullerton Genet Ctr, Asheville, NC 28803 USA; [Hall, Bryan D.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Innes, A. Micheil] Univ Calgary, Dept Med Genet, Cumming Sch Med, Calgary, AB T3B 6A8, Canada; [Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB T3B 6A8, Canada; [Kalish, Jennifer M.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Kalish, Jennifer M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Kalish, Jennifer M.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Keppler-Noreuil, Kim M.] Childrens Natl Med Ctr, Div Genet, Washington, DC 20010 USA; [Kosaki, Kenjiro] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Kozel, Beth A.] NHLBI, Translat Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Mirzaa, Ghayda M.] Univ Washington, Ctr Integrat Brain Res, Seattle Childrens Res Inst, Dept Pediat, Seattle, WA 98101 USA; [Mulvihill, John J.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Mulvihill, John J.] NHGRI, Bethesda, MD 20892 USA; [Nowaczyk, Malgorzata J. M.] McMaster Univ, Mol Med & Pathol & Pediat, Hamilton, ON L8S 3K9, Canada; [Retterer, Kyle] GeneDx, Gaithersburg, MD 20877 USA; [Rope, Alan F.] Genome Med, San Francisco, CA 94080 USA; [Sanchez-Lara, Pedro A.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Sanchez-Lara, Pedro A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Seaver, Laurie H.] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, Spectrum Hlth Med Genet & Genom,Helen Devos Child, Grand Rapids, MI 49503 USA; [Shieh, Joseph T.; Slavotinek, Anne M.] Univ Calif San Francisco, Dept Pediat, Inst Human Genet, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Shieh, Joseph T.; Slavotinek, Anne M.] Univ Calif San Francisco, Dept Pediat, Div Med Genet, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Sobering, Andrew K.] St Georges Univ, Dept Biochem, Sch Med, St Georges, Grenada; [Stevens, Cathy A.] Univ Tennessee, Dept Pediat, Coll Med, Chattanooga, TN 37403 USA; [Stevenson, David A.] Stanford Univ, Dept Pediat, Div Med Genet, Palo Alto, CA 94305 USA; [Tan, Tiong Yang] Univ Melbourne, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Tan, Tiong Yang] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Tan, Wen-Hann] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Tan, Wen-Hann] Harvard Med Sch, Boston, MA 02115 USA; [Tsai, Anne C.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Genet, Oklahoma City, OK 73104 USA; [Weaver, David D.] Indiana Univ Sch Med, Dept Med & Mol Genet, 975 W Walnut St, Indianapolis, IN 46202 USA; [Williams, Marc S.] Geisinger, Genom Med Inst, Danville, PA 17822 USA; [Zackai, Elaine] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Zarate, Yuri A.] Univ Arkansas Med Sci, Dept Pediat, Sect Genet & Metab, Little Rock, AR 72202 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; King Faisal Specialist Hospital & Research Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Utah System of Higher Education; University of Utah; University of Hong Kong; Loma Linda University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Rutgers State University Medical Center; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nemours Alfred I. duPont Hospital for Children; Greenwood Genetic Center; University of Calgary; University of Calgary; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Children's National Health System; Keio University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); McMaster University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Michigan State University; Michigan State University College of Human Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; Stanford University; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Oklahoma System; University of Oklahoma Health Sciences Center; Indiana University System; Indiana University Bloomington; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Arkansas System; University of Arkansas Medical Sciences	Biesecker, LG (corresponding author), NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA.	lesb@mail.nih.gov	Kozel, Beth/AAP-9177-2020; Biesecker, Leslie/AAG-2526-2021; Dobyns, William Brian/ABC-6525-2021; Sanchez, Pedro/HHM-5713-2022; Bird, Lynne/AAG-9533-2021; Beck, Anita E./AAS-8775-2021; Sanchez-Lara, Pedro A./AAP-5644-2021	Kozel, Beth/0000-0002-9757-7118; Sanchez, Pedro/0000-0003-1181-7828; Beck, Anita E./0000-0002-7965-0326; Sanchez-Lara, Pedro A./0000-0003-1181-7828; Girisha, Katta/0000-0002-0139-8239; Tan, Wen-Hann/0000-0002-1593-6149; Bird, Lynne/0000-0003-4833-3747	National Institutes of Health (NIH) [ZIA HG200388 06]; NIH [R01 DE027879, K08NS092898]; Alex's Lemonade Stand Foundation; Damon Runyon Cancer Research Foundation; Jordan's Guardian Angels; Brotman Baty Institute	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Damon Runyon Cancer Research Foundation; Jordan's Guardian Angels; Brotman Baty Institute	The authors thank Robert L. Nussbaum for critical review of a draft of this manuscript. L.G.B. was supported by the National Institutes of Health (NIH) (ZIA HG200388 06). M.P.A., A.R.A., and R.A.P. are supported by a subcontract from Computercraft Corporation to the University of Washington for editing GeneReviews. T.C.C. was supported by NIH R01 DE027879. J.M.K. was supported by Alex's Lemonade Stand Foundation, Damon Runyon Cancer Research Foundation, and NIH K08CA193915. G.M.M. was supported by NIH K08NS092898 and Jordan's Guardian Angels and the Brotman Baty Institute.	Amberger JS, 2019, NUCLEIC ACIDS RES, V47, pD1038, DOI 10.1093/nar/gky1151; Bamshad MJ, 2019, AM J HUM GENET, V105, P448, DOI 10.1016/j.ajhg.2019.07.011; Cornec-Le Gall E, 2018, J AM SOC NEPHROL, V29, P13, DOI 10.1681/ASN.2017050483; Gross AM, 2020, AM J MED GENET A, V182, P866, DOI 10.1002/ajmg.a.61485; Keppler-Noreuil KM, 2015, AM J MED GENET A, V167, P287, DOI 10.1002/ajmg.a.36836; LaRusch J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004376; Rasmussen SA, 2020, GENET MED, V22, P1573, DOI 10.1038/s41436-020-0851-0; Robin NH, 2001, GENET MED, V3, P290, DOI 10.1097/00125817-200107000-00004; Sakai LY, 2016, GENE, V591, P279, DOI 10.1016/j.gene.2016.07.033; Sapp JC, 2019, AM J MED GENET C, V181, P565, DOI 10.1002/ajmg.c.31744; Schrier SA, 2012, AM J MED GENET A, V158A, P1865, DOI 10.1002/ajmg.a.35415; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Steiner B, 2011, HUM MUTAT, V32, P912, DOI 10.1002/humu.21511; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	14	43	43	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2021	108	1					8	15		10.1016/j.ajhg.2020.11.013	http://dx.doi.org/10.1016/j.ajhg.2020.11.013		JAN 2021	8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PQ3NK	33417889	Bronze, Green Published			2022-12-18	WOS:000606453800002
J	He, XJ; Liu, CY; Yang, XY; Lv, MR; Ni, XQ; Li, Q; Cheng, HR; Liu, WJ; Tian, SX; Wu, H; Gao, Y; Yang, CY; Tan, Q; Cong, JS; Tang, DD; Zhang, JJ; Song, B; Zhong, YD; Li, H; Zhi, WW; Mao, XH; Fu, FF; Ge, L; Shen, QS; Zhang, MY; Saiyin, HXG; Jin, L; Xu, YP; Zhou, P; Wei, ZL; Zhang, F; Cao, YX				He, Xiaojin; Liu, Chunyu; Yang, Xiaoyu; Lv, Mingrong; Ni, Xiaoqing; Li, Qiang; Cheng, Huiru; Liu, Wangjie; Tian, Shixiong; Wu, Huan; Gao, Yang; Yang, Chenyu; Tan, Qing; Cong, Jiangshan; Tang, Dongdong; Zhang, Jingjing; Song, Bing; Zhong, Yading; Li, Hang; Zhi, Weiwei; Mao, Xiaohong; Fu, Feifei; Ge, Lei; Shen, Qunshan; Zhang, Manyu; Saiyin, Hexige; Jin, Li; Xu, Yuping; Zhou, Ping; Wei, Zhaolian; Zhang, Feng; Cao, Yunxia			Bi-allelic Loss-of-function Variants in CFAP58 Cause Flagellar Axoneme and Mitochondrial Sheath Defects and Asthenoteratozoospermia in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; MALE-INFERTILITY; SPERM; MUTATIONS; SPERMATOGENESIS; ORGANIZATION; CLONING; DYNEIN; SPAG6; SPEF2	Multiple morphological abnormalities of the sperm flagella (MMAF) is a severe form of asthenoteratozoospermia. Although recent studies have revealed several MMAF-associated genes and demonstrated MMAF to be a genetically heterogeneous disease, at least one-third of the cases are still not well understood for their etiology. Here, we identified bi-allelic loss-of-function variants in CFAP58 by using whole-exome sequencing in five (5.6%) unrelated individuals from a cohort of 90 MMAF-affected Chinese men. Each of the men harboring bi-allelic CFAP58 variants presented typical MMAF phenotypes. Transmission electron microscopy demonstrated striking flagellar defects with axonemal and mitochondrial sheath malformations. CFAP58 is predominantly expressed in the testis and encodes a cilia- and flagella-associated protein. Immunofluorescence assays showed that CFAP58 localized at the entire flagella of control sperm and predominantly concentrated in the mid-piece. Immunoblotting and immunofluorescence assays showed that the abundances of axoneme ultrastructure markers SPAG6 and SPEF2 and a mitochondrial sheath protein, HSP60, were significantly reduced in the spermatozoa from men harboring bi-allelic CFAP58 variants. We generated Cfap58-knockout mice via CRISPR/Cas9 technology. The male mice were infertile and presented with severe flagellar defects, consistent with the sperm phenotypes in MMAF-affected men. Overall, our findings in humans and mice strongly suggest that CFAP58 plays a vital role in sperm flagellogenesis and demonstrate that bi-allelic loss-of-function variants in CFAP58 can cause axoneme and peri-axoneme malformations leading to male infertility. This study provides crucial insights for understanding and counseling of MMAF-associated asthenoteratozoospermia.	[He, Xiaojin; Lv, Mingrong; Ni, Xiaoqing; Li, Qiang; Cheng, Huiru; Wu, Huan; Gao, Yang; Tan, Qing; Tang, Dongdong; Zhang, Jingjing; Song, Bing; Li, Hang; Zhi, Weiwei; Mao, Xiaohong; Fu, Feifei; Ge, Lei; Shen, Qunshan; Zhang, Manyu; Xu, Yuping; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Reprod Med Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei 230022, Peoples R China; [He, Xiaojin; Lv, Mingrong; Ni, Xiaoqing; Li, Qiang; Wu, Huan; Gao, Yang; Tang, Dongdong; Zhang, Jingjing; Song, Bing; Xu, Yuping; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, NHC Key Lab Study Abnormal Gametes & Reprod Tract, Hefei 230032, Peoples R China; [He, Xiaojin; Lv, Mingrong; Ni, Xiaoqing; Li, Qiang; Wu, Huan; Gao, Yang; Tang, Dongdong; Zhang, Jingjing; Song, Bing; Xu, Yuping; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Minist Educ Peoples Republ China, Key Lab Populat Hlth Life Cycle, Hefei 230032, Peoples R China; [Liu, Chunyu; Liu, Wangjie; Tian, Shixiong; Cong, Jiangshan; Saiyin, Hexige; Jin, Li; Zhang, Feng] Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn,Sch Life Sci, NHC Key Lab Reprod Regulat,Shanghai Inst Planned, Shanghai 200011, Peoples R China; [Liu, Chunyu; Liu, Wangjie; Tian, Shixiong; Cong, Jiangshan; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Liu, Chunyu; Liu, Wangjie; Zhang, Feng] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211166, Peoples R China; [Yang, Xiaoyu] Nanjing Med Univ, Clin Ctr Reprod Med, State Key Lab Reprod Med, Affiliated Hosp 1, Nanjing 210029, Peoples R China; [Cheng, Huiru; Shen, Qunshan; Zhang, Manyu] Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230032, Peoples R China; [Cheng, Huiru; Shen, Qunshan; Zhang, Manyu] Anhui Med Univ, Anhui Prov Engn Res Ctr, Biopreservat & Artificial Organs, Hefei 230032, Peoples R China; [Yang, Chenyu] Zhejiang Univ, Ctr Cryoelectron Microscopy, Hangzhou 310058, Peoples R China; [Tan, Qing; Li, Hang; Zhi, Weiwei; Mao, Xiaohong; Fu, Feifei; Ge, Lei] Anhui Med Univ, Anhui Prov Human Sperm Bank, Affiliated Hosp 1, Hefei 230022, Peoples R China; [Zhong, Yading] Anhui Med Univ, Dept Radiol, Affiliated Hosp 1, Hefei 230022, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Ministry of Education, China; Fudan University; Nanjing Medical University; Nanjing Medical University; Anhui Medical University; Zhejiang University; Anhui Medical University; Anhui Medical University	Cao, YX (corresponding author), Anhui Med Univ, Reprod Med Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei 230022, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, NHC Key Lab Study Abnormal Gametes & Reprod Tract, Hefei 230032, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, Minist Educ Peoples Republ China, Key Lab Populat Hlth Life Cycle, Hefei 230032, Peoples R China.; Zhang, F (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn,Sch Life Sci, NHC Key Lab Reprod Regulat,Shanghai Inst Planned, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211166, Peoples R China.	zhangfeng@fudan.edu.cn; caoyunxia6@126.com	Zhang, Feng/C-7735-2009; liu, chunyu/GWQ-9357-2022	Zhang, Feng/0000-0003-4556-8276; liu, chunyu/0000-0002-6732-3758; Saiyin, Hexige/0000-0003-2993-6817	National Natural Science Foundation of China [81971441, 81901541, 81601340, 31625015, 31521003, 81971374]; Foundation of the Department of Science and Technology of Anhui Province [2017070802D150]; Foundation of the Education Department of Anhui Province [KJ2016A370]; Shanghai Medical Center of Key Programs for Female Reproductive Diseases [2017ZZ01016]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; State Key Laboratory of Reproductive Medicine of China [SKLRM-K202002]; Science and Technology Major Project of Inner Mongolia Autonomous Region of China [zdzx2018065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the Department of Science and Technology of Anhui Province; Foundation of the Education Department of Anhui Province; Shanghai Medical Center of Key Programs for Female Reproductive Diseases; Shanghai Municipal Science and Technology Major Project; State Key Laboratory of Reproductive Medicine of China; Science and Technology Major Project of Inner Mongolia Autonomous Region of China	We would like to thank the families for participating and supporting this study. We also thank the Center of Cryo-Electron Microscopy at Zhejiang University. This work was supported by the National Natural Science Foundation of China (81971441, 81901541, 81601340, 31625015, 31521003, and 81971374), the Foundation of the Department of Science and Technology of Anhui Province (2017070802D150), the Foundation of the Education Department of Anhui Province (KJ2016A370), Shanghai Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ01016), Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), State Key Laboratory of Reproductive Medicine of China (SKLRM-K202002), and Science and Technology Major Project of Inner Mongolia Autonomous Region of China (zdzx2018065).	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0007-2; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Auguste Y, 2018, AM J HUM GENET, V103, P413, DOI 10.1016/j.ajhg.2018.07.013; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cocuzza M, 2008, CLINICS, V63, P395, DOI 10.1590/S1807-59322008000300018; Contreras CT, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00151; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Dong FN, 2018, AM J HUM GENET, V102, P636, DOI 10.1016/j.ajhg.2018.03.007; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Escalier D, 2003, BIOL REPROD, V69, P373, DOI 10.1095/biolreprod.103.015719; He XJ, 2019, J MED GENET, V56, P96, DOI 10.1136/jmedgenet-2018-105486; Inaba K, 2007, ANN NY ACAD SCI, V1101, P506, DOI 10.1196/annals.1389.017; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Krausz C, 2018, NAT REV UROL, V15, P369, DOI 10.1038/s41585-018-0003-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WY, 2020, J MED GENET, V57, P89, DOI 10.1136/jmedgenet-2019-106344; Li WY, 2019, J HUM GENET, V64, P49, DOI 10.1038/s10038-018-0520-1; Li ZZ, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20192666; Liu CY, 2019, AM J HUM GENET, V105, P1168, DOI 10.1016/j.ajhg.2019.10.010; Liu CY, 2020, J MED GENET, V57, P31, DOI 10.1136/jmedgenet-2019-106011; Liu WJ, 2019, AM J HUM GENET, V104, P738, DOI 10.1016/j.ajhg.2019.02.020; Liu WJ, 2019, J GENET GENOMICS, V46, P53, DOI 10.1016/j.jgg.2018.09.006; Lores P, 2019, AM J HUM GENET, V105, P1148, DOI 10.1016/j.ajhg.2019.10.007; Lv MR, 2020, J MED GENET, V57, P445, DOI 10.1136/jmedgenet-2019-106479; Martinez G, 2018, HUM REPROD, V33, P1973, DOI 10.1093/humrep/dey264; Neilson LI, 1999, GENOMICS, V60, P272, DOI 10.1006/geno.1999.5914; OLSON GE, 1992, MOL REPROD DEV, V33, P89, DOI 10.1002/mrd.1080330113; OLSON GE, 1990, J STRUCT BIOL, V103, P13, DOI 10.1016/1047-8477(90)90081-M; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pasek RC, 2016, DEV BIOL, V412, P208, DOI 10.1016/j.ydbio.2016.01.042; Sironen A, 2011, BIOL REPROD, V85, P690, DOI 10.1095/biolreprod.111.091132; Sironen A, 2010, BIOL REPROD, V82, P580, DOI 10.1095/biolreprod.108.074971; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Wang WL, 2020, ASIAN J ANDROL, V22, P236, DOI 10.4103/aja.aja_53_19; Whitfield M, 2019, AM J HUM GENET, V105, P198, DOI 10.1016/j.ajhg.2019.04.015; Wu H, 2019, REPROD BIOMED ONLINE, V38, P769, DOI 10.1016/j.rbmo.2018.12.037; Yamaguchi A, 2014, J HISTOCHEM CYTOCHEM, V62, P286, DOI 10.1369/0022155413520607; Zhang BB, 2020, J EXP MED, V217, DOI 10.1084/jem.20182365; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189; Zhao WL, 2018, J CELL MOL MED, V22, P1755, DOI 10.1111/jcmm.13457	43	43	47	4	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2020	107	3					514	526		10.1016/j.ajhg.2020.07.010	http://dx.doi.org/10.1016/j.ajhg.2020.07.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ2TF	32791035	Bronze, Green Published			2022-12-18	WOS:000565899700011
J	Schilit, SLP; Menon, S; Friedrich, C; Kammin, T; Wilch, E; Hanscom, C; Jiang, SZ; Kliesch, S; Talkowski, ME; Tuttelmann, F; MacQueen, AJ; Morton, CC				Schilit, Samantha L. P.; Menon, Shreya; Friedrich, Corinna; Kammin, Tammy; Wilch, Ellen; Hanscom, Carrie; Jiang, Sizun; Kliesch, Sabine; Talkowski, Michael E.; Tuettelmann, Frank; MacQueen, Amy J.; Morton, Cynthia C.			SYCP2 Translocation-Mediated Dysregulation and Frameshift Variants Cause Human Male Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-DISEASE ASSOCIATIONS; SYNAPTONEMAL COMPLEX; GENOME BROWSER; CHROMOSOME REARRANGEMENTS; PROXIMITY-LIGATION; CLINICAL VALIDITY; R-CADHERIN; GERM-CELLS; PROTEIN; AZOOSPERMIA	Unexplained infertility affects 2%-3% of reproductive-aged couples. One approach to identifying genes involved in infertility is to study subjects with this clinical phenotype and a de novo balanced chromosomal aberration (BCA). While BCAs may reduce fertility by production of unbalanced gametes, a chromosomal rearrangement may also disrupt or dysregulate genes important in fertility. One such subject, DGAP230, has severe oligozoospermia and 46,XY,t(20;22)(q13.3;q11.2). We identified exclusive overexpression of SYCP2 from the der(20) allele that is hypothesized to result from enhancer adoption. Modeling the dysregulation in budding yeast resulted in disrupted structural integrity of the synaptonemal complex, a common cause of defective spermatogenesis in mammals. Exome sequencing of infertile males revealed three heterozygous SYCP2 frameshift variants in additional subjects with cryptozoospermia and azoospermia. In sum, this investigation illustrates the power of precision cytogenetics for annotation of the infertile genome, suggests that these mechanisms should be considered as an alternative etiology to that of segregation of unbalanced gametes in infertile men harboring a BCA, and provides evidence of SYCP2-mediated male infertility in humans.	[Schilit, Samantha L. P.] Harvard Univ, Grad Sch Arts & Sci, Program Genet & Genom, Cambridge, MA 02138 USA; [Schilit, Samantha L. P.] Harvard Univ, Grad Sch Arts & Sci, Biol & Biomed Sci Program, Human Biol & Translat Med, Cambridge, MA 02138 USA; [Menon, Shreya] Harvard Univ, Harvard Coll, Cambridge, MA 02138 USA; [Friedrich, Corinna; Tuettelmann, Frank] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Kammin, Tammy; Wilch, Ellen; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA; [Hanscom, Carrie; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Genom Med, Mol Neurogenet Unit, Boston, MA 02114 USA; [Jiang, Sizun] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Kliesch, Sabine] Univ Hosp Munster, Dept Clin & Surg Androl, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Schilit, Samantha L. P.; Talkowski, Michael E.; Morton, Cynthia C.] Harvard Med Sch, Boston, MA 02115 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Psychol, Boston, MA 02114 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Talkowski, Michael E.; Morton, Cynthia C.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [MacQueen, Amy J.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England	Harvard University; Harvard University; Harvard University; University of Munster; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Stanford University; University of Munster; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wesleyan University; Harvard University; Brigham & Women's Hospital; University of Manchester	Tuttelmann, F (corresponding author), Univ Munster, Inst Human Genet, D-48149 Munster, Germany.; Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Morton, CC (corresponding author), Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA.; Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England.	frank.tuettelmann@ukmuenster.de; cmorton@bwh.harvard.edu	Tüttelmann, Frank/ABH-8185-2020; Jiang, Sizun/AAO-2333-2020	Tüttelmann, Frank/0000-0003-2745-9965; Jiang, Sizun/0000-0001-6149-3142; Schilit, Samantha/0000-0002-8991-6327	Eunice Kennedy Shriver National Institute of Child Health and Human Development [F31HD090780-01]; National Institute of General Medical Sciences [P01GM061354, R15GM104827, R15GM116109]; National Science Foundation [DGE1144152]; DFG Clinical Research Unit "Male Germ Cells: from Genes to Function'' [CRU326]; Leukemia & Lymphoma Society Career Development Program; NCI Cancer Center support grant [2P30CA006516-48]; NIHR Manchester Biomedical Research Centre	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); DFG Clinical Research Unit "Male Germ Cells: from Genes to Function''; Leukemia & Lymphoma Society Career Development Program; NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	We thank DGAP230 and his clinician for their participation in DGAP and the individuals and their families participating in MERGE. We also thank Courtney Thaxton (University of North Carolina at Chapel Hill) for her consultation regarding curation of gene-disease association using the Clinical Genome Resource (ClinGen) framework. This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (F31HD090780-01 to S.L.P.S.), the National Institute of General Medical Sciences (P01GM061354 to C.C.M., R15GM104827 and R15GM116109 to A.J.M.), and the National Science Foundation (DGE1144152 to S.L.P.S.). The exomesequencing study was funded by the DFG Clinical Research Unit "Male Germ Cells: from Genes to Function'' (CRU326). S.J. is supported by the Leukemia & Lymphoma Society Career Development Program. DGAP sequencing reactions were carried out with an ABI3730xl DNA analyzer at the DNA Resource Core of the Dana-Farber/Harvard Cancer Center (funded in part by NCI Cancer Center support grant 2P30CA006516-48). C.C.M. is supported by the NIHR Manchester Biomedical Research Centre. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Andrews GL, 2003, J NEUROSCI, V23, P9873; Arafat M, 2017, J MED GENET, V54, P633, DOI 10.1136/jmedgenet-2017-104514; Ayhan O, 2014, J MED GENET, V51, P239, DOI 10.1136/jmedgenet-2013-102102; Babb SG, 2005, DEV DYNAM, V233, P930, DOI 10.1002/dvdy.20431; Bailis JM, 2000, MOL CELL BIOL, V20, P4838, DOI 10.1128/MCB.20.13.4838-4848.2000; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Cassa CA, 2017, NAT GENET, V49, P806, DOI 10.1038/ng.3831; Champion MD, 2002, NAT CELL BIOL, V4, pS50, DOI 10.1038/ncb-nm-fertilityS50; Colombo R, 2017, GYNECOL OBSTET INVES, V82, P283, DOI 10.1159/000468934; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donker RB, 2017, HUM REPROD, V32, P2574, DOI 10.1093/humrep/dex307; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fakhro KA, 2018, GENET MED, V20, P1365, DOI 10.1038/gim.2018.10; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Gershoni M, 2017, GENET MED, V19, P998, DOI 10.1038/gim.2016.225; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Gou LT, 2017, CELL, V169, P1090, DOI 10.1016/j.cell.2017.04.034; Gudeloglu A, 2013, CLINICS, V68, P27, DOI 10.6061/clinics/2013(Sup01)04; Hanscom C., 2014, CURR PROTOC HUM GENE, V80, P1; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Jeffress JK, 2007, GENETICS, V177, P2445, DOI 10.1534/genetics.107.078717; Jiang S., 2018, CURR PROTOC MOL BIOL, V121; Kavalier F, 2005, BMJ-BRIT MED J, V331, P121, DOI 10.1136/bmj.331.7509.121; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerr GW, 2012, CELL MOL LIFE SCI, V69, P3037, DOI 10.1007/s00018-012-0974-9; Kherraf ZE, 2017, EMBO MOL MED, V9, P1132, DOI 10.15252/emmm.201607461; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Kliesch S, 2014, EUR UROL SUPPL, V13, P73, DOI 10.1016/j.eursup.2014.08.002; Kolas NK, 2004, CYTOGENET GENOME RES, V105, P182, DOI 10.1159/000078188; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar Naina, 2015, J Hum Reprod Sci, V8, P191, DOI 10.4103/0974-1208.170370; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lettice LA, 2011, HUM MUTAT, V32, P1492, DOI 10.1002/humu.21615; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; MacQueen AJ, 2017, METHODS MOL BIOL, V1471, P157, DOI 10.1007/978-1-4939-6340-9_8; Maor-Sagie E, 2015, J ASSIST REPROD GEN, V32, P887, DOI 10.1007/s10815-015-0445-y; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miele A, 2006, CURR PROTOC MOL BIOL, V21, P21, DOI DOI 10.1002/; Mitchell MJ, 2017, CLIN GENET, V91, P208, DOI 10.1111/cge.12900; Miyamoto T, 2016, ANDROLOGY-US, V4, P75, DOI 10.1111/andr.12113; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Offenberg HH, 1998, NUCLEIC ACIDS RES, V26, P2572, DOI 10.1093/nar/26.11.2572; Okutman O, 2018, J ASSIST REPROD GEN, V35, P1939, DOI 10.1007/s10815-018-1301-7; Ollinger R, 2005, MOL BIOL CELL, V16, P212; Ordulu Z, 2016, AM J HUM GENET, V99, P1015, DOI 10.1016/j.ajhg.2016.08.022; Ordulu Z, 2014, AM J HUM GENET, V94, P695, DOI 10.1016/j.ajhg.2014.03.020; Oud MS, 2019, HUM REPROD, V34, P932, DOI 10.1093/humrep/dez022; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Rives N, 2000, MOL HUM REPROD, V6, P107, DOI 10.1093/molehr/6.2.107; ROCKMILL B, 1990, GENETICS, V126, P563; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Ropke A, 2013, EUR J HUM GENET, V21, P1012, DOI 10.1038/ejhg.2012.290; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schalk JAC, 1999, MAMM GENOME, V10, P642, DOI 10.1007/s003359901062; Schilit SLP, 2019, CURR SEX HEALTH REP, V11, P331, DOI 10.1007/s11930-019-00225-8; Schilit SLP, 2018, HUM GENET, V137, P55, DOI 10.1007/s00439-017-1853-0; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shah K, 2003, REPRODUCTION, V126, P13, DOI 10.1530/rep.0.1260013; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smith ED, 2017, HUM MUTAT, V38, P600, DOI 10.1002/humu.23183; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tewes AC, 2014, FERTIL STERIL, V102, P816, DOI 10.1016/j.fertnstert.2014.05.022; Tuttelmann F, 2018, MED GENET-BERLIN, V30, P12, DOI 10.1007/s11825-018-0181-7; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Voelkel-Meiman K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002993; Vogt P.H., 2017, MONOGR HUM GENET, V21, P57; Vozdova M, 2013, J ASSIST REPROD GEN, V30, P391, DOI 10.1007/s10815-012-9921-9; Winkel K, 2009, CHROMOSOMA, V118, P259, DOI 10.1007/s00412-008-0194-0; World Health Organization, 2021, WHO LAB MAN EX PROC, V6th; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yang F, 2015, EMBO MOL MED, V7, P1198, DOI 10.15252/emmm.201404967; Yatsenko AN, 2006, HUM MOL GENET, V15, P3411, DOI 10.1093/hmg/ddl417; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhang HG, 2015, GENET MOL RES, V14, P18792, DOI 10.4238/2015.December.28.28; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	102	43	44	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2020	106	1					41	57		10.1016/j.ajhg.2019.11.013	http://dx.doi.org/10.1016/j.ajhg.2019.11.013			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JZ5VM	31866047	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000505170800004
J	Snellings, DA; Gallione, CJ; Clark, DS; Vozoris, NT; Faughnan, ME; Marchuk, DA				Snellings, Daniel A.; Gallione, Carol J.; Clark, Dewi S.; Vozoris, Nicholas T.; Faughnan, Marie E.; Marchuk, Douglas A.			Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIOVENOUS-MALFORMATIONS; EXPRESSION ANALYSIS; ENDOGLIN; GENES; HHT; DISORDERS; MECHANISM; SUGGESTS; GENOTYPE; FAMILIES	Hereditary hemorrhagic telangiectasia (HHT) is a Mendelian disease characterized by vascular malformations (VMs) including visceral arteriovenous malformations and mucosal telangiectasia. HHT is caused by loss-of-function (LoF) mutations in one of three genes, ENG, ACVRL1, or SMAD4, and is inherited as an autosomal-dominant condition. Intriguingly, the constitutional mutation causing HHT is present throughout the body, yet the multiple VMs in individuals with HHT occur focally, rather than manifesting as a systemic vascular defect. This disconnect between genotype and phenotype suggests that a local event is necessary for the development of VMs. We investigated the hypothesis that local somatic mutations seed the formation HHT-related telangiectasia in a genetic two-hit mechanism. We identified low-frequency somatic mutations in 9/19 telangiectasia through the use of next-generation sequencing. We established phase for seven of nine samples, which confirms that the germline and somatic mutations in all seven samples exist in trans configuration; this is consistent with a genetic two-hit mechanism. These combined data suggest that bi-allelic loss of ENG or ACVRL/ may be a required event in the development of telangiectasia, and that rather than haploinsufficiency, VMs in HHT are caused by a Knudsonian two-hit mechanism.	[Snellings, Daniel A.; Gallione, Carol J.; Marchuk, Douglas A.] Duke Univ, Mol Genet & Microbiol, Durham, NC 27710 USA; [Clark, Dewi S.; Vozoris, Nicholas T.; Faughnan, Marie E.] St Michaels Hosp, Toronto HHT Ctr, Div Respirol, Toronto, ON M5B 1A6, Canada; [Clark, Dewi S.; Vozoris, Nicholas T.; Faughnan, Marie E.] Li Ka Shing Knowledge Inst, Toronto, ON M5B 1A6, Canada; [Vozoris, Nicholas T.; Faughnan, Marie E.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	Duke University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto	Marchuk, DA (corresponding author), Duke Univ, Mol Genet & Microbiol, Durham, NC 27710 USA.	douglas.marchuk@duke.edu		Snellings, Daniel/0000-0003-0615-9111; Marchuk, Douglas/0000-0002-3110-6671	U.S. Department of Defense [W81XWH-17-1-0429]; Fondation Leducq Transatlantic Network of Excellence Grant in Neurovascular Disease [17 CVD 03]; Nelson Arthur Hyland Foundation	U.S. Department of Defense(United States Department of Defense); Fondation Leducq Transatlantic Network of Excellence Grant in Neurovascular Disease; Nelson Arthur Hyland Foundation	We thank all participants and their families who donated samples for this study. We thank Dr. Nicolas Devos and the Duke Sequencing and Genomic Technologies Core for assistance in designing experiments and sequencing. This study was supported by U.S. Department of Defense grant W81XWH-17-1-0429 and a Fondation Leducq Transatlantic Network of Excellence Grant in Neurovascular Disease (17 CVD 03). M.E.F. also received financial support from the Nelson Arthur Hyland Foundation.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Al-Olabi L, 2018, J CLIN INVEST, V128, P1496, DOI 10.1172/JCI98589; Argyriou L, 2006, INT J MOL MED, V17, P655; Bossler AD, 2006, HUM MUTAT, V27, P667, DOI 10.1002/humu.20342; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Choi EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088511; Choi EJ, 2012, CEREBROVASC DIS, V33, P540, DOI 10.1159/000337762; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; Couto JA, 2015, AM J HUM GENET, V96, P480, DOI 10.1016/j.ajhg.2015.01.007; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Detter MR, 2018, CIRC RES, V123, P1143, DOI 10.1161/CIRCRESAHA.118.313970; Eleftheriou NM, 2016, ONCOTARGET, V7, P84314, DOI 10.18632/oncotarget.12604; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Gallione CJ, 1998, HUM MUTAT, V11, P286, DOI 10.1002/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B; Garrido-Martin EM, 2014, ARTERIOSCL THROM VAS, V34, P2232, DOI 10.1161/ATVBAHA.114.303984; Gault J, 2009, NEUROSURGERY, V65, P138, DOI 10.1227/01.NEU.0000348049.81121.C1; Gonzalez CD, 2019, J AM ACAD DERMATOL, V81, P950, DOI 10.1016/j.jaad.2018.11.014; Grosse SD, 2014, GENET MED, V16, P33, DOI 10.1038/gim.2013.66; Jin Y, 2017, NAT CELL BIOL, V19, P639, DOI 10.1038/ncb3534; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; Kim YH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009514; Laver TW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21746; Letteboer TGW, 2008, AM J MED GENET A, V146A, P2733, DOI 10.1002/ajmg.a.32243; Limaye N, 2015, AM J HUM GENET, V97, P914, DOI 10.1016/j.ajhg.2015.11.011; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; Macmurdo CF, 2016, AM J MED GENET A, V170, P1450, DOI 10.1002/ajmg.a.37613; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Malinyerno M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10707-x; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McDonald DA, 2014, HUM MOL GENET, V23, P4357, DOI 10.1093/hmg/ddu153; Milholland B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15183; Nikolaev SI, 2018, NEW ENGL J MED, V378, P250, DOI 10.1056/NEJMoa1709449; Ola R, 2018, CIRCULATION, V138, P2379, DOI 10.1161/CIRCULATIONAHA.118.033842; Olivieri C, 2007, J HUM GENET, V52, P820, DOI 10.1007/s10038-007-0187-5; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ruiz-Llorente L, 2017, EXPERT OPIN THER TAR, V21, P933, DOI 10.1080/14728222.2017.1365839; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; Soblet J, 2017, J INVEST DERMATOL, V137, P207, DOI 10.1016/j.jid.2016.07.034; Srinivasan S, 2003, HUM MOL GENET, V12, P473, DOI 10.1093/hmg/ddg050; Tual-Chalot S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00025	55	43	43	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2019	105	5					894	906		10.1016/j.ajhg.2019.09.010	http://dx.doi.org/10.1016/j.ajhg.2019.09.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JL9XL	31630786	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000495878800002
J	Brechtmann, F; Mertes, C; Matuseviciute, A; Yepez, VA; Avsec, Z; Herzog, M; Bader, DM; Prokisch, H; Gagneur, J				Brechtmann, Felix; Mertes, Christian; Matuseviciute, Agne; Yepez, Vicente A.; Avsec, Ziga; Herzog, Maximilian; Bader, Daniel M.; Prokisch, Holger; Gagneur, Julien			OUTRIDER: A Statistical Method for Detecting Aberrantly Expressed Genes in RNA Sequencing Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFERENTIAL EXPRESSION; TRANSCRIPTOME; IMPACT	RNA sequencing (RNA-seq) is gaining popularity as a complementary assay to genome sequencing for precisely identifying the molecular causes of rare disorders. A powerful approach is to identify aberrant gene expression levels as potential pathogenic events. However, existing methods for detecting aberrant read counts in RNA-seq data either lack assessments of statistical significance, so that establishing cutoffs is arbitrary, or rely on subjective manual corrections for confounders. Here, we describe OUTRIDER (Outlier in RNA-Seq Finder), an algorithm developed to address these issues. The algorithm uses an autoencoder to model read-count expectations according to the gene covariation resulting from technical, environmental, or common genetic variations. Given these expectations, the RNA-seq read counts are assumed to follow a negative binomial distribution with a gene-specific dispersion. Outliers are then identified as read counts that significantly deviate from this distribution. The model is automatically fitted to achieve the best recall of artificially corrupted data. Precision-recall analyses using simulated outlier read counts demonstrated the importance of controlling for covariation and significance-based thresholds. OUTRIDER is open source and includes functions for filtering out genes not expressed in a dataset, for identifying outlier samples with too many aberrantly expressed genes, and for detecting aberrant gene expression on the basis of false-discovery-rate-adjusted p values. Overall, OUTRIDER provides an end-to-end solution for identifying aberrantly expressed genes and is suitable for use by rare-disease diagnostic platforms.	[Brechtmann, Felix; Mertes, Christian; Matuseviciute, Agne; Yepez, Vicente A.; Avsec, Ziga; Herzog, Maximilian; Bader, Daniel M.; Gagneur, Julien] Tech Univ Munich, Dept Informat, Boltzmannstr 3, D-85748 Garching, Germany; [Yepez, Vicente A.; Avsec, Ziga; Gagneur, Julien] Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Quantitat Biosci Munich, Feodor Lynen Str 25, D-81377 Munich, Germany; [Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Klinikum Rechts Isar, 13 Ismaninger Str 22, D-81675 Munich, Germany	Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Gagneur, J (corresponding author), Tech Univ Munich, Dept Informat, Boltzmannstr 3, D-85748 Garching, Germany.; Gagneur, J (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Quantitat Biosci Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	gagneur@in.tum.de		Mertes, Christian/0000-0002-1091-205X; Yepez, Vicente A/0000-0001-7916-3643; Prokisch, Holger/0000-0003-2379-6286; Gagneur, Julien/0000-0002-8924-8365	German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders [01GM1113C]; E-Rare project GENOMIT [01GM1207]; Graduate School of Quantitative Biosciences Munich; Katholischer Akademischer Auslander-Dienst; EU Horizon2020 Collaborative Research Project SOUND [633974]; Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke; National Institute of Neurological Disorders and Stroke; Juniorverbund in der Systemmedizin "mitOmics'' [FKZ 01ZX1405A]	German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; Graduate School of Quantitative Biosciences Munich; Katholischer Akademischer Auslander-Dienst; EU Horizon2020 Collaborative Research Project SOUND; Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Juniorverbund in der Systemmedizin "mitOmics''	We thank Gokcen Eraslan for fruitful and inspiring discussions about the usage of autoencoders on count data and Daniel MacArthur for clarifications about the Cummings et al. study.<SUP>6</SUP> This study was supported by the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET; 01GM1113C to H.P.), the E-Rare project GENOMIT (01GM1207 to H.P.), and the Juniorverbund in der Systemmedizin "mitOmics'' (FKZ 01ZX1405A to J.G. and V.A.Y.). A fellowship through the Graduate School of Quantitative Biosciences Munich supports V.A.Y. and Z.A.A.M was supported by a fellowship through the Katholischer Akademischer Auslander-Dienst. C.M., F.B., V.A.Y., H.P., and J.G. are supported by EU Horizon2020 Collaborative Research Project SOUND(633974). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by the National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The data used for the analyses described in this manuscript were obtained from the GTEx Portal on June 12, 2017, under accession number dbGaP: phs000424.v6.p1.	Aeberhard WH, 2014, BIOMETRICS, V70, P920, DOI 10.1111/biom.12212; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Benjamini Y, 2001, ANN STAT, V29, P1165; BOURLARD H, 1988, BIOL CYBERN, V59, P291, DOI 10.1007/BF00332918; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Eraslan G, 2018, BIORXIV, DOI [10.1101/300681, DOI 10.1101/300681]; Fisher R., 1970, STAT METHODS RES WOR; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hinton G. E., 1994, ADV NEURAL INFORM PR, P3, DOI DOI 10.1021/jp906511z; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; LeCun Y., 1987, THESIS U P M CURIE P; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lewis T., 1974, OUTLIERS STAT DATA; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Li X, 2014, AM J HUM GENET, V95, P245, DOI 10.1016/j.ajhg.2014.08.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Pala M, 2017, NAT GENET, V49, P700, DOI 10.1038/ng.3840; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vincent P., 2008, P 25 INT C MACH LEAR, P1096, DOI 10.1145/1390156.1390294; Way GP, 2018, BIOCOMPUT-PAC SYM, P80; Whitaker L, 1914, BIOMETRIKA, V10, P36, DOI 10.2307/2331739; Wold H., 1966, ESTIMATION PRINCIPAL; Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y; Wright CF, 2018, NAT REV GENET, V19, P253, DOI 10.1038/nrg.2017.116; Zeng Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004942; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	39	43	43	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					907	917		10.1016/j.ajhg.2018.10.025	http://dx.doi.org/10.1016/j.ajhg.2018.10.025			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30503520	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000452535600006
J	Marcogliese, PC; Shashi, V; Spillmann, RC; Stong, N; Rosenfeld, JA; Koenig, MK; Martinez-Agosto, JA; Herzog, M; Chen, AH; Dickson, PI; Lin, HJ; Vera, MU; Salamon, N; Ortiz, D; Infante, E; Steyaert, W; Dermaut, B; Poppe, B; Chung, HL; Zuo, ZY; Lee, PT; Kanca, O; Xia, F; Yang, Y; Smith, EC; Jasien, J; Kansagra, S; Spiridigliozzi, G; El-Dairi, M; Lark, R; Riley, K; Koeberl, DD; Golden-Grant, K; Yamamoto, S; Wangler, MF; Mirzaa, G; Hemelsoet, D; Lee, B; Nelson, SF; Goldstein, DB; Bellen, HJ; Pena, LDM				Marcogliese, Paul C.; Shashi, Vandana; Spillmann, Rebecca C.; Stong, Nicholas; Rosenfeld, Jill A.; Koenig, Mary Kay; Martinez-Agosto, Julian A.; Herzog, Matthew; Chen, Agnes H.; Dickson, Patricia I.; Lin, Henry J.; Vera, Moin U.; Salamon, Noriko; Ortiz, Damara; Infante, Elena; Steyaert, Wouter; Dermaut, Bart; Poppe, Bruce; Chung, Hyung-Lok; Zuo, Zhongyuan; Lee, Pei-Tseng; Kanca, Oguz; Xia, Fan; Yang, Yaping; Smith, Edward C.; Jasien, Joan; Kansagra, Sujay; Spiridigliozzi, Gail; El-Dairi, Mays; Lark, Robert; Riley, Kacie; Koeberl, Dwight D.; Golden-Grant, Katie; Yamamoto, Shinya; Wangler, Michael F.; Mirzaa, Ghayda; Hemelsoet, Dimitri; Lee, Brendan; Nelson, Stanley F.; Goldstein, David B.; Bellen, Hugo J.; Pena, Loren D. M.		Program Undiagnosed Dis UD-PrOZA; Undiagnosed Dis Network	IRF2BPL Is Associated with Neurological Phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECURRENT DE-NOVO; UNDIAGNOSED DISEASES NETWORK; DROSOPHILA; PROTEIN; EXPRESSION; MUTATIONS; GENE; EAP1; ADRENOLEUKODYSTROPHY; TRANSGENESIS	Interferon regulatory factor 2 binding protein-like (IRF2BPL) encodes a member of the IRF2BP family of transcriptional regulators. Currently the biological function of this gene is obscure, and the gene has not been associated with a Mendelian disease. Here we describe seven individuals who carry damaging heterozygous variants in IRF2BPL and are affected with neurological symptoms. Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination. Two additional individuals, both with missense variants, display global developmental delay and seizures and a relatively milder phenotype than those with nonsense alleles. The IRF2BPL bioinformatics signature based on population genomics is consistent with a gene that is intolerant to variation. We show that the fruit-fly IRF2BPL ortholog, called pits (protein interacting with Ttk69 and Sin3A), is broadly detected, including in the nervous system. Complete loss of pits is lethal early in development, whereas partial knockdown with RNA interference in neurons leads to neurodegeneration, revealing a requirement for this gene in proper neuronal function and maintenance. The identified IRF2BPL nonsense variants behave as severe loss-of-function alleles in this model organism, and ectopic expression of the missense variants leads to a range of phenotypes. Taken together, our results show that IRF2BPL and pits are required in the nervous system in humans and flies, and their loss leads to a range of neurological phenotypes in both species.	[Marcogliese, Paul C.; Rosenfeld, Jill A.; Chung, Hyung-Lok; Zuo, Zhongyuan; Lee, Pei-Tseng; Kanca, Oguz; Xia, Fan; Yang, Yaping; Yamamoto, Shinya; Wangler, Michael F.; Lee, Brendan; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shashi, Vandana; Spillmann, Rebecca C.; Riley, Kacie; Koeberl, Dwight D.; Pena, Loren D. M.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Stong, Nicholas; Goldstein, David B.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA; [Koenig, Mary Kay] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Child & Adolescent Neurol, Houston, TX 77030 USA; [Martinez-Agosto, Julian A.; Herzog, Matthew; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Resnick Neuropsychiat Hosp, Dept Child & Adolescent Psychiat, Los Angeles, CA 90095 USA; [Chen, Agnes H.; Dickson, Patricia I.; Lin, Henry J.; Vera, Moin U.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pediat, Torrance, CA 90502 USA; [Salamon, Noriko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA; [Ortiz, Damara; Infante, Elena] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Steyaert, Wouter; Dermaut, Bart; Poppe, Bruce] Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; [Smith, Edward C.; Jasien, Joan; Kansagra, Sujay] Duke Univ, Sch Med, Dept Pediat, Div Neurol, Durham, NC 27710 USA; [Spiridigliozzi, Gail] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [El-Dairi, Mays] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA; [Lark, Robert] Duke Univ, Sch Med, Dept Orthoped Surg, Durham, NC 27710 USA; [Golden-Grant, Katie] Seattle Childrens Hosp, Div Genet Med, Seattle, WA 98105 USA; [Yamamoto, Shinya; Wangler, Michael F.; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Yamamoto, Shinya; Wangler, Michael F.; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mirzaa, Ghayda] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Mirzaa, Ghayda] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Hemelsoet, Dimitri] Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Pena, Loren D. M.] Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA	Baylor College of Medicine; Duke University; Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ghent University; Ghent University Hospital; Duke University; Duke University; Duke University; Duke University; Seattle Children's Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Ghent University; Ghent University Hospital; Baylor College of Medicine; Howard Hughes Medical Institute; Cincinnati Children's Hospital Medical Center	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Pena, LDM (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.; Pena, LDM (corresponding author), Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA.	hbellen@bcm.edu; loren.pena@cchmc.org	Marcogliese, Paul/GQY-7404-2022; Martinez-Agosto, Julian A/I-9435-2019; Stong, Nicholas/ABB-7516-2021; Dermaut, Bart/AAM-2483-2020; Wangler, Michael/H-6368-2019; Yamamoto, Shinya/ABB-2837-2021; Xia, Fan/GQP-4575-2022; Coucke, Paul J/AAO-2954-2020; Steyaert, Wouter/AAB-6700-2019; Nelson, Stanley F/D-4771-2009; Goldstein, David/AAY-8125-2020	Martinez-Agosto, Julian A/0000-0001-6776-6949; Wangler, Michael/0000-0001-5245-5910; Yamamoto, Shinya/0000-0003-2172-8036; Coucke, Paul J/0000-0001-7119-586X; Steyaert, Wouter/0000-0001-8393-0788; Nelson, Stanley F/0000-0002-2082-3114; Douine, Emilie/0000-0002-6048-2887; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Allard, Patrick/0000-0001-7765-1547; Macnamara, Ellen/0000-0002-9418-3287; orange, jordan/0000-0001-7117-7725; Hemelsoet, Dimitri/0000-0001-5403-3092; Brown, Donna/0000-0002-8805-7225; Behnam, Babak/0000-0002-1266-1602; Callens, Steven/0000-0002-7245-527X	Undiagnosed Diseases Network [U01HG007672, U01HG007703, U54NS093793]; Simons Foundation [368479]; National Institute of Neurological Disorders and Stroke (NINDS) [K08NS092898]; Jordan's Guardian Angels; NIH [U54HD083092];  [R01GM067858];  [R24OD022005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007672, U01HG007703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS092898, U54NS093793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD022005] Funding Source: NIH RePORTER	Undiagnosed Diseases Network; Simons Foundation; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jordan's Guardian Angels; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is funded by the Undiagnosed Diseases Network U01HG007672 to V.S. and D.B.G., U01HG007703 to S.F.N., and U54NS093793 to H.J.B., S.Y., and M.J.W. H.J.B. is also supported by R01GM067858 and R24OD022005, and S.Y. and M.F.W. by a Simons Foundation Functional Screen Award (368479). We would like to thank Alejandro Lomniczi (OHSU) for sharing the IRF2BPL cDNA and Hongling Pan for technical assistance. Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) under award number K08NS092898 and Jordan's Guardian Angels (to G.M.). Confocal microscopy at Baylor College of Medicine is supported in part by NIH grant U54HD083092 to the Intellectual and Developmental Disabilities Research Center (IDDRC) Neurovisualization Core. H.J.B. is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding sources had no role in the design or conduct of the study, collection, management, analysis and interpretation of the data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication. The authors would like to thank the subjects and their families for their participation.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Burg MG, 2012, J NEUROGENET, V26, P189, DOI 10.3109/01677063.2012.690011; Chao HT, 2017, AM J HUM GENET, V100, P128, DOI 10.1016/j.ajhg.2016.11.018; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Chouhan AK, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0333-4; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; Cusack BP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002276; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Edvardson S, 2017, AM J HUM GENET, V101, P267, DOI 10.1016/j.ajhg.2017.07.002; Engelen M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0486-0; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gahl WA, 2015, JAMA-J AM MED ASSOC, V314, P1797, DOI 10.1001/jama.2015.12249; Gnerer JP, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv113; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Heger S, 2007, J CLIN INVEST, V117, P2145, DOI 10.1172/JCI31752; Higashimori A, 2018, CANCER RES, V78, P1643, DOI 10.1158/0008-5472.CAN-17-2403; Hsu CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20259; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jaiswal M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002197; Jiang Y, 2015, AM J HUM GENET, V97, P272, DOI 10.1016/j.ajhg.2015.06.013; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kohlschutter A, 2016, PEDIATR ENDOCR REV P, V13, P682; Lee PT, 2018, ELIFE, V7, DOI 10.7554/eLife.35574; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li CX, 2017, CELL PHYSIOL BIOCHEM, V43, P1402, DOI 10.1159/000481872; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Liaw GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33388; Lin G, 2018, CELL METAB, V28, P605, DOI 10.1016/j.cmet.2018.05.019; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Liu N, 2018, HUM MOL GENET, V27, P2454, DOI 10.1093/hmg/ddy146; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo X, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006905; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Madabattula ST, 2015, JOVE-J VIS EXP, DOI 10.3791/52741; Marcogliese PC, 2017, HUM MOL GENET, V26, P1247, DOI 10.1093/hmg/ddx030; Matagne V, 2009, ENDOCRINOLOGY, V150, P1870, DOI 10.1210/en.2008-0779; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Nagarkar-Jaiswal S, 2015, ELIFE, V4, P2743; Olahova M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020; PAVLIDIS P, 1995, J NEUROSCI, V15, P5810; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quinodoz M, 2017, AM J HUM GENET, V101, P623, DOI 10.1016/j.ajhg.2017.09.001; Rakheja D, 2007, CURR MOL MED, V7, P603, DOI 10.2174/156652407781695729; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Rampazzo A, 2000, BIOCHEM BIOPH RES CO, V278, P766, DOI 10.1006/bbrc.2000.3883; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rohrbaugh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053091; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shashi V, 2016, AM J HUM GENET, V99, P991, DOI 10.1016/j.ajhg.2016.08.017; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sumi-Akamaru H, 2015, NEUROPATHOLOGY, V35, P289, DOI 10.1111/neup.12202; Tan KL, 2018, DEV CELL, V45, P226, DOI 10.1016/j.devcel.2018.03.020; Toro C, 2018, HUM MOL GENET, V27, P691, DOI 10.1093/hmg/ddx435; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Venken KJT, 2010, GENETICS, V186, P1111, DOI 10.1534/genetics.110.121285; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/nmeth.1331, 10.1038/NMETH.1331]; Wang J, 2017, AM J HUM GENET, V100, P843, DOI 10.1016/j.ajhg.2017.04.010; Wangler MF, 2017, GENETICS, V207, P9, DOI 10.1534/genetics.117.203067; Xu J, 2016, ENDOCR J, V63, P681, DOI 10.1507/endocrj.EJ16-0123; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yoon WH, 2017, NEURON, V93, P115, DOI 10.1016/j.neuron.2016.11.038; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	77	43	44	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					245	260		10.1016/j.ajhg.2018.07.006	http://dx.doi.org/10.1016/j.ajhg.2018.07.006			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30057031	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000440563700007
J	Mendes, MI; Salazar, MG; Guerrero, K; Thiffault, I; Salomons, GS; Gauquelin, L; Tran, LT; Forget, D; Gauthier, MS; Waisfisz, Q; Smith, DEC; Simons, C; van der Knaap, MS; Marquardt, I; Lemes, A; Mierzewska, H; Weschke, B; Koehler, W; Coulombe, B; Wolf, NI; Bernard, G				Mendes, Marisa I.; Salazar, Mariana Gutierrez; Guerrero, Kether; Thiffault, Isabelle; Salomons, Gajja S.; Gauquelin, Laurence; Tran, Luan T.; Forget, Diane; Gauthier, Marie-Soleil; Waisfisz, Quinten; Smith, Desiree E. C.; Simons, Cas; van der Knaap, Marjo S.; Marquardt, Iris; Lemes, Aida; Mierzewska, Hanna; Weschke, Bernhard; Koehler, Wolfgang; Coulombe, Benoit; Wolf, Nicole I.; Bernard, Genevieve			Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; SPINAL-CORD INVOLVEMENT; MASS-SPECTROMETRY DATA; BRAIN-STEM; NONCANONICAL FUNCTION; HOMOZYGOUS MUTATION; TRANSLATION; VARIANT; COMPLEX; GENE	Hypomyelinating leukodystrophies are genetic disorders characterized by insufficient myelin deposition during development. They are diagnosed on the basis of both clinical and MRI features followed by genetic confirmation. Here, we report on four unrelated affected individuals with hypomyelination and bi-allelic pathogenic variants in EPRS, the gene encoding cytoplasmic glutamyl-prolyl-aminoacyl-tRNA synthetase. EPRS is a bifunctional aminoacyl-tRNA synthetase that catalyzes the aminoacylation of glutamic acid and proline tRNA species. It is a subunit of a large multisynthetase complex composed of eight aminoacyl-tRNA synthetases and its three interacting proteins. In total, five different EPRS mutations were identified. The p.Pro1115Arg variation did not affect the assembly of the multisynthetase complex (MSC) as monitored by affinity purification-mass spectrometry. However, immunoblot analyses on protein extracts from fibroblasts of the two affected individuals sharing the p.Pro1115Arg variant showed reduced EPRS amounts. EPRS activity was reduced in one affected individual's lymphoblasts and in a purified recombinant protein model. Interestingly, two other cytoplasmic aminoacyl-tRNA synthetases have previously been implicated in hypomyelinating leukodystrophies bearing clinical and radiological similarities to those in the individuals we studied. We therefore hypothesized that leukodystrophies caused by mutations in genes encoding cytoplasmic aminoacyl-tRNA synthetases share a common underlying mechanism, such as reduced protein availability, abnormal assembly of the multisynthetase complex, and/or abnormal aminoacylation, all resulting in reduced translation capacity and insufficient myelin deposition in the developing brain.	[Mendes, Marisa I.; Salomons, Gajja S.; Smith, Desiree E. C.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HZ Amsterdam, Netherlands; [Mendes, Marisa I.; Salomons, Gajja S.; Smith, Desiree E. C.] Amsterdam Neurosci Amsterdam, NL-1081 HZ Amsterdam, Netherlands; [Salazar, Mariana Gutierrez; Guerrero, Kether; Tran, Luan T.; Bernard, Genevieve] McGill Univ, Ctr Hlth, Res Inst, Child Hlth & Human Dev Program, Montreal, PQ H4A 3J1, Canada; [Salazar, Mariana Gutierrez; Forget, Diane; Gauthier, Marie-Soleil; Coulombe, Benoit] Inst Rech Clin Montreal, Translat Prote Lab, Montreal, PQ H2W 1R7, Canada; [Thiffault, Isabelle] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Gauquelin, Laurence; Bernard, Genevieve] McGill Univ, Dept Neurol & Neurosur, Montreal, PQ H4A 3J1, Canada; [Gauquelin, Laurence; Bernard, Genevieve] McGill Univ, Dept Pediat, Montreal, PQ H4A 3J1, Canada; [Waisfisz, Quinten] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 HZ Amsterdam, Netherlands; [Simons, Cas] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Simons, Cas] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [van der Knaap, Marjo S.; Wolf, Nicole I.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 HZ Amsterdam, Netherlands; [van der Knaap, Marjo S.; Wolf, Nicole I.] Amsterdam Neurosci, NL-1081 HZ Amsterdam, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HZ Amsterdam, Netherlands; [Marquardt, Iris] Oldenburg Hosp, Ctr Child & Adolescent Med, Dept Neuropediat, D-26131 Oldenburg, Germany; [Lemes, Aida] Natl Reference Ctr Congenital Defects & Rare Dis, Inborn Errors Metab Unit, Montevideo 11200, Uruguay; [Mierzewska, Hanna] Inst Mother & Child Hlth, Dept Child & Adolescent Neurol, Warsaw, Poland; [Weschke, Bernhard] Charite Univ Med Berlin, Ctr Chronically Sick Children, Dept Pediat Neurol, Berlin, Germany; [Koehler, Wolfgang] Univ Med Ctr, Dept Neurol, Leipzig, Germany; [Coulombe, Benoit] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Bernard, Genevieve] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Med Genet, Montreal, PQ H4A 3J1, Canada	Vrije Universiteit Amsterdam; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Children's Mercy Hospital; McGill University; McGill University; Vrije Universiteit Amsterdam; University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; Universite de Montreal; McGill University	Bernard, G (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Child Hlth & Human Dev Program, Montreal, PQ H4A 3J1, Canada.; Bernard, G (corresponding author), McGill Univ, Dept Neurol & Neurosur, Montreal, PQ H4A 3J1, Canada.; Bernard, G (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ H4A 3J1, Canada.; Bernard, G (corresponding author), McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Med Genet, Montreal, PQ H4A 3J1, Canada.	genevieve.bernard@mcgill.ca	Bernard, Geneviève/AAU-7569-2020; Simons, Cas/A-7905-2011; Wolf, Nicole I/H-3943-2014	Bernard, Geneviève/0000-0002-9634-2966; Simons, Cas/0000-0003-3147-8042; Wolf, Nicole I/0000-0003-1721-0728; Smith, Desiree/0000-0003-2053-3392; van der Knaap, Marjo/0000-0001-8912-0954; Weschke, Bernhard/0000-0003-4533-0743; Waisfisz, Quinten/0000-0002-7384-9182; Tran, Luan T/0000-0003-4666-1755; Gauquelin, Laurence/0000-0001-6820-1843	Canadian Institutes of Health Research [201610PJT- 377869, MOP-G2-341146-159133-BRIDG, 201512MSH-360766-171036]; Fondation du Grand Defi Pierre Lavoie; Fondation les Amis d'Eliott; Fondation Lueur d'Espoir pour Ayden; Reseau de Medecine Genetique Appliquee; ZonMw TOP [91211005]; Compute Canada; Fonds de Recherche du Quebec en Sante; McGill University Faculty of Medicine Internal Studentship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation du Grand Defi Pierre Lavoie; Fondation les Amis d'Eliott; Fondation Lueur d'Espoir pour Ayden; Reseau de Medecine Genetique Appliquee; ZonMw TOP; Compute Canada; Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); McGill University Faculty of Medicine Internal Studentship Award	The authors wish to thank the patients and their families for their participation. This study was supported by grants from the Canadian Institutes of Health Research (201610PJT- 377869 and MOP-G2-341146-159133-BRIDG), the Fondation du Grand Defi Pierre Lavoie, the Fondation les Amis d'Eliott, the Fondation Lueur d'Espoir pour Ayden, and the Reseau de Medecine Genetique Appliquee. Part of this study received financial support from ZonMw TOP (grant 91211005). This research was enabled in part by support provided by Compute Canada (www.computecanada.ca). We also wish to acknowledge the McGill University and Genome Quebec Innovation Centre, where Sanger sequencing of affected individuals P1 and P2 was performed. M.G.S. has received the 2016-2017 McGill University Faculty of Medicine Internal Studentship Award. G.B. has received a Research Scholar Junior 1 award from the Fonds de Recherche du Quebec en Sante (2012-2016) and the New Investigator Salary Award from the Canadian Institutes of Health Research (201512MSH-360766-171036, 2017-2022).	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Brozkova DS, 2015, BRAIN, V138, P2161, DOI 10.1093/brain/awv158; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cloutier P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15615; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hyun YS, 2014, CLIN GENET, V86, P592, DOI 10.1111/cge.12327; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Kevelam SH, 2016, NEUROPEDIATRICS, V47, P349, DOI 10.1055/s-0036-1588020; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lavallee-Adam M, 2013, J PROTEOME RES, V12, P272, DOI 10.1021/pr300778b; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miyake N, 2011, CLIN GENET, V80, P293, DOI 10.1111/j.1399-0004.2011.01644.x; Parikh S, 2015, MOL GENET METAB, V114, P501, DOI 10.1016/j.ymgme.2014.12.434; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Shukla A, 2018, J HUM GENET, V63, P19, DOI 10.1038/s10038-017-0363-1; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Thiffault I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8623; Vanderver A, 2016, ANN NEUROL, V79, P1031, DOI 10.1002/ana.24650; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	41	43	43	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					676	684		10.1016/j.ajhg.2018.02.011	http://dx.doi.org/10.1016/j.ajhg.2018.02.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29576217	Bronze, Green Published			2022-12-18	WOS:000429340800013
J	Liu, XY; Finucane, HK; Gusev, A; Bhatia, G; Gazal, S; O'Connor, L; Bulik-Sullivan, B; Wright, FA; Sullivan, PF; Neale, BM; Price, AL				Liu, Xuanyao; Finucane, Hilary K.; Gusev, Alexander; Bhatia, Gaurav; Gazal, Steven; O'Connor, Luke; Bulik-Sullivan, Brendan; Wright, Fred A.; Sullivan, Patrick F.; Neale, Benjamin M.; Price, Alkes L.			Functional Architectures of Local and Distal Regulation of Gene Expression in Multiple Human Tissues	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN CELL-TYPES; COMPLEX TRAITS; PARTITIONING HERITABILITY; INTEGRATIVE ANALYSIS; PERIPHERAL-BLOOD; SUPER-ENHANCERS; RARE VARIANTS; COMMON SNPS; DISEASE	Genetic variants that modulate gene expression levels play an important role in the etiology of human diseases and complex traits. Although large-scale eQTL mapping studies routinely identify many local eQTLs, the molecular mechanisms by which genetic variants regulate expression remain unclear, particularly for distal eQTLs, which these studies are not well powered to detect. Here, we leveraged all variants (not just those that pass stringent significance thresholds) to analyze the functional architecture of local and distal regulation of gene expression in 15 human tissues by employing an extension of stratified LD-score regression that produces robust results in simulations. The top enriched functional categories in local regulation of peripheral-blood gene expression included coding regions (11.41x), conserved regions (4.67x), and four histone marks (p<5 x 10(-5) for all enrichments); local enrichments were similar across the 15 tissues. We also observed substantial enrichments for distal regulation of peripheral-blood gene expression: coding regions (4.47x), conserved regions (4.51x), and two histone marks (p < 3 x 10(-7) for all enrichments). Analyses of the genetic correlation of gene expression across tissues confirmed that local regulation of gene expression is largely shared across tissues but that distal regulation is highly tissue specific. Our results elucidate the functional components of the genetic architecture of local and distal regulation of gene expression.	[Liu, Xuanyao; Finucane, Hilary K.; Gusev, Alexander; Bhatia, Gaurav; Gazal, Steven; O'Connor, Luke; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02142 USA; [O'Connor, Luke] Harvard Univ, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Bulik-Sullivan, Brendan; Neale, Benjamin M.; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Bulik-Sullivan, Brendan; Neale, Benjamin M.] Broad Inst tute MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Bulik-Sullivan, Brendan; Neale, Benjamin M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Wright, Fred A.] North Carolina State Univ, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Wright, Fred A.] North Carolina State Univ, Dept Biol Sci, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Liu, XY; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Price, AL (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xuliu@hsph.harvard.edu; aprice@hsph.harvard.edu	Gazal, Steven/AAK-3764-2020	Gazal, Steven/0000-0003-4510-5730	NIH [R01 MH107649]; US National Institute of Mental Health [U01MH109528]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107649, U01MH109528] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Soumya Raychaudhuri for helpful discussions. This research was funded by NIH grant R01 MH107649. P.F.S. acknowledges funding from the US National Institute of Mental Health (U01MH109528) for the Psychiatric Genomics Consortium.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fish AE, 2016, AM J HUM GENET, V99, P817, DOI 10.1016/j.ajhg.2016.07.022; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Ongen H, 2015, AM J HUM GENET, V97, P567, DOI 10.1016/j.ajhg.2015.09.004; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schork A. J., PLOS GENET, V9; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yin ZY, 2015, GENET EPIDEMIOL, V39, P357, DOI 10.1002/gepi.21900; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220; Zhao J, 2016, AM J HUM GENET, V98, P299, DOI 10.1016/j.ajhg.2015.12.023; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	66	43	43	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					605	616		10.1016/j.ajhg.2017.03.002	http://dx.doi.org/10.1016/j.ajhg.2017.03.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28343628	Green Published, Bronze			2022-12-18	WOS:000398389600004
J	Harding, BN; Moccia, A; Drunat, S; Soukarieh, O; Tubeuf, H; Chitty, LS; Verloes, A; Gressens, P; El Ghouzzi, V; Joriot, S; Di Cunto, F; Martins, A; Passemard, S; Bielas, SL				Harding, Brian N.; Moccia, Amanda; Drunat, Severine; Soukarieh, Omar; Tubeuf, Helene; Chitty, Lyn S.; Verloes, Alain; Gressens, Pierre; El Ghouzzi, Vincent; Joriot, Sylvie; Di Cunto, Ferdinando; Martins, Alexandra; Passemard, Sandrine; Bielas, Stephanie L.			Mutations in Citron Kinase Cause Recessive Microlissencephaly with Multinucleated Neurons	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTROSOMAL PROTEIN; GENETIC-VARIANTS; MIDBODY RING; CYTOKINESIS; ASPM; NEUROGENESIS; APOPTOSIS; ANILLIN; CELLS; WDR62	Primary microcephaly is a neurodevelopmental disorder that is caused by a reduction in brain size as a result of defects in the proliferation of neural progenitor cells during development. Mutations in genes encoding proteins that localize to the mitotic spindle and centrosomes have been implicated in the pathogenicity of primary microcephaly. In contrast, the contractile ring and midbody required for cytokinesis, the final stage of mitosis, have not previously been implicated by human genetics in the molecular mechanisms of this phenotype. Citron kinase (CIT) is a multi-domain protein that localizes to the cleavage furrow and midbody of mitotic cells, where it is required for the completion of cytokinesis. Rodent models of Cit deficiency highlighted the role of this gene in neurogenesis and microcephaly over a decade ago. Here, we identify recessively inherited pathogenic variants in CIT as the genetic basis of severe microcephaly and neonatal death. We present postmortem data showing that CIT is critical to building a normally sized human brain. Consistent with cytokinesis defects attributed to CIT, multinucleated neurons were observed throughout the cerebral cortex and cerebellum of an affected proband, expanding our understanding of mechanisms attributed to primary microcephaly.	[Harding, Brian N.] Univ Penn, Perelman Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA; [Harding, Brian N.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Moccia, Amanda; Bielas, Stephanie L.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Drunat, Severine; Verloes, Alain; Passemard, Sandrine] Hop Robert Debre, Protect, Dept Genet, F-75019 Paris, France; [Drunat, Severine; Verloes, Alain; Gressens, Pierre; El Ghouzzi, Vincent; Passemard, Sandrine] Hop Robert Debre, INSERM, U1141, F-75019 Paris, France; [Soukarieh, Omar; Tubeuf, Helene; Martins, Alexandra] Univ Rouen, Normandy Ctr Genom & Personalized Med, Inst Res & Innovat Biomed, INSERM,U1079, F-76183 Rouen, France; [Tubeuf, Helene] Interact Biosoftware, F-76000 Rouen, France; [Chitty, Lyn S.] UCL Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England; [Chitty, Lyn S.] Great Ormond St NHS Fdn Trust, London WC1N 1EH, England; [Gressens, Pierre; Passemard, Sandrine] Univ Paris Diderot, Hop Robert Debre, F-75019 Paris, France; [Gressens, Pierre] Kings Coll London, Ctr Dev Brain, St Thomas Campus, London WC2R 2LS, England; [Joriot, Sylvie] Ctr Hosp Reg Univ Lille, Serv Neuropediat, F-59037 Lille, France; [Di Cunto, Ferdinando] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; Universite de Lille - ISITE; CHU Lille; University of Turin	Bielas, SL (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	sbielas@umich.edu	Martins, Alexandra/J-9592-2013; Soukarieh, Omar/T-8244-2019; Di Cunto, Ferdinando/K-5575-2016; /AAK-8500-2021; gressens, pierre/M-7557-2017; EL GHOUZZI, Vincent/X-4364-2018	Martins, Alexandra/0000-0003-4322-8497; gressens, pierre/0000-0002-0909-4221; EL GHOUZZI, Vincent/0000-0001-5894-8978; chitty, lyn/0000-0002-4857-7138; di cunto, ferdinando/0000-0001-9367-6357; Soukarieh, Omar/0000-0003-4923-4353; Bielas, Stephanie/0000-0003-0567-5632	NIH [R00HD069624]; French Institut National du Cancer; Direction Generale de l'Offre de Soins (AAP/CFB/CI); French Ministry of Education; French Association Nationale de la Recherche et de la Technologie; Programme Hospitalizer de Recherche Clinique [P100128/IDRCB: 2010-A01481-38]; ERA-NET [ANR-13-RARE-0007-01 2013]; National Institute for Health Research [NF-SI-0513-10141] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD069624] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD069624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Institut National du Cancer(Institut National du Cancer (INCA) France); Direction Generale de l'Offre de Soins (AAP/CFB/CI); French Ministry of Education; French Association Nationale de la Recherche et de la Technologie; Programme Hospitalizer de Recherche Clinique; ERA-NET; National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the families for their participation and contribution to this research. We appreciate Ritesh K.C. and Brian McGrath for stimulating discussion during manuscript preparation and Dr. Joseph Loturco, Dr. Joseph Gleeson, Dr. Ozgur Rosti, and Dr. Hongda Li for collaborations on CIT genetics and molecular biology. This work was supported by the NIH (R00HD069624 to S.L.B), the French Institut National du Cancer and Direction Generale de l'Offre de Soins (AAP/CFB/CI to A.M.), the French Ministry of Education (PhD fellowship to O.S.), the French Association Nationale de la Recherche et de la Technologie in the context of public-private partnership between INSERM and Interactive Biosoftware (CIFRE PhD fellowship to H.T.), and the Programme Hospitalizer de Recherche Clinique (grant no. P100128/IDRCB: 2010-A01481-38) and ERA-NET E-Rare-2 2013 (grant no. ANR-13-RARE-0007-01 2013) to S.D., A.V., V.E.G., P.G., and S.P. The sponsors of the study had no role in study design, data collection, analysis and interpretation, or writing of the manuscript.	Ackman JB, 2007, DEV NEUROSCI-BASEL, V29, P113, DOI 10.1159/000096216; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bassi ZI, 2011, J CELL BIOL, V195, P595, DOI 10.1083/jcb.201105136; Berkovic S, 2012, EPILEPSIA, V53, P1457, DOI 10.1111/j.1528-1167.2012.03511.x; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; El Amine N, 2013, J CELL BIOL, V203, P487, DOI 10.1083/jcb.201305053; Fry AE, 2014, AM J MED GENET C, V166, P198, DOI 10.1002/ajmg.c.31402; Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952; Gaildrat P, 2010, METHODS MOL BIOL, V653, P249, DOI 10.1007/978-1-60761-759-4_15; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lek M, 2015, BIORXIV; Li HD, 2016, AM J HUM GENET, V99, P501, DOI 10.1016/j.ajhg.2016.07.004; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Moon HM, 2013, WIRES DEV BIOL, V2, P229, DOI 10.1002/wdev.67; Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Roberts MR, 2000, J NEUROSCI, V20, P2295; Sarkisian MR, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-08-j0001.2002; Soukarieh O, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005756	36	43	43	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					511	520		10.1016/j.ajhg.2016.07.003	http://dx.doi.org/10.1016/j.ajhg.2016.07.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27453579	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000381617200023
J	Fregeau, B; Kim, BJ; Hernandez-Garcia, A; Jordan, VK; Cho, MT; Schnur, RE; Monaghan, KG; Juusola, J; Rosenfeld, JA; Bhoj, E; Zackai, EH; Sacharow, S; Baranano, K; Bosch, DGM; de Vries, BBA; Lindstrom, K; Schroeder, A; James, P; Kulch, P; Lalani, SR; van Haelst, MM; van Gassen, KLI; van Binsbergen, E; Barkovich, AJ; Scott, DA; Sherr, EH				Fregeau, Brieana; Kim, Bum Jun; Hernandez-Garcia, Andres; Jordan, Valerie K.; Cho, Megan T.; Schnur, Rhonda E.; Monaghan, Kristin G.; Juusola, Jane; Rosenfeld, Jill A.; Bhoj, Elizabeth; Zackai, Elaine H.; Sacharow, Stephanie; Baranano, Kristin; Bosch, Danielle G. M.; de Vries, Bert B. A.; Lindstrom, Kristin; Schroeder, Audrey; James, Philip; Kulch, Peggy; Lalani, Seema R.; van Haelst, Mieke M.; van Gassen, Koen L. I.; van Binsbergen, Ellen; Barkovich, A. James; Scott, Daryl A.; Sherr, Elliott H.			De Novo Mutations of RERE Cause a Genetic Syndrome with Features that Overlap Those Associated with Proximal 1p36 Deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; MONOSOMY 1P36; TRUNCATING MUTATIONS; HISTONE DEACETYLASE; ANOPHTHALMIA; KIF21B; STRA6; IDENTIFICATION; MICROPHTHALMIA; ABNORMALITIES	Deletions of chromosome 1p36 affect approximately 1 in 5,000 newborns and are associated with developmental delay, intellectual disability, and defects involving the brain, eye, ear, heart, and kidney. Arginine-glutamic acid dipeptide repeats (RERE) is located in the proximal 1p36 critical region. RERE is a widely-expressed nuclear receptor coregulator that positively regulates retinoic acid signaling. Animal models suggest that RERE deficiency might contribute to many of the structural and developmental birth defects and medical problems seen in individuals with 1p36 deletion syndrome, although human evidence supporting this role has been lacking. In this report, we describe ten individuals with intellectual disability, developmental delay, and/or autism spectrum disorder who carry rare and putatively damaging changes in RERE. In all cases in which both parental DNA samples were available, these changes were found to be de novo. Associated features that were recurrently seen in these individuals included hypotonia, seizures, behavioral problems, structural CNS anomalies, ophthalmologic anomalies, congenital heart defects, and genitourinary abnormalities. The spectrum of defects documented in these individuals is similar to that of a cohort of 31 individuals with isolated 1p36 deletions that include RERE and are recapitulated in RERE-deficient zebrafish and mice. Taken together, our findings suggest that mutations in RERE cause a genetic syndrome and that haploinsufficiency of RERE might be sufficient to cause many of the phenotypes associated with proximal 1p36 deletions.	[Fregeau, Brieana; Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Kim, Bum Jun; Hernandez-Garcia, Andres; Rosenfeld, Jill A.; Lalani, Seema R.; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jordan, Valerie K.; Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Cho, Megan T.; Schnur, Rhonda E.; Monaghan, Kristin G.; Juusola, Jane] GeneDx, Gaithersburg, MD 20877 USA; [Bhoj, Elizabeth; Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Sacharow, Stephanie] Boston Childrens Hosp, Div Med Genet, Boston, MA 02115 USA; [Baranano, Kristin] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Bosch, Danielle G. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Lindstrom, Kristin; James, Philip; Kulch, Peggy] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85006 USA; [Bosch, Danielle G. M.] Bartimeus Inst Visually Impaired, NL-3702 AD Zeist, Netherlands; [Bosch, Danielle G. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 GA Nijmegen, Netherlands; [van Haelst, Mieke M.; van Gassen, Koen L. I.; van Binsbergen, Ellen] Univ Med Ctr Utrecht, Dept Genet, NL-3508 GA Utrecht, Netherlands; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94158 USA; [Schroeder, Audrey] Univ Rochester, Med Ctr, Div Genet, Rochester, NY 14642 USA	University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Boston Children's Hospital; Johns Hopkins University; Radboud University Nijmegen; Phoenix Children's Hospital; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; University of Rochester	Sherr, EH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Scott, DA (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	dscott@bcm.edu; elliott.sherr@ucsf.edu	Lalani, Seema/AAI-5090-2020; HERNANDEZ-GARCIA, ANDRES/B-9051-2014	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; van Gassen, Koen/0000-0001-7934-0662	National Institute of Neurological Disorders and Stroke [R01 NS058721]; Netherlands Organization for Health Research and Development [912-12-109]; ODAS Stichting; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058721] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); ODAS Stichting; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the family members for participating in this research. This work was supported by the National Institute of Neurological Disorders and Stroke (grant R01 NS058721 to E.H.S.), the Netherlands Organization for Health Research and Development (grant 912-12-109 to B.B.A.d.V), and ODAS Stichting (to D.G.M.B. and B.B.A.d.V). E.H.S is a member of the clinical advisory board of InVitae and consults for Personalis. M.T.C, R.S., K.G.M, and J.J. are all employees of GeneDx, which provides exome sequencing on a clinical basis. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from clinical laboratory testing conducted at Baylor Miraca Genetics Laboratories, which provides exome sequencing on a clinical basis.	Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Bosch DG, 2015, EUR J HUM GENET; Brown PR, 2003, BIOL REPROD, V68, P2241, DOI 10.1095/biolreprod.102.013466; Bursztejn AC, 2009, AM J MED GENET A, V149A, P2493, DOI 10.1002/ajmg.a.33051; Campeau PM, 2008, AM J MED GENET A, V146A, P3062, DOI 10.1002/ajmg.a.32563; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Fukasawa T, 2015, BRAIN DEV-JPN, V37, P631, DOI 10.1016/j.braindev.2014.10.001; Giraudeau F, 2001, J MED GENET, V38, P121, DOI 10.1136/jmg.38.2.121; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Heilstedt HA, 2003, CLIN GENET, V64, P310, DOI 10.1034/j.1399-0004.2003.00126.x; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; HERO I, 1990, INVEST OPHTH VIS SCI, V31, P197; Jordan VK, 2015, APPL CLIN GENET, V8, P189, DOI 10.2147/TACG.S65698; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; Kim BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087518; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068422, 10.1371/journal.pone.0057460]; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Liu YC, 2013, IMMUNOGENETICS, V65, P835, DOI 10.1007/s00251-013-0733-6; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Monroe GR, 2016, GENET MED; Nicoulaz A, 2011, AM J MED GENET A, V155A, P1964, DOI 10.1002/ajmg.a.33210; Paciorkowski AR, 2011, EUR J HUM GENET, V19, P1238, DOI 10.1038/ejhg.2011.121; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Schilling TF, 1996, DEVELOPMENT, V123, P329; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shimada S, 2015, BRAIN DEV-JPN, V37, P515, DOI 10.1016/j.braindev.2014.08.002; Slavotinek A, 1999, J MED GENET, V36, P657; Touma M, 2013, EPILEPSIA, V54, pe81, DOI 10.1111/epi.12137; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Zaveri HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085600; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	38	43	45	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					963	970		10.1016/j.ajhg.2016.03.002	http://dx.doi.org/10.1016/j.ajhg.2016.03.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27087320	Green Published, Bronze			2022-12-18	WOS:000375869300013
J	van Rahden, VA; Fernandez-Vizarra, E; Alawi, M; Brand, K; Fellmann, F; Horn, D; Zeviani, M; Kutsche, K				van Rahden, Vanessa A.; Fernandez-Vizarra, Erika; Alawi, Malik; Brand, Kristina; Fellmann, Florence; Horn, Denise; Zeviani, Massimo; Kutsche, Kerstin			Mutations in NDUFB11, Encoding a Complex I Component of the Mitochondrial Respiratory Chain, Cause Microphthalmia with Linear Skin Defects Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; MIDAS SYNDROME MICROPHTHALMIA; MLS SYNDROME; MOLECULAR CHARACTERIZATION; DERMAL APLASIA; X-INACTIVATION; GOLTZ-SYNDROME; GENE; SCLEROCORNEA; DISORDERS	Microphthalmia with linear skin defects (MLS) syndrome is an X-linked male-lethal disorder also known as MIDAS (microphthalmia, dermal aplasia, and sclerocornea). Additional clinical features include neurological and cardiac abnormalities. MLS syndrome is genetically heterogeneous given that heterozygous mutations in HCCS or COX7B have been identified in MLS-affected females. Both genes encode proteins involved in the structure and function of complexes III and IV, which form the terminal segment of the mitochondrial respiratory chain (MRC). However, not all individuals with MLS syndrome carry a mutation in either HCCS or COX7B. The majority of MLS-affected females have severe skewing of X chromosome inactivation, suggesting that mutations in HCCS, COX7B, and other as-yet-unidentified X-linked gene(s) cause selective loss of cells in which the mutated X chromosome is active. By applying whole-exome sequencing and filtering for X-chromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female individual and a heterozygous 1-bp deletion in a second individual, her asymptomatic mother, and an affected aborted fetus of the subject's mother. NDUFB11 encodes one of 30 poorly characterized supernumerary subunits of NADH: ubiquinone oxidoreductase, known as complex I (cI), the first and largest enzyme of the MRC. By shRNA-mediated NDUFB11 knockdown in HeLa cells, we demonstrate that NDUFB11 is essential for cI assembly and activity as well as cell growth and survival. These results demonstrate that X-linked genetic defects leading to the complete inactivation of complex I, III, or IV underlie MLS syndrome. Our data reveal an unexpected role of cI dysfunction in a developmental phenotype, further underscoring the existence of a group of mitochondrial diseases associated with neurocutaneous manifestations.	[van Rahden, Vanessa A.; Brand, Kristina; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Fernandez-Vizarra, Erika; Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Hamburg, Ctr Bioinformat, D-20146 Hamburg, Germany; [Alawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom Res Grp, D-20246 Hamburg, Germany; [Fellmann, Florence] CHU Vaudois, Serv Genet Med, CH-1011 Lausanne, Switzerland; [Horn, Denise] Charite, Inst Med Genet & Humangenet, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Heinrich Pette Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.	kkutsche@uke.de	Zeviani, Massimo/AAU-2632-2021; , Malik/AAB-7437-2021; Fernandez-Vizarra, Erika/AAE-5600-2020	Zeviani, Massimo/0000-0002-9067-5508; , Malik/0000-0002-5993-7709; Fellmann, Florence/0000-0003-3156-4768; Fernandez-Vizarra, Erika/0000-0002-2469-142X	Deutsche Forschungsgemeinschaft [KU 1240/6-1]; ERC-FP7 advanced grant [322424]; MRC [MC_UP_1002/1] Funding Source: UKRI; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC-FP7 advanced grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the individuals with MLS syndrome and their families who contributed to this study. We thank Dr. Luitgard Graul-Neumann for caring for subject 2 and her parents, Mrs. Inka Jantke and Mrs. Inga Ziemer for skilful technical assistance, Prof. Eva Klopocki for array CGH analysis, Dr. Isabella Rau for XCI analysis, Dr. Nicole Sekarski for clinical referral, and Dr. Pu Yan for pathological analysis of subject 1. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (KU 1240/6-1 to K.K.) and an ERC-FP7 advanced grant (322424 to M.Z.).	Abdollahpour H, 2015, EUR J HUM GENET, V23, P256, DOI 10.1038/ejhg.2014.73; Alberry MS, 2011, CLIN DYSMORPHOL, V20, P111, DOI 10.1097/MCD.0b013e328342eb66; ALLANSON J, 1991, J MED GENET, V28, P143, DOI 10.1136/jmg.28.2.143-a; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; BIRD LM, 1994, AM J MED GENET, V53, P141, DOI 10.1002/ajmg.1320530205; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cape CJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1070, DOI 10.1001/archopht.122.7.1070; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Chen XL, 2013, AM J HUM GENET, V92, P375, DOI 10.1016/j.ajhg.2013.02.006; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dabell MP, 2013, AM J MED GENET A, V161A, P717, DOI 10.1002/ajmg.a.35780; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Finsterer J, 2008, CLIN CARDIOL, V31, P225, DOI 10.1002/clc.20224; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Gurok U, 2007, GENE EXPR PATTERNS, V7, P370, DOI 10.1016/j.modgep.2006.07.004; HAPPLE R, 1993, AM J MED GENET, V47, P710, DOI 10.1002/ajmg.1320470525; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Indrieri A, 2013, EMBO MOL MED, V5, P280, DOI 10.1002/emmm.201201739; Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kobayashi M, 1998, J PEDIAT OPHTH STRAB, V35, P122; Kono T, 1999, J HUM GENET, V44, P63, DOI 10.1007/s100380050110; Kutsche K, 2002, CYTOGENET GENOME RES, V99, P297, DOI 10.1159/000071607; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Morleo M, 2005, AM J MED GENET A, V137A, P190, DOI 10.1002/ajmg.a.30864; MUCKE J, 1995, AM J MED GENET, V57, P117, DOI 10.1002/ajmg.1320570123; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Petruzzella V, 2007, BIOCHEM BIOPH RES CO, V355, P181, DOI 10.1016/j.bbrc.2007.01.140; Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005; Schaefer L, 1996, GENOMICS, V34, P166, DOI 10.1006/geno.1996.0261; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schwarz QP, 2002, GENOMICS, V79, P51, DOI 10.1006/geno.2001.6677; Sharma VM, 2008, PEDIATR DERMATOL, V25, P548, DOI 10.1111/j.1525-1470.2008.00724.x; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Van den Veyver IB, 2001, SEMIN REPROD MED, V19, P183, DOI 10.1055/s-2001-15398; van Rahden VA, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-53; Vergult S, 2013, MOL VIS, V19, P311; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Wimplinger I, 2007, EUR J MED GENET, V50, P421, DOI 10.1016/j.ejmg.2007.07.004; Wimplinger I, 2007, MOL VIS, V13, P1475; Wimplinger I, 2006, AM J HUM GENET, V79, P878, DOI 10.1086/508474; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zumwalt J, 2012, PEDIATR DERMATOL, V29, P217, DOI [10.1111/j.1525-1470.2011.01632.x, 10.1111/j.1525-1470.2011.01633.x]; Zvulunov A, 1998, BRIT J DERMATOL, V138, P1046	57	43	45	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					640	650		10.1016/j.ajhg.2015.02.002	http://dx.doi.org/10.1016/j.ajhg.2015.02.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25772934	Green Published, Bronze			2022-12-18	WOS:000352212600011
J	Amyere, M; Aerts, V; Brouillard, P; McIntyre, BAS; Duhoux, FP; Wassef, M; Enjolras, O; Mulliken, JB; Devuyst, O; Antoine-Poirel, H; Boon, LM; Vikkula, M				Amyere, Mustapha; Aerts, Virginie; Brouillard, Pascal; McIntyre, Brendan A. S.; Duhoux, Francois P.; Wassef, Michel; Enjolras, Odile; Mulliken, John B.; Devuyst, Olivier; Antoine-Poirel, Helene; Boon, Laurence M.; Vikkula, Miikka			Somatic Uniparental Isodisomy Explains Multifocality of Glomuvenous Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOMUS CELLS VMGLOM; VENOUS MALFORMATIONS; 2-HIT MECHANISM; MUTATIONS; GENE; KIDNEY; LOCUS; MODEL; GLOMANGIOMAS; CYSTOGENESIS	Inherited vascular malformations are commonly autosomal dominantly inherited with high, but incomplete, penetrance; they often present as multiple lesions. We hypothesized that Knudson's two-hit model could explain this multifocality and partial penetrance. We performed a systematic analysis of inherited glomuvenous malformations (GVMs) by using multiple approaches, including a sensitive allele-specific pairwise SNP-chip method. Overall, we identified 16 somatic mutations, most of which were not intragenic but were cases of acquired uniparental isodisomy (aUPID) involving chromosome 1p. The breakpoint of each aUPID is located in an A- and T-rich, high-DNA-flexibility region (1p13.1-1p12). This region corresponds to a possible new fragile site. Occurrences of these mutations render the inherited glomulin variant in 1p22.1 homozygous in the affected tissues without loss of genetic material. This finding demonstrates that a double hit is needed to trigger formation of a GVM. It also suggests that somatic UPID, only detectable by sensitive pairwise analysis in heterogeneous tissues, might be a common phenomenon in human cells. Thus, aUPID might play a role in the pathogenesis of various nonmalignant disorders and might explain local impaired function and/or clinical variability. Furthermore, these data suggest that pairwise analysis of blood and tissue, even on heterogeneous tissue, can be used for localizing double-hit mutations in disease-causing genes.	[Amyere, Mustapha; Aerts, Virginie; Brouillard, Pascal; McIntyre, Brendan A. S.; Boon, Laurence M.; Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium; [Duhoux, Francois P.; Antoine-Poirel, Helene; Vikkula, Miikka] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Wassef, Michel] Hop Lariboisiere, Serv Anat & Cytol Pathol, F-75010 Paris, France; [Enjolras, Odile] Hop Enfants Armand Trousseau, Dept Maxillofacial & Plast Surg, Pediat Vasc Clin, F-75571 Paris, France; [Mulliken, John B.] Childrens Hosp, Vasc Anomalies Ctr, Dept Plast Surg, Boston, MA 02115 USA; [Mulliken, John B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Devuyst, Olivier] Catholic Univ Louvain, Nephrol Unit, B-1200 Brussels, Belgium; [Boon, Laurence M.; Vikkula, Miikka] Catholic Univ Louvain, Clin Univ St Luc, Div Plast Surg, Ctr Vasc Anomalies, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Vikkula, M (corresponding author), Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium.	miikka.vikkula@uclouvain.be	Boon, Laurence/HCI-3629-2022; Vikkula, Miikka/Q-1038-2018; BROUILLARD, Pascal/AER-9771-2022	Vikkula, Miikka/0000-0002-6236-338X; BROUILLARD, Pascal/0000-0001-9548-8229; Devuyst, Olivier/0000-0003-3744-4767; Duhoux, Francois/0000-0002-5429-7888	Belgian Federal Science Policy; National Institutes of Health [P01 AR048564]; Fonds de la Recherche Scientifique; la Lotterie Nationale, Belgium; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture; Patrimoine de la Faculte de Medicine of the Universite catholique de Louvain; Patrimoine de la Faculte de Medecine fellowship from the Universite catholique de Louvain; National Science and Engineering Research Council of Canada; FRS-FNRS; Concerted Research Actions of the French Community of Belgium [07/12-005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	Belgian Federal Science Policy(Belgian Federal Science Policy Office); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); la Lotterie Nationale, Belgium; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Patrimoine de la Faculte de Medicine of the Universite catholique de Louvain; Patrimoine de la Faculte de Medecine fellowship from the Universite catholique de Louvain; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Concerted Research Actions of the French Community of Belgium; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to all the individuals for their invaluable contributions. These studies were supported by the Belgian Federal Science Policy, Concerted Research Actions (07/12-005) of the French Community of Belgium, the National Institutes of Health (program project P01 AR048564), the Fonds de la Recherche Scientifique (all to M.V.), and la Lotterie Nationale, Belgium. M.A. is a Scientific Logistics Manager of the Fonds de la Recherche Scientifique (FRS-FNRS). V.A. was supported by a fellowship from the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture and from the Patrimoine de la Faculte de Medicine of the Universite catholique de Louvain. B.A.S.M. was supported by a Patrimoine de la Faculte de Medecine fellowship from the Universite catholique de Louvain. He also received a doctoral research grant from the National Science and Engineering Research Council of Canada. F.P.D. is supported by fellowship from the FRS-FNRS. We thank Ms. Dominique Cottem and Ms. Anne Van Egeren for technical support and Ms. Liliana Niculescu for her secretarial and administrative contributions.	Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Badenas C, 2000, EUR J HUM GENET, V8, P487, DOI 10.1038/sj.ejhg.5200484; Boon LM, 1999, AM J HUM GENET, V65, P125, DOI 10.1086/302450; Boon LM, 2004, ARCH DERMATOL, V140, P971, DOI 10.1001/archderm.140.8.971; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; Brouillard P, 2000, GENOMICS, V67, P96, DOI 10.1006/geno.2000.6232; Brouillard P, 2002, AM J HUM GENET, V70, P866, DOI 10.1086/339492; Brouillard P, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024174; Brouillard P., 2008, INBORN ERRORS DEV, P1561; Brouillard P, 2007, HUM MOL GENET, V16, pR140, DOI 10.1093/hmg/ddm211; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gault J, 2009, NEUROSURGERY, V65, P138, DOI 10.1227/01.NEU.0000348049.81121.C1; GOODMAN TF, 1971, ARCH DERMATOL, V103, P11, DOI 10.1001/archderm.103.1.11; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Holt D, 1999, AM J HUM GENET, V65, P1423, DOI 10.1086/302614; Irrthum A, 2001, EUR J HUM GENET, V9, P34, DOI 10.1038/sj.ejhg.5200576; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Limaye N, 2009, HUM MOL GENET, V18, pR65, DOI 10.1093/hmg/ddp002; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Losekoot M, 2012, J MED GENET, V49, P37, DOI 10.1136/jmedgenet-2011-100452; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mallory SB, 2006, ARCH DERMATOL, V142, P892, DOI 10.1001/archderm.142.7.892; McDonald DA, 2011, HUM MOL GENET, V20, P211, DOI 10.1093/hmg/ddq433; Medves S, 2010, LEUKEMIA, V24, P1052, DOI 10.1038/leu.2010.13; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	39	43	43	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					188	196		10.1016/j.ajhg.2012.12.017	http://dx.doi.org/10.1016/j.ajhg.2012.12.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23375657	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000315179600003
J	Kia, SK; Verbeek, E; Engelen, E; Schot, R; Poot, RA; de Coo, IFM; Lequin, MH; Poulton, CJ; Pourfarzad, F; Grosveld, FG; Brehm, A; de Wit, MCY; Oegema, R; Dobyns, WB; Verheijen, FW; Mancini, GMS				Kia, Sima Kheradmand; Verbeek, Elly; Engelen, Erik; Schot, Rachel; Poot, Raymond A.; de Coo, Irenaeus F. M.; Lequin, Maarten H.; Poulton, Cathryn J.; Pourfarzad, Farzin; Grosveld, Frank G.; Brehm, Antonio; de Wit, Marie Claire Y.; Oegema, Renske; Dobyns, William B.; Verheijen, Frans W.; Mancini, Grazia M. S.			RTTN Mutations Link Primary Cilia Function to Organization of the Human Cerebral Cortex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLANAR CELL POLARITY; LEFT-RIGHT SPECIFICATION; LEFT-RIGHT ASYMMETRY; JOUBERT SYNDROME; GENETIC CLASSIFICATION; WNT GENES; MOUSE; CILIOPATHIES; DEFECTS; DISEASE	Polymicrogyria is a malformation of the developing cerebral cortex caused by abnormal organization and characterized by many small gyri and fusion of the outer molecular layer. We have identified autosomal-recessive mutations in RTTN, encoding Rotatin, in individuals with bilateral diffuse polymicrogyria from two separate families. Rotatin determines early embryonic axial rotation, as well as anteroposterior and dorsoventral patterning in the mouse. Human Rotatin has recently been identified as a centrosome-associated protein. The Drosophila melanogaster homolog of Rotatin, Ana3, is needed for structural integrity of centrioles and basal bodies and maintenance of sensory neurons. We show that Rotatin colocalizes with the basal bodies at the primary cilium. Cultured fibroblasts from affected individuals have structural abnormalities of the cilia and exhibit downregulation of BMP4, WNT5A, and WNT2B, which are key regulators of cortical patterning and are expressed at the cortical hem, the cortex-organizing center that gives rise to Cajal-Retzius (CR) neurons. Interestingly, we have shown that in mouse embryos, Rotatin colocalizes with CR neurons at the subpial marginal zone. Knockdown experiments in human fibroblasts and neural stem cells confirm a role for RTTN in cilia structure and function. RTTN mutations therefore link aberrant ciliary function to abnormal development and organization of the cortex in human individuals.	[Kia, Sima Kheradmand; Verbeek, Elly; Schot, Rachel; Poulton, Cathryn J.; Oegema, Renske; Verheijen, Frans W.; Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Dept Clin Genet, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Engelen, Erik; Poot, Raymond A.; Pourfarzad, Farzin; Grosveld, Frank G.] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [de Coo, Irenaeus F. M.; de Wit, Marie Claire Y.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Neurol, NL-3000 CB Rotterdam, Netherlands; [Lequin, Maarten H.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Radiol, NL-3000 CB Rotterdam, Netherlands; [Brehm, Antonio] Univ Madeira, Human Genet Lab, P-9000390 Funchal, Portugal; [Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [de Coo, Irenaeus F. M.; Lequin, Maarten H.; de Wit, Marie Claire Y.; Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Expertise Ctr Neurodev Disorders, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Universidade da Madeira; Seattle Children's Hospital; Erasmus University Rotterdam; Erasmus MC	Mancini, GMS (corresponding author), Erasmus Univ, Med Ctr, Dept Clin Genet, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	g.mancini@erasmusmc.nl	Oegema, Renske/AAA-4323-2020; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020; de Wit, Marie-Claire/X-4168-2019	Oegema, Renske/0000-0002-7146-617X; Dobyns, William/0000-0002-7681-2844; Brehm, Antonio/0000-0003-3168-5340; de Coo, Irenaeus/0000-0003-0533-7422				Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Chatterjee B, 2007, MAMM GENOME, V18, P310, DOI 10.1007/s00335-007-9023-7; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Wit MCY, 2008, ARCH NEUROL-CHICAGO, V65, P358, DOI 10.1001/archneur.65.3.358; Faisst AM, 2002, MECH DEVELOP, V113, P15, DOI 10.1016/S0925-4773(02)00003-5; Field M, 2012, EUR J HUM GENET, V20, P806, DOI 10.1038/ejhg.2012.9; Fischer E, 2009, SEMIN CELL DEV BIOL, V20, P998, DOI 10.1016/j.semcdb.2009.09.016; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fujiwara T, 2002, DEVELOPMENT, V129, P4685; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Judkins AR, 2011, J NEUROPATH EXP NEUR, V70, P438, DOI 10.1097/NEN.0b013e31821ccf1c; Komatsu Y, 2011, DEVELOPMENT, V138, P3915, DOI 10.1242/dev.068833; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Leventer RJ, 2010, BRAIN, V133, P1415, DOI 10.1093/brain/awq078; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Melloy PG, 1998, DEV BIOL, V193, P77, DOI 10.1006/dbio.1997.8787; Piedra ME, 2002, DEVELOPMENT, V129, P3431; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sattar S, 2011, DEV MED CHILD NEUROL, V53, P793, DOI 10.1111/j.1469-8749.2011.04021.x; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Stevens NR, 2009, J CELL BIOL, V187, P355, DOI 10.1083/jcb.200905031; Subramanian L, 2009, CEREB CORTEX, V19, pI90, DOI 10.1093/cercor/bhp031; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; UniProtKB/Swiss-Prot Rotatin reference, UNIPROTKB SWISS PROT; Vivancos V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-7; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250	46	43	45	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					533	540		10.1016/j.ajhg.2012.07.008	http://dx.doi.org/10.1016/j.ajhg.2012.07.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22939636	Green Published, Bronze			2022-12-18	WOS:000308683100014
J	Sarig, O; Nahum, S; Rapaport, D; Ishida-Yamamoto, A; Fuchs-Telem, D; Li, QL; Cohen-Katsenelson, K; Spiegel, R; Nousbeck, J; Israeli, S; Borochowitz, ZU; Padalon-Brauch, G; Uitto, J; Horowitz, M; Shalev, S; Sprecher, E				Sarig, Ofer; Nahum, Sagi; Rapaport, Debora; Ishida-Yamamoto, Akemi; Fuchs-Telem, Dana; Li Qiaoli; Cohen-Katsenelson, Ksenya; Spiegel, Ronen; Nousbeck, Janna; Israeli, Shirli; Borochowitz, Zvi-Uri; Padalon-Brauch, Gilly; Uitto, Jouni; Horowitz, Mia; Shalev, Stavit; Sprecher, Eli			Short Stature, Onychodysplasia, Facial Dysmorphism, and Hypotrichosis Syndrome Is Caused by a POC1A Mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; IDENTIFICATION; TRAFFICKING; COMPONENT; ATP6V0A2	Disproportionate short stature refers to a heterogeneous group of hereditary disorders that are classified according to their mode of inheritance, clinical skeletal and nonskeletal manifestations, and radiological characteristics. In the present study, we report on an autosomal-recessive osteocutaneous disorder that we termed SOFT (short stature, onychodysplasia, facial dysmorphism, and hypotrichosis) syndrome. We employed homozygosity mapping to locate the disease-causing mutation to region 3p21.1-3p21.31. Using whole-exome-sequencing analysis complemented with Sanger direct sequencing of poorly covered regions, we identified a homozygous point mutation (c.512T>C [p.Leu171Pro]) in POC1A (centriolar protein homolog A). This mutation was found to cosegregate with the disease phenotype in two families. The p.Leu171Pro substitution affects a highly conserved amino acid residue and is predicted to interfere with protein function. Pod, a POC1A ortholog, was previously found to have a role in centrosome stability in unicellular organisms. Accordingly, although centrosome structure was preserved, the number of centrosomes and their distribution were abnormal in affected cells. In addition, the Golgi apparatus presented a dispersed morphology, cholera-toxin trafficking from the plasma membrane to the Golgi was aberrant, and large vesicles accumulated in the cytosol. Collectively, our data underscore the importance of POC1A for proper bone, hair, and nail formation and highlight the importance of normal centrosomes in Golgi assembly and trafficking from the plasma membrane to the Golgi apparatus.	[Nahum, Sagi; Cohen-Katsenelson, Ksenya; Spiegel, Ronen; Borochowitz, Zvi-Uri; Shalev, Stavit] Technion Israel Inst Technol, Rappaport Fac Med, IL-32000 Haifa, Israel; [Sarig, Ofer; Fuchs-Telem, Dana; Nousbeck, Janna; Israeli, Shirli; Padalon-Brauch, Gilly; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-642395 Tel Aviv, Israel; [Rapaport, Debora; Horowitz, Mia] Tel Aviv Univ, Sackler Fac Med, Dept Cell Res & Immunol, IL-69978 Ramat Aviv, Israel; [Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Fuchs-Telem, Dana; Israeli, Shirli; Sprecher, Eli] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Ramat Aviv, Israel; [Li Qiaoli; Uitto, Jouni] Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Spiegel, Ronen; Shalev, Stavit] Haemek Med Ctr, Inst Human Genet, IL-18101 Afula, Israel; [Borochowitz, Zvi-Uri] Bnai Zion Med Ctr, Simon Winter Inst Human Genet, IL-31048 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Asahikawa Medical College; Tel Aviv University; Sackler Faculty of Medicine; Jefferson University; Emek Medical Center; Bnai Zion Medical Center	Shalev, S (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, IL-32000 Haifa, Israel.	stavit_sh@clalitorg.il; elisp@tasmc.health.gov.il	Li, Qiaoli/F-8383-2013	Li, Qiaoli/0000-0002-8495-7103				Basel-Vanagaite L, 2009, AM J HUM GENET, V85, P254, DOI 10.1016/j.ajhg.2009.07.001; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Fourrage C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013994; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Itin PH, 2004, AM J MED GENET C, V131C, P45, DOI 10.1002/ajmg.c.30033; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Malfait F, 2010, GENET MED, V12, P597, DOI 10.1097/GIM.0b013e3181eed412; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Morava E, 2009, EUR J HUM GENET, V17, P1099, DOI 10.1038/ejhg.2009.22; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shalev SA, 2012, EUR J MED GENET, V55, P256, DOI 10.1016/j.ejmg.2012.02.011; Syx D, 2010, HUM GENET, V128, P79, DOI 10.1007/s00439-010-0829-0; Uppal S, 2008, NAT GENET, V40, P789, DOI 10.1038/ng.153; Vinogradova T, 2012, MOL BIOL CELL, V23, P820, DOI 10.1091/mbc.E11-06-0550	25	43	45	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					337	342		10.1016/j.ajhg.2012.06.003	http://dx.doi.org/10.1016/j.ajhg.2012.06.003			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22840363	Green Published, Bronze			2022-12-18	WOS:000307608700012
J	Larsson, M; Duffy, DL; Zhu, G; Liu, JZ; Macgregor, S; McRae, AF; Wright, MJ; Sturm, RA; Mackey, DA; Montgomery, GW; Martin, NG; Medland, SE				Larsson, Mats; Duffy, David L.; Zhu, Gu; Liu, Jimmy Z.; Macgregor, Stuart; McRae, Allan F.; Wright, Margaret J.; Sturm, Richard A.; Mackey, David A.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.			GWAS Findings for Human Iris Patterns: Associations with Variants in Genes that Influence Normal Neuronal Pattern Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMEWIDE ASSOCIATION; SEMAPHORIN 3A; MELANOMA METASTASIS; EXPRESSION; PAX6; EYE; SCHIZOPHRENIA; PIGMENTATION; COMPLEX; LINKAGE	Human iris patterns are highly variable. The origins of this variation are of interest in the study of iris-related eye diseases and forensics, as well as from an embryological developmental perspective, with regard to their possible relationship to fundamental processes of neurodevelopment. We have performed genome-wide association scans on four iris characteristics (crypt frequency, furrow contractions, presence of peripupillary pigmented ring, and number of nevi) in three Australian samples of European descent. Both the discovery (n = 2121) and replication (n = 499 and 73) samples showed evidence for association between (1) crypt frequency and variants in the axonal guidance gene SEMA3A (p = 6.6 x 10(-11)), (2) furrow contractions and variants within the cytoskeleton gene TRAF3IP1 (p = 2.3 x 10(-12)), and (3) the pigmented ring and variants in the well-known pigmentation gene SLC24A4 (p = 7.6 x 10(-21)). These replicated findings individually accounted for around 1.5%-3% of the variance for these iris characteristics. Because both SEMA3A and TRAFIP1 are implicated in pathways that control neurogenesis, neural migration, and synaptogenesis, we also examined the evidence of enhancement among such genes, finding enrichment for crypts and furrows. These findings suggest that genes involved in normal neuronal pattern development may also influence tissue structures in the human iris.	[Larsson, Mats; Duffy, David L.; Zhu, Gu; Liu, Jimmy Z.; Macgregor, Stuart; McRae, Allan F.; Wright, Margaret J.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Larsson, Mats] Univ Orebro, Sch Law Psychol & Social Work, Res Dev Ctr, S-70182 Orebro, Sweden; [Mackey, David A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia	QIMR Berghofer Medical Research Institute; Orebro University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Queensland; Lions Eye Institute; University of Western Australia	Larsson, M (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	mats.larsson@oru.se	Macgregor, Stuart/C-6442-2009; Wright, Margaret J/H-3308-2014; Mackey, David A/H-5340-2014; Sturm, Richard A/C-9943-2009; Wright, Margaret Jane/A-4560-2016; Medland, Sarah/AAT-7595-2020; McRae, Allan F/J-2644-2014; Martin, Nicholas/R-9235-2019; Duffy, David L/B-7392-2013; Montgomery, Grant W/B-7148-2008; Medland, Sarah E/C-7630-2013	Macgregor, Stuart/0000-0001-6731-8142; Mackey, David A/0000-0001-7914-4709; Sturm, Richard A/0000-0003-1301-0294; Wright, Margaret Jane/0000-0001-7133-4970; Medland, Sarah/0000-0003-1382-380X; McRae, Allan F/0000-0001-5286-5485; Martin, Nicholas/0000-0003-4069-8020; Duffy, David L/0000-0001-7227-632X; Montgomery, Grant W/0000-0002-4140-8139; Medland, Sarah E/0000-0003-1382-380X	Australian National Health and Medical Research Council [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921]; FP-5 GenomEUtwin Project [QLG2-CT-2002-01254]; U.S. National Institutes of Health [AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, MH66206]; National Health and Medical Research Council (NHMRC); Swedish Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R01AA013326, R01AA007535, R01AA014041, R01AA013321] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); FP-5 GenomEUtwin Project; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by the Australian National Health and Medical Research Council (241944, 339462, 389927,389875, 389891, 389892, 389938, 442915, 442981, 496739,552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921),the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (NIH grants AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, MH66206). S.E.M., D.R.N., ARM., MARE, S.M., D.L.D., and G.W.M. are supported by the National Health and Medical Research Council (NHMRC) Fellowship Scheme. M.L. is a Postdoctoral Fellow supported by the Swedish Research Council.	Alaeddini R, 2010, FORENSIC SCI INT-GEN, V4, P148, DOI 10.1016/j.fsigen.2009.09.007; ASANO N, 1995, OPHTHALMOLOGY, V102, P1279, DOI 10.1016/S0161-6420(95)30873-1; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Davis-Silberman N, 2008, BRAIN RES, V1192, P17, DOI 10.1016/j.brainres.2007.03.043; de Snoo FA, 2008, EUR J HUM GENET, V16, P1135, DOI 10.1038/ejhg.2008.72; Deutsch SI, 2010, EUR NEUROPSYCHOPHARM, V20, P281, DOI 10.1016/j.euroneuro.2010.02.005; DONALDSON D, 1961, ARCH OPHTHALMOL-CHIC, V65, P26, DOI 10.1001/archopht.1961.01840020028007; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Eastwood SL, 2003, MOL PSYCHIATR, V8, P148, DOI 10.1038/sj.mp.4001233; Ellison-Wright Z, 2004, EUR J NEUROSCI, V19, P1505, DOI 10.1111/j.1460-9568.2004.03236.x; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Houlston RS, 1999, EYE, V13, P43, DOI 10.1038/eye.1999.9; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Larsson M, 2003, TWIN RES, V6, P192, DOI 10.1375/136905203765693843; Lee MJ, 2007, CURR OPIN NEUROL, V20, P135, DOI 10.1097/WCO.0b013e3280895da8; Liu F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000934; Liu F, 2009, CURR BIOL, V19, pR192, DOI 10.1016/j.cub.2009.01.027; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Mackey DA, 2009, TWIN RES HUM GENET, V12, P441, DOI 10.1375/twin.12.5.441; Marien P, 2008, CORTEX, V44, P54, DOI 10.1016/j.cortex.2005.12.001; Mashimo T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000784; MCCANNEL TA, 2010, INVEST OPHTH VIS SCI, V52, P3018; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Miele ME, 2000, INT J CANCER, V86, P524, DOI 10.1002/(SICI)1097-0215(20000515)86:4<524::AID-IJC13>3.0.CO;2-W; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Neale M. C., 1999, MX STAT MODELING; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pascual M, 2005, HIPPOCAMPUS, V15, P184, DOI 10.1002/hipo.20040; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richtig E, 2004, OPHTHALMOLOGICA, V218, P111, DOI 10.1159/000076146; Rosa JL, 1997, ONCOGENE, V15, P1, DOI 10.1038/sj.onc.1201170; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shirasaki F, 2001, CANCER RES, V61, P7422; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; STURM RA, 2009, NATURE, V22, P544; Sturm RA, 2008, PIGM CELL MELANOMA R, V21, P115, DOI 10.1111/j.1755-148X.2008.00444.x; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tamamaki N, 2003, J COMP NEUROL, V455, P238, DOI 10.1002/cne.10476; Ticho BH, 2006, OPHTHALMIC GENET, V27, P145, DOI 10.1080/13816810600976897; Treszl A, 2006, FRONT BIOSCI-LANDMRK, V11, P1844, DOI 10.2741/1927; Wedenoja J, 2008, MOL PSYCHIATR, V13, P673, DOI 10.1038/sj.mp.4002047; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865	55	43	44	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					334	343		10.1016/j.ajhg.2011.07.011	http://dx.doi.org/10.1016/j.ajhg.2011.07.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21835309	Green Published, Bronze			2022-12-18	WOS:000294148800015
J	Hartmann, L; Neveling, K; Borkens, S; Schneider, H; Freund, M; Grassman, E; Theiss, S; Wawer, A; Burdach, S; Auerbach, AD; Schindler, D; Hanenberg, H; Schaal, H				Hartmann, Linda; Neveling, Kornelia; Borkens, Stephanie; Schneider, Hildegard; Freund, Marcel; Grassman, Elke; Theiss, Stephan; Wawer, Angela; Burdach, Stefan; Auerbach, Arleen D.; Schindler, Detlev; Hanenberg, Helmut; Schaal, Heiner			Correct mRNA Processing at a Mutant TT Splice Donor in FANCC Ameliorates the Clinical Phenotype in Patients and Is Enhanced by Delivery of Suppressor U1 snRNAs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED GENETIC SUSCEPTIBILITY; SPINAL MUSCULAR-ATROPHY; COMPLEMENTATION GROUP; ANEMIA GENE; BREAST-CANCER; MINOR CLASS; MUTATIONS; PROTEIN; DIAGNOSIS; RESCUE	The U1 small nuclear RNA (U1 snRNA) as a component of the minor U2-dependent spliceosome recognizes 5' splice sites (5'ss) containing GT as the canonical dinucleotide in the intronic positions +1 and +2. The c 165+1G>T germline mutation in the 5'ss of exon 2 of the Fanconi anemia C (FANCC) gene commonly predicted to prevent correct splicing was identified in nine FA patients from three pedigrees. RT-PCR analysis of the endogenous FANCC mRNA splicing pattern of patient-derived fibroblasts revealed aberrant mRNA processing, but surprisingly also correct splicing at the TT dinucleotide, albeit with lower efficiency. This consequently resulted in low levels of correctly spliced transcript and minute levels of normal posttranslationally processed FANCD2 protein, indicating that this naturally occurring TT splicing might contribute to the milder clinical manifestations of the disease in these patients. Functional analysis of this FANCC 5'ss within splicing reporters revealed that both the noncanonical TT dinucleotide and the genomic context of FANCC were required for the residual correct splicing at this mutant 5'ss. Finally, use of lentiviral vectors as a delivery system to introduce expression cassettes for TT-adapted U1 snRNAs into primary FANCC patient fibroblasts allowed the correction of the DNA-damage-induced G2 cell-cycle arrest in these cells, thus representing an alternative transcript-targeting approach for genetic therapy of inherited splice-site mutations.	[Schneider, Hildegard; Freund, Marcel; Hanenberg, Helmut] Univ Dusseldorf, Dept Pediat Hematol Oncol & Clin Immunol, Childrens Hosp, D-40225 Dusseldorf, Germany; [Grassman, Elke] Cincinnati Childrens Hosp, Translat Trials Dev & Support Lab, Cincinnati, OH 45229 USA; [Theiss, Stephan] Result GmbH, D-40219 Dusseldorf, Germany; [Wawer, Angela; Burdach, Stefan] Tech Univ Munich, Childrens Hosp Schwabing, D-80804 Munich, Germany; [Auerbach, Arleen D.] Rockefeller Univ, Int Fanconi Anemia Registry, New York, NY 10021 USA; [Hanenberg, Helmut] Indiana Univ, Sch Med, Dept Pediat, Wells Ctr Pediat Res,Riley Hosp Children, Indianapolis, IN 46202 USA; [Hartmann, Linda; Borkens, Stephanie; Schaal, Heiner] Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Neveling, Kornelia; Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Bioctr, D-97074 Wurzburg, Germany	Heinrich Heine University Dusseldorf; Cincinnati Children's Hospital Medical Center; Technical University of Munich; Rockefeller University; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Heinrich Heine University Dusseldorf; University of Wurzburg	Hanenberg, H (corresponding author), Univ Dusseldorf, Dept Pediat Hematol Oncol & Clin Immunol, Childrens Hosp, D-40225 Dusseldorf, Germany.		Schaal, Heiner/A-5115-2008	Auerbach, Arleen/0000-0002-6911-8379; Theiss, Stephan/0000-0002-5881-6067	Jurgen-Manchot-Stiftung; Stiftung fur AIDS-Forschung, Dusseldorf; Cancer Society North-rhine-Westphalia; Forschungskommission of the Heinrich-Heine-University, Dusseldorf; Deutsche Forschungsgememschaft [DFG SPP1230]; National Institutes of Health [NIH-NHLBI/P01 HL053586-14, NIH-NCI/R01 CA138287-01]; Bundesministerium fur Bildung und Forschung (BMBF) network for Inherited Bone Marrow Failure Syndromes; Fanconi Anemia Research Fund; Deutsche Fanconi-Anamie-Hilfe; Aktionskreis Fanconi-Anamie funds; Cincinnati Children's Hospital Research Foundation; BMBF; Foamyviral Network for Genetic Therapy of FA; NIH [5ULRR024143-04]; NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053586] Funding Source: NIH RePORTER	Jurgen-Manchot-Stiftung; Stiftung fur AIDS-Forschung, Dusseldorf; Cancer Society North-rhine-Westphalia; Forschungskommission of the Heinrich-Heine-University, Dusseldorf; Deutsche Forschungsgememschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung (BMBF) network for Inherited Bone Marrow Failure Syndromes(Federal Ministry of Education & Research (BMBF)); Fanconi Anemia Research Fund; Deutsche Fanconi-Anamie-Hilfe; Aktionskreis Fanconi-Anamie funds; Cincinnati Children's Hospital Research Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); Foamyviral Network for Genetic Therapy of FA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank affected individuals and their families for providing samples for this,study. We thank Alan M Weiner (Seattle, University of Washington) for providing the plasmid pUCBU1 containing the U1 snRNA expression cassette We are indebted to Imke Meyer (Dusseldorf), Birgit Gottwald (Wurzburg), Richard Friedl (Wurzburg), and Waltraud Kuss (Dusseldorf) for expert technical assistance Research in our laboratories was supported by the Jurgen-Manchot-Stiftung (L H., H S), the Stiftung fur AIDS-Forschung, Dusseldorf (H S), the Cancer Society North-rhine-Westphalia (HS), the Forschungskommission of the Heinrich-Heine-University, Dusseldorf (M F, H H, H.S), the Deutsche Forschungsgememschaft (DFG SPP1230) (H), the National Institutes of Health (NIH-NHLBI/P01 HL053586-14 and NIH-NCI/R01 CA138287-01) (H H), the Bundesministerium fur Bildung und Forschung (BMBF) network for Inherited Bone Marrow Failure Syndromes (H H, D S, H S), the Fanconi Anemia Research Fund (H H), the Deutsche Fanconi-Anamie-Hilfe and the Aktionskreis Fanconi-Anamie funds (D S., H.), the Schroeder-Kurth-Fund (D.S), intramural funding from the Cincinnati Children's Hospital Research Foundation (E.G), the BMBF, Foamyviral Network for Genetic Therapy of FA (H), and the NIH Clinical and Translational Science Award (CTSA) grant 5ULRR024143-04 to The Rockefeller University Hospital (A D A)	AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4; Aiuti Alessandro, 2009, Hematology Am Soc Hematol Educ Program, P682, DOI 10.1182/asheducation-2009.1.682; Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Betz B, 2010, J CANCER RES CLIN, V136, P123, DOI 10.1007/s00432-009-0643-z; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; Davies SM, 2005, BRIT J HAEMATOL, V131, P118, DOI 10.1111/j.1365-2141.2005.05721.x; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Demuth I, 2000, EUR J HUM GENET, V8, P861, DOI 10.1038/sj.ejhg.5200552; Dorsman JC, 2007, CELL ONCOL, V29, P211; Faivre L, 2000, BLOOD, V96, P4064; Freund M, 2003, NUCLEIC ACIDS RES, V31, P6963, DOI 10.1093/nar/gkg901; Futaki M, 2000, BLOOD, V95, P1493, DOI 10.1182/blood.V95.4.1493.004k35_1493_1498; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gillio AP, 1997, BLOOD, V90, P105; Green AM, 2009, HEMATOL ONCOL CLIN N, V23, P193, DOI 10.1016/j.hoc.2009.01.008; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Hartmann L, 2008, FRONT BIOSCI-LANDMRK, V13, P3252; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huck K, 2006, BRIT J HAEMATOL, V133, P188, DOI 10.1111/j.1365-2141.2006.05998.x; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kammler S, 2001, RNA, V7, P421, DOI 10.1017/S1355838201001212; Kammler S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-89; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kohn DB, 2009, NEW ENGL J MED, V360, P518, DOI 10.1056/NEJMe0809614; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Kyriakopoulou C, 2006, RNA, V12, P1603, DOI 10.1261/rna.26506; Levran O, 2005, HUM MUTAT, V25, P142, DOI 10.1002/humu.20125; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Marquis J, 2007, MOL THER, V15, P1479, DOI 10.1038/sj.mt.6300200; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Neveling K, 2009, MUTAT RES-FUND MOL M, V668, P73, DOI 10.1016/j.mrfmmm.2009.05.006; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Pietschmann T, 1999, J VIROL, V73, P2613, DOI 10.1128/JVI.73.4.2613-2621.1999; Pinotti M, 2008, BLOOD, V111, P2681, DOI 10.1182/blood-2007-10-117440; Pinotti M, 2009, BLOOD, V113, P6461, DOI 10.1182/blood-2009-03-207613; Pinto FO, 2009, HAEMATOL-HEMATOL J, V94, P487, DOI 10.3324/haematol.13592; Popp H, 2003, CYTOGENET GENOME RES, V103, P54, DOI 10.1159/000076289; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; Roca X, 2009, NAT STRUCT MOL BIOL, V16, P176, DOI 10.1038/nsmb.1546; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; SCHAAL H, 1995, J VIROL, V69, P3308, DOI 10.1128/JVI.69.6.3308-3314.1995; Schild GC, 2007, INFLUENZA OTHER RESP, V1, P1, DOI 10.1111/j.1750-2659.2006.00001.x; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Tachibana A, 1999, HUM MUTAT, V13, P237, DOI 10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.3.CO;2-6; Tanner G, 2009, HUM MUTAT, V30, P255, DOI 10.1002/humu.20861; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Vassilopoulos G, 2008, GENE THER, V15, P1299, DOI 10.1038/gt.2008.129; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Williams DA, 2008, MOL THER, V16, P635, DOI 10.1038/mt.2008.34; Wimmer K, 2007, HUM MUTAT, V28, P599, DOI 10.1002/humu.20493; Yamada T, 2000, J HUM GENET, V45, P159, DOI 10.1007/s100380050203; Yamashita T, 1996, BLOOD, V87, P4424, DOI 10.1182/blood.V87.10.4424.bloodjournal87104424; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	80	43	43	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					480	493		10.1016/j.ajhg.2010.08.016	http://dx.doi.org/10.1016/j.ajhg.2010.08.016			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20869034	Bronze, Green Published			2022-12-18	WOS:000283037600004
J	Johnson, JO; Gibbs, JR; Van Maldergem, L; Houlden, H; Singleton, AB				Johnson, Janel O.; Gibbs, J. Raphael; Van Maldergem, Lionel; Houlden, Henry; Singleton, Andrew B.			Exome Sequencing in Brown-Vialetto-Van Laere Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									[Johnson, Janel O.; Gibbs, J. Raphael; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Johnson, Janel O.; Gibbs, J. Raphael] UCL, Dept Mol Neurosci, London WC1N 3BG, England; [Johnson, Janel O.; Gibbs, J. Raphael] UCL, Reta Lila Weston Labs, Inst Neurol, London WC1N 3BG, England; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, CHU Sart Tilman, B-4000 Liege, Belgium; [Houlden, Henry] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Houlden, Henry] Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; University of Liege; University of London; University College London; University of London; University College London	Singleton, AB (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Singleton, Andrew B/C-3010-2009; Van Maldergem, Lionel/G-9849-2017; Gibbs, J. Raphael/A-3984-2010; Van Maldergem, Lionel/O-3242-2019; Houlden, Henry J/C-1532-2008	Van Maldergem, Lionel/0000-0001-8880-5214; Gibbs, J. Raphael/0000-0002-6985-0658; Van Maldergem, Lionel/0000-0001-8880-5214; Houlden, Henry J/0000-0002-2866-7777	MRC [G0802760] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000958, Z01AG000958] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000958] Funding Source: Medline; Medical Research Council [G0802760] Funding Source: Medline; NIA NIH HHS [Z01 AG000958-07] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9	5	43	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					567	569		10.1016/j.ajhg.2010.05.021	http://dx.doi.org/10.1016/j.ajhg.2010.05.021			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20920669	Bronze, Green Published			2022-12-18	WOS:000283037600014
J	Sun, Y; Almomani, R; Aten, E; Celli, J; van der Heijden, J; Venselaar, H; Robertson, SP; Baroncini, A; Franco, B; Basel-Vanagaite, L; Horii, E; Drut, R; Ariyurek, Y; den Dunnen, JT; Breuning, MH				Sun, Yu; Almomani, Rowida; Aten, Emmelien; Celli, Jacopo; van der Heijden, Jaap; Venselaar, Hanka; Robertson, Stephen P.; Baroncini, Anna; Franco, Brunella; Basel-Vanagaite, Lina; Horii, Emiko; Drut, Ricardo; Ariyurek, Yavuz; den Dunnen, Johan T.; Breuning, Martijn H.			Terminal Osseous Dysplasia Is Caused by a Single Recurrent Mutation in the FLNA Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME INACTIVATION; PERIVENTRICULAR NODULAR HETEROTOPIA; SYNDROME SPECTRUM DISORDERS; EHLERS-DANLOS-SYNDROME; FILAMIN-A; FRONTOMETAPHYSEAL DYSPLASIA; PIGMENTARY DEFECTS; LAST NUCLEOTIDE; BASE SUBSTITUTION; PROTEIN	Terminal osseous dysplasia (TOO) is an X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin, and recurrent digital fibroma with onset in female infancy. After performing X-exome capture and sequencing, we identified a mutation at the last nucleotide of exon 31 of the FLNA gene as the most likely cause of the disease. The variant c.5217G>A was found in six unrelated cases (three families and three sporadic cases) and was not found in 400 control X chromosomes, pilot data from the 1000 Genomes Project, or the FLNA gene variant database. In the families, the variant segregated with the disease, and it was transmitted four times from a mildly affected mother to a more seriously affected daughter. We show that, because of nonrandom X chromosome inactivation, the mutant allele was not expressed in patient fibroblasts. RNA expression of the mutant allele was detected only in cultured fibroma cells obtained from 15-year-old surgically removed material. The variant activates a cryptic splice site, removing the last 48 nucleotides from exon 31. At the protein level, this results in a loss of 16 amino acids (p.Val1724_Thr1739del), predicted to remove a sequence at the surface of filamin repeat 15. Our data show that TOD is caused by this single recurrent mutation in the FLNA gene.	[Sun, Yu; Almomani, Rowida; Aten, Emmelien; Celli, Jacopo; van der Heijden, Jaap; Ariyurek, Yavuz; den Dunnen, Johan T.; Breuning, Martijn H.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Venselaar, Hanka] UMC Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Robertson, Stephen P.] Univ Otago, Dept Paediat & Child Hlth, Dunedin Sch Med, Dunedin 9054, New Zealand; [Baroncini, Anna] ASL Dept Maternal & Child Hlth, Unit Med Genet, I-40026 Imola, Italy; [Franco, Brunella] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy; [Franco, Brunella] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Basel-Vanagaite, Lina] Tel Aviv Univ, Schneider Childrens Med Ctr Israel, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Tel Aviv Univ, Raphael Recanati Genet Inst, Rabin Med Ctr, Petah Tikva & Sackler Fac Med, IL-49100 Petah Tiqwa, Israel; [Horii, Emiko] Nagoya 1st Red Cross Hosp, Nagoya, Aichi, Japan; [Horii, Emiko] Yokkaichi Municipal Hosp, Yokaichi 4538511, Japan; [Drut, Ricardo] Hosp Ninos La Plata, Serv Pathol, RA-1900 La Plata, Argentina; [Ariyurek, Yavuz; den Dunnen, Johan T.] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Otago; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Tel Aviv University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Red Cross Nagoya Daiichi Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Breuning, MH (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands.	m.h.breuning@lumc.nl	Venselaar, Hanka/D-2009-2016; dunnen, johan den/ABH-4228-2020; FRANCO, Brunella/S-2882-2018	Venselaar, Hanka/0000-0001-9824-6559; dunnen, johan den/0000-0002-6304-1710; FRANCO, Brunella/0000-0001-5588-4569; Robertson, Stephen/0000-0002-5181-7809; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Sun, Yu/0000-0002-2938-0233	China Scholarship Council (CSC); European Community [223026, 223143, 200754]; Italian Telethon Foundation	China Scholarship Council (CSC)(China Scholarship Council); European Community(European Commission); Italian Telethon Foundation(Fondazione Telethon)	We would like to thank the patients and their family members for their willingness to join the project, the China Scholarship Council (CSC) scholarship for supporting Yu Sun's studies in The Netherlands, Filip Kluin for sending paraffin-embedded tissue and Hans Morreau for isolating DNA from the tissue, Tobias Messemaker for helping us with immunoblotting, and the Leiden Genome Technology Center (LGTC) and the Laboratory for Diagnostic Genome Analysis (LDGA) for help with sequencing, DNA extraction, and XCI detection. X-exome capture was implemented in collaboration with ServiceXS (Leiden, www.servicexs.com). The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreements 223026 (NMD-chip), 223143 (Tech-Gene), and 200754 (Gen2Phen). B.F. was funded by the Italian Telethon Foundation.	Agarwal N, 2007, HAEMATOLOGICA, V92, P1715, DOI 10.3324/haematol.11543; Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bacino CA, 2000, AM J MED GENET, V94, P102, DOI 10.1002/1096-8628(20000911)94:2<102::AID-AJMG2>3.0.CO;2-X; Baroncini A, 2007, AM J MED GENET A, V143A, P51, DOI 10.1002/ajmg.a.31557; Breuning MH, 2000, AM J MED GENET, V94, P91, DOI 10.1002/1096-8628(20000911)94:2<91::AID-AJMG1>3.0.CO;2-D; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Drut R, 2005, INT J SURG PATHOL, V13, P181, DOI 10.1177/106689690501300209; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gargiulo A, 2007, AM J HUM GENET, V80, P751, DOI 10.1086/513321; Giuliano F, 2005, AM J MED GENET A, V132A, P222, DOI 10.1002/ajmg.a.30396; Hidalgo-Bravo A, 2005, AM J MED GENET A, V136A, P190, DOI 10.1002/ajmg.a.30792; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Horii E, 1998, AM J MED GENET, V80, P1, DOI 10.1002/(SICI)1096-8628(19981102)80:1<1::AID-AJMG1>3.0.CO;2-8; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; MAESTRINI E, 1993, HUM MOL GENET, V2, P761, DOI 10.1093/hmg/2.6.761; Marino-Enriquez A, 2007, AM J MED GENET A, V143A, P1120, DOI 10.1002/ajmg.a.31696; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nikki M, 2002, J BIOL CHEM, V277, P11432, DOI 10.1074/jbc.M111753200; Orstavik KH, 2009, HUM GENET, V126, P363, DOI 10.1007/s00439-009-0670-5; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2006, EUR J HUM GENET, V14, P549, DOI 10.1038/sj.ejhg.5201586; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Robertson SP, 2004, CLIN DYSMORPHOL, V13, P123, DOI 10.1097/01.mcd.0000130235.95356.40; Robertson SP, 2007, EUR J HUM GENET, V15, P3, DOI 10.1038/sj.ejhg.5201654; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Sheen VL, 2005, NEUROLOGY, V64, P254, DOI 10.1212/01.WNL.0000149512.79621.DF; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Yamada K, 2007, MOL GENET METAB, V90, P291, DOI 10.1016/j.ymgme.2006.10.010; Zenker M, 2006, AM J MED GENET A, V140A, P1069, DOI 10.1002/ajmg.a.31213; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhang WZ, 2000, AM J HUM GENET, V66, P1461, DOI 10.1086/302868; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	41	43	51	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					146	153		10.1016/j.ajhg.2010.06.008	http://dx.doi.org/10.1016/j.ajhg.2010.06.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598277	Green Published, Bronze			2022-12-18	WOS:000280029200016
J	Sirmaci, A; Erbek, S; Price, J; Huang, MQ; Duman, D; Cengiz, FB; Bademci, G; Tokgoz-Yilmaz, S; Hismi, B; Ozdag, H; Ozturk, B; Kulaksizoglu, S; Yildirim, E; Kokotas, H; Grigoriadou, M; Petersen, MB; Shahin, H; Kanaan, M; King, MC; Chen, ZY; Blanton, SH; Liu, XZ; Zuchner, S; Akar, N; Tekin, M				Sirmaci, Asli; Erbek, Seyra; Price, Justin; Huang, Mingqian; Duman, Duygu; Cengiz, F. Basak; Bademci, Gueney; Tokgoz-Yilmaz, Suna; Hismi, Burcu; Oezdag, Hilal; Oeztuerk, Banu; Kulaksizoglu, Sevsen; Yildirim, Erkan; Kokotas, Haris; Grigoriadou, Maria; Petersen, Michael B.; Shahin, Hashem; Kanaan, Moien; King, Mary-Claire; Chen, Zheng-Yi; Blanton, Susan H.; Liu, Xue Z.; Zuchner, Stephan; Akar, Nejat; Tekin, Mustafa			A Truncating Mutation in SERPINB6 Is Associated with Autosomal-Recessive Nonsyndromic Sensorineural Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEINASE-INHIBITOR 6; IDENTIFICATION; EVOLUTION; APOPTOSIS; PROTEASE; DEAFNESS	More than 270 million people worldwide have hearing loss that affects normal communication. Although astonishing progress has been made in the identification of more than 50 genes for deafness during the past decade, the majority of deafness genes are yet to be identified. In this study, we mapped a previously unknown autosomal-recessive nonsyndromic sensorineural hearing loss locus (DENB91) to chromosome 6p25 in a consanguineous Turkish family. The degree of hearing loss was moderate to severe in affected individuals. We subsequently identified a nonsense mutation (p.E245X) in SERPINB6, which is located within the linkage interval for DENB91 and encodes for an intracellular protease inhibitor. The p.E245X mutation cosegregated in the family as a completely penetrant autosomal-recessive trait and was absent in 300 Turkish controls. The mRNA expression of SERPINB6 was reduced and production of protein was absent in the peripheral leukocytes of homozygotes, suggesting that the hearing loss is due to loss of function of SERPINB6. We also demonstrated that SERPINB6 was expressed primarily in the inner ear hair cells. We propose that SERPINB6 plays an important role in the inner ear in the protection against leakage of lysosomal content during stress and that loss of this protection results in cell death and sensorineural hearing loss.	[Sirmaci, Asli; Price, Justin; Bademci, Gueney; Blanton, Susan H.; Zuchner, Stephan; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Sirmaci, Asli; Price, Justin; Bademci, Gueney; Blanton, Susan H.; Liu, Xue Z.; Zuchner, Stephan; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Erbek, Seyra] Baskent Univ, Sch Med, Dept Otorhinolaryngol, TR-06490 Ankara, Turkey; [Huang, Mingqian; Chen, Zheng-Yi] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otolaryngol,Eaton Peabody Lab, Boston, MA 02114 USA; [Duman, Duygu; Cengiz, F. Basak; Tokgoz-Yilmaz, Suna; Hismi, Burcu; Akar, Nejat] Ankara Univ, Sch Med, Dept Pediat, Div Genet, TR-06100 Ankara, Turkey; [Oezdag, Hilal] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey; [Oeztuerk, Banu] Selcuk Univ, Meram Sch Med, Dept Ophthalmol, TR-42080 Konya, Turkey; [Kulaksizoglu, Sevsen] Baskent Univ, Sch Med, Dept Biochem, TR-42080 Konya, Turkey; [Yildirim, Erkan] Baskent Univ, Sch Med, Dept Radiodiagnost, TR-42080 Konya, Turkey; [Kokotas, Haris; Grigoriadou, Maria; Petersen, Michael B.] Aghia Sophia Childrens Hosp, Inst Child Hlth, Dept Genet, Athens 11527, Greece; [Shahin, Hashem; Kanaan, Moien] Bethlehem Univ, Dept Life Sci, Bethlehem, Palestine; [King, Mary-Claire] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Liu, Xue Z.] Univ Miami, Miller Sch Med, Dept Otorhinolaryngol, Miami, FL 33136 USA	University of Miami; University of Miami; Baskent University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Ankara University; Ankara University; Selcuk University; Baskent University; Baskent University; The Aghia Sophia Children's Hospital; University of Washington; University of Washington Seattle; University of Miami	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA.	mtekin@med.miami.edu	Ozturk-Hismi, Burcu/AAH-6558-2019; Kulaksızoglu, Sevsen/AAI-8932-2021; Tokgoz-Yilmaz, Suna/AAA-1420-2020; Erbek, Seyra/AAJ-2445-2021; Tekin, Mustafa/ABG-7627-2020; yildirim, erkan/ABI-3856-2020; duman, duygu/AAF-8093-2020; Blanton, Susan Halloran/ABF-1323-2021; Özdag, Hilal/C-9929-2009; Petersen, Michael Bjørn B/D-1483-2017; Akar, Nejat/H-2949-2019; Tokgoz-Yilmaz, Suna/AAT-3892-2020; Duman, Duygu/AAG-7765-2019	Ozturk-Hismi, Burcu/0000-0001-7146-0248; Kulaksızoglu, Sevsen/0000-0002-7613-2240; Tokgoz-Yilmaz, Suna/0000-0002-4656-099X; Erbek, Seyra/0000-0002-8453-6069; yildirim, erkan/0000-0002-9057-722X; duman, duygu/0000-0001-7583-0349; Özdag, Hilal/0000-0001-7940-2499; Petersen, Michael Bjørn B/0000-0003-0316-8207; Tokgoz-Yilmaz, Suna/0000-0002-4656-099X; Bademci, Guney/0000-0002-4052-8833; King, Mary-Claire/0000-0001-9426-1743; Tekin, Mustafa/0000-0002-3525-7960; Kanaan, Moien/0000-0002-3227-4685	The Scientific AMP; Technological Research Council of Turkey [105S464, 108S045]; University of Miami; NIH [R01 DC006908]; National Natural Science Foundation of China [30728030]; Federick and Ines Yeatts [R01 DC005575]; Oticon Fonden, Denmark; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005575, R01DC006908] Funding Source: NIH RePORTER	The Scientific AMP; Technological Research Council of Turkey; University of Miami; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Federick and Ines Yeatts; Oticon Fonden, Denmark; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are thankful to all participating families. We thank Professor Phillip I. Bird from Monash University, Australia, for helpful suggestions and critical reading of the manuscript. This study was partially supported by The Scientific & Technological Research Council of Turkey Grants (105S464 and 108S045), funds from the University of Miami to M.T., NIH R01 DC006908 to Z.-Y.C., National Natural Science Foundation of China to Z.-Y.C. (30728030), the Federick and Ines Yeatts inner ear hair cell regeneration fellowship to M.H., R01 DC005575 to X.Z.L., and a grant from Oticon Fonden, Denmark, to M.B.P.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; COUGHLIN PB, 1993, J BIOL CHEM, V268, P9541; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; FISHELSON M, 1918, BIOINFORMATICS S1, V18, pS189; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Huang MQ, 2008, DEV DYNAM, V237, P3305, DOI 10.1002/dvdy.21735; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Scott FL, 2007, J BIOCHEM, V142, P435, DOI 10.1093/jb/mvm156; Scott FL, 1996, J BIOL CHEM, V271, P1605, DOI 10.1074/jbc.271.3.1605; Scott FL, 1999, GENOMICS, V62, P490, DOI 10.1006/geno.1999.6021; Scott FL, 1999, BLOOD, V93, P2089, DOI 10.1182/blood.V93.6.2089.406k10_2089_2097; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Tekin M, 2003, EUR J PEDIATR, V162, P154, DOI 10.1007/s00431-002-1129-z; Tekin M, 2007, AM J MED GENET A, V143A, P1583, DOI 10.1002/ajmg.a.31702; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zheng J, 2010, NEUROCHEM INT, V56, P516, DOI 10.1016/j.neuint.2009.12.012	27	43	48	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					797	804		10.1016/j.ajhg.2010.04.004	http://dx.doi.org/10.1016/j.ajhg.2010.04.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20451170	Bronze, Green Published			2022-12-18	WOS:000278045300016
J	Okamoto, K; Iwasaki, N; Nishimura, C; Doi, K; Noiri, E; Nakamura, S; Takizawa, M; Ogata, M; Fujimaki, R; Grarup, N; Pisinger, C; Borch-Johnsen, K; Lauritzen, T; Sandbaek, A; Hansen, T; Yasuda, K; Osawa, H; Nanjo, K; Kadowaki, T; Kasuga, M; Pedersen, O; Fujita, T; Kamatani, N; Iwamoto, Y; Tokunaga, K				Okamoto, Koji; Iwasaki, Naoko; Nishimura, Chisa; Doi, Kent; Noiri, Eisei; Nakamura, Shinko; Takizawa, Miho; Ogata, Makiko; Fujimaki, Risa; Grarup, Niels; Pisinger, Charlotta; Borch-Johnsen, Knut; Lauritzen, Torsten; Sandbaek, Annelli; Hansen, Torben; Yasuda, Kazuki; Osawa, Haruhiko; Nanjo, Kishio; Kadowaki, Takashi; Kasuga, Masato; Pedersen, Oluf; Fujita, Toshiro; Kamatani, Naoyuki; Iwamoto, Yasuhiko; Tokunaga, Katsushi			Identification of KCNJ15 as a Susceptibility Gene in Asian Patients with Type 2 Diabetes Mellitus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CALCIUM-SENSING RECEPTOR; MESSENGER-RNA STABILITY; BETA-CELL FUNCTION; SYNONYMOUS MUTATIONS; INSULIN SENSITIVITY; POPULATIONS; GLUCOSE; LOCI; RISK	Recent advances in genome research have enabled the identification of new genomic variations that are associated with type 2 diabetes mellitus (T2DM). Via fine mapping of SNPs in a candidate region of chromosome 21q, the Current study identifies potassium inwardly-rectifying, subfamily, J, member 15 (KCNJ15) as a new T2DM Susceptibility gene. KCNJ15 is expressed in the beta cell of the pancreas, and a synonymous SNIP, rs3746876, in exon 4 (C566T) of this gene, with T allele frequency among control Subjects of 3.1%, showed a significant association with T2DM affecting lean individuals in three independent Japanese sample sets (p = 2.5 x 10(-7), odds ratio |OR| = 2.54, 95% confidence interval |CT| = 1.76-3.67) and with Unstratified T2DM (p = 6.7 x 10(-6), OR = 1.76, 95% Cl = 1.37-2.25). The diabetes risk allele frequency was, however, very low among Europeans in whom no association between this variant and T2DM,l could be shown. Functional analysis in human embryonic kidney 293 cells demonstrated that the risk allele of the synonymous SNP in exon 4 increased KCNJ15 expression via increased mRNA stability, which resulted in the higher expression of protein as compared to that of the nonrisk allele. We also showed that KCNJ15 is expressed in human pancreatic beta cells. In conclusion, we demonstrated a significant association between a synonymous variant in KCNJ15 and T2DM in lean Japanese patients with T2DM, suggesting that KCNJ15 is a previously unreported susceptibility gene for T2DM among Asians.	[Iwasaki, Naoko; Nakamura, Shinko; Takizawa, Miho; Ogata, Makiko; Fujimaki, Risa; Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo 1628666, Japan; [Iwasaki, Naoko] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Iwasaki, Naoko] Tokyo Womens Med Univ, Inst Med Genet, Tokyo 1628666, Japan; [Kamatani, Naoyuki] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1628666, Japan; [Okamoto, Koji; Nishimura, Chisa; Doi, Kent; Tokunaga, Katsushi] Univ Tokyo, Grad Sch, Dept Human Genet, Tokyo 1130033, Japan; [Okamoto, Koji; Doi, Kent; Noiri, Eisei; Fujita, Toshiro] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo 1130033, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1130033, Japan; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Copenhagen, Denmark; [Pisinger, Charlotta] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Borch-Johnsen, Knut] Steno Diabet Ctr, DK-2820 Gentofte, Copenhagen, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Lauritzen, Torsten; Sandbaek, Annelli] Univ Aarhus, Dept Gen Practice, DK-8000 Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, DK-5230 Odense, Denmark; [Yasuda, Kazuki] Int Med Ctr Japan, Res Inst, Dept Metab Disorder, Tokyo 1628655, Japan; [Osawa, Haruhiko] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Matsuyama, Ehime 7908577, Japan; [Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Kasuga, Masato] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Kobe, Hyogo 6500017, Japan; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-2200 Copenhagen, Denmark	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University; University of Tokyo; University of Tokyo; University of Tokyo; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Steno Diabetes Center; Aarhus University; Aarhus University; University of Southern Denmark; National Center for Global Health & Medicine - Japan; Ehime University; Wakayama Medical University; Kobe University; University of Copenhagen	Iwasaki, N (corresponding author), Tokyo Womens Med Univ, Ctr Diabet, Tokyo 1628666, Japan.	niwasaki@dmc.twmu.ac.jp	Pedersen, Oluf/AAG-8015-2020; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Pisinger, Charlotta/0000-0002-7970-3168				Chen GJ, 2007, AM J KIDNEY DIS, V49, P394, DOI 10.1053/j.ajkd.2006.12.011; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Davis TME, 2001, DIABETES CARE, V24, P1167, DOI 10.2337/diacare.24.7.1167; Doi K, 2004, ELECTROPHORESIS, V25, P833, DOI 10.1002/elps.200305721; Doi K, 2006, J AM SOC NEPHROL, V17, P823, DOI 10.1681/ASN.2005010094; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duval S, 2007, OBES REV, V8, P263, DOI 10.1111/j.1467-789X.2006.00263.x; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Gray E, 2006, J ENDOCRINOL, V190, P703, DOI 10.1677/joe.1.06891; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Iwasaki N, 2003, DIABETES, V52, P209, DOI 10.2337/diabetes.52.1.209; Kamiyama M, 2007, HUM GENET, V122, P397, DOI 10.1007/s00439-007-0414-3; Malhotra A, 2007, DIABETES, V56, P890, DOI 10.2337/db06-1057; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Murakami Y, 2004, J HUM GENET, V49, P635, DOI 10.1007/s10038-004-0201-0; *OFF LIF REL DIS C, 1999, DIAB SURV 1997; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Rasschaert J, 1999, BIOCHEM BIOPH RES CO, V264, P615, DOI 10.1006/bbrc.1999.1577; Sagen JV, 2004, DIABETES, V53, P2713, DOI 10.2337/diabetes.53.10.2713; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shuck ME, 1997, J BIOL CHEM, V272, P586; Sone H, 2002, HORM METAB RES, V34, P509, DOI 10.1055/s-2002-34791; Squires PE, 2000, DIABETES, V49, P409, DOI 10.2337/diabetes.49.3.409; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; World Health Organization, 1985, DIAB MELL REP WHO ST; Yang TY, 2003, J BIOL CHEM, V278, P15291, DOI 10.1074/jbc.M300954200; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	43	45	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					54	64		10.1016/j.ajhg.2009.12.009	http://dx.doi.org/10.1016/j.ajhg.2009.12.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20085713	Green Published, Bronze			2022-12-18	WOS:000274471200005
J	Lausch, E; Keppler, R; Hilbert, K; Cormier-Daire, V; Nikkel, S; Nishimura, G; Unger, S; Spranger, J; Superti-Furga, A; Zabel, B				Lausch, Ekkehart; Keppler, Romy; Hilbert, Katja; Cormier-Daire, Valerie; Nikkel, Sarah; Nishimura, Gen; Unger, Sheila; Spranger, Juergen; Superti-Furga, Andrea; Zabel, Bernhard			Mutations in MMP9 and MMP13 Determine the Mode of Inheritance and the Clinical Spectrum of Metaphyseal Anadysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; LISTERIA-MONOCYTOGENES; COLLAGENASE-3 MMP-13; BONE-DEVELOPMENT; ACTIVATION; VEGF; MATRIX-METALLOPROTEINASE-9; ANGIOGENESIS	The matrix metalloprotemases MMP9 and MMP13 catalyze the degradation of extracellular matrix (ECM) components in the growth plate and at the same time cleave and release biologically active molecules stored in the ECM, such as VEGFA. In mice, ablation of Mmp9, Mmp13, or both Mmp9 and Mmp13 causes severe distortion of the metaphyseal growth plate. We report that mutations in either MMP9 or MMP13 are responsible for the human disease metaphyseal anadysplasia (MAD), a heterogeneous group of disorders for which a milder recessive variant and a more severe dominant variant are known. We found that recessive MAD is caused by homozygous loss of function of either MMP9 or MMP13, whereas dominant MAD is associated with missense mutations in the prodomain of MMP13 that determine autoactivation of MMP13 and intracellular degradation of both MMP13 and MMP9, resulting in a double enzymatic deficiency.	[Lausch, Ekkehart; Keppler, Romy; Hilbert, Katja; Unger, Sheila; Spranger, Juergen; Superti-Furga, Andrea; Zabel, Bernhard] Freiburg Univ Hosp, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Cormier-Daire, Valerie] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Cormier-Daire, Valerie] Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Nikkel, Sarah] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Nishimura, Gen] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol, Tokyo 204, Japan; [Unger, Sheila] Univ Freiburg Hosp, Inst Human Genet, D-79106 Freiburg, Germany	University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; Children's Hospital of Eastern Ontario; University of Freiburg	Lausch, E (corresponding author), Freiburg Univ Hosp, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany.	ekkehart.lausch@uniklinik-freiburg.de	unger, sheila/E-9177-2015; superti-furga, andrea/E-9162-2015; cormier-daire, valerie/H-6520-2017	superti-furga, andrea/0000-0002-3543-7531; Unger, Sheila/0000-0002-9539-8941; cormier-daire, valerie/0000-0002-2839-9856	Bundesministerium fur Bildung und Forschung (SKELNET); European Union; Deutsche Forschungs-gemeinschaft [1381/1-3]	Bundesministerium fur Bildung und Forschung (SKELNET)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG))	The authors are grateful to the affected individuals and their families for participation in the study. This work was underwritten in part by grants from the Bundesministerium fur Bildung und Forschung (SKELNET) and the European Union (FP6, EuroGrow). E.L. and B.Z. are supported by individual grants from Deutsche Forschungs-gemeinschaft (La 1381/1-3).	Bitar AP, 2008, J BACTERIOL, V190, P107, DOI 10.1128/JB.00852-07; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Dreier R, 2004, EXP CELL RES, V297, P303, DOI 10.1016/j.yexcr.2004.02.027; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; FREIMARK BD, 1994, J BIOL CHEM, V269, P26982; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; Han YP, 2007, J BIOL CHEM, V282, P12928, DOI 10.1074/jbc.M700554200; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kennedy AM, 2005, J CLIN INVEST, V115, P2832, DOI 10.1172/JCI22900; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Lausch E, 2008, AM J HUM GENET, V83, P649, DOI 10.1016/j.ajhg.2008.10.011; Le Merrer M, 1998, PEDIATR RADIOL, V28, P771, DOI 10.1007/s002470050463; MAROTEAUX P, 1991, AM J MED GENET, V1, P4; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Nagase H, 1997, BIOL CHEM, V378, P151; Nishimura G, 1999, AM J MED GENET, V82, P43, DOI 10.1002/(SICI)1096-8628(19990101)82:1<43::AID-AJMG9>3.0.CO;2-I; O'Neil HS, 2009, J BACTERIOL, V191, P3594, DOI 10.1128/JB.01168-08; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PATEL AC, 1993, MEDICINE, V72, P326, DOI 10.1097/00005792-199309000-00004; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Slama M, 1999, PEDIATR RADIOL, V29, P372, DOI 10.1007/s002470050610; Spangenberg C, 2006, CANCER RES, V66, P3715, DOI 10.1158/0008-5472.CAN-05-2823; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WIEDEMANN HR, 1970, Z KINDERHEILKD, V108, P171, DOI 10.1007/BF00439884; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	37	43	52	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					168	178		10.1016/j.ajhg.2009.06.014	http://dx.doi.org/10.1016/j.ajhg.2009.06.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19615667	Green Published, Bronze			2022-12-18	WOS:000269332900006
J	Lausch, E; Hermanns, P; Farin, HF; Alanay, Y; Unger, S; Nikkel, S; Steinwender, C; Scherer, G; Spranger, J; Zabel, B; Kispert, A; Superti-Furga, A				Lausch, Ekkehart; Hermanns, Pia; Farin, Henner F.; Alanay, Yasemin; Unger, Sheila; Nikkel, Sarah; Steinwender, Christoph; Scherer, Gerd; Spranger, Juergen; Zabel, Bernhard; Kispert, Andreas; Superti-Furga, Andrea			TBX15 Mutations Cause Craniofacial Dysmorphism, Hypoplasia of Scapula and Pelvis, and Short Stature in Cousin Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOX; DYSPLASIA; DEFECTS; LIMB	Members of the evolutionarily conserved T-box family of transcription factors are important players in developmental processes that include mesoderm formation and patterning and organogenesis both in vertebrates and invertebrates. The importance of T-box genes for human development is illustrated by the association between mutations in several of the 17 human family members and congenital errors of morphogenesis that include cardiac, craniofacial, and limb malformations. We identified two unrelated individuals with a complex cranial, cervical, auricular, and skeletal malformation syndrome with scapular and pelvic hypoplasia (Cousin syndrome) that recapitulates the dysmorphic phenotype seen in the Tbx 15-deficient mice, droopy ear. Both affected individuals were homozygous for genomic TBX 15 mutations that resulted in truncation of the protein and addition of a stretch of missense amino acids. Although the mutant proteins had an intact T-box and were able to bind to their target DNA sequence in vitro, the missense amino acid sequence directed them to early degradation, and cellular levels were markedly reduced. We conclude that Cousin syndrome is caused by TBX15 insufficiency and is thus the human counterpart of the droopy car mouse.	[Lausch, Ekkehart; Hermanns, Pia; Unger, Sheila; Nikkel, Sarah; Steinwender, Christoph; Spranger, Juergen; Zabel, Bernhard; Superti-Furga, Andrea] Univ Freiburg, Ctr Pediat & Adolescent Med, Dept Pediat, D-79106 Freiburg, Germany; [Farin, Henner F.; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Alanay, Yasemin] Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Dept Pediat, TR-06100 Ankara, Turkey; [Unger, Sheila; Scherer, Gerd; Zabel, Bernhard] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Nikkel, Sarah] Childrens Hosp Eastern Ontario, Div Genet, Ottawa, ON K1H 8L1, Canada	University of Freiburg; Hannover Medical School; Hacettepe University; University of Freiburg; University of Ottawa; Children's Hospital of Eastern Ontario	Superti-Furga, A (corresponding author), Univ Freiburg, Ctr Pediat & Adolescent Med, Dept Pediat, Hugstetter Str 55, D-79106 Freiburg, Germany.	asuperti@uniklinik-freiburg.de	superti-furga, andrea/E-9162-2015; Hermanns, Pia/HHN-5709-2022; Alanay, Yasemin/A-1516-2016; Farin, Henner/AAC-2574-2021; unger, sheila/E-9177-2015	superti-furga, andrea/0000-0002-3543-7531; Alanay, Yasemin/0000-0003-0683-9731; Farin, Henner/0000-0003-1558-5366; Unger, Sheila/0000-0002-9539-8941	SKELNET project of the German Bundesministerium fur Bildung und Forschung (BMBF); European Community; EuroGrow consortium; Deutsche Forschungsgemeinschaft (DFG)	SKELNET project of the German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); EuroGrow consortium; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the families for their gracious participation in this study. We are particularly grateful to subject 1, a language student whose strive for independence and ability to comment on her condition with philosophy and humor make her a leading figure in the German Association for Little People and their Families (BKMF, www. bknif.de). Work in the Freiburg Skeletal Dysplasia Centre and laboratory (www.skeldys.org) was supported by the SKELNET project of the German Bundesministerium fur Bildung und Forschung (BMBF), by the European Community, EuroGrow consortium, and by individual grants of the Deutsche Forschungsgemeinschaft (DFG). Work in the laboratory of A.K. in Hannover was Supported by individual grants of the DFG and the DFG-funded Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy).	Agulnik SI, 1998, GENOMICS, V51, P68, DOI 10.1006/geno.1998.5278; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; COUSIN J, 1982, ARCH FR PEDIATR, V39, P173; CURRY GA, 1959, J EMBRYOL EXP MORPH, V7, P39; Elliott AM, 2000, AM J MED GENET, V95, P496, DOI 10.1002/1096-8628(20001218)95:5<496::AID-AJMG16>3.0.CO;2-E; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Komaru K, 2005, FEBS J, V272, P1704, DOI 10.1111/j.1742-4658.2005.04597.x; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Trost TM, 2005, CANCER RES, V65, P840; Vallette-Kasic S, 2005, J CLIN ENDOCR METAB, V90, P1323, DOI 10.1210/jc.2004-1300; Wilson V, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6	21	43	44	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					649	655		10.1016/j.ajhg.2008.10.011	http://dx.doi.org/10.1016/j.ajhg.2008.10.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	19068278	Green Published, Bronze			2022-12-18	WOS:000261006900012
J	Hamm, D; Mautz, BS; Wolfner, MF; Aquadro, CF; Swanson, WJ				Hamm, David; Mautz, Brian S.; Wolfner, Mariana F.; Aquadro, Charles F.; Swanson, Willie J.			Evidence of amino acid diversity-enhancing selection within humans and among primates at the candidate sperm-receptor gene PKDREJ	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; POSITIVE SELECTION; MOUSE SPERM; MAMMALIAN FERTILIZATION; STATISTICAL-METHOD; COMBINING SITE; PROTEIN GENE; EVOLUTION; POLYMORPHISM; RECOGNITION	Sperm-egg interaction is a crucial step in fertilization, yet the identity of most interacting sperm-egg proteins that mediate this process remains elusive. Rapid evolution of some fertilization proteins has been observed in a number of species, including evidence of positive selection in the evolution of components of the mammalian egg coat. The rapid evolution of the egg-coat proteins could strongly select for changes on the sperm receptor, to maintain the interaction. Here, we present evidence that positive selection has driven the evolution of PKDREJ, a candidate sperm receptor of mammalian egg-coat proteins. We sequenced PKDREJ from a panel of 14 primates, including humans, and conducted a comparative maximum-likelihood analysis of nucleotide changes and found evidence of positive selection. An additional panel of 48 humans was surveyed for nucleotide polymorphisms at the PKDREJ locus. The regions predicted to have been subject to adaptive evolution among primates show several amino acid polymorphisms within humans. The distribution of polymorphisms suggests that balancing selection may maintain diverse PKDREJ alleles in some populations. It remains unknown whether there are functional differences associated with these diverse alleles, but their existence could have consequences for human fertility.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	University of Washington; University of Washington Seattle; University of California System; University of California Riverside; Cornell University	Swanson, WJ (corresponding author), Univ Washington, Dept Genome Sci, Box 357730, Seattle, WA 98195 USA.	wswanson@gs.washington.edu	Mautz, Brian/F-2415-2010	Swanson, Willie/0000-0002-6553-0921; Mautz, Brian/0000-0003-3870-2932	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036431] Funding Source: NIH RePORTER; NICHD NIH HHS [HD38921, R01 HD038921, R01 HD042563, HD41454, HD42563] Funding Source: Medline; NIGMS NIH HHS [GM36431, R01 GM036431] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUADE M, 1992, GENETICS, V132, P755; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Butscheid Y, 2006, MOL REPROD DEV, V73, P350, DOI 10.1002/mrd.20410; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; Dean J, 2004, BIOESSAYS, V26, P29, DOI 10.1002/bies.10412; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fay JC, 2000, GENETICS, V155, P1405; Frank SA, 2000, EVOL ECOL RES, V2, P613; FU YX, 1993, GENETICS, V133, P693; Galindo BE, 2003, P NATL ACAD SCI USA, V100, P4639, DOI 10.1073/pnas.0830022100; Gallagher AR, 2002, CELL MOL LIFE SCI, V59, P682, DOI 10.1007/s00018-002-8457-z; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; GOODMAN M, 1994, AM J PHYS ANTHROPOL, V94, P3, DOI 10.1002/ajpa.1330940103; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Hughes J, 1999, HUM MOL GENET, V8, P543, DOI 10.1093/hmg/8.3.543; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Jansa SA, 2003, J MOL EVOL, V56, P294, DOI 10.1007/s00239-002-2401-6; Kierszenbaum AL, 2004, MOL REPROD DEV, V67, P385, DOI 10.1002/mrd.20042; Kingan SB, 2003, J MOL EVOL, V57, P159, DOI 10.1007/s00239-002-2463-0; KINLOCH RA, 1995, P NATL ACAD SCI USA, V92, P263, DOI 10.1073/pnas.92.1.263; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; McDonald JH, 1996, MOL BIOL EVOL, V13, P253, DOI 10.1093/oxfordjournals.molbev.a025562; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; Mengerink KJ, 2000, ZYGOTE, V8, pS28; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rozen S, 2000, Methods Mol Biol, V132, P365; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sutton KA, 2006, J CELL PHYSIOL, V209, P493, DOI 10.1002/jcp.20755; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; Tsaur SC, 2001, MOL BIOL EVOL, V18, P22, DOI 10.1093/oxfordjournals.molbev.a003716; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; Wassarman PA, 2004, EUR J OBSTET GYN R B, V115, pS57, DOI 10.1016/j.ejogrb.2004.01.025; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Yang Z., 2000, PHYLOGENETIC ANAL MA; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	57	43	43	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					44	52		10.1086/518695	http://dx.doi.org/10.1086/518695			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564962	Green Published, Bronze			2022-12-18	WOS:000247039700004
J	Chaix, R; Austerlitz, F; Khegay, T; Jacquesson, S; Hammer, MF; Heyer, E; Quintana-Murci, L				Chaix, R; Austerlitz, F; Khegay, T; Jacquesson, S; Hammer, MF; Heyer, E; Quintana-Murci, L			The genetic or mythical ancestry of descent groups: Lessons from the Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSATELLITE LOCI; FREQUENCIES; MUTATIONS; AGE	Traditional societies are often organized into descent groups called "lineages," " clans," and "tribes." Each of these descent groups claims to have a common ancestor, and this ancestry distinguishes the group's members from the rest of the population. To test the hypothesis of common ancestry within these groups, we compared ethnological and genetic data from five Central Asian populations. We show that, although people from the same lineage and clan share generally a recent common ancestor, no such common ancestry is observed at the tribal level. Thus, a tribe might be a conglomerate of clans who subsequently invented a mythical ancestor to strengthen group unity.	Univ Paris 07, Musee Homme, CNRS, Unite Ecoanthropol,UMR 5145, F-75116 Paris, France; Inst Pasteur, CNRS, URA 1961, Unit Mol Prevent & Therapy Human Dis, Paris, France; Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, Orsay, France; Acad Sci, Inst Immunol, Tashkent, Uzbekistan; Inst Francais Etud Asie Cent, Tashkent, Uzbekistan; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Arizona	Heyer, E (corresponding author), Univ Paris 07, Musee Homme, CNRS, Unite Ecoanthropol,UMR 5145, 17 Pl Trocadero, F-75116 Paris, France.	heyer@mnhn.fr	Quintana-Murci, Lluis/AAB-7468-2022; Heyer, Evelyne/K-9184-2013	Hegay, Tatyana/0000-0003-4764-0841; Heyer, Evelyne/0000-0002-0266-3196; Austerlitz, Frederic/0000-0001-8031-455X; Quintana-Murci, Lluis/0000-0003-2429-6320; Chaix, Raphaelle/0000-0001-5160-1293				Bailey Y., 1977, DESERT, P240; Burton ML, 1996, CURR ANTHROPOL, V37, P87, DOI 10.1086/204474; GHASARIAN C, 1996, INTRO ETUDE PARENTE; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; JACQUESSON S, 2002, KARAKALPAKS AUTRES G, V10, P51; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Krader L., 1966, PEOPLES CENTRAL ASIA, V26; KRADER L, 1963, PEOPLES CENTRAL ASIA, V26; KRADER L, 1963, SOCIAL ORG MONGOL TU, V20; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; MAQUET J, 2003, CLAN; Redd AJ, 2002, FORENSIC SCI INT, V130, P97, DOI 10.1016/S0379-0738(02)00347-X; SLATKIN M, 1995, GENETICS, V139, P457; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770	18	43	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1113	1116		10.1086/425938	http://dx.doi.org/10.1086/425938			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15467979	Green Published, Bronze			2022-12-18	WOS:000224866400015
J	Falchi, M; Forabosco, P; Mocci, E; Borlino, CC; Picciau, A; Virdis, E; Persico, I; Parracciani, D; Angius, A; Pirastu, M				Falchi, M; Forabosco, P; Mocci, E; Borlino, CC; Picciau, A; Virdis, E; Persico, I; Parracciani, D; Angius, A; Pirastu, M			A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-HEART-DISEASE; MULTIPOINT LINKAGE ANALYSIS; BODY-MASS INDEX; QUANTITATIVE TRAIT LOCI; IV GENE-CLUSTER; COMPLEX TRAITS; LIPID-LEVELS; TRIGLYCERIDE LEVEL; EXTENDED PEDIGREES; LIPASE DEFICIENCY	A powerful approach to mapping the genes for complex traits is to study isolated founder populations, in which genetic heterogeneity and environmental noise are likely to be reduced and in which extended genealogical data are often available. Using graph theory, we applied an approach that involved sampling from the large number of pairwise relationships present in an extended genealogy to reconstruct sets of subpedigrees that maximize the useful information for linkage mapping while minimizing calculation burden. We investigated, through simulation, the properties of the different sets in terms of bias in identity-by-descent (IBD) estimation and power decrease under various genetic models. We applied this approach to a small isolated population from Sardinia, the village of Talana, consisting of a unique large and complex pedigree, and performed a genomewide search through variance-components linkage analysis for serum lipid levels. We identified a region of significant linkage on chromosome 2 for total serum cholesterol and low-density lipoprotein (LDL) cholesterol. Through higher-density mapping, we obtained an increased linkage for both traits on 2q21.2-q24.1, with a LOD score of 4.3 for total serum cholesterol and of 3.9 for LDL cholesterol. A replication study was performed in an independent and larger set from a genetically differentiated isolated population of the same region of Sardinia, the village of Perdasdefogu. We obtained consistent linkage to the region for total serum cholesterol (LOD score 1.4) and LDL cholesterol (LOD score 2.2), with a level of concordance uncommon for complex traits, and refined the location of the quantitative-trait locus. Interestingly, the 2q21.1-22 region has also been linked to premature coronary heart disease in Finns, and, in the adjacent 2q14 region, significant linkage with triglycerides has been reported in Hutterites.	Shardna Life Sci, I-09125 Cagliari, Italy; CNR, Ist Genet Popolaz, Alghero, Italy; Parco Genet Ogliastra, Perdasdefogu, Italy	Consiglio Nazionale delle Ricerche (CNR)	Falchi, M (corresponding author), Shardna Life Sci, Piazza Deffenu 4, I-09125 Cagliari, Italy.	falchi@shardna.it	Falchi, Mario/F-5956-2013; Persico, Ivana/AAX-7255-2020; Forabosco, Paola/AAM-5540-2021; Angius, Andrea/P-9549-2015; Angius, Andrea/B-8966-2015	Persico, Ivana/0000-0001-9946-1509; Angius, Andrea/0000-0003-2596-6461; Falchi, Mario/0000-0002-5646-1004; Angius, Andrea/0000-0001-9372-1162; FORABOSCO, PAOLA/0000-0002-2006-2693				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; BABEL L, 1991, COMPUTING, V46, P321, DOI 10.1007/BF02257777; BALAS E, 1996, DIMACS SERIES DISCRE, V26, P29; Boekholdt SM, 2003, J LIPID RES, V44, P1080, DOI 10.1194/jlr.R200018-JLR200; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chapman NH, 2001, GENET EPIDEMIOL, V21, pS230, DOI 10.1002/gepi.2001.21.s1.s230; Chapman NH, 2001, GENET EPIDEMIOL, V21, pS222, DOI 10.1002/gepi.2001.21.s1.s222; CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; CRIQUI MH, 1993, NEW ENGL J MED, V328, P1220, DOI 10.1056/NEJM199304293281702; DallingaThie GM, 1996, J LIPID RES, V37, P136; Dyer TD, 2001, GENET EPIDEMIOL, V21, pS236, DOI 10.1002/gepi.2001.21.s1.s236; Evans V, 2002, CARDIOVASC DRUG THER, V16, P283, DOI 10.1023/A:1021721707639; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Garcia CK, 2001, GENOME RES, V11, P1043, DOI 10.1101/gr.172301; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; HEGELE RA, 1995, ARTERIOSCL THROM VAS, V15, P861, DOI 10.1161/01.ATV.15.7.861; Higgins M, 2000, AM J MED, V108, P387, DOI 10.1016/S0002-9343(99)00409-X; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; Ikeda Y, 2001, J LIPID RES, V42, P1072; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Lamarche B, 1998, JAMA-J AM MED ASSOC, V279, P1955, DOI 10.1001/jama.279.24.1955; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Ledmyr H, 2002, J LIPID RES, V43, P51; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; McPeek MS, 2004, BIOMETRICS, V60, P359; Miettinen HE, 1998, ARTERIOSCL THROM VAS, V18, P591, DOI 10.1161/01.ATV.18.4.591; MILLER GJ, 1975, LANCET, V1, P16; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; National Cholesterol Education Program, 2001, 3 NIH NAT HEART LUNG; Newman DL, 2003, HUM MOL GENET, V12, P137, DOI 10.1093/hmg/ddg012; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pankratz VS, 2001, GENET EPIDEMIOL, V21, pS258, DOI 10.1002/gepi.2001.21.s1.s258; PATSCH W, 1994, ARTERIOSCLER THROMB, V14, P874, DOI 10.1161/01.ATV.14.6.874; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; RHOADS GG, 1976, NEW ENGL J MED, V294, P293, DOI 10.1056/NEJM197602052940601; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Schork NJ, 2004, AM J HUM GENET, V74, P306, DOI 10.1086/381714; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Warnick G.R., 1983, SELECTED METHODS CLI, V10, P91; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Zambon A, 2001, CIRCULATION, V103, P792, DOI 10.1161/01.CIR.103.6.792	72	43	44	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1015	1031		10.1086/426155	http://dx.doi.org/10.1086/426155			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15478097	Bronze, Green Published			2022-12-18	WOS:000224866400007
J	Paschou, P; Feng, Y; Pakstis, AJ; Speed, WC; DeMille, MM; Kidd, JR; Jaghori, B; Kurlan, R; Pauls, DL; Sandor, P; Barr, CL; Kidd, KK				Paschou, P; Feng, Y; Pakstis, AJ; Speed, WC; DeMille, MM; Kidd, JR; Jaghori, B; Kurlan, R; Pauls, DL; Sandor, P; Barr, CL; Kidd, KK			Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSESSIVE-COMPULSIVE DISORDER; TYROSINE KINASE SUBSTRATE; AUTOSOMAL-DOMINANT TRANSMISSION; PROGRESSIVE-MOTOR-NEURONOPATHY; D4 RECEPTOR LOCUS; INSULIN-RECEPTOR; BIPOLAR DISORDER; SEGREGATION ANALYSIS; MISSENSE MUTATION; TIC SEVERITY	Gilles de la Tourette syndrome (GTS) is characterized by multiple motor and phonic tics and high comorbidity rates with other neurobehavioral disorders. It is hypothesized that frontal-subcortical pathways and a complex genetic background are involved in the etiopathogenesis of the disorder. The genetic basis of GTS remains elusive. However, several genomic regions have been implicated. Among them, 17q25 appears to be of special interest, as suggested by various independent investigators. In the present study, we explored the possibility that 17q25 contributes to the genetic component of GTS. The initial scan of chromosome 17 performed on two large pedigrees provided a nonparametric LOD score of 2.41 near D17S928. Fine mapping with 17 additional microsatellite markers increased the peak to 2.61 (P = .002). The original families, as well as two additional pedigrees, were genotyped for 25 single-nucleotide polymorphisms (SNPs), with a focus on three genes in the indicated region that could play a role in the development of GTS, on the basis of their function and expression profile. Multiple three-marker haplotypes spanning all three genes studied provided highly significant association results (P < .001). An independent sample of 96 small families with one or two children affected with GTS was also studied. Of the 25 SNPs, 3 were associated with GTS at a statistically significant level. The transmission/disequilibrium test for a three-site haplotype moving window again provided multiple positive results. The background linkage disequilibrium (LD) of the region was studied in eight populations of European origin. A complicated pattern was revealed, with the pairwise tests producing unexpectedly high LD values at the telomeric TBCD gene. In conclusion, our findings warrant the further investigation of 17q25 as a candidate susceptibility region for GTS.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Hosp Sick Children, Dept Psychiat, Brain & Behav Programme, Toronto, ON M5G 1X8, Canada; Univ Rochester, Sch Med, Dept Neurol, Cognit & Behav Neurol Unit, Rochester, NY USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat,Psychiat & Neurodev Genet Unit, Charlestown, MA USA	Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Rochester; Harvard University; Massachusetts General Hospital	Paschou, P (corresponding author), Yale Univ, Sch Med, Dept Genet, Room I-347 Sterling Hall,333 Cedar St, New Haven, CT 06520 USA.	peristera.paschou@yale.edu	Sandor, Paul/I-7211-2016	Sandor, Paul/0000-0003-2397-0758; DeMille, Mellissa/0000-0001-7068-395X; Paschou, Peristera/0000-0002-9783-1024; Barr, Cathy/0000-0003-0361-0106	NINDS NIH HHS [R01-NS40024, R01 NS040024] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040024] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; [Anonymous], 1999, Am J Hum Genet, V65, P1428; Barr CL, 1999, AM J MED GENET, V88, P437, DOI 10.1002/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E; Berthier ML, 1998, BIOL PSYCHIAT, V43, P364, DOI 10.1016/S0006-3223(97)00025-5; Bockmann J, 2002, J NEUROCHEM, V83, P1013, DOI 10.1046/j.1471-4159.2002.01204.x; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; BRETT PM, 1995, AM J PSYCHIAT, V152, P437; Brett PM, 1996, PSYCHIAT GENET, V6, P99, DOI 10.1097/00041444-199623000-00001; Carter AS, 2000, J CHILD PSYCHOL PSYC, V41, P215, DOI 10.1111/1469-7610.00602; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; COMINGS DE, 1989, AM J MED GENET, V34, P413, DOI 10.1002/ajmg.1320340318; Comings DE, 1999, AM J MED GENET, V88, P358, DOI 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G; Crawford FC, 2003, HUM GENET, V113, P154, DOI 10.1007/s00439-003-0942-4; Cruz C, 1997, NEUROSCI LETT, V231, P1, DOI 10.1016/S0304-3940(97)00523-5; Diaz-Anzaldua A, 2004, MOL PSYCHIATR, V9, P272, DOI 10.1038/sj.mp.4001411; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; EAPEN V, 1993, BRIT J PSYCHIAT, V162, P593, DOI 10.1192/bjp.162.5.593; Elstner K, 2001, ACTA PSYCHIAT SCAND, V103, P52, DOI 10.1034/j.1600-0447.2001.00147.x; Fleming JA, 2000, GENETICS, V156, P69; Gade R, 1998, MOL PSYCHIATR, V3, P50, DOI 10.1038/sj.mp.4000326; Grice DE, 1996, AM J HUM GENET, V59, P644; Hanna GL, 2002, AM J MED GENET, V114, P541, DOI 10.1002/ajmg.10519; HASSTEDT SJ, 1995, AM J HUM GENET, V57, P682; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hebebrand J, 1997, AM J HUM GENET, V61, P238, DOI 10.1016/S0002-9297(07)64298-0; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; KERBESHIAN J, 1995, AM J PSYCHIAT, V152, P1646; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KIDD KK, IN PRESS J HERED; King RA, 1998, TOURETTES SYNDROME T, P43; Kroisel PM, 2001, AM J MED GENET, V101, P259, DOI 10.1002/1096-8628(20010701)101:3<259::AID-AJMG1374>3.0.CO;2-#; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; KURLAN R, 1986, NEUROLOGY, V36, P772, DOI 10.1212/WNL.36.6.772; KURLAN R, 1989, NEUROLOGY, V39, P1625, DOI 10.1212/WNL.39.12.1625; Kurlan R, 2002, NEUROLOGY, V59, P414, DOI 10.1212/WNL.59.3.414; KURLAN R, 1994, NEUROLOGY, V44, P2336, DOI 10.1212/WNL.44.12.2336; Leckman JF, 2000, NEURON, V28, P349, DOI 10.1016/S0896-6273(00)00114-8; Leckman JF, 1998, PEDIATRICS, V102, P14, DOI 10.1542/peds.102.1.14; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Leppert M., 1996, American Journal of Human Genetics, V59, pA225; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016; Merette C, 2000, AM J HUM GENET, V67, P1008, DOI 10.1086/303093; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; Okamura-Oho Y, 1999, HUM MOL GENET, V8, P947, DOI 10.1093/hmg/8.6.947; Omeis IA, 1996, GENOMICS, V36, P543, DOI 10.1006/geno.1996.0503; PAKSTIS AJ, 1991, AM J HUM GENET, V48, P281; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; PAULS DL, 1991, AM J HUM GENET, V48, P154; Pauls DL, 2003, J PSYCHOSOM RES, V55, P7, DOI 10.1016/S0022-3999(02)00586-X; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1990, J AM ACAD CHILD PSY, V29, P195, DOI 10.1097/00004583-199003000-00007; PAULS DL, 1987, SCHEDULE TOURETTE OT; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Peterson BS, 2001, J AM ACAD CHILD PSY, V40, P685, DOI 10.1097/00004583-200106000-00014; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Robertson MM, 2003, J PSYCHOSOM RES, V55, P3, DOI 10.1016/S0022-3999(02)00580-9; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Seuchter SA, 2000, GENET EPIDEMIOL, V18, P33, DOI 10.1002/(SICI)1098-2272(200001)18:1<33::AID-GEPI3>3.0.CO;2-2; Simonic I, 1998, AM J HUM GENET, V63, P839, DOI 10.1086/302002; Simonic I, 2001, AM J MED GENET, V105, P163, DOI 10.1002/ajmg.1192; Simons-Morton BG, 2002, INJURY PREV, V8, P24; Singer HS, 2000, MOVEMENT DISORD, V15, P1051, DOI 10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Spencer T, 1998, J CHILD PSYCHOL PSYC, V39, P1037, DOI 10.1017/S0021963098002984; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; State MW, 2003, P NATL ACAD SCI USA, V100, P4684, DOI 10.1073/pnas.0730775100; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Walkup JT, 1996, AM J HUM GENET, V59, P684; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Zhang HP, 2002, AM J HUM GENET, V70, P896, DOI 10.1086/339520; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x	81	43	48	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					545	560		10.1086/424389	http://dx.doi.org/10.1086/424389			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15303240	Green Published, Bronze			2022-12-18	WOS:000223634100002
J	Matsuura, T; Fang, P; Lin, X; Khajavi, M; Tsuji, K; Rasmussen, A; Grewal, RP; Achari, M; Alonso, ME; Pulst, SM; Zoghbi, HY; Nelson, DL; Roa, BB; Ashizawa, T				Matsuura, T; Fang, P; Lin, X; Khajavi, M; Tsuji, K; Rasmussen, A; Grewal, RP; Achari, M; Alonso, ME; Pulst, SM; Zoghbi, HY; Nelson, DL; Roa, BB; Ashizawa, T			Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; MYOTONIC-DYSTROPHY TYPE-2; UNSTABLE TRIPLET REPEAT; FRAGILE-X-SYNDROME; CGG REPEAT; TRINUCLEOTIDE REPEAT; INTERMEDIATE ALLELES; HUNTINGTONS-DISEASE; MUSCULAR-DYSTROPHY; MOLECULAR ANALYSIS	Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant disorder characterized by ataxia, seizures, and anticipation. It is caused by an expanded ATTCT pentanucleotide repeat in intron 9 of a novel gene, designated "SCA10." The ATTCT expansion in SCA10 represents a novel class of microsatellite repeat and is one of the largest found to cause human diseases. The expanded ATTCT repeat is unstably transmitted from generation to generation, and an inverse correlation has been observed between size of repeat and age at onset. In this multifamily study, we investigated the intergenerational instability, somatic and germline mosaicism, and age-dependent repeat-size changes of the expanded ATTCT repeat. Our results showed that (1) the expanded ATTCT repeats are highly unstable when paternally transmitted, whereas maternal transmission resulted in significantly smaller changes in repeat size; (2) blood leukocytes, lymphoblastoid cells, buccal cells, and sperm have a variable degree of mosaicism in ATTCT expansion; (3) the length of the expanded repeat was not observed to change in individuals over a 5-year period; and (4) clinically determined anticipation is sometimes associated with intergenerational contraction rather than expansion of the ATTCT repeat.	Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Inst Nacl Neurol & Neurocirug, Dept Neurogenet & Mol Biol, Mexico City, DF, Mexico; Seton Hall Univ, New Jersey Neurosci Inst, Edison, NJ USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Neurol,Burns & Allen Res Inst,Dept Neurol, Rose Moss Lab Parkinson & Neurodegenerat Dis, Los Angeles, CA 90048 USA	University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Seton Hall University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Ashizawa, T (corresponding author), Univ Texas, Med Branch, Dept Neurol, JSA9-128,301 Univ Blvd, Galveston, TX 77555 USA.	teashiza@utmb.edu	Rasmussen, Astrid/A-4878-2013	Rasmussen, Astrid/0000-0001-7744-2948; Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041547] Funding Source: NIH RePORTER; NINDS NIH HHS [NS041547, R01 NS041547] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHIZAWA T, 1994, NEUROLOGY, V44, P120, DOI 10.1212/WNL.44.1.120; Bidichandani SI, 1999, HUM MOL GENET, V8, P2425, DOI 10.1093/hmg/8.13.2425; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; DEMICHELE G, 1998, MUSCLE NERVE, V21, P390; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Grewal RP, 1998, NEUROLOGY, V51, P1423, DOI 10.1212/WNL.51.5.1423; Grewal RP, 2002, ARCH NEUROL-CHICAGO, V59, P1285, DOI 10.1001/archneur.59.8.1285; HARDING AE, 1981, J MED GENET, V18, P436, DOI 10.1136/jmg.18.6.436; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Khajavi M, 2001, HUM MOL GENET, V10, P855, DOI 10.1093/hmg/10.8.855; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; LA SA, 1991, NATURE, V352, P77; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Martorell L, 2001, NEUROLOGY, V56, P328, DOI 10.1212/WNL.56.3.328; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Rosa AL, 2002, NEUROL CLIN, V20, P727, DOI 10.1016/S0733-8619(02)00008-7; Schols L, 1997, ARCH NEUROL-CHICAGO, V54, P1073, DOI 10.1001/archneur.1997.00550210011007; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	36	43	46	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1216	1224		10.1086/421526	http://dx.doi.org/10.1086/421526			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15127363	Green Published, Bronze			2022-12-18	WOS:000221651900014
J	Lu, FM; Morrissette, JJD; Spinner, NB				Lu, FM; Morrissette, JJD; Spinner, NB			Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALAGILLE-SYNDROME; ARTERIOHEPATIC DYSPLASIA; JAGGED1 GENE; DEFECTS; MALFORMATIONS; FREQUENCY; FAMILY; NOTCH1	Mutations of Jagged 1 (JAG1), a ligand in the Notch signaling pathway, cause Alagille syndrome (AGS). AGS is an autosomal dominant, multisystem disorder with variable expressivity, characterized by bile duct paucity and resultant liver disease in combination with cardiac, ocular, skeletal, and facial findings. JAG1 mutations in AGS include gene deletions and protein truncating, splicing, and missense mutations, suggesting that haploinsufficiency is the mechanism of disease causation. With limited exceptions, there is no genotype-phenotype correlation. We have studied a JAG1 missense mutation (JAG1-G274D) that was previously identified in 13 individuals from an extended family with cardiac defects of the type seen in patients with AGS ( e. g., peripheral pulmonic stenosis and tetralogy of Fallot) in the absence of liver dysfunction. Our data indicate that this mutation is "leaky." Two populations of proteins are produced from this allele. One population is abnormally glycosylated and is retained intracellularly rather than being transported to the cell surface. A second population is normally glycosylated and is transported to the cell surface, where it is able to signal to the Notch receptor. The JAG1-G274D protein is temperature sensitive, with more abnormally glycosylated ( and nonfunctional) molecules produced at higher temperatures. Carriers of this mutation therefore have >50% but <100% of the normal concentration of JAG1 molecules on the cell surface. The cardiac-specific phenotype associated with this mutation suggests that the developing heart is more sensitive than the developing liver to decreased dosage of JAG1.	Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Dept Pediat & Clin Labs, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Spinner, NB (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Dept Pediat & Clin Labs, 1006 Abramson Res Ctr,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL062177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053104] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL62177] Funding Source: Medline; NIDDK NIH HHS [R01 DK53104, R01 DK053104] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Crosnier C, 1999, GASTROENTEROLOGY, V116, P1141, DOI 10.1016/S0016-5085(99)70017-X; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; ELMSLIE FV, 1995, J MED GENET, V32, P264, DOI 10.1136/jmg.32.4.264; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Kadesch T, 2000, EXP CELL RES, V260, P1, DOI 10.1006/excr.2000.4921; Krantz ID, 1999, AM J MED GENET, V84, P56; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; LABRECQUE DR, 1982, HEPATOLOGY, V2, P467; Le Caignec C, 2002, AM J HUM GENET, V71, P180, DOI 10.1086/341327; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; McCright B, 2002, DEVELOPMENT, V129, P1075; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morrissette JJD, 2001, HUM MOL GENET, V10, P405, DOI 10.1093/hmg/10.4.405; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SHULMAN SA, 1984, AM J MED GENET, V19, P325, DOI 10.1002/ajmg.1320190215; SILBERBACH M, 1994, AM HEART J, V127, P695, DOI 10.1016/0002-8703(94)90684-X; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; WATSON GH, 1973, ARCH DIS CHILD, V48, P459, DOI 10.1136/adc.48.6.459	25	43	52	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1065	1070		10.1086/374386	http://dx.doi.org/10.1086/374386			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12649809	Green Published, Bronze			2022-12-18	WOS:000181972600030
J	Lemke, J; Claussen, J; Michel, S; Chudoba, I; Muhlig, P; Westermann, M; Sperling, K; Rubtsov, N; Grummt, UW; Ullmann, P; Kromeyer-Hauschild, K; Liehr, T; Claussen, U				Lemke, J; Claussen, J; Michel, S; Chudoba, I; Muhlig, P; Westermann, M; Sperling, K; Rubtsov, N; Grummt, UW; Ullmann, P; Kromeyer-Hauschild, K; Liehr, T; Claussen, U			The DNA-based structure of human chromosome 5 in interphase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION; CHROMOSOME CONDENSATION; X-CHROMOSOME; IN-SITU; CHROMATIN; HYBRIDIZATION; TERRITORIES; CELLS; PHOSPHORYLATION; METAPHASE	In contrast to those of metaphase chromosomes, the shape, length, and architecture of human interphase chromosomes are not well understood. This is mainly due to technical problems in the visualization of interphase chromosomes in total and of their substructures. We analyzed the structure of chromosomes in interphase nuclei through use of high-resolution multicolor banding (MCB), which paints the total shape of chromosomes and creates a DNA-mediated, chromosome-region-specific, pseudocolored banding pattern at high resolution. A microdissection-derived human chromosome 5-specific MCB probe mixture was hybridized to human lymphocyte interphase nuclei harvested for routine chromosome analysis, as well as to interphase nuclei from HeLa cells arrested at different phases of the cell cycle. The length of the axis of interphase chromosome 5 was determined, and the shape and MCB pattern were compared with those of metaphase chromosomes. We show that, in lymphocytes, the length of the axis of interphase chromosome 5 is comparable to that of a metaphase chromosome at 600-band resolution. Consequently, the concept of chromosome condensation during mitosis has to be reassessed. In addition, chromosome 5 in interphase is not as straight as metaphase chromosomes, being bent and/or folded. The shape and banding pattern of interphase chromosome 5 of lymphocytes and HeLa cells are similar to those of the corresponding metaphase chromosomes at all stages of the cell cycle. The MCB pattern also allows the detection and characterization of chromosome aberrations. This may be of fundamental importance in establishing chromosome analyses in nondividing cells.	Univ Jena, Inst Human Genet & Anthropol, D-07740 Jena, Germany; Univ Jena, Inst Ultrastruct Res, D-07740 Jena, Germany; Univ Jena, Inst Phys Chem, D-07740 Jena, Germany; Inst Mol Biotechnol, Jena, Germany; Carl Zeiss Jena GmbH, Jena, Germany; Humboldt Univ, Berlin, Germany; MetaSyst GmbH, Altlussheim, Germany; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Carl Zeiss AG; Humboldt University of Berlin; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Claussen, U (corresponding author), Univ Jena, Inst Human Genet & Anthropol, Kollegiengasse 10, D-07740 Jena, Germany.	ucla@mti.uni-jena.de	Rubtsov, Nikolay/L-2365-2017; Liehr, Thomas/H-2852-2019; Lemke, Johannes/G-5804-2018	Rubtsov, Nikolay/0000-0001-7406-8057; Liehr, Thomas/0000-0003-1672-3054; Lemke, Johannes/0000-0002-4435-6610				Chevret E, 2000, CYTOGENET CELL GENET, V90, P13, DOI 10.1159/000015654; Chudoba I, 1999, CYTOGENET CELL GENET, V84, P156, DOI 10.1159/000015245; CLAUSSEN U, 1994, CYTOGENET CELL GENET, V66, P120, DOI 10.1159/000133681; COMINGS DE, 1968, AM J HUM GENET, V20, P440; CREMER T, 1982, HUM GENET, V62, P201, DOI 10.1007/BF00333519; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; Dietzel S, 1998, CHROMOSOME RES, V6, P25, DOI 10.1023/A:1009262223693; Dietzel S, 1999, EXP CELL RES, V252, P363, DOI 10.1006/excr.1999.4635; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Hliscs R, 1997, CYTOGENET CELL GENET, V79, P162, DOI 10.1159/000134710; Hliscs R, 1997, CYTOGENET CELL GENET, V76, P167, DOI 10.1159/000134537; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Kuechler A, 2001, CYTOGENET CELL GENET, V95, P12, DOI 10.1159/000057010; LAWRENCE JB, 1988, CELL, V52, P51; Lemke J, 2001, HUM GENET, V108, P478, DOI 10.1007/s004390100502; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MITTELMAN F, 1995, ISCN 1995 INT SYSTEM; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SCHMIADY H, 1981, EXP CELL RES, V134, P461, DOI 10.1016/0014-4827(81)90446-8; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; Volpi EV, 2000, J CELL SCI, V113, P1565; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Weise A, 2002, INT J MOL MED, V9, P359; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; YUNIS JJ, 1981, HUM GENET, V56, P293, DOI 10.1007/BF00274682; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	33	43	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1051	1059		10.1086/344286	http://dx.doi.org/10.1086/344286			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12370837	Bronze, Green Published			2022-12-18	WOS:000178884300005
J	Klutz, M; Brockmann, D; Lohmann, DR				Klutz, M; Brockmann, D; Lohmann, DR			A parent-of-origin effect in two families with retinoblastoma is associated with a distinct splice mutation in the RB1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERM-LINE MUTATIONS; INCOMPLETE PENETRANCE; RNA SURVEILLANCE; MUTANT ALLELES; EXPRESSION; PHENOTYPE; DISORDERS; PROTEIN; CANCER; LOCUS	We have identified a splice-site mutation (IVS6+1G-->T) in the RB1 gene, in two unrelated families with incomplete-penetrance retinoblastoma. Analysis of RNA from white blood cells showed that this mutation causes skipping of exon 6. Although this deletion results in a frameshift, most carriers of the mutation did not develop retinoblastoma. Interestingly, the relative abundance of the resultant nonsense messenger RNA varies between members of the same family and is either similar to or considerably lower than the transcript level of the normal allele. Moreover, variation of relative transcript levels is associated with both the sex of the parent that transmitted the mutant allele and phenotypic expression: All eight carriers with similar abundance of nonsense and normal transcript have received the mutant allele from their mother, and only one of them has developed retinoblastoma; by contrast, all eight carriers with reduced abundance of the nonsense transcript have received the mutant allele from their father, and all but two them have retinoblastoma. After treatment with cycloheximide, the relative abundance of transcripts from paternally inherited mutant alleles was partly restored, thus indicating that posttranscriptional mechanisms, rather than transcriptional silencing, are responsible for low levels of mutant messenger RNA. Our data suggest that a specific RB1 mutation can be associated with differential penetrance, on the basis of the sex of the transmitting parent.	Univ Essen Gesamthsch Klinikum, Inst Humangenet, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Inst Mol Biol, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Lohmann, DR (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Humangenet, Hufelandstr 55, D-45122 Essen, Germany.		Lohmann, Dietmar R/B-4041-2013; Lohmann, Dietmar R./X-4895-2019	Lohmann, Dietmar R/0000-0002-2624-9889; Lohmann, Dietmar R./0000-0002-2624-9889				Antelman D, 1997, ONCOGENE, V15, P2855, DOI 10.1038/sj.onc.1201465; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bhattacharyya S, 2000, GENOMICS, V70, P286, DOI 10.1006/geno.2000.6398; Bremner R, 1997, AM J HUM GENET, V61, P556, DOI 10.1086/515499; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang CC, 1998, AM J HUM GENET, V63, P1294, DOI 10.1086/302103; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; CZEIZEL A, 1974, HUMANGENETIK, V22, P153; Dryja TP, 1997, HUM GENET, V100, P446, DOI 10.1007/s004390050531; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GREGER V, 1994, HUM GENET, V94, P491; HAMEL PA, 1992, TRENDS GENET, V8, P180, DOI 10.1016/0168-9525(92)90221-O; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kato MV, 1996, AM J HUM GENET, V59, P1084; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lohmann DR, 1996, AM J HUM GENET, V58, P940; MACKLIN MT, 1960, AM J HUM GENET, V12, P1; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; MUNIER F, 1992, HUM GENET, V89, P508, DOI 10.1007/BF00219175; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; SAKAKI T, 1991, PHARMACOGENETICS, V1, P86, DOI 10.1097/00008571-199111000-00005; SEMINARA SB, 1994, HUM GENET, V93, P629; Taschner PEM, 2001, GENE CHROMOSOME CANC, V31, P274, DOI 10.1002/gcc.1144; VANDERMEY AGL, 1989, LANCET, V2, P1291; YANDELL DW, 1989, AM J HUM GENET, V45, P547	29	43	49	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					174	179		10.1086/341284	http://dx.doi.org/10.1086/341284			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12016586	Green Published, Bronze			2022-12-18	WOS:000176307700019
J	Hassold, TJ; Burrage, LC; Chan, ER; Judis, LM; Schwartz, S; James, SJ; Jacobs, PA; Thomas, NS				Hassold, TJ; Burrage, LC; Chan, ER; Judis, LM; Schwartz, S; James, SJ; Jacobs, PA; Thomas, NS			Maternal folate polymorphisms and the etiology of human nondisjunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ABERRANT RECOMBINATION; DOWN-SYNDROME; RISK-FACTORS; ORIGIN; TRISOMY-18; METABOLISM; MUTATION	Attempts to identify genetic contributors to human meiotic nondisjunction have met with little, if any, success. Thus, recent reports linking Down syndrome to maternal polymorphisms at either of two folate metabolism enzymes, methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR), have generated considerable interest. In the present report, we asked whether variation at MTHFR (677C-->T) or MTRR (66A-->G) might be associated with human trisomies other than trisomy 21. We analyzed maternal polymorphisms at MTHFR and MTRR in 93 cases of sex-chromosome trisomy, 44 cases of trisomy 18, and 158 cases of autosomal trisomies 2, 7, 10, 13, 14, 15, 16, 18, or 22, and compared the distributions of genotypes to those of control populations. We observed a significant increase in the MTHFR polymorphism in mothers of trisomy 18 conceptuses but were unable to identify any other significant associations. Overall, our observations suggest that, at least for the sex chromosomes and for a combined set of autosomal trisomies, polymorphisms in the folate pathway are not a significant contributor to human meiotic nondisjunction.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, Jefferson, AR USA; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; US Food & Drug Administration (FDA); Salisbury District Hospital	Hassold, TJ (corresponding author), Case Western Reserve Univ, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.			Chan, Ernest/0000-0001-9277-5329	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD021341, R37 HD021341, HD21341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRUZZO MA, 1995, ENVIRON MOL MUTAGEN, V25, P38, DOI 10.1002/em.2850250608; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; CHADEFAUXVEKEMA.B, IN PRESS PEDIAT RES; FISHER JM, 1995, AM J HUM GENET, V56, P669; FISHER JM, 1993, AM J HUM GENET, V52, P1139; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; James SJ, 1999, AM J CLIN NUTR, V70, P495; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; OLEARY VB, IN PRESS AM J MED GE; Petersen MB, 2000, AM J HUM GENET, V67, P141; RUBIN R, 1999, US TODAY        0929, pD1; Sayee R, 1998, J Indian Med Assoc, V96, P335; THOMAS N, 2001, IN PRESS HUM MOL GEN; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Zaragoza MV, 1998, J MED GENET, V35, P924, DOI 10.1136/jmg.35.11.924; ZARAGOZA RV, 1994, HUM GENET, V94, P411	19	43	47	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					434	439		10.1086/321971	http://dx.doi.org/10.1086/321971			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443546	Green Published, Bronze			2022-12-18	WOS:000170108200018
J	McEntagart, M; Norton, N; Williams, H; Teare, MD; Dunstan, M; Baker, P; Houlden, H; Reilly, M; Wood, N; Harper, PS; Futreal, PA; Williams, N; Rahman, N				McEntagart, M; Norton, N; Williams, H; Teare, MD; Dunstan, M; Baker, P; Houlden, H; Reilly, M; Wood, N; Harper, PS; Futreal, PA; Williams, N; Rahman, N			Localization of the gene for distal hereditary motor neuronopathy VII (dHMN-VII) to chromosome 2q14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; VOCAL CORD PARALYSIS; MARIE-TOOTH-DISEASE; NEUROPATHY; FORM	Distal hereditary motor neuronopathy type VII (dHMN-VII) is an autosomal dominant disorder characterized by distal muscular atrophy and vocal cord paralysis. We performed a genomewide linkage search in a large Welsh pedigree with dHMN-VII and established linkage to chromosome 2q14. Analyses of a second family with dHMN-VII confirmed the location of the gene and provided evidence for a founder mutation segregating in both pedigrees. The maximum three-point LOD score in the combined pedigree was 7.49 at D2S274. Expansion of a polyalanine tract in Engrailed-1, a transcription factor strongly expressed in the spinal cord, was excluded as the cause of dHMN-VII.	Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XW, S Glam, Wales; Univ Wales Hosp, Dept Psychol Med, Cardiff CF4 4XW, S Glam, Wales; Sanger Ctr, Canc Genome Project, Cambridge, England; Hawkes Bay Hosp, Dept Neurol, Hastings, New Zealand; Inst Neurol, London WC1N 3BG, England	Cardiff University; Cardiff University; University of Cambridge; Wellcome Trust Sanger Institute; University of London; University College London	Rahman, N (corresponding author), Univ Wales Hosp, Inst Med Genet, Heath Pk, Cardiff CF4 4XW, S Glam, Wales.	nazneen@icr.ac.uk	Houlden, Henry J/C-1532-2008; Rahman, Nazneen/B-8890-2012; Williams, Hywel/AAL-2440-2021; Rahman, Nazneen/D-2802-2013; Wood, Nicholas/C-2505-2009	Houlden, Henry J/0000-0002-2866-7777; Williams, Hywel/0000-0001-7758-0312; Rahman, Nazneen/0000-0003-4376-0440; Newton-Bishop, Julia/0000-0001-9147-6802; Wood, Nicholas/0000-0002-9500-3348; Teare, Marion Dawn/0000-0003-3994-0051				BOLTSHAUSER E, 1989, J MED GENET, V26, P105, DOI 10.1136/jmg.26.2.105; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Christodoulou K, 2000, ANN NEUROL, V48, P877, DOI 10.1002/1531-8249(200012)48:6<877::AID-ANA8>3.3.CO;2-R; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Donaghy M, 1999, J NEUROL, V246, P552, DOI 10.1007/s004150050402; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; Grohmann K, 1999, AM J HUM GENET, V65, P1459, DOI 10.1086/302636; HARDING AE, 1980, J NEUROL SCI, V45, P337, DOI 10.1016/0022-510X(80)90177-X; HARDING AE, 1993, PERIPHERAL NEUROPATH, V2, P1051; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Keller MP, 1999, SEMIN NEUROL, V19, P353, DOI 10.1055/s-2008-1040850; Kovach MJ, 1999, AM J HUM GENET, V64, P1580, DOI 10.1086/302420; Middleton LT, 1999, ANN NY ACAD SCI, V883, P65, DOI 10.1111/j.1749-6632.1999.tb08569.x; PRIDMORE C, 1992, J MED GENET, V29, P197, DOI 10.1136/jmg.29.3.197; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; Saueressig H, 1999, DEVELOPMENT, V126, P4201; SERRATRICE G, 1984, REV NEUROL, V140, P657; Timmerman V, 1996, HUM MOL GENET, V5, P1065, DOI 10.1093/hmg/5.7.1065; van der Vleuten AJW, 1998, EUR J HUM GENET, V6, P376, DOI 10.1038/sj.ejhg.5200229; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Yoshioka R, 1996, NEUROLOGY, V46, P569; YOUNG ID, 1980, J NEUROL NEUROSUR PS, V43, P413, DOI 10.1136/jnnp.43.5.413; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	24	43	44	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1270	1276		10.1086/320122	http://dx.doi.org/10.1086/320122			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11294660	Green Published, Bronze			2022-12-18	WOS:000168171200020
J	Garner, C; McInnes, LA; Service, SK; Spesny, M; Fournier, E; Leon, P; Freimer, NB				Garner, C; McInnes, LA; Service, SK; Spesny, M; Fournier, E; Leon, P; Freimer, NB			Linkage analysis of a complex pedigree with severe bipolar disorder, using a Markov chain Monte Carlo method	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COSTA-RICAN PEDIGREES; SCORES	Recently developed algorithms permit nonparametric linkage analysis of large, complex pedigrees with multiple inbreeding loops. We have used one such algorithm, implemented in the package SimWalk2, to reanalyze previously published genome-screen data from a Costa Rican kindred segregating for severe bipolar disorder. Our results are consistent with previous linkage findings on chromosome 18 and suggest a new locus on chromosome 5 that was not identified using traditional linkage analysis.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Costa Rica, Sch Med, San Jose, Costa Rica; Univ Costa Rica, Cell & Mol Biol Res Ctr, San Jose, Costa Rica	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidad Costa Rica; Universidad Costa Rica	Freimer, NB (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Gonda Ctr, Room 3506,695 Charles E Young Dr S,Box 951761, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049499, K21MH000916, K01MH001748] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-40282, R01 GM040282] Funding Source: Medline; NIMH NIH HHS [MH-01748, MH-00916, MH-49499, R01 MH049499] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BOEHNKE M, 1991, AM J HUM GENET, V48, P22; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Freimer NB, 1996, AM J MED GENET, V67, P254, DOI 10.1002/(SICI)1096-8628(19960531)67:3<254::AID-AJMG3>3.0.CO;2-N; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, AM J HUM GENET, V36, P460; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; Sobel E, 1996, AM J HUM GENET, V58, P1323; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	12	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1061	1064		10.1086/319517	http://dx.doi.org/10.1086/319517			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11222106	Green Published, Bronze			2022-12-18	WOS:000167666000027
J	Greene, CC; McMillan, PM; Barker, SE; Kurnool, P; Lomax, MI; Burmeister, M; Lesperance, MM				Greene, CC; McMillan, PM; Barker, SE; Kurnool, P; Lomax, MI; Burmeister, M; Lesperance, MM			DFNA25, a novel locus for dominant nonsyndromic hereditary hearing impairment, maps to 12q21-24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; GENE; MUTATIONS; DEAFNESS; LOCALIZATION	Using linkage analysis, we identified a novel dominant locus, DFNA25, for delayed-onset, progressive, high-frequency, nonsyndromic sensorineural hearing loss in a large, multigenerational United States family of Czech descent. On the basis of recombinations in affected individuals, we determined that DFNA25 is located in a 20-cM region of chromosome 12q21-24 between D12S327 (centromeric) and D12S84 (telomeric), with a maximum two-point LOD score of 6.82, at recombination fraction .041, for D12S1030. Candidate genes in this region include ATP2A2, ATP2B1, UBE3B, and VR-OAC. DFNA25 may be the human ortholog of bronx waltzer (bv).	Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Div Pediat Otolaryngol, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lesperance, MM (corresponding author), Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Div Pediat Otolaryngol, F6905 Mott,Box 0241,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	lesperan@umich.edu	Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434	NCRR NIH HHS [M01 RR000042, M01RR00042] Funding Source: Medline; NIDCD NIH HHS [K23 DC00161, K23 DC000161] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC000161] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bergstrom L, 1971, Otolaryngol Clin North Am, V4, P369; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bussoli TJ, 1997, MAMM GENOME, V8, P714, DOI 10.1007/s003359900552; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; FRASER G R, 1964, J Med Genet, V1, P118, DOI 10.1136/jmg.1.2.118; Gong TWL, 1996, HEARING RES, V96, P20, DOI 10.1016/0378-5955(96)00013-5; Haapaniemi JJ, 1996, EAR HEARING, V17, P469, DOI 10.1097/00003446-199612000-00003; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KONIGSMARK BW, 1976, GENETIC METABOLIC DE, P7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESPERANCE MM, 1995, HUM MOL GENET, V4, P1967, DOI 10.1093/hmg/4.10.1967; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lomax MI, 2000, HEARING RES, V147, P293, DOI 10.1016/S0378-5955(00)00139-8; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; OLSON S, 1991, GENOMICS, V9, P629, DOI 10.1016/0888-7543(91)90356-J; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rivolta MN, 1996, BBA-GENE STRUCT EXPR, V1306, P127, DOI 10.1016/0167-4781(96)00022-X; ROBINSON D W, 1988, British Journal of Audiology, V22, P5, DOI 10.3109/03005368809077793; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Skvorak AB, 1999, HUM MOL GENET, V8, P439, DOI 10.1093/hmg/8.3.439; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; VanCamp G, 1997, AM J HUM GENET, V60, P758; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yuan B, 1997, AM J HUM GENET, V60, P459	25	43	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					254	260		10.1086/316925	http://dx.doi.org/10.1086/316925			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11115382	Bronze, Green Published			2022-12-18	WOS:000166399900027
J	Mateu, E; Calafell, F; Lao, O; Bonne-Tamir, B; Kidd, JR; Pakstis, A; Kidd, KK; Bertranpetit, J				Mateu, E; Calafell, F; Lao, O; Bonne-Tamir, B; Kidd, JR; Pakstis, A; Kidd, KK; Bertranpetit, J			Worldwide genetic analysis of the CFTR region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS GENE; LINKAGE DISEQUILIBRIUM; HAPLOTYPE FREQUENCIES; ISOLATED POPULATIONS; REPEAT POLYMORPHISM; 1ST INTRON; CA REPEAT; MUTATIONS; MICROSATELLITES; ORIGIN	Mutations at the cystic fibrosis transmembrane conductance regulator gene (CFTR) cause cystic fibrosis, the most prevalent severe genetic disorder in individuals of European descent. We have analyzed normal allele and haplotype variation at four short tandem repeat polymorphisms (STRPs) and two single-nucleotide polymorphisms (SNPs) in CFTR in 18 worldwide population samples, comprising a total of 1,944 chromosomes. The rooted phylogeny of the SNP haplotypes was established by typing ape samples. STRP variation within SNP haplotype backgrounds was highest in most ancestral haplotypes-although, when STRP allele sizes were taken into account, differences among haplotypes became smaller. Haplotype background determines STRP diversity to a greater extent than populations do, which indicates that haplotype backgrounds are older than populations. Heterogeneity among STRPs can be understood as the outcome of differences in mutation rate and pattern. STRP sites had higher heterozygosities in Africans, although, when whole haplotypes were considered, no significant differences remained. Linkage disequilibrium (LD) shows a complex pattern not easily related to physical distance. The analysis of the fraction of possible different haplotypes not found may circumvent some of the methodological difficulties of LD measure. LD analysis showed a positive correlation with locus polymorphism, which could partly explain the unusual pattern of similar LD between Africans and non-Africans. The low values found in non-Africans may imply that the size of the modern human population that emerged "Out of Africa" may be larger than what previous LD studies suggested.	Univ Pompeu Fabra, Fac Ciencies Salut Vida, Unit Biol Evolut, Barcelona 08003, Catalonia, Spain; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Pompeu Fabra University; Tel Aviv University; Sackler Faculty of Medicine; Yale University	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut Vida, Unit Biol Evolut, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.	jaume.bertranpetit@cexs.upf.es	Bertranpetit, Jaume/F-8550-2012; Calafell, Francesc/C-8595-2014; Lao, Oscar/N-9930-2017	Bertranpetit, Jaume/0000-0003-0100-0590; Calafell, Francesc/0000-0002-1083-9438; Lao, Oscar/0000-0002-8525-9649				AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; BANDELT HJ, 1995, GENETICS, V141, P743; Bertranpetit J, 1996, CIBA F SYMP, V197, P97; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Calafell F, 2000, HUM HERED, V51, P85; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Calafell F, 2000, HUM GENET, V106, P133, DOI 10.1007/s004399900204; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; Claustres M, 1996, HUM GENET, V98, P336, DOI 10.1007/s004390050219; COOPER DN, 1990, HUM GENET, V85, P55; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Destro-Bisol G, 2000, HUM GENET, V106, P130, DOI 10.1007/s004399900203; Di Rienzo A, 1998, GENETICS, V148, P1269; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; Eaves IA, 2000, NAT GENET, V25, P320; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; EXCOFFIER L, 1992, GENETICS, V131, P479; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GASPARINI P, 1991, HUM GENET, V86, P625; GOLDSTEIN DB, 1995, GENETICS, V139, P463; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; HUGHES D, 1995, HUM GENET, V95, P462; Hughes D, 1996, HUM MUTAT, V8, P229, DOI 10.1002/(SICI)1098-1004(1996)8:3<229::AID-HUMU6>3.3.CO;2-M; Iyengar S, 1998, DNA SEQUENCE, V8, P317, DOI 10.3109/10425179809034076; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1994, AM J HUM GENET, V54, P884; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; LEWONTIN RC, 1964, GENETICS, V49, P49; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Mateu E, 1999, HUM HERED, V49, P15, DOI 10.1159/000022834; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; Morral N, 1996, HUM MUTAT, V8, P149, DOI 10.1002/(SICI)1098-1004(1996)8:2<149::AID-HUMU7>3.0.CO;2-6; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; Moulin DS, 1997, HUM HERED, V47, P295, DOI 10.1159/000154427; Ott J, 1997, GENETICS, V147, P927; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; PerezLezaun A, 1997, HUM GENET, V99, P1; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; QUERE I, 1991, NUCLEIC ACIDS RES, V19, P5453, DOI 10.1093/nar/19.19.5453-a; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUSSO MP, 1995, HUM MUTAT, V5, P23, DOI 10.1002/humu.1380050103; Sanchez-Mazas A, 2000, EUR J HUM GENET, V8, P33, DOI 10.1038/sj.ejhg.5200391; Schneider S., 2000, ARLEQUIN VER 2000 SO; Slatkin M, 1997, AM J HUM GENET, V60, P447; SLATKIN M, 1995, GENETICS, V139, P457; Slatkin M, 2000, GENETICS, V154, P1367; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; SLATKIN M, 1994, GENETICS, V137, P331; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x; Zhao HY, 1997, AM J HUM GENET, V61, pA17; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256	64	43	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					103	117		10.1086/316940	http://dx.doi.org/10.1086/316940			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11104661	Green Published, Bronze			2022-12-18	WOS:000166399900009
J	Nellis, MM; Danner, DJ				Nellis, MM; Danner, DJ			Gene preference in maple syrup urine disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRANCHED-CHAIN ACYLTRANSFERASE; KETOACID DEHYDROGENASE COMPLEX; ACTIVITY STATE; PATIENT; FIBROBLASTS; ABSENCE	Untreated maple syrup urine disease (MSUD) results in mental and physical disabilities and often leads to neonatal death. Newborn-screening programs, coupled with the use of protein-modified diets, have minimized the severity of this phenotype and allowed affected individuals to develop into productive adults. Although inheritance of MSUD adheres to rules for single-gene traits, mutations in the genes for E1 alpha, E1 beta, or E2 of the mitochondrial branched-chain cr-ketoacid dehydrogenase complex can cause the disease. Randomly selected cell lines from 63 individuals with clinically diagnosed MSUD were tested by retroviral complementation of branched-chain alpha -ketoacid dehydrogenase activity to identify the gene locus for mutant alleles. The frequencies of the mutations were 33% for the E1 alpha gene, 38% for the E1 beta gene, and 19% for the E2 gene. Ten percent of the tested cell lines gave ambiguous results by showing no complementation or restoration of activity with two gene products. These results provide a means to establish a genotype/phenotype relationship in MSUD, with the ultimate goal of unraveling the complexity of this single-gene trait. This represents the largest study to date providing information on the genotype for MSUD.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Nutr & Hlth Sci, Atlanta, GA 30322 USA	Emory University; Emory University	Danner, DJ (corresponding author), Emory Univ, Sch Med, Dept Genet, 1462 Clifton Rd,Room 446, Atlanta, GA 30322 USA.				NCRR NIH HHS [M01 RR000039, MO1-RR00039] Funding Source: Medline; NIDDK NIH HHS [T32 DK007734, 5T32DK07734-03] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007734] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AEvarsson A, 2000, STRUCTURE, V8, P277, DOI 10.1016/S0969-2126(00)00105-2; CHUANG DT, 1995, METABOLIC MOL BASES, V1, P1239; Danner Dean J., 1998, Frontiers in Bioscience, V3, pD517; DANNER DJ, 1989, J BIOL CHEM, V264, P7742; DANNER DJ, 1985, J CLIN INVEST, V75, P858, DOI 10.1172/JCI111783; DANNER DJ, 1975, NATURE, V254, P529, DOI 10.1038/254529a0; Danner DJ, 1989, METABOLIC BASIS INHE, P671; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; ELLERINE NP, 1993, BIOCHEM MED METAB B, V49, P363, DOI 10.1006/bmmb.1993.1037; ELSAS LJ, 1988, MODERN NUTRITION HLT, P1337; FERNHOFF PM, 1985, PEDIATR RES, V19, P1011, DOI 10.1203/00006450-198510000-00012; GILLIM SE, 1983, BIOCHEM BIOPH RES CO, V111, P74, DOI 10.1016/S0006-291X(83)80119-3; HERRING WJ, 1992, BIOCHIM BIOPHYS ACTA, V1138, P236, DOI 10.1016/0925-4439(92)90043-M; KOYATA H, 1993, BIOCHEM J, V295, P635, DOI 10.1042/bj2950635; LITWER S, 1989, J BIOL CHEM, V264, P14597; McConnell BB, 1997, BBA-MOL BASIS DIS, V1361, P263, DOI 10.1016/S0925-4439(97)00046-X; MUELLER GM, 1995, GENE THER, V2, P461; PEINEMANN F, 1994, J INHERIT METAB DIS, V17, P3, DOI 10.1007/BF00735389; REED LJ, 1990, J BIOL CHEM, V265, P8971; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; WAGENMAKERS AJM, 1984, BIOCHEM J, V220, P273, DOI 10.1042/bj2200273; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625	22	43	48	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					232	237		10.1086/316950	http://dx.doi.org/10.1086/316950			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112664	Green Published, Bronze			2022-12-18	WOS:000166399900023
J	Sloter, ED; Lowe, X; Moore, DH; Nath, J; Wyrobek, AJ				Sloter, ED; Lowe, X; Moore, DH; Nath, J; Wyrobek, AJ			Multicolor FISH analysis of chromosomal breaks, duplications, deletions, and numerical abnormalities in the sperm of healthy men	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; FLUORESCENCE INSITU HYBRIDIZATION; TANDEM DNA PROBES; MALE GERM-CELLS; HERITABLE TRANSLOCATIONS; HUMAN-LYMPHOCYTES; 1CEN-1Q12 REGION; DOMINANT LETHAL; MALE-MICE; NONRANDOM DISTRIBUTION	Transmitted de novo structural chromosomal abnormalities, the majority of which are paternally derived, can lead to abnormal reproductive outcomes as well as genetic diseases in offspring. We developed and validated a new multicolor FISH procedure (sperm ACM, which utilizes DNA probes specific for the alpha [1cen], classical, [1q12], and midi [1p36.3] satellites of chromosome 1) which utilizes DNA probes specific for three regions of chromosome 1 to detect human sperm that carry numerical abnormalities plus two categories of structural, aberrations: (1) duplications and deletions of 1pter and 1cen, and (2) chromosomal. breaks within the 1cen-1q12 region. In healthy men, the average frequencies of sperm with duplications and deletions were (a) 4.5 +/- 0.5 and 4.1 +/- 1.3 per 10(4) involving 1pter and (b) 0.9 +/- 0.4 and 0.8 +/- 0.3 per 104 involving 1cen, respectively. The frequency of sperm exhibiting breaks within the 1cen-1q12 region was 14.1 +/- 1.2 per 10(4). Structural aberrations accounted for 71% of the abnormalities detected by sperm ACM, which was significantly higher than numerical abnormalities (P = 2 x 10(-8)). Our findings also suggest that, for healthy men, (a) sperm carrying postmeiotic chromosomal breaks appear to be more prevalent than those carrying products of premeiotic or meiotic breakage or rearrangements, (b) the high frequency of chromosome breaks measured after "fertilization" by the hamster-egg cytogenetic method already appear to be present and detectable within human sperm by FISH, and (c) there are nonrandom and donor-specific distributions of breakpoint locations within 1q12 in sperm. FISH facilitates the analysis of much larger numbers of sperm than was possible when the hamster-egg method was used. Therefore, FISH-based procedures for simultaneously detecting chromosomal breaks, rearrangements, and numerical abnormalities in sperm may have widespread applications in human genetics, genetic toxicology, and reproductive medicine.	Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA; W Virginia Univ, Genet & Dev Biol Program, Morgantown, WV 26506 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; West Virginia University; California Pacific Medical Center; California Pacific Medical Center Research Institute	Wyrobek, AJ (corresponding author), Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, POB 808 L-448, Livermore, CA 94550 USA.			Wyrobek, Andrew/0000-0002-5921-5298	NIEHS NIH HHS [P42 ES004705, P4ZES04705] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADLER ID, 1994, MUTAT RES-FUND MOL M, V309, P285, DOI 10.1016/0027-5107(94)90103-1; AULA P, 1976, HUM GENET, V32, P143, DOI 10.1007/BF00291497; AYME S, 1976, HUM GENET, V31, P161, DOI 10.1007/BF00296144; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; BARRIOS L, 1989, CANCER GENET CYTOGEN, V41, P61, DOI 10.1016/0165-4608(89)90108-8; Baumgartner A, 1999, ENVIRON MOL MUTAGEN, V33, P49, DOI 10.1002/(SICI)1098-2280(1999)33:1<49::AID-EM6>3.0.CO;2-F; BENET J, 1992, HUM GENET, V89, P176; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; Brandriff B.F., 1990, BIOL MAMMALIAN GERM, P183; BRANDRIFF BF, 1994, HUM GENET, V93, P295, DOI 10.1007/BF00212026; BRANDRIFF BF, 1988, CYTOGENET CELL GENET, V47, P29, DOI 10.1159/000132500; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; CHAYKO CA, 1992, HUM GENET, V90, P79, DOI 10.1007/BF00210748; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; Dopp E, 1997, CANCER LETT, V120, P157, DOI 10.1016/S0304-3835(97)00305-4; Dopp E, 1997, MUTAT RES-FUND MOL M, V377, P77, DOI 10.1016/S0027-5107(97)00062-6; EASTMOND DA, 1994, MUTAT RES, V322, P9, DOI 10.1016/0165-1218(94)90028-0; ESTOP AM, 1991, HUM GENET, V87, P447; ESTOP AM, 1995, AM J HUM GENET, V56, P452; FUNESCRAVIOTO F, 1974, MUTAT RES, V23, P87, DOI 10.1016/0165-1218(74)90226-2; Generoso WM, 1995, MUTAT RES-GENET TOX, V345, P167, DOI 10.1016/0165-1218(95)90052-7; Generoso WM, 1996, MUTAT RES-GENET TOX, V371, P175, DOI 10.1016/S0165-1218(96)90106-8; GENESCA A, 1990, HUM REPROD, V5, P286, DOI 10.1093/oxfordjournals.humrep.a137091; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; HALES BF, 1990, MUTAT RES, V229, P129, DOI 10.1016/0027-5107(90)90087-K; Hassold TJ, 1998, CURR TOP DEV BIOL, V37, P383; HECHT F, 1984, CLIN GENET, V26, P174; Honda H, 2000, HUM GENET, V106, P188, DOI 10.1007/s004390051027; Howard-Peebles PN, 1999, PRINCIPLES OF CLINICAL CYTOGENETICS, P425; JENDERNY J, 1992, HUM GENET, V90, P151; Johnson KL, 1999, INT J RADIAT BIOL, V75, P131, DOI 10.1080/095530099140582; JOSHI DS, 1990, RADIAT RES, V121, P274, DOI 10.2307/3577777; KAMIGUCHI Y, 1986, AM J HUM GENET, V38, P724; KUCEROVA M, 1976, MUTAT RES, V34, P279, DOI 10.1016/0027-5107(76)90133-0; Marchetti F, 1997, ENVIRON MOL MUTAGEN, V30, P410, DOI 10.1002/(SICI)1098-2280(1997)30:4<410::AID-EM6>3.0.CO;2-M; Marchetti F, 1999, BIOL REPROD, V61, P948, DOI 10.1095/biolreprod61.4.948; Martin R, 1998, CHROMOSOMA, V107, P523, DOI 10.1007/s004120050338; Martin RH, 1999, CANCER GENET CYTOGEN, V108, P133, DOI 10.1016/S0165-4608(98)00125-3; MARTIN RH, 1986, MUTAT RES, V174, P219, DOI 10.1016/0165-7992(86)90155-7; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; MARTIN RH, 1991, AM J MED GENET, V39, P321, DOI 10.1002/ajmg.1320390315; MARTIN RH, 1989, MUTAT RES, V226, P21, DOI 10.1016/0165-7992(89)90088-2; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; McFadden D, 1997, MUTAT RES-FUND MOL M, V396, P129, DOI 10.1016/S0027-5107(97)00179-6; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; Monteil M, 1997, CYTOGENET CELL GENET, V76, P134, DOI 10.1159/000134531; MORAD M, 1977, MUTAT RES, V42, P125, DOI 10.1016/S0027-5107(77)80015-8; MORAD M, 1973, HEREDITAS, V74, P273; OLSON SB, 1988, CYTOGENETICS MAMMALI, P583; Parada LA, 2000, MED PEDIATR ONCOL, V34, P165, DOI 10.1002/(SICI)1096-911X(200003)34:3<165::AID-MPO1>3.0.CO;2-T; PELLESTOR F, 1987, HUM GENET, V76, P116, DOI 10.1007/BF00284905; REEVES BR, 1974, MUTAT RES, V26, P205, DOI 10.1016/S0027-5107(74)80076-X; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Robbins WA, 1996, MUTAT RES-FUND MOL M, V355, P235, DOI 10.1016/0027-5107(96)00030-9; Robbins WA, 1997, ENVIRON MOL MUTAGEN, V30, P175, DOI 10.1002/(SICI)1098-2280(1997)30:2<175::AID-EM10>3.0.CO;2-A; ROBBINS WA, 1995, REPROD FERT DEVELOP, V7, P1; Rousseaux S, 1998, MOL HUM REPROD, V4, P695, DOI 10.1093/molehr/4.7.695; Rubes J, 1998, FERTIL STERIL, V70, P715, DOI 10.1016/S0015-0282(98)00261-1; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; Rupa DS, 1997, ENVIRON MOL MUTAGEN, V29, P161; Rupa DS, 1997, CARCINOGENESIS, V18, P2347, DOI 10.1093/carcin/18.12.2347; Rupa DS, 1997, MUTAGENESIS, V12, P195, DOI 10.1093/mutage/12.4.195; RUPA DS, 1995, CANCER RES, V55, P640; RUSSELL LB, 1992, MUTAT RES, V282, P151, DOI 10.1016/0165-7992(92)90089-Z; SEGA GA, 1976, MUTAT RES, V38, P317, DOI 10.1016/0165-1161(76)90156-4; SHELBY MD, 1987, ENVIRON MOL MUTAGEN, V9, P363, DOI 10.1002/em.2860090403; SHELBY MD, 1986, MUTAT RES, V173, P35, DOI 10.1016/0165-7992(86)90008-4; SINGH NP, 1989, EXP CELL RES, V184, P461, DOI 10.1016/0014-4827(89)90344-3; SONTA S, 1991, CYTOGENET CELL GENET, V57, P200, DOI 10.1159/000133146; SUTHERLAND GR, 1991, GENET ANAL-BIOMOL E, V8, P161, DOI 10.1016/1050-3862(91)90056-W; TUCKER JD, 1994, RADIAT RES, V140, P31, DOI 10.2307/3578565; Tusell L, 1995, ENVIRON MOL MUTAGEN, V26, P315, DOI 10.1002/em.2850260407; VanHummelen P, 1997, AM J HUM GENET, V61, P651; VanHummelen P, 1996, HUM GENET, V98, P608; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WORKING PK, 1984, ENVIRON MUTAGEN, V6, P273, DOI 10.1002/em.2860060304; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; WYROBEK AJ, 1993, REPROD TOXICOL, V7, P3, DOI 10.1016/0890-6238(93)90064-E; WYROBEK AJ, 2000, IN PRESS NATO ASI SE	82	43	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					862	872		10.1086/303088	http://dx.doi.org/10.1086/303088			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10961911	Green Published, Bronze			2022-12-18	WOS:000089651100010
J	Virolainen, E; Wessman, M; Hovatta, I; Niemi, KM; Ignatius, J; Kere, J; Peltonen, L; Palotie, A				Virolainen, E; Wessman, M; Hovatta, I; Niemi, KM; Ignatius, J; Kere, J; Peltonen, L; Palotie, A			Assignment of a novel locus for autosomal recessive congenital ichthyosis chromosome 19p13.1-p13.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAMELLAR ICHTHYOSIS; KERATINOCYTE TRANSGLUTAMINASE; MUSCULAR-DYSTROPHY; LINKAGE ANALYSIS; HUMAN GENOME; MUTATIONS; GENE; POLYMORPHISMS; HETEROGENEITY; ERYTHRODERMA	Autosomal recessive congenital ichthyosis (ARCI) is a rare, clinically and genetically heterogeneous genodermatosis. One gene (transglutaminase 1, on 14q11) and one additional locus (on 2q33-35, with an unidentified gene) have been shown to be associated with a lamellar, nonerythrodermic type of ARCI. We performed a genomewide scan, with 370 highly polymorphic microsatellite markers, on five affected individuals from one large Finnish family with nonerythrodermic, nonlamellar ARCI. The only: evidence for Linkage emerged from markers in a 6.0-cM region on chromosome 19p13.1-2. The maximum two-point LOD score of 7.33 was obtained with the locus D19S252, and multipoint likelihood calculations gave a maximum location score of 5.2. The affected individuals share two common core halotypes, which makes compound heterozygosity possible. The novel disease Locus is the third focus linked to ARCI, supporting previous evidence for genetic heterogeneity of ARCI. This is also the first locus for a nonlamellar, nonerythrodermic phenotype of ARCI.	Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Gonda Ctr, Los Angeles, CA 90024 USA; Univ Helsinki, Cent Hosp, Dept Clin Chem, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Lab, Helsinki, Finland; Univ Helsinki, Dept Biosci, Div Genet, Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Dermatol, FIN-00170 Helsinki, Finland; Jorvi Hosp, Dept Clin Neurophysiol, SF-02740 Espoo, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Palotie, A (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, 695 Charles E Young Dr S,Box 708822, Los Angeles, CA 90024 USA.		Kere, Juha/AAX-9117-2021; Hovatta, Iiris/D-6871-2012; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Hovatta, Iiris/0000-0002-5990-7892; Kere, Juha/0000-0003-1974-0271; Palotie, Aarno/0000-0002-2527-5874				COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Hennies HC, 1998, AM J HUM GENET, V62, P1052, DOI 10.1086/301818; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Huber M, 1997, J BIOL CHEM, V272, P21018, DOI 10.1074/jbc.272.34.21018; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; Laiho E, 1997, AM J HUM GENET, V61, P529, DOI 10.1086/515498; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NORIO R, 1973, ANN CLIN RES, V5, P109; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; Parmentier L, 1996, HUM MOL GENET, V5, P555, DOI 10.1093/hmg/5.4.555; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Pigg M, 1998, EUR J HUM GENET, V6, P589, DOI 10.1038/sj.ejhg.5200224; RUSSELL LJ, 1994, AM J HUM GENET, V55, P1146; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sambrook J, 1987, MOL CLONING LAB MANU; Sobel E, 1996, AM J HUM GENET, V58, P1323; UDD B, 1991, MUSCLE NERVE, V14, P1050, DOI 10.1002/mus.880141103; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WELLS RS, 1966, BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5493.947; WILLIAMS ML, 1985, ARCH DERMATOL, V121, P477, DOI 10.1001/archderm.121.4.477	27	43	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1132	1137		10.1086/302813	http://dx.doi.org/10.1086/302813			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712223	Green Published, Bronze			2022-12-18	WOS:000088373200031
J	Catalan, J; Falck, GCM; Norppa, H				Catalan, J; Falck, GCM; Norppa, H			The X chromosome frequently lags behind in female lymphocyte anaphase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; SEX-CHROMOSOMES; MICRONUCLEI; ANEUPLOIDY; AGE; WOMEN	Pancentromeric FISH and X-chromosome painting were used to characterize anaphase aberrations in 2,048 cultured lymphocytes from a healthy 62-year-old woman. Of 163 aberrant anaphases, 66.9% contained either chromosomes or their fragments that lagged behind. Characterization of 200 laggards showed that 49% were autosomes, 33.5% were autosomal fragments, and 17.5% were X chromosomes. The X chromosome represented one-fourth of all lagging chromosomes and was involved much more often than would be expected by chance (1/23). Labeling of the late-replicating inactive X chromosome with 5-bromo-2'-deoxyuridine revealed that both X homologues contributed equally to the laggards. Among 200 micronuclei examined from interphase cells, the proportion of the X chromosome (31%) and autosomal fragments (50%) was higher than among anaphase laggards, whereas autosomes were involved less often (19%). These findings may reflect either selection or the fact that lagging autosomes, which were more proximal to the poles than were lagging X chromosomes, were more frequently included within the main nucleus. Our results suggest that the well-known high micronucleation and loss of the X chromosome in women's lymphocytes is the result of frequent distal lagging behind in anaphase and effective micronucleation of this chromosome. This lagging appears to affect the inactive and active X chromosomes equally.	Univ Zaragoza, Dept Anat Embryol & Genet, Zaragoza, Spain	University of Zaragoza	Norppa, H (corresponding author), Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Lab Mol & Cellular Toxicol, Topeliuksenkatu 41A A, FIN-00250 Helsinki, Finland.	hannu.norppa@occuphealth.fi		Norppa, Hannu/0000-0001-6637-904X; Catalan Rodriguez, Julia/0000-0003-2936-242X				ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; Catalan J, 1998, AM J HUM GENET, V63, P1464, DOI 10.1086/302092; CATALAN J, 1995, CYTOGENET CELL GENET, V68, P11, DOI 10.1159/000133879; FITZGERALD PH, 1977, HUM GENET, V39, P329, DOI 10.1007/BF00295428; FORD JH, 1987, CYTOBIOS, V51, P183; FORD JH, 1992, GENOME, V35, P702, DOI 10.1139/g92-107; FORD JH, 1988, AM J HUM GENET, V43, P733; GUTTENBACH M, 1994, HUM GENET, V94, P295; HANDO JC, 1994, CHROMOSOMA, V103, P186, DOI 10.1007/s004120050023; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; Kirsch-Volders M, 1998, MUTAGENESIS, V13, P321, DOI 10.1093/mutage/13.4.321; LINDHOLM C, 1991, MUTAT RES, V260, P369, DOI 10.1016/0165-1218(91)90022-E; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Marshall RR, 1996, MUTAT RES-FUND MOL M, V372, P233, DOI 10.1016/S0027-5107(96)00143-1; NORPPA H, 1993, MUTAGENESIS, V8, P519, DOI 10.1093/mutage/8.6.519; RICHARD F, 1993, MUTAT RES, V295, P71, DOI 10.1016/0921-8734(93)90003-L; RICHARD F, 1994, MUTAT RES, V316, P1, DOI 10.1016/0921-8734(94)90002-7; STOPPER H, EUR J GENET TOXICOL; Surralles J, 1996, AM J HUM GENET, V59, P1091; Surralles J, 1996, CYTOGENET CELL GENET, V75, P151, DOI 10.1159/000134467; Tucker JD, 1996, HUM GENET, V97, P471	21	43	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					687	691		10.1086/302769	http://dx.doi.org/10.1086/302769			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677326	Green Published, Bronze			2022-12-18	WOS:000088373100033
J	Page, GP; Amos, CI				Page, GP; Amos, CI			Comparison of linkage-disequilibrium methods for localization of genes influencing quantitative traits in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEASURED GENOTYPE INFORMATION; POWER; PHENOTYPES; TESTS; CHOLESTEROL; SAMPLE; REGION; LOCI	Linkage disequilibrium has been used to help in the identification of genes predisposing to certain qualitative diseases. Although several linkage-disequilibrium tests have been developed for localization of genes influencing quantitative traits, these tests have not been thoroughly compared with one another. In this report we compare, under a variety of conditions, several different linkage-disequilibrium tests for identification of loci affecting quantitative traits. These tests use either single individuals or parent-child trios. When we compared tests with equal samples, we found that the truncated measured allele (TMA) test was the most powerful. The trait allele frequencies, the stringency of sample ascertainment, the number of marker alleles, and the linked genetic variance affected the power, but the presence of polygenes did not. When there were more than two trait alleles at a locus in the population, power to detect disequilibrium was greatly diminished. The presence of unlinked disequilibrium (D'*) increased the false-positive error rates of disequilibrium tests involving single individuals but did not affect the error rates of tests using family trios. The increase in error rates was affected by the stringency of selection, the trait allele frequency, and the linked genetic variance but not by polygenic factors. In an equilibrium population, the TMA test is most powerful, but, when adjusted for the presence of admixture, Allison test 3 becomes the most powerful whenever D'* > .15.	Univ Texas, MD Anderson Cancer Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Amos, CI (corresponding author), Univ Texas, MD Anderson Cancer Ctr, Dept Epidemiol, 1515 Holcombe,Box 189, Houston, TX 77030 USA.	camos@request.mdacc.tmc.edu		Page, Grier/0000-0003-2582-3786	NHLBI NIH HHS [HL-53917] Funding Source: Medline; NIEHS NIH HHS [ES-09912] Funding Source: Medline; NIGMS NIH HHS [GM-52607] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052607] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel L, 1998, AM J HUM GENET, V63, P664, DOI 10.1086/301975; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Allison DB, 1997, AM J HUM GENET, V60, P676; AMOS CI, 1994, AM J HUM GENET, V54, P535; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; DEAN M, 1994, AM J HUM GENET, V55, P788; FUNKE H, 1986, CLIN CHEM, V32, P1285; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Kaplan NL, 1997, AM J HUM GENET, V60, P691; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li CC, 1976, 1 COURSE POPULATION; Mohrenweiser HW, 1998, MUTAT RES-FUND MOL M, V400, P15, DOI 10.1016/S0027-5107(98)00059-1; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Ott J, 1997, GENETICS, V147, P927; Ott J., 1991, ANAL HUMAN GENETIC L; Page GP, 1998, AM J HUM GENET, V62, P962, DOI 10.1086/301783; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Surguchov AP, 1996, ARTERIOSCL THROM VAS, V16, P941, DOI 10.1161/01.ATV.16.8.941; Traeger-Synodinos J, 1998, HUM GENET, V102, P343, DOI 10.1007/s004390050703; Wang JP, 1998, J CLIN INVEST, V101, P1283, DOI 10.1172/JCI1343; Weiss K. M., 1993, GENETIC VARIATION HU	27	43	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1194	1205		10.1086/302331	http://dx.doi.org/10.1086/302331			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090905	Bronze, Green Published			2022-12-18	WOS:000079632900031
J	Greenwood, CMT; Bull, SB				Greenwood, CMT; Bull, SB			Analysis of affected sib pairs, with covariates - With and without constraints	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE SUSCEPTIBILITY GENES; EVOLVING METHODS; LINKAGE ANALYSIS; IBD DISTRIBUTION; EPIDEMIOLOGY; EXTENSIONS; TRAITS	Covariate models have previously been developed as an extension to affected-sib-pair methods in which the covariate effects are jointly estimated with the degree of excess allele sharing. These models can estimate the differences in sib-pair allele sharing that are associated with measurable environment or genes. When there are no covariates, the pattern of identical-by-descent allele sharing in affected sib pairs is expected to fall within a small triangular region of the potential parameter space, under most genetic models. By restriction of the estimated allele sharing to this triangle, improved power is obtained in tests for genetic linkage. When the affected-sib-pair model is generalized to allow for covariates that affect allele sharing, however, new constraints and new methods for the application of constraints are required. Three generalized constraint methods are proposed and evaluated by use of simulated data. The results compare the power of the different methods, with and without covariates, for a single-gene model with age-dependent onset and for quantitative and qualitative gene-environment and gene-gene interaction models. Covariates can improve the power to detect linkage and can be particularly valuable when there are qualitative gene-environment interactions. In most situations, the best strategy is to assume that there is no dominance variance and to obtain constrained estimates for covariate models under this assumption.	McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada	McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Greenwood, CMT (corresponding author), Montreal Gen Hosp, Div Med Genet, L10-109,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.		Bull, Shelley B/A-1920-2013	Greenwood, Celia/0000-0002-2427-5696				Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Beaty TH, 1997, EPIDEMIOL REV, V19, P14, DOI 10.1093/oxfordjournals.epirev.a017936; CLERGETDARPOUX F, 1997, 6 ANN M INT GEN EP S; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; DAWSON DV, 1990, GENET EPIDEMIOL, V7, P453, DOI 10.1002/gepi.1370070607; FLANDERS WD, 1991, GENET EPIDEMIOL, V8, P399, DOI 10.1002/gepi.1370080606; Greenwood CMT, 1997, GENET EPIDEMIOL, V14, P635; GREENWOOD CMT, 1999, IN PRESS AM J HUM GE, V64; GREENWOOD CMT, 1998, THESIS U TORONTO TOR; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KHOURY MJ, 1987, AM J EPIDEMIOL, V126, P561, DOI 10.1093/oxfordjournals.aje.a114695; Knapp M, 1996, AM J HUM GENET, V59, P485; Kong A, 1997, NAT GENET, V17, P148, DOI 10.1038/ng1097-148; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lio P, 1997, P NATL ACAD SCI USA, V94, P5344, DOI 10.1073/pnas.94.10.5344; LOUIS EJ, 1987, ANN HUM GENET, V51, P75; Lunetta KL, 1998, GENET EPIDEMIOL, V15, P595, DOI 10.1002/(SICI)1098-2272(1998)15:6<595::AID-GEPI4>3.0.CO;2-4; MOTRO U, 1985, GENETICS, V110, P525; OLSON JM, 1995, AM J HUM GENET, V56, P788; RISCH N, 1990, AM J HUM GENET, V46, P229; *SAS I, SAS IML US GUID REL; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SUAREZ BK, 1978, TISSUE ANTIGENS, V12, P87, DOI 10.1111/j.1399-0039.1978.tb01303.x; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820; Yang QH, 1997, EPIDEMIOL REV, V19, P33, DOI 10.1093/oxfordjournals.epirev.a017944	27	43	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					871	885		10.1086/302288	http://dx.doi.org/10.1086/302288			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053022	Green Published, Bronze			2022-12-18	WOS:000079204700025
J	Imamura, A; Tsukamoto, T; Shimozawa, N; Suzuki, Y; Zhang, ZH; Imanaka, T; Fujiki, Y; Orii, T; Kondo, N; Osumi, T				Imamura, A; Tsukamoto, T; Shimozawa, N; Suzuki, Y; Zhang, ZH; Imanaka, T; Fujiki, Y; Orii, T; Kondo, N; Osumi, T			Temperature-sensitive phenotypes of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MAMMALIAN-CELL MUTANT; COMPLEMENTATION GROUP; ZELLWEGER SYNDROME; PROTEIN IMPORT; PTS1 RECEPTOR; FACTOR-II; GENE; FIBROBLASTS; MUTATIONS; DEFECTS		Himeji Inst Technol, Dept Life Sci, Kamigori, Hyogo, Japan; Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan; Chubu Gakuin Univ, Fac Human Welfare, Gifu, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Sagamiko, Kanagawa 19901, Japan; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	University of Hyogo; Gifu University; Teikyo University; Kyushu University	Osumi, T (corresponding author), Himeji Inst Technol, Dept Life Sci, Kamigori, Hyogo, Japan.	osumi@sci.himeji-tech.ac.jp		Shimozawa, Nobuyuki/0000-0003-3040-5458; Imanaka, Tsuneo/0000-0003-4677-1356				ARIAS JA, 1985, J CELL BIOL, V100, P1789, DOI 10.1083/jcb.100.5.1789; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; CHUANG DT, 1995, METABOLIC MOL BASES, P1239; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Giros M, 1996, ANN NY ACAD SCI, V804, P747, DOI 10.1111/j.1749-6632.1996.tb18689.x; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MAEDA K, 1990, ACTA PAEDIATR JAPON, V94, P1869; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MORLEY SN, 1995, J CELL SCI, V108, P3463; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1988, PEDIATR RES, V24, P723, DOI 10.1203/00006450-198812000-00015; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Shimozawa N, 1998, HUM MUTAT, pS134; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; TSUKAMOTO T, 1994, MOL CELL BIOL, V14, P5458, DOI 10.1128/MCB.14.8.5458; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; WIEMER EAC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P232, DOI 10.1016/0925-4439(91)90041-7; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	28	43	45	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1539	1543		10.1086/301881	http://dx.doi.org/10.1086/301881			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585609	Green Published, Bronze			2022-12-18	WOS:000074174700033
J	Ars, E; Kruyer, H; Gaona, A; Casquero, P; Rosell, J; Volpini, V; Serra, E; Lazaro, C; Estivill, X				Ars, E; Kruyer, H; Gaona, A; Casquero, P; Rosell, J; Volpini, V; Serra, E; Lazaro, C; Estivill, X			A clinical variant of neurofibromatosis type 1: Familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AU-LAIT SPOTS; DINUCLEOTIDE REPEAT; TUMOR SUPPRESSOR; NOONAN SYNDROME; I GENE; LOCUS; DELETIONS; IDENTIFICATION; FEATURES; ALLELES	Spinal neurofibromatosis (SNF) has been considered to be an alternative form of neurofibromatosis in which spinal cord tumors are the main clinical characteristic. Familial SNF has been reported, elsewhere, in three families-two linked to markers within the gene for neurofibromatosis type 1 (NF1) and the other not linked to NF1-but no molecular alterations have been described in these families. We describe a three-generation family that includes five members affected by SNF. All the affected members presented multiple spinal neurofibromas and cafe au lait spots, one member had cutaneous neurofibromas, and some members had other signs of NF1. Genetic analysis, performed with markers within and flanking the NF1 gene, showed segregation with the NF1 locus. Mutation analysis, performed with the protein-truncation test and SSCP/heteroduplex analysis of the whole coding region of the NF1 gene, identified a frameshift mutation (8042insA) in exon 46, which should result in a truncated NF1 protein. The 8042insA mutation was detected in all five family members with the SNF/ NF1 phenotype. To our knowledge, this is the first time that a mutation in the NF1 gene has been associated with SNF. The clinical homogeneity in the severity of the disease among the affected members of the family, which is unusual in NF1, suggests that a particular property of the NF1 mutation described here, a gene closely linked to NF1, or posttranscriptional events are involved in this severe neurological phenotype.	Hosp Duran & Reynals, Med & Mol Genet Ctr IRO, Barcelona 08907, Spain; Hosp Verge Toro, Unitat Neurol, Menorca, Balearic Isl, Spain; Hosp Son Dureta, Seccio Genet, Mallorca, Balearic Isl, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Hospital Mateu Orfila; Hospital Universitari Son Espases; Hospital Universitari Son Dureta	Estivill, X (corresponding author), Hosp Duran & Reynals, Med & Mol Genet Ctr IRO, Avia Castelldefels Km 2-7, Barcelona 08907, Spain.	estivill@iro.es	Ars, Elisabet/AAM-8454-2021; Estivill, Xavier/E-2957-2012; Serra, Eduard/K-1332-2013; GARCIA, CONXI LAZARO/Q-2410-2016; Estivill, Xavier/A-3125-2013	Ars, Elisabet/0000-0002-4118-4358; Serra, Eduard/0000-0003-2895-9857; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Estivill, Xavier/0000-0002-0723-2256				ABELIOVICH D, 1995, J MED GENET, V32, P985, DOI 10.1136/jmg.32.12.985; AHLBOM BE, 1995, CLIN GENET, V48, P85; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Bahuau M, 1996, AM J MED GENET, V66, P347, DOI 10.1002/(SICI)1096-8628(19961218)66:3<347::AID-AJMG20>3.0.CO;2-L; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BOURN D, 1995, HUM GENET, V95, P712; BRUNNER HG, 1993, AM J MED GENET, V46, P472, DOI 10.1002/ajmg.1320460428; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; DANGLOT G, 1995, HUM MOL GENET, V4, P915, DOI 10.1093/hmg/4.5.915; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HOFFMEYER S, 1994, HUM GENET, V94, P97, DOI 10.1007/BF02272852; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; KAYES LM, 1994, AM J HUM GENET, V54, P424; LAZARO C, 1993, HUM MOL GENET, V2, P725, DOI 10.1093/hmg/2.6.725; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Leppig KA, 1996, CYTOGENET CELL GENET, V72, P95, DOI 10.1159/000134171; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MARINEAU C, 1993, HUM MOL GENET, V2, P336, DOI 10.1093/hmg/2.3.336-a; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Poyhonen M, 1997, J MED GENET, V34, P184, DOI 10.1136/jmg.34.3.184; PULST SM, 1991, NEUROLOGY, V41, P1923, DOI 10.1212/WNL.41.12.1923; Pulst SM, 1997, NEUROLOGY, V48, P787, DOI 10.1212/WNL.48.3.787; RICCARDI VM, 1992, NEUROFIBROMATOSIS PH, P8; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SALA N, IN PRESS MOL METHODS; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Skuse GR, 1997, HUM MOL GENET, V6, P1707, DOI 10.1093/hmg/6.10.1707; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Upadhyaya M, 1996, J MED GENET, V33, P148, DOI 10.1136/jmg.33.2.148; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Viskochil D., 1994, P445; VONDEIMLING A, 1995, BRAIN PATHOL, V5, P153; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Wu BL, 1997, AM J MED GENET, V69, P98, DOI 10.1002/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J; Wu R, 1996, HUM MUTAT, V8, P51, DOI 10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	49	43	45	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					834	841		10.1086/301803	http://dx.doi.org/10.1086/301803			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529361	Green Published, Bronze			2022-12-18	WOS:000073514400014
J	Gottlieb, S; Driscoll, DA; Punnett, HH; Sellinger, B; Emanuel, BS; Budarf, ML				Gottlieb, S; Driscoll, DA; Punnett, HH; Sellinger, B; Emanuel, BS; Budarf, ML			Characterization of 10p deletions suggests two nonoverlapping regions contribute to the DiGeorge syndrome phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							INTERSTITIAL DELETION; HUMAN GENOME; MAP		Childrens Hosp, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19133 USA; Temple Univ, Hlth Sci Ctr, Sch Med, Philadelphia, PA 19140 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Budarf, ML (corresponding author), Childrens Hosp, Div Human Genet & Mol Biol, 1004 Abramson Res Bldg,34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL051533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL51533] Funding Source: Medline; NIDCD NIH HHS [DC02027] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		CHUMAKOV IM, 1995, NATURE, V377, P175; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; DRISCOLL DA, 1996, MENTAL RETARD DEV DI, V2, P130; GREENBERG F, 1986, J PEDIATR-US, V109, P489, DOI 10.1016/S0022-3476(86)80124-X; GREENBERG F, 1988, AM J HUM GENET, V43, P605; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Lipson A, 1996, AM J MED GENET, V65, P304, DOI 10.1002/(SICI)1096-8628(19961111)65:4<304::AID-AJMG11>3.0.CO;2-Y; MONACO G, 1991, AM J MED GENET, V39, P215, DOI 10.1002/ajmg.1320390220; Pignata C, 1996, CLIN IMMUNOL IMMUNOP, V80, P9, DOI 10.1006/clin.1996.0088	9	43	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					495	498		10.1086/301718	http://dx.doi.org/10.1086/301718			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463325	Bronze, Green Published			2022-12-18	WOS:000072416000038
J	Bassett, AS; Husted, J				Bassett, AS; Husted, J			Anticipation or ascertainment bias in Schizophrenia? Penrose's familial mental illness sample	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE; ONSET; DISORDER; REPEATS; AGE; DIAGNOSIS; EXPANSION; PAIRS	Several studies have observed anticipation (earlier age at onset [AAO] in successive generations) in familial schizophrenia. However, whether true anticipation or ascertainment bias is the principal originating mechanism remains unclear. Zn 1944 L. S. Penrose collected AAO data on a large, representative sample of familial mental illness, using a broad ascertainment strategy. These data allowed examination of anticipation and ascertainment biases in five two-generation samples of affected relative pairs. The median intergenerational. difference (MID) in AAO was used to assess anticipation. Results showed significant anticipation in parent-offspring pairs with schizophrenia (sl = 137 pairs; MID 15 years; P = .0001) and in a positive control sample with Huntington disease (n = 11; P = .01). Broadening the diagnosis of the schizophrenia sample suggested anticipation of severity of illness. However, other analyses provided evidence for ascertainment bias, especially in later-AAO parents, in parent-offspring pairs. Aunt/uncle-niece/nephew schizophrenia pairs showed anticipation (It = 111; P = .0001), but the MID was 8 years and aunts/uncles had earlier median AAO than parents. Anticipation effects were greatest in pairs with late-AAO parents but remained significant in a subgroup of schizophrenia pairs with early parental AAO (n = 31; P = .03), A small control sample of other diseases had MID of 5 years but no significant anticipation (n = 9; P = .38). These results suggest that, although ascertainment-bias effects were observed in parent-offspring pairs, true anticipation appears to be inherent in the transmission of familial schizophrenia. The findings support investigations of unstable mutations and other mechanisms that may contribute to true anticipation in schizophrenia.	UNIV TORONTO, DEPT PSYCHIAT, TORONTO, ON M5S 1A1, CANADA; UNIV WATERLOO, DEPT HLTH STUDIES & GERONTOL, WATERLOO, ON N2L 3G1, CANADA	University of Toronto; University of Waterloo	Bassett, AS (corresponding author), QUEEN ST MENTAL HLTH CTR, SCHIZOPHRENIA RES PROGRAM, GENET SECT, 1001 QUEEN ST W, TORONTO, ON M6J 1H4, CANADA.							ASHERSON P, 1994, BRIT J PSYCHIAT, V164, P619, DOI 10.1192/bjp.164.5.619; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; BASSETT AS, 1994, AM J HUM GENET, V54, P864; BEISER M, 1993, AM J PSYCHIAT, V150, P1349; Bleuler M., 1978, SCHIZOPHRENIC DISORD; BOLT JMW, 1970, BRIT J PSYCHIAT, V116, P259, DOI 10.1192/bjp.116.532.259; CROW TJ, 1991, EUR ARCH PSY CLIN N, V240, P314, DOI 10.1007/BF02279759; DECINA P, 1991, PSYCHIAT RES, V39, P81, DOI 10.1016/0165-1781(91)90010-M; DELISI LE, 1992, SCHIZOPHRENIA BULL, V18, P209, DOI 10.1093/schbul/18.2.209; FARAONE SV, 1994, BRIT J PSYCHIAT, V164, P625, DOI 10.1192/bjp.164.5.625; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KAY DWK, 1963, ACTA PSYCHIAT SCAND, V39, P159, DOI 10.1111/j.1600-0447.1963.tb07464.x; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1990, GENET EPIDEMIOL, V7, P409, DOI 10.1002/gepi.1370070603; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LESCH KP, 1994, J NEURAL TRANSM-GEN, V98, P153, DOI 10.1007/BF01277018; Link B. G., 1980, MENTAL ILLNESS US EP; Lovestone S, 1996, J MED GENET, V33, P128, DOI 10.1136/jmg.33.2.128; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; Mott FW, 1910, BRIT MED J, V1910, P1013, DOI 10.1136/bmj.2.2597.1013; Neri C, 1996, HUM MOL GENET, V5, P1001, DOI 10.1093/hmg/5.7.1001; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PENROSE LS, 1991, EUR ARCH PSY CLIN N, V240, P315, DOI 10.1007/BF02279760; PENROSE LS, 1971, MODERN PERSPECTIVES, P3; PFLANZ S, 1991, ACTA PSYCHIAT SCAND, V83, P53, DOI 10.1111/j.1600-0447.1991.tb05511.x; POWELL A, 1973, BRIT J PSYCHIAT, V123, P653, DOI 10.1192/bjp.123.6.653; RANEN NG, 1995, AM J HUM GENET, V57, P593; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Slater E, 1971, GENETICS MENTAL DISO; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; VOGLER GP, 1990, BEHAV GENET, V20, P461, DOI 10.1007/BF01067712	37	43	44	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					630	637						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WK403	9042924				2022-12-18	WOS:A1997WK40300021
J	Felbor, U; Suvanto, EA; Forsius, HR; Eriksson, AW; Weber, BHF				Felbor, U; Suvanto, EA; Forsius, HR; Eriksson, AW; Weber, BHF			Autosomal recessive Sorsby fundus dystrophy revisited: Molecular evidence for dominant inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METALLOPROTEINASES-3 TIMP3; TISSUE INHIBITOR; MUTATIONS	Sorsby fundus dystrophy (SFD) originally was characterized as an autosomal dominant disorder in which patients lose central vision during the 4th or 5th decade of life. Since Sorsby's initial description, interfamilial phenotypic variations have been noted and have given rise to controversy as to whether SFD constitutes more than one nosologic entity. In addition, several reports have proposed the existence of a recessively inherited form of SFD. The recent identification of the tissue inhibitor of metalloproteinases-3 (TIMP3) as the disease-causing gene in SFD has made it possible to address the questions of clinical and genetic heterogeneity. In this study, we reinvestigated a large, highly consanguineous Finnish family previously diagnosed as having early-onset autosomal recessive SFD. We identified a novel heterozygous Gly16Cys mutation in TIMP3 in all affected individuals and provide strong evidence for an autosomal dominant inheritance of the SFD phenotype in this family. Our results, in conjunction with a critical review of the reported cases, render the existence of a recessive mode of inheritance in SFD questionable. Considering all available data, we suggest that SFD is a genetically homogeneous, autosomal dominant condition.	UNIV WURZBURG,INST HUMAN GENET,BIOZENTRUM,D-97074 WURZBURG,GERMANY; FOLKHALSAN INST GENET,POPULAT GENET UNIT,HELSINKI,FINLAND	University of Wurzburg				Weber, Bernhard H.F./0000-0002-8808-7723				CAPON MRC, 1988, EYE, V2, P114, DOI 10.1038/eye.1988.23; CarreroValenzuela RD, 1996, ARCH OPHTHALMOL-CHIC, V114, P737, DOI 10.1001/archopht.1996.01100130729016; ERIKSSON AW, 1990, CLIN GENET, V38, P21; Felbor U, 1996, J MED GENET, V33, P233, DOI 10.1136/jmg.33.3.233; FELBOR U, 1995, HUM MOL GENET, V4, P2415, DOI 10.1093/hmg/4.12.2415; FORSIUS HR, 1982, AM J OPHTHALMOL, V94, P634, DOI 10.1016/0002-9394(82)90009-5; FRANCOIS J, 1958, HEREDITE OPHTHALMOLO, P552; GREGORY CY, 1995, J MED GENET, V32, P240, DOI 10.1136/jmg.32.3.240; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOSKIN A, 1981, BRIT J OPHTHALMOL, V65, P859, DOI 10.1136/bjo.65.12.859; JACOBSON SG, 1995, NAT GENET, V11, P27, DOI 10.1038/ng0995-27; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Peters AL, 1995, RETINA-J RET VIT DIS, V15, P480, DOI 10.1097/00006982-199515060-00004; POLKINGHORNE PJ, 1989, OPHTHALMOLOGY, V96, P1763; Sorsby A, 1940, Br J Ophthalmol, V24, P469, DOI 10.1136/bjo.24.10.469; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; Stohr H, 1995, GENOME RES, V5, P483, DOI 10.1101/gr.5.5.483; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Wijesuriya SD, 1996, GENOME RES, V6, P92, DOI 10.1101/gr.6.2.92	19	43	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					57	62						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981947				2022-12-18	WOS:A1997WA81800010
J	Zhang, HP; Risch, N				Zhang, HP; Risch, N			Mapping quantitative-trait loci in humans by use of extreme concordant sib pairs: Selected sampling by parental phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								In two previous articles, we have considered sample sizes required to detect linkage for mapping quantitative-trait loci in humans, using extreme discordant sib pairs. Here, we examine further the use of extreme concordant sib pairs but consider the effect of parents' phenotypes. Sample sizes necessary to obtain a power of 80% with concordant sib pairs at a significance level of .0001 are given, stratified by parental phenotypes. When there is no residual correlation between sibs, the parental phenotypes have little impact on the sample sizes. When residual correlations between sibs exist, we show, however, that power can be considerably reduced by including extreme sib pairs when the parents also have similarly extreme values. Thus, we recommend the exclusion of such pairs from linkage studies. This recommendation reduces the required sample sizes by 3- to 28-fold. The degree of saving in the required sample sizes varies among different models and allele frequencies. The reduction is most dramatic (a 28-fold reduction) for a rare recessive gene.	STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	Stanford University	Zhang, HP (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 208034,NEW HAVEN,CT 06520, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD030712] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00348] Funding Source: Medline; NICHD NIH HHS [HD30712] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; NIELSEN KL, 1964, METHODS NUMERICAL AN; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; STECK GP, 1958, ANN MATH STAT, V29, P780, DOI 10.1214/aoms/1177706536	5	43	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					951	957						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808613				2022-12-18	WOS:A1996VL28300027
J	MONTERMINI, L; RODIUS, F; PIANESE, L; MOLTO, MD; COSSEE, M; CAMPUZANO, V; CAVALCANTI, F; MONTICELLI, A; PALAU, F; GYAPAY, G; WENHERT, M; ZARA, F; PATEL, PI; COCOZZA, S; KOENIG, M; PANDOLFO, M				MONTERMINI, L; RODIUS, F; PIANESE, L; MOLTO, MD; COSSEE, M; CAMPUZANO, V; CAVALCANTI, F; MONTICELLI, A; PALAU, F; GYAPAY, G; WENHERT, M; ZARA, F; PATEL, PI; COCOZZA, S; KOENIG, M; PANDOLFO, M			THE FRIEDREICH ATAXIA CRITICAL REGION SPANS A 150-KB INTERVAL ON CHROMOSOME 9Q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; MICROSATELLITE; FAMILIES; MARKER	By analysis of crossovers in key recombinant families and by homozygosity analysis of inbred families, the Friedreich ataxia (FRDA) locus was localized in a 300-kb interval between the X104 gene and the microsatellite marker FR8 (D9S888). By homology searches of the sequence databases, we identified X104 as the human tight junction protein ZO-2 gene. We generated a large-scale physical map of the FRDA region by pulsed-held gel electrophoresis analysis of genomic DNA and of three YAC clones derived from different libraries, and we constructed an uninterrupted cosmid contig spanning the FRDA locus. The cAMP-dependent protein kinase gamma-catalytic subunit gene was identified within the critical FRDA interval, but it was excluded as candidate because of its biological properties and because of lack of mutations in FRDA patients. Six new polymorphic markers were isolated between FR2 (D9S886) and FR8 (D9S888), which were used for homozygosity analysis in a family in which parents of an affected child are distantly related. An ancient recombination involving the centromeric FRDA flanking markers had been previously demonstrated in this family. Homozygosity analysis indicated that the FRDA gene is localized in the telomeric 150 kb of the FR2-FR8 interval.	BAYLOR COLL MED,DEPT NEUROL NB424,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN & MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030; CHU STRASBOURG,F-67000 STRASBOURG,FRANCE; CNRS,INSERM,INST MOLEC & CELLULAR BIOL,STRASBOURG,FRANCE; UNIV NAPLES FEDERICO II,DEPT NEUROL,NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT MOLEC & CELLULAR BIOL,NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT PATHOL,NAPLES,ITALY; CNR,CEOS,I-80125 NAPLES,ITALY; IST MEDITERRANEO NEUROSCI SANATRIX,ISERNIA,ITALY; GENETHON,EVRY,FRANCE; HOSP LA FE,E-46009 VALENCIA,SPAIN; UNIV VALENCIA,FAC BIOL SCI,E-46100 VALENCIA,SPAIN; UNIV GREIFSWALD,INST MED GENET,O-2200 GREIFSWALD,GERMANY; NATL NEUROL INST C BESTA,DIV BIOCHEM & GENET NERVOUS SYST,MILAN,ITALY	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Hospital Universitari i Politecnic La Fe; University of Valencia; Ernst Moritz Arndt Universitat Greifswald; IRCCS Istituto Neurologico Besta			Zara, Federico/U-3477-2017; CAVALCANTI, FRANCESCA/I-3651-2014; Campuzano, Victoria/ABG-7429-2020; CAMPUZANO, VICTORIA/K-7883-2019; Palau, Francesc/A-9391-2014; Campuzano, V/G-1826-2014; Pandolfo, Massimo/B-2853-2010; Cavalcanti, Francesca/N-3901-2019; Cocozza, Sergio/F-6488-2010; Patel, Pragna/H-9129-2017	Zara, Federico/0000-0001-9744-5222; CAVALCANTI, FRANCESCA/0000-0001-5769-4582; Campuzano, Victoria/0000-0001-8128-2641; Palau, Francesc/0000-0002-8635-5421; Campuzano, V/0000-0001-8128-2641; Cavalcanti, Francesca/0000-0001-5769-4582; Molto, Maria Dolores/0000-0001-5219-2022; Patel, Pragna/0000-0003-3584-1072	Telethon [722] Funding Source: Medline	Telethon(Fondazione Telethon)		CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CHAMBERLAIN S, 1993, AM J HUM GENET, V52, P99; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; FOSS KB, 1992, CYTOGENET CELL GENET, V60, P22, DOI 10.1159/000133286; FUJITA R, 1992, HUM GENET, V89, P531, DOI 10.1007/BF00219179; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HARDING A, 1984, HEREDITARY ATAXIAS R; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; LEONE M, 1988, NEUROLOGY, V38, P1433, DOI 10.1212/WNL.38.9.1433; Monros Eugenia, 1994, European Journal of Human Genetics, V2, P291; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; PANDOLFO M, 1994, BIOCHEM MED METAB B, V52, P115, DOI 10.1006/bmmb.1994.1041; RODIUS F, 1994, AM J HUM GENET, V54, P1050; SIRUGO G, 1992, AM J HUM GENET, V50, P559; Sirugo G., 1993, European Journal of Human Genetics, V1, P133	17	43	44	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1061	1067						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485155				2022-12-18	WOS:A1995TA44900011
J	SCOTT, DA; CARMI, R; ELBEDOUR, K; DUYK, GM; STONE, EM; SHEFFIELD, VC				SCOTT, DA; CARMI, R; ELBEDOUR, K; DUYK, GM; STONE, EM; SHEFFIELD, VC			NONSYNDROMIC AUTOSOMAL RECESSIVE DEAFNESS IS LINKED TO THE DFNB1 LOCUS IN A LARGE INBRED BEDOUIN FAMILY FROM ISRAEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE		UNIV IOWA,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; BEN GURION UNIV NEGEV,SOROKA MED CTR,INST GENET,IL-84105 BEER SHEVA,ISRAEL; MILLENIUM PHARMACEUT INC,BOSTON,MA	University of Iowa; University of Iowa; Ben Gurion University; Soroka Medical Center; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals				Stone, Edwin M./0000-0003-3343-4414	NHGRI NIH HHS [P50HG00835, HG00457] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457, P50HG000835] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BUETOW KH, 1994, NAT GENET, V4, P391; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; COHEN AH, 1995, HUM MOL GENET, V4, P1073; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; FIREDMAN TB, 1995, NAT GENET, V9, P86; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; LEON PE, 1992, P NATL ACAD SCI USA, V89, P5181, DOI 10.1073/pnas.89.11.5181; Moatti L, 1990, Ann Otolaryngol Chir Cervicofac, V107, P181; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; REARDON W, 1992, AM J MED GENET, V44, P513, DOI 10.1002/ajmg.1320440427; ROBINSON D, 1992, HUM GENET, V90, P316	12	43	45	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					965	968						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573061				2022-12-18	WOS:A1995RV79300031
J	PEPPER, AE; BUCKLEY, RH; SMALL, TN; PUCK, JM				PEPPER, AE; BUCKLEY, RH; SMALL, TN; PUCK, JM			2 MUTATIONAL HOTSPOTS IN THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN GENE CAUSING HUMAN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNCTIONAL COMPONENT; CELLS; TRANSPLANTATION; DEFICIENCY; CLONING; SCIDX1	Human severe combined immunodeficiency (SCID), a syndrome of profoundly impaired cellular and humoral immunity, is most commonly caused by mutations in the X-linked gene for interleukin-2 (IL-2) receptor gamma chain (lL2RG). For mutational analysis of IL2RG in males with SCID, SSCP screening was followed by DNA sequencing. Of 40 IL2RG mutations found in unrelated SCID patients, 6 were point mutations at the CpG dinucleotide at cDNA 690-691, encoding amino acid R226. This residue lies in the extracellular domain of the protein in a region not previously recognized to be significantly conserved in the cytokine receptor gene family, 11 amino acids upstream from the highly conserved WSXWS motif. Three additional instances of mutation at another CpG dinucleotide at cDNA 879 produced a premature termination signal in the introcellular domain of IL2RG, resulting in loss of the SH2-homologous intracellular domain known to be essential for signaling from the IL-2 receptor complex. Mutations at these two hotspots constitute >20% of the X-linked SCID mutations found by our group and a similar proportion of all reported IL2RG mutations.	NIH,NATL CTR HUMAN GENOME RES,GENE TRANSFER LAB,BETHESDA,MD 20892; DUKE UNIV,SCH MED,DEPT PEDIAT,DIV ALLERGY & IMMUNOL,DURHAM,NC; DUKE UNIV,SCH MED,DEPT IMMUNOL,DIV ALLERGY & IMMUNOL,DURHAM,NC; MEM HOSP,MEM SLOAN KETTERING CANC CTR,DEPT PEDIAT,DIV IMMUNOL,NEW YORK,NY	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; Duke University; Memorial Sloan Kettering Cancer Center			Buckley, Rebecca/AAB-1578-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI032918, R37AI018613] Funding Source: NIH RePORTER; NIAID NIH HHS [9-P01-AI32918, R37 AI18613-13] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHWORTH A, 1990, NUCLEIC ACIDS RES, V18, P7178, DOI 10.1093/nar/18.23.7178; BARRETT MJ, 1988, CLIN EXP IMMUNOL, V72, P118; BORTIN MM, 1977, JAMA-J AM MED ASSOC, V238, P591, DOI 10.1001/jama.238.7.591; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; BUCKLEY RH, 1995, J ALLERGY CLIN IMMUN, V95, P232; CHUA AO, 1994, J IMMUNOL, V153, P128; CONLEY ME, 1984, CLIN IMMUNOL IMMUNOP, V31, P87, DOI 10.1016/0090-1229(84)90192-2; CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; COOPER D, 1993, HUMAN GENE MUTATION, P209; DISANTO JP, 1994, P NATL ACAD SCI USA, V91, P9466, DOI 10.1073/pnas.91.20.9466; DISANTO JP, 1994, EUR J IMMUNOL, V24, P475, DOI 10.1002/eji.1830240232; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FISCHER A, 1992, Immunodeficiency Reviews, V3, P83; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; HENTHORN PS, 1994, GENOMICS, V23, P69, DOI 10.1006/geno.1994.1460; HIRSCHHORN R, 1993, PEDIATR RES, V33, pS35; ISHII N, 1994, J IMMUNOL, V153, P1310; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; MARKIEWICZ S, 1994, GENOMICS, V21, P291, DOI 10.1006/geno.1994.1265; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OREILLY RJ, 1994, BONE MARROW TRANSPL, P314; PENNY LA, 1991, GENOMICS, V11, P974, DOI 10.1016/0888-7543(91)90022-7; Puck Jennifer M., 1993, V21, P107; PUCK JM, 1994, J CLIN IMMUNOL, V14, P81, DOI 10.1007/BF01541340; PUCK JM, 1995, J CLIN INVEST, V95, P895, DOI 10.1172/JCI117740; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; PUCK JM, 1993, AM J HUM GENET, V53, P176; PUCK JM, 1994, HUM MOL GENET, V3, P1457, DOI 10.1093/hmg/3.suppl_1.1457; PUCK JM, 1992, AM J HUM GENET, V450, P742; RAM KT, 1992, NUCLEIC ACIDS RES, V20, P1428, DOI 10.1093/nar/20.6.1428; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCHIFF SE, 1994, J ALLERGY CLIN IMMUN, V93, P273; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; 1992, IMMUNODEFICIENCY REV, V3, P195	41	43	44	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					564	571						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668284				2022-12-18	WOS:A1995RR60500005
J	GERKEN, SC; ALBERTSEN, H; ELSNER, T; BALLARD, L; HOLIK, P; LAWRENCE, E; MOORE, M; ZHAO, XY; WHITE, R				GERKEN, SC; ALBERTSEN, H; ELSNER, T; BALLARD, L; HOLIK, P; LAWRENCE, E; MOORE, M; ZHAO, XY; WHITE, R			A STRATEGY FOR CONSTRUCTING HIGH-RESOLUTION GENETIC MAPS OF THE HUMAN GENOME - A GENETIC-MAP OF CHROMOSOME 17P, ORDERED WITH MEIOTIC BREAKPOINT-MAPPING PANELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; DNA; RECOMBINATION; MARKERS; INTERFERENCE; REGION; MOUSE	Genetic linkage analyses with genotypic data obtained from four CEPH reference families initially assigned 24 new PCR-based markers to chromosome 17 and located the markers at specific intervals of an existing genetic map of chromosome 17p. Each marker was additionally genotyped with an ordered set of obligate, phase-known recombinant chromosomes. The breakpoint-mapping panels for each family consisted of two parents, one sib with a nonrecombinant chromosome, and one or more sibs with obligate recombinant chromosomes. The relative order of markers was determined by sorting segregation patterns of new markers and ordered anchor markers and by minimizing double-recombination events. Consistency of segregation patterns with multiple nanking loci constituted support for order. A genetic map of chromosome 17p was completed with 39 markers in 23 clusters, with an average space of 3 cM between clusters. The collection of informative genotypes was highly efficient, requiring fivefold fewer genotypes than would be collected with all the CEPH families. Given the availability of large numbers of highly informative PCR-based markers, meiotic breakpoint mapping should facilitate construction of a human genomic map with 1-cM resolution.	UNIV UTAH, HUNTSMAN CANC INST, SALT LAKE CITY, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	GERKEN, SC (corresponding author), UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA.			Leppert, Tami/0000-0002-7893-8619	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00367] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ATTWOOD J, 1994, GENOMICS, V19, P203, DOI 10.1006/geno.1994.1049; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; BUETOW KH, 1991, AM J HUM GENET, V49, P985; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHANCE PF, 1993, ARCH NEUROL-CHICAGO, V50, P1180, DOI 10.1001/archneur.1993.00540110060006; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; ELSNER TI, 1995, AM J HUM GENET, V56, P500; FAIN PR, 1989, AM J HUM GENET, V44, P68; FAIN PR, 1992, CYTOGENET CELL GENET, V60, P178; GUENET JL, 1993, GENOME DIG, V1, P8; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; ISOMURA M, 1994, GENE CHROMOSOME CANC, V9, P173, DOI 10.1002/gcc.2870090305; JONES MH, 1994, GENE CHROMOSOME CANC, V9, P119, DOI 10.1002/gcc.2870090207; JORDE LB, 1994, AM J HUM GENET, V54, P884; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LICHTER JB, 1992, GENOMICS, V13, P607, DOI 10.1016/0888-7543(92)90131-B; MAESTRI NE, 1992, CYTOGENET CELL GENET, V59, P116, DOI 10.1159/000133219; MAESTRO RG, 1990, HUM GENET, V86, P228; McKusick V.A., 1992, MENDELIAN INHERITANC; MELIS R, 1993, GENOMICS, V16, P56, DOI 10.1006/geno.1993.1140; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OCONNELL P, 1989, AM J HUM GENET, V44, P51; OCONNELL P, 1993, GENOMICS, V15, P38, DOI 10.1006/geno.1993.1007; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; SPRINKLE TJ, 1993, GENOMICS, V16, P542, DOI 10.1006/geno.1993.1227; VANAGAITE L, 1994, GENOMICS, V22, P231, DOI 10.1006/geno.1994.1370; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WHITE R, 1987, ADV HUM GENET, V16, P121; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; 1992, SCIENCE, V258, P1; 1991, PROGRAM MANUAL GCG P	39	43	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					484	499						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847385				2022-12-18	WOS:A1995QF42300018
J	WOODAGE, T; PRASAD, M; DIXON, JW; SELBY, RE; ROMAIN, DR; COLUMBANOGREEN, LM; GRAHAM, D; ROGAN, PK; SEIP, JR; SMITH, A; TRENT, RJ				WOODAGE, T; PRASAD, M; DIXON, JW; SELBY, RE; ROMAIN, DR; COLUMBANOGREEN, LM; GRAHAM, D; ROGAN, PK; SEIP, JR; SMITH, A; TRENT, RJ			BLOOM-SYNDROME AND MATERNAL UNIPARENTAL DISOMY FOR CHROMOSOME-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; SISTER CHROMATID EXCHANGE; NONPOLYPOSIS COLON-CANCER; COLORECTAL-CANCER; HIGH-RESOLUTION; LOCUS; ISODISOMY; ASSOCIATION; MECHANISM; HOMOLOG	Bloom syndrome (BS) is an autosomal recessive disorder characterized by increases in the frequency of sister-chromatid exchange and in the incidence of malignancy. Chromosome-transfer studies have shown the BS locus to map to chromosome 15q. This report describes a subject with features of both BS and Prader-Willi syndrome (PWS). Molecular analysis showed maternal uniparental disomy for chromosome 15. Meiotic recombination between the two disomic chromosomes 15 has resulted in heterodisomy for proximal 15q and isodisomy for distal 15q. In this individual BS is probably due to homozygosity for a gene that is telomeric to D15S95 (15q25), rather than to genetic imprinting, the mechanism responsible for the development of PWS. This report represents the first application of disomy analysis to the regional localization of a disease gene. This strategy promises to be useful in the genetic mapping of other uncommon autosomal recessive conditions.	ROYAL PRINCE ALFRED HOSP,DEPT MOLEC GENET,CAMPERDOWN 2050,NSW,AUSTRALIA; CHILDRENS HOSP,CYTOGENET LAB,CAMPERDOWN,NSW,AUSTRALIA; WELLINGTON HOSP,WELLINGTON REG GENET SERV,WELLINGTON,NEW ZEALAND; WELLINGTON HOSP,DEPT PAEDIAT,WELLINGTON,NEW ZEALAND; WAIKATO HOSP,CTR CHILD DEV,HAMILTON,NEW ZEALAND; PENN STATE UNIV,COLL MED,DEPT PEDIAT,DIV GENET,HERSHEY,PA	University of Sydney; Waikato Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health			Rogan, Peter/B-9845-2017	Rogan, Peter/0000-0003-2070-5254	PHS HHS [R29H029098-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Barnes R., 1992, American Journal of Human Genetics, V51, pA182; BECKER RA, 1992, CANCER GENET CYTOGEN, V62, P53, DOI 10.1016/0165-4608(92)90039-B; BELDJORD C, 1992, BLOOD, V80, P287; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; BUTLER MG, 1987, AM J MED GENET, V28, P821, DOI 10.1002/ajmg.1320280406; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; Ellis N. A., 1992, American Journal of Human Genetics, V51, pA187; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GERMAN J, 1989, CLIN GENET, V35, P57; GRODEN J, 1992, HUM GENET, V90, P360; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HOLM VA, 1993, PEDIATRICS, V91, P398; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCDANIEL LD, 1992, P NATL ACAD SCI USA, V89, P7968, DOI 10.1073/pnas.89.17.7968; NICHOLLS RD, 1991, AM J MED GENET, V41, P273, DOI 10.1002/ajmg.1320410233; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; Rogan P. K., 1992, American Journal of Human Genetics, V51, pA46; ROGAN PK, UNPUB MOL GENETIC AN; Sambrook J., 1989, MOL CLONING LAB MANU; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; TRENT RJ, 1991, J MED GENET, V28, P649, DOI 10.1136/jmg.28.10.649; VOSS R, 1989, AM J HUM GENET, V45, P373; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEKSBERG R, 1988, AM J HUM GENET, V42, P816; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	37	43	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					74	80						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912890				2022-12-18	WOS:A1994NW46100011
J	GREBE, TA; SELTZER, WK; DEMARCHI, J; SILVA, DK; DOANE, WW; GOZAL, D; RICHTER, SF; BOWMAN, CM; NORMAN, RA; RHODES, SN; HERNRIED, LS; MURPHY, S; HARWOOD, IR; ACCURSO, FJ; JAIN, KD				GREBE, TA; SELTZER, WK; DEMARCHI, J; SILVA, DK; DOANE, WW; GOZAL, D; RICHTER, SF; BOWMAN, CM; NORMAN, RA; RHODES, SN; HERNRIED, LS; MURPHY, S; HARWOOD, IR; ACCURSO, FJ; JAIN, KD			GENETIC-ANALYSIS OF HISPANIC INDIVIDUALS WITH CYSTIC-FIBROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-BINDING FOLD; CFTR GENE; MUTATIONS; IDENTIFICATION	We have performed molecular genetic analyses of Hispanic individuals with cystic fibrosis (CF) in the southwestern United States. Of 129 CF chromosomes analyzed, only 46% (59/129) carry Delta F508. The G542X mutation was found on 5% (7/129) of CF chromosomes. The 3849+10kbC-->T mutation, detected primarily in Ashkenazi Jews, was present on 2% (3/129). R1162X and R334W, mutations identified in Spain and Italy, each occurred on 1.6% (2/129) of CF chromosomes. W1282X and R553X were each detected once. G551D and N1303K were not found. Overall, screening for 22 or more mutations resulted in detection of only 58% of CF transmembrane conductance regulator gene mutations among Hispanic individuals. Analysis of KM19/XV2c haplotypes revealed an unusual distribution. Although the majority of Delta F508 mutations are on chromosomes of B haplotypes, the other CF mutations are on A and C haplotypes at higher-than-expected frequencies. These genetic analyses demonstrate significant differences between Hispanic individuals with CF and those of the general North American population. Assessment of carrier/affected risk in Hispanic CF individuals cannot, therefore, be based on the mutation frequencies found through studies of the general population but must be adjusted to better reflect the genetic makeup of this ethnic group. Further studies are necessary to identify the causative mutation(s) in this population and to better delineate genotype/phenotype correlations. These will enable counselors to provide more accurate genetic counseling.	CHILDRENS HOSP LOS ANGELES, DIV MED GENET, LOS ANGELES, CA 90027 USA; ARIZONA STATE UNIV, DEPT ZOOL, TEMPE, AZ 85287 USA; UNIV COLORADO, HLTH SCI CTR, DEPT PEDIAT, DIV GENET, DENVER, CO 80262 USA; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; UNIV ARIZONA, DEPT PEDIAT, GENET DYSMORPHOL SECT, TUCSON, AZ 85721 USA; PHOENIX CHILDRENS HOSP, PHOENIX, AZ USA; UNIV NEW MEXICO, DEPT PEDIAT, ALBUQUERQUE, NM 87131 USA; UNIV CALIF SAN DIEGO, DEPT PEDIAT, LA JOLLA, CA 92093 USA	Children's Hospital Los Angeles; Arizona State University; Arizona State University-Tempe; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Baylor College of Medicine; University of Arizona; Phoenix Children's Hospital; University of New Mexico; University of California System; University of California San Diego			Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020		PHS HHS [MCJ-080508-03, MCJ-000252] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BEAUDET AL, 1989, AM J HUM GENET, V44, P319; BONDUELLE M, 1990, HUM GENET, V85, P436; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DEMARCHI JM, UNPUB ROBOTICS ASSIS; FELDMAN GL, 1988, LANCET, V2, P102; GASPARINI P, 1991, GENOMICS, V10, P193, DOI 10.1016/0888-7543(91)90500-E; HIGHSMITH WE, UNPUB NOVEL CYSTIC F; KAN YW, 1977, NEW ENGL J MED, V297, P1081, DOI 10.1056/NEJM197711172972002; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; MERCIER B, 1992, AM J HUM GENET S, V51, P1341; NG ISL, 1991, HUM GENET, V87, P613; NUNES V, 1991, HUM GENET, V87, P737; OROZCO L, 1993, AM J HUM GENET, V53, P1209; OSBORNE L, 1991, AM J HUM GENET, V48, P608; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROSENBLOOM CL, 1989, NUCLEIC ACIDS RES, V17, P7117, DOI 10.1093/nar/17.17.7117; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; 1976, VITAL STAT REP S, V25, P76; 1992, PATIENT REGISTRY 199	22	43	44	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					443	446						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	7509564				2022-12-18	WOS:A1994MZ15800006
J	THOMAS, GR; BULL, PC; ROBERTS, EA; WALSHE, JM; COX, DW				THOMAS, GR; BULL, PC; ROBERTS, EA; WALSHE, JM; COX, DW			HAPLOTYPE STUDIES IN WILSON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESTERASE-D; LOCUS; LINKAGE; DNA; CHROMOSOME-13; HETEROGENEITY; MARKERS; REGION	In 51 families with Wilson disease, we have studied DNA haplotypes of dinucleotide repeat polymorphisms (CA repeats) in the 13q14.3 region, to examine these markers for association with the Wilson disease gene (WND). In addition to a marker (D13S133) described elsewhere, we have developed three new highly polymorphic markers (D13S314, D13S315, and D13S316) close to the WND locus. We have examined the distribution of marker alleles at the loci studied and have found that D13S314, D13S133, and D13S316 each show nonrandom distribution on chromosomes carrying the WND mutation. We have studied haplotypes of these three markers and have found that there are highly significant differences between WND and normal haplotypes in northern European families. These findings have important implications for mutation detection and molecular diagnosis in families with Wilson disease.	HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; MIDDLESEX HOSP,LONDON W1,ENGLAND; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of London; University College London; University of Toronto				Bull, Peter/0000-0002-7674-6752				BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; BULL PC, 1993, CYTOGENET CELL GENET, V64, P12, DOI 10.1159/000133550; BULL PC, 1993, GENOMICS, V16, P593, DOI 10.1006/geno.1993.1235; BULL PC, UNPUB GENE CANDIDATE; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; COX DW, 1972, AM J HUM GENET, V24, P646; Danks DM, 1989, METABOLIC BASIS INHE, P1411; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; HOOGENRAAD TU, 1979, EUR NEUROL, V18, P205, DOI 10.1159/000115077; HOUWEN RHJ, 1993, J HEPATOL, V17, P269, DOI 10.1016/S0168-8278(05)80204-1; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OUDET C, 1993, AM J HUM GENET, V52, P297; PERTRUKHIN KE, 1993, GENOMICS, V15, P76; Scheinberg IH, 1984, MAJOR PROBLEMS INTER; SIRUGO G, 1992, AM J HUM GENET, V50, P559; THOMAS GR, HUM MOL GENET, V2, P1401; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; WALSHE JM, 1956, AM J MED, V21, P487, DOI 10.1016/0002-9343(56)90066-3; YUZBASIYANGURKAN V, 1988, AM J HUM GENET, V42, P825	25	43	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					71	78						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279472				2022-12-18	WOS:A1994MQ70000010
J	MOGHRABI, N; CLARKE, DJ; BURCHELL, B; BOXER, M				MOGHRABI, N; CLARKE, DJ; BURCHELL, B; BOXER, M			COSEGREGATION OF INTRAGENIC MARKERS WITH A NOVEL MUTATION THAT CAUSES CRIGLER-NAJJAR SYNDROME TYPE-I - IMPLICATION IN CARRIER DETECTION AND PRENATAL-DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE; NONSENSE MUTATIONS; GENE-COMPLEX; PHENOL; EXPRESSION; CLONING; CELLS; DNA; IDENTIFICATION; PATIENT	Crigler-Najjar syndrome type 1 (CN-1) is a familial disorder characterized by severe unconjugated hyperbilirubinemia and jaundice and leads to kernicterus, neurological damage, and eventual death unless treated with liver transplantation. Previous reports identified mutations in the UGT1 gene complex to be the cause of the disease. The total absence of all phenol/bilirubin UGT proteins and their activities in liver homogenate of a CN-1 patient was determined by enzymological and immunochemical analysis. A novel homozygous nonsense mutation (CGA-->TGA) was identified in the patient by the combined techniques of PCR and direct sequencing. This mutation was located in exon 3 of the constant region in the gene complex which is common to all phenol and bilirubin UGTs. The segregation of the mutation in the patient's family was analyzed and confirmed the recessive nature of the disease. Newly developed intragenic polymorphic probes (UGT1*4 and UGT-Const) were used on Southern blots of MspI-digested genomic DNA of the patient and his family. The segregation of individual alleles within the family was observed from haplotypes generated. Comparison of the segregation of haplotypes with the mutation for the patient and his family revealed the allele identified by the A1-B1-C2 haplotype to be carrying the mutation. The risk of recombination occurring is negligible, because of the intragenic nature of the probes. This study demonstrates the potential usefulness of these probes in carrier detection and prenatal/presymptomatic diagnosis.	UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT PATHOL,DUNDEE DD1 9SY,SCOTLAND; UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT BIOCHEM MED,DUNDEE DD1 9SY,SCOTLAND	University of Dundee; University of Dundee				Clarke, Douglas/0000-0001-7281-8766	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARIAS IM, 1969, AM J MED, V47, P395, DOI 10.1016/0002-9343(69)90224-1; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BOSMA PJ, 1992, FASEB J, V6, P2859, DOI 10.1096/fasebj.6.10.1634050; BOSMA PJ, 1992, HEPATOLOGY, V15, P941, DOI 10.1002/hep.1840150531; BURCHELL B, 1991, DNA CELL BIOL, V10, P487, DOI 10.1089/dna.1991.10.487; BURCHELL B, 1989, PHARMACOL THERAPEUT, V43, P261, DOI 10.1016/0163-7258(89)90122-8; Burchell Brain, 1993, P489; CHOWDHURY JR, 1989, METABOLIC BASIS INHE, P1085; COOPER DN, 1990, HUM GENET, V85, P55; COUGHTRIE MWH, 1987, MOL PHARMACOL, V31, P585; CRIGLER JF, 1952, PEDIATRICS, V10, P169; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EBNER T, 1993, DRUG METAB DISPOS, V21, P50; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; HARDING D, 1988, P NATL ACAD SCI USA, V85, P8381, DOI 10.1073/pnas.85.22.8381; HARDING D, 1990, ANN HUM GENET, V54, P17, DOI 10.1111/j.1469-1809.1990.tb00356.x; HARDING D, 1988, CELLULAR MOL ASPECTS, V173, P13; LOU MM, 1989, J BIOL CHEM, V264, P21376; MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432; MANIATIS T, 1989, MOL CLONING, V2; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOGHRABI N, 1992, ANN HUM GENET, V56, P83; MOGHRABI N, IN PRESS HUM MOL GEN; ODELL GB, 1990, J CHROMATOGR-BIOMED, V529, P287, DOI 10.1016/S0378-4347(00)83835-9; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, J BIOL CHEM, V267, P3257; RITTER JK, 1991, J BIOL CHEM, V266, P1043; ROBERTSON KJ, 1991, J INHERIT METAB DIS, V14, P563, DOI 10.1007/BF01797927; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMONS PJ, 1988, XENOBIOTICA, V18, P429, DOI 10.3109/00498258809041679; SINAASAPPEL M, 1991, GASTROENTEROLOGY, V100, P783, DOI 10.1016/0016-5085(91)80026-6; SUTHERLAND L, 1992, FEBS LETT, V308, P161, DOI 10.1016/0014-5793(92)81266-O; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VANES HHG, 1990, J CLIN INVEST, V85, P1199, DOI 10.1172/JCI114553; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465	36	43	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					722	729						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8102509				2022-12-18	WOS:A1993LU55900016
J	CROSBY, JL; VARNUM, DS; NADEAU, JH				CROSBY, JL; VARNUM, DS; NADEAU, JH			2-HIT MODEL FOR SPORADIC CONGENITAL-ANOMALIES IN MICE WITH THE DISORGANIZATION MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE MUTANT DISORGANIZATION; POSSIBLE HUMAN HOMOLOG; CANCER; RETINOBLASTOMA; MORPHOGENESIS; GENETICS; LINKAGE; LIMB	Congenital anomalies have complex etiologies involving both genetic and nongenetic components. Many are sporadic, without obvious evidence for heritability. An important model for these anomalies is a mutation in laboratory mice that is called ''disorganization'' (Ds), which functions as a variable autosomal dominant and leads to a wide variety of congenital anomalies involving many developmental processes and systems. Variable expressivity, asymmetrical manifestations, and low penetrance suggest that somatic events determine the location and nature of these anomalies. A statistical analysis suggests that occurrence of anomalies in mice with the Ds mutation follows a Poisson distribution. These results suggest that congenital anomalies in mice with the Ds mutation occur independently of each other. We propose that Ds causes a heritable predisposition to congenital anomalies and that Ds and appropriate somatic events combine to compromise normal development. We also propose that some sporadic, nonheritable congenital anomalies involve somatic mutations at Ds-like loci. Ds may therefore serve not only as a model for developmental anomalies in cell fate and pattern formation but also for complex developmental traits showing variable expressivity, low penetrance, and sporadic occurrence in mice and humans.	JACKSON LAB, 600 MAIN ST, BAR HARBOR, ME 04609 USA; UNIV MAINE, DEPT BIOCHEM, ORONO, ME 04473 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT CELL BIOL, NASHVILLE, TN 37232 USA	Jackson Laboratory; University of Maine System; University of Maine Orono; Vanderbilt University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025389] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25389] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABEL EL, 1986, LANCET, V2, P1222; ADAMS MS, 1967, GENET RES, V10, P313, DOI 10.1017/S0016672300011071; BRENT RL, 1987, BANBURY REPORT, V26, P287; Buyse ML, 1990, BIRTH DEFECTS ENCY; CARTER C. O., 1965, PROGR MED GENET, V4, P59; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COX DR, 1978, STATISTICAL ANAL SER; CROSBY JL, 1992, MECH DEVELOP, V37, P121, DOI 10.1016/0925-4773(92)90074-T; De Grouchy J, 1977, CLIN ATLAS HUMAN CHR; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONNAI D, 1989, J MED GENET, V26, P421, DOI 10.1136/jmg.26.7.421; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; FRASER FC, 1977, HDB TERATOLOGY, V1, P445; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Green M. C., 1991, HDB GENETICALLY STAN; GRUNEBERG H, 1950, J GENET, V50, P142, DOI 10.1007/BF02986800; HALL JG, 1990, AM J HUM GENET, V46, P857; Heinonen OP, 1977, BIRTH DEFECTS DRUGS; HOLMES LB, 1974, NEW ENGL J MED, V291, P763, DOI 10.1056/NEJM197410102911505; HUMMEL KP, 1958, J EXP ZOOL, V137, P389, DOI 10.1002/jez.1401370303; HUMMEL KP, 1959, PEDIATRICS, V23, P212; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LI CC, 1987, AM J HUM GENET, V41, P517; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LIN AE, 1991, J MED GENET, V28, P645, DOI 10.1136/jmg.28.9.645; LOWRY RB, 1991, J MED GENET, V28, P135, DOI 10.1136/jmg.28.2.135; LYONS KL, 1988, SMITHS RECOGNIZABLE; MAINI PK, 1991, INT REV CYTOL, V129, P91; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McKusick VA, 1990, MENDELIAN INHERITANC; Myrianthopoulos NC; Collaborative Perinatal Project (U.S.), 1985, MALFORMATIONS CHILDR; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; NADEAU JH, 1992, MAMM GENOME, V3, P480, DOI 10.1007/BF00778825; NADEAU JH, 1992, MAMM GENOME, V3, pS206, DOI 10.1007/BF00648432; NAGUIB KK, 1991, J MED GENET, V28, P138, DOI 10.1136/jmg.28.2.138; PENROSE L S, 1953, Acta Genet Stat Med, V4, P257; PETZEL MA, 1991, J MED GENET, V28, P712, DOI 10.1136/jmg.28.10.712; SCHARDEIN JL, 1985, CHEM IND BIRTH DEFEC; Scrable H J, 1990, Adv Cancer Res, V54, P25, DOI 10.1016/S0065-230X(08)60807-6; SELBY PB, 1987, STAIN TECHNOL, V62, P143, DOI 10.3109/10520298709107984; Shepard TH, 1986, CATALOG TERATOGENIC; Smith, 1982, RECOGNIZABLE PATTERN; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TICKLE C, 1991, DEVELOPMENT, P113; Torpin R., 1968, FETAL MALFORMATIONS; WILSON GN, 1992, AM J MED GENET, V42, P187, DOI 10.1002/ajmg.1320420211; WILSON JG, 1976, HDB TERATOLOGY, V1; WINTER RM, 1989, J MED GENET, V26, P417, DOI 10.1136/jmg.26.7.417; 1992, GLOBAL HLTH SITUATIO	58	43	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					866	874						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488837				2022-12-18	WOS:A1993LB88900003
J	FEUNTEUN, J; NAROD, SA; LYNCH, HT; WATSON, P; CONWAY, T; LYNCH, J; PARBOOSINGH, J; OCONNELL, P; WHITE, R; LENOIR, GM				FEUNTEUN, J; NAROD, SA; LYNCH, HT; WATSON, P; CONWAY, T; LYNCH, J; PARBOOSINGH, J; OCONNELL, P; WHITE, R; LENOIR, GM			A BREAST-OVARIAN CANCER SUSCEPTIBILITY GENE MAPS TO CHROMOSOME-17Q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HETEROGENEITY; EPIDEMIOLOGY	Nineteen North American Caucasian families that contain a minimum of four confirmed cases of breast or ovarian cancer have been studied. Four polymorphisms (cLB17.1, D17S579, D17S588, and D17S74), which span a region of approximately 15 cM on chromosome 17q12, were typed. Our data confirm the location of a dominant gene conferring susceptibility to breast and ovarian cancer (maximum lod = 9.78) and suggest that the breast-ovarian cancer syndrome is genetically heterogeneous. Two recombinants in one large family suggest that the breast-ovarian cancer locus lies between D17S588 and D17S579.	INT AGCY RES CANC,ISO COURS ALBERT THOMAS,F-69372 LYON 08,FRANCE; INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,URA 1158,F-94805 VILLEJUIF,FRANCE; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT ONCOL,MONTREAL H3A 2T5,QUEBEC,CANADA; CREIGHTON UNIV,SCH MED,DEPT PREVENT MED,OMAHA,NE 68178; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; McGill University; McGill University; McGill University; Creighton University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah			Narod, Steven A/AAA-6112-2022; Feunteun, Jean/AAZ-1267-2020	Feunteun, Jean/0000-0003-1212-9189	NATIONAL CANCER INSTITUTE [R01CA048802] Funding Source: NIH RePORTER; NCI NIH HHS [5 RO1 CA48802] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLAUS EB, 1991, AM J HUM GENET, V48, P232; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EASTON DF, 1993, AM J HUM GENET, V52, P678; GO RCP, 1983, J NATL CANCER I, V71, P455; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; ISELIUS L, 1991, ANN HUM GENET, V55, P151, DOI 10.1111/j.1469-1809.1991.tb00408.x; LYNCH HT, 1981, GENETICS BREAST CANC; MARGARITTE P, 1992, AM J HUM GENET, V50, P1231; MARTINEZ M, 1991, AM J HUM GENET, V49, P1300; NAROD SA, 1991, LANCET, V338, P82; NAROD SA, 1991, GENET EPIDEMIOL, V8, P209, DOI 10.1002/gepi.1370080402; OTT J, 1985, ANAL HUMAN GENETIC L; RISCH N, 1989, GENET EPIDEMIOL, V6, P473, DOI 10.1002/gepi.1370060402; YOUNG JL, 1981, NATL CANCER I MONOGR, V57, P1	14	43	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					736	742						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460639				2022-12-18	WOS:A1993KY05900011
J	EISENSMITH, RC; WOO, SLC				EISENSMITH, RC; WOO, SLC			UPDATED LISTING OF HAPLOTYPES AT THE HUMAN PHENYLALANINE-HYDROXYLASE (PAH) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PVUII EA RFLP; PRENATAL-DIAGNOSIS; PCR DETECTION; PHENYLKETONURIA LOCUS; GENE; MUTATIONS		BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute	EISENSMITH, RC (corresponding author), BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030, USA.							Aoki K, 1988, Acta Paediatr Jpn, V30, P429; BICKEL H, 1981, EUR J PEDIATR, V137, P133; DAIGER SP, 1986, LANCET, V1, P229; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; DWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P1958; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; EISENSMITH RC, 1991, MOL BIOL MED, V8, P3; GOLTSOV AA, 1992, NUCLEIC ACIDS RES, V20, P927, DOI 10.1093/nar/20.4.927-a; GOLTSOV AA, UNPUB DETECTION PVUI; GOLTSOVAA, 1992, AM J HUM GENET, V51, P627; JOHN SWM, 1990, AM J HUM GENET, V46, P970; KONECKI DS, 1991, HUM GENET, V87, P377; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, P NATL ACAD SCI USA, V82, P6221, DOI 10.1073/pnas.82.18.6221; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LIDSKY AS, 1984, AM J HUM GENET, V36, P527; OZALP I, 1986, J INHERIT METAB DIS, V9, P237, DOI 10.1007/BF01799716; SCRIVER CR, IN PRESS BRAIN DYS; WEDEMEYER N, 1991, NUCLEIC ACIDS RES, V19, P1959, DOI 10.1093/nar/19.8.1959; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	21	43	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1445	1448						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1361103				2022-12-18	WOS:A1992KC99500028
J	BICHET, DG; HENDY, GN; LONERGAN, M; ARTHUS, MF; LIGIER, S; PAUSOVA, Z; KLUGE, R; ZINGG, H; SAENGER, P; OPPENHEIMER, E; HIRSCH, DJ; GILGENKRANTZ, S; SALLES, JP; OBERLE, I; MANDEL, JL; GREGORY, MC; FUJIWARA, TM; MORGAN, K; SCRIVER, CR				BICHET, DG; HENDY, GN; LONERGAN, M; ARTHUS, MF; LIGIER, S; PAUSOVA, Z; KLUGE, R; ZINGG, H; SAENGER, P; OPPENHEIMER, E; HIRSCH, DJ; GILGENKRANTZ, S; SALLES, JP; OBERLE, I; MANDEL, JL; GREGORY, MC; FUJIWARA, TM; MORGAN, K; SCRIVER, CR			X-LINKED NEPHROGENIC DIABETES-INSIPIDUS - FROM THE SHIP HOPEWELL TO RFLP STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOME; MULTILOCUS LINKAGE ANALYSIS; DNA PROBE; DXS52; VASOPRESSIN; LOCUS; RESPONSES; MARKERS; REGION; GENE	Nephrogenic diabetes insipidus (NDI; designated 304800 in Mendelian Inheritance in Man) is an X-linked disorder with abnormal renal and extrarenal V2 vasopressin receptor responses. The mutant gene has been mapped to Xq28 by analysis of RFLPs, and tight linkage between DXS52 and NDI has been reported. In 1969, Bode and Crawford proposed, under the term "the Hopewell hypothesis," that most cases in North America could be traced to descendants of Ulster Scots who arrived in Nova Scotia in 1761 on the ship Hopewell. They also suggested a link between this family and a large Mormon pedigree. DNA samples obtained from 13 independent affected families, including 42 members of the Hopewell and Mormon pedigrees, were analyzed with probes in the Xq28 region. Genealogical reconstructions were performed. Linkage between NDI and DXS304 (probe U6:2.spl), DXS305 (St35-691), DXS52 (St14-1), DXS15 (DX13), and F8C (F814) showed no recombination in 12 families, with a maximum lod score of 13.5 for DXS52. A recombinant between NDI and DXS304, DXS305, was identified in one family. The haplotype segregating with the disease in the Hopewell pedigree was not shared by other North American families. PCR analysis of the St14 VNTR allowed the distinction of two alleles that were not distinguishable by Southern analysis. Carrier status was predicted in 24 of 26 at-risk females. The Hopewell hypothesis cannot explain the origin of NDI in many of the North American families, since they have no apparent relationship with the Hopewell early settlers, either by haplotype or by genealogical analysis. We confirm the locus homogeneity of the disease by linkage analysis in ethnically diverse families. PCR analysis of the DXS52 VNTR in NDI families is very useful for carrier testing and presymptomatic diagnosis, which can prevent the first manifestations of dehydration.	UNIV NANCY,SERV GENET,NANCY,FRANCE; CTR HOSP PURPAN,SERV MED INFANTILE,TOULOUSE,FRANCE; UNITE BIOL MOLEC & GENIE GENET,STRASBOURG,FRANCE; UNIV UTAH,DEPT PHARMACOL & TOXIKOL,DIV NEPHROL,SALT LAKE CITY,UT 84112; ROYAL VICTORIA HOSP,CALCIUM RES LAB,MONTREAL H3A 1A1,QUEBEC,CANADA; ROYAL VICTORIA HOSP,MOLEC ENDOCRINOL LAB,MONTREAL H3A 1A1,QUEBEC,CANADA; MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL H3A 2T5,QUEBEC,CANADA; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PEDIAT,BRONX,NY 10461; DALHOUSIE UNIV,DEPT MED,HALIFAX B3H 4H2,NS,CANADA	Universite de Lorraine; CHU de Toulouse; Utah System of Higher Education; University of Utah; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University; McGill University; Yeshiva University; Albert Einstein College of Medicine; Dalhousie University	BICHET, DG (corresponding author), UNIV MONTREAL,HOP SACRE COEUR,DEPT MED,CTR RECH,5400 BLVD GOUIN OUEST,MONTREAL H4J 1C5,QUEBEC,CANADA.		SALLES, Jean Pierre/K-2998-2014	BICHET, DANIEL-G/0000-0003-2856-6850				BICHET DG, 1989, KIDNEY INT, V36, P859, DOI 10.1038/ki.1989.272; BICHET DG, 1988, NEW ENGL J MED, V318, P881, DOI 10.1056/NEJM198804073181403; BICHET DG, 1991, KIDNEY INT, V39, P693, DOI 10.1038/ki.1991.83; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BODE HH, 1969, NEW ENGL J MED, V280, P750, DOI 10.1056/NEJM196904032801404; BROMMER EJP, 1990, EUR J CLIN INVEST, V20, P72, DOI 10.1111/j.1365-2362.1990.tb01794.x; CANNON JF, 1955, ARCH INTERN MED, V98, P215; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EATON AWH, 1912, P T R SOC CAN 3, V6, P221; FEIL R, 1990, AM J HUM GENET, V46, P720; HARPER K, 1984, LANCET, V2, P6; HEILIG R, 1988, AM J MED GENET, V30, P543, DOI 10.1002/ajmg.1320300156; JANS DA, 1990, J BIOL CHEM, V265, P15379; KAMBOURIS M, 1988, AM J MED GENET, V29, P239, DOI 10.1002/ajmg.1320290138; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KNOERS N, 1988, NEPHRON, V50, P187, DOI 10.1159/000185155; KNOERS N, 1990, NEPHRON, V54, P322, DOI 10.1159/000185888; KNOERS N, 1988, HUM GENET, V80, P31, DOI 10.1007/BF00451451; KNOERS N, 1989, GENOMICS, V4, P434, DOI 10.1016/0888-7543(89)90352-2; KOBRINSKY NL, 1985, LANCET, V1, P1293; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; MANDEL JL, 1986, COLD SPRING HARB SYM, V51, P195, DOI 10.1101/SQB.1986.051.01.024; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1585; MILLER T, 1972, HISTORICAL GENEALOGI; MULLIGAN LM, 1987, AM J MED GENET, V26, P751, DOI 10.1002/ajmg.1320260334; OBERLE I, 1985, NEW ENGL J MED, V312, P682, DOI 10.1056/NEJM198503143121103; Ott J., 1991, ANAL HUMAN GENETIC L; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; REEVES WB, 1989, METABOLIC BASIS INHE, P1985; RICHARDS B, 1991, NUCLEIC ACIDS RES, V19, P1944, DOI 10.1093/nar/19.8.1944; ROUSSEAU F, 1990, HUM GENET, V84, P263; Sambrook J., 1989, MOL CLONING LAB MANU; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; SHARIF M, 1992, NATURE, V357, P279, DOI 10.1038/357279a0; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; VANDENOUWELAND AMW, 1992, GENOMICS, V13, P1350, DOI 10.1016/0888-7543(92)90067-3; VINCENT A, 1989, HUM GENET, V82, P85, DOI 10.1007/BF00288280	39	43	43	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1089	1102						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1357965				2022-12-18	WOS:A1992JU84000020
J	ROSENBERG, C; BLAKEMORE, KJ; KEARNS, WG; GIRALDEZ, RA; ESCALLON, CS; PEARSON, PL; STETTEN, G				ROSENBERG, C; BLAKEMORE, KJ; KEARNS, WG; GIRALDEZ, RA; ESCALLON, CS; PEARSON, PL; STETTEN, G			ANALYSIS OF RECIPROCAL TRANSLOCATIONS BY CHROMOSOME PAINTING - APPLICATIONS AND LIMITATIONS OF THE TECHNIQUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU SUPPRESSION HYBRIDIZATION; CHORIONIC VILLI; LIBRARIES	Fluorescent in situ hybridization with chromosome-specific DNA libraries (chromosome painting) is an important new method for assessing chromosome rearrangements. In the research presented in this paper, two familial reciprocal translocations have been studied in the balanced and unbalanced forms, using both traditional G-banding techniques and chromosome painting. Although for each case two chromosomes were involved in the rearrangement, we found that only one chromosome library was suitable for detecting the translocation. These findings illustrate both the potential and the limitations of chromosome painting as a diagnostic tool in cytogenetics.	JOHNS HOPKINS MED INST,DEPT GYNECOL & OBSTET,PK BLDG B2-202,600 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT GYNECOL & OBSTET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHN F KENNEDY INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Kearns, William/AAE-7699-2020; rosenberg, carla/N-4148-2015; Slagboom, P. Eline/R-4790-2016	rosenberg, carla/0000-0003-3253-4448; Slagboom, P. Eline/0000-0002-2875-4723				CHEUNG SW, 1987, PRENATAL DIAG, V7, P535, DOI 10.1002/pd.1970070802; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; JAUCH A, 1990, HUM GENET, V85, P145; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SEABRIGH.M, 1971, LANCET, V2, P971; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761	8	43	43	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					700	705						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550115				2022-12-18	WOS:A1992HL84800005
J	SHEFFIELD, VC; BECK, JS; NICHOLS, B; COUSINEAU, A; LIDRAL, AC; STONE, EM				SHEFFIELD, VC; BECK, JS; NICHOLS, B; COUSINEAU, A; LIDRAL, AC; STONE, EM			DETECTION OF MULTIALLELE POLYMORPHISMS WITHIN GENE-SEQUENCES BY GC-CLAMPED DENATURING GRADIENT GEL-ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS GENE; SINGLE-BASE CHANGES; FRAGMENT LENGTH POLYMORPHISMS; POLYMERASE CHAIN-REACTION; POINT MUTATIONS; DNA FRAGMENTS; HUMAN GENOME; IDENTIFICATION; SUBSTITUTIONS; ALPHA	The ability to efficiently detect DNA polymorphisms is essential for the completion of a high-resolution polymorphic linkage map of the human genome. Currently the most informative polymorphisms are the multiallelic dinucleotide repeat polymorphisms. However, many gene sequences lack an associated dinucleotide repeat sequence. We used GC-clamped denaturing gradient gel electrophoresis to screen for DNA polymorphisms in the following six gene sequences: MCC, p53, prealbumin (transthyretin), rhodopsin, S-antigen, and TGF-alpha. A single-base sequence polymorphism was identified in each of these gene sequences. Some of these polymorphisms were multiallelic and highly informative. Our results demonstrate the value of denaturing gradient gel electrophoresis for both identifying and analyzing human DNA polymorphisms. The ability to detect highly informative polymorphisms within gene sequences will greatly contribute to a gene-based polymorphic linkage map.	UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242	University of Iowa; University of Iowa				Stone, Edwin M./0000-0003-3343-4414	NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER; NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [HG00457] Funding Source: Medline; PHS HHS [P30H027748] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COTTON RGH, 1989, BIOCHEM J, V263, P1; DUBOSE RF, 1990, BIOTECHNIQUES, V8, P271; GRAY M, 1991, GENETICS, V127, P139; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P390; HOFKER MH, 1986, AM J HUM GENET, V39, P438; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KEEN J, 1991, TRENDS GENET, V7, P5; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; METZGER AK, 1991, P NATL ACAD SCI USA, V88, P7825, DOI 10.1073/pnas.88.17.7825; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; Myers R, 1989, PCR TECHNOLOGY PRINC, P71; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; MYERS RM, 1986, COLD SPRING HARB SYM, V51, P275, DOI 10.1101/SQB.1986.051.01.033; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NICHOLS WC, 1990, CLIN GENET, V37, P44; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PUDUSLO SE, 1991, AM J HUM GENET, V49, P106; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHEFFIELD VC, IN PRESS BIOTECHNIQU; SHEFFIELD VC, 1990, PCR PROTOCOLS GUIDE, P206; STINISSEN P, 1990, NUCLEIC ACIDS RES, V18, P3672, DOI 10.1093/nar/18.12.3672; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; TSUZUKI T, 1985, J BIOL CHEM, V260, P2224; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; YAMAKI K, 1988, FEBS LETT, V234, P39, DOI 10.1016/0014-5793(88)81298-5; YAMAKI K, 1990, J BIOL CHEM, V265, P20757	41	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					567	575						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539594				2022-12-18	WOS:A1992HH97400016
J	MURRAY, EW; GILES, AR; LILLICRAP, D				MURRAY, EW; GILES, AR; LILLICRAP, D			GERM-LINE MOSAICISM FOR A VALINE-TO-METHIONINE SUBSTITUTION AT RESIDUE-553 IN THE GLYCOPROTEIN-IB-BINDING DOMAIN OF VONWILLEBRAND-FACTOR, CAUSING TYPE-IIB VONWILLEBRAND DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; HUMAN GENETIC-DISEASE; HEMOPHILIA-A; PLATELET-AGGREGATION; SPORADIC HEMOPHILIA; DELETION; FAMILY; THROMBOCYTOPENIA	The origin of new single-gene mutations resulting in inherited disease is an issue which may be at least partially resolved by our enhanced ability to detect these changes. In this report we describe the identification of a missense mutation at codon 553 (guanine to adenine) in the von Willebrand factor (vWf) gene in affected members of a family with type IIB von Willebrand's disease (vWd). We found no evidence for this substitution in 190 normal vWf genes. The encoded substitution of a methionine for a valine at this residue is nonconservative in nature and has affected a vWf protein region which has been shown to facilitate binding to the platelet receptor glycoprotein Ib. In patients with type IIB vWd this interaction is characteristically increased in affinity. This mutation has also recently been recorded in four other type IIB vWd families. Thus, there is strong circumstantial evidence to incriminate this substitution as the disease causing mutation in this family. As further supporting evidence for this claim, we have shown by vWf polymorphism analysis that the mutation originated in a vWf gene transmitted from a phenotypically normal grandfather. Analysis of the sperm from this individual showed that approximately 5% of the germ line contained the mutant 553 sequence. These results confirm (1) that the candidate type IIB vWd mutation in this family occurred at some time during the development of the germ line of the grandfather and presumably was related to a mitotic cell division and (2) that, as a result, he is a low-level germ-line mosaic for the mutation.	QUEENS UNIV,DEPT PATHOL,KINGSTON K7L 3N6,ONTARIO,CANADA; QUEENS UNIV,DEPT MED,KINGSTON K7L 3N6,ONTARIO,CANADA	Queens University - Canada; Queens University - Canada								ALLANSON JE, 1986, CLIN GENET, V29, P429; BAHOU WF, 1988, BLOOD, V72, P308; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BIGNELL P, 1990, LANCET, V336, P638, DOI 10.1016/0140-6736(90)93445-U; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; CHANG HY, 1989, BLOOD S, V74, pA131; COHN DH, 1990, AM J HUM GENET, V46, P591; COONEY KA, 1991, J CLIN INVEST, V87, P1227, DOI 10.1172/JCI115123; COOPER DN, 1990, HUM GENET, V85, P55; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, P89; DEMARCO L, 1987, J CLIN INVEST, V80, P475, DOI 10.1172/JCI113095; DEMARCO L, 1990, J CLIN INVEST, V86, P785, DOI 10.1172/JCI114775; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; DROUIN J, 1989, AM J CLIN PATHOL, V92, P471, DOI 10.1093/ajcp/92.4.471; GILES AR, 1987, BRIT J HAEMATOL, V67, P349, DOI 10.1111/j.1365-2141.1987.tb02356.x; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; GINSBURG D, 1989, P NATL ACAD SCI USA, V86, P3723, DOI 10.1073/pnas.86.10.3723; GIRMA JP, 1990, THROMB HAEMOSTASIS, V64, P326; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; GITSCHIER J, 1989, LANCET, V1, P273; HALL JG, 1988, AM J HUM GENET, V43, P355; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HIGUCHI M, 1988, MOL BIOL MED, V5, P23; IANNUZZI MC, 1991, AM J HUM GENET, V48, P757; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; KRONER PA, 1991, THROMB HAEMOSTASIS, V65, pA763; LEVINSON B, 1990, AM J HUM GENET, V46, P53; LYONS S, 1989, BLOOD, V74, pA54; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MILLER JL, 1982, BLOOD, V60, P790; MOHRI H, 1988, J BIOL CHEM, V263, P17901; MURRAY EW, 1991, BLOOD, V77, P1476; NGO KY, 1988, P NATL ACAD SCI USA, V85, P2753, DOI 10.1073/pnas.85.8.2753; NISHIO K, 1990, AM J HEMATOL, V33, P261, DOI 10.1002/ajh.2830330409; PEAKE IR, 1990, BLOOD, V76, P555; PEAKE IR, 1990, BLOOD, V75, P654; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; RIBBA AS, 1991, THROMB HAEMOSTASIS, V65, pA764; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; RUGGERI ZM, 1987, BLOOD, V70, P895; SABA HI, 1985, BLOOD, V66, P282; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5468; SARKAR G, 1991, BIOTECHNIQUES, V10, P590; SHELTONINLOES BB, 1987, J CLIN INVEST, V79, P1459, DOI 10.1172/JCI112974; STANDEN GR, 1990, BRIT J HAEMATOL, V76, P242, DOI 10.1111/j.1365-2141.1990.tb07879.x; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; TUDDENHAM EGD, 1984, CLIN LAB HAEMATOL, V6, P307; TUDDENHAM EGD, 1989, BLOOD REV, V3, P251, DOI 10.1016/0268-960X(89)90032-5; VERWEIJ CL, 1988, J CLIN INVEST, V81, P1116, DOI 10.1172/JCI113425; VOGEL F, 1986, HUM GENET, P334; WARE J, 1991, P NATL ACAD SCI USA, V88, P2946, DOI 10.1073/pnas.88.7.2946; WEISS HJ, 1982, NEW ENGL J MED, V306, P326, DOI 10.1056/NEJM198202113060603; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677	57	43	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					199	207						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729889				2022-12-18	WOS:A1992HA04000022
J	SCHWAB, S; SOYKA, M; NIEDERECKER, M; ACKENHEIL, M; SCHERER, J; WILDENAUER, DB				SCHWAB, S; SOYKA, M; NIEDERECKER, M; ACKENHEIL, M; SCHERER, J; WILDENAUER, DB			ALLELIC ASSOCIATION OF HUMAN DOPAMINE D2-RECEPTOR DNA POLYMORPHISM RULED OUT IN 45 ALCOHOLICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									UNIV MUNICH,HOSP PSYCHIAT,W-8000 MUNICH 2,GERMANY	University of Munich									0	43	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4		S			203	203						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR309					2022-12-18	WOS:A1991GR30901090
J	ZHONG, N; MARTINIUK, F; TZALL, S; HIRSCHHORN, R				ZHONG, N; MARTINIUK, F; TZALL, S; HIRSCHHORN, R			IDENTIFICATION OF A MISSENSE MUTATION IN ONE ALLELE OF A PATIENT WITH POMPE DISEASE, AND USE OF ENDONUCLEASE DIGESTION OF PCR-AMPLIFIED RNA TO DEMONSTRATE LACK OF MESSENGER-RNA EXPRESSION FROM THE 2ND ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID ALPHA-GLUCOSIDASE; GLYCOGENOSIS TYPE-II; GENETIC-HETEROGENEITY; ENZYMATIC AMPLIFICATION; SECONDARY-STRUCTURE; MALTASE DEFICIENCY; GAA LOCUS; DNA; SEQUENCE; FIBROBLASTS	Infantile-onset glycogen storage disease type II, or Pompe disease, results from a genetic deficiency of the lysosomal enzyme acid alpha glucosidase (GAA). Sequencing of the cDNA from a cell line (GM 244) derived from a patient with Pompe disease demonstrated a T953-to-C transition that predicted a methionine-to-threonine substitution at codon 318. The basepair substitution resulted in loss of restriction-endonuclease sites for NcoI and StyI. Analysis of genomic DNA revealed both a normal and an abnormal NcoI fragment, indicating that the patient was a genetic compound. NcoI and StyI digestion of cDNA, amplified by PCR from reverse-transcribed RNA, demonstrated that > 95% of the GAA mRNA in GM 244 was derived from the allele carrying the missense mutation. The missense mutation was uncommon, since it was not detected in 37 additional GAA-deficient chromosomes, as determined by digestion of genomic DNA with NcoI and hybridization. The amino acid substitution predicts a new potential site for N-linked glycosylation, as well as major changes in secondary structure of the protein. We could confirm that the mutation was responsible for the enzyme deficiency by demonstrating that a hybrid minigene containing the mutation did not express GAA enzyme activity after transient gene expression. We have therefore now provided the first identification of a single-basepair missense mutation in a patient with Pompe disease and furthermore have demonstrated that the patient is a genetic compound with the second allele barely expressing mRNA.			MARTINIUK, F (corresponding author), NYU MED CTR,DIV MED GENET,550 1ST AVE,NEW YORK,NY 10016, USA.				NIDDK NIH HHS [R0I DK 39669] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039669] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERATIS NG, 1978, J CLIN INVEST, V62, P1264, DOI 10.1172/JCI109247; BERATIS NG, 1983, AM J HUM GENET, V35, P21; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BROWN BI, 1970, BIOCHEMISTRY-US, V9, P1423, DOI 10.1021/bi00808a017; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COOPER DN, 1990, HUM GENET, V85, P55; COURTECU.V, 1965, ARCH FR PEDIATR, V22, P1153; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ELFERINK RPJO, 1985, EUR J BIOCHEM, V153, P55, DOI 10.1111/j.1432-1033.1985.tb09266.x; ENGEL AG, 1973, NEUROLOGY, V23, P95, DOI 10.1212/WNL.23.1.95; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hers HG, 1989, METABOLIC BASIS INHE, P425; HIDAKA Y, 1988, J CLIN INVEST, V81, P945, DOI 10.1172/JCI113408; HILKENS J, 1981, BIOCHIM BIOPHYS ACTA, V678, P7, DOI 10.1016/0304-4165(81)90041-6; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; HOEFSLOOT LH, 1990, AM J HUM GENET, V46, P45; LABADIE GU, 1986, THESIS CITY U NEW YO; MARTINIUK F, 1984, ARCH BIOCHEM BIOPHYS, V231, P454, DOI 10.1016/0003-9861(84)90408-9; MARTINIUK F, 1990, DNA CELL BIOL, V9, P85, DOI 10.1089/dna.1990.9.85; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; MARTINIUK F, 1990, AM J HUM GENET, V47, P73; MARTINIUK F, IN PRESS DNA CELL BI; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SALAFSKY IS, 1973, J LAB CLIN MED, V81, P450; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SWALLOW DM, 1975, ANN HUM GENET, V38, P391, DOI 10.1111/j.1469-1809.1975.tb00629.x; TAGER JM, 1987, ENZYME, V38, P280, DOI 10.1159/000469217; TZALL S, 1990, NUCLEIC ACIDS RES, V18, P1930, DOI 10.1093/nar/18.7.1930-a; TZALL S, 1990, NUCLEIC ACIDS RES, V18, P1661, DOI 10.1093/nar/18.6.1661-a; TZALL S, IN PRESS BIOCH BIOPH; TZALL S, IN PRESS NUCLEIC ACI; VANDERPLOEG AT, 1989, AM J HUM GENET, V44, P787; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	45	43	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					635	645						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1652892				2022-12-18	WOS:A1991GE36700017
J	CLARKE, JTR; GREER, WL; STRASBERG, PM; PEARCE, RD; SKOMOROWSKI, MA; RAY, PN				CLARKE, JTR; GREER, WL; STRASBERG, PM; PEARCE, RD; SKOMOROWSKI, MA; RAY, PN			HUNTER DISEASE (MUCOPOLYSACCHARIDOSIS TYPE-II) ASSOCIATED WITH UNBALANCED INACTIVATION OF THE X-CHROMOSOMES IN A KARYOTYPICALLY NORMAL GIRL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE SULFATASE DEFICIENCY; WISKOTT-ALDRICH SYNDROME; CARRIER DETECTION; LONG ARM; POLYETHYLENE-GLYCOL; GENE DEFECT; DNA; EXPRESSION; COMPLEMENTATION; DELETION	The mechanism of profound generalized iduronate sulfatase (IDS) deficiency in a developmentally delayed female with clinical Hunter syndrome was studied. Methylation-sensitive RFLP analysis of DNA from peripheral blood lymphocytes from the patient, using MspI/HpaII digestion and probing with M27-beta, showed that the paternal allele was resistant to HpaII digestion (i.e., was methylated) while the maternal allele was digested (i.e., was hypomethylated), indicating marked imbalance of X-chromosome inactivation in peripheral blood lymphocytes of the patient. Similar studies on DNA from maternal lymphocytes showed random X-chromosome inactivation. Among a total of 40 independent maternal fibroblast clones isolated by dilution plating and analyzed for IDS activity, no IDS- clone was found. Somatic cell hybrid clones containing at least one active human X chromosome were produced by fusion of patient fibroblasts with Hprt- hamster fibroblasts (RJK88) and grown in HAT-ouabain medium. Methylation-sensitive RFLP analysis of DNA from the hybrids showed that of the 22 clones that retained the DXS255 locus (M27-beta), all contained the paternal allele in the methylated (active) form. No clone was isolated containing only the maternal X chromosome, and in no case was the maternal allele hypermethylated. We postulate from these studies that the patient has MPS II as a result of a mutation resulting in both the disruption of the IDS locus on her paternal X chromosome and unbalanced inactivation of the nonmutant maternal X chromosome.	UNIV TORONTO,HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	CLARKE, JTR (corresponding author), UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,DIV CLIN GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							ARCHER IM, 1983, AM J MED GENET, V16, P61, DOI 10.1002/ajmg.1320160111; BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; BOOTH CW, 1974, PEDIATRICS, V53, P396; BOOTH CW, 1973, NEW ENGL J MED, V288, P636; BROADHEAD DM, 1986, CLIN GENET, V30, P392; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN RM, 1990, GENOMICS, V7, P215, DOI 10.1016/0888-7543(90)90543-4; CHANG PL, 1979, NATURE, V278, P168, DOI 10.1038/278168a0; CHANG PL, 1983, J INHERIT METAB DIS, V6, P167, DOI 10.1007/BF02310875; CHASE DS, 1986, ANN HUM GENET, V50, P349, DOI 10.1111/j.1469-1809.1986.tb01756.x; CLARKE JTR, 1990, CLIN GENET, V37, P355; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DONNELLY PV, 1975, PEDIATRICS, V56, P429; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLUHARTY AL, 1978, AM J HUM GENET, V30, P249; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GRAVEL RA, 1979, P NATL ACAD SCI USA, V76, P6520, DOI 10.1073/pnas.76.12.6520; GRAVEL RA, 1983, HUM GENET, V65, P112, DOI 10.1007/BF00286645; GREER WL, 1989, GENOMICS, V4, P60, DOI 10.1016/0888-7543(89)90315-7; Hall C W, 1978, Methods Enzymol, V50, P439; HAM RG, 1962, METHOD ENZYMOL, V5, P90, DOI 10.1016/S0076-6879(62)05191-5; JOLLY DJ, 1982, P NATL ACAD SCI-BIOL, V79, P5038, DOI 10.1073/pnas.79.16.5038; LEGUERN E, 1990, GENOMICS, V7, P358, DOI 10.1016/0888-7543(90)90169-U; MAGENIS RE, 1984, CYTOGENET CELL GENET, V37, P528; Maniatis T., 1982, MOL CLONING; MIGEON BR, 1977, AM J HUM GENET, V29, P448; MOHANDAS T, 1987, P NATL ACAD SCI USA, V84, P4954, DOI 10.1073/pnas.84.14.4954; MOSSMAN J, 1983, ARCH DIS CHILD, V58, P911, DOI 10.1136/adc.58.11.911; NEUFELD EF, 1977, AM J HUM GENET, V29, P455; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; PRCHAL JT, 1980, BLOOD, V56, P1048; ROBERTS SH, 1989, J MED GENET, V26, P309, DOI 10.1136/jmg.26.5.309; SCHMIDT M, 1990, HUM GENET, V84, P347, DOI 10.1007/BF00196232; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TANTRAVAHI U, 1983, HUM GENET, V64, P33, DOI 10.1007/BF00289475; THERMAN E, 1974, HUMANGENETIK, V25, P1; THERMAN E, 1979, HUM GENET, V50, P59, DOI 10.1007/BF00295590; WASTESON A, 1982, METHOD ENZYMOL, V83, P573; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WOOD S, 1978, HUM GENET, V41, P325, DOI 10.1007/BF00284766	45	43	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					289	297						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1678247				2022-12-18	WOS:A1991GA86600005
J	CONSALEZ, GG; THOMAS, NST; STAYTON, CL; KNIGHT, SJL; JOHNSON, M; HOPKINS, LC; HARPER, PS; ELSAS, LJ; WARREN, ST				CONSALEZ, GG; THOMAS, NST; STAYTON, CL; KNIGHT, SJL; JOHNSON, M; HOPKINS, LC; HARPER, PS; ELSAS, LJ; WARREN, ST			ASSIGNMENT OF EMERY-DREIFUSS MUSCULAR-DYSTROPHY TO THE DISTAL REGION OF XQ28 - THE RESULTS OF A COLLABORATIVE STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HUMEROPERONEAL NEUROMUSCULAR DISEASE; HUMAN X-CHROMOSOME; MYOTUBULAR MYOPATHY; POLYMORPHIC MARKER; DNA POLYMORPHISMS; LINKED MYOPATHY; GENE; CONTRACTURES; RECOMBINATION	Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked humeroperoneal dystrophy associated with cardiomyopathy that is distinct from the Duchenne and Becker forms of X-linked muscular dystrophy. Linkage analysis has assigned EDMD to the terminal region of the human X chromosome long arm. We report here further linkage analysis in two multigenerational EDMD families using seven Xq28 marker loci. Cumulative lod scores suggest that EDMD is approximately 2 cM from DXS52 (lod = 15.67) and very close to the factor VIII (F8C) and the red/green color pigment (R/GCP) loci, with respective lod scores of 9.62 and 10.77, without a single recombinant. Several recombinations between EDMD and three proximal Xq28 markers suggest that the EDMD gene is located in distal Xq28. Multipoint linkage analysis indicates that the odds are 2,000:1 that EDMD lies distal to DXS305. These data substantially refine the ability to perform accurate carrier detection, prenatal diagnosis, and the presymptomatic diagnosis of at-risk males for EDMD by linkage analysis. The positioning of the EDMD locus close to the loci for F8C and R/GCP will assist in future efforts to identify and isolate the disease gene.	EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; UNIV COLL CARDIFF,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES	Emory University; Emory University; Emory University; Cardiff University			Warren, Stephen T/A-2498-2012; Consalez, Giacomo/AAA-2146-2019	Consalez, Giacomo/0000-0003-4594-6273; Knight, Samantha/0000-0002-6047-3462	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD020521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR-00039] Funding Source: Medline; NICHD NIH HHS [HD20521] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BOSWINKEL E, 1985, CYTOGENET CELL GENET, V40, P586; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CONSALEZ GG, UNPUB ISOLATION CHAR; DAHL N, 1989, AM J HUM GENET, V45, P304; DREIFUSS FE, 1961, NEUROLOGY, V11, P734, DOI 10.1212/WNL.11.8.734; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1987, CLIN GENET, V32, P360; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; FEIL R, 1990, AM J HUM GENET, V46, P720; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDBLATT J, 1989, CLIN GENET, V35, P1; HODGSON S, 1986, HUM GENET, V74, P409, DOI 10.1007/BF00280495; HODGSON SV, 1986, J MED GENET, V23, P169; HOPKINS LC, 1981, ANN NEUROL, V10, P230, DOI 10.1002/ana.410100306; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEHESJOKI AE, 1990, J MED GENET, V27, P288, DOI 10.1136/jmg.27.5.288; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; PATTERSON MN, 1989, GENOMICS, V4, P570, DOI 10.1016/0888-7543(89)90281-4; ROMEO G, 1988, HUM GENET, V80, P59, DOI 10.1007/BF00451457; ROUSSEAU F, IN PRESS HUM GENET; Sambrook J., 1989, MOL CLONING LAB MANU; SAVIRANTA P, 1988, AM J HUM GENET, V42, P84; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS NST, 1987, CYTOGENET CELL GENET, V46, P704; THOMAS NST, 1986, J MED GENET, V23, P596, DOI 10.1136/jmg.23.6.596; THOMAS PK, 1972, J NEUROL NEUROSUR PS, V35, P208, DOI 10.1136/jnnp.35.2.208; VINCENT A, 1989, HUM GENET, V82, P85, DOI 10.1007/BF00288280; VINCENT A, 1989, GENOMICS, V5, P797, DOI 10.1016/0888-7543(89)90121-3; WATERS DD, 1975, NEW ENGL J MED, V293, P1017, DOI 10.1056/NEJM197511132932004; WRIGHT ML, 1980, AM J MED GENET, V6, P315, DOI 10.1002/ajmg.1320060409; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587	38	43	43	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					468	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998333				2022-12-18	WOS:A1991FK47000006
J	MONTANARO, V; CASAMASSIMI, A; DURSO, M; YOON, JY; FREIJE, W; SCHLESSINGER, D; MUENKE, M; NUSSBAUM, RL; SACCONE, S; MAUGERI, S; SANTORO, AM; MOTTA, S; DELLAVALLE, G				MONTANARO, V; CASAMASSIMI, A; DURSO, M; YOON, JY; FREIJE, W; SCHLESSINGER, D; MUENKE, M; NUSSBAUM, RL; SACCONE, S; MAUGERI, S; SANTORO, AM; MOTTA, S; DELLAVALLE, G			INSITU HYBRIDIZATION TO CYTOGENETIC BANDS OF YEAST ARTIFICIAL CHROMOSOMES COVERING 50-PERCENT OF HUMAN XQ24-XQ28 DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION; X-CHROMOSOME; SEQUENCES; LOCALIZATION; METAPHASE; LIBRARIES; CLONING; GENES; SITE	From the collection described by Abidi et al., 102 yeast artificial chromosomes (YACs) with human DNA inserts more than 300 kb in length were assigned to chromosomal band positions on early metaphase chromosomes by in situ hybridization using the biotin-avidin method. All the YACs hybridized within the Xq24-Xqter region, supporting the origin of the vast majority of the YACs from single human X-chromosomal sites. With assignments precise to +/- 0.5 bands, YACs were distributed among cytogenetic bands to roughly equal extents. Thus, there is no gross bias in the cloning of DNA from different bands into large YACs. To test band assignments further, hybridizations were carried out blind, and band positions were then compared with (1) probe localizations in cases in which a reported location was present in one of the YACs; (2) cross-hybridization of a labeled YAC with others kin the collection; and (3) hybridization to a panel of DNAs from a series of hybrid cells containing Xq DNA truncated at various regions. Of 31 cases in which YACs contained a probe with a previously reported location, 28 in situ assignments were in agreement, and 14 other assignments, including one of the three discordant with probe localization, were confirmed by YAC cross-hybridization studies. Results with a group of nine YACs were further confirmed with a panel of somatic cell hybrid DNAs from that region. Five YACs hybridized both to Xq25 and to a second site (four in Xq27 and one in Xq28), suggestive of some duplication of DNA of the hybrid cell and perhaps in normal X chromosomes. The in situ assignments are thus sufficient to place YACs easily and systematically within bins of about 7-10 Mb and to detect some possible anomalies. Furthermore, on the basis of expectations for random cloning of DNA in YACs, the assigned YACs probably cover more than 50% of the total Xq24-Xq28 region. This provides one way to initiate the assembly of YAC contigs over extended chromosomal regions.	INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,CTR GENET MED,ST LOUIS,MO 63110; UNIV CATANIA,DIPARTMENTO BIOL ANIM,I-95124 CATANIA,ITALY; UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL,I-27100 PAVIA,ITALY; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Washington University (WUSTL); Washington University (WUSTL); University of Catania; University of Pavia; University of Pennsylvania			Saccone, Salvatore/H-1548-2012; Casamassimi, Amelia/AAD-2816-2020	Saccone, Salvatore/0000-0001-7568-5823; Casamassimi, Amelia/0000-0002-6010-4261; Muenke, Maximilian/0000-0002-7719-6545; Santoro, Anna Maria/0000-0002-1014-197X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041675] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41675] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABIDI FE, 1990, GENOMICS, V7, P363, DOI 10.1016/0888-7543(90)90170-Y; ALBERTSON DG, 1985, EMBO J, V4, P2493, DOI 10.1002/j.1460-2075.1985.tb03961.x; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHANDLER ME, 1978, CYTOGENET CELL GENET, V22, P352, DOI 10.1159/000130970; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Davies KE, 1989, FRAGILE X SYNDROME; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; GOODMAN HM, 1977, P NATL ACAD SCI USA, V74, P5453, DOI 10.1073/pnas.74.12.5453; LANDEGENT JE, 1985, NATURE, V317, P175, DOI 10.1038/317175a0; LANDEGENT JE, 1987, HUM GENET, V77, P366, DOI 10.1007/BF00291428; LAWRENCE JB, 1988, CELL, V52, P51; LEDBETTER SA, 1990, GENOMICS, V6, P475, DOI 10.1016/0888-7543(90)90477-C; LEDBETTER SA, IN PRESS AM J MED GE; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; REILLY DS, 1988, AM J HUM GENET, V42, P748; Sambrook J., 1989, MOL CLONING LAB MANU; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; TRAKS B, 1989, GENOMICS, V5, P710; WADA M, 1990, AM J HUM GENET, V46, P95; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017	30	43	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					183	194						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990831				2022-12-18	WOS:A1991EV74400002
J	BEAUDET, AL				BEAUDET, AL			CARRIER SCREENING FOR CYSTIC-FIBROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor University; Howard Hughes Medical Institute	BEAUDET, AL (corresponding author), BAYLOR UNIV,INST MOLEC GENET,ONE BAYLOR PLAZA,HOUSTON,TX 77030, USA.							BEAUDET AL, 1989, AM J HUM GENET, V44, P319; BILLINGS PR, 1990, NEW ENGL J MED, V323, P62; BROCK D, 1990, AM J HUM GENET, V47, P164; CASKEY CT, 1990, AM J HUM GENET, V46, P393; COLTEN HR, 1990, NEW ENGL J MED, V322, P328, DOI 10.1056/NEJM199002013220510; GOODFELLOW PN, 1989, NATURE, V341, P102, DOI 10.1038/341102a0; SCHULMAN JD, 1990, AM J HUM GENET, V47, P740; TENKATE LP, 1990, AM J HUM GENET, V47, P259; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; 1990, NEW ENGL J MED, V323, P70; 1975, GENETIC SCREENING PR	11	43	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					603	605						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220802				2022-12-18	WOS:A1990EB31900002
J	HOWELL, N; MCCULLOUGH, D				HOWELL, N; MCCULLOUGH, D			AN EXAMPLE OF LEBER HEREDITARY OPTIC NEUROPATHY NOT INVOLVING A MUTATION IN THE MITOCHONDRIAL ND4 GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL,GALVESTON,TX 77550, USA.				NIGMS NIH HHS [R01 GM33683] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033683] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BRUYN GW, 1964, J NEUROL SCI, V1, P59, DOI 10.1016/0022-510X(64)90054-1; CROUSE GF, 1983, METHOD ENZYMOL, V101, P78; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1988, J MOL BIOL, V203, P618; NIKOSKELAINEN E, 1984, NEUROLOGY, V34, P1482, DOI 10.1212/WNL.34.11.1482; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; ROSE FC, 1970, BRIT J OPHTHALMOL, V54, P388, DOI 10.1136/bjo.54.6.388; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEDORF T, 1970, ACTA OPHTHALMOL, V63, P135; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WENT LN, 1964, ACTA GENET STAT MED, V14, P220; YONEDA M, 1989, LANCET, V1, P1076	22	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					629	634						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2121024				2022-12-18	WOS:A1990EB31900007
J	MARTINIUK, F; MEHLER, M; TZALL, S; MEREDITH, G; HIRSCHHORN, R				MARTINIUK, F; MEHLER, M; TZALL, S; MEREDITH, G; HIRSCHHORN, R			EXTENSIVE GENETIC-HETEROGENEITY IN PATIENTS WITH ACID ALPHA GLUCOSIDASE DEFICIENCY AS DETECTED BY ABNORMALITIES OF DNA AND MESSENGER-RNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSURG,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine	MARTINIUK, F (corresponding author), NYU MED CTR,DEPT MED,550 1ST AVE,NEW YORK,NY 10016, USA.				NINDS NIH HHS [NS00856] Funding Source: Medline; PHS HHS [R0I 39669-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K07NS000856] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN GS, 1983, J CLIN INVEST, V71, P1649, DOI 10.1172/JCI110920; BERATIS NG, 1978, J CLIN INVEST, V62, P1264, DOI 10.1172/JCI109247; BERATIS NG, 1983, AM J HUM GENET, V35, P21; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COURTECU.V, 1965, ARCH FR PEDIATR, V22, P1153; ENGEL AG, 1973, NEUROLOGY, V23, P95, DOI 10.1212/WNL.23.1.95; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hers HG, 1989, METABOLIC BASIS INHE, P425; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; LABADIE G U, 1985, American Journal of Human Genetics, V37, pA12; LABADIE GU, 1986, THESIS CITY U NEW YO; Maniatis T., 1982, MOL CLONING; MARTINIUK F, 1981, BIOCHIM BIOPHYS ACTA, V658, P248, DOI 10.1016/0005-2744(81)90295-3; MARTINIUK F, 1990, DNA CELL BIOL, V9, P85, DOI 10.1089/dna.1990.9.85; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; ORKIN SH, 1983, J BIOL CHEM, V258, P2753; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; REUSER AJJ, 1987, J CLIN INVEST, V79, P1689, DOI 10.1172/JCI113008; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANDERPLOEG AT, 1989, AM J HUM GENET, V44, P787; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4	25	43	43	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					73	78						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2112341				2022-12-18	WOS:A1990DK48200010
J	NANCE, WE				NANCE, WE			DO TWIN LYONS HAVE LARGER SPOTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											NANCE, WE (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,BOX 33,MCV STN,RICHMOND,VA 23298, USA.							ALBERTINI RJ, 1974, BIOCHEM GENET, V11, P397, DOI 10.1007/BF00486413; BENIRSCHKE K, 1973, NEW ENGL J MED, V288, P1276, DOI 10.1056/NEJM197306142882406; BIEBER FR, 1981, SCIENCE, V231, P775; BURN J, 1986, J MED GENET, V23, P494, DOI 10.1136/jmg.23.6.494; EDWARDS R G, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P114, DOI 10.1007/BF01139357; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NANCE WE, 1968, THESIS U WISCONSIN M; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; WITSCHI E, 1952, CANCER RES, V12, P763	12	43	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					646	648						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316517				2022-12-18	WOS:A1990CW54900002
J	LEDLEY, FD; CRANE, AM; LUMETTA, M				LEDLEY, FD; CRANE, AM; LUMETTA, M			HETEROGENEOUS ALLELES AND EXPRESSION OF METHYLMALONYL COA MUTASE IN MUT METHYLMALONIC ACIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR UNIV, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA	Baylor University; Baylor University; Howard Hughes Medical Institute	LEDLEY, FD (corresponding author), BAYLOR UNIV, DEPT CELL BIOL, ONE BAYLOR PLAZA, HOUSTON, TX 77030 USA.				NICHD NIH HHS [HD-24186, HD-24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD024186, R01HD024186] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; Berger S.L., 1987, METHODS ENZYMOLOGY, V152; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER BA, 1987, ANNU REV NUTR, V7, P1319; COULOMBE JT, 1981, PEDIATRICS, V67, P26; FENTON WA, 1984, J BIOL CHEM, V259, P6616; FENTON WA, 1982, ARCH BIOCHEM BIOPHYS, V214, P815, DOI 10.1016/0003-9861(82)90088-1; FENTON WA, 1987, P NATL ACAD SCI USA, V84, P1421, DOI 10.1073/pnas.84.5.1421; JANSEN R, 1989, GENOMICS, V4, P198, DOI 10.1016/0888-7543(89)90300-5; KOLHOUSE JF, 1981, P NATL ACAD SCI-BIOL, V78, P7737, DOI 10.1073/pnas.78.12.7737; KOLHOUSE JF, 1980, J BIOL CHEM, V255, P2708; KOLHOUSE JF, 1988, METHOD ENZYMOL, V166, P407; LEADLAY PF, 1989, COBALAMIN 88, P343; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; LEDLEY FD, 1984, NEW ENGL J MED, V311, P1015, DOI 10.1056/NEJM198410183111604; MARSH EN, 1989, BIOCHEM J, V260, P345, DOI 10.1042/bj2600345; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; MORROW G, 1976, CLIN GENET, V10, P218; ROSENBERG LE, 1983, METABOLIC BASIS INHE, P474; ROSENBLATT DS, 1984, J CLIN INVEST, V74, P2149, DOI 10.1172/JCI111641; SCHUH S, 1984, NEW ENGL J MED, V310, P686, DOI 10.1056/NEJM198403153101104; WILLARD HF, 1979, BIOCHEM GENET, V17, P57, DOI 10.1007/BF00484474; WILLARD HF, 1978, AM J HUM GENET, V30, P1; WILLARD HF, 1977, BIOCHEM BIOPH RES CO, V78, P927, DOI 10.1016/0006-291X(77)90511-3; WILLARD HF, 1980, J CLIN INVEST, V65, P690, DOI 10.1172/JCI109715; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718; ZOGHBI HY, 1988, GENOMICS, V3, P396, DOI 10.1016/0888-7543(88)90135-8	29	43	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					539	547						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1968706				2022-12-18	WOS:A1990CT66800017
J	DEBAUCHE, DM; PAI, GS; STANLEY, WS				DEBAUCHE, DM; PAI, GS; STANLEY, WS			ENHANCED-G2 CHROMATID RADIOSENSITIVITY IN DYSKERATOSIS CONGENITA FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MED UNIV S CAROLINA,DEPT PATHOL & LAB MED,171 ASHLEY AVE,CHARLESTON,SC 29425; MED UNIV S CAROLINA,DEPT PEDIAT,CHARLESTON,SC 29425	Medical University of South Carolina; Medical University of South Carolina								ADDISON M, 1965, Med J Aust, V1, P797; AGUILAR AR, 1974, DERMATOLOGICA, V148, P98; BENDER MA, 1974, MUTAT RES, V23, P197, DOI 10.1016/0027-5107(74)90140-7; BIGELOW SB, 1979, MUTAT RES, V63, P189, DOI 10.1016/0027-5107(79)90115-5; BRYAN HG, 1965, JAMA-J AM MED ASSOC, V192, P103; BURGDORF W, 1977, J MED GENET, V14, P256, DOI 10.1136/jmg.14.4.256; CARTER DM, 1979, J INVEST DERMATOL, V73, P97, DOI 10.1111/1523-1747.ep12532783; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; ELGIN SCR, 1982, NATURE, V300, P402, DOI 10.1038/300402a0; FUDENBERG HH, 1979, GERONTOLOGY, V25, P231, DOI 10.1159/000212345; GANTT R, 1986, RADIAT RES, V108, P117, DOI 10.2307/3576817; Gasparini G, 1985, G Ital Dermatol Venereol, V120, P429; GUTMAN A, 1978, ARCH DERMATOL, V114, P1667, DOI 10.1001/archderm.114.11.1667; JUNEJA HS, 1987, EUR J HAEMATOL, V39, P306; KANO Y, 1982, MUTAT RES, V103, P327, DOI 10.1016/0165-7992(82)90062-8; LEBEAU MM, 1986, ADV HUM GENET, V15, P1; LEBEAU MM, 1986, BLOOD, V67, P849; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; MENON V, 1986, JPN J OPHTHALMOL, V30, P192; MILGROM H, 1964, ARCH DERMATOL, V89, P345, DOI 10.1001/archderm.1964.01590270031007; MORRISON JG, 1974, S AFR MED J, V48, P223; NATARAJAN AT, 1978, MUTAT RES, V52, P137, DOI 10.1016/0027-5107(78)90102-1; ORTEGA JA, 1972, AM J DIS CHILD, V124, P701, DOI 10.1001/archpedi.1972.02110170079012; PAI GS, 1989, AM J MED GENET, V32, P63, DOI 10.1002/ajmg.1320320114; PAI GS, IN PRESS CYTOGENET C; PARSHAD R, 1985, CANCER GENET CYTOGEN, V14, P163, DOI 10.1016/0165-4608(85)90227-4; PARSHAD R, 1984, CANCER RES, V44, P5577; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; PARSHAD R, 1985, MUTAT RES, V151, P57, DOI 10.1016/0027-5107(85)90182-4; PARSHAD R, 1985, P NATL ACAD SCI USA, V82, P5460; PRESTON RJ, 1980, MUTAT RES, V69, P71, DOI 10.1016/0027-5107(80)90177-3; SANCHEZ O, 1973, LANCET, V2, P269; SCHNEIDER A, 1988, EUR J PEDIATR, V148, P37, DOI 10.1007/BF00441811; SCOGGINS RB, 1971, CLIN RES, V19, P409; SIRINAVIN C, 1975, J MED GENET, V12, P339, DOI 10.1136/jmg.12.4.339; SNEDECOR GW, 1980, STATISTICAL METHODS, P208; WOMER R, 1983, PEDIATRICS, V71, P603; Zinsser F, 1910, IKONOGRAPHIA DERMATO, V5, P219	40	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					350	357						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301400				2022-12-18	WOS:A1990CM93800016
J	LAU, YFC; CHAN, KM				LAU, YFC; CHAN, KM			THE PUTATIVE TESTIS-DETERMINING FACTOR AND RELATED GENES ARE EXPRESSED AS DISCRETE-SIZED TRANSCRIPTS IN ADULT GONADAL AND SOMATIC TISSUES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT ONCOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	LAU, YFC (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, U-426, SAN FRANCISCO, CA 94143 USA.		Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024384] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24384] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFFARA NA, 1989, NUCLEIC ACIDS RES, V17, P2987, DOI 10.1093/nar/17.8.2987; ASHWORTH A, 1989, NUCLEIC ACIDS RES, V17, P2864, DOI 10.1093/nar/17.7.2864; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BULL JJ, 1988, SCIENCE, V242, P567, DOI 10.1126/science.3140382; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; DUGGAL RN, 1987, ANN NY ACAD SCI, V513, P112, DOI 10.1111/j.1749-6632.1987.tb25002.x; EICHER EM, 1986, ANNU REV GENET, V20, P327, DOI 10.1146/annurev.ge.20.120186.001551; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; GOODFELLOW PN, 1988, DEVELOPMENT, V102, P251; HODGKIN J, 1988, NATURE, V336, P712, DOI 10.1038/336712a0; LAU YF, 1983, P NATL ACAD SCI-BIOL, V80, P5225, DOI 10.1073/pnas.80.17.5225; LAU YF, IN PRESS P NATL ACAD; LAU YF, 1988, T ASSOC AM PHYSICIAN, V100, P45; LAU YFC, UNPUB POSSIBLE INVOL; Maniatis T., 1982, MOL CLONING; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; MARDON G, 1989, SCIENCE, V243, P78, DOI 10.1126/science.2563173; MCLAREN A, 1988, TRENDS GENET, V4, P153, DOI 10.1016/0168-9525(88)90020-0; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; NAGAMINE CM, UNPUB 2 CANDIDATE TE; O WS, 1988, NATURE, V331, P716; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1988, PHILOS T ROY SOC B, V322, P155, DOI 10.1098/rstb.1988.0123; PONZETTO C, 1985, MOL CELL BIOL, V5, P1791, DOI 10.1128/MCB.5.7.1791; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; SORRENTINO V, 1988, P NATL ACAD SCI USA, V85, P2191, DOI 10.1073/pnas.85.7.2191; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	34	43	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					942	952						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2511751				2022-12-18	WOS:A1989CF40300014
J	SCHNUR, RE; TRASK, BJ; VANDENENGH, G; PUNNETT, HH; KISTENMACHER, M; TOMEO, MA; NAIDS, RE; NUSSBAUM, RL				SCHNUR, RE; TRASK, BJ; VANDENENGH, G; PUNNETT, HH; KISTENMACHER, M; TOMEO, MA; NAIDS, RE; NUSSBAUM, RL			AN XP22 MICRODELETION ASSOCIATED WITH OCULAR ALBINISM AND ICHTHYOSIS - APPROXIMATION OF BREAKPOINTS AND ESTIMATION OF DELETION SIZE BY USING CLONED DNA PROBES AND FLOW-CYTOMETRY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LAWRENCE LIVERMORE NATL LAB,LIVERMORE,CA 94550; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT OPHTHALMOL,PHILADELPHIA,PA 19140; HOWARD HUGHES MED INST,PHILADELPHIA,PA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Howard Hughes Medical Institute	SCHNUR, RE (corresponding author), UNIV PENN,SCH MED,DEPT HUMAN GENET,37TH ST & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.				NEI NIH HHS [R01 EY06566-03, 1 K11 EY00298-01] Funding Source: Medline; NICHD NIH HHS [HD-17665] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006566, K11EY000298] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABE K, 1976, CLIN GENET, V9, P341; AGEMATSU K, 1988, HUM GENET, V80, P105, DOI 10.1007/BF00451470; ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALLERDICE PW, 1983, AM J HUM GENET, V35, pA124; ANDRIA G, 1987, ANN NEUROL, V22, P98, DOI 10.1002/ana.410220130; ANDRIA G, 1984, J INHERIT METAB DIS, V7, P159; BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BALLABIO A, 1986, HUM GENET, V72, P237, DOI 10.1007/BF00291885; BALLABIO A, 1987, HUM GENET, V77, P338, DOI 10.1007/BF00291422; BALLABIO A, 1989, GENOMICS, V4, P36, DOI 10.1016/0888-7543(89)90311-X; BALLABIO A, 1988, CLIN GENET, V34, P31; BERNSTEIN R, 1978, J MED GENET, V15, P466, DOI 10.1136/jmg.15.6.466; BICK D P, 1988, American Journal of Human Genetics, V43, pA39; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BONIFAS JM, 1987, P NATL ACAD SCI USA, V84, P9248, DOI 10.1073/pnas.84.24.9248; BROWN CJ, 1988, HUM GENET, V80, P296, DOI 10.1007/BF01790101; CONARY JT, 1987, BIOCHEM BIOPH RES CO, V144, P1010, DOI 10.1016/S0006-291X(87)80064-5; COOKE A, 1988, HUM GENET, V79, P49, DOI 10.1007/BF00291709; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P227; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; FALLS HF, 1951, AM J OPHTHALMOL, V34, P41, DOI 10.1016/0002-9394(51)90007-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIALKOW PJ, 1967, AM J HUM GENET, V19, P63; FRANCKE U, 1985, AM J HUM GENET, V37, P250; GARNER A, 1980, HISTOPATHOLOGY, V4, P243, DOI 10.1111/j.1365-2559.1980.tb02919.x; GILLARD EF, 1987, NUCLEIC ACIDS RES, V15, P3977, DOI 10.1093/nar/15.10.3977; GRAHAM J M JR, 1987, American Journal of Human Genetics, V41, pA64; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; HOFNAGEL D, 1969, LANCET, V1, P1314; JAEGER C, 1981, HUM GENET, V56, P299, DOI 10.1007/BF00274683; KIDD J R, 1985, American Journal of Human Genetics, V37, pA161; KNOWLTON RG, 1989, NUCLEIC ACIDS RES, V17, P423, DOI 10.1093/nar/17.1.423; LEWEN RM, 1988, ARCH OPHTHALMOL-CHIC, V106, P120; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; LYKKESFELDT G, 1985, CLIN GENET, V28, P231; LYON MF, 1962, AM J HUM GENET, V14, P134; MAYALL BH, 1984, CYTOMETRY, V5, P375; MERRY DE, 1989, AM J HUM GENET, V45; METAXOTOU C, 1983, CLIN GENET, V23, P380; MIDDLESWORTH W, 1985, NUCLEIC ACIDS RES, V13, P5723, DOI 10.1093/nar/13.15.5723; MUNKE M, 1983, EUR J PEDIATR, V141, P8, DOI 10.1007/BF00445661; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; NETTLESHIP E, 1909, T OPHTHALMOLOGICAL S, V29, P57; Nissley P S, 1971, Birth Defects Orig Artic Ser, V7, P246; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; ODONNELL FE, 1980, CLIN GENET, V17, P403; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1189, DOI 10.1001/archopht.1978.03910060023005; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1621, DOI 10.1001/archopht.1978.03910060255013; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PEARCE WG, 1971, LANCET, V1, P1072; PEARCE WG, 1968, LANCET, V1, P1282; PIKE MG, 1989, EUR J PEDIATR, V148, P442, DOI 10.1007/BF00595908; PUCK JM, 1989, AM J HUM GENET, V44, P724; ROSS JB, 1985, ARCH DERMATOL, V121, P1524, DOI 10.1001/archderm.121.12.1524; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHAPIRO LJ, 1985, ADV HUM GENET, V14, P331; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNOHARA N, 1986, ANN NEUROL, V19, P174, DOI 10.1002/ana.410190211; SZYMANSKI KA, 1984, ANN OPHTHALMOL, V16, P183; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973; TRAUPE H, 1984, CLIN GENET, V25, P42; VANDENENGH G, 1988, CYTOMETRY, V9, P266; VANDENENGH GJ, 1985, CYTOMETRY, V6, P92, DOI 10.1002/cyto.990060203; VANDORP DB, 1987, CLIN GENET, V31, P228; WIEACKER P, 1983, HUM GENET, V63, P113, DOI 10.1007/BF00291528; WINSHIP I, 1984, AM J MED GENET, V19, P797, DOI 10.1002/ajmg.1320190421; WIRTH B, 1988, HUM GENET, V80, P191, DOI 10.1007/BF00702868; WISNIEWSKI K, 1985, American Journal of Human Genetics, V37, pA83; WONG L, 1983, OPHTHALMIC PAED GEN, V2, P47, DOI 10.3109/13816818309007149; WROGEMANN K, 1986, NUCLEIC ACIDS RES, V14, P4377, DOI 10.1093/nar/14.10.4377; YAMADA K, 1982, HUM GENET, V60, P85, DOI 10.1007/BF00281273; YATES J R W, 1987, Genomics, V1, P52, DOI 10.1016/0888-7543(87)90104-2; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; YOSHIIKE T, 1985, ACTA DERM-VENEREOL, V65, P66	77	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					706	720						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2573275				2022-12-18	WOS:A1989AZ04900007
J	FRAIZER, GC; HARROLD, TR; HOFKER, MH; COX, DW				FRAIZER, GC; HARROLD, TR; HOFKER, MH; COX, DW			IN-FRAME SINGLE CODON DELETION IN THE MMALTON DEFICIENCY ALLELE OF ALPHA-1-ANTITRYPSIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT PAEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT MED GENET, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto								BAO J-J, 1988, Genomics, V2, P165, DOI 10.1016/0888-7543(88)90099-7; BATES PF, 1983, GENE, V26, P137, DOI 10.1016/0378-1119(83)90183-X; BRANTLY M, 1988, AM J MED, V84, P13; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; COX DW, 1987, AM J HUM GENET, V41, P891; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; COX DW, 1989, AM J HUM GENET, V44, P844; COX DW, 1986, FEBS LETT, V205, P255, DOI 10.1016/0014-5793(86)80908-5; COX DW, 1987, NUCLEIC ACIDS RES, V15, P4701, DOI 10.1093/nar/15.11.4701; COX DW, IN PRESS METABOLIC B; COX DW, 1981, ELECTROPHORESIS 81, P505; COX DW, 1976, PROTIDES BIOL FLUIDS, V23, P375; CURIEL D, 1988, AM REV RESPIR DIS, V143, pA210; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; ERIKSSON S, 1974, ACTA MED SCAND, V195, P451; Fagerhol M K, 1981, Adv Hum Genet, V11, P1; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; FOREMAN RC, 1984, FEBS LETT, V168, P84, DOI 10.1016/0014-5793(84)80211-2; FOREMAN RC, 1987, FEBS LETT, V216, P79, DOI 10.1016/0014-5793(87)80760-3; HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4; HODGSON I, 1987, J MED GENET, V24, P47, DOI 10.1136/jmg.24.1.47; HOFKER MH, 1989, HUM GENET, V81, P264, DOI 10.1007/BF00279001; HOFKER MH, 1988, BIOCHEM BIOPH RES CO, V155, P634, DOI 10.1016/S0006-291X(88)80542-4; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; JEPPSSON JO, 1978, CLIN SCI MOL MED, V55, P103, DOI 10.1042/cs0550103; KRAMPS JA, 1981, HUM GENET, V59, P104, DOI 10.1007/BF00293055; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LIEBERMAN J, 1976, AM REV RESPIR DIS, V113, P31; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Maniatis T., 1982, MOL CLONING; MARTIN JP, 1975, HUMANGENETIK, V30, P121, DOI 10.1007/BF00291944; NUKIWA T, 1988, AM J HUM GENET, V43, P322; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; REID CL, 1987, GASTROENTEROLOGY, V93, P181, DOI 10.1016/0016-5085(87)90332-5; ROBERTS EA, 1984, AM J CLIN PATHOL, V82, P424, DOI 10.1093/ajcp/82.4.424; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SATOH K, 1988, AM J HUM GENET, V42, P77; SHARP HL, 1969, J LAB CLIN MED, V73, P934; SHARP HL, 1971, HOSP PRACT, V5, P83; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; TAKAHASHI H, 1988, J BIOL CHEM, V263, P15528; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VANOMMEN GJ, 1983, NUCLEIC ACIDS RES, V11, P2273	49	43	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					894	902						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2786335				2022-12-18	WOS:A1989U854900016
J	YAM, P; PETZ, LD; ALI, S; STOCK, AD; WALLACE, RB				YAM, P; PETZ, LD; ALI, S; STOCK, AD; WALLACE, RB			DEVELOPMENT OF A SINGLE PROBE FOR DOCUMENTATION OF CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR,DEPT CLIN & EXPTL IMMUNOL,DUARTE,CA 91010; CITY HOPE NATL MED CTR,DEPT MOLEC GENET,DUARTE,CA 91010; CITY HOPE NATL MED CTR,DEPT CYTOGENET,DUARTE,CA 91010	City of Hope; City of Hope; City of Hope					NCI NIH HHS [CA33572, CA30206] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA033572, P01CA030206] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI S, 1986, HUM GENET, V74, P239; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENSINGER WI, 1982, TRANSPLANTATION, V33, P427, DOI 10.1097/00007890-198204000-00017; BLAZAR BR, 1985, BLOOD, V66, P1436; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; FORMAN SJ, 1987, TRANSPLANT P, V19, P2605; GINSBURG D, 1985, J CLIN INVEST, V75, P596, DOI 10.1172/JCI111736; HILL RS, 1986, BLOOD, V67, P811; ITAKURA K, 1984, ANNU REV BIOCHEM, V53, P323; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KNOWLTON RG, 1986, BLOOD, V68, P378; MARTIN PJ, 1985, BLOOD, V66, P664; MINDEN MD, 1985, J CLIN INVEST, V75, P91, DOI 10.1172/JCI111702; PETZ LD, 1987, UCLA S MOL CELLULAR, V53, P121; PETZ LD, 1986, RED CELL ANTIGENS AN, P195; SCHMITZ N, 1985, BRIT J HAEMATOL, V60, P239, DOI 10.1111/j.1365-2141.1985.tb07409.x; SCHUBACH WH, 1982, BLOOD, V60, P180; SODERLING CCB, 1985, J IMMUNOL, V135, P941; Thein SI., 1986, HUMAN GENETIC DIS PR, P33; THEIN SL, 1986, LANCET, V2, P37; VINCENT PC, 1986, BRIT J HAEMATOL, V63, P181, DOI 10.1111/j.1365-2141.1986.tb07508.x; WALKER H, 1986, BRIT J HAEMATOL, V62, P385, DOI 10.1111/j.1365-2141.1986.tb02942.x; WALLACE RB, 1986, COLD SPRING HARB SYM, V51, P257, DOI 10.1101/SQB.1986.051.01.031; WITHERSPOON RP, 1985, BLOOD, V65, P1172; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; YAM PY, 1987, TRANSPLANTATION, V43, P399, DOI 10.1097/00007890-198703000-00016; YAM PY, 1986, CLIN RES, V34, pA42	28	43	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					867	881						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	2890295				2022-12-18	WOS:A1987K936100008
J	EMANUEL, BS; SELLINGER, BT; GUDAS, LJ; MYERS, JC				EMANUEL, BS; SELLINGER, BT; GUDAS, LJ; MYERS, JC			LOCALIZATION OF THE HUMAN PROCOLLAGEN ALPHA-1(IV) GENE TO CHROMOSOME-13Q34 BY INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; HARVARD UNIV,SCH MED,DEPT PHARMACOL,BOSTON,MA 02115; UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,CONNECT TISSUE RES INST,PHILADELPHIA,PA 19104; DANA FARBER CANC INST,BOSTON,MA 02115	University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute	EMANUEL, BS (corresponding author), CHILDRENS HOSP,PHILADELPHIA,PA 19104, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM020553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032592, T32GM007511] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM20553] Funding Source: Medline; NIGMS NIH HHS [GM07511, GM32592] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABEL W, 1984, EUR J BIOCHEM, V143, P545, DOI 10.1111/j.1432-1033.1984.tb08404.x; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; BRINKER JM, 1985, P NATL ACAD SCI USA, V82, P3649, DOI 10.1073/pnas.82.11.3649; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CROUCH E, 1980, P NATL ACAD SCI-BIOL, V77, P745, DOI 10.1073/pnas.77.2.745; DEHM P, 1978, J BIOL CHEM, V253, P6680; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FULLER F, 1981, BIOCHEMISTRY-US, V20, P996, DOI 10.1021/bi00507a054; HENDERSON AS, 1983, CYTOGENET CELL GENET, V36, P586, DOI 10.1159/000131978; HUERRE C, 1982, P NATL ACAD SCI-BIOL, V79, P6627, DOI 10.1073/pnas.79.21.6627; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; KURKINEN M, 1983, NUCLEIC ACIDS RES, V11, P6199, DOI 10.1093/nar/11.18.6199; LOIDL HR, 1984, NUCLEIC ACIDS RES, V12, P9383, DOI 10.1093/nar/12.24.9383; MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller E. J., 1984, EXTRACELLULAR MATRIX, P41; MINOR RR, 1976, J BIOL CHEM, V251, P1789; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MYERS JC, 1985, J BIOL CHEM, V260, P5533; NINOMIYA Y, 1984, BIOCHEMISTRY-US, V23, P617, DOI 10.1021/bi00299a005; SANDELL LJ, 1984, J BIOL CHEM, V259, P7826; SCHUPPAN D, 1984, BIOCHEM J, V220, P227, DOI 10.1042/bj2200227; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; SCHUPPAN D, 1980, FEBS LETT, V115, P297, DOI 10.1016/0014-5793(80)81191-4; SOLOMON E, 1983, CYTOGENET CELL GENET, V35, P64, DOI 10.1159/000131838; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; STROM CM, 1984, SOMAT CELL MOLEC GEN, V10, P651, DOI 10.1007/BF01535232; TRYGGVASON K, 1980, BIOCHEMISTRY-US, V19, P1284, DOI 10.1021/bi00548a003; WANG SY, 1983, P NATL ACAD SCI-BIOL, V80, P5880, DOI 10.1073/pnas.80.19.5880; YAMADA Y, 1983, NUCLEIC ACIDS RES, V11, P2733, DOI 10.1093/nar/11.9.2733; YOUNG MF, 1984, NUCLEIC ACIDS RES, V12, P4207, DOI 10.1093/nar/12.10.4207	34	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1986	38	1					38	44						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AYP17	3753820				2022-12-18	WOS:A1986AYP1700004
J	MYERS, RH; CUPPLES, LA; SCHOENFELD, M; DAGOSTINO, RB; TERRIN, NC; GOLDMAKHER, N; WOLF, PA				MYERS, RH; CUPPLES, LA; SCHOENFELD, M; DAGOSTINO, RB; TERRIN, NC; GOLDMAKHER, N; WOLF, PA			MATERNAL FACTORS IN ONSET OF HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; BOSTON UNIV,SCH PUBL HLTH,BOSTON,MA 02215; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; BOSTON UNIV,DEPT MATH,BOSTON,MA 02215; BOSTON UNIV,DEPT INTERNAL MED,BOSTON,MA 02215	Harvard University; Harvard Medical School; Boston University; Yale University; Boston University; Boston University	MYERS, RH (corresponding author), BOSTON UNIV,DEPT NEUROL,BOSTON,MA 02215, USA.			Myers, Richard/0000-0002-8365-2674; Wolf, Philip/0000-0002-3628-301X	NINDS NIH HHS [NS-16367] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016367, P50NS016367] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BOEHNKE M, 1983, AM J HUM GENET, V35, P845; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P23, DOI 10.1136/jmg.9.1.23; Bruyn G., 1968, HDB CLINICAL NEUROLO, V6, P298; BUTTERFIELD DA, 1977, NATURE, V267, P453, DOI 10.1038/267453a0; BYERS RK, 1973, NEUROLOGY, V23, P561, DOI 10.1212/WNL.23.6.561; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209; EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FOLSTEIN SE, 1983, PSYCHOL MED, V13, P45, DOI 10.1017/S0033291700050054; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HALL JG, 1983, AM J MED GENET, V16, P289, DOI 10.1002/ajmg.1320160218; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; JONES MB, 1973, ADV NEUROL, V1, P171; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P375, DOI 10.1111/j.1469-1809.1981.tb00351.x; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PETTEGREW JW, 1979, J NEUROCHEM, V33, P905, DOI 10.1111/j.1471-4159.1979.tb09920.x; REED TE, 1958, AM J HUM GENET, V10, P201; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; STEVENS DL, 1976, THESIS U LONDON; SUDARSKY L, 1983, J MED GENET, V20, P408, DOI 10.1136/jmg.20.6.408; WALKER DA, 1983, J MED GENET, V20, P12, DOI 10.1136/jmg.20.1.12; WENT LN, 1984, LANCET, V1, P1100	28	43	43	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					511	523						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	3159258				2022-12-18	WOS:A1985AKE0700007
J	HANIS, CL; SING, CF; CLARKE, WR; SCHROTT, HG				HANIS, CL; SING, CF; CLARKE, WR; SCHROTT, HG			MULTIVARIATE MODELS FOR HUMAN GENETIC-ANALYSIS - AGGREGATION, COAGGREGATION, AND TRACKING OF SYSTOLIC BLOOD-PRESSURE AND WEIGHT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV IOWA, COLL MED, DEPT PREVENT MED, IOWA CITY, IA 52242 USA	University of Michigan System; University of Michigan; University of Iowa				Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [HL-14230, NIH-NHLB1-N01-HV-2-2913-L] Funding Source: Medline; NIGMS NIH HHS [1-T32-GM07554-04] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV022913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014230] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANNEST JL, 1983, AM J EPIDEMIOL, V117, P492, DOI 10.1093/oxfordjournals.aje.a113567; ANNEST JL, 1979, AM J EPIDEMIOL, V110, P492, DOI 10.1093/oxfordjournals.aje.a112830; ANNEST JL, 1979, AM J EPIDEMIOL, V110, P479, DOI 10.1093/oxfordjournals.aje.a112829; BIRON P, 1977, J PEDIATR-US, V91, P555, DOI 10.1016/S0022-3476(77)80501-5; CHIANG BN, 1969, CIRCULATION, V39, P403, DOI 10.1161/01.CIR.39.3.403; CLARKE WR, 1978, CIRCULATION, V58, P626, DOI 10.1161/01.CIR.58.4.626; DUSTAN HP, 1980, CHILDHOOD PREVENTION, P305; ELSTON RC, 1978, GENETIC EPIDEMIOLOGY, P223; FEINLEIB M, 1980, CHILDHOOD PREVENTION, P271; HANIS CL, 1981, THESIS U MICHIGAN AN; HANIS CL, UNPUB MULTIVARIATE M; HIGGINS M, 1980, AM J EPIDEMIOL, V111, P142, DOI 10.1093/oxfordjournals.aje.a112882; JOHNSON BC, 1965, J CHRON DIS, V18, P147, DOI 10.1016/0021-9681(65)90098-6; KLEIN BE, 1975, EPIDEMIOLOGY CONTROL, P387; KOTCHEN JM, 1977, AM J EPIDEMIOL, V105, P214, DOI 10.1093/oxfordjournals.aje.a112377; KRIEGER H, 1980, HUM GENET, V53, P415, DOI 10.1007/BF00287065; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LAUER RM, 1975, J PEDIATR-US, V86, P697, DOI 10.1016/S0022-3476(75)80353-2; MCGUE M, UNPUB CINCINNATI LIP; MOLL PP, 1978, RED CELL, P385; MORTON NE, 1980, HUM GENET, V53, P261; NETER J, 1974, APPLIED LINEAR STATI; PLOMIN R, 1979, BEHAV GENET, V9, P505, DOI 10.1007/BF01067347; RAO DC, 1975, AM J HUM GENET, V27, P509; ROSE RJ, 1979, AM J EPIDEMIOL, V109, P503, DOI 10.1093/oxfordjournals.aje.a112707; SCHROTT HG, 1979, GENETIC ANAL COMMON, P619; SING CF, 1982, GENETIC BASIS EPILEP, P239; VOORS AW, 1977, AM J EPIDEMIOL, V106, P101, DOI 10.1093/oxfordjournals.aje.a112439; WARD RH, 1980, HYPERTENSION, V2, pI43, DOI 10.1161/01.HYP.2.4_Pt_2.I43; ZINNER SH, 1971, NEW ENGL J MED, V284, P401, DOI 10.1056/NEJM197102252840801; 1977, DHEW781650 PUBL; 1978, DHEW781472 PUBL	32	43	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1196	1210						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6650502				2022-12-18	WOS:A1983RU70500014
J	MORTON, NE; GREEN, A; DUNSWORTH, T; SVEJGAARD, A; BARBOSA, J; RICH, SS; ISELIUS, L; PLATZ, P; RYDER, LP				MORTON, NE; GREEN, A; DUNSWORTH, T; SVEJGAARD, A; BARBOSA, J; RICH, SS; ISELIUS, L; PLATZ, P; RYDER, LP			HETEROZYGOUS EXPRESSION OF INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) DETERMINANTS IN THE HLA SYSTEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ODENSE UNIV,INST CLIN GENET,DK-5000 ODENSE,DENMARK; UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; RIGSHOSP,TISSUE TYPING LAB,DK-2100 COPENHAGEN O,DENMARK	University of Southern Denmark; University of Minnesota System; University of Minnesota Twin Cities; Rigshospitalet	MORTON, NE (corresponding author), UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822, USA.		ryder, lars p/Q-2060-2015	ryder, lars p/0000-0002-4744-3496; Rich, Stephen/0000-0003-3872-7793	NIGMS NIH HHS [GM-17173] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBOSA J, 1982, CLIN GENET, V21, P25; BARBOSA J, 1982, J CLIN ENDOCR METAB, V55, P193, DOI 10.1210/jcem-55-1-193; CLERGETDARPOUX F, 1981, ANN HUM GENET, V45, P199, DOI 10.1111/j.1469-1809.1981.tb00321.x; CLERGETDARPOUX F, 1981, AM J HUM GENET, V33, pA135; DUNSWORTH TS, 1982, CLIN GENET, V21, P233; GREEN A, 1982, TISSUE ANTIGENS, V19, P213, DOI 10.1111/j.1399-0039.1982.tb01442.x; HODGE SE, 1981, LANCET, V2, P893; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1981, HUM HERED, V31, P3, DOI 10.1159/000153168; MORTON NE, 1982, METHODS GENETIC EPID; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; STOCKERT E, 1976, P NATL ACAD SCI USA, V73, P2077, DOI 10.1073/pnas.73.6.2077; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84; WEITKAMP LR, 1981, AM J HUM GENET, V33, P776	19	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					201	213						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6573128				2022-12-18	WOS:A1983QJ26500004
J	WILSON, GN; SZURA, LL; RUSHFORD, C; JACKSON, D; ERICKSON, J				WILSON, GN; SZURA, LL; RUSHFORD, C; JACKSON, D; ERICKSON, J			STRUCTURE AND VARIATION OF HUMAN RIBOSOMAL DNA - THE EXTERNAL TRANSCRIBED SPACER AND ADJACENT REGIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT MICROBIOL & IMMUNOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	WILSON, GN (corresponding author), UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109, USA.				NICHD NIH HHS [5-P01-HD13506] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARNHEIM N, 1979, J MOL BIOL, V134, P743, DOI 10.1016/0022-2836(79)90483-2; ARNHEIM N, 1977, CELL, V11, P363, DOI 10.1016/0092-8674(77)90053-8; ARNHEIM N, 1980, CELL, V22, P179, DOI 10.1016/0092-8674(80)90166-X; BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462; BOLIVAR F, 1977, GENE, V2, P75, DOI 10.1016/0378-1119(77)90074-9; BOSELEY P, 1979, CELL, V17, P19, DOI 10.1016/0092-8674(79)90291-5; BOTCHAN P, 1977, CELL, V11, P599, DOI 10.1016/0092-8674(77)90077-0; BROSS K, 1972, HUMANGENETIK, V14, P137, DOI 10.1007/BF00273298; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; DAWID IB, 1976, CELL, V8, P443, DOI 10.1016/0092-8674(76)90157-4; FALLS HF, 1951, AMA ARCH OPHTHALMOL, V46, P367; GRUMMT I, 1980, MOL GEN GENET, V177, P223, DOI 10.1007/BF00267433; KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007; KRYSTAL M, 1978, J MOL BIOL, V126, P91, DOI 10.1016/0022-2836(78)90281-4; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LEDER P, 1977, SCIENCE, V196, P1175; MURRAY K, 1973, BIOCHEM J, V131, P569, DOI 10.1042/bj1310569; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; REEDER R, 1972, RIBOSOMES, P489; SCHMICKEL RD, 1977, PEDIATR RES, V11, P929, DOI 10.1203/00006450-197708000-00015; SCHMICKEL RD, 1973, PEDIATR RES, V7, P5, DOI 10.1203/00006450-197301000-00002; SCHMICKEL RD, 1980, AM J HUM GENET, V32, P890; SMITH HO, 1976, NUCLEIC ACIDS RES, V3, P2387, DOI 10.1093/nar/3.9.2387; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; SUTCLIFFE JG, 1978, NUCLEIC ACIDS RES, V5, P2721, DOI 10.1093/nar/5.8.2721; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WELLAUER PK, 1979, J MOL BIOL, V128, P289, DOI 10.1016/0022-2836(79)90089-5; WILLIAMS JG, 1975, CELL, V6, P197, DOI 10.1016/0092-8674(75)90010-0; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367; YOUNG BD, 1976, BIOCHIM BIOPHYS ACTA, V454, P539, DOI 10.1016/0005-2787(76)90279-3	31	43	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	1					32	49						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ585	6282117				2022-12-18	WOS:A1982MZ58500003
J	BARCINSKI, MA; ABREU, MDCA; ALMEIDA, JCCD; NAYA, JM; FONSECA, LG; CASTRO, LE				BARCINSKI, MA; ABREU, MDCA; ALMEIDA, JCCD; NAYA, JM; FONSECA, LG; CASTRO, LE			CYTOGENETIC INVESTIGATION IN A BRAZILIAN POPULATION LIVING IN AN AREA OF HIGH NATURAL RADIOACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR CIENCIAS MED,INST BIOPHYS,RADIOBIOL DEPT,BLOCO G,CIDADE UNIVERSITARIA ZC-32,RIO DE JANEIRO,BRAZIL									BARCINSKI MA, 1974, THESIS U FEDERAL RIO; BOOKER DV, 1969, BRIT J RADIOL, V42, P457, DOI 10.1259/0007-1285-42-498-457; CULLEN TL, 1966, HEALTH PHYS, V12, P970; CULLEN TL, 1972, NYO257713 US AT EN C; FRANCA PE, 1975, NATURAL RADIATION EN; FRANCA PE, 1965, HLTH PHYS, V11, P1471; FRANCA PE, 1965, HLTH PHYS, V11, P699; GONZALES DE, 1974, 8TH P MIDY TOP S; HURSH JB, 1969, HEALTH PHYS, V16, P257, DOI 10.1097/00004032-196903000-00001; HURSH JB, 1970, J APPL PHYSIOL, V28, P268, DOI 10.1152/jappl.1970.28.3.268; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; RIBEIROCOSTA C, 1975, HLTH PHYS, V28, P225; Roser FX, 1964, NATURAL RAD ENV, P855; 1969, REPORT UN SCIENT S13	14	43	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					802	806						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	1200032				2022-12-18	WOS:A1975AX92400012
J	HUISMAN, THJ; MILLER, A; SCHROEDER, WA				HUISMAN, THJ; MILLER, A; SCHROEDER, WA			GAMMA-G-TYPE OF HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN WITH BETA-CHAIN PRODUCTION IN CIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125; VET ADM HOSP,AUGUSTA,GA 30902; MED COLL GEORGIA,LAB PROTEIN CHEM,AUGUSTA,GA 30902; MED COLL GEORGIA,SICKLE CELL CTR,AUGUSTA,GA 30902	California Institute of Technology; University System of Georgia; Augusta University; University System of Georgia; Augusta University								ABRAHAM EC, IN PRESS; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; DESIMONE J, 1974, BIOCHEM BIOPH RES CO, V59, P564, DOI 10.1016/S0006-291X(74)80017-3; DOZY AM, 1968, J CHROMATOGR, V32, P723, DOI 10.1016/S0021-9673(01)80551-3; EFREMOV GD, 1969, J BIOL CHEM, V244, P6105; EFREMOV GD, 1974, J LAB CLIN MED, V83, P657; FESSAS P, 1964, BLOOD, V24, P223, DOI 10.1182/blood.V24.3.223.223; FRIEDMAN S, 1973, J CLIN INVEST, V52, P1453, DOI 10.1172/JCI107319; Huisman T H, 1972, Adv Clin Chem, V15, P149, DOI 10.1016/S0065-2423(08)60160-2; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; HUISMAN THJ, 1974, ANN NY ACAD SCI, V232, P107, DOI 10.1111/j.1749-6632.1974.tb20576.x; HUISMAN THJ, 1972, CLIN CHIM ACTA, V38, P5, DOI 10.1016/0009-8981(72)90201-X; HUISMAN THJ, 1975, 1974 P INT S ABN HEM; KENDALL AG, 1973, AM J HUM GENET, V25, P548; KLEIHAUER E, 1966, FETALES HAMOGLOBIN F; MANN JR, 1972, BRIT J HAEMATOL, V23, P393, DOI 10.1111/j.1365-2141.1972.tb07074.x; NATTA CL, 1974, J CLIN INVEST, V54, P433, DOI 10.1172/JCI107779; RINGELHANN B, 1970, ACTA HAEMATOL-BASEL, V43, P100, DOI 10.1159/000208719; SCHROEDER WA, 1970, ANAL BIOCHEM, V35, P235, DOI 10.1016/0003-2697(70)90030-8; SCHROEDER WA, 1970, AM J HUM GENET, V22, P505; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; SIEGEL W, 1970, ANN INTERN MED, V72, P533, DOI 10.7326/0003-4819-72-4-533; SUKUMARAN PK, 1972, BRIT J HAEMATOL, V23, P403, DOI 10.1111/j.1365-2141.1972.tb07075.x; WHEELER JT, 1961, B JOHNS HOPKINS HOSP, V109, P217; WINTROBE MM, 1974, CLINICAL HEMATOLOGY	25	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					765	777						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	1200028				2022-12-18	WOS:A1975AX92400007
J	SANDLER, L; HECHT, F				SANDLER, L; HECHT, F			GENETIC EFFECTS OF ANEUPLOIDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV OREGON,MED SCH,DEPT PEDIAT,PORTLAND,OR 97403; UNIV OREGON,MED SCH,DEPT MED GENET,PORTLAND,OR 97403	University of Washington; University of Washington Seattle; University of Oregon; University of Oregon								ALAISH MS, 1967, NEW ENGL J MED, V277, P777, DOI 10.1056/NEJM196710122771502; BECKER KL, 1963, MAYO CLIN PROC, V38, P242; CARR DH, 1971, ADV HUMAN GENETICS; CASPERSSON T, 1972, J MED GENET, V9, P1, DOI 10.1136/jmg.9.1.1; DECAPOA A, 1967, AM J HUM GENET, V19, P586; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; EDWARDS JH, 1967, CYTOGENETICS, V6, P81, DOI 10.1159/000129932; ENGEL E, 1966, LANCET, V1, P1130; GAGNON J, 1961, Union Med Can, V90, P1220; GRELL EH, 1962, Z VEREBUNGSL, V93, P371, DOI 10.1007/BF00888795; HECHT F, 1971, NATURE, V233, P480, DOI 10.1038/233480a0; Lejeune J, 1965, Ann Genet, V8, P11; LEJEUNE J, 1964, CR HEBD ACAD SCI, V259, P4187; LINDSLEY D, 1968, 627 CARN I WASH PUBL; LINDSLEY DL, 1972, GENETICS, V71, P157; LOBITZ JR, 1972, J MED GENET, V9, P276, DOI 10.1136/jmg.9.3.276; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; MANGE AP, 1973, GENETICS, V73, P73; PENROSE LS, 1964, ANN HUM GENET, V28, P195, DOI 10.1111/j.1469-1809.1964.tb00477.x; ROBSON EB, 1969, NATURE, V223, P1163, DOI 10.1038/2231163a0; SCHINDLER A-M, 1970, Cytogenetics (Basel), V9, P116, DOI 10.1159/000130082; STEWART B, 1972, Genetics, V71, pS62; WYANDT HE, 1972, CYTOGENETICS, V10, P413; YING KL, 1968, CAN J GENET CYTOL, V10, P575, DOI 10.1139/g68-076	24	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					332	339						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704865				2022-12-18	WOS:A1973P918200015
J	MORTON, NE				MORTON, NE			DETECTION OF MAJOR GENES UNDER ADDITIVE CONTINUOUS VARIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABRAMOWITZ M, 1965, HANDBOOK MATHEMATICA; BARRAI I, 1965, AM J HUM GENET, V17, P221; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; CROW JF, 1965, GENETICS TODAY, P495; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FALCONER DS, 1960, INTRODUCTION QUANTIT; GEERTS SJ, 1965, GENETICS TODAY    ED, P495; GEERTS SJ, 1965, GENETICS TODAY    ED, P935; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; KRIEGER H, 1966, THESIS U HAWAII; MI MP, 1965, ACTA GENET STAT MED, V15, P177; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1965, GENETICS TODAY, P935; NEWCOMBE HB, 1964, COLD SPRING HARBOR S, V29, P78; PENROSE LS, 1957, J MENT DEFIC RES, V1, P4; STEVENSON AC, 1956, ANN HUM GENET, V20, P177; WRIGHT S, 1951, ANN EUGENIC, V15, P323	21	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	1					23	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	88552	6066918				2022-12-18	WOS:A19678855200003
J	GIBLETT, ER; MOTULSKY, AG; FRASER, GR				GIBLETT, ER; MOTULSKY, AG; FRASER, GR			POPULATION GENETIC STUDIES IN CONGO .4. HAPTOGLOBIN AND TRANSFERRIN SERUM GROUPS IN CONGO AND IN OTHER AFRICAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON A. C., 1960, ACTA GENET ET STATIST MED, V10, P17; ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; BARNICOT NA, 1960, ANN HUM GENET, V24, P171; BARNICOT NA, 1959, NATURE, V184, P2042, DOI 10.1038/1842042a0; BLUMBERG BS, 1961, NATURE, V189, P897, DOI 10.1038/189897a0; FRASER GR, 1966, AM J HUM GENET, V18, P546; FRASER GR, 1966, AM J HUM GENET, V18, P538; GIBLETT E. R., 1962, PROGR MED GENET, V2, P34; GIBLETT ER, 1959, NATURE, V183, P192, DOI 10.1038/183192a0; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; HARRIS H, 1959, CIBA F S BIOCHEMISTR, P151; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; MOULLEC J., 1960, REV HEMATOL, V15, P174; NEEL JV, 1961, AM J HUM GENET, V13, P262; NYMAN M, 1959, SCAND J CLIN LAB S39, V2; PARKER WC, 1961, ANN HUM GENET, V25, P227; PARKER WC, 1963, AM J HUM GENET, V15, P159; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9; SONNET J, 1960, NATURE, V188, P504, DOI 10.1038/188504a0; SUTTON H E, 1959, Ann Hum Genet, V23, P175; VAN ROS G, 1963, Ann Soc Belg Med Trop (1920), V43, P511; VANSANDE M, 1963, NATURE, V197, P603, DOI 10.1038/197603a0; WOLSTENHOLME GEW, 1959, CIBA F S BIOCHEMI ED, P151	25	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	6					553	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	86655	5927875				2022-12-18	WOS:A19668665500005
J	BOYER, SH; GRAHAM, JB				BOYER, SH; GRAHAM, JB			LINKAGE BETWEEN X CHROMOSOME LOCI FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE ELECTROPHORETIC VARIATION AND HEMOPHILIA A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAM A, 1963, ANN HUM GENET, V26, P187, DOI 10.1111/j.1469-1809.1963.tb01974.x; ADAM A, 1961, NATURE, V189, P686, DOI 10.1038/189686a0; ADAMS A, 1962, LANCET, V1, P1188; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; DAVIES SH, 1963, AM J HUM GENET, V15, P481; JACKSON CE, 1964, AM J HUM GENET, V16, P403; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; LYON MF, 1962, AM J HUM GENET, V14, P135; McKusick V.A., 1964, X CHROMOSOME MAN; PORTER IH, 1964, LANCET, V1, P895; PORTER IH, 1962, ANN HUM GENET, V26, P107, DOI 10.1111/j.1469-1809.1962.tb01316.x; RENWICK JH, 1964, AM J HUM GENET, V16, P410; WHITTAKER DL, 1962, AM J HUM GENET, V14, P149	13	43	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	4					320	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	66220	17948498				2022-12-18	WOS:A19656622000004
J	CATTELL, RB; YOUNG, HB; HUNDLEBY, JD				CATTELL, RB; YOUNG, HB; HUNDLEBY, JD			BLOOD GROUPS + PERSONALITY TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AIRD I, 1954, Br Med J, V2, P315; BISCHOP L, 1964, INTERPRETING PERSONA; BUCKWALTER JA, 1956, JAMA-J AM MED ASSOC, V162, P1210, DOI 10.1001/jama.1956.02970300010005; Cattell R.B., 1950, PERSONALITY SYSTEMAT; Cattell R. B., 1957, PERSONALITY MOTIVATI; CATTELL RB, 1955, AM J HUM GENET, V7, P122; CATTELL RB, 1957, J ABNORM SOC PSYCH, V54, P143, DOI 10.1037/h0048561; CATTELL RB, 1961, REV PSYCHOL APPL, V11, P165; CATTELL RB, 1957, HIGH SCHOOL PERSONAL; CATTELL RB, 1961, HIGH SCHOOL PERSONAL; COHEN BH, 1962, B JOHNS HOPKINS HOSP, V110, P1; EYSENCK HJ, 1951, J MENT SCI, V97, P441, DOI 10.1192/bjp.97.408.441; FRENCH J, 1953, ETS B; GOTTESMAN I, 1960, DISSERTATION U MINNE; Hall C.S., 1957, THEORIES PERSONALITY; HUNDLEBY J, 1964, PERSONALITY FACTORS; LOEHLIN JC, IN PRESS; PARKER JB, 1961, J MENT SCI, V107, P450; Race Robert Russell, 1958, BLOOD GROUPS MAN	19	43	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					397	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250420				2022-12-18	WOS:A19642974A00003
J	Melo, US; Schopflin, R; Acuna-Hidalgo, R; Mensah, MA; Fischer-Zirnsak, B; Holtgrewe, M; Klever, MK; Turkmen, S; Heinrich, V; Pluym, ID; Matoso, E; de Sousa, SB; Louro, P; Hulsemann, W; Cohen, M; Dufke, A; Latos-Bielenska, A; Vingron, M; Kalscheuer, V; Quintero-Rivera, F; Spielmann, M; Mundlos, S				Melo, Uira Souto; Schoepflin, Robert; Acuna-Hidalgo, Rocio; Mensah, Martin Atta; Fischer-Zirnsak, Bjoern; Holtgrewe, Manuel; Klever, Marius-Konstantin; Tuerkmen, Seval; Heinrich, Verena; Pluym, Ilina Datkhaeva; Matoso, Eunice; de Sousa, Sergio Bernardo; Louro, Pedro; Huelsemann, Wiebke; Cohen, Monika; Dufke, Andreas; Latos-Bielenska, Anna; Vingron, Martin; Kalscheuer, Vera; Quintero-Rivera, Fabiola; Spielmann, Malte; Mundlos, Stefan			Hi-C Identifies Complex Genomic Rearrangements and TAD-Shuffling in Developmental Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENOTYPES; DOMAINS; PRINCIPLES; MUTATIONS; DISCOVERY; PROVIDES; ELEMENTS; SYSTEM; EXOME	Genome-wide analysis methods, such as array comparative genomic hybridization (CGH) and whole-genome sequencing (WGS), have greatly advanced the identification of structural variants (SVs) in the human genome. However, even with standard high-throughput sequencing techniques, complex rearrangements with multiple breakpoints are often difficult to resolve, and predicting their effects on gene expression and phenotype remains a challenge. Here, we address these problems by using high-throughput chromosome conformation capture (Hi-C) generated from cultured cells of nine individuals with developmental disorders (DDs). Three individuals had previously been identified as harboring duplications at the SOX9 locus and six had been identified with translocations. Hi-C resolved the positions of the duplications and was instructive in interpreting their distinct pathogenic effects, including the formation of new topologically associating domains (neo-TADs). Hi-C was very sensitive in detecting translocations, and it revealed previously unrecognized complex rearrangements at the breakpoints. In several cases, we observed the formation of fused-TADs promoting ectopic enhancer-promoter interactions that were likely to be involved in the disease pathology. In summary, we show that Hi-C is a sensible method for the detection of complex SVs in a clinical setting. The results help interpret the possible pathogenic effects of the SVs in individuals with DDs.	[Melo, Uira Souto; Schoepflin, Robert; Acuna-Hidalgo, Rocio; Fischer-Zirnsak, Bjoern; Klever, Marius-Konstantin; Kalscheuer, Vera; Mundlos, Stefan] Max Planck Inst Mol Genet, RG Dev & Dis, D-13353 Berlin, Germany; [Melo, Uira Souto; Schoepflin, Robert; Acuna-Hidalgo, Rocio; Mensah, Martin Atta; Fischer-Zirnsak, Bjoern; Holtgrewe, Manuel; Klever, Marius-Konstantin; Tuerkmen, Seval; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Holtgrewe, Manuel] Berlin Inst Hlth BIH, Core Unit Bioinformat, D-10117 Berlin, Germany; [Heinrich, Verena; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-13353 Berlin, Germany; [Pluym, Ilina Datkhaeva] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Matoso, Eunice; de Sousa, Sergio Bernardo; Louro, Pedro] Ctr Hosp & Univ Coimbra, Med Genet Unit, P-3000075 Coimbra, Portugal; [Matoso, Eunice] Univ Coimbra, Fac Med, Ctr Invest Environm Genet & Oncobiol iCBR CIMAGO, P-3000548 Coimbra, Portugal; [Louro, Pedro] Inst Portugues Oncol Francisco Gentil, Familial Risk Clin, P-1099023 Lisbon, Portugal; [Louro, Pedro] Univ Beira Interior, Fac Hlth Sci, P-6201001 Covilha, Portugal; [Huelsemann, Wiebke] Handchirurg Kinderkrankenhaus Wilhelmstift, D-22149 Hamburg, Germany; [Cohen, Monika] Kbo Kinderzentrum Munchen, D-81377 Munich, Germany; [Dufke, Andreas] Inst Med Genet & Angew Genom, D-72076 Tubingen, Germany; [Latos-Bielenska, Anna] Poznan Univ Med Sci, Dept Med Genet, PL-60806 Poznan, Poland; [Latos-Bielenska, Anna] Ctr Med Genet GENESIS, Grudzieniec St, PL-60601 Poznan, Poland; [Quintero-Rivera, Fabiola] Univ Calif Los Angeles, Clin Genom Ctr, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Spielmann, Malte] Max Planck Inst Mol Genet, Human Mol Genom Grp, D-13353 Berlin, Germany; [Spielmann, Malte] Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Max Planck Society; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Portuguese Institute of Oncology; Universidade da Beira Interior; Poznan University of Medical Sciences; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Max Planck Society; University of Lubeck	Mundlos, S (corresponding author), Max Planck Inst Mol Genet, RG Dev & Dis, D-13353 Berlin, Germany.; Mundlos, S (corresponding author), Charite Univ Med Berlin, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.; Spielmann, M (corresponding author), Max Planck Inst Mol Genet, Human Mol Genom Grp, D-13353 Berlin, Germany.; Spielmann, M (corresponding author), Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany.	spielman@molgen.mpg.de; mundlos@molgen.mpg.de	Mundlos, Stefan/ABH-9585-2020; Matoso, Eunice MRC/O-8435-2015; Fischer-Zirnsak, Björn/D-7487-2013	Matoso, Eunice MRC/0000-0002-0775-0061; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Melo, Uira/0000-0003-4065-8635; Mundlos, Stefan/0000-0002-9788-3166; Klever, Marius-Konstantin/0000-0003-4191-686X	Deutsche Forschungsgemeinschaft (DFG) [SP1532/3-1, SP1532/4-1, SP1532/5-1, MU 880/16-1]; Max Planck Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Foundation(Foundation CELLEX)	We would like to thank the individuals and families for their collaboration and contribution to this project. Technical assistance: We thank Susanne Rothe, Vanessa Suckow, and Celina Sao-Jose for their excellent work. We thank Angela Maria Vianna-Morgante for assistance in reviewing the cytogenetics nomenclature. Funding: M.S. and S.M. are supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SP1532/3-1, SP1532/4-1, SP1532/5-1, and MU 880/16-1) and the Max Planck Foundation. U.S.M. is a fellow of the Capes-Alexander von Humboldt Foundation.	Allou L, 2012, EUR J HUM GENET, V20, P1216, DOI 10.1038/ejhg.2012.127; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Blok LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06014-6; Chakraborty A, 2018, BIOINFORMATICS, V34, P338, DOI 10.1093/bioinformatics/btx664; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Diaz N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06961-0; Dixon JR, 2018, NAT GENET, V50, P1388, DOI 10.1038/s41588-018-0195-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flottmann R, 2018, GENET MED, V20, P599, DOI 10.1038/gim.2017.154; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Harewood L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1253-8; Hombach D, 2019, NUCLEIC ACIDS RES, V47, pW114, DOI 10.1093/nar/gkz330; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Kraft K, 2019, NAT CELL BIOL, V21, P305, DOI 10.1038/s41556-019-0273-x; Kragesteen BK, 2018, NAT GENET, V50, P1463, DOI 10.1038/s41588-018-0221-x; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813; Li H., 2013, ARXIV 1303 3997; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YQ, 2020, J HUM GENET, V65, P497, DOI 10.1038/s10038-020-0737-7; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Roskosch S., 2019, POPDEL IDENTIFIES ME, DOI [10.1101/740225, DOI 10.1101/740225]; Sanchis-Juan A, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0606-6; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Stansfield JC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2288-x; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wang S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01986-5; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004	45	42	44	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2020	106	6					872	884		10.1016/j.ajhg.2020.04.016	http://dx.doi.org/10.1016/j.ajhg.2020.04.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LW4IW	32470376	Green Published, Bronze			2022-12-18	WOS:000539109000013
J	Ghosh, SG; Becker, K; Huang, H; Salazar, TD; Chai, GL; Salpietro, V; Al-Gazali, L; Waisfisz, Q; Wang, H; Vaux, KK; Stanley, V; Manole, A; Akpulat, U; Weiss, MM; Efthymiou, S; Hanna, MG; Minetti, C; Striano, P; Pisciotta, L; De Grandis, E; Altmuller, J; Nurnberg, P; Thiele, H; Yis, U; Okur, TD; Polat, AI; Amiri, N; Doosti, M; Karimani, EG; Toosi, MB; Haddad, G; Karakaya, M; Wirth, B; van Hagen, JM; Wolf, NI; Maroofian, R; Houlden, H; Cirak, S; Gleeson, JG				Ghosh, Shereen G.; Becker, Kerstin; Huang, He; Salazar, Tracy D.; Chai, Guoliang; Salpietro, Vincenzo; Al-Gazali, Lihadh; Waisfisz, Quinten; Wang, Haicui; Vaux, Keith K.; Stanley, Valentina; Manole, Andreea; Akpulat, Ugur; Weiss, Marjan M.; Efthymiou, Stephanie; Hanna, Michael G.; Minetti, Carlo; Striano, Pasquale; Pisciotta, Livia; De Grandis, Elisa; Altmueller, Janine; Nuernberg, Peter; Thiele, Holger; Yis, Uluc; Okur, Tuncay Derya; Polat, Ayse Ipek; Amiri, Nafise; Doosti, Mohammad; Karimani, Ehsan Ghayoor; Toosi, Mehran B.; Haddad, Gabriel; Karakaya, Mert; Wirth, Brunhilde; van Hagen, Johanna M.; Wolf, Nicole I.; Maroofian, Reza; Houlden, Henry; Cirak, Sebahattin; Gleeson, Joseph G.			Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLY(ADP-RIBOSE) GLYCOHYDROLASE; POLYMERASE-1; RIBOSYLATION; DROSOPHILA; ARH3; PAR	ADP-ribosylation, the addition of poly-ADP ribose (PAR) onto proteins, is a response signal to cellular challenges, such as excitotoxicity or oxidative stress. This process is catalyzed by a group of enzymes referred to as poly(ADP-ribose) polymerases (PARPs). Because the accumulation of proteins with this modification results in cell death, its negative regulation restores cellular homeostasis: a process mediated by poly-ADP ribose glycohydrolases (PARGs) and ADP-ribosylhydrolase proteins (ARHs). Using linkage analysis and exome or genome sequencing, we identified recessive inactivating mutations in ADPRHL2 in six families. Affected individuals exhibited a pediatric-onset neurodegenerative disorder with progressive brain atrophy, developmental regression, and seizures in association with periods of stress, such as infections. Loss of the Drosophila paralog Parg showed lethality in response to oxidative challenge that was rescued by human ADPRHL2, suggesting functional conservation. Pharmacological inhibition of PARP also rescued the phenotype, suggesting the possibility of postnatal treatment for this genetic condition.	[Ghosh, Shereen G.; Salazar, Tracy D.; Chai, Guoliang; Stanley, Valentina; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Lab Pediat Brain Dis, La Jolla, CA 92093 USA; [Ghosh, Shereen G.; Salazar, Tracy D.; Chai, Guoliang; Stanley, Valentina; Gleeson, Joseph G.] Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Becker, Kerstin; Wang, Haicui; Akpulat, Ugur; Cirak, Sebahattin] Ctr Mol Med Cologne, Cologne, Germany; [Becker, Kerstin; Wang, Haicui; Akpulat, Ugur; Cirak, Sebahattin] Univ Hosp Cologne, Dept Pediat, Cologne, Germany; [Becker, Kerstin; Wang, Haicui; Wirth, Brunhilde; Cirak, Sebahattin] Ctr Rare Dis, D-50937 Cologne, Germany; [Huang, He; Haddad, Gabriel] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Huang, He; Haddad, Gabriel] Rady Childrens Hosp, San Diego, CA USA; [Salpietro, Vincenzo; Manole, Andreea; Efthymiou, Stephanie; Hanna, Michael G.; Houlden, Henry] UCL, Dept Neuromuscular Dis, London WC1E 6BT, England; [Salpietro, Vincenzo; Manole, Andreea; Efthymiou, Stephanie; Hanna, Michael G.; Houlden, Henry] UCL, Neurogenet Lab, London WC1E 6BT, England; [Al-Gazali, Lihadh] United Arab Emirates Univ, Dept Pediat, POB 15551, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] Tawam Hosp, POB 15551, Al Ain, U Arab Emirates; [Waisfisz, Quinten; Weiss, Marjan M.; van Hagen, Johanna M.] Vrije Univ Amsterdam, Amsterdam UMC, Dept Clin Genet, De Boelelaan 1117, Amsterdam, Netherlands; [Vaux, Keith K.] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet, La Jolla, CA 92093 USA; [Akpulat, Ugur] Kastamonu Univ, Fac Med, TR-37150 Kastamonu, Turkey; [Minetti, Carlo; Striano, Pasquale] Univ Genoa, Pediat Neurol & Muscular Dis Unit, Ist Giannina Gaslini, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, I-16126 Genoa, Italy; [Pisciotta, Livia; De Grandis, Elisa] Univ Genoa, Child Neuropsychiat Unit, Ist Giannina Gaslini, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, I-16126 Genoa, Italy; [Altmueller, Janine; Nuernberg, Peter; Thiele, Holger] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Yis, Uluc; Okur, Tuncay Derya; Polat, Ayse Ipek] Dokuz Eylul Univ, Sch Med, Dept Pediat, Div Child Neurol, TR-35340 Izmir, Turkey; [Amiri, Nafise] Univ Med Sci, Targeted Drug Delivery Res Ctr, Pharmaceut Technol Inst, Mashhad 15731, Iran; [Doosti, Mohammad; Karimani, Ehsan Ghayoor] Next Generat Genet Clin, Mashhad 15731, Iran; [Karimani, Ehsan Ghayoor; Maroofian, Reza] St Georges Univ London, Mol & Clin Sci Inst, Cranmer Terrace, London SW17 0RE, England; [Toosi, Mehran B.] Mashhad Univ Med Sci, Fac Med, Dept Pediat Dis, Pediat Neurol, Mashhad 15731, Iran; [Karakaya, Mert; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, Ctr Mol Med, D-50937 Cologne, Germany; [Karakaya, Mert; Wirth, Brunhilde] Univ Cologne, Ctr Rare Dis, D-50937 Cologne, Germany; [Wolf, Nicole I.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1117 Amsterdam, Netherlands; [Wolf, Nicole I.] Amsterdam Neurosci, NL-1117 Amsterdam, Netherlands	Howard Hughes Medical Institute; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of Cologne; University of Cologne; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of London; University College London; University of London; University College London; United Arab Emirates University; Vrije Universiteit Amsterdam; University of California System; University of California San Diego; Kastamonu University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Cologne; Dokuz Eylul University; Tehran University of Medical Sciences; St Georges University London; Mashhad University Medical Science; University of Cologne; University of Cologne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Lab Pediat Brain Dis, La Jolla, CA 92093 USA.; Gleeson, JG (corresponding author), Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA 92123 USA.; Cirak, S (corresponding author), Ctr Mol Med Cologne, Cologne, Germany.; Cirak, S (corresponding author), Univ Hosp Cologne, Dept Pediat, Cologne, Germany.; Cirak, S (corresponding author), Ctr Rare Dis, D-50937 Cologne, Germany.	sebahattin.cirak@uk-koeln.de; jogleeson@ucsd.edu	amiri, nafise/AAI-4085-2021; Minetti, Carlo/K-4666-2018; Weiss, Marjan M/AAN-4979-2020; AKPULAT, UGUR/I-8268-2013; Wirth, Brunhilde/H-3192-2019; Cirak, Sebahattin/AAZ-6829-2020; Houlden, Henry J/C-1532-2008; POLAT, IPEK/AGR-4475-2022; Karakaya, Mert/L-9863-2019; Cirak, Sebahattin/AAX-9593-2020; Salpietro, Vincenzo/AAA-8706-2020; Thiele, Holger/ABE-6792-2020; Striano, Pasquale/F-9117-2014; Vaux, Keith/R-2716-2019; POLAT, ipek/A-9714-2016; Wolf, Nicole I/H-3943-2014; Toosi, Mehran Beiraghi/K-7403-2019	amiri, nafise/0000-0002-8601-8142; Minetti, Carlo/0000-0002-0640-1804; Weiss, Marjan M/0000-0002-0936-1406; AKPULAT, UGUR/0000-0001-8126-8209; Houlden, Henry J/0000-0002-2866-7777; POLAT, IPEK/0000-0002-8270-3249; Thiele, Holger/0000-0002-0169-998X; Striano, Pasquale/0000-0002-6065-1476; Vaux, Keith/0000-0001-8738-5940; POLAT, ipek/0000-0002-8270-3249; Wolf, Nicole I/0000-0003-1721-0728; Beiraghi Toosi, Mehran/0000-0002-0569-1117; Pisciotta, Livia/0000-0001-7653-981X; Wirth, Brunhilde/0000-0003-4051-5191; Ghosh, Shereen/0000-0002-0689-0193; DE GRANDIS, ELISA/0000-0002-9733-9216; Altmuller, Janine/0000-0003-4372-1521; Waisfisz, Quinten/0000-0002-7384-9182; Karakaya, Mert/0000-0001-5395-8894; Weixler, Lisa/0000-0003-4453-017X	Ruth L. Kirschstein Institutional National Research Service Award from the National Institute on Deafness and Other Communica-tion Disorders [T32 GM008666]; Ruth L. Kirschstein Institutional National Research Service Award from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [F31HD095602]; Broad Institute [U54HG003067, UM1HG008900]; Yale Center for Mendelian Disorders [U54HG006504]; NIH [R01NS048453, R01NS052455]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft Emmy Noether Programme [CI 218/1-1]; Wellcome Trust [WT093205MA, WT104033AIA]; Ataxia UK; UCL/UCLH NIHR Biomedical Research Centre; Medical Research Council; EU Horizon 2020 Solve-RD; European Community's Seventh Framework Programme (FP7/2007-2013) [2012-305121]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD095602] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG006504, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455] Funding Source: NIH RePORTER; MRC [MR/K000608/1, G0601943] Funding Source: UKRI	Ruth L. Kirschstein Institutional National Research Service Award from the National Institute on Deafness and Other Communica-tion Disorders; Ruth L. Kirschstein Institutional National Research Service Award from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development; Broad Institute; Yale Center for Mendelian Disorders; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft Emmy Noether Programme(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Ataxia UK; UCL/UCLH NIHR Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Horizon 2020 Solve-RD; European Community's Seventh Framework Programme (FP7/2007-2013)(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the subjects and their families for participating in this study. S.G. was sponsored by the Ruth L. Kirschstein Institutional National Research Service Award (T32 GM008666) from the National Institute on Deafness and Other Communica-tion Disorders and by award F31HD095602 from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development. We thank the Broad Institute (U54HG003067 to E. Lander and UM1HG008900 to D. MacArthur) and the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton and M. Gunel). We also thank Lisa Weixler for technical assistance and all the staff of the Cologne Center for Genomics for next-generation sequencing. The sequencing data were analyzed with the CHEOPS high-performace computer cluster of the Regional Computing Center of the University of Cologne. We thank DeCode for whole-genome sequencing. This work was supported by NIH grants R01NS048453 and R01NS052455, the Simons Foundation Autism Research Initiative, the Howard Hughes Medical Institute (to J.G.G.), the Deutsche Forschungsgemeinschaft Emmy Noether Programme (grant CI 218/1-1 to S.C.), the Wellcome Trust (WT093205MA and WT104033AIA), Ataxia UK, the UCL/UCLH NIHR Biomedical Research Centre, the Medical Research Council (to H.H. and M.H), EU Horizon 2020 Solve-RD, and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant 2012-305121 for the "Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)" to B.W.	Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Butepage M, 2015, CELLS-BASEL, V4, P569, DOI 10.3390/cells4040569; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Lee GJ, 2017, ONCOTARGET, V8, P87878, DOI 10.18632/oncotarget.21224; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Madabattula ST, 2015, JOVE-J VIS EXP, DOI 10.3791/52741; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Niere M, 2012, J BIOL CHEM, V287, P16088, DOI 10.1074/jbc.M112.349183; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Poitras MF, 2007, NEUROSCIENCE, V148, P198, DOI 10.1016/j.neuroscience.2007.04.062; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wang Zhifeng, 2012, Front Med, V6, P156, DOI 10.1007/s11684-012-0197-3	25	42	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					431	439		10.1016/j.ajhg.2018.07.010	http://dx.doi.org/10.1016/j.ajhg.2018.07.010			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30388405	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-18	WOS:000443819500012
J	Guo, XY; Lin, WQ; Bao, JD; Cai, QY; Pan, X; Bai, MQ; Yuan, Y; Shi, JJ; Sun, YQ; Han, MR; Wang, J; Liu, Q; Wen, WQ; Li, BS; Long, JR; Chen, JH; Zheng, W				Guo, Xingyi; Lin, Weiqiang; Bao, Jiandong; Cai, Qiuyin; Pan, Xiao; Bai, Mengqiu; Yuan, Yuan; Shi, Jiajun; Sun, Yaqiong; Han, Mi-Ryung; Wang, Jing; Liu, Qi; Wen, Wanqing; Li, Bingshan; Long, Jirong; Chen, Jianghua; Zheng, Wei			A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PUTATIVE FUNCTIONAL VARIANTS; INDEPENDENT RISK VARIANTS; COMPLEX TRAITS; EXPRESSION; POLYMORPHISMS; HERITABILITY; METAANALYSIS; REGULATORS	Genome-wide association studies (GWASs) have identified more than 150 common genetic loci for breast cancer risk. However, the target genes and underlying mechanisms remain largely unknown. We conducted a cis-expression quantitative trait loci (cis-eQTL) analysis using normal or tumor breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project. We identified a total of 101 genes for 51 lead variants after combing the results of a meta-analysis of METABRIC and TCGA, and the results from GTEx at a Benjamini-Hochberg (BH)-adjusted p < 0.05. Using luciferase reporter assays in both estrogen-receptor positive (ER+) and negative (ER-) cell lines, we showed that alternative alleles of potential functional single-nucleotide polymorphisms (SNPs), rs11552449 (DCLREIB), rs7257932 (SSBP4), rs3747479 (MRPS30), rs2236007 (PAX9), and rs73134739 (ATG10), could significantly change promoter activities of their target genes compared to reference alleles. Furthermore, we performed in vitro assays in breast cancer cell lines, and our results indicated that DCLREIB, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors. Our findings revealed potential target genes for associations of genetic susceptibility risk loci and provided underlying mechanisms for a better understanding of the pathogenesis of breast cancer.	[Guo, Xingyi; Bao, Jiandong; Cai, Qiuyin; Shi, Jiajun; Sun, Yaqiong; Han, Mi-Ryung; Wen, Wanqing; Long, Jirong; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37203 USA; [Guo, Xingyi; Bao, Jiandong; Cai, Qiuyin; Shi, Jiajun; Sun, Yaqiong; Han, Mi-Ryung; Wen, Wanqing; Long, Jirong; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Lin, Weiqiang; Pan, Xiao; Bai, Mengqiu; Yuan, Yuan; Chen, Jianghua] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310029, Zhejiang, Peoples R China; [Lin, Weiqiang; Pan, Xiao; Bai, Mengqiu; Yuan, Yuan] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China; [Bao, Jiandong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Wang, Jing; Liu, Qi] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37232 USA; [Li, Bingshan] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Zhejiang University; Zhejiang University; Fujian Agriculture & Forestry University; Vanderbilt University; Vanderbilt University	Guo, XY (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37203 USA.; Guo, XY (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA.	xingyi.guo@vanderbilt.edu	Bao, Jiandong/AAG-7303-2020; Zheng, Wei/GQQ-8951-2022	Bao, Jiandong/0000-0003-3423-5118; Lin, Weiqiang/0000-0002-2171-8009; Wang, Jing/0000-0003-2775-9001; Long, Jirong/0000-0002-7433-9766; SHI, JIAJUN/0000-0001-5194-0009	Vanderbilt University Medical Center; Vanderbilt-Ingram Cancer Center [P30 CA068485]; US National Institutes of Health [R01 CA148667]; National Natural Science Foundation of China [31470776]; NATIONAL CANCER INSTITUTE [R01CA148667, P30CA068485] Funding Source: NIH RePORTER	Vanderbilt University Medical Center; Vanderbilt-Ingram Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by research development funds from Vanderbilt University Medical Center, the US National Institutes of Health grant R01 CA148667, and the grant from the National Natural Science Foundation of China (31470776). The sample preparation and ASE assays were performed at the Survey and Biospecimen Shared Resource, which was supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA068485). We thank the METABRIC, TCGA, GTEx, ENCODE, and Roadmap for providing valuable data resources for the research. We also thank Regina Courtney and Jie Wu for laboratory assistance, and Kim Kreth and Marshal Younger for assistance with editing and manuscript preparation. The data analyses were conducted using the Advanced Computing Center for Research and Education (ACCRE) at Vanderbilt University.	Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barutcu AR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0768-0; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Darabi H, 2015, AM J HUM GENET, V97, P22, DOI 10.1016/j.ajhg.2015.05.002; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Gao YT, 2000, INT J CANCER, V87, P295, DOI 10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7; Ghoussaini M, 2016, AM J HUM GENET, V99, P903, DOI 10.1016/j.ajhg.2016.07.017; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Guo XY, 2015, CANCER EPIDEM BIOMAR, V24, P1680, DOI 10.1158/1055-9965.EPI-15-0363; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hamdi Y, 2016, ONCOTARGET, V7, P80140, DOI 10.18632/oncotarget.12818; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Lin WY, 2015, HUM MOL GENET, V24, P285, DOI 10.1093/hmg/ddu431; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2017, NAT GENET, V49, P1767, DOI 10.1038/ng.3785; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Pierce BL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004818; Purrington KS, 2014, CARCINOGENESIS, V35, P1012, DOI 10.1093/carcin/bgt404; Quigley DA, 2014, MOL ONCOL, V8, P273, DOI 10.1016/j.molonc.2013.11.008; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014; Shi JJ, 2016, INT J CANCER, V139, P1303, DOI 10.1002/ijc.30150; Shi JJ, 2013, CANCER EPIDEM BIOMAR, V22, P1297, DOI 10.1158/1055-9965.EPI-12-1393; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Sun YQ, 2016, CARCINOGENESIS, V37, P163, DOI 10.1093/carcin/bgv170; Teng L, 2015, BIOINFORMATICS, V31, P2560, DOI 10.1093/bioinformatics/btv158; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Zeng C, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0718-0; Zhu XG, 2009, MOL ENDOCRINOL, V23, P1397, DOI 10.1210/me.2009-0071	60	42	42	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					890	903		10.1016/j.ajhg.2018.03.016	http://dx.doi.org/10.1016/j.ajhg.2018.03.016			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727689	Green Published, Bronze			2022-12-18	WOS:000432440100013
J	Olahova, M; Yoon, WH; Thompson, K; Jangam, S; Fernandez, L; Davidson, JM; Kyle, JE; Grove, ME; Fisk, DG; Kohler, JN; Holmes, M; Dries, AM; Huang, Y; Zhao, CL; Contrepois, K; Zappala, Z; Fresard, L; Waggott, D; Zink, EM; Kim, YM; Heyman, HM; Stratton, KG; Webb-Robertson, BJM; Snyder, M; Merker, JD; Montgomery, SB; Fisher, PG; Feichtinger, RG; Mayr, JA; Hall, J; Barbosa, IA; Simpson, MA; Deshpande, C; Waters, KM; Koeller, DM; Metz, TO; Morris, AA; Schelley, S; Cowan, T; Friederich, MW; McFarland, R; Van Hove, JLK; Enns, GM; Yamamoto, S; Ashley, EA; Wangler, MF; Taylor, RW; Bellen, HJ; Bernstein, JA; Wheeler, MT				Olahova, Monika; Yoon, Wan Hee; Thompson, Kyle; Jangam, Sharayu; Fernandez, Liliana; Davidson, Jean M.; Kyle, Jennifer E.; Grove, Megan E.; Fisk, Dianna G.; Kohler, Jennefer N.; Holmes, Matthew; Dries, Annika M.; Huang, Yong; Zhao, Chunli; Contrepois, Kevin; Zappala, Zachary; Fresard, Laure; Waggott, Daryl; Zink, Erika M.; Kim, Young-Mo; Heyman, Heino M.; Stratton, Kelly G.; Webb-Robertson, Bobbie-Jo M.; Snyder, Michael; Merker, Jason D.; Montgomery, Stephen B.; Fisher, Paul G.; Feichtinger, Rene G.; Mayr, Johannes A.; Hall, Julie; Barbosa, Ines A.; Simpson, Michael A.; Deshpande, Charu; Waters, Katrina M.; Koeller, David M.; Metz, Thomas O.; Morris, Andrew A.; Schelley, Susan; Cowan, Tina; Friederich, Marisa W.; McFarland, Robert; Van Hove, Johan L. K.; Enns, Gregory M.; Yamamoto, Shinya; Ashley, Euan A.; Wangler, Michael F.; Taylor, Robert W.; Bellen, Hugo J.; Bernstein, Jonathan A.; Wheeler, Matthew T.		Undiagnosed Diseases Network	Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX-V DEFICIENCY; MITOCHONDRIAL DISEASE; GENETIC-DEFECTS; ONSET; CARDIOMYOPATHY; EXPRESSION; DIAGNOSIS; PATIENT	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit (ATP5F1D; formerly ATP5D) is a subunit of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2, homozygous for c.317T>G (p.Val106Gly), presented with acute encephalopathy in childhood. Cultured skin fibroblasts from these individuals exhibited impaired assembly of F1FO ATP synthase and subsequent reduced complex Vactivity. Cells from subject 1 also exhibited a significant decrease in mitochondrial cristae. Knockdown of Drosophila ATPsyn delta, the ATP5F1D homolog, in developing eyes and brains caused a near complete loss of the fly head, a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants rescued the head-size phenotype but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our data establish c. 245C>T (p.Pro82Leu) and c. 317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants leading to a Mendelian mitochondrial disease featuring episodic metabolic decompensation.	[Olahova, Monika; Thompson, Kyle; Holmes, Matthew; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Yoon, Wan Hee; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Yoon, Wan Hee; Jangam, Sharayu; Yamamoto, Shinya; Wangler, Michael F.; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Fernandez, Liliana; Davidson, Jean M.; Kohler, Jennefer N.; Dries, Annika M.; Huang, Yong; Zhao, Chunli; Waggott, Daryl; Fisher, Paul G.; Ashley, Euan A.; Bernstein, Jonathan A.; Wheeler, Matthew T.] Stanford Univ, Ctr Undiagnosed Dis, Stanford, CA 94305 USA; [Kyle, Jennifer E.; Zink, Erika M.; Kim, Young-Mo; Heyman, Heino M.; Waters, Katrina M.; Metz, Thomas O.] Pacific Northwest Natl Lab, Div Biol Sci, Earth & Biol Sci Directorate, Richland, WA 99352 USA; [Grove, Megan E.; Fisk, Dianna G.; Merker, Jason D.; Ashley, Euan A.] Stanford Hlth Care, Clin Genom Program, Stanford, CA USA; [Contrepois, Kevin; Zappala, Zachary; Snyder, Michael; Montgomery, Stephen B.; Ashley, Euan A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Fresard, Laure; Merker, Jason D.; Montgomery, Stephen B.; Cowan, Tina] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Stratton, Kelly G.; Webb-Robertson, Bobbie-Jo M.] Pacific Northwest Natl Lab, Comp & Analyt Div, Natl Secur Directorate, Richland, WA 99352 USA; [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria; [Hall, Julie] Royal Victoria Infirm, Dept Neuroradiol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Barbosa, Ines A.; Simpson, Michael A.] Kings Coll London, Sch Basic & Med Biosci, Dept Med & Mol Genet, London SE1 9RT, England; [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Clin Genet Unit, London SE1 9RT, England; [Koeller, David M.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Morris, Andrew A.] Univ Manchester, Inst Human Dev, Manchester M13 9PL, Lancs, England; [Morris, Andrew A.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Willink Metab Unit, Genom Med, Manchester M13 9WL, Lancs, England; [Schelley, Susan; Enns, Gregory M.; Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Friederich, Marisa W.; Van Hove, Johan L. K.] Univ Colorado Denver, Dept Pediat, Clin Genet & Metab, Aurora, CO 80045 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Yamamoto, Shinya; Wangler, Michael F.; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Duncan Neurol Res Inst, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ashley, Euan A.; Wheeler, Matthew T.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Yoon, Wan Hee] Oklahoma Med Res Fdn, Funct & Chem Genom Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	Newcastle University - UK; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Stanford University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Paracelsus Private Medical University; Newcastle University - UK; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Oregon Health & Science University; University of Manchester; University of Manchester; Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Stanford University; Oklahoma Medical Research Foundation	Wheeler, MT (corresponding author), Stanford Univ, Ctr Undiagnosed Dis, Stanford, CA 94305 USA.; Wheeler, MT (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	wheelerm@stanford.edu	Kim, Young-Mo/AAG-2866-2019; Gourdine, Jean-Philippe/P-4323-2018; Kim, Young-Mo/D-3282-2009; Heyman, Heino Martin/I-1670-2014; Yamamoto, Shinya/ABB-2837-2021; Wangler, Michael/H-6368-2019; Webb-Robertson, Bobbie-Jo/K-8230-2019; Jangam, Sharayu/AFN-7393-2022; Simpson, Michael/F-4737-2011	Kim, Young-Mo/0000-0002-8972-7593; Gourdine, Jean-Philippe/0000-0001-9969-8610; Kim, Young-Mo/0000-0002-8972-7593; Heyman, Heino Martin/0000-0003-0941-2506; Yamamoto, Shinya/0000-0003-2172-8036; Wangler, Michael/0000-0001-5245-5910; Jangam, Sharayu/0000-0001-7389-0890; Sweetser, David/0000-0002-1621-3284; Stong, Nicholas/0000-0002-0678-637X; Wheeler, Matthew/0000-0001-8721-3022; Douine, Emilie/0000-0002-6048-2887; Simpson, Michael/0000-0002-8539-8753; Snyder, Michael/0000-0003-0784-7987; Fisher, Paul/0000-0002-1196-1590; Reuter, Chloe/0000-0002-0429-9922; Holm, Ingrid/0000-0003-4712-8821; Azamian, Mahshid/0000-0002-8543-8284; Behnam, Babak/0000-0002-1266-1602; Urv, Tiina/0000-0002-2040-4972; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397; McFarland, Robert/0000-0002-8833-2688; orange, jordan/0000-0001-7117-7725; Bellen, Hugo/0000-0001-5992-5989; Fresard, Laure/0000-0001-8154-6328; Brown, Donna/0000-0002-8805-7225; Haendel, Melissa/0000-0001-9114-8737; Zastrow, Diane/0000-0002-8506-6812; Yoon, Wan Hee/0000-0002-9459-3139; Macnamara, Ellen/0000-0002-9418-3287; Montgomery, Stephen/0000-0002-5200-3903; Grove, Megan/0000-0002-7972-0005; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Kohler, Jennefer/0000-0003-0830-3535	NIH Common Fund through the Office of Strategic Coordination; Office of the NIH Director [U01HG007708, U01HG007942, U01TR001395, U54NS093793]; NIH National Center for Advancing Translational Sciences [UL1TR001085]; NIH National Center for Research Resources [S10 RR026780]; NIH National Human Genome Research Institute [P50HG007735]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council Centre for Translational Research in Neuromuscular Disease; UK Mitochondrial Disease Patient Cohort [G0800674]; Lily Foundation; UK National Health Service Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; E-Rare project GENOMIT by the Austrian Science Fonds [I 2741-B26]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Department of Energy (DOE) Office of Biological and Environmental Research; DOE [DE-AC05-76RLO1830]; Wolfson intercalation bursary award from the UK Royal College of Physicians; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085, U01TR001395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026780] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007942, U01HG007708, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS093793] Funding Source: NIH RePORTER	NIH Common Fund through the Office of Strategic Coordination; Office of the NIH Director; NIH National Center for Advancing Translational Sciences; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Centre for Mitochondrial Research; Medical Research Council Centre for Translational Research in Neuromuscular Disease; UK Mitochondrial Disease Patient Cohort; Lily Foundation; UK National Health Service Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; E-Rare project GENOMIT by the Austrian Science Fonds; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Wolfson intercalation bursary award from the UK Royal College of Physicians; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Duraine, Z. Zuo, K. Schulze, A. Chang, and Y. He for technical support. Research reported in this manuscript was supported by the NIH Common Fund through the Office of Strategic Coordination and Office of the NIH Director (award numbers U01HG007708, U01HG007942, U01TR001395, and U54NS093793), the NIH National Center for Advancing Translational Sciences (UL1TR001085), the NIH National Center for Research Resources (S10 RR026780), the NIH National Human Genome Research Institute (P50HG007735), the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical Research Council Centre for Translational Research in Neuromuscular Disease, the UK Mitochondrial Disease Patient Cohort (G0800674), the Lily Foundation, the UK National Health Service Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, E-Rare project GENOMIT by the Austrian Science Fonds (I 2741-B26), and the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London. Portions of the metabolomics and lipidomics analyses were performed in the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy (DOE) Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory (PNNL). PNNL is operated by Battelle Memorial Institute for the DOE under contract DE-AC05-76RLO1830. M.H. was supported by a Wolfson intercalation bursary award from the UK Royal College of Physicians. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPALDI RA, 1994, NAT STRUCT BIOL, V1, P660, DOI 10.1038/nsb1094-660; Chennamsetty I, 2016, CELL REP, V17, P527, DOI 10.1016/j.celrep.2016.09.005; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Cohen MJ., 1997, CHILDRENS MEMORY SCA; Contrepois K, 2015, MOL CELL PROTEOMICS, V14, P1684, DOI 10.1074/mcp.M114.046508; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Hejzlarova K, 2014, PHYSIOL RES, V63, pS57, DOI 10.33549/physiolres.932643; Hejzlarova K, 2011, BBA-BIOENERGETICS, V1807, P144, DOI 10.1016/j.bbabio.2010.10.005; Hernandez-Corbacho MJ, 2017, BBA-MOL CELL BIOL L, V1862, P56, DOI 10.1016/j.bbalip.2016.09.019; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Honzik T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096; Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012; Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006; Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; JORDAN EM, 1992, BIOCHIM BIOPHYS ACTA, V1130, P123, DOI 10.1016/0167-4781(92)90477-H; Knupp J, 2017, CELL DEATH DIFFER, V24, P2044, DOI 10.1038/cdd.2017.128; Kogot-Levin A, 2014, BIOCHIMIE, V100, P88, DOI 10.1016/j.biochi.2013.07.027; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Meulemans A, 2010, J BIOL CHEM, V285, P4099, DOI 10.1074/jbc.M109.046920; Mkaouar-Rebai E, 2010, J CHILD NEUROL, V25, P770, DOI 10.1177/0883073809344351; Nagarkar-Jaiswal S, 2017, ELIFE, V6, DOI 10.7554/eLife.26420; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Olahova M, 2015, EUR J HUM GENET, V23, P935, DOI 10.1038/ejhg.2014.214; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Paumard P, 2002, BIOCHEMISTRY-US, V41, P10390, DOI 10.1021/bi025923g; Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y; Sarajlija A, 2017, CONGENIT ANOM, V57, P64, DOI 10.1111/cga.12194; Scaglia F, 2012, METHODS MOL BIOL, V837, P17, DOI 10.1007/978-1-61779-504-6_2; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Spincemaille P, 2014, BBA-GEN SUBJECTS, V1840, P3131, DOI 10.1016/j.bbagen.2014.06.015; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Teixeira FK, 2015, NAT CELL BIOL, V17, P689, DOI 10.1038/ncb3165; Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014; Wang J, 2017, AM J HUM GENET, V100, P843, DOI 10.1016/j.ajhg.2017.04.010; Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149; Wechsler D., 2002, WECHSLER PRESCHOOL P; Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	53	42	42	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					494	504		10.1016/j.ajhg.2018.01.020	http://dx.doi.org/10.1016/j.ajhg.2018.01.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29478781	hybrid, Green Published			2022-12-18	WOS:000426469600020
J	Drecourt, A; Babdor, J; Dussiot, M; Petit, F; Goudin, N; Garfa-Traore, M; Habarou, F; Bole-Feysot, C; Nitschke, P; Ottolenghi, C; Metodiev, MD; Serre, V; Desguerre, I; Boddaert, N; Hermine, O; Munnich, A; Rotig, A				Drecourt, Anthony; Babdor, Joel; Dussiot, Michael; Petit, Floriane; Goudin, Nicolas; Garfa-Traore, Meriem; Habarou, Florence; Bole-Feysot, Christine; Nitschke, Patrick; Ottolenghi, Chris; Metodiev, Metodi D.; Serre, Valerie; Desguerre, Isabelle; Boddaert, Nathalie; Hermine, Olivier; Munnich, Arnold; Rotig, Agnes			Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KINASE-ASSOCIATED NEURODEGENERATION; PROTEIN; INHIBITION; TRAFFICKING; ARTEMISININ; ENDOCYTOSIS; MECHANISMS; MORPHOLOGY; MUTATIONS; ACYLATION	Neurodegeneration with brain iron accumulation (NBIA) is a genetically heterogeneous condition characterized by progressive dystonia with iron accumulation in the basal ganglia. How NBIA-associated mutations trigger iron overload remains poorly understood. After studying fibroblast cell lines from subjects carrying both known and unreported biallelic mutations in CRAT and REPS1, we ascribe iron overload to the abnormal recycling of transferrin receptor (TfR1) and the reduction of TfR1 palmitoylation in NBIA. Moreover, we describe palmitoylation as a hitherto unreported level of post-translational TfR1 regulation. A widely used antimalarial agent, artesunate, rescued abnormal TfR1 palmitoylation in cultured fibroblasts of NBIA subjects. These observations suggest therapeutic strategies aimed at targeting impaired TfR1 recycling and palmitoylation in NBIA.	[Drecourt, Anthony; Babdor, Joel; Dussiot, Michael; Petit, Floriane; Goudin, Nicolas; Garfa-Traore, Meriem; Habarou, Florence; Bole-Feysot, Christine; Nitschke, Patrick; Ottolenghi, Chris; Metodiev, Metodi D.; Boddaert, Nathalie; Hermine, Olivier; Munnich, Arnold; Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite, Inst IMAGINE, UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France; [Drecourt, Anthony; Babdor, Joel; Dussiot, Michael; Hermine, Olivier; Rotig, Agnes] Inst IMAGINE, Lab Excellence GR Ex, 24 Blvd Montparnasse, F-75015 Paris, France; [Goudin, Nicolas; Garfa-Traore, Meriem] CNRS, INSERM, Plateau Tech Cytometrie & Imagerie Cellulaires, US 24,UMS 3633,Struct Federat Rech Necker, 24 Blvd Montparnasse, F-75015 Paris, France; [Habarou, Florence; Ottolenghi, Chris] Hop Necker Enfants Malad, Biochim Metabol & Prote, 149 Rue Sevres, F-75015 Paris, France; [Serre, Valerie] Univ Paris Diderot, UMR 7592, 15 Rue Helene, F-75013 Paris, France; [Serre, Valerie] CNRS, Inst Jacques Monod, 15 Rue Helene, F-75013 Paris, France; [Desguerre, Isabelle; Boddaert, Nathalie; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, 149 Rue Sevres, F-75015 Paris, France; [Desguerre, Isabelle; Boddaert, Nathalie; Munnich, Arnold] Hop Necker Enfants Malad, Dept Radiol, 149 Rue Sevres, F-75015 Paris, France; [Desguerre, Isabelle; Boddaert, Nathalie; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, 149 Rue Sevres, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Rotig, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst IMAGINE, UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France.; Rotig, A (corresponding author), Inst IMAGINE, Lab Excellence GR Ex, 24 Blvd Montparnasse, F-75015 Paris, France.	agnes.rotig@inserm.fr	Hermine, Olivier/Q-7072-2018; Metodiev, Metodi/C-4780-2015; Ottolenghi, Chris/H-3745-2017; boddaert, nathalie/GWV-2865-2022; ROTIG, AGNES/G-9592-2017	Metodiev, Metodi/0000-0002-9596-2434; Ottolenghi, Chris/0000-0002-0734-344X; GARFA TRAORE, Meriem/0000-0001-8597-6472; ROTIG, AGNES/0000-0003-0589-0703; Serre, Valerie/0000-0001-5277-1120	E-Rare project GENOMIT [01GM1207]; Agence Nationale de la Recherche [ANR-10-IAHU-01]; GIS-Institut des Maladies Rares; Imagine Foundation; ARC foundation; GR-Ex LabEx; ApoPharma	E-Rare project GENOMIT; Agence Nationale de la Recherche(French National Research Agency (ANR)); GIS-Institut des Maladies Rares; Imagine Foundation; ARC foundation(Australian Research Council); GR-Ex LabEx; ApoPharma	This work was partially funded through the E-Rare project GENOMIT (01GM1207) and the Agence Nationale de la Recherche (ANR-10-IAHU-01). Whole-exome sequencing was funded by the GIS-Institut des Maladies Rares. Imaging and Amnis studies were performed at the Cell Imaging Platform and Cell Sorting Facility of the Imagine Institute and funded by the Imagine Foundation, ARC foundation, and GR-Ex LabEx. A. D. was supported by a fellowship from ApoPharma. We thank Olivier Pelle (Flow Cytometry Facility at INSERM UMR 1163) for assisting with cell sorting; Martial Saumier (BioRAD) for digital droplet PCR technical advice and support; Genevieve Courtois (Imagine Institute) for L3 maintenance, virus production, teaching, and advice; Sylvain Hanein (Imagine Institute) for assisting with confocal microscopy; Leona Enke for REPS1 Sanger sequencing; and Yanick Crow for helping with editing the manuscript. We acknowledge the use of bioresources of the Necker Imagine DNA biobank (BB-033-00065).	ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Ba Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042703; Barbeito AG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-50; Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022; Boissel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033193; Byrne SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070199; Campanella A, 2012, HUM MOL GENET, V21, P4049, DOI 10.1093/hmg/dds229; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chavda B, 2014, EXPERT OPIN DRUG DIS, V9, P1005, DOI 10.1517/17460441.2014.933802; Cullis DN, 2002, J BIOL CHEM, V277, P49158, DOI 10.1074/jbc.M206316200; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; Doody AM, 2009, BIOCHEM BIOPH RES CO, V388, P695, DOI 10.1016/j.bbrc.2009.08.067; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Efferth T, 2010, CRIT REV TOXICOL, V40, P405, DOI 10.3109/10408441003610571; Hanein S, 2013, BBA-GEN SUBJECTS, V1830, P3719, DOI 10.1016/j.bbagen.2013.02.025; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jaberi E., 2016, NEUROBIOL AGING, V38, pe18, DOI [10.1016/I.neurobiolaging.2015.10.034, DOI 10.1016/I.NEUR0BI0LAGING.2015.10.03]; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Krieger JR, 2013, MOL CELL PROTEOMICS, V12, P499, DOI 10.1074/mcp.M112.020768; Lai HC, 2013, INVEST NEW DRUG, V31, P230, DOI 10.1007/s10637-012-9873-z; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Leoni V, 2012, MOL GENET METAB, V105, P463, DOI 10.1016/j.ymgme.2011.12.005; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Meyer E, 2015, ANNU REV GENOM HUM G, V16, P257, DOI 10.1146/annurev-genom-090314-025011; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; Mutterer J, 2013, J MICROSC-OXFORD, V252, P89, DOI 10.1111/jmi.12069; Poli M, 2010, NEUROBIOL DIS, V39, P204, DOI 10.1016/j.nbd.2010.04.009; Schmidt JA, 2010, TRAFFIC, V11, P1530, DOI 10.1111/j.1600-0854.2010.01115.x; Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Song HW, 2010, AM J PHYSIOL-ENDOC M, V298, pE1097, DOI 10.1152/ajpendo.00780.2009; Xu J, 2001, BBA-GENE STRUCT EXPR, V1522, P118, DOI 10.1016/S0167-4781(01)00310-4; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Zaliauskiene L, 2000, MOL BIOL CELL, V11, P2643, DOI 10.1091/mbc.11.8.2643; Zaliauskiene L, 2002, IMMUNOL RES, V26, P77, DOI 10.1385/IR:26:1-3:077	38	42	49	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 1	2018	102	2					266	277		10.1016/j.ajhg.2018.01.003	http://dx.doi.org/10.1016/j.ajhg.2018.01.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV2OL	29395073	Green Published, Bronze			2022-12-18	WOS:000424407600006
J	Guidugli, L; Shimelis, H; Masica, DL; Pankratz, VS; Lipton, GB; Singh, N; Hu, CL; Monteiro, ANA; Lindor, NM; Goldgar, DE; Karchin, R; Iversen, ES; Couch, FJ				Guidugli, Lucia; Shimelis, Hermela; Masica, David L.; Pankratz, Vernon S.; Lipton, Gary B.; Singh, Namit; Hu, Chunling; Monteiro, Alvaro N. A.; Lindor, Noralane M.; Goldgar, David E.; Karchin, Rachel; Iversen, Edwin S.; Couch, Fergus J.			Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER-RISK ASSESSMENT; SEQUENCE VARIANTS; UNCERTAIN SIGNIFICANCE; POLY(ADP-RIBOSE) POLYMERASE; BREAST-CANCER; CLASSIFICATION; SUBSTITUTIONS; GUIDELINES; MUTATION; INHIBITION	Many variants of uncertain significance (VUS) have been identified in BRCA2 through clinical genetic testing. VUS pose a significant clinical challenge because the contribution of these variants to cancer risk has not been determined. We conducted a comprehensive assessment of VUS in the BRCA2 C-terminal DNA binding domain (DBD) by using a validated functional assay of BRCA2 homologous recombination (HR) DNA-repair activity and defined a classifier of variant pathogenicity. Among 139 variants evaluated, 54 had >= 99% probability of pathogenicity, and 73 had >= 95% probability of neutrality. Functional assay results were compared with predictions of variant pathogenicity from the Align-GVGD protein-sequence-based prediction algorithm, which has been used for variant classification. Relative to the HR assay, Align-GVGD significantly (p < 0.05) over-predicted pathogenic variants. We subsequently combined functional and Align-GVGD prediction results in a Bayesian hierarchical model (VarCall) to estimate the overall probability of pathogenicity for each VUS. In addition, to predict the effects of all other BRCA2 DBD variants and to prioritize variants for functional studies, we used the endoPhenotype-Optimized Sequence Ensemble (ePOSE) algorithm to train classifiers for BRCA2 variants by using data from the HR functional assay. Together, the results show that systematic functional assays in combination with in silico predictors of pathogenicity provide robust tools for clinical annotation of BRCA2 VUS.	[Guidugli, Lucia; Shimelis, Hermela; Hu, Chunling; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Masica, David L.; Karchin, Rachel] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Masica, David L.; Karchin, Rachel] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21205 USA; [Pankratz, Vernon S.] Univ New Mexico, Div Nephrol, Albuquerque, NM 87131 USA; [Lipton, Gary B.; Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA; [Singh, Namit] Univ Calif San Diego, Dept Struct Biol, San Diego, CA 92093 USA; [Monteiro, Alvaro N. A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ 85259 USA; [Goldgar, David E.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Goldgar, David E.] Univ Utah, Dept Dermatol, Salt Lake City, UT 84132 USA; [Karchin, Rachel] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21218 USA	Mayo Clinic; Johns Hopkins University; Johns Hopkins University; University of New Mexico; Duke University; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Johns Hopkins University	Couch, FJ (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	couch.fergus@mayo.edu	Karchin, Rachel/AFO-2592-2022; Monteiro, Alvaro N. A./A-7566-2009	Monteiro, Alvaro N. A./0000-0002-8448-4801; Hu, Chunling/0000-0002-6814-4639; Karchin, Rachel/0000-0002-5069-1239	National Cancer Institute Specialized Program of Research Excellence (SPORE) in breast cancer at the Mayo Clinic [P50 CA116201]; NIH [CA116167, CA192393]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U01CA116167, R01CA192393, P50CA116201, R01CA116167] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence (SPORE) in breast cancer at the Mayo Clinic; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by a National Cancer Institute Specialized Program of Research Excellence (SPORE) in breast cancer at the Mayo Clinic (P50 CA116201), NIH grants CA116167 and CA192393, and the Breast Cancer Research Foundation.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Biswas K, 2012, HUM MOL GENET, V21, P3993, DOI 10.1093/hmg/dds222; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Farrugia DJ, 2008, CANCER RES, V68, P3523, DOI 10.1158/0008-5472.CAN-07-1587; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Houdayer C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/humu.22101; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Kuznetsov SG, 2010, METHODS MOL BIOL, V653, P259, DOI 10.1007/978-1-60761-759-4_16; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lovelock PK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1826; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Masica DL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004725; Masica DL, 2015, HUM MOL GENET, V24, P1908, DOI 10.1093/hmg/ddu607; Masica DL, 2012, HUM MUTAT, V33, P1267, DOI 10.1002/humu.22110; Mclachlan GJ., 2005, DISCRIMINANT ANAL ST; Mondal G, 2012, DEV CELL, V23, P137, DOI 10.1016/j.devcel.2012.05.008; Monteiro ANA, 2006, CANCER RES, V66, P1897, DOI 10.1158/0008-5472.CAN-05-3034; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sandhu SK, 2013, LANCET ONCOL, V14, P882, DOI 10.1016/S1470-2045(13)70240-7; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shimelis H, 2017, CANCER RES, V77, P2789, DOI 10.1158/0008-5472.CAN-16-2568; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Walker LC, 2010, HUM MUTAT, V31, pE1484, DOI 10.1002/humu.21267; Wu KJ, 2005, CANCER RES, V65, P417	38	42	42	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 1	2018	102	2					233	248		10.1016/j.ajhg.2017.12.013	http://dx.doi.org/10.1016/j.ajhg.2017.12.013			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV2OL	29394989	Bronze, Green Published			2022-12-18	WOS:000424407600004
J	Ehmke, N; Graul-Neumann, L; Smorag, L; Koenig, R; Segebrecht, L; Magoulas, P; Scaglia, F; Kilic, E; Hennig, AF; Adolphs, N; Saha, N; Fauler, B; Kalscheuer, VM; Hennig, F; Altmuller, J; Netzer, C; Thiele, H; Nurnberg, P; Yigit, G; Jager, M; Hecht, J; Kruger, U; Mielke, T; Krawitz, PM; Horn, D; Schuelke, M; Mundlos, S; Bacino, CA; Bonnen, PE; Wollnik, B; Fischer-Zirnsak, B; Kornak, U				Ehmke, Nadja; Graul-Neumann, Luitgard; Smorag, Lukasz; Koenig, Rainer; Segebrecht, Lara; Magoulas, Pilar; Scaglia, Fernando; Kilic, Esra; Hennig, Anna F.; Adolphs, Nicolai; Saha, Namrata; Fauler, Beatrix; Kalscheuer, Vera M.; Hennig, Friederike; Altmueller, Janine; Netzer, Christian; Thiele, Holger; Nuernberg, Peter; Yigit, Goekhan; Jaeger, Marten; Hecht, Jochen; Krueger, Ulrike; Mielke, Thorsten; Krawitz, Peter M.; Horn, Denise; Schuelke, Markus; Mundlos, Stefan; Bacino, Carlos A.; Bonnen, Penelope E.; Wollnik, Bernd; Fischer-Zirnsak, Bjoern; Kornak, Uwe			De Novo Mutations in SLC25A24 Cause a Craniosynostosis Syndrome with Hypertrichosis, Progeroid Appearance, and Mitochondrial Dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GORLIN-CHAUDHRY-MOSS; CA-2&-INDUCED MEMBRANE TRANSITION; PERMEABILITY TRANSITION; CRANIOFACIAL DYSOSTOSIS; TRANSCRIPTION FACTOR; TWIST; GENE; ROLES; HYPOPLASIA; FRAMEWORK	Gorlin-Chaudhry-Moss syndrome (GCMS) is a dysmorphic syndrome characterized by coronal craniosynostosis and severe midface hypoplasia, body and facial hypertrichosis, microphthalmia, short stature, and short distal phalanges. Variable lipoatrophy and cutis laxa are the basis for a progeroid appearance. Using exome and genome sequencing, we identified the recurrent de novo mutations c. 650G>A (p.Arg217His) and c. 649C>T (p.Arg217Cys) in SLC25A24 in five unrelated girls diagnosed with GCMS. Two of the girls had pronounced neonatal progeroid features and were initially diagnosed with Wiedemann-Rautenstrauch syndrome. SLC25A24 encodes a mitochondrial inner membrane ATP-Mg/Pi carrier. In fibroblasts from affected individuals, the mutated SLC25A24 showed normal stability. In contrast to control cells, the probands' cells showed mitochondrial swelling, which was exacerbated upon treatment with hydrogen peroxide (H2O2). The same effect was observed after overexpression of the mutant cDNA. Under normal culture conditions, the mitochondrial membrane potential of the probands' fibroblasts was intact, whereas ATP content in the mitochondrial matrix was lower than that in control cells. However, upon H2O2 exposure, the membrane potential was significantly elevated in cells harboring the mutated SLC25A24. No reduction of mitochondrial DNA copy number was observed. These findings demonstrate that mitochondrial dysfunction with increased sensitivity to oxidative stress is due to the SLC25A24 mutations. Our results suggest that the SLC25A24 mutations induce a gain of pathological function and link mitochondrial ATP-Mg/P-i transport to the development of skeletal and connective tissue.	[Ehmke, Nadja; Graul-Neumann, Luitgard; Segebrecht, Lara; Krawitz, Peter M.; Horn, Denise; Mundlos, Stefan; Fischer-Zirnsak, Bjoern; Kornak, Uwe] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Ehmke, Nadja] Berlin Inst Hlth, D-10117 Berlin, Germany; [Ehmke, Nadja; Saha, Namrata; Kalscheuer, Vera M.; Hennig, Friederike; Krawitz, Peter M.; Mundlos, Stefan; Fischer-Zirnsak, Bjoern; Kornak, Uwe] Max Planck Inst Mol Genet, Dev & Dis Grp, D-14195 Berlin, Germany; [Smorag, Lukasz; Yigit, Goekhan; Wollnik, Bernd] Univ Med Gottingen, Inst Humangenet, D-37073 Gottingen, Germany; [Koenig, Rainer] Goethe Univ Frankfurt, Inst Human Genet, D-60590 Frankfurt, Germany; [Magoulas, Pilar; Scaglia, Fernando; Bacino, Carlos A.; Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Magoulas, Pilar; Scaglia, Fernando; Bacino, Carlos A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Kilic, Esra] Pediat Hematol Oncol Res & Training Hosp, Pediat Genet, TR-06110 Ankara, Turkey; [Hennig, Anna F.; Mundlos, Stefan; Kornak, Uwe] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Adolphs, Nicolai] Charite, Dept Craniomaxillofacial Surg, D-13353 Berlin, Germany; [Saha, Namrata] Charite, Berlin Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany; [Saha, Namrata] Max Planck Int Res Network Aging, D-18057 Rostock, Germany; [Fauler, Beatrix; Mielke, Thorsten] Max Planck Inst Mol Genet, Microscopy & Cryoelectron Microscopy Grp, D-14195 Berlin, Germany; [Altmueller, Janine; Thiele, Holger; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Netzer, Christian] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Jaeger, Marten; Krueger, Ulrike] Campus Virchow Klinikum, Berlin Inst Hlth, Genom Core Facil, D-13353 Berlin, Germany; [Hecht, Jochen] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Dr Aiguader 88, Barcelona 08003, Spain; [Hecht, Jochen] Univ Pompeu Fabra, Barcelona 08002, Spain; [Schuelke, Markus] Charite, Dept Neuropediatr, D-10117 Berlin, Germany; [Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Max Planck Society; University of Gottingen; Goethe University Frankfurt; Baylor College of Medicine; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ehmke, N; Kornak, U (corresponding author), Charite, Inst Med & Human Genet, D-13353 Berlin, Germany.; Ehmke, N (corresponding author), Berlin Inst Hlth, D-10117 Berlin, Germany.; Ehmke, N; Kornak, U (corresponding author), Max Planck Inst Mol Genet, Dev & Dis Grp, D-14195 Berlin, Germany.; Kornak, U (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.	nadja.ehmke@charite.de; uwe.kornak@charite.de	Wollnik, Bernd/GRY-6062-2022; Kılıç, Esra/AFR-3024-2022; Mundlos, Stefan/ABH-9585-2020; Fischer-Zirnsak, Björn/D-7487-2013; Ehmke, Nadja/F-3341-2019; Thiele, Holger/ABE-6792-2020; Krawitz, Peter/F-3142-2012	Wollnik, Bernd/0000-0003-2589-0364; Kılıç, Esra/0000-0003-0522-1809; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Thiele, Holger/0000-0002-0169-998X; Segebrecht, Lara/0000-0002-0939-3213; Mundlos, Stefan/0000-0002-9788-3166; Kalscheuer, Vera/0000-0001-6898-3259; Krawitz, Peter/0000-0002-3194-8625; Jager, Marten/0000-0002-1774-7085; Hennig, Anna Floriane/0000-0002-3942-3209; Schuelke, Markus/0000-0003-2824-3891; Altmuller, Janine/0000-0003-4372-1521	Charite - Universitatsmedizin Berlin; Berlin Institute of Health; Deutsche Forschungsgemeinschaft (DFG); Max Planck Foundation; DFG [SFB1002, FI 2240/1-1]; FP7-EU grant agreement [602300]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS08372]; DFG Research Unit FOR 2165 [249509554]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083726] Funding Source: NIH RePORTER	Charite - Universitatsmedizin Berlin; Berlin Institute of Health; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Foundation(Foundation CELLEX); DFG(German Research Foundation (DFG)); FP7-EU grant agreement; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DFG Research Unit FOR 2165(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the families for their collaboration and contribution to this project. We thank Gabriele Hildebrand, Susanne Rothe, Catrin Janetzki, Esther Gill, and Gundula Leschik for excellent technical assistance. We thank Tori Pantel for helping with the design of figure layout and Dr. Peter N. Robinson for proof-reading. We want to thank Peter Meinecke for valuable advice. The plasmid containing the SLC25A24 open reading frame was obtained from the DNASU Plasmid Repository (HsCD00296732). N.E. is a participant in the Berlin Institute of Health Charite Clinician Scientist Program, funded by the Charite - Universitatsmedizin Berlin and the Berlin Institute of Health. S.M. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Max Planck Foundation, B.W. was supported by grants from the DFG SFB1002 project D02, and B.F.-Z. was supported by a grant from the DFG (FI 2240/1-1). U.K. received funding from FP7-EU grant agreement no. 602300 (SYBIL) and the DFG Research Unit FOR 2165 (249509554). Research reported in this publication was supported by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS08372 to P.E.B.	Adolphs N, 2011, J CRANIO MAXILL SURG, V39, P554, DOI 10.1016/j.jcms.2010.11.016; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; Aravena T, 2011, AM J MED GENET A, V155A, P2552, DOI 10.1002/ajmg.a.34204; Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Castori M, 2009, AM J MED GENET A, V149A, P2193, DOI 10.1002/ajmg.a.32763; Cohen M M Jr, 1975, Birth Defects Orig Artic Ser, V11, P137; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; ElGhouzzi V, 1997, NAT GENET, V15, P42; Fischer-Zirnsak B, 2015, AM J HUM GENET, V97, P483, DOI 10.1016/j.ajhg.2015.08.001; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; GORLIN RJ, 1960, J PEDIATR-US, V56, P778, DOI 10.1016/S0022-3476(60)80315-0; Harborne SPD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45383; Hartmann B, 2016, ELIFE, V5, DOI 10.7554/eLife.16078; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Heinrich V, 2017, BIOINFORMATICS, V33, P72, DOI 10.1093/bioinformatics/btw550; Heinrich V, 2013, GENOME MED, V5, DOI 10.1186/gm473; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Hussain MS, 2014, AM J HUM GENET, V95, P622, DOI 10.1016/j.ajhg.2014.10.008; IPPEL PF, 1992, AM J MED GENET, V44, P518, DOI 10.1002/ajmg.1320440428; Jager M, 2014, HUM MUTAT, V35, P548, DOI 10.1002/humu.22531; Kamphans T, 2012, BIOINFORMATICS, V28, P2515, DOI 10.1093/bioinformatics/bts462; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Marchegiani S, 2015, AM J HUM GENET, V97, P99, DOI 10.1016/j.ajhg.2015.05.017; Menges S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42942; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; PREIS S, 1995, CLIN GENET, V47, P267; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Rosti RO, 2013, AM J MED GENET A, V161A, P1737, DOI 10.1002/ajmg.a.35954; Run CQ, 2015, STRUCTURE, V23, P1394, DOI 10.1016/j.str.2015.06.004; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Stiles AR, 2015, MOL GENET METAB, V115, P161, DOI 10.1016/j.ymgme.2015.05.008; Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; Urano T, 2015, J CLIN ENDOCR METAB, V100, pE655, DOI 10.1210/jc.2014-2829; Writzl K, 2017, AM J HUM GENET, V101, P844, DOI 10.1016/j.ajhg.2017.09.017; Yang Q, 2014, STRUCTURE, V22, P209, DOI 10.1016/j.str.2013.10.018	54	42	42	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					833	843		10.1016/j.ajhg.2017.09.016	http://dx.doi.org/10.1016/j.ajhg.2017.09.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100093	Green Published, Bronze			2022-12-18	WOS:000414251600014
J	Sanna-Cherchi, S; Khan, K; Westland, R; Krithivasan, P; Fievet, L; Rasouly, HM; Ionita-Laza, I; Capone, VP; Fasel, DA; Kiryluk, K; Kamalakaran, S; Bodria, M; Otto, EA; Sampson, MG; Gillies, CE; Vega-Warner, V; Vukojevic, K; Pediaditakis, I; Makar, GS; Mitrotti, A; Verbitsky, M; Martino, J; Liu, QX; Na, YJ; Goj, V; Ardissino, G; Gigante, M; Gesualdo, L; Janezcko, M; Zaniew, M; Mendelsohn, CL; Shril, S; Hildebrandt, F; van Wijk, JAE; Arapovic, A; Saraga, M; Allegri, L; Izzi, C; Scolari, F; Tasic, V; Ghiggeri, GM; Latos-Bielenska, A; Kiryluk, AM; Mane, S; Goldstein, DB; Lifton, RP; Katsanis, N; Davis, EE; Gharavi, AG				Sanna-Cherchi, Simone; Khan, Kamal; Westland, Rik; Krithivasan, Priya; Fievet, Lorraine; Rasouly, Hila Milo; Ionita-Laza, Iuliana; Capone, Valentina P.; Fasel, David A.; Kiryluk, Krzysztof; Kamalakaran, Sitharthan; Bodria, Monica; Otto, Edgar A.; Sampson, Matthew G.; Gillies, Christopher E.; Vega-Warner, Virginia; Vukojevic, Katarina; Pediaditakis, Igor; Makar, Gabriel S.; Mitrotti, Adele; Verbitsky, Miguel; Martino, Jeremiah; Liu, Qingxue; Na, Young-Ji; Goj, Vinicio; Ardissino, Gianluigi; Gigante, Maddalena; Gesualdo, Loreto; Janezcko, Magdalena; Zaniew, Marcin; Mendelsohn, Cathy Lee; Shril, Shirlee; Hildebrandt, Friedhelm; van Wijk, Joanna A. E.; Arapovic, Adela; Saraga, Marijan; Allegri, Landino; Izzi, Claudia; Scolari, Francesco; Tasic, Velibor; Ghiggeri, Gian Marco; Latos-Bielenska, Anna; Kiryluk, Anna-Materna; Mane, Shrikant; Goldstein, David B.; Lifton, Richard P.; Katsanis, Nicholas; Davis, Erica E.; Gharavi, Ali G.			Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URINARY-TRACT; RENAL HYPODYSPLASIA; GENETIC-VARIATION; CANDIDATE GENES; CHILDREN; ANOMALIES; DISEASE; RISK; ABNORMALITIES; EPIDEMIOLOGY	Renal agenesis and hypodysplasia (RHD) are major causes of pediatric chronic kidney disease and are highly genetically heterogeneous. We conducted whole-exome sequencing in 202 case subjects with RHD and identified diagnostic mutations in genes known to be associated with RHD in 7/202 case subjects. In an additional affected individual with RHD and a congenital heart defect, we found a homozygous loss-of-function (LOF) variant in SLIT3, recapitulating phenotypes reported with Slit3 inactivation in the mouse. To identify genes associated with RHD, we performed an exome-wide association study with 195 unresolved case subjects and 6,905 control subjects. The top signal resided in GREB1L, a gene implicated previously in Hoxb1 and Shha signaling in zebrafish. The significance of the association, which was p = 2.0 3 10(-5) for novel LOF, increased to p = 4.1 3 10(-6) for LOF and deleterious missense variants combined, and augmented further after accounting for segregation and de novo inheritance of rare variants (joint p = 2.3 3 10(-7)). Finally, CRISPR/Cas9 disruption or knockdown of greb1l in zebrafish caused specific pronephric defects, which were rescued by wild-type human GREB1L mRNA, but not mRNA containing alleles identified in case subjects. Together, our study provides insight into the genetic landscape of kidney malformations in humans, presents multiple candidates, and identifies SLIT3 and GREB1L as genes implicated in the pathogenesis of RHD.	[Sanna-Cherchi, Simone; Westland, Rik; Krithivasan, Priya; Rasouly, Hila Milo; Capone, Valentina P.; Fasel, David A.; Kiryluk, Krzysztof; Makar, Gabriel S.; Mitrotti, Adele; Verbitsky, Miguel; Martino, Jeremiah; Liu, Qingxue; Na, Young-Ji] Columbia Univ, Div Nephrol, New York, NY 10032 USA; [Khan, Kamal; Fievet, Lorraine; Pediaditakis, Igor; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Westland, Rik; van Wijk, Joanna A. E.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Nephrol, NL-1007 MB Amsterdam, Netherlands; [Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Kamalakaran, Sitharthan; Goldstein, David B.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA; [Bodria, Monica; Ghiggeri, Gian Marco] Ist Giannina Gaslini, Div Nephrol Dialysis Transplantat, I-16147 Genoa, Italy; [Bodria, Monica; Ghiggeri, Gian Marco] Ist Giannina Gaslini, Lab Pathophysiol Uremia, I-16147 Genoa, Italy; [Otto, Edgar A.] Univ Michigan, Dept Internal Med Nephrol, Sch Med, Ann Arbor, MI 48109 USA; [Sampson, Matthew G.; Gillies, Christopher E.; Vega-Warner, Virginia] Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA; [Vukojevic, Katarina] Univ Split, Sch Med, Dept Anat Histol & Embryol, Split 21000, Croatia; [Goj, Vinicio] Fatebenefratelli Hosp, Pediat Unit, I-20121 Milan, Italy; [Ardissino, Gianluigi] Fdn Ca Granda IRCCS Osped Maggiore Policlin Milan, Pediatr Nephrol & Dialysis Unit, I-20122 Milan, Italy; [Gigante, Maddalena] Univ Foggia, Dept Med & Surg Sci, I-71121 Foggia, Italy; [Gesualdo, Loreto] Univ Bari, Dept Emergency & Organ Transplantat, Sect Nephrol, I-70121 Bari, Italy; [Janezcko, Magdalena] Jagiellonian Univ, Dept Med Genet, Chair Pediat, Collegium Medicum, PL-31008 Krakow, Poland; [Zaniew, Marcin] Childrens Hosp, PL-61825 Poznan, Poland; [Mendelsohn, Cathy Lee] Columbia Univ, Dept Urol Pathol & Cell Biol Genet & Dev, New York, NY 10032 USA; [Shril, Shirlee; Hildebrandt, Friedhelm] Boston Childrens Hosp, Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Arapovic, Adela; Saraga, Marijan] Univ Hosp Split, Dept Pediat, Nanjing 21000, Peoples R China; [Saraga, Marijan] Univ Split, Sch Med, Split 21000, Croatia; [Allegri, Landino] Univ Parma, Dept Med & Surg, I-43100 Parma, Italy; [Izzi, Claudia; Scolari, Francesco] Univ Brescia, Div 2, Cattedra Nefrol, Nefrol Azienda Osped Spedali Civili Brescia Presi, I-25018 Brescia, Italy; [Izzi, Claudia] Azienda Osped Spedali Civili Brescia, Dipartimento Ostetr Ginecol, I-25018 Brescia, Italy; [Tasic, Velibor] Univ Childrens Hosp, Dept Pediat Nephrol, Med Fac Skopje, Skopje 1000, North Macedonia; [Latos-Bielenska, Anna; Kiryluk, Anna-Materna] Poznan Univ Med Sci, Dept Med Genet, PL-61701 Poznan, Poland; [Latos-Bielenska, Anna; Kiryluk, Anna-Materna] Ctr Med Genet GENESIS, PL-61701 Poznan, Poland; [Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Dept Human Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Columbia University; Duke University; Vrije Universiteit Amsterdam; Columbia University; Columbia University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Split; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Foggia; Universita degli Studi di Bari Aldo Moro; Jagiellonian University; Collegium Medicum Jagiellonian University; Columbia University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Split; University of Split; University of Parma; University of Brescia; Hospital Spedali Civili Brescia; Poznan University of Medical Sciences; Yale University; Howard Hughes Medical Institute	Sanna-Cherchi, S (corresponding author), Columbia Univ, Div Nephrol, New York, NY 10032 USA.; Davis, EE (corresponding author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27701 USA.	ss2517@cumc.columbia.edu; erica.davis@duke.edu	Izzi, Claudia/GZG-8769-2022; scolari, francesco/AAC-5957-2022; Vukojevic, Katarina/AAU-1906-2020; Mendelsohn, Cathy/H-4280-2016; Saraga, Marijan/E-7647-2017; Izzi, Claudia/AAB-7004-2022; Tasic, Velibor/H-8714-2019; bodria, monica/K-2115-2016; Goldstein, David/AAY-8125-2020; Shril, Shirlee/Q-5825-2016; Arapovic, Adela/D-7022-2017; Gigante, Maddalena/R-4369-2016; Sampson, Matthew/U-4501-2017	Vukojevic, Katarina/0000-0003-2182-2890; Mendelsohn, Cathy/0000-0002-4026-4073; Tasic, Velibor/0000-0002-3377-1245; bodria, monica/0000-0001-9690-9945; Makar, Gabriel/0000-0002-0402-5577; Gigante, Maddalena/0000-0001-8228-7639; Izzi, Claudia/0000-0001-6253-3185; Scolari, Francesco/0000-0003-0233-9705; Sampson, Matthew/0000-0001-9560-076X; Ghiggeri, Gian Marco/0000-0003-3659-9062; Arapovic, Adela/0000-0002-2462-039X; Milo Rasouly, Hila/0000-0002-0770-2190; Davis, Erica/0000-0002-2412-8397; Westland, Rik/0000-0003-4960-4078	National Institutes of Health [R01DK103184, UL1 TR000040, R01DK108805, R01DK088767, P50DK096415, P30DK096493, R01DK080099, U54DK104309, R01DK105124]; American Heart Association [13GRNT14680075]; Joint Italian Ministry of Health; NIH Young Investigators Finalized Research; National Human Genome Research Institute Centers for Mendelian Genomics [HG006504]; Fondazione Malattie Renali nel Bambino; Charles Woodson Clinical Research Fund; Polish Ministry of Health; Dutch Kidney Foundation for the Kolff post-doc abroad gran [15OKK95]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103184, P50DK096415, P30DK079310, R01DK080099, U54DK104309, R01DK088767, R01DK105124, P30DK096493, R01DK108805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Joint Italian Ministry of Health; NIH Young Investigators Finalized Research; National Human Genome Research Institute Centers for Mendelian Genomics; Fondazione Malattie Renali nel Bambino; Charles Woodson Clinical Research Fund; Polish Ministry of Health; Dutch Kidney Foundation for the Kolff post-doc abroad gran; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all individuals with RHD and their family members for participating to this study. This work was supported by grants from the National Institutes of Health (R01DK103184 and UL1 TR000040 to S.S.-C.; R01DK108805 to M.G.S.; R01DK088767 to F.H.; P50DK096415 to N.K.; P30DK096493 to N.K. and E.E.D.; R01DK080099 to A.G.G.; U54DK104309 to A.G.G.; R01DK105124 to K. Kiryluk), the American Heart Association grant-in-aid 13GRNT14680075 to S.S.-C., the Joint Italian Ministry of Health and NIH Young Investigators Finalized Research 2012 to S.S.-C. and G.M.G., the National Human Genome Research Institute Centers for Mendelian Genomics (HG006504 to R.P.L.), and the Fondazione Malattie Renali nel Bambino (to G.M.G.). M.G.S. is supported by the Charles Woodson Clinical Research Fund. A.-M. K. and A.L.-B. are funded by the Polish Ministry of Health. We acknowledge the Polish Kidney Genetics Network (POLYGENES), the Polish Registry of Congenital Malformations (PRCM), the NZOZ Center for Medical Genetics (GENESIS) in Poznan, Poland, and the Dutch Kidney Foundation for the Kolff post-doc abroad grant (15OKK95 to R.W.). The list of contributors for the 6,905 exome controls used in this study is available in the Supplemental Data.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2017, LANCET NEUROL, V16, P135, DOI 10.1016/S1474-4422(16)30359-3; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; BARAKAT AJ, 1991, UROLOGY, V38, P347, DOI 10.1016/0090-4295(91)80150-6; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Brophy PD, 2017, GENETICS, V207, P215, DOI 10.1534/genetics.117.1125; Brunskill EW, 2014, DEVELOPMENT, V141, P3093, DOI 10.1242/dev.110601; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Choe SK, 2011, DEV BIOL, V358, P356, DOI 10.1016/j.ydbio.2011.05.676; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Ghosh MG, 2000, CANCER RES, V60, P6367; Gillies CE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1108-4; Goodyer P. R., 2004, PEDIAT NEPHROLOGY, P83; Guo MH, 2016, AM J HUM GENET, V99, P527, DOI 10.1016/j.ajhg.2016.06.031; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Held T, 2006, MOL CELL BIOL, V26, P8099, DOI 10.1128/MCB.01332-06; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu JM, 2003, MECH DEVELOP, V120, P1059, DOI 10.1016/S0925-4773(03)00161-8; LIVERA LN, 1989, BRIT MED J, V298, P1421, DOI 10.1136/bmj.298.6685.1421; Lopez-Rivera E, 2017, NEW ENGL J MED, V376, P742, DOI 10.1056/NEJMoa1609009; Miklovicova D, 2005, PEDIATR NEPHROL, V20, P1136, DOI 10.1007/s00467-005-1896-7; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Nicolaou N, 2016, KIDNEY INT, V89, P476, DOI 10.1038/ki.2015.319; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Pennimpede T, 2012, DEV BIOL, V372, P55, DOI 10.1016/j.ydbio.2012.09.003; Petrovski S, 2017, AM J RESP CRIT CARE, V196, P82, DOI [10.1164/rccm.201610-2088OC, 10.1164/rccm.201610-2088oc]; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Saisawat P, 2014, KIDNEY INT, V85, P1310, DOI 10.1038/ki.2013.417; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sampson MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081062; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2007, AM J HUM GENET, V80, P539, DOI 10.1086/512248; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Thomas R, 2011, PEDIATR NEPHROL, V26, P897, DOI 10.1007/s00467-011-1826-9; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Vivante A, 2015, AM J HUM GENET, V97, P291, DOI 10.1016/j.ajhg.2015.07.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Westland R, 2015, KIDNEY INT, V88, P1402, DOI 10.1038/ki.2015.239; Westland R, 2014, J AM SOC NEPHROL, V25, P1408, DOI 10.1681/ASN.2013080886; Westland R, 2014, CLIN J AM SOC NEPHRO, V9, P978, DOI 10.2215/CJN.08900813; Westland R, 2011, NEPHROL DIAL TRANSPL, V26, P1533, DOI 10.1093/ndt/gfq844; Wuhl E, 2013, CLIN J AM SOC NEPHRO, V8, P67, DOI 10.2215/CJN.03310412; Xu J, 2006, GENETICS, V174, P735, DOI 10.1534/genetics.106.061523; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	68	42	45	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					789	802		10.1016/j.ajhg.2017.09.018	http://dx.doi.org/10.1016/j.ajhg.2017.09.018			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100090	Green Published, Bronze			2022-12-18	WOS:000414251600010
J	Feichtinger, RG; Olahova, M; Kishita, Y; Garone, C; Kremer, LS; Yagi, M; Uchiumi, T; Jourdain, AA; Thompson, K; D'Souza, AR; Kopajtich, R; Alston, CL; Koch, J; Sperl, W; Mastantuono, E; Strom, TM; Wortmann, SB; Meitinger, T; Pierre, G; Chinnery, PF; Chrzanowska-Lightowlers, ZM; Lightowlers, RN; DiMauro, S; Calvo, SE; Mootha, VK; Moggio, M; Sciacco, M; Comi, GP; Ronchi, D; Murayama, K; Ohtake, A; Rebelo-Guiomar, P; Kohda, M; Kang, D; Mayr, JA; Taylor, RW; Okazaki, Y; Minczuk, M; Prokisch, H				Feichtinger, Rene G.; Olahova, Monika; Kishita, Yoshihito; Garone, Caterina; Kremer, Laura S.; Yagi, Mikako; Uchiumi, Takeshi; Jourdain, Alexis A.; Thompson, Kyle; D'Souza, Aaron R.; Kopajtich, Robert; Alston, Charlotte L.; Koch, Johannes; Sperl, Wolfgang; Mastantuono, Elisa; Strom, Tim M.; Wortmann, Saskia B.; Meitinger, Thomas; Pierre, Germaine; Chinnery, Patrick F.; Chrzanowska-Lightowlers, Zofia M.; Lightowlers, Robert N.; DiMauro, Salvatore; Calvo, Sarah E.; Mootha, Vamsi K.; Moggio, Maurizio; Sciacco, Monica; Comi, Giacomo P.; Ronchi, Dario; Murayama, Kei; Ohtake, Akira; Rebelo-Guiomar, Pedro; Kohda, Masakazu; Kang, Dongchon; Mayr, Johannes A.; Taylor, Robert W.; Okazaki, Yasushi; Minczuk, Michal; Prokisch, Holger			Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DELETIONS; P-32 PROTEIN; MATRIX; MAINTENANCE; P32/GC1QR; DISORDER; SPECTRUM; RECEPTOR	Complement component 1 Q subcomponent-binding protein (C1QBP; also known as p32) is a multi-compartmental protein whose precise function remains unknown. It is an evolutionary conserved multifunctional protein localized primarily in the mitochondrial matrix and has roles in inflammation and infection processes, mitochondrial ribosome biogenesis, and regulation of apoptosis and nuclear transcription. It has an N-terminal mitochondrial targeting peptide that is proteolytically processed after import into the mitochondrial matrix, where it forms a homotrimeric complex organized in a doughnut-shaped structure. Although C1QBP has been reported to exert pleiotropic effects on many cellular processes, we report here four individuals from unrelated families where biallelic mutations in C1QBP cause a defect in mitochondrial energy metabolism. Infants presented with cardiomyopathy accompanied by multisystemic involvement (liver, kidney, and brain), and children and adults presented with myopathy and progressive external ophthalmoplegia. Multiple mitochondrial respiratory-chain defects, associated with the accumulation of multiple deletions of mitochondrial DNA in the later-onset myopathic cases, were identified in all affected individuals. Steady-state C1QBP levels were decreased in all individuals' samples, leading to combined respiratory-chain enzyme deficiency of complexes I, III, and IV. C1qbp(-/-) mouse embryonic fibroblasts (MEFs) resembled the human disease phenotype by showing multiple defects in oxidative phosphorylation (OXPHOS). Complementation with wild-type, but not mutagenized, C1qbp restored OXPHOS protein levels and mitochondrial enzyme activities in C1qbp(-/-) MEFs. C1QBP deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio) myopathy and late-onset progressive external ophthalmoplegia.	[Feichtinger, Rene G.; Koch, Johannes; Sperl, Wolfgang; Wortmann, Saskia B.; Mayr, Johannes A.] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Olahova, Monika; Thompson, Kyle; Alston, Charlotte L.; Chrzanowska-Lightowlers, Zofia M.; Lightowlers, Robert N.; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Olahova, Monika; Thompson, Kyle; Alston, Charlotte L.; Chrzanowska-Lightowlers, Zofia M.; Lightowlers, Robert N.; Taylor, Robert W.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kishita, Yoshihito; Kohda, Masakazu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Saitama 3501241, Japan; [Kishita, Yoshihito; Kohda, Masakazu; Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Diagnost & Therapeut Intractable Dis, Intractable Dis Res Ctr, Tokyo 1138421, Japan; [Garone, Caterina; D'Souza, Aaron R.; Chinnery, Patrick F.; Rebelo-Guiomar, Pedro; Minczuk, Michal] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Wellcome Trust, MRC Bldg, Cambridge CB2 0XY, England; [Kremer, Laura S.; Kopajtich, Robert; Mastantuono, Elisa; Strom, Tim M.; Wortmann, Saskia B.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kremer, Laura S.; Mastantuono, Elisa; Strom, Tim M.; Wortmann, Saskia B.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Yagi, Mikako; Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Jourdain, Alexis A.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Genome Med, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; [Jourdain, Alexis A.; Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany; [Pierre, Germaine] Bristol Royal Hosp Children, South West Reg Metab Dept, Bristol BS1 3NU, Avon, England; [DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Moggio, Maurizio; Sciacco, Monica] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Neuromuscular Unit, I-20122 Milan, Italy; [Comi, Giacomo P.; Ronchi, Dario] Univ Milan, IRCCS, Fdn Ca Granda,Osped Maggiore Policlin, Neurosci Sect,Dept Pathophysiol & Transplantat,Di, I-20122 Milan, Italy; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan; [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Saitama 3500495, Japan; [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4099002 Oporto, Portugal	Paracelsus Private Medical University; Newcastle University - UK; Newcastle University - UK; Saitama Medical University; Juntendo University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kyushu University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; German Centre for Cardiovascular Research; Munich Heart Alliance; Bristol Royal Hospital For Children; Columbia University; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Chiba Children's Hospital; Saitama Medical University; Universidade do Porto	Prokisch, H (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.; Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.	prokisch@helmholtz-muenchen.de	Rebelo-Guiomar, Pedro/AAT-3575-2021; Sciacco, Monica/AAC-6500-2022; Garone, Caterina/AAB-8659-2019; Comi, Giacomo P/K-5702-2016; Meitinger, Thomas/O-1318-2015; Jourdain, Alexis A./ABF-4838-2020; Alston, Charlotte/ABG-9602-2020; Minczuk, Michal/G-1638-2014	Rebelo-Guiomar, Pedro/0000-0002-5060-7519; Sciacco, Monica/0000-0003-4593-4977; Garone, Caterina/0000-0003-4928-1037; Comi, Giacomo P/0000-0002-1383-5248; Alston, Charlotte/0000-0003-2095-5464; Chinnery, Patrick/0000-0002-7065-6617; Ronchi, Dario/0000-0002-6093-9816; Kremer, Laura/0000-0002-1647-7538; Minczuk, Michal/0000-0001-8242-1420; Okazaki, Yasushi/0000-0003-3241-5502; Kishita, Yoshihito/0000-0003-4978-1680; Ohtake, Akira/0000-0003-1147-3113; KOHDA, Masakazu/0000-0001-5970-2224; Jourdain, Alexis A./0000-0001-5321-6938; Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286	Horizon through E-Rare project GENOMIT [01GM1603, 01GM1207, FWF-I2741-B26]; Vereinigung zur Forderung Padiatrischer Forschung Salzburg; EU FP7 MEET Project [317433]; Horizon Project SOUND [633974]; Marie Sklodowska-Curie Actions Reintegration Fellowship [Mitobiopath-705560]; UK NHS Highly Specialised Mitochondrial Service; Wellcome Centre for Mitochondrial Research [203105/Z/16]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NIHR fellowship [NIHR-HCS-D12-03-04]; Wellcome Senior Fellowship [101876/Z/13/Z]; UK NIHR award; MRC Mitochondrial Biology Unit [MC_UP_1501/2]; NIH [R01 GM0077465, R35 GM122455]; EMBO fellowship [ALTF554-2015]; UK MRC core funding for the Mitochondrial Biology Unit of the University of Cambridge [MC_U105697135]; Portuguese Fundacao para a Ciencia e a Tecnologia [PD/BD/105750/2014]; Italian Telethon [GSP16001]; Fondazione Cariplo [2014-1010]; Strategic Research Center in Private Universities from MEXT; Practical Research Project for Rare/Intractable Diseases from AMED; German BMBF; MRC [MC_U105697135, MC_UU_00015/4] Funding Source: UKRI; Grants-in-Aid for Scientific Research [16K09973] Funding Source: KAKEN; Medical Research Council [MC_UP_1501/2, MC_U105697135, MC_UU_00015/4] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10016, NIHR-HCS-D12-03-04] Funding Source: researchfish; Wellcome Trust [101876/B/13/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465, R35GM122455] Funding Source: NIH RePORTER	Horizon through E-Rare project GENOMIT; Vereinigung zur Forderung Padiatrischer Forschung Salzburg; EU FP7 MEET Project; Horizon Project SOUND; Marie Sklodowska-Curie Actions Reintegration Fellowship; UK NHS Highly Specialised Mitochondrial Service; Wellcome Centre for Mitochondrial Research; MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK NIHR fellowship; Wellcome Senior Fellowship; UK NIHR award; MRC Mitochondrial Biology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO fellowship(European Molecular Biology Organization (EMBO)); UK MRC core funding for the Mitochondrial Biology Unit of the University of Cambridge(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Italian Telethon(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Strategic Research Center in Private Universities from MEXT; Practical Research Project for Rare/Intractable Diseases from AMED; German BMBF(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the German BMBF and Horizon2020 through E-Rare project GENOMIT (01GM1603 and 01GM1207 to H.P.; FWF-I2741-B26 to J.A.M.); Vereinigung zur Forderung Padiatrischer Forschung Salzburg; EU FP7 MEET Project (317433 to H.P. and J.A.M.); Horizon2020 Project SOUND (633974 to H.P.); Marie Sklodowska-Curie Actions Reintegration Fellowship (Mitobiopath-705560 to C.G.); UK NHS Highly Specialised Mitochondrial Service (R.W.T.); Wellcome Centre for Mitochondrial Research (203105/Z/16 to Z.M.C.-L.,R.N.L., and R.W.T.); MRC Centre for Neuromuscular Diseases (G0601943 to R.W.T. and P.F.C.); Lily Foundation (R.W.T. and K.T.); UK NIHR fellowship (NIHR-HCS-D12-03-04 to C.L.A.); Wellcome Senior Fellowship (101876/Z/13/Z to P.F.C.); UK NIHR award and MRC Mitochondrial Biology Unit (MC_UP_1501/2 to P.F.C.); NIH (R01 GM0077465 and R35 GM122455 to V.K.M.); EMBO fellowship (ALTF554-2015 to A.A.J.); UK MRC core funding for the Mitochondrial Biology Unit of the University of Cambridge (MC_U105697135 to A.R.D., P.R.G., and M. Minczuk); Portuguese Fundacao para a Ciencia e a Tecnologia (PD/BD/105750/2014 to P.R.G.); Italian Telethon (GSP16001 to G.P.C.); Fondazione Cariplo (2014-1010 to D.R.); Strategic Research Center in Private Universities from MEXT; and Practical Research Project for Rare/Intractable Diseases from AMED. We acknowledge Dr. Yosikatsu Matsumura for providing clinical information. M. Moggio and M. S. thank the Associazione Italiana di Miologia, the Associazione Amici del "Centro Dino Ferrari,'' the Biobank for Skeletal Muscle, Peripheral Nerve, DNA, and Cell Cultures (Telethon Network of Genetic Biobanks GTB12001E), and the Eurobiobank Network.	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802; CALVO SE, 2012, SCI TRANSL MED, V4, DOI DOI 10.1093/BIOINFORMATICS/BTP324; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621; FEICHTINGER RG, 2010, BMC CANCER, V10, DOI DOI 10.1002/GLIA.22621; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Kremer LS, 2016, AM J HUM GENET, V99, P894, DOI 10.1016/j.ajhg.2016.07.018; Kremer LS, 2016, J HEPATOL, V65, P377, DOI 10.1016/j.jhep.2016.04.017; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Rahman S., 2016, INBORN METABOLIC DIS, P223; Rubinstein DB, 2004, INT J CANCER, V110, P741, DOI 10.1002/ijc.20105; Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seytter T, 1998, YEAST, V14, P303, DOI 10.1002/(SICI)1097-0061(19980315)14:4<303::AID-YEA217>3.0.CO;2-N; Soltys BJ, 2000, HISTOCHEM CELL BIOL, V114, P245; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731; van Leeuwen HC, 2001, J CELL SCI, V114, P2115; Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5; Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037; Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118	40	42	45	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					525	538		10.1016/j.ajhg.2017.08.015	http://dx.doi.org/10.1016/j.ajhg.2017.08.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28942965	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000412277300004
J	Maddirevula, S; Coskun, S; Alhassan, S; Elnour, A; Alsaif, HS; Ibrahim, N; Abdulwahab, F; Arold, ST; Alkuraya, FS				Maddirevula, Sateesh; Coskun, Serdar; Alhassan, Saad; Elnour, Atif; Alsaif, Hessa S.; Ibrahim, Niema; Abdulwahab, Firdous; Arold, Stefan T.; Alkuraya, Fowzan S.			Female Infertility Caused by Mutations in the Oocyte-Specific Translational Repressor PATL2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; C-MOS; XENOPUS-OOCYTES; PROTEIN; MATURATION; MEIOSIS; MICE; ACTIVATION; FAILURE	Infertility is a relatively common disorder of the reproductive system and remains unexplained in many cases. In vitro fertilization techniques have uncovered previously unrecognized infertility phenotypes, including oocyte maturation arrest, the molecular etiology of which remains largely unknown. We report two families affected by female-limited infertility caused by oocyte maturation failure. Positional mapping and whole-exome sequencing revealed two homozygous, likely deleterious variants in PATL2, each of which fully segregates with the phenotype within the respective family. PATL2 encodes a highly conserved oocyte-specific mRNP repressor of translation. Previous data have shown the strict requirement for PATL2 in oocyte-maturation in model organisms. Data gathered from the families in this study suggest that the role of PATL2 is conserved in humans and expand our knowledge of the factors that are necessary for female meiosis.	[Maddirevula, Sateesh; Alsaif, Hessa S.; Ibrahim, Niema; Abdulwahab, Firdous; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Coskun, Serdar] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Coskun, Serdar] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Alhassan, Saad] King Faisal Specialist Hosp & Res Ctr, Dept Obstet & Gynecol, Riyadh 11211, Saudi Arabia; [Elnour, Atif] Dr Sulaiman Al Habib Med Grp, Olaya Complex, Riyadh 11643, Saudi Arabia; [Arold, Stefan T.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 11442, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University; King Faisal Specialist Hospital & Research Center; King Abdullah University of Science & Technology; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.; Alkuraya, FS (corresponding author), King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 11442, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Maddirevula, Sateesh/ABE-3655-2021; Coskun, Serdar/I-1470-2018; Coskun, Serdar/AAI-4625-2020; Arold, Stefan/T-2612-2019	Maddirevula, Sateesh/0000-0003-2999-2229; Coskun, Serdar/0000-0002-7278-0902; Arold, Stefan T/0000-0001-5278-0668	King Abdulaziz City for Science and Technology [13-BIO1113-20]; Saudi Human Genome Project; King Abdullah University of Science and Technology	King Abdulaziz City for Science and Technology; Saudi Human Genome Project; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	We thank the study participants for their enthusiastic participation. We also thank the Sequencing and Genotyping Core Facilities at the King Faisal Specialist Hospital and Research Center for their technical help. This work was funded in part by the King Abdulaziz City for Science and Technology (13-BIO1113-20), and we acknowledge the support of the Saudi Human Genome Project. The research reported by S.T.A. in this publication was supported by funding from the King Abdullah University of Science and Technology.	Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Beall S, 2010, FERTIL STERIL, V94, P2507, DOI 10.1016/j.fertnstert.2010.02.037; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; Braun JE, 2010, EMBO J, V29, P2368, DOI 10.1038/emboj.2010.124; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Haas G, 2010, J CELL BIOL, V189, P289, DOI 10.1083/jcb.200910141; Hahn KL, 2005, DEVELOPMENT, V132, P817, DOI 10.1242/dev.01601; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Libby BJ, 2002, DEV BIOL, V242, P174, DOI 10.1006/dbio.2001.0535; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Maddirevula S, 2017, CLIN GENET, V91, P344, DOI 10.1111/cge.12866; Marnef A, 2010, RNA, V16, P2094, DOI 10.1261/rna.2295410; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Mrazek M, 2003, HUM REPROD, V18, P2249, DOI 10.1093/humrep/deg434; Nakamura Y, 2010, DEV BIOL, V344, P272, DOI 10.1016/j.ydbio.2010.05.006; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; ROTHER RP, 1992, EUR J BIOCHEM, V206, P673, DOI 10.1111/j.1432-1033.1992.tb16973.x; Spruck CH, 2003, SCIENCE, V300, P647, DOI 10.1126/science.1084149	28	42	45	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					603	608		10.1016/j.ajhg.2017.08.009	http://dx.doi.org/10.1016/j.ajhg.2017.08.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28965844	Green Published, Bronze			2022-12-18	WOS:000412277300010
J	Hormozdiari, F; Zhu, A; Kichaev, G; Ju, CJT; Segre, AV; Joo, JWJ; Won, HJ; Sankararaman, S; Pasaniuc, B; Shifman, S; Eskin, E				Hormozdiari, Farhad; Zhu, Anthony; Kichaev, Gleb; Ju, Chelsea J. -T.; Segre, Ayellet V.; Joo, Jong Wha J.; Won, Hyejung; Sankararaman, Sriram; Pasaniuc, Bogdan; Shifman, Sagiv; Eskin, Eleazar			Widespread Allelic Heterogeneity in Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MIXED-MODEL ANALYSIS; INCREASING POWER; GENETIC-VARIANTS; LOCI; GWAS; IDENTIFICATION; COLOCALIZATION; EXPRESSION; SIGNALS	Recent successes in genome-wide association studies (GWASs) make it possible to address important questions about the genetic architecture of complex traits, such as allele frequency and effect size. One lesser-known aspect of complex traits is the extent of allelic heterogeneity (AH) arising from multiple causal variants at a locus. We developed a computational method to infer the probability of AH and applied it to three GWASs and four expression quantitative trait loci (eQTL) datasets. We identified a total of 4,152 loci with strong evidence of AH. The proportion of all loci with identified AH is 4%-23% in eQTLs, 35% in GWASs of high-density lipoprotein (HDL), and 23% in GWASs of schizophrenia. For eQTLs, we observed a strong correlation between sample size and the proportion of loci with AH (R-2 = 0.85, p = 2.2 x 10(-16)), indicating that statistical power prevents identification of AH in other loci. Understanding the extent of AH may guide the development of new methods for fine mapping and association mapping of complex traits.	[Hormozdiari, Farhad; Zhu, Anthony; Ju, Chelsea J. -T.; Joo, Jong Wha J.; Sankararaman, Sriram; Eskin, Eleazar] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Hormozdiari, Farhad] Harvard TH Chan Sch Pub lic Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kichaev, Gleb] Univ Calif Los Angeles, Bioinformat IDP, Los Angeles, CA 90095 USA; [Segre, Ayellet V.] MIT, Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Segre, Ayellet V.] Harvard Univ, Cambridge, MA 02142 USA; [Joo, Jong Wha J.] Dongguk Univ Seoul, Dept Comp Sci Engn, Seoul 04620, South Korea; [Won, Hyejung] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA; [Sankararaman, Sriram; Pasaniuc, Bogdan; Shifman, Sagiv] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Lab Med, Los Angeles, CA 90095 USA; [Shifman, Sagiv] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dongguk University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hebrew University of Jerusalem	Eskin, E (corresponding author), Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA.; Shifman, S (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.; Shifman, S (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	sagiv@vms.huji.ac.il; eeskin@cs.ucla.edu		Pasaniuc, Bogdan/0000-0002-0227-2056	National Science Foundation [0513612, 0731455, 0729049, 0916676, 1065276, 1302448, 1320589, 1331176]; NIH [K25-HL080079, U01-DA024417, P01-HL30568, P01-HL28481, R01-GM083198, R01-ES021801, R01-MH101782, R01-ES022282, R00-GM 111744-03]; NIH BD2K award [U54EB020403]; Biomedical Big Data Training Program (NIH-NCI) [T32CA201160]; National Institute for Psychobiology in Israel; Israel Science Foundation [688/12]; NINDS Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691];  [HHSN268201000029C]; NATIONAL CANCER INSTITUTE [T32CA201160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481, K25HL080079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022282, R01ES021801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM111744, R01GM083198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH113823, R01MH101782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1320589] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH BD2K award; Biomedical Big Data Training Program (NIH-NCI); National Institute for Psychobiology in Israel; Israel Science Foundation(Israel Science Foundation); NINDS Informatics Center for Neurogenetics and Neurogenomics; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	F.H., J.W.J.J., and E.E. are supported by National Science Foundation grants 0513612, 0731455, 0729049, 0916676, 1065276, 1302448, 1320589, and 1331176 and NIH grants K25-HL080079, U01-DA024417, P01-HL30568, P01-HL28481, R01-GM083198, R01-ES021801, R01-MH101782, and R01-ES022282. E.E. is supported in part by the NIH BD2K award U54EB020403. A.V.S. is supported by a contract (HHSN268201000029C) to the Laboratory, Data Analysis, and Coordinating Center (LDACC) at The Broad Institute. S. Sankararaman was supported in part by NIH grant R00-GM 111744-03. G.K. is supported by the Biomedical Big Data Training Program (NIH-NCI T32CA201160). S. Shifman was supported by the National Institute for Psychobiology in Israel, founded by The Charles E. Smith Family and by the Israel Science Foundation (grant no. 688/12). We acknowledge the support of the NINDS Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eskin E, 2008, GENOME RES, V18, P653, DOI 10.1101/gr.072785.107; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; Fang M., 2016, BIORXIV; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Han B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002555; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hormozdiari F, 2015, BIOINFORMATICS, V31, P206, DOI 10.1093/bioinformatics/btv240; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Jansen R, 2017, HUM MOL GENET, V26, P1444, DOI 10.1093/hmg/ddx043; Joo JWJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0903-6; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kostem E, 2011, GENETICS, V188, P449, DOI 10.1534/genetics.111.128595; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005272; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	53	42	42	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2017	100	5					789	802		10.1016/j.ajhg.2017.04.005	http://dx.doi.org/10.1016/j.ajhg.2017.04.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET8OV	28475861	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000400560000008
J	Nevin, ZS; Factor, DC; Karl, RT; Douvaras, P; Laukka, J; Windrem, MS; Goldman, SA; Fossati, V; Hobson, GM; Tesar, PJ				Nevin, Zachary S.; Factor, Daniel C.; Karl, Robert T.; Douvaras, Panagiotis; Laukka, Jeremy; Windrem, Martha S.; Goldman, Steven A.; Fossati, Valentina; Hobson, Grace M.; Tesar, Paul J.			Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELIN PROTEOLIPID PROTEIN; PROGENITOR CELLS; STEM-CELLS; ENDOPLASMIC-RETICULUM; MOUSE MODEL; GENE; PLP; LEUKODYSTROPHIES; GENERATION; EXPRESSION	Pelizaeus-Merzbacher disease (PMD) is a pediatric disease of myelin in the central nervous system and manifests with a wide spectrum of clinical severities. Although PMD is a rare monogenic disease, hundreds of mutations in the X-linked myelin gene proteolipid protein 1 (PLP1) have been identified in humans. Attempts to identify a common pathogenic process underlying PMD have been complicated by an incomplete understanding of PLP1 dysfunction and limited access to primary human oligodendrocytes. To address this, we generated panels of human induced pluripotent stem cells (hiPSCs) and hiPSC-derived oligodendrocytes from 12 individuals with mutations spanning the genetic and clinical diversity of PMD-including point mutations and duplication, triplication, and deletion of PLP1- and developed an in vitro platform for molecular and cellular characterization of all 12 mutations simultaneously. We identified individual and shared defects in PLP1 mRNA expression and splicing, oligodendrocyte progenitor development, and oligodendrocyte morphology and capacity for myelination. These observations enabled classification of PMD subgroups by cell-intrinsic phenotypes and identified a subset of mutations for targeted testing of small-molecule modulators of the endoplasmic reticulum stress response, which improved both morphologic and myelination defects. Collectively, these data provide insights into the pathogeneses of a variety of PLP1 mutations and suggest that disparate etiologies of PMD could require specific treatment approaches for subsets of individuals. More broadly, this study demonstrates the versatility of a hiPSC-based panel spanning the mutational heterogeneity within a single disease and establishes a widely applicable platform for genotype-phenotype correlation and drug screening in any human myelin disorder.	[Nevin, Zachary S.; Factor, Daniel C.; Karl, Robert T.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Douvaras, Panagiotis; Fossati, Valentina] New York Stem Cell Fdn Res Inst, New York, NY 10032 USA; [Laukka, Jeremy] Univ Toledo, Coll Med & Life Sci, Dept Neurol, Toledo, OH 43614 USA; [Laukka, Jeremy] Univ Toledo, Coll Med & Life Sci, Dept Neurosci, Toledo, OH 43614 USA; [Windrem, Martha S.; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Goldman, Steven A.] Univ Copenhagen, Fac Med & Hlth Sci, Ctr Neurosci, DK-2200 Copenhagen, Denmark; [Hobson, Grace M.] Alfred I duPont Hosp Children, Nemours Biomed Res, Wilmington, DE 19803 USA; [Hobson, Grace M.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Hobson, Grace M.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pediat, Philadelphia, PA 19107 USA	Case Western Reserve University; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Rochester; University of Copenhagen; Nemours Alfred I. duPont Hospital for Children; University of Delaware; Jefferson University	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	paul.tesar@case.edu	Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014	Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Douvaras, Panagiotis/0000-0002-4430-997X; fossati, valentina/0000-0003-1825-9371; Goldman, Steven/0000-0002-5498-4303; Nevin, Zachary/0000-0003-4987-924X	Pelizaeus-Merzbacher Disease Foundation; NIH [R01NS093357, R01NS058978, T32GM007250, F30HD084167]; New York Stem Cell Foundation; Adelson Medical Research Foundation; Novo Nordisk Foundation; Cytometry & Imaging Microscopy and Genomics core facilities of the Case Comprehensive Cancer Center [P30CA043703]; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F30HD084167] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104701, R01MH099578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093357, R01NS058978, R01NS075345] Funding Source: NIH RePORTER	Pelizaeus-Merzbacher Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Adelson Medical Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cytometry & Imaging Microscopy and Genomics core facilities of the Case Comprehensive Cancer Center; Novo Nordisk Fonden(Novo Nordisk Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Pelizaeus-Merzbacher Disease Foundation (P.J.T. and G.M.H.), NIH grants R01NS093357 (P.J.T. and M.W.) and R01NS058978 (G.M.H.), the New York Stem Cell Foundation (P.J.T. and V.F.), NIH predoctoral training grants T32GM007250 and F30HD084167 (Z.S.N.), and the Adelson Medical Research and Novo Nordisk Foundations (S.A.G. and M.S.W.). P.D. is a NYSCF-Druckenmiller fellow. Additional support was provided by the Cytometry & Imaging Microscopy and Genomics core facilities of the Case Comprehensive Cancer Center (P30CA043703). We are grateful to the late James Garbern for providing PMD samples; Leslie Cooperman, Elizabeth Shick, and William Qu for technical assistance; and Peter Scacheri, Anthony Wynshaw-Boris, Nancy Bass, Marius Wernig, and the Tesar Lab for discussion and comments on the manuscript.	Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bonkowsky JL, 2010, NEUROLOGY, V75, P718, DOI 10.1212/WNL.0b013e3181eee46b; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; Cailloux F, 2000, EUR J HUM GENET, V8, P837, DOI 10.1038/sj.ejhg.5200537; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Clark K, 2013, J NEUROSCI, V33, P11788, DOI 10.1523/JNEUROSCI.1336-13.2013; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; Dhaunchak AS, 2007, P NATL ACAD SCI USA, V104, P17813, DOI 10.1073/pnas.0704975104; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075; Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012; DUNCAN ID, 1987, P NATL ACAD SCI USA, V84, P6287, DOI 10.1073/pnas.84.17.6287; EICHER EM, 1973, J EXP ZOOL, V183, P181, DOI 10.1002/jez.1401830205; Gao Q, 2005, CLIN GENET, V68, P466, DOI 10.1111/j.1399-0004.2005.00522.x; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; GENCIC S, 1989, AM J HUM GENET, V45, P435; Gow A, 1998, J CELL BIOL, V140, P925, DOI 10.1083/jcb.140.4.925; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Griffiths I, 1998, MICROSC RES TECHNIQ, V41, P344, DOI 10.1002/(SICI)1097-0029(19980601)41:5<344::AID-JEMT2>3.0.CO;2-Q; GRIFFITHS IR, 1981, J NEUROL SCI, V50, P423, DOI 10.1016/0022-510X(81)90154-4; GRIFFITHS IR, 1990, J NEUROCYTOL, V19, P273, DOI 10.1007/BF01217305; Harlow DE, 2015, J NEUROSCI, V35, P12018, DOI 10.1523/JNEUROSCI.5151-14.2015; Harlow DE, 2014, J NEUROSCI, V34, P1333, DOI 10.1523/JNEUROSCI.2477-13.2014; Helman G, 2015, PEDIATR CLIN N AM, V62, P649, DOI 10.1016/j.pcl.2015.03.006; Helman G, 2015, MOL GENET METAB, V114, P527, DOI 10.1016/j.ymgme.2015.01.014; Hobson GM, 2000, NEUROLOGY, V55, P1089, DOI 10.1212/WNL.55.8.1089; Hobson GM, 2012, SEMIN NEUROL, V32, P62, DOI 10.1055/s-0032-1306388; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; Hudson LD, 2003, J CHILD NEUROL, V18, P616, DOI 10.1177/08830738030180090801; Huttemann M, 2009, ASN NEURO, V1, DOI 10.1042/AN20090028; Hurst S, 2006, GENET MED, V8, P371, DOI 10.1097/01.gim.0000223551.95862.c3; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Karim SA, 2007, GLIA, V55, P341, DOI 10.1002/glia.20465; Kevelam SH, 2016, NEUROPEDIATRICS, V47, P349, DOI 10.1055/s-0036-1588020; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; KOEPPEN AH, 1987, ANN NEUROL, V21, P159, DOI 10.1002/ana.410210208; Laukka JJ, 2016, NEUROSCI LETT, V627, P222, DOI 10.1016/j.neulet.2016.05.028; Laukka JJ, 2014, J NEUROSCI RES, V92, P1723, DOI 10.1002/jnr.23458; Laukka JJ, 2013, J NEUROL SCI, V335, P75, DOI 10.1016/j.jns.2013.08.030; LEVINE SM, 1990, DEV NEUROSCI-BASEL, V12, P235, DOI 10.1159/000111853; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Numata Y, 2014, J NEUROL, V261, P752, DOI 10.1007/s00415-014-7263-5; Numata Y, 2013, J BIOL CHEM, V288, P7451, DOI 10.1074/jbc.M112.435388; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Parikh S, 2015, MOL GENET METAB, V114, P501, DOI 10.1016/j.ymgme.2014.12.434; Pelizaeus F., 1885, ARCH PSYCHIAT NERVEN, V16, P698; PHILLIPS RJS, 1954, Z INDUKT ABSTAMM VER, V86, P322, DOI 10.1007/BF00312228; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Roboti P, 2009, J CELL SCI, V122, P3942, DOI 10.1242/jcs.055160; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimojima K, 2012, J HUM GENET, V57, P580, DOI 10.1038/jhg.2012.71; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Simons M, 2002, J CELL BIOL, V157, P327, DOI 10.1083/jcb.200110138; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Sumida K, 2016, BRAIN DEV-JPN, V38, P571, DOI 10.1016/j.braindev.2015.12.007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Van Haren K, 2015, MOL GENET METAB, V114, P516, DOI 10.1016/j.ymgme.2014.12.433; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606; Yamazaki R, 2016, ASN NEURO, V8, DOI 10.1177/1759091416669609	71	42	42	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					617	634		10.1016/j.ajhg.2017.03.005	http://dx.doi.org/10.1016/j.ajhg.2017.03.005			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28366443	Green Published, Bronze			2022-12-18	WOS:000398389600005
J	Delle Vedove, A; Storbeck, M; Heller, R; Holker, I; Hebbar, M; Shulda, A; Magnusson, O; Cirak, S; Girisha, KM; O'Driscoll, M; Loeys, B; Wirth, B				Delle Vedove, Andrea; Storbeck, Markus; Heller, Raoul; Hoelker, Irmgard; Hebbar, Malavika; Shulda, Anju; Magnusson, Olafur; Cirak, Sebahattin; Girisha, Katta M.; O'Driscoll, Mary; Loeys, Bart; Wirth, Brunhilde			Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARDEN-WALKER-SYNDROME; DISTAL ARTHROGRYPOSIS; 5-SPLICE-SITE RECOGNITION; MUTATIONS; CHANNELS; MECHANOTRANSDUCTION; GENE; PHENOTYPES; MECHANISM; PROTEINS	We report ten individuals of four independent consanguineous families from Turkey, India, Libya, and Pakistan with a variable clinical phenotype that comprises arthrogryposis, spontaneously resolving respiratory insufficiency at birth, muscular atrophy predominantly of the distal lower limbs, scoliosis, and mild distal sensory involvement. Using whole-exome sequencing, SNPchip-based linkage analysis, DNA microarray, and Sanger sequencing, we identified three independent homozygous frameshift mutations and a homozygous deletion of two exons in PIEZO2 that segregated in all affected individuals of the respective family. The mutations are localized in the N-terminal and central region of the gene, leading to nonsense-mediated transcript decay and consequently to lack of PIEZO2 protein. In contrast, heterozygous gain-of-function missense mutations, mainly localized at the C terminus, cause dominant distal arthrogryposis 3 (DA3), distal arthrogryposis 5 (DA5), or Marden-Walker syndrome (MWKS), which encompass contractures of hands and feet, scoliosis, ophthalmoplegia, and ptosis. PIEZO2 encodes a mechanosensitive ion channel that plays a major role in light-touch mechanosensation and has recently been identified as the principal mechanotransduction channel for proprioception. Mice ubiquitously depleted of PIEZO2 are postnatally lethal. However, individuals lacking PIEZO2 develop a not life-threatening, slowly progressive disorder, which is likely due to loss of PIEZO2 protein in afferent neurons leading to disturbed proprioception causing aberrant muscle development and function. Here we report a recessively inherited PIEZO2-related disease and demonstrate that depending on the type of mutation and the mode of inheritance, PIEZO2 causes clinically distinguishable phenotypes.	[Delle Vedove, Andrea; Storbeck, Markus; Heller, Raoul; Hoelker, Irmgard; Cirak, Sebahattin; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Delle Vedove, Andrea; Storbeck, Markus; Hoelker, Irmgard; Cirak, Sebahattin; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Delle Vedove, Andrea; Storbeck, Markus; Hoelker, Irmgard; Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Hebbar, Malavika; Shulda, Anju; Girisha, Katta M.] Manipal Univ, Dept Med Genet, Kasturba Med Coll, Manipal 576104, Karnataka, India; [Magnusson, Olafur] DeCODE Genet, IS-101 Reykjavik, Iceland; [Cirak, Sebahattin] Univ Hosp Cologne, Childrens Hosp, D-50931 Cologne, Germany; [O'Driscoll, Mary] Birmingham Womens NHS Fdn Trust, Birmingham T15 2TH, W Midlands, England; [Loeys, Bart] Univ Antwerp Hosp, B-2650 Edegem, Belgium	University of Cologne; University of Cologne; University of Cologne; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; University of Cologne; University of Antwerp	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Inst Genet, D-50674 Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Cirak, Sebahattin/AAZ-6829-2020; Loeys, Bart/B-3236-2017; Wirth, Brunhilde/H-3192-2019; KM, Girisha/AAK-6867-2020; Cirak, Sebahattin/AAX-9593-2020	Loeys, Bart/0000-0003-3703-9518; KM, Girisha/0000-0002-0139-8239; Wirth, Brunhilde/0000-0003-4051-5191	European Community [2012-305121]; Department of Science and Technology, India [SB/SO/HS/005/2014]	European Community(European Commission); Department of Science and Technology, India(Department of Science & Technology (India))	We are grateful to Dr. Spier and Dr. Lyding from the University Hospital Bonn and to Dr. Herkenrath from the University Hospital of Cologne for referral of affected individuals, and to Dr. Wunderlich for electrophysiological examination. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 2012-305121 "Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)." The work was also partially funded by The Department of Science and Technology, India, through the project titled "Application of autozygosity mapping and exome sequencing to identify genetic basis of disorders of skeletal development" (SB/SO/HS/005/2014).	Bagriantsev SN, 2014, J BIOL CHEM, V289, P31673, DOI 10.1074/jbc.R114.612697; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dauksaite V, 2002, J BIOL CHEM, V277, P12579, DOI 10.1074/jbc.M107867200; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Elsayed SM, 2014, EUR J HUM GENET, V22, P286, DOI 10.1038/ejhg.2013.150; Fatscher T, 2015, CELL MOL LIFE SCI, V72, P4523, DOI 10.1007/s00018-015-2017-9; Francey LJ, 2012, AM J MED GENET A, V158A, P298, DOI 10.1002/ajmg.a.34391; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Fryns JP, 1998, CLIN GENET, V54, P86; Goutman JD, 2015, FEBS LETT, V589, P3354, DOI 10.1016/j.febslet.2015.08.030; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Grohmann K, 2003, ANN NEUROL, V54, P719, DOI 10.1002/ana.10755; Haack T, 2016, DEVELOPMENT, V143, P373, DOI 10.1242/dev.131425; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; MCBRIDE DW, 1992, PFLUG ARCH EUR J PHY, V421, P606, DOI 10.1007/BF00375058; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nikolaou S, 2015, J HAND SURG-AM, V40, P2007, DOI 10.1016/j.jhsa.2015.07.008; Okubo M, 2015, AM J MED GENET A, V167, P1100, DOI 10.1002/ajmg.a.36881; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Viana F, 2016, J PHYSIOL-LONDON, V594, P4151, DOI 10.1113/JP270935; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Williams MS, 2007, AM J MED GENET A, V143A, P752, DOI 10.1002/ajmg.a.31648; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	35	42	43	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1206	1216		10.1016/j.ajhg.2016.09.019	http://dx.doi.org/10.1016/j.ajhg.2016.09.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27843126	Green Published, Bronze			2022-12-18	WOS:000387529600018
J	Garber, KB; Vincent, LM; Alexander, JJ; Bean, LJH; Bale, S; Hegde, M				Garber, Kathryn B.; Vincent, Lisa M.; Alexander, John J.; Bean, Lora J. H.; Bale, Sherri; Hegde, Madhuri			Reassessment of Genomic Sequence Variation to Harmonize Interpretation for Personalized Medicine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANT-INTERPRETATION; MUTATIONS; GENE; CARDIOMYOPATHY; CLASSIFICATION; LABORATORIES; GUIDELINES; PHENOTYPE; NONSENSE	Accurate interpretation of DNA sequence variation is a prerequisite for implementing personalized medicine. Discrepancies in interpretation between testing laboratories impede the effective use of genetic test results in clinical medicine. To better understand the underpinnings of these discrepancies, we quantified differences in variant classification internally over time and those between our diagnostic laboratory and other laboratories and resources. We assessed the factors that contribute to these discrepancies and those that facilitate their resolution. Our process resolved 72% of nearly 300 discrepancies between pairs of laboratories to within a one-step classification difference and identified key sources of data that facilitate changes in variant interpretation. The identification and harmonization of variant discrepancies will maximize the clinical use of genetic information; these processes will be fostered by the accumulation of additional population data as well as the sharing of data between diagnostic laboratories.	[Garber, Kathryn B.; Alexander, John J.; Bean, Lora J. H.; Hegde, Madhuri] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Garber, Kathryn B.; Alexander, John J.; Bean, Lora J. H.; Hegde, Madhuri] Emory Genet Lab, Decatur, GA 30033 USA; [Vincent, Lisa M.; Bale, Sherri] GeneDx, Gaithersburg, MD 20877 USA	Emory University	Hegde, M (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Hegde, M (corresponding author), Emory Genet Lab, Decatur, GA 30033 USA.	mhegde@emory.edu	Alexander, John/GVS-7271-2022		Ingenuity in the form of the QIAGEN Genomic Medicine Fellowship Award; NIH [U41 HG006834]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006834] Funding Source: NIH RePORTER	Ingenuity in the form of the QIAGEN Genomic Medicine Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors Wish to thank Steven-Harrison and Kush Panchani for providing data and advising on calculating concordance rates between laboratories. Support for K.B.G. was provided by Ingenuity in the form of the QIAGEN Genomic Medicine Fellowship Award. Partial support for K.B.G., M.H., and L.M.V. was also provided by NIH grant U41 HG006834. K.B.G., L.J.H.B., J.J.A., and M.H. are employees of Emory University and EGL Genetic Diagnostics, which became a joint venture with Eurofins while this work was underway. L.M.V. and S.B. are employed by GeneDx, an OPKO Health Inc. company.	Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Bean LJH, 2016, HUM MUTAT, V37, P559, DOI 10.1002/humu.22982; Bean LJH, 2013, HUM MUTAT, V34, P1183, DOI 10.1002/humu.22364; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Golbus JR, 2012, CIRC-CARDIOVASC GENE, V5, P391, DOI 10.1161/CIRCGENETICS.112.962928; Han CY, 2012, BRAIN, V135, P2613, DOI 10.1093/brain/aws187; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Higgs JE, 2015, J MED GENET, V52, P642, DOI 10.1136/jmedgenet-2015-103206; Klee EW, 2011, EXPERT REV MOL DIAGN, V11, P703, DOI [10.1586/erm.11.58, 10.1586/ERM.11.58]; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Narravula A., 2016, GENET MED; Pepin MG, 2016, GENET MED, V18, P20, DOI 10.1038/gim.2015.31; Raivio T, 2012, J CLIN ENDOCR METAB, V97, pE694, DOI 10.1210/jc.2011-2938; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Smith EH, 2010, MOL GENET METAB, V100, P241, DOI 10.1016/j.ymgme.2010.04.001; Vail PJ, 2015, J COMMUN GENET, V6, P351, DOI 10.1007/s12687-015-0220-x; Vrijenhoek T, 2015, EUR J HUM GENET, V23, P1270, DOI 10.1038/ejhg.2015.44	21	42	43	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1140	1149		10.1016/j.ajhg.2016.09.015	http://dx.doi.org/10.1016/j.ajhg.2016.09.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27843123	Green Published, Bronze			2022-12-18	WOS:000387529600011
J	Vetrini, F; D'Alessandro, LCA; Akdemir, ZC; Braxton, A; Azamian, MS; Eldomery, MK; Miller, K; Kois, C; Sack, V; Shur, N; Rijhsinghani, A; Chandarana, J; Ding, Y; Holtzman, J; Jhangiani, SN; Muzny, DM; Gibbs, RA; Eng, CM; Hanchard, NA; Harel, T; Rosenfeld, JA; Belmont, JW; Lupski, JR; Yang, YP				Vetrini, Francesco; D'Alessandro, Lisa C. A.; Akdemir, Zeynep C.; Braxton, Alicia; Azamian, Mahshid S.; Eldomery, Mohammad K.; Miller, Kathryn; Kois, Chelsea; Sack, Virginia; Shur, Natasha; Rijhsinghani, Asha; Chandarana, Jignesh; Ding, Yan; Holtzman, Judy; Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Eng, Christine M.; Hanchard, Neil A.; Harel, Tamar; Rosenfeld, Jill A.; Belmont, John W.; Lupski, James R.; Yang, Yaping			Bi-allelic Mutations in PKD1L1 Are Associated with Laterality Defects in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; MOLECULAR-GENETICS; HUMAN HETEROTAXY; SITUS-INVERSUS; COILED-COIL; PROTEIN; IDENTIFICATION; POLYCYSTIN-2; EXPRESSION; DOMAIN	Disruption of the establishment of left-right (L-R) asymmetry leads to situs anomalies ranging from situs inversus totalis (SIT) to situs ambiguus (heterotaxy). The genetic causes of laterality defects in humans are highly heterogeneous. Via whole-exome sequencing (WES), we identified homozygous mutations in PKD1L1 from three affected individuals in two unrelated families. PKD1L1 encodes a polycystin-1-like protein and its loss of function is known to cause laterality defects in mouse and medaka fish models. Family 1 had one fetus and one deceased child with heterotaxy and complex congenital heart malformations. WES identified a homozygous splicing mutation, c.6473+2_6473+3delTG, which disrupts the invariant splice donor site in intron 42, in both affected individuals. In the second family, a homozygous c.5072G>C (p.Cys1691Ser) missense mutation was detected in an individual with SIT and congenital heart disease. The p.Cys1691Ser substitution affects a highly conserved cysteine residue and is predicted by molecular modeling to disrupt a disulfide bridge essential for the proper folding of the G protein-coupled receptor proteolytic site (GPS) motif. Damaging effects associated with substitutions of this conserved cysteine residue in the GPS motif have also been reported in other genes, namely GPR56, BAI3, and PKD1 in human and lat-1 in C. elegans, further supporting the likely pathogenicity of p.Cys1691Ser in PKD1L1. The identification of bi-allelic PKD1L1 mutations recapitulates previous findings regarding phenotypic consequences of loss of function of the orthologous genes in mice and medaka fish and further expands our understanding of genetic contributions to laterality defects in humans.	[Vetrini, Francesco; Braxton, Alicia; Chandarana, Jignesh; Eng, Christine M.; Yang, Yaping] Baylor Genet, Houston, TX 77030 USA; [D'Alessandro, Lisa C. A.] Texas Childrens Hosp, Div Cardiol, Houston, TX 77030 USA; [D'Alessandro, Lisa C. A.; Hanchard, Neil A.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Akdemir, Zeynep C.; Braxton, Alicia; Azamian, Mahshid S.; Eldomery, Mohammad K.; Gibbs, Richard A.; Eng, Christine M.; Hanchard, Neil A.; Harel, Tamar; Rosenfeld, Jill A.; Belmont, John W.; Lupski, James R.; Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Miller, Kathryn; Kois, Chelsea; Sack, Virginia; Shur, Natasha; Rijhsinghani, Asha] Albany Med Ctr, Albany, NY 12208 USA; [Ding, Yan; Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Holtzman, Judy] Kaiser Permanente Med Grp, Dept Genet, San Jose, CA 95123 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Albany Medical College; Baylor College of Medicine; Kaiser Permanente; Permanente Medical Groups	Yang, YP (corresponding author), Baylor Genet, Houston, TX 77030 USA.; Yang, YP (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	yapingy@bcm.edu	Hanchard, Neil/AAY-9075-2021; Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021; chandarana, Jignesh/W-8379-2019	Hanchard, Neil/0000-0003-1925-2665; Belmont, John W/0000-0001-7409-3578; chandarana, Jignesh/0000-0003-0374-5721; Azamian, Mahshid/0000-0002-8543-8284	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [U54HG006542]; NIH/NIGMS [T32 GM07526]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the families for their participation and collaboration. We thank Irene Miloslavskaya, Anh Dang from Baylor Genetics, and Theodore Chiang from Human Genome Center for their technical support. The study was supported in part by the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) grant no. U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics (J.R.L.). T.H. is supported by the NIH/NIGMS T32 GM07526 Medical Genetics Research Fellowship Program.	Andersen TA, 2014, CELL MOL LIFE SCI, V71, P1327, DOI 10.1007/s00018-013-1430-1; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bataille S, 2011, AM J KIDNEY DIS, V58, P456, DOI 10.1053/j.ajkd.2011.05.015; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Grimes DT, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006070; Guimier A, 2015, NAT GENET, V47, P1260, DOI 10.1038/ng.3376; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Izumi K, 2014, EUR J MED GENET, V57, P558, DOI 10.1016/j.ejmg.2014.08.003; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Kaasinen E, 2010, HUM MOL GENET, V19, P2747, DOI 10.1093/hmg/ddq164; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kathiriya IS, 2000, AM J MED GENET, V97, P271, DOI 10.1002/1096-8628(200024)97:4<271::AID-AJMG1277>3.0.CO;2-O; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Lalani SR, 2016, AM J HUM GENET, V98, P347, DOI 10.1016/j.ajhg.2015.12.008; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Mohapatra B, 2009, HUM MOL GENET, V18, P861, DOI 10.1093/hmg/ddn411; Narasimhan V, 2015, HUM MUTAT, V36, P307, DOI 10.1002/humu.22738; Peeters H, 2006, EUR J MED GENET, V49, P349, DOI 10.1016/j.ejmg.2005.12.003; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Perles Z, 2015, J MED GENET, V52, P840, DOI 10.1136/jmedgenet-2015-103336; Peterson TA, 2010, BIOINFORMATICS, V26, P2458, DOI 10.1093/bioinformatics/btq447; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Shiraishi I, 2012, CIRC J, V76, P2066, DOI 10.1253/circj.CJ-12-0957; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Tariq M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r91; Twigg SRF, 2012, AM J HUM GENET, V91, P897, DOI 10.1016/j.ajhg.2012.08.027; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; Ware SM, 2006, DEV DYNAM, V235, P1631, DOI 10.1002/dvdy.20719; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yuasa T, 2002, GENOMICS, V79, P376, DOI 10.1006/geno.2002.6719; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zhu LR, 2006, EUR J HUM GENET, V14, P17, DOI 10.1038/sj.ejhg.5201506	43	42	44	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					886	893		10.1016/j.ajhg.2016.07.011	http://dx.doi.org/10.1016/j.ajhg.2016.07.011			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616478	Green Published, Bronze			2022-12-18	WOS:000385333700008
J	Mahajan, A; Rodan, AR; Le, TH; Gaulton, KJ; Haessler, J; Stilp, AM; Kamatani, Y; Zhu, G; Sofer, T; Puri, S; Schellinger, JN; Chu, PL; Cechova, S; van Zuydam, N; Arnlov, J; Flessner, MF; Giedraitis, V; Heath, AC; Kubo, M; Larsson, A; Lindgren, CM; Madden, PAF; Montgomery, GW; Papanicolaou, GJ; Reiner, AP; Sundstrom, J; Thornton, TA; Lind, L; Ingelsson, E; Cai, J; Martin, NG; Kooperberg, C; Matsuda, K; Whitfield, JB; Okada, Y; Laurie, CC; Morris, AP; Franceschini, N				Mahajan, Anubha; Rodan, Aylin R.; Le, Thu H.; Gaulton, Kyle J.; Haessler, Jeffrey; Stilp, Adrienne M.; Kamatani, Yoichiro; Zhu, Gu; Sofer, Tamar; Puri, Sanjana; Schellinger, Jeffrey N.; Chu, Pei-Lun; Cechova, Sylvia; van Zuydam, Natalie; Arnlov, Johan; Flessner, Michael F.; Giedraitis, Vilmantas; Heath, Andrew C.; Kubo, Michiaki; Larsson, Anders; Lindgren, Cecilia M.; Madden, Pamela A. F.; Montgomery, Grant W.; Papanicolaou, George J.; Reiner, Alex P.; Sundstrom, Johan; Thornton, Timothy A.; Lind, Lars; Ingelsson, Erik; Cai, Jianwen; Martin, Nicholas G.; Kooperberg, Charles; Matsuda, Koichi; Whitfield, John B.; Okada, Yukinori; Laurie, Cathy C.; Morris, Andrew P.; Franceschini, Nora		SUMMIT Consortium	Trans-ethnic Fine Mapping Highlights Kidney-Function Genes Linked to Salt Sensitivity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NITRIC-OXIDE SYNTHASE; CELL-TYPES; LOCI; METAANALYSIS; DISEASE; HYPERTENSION; INDIVIDUALS; HOMOLOG; PROTEIN	We analyzed genome-wide association studies (GWASs), including data from 71,638 individuals from four ancestries, for estimated glomerular filtration rate (eGFR), a measure of kidney function used to define chronic kidney disease (CKD). We identified 20 loci attaining genome-wide-significant evidence of association (p < 5 x 10(-8)) with kidney function and highlighted that allelic effects on eGFR at lead SNPs are homogeneous across ancestries. We leveraged differences in the pattern of linkage disequilibrium between diverse populations to fine-map the 20 loci through construction of "credible sets" of variants driving eGFR association signals. Credible variants at the 20 eGFR loci were enriched for DNase I hypersensitivity sites (DHSS) in human kidney cells. DHS credible variants were expression quantitative trait loci for NFATC1 and RGS14 (at the SLC34A1 locus) in multiple tissues. Loss-of-function mutations in ancestral orthologs of both genes in Drosophila melanogaster were associated with altered sensitivity to salt stress. Renal mRNA expression of Nfatcl and Rgs14 in a salt-sensitive mouse model was also reduced after exposure to a high-salt diet or induced CKD. Our study (1) demonstrates the utility of trans-ethnic fine mapping through integration of GWASs involving diverse populations with genomic annotation from relevant tissues to define molecular mechanisms by which association signals exert their effect and (2) suggests that salt sensitivity might be an important marker for biological processes that affect kidney function and CKD in humans.	[Mahajan, Anubha; van Zuydam, Natalie; Lindgren, Cecilia M.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Rodan, Aylin R.; Puri, Sanjana; Schellinger, Jeffrey N.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75229 USA; [Le, Thu H.; Chu, Pei-Lun; Cechova, Sylvia] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Gaulton, Kyle J.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Haessler, Jeffrey; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Stilp, Adrienne M.; Sofer, Tamar; Thornton, Timothy A.; Laurie, Cathy C.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kamatani, Yoichiro; Okada, Yukinori] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Zhu, Gu; Martin, Nicholas G.; Whitfield, John B.] QIMR Berghofer Med Res Inst, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; [Arnlov, Johan; Larsson, Anders; Sundstrom, Johan; Lind, Lars] Uppsala Univ, Dept Med Sci, Cardiovasc Epidemiol, S-75185 Uppsala, Sweden; [Arnlov, Johan] Dalama Univ, Sch Hlth & Social Studies, S-79188 Falun, Sweden; [Flessner, Michael F.] Natl Inst Diabet Digest & Kidney Dis, NIH, Bethesda, MD 20892 USA; [Giedraitis, Vilmantas] Uppsala Univ, Dept Publ Hlth & Caring Sci, Mol Geriatr, S-75237 Uppsala, Sweden; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford OX3 7BN, England; [Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol Lab, Brisbane, Qld 4006, Australia; [Papanicolaou, George J.] NHLBI, Epidemiol Branch, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, S-75237 Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Cai, Jianwen] Univ N Carolina, Collaborat Studies Coordinating Ctr, Dept Biostat, Chapel Hill, NC 27599 USA; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo 1088639, Japan; [Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of California System; University of California San Diego; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; RIKEN; QIMR Berghofer Medical Research Institute; Uppsala University; Dalarna University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uppsala University; Washington University (WUSTL); RIKEN; University of Oxford; QIMR Berghofer Medical Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Uppsala University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of Tokyo; Osaka University; University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill	Morris, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.; Morris, AP (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England.; Franceschini, N (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA.	apmorris@liverpool.ac.uk; noraf@unc.edu	Ärnlöv, Johan/AAF-2746-2019; Montgomery, Grant W/B-7148-2008; Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009; Matsuda, Koichi/D-4597-2011	Ärnlöv, Johan/0000-0002-6933-4637; Montgomery, Grant W/0000-0002-4140-8139; Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Mahajan, Anubha/0000-0001-5585-3420; Marini, Simone/0000-0002-5704-3533; Lindgren, Cecilia/0000-0002-4903-9374; Matsuda, Koichi/0000-0001-7292-2686; Sofer, Tamar/0000-0001-8520-8860	US NIH [K08DK091316, R25DK101401, 5R21HL123677-02]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK094907-01]; Australian National Health and Medical Research Council; Japan Society for the Promotion of Science KAKENHI [15H05911, 15H05670, 15K14429]; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation; Wellcome Trust [WT098017]; Grants-in-Aid for Scientific Research [15H05670, 15K14429] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK072922, K08DK091316, R01DK094907, R25DK101401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation(Japan Rheumatism Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.R.R. and J.N.S. are supported by the US NIH (K08DK091316). T.H.L. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK094907-01). S.P. is supported by the US NIH (R25DK101401). G.W.M. is supported by the Australian National Health and Medical Research Council Fellowship Scheme. Yukinori Okada was supported by the Japan Society for the Promotion of Science KAKENHI (15H05911, 15H05670, 15K14429), the Japan Science and Technology Agency, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Takeda Science Foundation, Gout Research Foundation, the Tokyo Biochemical Research Foundation, and the Japan Rheumatism Foundation. A.P.M. is a Wellcome Trust Senior Fellow in Basic Biomedical Science (grant WT098017). N.F. is supported by the US NIH (5R21HL123677-02). The ESRD data reported here have been supplied by the United States Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government. Additional acknowledgments are provided in the Supplemental Data.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barba G, 2007, J HYPERTENS, V25, P1465, DOI 10.1097/HJH.0b013e3281139ebd; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; BIGAZZI R, 1994, HYPERTENSION, V23, P195, DOI 10.1161/01.HYP.23.2.195; Bihorac A, 2000, AM J HYPERTENS, V13, P864, DOI 10.1016/S0895-7061(00)00253-3; Brilli LL, 2013, PEDIATR NEPHROL, V28, P1909, DOI 10.1007/s00467-012-2320-8; Cechova S, 2013, CIRCULATION, V128, P1770, DOI 10.1161/CIRCULATIONAHA.113.003301; Chen SW, 2011, J BIOL CHEM, V286, P32775, DOI 10.1074/jbc.M111.248278; Collins AJ, 2015, KIDNEY INT SUPPL, V5, P2, DOI 10.1038/kisup.2015.2; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deshmukh HA, 2013, DIABETIC MED, V30, P1230, DOI 10.1111/dme.12211; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kanbay M, 2011, CURR OPIN NEPHROL HY, V20, P37, DOI 10.1097/MNH.0b013e32834122f1; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keyser P, 2007, INSECT BIOCHEM MOLEC, V37, P356, DOI 10.1016/j.ibmb.2006.12.009; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Lin YR, 2011, AGING CELL, V10, P438, DOI 10.1111/j.1474-9726.2011.00678.x; Lu Y, 2016, J AM SOC NEPHROL, V27, P2346, DOI 10.1681/ASN.2015050515; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Morris RC, 2016, CIRCULATION, V133, P881, DOI 10.1161/CIRCULATIONAHA.115.017923; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Persson AEG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00187; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Reiss AB, 2015, AM J KIDNEY DIS, V66, P1071, DOI 10.1053/j.ajkd.2015.06.028; Salzler HR, 2007, KIDNEY INT, V72, P1226, DOI 10.1038/sj.ki.5002519; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; Sveinbjornsson G, 2014, HUM MOL GENET, V23, P6935, DOI 10.1093/hmg/ddu399; THURAU K, 1965, KLIN WOCHENSCHR, V43, P410, DOI 10.1007/BF01483845; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; Wilcox CS, 1996, KIDNEY INT, pS9; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524; Yang YQ, 2009, HYPERTENSION, V54, P1360, DOI 10.1161/HYPERTENSIONAHA.109.139428	55	42	43	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					636	646		10.1016/j.ajhg.2016.07.012	http://dx.doi.org/10.1016/j.ajhg.2016.07.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27588450	Green Published, hybrid			2022-12-18	WOS:000383114800009
J	Chami, N; Chen, MH; Slater, AJ; Eicher, JD; Evangelou, E; Tajuddin, SM; Love-Gregory, L; Kacprowski, T; Schick, UM; Nomura, A; Giri, A; Lessard, S; Brody, JA; Schurmann, C; Pankratz, N; Yanek, LR; Manichaikul, A; Pazoki, R; Mihailov, E; Hill, WD; Raffield, LM; Burt, A; Bartz, TM; Becker, DM; Becker, LC; Boerwinkle, E; Bork-Jensen, J; Bottinger, EP; O'Donoghue, ML; Crosslin, DR; de Denus, S; Dube, MP; Elliott, P; Engstrom, G; Evans, MK; Floyd, JS; Fornage, M; Gao, H; Greinacher, A; Gudnason, V; Hansen, T; Harris, TB; Hayward, C; Hernesniemi, J; Highland, HM; Hirschhorn, JN; Hofman, A; Irvin, MR; Kahonen, M; Lange, E; Launer, LJ; Lehtimaki, T; Li, J; Liewald, DCM; Linneberg, A; Liu, YM; Lu, YC; Lyytikainen, LP; Magi, R; Mathias, RA; Melander, O; Metspalu, A; Mononen, N; Nalls, MA; Nickerson, DA; Nikus, K; O'Donnell, CJ; Orho-Melander, M; Pedersen, O; Petersmann, A; Polfus, L; Psaty, BM; Raitakari, OT; Raitoharju, E; Richard, M; Rice, KM; Rivadeneira, F; Rotter, JI; Schmidt, F; Smith, AV; Starr, JM; Taylor, KD; Teumer, A; Thuesen, BH; Torstenson, ES; Tracy, RP; Tzoulaki, I; Zakai, NA; Vacchi-Suzzi, C; van Duijn, CM; van Rooij, FJA; Cushman, M; Deary, IJ; Edwards, DRV; Vergnaud, AC; Wallentin, L; Waterworth, DM; White, HD; Wilson, JG; Zonderman, AB; Kathiresan, S; Grarup, N; Esko, T; Loos, RJF; Lange, LA; Faraday, N; Abumrad, NA; Edwards, TL; Ganesh, SK; Auer, PL; Johnson, AD; Reiner, AP; Lettre, G				Chami, Nathalie; Chen, Ming-Huei; Slater, Andrew J.; Eicher, John D.; Evangelou, Evangelos; Tajuddin, Salman M.; Love-Gregory, Latisha; Kacprowski, Tim; Schick, Ursula M.; Nomura, Akihiro; Giri, Ayush; Lessard, Samuel; Brody, Jennifer A.; Schurmann, Claudia; Pankratz, Nathan; Yanek, Lisa R.; Manichaikul, Ani; Pazoki, Raha; Mihailov, Evelin; Hill, W. David; Raffield, Laura M.; Burt, Amber; Bartz, Traci M.; Becker, Diane M.; Becker, Lewis C.; Boerwinkle, Eric; Bork-Jensen, Jette; Bottinger, Erwin P.; O'Donoghue, Michelle L.; Crosslin, David R.; de Denus, Simon; Dube, Marie-Pierre; Elliott, Paul; Engstrom, Gunnar; Evans, Michele K.; Floyd, James S.; Fornage, Myriam; Gao, He; Greinacher, Andreas; Gudnason, Vilmundur; Hansen, Torben; Harris, Tamara B.; Hayward, Caroline; Hernesniemi, Jussi; Highland, Heather M.; Hirschhorn, Joel N.; Hofman, Albert; Irvin, Marguerite R.; Kahonen, Mika; Lange, Ethan; Launer, Lenore J.; Lehtimaki, Terho; Li, Jin; Liewald, David C. M.; Linneberg, Allan; Liu, Yongmei; Lu, Yingchang; Lyytikainen, Leo-Pekka; Magi, Reedik; Mathias, Rasika A.; Melander, Olle; Metspalu, Andres; Mononen, Nina; Nalls, Mike A.; Nickerson, Deborah A.; Nikus, Kjell; O'Donnell, Chris J.; Orho-Melander, Marju; Pedersen, Oluf; Petersmann, Astrid; Polfus, Linda; Psaty, Bruce M.; Raitakari, Olli T.; Raitoharju, Emma; Richard, Melissa; Rice, Kenneth M.; Rivadeneira, Fernando; Rotter, Jerome I.; Schmidt, Frank; Smith, Albert Vernon; Starr, John M.; Taylor, Kent D.; Teumer, Alexander; Thuesen, Betina H.; Torstenson, Eric S.; Tracy, Russell P.; Tzoulaki, Ioanna; Zakai, Neil A.; Vacchi-Suzzi, Caterina; van Duijn, Cornelia M.; van Rooij, Frank J. A.; Cushman, Mary; Deary, Ian J.; Edwards, Digna R. Velez; Vergnaud, Anne-Claire; Wallentin, Lars; Waterworth, Dawn M.; White, Harvey D.; Wilson, James G.; Zonderman, Alan B.; Kathiresan, Sekar; Grarup, Niels; Esko, Tonu; Loos, Ruth J. F.; Lange, Leslie A.; Faraday, Nauder; Abumrad, Nada A.; Edwards, Todd L.; Ganesh, Santhi K.; Auer, Paul L.; Johnson, Andrew D.; Reiner, Alexander P.; Lettre, Guillaume			Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; AFRICAN-AMERICANS; SEQUENCE VARIANTS; PYRUVATE-KINASE; LOW-FREQUENCY; LOCI; RECEPTOR; GENE; METAANALYSIS	Red blood cell (RBC) traits are important heritable clinical biomarkers and modifiers of disease severity. To identify coding genetic variants associated with these traits, we conducted meta-analyses of seven RBC phenotypes in 130,273 multi-ethnic individuals from studies genotyped on an exome array. After conditional analyses and replication in 27,480 independent individuals, we identified 16 new RBC variants. We found low-frequency missense variants in MAP1A (rs55707100, minor allele frequency [MAF] = 3.3%, p = 2 x 10(-10) for hemoglobin [HGB]) and HNF4A (rs1800961, MAF = 2.4%, p < 3 x 10(-8) for hematocrit [HCT] and HGB). In African Americans, we identified a nonsense variant in CD36 associated with higher RBC distribution width (rs3211938, MAF = 8.7%, p = 7 x 10(-11)) and showed that it is associated with lower CD36 expression and strong allelic imbalance in ex vivo differentiated human erythroblasts. We also identified a rare missense variant in ALAS2 (rs201062903, MAF = 0.2%) associated with lower mean corpuscular volume and mean corpuscular hemoglobin (p < 8 x 10(-9)). Mendelian mutations in ALAS2 are a cause of sideroblastic anemia and erythropoietic protoporphyria. Gene-based testing highlighted three rare missense variants in PKLR, a gene mutated in Mendelian non-spherocytic hemolytic anemia, associated with HGB and HCT (SKAT p < 8 x 10(-7)). These rare, low-frequency, and common RBC variants showed pleiotropy, being also associated with platelet, white blood cell, and lipid traits. Our association results and functional annotation suggest the involvement of new genes in human erythropoiesis. We also confirm that rare and low-frequency variants play a role in the architecture of complex human traits, although their phenotypic effect is generally smaller than originally anticipated.	[Chami, Nathalie; Lessard, Samuel; Dube, Marie-Pierre; Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Chami, Nathalie; Lessard, Samuel; de Denus, Simon; Dube, Marie-Pierre; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1CB, Canada; [Chen, Ming-Huei; Eicher, John D.; O'Donnell, Chris J.; Johnson, Andrew D.] NHLBI, Populat Sci Branch, Framingham Heart Study, Framingham, MA 01702 USA; [Slater, Andrew J.] GlaxoSmithKline, Genet Target Sci, Res Triangle Pk, Res Triangle Pk, NC 27709 USA; [Slater, Andrew J.] OmicSoft Corp, Cary, NC 27513 USA; [Evangelou, Evangelos; Elliott, Paul; Gao, He; Tzoulaki, Ioanna; Vergnaud, Anne-Claire] Imperial Coll London, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England; [Evangelou, Evangelos; Tzoulaki, Ioanna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina 45110, Greece; [Tajuddin, Salman M.; Evans, Michele K.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA; [Love-Gregory, Latisha; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Kacprowski, Tim; Schmidt, Frank] Ernst Moritz Arndt Univ Greifswald, Dept Funct Gen, Interfaculty Inst Genet & Funct Gen, Univ Med, D-17475 Greifswald, Germany; [Kacprowski, Tim] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Schick, Ursula M.; Schurmann, Claudia; Bottinger, Erwin P.; Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10069 USA; [Nomura, Akihiro; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Nomura, Akihiro; Hirschhorn, Joel N.; Kathiresan, Sekar; Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Nomura, Akihiro; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Nomura, Akihiro; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Nomura, Akihiro] Kanazawa Univ, Grad Sch Med Sci, Div Cardiovasc Med, Kanazawa, Ishikawa 9200942, Japan; [Giri, Ayush; Torstenson, Eric S.; Edwards, Todd L.] Vanderbilt Univ, Inst Med & Publ Hlth, Vanderbilt Genet Inst, Div Epidemiol, Nashville, TN 37235 USA; [Brody, Jennifer A.; Floyd, James S.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Schurmann, Claudia; Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10069 USA; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Yanek, Lisa R.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med Div Gen Internal Med icine, Div Gen Internal Med, Baltimore, MD 21205 USA; [Manichaikul, Ani] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA; [Pazoki, Raha; Hofman, Albert; Rivadeneira, Fernando; van Duijn, Cornelia M.; van Rooij, Frank J. A.] Erasmus, Dept Epidemiol, NL-3000 Mcrotterdam, Netherlands; [Mihailov, Evelin; Magi, Reedik; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Hill, W. David; Liewald, David C. M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Hill, W. David; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Raffield, Laura M.; Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Burt, Amber] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Bartz, Traci M.; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Becker, Lewis C.] Johns Hopkins Univ Sch Med, Dept Med, Div Cardiol & Gen Internal Med, Baltimore, MD 21205 USA; [Boerwinkle, Eric; Highland, Heather M.; Polfus, Linda] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bork-Jensen, Jette; Hansen, Torben; Pedersen, Oluf; Grarup, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metabol Res, DK-2100 Copenhagen, Denmark; [O'Donoghue, Michelle L.] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, Boston, MA 02115 USA; [Crosslin, David R.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [de Denus, Simon] Univ Montreal, Fac Pharm, Montreal, PQ H3T 1J4, Canada; [Engstrom, Gunnar; Melander, Olle; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, S-22100 Malmo, Sweden; [Engstrom, Gunnar; Melander, Olle; Orho-Melander, Marju] Skane Univ Hosp, S-22241 Malmo, Sweden; [Fornage, Myriam; Richard, Melissa] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; [Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany; [Gudnason, Vilmundur; Smith, Albert Vernon] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Gudnason, Vilmundur; Smith, Albert Vernon] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Intramural Res Program, NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hayward, Caroline] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hernesniemi, Jussi; Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Mononen, Nina; Raitoharju, Emma] Fimlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Hernesniemi, Jussi; Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Mononen, Nina; Raitoharju, Emma] Univ Tampere, Dept Clin Chem, Sch Med, Tampere 33014, Finland; [Hernesniemi, Jussi; Nikus, Kjell] Univ Tampere, Sch Med, Tampere 33014, Finland; [Highland, Heather M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Hirschhorn, Joel N.] Boston Childrens Hosp, Dept Endocrinol, Boston, MA 02115 USA; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Irvin, Marguerite R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35233 USA; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Sch Med, Tampere 33014, Finland; [Lange, Ethan] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Lange, Ethan] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Li, Jin] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Palo Alto, CA 94305 USA; [Linneberg, Allan; Thuesen, Betina H.] Capital Region Denmark, Res Ctr Prevent & Hlth, DK-2600 Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, DK-2100 Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, DK-2200 Copenhagen, Denmark; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC 27157 USA; [Mathias, Rasika A.] Johns Hopkins Univ Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Mathias, Rasika A.] Johns Hopkins Univ Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Nalls, Mike A.] NIA, NIH, Neurogenet Lab, Bethesda, MD 20892 USA; [Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA; [Nikus, Kjell] Tampere Univ Hosp, Dept Cardiol, Ctr Heart, Tampere 33521, Finland; [O'Donnell, Chris J.] Boston Vet Adm VA Healthcare, Cardiol Sect, Boston, MA 02118 USA; [O'Donnell, Chris J.] Boston Vet Adm VA Healthcare, Ctr Populat Gen, Boston, MA 02118 USA; [Petersmann, Astrid] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Psaty, Bruce M.] Univ Washington, Dept Med Epidemiol & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98101 USA; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20521, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20520, Finland; [Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, NL-3000 Rotterdam, Netherlands; [Rivadeneira, Fernando] NCHA, NL-3015 Rotterdam, Netherlands; [Rotter, Jerome I.; Taylor, Kent D.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Rotter, Jerome I.; Taylor, Kent D.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Starr, John M.] Alzheimer Scotland Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Tracy, Russell P.] Univ Vermont Coll Med, Dept Pathol, Colchester, VT 05446 USA; [Tracy, Russell P.] Univ Vermont Coll Med, Dept Lab Med, Colchester, VT 05446 USA; [Tracy, Russell P.] Univ Vermont Coll Med, Dept Biochem, Colchester, VT 05446 USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont Coll Med, Dept Med, Burlington, VT 05405 USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Vacchi-Suzzi, Caterina] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Dept Obstet & Gynecol, Inst Med & Publ Hlth,Vanderbilt Genet Inst, Nashville, TN 37203 USA; [Wallentin, Lars] Uppsala Univ, Dept Med Sci, Cardiol & Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; [Waterworth, Dawn M.] Genet Target Sci, GlaxoSmithKline, King Of Prussia, PA 19406 USA; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1142, New Zealand; [White, Harvey D.] Univ Auckland, Auckland 1142, New Zealand; [Wilson, James G.] Univ Mississippi Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10069 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48108 USA; [Ganesh, Santhi K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48108 USA; [Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53205 USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	Universite de Montreal; Universite de Montreal; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); GlaxoSmithKline; Imperial College London; University of Ioannina; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Washington University (WUSTL); Ernst Moritz Arndt Universitat Greifswald; German Centre for Cardiovascular Research; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kanazawa University; Vanderbilt University; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; University of Virginia; Erasmus University Rotterdam; University of Tartu; University of Edinburgh; University of Edinburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Novo Nordisk Foundation; University of Copenhagen; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; Universite de Montreal; Lund University; Lund University; Skane University Hospital; University of Texas System; University of Texas Health Science Center Houston; Greifswald Medical School; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; Tampere University; Tampere University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Alabama System; University of Alabama Birmingham; Tampere University; Tampere University Hospital; Tampere University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; Rigshospitalet; University of Copenhagen; Wake Forest University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Tampere University; Tampere University Hospital; Greifswald Medical School; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Turku; University of Turku; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Greifswald Medical School; University of Vermont; University of Vermont; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Vanderbilt University; Uppsala University; GlaxoSmithKline; Auckland City Hospital; University of Auckland; University of Mississippi; University of Mississippi Medical Center; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Lettre, G (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada.; Lettre, G (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1CB, Canada.; Reiner, AP (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Reiner, AP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	apreiner@u.washington.edu; guillaume.lettre@umontreal.ca	Schurmann, Claudia/L-1204-2016; Nomura, Akihiro/ABE-2871-2020; Rivadeneira, Fernando/O-5385-2015; Grarup, Niels/K-2807-2015; Kacprowski, Tim/K-8650-2013; Gudnason, Vilmundur/AAE-7126-2019; Nikus, Kjell/K-7813-2019; Cushman, Mary/K-1157-2019; Teumer, Alexander/S-7438-2019; Lehtimäki, Terho/AAD-1094-2022; Kacprowski, Tim/N-9692-2019; Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Evangelou, Evangelos/C-3033-2013; Deary, Ian J/C-6297-2009; Mägi, Reedik/AAJ-9679-2021; Raitakari, Olli/AAQ-7389-2021; Floyd, James/G-7563-2015; Tzoulaki, Ioanna/ABE-6269-2020; Hernesniemi, Jussi/ABH-1842-2021; Dubé, Marie-Pierre/B-9364-2008; Johnson, Andrew D/G-6520-2013; Pedersen, Oluf/Z-1731-2019; Auer, Paul/AAC-5060-2019; Evans, Michele Kim/AAE-4776-2019; Pedersen, Oluf/AAG-8015-2020; Rotter, Jerome/AAY-6598-2021; Smith, Albert Vernon/K-5150-2015	Schurmann, Claudia/0000-0003-4158-9192; Nomura, Akihiro/0000-0001-6647-8240; Rivadeneira, Fernando/0000-0001-9435-9441; Grarup, Niels/0000-0001-5526-1070; Kacprowski, Tim/0000-0002-5393-2413; Gudnason, Vilmundur/0000-0001-5696-0084; Cushman, Mary/0000-0002-7871-6143; Teumer, Alexander/0000-0002-8309-094X; Lehtimäki, Terho/0000-0002-2555-4427; Kacprowski, Tim/0000-0002-5393-2413; Loos, Ruth J F/0000-0002-8532-5087; Evangelou, Evangelos/0000-0002-5488-2999; Deary, Ian J/0000-0002-1733-263X; Tzoulaki, Ioanna/0000-0002-4275-9328; Hernesniemi, Jussi/0000-0002-8111-6421; Dubé, Marie-Pierre/0000-0001-8442-4393; Johnson, Andrew D/0000-0001-6369-5178; Pedersen, Oluf/0000-0002-3321-3972; Nikus, Kjell/0000-0002-9345-9851; Zonderman, Alan B/0000-0002-6523-4778; Pankratz, Nathan/0000-0001-5958-693X; Linneberg, Allan/0000-0002-0994-0184; Gueranger, Anne-Claire/0000-0003-0728-9313; Melander, Olle/0000-0002-2581-484X; Elliott, Paul/0000-0002-7511-5684; Chen, Ming-Huei/0000-0003-3551-8726; Slater, Andrew/0000-0002-2467-0231; Raitoharju, Emma/0000-0002-7023-8706; Manichaikul, Ani/0000-0002-5998-795X; Pazoki, Raha/0000-0002-5142-2348; Chami, Nathalie/0000-0002-8547-6424; Tajuddin, Salman M./0000-0002-7919-8528; Kahonen, Mika/0000-0002-4510-7341; Raffield, Laura/0000-0002-7892-193X; Smith, Albert Vernon/0000-0003-1942-5845; Schmidt, Frank/0000-0001-5406-3988; Thuesen, Betina/0000-0001-9772-4344; Hansen, Torben/0000-0001-8748-3831; Van Duijn, Cornelia/0000-0002-2374-9204; Evans, Michele/0000-0002-8546-2831; Magi, Reedik/0000-0002-2964-6011	Fonds de Recherche du Queebec-Santee (FRQS); Canadian Institute of Health Research (Banting-CIHR); Canadian Institute of Health Research (operating grant MOP) [123382]; Canada Research Chair program; NHLBI [R21 HL121422-02]; NIH [DK060022]; Yoshida Scholarship Foundation; Research Scholar award from the Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation [R01HL107816]; Fondation Leducq; MRC [MC_PC_U127561128, MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MC_PC_U127561128, MR/L01341X/1, MR/K026992/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074711] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122684, R01HL120393, R21HL121429, ZIAHL006170, T32HL007055, R01HL105756, R01HL107816, R21HL121422, R01HL112064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P30DK056341, R01DK033301, R01DK060022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000519] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Fonds de Recherche du Queebec-Santee (FRQS); Canadian Institute of Health Research (Banting-CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research (operating grant MOP)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yoshida Scholarship Foundation(Yoshida Scholarship Foundation); Research Scholar award from the Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation; Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all participants, staff, and study coordinating centers. We also thank Raymond Doty and Jan Abkowitz for discussion of the ALAS2 finding. We would like to thank Liling Warren for contributions to the genetic analysis of the SOLID-TIMI-52 and STABILITY datasets. Young Finns Study (YFS) acknowledges the expert technical assistance in the statistical analyses by Ville Aalto and Irina Lisinen. Estonian Genome Center, University of Tartu (EGCUT) thanks co-workers at the Estonian Biobank, especially Mr. V. Soo, Mr. S. Smith, and Dr. L. Milani. Airwave thanks Louisa Cavaliero who assisted in data collection and management as well as Peter McFarlane and the Glasgow CARE, Patricia Munroe at Queen Mary University of London, and Joanna Sarnecka and Ania Zawodniak at Northwick Park for their contributions to the study. This work was supported by the Fonds de Recherche du Queebec-Santee (FRQS, scholarship to N.C.), the Canadian Institute of Health Research (Banting-CIHR, scholarship to S.L. and operating grant MOP#123382 to G.L.), and the Canada Research Chair program (to G.L.). P.L.A. was supported by NHLBI R21 HL121422-02. N.A.A. is funded by NIH DK060022. A.N. was supported by the Yoshida Scholarship Foundation. S.K. was supported by a Research Scholar award from the Massachusetts General Hospital (MGH), the Howard Goodman Fellowship from MGH, the Donovan Family Foundation, R01HL107816, and a grant from Fondation Leducq. Additional acknowledgments and funding information is provided in the Supplemental Data.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Brugnara C, 2003, CLIN CHEM, V49, P1573, DOI 10.1373/49.10.1573; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Colin Y, 2014, CURR OPIN HEMATOL, V21, P186, DOI 10.1097/MOH.0000000000000036; de Vries PS, 2016, HUM MOL GENET, V25, P358, DOI 10.1093/hmg/ddv454; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dobbeling U, 1997, SCAND J IMMUNOL, V45, P494, DOI 10.1046/j.1365-3083.1997.d01-426.x; Eicher JD, 2016, AM J HUM GENET, V99, P40, DOI 10.1016/j.ajhg.2016.05.005; Elbers CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050198; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Guastadisegni MC, 2010, LEUKEMIA, V24, P1516, DOI 10.1038/leu.2010.106; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Huang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104861; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Limongelli G., 2012, APPROACHING GENETIC; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Nada AM, 2015, DIABETES METAB SYNDR, V8, P525, DOI 10.2147/DMSO.S85318; Nicholson AC, 2001, ANN NY ACAD SCI, V947, P224; OKUMURA N, 1992, BLOOD, V80, P642; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Patel HH, 2015, AM J HEMATOL, V90, P422, DOI 10.1002/ajh.23982; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pradel LC, 2015, M S-MED SCI, V31, P236, DOI 10.1051/medsci/20153103003; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Serbanovic-Canic J, 2011, BLOOD, V118, P4967, DOI 10.1182/blood-2011-02-337295; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Tajuddin SM, 2016, AM J HUM GENET, V99, P22, DOI 10.1016/j.ajhg.2016.05.003; Takei Y, 2015, J NEUROSCI, V35, P15539, DOI 10.1523/JNEUROSCI.2671-15.2015; Taylor KC, 2011, HUM MOL GENET, V20, P3525, DOI 10.1093/hmg/ddr264; Ulker P, 2009, BIORHEOLOGY, V46, P121, DOI 10.3233/BIR-2009-0532; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Wells QS, 2013, CIRC-CARDIOVASC GENE, V6, P317, DOI 10.1161/CIRCGENETICS.113.000011; Whelihan MF, 2013, THROMB RES, V131, P377, DOI 10.1016/j.thromres.2013.01.023; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zalawadiya SK, 2012, VASC MED, V17, P155, DOI 10.1177/1358863X12442443; Zalawadiya SK, 2011, J CARD FAIL, V17, P292, DOI 10.1016/j.cardfail.2010.11.006; Zarza R, 1998, BRIT J HAEMATOL, V103, P377; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532	65	42	43	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					8	21		10.1016/j.ajhg.2016.05.007	http://dx.doi.org/10.1016/j.ajhg.2016.05.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27346685	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000381616600002
J	Willems, T; Gymrek, M; Poznik, GD; Tyler-Smith, C; Erlich, Y				Willems, Thomas; Gymrek, Melissa; Poznik, G. David; Tyler-Smith, Chris; Erlich, Yaniv		1000 Genomes Project Chromosome Y	Population-Scale Sequencing Data Enable Precise Estimates of Y-STR Mutation Rates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT TANDEM REPEATS; DE-NOVO MUTATIONS; MICROSATELLITE LOCI; DNA-SEQUENCES; LIKELIHOOD APPROACH; MAXIMUM-LIKELIHOOD; HUMAN-DISEASE; CHROMOSOME; GENOME; HUMANS	Short tandem repeats (STRs) are mutation-prone loci that span nearly 1% of the human genome. Previous studies have estimated the mutation rates of highly polymorphic STRs by using capillary electrophoresis and pedigree-based designs. Although this work has provided insights into the mutational dynamics of highly mutable STRs, the mutation rates of most others remain unknown. Here, we harnessed whole-genome sequencing data to estimate the mutation rates of Y chromosome STRs (Y-STRs) with 2-6 bp repeat units that are accessible to Illumina sequencing. We genotyped 4,500 Y-STRs by using data from the 1000 Genomes Project and the Simons Genome Diversity Project. Next, we developed MUTEA, an algorithm that infers STR mutation rates from population-scale data by using a high-resolution SNP-based phylogeny. After extensive intrinsic and extrinsic validations, we harnessed MUTEA to derive mutation-rate estimates for 702 polymorphic STRs by tracing each locus over 222,000 meioses, resulting in the largest collection of Y-STR mutation rates to date. Using our estimates, we identified determinants of STR mutation rates and built a model to predict rates for STRs across the genome. These predictions indicate that the load of de novo STR mutations is at least 75 mutations per generation, rivaling the load of all other known variant types. Finally, we identified Y-STRs with potential applications in forensics and genetic genealogy, assessed the ability to differentiate between the Y chromosomes of father-son pairs, and imputed Y-STR genotypes.	[Willems, Thomas; Gymrek, Melissa; Erlich, Yaniv] New York Genome Ctr, New York, NY 10013 USA; [Willems, Thomas] MIT, Computat & Syst Biol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Willems, Thomas; Gymrek, Melissa; Erlich, Yaniv] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Gymrek, Melissa] MIT, Harvard MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gymrek, Melissa] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Poznik, G. David] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Poznik, G. David] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, Cambs, England; [Erlich, Yaniv] Columbia Univ, Sch Engn, Fu Fdn, Dept Comp Sci, New York, NY 10027 USA; [Erlich, Yaniv] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Stanford University; Wellcome Trust Sanger Institute; Columbia University; Columbia University	Erlich, Y (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; Erlich, Y (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Erlich, Y (corresponding author), Columbia Univ, Sch Engn, Fu Fdn, Dept Comp Sci, New York, NY 10027 USA.; Erlich, Y (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA.	yaniv@cs.columbia.edu			National Defense Science and Engineering Graduate Fellowship; National Science Foundation [DGE-1147470]; Wellcome Trust [098051]; Burroughs Wellcome Fund; National Institute of Justice [2014-DN-BX-K089]	National Defense Science and Engineering Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome Trust); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Justice(US National Institute of Justice)	M.G. was supported by the National Defense Science and Engineering Graduate Fellowship. G.D.P. was supported by the National Science Foundation Graduate Research Fellowship under grant DGE-1147470. C.T.-S. was supported by Wellcome Trust grant 098051. Y.E. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. This study was supported by National Institute of Justice grant 2014-DN-BX-K089 (to Y.E. and T.W.). Y.E. is a scientific advisory board member of Identity Genomics, BigDataBio, and Solve Inc. G.D.P is an employee of 23andMe. None of these entities played a role in the design, execution, interpretation, or presentation of this study.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bacon AL, 2000, HUM MOL GENET, V9, P2707, DOI 10.1093/hmg/9.18.2707; Ballantyne KN, 2014, HUM MUTAT, V35, P1021, DOI 10.1002/humu.22599; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Burgarella C, 2011, EUR J HUM GENET, V19, P70, DOI 10.1038/ejhg.2010.154; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gymrek M., 2016, BIORXIV; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hanson Erin K., 2006, Legal Medicine, V8, P110, DOI 10.1016/j.legalmed.2005.10.001; Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Highnam G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks981; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2011, NAT REV GENET, V12, P179, DOI 10.1038/nrg2952; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Li H., 2013, ARXIV13033997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nielsen R, 1997, GENETICS, V146, P711; Petes TD, 1997, GENETICS, V146, P491; Poznik G.D., 2016, NAT GENET; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sainudiin R, 2004, GENETICS, V168, P383, DOI 10.1534/genetics.103.022665; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; SHAO J, 1989, ANN STAT, V17, P1176, DOI 10.1214/aos/1176347263; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; SLATKIN M, 1995, GENETICS, V139, P457; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Sureshkumar S, 2009, SCIENCE, V323, P1060, DOI 10.1126/science.1164014; Vermeulen M, 2009, FORENSIC SCI INT-GEN, V3, P205, DOI 10.1016/j.fsigen.2009.01.009; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Warshauer DH, 2013, FORENSIC SCI INT-GEN, V7, P409, DOI 10.1016/j.fsigen.2013.04.005; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wei W, 2013, FORENSIC SCI INT-GEN, V7, P568, DOI 10.1016/j.fsigen.2013.03.014; WEISER JN, 1989, CELL, V59, P657, DOI 10.1016/0092-8674(89)90011-1; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017; Wilson IJ, 1998, GENETICS, V150, P499; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	67	42	43	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					919	933		10.1016/j.ajhg.2016.04.001	http://dx.doi.org/10.1016/j.ajhg.2016.04.001			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27126583	Green Published, Bronze			2022-12-18	WOS:000375869300010
J	Kremer, LS; Distelmaier, F; Alhaddad, B; Hempel, M; Iuso, A; Kupper, C; Muhlhausen, C; Kovacs-Nagy, R; Satanovskij, R; Graf, E; Berutti, R; Eckstein, G; Durbin, R; Sauer, S; Hoffmann, GF; Strom, TM; Santer, R; Meitinger, T; Klopstock, T; Prokisch, H; Haack, TB				Kremer, Laura S.; Distelmaier, Felix; Alhaddad, Bader; Hempel, Maja; Iuso, Arcangela; Kuepper, Clemens; Muehlhausen, Chris; Kovacs-Nagy, Reka; Satanovskij, Robin; Graf, Elisabeth; Berutti, Riccardo; Eckstein, Gertrud; Durbin, Richard; Sauer, Sascha; Hoffmann, Georg F.; Strom, Tim M.; Santer, Rene; Meitinger, Thomas; Klopstock, Thomas; Prokisch, Holger; Haack, Tobias B.			Bi-allelic Truncating Mutations in TANGO2 Cause Infancy-Onset Recurrent Metabolic Crises with Encephalocardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELETION SYNDROME; MITOCHONDRIAL; DEFICIENCY; GENES	Molecular diagnosis of mitochondrial disorders is challenging because of extreme clinical and genetic heterogeneity. By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation. Over the course of the disease, all individuals developed global brain atrophy with cognitive impairment and pyramidal signs. TANGO2 (transport and Golgi organization 2) encodes a protein with a putative function in redistribution of Golgi membranes into the endoplasmic reticulum in Drosophila and a mitochondrial localization has been confirmed in mice. Investigation of palmitate-dependent respiration in mutant fibroblasts showed evidence of a functional defect in mitochondrial b-oxidation. Our results establish TANGO2 deficiency as a clinically recognizable cause of pediatric disease with multiorgan involvement.	[Kremer, Laura S.; Alhaddad, Bader; Iuso, Arcangela; Kovacs-Nagy, Reka; Satanovskij, Robin; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger; Haack, Tobias B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kremer, Laura S.; Iuso, Arcangela; Graf, Elisabeth; Berutti, Riccardo; Eckstein, Gertrud; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger; Haack, Tobias B.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Distelmaier, Felix] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Hempel, Maja] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Kuepper, Clemens; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany; [Kuepper, Clemens; Meitinger, Thomas; Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Kuepper, Clemens; Klopstock, Thomas] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Muehlhausen, Chris; Santer, Rene] Univ Med Ctr Hamburg Eppendorf, Univ Childrens Hosp, D-20246 Hamburg, Germany; [Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, D-97080 Wurzburg, Germany; [Hoffmann, Georg F.] Univ Heidelberg Hosp, Dept Gen Pediat, Div Pediat Metab Med & Neuropediat, D-69120 Heidelberg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Hamburg; University Medical Center Hamburg-Eppendorf; Wellcome Trust Sanger Institute; Max Planck Society; University of Wurzburg; Ruprecht Karls University Heidelberg	Meitinger, T (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.; Meitinger, T (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.; Meitinger, T (corresponding author), Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany.	meitinger@helmholtz-muenchen.de	Alhaddad, Bader/AAJ-5504-2021; Meitinger, Thomas/O-1318-2015; Durbin, Richard/AAE-7178-2019	Alhaddad, Bader/0000-0003-4542-5267; Durbin, Richard/0000-0002-9130-1006; Muhlhausen, Chris/0000-0003-0516-1826; Meitinger, Thomas/0000-0002-8838-8403; Kremer, Laura/0000-0002-1647-7538; Prokisch, Holger/0000-0003-2379-6286; Kupper, Clemens/0000-0003-3919-639X	European Commission [262055]; German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET) [01GM1113A, 01GM1113C]; German Bundesministerium fur Bildung und Forschung (BMBF) through the E-Rare project GENOMIT [01GM1207]; BMBF through the Juniorverbund in der Systemmedizin "mitOmics'' [FKZ 01ZX1405C]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); German Bundesministerium fur Bildung und Forschung (BMBF) through the E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); BMBF through the Juniorverbund in der Systemmedizin "mitOmics''(Federal Ministry of Education & Research (BMBF))	The authors thank Veronika Schwarz for excellent technical assistance. This study was supported by the European Commission (FP7/2007-2013, under grant agreement number no. 262055 [ESGI], as a Transnational Access project of the European Sequencing and Genotyping Infrastructure); the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET, 01GM1113A to T.K., 01GM1113C to T.M. and H.P.), and through the E-Rare project GENOMIT (01GM1207 for T.M. and H.P.). T.B.H. was supported by the BMBF through the Juniorverbund in der Systemmedizin "mitOmics'' (FKZ 01ZX1405C).	Barca E, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0590-9; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bastin J, 2014, BIOCHIMIE, V96, P113, DOI 10.1016/j.biochi.2013.05.012; Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023; Haack TB, 2015, ANN CLIN TRANSL NEUR, V2, P492, DOI 10.1002/acn3.189; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184	11	42	46	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					358	362		10.1016/j.ajhg.2015.12.009	http://dx.doi.org/10.1016/j.ajhg.2015.12.009			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26805782	Green Published, Bronze			2022-12-18	WOS:000370502300012
J	Racedo, SE; McDonald-McGinn, DM; Chung, JH; Goldmuntz, E; Zackai, E; Emanuel, BS; Zhou, B; Funke, B; Morrow, BE				Racedo, Silvia E.; McDonald-McGinn, Donna M.; Chung, Jonathan H.; Goldmuntz, Elizabeth; Zackai, Elaine; Emanuel, Beverly S.; Zhou, Bin; Funke, Birgit; Morrow, Bernice E.			Mouse and Human CRKL Is Dosage Sensitive for Cardiac Outflow Tract Formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPARIN-COFACTOR II; 22Q11.2 DELETIONS; ADAPTER PROTEINS; DIGEORGE-SYNDROME; PLASMA-MEMBRANE; FACIAL SYNDROME; GENE; TBX1; EXPRESSION; PHENOTYPE	The human chromosome 22q11.2 region is susceptible to rearrangements during meiosis leading to velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome (22q11DS) characterized by conotruncal heart defects (CTDs) and other congenital anomalies. The majority of individuals have a 3 Mb deletion whose proximal region contains the presumed disease-associated gene TBX1 (T-box 1). Although a small subset have proximal nested deletions including TBX1, individuals with distal deletions that exclude TBX1 have also been identified. The deletions are flanked by low-copy repeats (LCR22A, B, C, D). We describe cardiac phenotypes in 25 individuals with atypical distal nested deletions within the 3 Mb region that do not include TBX1 including 20 with LCR22B to LCR22D deletions and 5 with nested LCR22C to LCR22D deletions. Together with previous reports, 12 of 37 (32%) with LCR22B-D deletions and 5 of 34 (15%) individuals with LCR22C-D deletions had CTDs including tetralogy of Fallot. In the absence of TBX1, we hypothesized that CRKL (Crk-like), mapping to the LCR22C-D region, might contribute to the cardiac phenotype in these individuals. We created an allelic series in mice of Crkl, including a hypomorphic allele, to test for gene expression effects on phenotype. We found that the spectrum of heart defects depends on Crkl expression, occurring with analogous malformations to that in human individuals, suggesting that haploinsufficiency of CRKL could be responsible for the etiology of CTDs in individuals with nested distal deletions and might act as a genetic modifier of individuals with the typical 3 Mb deletion.	[Racedo, Silvia E.; Chung, Jonathan H.; Zhou, Bin; Morrow, Bernice E.] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [McDonald-McGinn, Donna M.; Zackai, Elaine; Emanuel, Beverly S.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Genet, Philadelphia, PA 19104 USA; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Funke, Birgit] Partners HealthCare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA 02139 USA	Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Partners Healthcare System	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	bernice.morrow@einstein.yu.edu	McDonald-McGinn, Donna/L-8643-2019	Morrow, Bernice/0000-0002-8076-4726; McDonald-McGinn, Donna/0000-0003-4077-250X; Chung, Jonathan/0000-0003-3010-1059	NIH [P01HD070454]; AHA [12POST9100003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank the families and individuals who kindly provided biological samples for genetic research as well as the information about their cardiac diagnosis. We also want to thank the Histopathology and Genomics Core Facilities at Einstein. This work was supported by NIH P01HD070454 (B.E.M., D.M.M.-M., B.S.E., E.G.) and an AHA postdoctoral grant 12POST9100003 (S.E.R.).	Aihara K, 2009, J ATHEROSCLER THROMB, V16, P523, DOI 10.5551/jat.1552; Anastasio N, 2010, AM J HUM GENET, V87, P553, DOI 10.1016/j.ajhg.2010.09.005; Beck J, 2013, NAT CELL BIOL, V15, P430, DOI 10.1038/ncb2695; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Burn J, 1996, CURR OPIN GENET DEV, V6, P322, DOI 10.1016/S0959-437X(96)80009-8; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Cote F, 2001, DNA CELL BIOL, V20, P159, DOI 10.1089/104454901300069004; Dykes IM, 2014, CIRC RES, V115, P23, DOI 10.1161/CIRCRESAHA.115.303300; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; Garcia-Minaur S, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.10.e62; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grondin B, 1997, J BIOL CHEM, V272, P27877, DOI 10.1074/jbc.272.44.27877; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Hausmann R, 2012, J BIOL CHEM, V287, P13930, DOI 10.1074/jbc.M112.345207; Hwang J, 2007, J BIOL CHEM, V282, P18645, DOI 10.1074/jbc.M702035200; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kodo K, 2011, CIRC J, V75, P2296, DOI 10.1253/circj.CJ-11-0636; Kumar A, 2014, IMMUNOBIOLOGY, V219, P713, DOI 10.1016/j.imbio.2014.05.003; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; Macfarlan T, 2006, MOL ENDOCRINOL, V20, P335, DOI 10.1210/me.2005-0248; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Nacak TG, 2006, J BIOL CHEM, V281, P5065, DOI 10.1074/jbc.M509073200; Park TJ, 2006, MOL CELL BIOL, V26, P6272, DOI 10.1128/MCB.00472-06; Prosser S, 2003, ONCOGENE, V22, P4799, DOI 10.1038/sj.onc.1206714; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Rump P, 2014, AM J MED GENET A, V164, P2707, DOI 10.1002/ajmg.a.36711; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Vaillancourt FH, 2012, J VIROL, V86, P11595, DOI 10.1128/JVI.01320-12; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Verhagen JMA, 2012, AM J MED GENET A, V158A, P2412, DOI 10.1002/ajmg.a.35517; Wolf S, 2002, BIOCHEM J, V364, P767, DOI 10.1042/BJ20020084; Xie Q, 2005, J BIOL CHEM, V280, P19673, DOI 10.1074/jbc.M409517200; Xu XL, 2001, GENESIS, V30, P1, DOI 10.1002/gene.1025; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Yu Q, 2010, HISTOCHEM CELL BIOL, V133, P177, DOI 10.1007/s00418-009-0659-0; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	47	42	48	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					235	244		10.1016/j.ajhg.2014.12.025	http://dx.doi.org/10.1016/j.ajhg.2014.12.025			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25658046	Green Published, Bronze			2022-12-18	WOS:000349276700005
J	Dal Mas, A; Rogalska, ME; Bussani, E; Pagani, F				Dal Mas, Andrea; Rogalska, Malgorzata Ewa; Bussani, Erica; Pagani, Franco			Improvement of SMN2 Pre-mRNA Processing Mediated by Exon-Specific U1 Small Nuclear RNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; 5' SPLICE SITES; GENE; SNRNP; ENHANCER; EXPRESSION; SURVIVAL; DEFECTS; RESCUE; LENGTH	Exon-specific U1 snRNAs (ExSpe U1s) are modified U1 snRNAs that interact with intronic sequences downstream of the 5' splice site (ss) by complementarity. This process restores exon skipping caused by different types of mutation. We have investigated the molecular mechanism and activity of these molecules in spinal muscular atrophy (SMA), a genetic neuromuscular disease where a silent exonic transition on the survival motor neuron 2 (SMN2) leads to exon 7 (E7) skipping. By using different cellular models, we show that a single chromosome-integrated copy of ExSpe U1 induced a significant correction of endogenous SMN2 E7 splicing and resulted in the restoration of the corresponding SMN protein levels. Interestingly, the analysis of pre-mRNA transcript abundance and decay showed that ExSpe U1s promote E7 inclusion and stabilizes the SMN pre-mRNA intermediate. This selective effect on pre-mRNA stability resulted in higher levels of SMN mRNAs in comparison with those after treatment with an antisense oligonucleotide (AON) that targets corresponding intronic sequences. In mice harboring the SMN2 transgene, AAV-mediated delivery of ExSpe U1 increased E7 inclusion in brain, heart, liver, kidney, and skeletal muscle. The positive effect of ExSpe U1s on SMN pre-mRNA processing highlights their therapeutic potential in SMA and in other pathologies caused by exon-skipping mutations.	[Dal Mas, Andrea; Rogalska, Malgorzata Ewa; Bussani, Erica; Pagani, Franco] Int Ctr Genet Engn & Biotechnol, Human Mol Genet Lab, I-34149 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Pagani, F (corresponding author), Int Ctr Genet Engn & Biotechnol, Human Mol Genet Lab, Padriciano 99, I-34149 Trieste, Italy.	pagani@icgeb.org	Rogalska, Malgorzata Ewa/O-5962-2016; Rogalska, Malgorzata/ABF-1334-2020	Rogalska, Malgorzata Ewa/0000-0002-6331-9815; Pagani, Franco/0000-0002-2678-3459	Association Francais contre les Myophaties (AFM) [16101]; Telethon foundation [GGP14190]	Association Francais contre les Myophaties (AFM); Telethon foundation(Fondazione Telethon)	We thank Rodolfo Garcia and Marco Baralle for the proofreading of the manuscript, Maurizio Romano for the help with the statistic analysis, Alessandro Marcello for the helpful discussions on lentiviral vectors, and Adrian Krainer and Xavier Roca for U1 snRNA decoy and pCI-SMN2 plasmids. This work was supported by the Association Francais contre les Myophaties (AFM) (grant number 16101) and Telethon foundation (grant number GGP14190).	Alanis EF, 2012, HUM MOL GENET, V21, P2389, DOI 10.1093/hmg/dds045; Alexander MR, 2010, NUCLEIC ACIDS RES, V38, P3041, DOI 10.1093/nar/gkp1224; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Blazquez L, 2013, CURR MOL MED, V13, P1203; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cavallari N, 2012, BBA-MOL BASIS DIS, V1822, P1109, DOI 10.1016/j.bbadis.2012.03.001; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Le Hir M, 2013, MOL THER, V21, P1551, DOI 10.1038/mt.2013.121; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Marquis J, 2007, MOL THER, V15, P1479, DOI 10.1038/sj.mt.6300200; Merkhofer EC, 2012, CELL, V150, P9, DOI 10.1016/j.cell.2012.06.017; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pinotti M, 2008, BLOOD, V111, P2681, DOI 10.1182/blood-2007-10-117440; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Sanchez-Alcudia R, 2011, MOL GENET METAB, V102, P134, DOI 10.1016/j.ymgme.2010.10.013; Schmid F, 2013, HUM GENE THER, V24, P97, DOI 10.1089/hum.2012.110; Schmid F, 2011, HUM MUTAT, V32, P815, DOI 10.1002/humu.21509; Scholl R, 2007, RNA BIOL, V4, P34, DOI 10.4161/rna.4.1.4534; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; Sumner Charlotte J, 2006, NeuroRx, V3, P235, DOI 10.1007/BF03207053; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200	48	42	42	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					93	103		10.1016/j.ajhg.2014.12.009	http://dx.doi.org/10.1016/j.ajhg.2014.12.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557785	Green Published, hybrid			2022-12-18	WOS:000347707800007
J	Melchionda, L; Haack, TB; Hardy, S; Abbink, TEM; Fernandez-Vizarra, E; Lamantea, E; Marchet, S; Morandi, L; Moggio, M; Carrozzo, R; Torraco, A; Diodato, D; Strom, TM; Meitinger, T; Tekturk, P; Yapici, Z; Al-Murshedi, F; Stevens, R; Rodenburg, RJ; Lamperti, C; Ardissone, A; Moroni, I; Uziel, G; Prokisch, H; Taylor, RW; Bertini, E; van der Knaap, MS; Ghezzi, D; Zeviani, M				Melchionda, Laura; Haack, Tobias B.; Hardy, Steven; Abbink, Truus E. M.; Fernandez-Vizarra, Erika; Lamantea, Eleonora; Marchet, Silvia; Morandi, Lucia; Moggio, Maurizio; Carrozzo, Rosalba; Torraco, Alessandra; Diodato, Daria; Strom, Tim M.; Meitinger, Thomas; Tekturk, Pinar; Yapici, Zuhal; Al-Murshedi, Fathiya; Stevens, Rene; Rodenburg, Richard J.; Lamperti, Costanza; Ardissone, Anna; Moroni, Isabella; Uziel, Graziella; Prokisch, Holger; Taylor, Robert W.; Bertini, Enrico; van der Knaap, Marjo S.; Ghezzi, Daniele; Zeviani, Massimo			Mutations in APOPT1, Encoding a Mitochondria! Protein, Cause Cavitating Leukoencephalopathy with Cytochrome c Oxidase Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX-I DEFICIENCY; 2.8 ANGSTROM; BRAIN-STEM; INVOLVEMENT; CELLS; ENCEPHALOMYOPATHY; QUANTIFICATION; INHIBITOR; CHILDREN; DISEASES	Cytochrome c oxidase (COX) deficiency is a: frequent biochemical abnormality in mitochondrial disorders, but a large fraction of cases remains genetically undetermined. Whole-exome sequencing led to the identification of APOPT1 mutations in two Italian sisters and in a third Turkish individual presenting severe COX deficiency. All three subjects presented a distinctive brain MRI pattern characterized by cavitating leukodystrophy, predominantly in the posterior region of the cerebral hemispheres. We then found APOPT1 mutations in three additional unrelated children, selected on the basis of these particular MRI features. All identified mutations predicted the synthesis of severely damaged protein variants. The clinical features of the six subjects varied widely from acute neurometabolic decompensation in late infancy to subtle neurological signs, which appeared in adolescence; all presented a chronic, long-surviving clinical course. We showed that APOPT1 is targeted to and localized within mitochondria by an N-terminal mitochondrial targeting sequence that is eventually cleaved off from the mature protein. We then showed that APOPT1 is virtually absent in fibroblasts cultured in standard conditions, but its levels increase by inhibiting the proteasome or after oxidative challenge. Mutant fibroblasts showed reduced amount of COX holocomplex and higher levels of reactive oxygen species, which both shifted toward control values by expressing a recombinant, wild-type APOPT1 cDNA. The shRNA-mediated knockdown of APOPT1 in myoblasts and fibroblasts caused dramatic decrease in cell viability. APOPT1 mutations are responsible for infantile or childhood-onset mitochondrial disease, hallmarked by the combination of profound COX deficiency with a distinctive neuroimaging presentation.	[Melchionda, Laura; Lamantea, Eleonora; Marchet, Silvia; Diodato, Daria; Lamperti, Costanza; Ghezzi, Daniele; Zeviani, Massimo] Fdn IRCCS Inst Neurol Besta, Unit Mol Neurogenet, I-20126 Milan, Italy; [Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Hardy, Steven; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Abbink, Truus E. M.; van der Knaap, Marjo S.] Vrije Univ Amsterdam, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Abbink, Truus E. M.; van der Knaap, Marjo S.] Vrije Univ Amsterdam, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Abbink, Truus E. M.; van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Fernandez-Vizarra, Erika; Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Morandi, Lucia] Fdn IRCCS Inst Neurol Besta, Neuromuscular Dis & Neuroimmunol Unit, I-20133 Milan, Italy; [Moggio, Maurizio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurol, Neuromuscular Unit,Ctr Dino Ferrari, I-20122 Milan, Italy; [Carrozzo, Rosalba; Torraco, Alessandra; Diodato, Daria; Bertini, Enrico] Bambino Gesu Childrens Res Hosp, Mol Med Lab, Unit Neuromuscular Disorders, I-00165 Rome, Italy; [Tekturk, Pinar; Yapici, Zuhal] Istanbul Univ, Istanbul Fac Med, Dept Neurol, TR-34098 Istanbul, Turkey; [Al-Murshedi, Fathiya] Sultan Qaboos Univ Hosp, Genet & Dev Med Clin, Muscat 123, Oman; [Stevens, Rene] CHC Clin Esperance Liege, Dept Paediat, B-4000 Liege, Belgium; [Rodenburg, Richard J.] Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Lab Genet Endocrine & Metab Disorders, Dept Pediat,Med Ctr, NL-9101 Nijmegen, Netherlands; [Ardissone, Anna; Moroni, Isabella; Uziel, Graziella] Fdn IRCCS Inst Neurol Sesta, Dept Child Neurol, I-20133 Milan, Italy	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Newcastle University - UK; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Bambino Gesu; Istanbul University; Sultan Qaboos University; Radboud University Nijmegen	Ghezzi, D (corresponding author), Fdn IRCCS Inst Neurol Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.	dghezzi@instituto-besta.it; mdz21@mrc-mbu.cam.ac.uk	Meitinger, Thomas/O-1318-2015; lamperti, costanza/J-8801-2016; Abbink, Truus/N-4990-2018; MARCHET, SILVIA/AAF-5898-2021; Moroni, Isabella/AAL-1336-2021; Ardissone, Anna/K-8495-2016; Lamantea, Eleonora/J-8339-2016; Torraco, Alessandra/J-9127-2016; Fernandez-Vizarra, Erika/AAE-5600-2020; Torraco, Alessandra/AAA-6212-2020; Bertini, Enrico/ABG-1278-2020; Carrozzo, Rosalba/A-2808-2014; Rodenburg, Richard/N-3579-2014; Ghezzi, Daniele/J-7873-2016; Diodato, Daria/K-2639-2016; Bertini, Enrico/A-2284-2014; Topaloglu, Pinar/AAU-6176-2020; Zeviani, Massimo/AAU-2632-2021	lamperti, costanza/0000-0002-2280-2253; MARCHET, SILVIA/0000-0002-7858-3256; Moroni, Isabella/0000-0002-3322-1681; Ardissone, Anna/0000-0003-1969-0147; Lamantea, Eleonora/0000-0001-5090-6028; Torraco, Alessandra/0000-0002-2489-8535; Torraco, Alessandra/0000-0002-8148-9295; Carrozzo, Rosalba/0000-0002-3327-4054; Rodenburg, Richard/0000-0001-5227-3527; Ghezzi, Daniele/0000-0002-6564-3766; Diodato, Daria/0000-0003-3607-8523; Bertini, Enrico/0000-0001-9276-4590; Zeviani, Massimo/0000-0002-9067-5508; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Meitinger, Thomas/0000-0002-8838-8403; Prokisch, Holger/0000-0003-2379-6286; van der Knaap, Marjo/0000-0001-8912-0954	Telethon Network of Genetic Biobanks [GTB12001J]; Fondazione Telethon [GGP11011, GPP10005]; Italian Ministry of Health [GR2010-2316392, RF-INN-2007-634163]; CARIPLO [2011/0526]; Pierfranco and Luisa Mariani Foundation of Italy; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); European Research Council (ERC) [FP7-322424]; Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]; German Federal Ministry of Education and Research (BMBF) - German Center for Diabetes Research (DZD e.V.); Systems Biology of Metabotypes (SysMBo) [0315494A]; German Network for Mitochondrial Disorders (mitoNET) [01GM1113C]; E-Rare project GENOMIT, Medical Research Council, UK [01GM1207, FWF I 920-B13]; Dutch Organisation for Scientific Research (ZonMw, TOP) [91211005]; Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; MRC [G0601943, MC_UP_1002/1, MR/K000608/1] Funding Source: UKRI; Medical Research Council [G0601943, MC_UP_1002/1, MR/K000608/1] Funding Source: researchfish	Telethon Network of Genetic Biobanks(Fondazione Telethon); Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy); CARIPLO(Fondazione Cariplo); Pierfranco and Luisa Mariani Foundation of Italy; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); European Research Council (ERC)(European Research Council (ERC)European Commission); Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society; German Federal Ministry of Education and Research (BMBF) - German Center for Diabetes Research (DZD e.V.); Systems Biology of Metabotypes (SysMBo); German Network for Mitochondrial Disorders (mitoNET); E-Rare project GENOMIT, Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dutch Organisation for Scientific Research (ZonMw, TOP)(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust Strategic Award(Wellcome Trust); MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Carola G.M. van Berkel and Gigliola Fagiolari for their excellent technical support. We acknowledge the "Cell lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" and the "Bank of muscle tissue, peripheral nerve, DNA and cell culture" of the Telethon Network of Genetic Biobanks (grant GTB12001J) and the EurobiobanK Network. This work was supported by Fondazione Telethon grants GGP11011 and GPP10005; the Italian Ministry of Health (GR2010-2316392); CARIPLO grant 2011/0526; the Pierfranco and Luisa Mariani Foundation of Italy; the Italian Association of Mitochondrial Disease Patients and Families (Mitocon); the European Research Council (ERC) Advanced Grant FP7-322424; the Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215) and the German Federal Ministry of Education and Research (BMBF)funded German Center for Diabetes Research (DZD e.V.) and Systems Biology of Metabotypes grant (SysMBo #0315494A), the grant RF-INN-2007-634163 of the Italian Ministry of Health, the BMBF-funded German Network for Mitochondrial Disorders (mitoNET #01GM1113C), and the E-Rare project GENOMIT (01GM1207 and FWF I 920-B13) Medical Research Council, UK. T.E.M.A. and M.S.v.d.K. were supported by the Dutch Organisation for Scientific Research (ZonMw, TOP grant 91211005). R.W.T. is funded by a Wellcome Trust Strategic Award (096919/Z/11/Z), the MRC Centre for Neuromuscular Diseases (G0601943), the Lily Foundation, and the UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service.	Almalki A, 2014, BBA-MOL BASIS DIS, V1842, P56, DOI 10.1016/j.bbadis.2013.10.008; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497; Di Giovanni S, 2001, MOL CELL NEUROSCI, V17, P696, DOI 10.1006/mcne.2001.0970; DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14; DiMauro S, 2009, ADV EXP MED BIOL, V652, P139, DOI 10.1007/978-90-481-2813-6_10; Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624; MOCALI A, 1995, EXP CELL RES, V216, P388, DOI 10.1006/excr.1995.1049; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Sun X, 2008, BIOCHEM BIOPH RES CO, V377, P1097, DOI 10.1016/j.bbrc.2008.10.109; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003; Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96; Yasuda O, 2006, J BIOL CHEM, V281, P23899, DOI 10.1074/jbc.M512610200; Yoshikawa S, 1998, J BIOENERG BIOMEMBR, V30, P7, DOI 10.1023/A:1020595108560; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05	30	42	44	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					315	325		10.1016/j.ajhg.2014.08.003	http://dx.doi.org/10.1016/j.ajhg.2014.08.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25175347	hybrid, Green Published			2022-12-18	WOS:000341404100008
J	Xia, F; Bainbridge, MN; Tan, TY; Wangler, MF; Scheuerle, AE; Zackai, EH; Harr, MH; Sutton, VR; Nalam, RL; Zhu, WM; Nash, M; Ryan, MM; Yaplito-Lee, J; Hunter, JV; Deardorff, MA; Penney, SJ; Beaudet, AL; Plon, SE; Boerwinkle, EA; Lupski, JR; Eng, CM; Muzny, DM; Yang, YP; Gibbs, RA				Xia, Fan; Bainbridge, Matthew N.; Tan, Tiong Yang; Wangler, Michael F.; Scheuerle, Angela E.; Zackai, Elaine H.; Harr, Margaret H.; Sutton, V. Reid; Nalam, Roopa L.; Zhu, Wenmiao; Nash, Margot; Ryan, Monique M.; Yaplito-Lee, Joy; Hunter, Jill V.; Deardorff, Matthew A.; Penney, Samantha J.; Beaudet, Arthur L.; Plon, Sharon E.; Boerwinkle, Eric A.; Lupski, James R.; Eng, Christine M.; Muzny, Donna M.; Yang, Yaping; Gibbs, Richard A.			De Novo Truncating Mutations in AHDC1 in Individuals with Syndromic Expressive Language Delay, Hypotonia, and Sleep Apnea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MONOSOMY 1P36; KBG SYNDROME; DISORDERS; PROTEIN; IDENTIFICATION; EVOLUTION; DELETIONS; PATTERNS; DISEASE; GENES	Clinical whole-exome sequencing (WES) for identification of mutations leading to Mendelian disease has been offered to the medical community since 2011. Clinically undiagnosed neurological disorders are the most frequent basis for test referral, and currently, approximately 25% of such cases are diagnosed at the molecular level. To date, there are approximately 4,000 "known" disease-associated loci, and many are associated with striking dysmorphic features, making genotype-phenotype correlations relatively straightforward. A significant fraction of cases, however, lack characteristic dysmoiphism or clinical pathognomonic traits and are dependent upon molecular tests for definitive diagnoses. Further, many molecular diagnoses are guided by recent gene-disease association discoveries. Hence, there is a critical interplay between clinical testing and research leading to gene-disease association discovery. Here, we describe four probands, all of whom presented with hypotonia, intellectual disability, global developmental delay, and mildly dysmorphic facial features. Three of the four also had sleep apnea. Each was a simplex case without a remarkable family history. Using WES, we identified AHDC1 de novo truncating mutations that most likely cause this genetic syndrome.	[Xia, Fan; Wangler, Michael F.; Sutton, V. Reid; Zhu, Wenmiao; Penney, Samantha J.; Beaudet, Arthur L.; Plon, Sharon E.; Lupski, James R.; Eng, Christine M.; Yang, Yaping; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bainbridge, Matthew N.; Nalam, Roopa L.; Boerwinkle, Eric A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Tan, Tiong Yang; Nash, Margot; Ryan, Monique M.; Yaplito-Lee, Joy] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Tan, Tiong Yang] Univ Melbourne, Dept Pediat, Parkville, Vic 3052, Australia; [Wangler, Michael F.; Sutton, V. Reid; Hunter, Jill V.; Plon, Sharon E.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Scheuerle, Angela E.] Tesserae Genet, Dallas, TX 75230 USA; [Zackai, Elaine H.; Harr, Margaret H.; Deardorff, Matthew A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Nalam, Roopa L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Boerwinkle, Eric A.] Univ Texas Hlth Sci Ctr, Human Genet Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Gibbs, RA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	agibbs@bcm.edu	Ryan, Monique Marie/AAG-9870-2019; Tan, Tiong Yang/AAV-6563-2020; Wangler, Michael/H-6368-2019	Tan, Tiong Yang/0000-0001-8455-7778; Wangler, Michael/0000-0001-5245-5910; Ryan, Monique/0000-0001-6397-1910	NIH [NHGRI 5 U54 HG003273, NHGRI RO1NS058529, U54HG006542, NHGRI 5 U01 HG006485]; National Institute of Neurological Disorders and Stroke [NS076547]; Simons Foundation; National Health and Medical Research Council of Australia [607431]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U01HG006485, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076547, R01NS058529] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families and clinical staff at all locations for participation in this study. This work was supported in part by NIH grants to R.A.G. (NHGRI 5 U54 HG003273), J.R.L. (NHGRI RO1NS058529 and U54HG006542), and S.E.P. (NHGRI 5 U01 HG006485). M.W. received funding from the National Institute of Neurological Disorders and Stroke (NS076547) and the Simons Foundation. T.Y.T. is partially supported by the National Health and Medical Research Council of Australia (fellowship 607431). Baylor College of Medicine performs genetic testing as a service for a fee. M.N.B. is a founder of Codified Genomics, and J.R.L. is a consultant for Athena Diagnostics, 23andMe, and Ion Torrent Systems Inc. and holds multiple US and European patents for DNA diagnostics.	Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Gajecka M, 2007, AM J MED GENET C, V145C, P346, DOI 10.1002/ajmg.c.30154; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; KARLSON JR, 1989, BIOCHEM BIOPH RES CO, V158, P646, DOI 10.1016/0006-291X(89)92770-8; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Long MY, 2013, ANNU REV GENET, V47, P307, DOI 10.1146/annurev-genet-111212-133301; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shabalina SA, 2010, MOL BIOL EVOL, V27, P1745, DOI 10.1093/molbev/msq086; Shalaby MA, 2011, GENES GENOM, V33, P399, DOI 10.1007/s13258-011-0033-1; Sirmaci A, 2011, AM J HUM GENET, V89, P289, DOI 10.1016/j.ajhg.2011.06.007; Skjei KL, 2007, AM J MED GENET A, V143A, P292, DOI 10.1002/ajmg.a.31597; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036023; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	22	42	47	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					784	789		10.1016/j.ajhg.2014.04.006	http://dx.doi.org/10.1016/j.ajhg.2014.04.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24791903	Green Published, Bronze			2022-12-18	WOS:000335485700012
J	El Shamieh, S; Neuille, M; Terray, A; Orhan, E; Condroyer, C; Demontant, V; Michiels, C; Antonio, A; Boyard, F; Lancelot, ME; Letexier, M; Saraiva, JP; Leveillard, T; Mohand-Said, S; Goureau, O; Sahel, JA; Zeitz, C; Audo, I				El Shamieh, Said; Neuille, Marion; Terray, Angelique; Orhan, Elise; Condroyer, Christel; Demontant, Vanessa; Michiels, Christelle; Antonio, Aline; Boyard, Fiona; Lancelot, Marie-Elise; Letexier, Melanie; Saraiva, Jean-Paul; Leveillard, Thierry; Mohand-Said, Saddek; Goureau, Olivier; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle			Whole-Exome Sequencing Identifies KIZ as a Ciliary Gene Associated with Autosomal-Recessive Rod-Cone Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINITIS-PIGMENTOSA; MUTATIONS; PROTEIN; MECHANISMS; DEFECTS; DISEASE; EXPRESSION; DISCOVERY; TOPORS; MAK	Rod-cone dystrophy (RCD), also known as retinitis pigmentosa, is a progressive inherited retinal disorder characterized by photoreceptor cell death and genetic heterogeneity. Mutations in many genes have been implicated in the pathophysiology of RCD, but several others remain to be identified. Herein, we applied whole-exome sequencing to a consanguineous family with one subject affected with RCD and identified a homozygous nonsense mutation, c.226C>T (p.Arg76*), in KIZ, which encodes centrosomal protein kizuna. Subsequent Sanger sequencing of 340 unrelated individuals with sporadic and autosomal-recessive RCD identified two other subjects carrying pathogenic variants in KIZ: one with the same homozygous nonsense mutation (c.226C>T [p.Arg76*]) and another with compound-heterozygous mutations c.119_122delAACT (p.Lys40Ilefs*14) and c.52G>T (p.Glu18*). Transcriptomic analysis in mice detected mRNA levels of the mouse ortholog (Plk1s1) in rod photoreceptors, as well as its decreased expression when photoreceptors degenerated in rd1 mice. The presence of the human KIZ transcript was confirmed by quantitative RT-PCR in the retina, the retinal pigment epithelium, fibroblasts, and whole-blood cells (highest expression was in the retina). RNA in situ hybridization demonstrated the presence of Plk1s1 mRNA in the outer nuclear layer of the mouse retina. Immunohistology revealed KIZ localization at the basal body of the cilia in human fibroblasts, thus shedding light on another ciliary protein implicated in autosomal-recessive RCD.	[El Shamieh, Said; Neuille, Marion; Terray, Angelique; Orhan, Elise; Condroyer, Christel; Demontant, Vanessa; Michiels, Christelle; Antonio, Aline; Boyard, Fiona; Lancelot, Marie-Elise; Leveillard, Thierry; Mohand-Said, Saddek; Goureau, Olivier; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] INSERM, U968, F-75012 Paris, France; [El Shamieh, Said; Neuille, Marion; Terray, Angelique; Orhan, Elise; Condroyer, Christel; Demontant, Vanessa; Michiels, Christelle; Antonio, Aline; Boyard, Fiona; Lancelot, Marie-Elise; Leveillard, Thierry; Mohand-Said, Saddek; Goureau, Olivier; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] CNRS, UMR 7210, F-75012 Paris, France; [El Shamieh, Said; Neuille, Marion; Terray, Angelique; Orhan, Elise; Condroyer, Christel; Demontant, Vanessa; Michiels, Christelle; Antonio, Aline; Boyard, Fiona; Lancelot, Marie-Elise; Leveillard, Thierry; Mohand-Said, Saddek; Goureau, Olivier; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] Univ Paris 06, Inst Vis, UMR S 968, F-75012 Paris, France; [Letexier, Melanie; Saraiva, Jean-Paul] IntegraGen SA, F-91030 Evry, France; [Mohand-Said, Saddek; Sahel, Jose-Alain; Audo, Isabelle] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, F-75012 Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Alain; Audo, Isabelle] Ctr Hosp Natl Ophtalmol Quinze Vingts, Direct Hospitalisat & Org Soins, Ctr Invest Clin 1423, F-75012 Paris, France; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, F-75019 Paris, France; [Sahel, Jose-Alain] Inst France, Acad Sci, F-75006 Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] UCL, Inst Ophthalmol, London EC1V 9EL, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Fondation Adolphe de Rothschild; University of London; University College London	Zeitz, C (corresponding author), INSERM, U968, F-75012 Paris, France.	christina.zeitz@inserm.fr; isabelle.audo@inserm.fr	GOUREAU, Olivier/ABH-9547-2020; GOUREAU, Olivier/F-2752-2017; Shamieh, Said El/J-6343-2019; Léveillard, Thierry/AAR-1804-2020; Sahel, Jose-Alain/F-3172-2017; Zeitz, Christina/F-2757-2017	GOUREAU, Olivier/0000-0001-7730-9143; GOUREAU, Olivier/0000-0001-7730-9143; Shamieh, Said El/0000-0002-8522-0445; Léveillard, Thierry/0000-0001-5692-8770; Sahel, Jose-Alain/0000-0002-4831-1153; Zeitz, Christina/0000-0002-3510-1712; Audo, Isabelle/0000-0003-0698-5309; Orhan, Elise/0000-0002-8306-5250	Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO]; FFB center [C-CMM-0907-0428-INSERM04]; Foundation Voir et Entendre; Fondation Dalloz prix "pour la recherche en ophtalmologie"; Ville de Paris; Region Ile de France; Labex LIFESENSES [ANR-10-LABX-65]; French state funds [ANR-11-IDEX-0004-0]	Foundation Fighting Blindness (FFB); FFB center; Foundation Voir et Entendre; Fondation Dalloz prix "pour la recherche en ophtalmologie"; Ville de Paris; Region Ile de France(Region Ile-de-France); Labex LIFESENSES; French state funds	We thank the affected subjects and family members who participated in this study. In addition, we would like to thank Caroline Moreau Fauvarque and Antoine Mialot for their fruitful technical support, Stephane Fouquet and David Godefroy for their help in acquiring the images, and Cameron Parsa for critical reading. The project was supported by Foundation Fighting Blindness (FFB) grant CD-CL-0808-0466-CHNO (to I. A.), FFB center grant C-CMM-0907-0428-INSERM04, Foundation Voir et Entendre (C.Z.), Fondation Dalloz prix "pour la recherche en ophtalmologie" (to C.Z.), Ville de Paris and Region Ile de France, and Labex LIFESENSES (reference ANR-10-LABX-65), supported by French state funds managed by the Agence Nationale de la Recherche within the Investissements d'Avenir program (ANR-11-IDEX-0004-0).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AFZELIUS BA, 1988, J ULTRA MOL STRUCT R, V98, P94, DOI 10.1016/S0889-1605(88)80937-6; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Audo I, 2014, HUM MOL GENET, V23, P491, DOI 10.1093/hmg/ddt439; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2011, HUM MUTAT, V32, pE2091, DOI 10.1002/humu.21460; Audo I, 2010, INVEST OPHTH VIS SCI, V51, P3687, DOI 10.1167/iovs.09-4766; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Collin RWJ, 2010, AM J HUM GENET, V86, P783, DOI 10.1016/j.ajhg.2010.03.016; Conroy PC, 2012, CELL CYCLE, V11, P3769, DOI 10.4161/cc.21986; Davidson AE, 2013, AM J HUM GENET, V93, P321, DOI 10.1016/j.ajhg.2013.06.003; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Meglio T, 2008, J NEUROSCI, V28, P6285, DOI 10.1523/JNEUROSCI.0078-08.2008; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Nishiguchi KM, 2013, P NATL ACAD SCI USA, V110, P16139, DOI 10.1073/pnas.1308243110; Nishimura DY, 2010, AM J HUM GENET, V86, P686, DOI 10.1016/j.ajhg.2010.03.005; Orhan E, 2013, INVEST OPHTH VIS SCI, V54, P8041, DOI 10.1167/iovs.13-12610; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Schmid F, 2011, HUM MUTAT, V32, P815, DOI 10.1002/humu.21509; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Siemiatkowska AM, 2013, OPHTHALMOLOGY, V120, P2697, DOI 10.1016/j.ophtha.2013.07.052; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023	48	42	43	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					625	633		10.1016/j.ajhg.2014.03.005	http://dx.doi.org/10.1016/j.ajhg.2014.03.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24680887	Bronze, Green Published			2022-12-18	WOS:000333765300013
J	Grant, AV; El Baghdadi, J; Sabri, A; El Azbaoui, S; Alaoui-Tahiri, K; Rhorfi, IA; Gharbaoui, Y; Abid, A; Benkirane, M; Raharimanga, V; Richard, V; Orlova, M; Boland, A; Migaud, M; Okada, S; Nolan, DK; Bustamante, J; Barreiro, LB; Schurr, E; Boisson-Dupuis, S; Rasolofo, V; Casanova, JL; Abel, L				Grant, Audrey V.; El Baghdadi, Jamila; Sabri, Ayoub; El Azbaoui, Safa; Alaoui-Tahiri, Kebir; Rhorfi, Ismail Abderrahmani; Gharbaoui, Yasser; Abid, Ahmed; Benkirane, Majid; Raharimanga, Vaomalala; Richard, Vincent; Orlova, Marianna; Boland, Anne; Migaud, Melanie; Okada, Satoshi; Nolan, Daniel K.; Bustamante, Jacinta; Barreiro, Luis B.; Schurr, Erwin; Boisson-Dupuis, Stephanie; Rasolofo, Voahangy; Casanova, Jean-Laurent; Abel, Laurent			Age-Dependent Association between Pulmonary Tuberculosis and Common TOX Variants in the 8q12-13 Linkage Region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR BETA-1 DEFICIENCY; MYCOBACTERIUM-TUBERCULOSIS; CLINICAL TUBERCULOSIS; PROPHIT SURVEY; SUSCEPTIBILITY; IMMUNITY; LEPROSY; TWINS; GENE; DISEASE	Only a small fraction of individuals infected with Mycobacterium tuberculosis develop clinical tuberculosis (TB) in their lifetime. Genetic epidemiological evidence suggests a genetic determinism of pulmonary TB (PTB), but the molecular basis of genetic predisposition to PTB remains largely unknown. We used a positional-cloning approach to carry out ultrafine linkage-disequilibrium mapping of a previously identified susceptibility locus in chromosomal region 8q12-13 by genotyping 3,216 SNPs in a family-based Moroccan sample including 286 offspring with PTB. We observed 44 PTB-associated SNPs (p < 0.01), which were genotyped in an independent set of 317 cases and 650 controls from Morocco. A single signal, consisting of two correlated SNPs close to TOX, rs1568952 and rs2726600 (combined p = 1.1 x 10(-5) and 9.2 x 10(-5), respectively), was replicated. Stronger evidence of association was found in individuals who developed PTB before the age of 25 years (combined p for rs1568952 = 4.4 x 10(-8); odds ratio of PTB for AA versus AG/GG = 3.09 [1.99-4.78]). The association with rs2726600 (p = 0.04) was subsequently replicated in PTB-affected subjects under 25 years in a study of 243 nuclear families from Madagascar. Stronger evidence of replication in Madagascar was obtained for additional SNPs in strong linkage disequilibrium with the two initial SNPs (p = 0.003 for rs2726597), further confirming the signal. We thus identified around rs1568952 and rs2726600 a cluster of SNPs strongly associated with early-onset PTB in Morocco and Madagascar. SNP rs2726600 is located in a transcription-factor binding site in the 3' region of TOX, and further functional explorations will focus on CD4 T lymphocytes.	[Grant, Audrey V.; Migaud, Melanie; Nolan, Daniel K.; Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Abel, Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, U980, F-75015 Paris, France; [Grant, Audrey V.; Migaud, Melanie; Nolan, Daniel K.; Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Abel, Laurent] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [El Baghdadi, Jamila; Sabri, Ayoub; El Azbaoui, Safa] Mil Hosp Mohamed V, Genet Unit, Rabat 10100, Morocco; [Alaoui-Tahiri, Kebir; Rhorfi, Ismail Abderrahmani; Gharbaoui, Yasser; Abid, Ahmed] Mil Hosp Mohamed V, Dept Pneumol, Rabat 10100, Morocco; [Benkirane, Majid] Mil Hosp Mohamed V, Ctr Blood Transfus, Rabat 10100, Morocco; [Raharimanga, Vaomalala; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo 101, Madagascar; [Orlova, Marianna; Schurr, Erwin] McGill Univ, McGill Ctr Study Host Resistance, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Boland, Anne] Ctr Natl Genotypage, CEA, Inst Genom, F-91000 Evry, France; [Okada, Satoshi; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Abel, Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [Bustamante, Jacinta] Hop Necker Enfants Malad, AP HP, Ctr Study Primary Immunodeficiencies, F-75015 Paris, France; [Barreiro, Luis B.] Univ Montreal, St Justine Hosp, Res Ctr, Dept Pediat,Fac Med, Montreal, PQ H3T 1C5, Canada; [Rasolofo, Voahangy] Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo 101, Madagascar; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, AP HP, Pediat Hematol Immunol Unit, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; McGill University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	El Baghdadi, J (corresponding author), Mil Hosp Mohamed V, Genet Unit, Rabat 10100, Morocco.	baghdadijamila@yahoo.fr; laurent.abel@inserm.fr	Barreiro, Luis/I-7772-2015; Boisson-Dupuis, Stephanie/AAF-5066-2021; Okada, Satoshi/B-8901-2011; Bustamante, Jacinta/H-7877-2017; Abel, Laurent/H-8888-2017; Casanova, Jean-Laurent/I-3418-2017; Migaud, Mélanie/H-8044-2017; Boisson-Dupuis, Stéphanie/I-2040-2017	Okada, Satoshi/0000-0002-4622-5657; Bustamante, Jacinta/0000-0002-3439-2482; Abel, Laurent/0000-0001-7016-6493; Migaud, Mélanie/0000-0003-3062-1214; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Orlova, Marianna/0000-0002-8108-938X; Casanova, Jean-Laurent/0000-0002-7782-4169; Vincent, RICHARD/0000-0002-6961-1753; Nolan, Daniel/0000-0003-3584-6148; Barreiro, Luis/0000-0001-9456-367X	French National Agency for Research; European Commission [HEALTH-F3-2008-200732]; European Research Council [ERC-2010-AdG-268777]; Pasteur Institute of Paris (Progamme Transversal de Recherche) [PTR202]; Bill and Melinda Gates Foundation; St. Giles Foundation; Jeffrey Modell Foundation; Talecris Biotherapeutics; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143-04]; Rockefeller University; National Institute of Allergy and Infectious Diseases [1R01AI089970-01, U01AI088685]; Fondation pour la Recherche Medicale and Fondation BNP Paribas; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089970, U01AI088685] Funding Source: NIH RePORTER	French National Agency for Research(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Pasteur Institute of Paris (Progamme Transversal de Recherche); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); St. Giles Foundation; Jeffrey Modell Foundation; Talecris Biotherapeutics; Rockefeller University Center for Clinical and Translational Science; Rockefeller University; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondation pour la Recherche Medicale and Fondation BNP Paribas; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all pulmonary-tuberculosis (PTB)-affected study participants and family members from Morocco and Madagascar and all healthy Moroccan subjects for their participation in this study. We thank the late M. Chentoufi (Centre de Diagnostic et Traitement des Maladies Respiratoires [CDTMR] of Hay Mohammadi), I. Sentissi and F. Bourkadi (CDTMR of Sale), and F. El Bordi for recruitment of PTB-affected subjects. We thank N. El Amraoui and M. Hakam (National Blood Transfusion Center) for recruiting healthy donors. We thank B. Rakotondrasoa and D. Rakotomanajanahary for recruiting PTB-affected subjects and family members in Madagascar. We thank E. Ranaivoson, J. Razananirinomenjanahary, B. Ravalison, D. Ramarinarisoa, and the staff at the Dispensaire Anti-tuberculeux de Tananarive, as well as Professors H. Raobijaona and N. Ravelomanana and the staff of the pediatric units of Antananarivo hospitals, for assistance. We thank the Centre National de Genotypage for carrying out the genotyping for the initial fine-mapping screen. This work was supported by grants from the French National Agency for Research, European Commission (HEALTH-F3-2008-200732), European Research Council (ERC-2010-AdG-268777), Pasteur Institute of Paris (Progamme Transversal de Recherche PTR202), Bill and Melinda Gates Foundation, St. Giles Foundation, Jeffrey Modell Foundation and Talecris Biotherapeutics, Rockefeller University Center for Clinical and Translational Science (5UL1RR024143-04), Rockefeller University, and National Institute of Allergy and Infectious Diseases (1R01AI089970-01 and U01AI088685). A.V.G. was partly supported by the Fondation pour la Recherche Medicale and Fondation BNP Paribas. L.B.B. is a scholar of the Fonds de la Recherche en Sante du Quebec.	Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2012, CURR OPIN IMMUNOL, V24, P173, DOI 10.1016/j.coi.2011.12.001; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; Alter A, 2013, HUM GENET, V132, P107, DOI 10.1007/s00439-012-1227-6; Alter A, 2011, J INFECT DIS, V203, P1274, DOI 10.1093/infdis/jir024; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Caragol I, 2003, CLIN INFECT DIS, V37, P302, DOI 10.1086/375587; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cobat A, 2012, CLIN INFECT DIS, V54, P968, DOI 10.1093/cid/cir972; Cobat A, 2010, J INFECT DIS, V201, P15, DOI 10.1086/648611; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Delgado JC, 2006, J IMMUNOL, V176, P1090, DOI 10.4049/jimmunol.176.2.1090; Dubos Rene, 1987, WHITE PLAGUE TUBERCU; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Goldfeld AE, 1998, JAMA-J AM MED ASSOC, V279, P226, DOI 10.1001/jama.279.3.226; Greenwood CMT, 2000, AM J HUM GENET, V67, P405, DOI 10.1086/303012; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Montfort A, 2009, J IMMUNOL, V183, P5369, DOI 10.4049/jimmunol.0803384; Ozbek N, 2005, CLIN INFECT DIS, V40, pE55, DOI 10.1086/427879; Puffer R., 1944, FAMILIAL SUSCEPTIBIL; Rom WN., 2004, TUBERCULOSIS, V2; SEPULVEDA RL, 1994, TUBERCLE LUNG DIS, V75, P138, DOI 10.1016/0962-8479(94)90043-4; Tabarsi P, 2011, J CLIN IMMUNOL, V31, P537, DOI 10.1007/s10875-011-9523-9; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; WHO, 2011, WHO GLOBAL TUBERCULO; Zhang WH, 2005, CLIN INFECT DIS, V40, P1232, DOI 10.1086/428726	54	42	42	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					407	414		10.1016/j.ajhg.2013.01.013	http://dx.doi.org/10.1016/j.ajhg.2013.01.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23415668	Green Published, Bronze			2022-12-18	WOS:000316161700014
J	Barbieri, C; Vicente, M; Rocha, J; Mpoloka, SW; Stoneking, M; Pakendorf, B				Barbieri, Chiara; Vicente, Mario; Rocha, Jorge; Mpoloka, Sununguko W.; Stoneking, Mark; Pakendorf, Brigitte			Ancient Substructure in Early mtDNA Lineages of Southern Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; BANTU EXPANSIONS; MITOCHONDRIAL; HISTORY; TREE	Among the deepest-rooting clades in the human mitochondrial DNA (mtDNA) phylogeny are the haplogroups defined as L0d and L0k, which are found primarily in southern Africa. These lineages are typically present at high frequency in the so-called Khoisan populations of hunter-gatherers and herders who speak non-Bantu languages, and the early divergence of these lineages led to the hypothesis of ancient genetic substructure in Africa. Here we update the phylogeny of the basal haplogroups L0d and L0k with 500 full mtDNA genome sequences from 45 southern African Khoisan and Bantu-speaking populations. We find previously unreported subhaplogroups and greatly extend the amount of variation and time-depth of most of the known subhaplogroups. Our major finding is the definition of two ancient sublineages of L0k (L0k1b and L0k2) that are present almost exclusively in Bantu-speaking populations from Zambia; the presence of such relic haplogroups in Bantu speakers is most probably due to contact with ancestral pre-Bantu populations that harbored different lineages than those found in extant Khoisan. We suggest that although these populations went extinct after the immigration of the Bantu-speaking populations, some traces of their haplogroup composition survived through incorporation into the gene pool of the immigrants. Our findings thus provide evidence for deep genetic substructure in southern Africa prior to the Bantu expansion that is not represented in extant Khoisan populations.	[Barbieri, Chiara; Pakendorf, Brigitte] MPI Evolutionary Anthropol, Max Planck Res Grp Comparat Populat Linguist, D-04103 Leipzig, Germany; [Stoneking, Mark] MPI Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Vicente, Mario] STAB VIDA Invest & Serv Ciencias Biol Lda, P-2780182 Oeiras, Portugal; [Vicente, Mario; Rocha, Jorge] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal; [Rocha, Jorge] Univ Porto, Fac Ciencias, Dept Biol, P-4169007 Oporto, Portugal; [Mpoloka, Sununguko W.] Univ Botswana, Dept Biol Sci, Gaborone 0022, UB, Botswana	Max Planck Society; Max Planck Society; Universidade do Porto; Universidade do Porto; University of Botswana	Barbieri, C (corresponding author), MPI Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	chiara_barbieri@eva.mpg.de	Mpoloka, Sununguko W/C-4667-2008; Mpoloka, Sununguko/GQP-6235-2022	Vicente, Mario/0000-0002-9122-4530; Mpoloka, Sununguko/0000-0003-0147-1819; Barbieri, Chiara/0000-0001-8827-5655; rocha, jorge/0000-0001-5460-7615	government of Angola; government of Botswana; government of Namibia; government of Zambia; Deutsche Forschungsgemeinschaft; Max Planck Society; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BIA-BDE/68999/2006]; STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda.; Portuguese Ministry for Science, Technology and Higher Education [SFRH/BDE/51828/2012]	government of Angola; government of Botswana; government of Namibia; government of Zambia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda.; Portuguese Ministry for Science, Technology and Higher Education	We are grateful to all the individuals who voluntarily participated in this study and to the governments of Angola, Botswana, Namibia, and Zambia for supporting our research. We thank Hongyang Xu for help with the imputation process, Roland Schroder for lab assistance, and Martin Kircher and Mingkun Li for support in processing raw data and read alignments. This work has been carried out within the EUROCORES Programme EuroBABEL of the European Science Foundation and was supported by funds from the Deutsche Forschungsgemeinschaft and the Max Planck Society. J.R. was partially supported by a grant from Fundacao para a Ciencia e a Tecnologia (FCT; PTDC/BIA-BDE/68999/2006) and M.V. is supported by STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda., and by the Portuguese Ministry for Science, Technology and Higher Education through PhD grant SFRH/BDE/51828/2012.	Barbieri C., 2012, EUR J HUM GENET; Barnard A., 1992, HUNTERS HERDERS SO A; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Deacon H.J., 1999, HUMAN BEGINNINGS S A; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Guldemann T, 2008, ANNU REV ANTHROPOL, V37, P93, DOI 10.1146/annurev.anthro.37.081407.085109; Guldemann T, 2008, SOUTH AFR HUMANIT, V20, P93; Guldemann T., 1997, LANGUAGE IDENTITY CO, P137; Guldemann Tom, 2005, U LEIPZIG PAPERS AFR, V23; Guldemann Tom, 2010, RES KHOISAN STUDIES, V24, P15; Heine Bernd, 2010, J ASIAN AFR STUD, V79, P5; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Kinahan J., 2011, HIST NAMIBIA BEGINNI, P15; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Knight A, 2003, CURR BIOL, V13, P464, DOI 10.1016/S0960-9822(03)00130-1; Lewis CA, 2008, EARTH-SCI REV, V88, P167, DOI 10.1016/j.earscirev.2008.01.006; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer M., 2010, COLD SPRING HARB PRO, V2010, P5448; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mitchell P., 2002, ARCHAEOLOGY SO AFRIC; Pakendorf B, 2011, LANG DYN CHANG, V1, P50, DOI 10.1163/221058211X570349; Phillipson D. W., 2005, AFRICAN ARCHAEOLOGY; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Reid DAM., 1998, DITSWA MMUNG ARCHAEO, P81; Schlebusch C.M., 2010, THESIS U WITWATERSRA; Schlebusch CM, 2011, J HUM GENET, V56, P623, DOI 10.1038/jhg.2011.71; Schlebusch CM, 2009, ELECTROPHORESIS, V30, P3657, DOI 10.1002/elps.200900197; Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106; Thomas DSG, 2002, QUATERNARY SCI REV, V21, P783, DOI 10.1016/S0277-3791(01)00127-5; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Veeramah KR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-92	44	42	43	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					285	292		10.1016/j.ajhg.2012.12.010	http://dx.doi.org/10.1016/j.ajhg.2012.12.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23332919	Bronze, Green Published			2022-12-18	WOS:000315179600014
J	Schossig, A; Wolf, NI; Fischer, C; Fischer, M; Stocker, G; Pabinger, S; Dander, A; Steiner, B; Tonz, O; Kotzot, D; Haberlandt, E; Amberger, A; Burwinkel, B; Wimmer, K; Fauth, C; Grond-Ginsbach, C; Koch, MJ; Deichmann, A; von Kalle, C; Bartram, CR; Kohlschutter, A; Trajanoski, Z; Zschocke, J				Schossig, Anna; Wolf, Nicole I.; Fischer, Christine; Fischer, Maria; Stocker, Gemot; Pabinger, Stephan; Dander, Andreas; Steiner, Bernhard; Toenz, Otmar; Kotzot, Dieter; Haberlandt, Edda; Amberger, Albert; Burwinkel, Barbara; Wimmer, Katharina; Fauth, Christine; Grond-Ginsbach, Caspar; Koch, Martin J.; Deichmann, Annette; von Kalle, Christof; Bartram, Claus R.; Kohlschuetter, Alfried; Trajanoski, Zlatko; Zschocke, Johannes			Mutations in ROGDI Cause Kohlschutter-Tonz Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMELOGENESIS-IMPERFECTA; YELLOW TEETH; SEQUENCING DATA; EPILEPSY; DEMENTIA; ANNOTATION; ILLNESS	Kohlschutter-Tonz syndrome (KTS) is an autosomal-recessive disease characterized by the combination of epilepsy, psychomotor regression, and amelogenesis imperfecta. The molecular basis has not yet been elucidated. Here, we report that KTS is caused by mutations in ROGDI. Using a combination of autozygosity mapping and exome sequencing, we identified a homozygous frameshift deletion, c.229_230del (p.Leu77Alafs*64), in ROGDI in two affected individuals from a consanguineous family. Molecular studies in two additional KTS-affected individuals from two unrelated Austrian and Swiss families revealed homozygosity for nonsense mutation c.286C>T (p.Gln96*) and compound heterozygosity for the splice-site mutations c.531+5G>C and c.532-2A>T in ROGDI, respectively The latter mutation was also found to be heterozygous in the mother of the Swiss affected individual in whom KTS was reported for the first time in 1974. ROGDI is highly expressed throughout the brain and other organs, but its function is largely unknown. Possible interactions with DISC1, a protein involved in diverse cytoskeletal functions, have been suggested. Our finding that ROGDI mutations cause KTS indicates that the protein product of this gene plays an important role in neuronal development as well as amelogenesis.	[Schossig, Anna; Kotzot, Dieter; Amberger, Albert; Wimmer, Katharina; Fauth, Christine; Zschocke, Johannes] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Wolf, Nicole I.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands; [Schossig, Anna; Fischer, Christine; Bartram, Claus R.; Zschocke, Johannes] Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany; [Wolf, Nicole I.] Heidelberg Univ, Dept Child Neurol, D-69120 Heidelberg, Germany; [Fischer, Maria; Stocker, Gemot; Pabinger, Stephan; Dander, Andreas; Trajanoski, Zlatko] Med Univ Innsbruck, Div Bioinformat, A-6020 Innsbruck, Austria; [Steiner, Bernhard; Toenz, Otmar] Childrens Hosp, CH-6000 Luzern, Switzerland; [Haberlandt, Edda] Med Univ Innsbruck, Dept Pediat, A-6020 Innsbruck, Austria; [Burwinkel, Barbara] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, D-69120 Heidelberg, Germany; [Grond-Ginsbach, Caspar] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Koch, Martin J.] Heidelberg Univ, Dept Oral Dent & Maxillofacial Dis, D-69120 Heidelberg, Germany; [Deichmann, Annette; von Kalle, Christof] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Deichmann, Annette; von Kalle, Christof] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Kohlschuetter, Alfried] Univ Hosp Child & Adolescent Med, D-20246 Hamburg, Germany	Medical University of Innsbruck; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Medical University of Innsbruck; Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Zschocke, J (corresponding author), Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria.	johannes.zschocke@i-med.ac.at	Stocker, Gernot/Q-2461-2019; Wolf, Nicole I/H-3943-2014; Kohlschütter, Alfried/ABH-5710-2020; Zschocke, Johannes/C-5885-2013; Trajanoski, Zlatko/AAT-6703-2021; Kohlschütter, Alfried/ABE-3495-2021	Wolf, Nicole I/0000-0003-1721-0728; Zschocke, Johannes/0000-0002-0046-8274; Kohlschütter, Alfried/0000-0002-2700-0401; Stocker, Gernot/0000-0001-8326-1852; Pabinger, Stephan/0000-0001-9876-5965; Koch, Martin Jean/0000-0003-3871-8803	Standortagentur Tirol	Standortagentur Tirol	This work was supported by a grant from the Standortagentur Tirol. We wish to thank Josef Muheim (Greppen, Switzerland) for considerable help with the genealogical studies that allowed us to link the two Swiss nuclear families into a single pedigree. Long-term medical care to the affected individuals in the study was provided by Thomas Schmitt-Mechelke and Petra Kolditz, (both from Children's Hospital, Lucerne, Switzerland). Bart Janssen and Thomas Chin-A-Woeng (both from ServiceXS, Leiden, The Netherlands) assisted with the exome sequencing. We gratefully acknowledge expert technical assistance by Brunhild Schagen (Department of Oral, Dental, and Maxillofacial Diseases, Heidelberg University, Germany) as well as by Pia Traunfellner, Sandra Unterkirchner, and Ramona Berberich (all from the Division of Human Genetics, Medical University Innsbruck, Austria).	Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; CHRISTODOULOU J, 1988, J MED GENET, V25, P827, DOI 10.1136/jmg.25.12.827; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donnai D, 2005, CLIN DYSMORPHOL, V14, P123, DOI 10.1097/00019605-200507000-00003; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Haberlandt E, 2006, AM J MED GENET A, V140A, P281, DOI 10.1002/ajmg.a.31071; Kohlsch?tter, 2007, MED GENET, V19, P422, DOI 10.1007/s11825-007-0053-z; KOHLSCHUTTER A, 1974, HELV PAEDIATR ACTA, V29, P283; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lo C., 2009, THESIS U COLL LONDON; MUSUMECI SA, 1995, BRAIN DEV-JPN, V17, P133, DOI 10.1016/0387-7604(95)00013-2; Ooi HS, 2009, NUCLEIC ACIDS RES, V37, pW435, DOI 10.1093/nar/gkp254; PETERMOLLER M, 1993, NEUROPEDIATRICS, V24, P337, DOI 10.1055/s-2008-1071567; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wygold T, 1996, KLIN PADIATR, V208, P271, DOI 10.1055/s-2008-1046481; ZLOTOGORA J, 1993, AM J MED GENET, V46, P453, DOI 10.1002/ajmg.1320460422	21	42	44	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					701	707		10.1016/j.ajhg.2012.02.012	http://dx.doi.org/10.1016/j.ajhg.2012.02.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22424600	Bronze, Green Published			2022-12-18	WOS:000302833400013
J	Webb, TR; Matarin, M; Gardner, JC; Kelberman, D; Hassan, H; Ang, W; Michaelides, M; Ruddle, JB; Pennell, CE; Yazar, S; Khor, CC; Aung, T; Yogarajah, M; Robson, AG; Holder, GE; Cheetham, ME; Traboulsi, EI; Moore, AT; Sowden, JC; Sisodiya, SM; Mackey, DA; Tuft, SJ; Hardcastle, AJ				Webb, Tom R.; Matarin, Mar; Gardner, Jessica C.; Kelberman, Dan; Hassan, Hala; Ang, Wei; Michaelides, Michel; Ruddle, Jonathan B.; Pennell, Craig E.; Yazar, Seyhan; Khor, Chiea C.; Aung, Tin; Yogarajah, Mahinda; Robson, Anthony G.; Holder, Graham E.; Cheetham, Michael E.; Traboulsi, Elias I.; Moore, Anthony T.; Sowden, Jane C.; Sisodiya, Sanjay M.; Mackey, David A.; Tuft, Stephen J.; Hardcastle, Alison J.			X-Linked Megalocornea Caused by Mutations in CHRDL1 Identifies an Essential Role for Ventroptin in Anterior Segment Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE MORPHOGENETIC PROTEIN; WATER DIFFUSION; ISCEV STANDARD; CHORDIN; EYE; ACQUISITION; BIOMETRY; LINKAGE; UPDATE; BRAIN	X-linked megalocornea (MGC1) is an ocular anterior segment disorder characterized by an increased cornea diameter and deep anterior chamber evident at birth and later onset of mosaic corneal degeneration (shagreen), arcus juvenilis, and presenile cataracts. We identified copy-number variation, frameshift, missense, splice-site and nonsense mutations in the Chordin-like 1 gene (CHRDL1) on Xq23 as the cause of the condition in seven MGC1 families. CHRDL1 encodes ventroptin, a bone morphogenic protein antagonist with a proposed role in specification of topographic retinotectal projections. Electrophysiological evaluation revealed mild generalized cone system dysfunction and, in one patient, an interhemispheric asymmetry in visual evoked potentials. We show that CHRDL1 is expressed in the developing human cornea and anterior segment in addition to the retina. We explored the impact of loss of ventroptin function on brain function and morphology in vivo. CHRDL1 is differentially expressed in the human fetal brain, and there is high expression in cerebellum and neocortex. We show that MGC1 patients have a superior cognitive ability despite a striking focal loss of myelination of white matter. Our findings reveal an unexpected requirement for ventroptin during anterior segment development and the consequences of a lack of function in the retina and brain.	[Webb, Tom R.; Gardner, Jessica C.; Hassan, Hala; Michaelides, Michel; Robson, Anthony G.; Holder, Graham E.; Cheetham, Michael E.; Moore, Anthony T.; Tuft, Stephen J.; Hardcastle, Alison J.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Matarin, Mar; Yogarajah, Mahinda; Sisodiya, Sanjay M.] UCL, Inst Neurol, London WC1N 3BG, England; [Kelberman, Dan; Sowden, Jane C.] UCL, Inst Child Hlth, London WC1N 1EH, England; [Hassan, Hala; Michaelides, Michel; Robson, Anthony G.; Holder, Graham E.; Moore, Anthony T.; Tuft, Stephen J.] Moorfields Eye Hosp, London EC1V 2PD, England; [Ang, Wei; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Ruddle, Jonathan B.] Univ Melbourne, Ctr Eye Res Australia, Dept Ophthalmol, Melbourne, Vic 3002, Australia; [Yazar, Seyhan] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Khor, Chiea C.; Aung, Tin] Singapore Eye Res Inst, Singapore 168751, Singapore; [Khor, Chiea C.; Aung, Tin] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Khor, Chiea C.] Genome Inst Singapore, Singapore 138672, Singapore; [Traboulsi, Elias I.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Western Australia; Centre for Eye Research Australia; University of Melbourne; Lions Eye Institute; University of Western Australia; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cleveland Clinic Foundation	Hardcastle, AJ (corresponding author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	a.hardcastle@ucl.ac.uk	Study, Raine/K-4517-2013; Mackey, David A/H-5340-2014; Kelberman, Daniel/K-3411-2013; Traboulsi, Elias/AAY-7443-2020; Webb, Tom/GMW-5311-2022; Yazar, Seyhan/U-4032-2018; Matarin, Mar/F-1771-2016; Study, Raine/G-9547-2015; Webb, Tom/C-6237-2011; Pennell, Craig/ABD-6902-2020	Mackey, David A/0000-0001-7914-4709; Kelberman, Daniel/0000-0003-0583-5237; Yazar, Seyhan/0000-0003-0994-6196; Matarin, Mar/0000-0002-4717-5735; Pennell, Craig/0000-0002-0937-6165; Sowden, Jane/0000-0003-0937-2479; Hardcastle, Alison/0000-0002-0038-6770; Webb, Tom/0000-0001-5998-8226; Cheetham, Michael/0000-0001-6429-654X; Robson, Anthony/0000-0002-8391-6123; Khor, Chiea Chuen/0000-0002-1128-4729	Department of Health through the National Institute for Health Research (NIHR); Moorfields Special Trustees; Fight for Sight and Retintis Pigmentosa Fighting Blindness; Big Lottery Fund; Wolfson Trust; National Society for Epilepsy; NIHR BMRC; Great Ormond Street Hospital Children's Charity; Ulverscroft Foundation; University of Western Australia; Australian Foundation for the Prevention of Blindness; National Health and Medical Research Council; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Western Australian DNA Bank; National Health and Medical Research Council of Australia; Canadian Institutes of Health Research; Great Ormond Street Hospital Childrens Charity [V1257] Funding Source: researchfish; Fight for Sight [1976] Funding Source: researchfish	Department of Health through the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Moorfields Special Trustees; Fight for Sight and Retintis Pigmentosa Fighting Blindness; Big Lottery Fund; Wolfson Trust; National Society for Epilepsy; NIHR BMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Ormond Street Hospital Children's Charity; Ulverscroft Foundation; University of Western Australia; Australian Foundation for the Prevention of Blindness; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Western Australian DNA Bank; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Great Ormond Street Hospital Childrens Charity; Fight for Sight	This research was funded by the Department of Health through the National Institute for Health Research (NIHR) award to Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology (BMRC) and by Moorfields Special Trustees. We were supported in part by Fight for Sight and Retintis Pigmentosa Fighting Blindness. We are grateful to the Big Lottery Fund, Wolfson Trust, and the National Society for Epilepsy for supporting the National Society for Epilepsy Magnetic Resonance Imaging unit scanner. This research was also supported by funding from the NIHR BMRC to Great Ormond Street Hospital for Children/UCL Institute of Child Health and University College London Hospitals/UCL. We are grateful to all families for their participation in this study, and we thank Beverly Scott for technical assistance. J.C.S. and D.K. are funded by Great Ormond Street Hospital Children's Charity and the Ulverscroft Foundation. The authors are grateful to the Raine Study participants and the research staff. Funds for the Raine Eye Health Study were provided by the University of Western Australia, Australian Foundation for the Prevention of Blindness and National Health and Medical Research Council. Funding for Core Management of the Raine Study was provided by The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research and Women and Infants Research Foundation. The authors gratefully acknowledge the assistance of the Western Australian DNA Bank and the support of the National Health and Medical Research Council of Australia and the Canadian Institutes of Health Research.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; CHEN JD, 1989, HUM GENET, V83, P292, DOI 10.1007/BF00285176; Coffinier C, 2001, MECH DEVELOP, V100, P119, DOI 10.1016/S0925-4773(00)00507-4; Cook PA, 2007, J MAGN RESON IMAGING, V25, P1051, DOI 10.1002/jmri.20905; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Foster PJ, 2010, BRIT J OPHTHALMOL, V94, P827, DOI 10.1136/bjo.2009.163899; Gaughwin P., 2011, CEREB CORTEX, V21, P1857; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Hoffmann PC, 2010, J CATARACT REFR SURG, V36, P1479, DOI 10.1016/j.jcrs.2010.02.025; Idrees F, 2006, SURV OPHTHALMOL, V51, P213, DOI 10.1016/j.survophthal.2006.02.006; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; MACKEY DA, 1991, ARCH OPHTHALMOL-CHIC, V109, P829, DOI 10.1001/archopht.1991.01080060093033; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; MEIRE FM, 1991, OPHTHALMIC PAED GEN, V12, P153, DOI 10.3109/13816819109029398; MEIRE FM, 1994, BRIT J OPHTHALMOL, V78, P781, DOI 10.1136/bjo.78.10.781; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Reis L, 2011, HUM GENET, V130, P495, DOI 10.1007/s00439-011-0968-y; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Savin L H, 1942, Br J Ophthalmol, V26, P265, DOI 10.1136/bjo.26.6.265; See JM, 2009, J NEUROPATH EXP NEUR, V68, P595, DOI 10.1097/NEN.0b013e3181a66ad9; Sisodiya SM, 2007, J MED GENET, V44, P373, DOI 10.1136/jmg.2006.047407; SKUTA GL, 1983, ARCH OPHTHALMOL-CHIC, V101, P51; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Ueki T, 2003, J NEUROSCI, V23, P11732; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345	38	42	46	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					247	259		10.1016/j.ajhg.2011.12.019	http://dx.doi.org/10.1016/j.ajhg.2011.12.019			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22284829	Green Published, hybrid			2022-12-18	WOS:000300742200005
J	Donnelly, MP; Paschou, P; Grigorenko, E; Gurwitz, D; Mehdi, SQ; Kajuna, SLB; Barta, C; Kungulilo, S; Karoma, NJ; Lu, RB; Zhukova, OV; Kim, JJ; Comas, D; Siniscalco, M; New, M; Li, PN; Li, H; Manolopoulos, VG; Speed, WC; Rajeevan, H; Pakstis, AJ; Kidd, JR; Kidd, KK				Donnelly, Michael P.; Paschou, Peristera; Grigorenko, Elena; Gurwitz, David; Mehdi, Syed Qasim; Kajuna, Sylvester L. B.; Barta, Csaba; Kungulilo, Selemani; Karoma, N. J.; Lu, Ru-Band; Zhukova, Olga V.; Kim, Jong-Jin; Comas, David; Siniscalco, Marcello; New, Maria; Li, Peining; Li, Hui; Manolopoulos, Vangelis G.; Speed, William C.; Rajeevan, Haseena; Pakstis, Andrew J.; Kidd, Judith R.; Kidd, Kenneth K.			The Distribution and Most Recent Common Ancestor of the 17q21 Inversion in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; POPULATION GENOTYPE DATA; H2 MAPT HAPLOTYPE; FRONTOTEMPORAL DEMENTIA; PARKINSONS-DISEASE; TAU HAPLOTYPE; HUMAN GENOME; ARCHITECTURE; ASSOCIATION; H1	The polymorphic inversion on 17q21, sometimes called the microtubular associated protein tau (MAPT) inversion, is an similar to 900 kb inversion found primarily in Europeans and Southwest Asians. We have identified 21. SNPs that act as markers of the inverted, i.e., H2, haplotype. The inversion is found at the highest frequencies in Southwest Asia and Southern Europe (frequencies of similar to 30%); elsewhere in Europe, frequencies vary from <5%, in Finns, to 28%, in Orcadians. The H2 inversion haplotype also Occurs at low frequencies in Africa, Central Asia, East Asia, and the Americas, though the East Asian and Amerindian alleles may be due to recent gene flow from Europe. Molecular evolution analyses indicate that the H2 haplotype originally arose in Africa or Southwest Asia. Though the H2 inversion has many fixed differences across the similar to 900 kb, short tandem repeat polymorphism data indicate a very recent date for the most recent common ancestor, with dates ranging from 13,600 to 108,400 years, depending on assumptions and estimation methods. This estimate range is much more recent than the 3 million year age estimated by Stefansson et al. in 2005.(1)	[Donnelly, Michael P.; Speed, William C.; Rajeevan, Haseena; Pakstis, Andrew J.; Kidd, Judith R.; Kidd, Kenneth K.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Grigorenko, Elena] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Li, Peining] Yale Univ, Sch Med, Dept Genet, Mol Cytogenet Lab, New Haven, CT 06520 USA; [Paschou, Peristera] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandropoulis 68100, Greece; [Gurwitz, David] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Natl Lab Genet Israeli Populat, IL-69978 Tel Aviv, Israel; [Mehdi, Syed Qasim] SIUT, Karachi 74200, Pakistan; [Kajuna, Sylvester L. B.; Karoma, N. J.] Hubert Kairuki Mem Univ, Dept Biochem & Mol Biol, Dar Es Salaam, Tanzania; [Barta, Csaba] Semmelweis, Inst Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Kungulilo, Selemani] Muhimbili Univ, Coll Hlth Sci, Dar Es Salaam, Tanzania; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Psychiat, Tainan 70101, Taiwan; [Zhukova, Olga V.] Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia; [Kim, Jong-Jin] Inst Nat Sci Invest, DNA Anal Div, Seoul, South Korea; [Comas, David] UPF, PRBB, Dept Expt & Hlth Sci, CSIC,Inst Evolutionary Biol, Barcelona 08003, Spain; [Comas, David] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Barcelona 08003, Spain; [Siniscalco, Marcello] Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; [New, Maria] Mt Sinai Sch Med, New York, NY 10029 USA; [Li, Hui] Fudan Univ, Key Lab Contemporary Anthropol, Minist Educ, Shanghai 200433, Peoples R China; [Li, Hui] Fudan Univ, Sch Life Sci, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Li, Hui] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Manolopoulos, Vangelis G.] Democritus Univ Thrace, Sch Med, Pharmacol Lab, Alexandroupolis 68100, Greece	Yale University; Yale University; Yale University; Democritus University of Thrace; Tel Aviv University; Sackler Faculty of Medicine; Semmelweis University; National Cheng Kung University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Rockefeller University; Icahn School of Medicine at Mount Sinai; Fudan University; Fudan University; Fudan University; Democritus University of Thrace	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	kenneth.kidd@yale.edu	Li, Hui/A-2014-2010; Anthropology, MOE KeyLab Fudan/A-9454-2010; Comas, David/D-5382-2014; Grigorenko, Elena/V-2418-2019; Manolopoulos, Vangelis G/J-3312-2015; Mehdi, Syed Qasim/L-2385-2015; Gurwitz, David/E-7642-2013	Comas, David/0000-0002-5075-0956; Manolopoulos, Vangelis G/0000-0003-0849-5469; Gurwitz, David/0000-0002-9363-1869; Paschou, Peristera/0000-0002-9783-1024	National Institutes of Health [GM57672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by National Institutes of Health grant GM57672. We would like to thank Elena Grigorenko and Carolyn Yrigollen for providing help with the STRP typing. We would also like to thank all of the collaborators who helped to collect the samples, the National Laboratory for the Genetics of Israeli Populations at Tel-Aviv University, the Coriell Cell Repositories, and the thousands of individuals who contributed samples for studies like this.	ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Fung HC, 2005, NEUROSCI LETT, V377, P81, DOI 10.1016/j.neulet.2004.11.072; Ghidoni R, 2006, NEUROBIOL DIS, V22, P357, DOI 10.1016/j.nbd.2005.11.013; Gijselinck I, 2006, HUM MUTAT, V27, P1057, DOI 10.1002/humu.20391; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Holzer M, 2004, GENE, V341, P313, DOI 10.1016/j.gene.2004.07.013; Iyengar S, 1998, DNA SEQUENCE, V8, P317, DOI 10.3109/10425179809034076; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; KIDD KK, 2008, HUMAN GENETIC VARIAT, P51; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Pastor P, 2002, MOVEMENT DISORD, V17, P550, DOI 10.1002/mds.10076; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sambrook J, 1989, MOL CLONING LAB MANU; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Winkler S, 2007, EUR J HUM GENET, V15, P1163, DOI 10.1038/sj.ejhg.5201901; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	32	42	42	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					161	171		10.1016/j.ajhg.2010.01.007	http://dx.doi.org/10.1016/j.ajhg.2010.01.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20116045	Bronze, Green Published			2022-12-18	WOS:000274637200006
J	Smirnov, DA; Cheung, VG				Smirnov, Denis A.; Cheung, Vivian G.			ATM gene mutations result in both recessive and dominant expression phenotypes of genes and MicroRNAs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA-TELANGIECTASIA; BREAST-CANCER; DEFICIENT MICE; SUSCEPTIBILITY; HETEROZYGOTES; ACTIVATION; MISSENSE; CARRIERS; DISEASE; REPRESSION	The defining characteristic of recessive disorders is the absence of disease in heterozygous carriers of the mutant alleles. However, it has been recognized that recessive carriers may differ from noncarriers in some phenotypes. Here, we studied ataxia telangiectasia (AT), a classical recessive disorder caused by mutations in the ataxia telangiectasia mutated (ATM) gene. We compared the gene and microRNA expression phenotypes of noncarriers, AT carriers who have one copy of the ATM mutations, and AT patients with two copies of ATM mutations. We found that some phenotypes are more similar between noncarriers and AT carriers compared to AT patients, as expected for a recessive disorder. However, for some expression phenotypes, AT carriers are more similar to the patients than to the noncarriers. Analysis of one of these expression phenotypes, TNFSF4 level, allowed us to uncover a regulatory pathway where ATM regulates TNFSF4 expression through MIRN125B. In AT carriers and AT patients, this pathway is disrupted. As a result, the level of MIRN125B is lower and the level of its target gene, TNFSF4, is higher than in noncarriers. A decreased level of MIRN125B is associated with breast cancer, and an elevated level of TNFSF4 is associated with atherosclerosis. Thus, our findings provide a mechanistic suggestion for the increased risk of breast cancer and heart disease in AT carriers. By integrating molecular and computational analyses of gene and microRNA expression, we show the complex consequences of a human gene mutation.	[Smirnov, Denis A.; Cheung, Vivian G.] Univ Penn, Dept Pediat, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Smirnov, Denis A.; Cheung, Vivian G.] Univ Penn, Dept Genet, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Smirnov, Denis A.; Cheung, Vivian G.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Dept Pediat, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020		National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Donna George for ideas and discussions and Dr. Richard Spielman for advice on data analysis. We also thank Dr. Kuang-Yu Jen for generating gene-expression data, Ms. NaRae Ju for the miRNA measurements, and Ms. Teresa Weber for performing the CDX2 chromatin-immunoprecipitation assay. This work was supported by grants from the National Institutes of Health (to V.G.C.) and the W.W. Smith Chair (to V.G.C.), and by the Howard Hughes Medical Institute.	Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chun SY, 2007, ONCOGENE, V26, P4725, DOI 10.1038/sj.onc.1210258; Dahl M, 1998, LANCET, V351, P1911, DOI 10.1016/S0140-6736(97)11419-2; Fernet M, 2004, BRIT J CANCER, V90, P866, DOI 10.1038/sj.bjc.6601549; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lorentz O, 1999, ONCOGENE, V18, P87, DOI 10.1038/sj.onc.1202280; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; NEEL JV, 1947, MEDICINE, V26, P115, DOI 10.1097/00005792-194705000-00001; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Scott SP, 2002, P NATL ACAD SCI USA, V99, P925, DOI 10.1073/pnas.012329699; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Su Y, 2000, ANN INTERN MED, V133, P770, DOI 10.7326/0003-4819-133-10-200011210-00009; SWIFT M, 1983, LANCET, V1, P1049; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Wanrooij EJA, 2007, ARTERIOSCL THROM VAS, V27, P204, DOI 10.1161/01.ATV.0000251007.07648.81; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103	45	42	49	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					243	253		10.1016/j.ajhg.2008.07.003	http://dx.doi.org/10.1016/j.ajhg.2008.07.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18674748	Green Published, Bronze			2022-12-18	WOS:000258418200009
J	Leutenegger, AL; Labalme, A; Genin, E; Toutain, A; Steichen, E; Clerget-Darpoux, F; Edery, P				Leutenegger, Anne-Louise; Labalme, Audrey; Genin, Emmanuelle; Toutain, Annick; Steichen, Elisabeth; Clerget-Darpoux, Francoise; Edery, Patrick			Using genomic inbreeding coefficient estimates for homozygosity mapping of rare recessive traits: Application to Taybi-Linder syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DWARFISM; IDENTITY; MAP	The use of inbred patients whose exact genealogy may not be available is of primary interest in mapping genes involved in rare recessive diseases. We show here that this can be achieved by estimating inbreeding coefficients from the patients' genomic information and using these estimates to perform homozygosity mapping. We show the interest of the approach by mapping a gene for Taybi-Linder syndrome to chromosome 2q, with the use of a key patient with no genealogical information.	INSERM, U535, F-94817 Villejuif, France; INSERM, U679, Paris, France; Univ Paris 06, Paris, France; Hop La Pitie Salpetriere, Paris, France; Univ Paris 11, Paris, France; Univ Lyon 1, Hospices Civils Lyon, Lyon, France; Univ Lyon 1, EA 3739, Lyon, France; CHU Tours, Tours, France; Univ Klin Kinder & Jugendheilkunde, Innsbruck, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Tours	Clerget-Darpoux, F (corresponding author), INSERM, U535, BP 1000, F-94817 Villejuif, France.	clerget@vjf.inserm.fr	Genin, Emmanuelle/C-4974-2013; Leutenegger, Anne-Louise/B-5597-2009; Edery, Patrick/B-6407-2012; Clerget-Darpoux, Francoise/I-4825-2017	Genin, Emmanuelle/0000-0003-4117-2813; Leutenegger, Anne-Louise/0000-0002-1302-4357; Toutain, Annick/0000-0002-5999-5300; Clerget-Darpoux, Francoise/0000-0003-4816-6619				COCKERHAM CC, 1971, GENETICS, V69, P235; DENNISTON C, 1968, THESIS U WISCONSIN M; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Jacquard A., 1966, POPULATION, V21, P751, DOI [10.2307/1527654, DOI 10.2307/1527654]; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2002, GENET EPIDEMIOL, V23, P413, DOI 10.1002/gepi.10190; LEUTENEGGER AL, 2003, THESIS U PARIS 11 PA; Malecot G, 1948, MATH HEREDITE; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	15	42	44	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					62	66		10.1086/504640	http://dx.doi.org/10.1086/504640			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773566	Green Published, Bronze			2022-12-18	WOS:000238341200007
J	Goris, A; Williams-Gray, CH; Foltynie, T; Compston, DAS; Barker, RA; Sawcer, SJ				Goris, A.; Williams-Gray, C. H.; Foltynie, T.; Compston, D. A. S.; Barker, R. A.; Sawcer, S. J.			No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							WIDE ASSOCIATION		Univ Cambridge, Dept Clin Neurosci, Neurol Unit, Cambridge CB2 1TN, England; Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CB2 1TN, England; Katholieke Univ Leuven, Sect Expt Neurol, Lab Neuroimmunol, Louvain, Belgium	University of Cambridge; University of Cambridge; KU Leuven	Goris, A (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Neurol Unit, Box 165,Hills Rd, Cambridge CB2 2QQ, England.	ag441@medschl.cam.ac.uk	Goris, An/L-5852-2019; Goris, An/F-2943-2010	Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; Barker, Roger Alistair/0000-0001-8843-7730; Williams-Gray, Caroline/0000-0002-2648-9743	MRC [G0001067] Funding Source: UKRI; Medical Research Council [G0001067] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	6	42	43	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1088	1090		10.1086/504726	http://dx.doi.org/10.1086/504726			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685662	Green Published, Bronze			2022-12-18	WOS:000237553800021
J	Burzynski, GM; Nolte, IM; Bronda, A; Bos, KK; Osinga, J; Menacho, IP; Twigt, B; Maas, S; Brooks, AS; Verheij, JBGM; Buys, CHCM; Hofstra, RMW				Burzynski, GM; Nolte, IM; Bronda, A; Bos, KK; Osinga, J; Menacho, IP; Twigt, B; Maas, S; Brooks, AS; Verheij, JBGM; Buys, CHCM; Hofstra, RMW			Identifying candidate Hirschsprung disease-associated RET variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTOONCOGENE; HAPLOTYPE; RISK; TRANSCRIPTION; PROMOTER; GENE; EXPRESSION; CARCINOMA; THERAPY; REGION	Patients with sporadic Hirschsprung disease (HSCR) show increased allele sharing at markers in the 5' region of the RET locus, indicating the presence of a common ancestral RET mutation. In a previous study, we found a haplotype of six SNPs that was transmitted to 55.6% of our patients, whereas it was present in only 16.2% of the controls we used. Among the patients with that haplotype, 90.8% had it on both chromosomes, which led to a much higher risk of developing HSCR than when the haplotype occurred heterozygously. To more precisely define the HSCR-associated region and to identify candidate disease-associated variant(s), we sequenced the shared common haplotype region from 10 kb upstream of the RET gene through intron 1 and exon 2 (in total, 33 kb) in a patient homozygous for the common risk haplotype and in a control individual homozygous for the most common nonrisk haplotype. A comparison of these sequences revealed 86 sequence differences. Of these 86 variations, 8 proved to be in regions highly conserved among different vertebrates and within putative transcription factor binding sites. We therefore considered these as candidate disease-associated variants. Subsequent genotyping of these eight variants revealed a strong disease association for six of the eight markers. These six markers also showed the largest distortions in allele transmission. Interspecies comparison showed that only one of the six variations was located in a region also conserved in a nonmammalian species, making it the most likely candidate HSCR-associated variant.	Univ Groningen, Dept Med Genet, NL-9713 AW Groningen, Netherlands; Univ Groningen, Dept Med Biol, NL-9713 AW Groningen, Netherlands; Acad Hosp Groningen, Dept Clin Genet, Groningen, Netherlands; Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Hofstra, RMW (corresponding author), Univ Groningen, Dept Med Genet, Antonius Deusinglaan 4, NL-9713 AW Groningen, Netherlands.	r.m.w.hofstra@medgen.azg.nl	Burzynski, Grzegorz M/D-2800-2009; Piris, Alejandro/D-3830-2014; Plaza-Menacho, Ivan/K-8517-2017	Hofstra, Robert/0000-0001-7498-3829; Plaza-Menacho, Ivan/0000-0003-4666-9431				Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Burzynski GM, 2004, EUR J HUM GENET, V12, P604, DOI 10.1038/sj.ejhg.5201199; CECCHERINI I, 1994, ONCOGENE, V9, P3025; Davidson B, 2004, CLIN EXP METASTAS, V21, P191, DOI 10.1023/B:CLIN.0000037703.37275.35; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; HOLSCHNEIDER AM, 1982, MED WELT, V33, P210; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; Sancandi M, 2003, J MED GENET, V40, P714, DOI 10.1136/jmg.40.9.714; Spielman RS, 1996, AM J HUM GENET, V59, P983; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096	19	42	45	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					850	858		10.1086/429589	http://dx.doi.org/10.1086/429589			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15759212	Green Published, Bronze			2022-12-18	WOS:000228198300011
J	Econs, MJ; Koller, DL; Hui, SL; Fishburn, T; Conneally, PM; Johnston, CC; Peacock, M; Foroud, TM				Econs, MJ; Koller, DL; Hui, SL; Fishburn, T; Conneally, PM; Johnston, CC; Peacock, M; Foroud, TM			Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GENOME SCREEN; ABSORPTIVE HYPERCALCIURIA; GENDER SPECIFICITY; COMPLEX TRAITS; PAIR ANALYSIS; OSTEOPOROSIS; MASS; C57BL/6J; MICE	Peak bone mineral density (BMD) is a highly heritable trait and is a good predictor of the risk of osteoporosis and fracture in later life. Recent studies have sought to identify the genes underlying peak BMD. Linkage analysis in a sample of 464 premenopausal white sister pairs detected linkage of spine BMD to chromosome 1q (LOD 3.6). An independent sample of 254 white sister pairs has now been genotyped, and it also provides evidence of linkage to chromosome 1q (LOD 2.5) for spine BMD. Microsatellite markers were subsequently genotyped for a 4-cM map in the chromosome 1q region in all available white sister pairs (n=938), and a LOD score of 4.3 was obtained near the marker D1S445. Studies in the mouse have also detected evidence of linkage to BMD phenotypes in the region syntenic to our linkage finding on chromosome 1q. Thus, we have replicated a locus on 1q contributing to BMD at the spine and have found further support for the region in analyses employing an enlarged sample. Studies are now ongoing to identify the gene(s) contributing to peak spine BMD in women.	Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Econs, MJ (corresponding author), 541 N Clin Dr,CL 459, Indianapolis, IN 46202 USA.	mecons@iupui.edu		Econs, Michael/0000-0003-0940-1911	NCRR NIH HHS [M01 RR000750, M01 RR-00750] Funding Source: Medline; NIAMS NIH HHS [R01 AR-43476, K24 AR-02095, AR-4370] Funding Source: Medline; NIA NIH HHS [P01 AG-18397, P01 AG018397] Funding Source: Medline; NICHD NIH HHS [T32 HD-07373, T32 HD007373] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043476, K24AR002095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG018397] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; Beamer WG, 2001, J BONE MINER RES, V16, P1195, DOI 10.1359/jbmr.2001.16.7.1195; Bell NH, 1997, TRENDS ENDOCRIN MET, V8, P240, DOI 10.1016/S1043-2760(97)00065-9; BELL NH, 1991, J BONE MINER RES, V6, P719; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Bohannon AD, 1999, AM J EPIDEMIOL, V149, P1002; CHRISTIAN JC, 1989, AM J HUM GENET, V44, P429; CHRISTIANSEN C, 1991, AM J MED, V90, P107; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Duncan EL, 2003, J BONE MINER RES, V18, P1531, DOI 10.1359/jbmr.2003.18.8.1531; Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Jones G, 2000, J BONE MINER RES, V15, P1998, DOI 10.1359/jbmr.2000.15.10.1998; Karasik D, 2002, J BONE MINER RES, V17, P1718, DOI 10.1359/jbmr.2002.17.9.1718; KELLY PJ, 1993, J BONE MINER RES, V8, P11; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Klein RF, 2001, J BONE MINER RES, V16, P1953, DOI 10.1359/jbmr.2001.16.11.1953; Koller DL, 2000, J CLIN ENDOCR METAB, V85, P3116, DOI 10.1210/jc.85.9.3116; Koller DL, 2003, J BONE MINER RES, V18, P1758, DOI 10.1359/jbmr.2003.18.10.1758; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; MELTON LJ, 1995, J BONE MINER RES, V10, P175; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Niu TH, 1999, HUM GENET, V104, P226, DOI 10.1007/s004390050940; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; PIETSCHMANN F, 1992, J BONE MINER RES, V7, P1383; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Reed BY, 1999, J CLIN ENDOCR METAB, V84, P3907, DOI 10.1210/jc.84.11.3907; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Van Pottelbergh I, 2003, J BONE MINER RES, V18, P303, DOI 10.1359/jbmr.2003.18.2.303; Wilson SG, 2003, AM J HUM GENET, V72, P144, DOI 10.1086/345819	34	42	46	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					223	228		10.1086/381401	http://dx.doi.org/10.1086/381401			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14730478	Bronze, Green Published			2022-12-18	WOS:000188860000003
J	Roberts, SE; Maggouta, F; Thomas, NS; Jacobs, PA; Crolla, JA				Roberts, SE; Maggouta, F; Thomas, NS; Jacobs, PA; Crolla, JA			Molecular and fluorescence in situ hybridization characterization of the breakpoints in 46 large supernumerary marker 15 chromosomes reveals an unexpected level of complexity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILLI/ANGELMAN SYNDROME REGION; INTERSTITIAL DUPLICATIONS; DUP(15) CHROMOSOMES; COMMON BREAKPOINT; ORIGIN; ANGELMAN; MAP; DNA; PHENOTYPE; 15Q11-Q13	Supernumerary marker chromosomes (SMCs) of chromosome 15, designated "SMC(15)s," are the most common SMC in humans, accounting for as much as 60% of all those observed. We report the characterization of 46 large SMC(15) s, using both fluorescence in situ hybridization and polymerase chain reaction analysis within and distal to the Prader-Willi/Angelman syndrome critical region (PWACR). Our aim was to establish detailed information on origin, content, and breakpoints, to address the formation of SMC(15) s, and to facilitate genotype-phenotype correlations. For all patients in whom we were able to establish the parental origin, the SMC(15) s were maternally derived. Two patients were observed who had familial SMC(15) s, both inherited from the mother; however, in all remaining patients for whom parental samples were available, the SMC(15) s were shown to have arisen de novo. With one exception, all the SMC(15) s were shown to include the entire PWACR. Detailed investigations of the distal breakpoints categorized the SMC(15) s into two groups. Group A, representing approximately two-thirds of the SMC(15) s, had a breakpoint beyond the standard distal PWS/AS deletion breakpoint BP3, at a position close to the microsatellite marker D15S1010 and the bacterial artificial chromosome 10I10. The group B SMC(15) s were shorter, with more variable breakpoints located around BP3. The majority of the SMC(15) s were shown to have asymmetrical breakpoints, with the two inverted arms of the SMC being unequal in length. Our study revealed an unexpected level of complexity and heterogeneity among SMC(15) s that is not seen in other chromosome 15 rearrangements, such as deletions and duplications. This suggests that multiple mechanisms are involved in the formation of large SMC(15) s.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Univ Southampton, Dept Human Genet, Southampton, Hants, England	Salisbury District Hospital; University of Southampton	Roberts, SE (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.							BLENNOW E, 1994, PRENATAL DIAG, V14, P1019, DOI 10.1002/pd.1970141103; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CASSIDY SB, 1996, AM J MED GENET, V62, P205; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; Christian SL, 1998, GENOME RES, V8, P146, DOI 10.1101/gr.8.2.146; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Cotter PD, 2000, CLIN GENET, V58, P488, DOI 10.1034/j.1399-0004.2000.580611.x; CROLLA JA, 1995, HUM GENET, V95, P161; Dawson AJ, 2002, AM J MED GENET, V107, P334, DOI 10.1002/ajmg.10170; Eggermann K, 2002, CLIN GENET, V62, P89, DOI 10.1034/j.1399-0004.2002.620113.x; Huang B, 1997, HUM GENET, V99, P11; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEANACOX J, 1994, AM J HUM GENET, V54, P748; Maggouta F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e84; Martinsson T, 1996, EUR CHILD ADOLES PSY, V5, P185, DOI 10.1007/BF00538845; Mignon C, 1996, EUR J HUM GENET, V4, P88; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Repetto GR, 1998, AM J MED GENET, V79, P82, DOI 10.1002/(SICI)1096-8628(19980901)79:2<82::AID-AJMG2>3.0.CO;2-P; Roberts SE, 2003, CLIN GENET, V64, P76, DOI 10.1034/j.1399-0004.2003.00094.x; Roberts SE, 2002, HUM GENET, V110, P227, DOI 10.1007/s00439-002-0678-6; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; Ungaro P, 2001, J MED GENET, V38, P26, DOI 10.1136/jmg.38.1.26; VANDYKE DL, 1977, AM J HUM GENET, V29, P294; Wandstrat AE, 2000, CHROMOSOMA, V109, P498, DOI 10.1007/s004120000103; Wandstrat AE, 1998, AM J HUM GENET, V62, P925, DOI 10.1086/301777; Webb T, 1998, CLIN GENET, V53, P34, DOI 10.1034/j.1399-0004.1998.531530107.x; Zeschnigk M, 1997, HUM MOL GENET, V6, P387, DOI 10.1093/hmg/6.3.387	32	42	47	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1061	1072		10.1086/379155	http://dx.doi.org/10.1086/379155			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14560400	Green Published, Bronze			2022-12-18	WOS:000186493400008
J	Francks, C; DeLisi, LE; Fisher, SE; Laval, SH; Rue, JE; Stein, JF; Monaco, AP				Francks, C; DeLisi, LE; Fisher, SE; Laval, SH; Rue, JE; Stein, JF; Monaco, AP			Confirmatory evidence for linkage of relative hand skill to 2p12-q11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							X-CHROMOSOME; HANDEDNESS; ASYMMETRY		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Physiol, Oxford, England; Churchill Hosp, Res Inst, Oxford OX3 7LJ, England; NYU, Dept Psychiat, New York, NY 10016 USA; Univ Newcastle, Sch Biochem & Genet, Newcastle Upon Tyne, Tyne & Wear, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; New York University; Newcastle University - UK	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Monaco, Anthony P/A-4495-2010; Francks, Clyde/AGU-8875-2022; Fisher, Simon E./E-9130-2012; Francks, Clyde/E-1384-2012	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; Francks, Clyde/0000-0002-9098-890X; Stein, John/0000-0001-5843-8986				Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Annett M., 1985, LEFT RIGHT HAND BRAI; Bishop DVM, 2001, BEHAV GENET, V31, P339, DOI 10.1023/A:1012239617367; Corballis MC, 1996, AM J MED GENET, V67, P50; Crow TJ, 2002, BRIT J PSYCHIAT, V181, P295, DOI 10.1192/bjp.181.4.295; Fisher S. E., 2002, AM J HUM GENET, V70, P1075; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Francks C, 2002, AM J HUM GENET, V70, P800, DOI 10.1086/339249; FULKER DW, 1991, READING DISABILITIES; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Laval SH, 1998, AM J MED GENET, V81, P420, DOI 10.1002/(SICI)1096-8628(19980907)81:5<420::AID-AJMG11>3.0.CO;2-E; Lessem JL, 2001, BIOINFORMATICS, V17, P371, DOI 10.1093/bioinformatics/17.4.371; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; McKeever WF, 2000, BRIT J PSYCHOL, V91, P21, DOI 10.1348/000712600161655; McManus IC, 1992, HDB NEUROPSYCHOLOGY; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Van Agtmael T, 2002, EUR J HUM GENET, V10, P623, DOI 10.1038/sj.ejhg.5200851	18	42	46	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					499	502		10.1086/367548	http://dx.doi.org/10.1086/367548			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12596796	Green Published, Bronze			2022-12-18	WOS:000180680000033
J	Corzo, D; Gibson, W; Johnson, K; Mitchell, G; LePage, G; Cox, GF; Casey, R; Zeiss, C; Tyson, H; Cutting, GR; Raymond, GV; Smith, KD; Watkins, PA; Moser, AB; Moser, HW; Steinberg, SJ				Corzo, D; Gibson, W; Johnson, K; Mitchell, G; LePage, G; Cox, GF; Casey, R; Zeiss, C; Tyson, H; Cutting, GR; Raymond, GV; Smith, KD; Watkins, PA; Moser, AB; Moser, HW; Steinberg, SJ			Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: A novel neonatal phenotype similar to peroxisomal biogenesis disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CREATINE-TRANSPORTER GENE; URINARY ORGANIC-ACIDS; CHAIN FATTY-ACIDS; ZELLWEGER SYNDROME; BIFUNCTIONAL ENZYME; PRENATAL-DIAGNOSIS; DEFICIENCY; XQ28; EXPRESSION; SYNTHETASE	X-linked adrenoleukodystrophy (X-ALD) results from mutations in ABCD1.ABCD1 resides on Xq28 and encodes an integral peroxisomal membrane protein (ALD protein [ALDP]) that is of unknown function and that belongs to the ATP-binding cassette-transporter superfamily. Individuals with ABCD1 mutations accumulate very-long-chain fatty acids (VLCFA) (carbon length >22). Childhood cerebral X-ALD is the most devastating form of the disease. These children have the earliest onset (age 7.2 +/- 1.7 years) among the clinical phenotypes for ABCD1 mutations, but onset does not occur at <3 years of age. Individuals with either peroxisomal biogenesis disorders (PBD) or single-enzyme deficiencies (SED) in the peroxisomal beta-oxidation pathway-disorders such as acyl CoA oxidase deficiency and bifunctional protein deficiency-also accumulate VLCFA, but they present during the neonatal period. Until now, it has been possible to distinguish unequivocally between individuals with these autosomal recessively inherited syndromes and individuals with ABCD1 mutations, on the basis of the clinical presentation and measurement of other biochemical markers. We have identified three newborn boys who had clinical symptoms and initial biochemical results consistent with PBD or SED. In further study, however, we showed that they lacked ALDP, and we identified deletions that extended into the promoter region of ABCD1 and the neighboring gene, DXS1357E. Mutations in DXS1357E and the ABCD1 promoter region have not been described previously. We propose that the term "contiguous ABCD1 DXS1357E deletion syndrome" (CADDS) be used to identify this new contiguous-gene syndrome. The three patients with CADDS who are described here have important implications for genetic counseling, because individuals with CADDS may previously have been misdiagnosed as having an autosomal recessive PBD or SED.	Kennedy Krieger Inst, Peroxisomal Dis Lab, Baltimore, MD 21205 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Hop St Justine, Serv Gastroenterol, Montreal, PQ H3T 1C5, Canada; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB T2T 5C7, Canada; Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB T2T 5C7, Canada; Univ Calgary, Calgary, AB, Canada; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	Kennedy Krieger Institute; Harvard University; Boston Children's Hospital; Universite de Montreal; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; Yale University	Steinberg, SJ (corresponding author), Kennedy Krieger Inst, Peroxisomal Dis Lab, 707 N Broadway, Baltimore, MD 21205 USA.	SteinbergS@KennedyKrieger.org		Watkins, Paul A./0000-0002-3246-1405	NCRR NIH HHS [M01 RR000052, RR 00052] Funding Source: Medline; NICHD NIH HHS [P01 HD010981, HD 10981] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101.abs; BJORKHEM I, 1986, J LIPID RES, V27, P786; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Corzo D, 1999, AM J HUM GENET, V65, pA233; DORMAN BP, 1978, P NATL ACAD SCI USA, V75, P2363, DOI 10.1073/pnas.75.5.2363; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Feigenbaum V, 1996, AM J HUM GENET, V58, P1135; Gould SJ., 2001, METABOLIC MOL BASES, P3181; GOVAERTS L, 1984, EUR J PEDIATR, V143, P10, DOI 10.1007/BF00442740; Iyer GS, 1996, GENOMICS, V34, P143, DOI 10.1006/geno.1996.0254; Kelley RI, 1991, TECHNIQUES DIAGNOSTI, P205; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; KOIKE R, 1995, HUM MUTAT, V6, P263, DOI 10.1002/humu.1380060314; LAZO O, 1988, P NATL ACAD SCI USA, V85, P7647, DOI 10.1073/pnas.85.20.7647; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; MAESTRI NE, 1992, AM J MED GENET, V44, P576, DOI 10.1002/ajmg.1320440509; Moser AB, 1999, PRENATAL DIAG, V19, P46, DOI 10.1002/(SICI)1097-0223(199901)19:1<46::AID-PD501>3.0.CO;2-E; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Moser HW, 1998, ANN NEUROL, V44, P713, DOI 10.1002/ana.410440502; MOSER HW, 1982, PEDIATR RES, V16, P172, DOI 10.1203/00006450-198203000-00002; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; MOSSER J, 1994, GENOMICS, V22, P469, DOI 10.1006/geno.1994.1413; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Natowicz MR, 1996, AM J MED GENET, V63, P356; O'Neill GN, 2001, NEUROLOGY, V57, P1956, DOI 10.1212/WNL.57.11.1956; RASMUSSEN M, 1994, NEUROCHEM RES, V19, P1073, DOI 10.1007/BF00968719; Roerig P, 2001, FEBS LETT, V492, P66, DOI 10.1016/S0014-5793(01)02235-9; ROSCHER A, 1985, PEDIATR RES, V19, P930, DOI 10.1203/00006450-198509000-00013; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; SARDE CO, 1994, GENOMICS, V22, P13, DOI 10.1006/geno.1994.1339; SMITH KD, 1991, AM J HUM GENET, V49, P165; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Steinberg SJ, 1999, ANN NEUROL, V46, P409, DOI 10.1002/1531-8249(199909)46:3<409::AID-ANA18>3.0.CO;2-9; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; STEINBERG SJ, 2001, AM J HUM GENET S, V69, pA1823; TANAKA K, 1980, CLIN CHEM, V26, P1847; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; WANDERS RJA, 1984, BIOCHEM BIOPH RES CO, V123, P1054, DOI 10.1016/S0006-291X(84)80240-5; WANDERS RJA, 1988, BIOCHEM BIOPH RES CO, V153, P618, DOI 10.1016/S0006-291X(88)81140-9; WATKINS PA, 1995, AM J HUM GENET, V57, P292; WATKINS PA, 1995, ANN NEUROL, V38, P472, DOI 10.1002/ana.410380322; Yamaguchi S, 2001, J CHROMATOGR B, V758, P81, DOI 10.1016/S0378-4347(01)00102-5; ZENGERHAIN J, 1992, NEW DEV FATTY ACID O, P339	48	42	49	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1520	1531		10.1086/340849	http://dx.doi.org/10.1086/340849			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992258	Green Published, Bronze			2022-12-18	WOS:000175445700013
J	Verlaan, DJ; Siegel, AM; Rouleau, GA				Verlaan, DJ; Siegel, AM; Rouleau, GA			Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENCODING KRIT1; CHROMOSOME 7Q; CCM1 GENE; FAMILIES; EXONS; MAPS	At least 40% of families affected with cerebral cavernous malformation have a mutation in Krit1. We previously identified two point mutations in Krit1 leading to changes in amino acids (D137G and Q210E) in two different families. Further RNA analysis reveals that both point mutations actually activate cryptic splice-donor sites, causing aberrant splicing and leading to a frameshift and protein truncation. To date, no simple missense mutations have been detected in Krit1.	Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; Univ Zurich Hosp, Dept Neurol, Epilepsy Program, CH-8091 Zurich, Switzerland	McGill University; McGill University; University of Zurich; University Zurich Hospital	Rouleau, GA (corresponding author), Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.							Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Davenport WJ, 2001, NEUROLOGY, V56, P540, DOI 10.1212/WNL.56.4.540; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Eerola I, 2001, BBA-GENE STRUCT EXPR, V1517, P464, DOI 10.1016/S0167-4781(00)00303-1; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; MARCHUK DA, 1995, GENOMICS, V28, P311, DOI 10.1006/geno.1995.1147; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Sahoo T, 2001, GENOMICS, V71, P123, DOI 10.1006/geno.2000.6426; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Verlaan DJ, 2002, NEUROLOGY, V58, P853, DOI 10.1212/WNL.58.6.853; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2000, GENOMICS, V70, P392, DOI 10.1006/geno.2000.6410	14	42	43	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1564	1567		10.1086/340604	http://dx.doi.org/10.1086/340604			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11941540	Green Published, Bronze			2022-12-18	WOS:000175445700017
J	Lamoril, J; Puy, H; Whatley, SD; Martin, C; Woolf, JR; Da Silva, V; Deybach, JC; Elder, GH				Lamoril, J; Puy, H; Whatley, SD; Martin, C; Woolf, JR; Da Silva, V; Deybach, JC; Elder, GH			Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE INTERMITTENT PORPHYRIA; VARIEGATE PORPHYRIA; OXIDASE GENE; EXPRESSION; DEFECTS; FAMILY; PLASMA	Hereditary coproporphyria (HCP) is the least common of the autosomal dominant acute hepatic porphyrias. It results from mutations in the CPO gene that encodes the mitochondrial enzyme, coproporphyrinogen oxidase. A few patients have also been reported who are homoallellic or heteroallelic for CPO mutations and are clinically distinct from those with HCP. In such patients the presence of a specific mutation (K404E) on one or both alleles produces a neonatal hemolytic anemia that is known as "harderoporphyria"; mutations on both alleles elsewhere in the gene give rise to the "homozygous" variant of HCP. The molecular relationship between these disorders and HCP has not been defined. We describe the molecular investigation and clinical features of 17 unrelated British patients with HCP. Ten novel and four previously reported CPO mutations, together with three previously unrecognized single-nucleotide polymorphisms, were identified in 15 of the 17 patients. HCP is more heterogeneous than other acute porphyrias, with all but one mutation being restricted to a single family, with a predominance of missense mutations (10 missense, 2 nonsense, 1 frameshift, and 1 splice site). Of the four known mutations, one (R331W) has previously been reported to cause disease only in homozygotes. Heterologous expression of another mutation (R401W) demonstrated functional properties similar to those of the K404E harderoporphyria mutation. In all patients, clinical presentation was uniform, in spite of the wide range (1%-64%) of residual coproporphyrinogen oxidase activity, as determined by heterologous expression. Our findings add substantially to knowledge of the molecular epidemiology of HCP, show that single copies of CPO mutations that are known or predicted to cause "homozygous" HCP or harderoporphyria can produce typical HCP in adults, and demonstrate that the severity of the phenotype does not correlate with the degree of inactivation by mutation of coproporphyrinogen oxidase.	Univ Paris 07, Hop Louis Mourier, Ctr Francais Porphyries, Biochim Lab, F-92701 Colombes, France; Univ Paris 07, Hop Louis Mourier, INSERM, U409, Colombes, France; Univ Wales Coll Med, Dept Biochem Med, Cardiff CF4 4XN, S Glam, Wales	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cardiff University	Deybach, JC (corresponding author), Univ Paris 07, Hop Louis Mourier, Ctr Francais Porphyries, Biochim Lab, F-92701 Colombes, France.		PUY, HERVE/O-1785-2017; SCHMITT, Caroline/P-2859-2017	PUY, HERVE/0000-0003-3362-2634; SCHMITT, Caroline/0000-0001-5145-7260				ANDREWS J, 1984, J MED GENET, V21, P341, DOI 10.1136/jmg.21.5.341; BLAKE D, 1992, CLIN CHEM, V38, P96; BRODIE MJ, 1977, Q J MED, V46, P229; Cooper D. N., 1993, HUMAN GENE MUTATION; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Daimon M, 1997, HUM GENET, V99, P199, DOI 10.1007/s004390050338; DELFAULARUE MH, 1994, HUM MOL GENET, V3, P1325, DOI 10.1093/hmg/3.8.1325; Doss MO, 1999, ANN CLIN BIOCHEM, V36, P680, DOI 10.1177/000456329903600522; Elder GH, 1997, J INHERIT METAB DIS, V20, P237, DOI 10.1023/A:1005313024076; ELDER GH, 1976, LANCET, V2, P1217; ELDER GH, 1978, BIOCHEM J, V169, P215, DOI 10.1042/bj1690215; FUJITA H, 1994, HUM MOL GENET, V3, P1807, DOI 10.1093/hmg/3.10.1807; Goudet J., 2001, CLADISTICS; GRANDCHAMP B, 1977, LANCET, V2, P1348; Grandchamp B, 1996, J GASTROEN HEPATOL, V11, P1046, DOI 10.1111/j.1440-1746.1996.tb00035.x; GRANDCHAMP B, 1977, BIOCHEM BIOPH RES CO, V74, P1089, DOI 10.1016/0006-291X(77)91630-8; HAWK JLM, 1978, J ROY SOC MED, V71, P775, DOI 10.1177/014107687807101018; Kappas A, 1995, METABOLIC MOL BASES, P2103; Kirsch RE, 1998, SEMIN LIVER DIS, V18, P33, DOI 10.1055/s-2007-1007138; Kuhnel A, 2000, CLIN BIOCHEM, V33, P465, DOI 10.1016/S0009-9120(00)00159-4; LAMORIL J, 1995, HUM MOL GENET, V4, P275, DOI 10.1093/hmg/4.2.275; Lamoril J, 1998, BLOOD, V91, P1453, DOI 10.1182/blood.V91.4.1453; Lamoril J, 1997, HUM MUTAT, V9, P78; LOCKWOOD WH, 1985, CLIN CHEM, V31, P1163; LONG C, 1993, BRIT J DERMATOL, V129, P9, DOI 10.1111/j.1365-2133.1993.tb03303.x; Martasek P, 1998, SEMIN LIVER DIS, V18, P25, DOI 10.1055/s-2007-1007137; MARTASEK P, 1994, HUM MOL GENET, V3, P477, DOI 10.1093/hmg/3.3.477; MARTASEK P, 1994, P NATL ACAD SCI USA, V91, P3024, DOI 10.1073/pnas.91.8.3024; Martasek P, 1997, CELL MOL BIOL, V43, P47; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; NORDMANN Y, 1990, BIOSYNTHESIS HEME CH, P491; POHFITZPATRICK MB, 1980, ARCH DERMATOL, V116, P543, DOI 10.1001/archderm.116.5.543; Puy H, 1997, AM J HUM GENET, V60, P1373, DOI 10.1086/515455; Roberts AG, 1998, HUM MOL GENET, V7, P1921, DOI 10.1093/hmg/7.12.1921; Rosipal R, 1999, HUM MUTAT, V13, P44, DOI 10.1002/(SICI)1098-1004(1999)13:1<44::AID-HUMU5>3.0.CO;2-Q; Schreiber WE, 1997, HUM MUTAT, V10, P196; Susa S, 1998, J HUM GENET, V43, P182, DOI 10.1007/s100380050065; TAKETANI S, 1994, BBA-BIOENERGETICS, V1183, P547, DOI 10.1016/0005-2728(94)90083-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Whatley SD, 1999, HUM GENET, V104, P505, DOI 10.1007/s004390050995; Whatley SD, 1999, AM J HUM GENET, V65, P984, DOI 10.1086/302586	41	42	44	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1130	1138		10.1086/320118	http://dx.doi.org/10.1086/320118			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309681	Green Published, Bronze			2022-12-18	WOS:000168171200007
J	Buard, J; Shone, AC; Jeffreys, AJ				Buard, J; Shone, AC; Jeffreys, AJ			Meiotic recombination and flanking marker exchange at the highly unstable human minisatellite CEB1 (D2S90)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOUBLE-STRAND BREAKS; HUMAN DNA; GERMLINE MUTATION; GENE CONVERSION; LINKAGE MAP; VNTR LOCI; SEQUENCE; ALLELE; AMPLIFICATION; GENERATION	Unequal crossover has long been suspected to play a role in the germline-specific instability of tandem-repeat DNA, but little information exists on the dynamics and processes of unequal exchange. We have therefore characterized new length alleles associated with flanking-marker exchange at the highly unstable human minisatellite CEB1, which mutates in the male germline by a complex process often resulting in the gene conversion-like transfer of repeats between alleles. DNA flanking CEB1 is rich in single-nucleotide polymorphisms (SNPs) and shows extensive haplotype diversity, consistent with elevated recombinational activity near the minisatellite. These SNPs were used to recover mutant CEB1 molecules associated with flanking-marker exchange, directly from sperm DNA. Mutants with both proximal and distal flanking-marker exchange were shown to contribute significantly to CEB1 turnover and suggest that the 5' end of the array is very active in meiotic unequal crossover. Coconversions involving the interallelic transfer of repeats plus immediate flanking DNA were also common, were also polarized at the 5' end of CEB1, and appeared to define a conversion gradient extending from the repeat array into adjacent DNA. Whereas many mutants associated with complete exchange resulted in simple recombinant-repeat arrays that show reciprocity, coconversions were highly gain-biassed and were, on average, more complex, with allele rearrangements similar to those seen in the bulk of sperm mutants. This suggests distinct recombination-processing pathways producing, on the one hand, simple crossovers in CEB1 and, on the other hand, complex conversions that sometimes extend into flanking DNA.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Buard, J (corresponding author), Inst Genet Humaine, CNRS, UPR 1142, 141 Rue Cardonille, F-34296 Montpellier 5, France.	Jerome.Buard@igh.cnrs.fr						Amarger V, 1998, GENOMICS, V52, P62, DOI 10.1006/geno.1998.5365; Andreassen R, 1998, HUM MOL GENET, V7, P2113, DOI 10.1093/hmg/7.13.2113; Berg I, 2000, GENET RES, V75, P1, DOI 10.1017/S0016672399004139; Buard J, 1997, NAT GENET, V15, P327, DOI 10.1038/ng0497-327; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Debrauwere H, 1999, NAT GENET, V23, P367, DOI 10.1038/15557; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HEDRICK PW, 1988, HEREDITY, V60, P435, DOI 10.1038/hdy.1988.61; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 1997, HUM MOL GENET, V6, P129, DOI 10.1093/hmg/6.1.129; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; May CA, 1996, HUM MOL GENET, V5, P1823, DOI 10.1093/hmg/5.11.1823; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SCHULTES NP, 1990, GENETICS, V126, P813; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	31	42	43	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					333	344		10.1086/303015	http://dx.doi.org/10.1086/303015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10869237	Green Published, Bronze			2022-12-18	WOS:000089357800010
J	Fox, CJ; Paterson, AD; Mortin-Toth, SM; Danska, JS				Fox, CJ; Paterson, AD; Mortin-Toth, SM; Danska, JS			Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTOR TYROSINE KINASE; BINDING-PROTEIN HDLBP; CLASS-II GENES; NOD MICE; SUSCEPTIBILITY GENES; CONGENIC STRAINS; LINKAGE DISEQUILIBRIUM; MOUSE CHROMOSOME-1; INSULIN GENE	Insulin-dependent diabetes mellitus (IDDM) is a polygenic disease caused by progressive autoimmune infiltration (insulitis) of the pancreatic islets of Langerhan, culminating in the destruction of insulin-producing beta cells. Genome scans of families with diabetes suggest that multiple loci make incremental contributions to disease susceptibility. However, only the IDDM1 locus is well characterized, at a molecular and functional level, as alleleic variants of the major histocompatibility complex (MHC) class II HLA-DQB1, DRB1, and DPB1 genes that mediate antigen presentation to T cells. In the nonobese diabetic (NOD) mouse model, the Idd1 locus was shown to be the orthologous MHC gene I-Ab. Inheritance of susceptibility alleles at IDDM1/Idd1 is insufficient for disease development in humans and NOD mice. However, the identities and functions of the remaining diabetes loci (Idd2-Idd19 in NOD mice) are largely undefined. A crucial limitation in previous genetic linkage studies of this disease has been reliance on a single complex phenotype-diabetes that displays low penetrance and is of limited utility for high-resolution genetic mapping. Using the NOD model, we have identified an early step in diabetes pathogenesis that behaves as a highly penetrant trait. We report that NOD-derived alleles at both the Idd5 and Idd13 loci regulate a T lymphocyte-dependent progression from a benign to a destructive stage of insulitis. Human chromosomal regions orthologous to the Idd5 and -13 intervals are also linked to diabetes risk, suggesting that conserved genes encoded at these loci are central regulators of disease pathogenesis. These data are the first to reveal a role for individual non-MHC Idd loci in a specific, critical step in diabetes pathogenesis-T cell recruitment to islet lesions driving destructive inflammation. Importantly, identification of intermediate phenotypes in complex disease pathogenesis provides the tools required to progress toward gene identification at these loci.	Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Program Genet & Gen, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Danska, JS (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Paterson, Andrew D/A-4088-2011	Paterson, Andrew D/0000-0002-9169-118X				ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; BONNEVIENIELSEN V, 1983, ENDOCRINOLOGY, V112, P1049, DOI 10.1210/endo-112-3-1049; CAILLATZUCMAN S, 1995, HUM IMMUNOL, V44, P80, DOI 10.1016/0198-8859(95)00062-9; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CHARLTON B, 1988, DIABETES, V37, P930, DOI 10.2337/diabetes.37.7.930; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; COHENHAGUENAUER O, 1989, CYTOGENET CELL GENET, V52, P124, DOI 10.1159/000132860; COLLE E, 1981, J EXP MED, V154, P1237, DOI 10.1084/jem.154.4.1237; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; COLUCCI G, 1996, P NATL ACAD SCI USA, V9, P217; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Cordell HJ, 1998, GENET RES, V71, P51, DOI 10.1017/S0016672398003152; CORDELL HJ, 1995, TRENDS GENET, V11, P499, DOI 10.1016/S0168-9525(00)89160-X; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DANCIGER M, 1989, GENOMICS, V5, P378, DOI 10.1016/0888-7543(89)90075-X; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DENG GY, 1995, AM J HUM GENET, V56, P528; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; Esposito L, 1998, DIABETES, V47, P1797, DOI 10.2337/diabetes.47.11.1797; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Fox CJ, 1998, DIABETES, V47, P331, DOI 10.2337/diabetes.47.3.331; Fox CJ, 1997, J IMMUNOL, V158, P2414; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; GARCHON HJ, 1991, NATURE, V353, P260, DOI 10.1038/353260a0; GARCHON HJ, 1994, EUR J IMMUNOL, V24, P380, DOI 10.1002/eji.1830240217; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; GRAFF RJ, 1994, IMMUNOGENETICS, V40, P21, DOI 10.1007/BF00163960; HANNINEN A, 1992, J CLIN INVEST, V90, P1901, DOI 10.1172/JCI116067; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Hattori M, 1999, J IMMUNOL, V163, P1721; HEIDMANN O, 1986, SCIENCE, V234, P866, DOI 10.1126/science.3022377; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jarpe A J, 1990, Reg Immunol, V3, P305; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEBOEUF RC, 1994, GENOMICS, V23, P296, DOI 10.1006/geno.1994.1501; Leiter Edward H., 1992, Regional Immunology, V4, P263; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Liao X, 1996, MAMM GENOME, V7, P395, DOI 10.1007/s003359900116; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Martin AM, 1999, DIABETES, V48, P50, DOI 10.2337/diabetes.48.1.50; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; MICHAELSON J, 1983, IMMUNOGENETICS, V17, P219, DOI 10.1007/BF00364409; Mohan C, 1997, J IMMUNOL, V159, P454; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; NAGGERT JK, 1995, MAMM GENOME, V6, P131, DOI 10.1007/BF00303258; Nakamura YS, 1998, STEM CELLS, V16, P229, DOI 10.1002/stem.160229; Noble JA, 1996, TISSUE ANTIGENS, V47, P159, DOI 10.1111/j.1399-0039.1996.tb02533.x; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2000, DIABETES, V49, P121, DOI 10.2337/diabetes.49.1.121; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; Podolin PL, 1997, J IMMUNOL, V159, P1835; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Reifsnyder PC, 1999, MAMM GENOME, V10, P161, DOI 10.1007/s003359900962; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SCHURR E, 1990, GENOMICS, V8, P477, DOI 10.1016/0888-7543(90)90034-R; Seldin MF, 1997, MAMM GENOME, V7, pS3, DOI 10.1007/s003359900313; SELDIN MF, 1996, MAMM GENOME, V6, P28; SEMPE P, 1991, EUR J IMMUNOL, V21, P1163, DOI 10.1002/eji.1830210511; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Serreze DV, 1998, J IMMUNOL, V160, P1472; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SIGNORE A, 1994, HISTOCHEMISTRY, V101, P263, DOI 10.1007/BF00315913; SIGNORE A, 1989, DIABETOLOGIA, V32, P282, DOI 10.1007/BF00265543; Siracusa LD, 1996, MAMM GENOME, V6, pS51; SIRACUSA LD, 1997, MAMM GENOME, V7, P28; Snijders AJ, 1997, J BIOL CHEM, V272, P1297, DOI 10.1074/jbc.272.2.1297; STEIN PH, 1992, TRANSPLANTATION, V53, P1347, DOI 10.1097/00007890-199206000-00032; TAKAHASHI E, 1994, GENOMICS, V19, P376, DOI 10.1006/geno.1994.1074; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Toyoda H, 1998, BIOESSAYS, V20, P750, DOI 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.3.CO;2-8; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vyse TJ, 1996, J IMMUNOL, V157, P2719; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WATERS SH, 1992, DIABETES, V41, P308, DOI 10.2337/diabetes.41.3.308; WICKER LS, 1987, J EXP MED, V165, P1639, DOI 10.1084/jem.165.6.1639; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; XIA YR, 1993, GENOMICS, V16, P524, DOI 10.1006/geno.1993.1221; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	97	42	42	1	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					67	81		10.1086/302995	http://dx.doi.org/10.1086/302995			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10848492	Green Published, Bronze			2022-12-18	WOS:000088926900010
J	Kort, EN; Ballinger, DG; Ding, W; Hunt, SC; Bowen, BR; Abkevich, V; Bulka, K; Campbell, B; Capener, C; Gutin, A; Harshman, K; McDermott, M; Thorne, T; Wang, H; Wardell, B; Wong, J; Hopkins, PN; Skolnick, M; Samuels, M				Kort, EN; Ballinger, DG; Ding, W; Hunt, SC; Bowen, BR; Abkevich, V; Bulka, K; Campbell, B; Capener, C; Gutin, A; Harshman, K; McDermott, M; Thorne, T; Wang, H; Wardell, B; Wong, J; Hopkins, PN; Skolnick, M; Samuels, M			Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-A-I; DENSITY-LIPOPROTEIN-CHOLESTEROL; BODY-MASS INDEX; BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; COMBINED HYPERLIPIDEMIA; LIPID-LEVELS; CIII-AIV; HEPATIC LIPASE; AFRICAN BLACKS	Coronary heart disease (CHD) accounts for half of the 1 million deaths annually ascribed to cardiovascular disease and for almost all of the 1.5 million acute myocardial infarctions. Within families affected by early and apparently heritable CHD, dyslipidemias have a much higher prevalence than in the general population; 20%-30% of early familial CHD has been ascribed to primary hypoalphalipoproteinemia (low HDL-C). This study assesses the evidence for linkage of low HDL-C to chromosomal region 11q23 in 105 large Utah pedigrees ascertained with closely related clusters of early CHD and expanded on the basis of dyslipidemia. Linkage analysis was performed by use of 22 STRP markers in a 55-cM region of chromosome 11. Two-point analysis based on a general, dominant-phenotype model yielded LODs of 2.9 for full pedigrees and 3.5 for 167 four-generation split pedigrees. To define a localization region, model optimization was performed using the heterogeneity, multipoint LOD score (mpHLOD). This linkage defines a region on 11q23.3 that is similar to 10 cM distal to-and apparently distinct from-the ApoAI/CIII/AlV gene cluster and thus represents a putative novel localization for the low HDL-C phenotype.	Myriad Genet Inc, Salt Lake City, UT 84108 USA; Intermountain Hlth Care, Genet Res, Salt Lake City, UT USA; Univ Utah, Salt Lake City, UT USA	Myriad Genetics, Inc; Intermountain Healthcare; Utah System of Higher Education; University of Utah	Samuels, M (corresponding author), Myriad Genet Inc, 320 Wakara Way, Salt Lake City, UT 84108 USA.							Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Adams T D, 1993, Obes Res, V1, P261; Almasy L, 1999, AM J HUM GENET, V64, P1686, DOI 10.1086/302425; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Boright AP, 1998, ATHEROSCLEROSIS, V139, P131, DOI 10.1016/S0021-9150(98)00071-9; BRESLOW JL, 1995, METABOLIC MOL BASES, V2, P2031; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; BU XD, 1994, HUM GENET, V93, P639, DOI 10.1007/BF00201563; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Connelly PW, 1998, CRIT REV CL LAB SCI, V35, P547, DOI 10.1080/10408369891234273; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUPPLES LA, 1998, AM J HUM GENET SA16, V63; DAMMERMAN M, 1993, P NATL ACAD SCI USA, V90, P4562, DOI 10.1073/pnas.90.10.4562; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; FRIEDLANDER Y, 1986, HUM HERED, V36, P143, DOI 10.1159/000153618; FUNKE H, 1991, J CLIN INVEST, V87, P371, DOI 10.1172/JCI114997; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Huang W, 1998, ARTERIOSCL THROM VAS, V18, P389, DOI 10.1161/01.ATV.18.3.389; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; IMPERATORE G, 1998, AM J HUM GENET S, V63, pA293; JAQUISH CE, 1998, AM J HUM GENET S, V63, pA329; Kamboh MI, 1999, GENET EPIDEMIOL, V16, P205, DOI 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.0.CO;2-P; KAPRIO J, 1991, ARTERIOSCLER THROMB, V11, P1330, DOI 10.1161/01.ATV.11.5.1330; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; *LIP RES CLIN, 1980, NIH PUBL US DEP HHS, V1; LITTLE J, 1995, J RURAL STUD, V11, P101, DOI 10.1016/0743-0167(95)90009-8; MAHENY MC, 1995, ARTERIOSCLER THROMB, V15, P1730; Nestlerode CS, 1999, HUM BIOL, V71, P197; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; PEACOCK RE, 1994, CLIN GENET, V46, P273; PERUSSE L, 1989, ARTERIOSCLEROSIS, V9, P308, DOI 10.1161/01.ATV.9.3.308; Pocovi M, 1998, LANCET, V351, P1919, DOI 10.1016/S0140-6736(97)09490-7; PRENGER VL, 1992, AM J HUM GENET, V51, P1047; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; ROMLING R, 1994, ARTERIOSCLER THROMB, V14, P1915, DOI 10.1161/01.ATV.14.12.1915; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; TALL AR, 1996, ATHEROSCLEROSIS CORO, P105; THOMAS A, IN PRESS STAT COMPUT; UTERMANN G, 1982, HUM GENET, V61, P329; VONECKARDSTEIN A, 1989, J CLIN INVEST, V84, P1722, DOI 10.1172/JCI114355; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Wijsman EM, 1998, ARTERIOSCL THROM VAS, V18, P215, DOI 10.1161/01.ATV.18.2.215; WILLIAMS RR, 1990, ARCH INTERN MED, V150, P582, DOI 10.1001/archinte.150.3.582; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; WU LL, 1989, CLIN CHEM, V35, P1486; Yamakawa-Kobayashi K, 1999, HUM MOL GENET, V8, P331, DOI 10.1093/hmg/8.2.331; Yamashita S, 1996, J Atheroscler Thromb, V3, P1	66	42	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1845	1856		10.1086/302945	http://dx.doi.org/10.1086/302945			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775531	Green Published, Bronze			2022-12-18	WOS:000088373800012
J	Horvath, S; Laird, NM; Knapp, M				Horvath, S; Laird, NM; Knapp, M			The transmission/disequilibrium test and parental-genotype reconstruction for X-chromosomal markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SIBSHIP TEST; ASSOCIATION; GENE	Family-based association methods have recently been introduced that allow testing for linkage in the presence of linkage disequilibrium between a marker and a disease even if there is only incomplete parental-marker information. No such tests are currently available for X-linked markers. This report fills this methodological gap by presenting the X-linked sibling transmission/disequilibrium test (XS-TDT) and the X-linked reconstruction-combination transmission/disequilibrium test (XRC-TDT). As do their autosomal counterparts (S-TDT and RC-TDT), these tests make no assumption about the mode of inheritance of the disease and the ascertainment of the sample. They protect against spurious association due to population stratification. The two tests were compared by simulations, which show that (1) the X-linked RC-TDT is, in general, considerably more powerful than the X-linked S-TDT and (2) the lack of parental-genotype information can be offset by the typing of a sufficient number of sibling controls. A freely available SAS implementation of these tests allows the calculation of exact P values.	Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health	Knapp, M (corresponding author), Univ Bonn, Inst Med Biometry Informat & Epidemiol, Sigmund Freud Str 25, D-53105 Bonn, Germany.							Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Karayiorgou M, 1999, BIOL PSYCHIAT, V45, P1178, DOI 10.1016/S0006-3223(98)00319-9; Knapp M, 1999, AM J HUM GENET, V65, P1208, DOI 10.1086/302591; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Nemeth AH, 1999, GENOMICS, V60, P320, DOI 10.1006/geno.1999.5929; Paterson AD, 1999, AM J MED GENET, V88, P279, DOI 10.1002/(SICI)1096-8628(19990618)88:3<279::AID-AJMG14>3.3.CO;2-2; RABINOWITZ D, IN PRESS HUM HERED; SAS Institute Inc., 1990, SAS LANG REF VERS 6; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101	14	42	43	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1161	1167		10.1086/302823	http://dx.doi.org/10.1086/302823			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712229	Green Published, Bronze			2022-12-18	WOS:000088373200037
J	Watkins, KE; Gadian, DG; Vargha-Khadem, F				Watkins, KE; Gadian, DG; Vargha-Khadem, F			Functional and structural brain abnormalities associated with a genetic disorder of speech and language	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT ASYMMETRIES; DEVELOPMENTAL DYSLEXIA; COGNITIVE DEFICITS; LEFT-HEMISPHERE; CHILDREN; MORPHOMETRY; IMPAIRMENT; PET		McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada; UCL, Sch Med, Inst Child Hlth, Radiol & Phys Unit, London W1N 8AA, England; UCL, Sch Med, Inst Child Hlth, Cognit Neurosci Unit, London W1N 8AA, England	McGill University; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Watkins, KE (corresponding author), McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada.	kwatkins@bic.mni.mcgill.ca	Watkins, Kate E/A-6559-2012; Gadian, David G/C-4961-2008; Vargha-Khadem, Faraneh/C-2558-2008	Watkins, Kate E/0000-0002-2621-482X; vargha-khadem, faraneh/0000-0003-4890-8379	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aglioti S, 1996, BRAIN, V119, P1551, DOI 10.1093/brain/119.5.1551; ARNOLD GE, 1961, FOLIA PHONIATR, V13, P246, DOI 10.1159/000262921; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; FILIPEK PA, 1989, ANN NEUROL, V25, P61, DOI 10.1002/ana.410250110; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Galaburda A M, 1988, Res Publ Assoc Res Nerv Ment Dis, V66, P127; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; JERNIGAN TL, 1991, ARCH NEUROL-CHICAGO, V48, P539, DOI 10.1001/archneur.1991.00530170103028; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEWIS BA, 1992, J LEARN DISABIL-US, V25, P586, DOI 10.1177/002221949202500908; LOU HC, 1990, LANCET, V335, P8, DOI 10.1016/0140-6736(90)90136-S; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PEMBREY M, 1992, SPECIFIC SPEECH AND LANGUAGE DISORDERS IN CHILDREN : CORRELATES, CHARACTERISTICS AND OUTCOMES, P51; Pickett ER, 1998, NEUROPSYCHOLOGIA, V36, P173, DOI 10.1016/S0028-3932(97)00065-1; PLANTE E, 1991, BRAIN LANG, V41, P52, DOI 10.1016/0093-934X(91)90110-M; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Samples J M, 1985, ASHA, V27, P27; TALLAL P, 1994, J MED SPEECH-LANG PA, V2, P23; TZOURIO N, 1994, PEDIATR NEUROL, V10, P20, DOI 10.1016/0887-8994(94)90062-0; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; WADA JA, 1975, ARCH NEUROL-CHICAGO, V32, P239, DOI 10.1001/archneur.1975.00490460055007; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; WITELSON SF, 1973, BRAIN, V96, P641, DOI 10.1093/brain/96.3.641	36	42	42	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1215	1221		10.1086/302631	http://dx.doi.org/10.1086/302631			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	252YZ	10521285	Bronze, Green Published			2022-12-18	WOS:000083531000001
J	Su, B; Jin, L; Hu, F; Xiao, JH; Luo, JC; Lu, DR; Zhang, WL; Chu, JY; Du, RF; Geng, ZC; Qiu, XF; Xue, JL; Tan, JZ; O'Brien, SJ; Chakraborty, R				Su, B; Jin, L; Hu, F; Xiao, JH; Luo, JC; Lu, DR; Zhang, WL; Chu, JY; Du, RF; Geng, ZC; Qiu, XF; Xue, JL; Tan, JZ; O'Brien, SJ; Chakraborty, R			Distribution of two HIV-1-resistant polymorphisms (SDF1-3 ' A and CCR2-641) in east Asian and world populations and its implication in AIDS epidemiology	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIV-1 INFECTION; GENETIC RESTRICTION; CHEMOKINE RECEPTORS; DISEASE PROGRESSION; RESISTANCE; CCR5; ALLELE; PATHOGENESIS; INDIVIDUALS; DELETION	Chemokine receptor CCR2 and stromal-derived factor (SDF-1) are involved in HIV infection and AIDS symptom onset. Recent cohort studies showed that point mutations in these two genes, CCR2-64I and SDF1-3'A, can delay AIDS onset greater than or equal to 16 years after seroconversions. The protective effect of CCR2-64I is dominant, whereas that of SDF1-3'A is recessive. SDF1-3'A homozygotes also showed possible protection against HIV-1 infection. In this study, we surveyed the frequency distributions of the two alleles at both loci in world populations, with emphasis on those in east Asia. The CCR2-64I frequencies do not vary significantly in the different continents, having a range of 0.1-0.2 in most populations. A decreasing dine of the CCR2-64I frequency from north to south was observed in east Asia. In contrast, the distribution of SDF1-3'A in world populations varies substantially, and the highest frequency was observed in Oceanian populations. Moreover, an increasing dine of the SDF1-3'A frequency from north to south was observed in east Asia. The relative hazard values were computed to evaluate the risk of AIDS onset on the basis of two-locus genotypes in the east Asian and world populations.	Univ Texas, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77225 USA; Fudan Univ, Inst Genet, Shanghai, Peoples R China; Jingan Cent Hosp, Shanghai, Peoples R China; Suzhou Med Sch, Suzhou, Jiangsu, Peoples R China; Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; Chinese Acad Sci, Inst Genet, Beijing, Peoples R China; NCI, Lab Genome Divers, Frederick, MD 21701 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jin, L (corresponding author), Univ Texas, Sch Publ Hlth, Ctr Human Genet, 6901 Bertner Ave,POB 20334, Houston, TX 77225 USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; OBRIEN, STEPHEN/ABD-1346-2020	Jin, Li/0000-0002-4546-2415; OBRIEN, STEPHEN/0000-0001-7857-0757	NIGMS NIH HHS [R01GM41399, R01GM55759, R01 GM041399] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055759, R01GM041399] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Fauci AS, 1996, NAT MED, V2, P966, DOI 10.1038/nm0996-966; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Hill CM, 1996, NATURE, V382, P668, DOI 10.1038/382668a0; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Su B, 1998, JAMA-J AM MED ASSOC, V280, P1830, DOI 10.1001/jama.280.21.1830; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389	18	42	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1047	1053		10.1086/302568	http://dx.doi.org/10.1086/302568			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486323	Green Published, Bronze			2022-12-18	WOS:000082910000013
J	Mefford, HC; Baumbach, L; Panguluri, RCK; Whitfield-Broome, C; Szabo, C; Smith, S; King, MC; Dunston, G; Stoppa-Lyonnet, D; Arena, F				Mefford, HC; Baumbach, L; Panguluri, RCK; Whitfield-Broome, C; Szabo, C; Smith, S; King, MC; Dunston, G; Stoppa-Lyonnet, D; Arena, F			Evidence for a BRCA1 founder mutation in families of west African ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							OVARIAN-CANCER FAMILIES; BREAST-CANCER; GENE BRCA1; 185DELAG; SEQUENCE; DUTCH		Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Miami, Sylvester Canc Ctr, Miami, FL 33152 USA; Howard Univ, Dept Mol Biol & Microbiol, Washington, DC 20059 USA; Howard Univ, Ctr Canc, Washington, DC 20059 USA; Inst Curie, Unite Genet Oncol, Paris, France; INSERM U434, Paris, France	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Miami; Howard University; Howard University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	King, MC (corresponding author), Univ Washington, Dept Genet, Box 357720, Seattle, WA 98195 USA.			King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [CA27632, CA55772] Funding Source: Medline; NCRR NIH HHS [RR03048] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632, R01CA055772] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Arena JF, 1997, AM J HUM GENET, V61, pA14; Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; Gao Q, 1997, AM J HUM GENET, V60, P1233; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; PANGULURI RCK, 1999, IN PRESS HUM GENET; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; Peelen T, 1997, AM J HUM GENET, V60, P1041; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021	15	42	43	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					575	578		10.1086/302511	http://dx.doi.org/10.1086/302511			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417303	Green Published, Bronze			2022-12-18	WOS:000081836900036
J	van Steensel, M; Smith, FJD; Steijlen, PM; Kluijt, I; Stevens, HP; Messenger, A; Kremer, H; Dunnill, MGS; Kennedy, C; Munro, CS; Doherty, VR; McGrath, JA; Covello, SP; Coleman, CM; Uitto, J; McLean, WHI				van Steensel, M; Smith, FJD; Steijlen, PM; Kluijt, I; Stevens, HP; Messenger, A; Kremer, H; Dunnill, MGS; Kennedy, C; Munro, CS; Doherty, VR; McGrath, JA; Covello, SP; Coleman, CM; Uitto, J; McLean, WHI			The gene for hypotrichosis of Marie Unna maps between D8S258 and D8S298: Exclusion of the hr gene by cDNA and genomic sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN HAIRLESS GENE; UNIVERSAL CONGENITAL ALOPECIA; ECTODERMAL DYSPLASIA; MOLECULAR-BASIS; NONSENSE MUTATION; MOUSE; MONILETHRIX; PHENOTYPE; SKIN; ATRICHIA	Hypotrichosis of Marie Unna (MU) is an autosomal dominant hair-loss disorder with onset in childhood. A genomewide search for the gene was performed in a large Dutch family using 400 fluorescent microsatellite markers. Linkage was detected with marker D8S258, and analysis of this family and a further British kindred with additional markers in the region gave a combined maximum two-point LOD score of 13.42, with D8S560. Informative recombinants placed the MU gene in a 2.4-cM interval between markers D8S258 and D8S298. Recently, recessive mutations in the hv gene were reported in families with congenital atrichia, and this gene was previously mapped close to the MU interval. By radiation-hybrid mapping, we placed the hr gene close to D8S298 but were unable to exclude it from the MU interval. This, with the existence of the semidominant murine hr allele, prompted us to perform mutation analysis for this gene. Full-length sequencing of hr cDNA obtained from an affected individual showed no mutations. Similarly, screening of all exons of the hr gene amplified from the genomic DNA of an affected individual revealed no mutations. Analysis of expressed sequences and positional cloning of the MU locus is underway.	Ninewells Med Sch, Dept Mol & Cellular Pathol, Epithelial Genet Grp, Dundee DD1 9SY, Scotland; Univ Nijmegen, Dept Dermatol, Nijmegen, Netherlands; Univ Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Thomas Jefferson Univ, Epithelial Genet Grp, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Mol Med & Mol Pharmacol, Philadelphia, PA 19107 USA; Free Univ Amsterdam Hosp, Dept Clin Genet, Amsterdam, Netherlands; Royal London Hosp, Acad Dept Dermatol, London E1 1BB, England; St Thomas Hosp, St Johns Inst Dermatol, London, England; Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2JF, S Yorkshire, England; Bristol Royal Infirm, Dept Dermatol, Bristol, Avon, England; So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Victoria Hosp, Kirkcaldy, Scotland	University of Dundee; Radboud University Nijmegen; Radboud University Nijmegen; Jefferson University; Jefferson University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Barts Health NHS Trust; Royal London Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Sheffield; Bristol Royal Infirmary; University of Glasgow	McLean, WHI (corresponding author), Ninewells Med Sch, Dept Mol & Cellular Pathol, Epithelial Genet Grp, Dundee DD1 9SY, Scotland.		Messenger, Andrew/J-1240-2019; Steijlen, Peter/X-2729-2019; Kremer, Hannie/F-5126-2010; McLean, William HI/C-6352-2009; van Steensel, Maurice A.M./V-3852-2019; McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	Messenger, Andrew/0000-0003-1424-8069; Kremer, Hannie/0000-0002-0841-8693; van Steensel, Maurice/0000-0002-7507-2442; McGrath, John/0000-0002-3708-9964; McLean, William Henry Irwin/0000-0001-5539-5757	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		AHMAD M, 1993, AM J MED GENET, V46, P369, DOI 10.1002/ajmg.1320460405; Ahmad W, 1998, GENOMICS, V53, P383, DOI 10.1006/geno.1998.5495; Ahmad W, 1998, AM J HUM GENET, V63, P984, DOI 10.1086/302069; Ahmad W, 1999, GENOMICS, V56, P141, DOI 10.1006/geno.1998.5699; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Ahmad W, 1998, EXP DERMATOL, V7, P298; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENTLEYPHILLIPS B, 1979, BRIT J DERMATOL, V101, P331; BORELLI S, 1954, Hautarzt, V5, P18; Brooke HC, 1926, J HERED, V17, P173, DOI 10.1093/oxfordjournals.jhered.a102700; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Dawber R., 1997, DIS HAIR SCALP; GARBER ED, 1952, J HERED, V43, P45, DOI 10.1093/oxfordjournals.jhered.a106258; HEALY E, 1995, HUM MOL GENET, V4, P2399, DOI 10.1093/hmg/4.12.2399; Howard A, 1940, J HERED, V31, P467, DOI 10.1093/oxfordjournals.jhered.a104815; JONES JM, 1993, MAMM GENOME, V4, P639, DOI 10.1007/BF00360900; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kibar Z, 1996, HUM MOL GENET, V5, P543, DOI 10.1093/hmg/5.4.543; Laass MW, 1997, HUM GENET, V101, P376, DOI 10.1007/s004390050645; LUDWIG E, 1953, Arch Dermatol Syph, V196, P261; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Nothen MM, 1998, AM J HUM GENET, V62, P386, DOI 10.1086/301717; Panteleyev AA, 1998, EXP DERMATOL, V7, P281; Panteleyev AA, 1998, EXP DERMATOL, V7, P249, DOI 10.1111/j.1600-0625.1998.tb00295.x-i1; PEACHEY R D G, 1971, Transactions of the St. John's Hospital Dermatological Society, V57, P157; SOLOMON LM, 1971, J INVEST DERMATOL, V57, P389, DOI 10.1111/1523-1747.ep12293186; SPEIGEL B, 1979, FORTSCHR MED, V97, P2018; STELZNER KF, 1983, J HERED, V74, P193, DOI 10.1093/oxfordjournals.jhered.a109761; STEVANOV.DV, 1970, BRIT J DERMATOL, V83, P331, DOI 10.1111/j.1365-2133.1970.tb15711.x; Unna M, 1925, DERMATOL WOCHENSCHR, V81, P1167; Winter H, 1997, HUM GENET, V101, P165, DOI 10.1007/s004390050607; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; WIRTH G, 1985, HAUTARZT, V36, P577; Zlotogorski A, 1998, HUM GENET, V103, P400, DOI 10.1007/s004390050840	37	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					413	419		10.1086/302506	http://dx.doi.org/10.1086/302506			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417283	Green Published, Bronze			2022-12-18	WOS:000081836900016
J	Fox, JW; Walsh, CA				Fox, JW; Walsh, CA			Periventricular heterotopia and the genetics of neuronal migration in the cerebral cortex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIN-BINDING PROTEIN; PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; REELER-LIKE PHENOTYPE; CORTICAL DEVELOPMENT; CYTOPLASMIC DOMAIN; CELL-ADHESION; TISSUE-FACTOR; MICE; FILAMIN		Harvard Univ, Dept Neurol, Div Neurogenet, Beth Israel Deaconess Med Ctr,Inst Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Dept Neurol, Div Neurogenet, Beth Israel Deaconess Med Ctr,Inst Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.				PHS HHS [R0138097, R0135129] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bellanger Jean-Michel, 1998, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V192, P367; Bix GJ, 1998, J NEUROSCI, V18, P307; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cox D, 1996, MOL BIOL CELL, V7, P803, DOI 10.1091/mbc.7.5.803; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; des Portes V, 1998, CELL, V92, P51; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GLEESON JG, IN PRESS NEURON; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; LETOURNEAU PC, 1989, DEVELOPMENT, V105, P505; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Meyer SC, 1997, J BIOL CHEM, V272, P2914, DOI 10.1074/jbc.272.5.2914; Miyata T, 1996, J COMP NEUROL, V372, P215; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NURDEN AT, 1981, J CLIN INVEST, V67, P1431, DOI 10.1172/JCI110172; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 1998, DEVELOPMENT, V125, P3719; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Saxe CL, 1999, AM J HUM GENET, V65, P25, DOI 10.1086/302476; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; STENDAHL OI, 1980, J CELL BIOL, V84, P215, DOI 10.1083/jcb.84.2.215; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Zhang WJ, 1998, J NEUROSCI, V18, P914	40	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					19	24		10.1086/302474	http://dx.doi.org/10.1086/302474			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364512	Green Published, Bronze			2022-12-18	WOS:000081224300004
J	Satre, V; Monnier, N; Berthoin, F; Ayuso, C; Joannard, A; Jouk, PS; Lopez-Pajares, I; Megabarne, A; Philippe, HJ; Plauchu, H; Torres, ML; Lunardi, J				Satre, V; Monnier, N; Berthoin, F; Ayuso, C; Joannard, A; Jouk, PS; Lopez-Pajares, I; Megabarne, A; Philippe, HJ; Plauchu, H; Torres, ML; Lunardi, J			Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULOCEREBRORENAL SYNDROME; POLYPHOSPHATE 5-PHOSPHATASES; INOSITOL	The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder characterized by major abnormalities of eyes, nervous system, and kidneys. Mutations in the OCRL1 gene have been associated with the disease. OCRL1 encodes a phosphatidylinositol 4,5-biphosphate (PtdIns[4,5]P2) 5-phosphatase. We have examined the OCRL1 gene in eight unrelated patients with OCRL and have found seven new mutations and one recurrent in-frame deletion. Among the new mutations, two nonsense mutations (R317X and E558X) and three other frameshift mutations caused premature termination of the protein. A missense mutation, R483G, was located in the highly conserved PtdIns(4,5)P2 5-phosphatase domain. Finally, one frameshift mutation, 2733delC, modifies the C-terminal part of OCRL1, with an extension of six amino acids. Altogether, 70% of missense mutations are located in exon 15, and 52% of all mutations cluster in exons 11-15. We also identified two new microsatellite markers for the OCRL1 locus, and we detected a germline mosaicism in one family. This observation has direct implications for genetic counseling of Lowe syndrome families.	CEA Grenoble, DBMS, Lab BECP, EA 2411 UJF, F-38054 Grenoble 09, France; CEA Grenoble, DBMS, Lab BECP, EA 2019 UJF, F-38054 Grenoble, France; Fundac Jimenez Diaz, Madrid, Spain; CHU Grenoble, Dept Med Infantile, F-38043 Grenoble, France; CHU Grenoble, Serv Genet, F-38043 Grenoble, France; Hosp La Paz, Madrid, Spain; St Josephs Univ, Sch Med, Beirut, Lebanon; CH Leon Touhladjian, Serv Gynecol Obstet, Poissy, France; Hotel Dieu, HCL, Serv Genet, Lyon, France	CEA; CEA; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Hospital Universitario La Paz; Saint Joseph University Beirut; CHU Lyon	Lunardi, J (corresponding author), CEA Grenoble, DBMS, Lab BECP, EA 2411 UJF, 17 Rue des Martyrs, F-38054 Grenoble 09, France.		Jouk, Pierre-Simon/AAB-5262-2022; Jouk, Pierre-Simon/M-7367-2014; SATRE, Veronique/G-2864-2014	Jouk, Pierre-Simon/0000-0001-8301-320X; Ayuso, Carmen/0000-0002-9242-7065; SATRE, Veronique/0000-0001-7852-8591				ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; HABIB R, 1962, Arch Fr Pediatr, V19, P945; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Kawano T, 1998, AM J MED GENET, V77, P348, DOI 10.1002/(SICI)1096-8628(19980605)77:5<348::AID-AJMG2>3.0.CO;2-J; Kubota T, 1998, CLIN GENET, V54, P199; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEAHEY AM, 1993, HUM MOL GENET, V2, P461, DOI 10.1093/hmg/2.4.461; Lin T, 1998, MOL GENET METAB, V64, P58, DOI 10.1006/mgme.1998.2687; Lin T, 1997, AM J HUM GENET, V60, P1384, DOI 10.1086/515471; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; MURPHY EA, 1974, AM J HUM GENET, V26, P207; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; PASSOSBUENO MR, 1992, AM J HUM GENET, V51, P1150; SILVER DN, 1987, J CLIN INVEST, V79, P282, DOI 10.1172/JCI112795; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574	26	42	47	2	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					68	76		10.1086/302443	http://dx.doi.org/10.1086/302443			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364518	Green Published, Bronze			2022-12-18	WOS:000081224300010
J	Hobbs, MR; Pole, AR; Pidwirny, GN; Rosen, IB; Zarbo, RJ; Coon, H; Heath, H; Leppert, M; Jackson, CE				Hobbs, MR; Pole, AR; Pidwirny, GN; Rosen, IB; Zarbo, RJ; Coon, H; Heath, H; Leppert, M; Jackson, CE			Hyperparathyroidism-jaw tumor syndrome: The HRPT2 locus is within a 0.7-cM region on chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BENIGN HYPOCALCIURIC HYPERCALCEMIA; FAMILIAL HYPERPARATHYROIDISM; LINKAGE ANALYSIS; WILMS-TUMOR; HEREDITARY HYPERPARATHYROIDISM; HUMAN GENOME; GENE; MAP; MUTATIONS; FIBROMAS	Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease characterized by the development of multiple parathyroid adenomas and multiple fibro-osseous tumors of the maxilla and mandible. Some families have had affected members with involvement of the kidneys, variously reported as Wilms tumors, nephroblastomas, and hamartomas. The HPT-JT gene (HRPT2) maps to chromosome 1q25-q31. We describe further investigation of two HPT-JT families (K3304 and K3349) identified through the literature. These two expanded families and two previously reported families were investigated jointly for linkage with 21 new, closely linked markers. Multipoint linkage analysis resulted in a maximum LOD score of 7.83 (at recombination fraction 0) for markers D1S2848-D1S191. Recombination events in these families reduced the HRPT2 region to similar to 14.7 cM. In addition, two of these four study families (i.e., K3304 and K11687) share a 2.2-cM length of their (expanded) affected haplotype, indicating a possible common origin. Combining the linkage data and shared-haplotype data, we propose a 0.7-cM candidate region for HRPT2.	Univ Utah, Dept Internal Med, Div Endocrinol Diabet & Metab, Sch Med, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Howard Hughes Med Inst, Eccles Inst Human Genet,Dept Human Genet, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84132 USA; Isl lakes Med Ctr, Winnipeg, MB, Canada; Univ Toronto, Toronto, ON, Canada; Henry Ford Hosp, Dept Med, Clin & Mol Genet Div, Detroit, MI 48202 USA; Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Toronto; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Hobbs, MR (corresponding author), Univ Utah, Dept Internal Med, Div Endocrinol Diabet & Metab, Sch Med, 50 N Med Dr,Room 4C116, Salt Lake City, UT 84132 USA.	Maurine.Hobbs@hsc.utah.edu		Coon, Hilary/0000-0002-8877-5446	NATIONAL CANCER INSTITUTE [R55CA075177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038855] Funding Source: NIH RePORTER; NCI NIH HHS [1 R55 CA75177-01] Funding Source: Medline; NCRR NIH HHS [MO1-RR00064] Funding Source: Medline; NIDDK NIH HHS [DK-38855] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; DINNEN JS, 1977, J CLIN PATHOL, V30, P966, DOI 10.1136/jcp.30.10.966; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; EVERSOLE LR, 1985, ORAL SURG ORAL MED O, V60, P505, DOI 10.1016/0030-4220(85)90239-7; FIRAT D, 1968, AM J MED, V44, P421, DOI 10.1016/0002-9343(68)90112-5; Fujikawa M, 1998, EUR J ENDOCRINOL, V138, P557, DOI 10.1530/eje.0.1380557; Heath H, 1996, J CLIN ENDOCR METAB, V81, P1312, DOI 10.1210/jcem.81.4.8636323; HEATH H, 1993, AM J HUM GENET, V53, P193; HOBBS MR, 1998, PRIMER METABOLIC BON, P187; HUFF V, 1993, BIOCHIM BIOPHYS ACTA, V1155, P295, DOI 10.1016/0304-419X(93)90011-Z; INOUE H, 1995, CLIN ENDOCRINOL, V43, P225, DOI 10.1111/j.1365-2265.1995.tb01919.x; JACKSON CE, 1990, SURGERY, V108, P1006; JACKSON CE, 1958, ANN INTERN MED, V49, P829, DOI 10.7326/0003-4819-49-4-829; KAKINUMA A, 1994, INTERNAL MED, V33, P123, DOI 10.2169/internalmedicine.33.123; KENNETT S, 1971, ORAL SURG ORAL MED O, V31, P502, DOI 10.1016/0030-4220(71)90347-1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIEBHABER SA, 1990, NUCLEIC ACIDS RES, V18, P3871, DOI 10.1093/nar/18.13.3871; MALLETTE LE, 1987, ANN INTERN MED, V107, P54, DOI 10.7326/0003-4819-107-1-54; MATSUNAGA E, 1981, HUM GENET, V57, P231; Ott J, 1996, NATURE, V379, P772, DOI 10.1038/379772a0; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; Pidwirny G. N., 1995, American Journal of Human Genetics, V57, pA75; REGEZI JA, 1978, J ORAL SURG, V36, P771; ROSEN IB, 1981, AM J SURG, V142, P494, DOI 10.1016/0002-9610(81)90382-2; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; SLOOTWEG PJ, 1990, J CRANIO MAXILL SURG, V18, P210, DOI 10.1016/S1010-5182(05)80413-5; SZABO J, 1995, AM J HUM GENET, V56, P944; Teh BT, 1998, J CLIN ENDOCR METAB, V83, P2114, DOI 10.1210/jc.83.6.2114; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; WARNAKULASURIYA S, 1985, ORAL SURG ORAL MED O, V59, P269, DOI 10.1016/0030-4220(85)90165-3; Weeks DE., 1990, AM J HUM GENET, V47, pA203; ZARBO RJ, 1993, MODERN PATHOL, V6, pA42	38	42	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					518	525		10.1086/302259	http://dx.doi.org/10.1086/302259			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973288	Green Published, Bronze			2022-12-18	WOS:000078740600020
J	Elston, RC				Elston, RC			Methods of linkage analysis - and the assumptions underlying them	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC DISSECTION; COMPLEX TRAITS		Case Western Reserve Univ, Metrohlth Med Ctr, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Elston, RC (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, R-258,2500 Metrohlth Dr, Cleveland, OH 44109 USA.	rce@darwin.cwru.edu			NCRR NIH HHS [RR 03655] Funding Source: Medline; NIGMS NIH HHS [GM 28356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS CI, 1994, AM J HUM GENET, V54, P535; BERGER JO, 1988, AM SCI, V76, P159; GOODMAN SN, 1993, AM J EPIDEMIOL, V137, P485, DOI 10.1093/oxfordjournals.aje.a116700; Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; Jarvik GP, 1998, AM J HUM GENET, V63, P942, DOI 10.1086/302075; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MALECOT G, 1947, ANN U LYON, V10, P43; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Penrose LS, 1935, ANN EUGENIC, V4, P133; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355	13	42	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					931	934		10.1086/302073	http://dx.doi.org/10.1086/302073			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758631	Bronze, Green Published			2022-12-18	WOS:000076577800002
J	Friedman, E; Bruchim, RB; Kruglikova, A; Risel, S; Levy-Lahad, E; Halle, D; Bar-On, E; Gershoni-Baruch, R; Dagan, E; Kepten, I; Peretz, T; Lerer, I; Wienberg, N; Shushan, A; Abeliovich, D				Friedman, E; Bruchim, RB; Kruglikova, A; Risel, S; Levy-Lahad, E; Halle, D; Bar-On, E; Gershoni-Baruch, R; Dagan, E; Kepten, I; Peretz, T; Lerer, I; Wienberg, N; Shushan, A; Abeliovich, D			Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							OVARIAN-CANCER; FREQUENCY; 185DELAG		Hebrew Univ Jerusalem, Hadassah Univ Hosp, Sharett Inst Oncol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; Chaim Sheba Med Ctr, Oncogenet Unit, IL-52621 Tel Hashomer, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Chaim Sheba Medical Center			Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921				Abeliovich D, 1997, AM J HUM GENET, V60, P505; Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; BOYD M, 1995, NATURE, V375, P541, DOI 10.1038/375541b0; Gershoni-Baruch R, 1997, EUR J CANCER, V33, P2283, DOI 10.1016/S0959-8049(97)00223-2; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; ODDUOUX C, 1996, NAT GENET, V14, P188; Ramus SJ, 1997, NAT GENET, V15, P14, DOI 10.1038/ng0197-14; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198	10	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1224	1227		10.1086/302040	http://dx.doi.org/10.1086/302040			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758598	Green Published, Bronze			2022-12-18	WOS:000076577800037
J	Jarvela, I; Enattah, NS; Kokkonen, J; Varilo, T; Savilahti, E; Peltonen, L				Jarvela, I; Enattah, NS; Kokkonen, J; Varilo, T; Savilahti, E; Peltonen, L			Assignment of the locus for congenital lactase deficiency to 2q21, in the vicinity of but separate from the lactase-phlorizin hydrolase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; FINNISH POPULATION; HUMAN GENOME; MUTATION; MAP; DNA; AGE	Congenital lactase deficiency (CLD) is an autosomal recessive, gastrointestinal disorder characterized by watery diarrhea starting during the first 1-10 d of life, in infants fed lactose-containing milks. Since 1966, 42 patients have been diagnosed in Finland. CLD is the most severe form of lactase deficiency, with an almost total lack of lactase-phlorizin hydrolase (LPH) activity on jejunal biopsy. In adult-type hypolactasia, the most common genetic enzyme deficiency in humans, this enzyme activity is reduced to 5%-10%. Although the activity of intestinal LPH has been found to be greatly reduced in both forms, the molecular pathogenesis of lactase deficiencies is unknown. On the basis of the initial candidate-gene approach, we assigned the CLD locus to an 8-cM interval on chromosome 2q21 in 19 Finnish families. At the closest marker locus, a specific allele 2 was present in 92% of disease alleles. On the basis of a genealogical study, the CLD mutation was found to be enriched in sparsely populated eastern and northern Finland, because of a founder effect. The results of both the genealogical study and the haplotype analysis indicate that one major mutation in a novel gene causes CLD in the Finnish population. Consequently, the critical region could be restricted further, to an similar to 350-kb interval, by ancient-haplotype and linkage-disequilibrium analyses. Surprisingly, the LPH gene was shown to lie outside the critical CLD region, excluding it as a causative gene for CLD. The LPH locus was found to reside >2 Mb from the critical CLD region.	Natl Publ Hlth Inst, Dept Human Mol Genet, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Oulu Univ Hosp, Dept Pediat, Oulu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Oulu	Jarvela, I (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, SF-00300 Helsinki, Finland.		Jarvela, Irma E/L-5836-2013; Alshali, Rasha A/K-8051-2012	Jarvela, Irma E/0000-0002-1770-6187; Varilo, Teppo/0000-0002-5839-8854				BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BOLL W, 1991, AM J HUM GENET, V48, P889; CHUMAKOV IM, 1995, NATURE, V377, P175; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HARVEY CB, 1993, ANN HUM GENET, V57, P179, DOI 10.1111/j.1469-1809.1993.tb01593.x; HOLZEL A, 1959, LANCET, V1, P1126; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KRUSE TA, 1988, FEBS LETT, V240, P123, DOI 10.1016/0014-5793(88)80352-1; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NIKALI K, 1994, PEDIATR RES, V36, P607, DOI 10.1203/00006450-199411000-00012; NORIO R, 1973, ANN CLIN RES, V5, P109; Peltonen L, 1997, GENOME RES, V7, P765, DOI 10.1101/gr.7.8.765; POGGI V, 1991, AM J HUM GENET, V49, P105; SAHI T, 1972, ACTA PAEDIATR SCAND, V61, P11, DOI 10.1111/j.1651-2227.1972.tb15897.x; Sambrook J, 1989, MOL CLONING LAB MANU; SAVILAHTI E, 1983, ARCH DIS CHILD, V58, P246, DOI 10.1136/adc.58.4.246; Terwilliger JD, 1996, AM J HUM GENET, V58, P1095; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Varilo T, 1996, AM J HUM GENET, V58, P506; Varilo T, 1996, GENOME RES, V6, P870, DOI 10.1101/gr.6.9.870	24	42	44	0	9	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1078	1085		10.1086/302064	http://dx.doi.org/10.1086/302064			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758622	Bronze, Green Published			2022-12-18	WOS:000076577800021
J	Cerosaletti, KM; Lange, E; Stringham, HM; Weemaes, CMR; Smeets, D; Solder, B; Belohradsky, BH; Taylor, AMR; Karnes, P; Elliott, A; Komatsu, K; Gatti, RA; Boehnke, M; Concannon, P				Cerosaletti, KM; Lange, E; Stringham, HM; Weemaes, CMR; Smeets, D; Solder, B; Belohradsky, BH; Taylor, AMR; Karnes, P; Elliott, A; Komatsu, K; Gatti, RA; Boehnke, M; Concannon, P			Fine localization of the Nijmegen breakage syndrome gene to 8q21: Evidence for a common founder haplotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL INSTABILITY DISORDER; ATAXIA-TELANGIECTASIA; IMMUNODEFICIENCY; COMPLEMENTATION; RADIATION; VARIANT; CELL	Nijmegen breakage syndrome (NBS) is a rare autosomal recessive disorder characterized by microcephaly, a birdlike face, growth retardation, immunodeficiency, lack of secondary sex characteristics in females, and increased incidence of lymphoid cancers. NBS cells display a phenotype similar to that of cells from ataxia-telangiectasia patients, including chromosomal instability, radiation sensitivity, and aberrant cell-cycle-checkpoint control following exposure to ionizing radiation. A recent study reported genetic linkage of NBS to human chromosome 8q21, with strong linkage disequilibrium detected at marker D8S1811 in eastern European NBS families. We collected a geographically diverse group of NBS families and tested them for linkage, using an expanded panel of markers at 8q21. In this article, we report linkage of NBS to 8q21 in 6/7 of these families, with a maximum LOD score of 3.58. Significant linkage disequilibrium was detected for 8/13 markers tested in the 8q21 region, including D8S1811, In order to further localize the gene for NBS, we generated a radiation-hybrid map of markers at 8q21 and constructed haplotypes based on this map. Examination of disease haplotypes segregating in 11 NBS pedigrees revealed recombination events that place the NBS gene between D8S1757 and D8S270. A common founder haplotype was present on 15/18 disease chromosomes from 9/11 NBS families. Inferred (ancestral) recombination events involving this common haplotype suggest that NBS can be localized further, to an interval flanked by markers D8S273 and D8S88.	Univ Washington, Sch Med, Virginia Mason Res Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98101 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands; Univ Munich, Dr Von Haunerschen Kinderspital, Immundefekt Ambulanzder Kinderklin, D-80337 Munich, Germany; Univ Birmingham, Sch Med, Birmingham B15 2TT, W Midlands, England; Mayo Clin, Rochester, MN USA; Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal, PQ, Canada; Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Radboud University Nijmegen; University of Munich; University of Birmingham; Mayo Clinic; McGill University; McGill University; Hiroshima University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Concannon, P (corresponding author), Univ Washington, Sch Med, Virginia Mason Res Ctr, 1000 Seneca St, Seattle, WA 98101 USA.	patcon@u.washington.edu	Weemaes, C.M.R./L-4747-2015	Concannon, Patrick/0000-0002-5801-1859; Elliott, Alison/0000-0002-9896-1314	NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NCI NIH HHS [CA57569] Funding Source: Medline; NHGRI NIH HHS [T32HG00040] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CHRZANOWSKA KH, 1995, AM J MED GENET, V57, P462, DOI 10.1002/ajmg.1320570321; CHRZANOWSKA KH, 1997, 7 AT TEL WORKSH CLER; CONLEY ME, 1986, BLOOD, V67, P1251; COOPER PR, 1997, AM SOC HUM GEN 47 AN; CURRY CJR, 1989, AM J HUM GENET, V45, P270; DerKaloustian VM, 1996, AM J MED GENET, V65, P21, DOI 10.1002/(SICI)1096-8628(19961002)65:1<21::AID-AJMG3>3.0.CO;2-0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GATTI RA, 1998, METABOLIC MOL BASES, P275; GREEN AJ, 1995, ARCH DIS CHILD, V73, P431, DOI 10.1136/adc.73.5.431; HUE YK, 1994, CANCER RES, V54, P2544; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; Komatsu K, 1996, AM J HUM GENET, V58, P885; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lunetta KL, 1996, AM J HUM GENET, V59, P717; Matsuura S, 1997, AM J HUM GENET, V60, P1487, DOI 10.1086/515461; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; Saar K, 1997, AM J HUM GENET, V60, P605; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; STUMM M, 1995, AM J HUM GENET, V57, P960; Sullivan KE, 1997, CLIN IMMUNOL IMMUNOP, V82, P43, DOI 10.1006/clin.1996.4275; TAALMAN RDFM, 1983, MUTAT RES, V112, P23, DOI 10.1016/0167-8817(83)90021-4; TAALMAN RDFM, 1989, AM J MED GENET, V32, P425, DOI 10.1002/ajmg.1320320332; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; WEGNER RD, 1988, CLIN GENET, V33, P20; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	30	42	44	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					125	134		10.1086/301927	http://dx.doi.org/10.1086/301927			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634525	Green Published, Bronze			2022-12-18	WOS:000074761000019
J	Schachter, F				Schachter, F			Causes, effects, and constraints in the genetics of human longevity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENESCENCE; EVOLUTION		Inst Pasteur, Human Immunogenet Lab, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schachter, F (corresponding author), Inst Pasteur, Human Immunogenet Lab, 25 Rue Dr Roux, F-75724 Paris, France.	Francois.Schachter@Devinci.fr						ABBOTT MH, 1974, JOHNS HOPKINS MED J, V134, P1; BUCHER K, 1980, AM J MED GENET, V7, P27, DOI 10.1002/ajmg.1320070107; CUTLER RG, 1975, P NATL ACAD SCI USA, V72, P4664, DOI 10.1073/pnas.72.11.4664; Effros RB, 1998, AM J HUM GENET, V62, P1003, DOI 10.1086/301845; Finch CE, 1997, TRENDS NEUROSCI, V20, P501; FINCH CE, 1995, Q REV BIOL, V70, P1, DOI 10.1086/418864; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Gavrilov LA, 1997, MUTAT RES-FUND MOL M, V377, P61, DOI 10.1016/S0027-5107(97)00058-4; Gavrilova N.S., 1991, BIOL LIFE SPAN QUANT; Ivanova R, 1998, HUM MOL GENET, V7, P187, DOI 10.1093/hmg/7.2.187; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; MACIEIRACOELHO A, 1995, MECH AGEING DEV, V82, P91, DOI 10.1016/0047-6374(95)01610-C; Mannucci PM, 1997, ARTERIOSCL THROM VAS, V17, P755, DOI 10.1161/01.ATV.17.4.755; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MELTZER PS, 1993, NAT GENET, V4, P252, DOI 10.1038/ng0793-252; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; PAZ MA, 1981, J GERONTOL, V36, P142, DOI 10.1093/geronj/36.2.142; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Qian F, 1997, AM J HUM GENET, V61, P1000, DOI 10.1086/301618; RADMAN M, 1995, PHILOS T ROY SOC B, V347, P97, DOI 10.1098/rstb.1995.0015; REITER RJ, 1995, EXP GERONTOL, V30, P199, DOI 10.1016/0531-5565(94)00045-5; Robine JM, 1998, SCIENCE, V279, P1834; Robinson WP, 1996, AM J HUM GENET, V59, P1175; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; Sing Charles F., 1993, P140; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; Tischfield JA, 1997, AM J HUM GENET, V61, P995, DOI 10.1086/301617; TOUPANCE B, 1998, IN PRESS AM J HUM GE, P62; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WEI JY, 1992, NEW ENGL J MED, V327, P1735, DOI 10.1056/NEJM199212103272408; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	38	42	42	1	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1008	1014		10.1086/301849	http://dx.doi.org/10.1086/301849			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545419	Green Published, Bronze			2022-12-18	WOS:000073487000002
J	Chomyn, A				Chomyn, A			The myoclonic epilepsy and ragged-red fiber mutation provides new insights into human mitochondrial function and genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-SYNTHESIS; RNALYS MUTATION; DNA; MERRF; CELLS; DISEASE; COMPLEMENTATION; TRNA(LYS); MUSCLE; MTDNA		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Chomyn, A (corresponding author), CALTECH, Div Biol, 156-29, Pasadena, CA 91125 USA.				NIGMS NIH HHS [GM11726] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1986, COLD SPRING HARB SYM, V51, P103, DOI 10.1101/SQB.1986.051.01.013; BAKEEVA LE, 1981, EUR J CELL BIOL, V25, P175; BOULET L, 1992, AM J HUM GENET, V51, P1187; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; Chomyn A, 1997, AM J HUM GENET, V61, pA306; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; GOLDMAN E, 1990, MOL MICROBIOL, V4, P2035, DOI 10.1111/j.1365-2958.1990.tb00563.x; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Guan MX, 1997, AM J HUM GENET, V61, pA309; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Parker WD, 1998, AM J HUM GENET, V62, P758, DOI 10.1086/301812; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699; Zhou L, 1997, J NEUROSCI, V17, P7746	28	42	42	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					745	751		10.1086/301813	http://dx.doi.org/10.1086/301813			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529371	Bronze, Green Published			2022-12-18	WOS:000073514400001
J	Gantla, S; Bakker, CTM; Deocharan, B; Thummala, NR; Zweiner, J; Sinaasappel, M; Chowdhury, JR; Bosma, PJ; Chowdhury, NR				Gantla, S; Bakker, CTM; Deocharan, B; Thummala, NR; Zweiner, J; Sinaasappel, M; Chowdhury, JR; Bosma, PJ; Chowdhury, NR			Splice-site mutations: A novel genetic mechanism of Crigler-Najjar syndrome type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE; SYNDROME TYPE-I; GLOBIN GENE; RNA; COMPLEX; IDENTIFICATION; SUBSTITUTION; SEQUENCE; PATIENT; PHENOL	Crigler-Najjar syndrome type 1 (CN-1) is a recessively inherited, potentially lethal disorder characterized by severe unconjugated hyperbilirubinemia resulting from deficiency of the hepatic enzyme bilirubin-UDP-glucuronosyltransferase. In all CN-1 patients studied, structural mutations in one of the five exons of the gene (UGT1A1) encoding the uridinediphosphoglucuronate glucuronosyltransferase (UGT) isoform bilirubin-UGT(1), were implicated in the absence or inactivation of the enzyme. We report two patients in whom CN-1 is caused, instead, by mutations in the noncoding intronic region of the UGT1A1 gene. One patient (A) was homozygous for a G-->C mutation at the splice-donor site in the intron, between exon 1 and exon 2. The other patient (B) was heterozygous for an A-->G shift at the splice-acceptor site in intron 3, and in the second allele a premature translation-termination codon in exon 1 was identified. Bilirubin-UGT(1), mRNA is difficult to obtain, since it is expressed in the liver only. To determine the effects of these splice-junction mutations, we amplified genomic DNA of the relevant splice junctions. The amplicons were expressed in COS-7 cells, and the expressed mRNAs were analyzed. In both cases, splice-site mutations led to the use of cryptic splice sites, with consequent deletions in the processed mRNA. This is the first report of intronic mutations causing CN-1 and of the determination of the consequences of these mutations on mRNA structure, by ex vivo expression.	Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Liver Dis, NL-1105 AZ Amsterdam, Netherlands; Univ Rotterdam, Sophia Childrens Hosp, Rotterdam, Netherlands; Childrens Med Ctr, Dept Pediat, Dallas, TX 75235 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Chowdhury, NR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046057, R01DK039137, P30DK041296] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK39137, R01 DK 46057, P30 DK 41296] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARIAS IM, 1969, AM J MED, V47, P395, DOI 10.1016/0002-9343(69)90224-1; BOSMA PJ, 1992, FASEB J, V6, P2859, DOI 10.1096/fasebj.6.10.1634050; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BOSMA PJ, 1992, HEPATOLOGY, V15, P941, DOI 10.1002/hep.1840150531; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chowdhury J. R., 1986, BILE PIGMENTS JAUNDI, P317; CHOWDHURY JR, 1985, P NATL ACAD SCI USA, V82, P2990, DOI 10.1073/pnas.82.9.2990; CRIGLER JF, 1952, PEDIATRICS, V10, P169; Dutton G.F., 1980, GLUCURONIDATION DRUG; GOLDSMITH ME, 1983, P NATL ACAD SCI-BIOL, V80, P2318, DOI 10.1073/pnas.80.8.2318; KRAWCZAK M, 1992, HUM GENET, V90, P41; LABRUNE P, 1994, HUM GENET, V94, P693; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MOGHRABI N, 1993, GENOMICS, V18, P171, DOI 10.1006/geno.1993.1451; MOGHRABI N, 1993, AM J HUM GENET, V53, P722; ORKIN SH, 1984, BLOOD, V64, P311; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, J BIOL CHEM, V267, P3257; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; SCHMID R, 1958, J CLIN INVEST, V37, P1123, DOI 10.1172/JCI103702; SEPPEN J, 1994, J CLIN INVEST, V94, P2385, DOI 10.1172/JCI117604; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; YAMADA S, 1995, HUM MOL GENET, V4, P651, DOI 10.1093/hmg/4.4.651	26	42	44	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					585	592		10.1086/301756	http://dx.doi.org/10.1086/301756			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497253	Green Published, Bronze			2022-12-18	WOS:000072894400011
J	Aral, B; Benelli, C; Ait-Ghezala, G; Amessou, M; Fouque, F; Maunoury, C; Creau, N; Kamoun, P; Marsac, C				Aral, B; Benelli, C; Ait-Ghezala, G; Amessou, M; Fouque, F; Maunoury, C; Creau, N; Kamoun, P; Marsac, C			Mutations in PDX1, the human lipoyl-containing component X of the pyruvate dehydrogenase complex gene on chromosome 11p1, in congenital lactic acidosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELTA(1)-PYRROLINE-5-CARBOXYLATE SYNTHETASE P5CS; DIHYDROLIPOYL TRANSACETYLASE COMPONENT; PROTEIN-X; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; MULTIENZYME COMPLEX; DNA; ACETYLATION; CLONING; SUBUNIT	We have identified and sequenced a cDNA that encodes an apparent human orthologue of a yeast protein-X component (ScPDX1) of pyruvate dehydrogenase multienzyme complexes. The new human cDNA that has been referred to as "HsPDX1" cDNA was cloned by use of the "database cloning" strategy and had a 1,506-bp open reading frame. The amino acid sequence of the protein encoded by the cDNA was 20% identical with that encoded by the yeast PDX1 gene and 40% identical with that encoded by the lipoate acetyltransferase :component of the pyruvate dehydrogenase and included a lipoyl-bearing domain that is conserved in some dehydrogenase enzyme complexes. Northern blot analysis demonstrated that the major HsPDX1 mRNA was 2.5 kb in length and was expressed mainly in human skeletal and cardiac muscles but was also present, at low levels, in other tissues. FISH analysis performed with a P1-derived artifical chromosome (PAC)-containing HsPDX1 gene sublocalized the gene to 11p1.3. Molecular investigation of PDX1 deficiency in four patients with neonatal lactic acidemias revealed mutations 78del85 and 965del59 in a homozygous state, and one other patient had no PDX1 mRNA expression.	Hop Necker Enfants Malad, Inst Necker, IFREM, Lab Biochim Med B,CNRS,URA1335, Paris, France; Hop Necker Enfants Malad, Inst Necker, IFREM, INSERM,U30,Unite Rech Mecan Act Cellulaire Hormon, Paris, France; Hop Necker Enfants Malad, Inst Necker, IFREM, INSERM,U75,Lab Biochim Pharmacol & Metab, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Aral, B (corresponding author), Fac Med Necker, CNRS, URA1335, 156 Rue Vaugirard, F-75015 Paris, France.	aral@necker.fr		Ait-Ghezala, Ghania/0000-0002-9836-8617				Aral B, 1996, CR ACAD SCI III-VIE, V319, P171; BASSET DE, 1995, TRENDS GENET, V11, P372, DOI 10.1016/S0168-9525(00)89109-X; Bassett DE, 1997, NAT GENET, V15, P339, DOI 10.1038/ng0497-339; BEHAL RH, 1989, P NATL ACAD SCI USA, V86, P8732, DOI 10.1073/pnas.86.22.8732; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CHENCHIK A, 1995, CLONTECHNIQUES, V1, P5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEMARCUCCI O, 1985, EUR J BIOCHEM, V149, P641, DOI 10.1111/j.1432-1033.1985.tb08972.x; DEMARCUCCI OGL, 1986, EUR J BIOCHEM, V158, P587; DEMEIRLEIR L, IN PRESS J INHERIT M; Dodt G, 1996, ANN NY ACAD SCI, V804, P516, DOI 10.1111/j.1749-6632.1996.tb18641.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL R, 1994, CELL, V77, P167; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Geoffroy V, 1996, PEDIATRICS, V97, P267; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HODGSON JA, 1986, EUR J BIOCHEM, V158, P595, DOI 10.1111/j.1432-1033.1986.tb09796.x; JILKA JM, 1986, J BIOL CHEM, V261, P1858; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; LEHRACH H., 1990, GENOME ANAL, P39; Liu G, 1996, GENOMICS, V37, P145, DOI 10.1006/geno.1996.0535; MARSAC C, 1993, J PEDIATR-US, V123, P915, DOI 10.1016/S0022-3476(05)80387-7; NEAGLE JC, 1991, BIOCHEM J, V278, P423, DOI 10.1042/bj2780423; NIU XD, 1988, P NATL ACAD SCI USA, V85, P7546, DOI 10.1073/pnas.85.20.7546; POWERSGREENWOOD SL, 1989, J BIOL CHEM, V264, P3655; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P1245; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P2221; RAHMATULLAH M, 1987, J BIOL CHEM, V262, P10265; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; RICE JE, 1992, EMBO J, V11, P3229, DOI 10.1002/j.1460-2075.1992.tb05400.x; ROBINSON BH, 1990, J CLIN INVEST, V85, P1821, DOI 10.1172/JCI114641; Sambrook J, 1989, MOL CLONING LAB MANU; Sanderson SJ, 1996, BIOCHEM J, V319, P109, DOI 10.1042/bj3190109; THEKKUMKARA TJ, 1988, FEBS LETT, V240, P45, DOI 10.1016/0014-5793(88)80337-5; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG LF, 1994, BIOTECHNIQUES, V17, P26	39	42	44	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1318	1326		10.1086/301653	http://dx.doi.org/10.1086/301653			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399911	Green Published, Bronze			2022-12-18	WOS:000071555900015
J	Assink, JJM; Tijmes, NT; tenBrink, JB; Oostra, RJ; Riemslag, FC; deJong, PTVM; Bergen, AAB				Assink, JJM; Tijmes, NT; tenBrink, JB; Oostra, RJ; Riemslag, FC; deJong, PTVM; Bergen, AAB			A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; NERVE ATROPHY; NEUROPATHY; SUSCEPTIBILITY; FAMILIES; NEURORETINOPATHY; OPHTHALMOPLEGIA; INACTIVATION; MUTATION; DXS7	The aim of this study was to-identify the chromosomal location of the disease-causing gene in a family apparently segregating X-linked optic atrophy. A large family of 45 individuals with a four-generation history of X-linked optic atrophy was reexamined in a full ophthalmic as well. as electrophysiological examination. A DNA linkage analysis of the family was undertaken in order to identify the chromosomal location of the disease-causing gene. Linkage analysis was performed with 26 markers that spanned the entire X chromosome. The affected males showed very early onset and slow progression of the disease. Ophthalmic study of the female carriers did not reveal any abnormalities. Close linkage without recombination was found at the MAOB locus (maximum LOD score [Z(max)] 4.19). The Z(max) - 1 support interval was found at a recombination fraction of .076 distal and .018 proximal to MAOB. Multipoint linkage analysis placed the optic atrophy-causing gene in the Xp11.4-p11.21 interval between markers DXS993 and DXS991, whereas any other localization along the X chromosome could be excluded.	NETHERLANDS OPHTHALM RES INST,DEPT OPHTHALMOGENET,NL-1100 AC AMSTERDAM,NETHERLANDS; NETHERLANDS OPHTHALM RES INST,DIV VISUAL SYST ANAL,NL-1100 AC AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT CLIN GENET,AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT OPHTHALMOL,NL-1105 AZ AMSTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT EPIDEMIOL & BIOSTAT,NL-3000 DR ROTTERDAM,NETHERLANDS	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam			Bergen, Arthur/J-3637-2013	Oostra, Roelof-Jan/0000-0002-2452-8307; Bergen, Arthur/0000-0002-6333-9576				Behr C., 1909, KLIN MBL AUGENHEILKD, V47, P138; BERGEN AAB, 1991, HUM GENET, V88, P162, DOI 10.1007/BF00206065; BLACK GCM, 1995, EYE, V9, P513, DOI 10.1038/eye.1995.117; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089; CHEN JD, 1989, HUM GENET, V82, P203, DOI 10.1007/BF00291154; EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; JENSEN PKA, 1987, AM J MED GENET, V28, P517, DOI 10.1002/ajmg.1320280234; JUVONEN V, 1993, AM J HUM GENET, V53, P289; KJER P, 1972, HDB CLIN NEUROLOGY, P111; Kok-van Alphen CC, 1970, ACTA OPHTHALMOL, V48, P905; LYSEN JC, 1947, B DIGHT I, V5, P20; MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861; Oostra RJ, 1996, HUM GENET, V97, P500; ROSENBER.RN, 1967, NEUROLOGY, V17, P827, DOI 10.1212/WNL.17.9.827; SWEENEY MG, 1992, AM J HUM GENET, V51, P741; TIPTON RE, 1984, AM J MED GENET, V19, P27; TREFT RL, 1984, OPHTHALMOLOGY, V91, P908; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VOLKERDIEBEN HJM, 1974, DOC OPHTHALMOL, V37, P307, DOI 10.1007/BF00147264; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WENT LN, 1975, J MED GENET, V12, P94, DOI 10.1136/jmg.12.1.94; Wolfram DJ, 1938, P MAYO CLIN, V13, P715	24	42	44	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					934	939		10.1086/514884	http://dx.doi.org/10.1086/514884			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382106	Green Published, Green Submitted, Bronze			2022-12-18	WOS:A1997YA59100022
J	Heikkinen, J; Toppinen, T; Yeowell, H; Krieg, T; Steinmann, B; Kivirikko, KI; Myllyla, R				Heikkinen, J; Toppinen, T; Yeowell, H; Krieg, T; Steinmann, B; Kivirikko, KI; Myllyla, R			Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALU-ALU RECOMBINATION; DEFICIENT COLLAGEN; 2 SIBLINGS; 7 EXONS; PATIENT; CLONING; PLOD	The type VI variant of the Ehlers-Danlos syndrome (EDS) is a recessively inherited connective tissue disorder which, In most families, is due to a deficiency in lysyl hydroxylase activity, We have recently characterized a homozygous duplication of 8.9 kb in the lysyl hydroxylase gene (PLOD) in two EDS VI families. The duplication is caused by a homologous recombination of Alu sequences in introns 9 and 16, Using PCR, we have analyzed 26 additional EDS VI families from various countries and found that 7 of them have this duplication, ur data has shown a frequency of 19.1% for this mutant allele among 35 EDS VI families studied by ms so far, Our haplotype analysis shows a variation in the sequence of DNA region surrounding the duplication, There is an association between a particular allele size class, the long form, at the dinucleotide repeat within intron 16 and the duplication mutation in PLOD, Screening of a general population revealed one positive finding among 582 alleles tested, An abnormal sequence in exon 17 of the gene, which generated a stop codon in the exon sequence and aberrant mRNA processing, was responsible for time nonfunctionality of the other allele in one of the compound heterozygous patients.	UNIV OULU, DEPT BIOCHEM, FIN-90570 OULU, FINLAND; UNIV OULU, BIOCTR, COLLAGEN RES UNIT, FIN-90570 OULU, FINLAND; UNIV OULU, DEPT BIOCHEM MED, FIN-90570 OULU, FINLAND; DUKE UNIV, MED CTR, DIV DERMATOL, DURHAM, NC 27710 USA; UNIV COLOGNE, DEPT DERMATOL & VENEROL, COLOGNE, GERMANY; UNIV ZURICH, DEPT PEDIAT, DIV METAB & MOL DIS, ZURICH, SWITZERLAND	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Duke University; University of Cologne; University of Zurich					NIA NIH HHS [AG10215] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R29AG010215, R01AG010215] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEIGHTON P, 1993, MCKUSICKS HERITABLE, P189; Beltinger CP, 1996, GENOMICS, V35, P94, DOI 10.1006/geno.1996.0327; BYERS PH, 1995, METABOLIC MOL BASES, P4029; DRACOPOLI NC, 1994, CYTOGENET CELL GENET, V67, P143, DOI 10.1159/000133816; HA VT, 1994, J CLIN INVEST, V93, P1716, DOI 10.1172/JCI117155; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; HAUTALA T, 1993, GENOMICS, V15, P399, DOI 10.1006/geno.1993.1074; HEIKKINEN J, 1994, GENOMICS, V24, P464, DOI 10.1006/geno.1994.1654; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1980, ENZYMOLOGY POST TRAN, P53; KRANE SM, 1972, P NATL ACAD SCI USA, V69, P2899, DOI 10.1073/pnas.69.10.2899; KRANE SM, 1984, EXTRACELLULAR MATRIX, P413; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MARCUS S, 1993, HUM GENET, V90, P477; Marshall M., 1994, Matrix Biology, V14, P398, DOI 10.1016/0945-053X(94)90129-5; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P1786; MYLLYLA R, 1991, J BIOL CHEM, V266, P2805; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; POUSI B, 1994, AM J HUM GENET, V55, P899; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Schmid C, 1992, CURR OPIN GENET DEV, V2, P874, DOI 10.1016/S0959-437X(05)80110-8; Steinmann Beat, 1993, P351; SUSSMAN M, 1974, J BONE JOINT SURG AM, VA 56, P1228, DOI 10.2106/00004623-197456060-00015; VANROY N, 1993, GENOMICS, V18, P71, DOI 10.1006/geno.1993.1427; WAHLS WP, 1990, MOL CELL BIOL, V10, P794, DOI 10.1128/MCB.10.2.794; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; ZIETKIEWICZ E, 1994, NUCLEIC ACIDS RES, V22, P5608, DOI 10.1093/nar/22.25.5608	32	42	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					48	56						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981946				2022-12-18	WOS:A1997WA81800009
J	Spurdle, AB; Jenkins, T				Spurdle, AB; Jenkins, T			The origins of the Lemba ''Black Jews'' of southern Africa: Evidence from p12F2 and other Y-chromosome markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC AFFINITIES; POPULATIONS; POLYMORPHISMS; HAPLOTYPES	The Lemba are a southern African Bantu-speaking population claiming Jewish ancestry. Allele frequencies at four different Y-specific polymorphic loci, as well as extended-haplotype frequencies that included data from several loci, were analyzed in an attempt to establish the genetic affinities and origins of the Lemba. The results suggest that greater than or equal to 50% of the Lemba Y chromosomes are Semitic in origin, similar to 40% are Negroid, and the ancestry of the remainder cannot be resolved. These Y-specific genetic findings are consistent with Lemba oral tradition, and analysis of the history of Jewish people and their association with Africa indicates that the historical facts are not incompatible with theories concerning the origin of the Lemba.	S AFRICAN INST MED RES, DEPT HUMAN GENET, SCH PATHOL, ZA-2000 JOHANNESBURG, SOUTH AFRICA; UNIV WITWATERSRAND, JOHANNESBURG, SOUTH AFRICA	University of Witwatersrand			Spurdle, Amanda B/A-4978-2011	Spurdle, Amanda B/0000-0003-1337-7897				BARON Salo W, 1952, SOCIAL RELIG HIST JE, V3; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; Brega A, 1987, Gene Geogr, V1, P201; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; GOITEIN SD, 1971, JEWISH SOC AGES, P170; GUTMANN J, 1987, JEWISH LIFE CYCLE IC; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Harpending H.C., 1973, METHODS THEORIES ANT; JENKINS T, 1971, AM J HUM GENET, V23, P513; LEwCOCK Ronald B, 1986, OLD WALLED CITY SANA; LIVSHITS G, 1991, AM J HUM GENET, V49, P131; Mathivha M.E.R, 1992, BASENA VAMWENYA BALE; Mourant AE, 1978, BLOOD GROUPS DIS; NGO KY, 1986, AM J HUM GENET, V38, P407; NURSE GT, 1985, PEOPLES SO AFRICAN T; NYROP RF, 1985, YEMENS COUNTRY STUDI; Parfitt Tudor, 1992, JOURNEY VANISHED CIT; RITTE U, 1993, J MOL EVOL, V37, P435; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSRA; SPURDLE, 1994, AM J HUM GENET, V54, P929; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE A, 1992, AM J HUM GENET, V50, P1301; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; SPURDLE AB, 1994, HUM HERED, V44, P261, DOI 10.1159/000154227; SPURDLE AB, 1992, THESIS U WITWATERSRA; TORRONI A, 1990, ANN HUM GENET, V54, P287; TORRONI A, 1994, AM J HUM GENET, V54, P303; Van Warmelo N. J., 1974, BANTU SPEAKING PEOPL, P56; VANWARMELO NJ, 1948, ETHNOLOGICAL PUBLICA, V23; WENNER MW, 1991, YEMEN ARAB REPUBLIC; ZOOSSMANNDISKIN A, 1991, ISRAEL J MED SCI, V27, P245	32	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1126	1133						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900243				2022-12-18	WOS:A1996VN90000022
J	Gellera, C; Meoni, C; Castellotti, B; Zappacosta, B; Girotti, F; Taroni, F; DiDonato, S				Gellera, C; Meoni, C; Castellotti, B; Zappacosta, B; Girotti, F; Taroni, F; DiDonato, S			Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							REPEAT LENGTH; CAG REPEAT; INSTABILITY		IST NAZL NEUROL CARLO BESTA,DEPT BIOCHEM & GENET,DIV BIOCHEM & GENET,I-20133 MILAN,ITALY; IST NAZL NEUROL CARLO BESTA,DIV NEUROL,I-20133 MILAN,ITALY	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta			Di Donato, Stefano/B-9717-2012; CASTELLOTTI, BARBARA/J-4939-2016; GELLERA, CINZIA/J-7887-2016	CASTELLOTTI, BARBARA/0000-0002-9098-3041; GELLERA, CINZIA/0000-0002-3582-665X				ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; 1993, CELL, V72, P971	7	42	42	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					475	477						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755937				2022-12-18	WOS:A1996VM28800026
J	Chakraborty, R; Stivers, DN; Deka, R; Yu, LM; Shriver, MD; Ferrell, RE				Chakraborty, R; Stivers, DN; Deka, R; Yu, LM; Shriver, MD; Ferrell, RE			Segregation distortion of the CTG repeats at the myotonic dystrophy locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNSTABLE DNA REGION; MEIOTIC DRIVE; GENE; EXPANSION; MUTATION; ORIGIN; CHROMOSOME-19; POPULATIONS; FORM	Myotonic dystrophy (DM), an autosomal dominant neuromuscular disease, is caused by a CTG-repeat expansion, with affected individuals having greater than or equal to 50 repeats of this trinucleotide, at the DMPK locus of human chromosome 19q13.3. Severely affected individuals die early in life; the milder form of this disease reduces reproductive ability. Alleles in the normal range of CTG repeats are not as unstable as the (CTG)(greater than or equal to 50) alleles. In the DM families, anticipation and parental bias of allelic expansions have been noted. However, data on mechanism of maintenance of DM in populations are conflicting. We present a maximum-likelihood model for examining segregation distortion of CTG-repeat alleles in normal families. Analyzing 726 meiotic events in 95 nuclear families from the CEPH panel pedigrees, we find evidence of preferential transmission of larger alleles (of size less than or equal to 29 repeats) from females (the probability of transmission of larger alleles is .565 +/- 0.03, different from .5 at P approximate to .028). There is no evidence of segregation distortion during male meiosis. We propose a hypothesis that preferential transmission of larger CTG-repeat alleles during female meiosis can compensate for mutational contraction of repeats within the normal allelic size range, and reduced viability and fertility of affected individuals. Thus, the pool of premutant alleles at the DM locus can be maintained in populations, which can subsequently mutate to the full mutation status to give rise to DM.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chakraborty, R (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR HUMAN GENET,POB 20334,HOUSTON,TX 77225, USA.			Shriver, Mark/0000-0003-0006-0479	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399, R01GM045861] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45861, GM41399] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASHIZAWA T, 1994, AM J HUM GENET, V54, P414; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; CHAKRABORTY R, 1994, AM J HUM GENET, V55, P391; Dada T O, 1973, East Afr Med J, V50, P213; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES J, 1992, J MED GENET, V29, P766, DOI 10.1136/jmg.29.11.766; Deka R, 1996, GENOME RES, V6, P142, DOI 10.1101/gr.6.2.142; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GENNARELLI M, 1994, J MED GENET, V31, P980, DOI 10.1136/jmg.31.12.980; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HURST GDD, 1995, NAT GENET, V10, P132, DOI 10.1038/ng0695-132; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; KRABE R, 1995, AM J HUM GENET, V56, P1067; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; RAO CR, 1973, LINEAR STATISTICAL I; STALLINGS RL, 1988, AM J HUM GENET, V43, P144; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W; ZERYLNICK C, 1995, AM J HUM GENET, V56, P123; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	31	42	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					109	118						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659513				2022-12-18	WOS:A1996VL45500016
J	ZSCHOCKE, J; GRAHAM, CA; CARSON, DJ; NEVIN, NC				ZSCHOCKE, J; GRAHAM, CA; CARSON, DJ; NEVIN, NC			PHENYLKETONURIA MUTATION ANALYSIS IN NORTHERN-IRELAND - A RAPID STEPWISE APPROACH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENYLALANINE-HYDROXYLASE; SITES	We present a multistep approach for the rapid analysis of phenylketonuria (PKU) mutations. In the first step, three common mutations and a polymorphic short tandem repeat (STR) system are rapidly analyzed with a fluorescent multiplex assay. In the second step, mini-haplotypes combining STR and VNTR data are used to determine rare mutations likely to be present in an investigated patient, which are then confirmed by restriction enzyme analysis. The remaining mutations are analyzed with denaturant gradient-gel electrophoresis and sequencing. The first two steps together identify both mutations in 90%-95% of PKU patients, and results can be obtained within 2 d. We have investigated 121 Northern Irish families with hyperphenylalaninemia, including virtually all patients born since 1972, and have found 34 different mutations on 241 of the 242 mutant alleles. Three mutations (R408W, I65T, and F39L) account for 57.5% of mutations, while 14 mutations occur with a frequency of 1%-6%. The present analysis system is efficient and inexpensive and is particularly well suited to routine mutation analysis in a diagnostic setting.	BELFAST CITY HOSP,DEPT MED GENET,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND; QUEENS UNIV BELFAST,DEPT CHILD HLTH,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND	Belfast City Hospital; Queens University Belfast			Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274				COTTON RGH, 1993, ADV EXP MED BIOL, V338, P55; Eiken Hans Geir, 1993, Developmental Brain Dysfunction, V6, P53; EIKEN HG, 1991, NUCLEIC ACIDS RES, V19, P1427, DOI 10.1093/nar/19.7.1427; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1445; GOLTSOV AA, 1992, AM J HUM GENET, V51, P627; GOLTSOV AA, 1993, HUM MOL GENET, V3, P577; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; GULDBERG P, 1994, GENOMICS, V21, P453, DOI 10.1006/geno.1994.1296; GULDBERG P, 1995, EUR J PEDIATR, V154, P551, DOI 10.1007/BF02074833; JENNINGS IG, 1991, P NATL ACAD SCI USA, V88, P5734, DOI 10.1073/pnas.88.13.5734; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; Scriver C.R., 1995, METABOLIC MOL BASIS, V7th ed, P1015; SCRIVER CR, 1994, PAH GENE MUTATION AN; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; ZSCHOCKE J, 1994, HUM MUTAT, V4, P114, DOI 10.1002/humu.1380040204; Zschocke J, 1994, Acta Paediatr Suppl, V407, P37; ZSCHOCKE J, 1995, J INHERIT METAB DIS, V18, P369, DOI 10.1007/BF00710439; ZSCHOCKE J, IN PRESS MOL CELL PR; ZSCHOCKE J, 1994, ACTA PAEDIATRICA S, V407, P41	19	42	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1311	1317						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533759				2022-12-18	WOS:A1995TE65500007
J	CLAYTON, EW; HANNIG, VL; PFOTENHAUER, JP; PARKER, RA; CAMPBELL, PW; PHILLIPS, JA				CLAYTON, EW; HANNIG, VL; PFOTENHAUER, JP; PARKER, RA; CAMPBELL, PW; PHILLIPS, JA			TEACHING ABOUT CYSTIC-FIBROSIS CARRIER SCREENING BY USING WRITTEN AND VIDEO INFORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KNOWLEDGE; PHYSICIANS; COMMUNITY; ATTITUDES; GENETICS	We performed two studies using only written and video materials to educate people about cystic fibrosis (CF) and carrier screening. Participants were randomized to receive written or video materials. Ah received a brief questionnaire. Subjects in group I (n = 238) were (1) individuals in steady relationships and their partners, (2) greater than or equal to 18 years old, and (3) not pregnant. Those who accepted free screening and were not demonstrable carriers were sent a letter explaining their results and another questionnaire. Subjects in group II (n = 108) were parents seeking well child care in a university clinic. The main outcome measures were ability to answer questions correctly about (1) health status of CF carriers and people with CF, (2) the possibility of false-negative results, and (3) for those who had screening, the implications of their own results. Written and video materials were equally effective in conveying information. Prior to screening, subjects answered an average of 86% of questions correctly. Subjects with less formal education answered fewer questions correctly; 60% of those with less than a high school education had adequate knowledge of the health consequences of having CF or being a carrier, compared with greater than or equal to 94% of college graduates. Performance improved after screening. Where neither partner was a demonstrable carrier, 88% knew their own and their partner's test results, and 90% indicated that their risk of having a child with CF was not zero. Written and video educational materials can be used without face-to-face counseling to inform most people about carrier screening and their test results. These materials may be less effective for those with lower educational backgrounds.	VANDERBILT UNIV,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37212; VANDERBILT UNIV,SCH MED,DEPT PREVENT MED,NASHVILLE,TN 37212; VANDERBILT UNIV,SCH LAW,NASHVILLE,TN 37240	Vanderbilt University; Vanderbilt University; Vanderbilt University				Clayton, Ellen/0000-0002-0308-4110	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000638] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01 HG 00638-2] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 1986, HIST THEORY INFORM C; ASCH DA, 1993, AM J OBSTET GYNECOL, V108, P1; BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364; CASKEY CT, 1990, AM J HUM GENET, V46, P393; DECRUYENAERE M, 1992, CLIN GENET, V41, P189; Funnell M M, 1992, Diabetes Educ, V18, P139, DOI 10.1177/014572179201800207; Geller G, 1993, Arch Fam Med, V2, P1119, DOI 10.1001/archfami.2.11.1119; HOFMAN KJ, 1993, ACAD MED, V68, P625, DOI 10.1097/00001888-199308000-00013; HOLTZMAN NA, 1993, FETAL DIAGN THER, V8, P213, DOI 10.1159/000263890; Katz J., 1984, SILENT WORLD DOCTOR; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; Lidz CW, 1984, INFORMED CONSENT STU; MAGNAY D, 1992, J ROY COLL PHYS LOND, V26, P69; Magyari T., 1994, American Journal of Human Genetics, V55, pA21; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; MYERS MF, 1994, AM J HUM GENET, V54, P719; SHAW MW, 1977, GENETIC COUNSELING, P35; SOLOMON MZ, 1989, AM J PUBLIC HEALTH, V79, P453, DOI 10.2105/AJPH.79.4.453; Tatsugawa Z H, 1994, J Genet Couns, V3, P279, DOI 10.1007/BF01412373; TSUI LC, 1994, 1994 ANN M AM SOC HU; WALD NJ, 1991, LANCET, V338, P1318, DOI 10.1016/0140-6736(91)92605-2; WILFOND BS, 1992, MILBANK Q, V70, P629, DOI 10.2307/3350214; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; 1992, OTABA532 US C OFF TE; 1990, NEW ENGL J MED, V323, P70; 1994, INTEGRATED GENETICS; 1994, NY TIMES        0808, pD2; 1994, ASSESSING GENETIC RI; 1994, GRAMMATIK, V5; 1992, AM J HUM GENET, V51, P1443	30	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					171	181						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611285				2022-12-18	WOS:A1995RE62900020
J	UHRHAMMER, N; LANGE, E; PORRAS, O; NAEIM, A; CHEN, XG; SHEIKHAVANDI, S; CHIPLUNKAR, S; YANG, L; DANDEKAR, S; LIANG, T; PATEL, N; TERAOKA, S; UDAR, N; CALVO, N; CONCANNON, P; LANGE, K; GATTI, RA				UHRHAMMER, N; LANGE, E; PORRAS, O; NAEIM, A; CHEN, XG; SHEIKHAVANDI, S; CHIPLUNKAR, S; YANG, L; DANDEKAR, S; LIANG, T; PATEL, N; TERAOKA, S; UDAR, N; CALVO, N; CONCANNON, P; LANGE, K; GATTI, RA			SUBLOCALIZATION OF AN ATAXIAL-TELANGIECTASIA GENE DISTAL TO D115384 BY ANCESTRAL HAPLOTYPING IN COSTA-RICAN FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; CHROMOSOME-11; LOCALIZATION; REGION; MAP	In an effort to localize a gene for ataxia-telangiectasia (A-T), we have genotyped 27 affected Costa Rican families, with 13 markers, in the chromosome 11q22-23 region. Significant linkage disequilibrium was detected for 9/13 markers between D11S1816 and D11S1391. Recombination events observed in these pedigrees places A-T between D11S1819 and D11S1960. One ancestral haplotype is common to 24/54 affected chromosomes and roughly two-thirds of the families. Inferred (ancestral) recombination events involving this common haplotype in earlier generations suggest that A-T is distal to D11S384 and proximal to D11S1960. Several other common haplotypes were identified, consistent with multiple mutations in a single gene. When considered together with all other evidence, this study further sublocalizes the major A-T locus to approximate to 200 kb, between markers S384 and S535.	UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90095 USA; UNIV MICHIGAN, DEPT BIOSTAT, ANN ARBOR, MI 48109 USA; NATL CHILDRENS HOSP, DEPT IMMUNOL, SAN JOSE, COSTA RICA; INCIENSA, SAN JOSE, COSTA RICA; VIRGINIA MASON RES CTR, SEATTLE, WA 98101 USA; UNIV WASHINGTON, SCH MED, DEPT IMMUNOL, SEATTLE, WA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; Virginia Mason Medical Center; University of Washington; University of Washington Seattle				Udar, Nitin/0000-0001-8533-9190; Concannon, Patrick/0000-0002-5801-1859	NCI NIH HHS [CA57569, CA16042] Funding Source: Medline; NIGMS NIH HHS [GM07104] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042, R01CA057569] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agresti A., 1992, STAT SCI, V7, P131, DOI 10.1214/ss/1177011454; AMBROSE HJ, 1994, GENOMICS, V21, P612, DOI 10.1006/geno.1994.1321; FOROUD T, 1991, AM J HUM GENET, V49, P1263; GATTI R A, 1984, Biotechniques, V2, P148; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1994, CANCER RES, V54, P6007; GATTI RA, 1994, INT J RADIAT BIOL, V66, pS57, DOI 10.1080/09553009414551861; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; JULIER C, 1989, NUCLEIC ACIDS RES, V17, P9501, DOI 10.1093/nar/17.22.9501; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANGE E, 1995, AM J HUM GENET, V57, P112; LANGE E, 1993, ATAXIA TELANGIECTASI, P37; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MCCONVILLE CM, 1991, CYTOGENET CELL GENET, V58, P1967; ROTMAN G, 1994, INT J RADIAT BIOL, V66, pS63, DOI 10.1080/09553009414551871; SANAL O, 1990, AM J HUM GENET, V47, P860; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; SULISALO T, 1994, AM J HUM GENET, V55, P937; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1994, INT J RADIAT BIOL, V66, pS35, DOI 10.1080/09553009414551841; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; UHRHAMMER N, 1994, GENOMICS, V20, P278, DOI 10.1006/geno.1994.1165; VERBEEK A, 1985, COMPUT STAT DATA AN, V3, P159, DOI 10.1016/0167-9473(85)90080-5; WRIGHT J, 1994, OCT C VDJ REC DNA RE; ZIV Y, 1991, GENOMICS, V9, P373, DOI 10.1016/0888-7543(91)90268-J	32	42	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					103	111						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611278				2022-12-18	WOS:A1995RE62900013
J	LINDSAY, EA; MORRIS, MA; GOS, A; NESTADT, G; WOLYNIEC, PS; LASSETER, VK; SHPRINTZEN, R; ANTONARAKIS, SE; BALDINI, A; PULVER, AE				LINDSAY, EA; MORRIS, MA; GOS, A; NESTADT, G; WOLYNIEC, PS; LASSETER, VK; SHPRINTZEN, R; ANTONARAKIS, SE; BALDINI, A; PULVER, AE			SCHIZOPHRENIA AND CHROMOSOMAL DELETIONS WITHIN 22Q11.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CARDIO-FACIAL SYNDROME; PSYCHOSIS		BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,GENES R US LAB,CH-1211 GENEVA,SWITZERLAND; CANTONAL HOSP GENEVA,DIV MED GENET,GENEVA,SWITZERLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205; CTR CRANIOFACIAL DISORDERS,BRONX,NY; MONTEFIORE MED CTR,DEPT PLAST SURG,BRONX,NY; MONTEFIORE MED CTR,DEPT MOLEC GENET,BRONX,NY; ALBERT EINSTEIN COLL MED,BRONX,NY	Baylor College of Medicine; Baylor College of Medicine; University of Geneva; University of Geneva; Johns Hopkins University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine			Antonarakis, Stylianos E/N-8866-2014; Baldini, Antonio/M-2355-2015	Antonarakis, Stylianos E/0000-0001-8907-5823; Baldini, Antonio/0000-0002-5330-0256	NCRR NIH HHS [RR00722] Funding Source: Medline; NIMH NIH HHS [MH45588] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045588] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; DUNHAM I, 1992, LANCET, V340, P1361, DOI 10.1016/0140-6736(92)92553-R; LASSETER VK, IN PRESS AM J MED GE; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; PULVER AE, 1989, GENET EPIDEMIOL, V6, P671, DOI 10.1002/gepi.1370060604; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131	9	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1502	1503						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762575				2022-12-18	WOS:A1995RA79400031
J	RIMOIN, DL				RIMOIN, DL			CERVICOMEDULLARY JUNCTION COMPRESSION IN INFANTS WITH ACHONDROPLASIA - WHEN TO PERFORM NEUROSURGICAL DECOMPRESSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											RIMOIN, DL (corresponding author), UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90048, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		FRANCOMANO CA, 1994, NEW ENGL J MED, V332, P58; FRANCOMANO CA, 1993, AM J HUM GENET S, V53, pA112; HECHT JT, 1987, AM J HUM GENET, V41, P454; HECHT JT, 1989, AM J MED GENET, V32, P528, DOI 10.1002/ajmg.1320320421; OAYKU RN, 1995, AM J HUM GENET, V56, P732; PAULI RM, 1984, J PEDIATR-US, V104, P342, DOI 10.1016/S0022-3476(84)81092-6; REID CS, 1987, J PEDIATR-US, V110, P522, DOI 10.1016/S0022-3476(87)80542-5; RIMOIN DL, 1970, NEW ENGL J MED, V283, P728, DOI 10.1056/NEJM197010012831404; THOMAS IT, 1988, AM J DIS CHILD, V142, P989; WASSMAN ER, 1988, J PEDIATR-US, V113, P411, DOI 10.1016/S0022-3476(88)80295-6	10	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					824	827						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717392				2022-12-18	WOS:A1995QP66300002
J	FENG, HS; SASSANI, R; BARTLETT, SP; LEE, A; HECHT, JT; MALCOLM, S; WINTER, RM; VINTINER, GM; BUETOW, KH; GASSER, DL				FENG, HS; SASSANI, R; BARTLETT, SP; LEE, A; HECHT, JT; MALCOLM, S; WINTER, RM; VINTINER, GM; BUETOW, KH; GASSER, DL			EVIDENCE, FROM FAMILY STUDIES, FOR LINKAGE DISEQUILIBRIUM BETWEEN TGFA AND A GENE FOR NONSYNDROMIC CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-ALPHA; DEPENDENT DIABETES-MELLITUS; INSULIN-GENE; NO EVIDENCE; ASSOCIATION; LOCUS; IDDM; EXPRESSION; MOUSE; MICE	The inheritance of alleles of the transforming growth factor alpha (TGFA) locus has been studied in families affected with cleft lip with or without cleft palate (CL/P), by using the transmission/disequilibrium test described by Spielman and colleagues. Only heterozygous parents with an affected child can be included in this test, but within such families a significantly greater frequency of C2 alleles were transmitted to affected children than would be expected by chance. There was no evidence that the total number of C2 alleles transmitted to affected and unaffected children differed significantly from random segregation. These data provide evidence from within families that a gene for susceptibility to CL/P is in significant linkage disequilibrium with the C2 allele of the TCFA locus.	UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; HOSP UNIV PENN, DEPT SURG, PHILADELPHIA, PA 19104 USA; CHILDRENS HOSP PHILADELPHIA, DEPT SURG, PHILADELPHIA, PA 19104 USA; FOX CHASE CANC CTR, INST CANC RES, PHILADELPHIA, PA 19111 USA; UNIV TEXAS, SCH MED, DEPT PEDIAT, HOUSTON, TX USA; UNIV LONDON, INST CHILD HLTH, LONDON WC1N 1EH, ENGLAND	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fox Chase Cancer Center; University of Texas System; University of London; University College London					NIDCR NIH HHS [P50 DE09164, 5R29 DE09954] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009164, R29DE009954] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABBOTT BD, 1987, J CRAN GENET DEV BIO, V7, P219; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BASART AM, 1994, HUM MOL GENET, V3, P678, DOI 10.1093/hmg/3.4.678-a; BEDRICK AD, 1978, TERATOLOGY, V17, P13, DOI 10.1002/tera.1420170106; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHUNG CS, 1974, AM J HUM GENET, V26, P177; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; COX NJ, 1988, AM J HUM GENET, V42, P167; FARRALL M, 1993, AM J HUM GENET, V52, P434; HECHT JT, 1991, AM J HUM GENET, V49, P682; HECHT JT, 1993, AM J HUM GENET, V52, P436; HOLDER SE, 1992, J MED GENET, V29, P390, DOI 10.1136/jmg.29.6.390; JURILOFF DM, 1986, J CRAN GENET DEV BIO, P55; JURILOFF DM, 1993, J CRAN GENET DEV BIO, V13, P223; LEE DC, 1985, MOL CELL BIOL, V5, P3644, DOI 10.1128/MCB.5.12.3644; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; QIAN JF, 1993, AM J HUM GENET, V53, P168; RAY AK, 1993, AM J HUM GENET, V52, P1006; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; SASSANI R, 1993, AM J MED GENET, V45, P565, DOI 10.1002/ajmg.1320450508; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; TIWARI JL, 1985, HLA DISEASE ASS, P185; TWARDZIK DR, 1985, CANCER RES, V45, P5413; VINTINER GM, 1992, J MED GENET, V29, P393, DOI 10.1136/jmg.29.6.393	30	42	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					932	936						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977355				2022-12-18	WOS:A1994QB68200012
J	ELLIS, NA; ROE, AM; KOZLOSKI, J; PROYTCHEVA, M; FALK, C; GERMAN, J				ELLIS, NA; ROE, AM; KOZLOSKI, J; PROYTCHEVA, M; FALK, C; GERMAN, J			LINKAGE DISEQUILIBRIUM BETWEEN THE FES, D15S127, AND BLM LOCI IN ASHKENAZI JEWS WITH BLOOM-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; DNA; LOCALIZATION; DISEASE; HYBRIDIZATION; PROTOONCOGENE; CLONING; REGION; CELLS	Bloom syndrome (BS) is more common in the Ashkenazi Jewish than in any other population. Approximately 1 in 110 Ashkenazi Jews carries blm, the BS mutation. The locus mutated in BS, BLM, maps to chromosome subband 15q26.1, tightly linked to the proto-oncogene FES. We have investigated the basis for the increased frequency of blm in the Ashkenazim by genotyping polymorphic microsatellite loci tightly linked to BLM in affected and unaffected individuals from Ashkenazi Jewish and non-Ash-kenazi populations. A striking association of the C3 allele at FES with blm (Delta = .422; p = 5.52 X 10(-7)) and of the 145-bp and 147-bp alleles at D15S127 with blm (Delta = .392 and Delta = .483, respectively; p = 2.8 X 10(-5) and p = 5.4 X 10(-7), respectively) was detected in Ashkenazi Jews with BS. This linkage disequilibrium constitutes strong support for a founder-effect hypothesis: the chromosome in the hypothetical founder who carried blm also carried the C3 allele at FES and either the 145-bp or the 147-bp allele at D15S127.			ELLIS, NA (corresponding author), NEW YORK BLOOD CTR, HUMAN GENET LAB, 310 E 67TH ST, NEW YORK, NY 10021 USA.				NCI NIH HHS [CA50897] Funding Source: Medline; NHLBI NIH HHS [HL 09011] Funding Source: Medline; NICHD NIH HHS [HD04134] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004134] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA050897] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL009011] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; Ankori Zvi., 1979, GENETIC DIS ASHKENAZ, P19; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; BRYANT EM, 1979, NATURE, V279, P795, DOI 10.1038/279795a0; FLINT J, 1993, BAILLIERE CLIN HAEM, V6, P215, DOI 10.1016/S0950-3536(05)80071-X; GERMAN J, 1989, CLIN GENET, V35, P57; GERMAN J, 1994, P NATL ACAD SCI USA, V91, P6669, DOI 10.1073/pnas.91.14.6669; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1977, AM J HUM GENET, V29, P553; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JHANWAR SC, 1984, CYTOGENET CELL GENET, V38, P73, DOI 10.1159/000132033; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MATHEW S, 1993, CYTOGENET CELL GENET, V63, P33, DOI 10.1159/000133496; Mayr E., 1942, SYSTEMATICS ORIGIN S; MCDANIEL LD, 1992, P NATL ACAD SCI USA, V89, P7968, DOI 10.1073/pnas.89.17.7968; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; PIERCE JC, 1992, P NATL ACAD SCI USA, V89, P2056, DOI 10.1073/pnas.89.6.2056; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018-a; RAY JH, 1983, CHROMOSOME MUTATION, P135; SIRUGO G, 1992, AM J HUM GENET, V50, P559; THOMAS GR, 1994, AM J HUM GENET, V54, P71; WEKSBERG R, 1988, AM J HUM GENET, V42, P816; Wright S, 1921, GENETICS, V6, P124; YOSHIDA M, 1981, 40TH ANN M JAP CANC	32	42	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					453	460						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079989				2022-12-18	WOS:A1994PF50900006
J	LIM, LCC; POWELL, JF; MURRAY, R; GILL, M				LIM, LCC; POWELL, JF; MURRAY, R; GILL, M			MONOAMINE-OXIDASE-A GENE AND BIPOLAR AFFECTIVE-DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ILLNESS; MARKER; INHERITANCE; ASSOCIATION; LINKAGE		INST PSYCHIAT,DEPT NEUROSCI,LONDON SE5 8AF,ENGLAND; NATL UNIV SINGAPORE,DEPT PSYCHOL MED,SINGAPORE 0511,SINGAPORE	University of London; King's College London; National University of Singapore	LIM, LCC (corresponding author), INST PSYCHIAT,DEPT PSYCHOL MED,LONDON SE5 8AF,ENGLAND.		Powell, John F/G-4412-2011; murray, robin/F-8658-2012	Powell, John F/0000-0001-6124-439X; Gill, Michael/0000-0003-0206-5337; murray, robin/0000-0003-0829-0519				BLACK GCM, 1991, NUCLEIC ACIDS RES, V19, P689; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GERSHON ES, 1991, BIOL PSYCHIAT, V29, P721, DOI 10.1016/0006-3223(91)90149-G; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; HEBEBRAND J, 1992, BRIT J PSYCHIAT, V160, P7, DOI 10.1192/bjp.160.1.7; NOTHEN MM, 1993, AM J HUM GENET, V52, P841; RISCH N, 1986, J PSYCHIAT RES, V20, P275, DOI 10.1016/0022-3956(86)90031-2; SAMSON JA, 1985, J PSYCHIATR RES, V19, P547, DOI 10.1016/0022-3956(85)90072-X; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; VONKNORRING L, 1985, PSYCHIAT RES, V15, P271, DOI 10.1016/0165-1781(85)90064-2; Walsh C., 1992, Psychiatric Genetics, V2, P239, DOI 10.1097/00041444-199210000-00002; YONEDA H, 1992, AM J HUM GENET, V51, P1172; 1987, DIAGNOSTIC STATISITC; 1993, SOFTWARE EXACT NONPA	16	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1122	1124						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	NP053	8018211				2022-12-18	WOS:A1994NP05300022
J	THONY, B; LEIMBACHER, W; BLAU, N; HARVIE, A; HEIZMANN, CW				THONY, B; LEIMBACHER, W; BLAU, N; HARVIE, A; HEIZMANN, CW			HYPERPHENYLALANINEMIA DUE TO DEFECTS IN TETRAHYDROBIOPTERIN METABOLISM - MOLECULAR CHARACTERIZATION OF MUTATIONS IN 6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIHYDROPTERIDINE REDUCTASE DEFICIENCY; PROTEINS; DISEASE	A variant type of hyperphenylalaninemia is caused by a deficiency of tetrahydrobiopterin (BH4), the obligatory cofactor for phenylalanine hydroxylase. The most frequent form of this cofactor deficiency is due to lack of 6-pyruvoyl-tetrahydropterin synthase (PTPS) activity, the second enzyme in the biosynthetic pathway for BH4. The human liver cDNA for PTPS was previously isolated, and the recombinant protein was found to be active when expressed in Escherichia coli. We now have investigated two patients for their molecular nature of this autosomal recessive disorder. Both patients were diagnosed as PTPS deficient, one with the central and one with the peripheral form, on the basis of an elevated serum phenylalanine concentration concomitant with lowered levels of urinary biopterin and PTPS activity in erythrocytes. Molecular analysis was performed on the patients' cultured primary skin fibroblasts. PTPS activities were found in vitro to be reduced to background activity. Direct cDNA sequence analysis using reverse transcriptase-PCR technology showed for the patient with the central form a homozygous G-to-A transition at codon 25, causing the replacement of an arginine by glutamine (R25Q). Expression of this mutant allele in E. coli revealed 14% activity when compared with the wild-type enzyme. The patient with the peripheral form exhibited compound heterozygosity, having on one allele a C-to-T transition resulting in the substitution of arginine 16 for cysteine (R16C) in the enzyme and having on the second allele a 14-bp deletion (Delta 14bp), leading to a frameshift at lysine 120 and a premature stop codon (K120-->Stop). Heterologous expression of the enzyme with the single-amino-acid exchange R16C revealed only 7% enzyme activity, whereas expression of the deletion allele Delta 14bp exhibited no detectable activity. All three mutations, R25Q, R16C, and K120-->Stop, affect evolutionarily conserved residues in PTPS, result in reduced enzymatic activity when reconstituted in E. coli and are thus believed to be the molecular cause for the BH4 deficiency. This is the first report describing mutations in PTPS that lead to BH4 deficiency.	UNIV GLASGOW, ROYAL HOSP SICK CHILDREN, DEPT CHILD HLTH, GLASGOW, SCOTLAND	University of Glasgow	THONY, B (corresponding author), UNIV ZURICH, DEPT PEDIAT, DIV CLIN CHEM, STEINWIESSTR 75, CH-8032 ZURICH, SWITZERLAND.			Blau, Nenad/0000-0003-4347-3230				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; Blau N., 1993, PTERIDINES, V4, P1; BURGISSER DM, 1994, EUR J BIOCHEM, V219, P497, DOI 10.1111/j.1432-1033.1994.tb19964.x; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CITRON BA, 1993, AM J HUM GENET, V53, P768; DAHL HHM, 1987, NUCLEIC ACIDS RES, V15, P1921, DOI 10.1093/nar/15.5.1921; DEBOER M, 1992, AM J HUM GENET, V51, P1127; DHONDT JL, 1984, J PEDIATR-US, V104, P501, DOI 10.1016/S0022-3476(84)80537-5; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUZMAN J, 1992, PTERIDINES, V3, P43; HALL K, 1991, SOC STUDY INBORN ERR, V17; HAUER CR, 1993, J BIOL CHEM, V268, P4828; HOWELLS DW, 1990, AM J HUM GENET, V47, P279; KRAWCZAK M, 1991, HUM GENET, V86, P425; LOCKYER J, 1987, P NATL ACAD SCI USA, V84, P3329, DOI 10.1073/pnas.84.10.3329; NIEDERWIESER A, 1984, J CHROMATOGR, V290, P237, DOI 10.1016/S0021-9673(01)93579-4; NIEDERWIESER A, 1987, EUR J PEDIATR, V146, P228, DOI 10.1007/BF00716465; Sambrook J., 1989, MOL CLONING LAB MANU; SHINTAKU H, 1988, EUR J PEDIATR, V147, P15, DOI 10.1007/BF00442604; SMOOKER PM, 1993, BIOCHEMISTRY-US, V32, P6443, DOI 10.1021/bi00076a018; TAKIKAWA SI, 1986, EUR J BIOCHEM, V161, P295, DOI 10.1111/j.1432-1033.1986.tb10446.x; THONY B, 1993, ADV EXP MED BIOL, V338, P103; THONY B, 1994, GENOMICS, V19, P365, DOI 10.1006/geno.1994.1071; THONY B, 1992, BIOCHEM BIOPH RES CO, V189, P1437, DOI 10.1016/0006-291X(92)90235-D; TOGARI A, 1992, BIOCHEM BIOPH RES CO, V187, P359, DOI 10.1016/S0006-291X(05)81501-3; [No title captured]	26	42	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					782	792						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178819				2022-12-18	WOS:A1994NH39400007
J	RISSTALPERS, C; VERLEUNMOOIJMAN, MCT; DEBLAEIJ, TJP; DEGENHART, HJ; TRAPMAN, J; BRINKMANN, AO				RISSTALPERS, C; VERLEUNMOOIJMAN, MCT; DEBLAEIJ, TJP; DEGENHART, HJ; TRAPMAN, J; BRINKMANN, AO			DIFFERENTIAL SPLICING OF HUMAN ANDROGEN RECEPTOR PRE-MESSENGER-RNA IN X-LINKED REIFENSTEIN SYNDROME, BECAUSE OF A DELETION INVOLVING A PUTATIVE BRANCH SITE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-BINDING DOMAIN; MESSENGER-RNA; POINT MUTATIONS; RESISTANCE; GENE; EXPRESSION; SEQUENCE; INTRON; TRANSFORMATION; ORGANIZATION	The analysis of the androgen receptor (AR) gene, mRNA, and protein in a subject with X-linked Reifenstein syndrome (partial androgen insensitivity) is reported. The presence of two mature AR transcripts in genital skin fibroblasts of the patient is established, and, by reverse transcriptase-PCR and RNase transcription analysis, the wild-type transcript and a transcript in which exon 3 sequences are absent without disruption of the translational reading frame are identified. Sequencing and hybridization analysis show a deletion of >6 kb in intron 2 of the human AR gene, starting 18 bp upstream of exon 3. The deletion includes the putative branchpoint sequence (BPS) but not the acceptor splice site on the intron 2/exon 3 boundary. The deletion of the putative intron 2 BPS results in 30% inhibition of wild-type splicing. The mutant transcript encodes an AR protein lacking the second zinc finger of the DNA-binding domain. Western/immunoblotting analysis is used to show that the mutant AR protein is expressed in genital skin fibroblasts of the patient. The residual 10% wild-type transcript can be the result of the use of a cryptic BPS located 63 bp upstream of the intron 2/exon 3 boundary of the mutant AR gene. The mutated AR protein has no transcription-activating potential and does not influence the transactivating properties of the wild-type AR, as tested in cotransfection studies. It is concluded that the partial androgen-insensitivity syndrome of this patient is the consequence of the limited amount of wild-type AR protein expressed in androgen target cells, resulting from the deletion of the intron 2 putative BPS.	ERASMUS UNIV ROTTERDAM, DEPT ENDOCRINOL & REPROD, 3000 DR ROTTERDAM, NETHERLANDS; ERASMUS UNIV ROTTERDAM, DEPT PEDIAT, ROTTERDAM, NETHERLANDS; ERASMUS UNIV ROTTERDAM, DEPT PATHOL, ROTTERDAM, NETHERLANDS	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam								[Anonymous], METABOLIC BASIS INHE; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; BRINKMANN AO, 1992, CANCER SURV, V14, P95; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHANG YT, 1991, 73D ANN M END SOC WA; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; FABER PW, 1991, J BIOL CHEM, V266, P10743; GRIFFIN JE, 1992, NEW ENGL J MED, V326, P611; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KLOCKER H, 1992, AM J HUM GENET, V50, P1318; KUIPER GGJM, 1989, J MOL ENDOCRINOL, V2, pR1, DOI 10.1677/jme.0.002R001; LANGFORD CJ, 1984, CELL, V36, P645, DOI 10.1016/0092-8674(84)90344-1; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MARCELLI M, 1991, J CLIN INVEST, V87, P1123, DOI 10.1172/JCI115076; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; OCHMAN H, 1988, GENETICS, V120, P621; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PINSKY L, 1992, CLIN INVEST MED, V15, P456; QUIGLEY A, 1992, MOL ENDOCRINOL, V6, P1103; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; RISSTALPERS C, 1991, MOL ENDOCRINOL, V5, P1562, DOI 10.1210/mend-5-10-1562; RISSTALPERS C, 1990, P NATL ACAD SCI USA, V87, P7866, DOI 10.1073/pnas.87.20.7866; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; SONE T, 1990, MOL ENDOCRINOL, V4, P623, DOI 10.1210/mend-4-4-623; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; TRAPMAN J, 1988, BIOCHEM BIOPH RES CO, V153, P241, DOI 10.1016/S0006-291X(88)81214-2; VANLAAR JH, 1991, J BIOL CHEM, V266, P3734; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; WANG YL, 1991, MOL ENDOCRINOL, V5, P1707, DOI 10.1210/mend-5-11-1707; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; ZOPPI S, 1992, MOL ENDOCRINOL, V6, P409, DOI 10.1210/me.6.3.409	42	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					609	617						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128958				2022-12-18	WOS:A1994NC83600005
J	NICHOLS, BE; BASCOM, R; LITT, M; MCINNES, R; SHEFFIELD, VC; STONE, EM				NICHOLS, BE; BASCOM, R; LITT, M; MCINNES, R; SHEFFIELD, VC; STONE, EM			REFINING THE LOCUS FOR BEST VITELLIFORM MACULAR DYSTROPHY AND MUTATION ANALYSIS OF THE CANDIDATE GENE ROM-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINITIS-PIGMENTOSA; GENOMIC DNA; FAMILY; 11Q13; PYGM; PGA	Vitelliform macular dystrophy (Best disease) is an autosomal dominant macular dystrophy which shares important clinical features with age-related macular degeneration, the most common cause of legal blindness in the elderly. Unfortunately, our understanding and treatment for this common age-related disorder is limited. Discovery of the gene which causes Best disease has the potential to increase our understanding of the pathogenesis of all types of macular degeneration, including the common age-related form. Best disease has recently been mapped to chromosome 11q13. The photoreceptor-specific protein ROM1 has also been recently mapped to this location, and the ROM1 gene is a candidate gene for Best disease. Using highly polymorphic markers, we have narrowed the genetic region which contains the Best disease gene to the 10-cM region between markers D11S871 and PYGM. Marker D11S956 demonstrated no recombinants with Best disease in three large families and resulted in a lod score of 18.2. In addition, a polymorphism within the ROM1 gene also demonstrated no recombinants and resulted in a lod score of 10.0 in these same three families. We used a combination of SSCP analysis, denaturing gradient gel electrophoresis, and DNA sequencing to screen the entire coding region of the ROM1 gene in 11 different unrelated patients affected with Best disease. No nucleotide changes were found in the coding sequence of any affected patient, indicating that mutations within the coding sequence are unlikely to cause Best disease.	UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT GENET,IOWA CITY,IA 52242; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	University of Iowa; University of Iowa; University of Iowa; University of Toronto; Oregon Health & Science University; Oregon Health & Science University				Stone, Edwin M./0000-0003-3343-4414; Bascom, Roger/0000-0002-9106-8224	NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457, P50HG000835] Funding Source: NIH RePORTER; NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [P50HG00835, HG00457] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Arden G B, 1962, Br J Ophthalmol, V46, P449, DOI 10.1136/bjo.46.8.449; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BASCOM RA, 1992, AM J HUM GENET, V51, P1028; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Best F., 1905, OPHTHALMOLOGICA, V13, P199, DOI [10.1159/000290318, DOI 10.1159/000290318]; EVERS MPJ, 1989, GENOMICS, V4, P232, DOI 10.1016/0888-7543(89)90325-X; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FORSMAN K, 1992, CLIN GENET, V42, P156; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; IWASAKI H, 1992, GENOMICS, V13, P7, DOI 10.1016/0888-7543(92)90194-W; KAJIWAR K, 1992, INVEST OPHTH VIS SCI, V4, P1396; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KAJIWARA K, 1993, NAT GENET, V3, P208, DOI 10.1038/ng0393-208; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LI Y, 1992, AM J HUM GENET, V51, P749; Liebowitz H.M., 1980, SURV OPHTHALMOL S, V24, P335; MEYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131; Nichols B. E., 1992, American Journal of Human Genetics, V51, pA369; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; NICHOLS BE, 1993, HUM MOL GENET, V2, P601, DOI 10.1093/hmg/2.5.601; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213	28	42	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					95	103						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279475				2022-12-18	WOS:A1994MQ70000013
J	WILSON, L; CURTIS, A; KORENBERG, JR; SCHIPPER, RD; ALLAN, L; CHENEVIXTRENCH, G; STEPHENSON, A; GOODSHIP, J; BURN, J				WILSON, L; CURTIS, A; KORENBERG, JR; SCHIPPER, RD; ALLAN, L; CHENEVIXTRENCH, G; STEPHENSON, A; GOODSHIP, J; BURN, J			A LARGE, DOMINANT PEDIGREE OF ATRIOVENTRICULAR SEPTAL-DEFECT (AVSD) - EXCLUSION FROM THE DOWN-SYNDROME CRITICAL REGION ON CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DISEASE; MULTILOCUS LINKAGE ANALYSIS; GT DINUCLEOTIDE REPEAT; DOWN-SYNDROME; MALFORMATIONS; MARKERS	We describe a large pedigree of individuals with autosomal dominant atrioventricular septal defect (AVSD). The pedigree includes affected individuals and individuals who have transmitted the defect but are not clinically affected. AVSDs are a rare congenital heart malformation that occurs as only 2.8% of isolated cardiac lesions. They are the predominant heart defect in children with Down syndrome, making chromosome 21 a candidate for genes involved in atrioventricular septal development. We have carried out a linkage study in the pedigree by using 10 simple-sequence polymorphisms from chromosome 21. Multipoint linkage analysis gives lod scores of less than -2 for the region of trisomy 21 associated with heart defects, which excludes a locus within this region as the cause of the defect in this family.	UNIV NEWCASTLE UPON TYNE, DIV HUMAN GENET, NEWCASTLE UPON TYNE NE2 4AA, ENGLAND; CEDARS SINAI MED CTR, DIV MED GENET, LOS ANGELES, CA USA; GUYS HOSP, DIV PAEDIAT CARDIOL, LONDON, ENGLAND; QUEENSLAND INST MED RES, BRISBANE, AUSTRALIA	Newcastle University - UK; Cedars Sinai Medical Center; Guy's & St Thomas' NHS Foundation Trust; QIMR Berghofer Medical Research Institute			Chenevix-Trench, Georgia/AAV-2014-2020	Chenevix-Trench, Georgia/0000-0002-1878-2587; Burn, John/0000-0002-9823-2322				ANDERSON RH, 1990, DEVELOPMENTAL CARDIOLOGY, P575; BURN J, 1990, AM J HUM GENET S, V47, pA121; BURN J, 1991, THESIS U NEWCASTLE U; CARMI R, 1992, AM J MED GENET, V43, P569, DOI 10.1002/ajmg.1320430313; CHENG SV, 1988, P NATL ACAD SCI USA, V85, P6032, DOI 10.1073/pnas.85.16.6032; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; EMANUEL R, 1983, BRIT HEART J, V49, P144; FERENCZ C, 1989, J PEDIATR-US, V114, P79, DOI 10.1016/S0022-3476(89)80605-5; GUO Z, 1990, NUCLEIC ACIDS RES, V18, P4967, DOI 10.1093/nar/18.16.4967-a; GUYER M, 1992, SCIENCE, V258, P67; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; KURNIT DM, 1985, AM J MED GENET, V20, P385, DOI 10.1002/ajmg.1320200222; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; MACDONALD G, 1991, GENOMICS, V11, P317, DOI 10.1016/0888-7543(91)90138-5; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MIYABARA S, 1982, TERATOLOGY, V25, P369, DOI 10.1002/tera.1420250314; MIYABARA S, 1990, DEV CARDIOLOGY MORPH, P219; NORA JJ, 1971, PEDIATR CLIN N AM, V18, P1059; ONUALLAINS, 1977, BIRTH DEFECTS, V13, P143; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, 1990, AM J MED GENET, P104; PETERSEN MB, 1991, HUM GENET, V87, P401; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RAHMANI Z, 1990, AM J MED GENET, P98; SANCHEZCASCOS A, 1978, EUR J CARDIOL, V7, P197; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793; VANMIEROP LHS, 1962, J THORAC CARDIOV SUR, V43, P71; WARREN AC, 1992, GENOMICS, V14, P818, DOI 10.1016/S0888-7543(05)80198-3; WARREN AC, 1993, HUM GENET, V91, P87; WATKINS PC, 1988, CYTOGENET CELL GENET, V46, P712; YAO J, 1968, CAN MED ASSOC J, V98, P218	35	42	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1262	1268						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250042				2022-12-18	WOS:A1993MJ81800013
J	GU, XF; DEROOIJ, F; VOORTMAN, G; TEVELDE, K; NORDMANN, Y; GRANDCHAMP, B				GU, XF; DEROOIJ, F; VOORTMAN, G; TEVELDE, K; NORDMANN, Y; GRANDCHAMP, B			HIGH-FREQUENCY OF MUTATIONS IN EXON-10 OF THE PORPHOBILINOGEN DEAMINASE GENE IN PATIENTS WITH A CRIM-POSITIVE SUBTYPE OF ACUTE INTERMITTENT PORPHYRIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; NUCLEOTIDE-SEQUENCE; DNA; POLYMERASE; ENZYME; CDNA	Acute intermittent porphyria (AIP) is an autosomal dominant disease characterized by a partial deficiency of porphobilinogen (PBG) deaminase. Different subtypes of the disease have been defined, and more than 10 different mutations have been described. We focused our study on exon 10, since we previously found that three different mutations were located in this exon and that two of them seemed to be relatively common. We used denaturing gradient gel electrophoresis (DGGE) after in vitro amplification to detect all possible mutations in exon 10 in 41 unrelated AIP patients. In about one-fourth of these patients we could distinguish three abnormal migration patterns, indicating the presence of various mutations. Additional sequencing demonstrated the presence of three different single-base substitutions. Two of these mutations had already been described. A third one consisted of a C-to-T transition located at position 499 of the PBG deaminase mRNA and resulted in an Arg-to-Trp substitution. All three mutations were found in patients with cross-reacting immunological material (CRIM)-positive forms of AIP. The high frequency of these mutations make DGGE analysis of exon 10 a useful approach allowing the direct detection of the DNA abnormality in most of the families with the CRIM-positive subtype of AIP.	FAC XAVIER BICHAT, GENET MOLEC LAB, 16 RUE H HUCHARD, F-75018 PARIS, FRANCE; ERASMUS UNIV, HOSP DIJKZIGT, DEPT INTERNAL MED 2, ROTTERDAM, NETHERLANDS; ST GEERTRUIDEN HOSP, DEPT INTERNAL MED, DEVENTER, NETHERLANDS; HOP LOUIS MOURIER, BIOCHIM LAB, F-92701 COLOMBES, FRANCE	UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite								BEAUMONT C, 1989, J BIOL CHEM, V264, P14829; DAILEY HA, 1986, J BIOL CHEM, V261, P7902; DELFAU MH, 1990, J CLIN INVEST, V86, P1511, DOI 10.1172/JCI114869; DELFAU MH, 1991, AM J HUM GENET, V49, P421; DEROOIJ FWM, 1987, B I DERMATOLOGICA S, V13, P175; DESNICK RJ, 1985, J CLIN INVEST, V76, P865, DOI 10.1172/JCI112044; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; GRANDCHAMP B, 1989, EUR J CLIN INVEST, V19, P415, DOI 10.1111/j.1365-2362.1989.tb00252.x; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HUTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; LEE JS, 1988, HUM GENET, V79, P379; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LLEWELLYN DH, 1987, LANCET, V2, P706; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCOBIE GA, 1990, HUM GENET, V85, P631; SHARIF AL, 1989, EUR J BIOCHEM, V184, P353, DOI 10.1111/j.1432-1033.1989.tb15026.x; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; STUBNICER AC, 1988, NUCLEIC ACIDS RES, V16, P3102, DOI 10.1093/nar/16.7.3102; THOMAS SD, 1986, NUCLEIC ACIDS RES, V14, P6215, DOI 10.1093/nar/14.15.6215	23	42	43	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					660	665						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496994				2022-12-18	WOS:A1992JJ82800023
J	RISCH, N				RISCH, N			CORRECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction, Addition															NHGRI NIH HHS [HG00348] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		RISCH N, 1990, AM J HUM GENET, V46, P242	1	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					673	675						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496996				2022-12-18	WOS:A1992JJ82800025
J	WEITZ, CJ; WENT, LN; NATHANS, J				WEITZ, CJ; WENT, LN; NATHANS, J			HUMAN TRITANOPIA ASSOCIATED WITH A 3RD AMINO-ACID SUBSTITUTION IN THE BLUE-SENSITIVE VISUAL PIGMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							COLOR-VISION		JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Leiden University; Leiden University - Excl LUMC	WEITZ, CJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.							Boynton R. M., 1979, HUMAN COLOR VISION; HIGGINS KE, 1983, AM J OPTOM PHYS OPT, V60, P964; LI T, UNPUB POINT MUTATION; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; WEITZ CJ, 1992, AM J HUM GENET, V50, P498; WOOTEN BR, 1973, J GEN PHYSIOL, V61, P125, DOI 10.1085/jgp.61.2.125	7	42	43	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					444	446						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1386496				2022-12-18	WOS:A1992JF77600029
J	DUNNING, AM; RENGES, HH; XU, CF; PEACOCK, R; BRASSEUR, R; LAXER, G; TIKKANEN, MJ; BUTLER, R; SAHA, N; HAMSTEN, A; ROSSENEU, M; TALMUD, P; HUMPHRIES, SE				DUNNING, AM; RENGES, HH; XU, CF; PEACOCK, R; BRASSEUR, R; LAXER, G; TIKKANEN, MJ; BUTLER, R; SAHA, N; HAMSTEN, A; ROSSENEU, M; TALMUD, P; HUMPHRIES, SE			2 AMINO-ACID SUBSTITUTIONS IN APOLIPOPROTEIN-B ARE IN COMPLETE ALLELIC ASSOCIATION WITH THE ANTIGEN GROUP (X/Y) POLYMORPHISM - EVIDENCE FOR LITTLE RECOMBINATION IN THE 3' END OF THE HUMAN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; YOUNG MALE SURVIVORS; MYOCARDIAL-INFARCTION; SERUM-LIPOPROTEINS; INTERNAL REPEATS; DNA POLYMORPHISM; RESTRICTION SITE; LDL-CHOLESTEROL; CATABOLIC RATE	We report the identification of an A-to-G base change, in exon 29 of the apolipoprotein B (apo B) gene, that results in the substitution of serine for asparagine at residue 4311 of mature apo B100. In a recent publication, Huang et al. have reported a C-to-T base change in exon 26 that causes the substitution of leucine for proline at residue 2712 of apo B. We have found complete linkage disequilibrium between the alleles at both these sites and an immunochemical polymorphism of LDL designated antigen group (x/y) (Ag(x/y)) in a sample of 118 Finnish individuals. This implies that either one of these substitutions-or both of them combined-could be the molecular basis of the Ag(x/y) antigenic determinants, with the allele encoding serine4311 plus leucine2712 representing the Ag(x) epitope, and that encoding asparagine4311 plus proline2712 the Ag(y) epitope. In a sample of 90 healthy Swedish individuals the Leu2712/Ser4311 allele is associated both with reduced serum levels of LDL-cholesterol and apo B and with raised levels of HDL. However, these differences are of smaller effect than those associated with the XbaI RFLP of the apo B gene in this sample. We have also genotyped 523 individuals from European, Asian, Chinese, and Afro-Caribbean populations and have found complete association between the sites encoding residues 2712 and 4311 in all of these samples, although there are large allele frequency differences between these populations. In addition, there is strong linkage disequilibrium with allelic association between the alleles of these sites and those of the XbaI RFLP in all the populations examined. Taken together, these data suggest that, since the divergence of the major ethnic groups, there has been little or no recombination in the 3' end of the human apo B gene.	CHARING CROSS SUNLEY MED RES CTR,LONDON,ENGLAND; UNIV LONDON BIRKBECK COLL,DEPT CRYSTALLOG,LONDON WC1E 7HX,ENGLAND; AKAD ZIEKENHAUS ST JAN,DEPT CLIN BIOCHEM,BRUGES,BELGIUM; FREE UNIV BRUSSELS,MACROMOLEC INTERFACES LAB,B-1050 BRUSSELS,BELGIUM; UNIV HELSINKI,DEPT MED 3,SF-00100 HELSINKI 10,FINLAND; SWISS RED CROSS,CENT LAB BLOOD TRANSFUS SERV,CH-3000 BERN 22,SWITZERLAND; NATL UNIV SINGAPORE,DEPT PEDIAT,SINGAPORE 0511,SINGAPORE; KAROLINSKA INST,KING GUSTAV 5 RES INST,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA HOSP,DEPT INTERNAL MED,S-10401 STOCKHOLM 60,SWEDEN	University of Oxford; University of London; Birkbeck University London; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Helsinki; National University of Singapore; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital			Talmud, Philippa J/C-4402-2008	Talmud, Philippa/0000-0002-5560-1933; Xu, Chun-Fang/0000-0002-8747-0683				AALTOSETALA K, 1989, HUM GENET, V82, P305; ALLISON AC, 1961, LANCET, V1, P634; BERG K, 1987, CIBA F SYMP, V130, P14; BERG K, 1976, P NATL ACAD SCI USA, V73, P937, DOI 10.1073/pnas.73.3.937; BERG K, 1986, P NATL ACAD SCI USA, V83, P7367, DOI 10.1073/pnas.83.19.7367; BLACKHART BD, 1986, J BIOL CHEM, V261, P5364; BREGUET G, 1990, AM J HUM GENET, V46, P502; CARLSSON P, 1986, GENE, V49, P29, DOI 10.1016/0378-1119(86)90383-5; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DELOOF H, 1987, J LIPID RES, V28, P1455; DELOOF H, 1987, BIOCHIM BIOPHYS ACTA, V911, P45, DOI 10.1016/0167-4838(87)90268-8; DEMANT T, 1988, J CLIN INVEST, V82, P797, DOI 10.1172/JCI113681; DUNNING AM, 1991, BIOCHIM BIOPHYS ACTA, V1096, P231, DOI 10.1016/0925-4439(91)90010-7; DUNNING AM, 1988, HUM GENET, V78, P325, DOI 10.1007/BF00291728; DURRINGTON PN, 1986, BRIT HEART J, V56, P206, DOI 10.1136/hrt.56.3.206; EHNHOLM C, 1984, ARTERIOSCLEROSIS, V4, P265, DOI 10.1161/01.ATV.4.3.265; EHNHOLM C, 1982, NEW ENGL J MED, V307, P850, DOI 10.1056/NEJM198209303071403; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; FROSTEGARD J, 1990, J LIPID RES, V31, P33; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; HAMSTEN A, 1986, ATHEROSCLEROSIS, V59, P223, DOI 10.1016/0021-9150(86)90051-1; HAMSTEN A, 1987, AM HEART J, V113, P917, DOI 10.1016/0002-8703(87)90052-4; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HASSTEDT SJ, 1987, GENET EPIDEMIOL, V4, P67, DOI 10.1002/gepi.1370040202; HOULSTON RS, 1988, ATHEROSCLEROSIS, V71, P81, DOI 10.1016/0021-9150(88)90305-X; HUANG LS, 1990, NUCLEIC ACIDS RES, V18, P5922, DOI 10.1093/nar/18.19.5922-a; INNERARITY TL, 1990, CURR OPIN LIPIDOL, V1, P104; KINGUNDERWOOD L, 1991, CLIN GENET, V40, P17; KUUSI T, 1985, J LIPID RES, V26, P360; LAW A, 1986, LANCET, V1, P1301; LUDWIG EH, 1990, AM J HUM GENET, V47, P712; MA Y, 1987, ARTERIOSCLEROSIS, V3, P301; MA YH, 1989, ARTERIOSCLEROSIS, V9, P242, DOI 10.1161/01.ATV.9.2.242; Maniatis T., 1982, MOL CLONING; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MILLER GJ, 1989, ETHNIC FACTORS HLTH, P280; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MYANT NB, 1991, ARTERIOSCLER THROMB, V11, P691, DOI 10.1161/01.ATV.11.3.691; PAIRITZ G, 1988, AM J HUM GENET, V43, P311; PAULWEBER B, 1990, ARTERIOSCLEROSIS, V10, P17, DOI 10.1161/01.ATV.10.1.17; RAPACZ J, 1991, P NATL ACAD SCI USA, V88, P1403, DOI 10.1073/pnas.88.4.1403; ROSSENEU M, 1990, MOL DESCRIPTION BIOL, V2, P173; SAHA N, UNPUB APOLIPOPROTEIN; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; TALMUD PJ, 1987, ATHEROSCLEROSIS, V67, P81, DOI 10.1016/0021-9150(87)90267-X; TIKKANEN MJ, 1990, CLIN GENET, V37, P327, DOI 10.1111/j.1399-0004.1990.tb03514.x; WANG X, 1988, ARTERIOSCLEROSIS, V8, P429, DOI 10.1161/01.ATV.8.4.429; WHAYNE TF, 1981, ATHEROSCLEROSIS, V39, P411, DOI 10.1016/0021-9150(81)90026-5; WU MJ, 1991, ARTERIOSCLER THROMB, V11, P379, DOI 10.1161/01.ATV.11.2.379; XU C, 1989, HUM GENET, V82, P322; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YOUNG SG, 1989, J LIPID RES, V30, P443	54	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					208	221						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1370364				2022-12-18	WOS:A1992HA04000023
J	SKUSE, GR; KOSCIOLEK, BA; ROWLEY, PT				SKUSE, GR; KOSCIOLEK, BA; ROWLEY, PT			THE NEUROFIBROMA IN VONRECKLINGHAUSEN NEUROFIBROMATOSIS HAS A UNICELLULAR ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARATHYROID ADENOMAS; X-CHROMOSOME; TYPE-1 GENE; TRANSLOCATION; 17Q11.2; HETEROZYGOSITY; IDENTIFICATION; ASTROCYTOMAS; SEQUENCES; SEGMENT	Von Recklinghausen neurofibromatosis (NF1) is the most common hereditary syndrome predisposing to neoplasia. NF1 is an autosomal dominant disease caused by a single gene which maps to chromosome 17q11.2. The most common symptomatic manifestation of NF1 is the benign neurofibroma. Our previous studies of tumors in NF1, studies which detected a loss of heterozygosity for DNA markers from the NF1 region of chromosome 17 in malignant tumors, did not detect a loss in neurofibromas. We report here that a more extensive study, including the analysis of neurofibromas from 19 unrelated NF1 patients by using seven probes, failed to detect a single instance of loss of heterozygosity. This finding suggests that neurofibromas are either polyclonal or monoclonal in origin but arise by a mechanism different from that of NF1 malignancies. In order to investigate the first possibility, we analyzed neurofibromas from female NF1 patients by using an X chromosome-specific probe, from the phosphoglycerokinase (PGK) gene, which detects an RFLP. The detected alleles carry additional recognition sites for the methylation-sensitive enzyme HpaII, so that the allele derived from the active X chromosome is digested by HpaII while the one from the hypermethylated, inactive X chromosome is not. We analyzed neurofibromas from 30 unrelated females with NF1. Eight patients were heterozygous for the PGK RFLP. By this assay, neurofibromas from all eight appeared monoclonal in origin. These results suggest that benign neurofibromas in NF1 arise by a mechanism that is different from that of malignant tumors. This mechanism may involve (a) an NF1 gene mutation that, by our analysis, is not detectable as a loss of heterozygosity or (b) a gene or genes other than the NF1 gene.	UNIV ROCHESTER,SCH MED,DIV GENET,ROCHESTER,NY 14627; UNIV ROCHESTER,SCH MED,DEPT MED,ROCHESTER,NY 14627	University of Rochester; University of Rochester					NCI NIH HHS [CA38685] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038685] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Crowe FW, 1956, CLIN PATHOLOGICAL GE; DANCIS J, 1968, LIFE SCI PT 1 PHYSI, V7, P587, DOI 10.1016/0024-3205(68)90079-9; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DIEHL S R, 1987, Genomics, V1, P361, DOI 10.1016/0888-7543(87)90039-5; ELAZOUZI M, 1989, P NATL ACAD SCI USA, V86, P7186, DOI 10.1073/pnas.86.18.7186; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FIALKOW PJ, 1971, NEW ENGL J MED, V284, P298, DOI 10.1056/NEJM197102112840604; FIALKOW PJ, 1977, NEW ENGL J MED, V297, P696, DOI 10.1056/NEJM197709292971304; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; JAMES CD, 1989, P NATL ACAD SCI USA, V86, P2858, DOI 10.1073/pnas.86.8.2858; JAMES CD, 1988, CANCER RES, V48, P5546; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LINDER D, 1965, AM J HUM GENET, V17, P212; LYON MF, 1972, BIOL REV, V47, P1; MENON AG, 1989, GENOMICS, V5, P245, DOI 10.1016/0888-7543(89)90053-0; NAKAMURA Y, 1987, CYTOGENET CELL GENET, V46, P668; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; PERICAKVANCE MA, 1987, GENOMICS, V4, P349; RASKIND WH, 1987, ADV CANCER RES, V49, P127, DOI 10.1016/S0065-230X(08)60796-4; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; ROULEAU GA, 1990, AM J HUM GENET, V46, P323; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SEIZINGER B R, 1987, Genomics, V1, P346, DOI 10.1016/0888-7543(87)90035-8; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; UPDAHYAYA M, 1987, GENOMICS, V1, P358; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VOGELSTEIN B, 1985, SCIENCE, V227, P642, DOI 10.1126/science.2982210; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; WOODRUFF MFA, 1988, ADV CANCER RES, V50, P197, DOI 10.1016/S0065-230X(08)60438-8; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	46	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					600	607						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1715669				2022-12-18	WOS:A1991GE36700013
J	IANNUZZI, MC; HIDAKA, N; BOEHNKE, M; BRUCK, ME; HANNA, WT; COLLINS, FS; GINSBURG, D				IANNUZZI, MC; HIDAKA, N; BOEHNKE, M; BRUCK, ME; HANNA, WT; COLLINS, FS; GINSBURG, D			ANALYSIS OF THE RELATIONSHIP OF VONWILLEBRAND DISEASE (VWD) AND HEREDITARY HEMORRHAGIC TELANGIECTASIA AND IDENTIFICATION OF A POTENTIAL TYPE-IIA VWD MUTATION (IIE865 TO THR)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WEBER-RENDU DISEASE; GENE; AMPLIFICATION; ASSOCIATION; FRAGMENTS; LINKAGE; CLONES; CDNA	Reports of families with members affected with both von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia (HHT) suggest a possible relationship between these two disorders. vWD, the most common inherited bleeding disorder in humans, is due to either a quantitative or qualitative defect in von Willebrand factor (vWF). The gene for vWF has been cloned and mapped to chromosome 12 (12p12-->12pter). HHT, an uncommon inherited bleeding disorder, is characterized by malformed, dilated, fragile blood vessels. The chromosomal location of the gene for HHT is unknown. We studied two families by RFLP analysis to determine whether there is a molecular basis for the association of vWD and HHT. Family A is affected with both type IIA vWD and HHT; family B is affected with HHT alone. Linkage of HHT to the vWF gene was not detected, and vWF was ruled out as a candidate gene for HHT. The vWF gene was found to be tightly linked to type IIA vWD in family A (lod score 3.61 at recombination fraction .00). By PCR and DNA sequence analysis of vWF exon 28, a single T-->C transition resulting in the substitution of Thr for Ile865 was identified. This substitution is located immediately adjacent to two previously identified type IIA vWD mutations.	UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH PUBL HLTH, DEPT BIOSTAT, ANN ARBOR, MI 48109 USA; UNIV TENNESSEE, MED CTR HOSP, DEPT INTERNAL MED, KNOXVILLE, TN 37996 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tennessee System; University of Tennessee Health Science Center	IANNUZZI, MC (corresponding author), UNIV MICHIGAN, DEPT INTERNAL MED, MSRB 1, ROOM 5520B, ANN ARBOR, MI 48109 USA.				NHGRI NIH HHS [R29HG00376] Funding Source: Medline; NHLBI NIH HHS [R0I-HL39693-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHR DJ, 1977, AM J MED, V62, P452, DOI 10.1016/0002-9343(77)90846-4; BERKOWITZ SD, 1987, J CLIN INVEST, V79, P524, DOI 10.1172/JCI112843; BERNARDI F, 1988, BRIT J HAEMATOL, V68, P243, DOI 10.1111/j.1365-2141.1988.tb06196.x; BONTHRON D, 1986, NUCLEIC ACIDS RES, V14, P7125, DOI 10.1093/nar/14.17.7125; COLLER BS, 1987, HEMOSTASIS THROMBOSI, P65; CONLON CL, 1978, ANN INTERN MED, V89, P921, DOI 10.7326/0003-4819-89-6-921; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; GINSBURG D, 1989, P NATL ACAD SCI USA, V86, P3723, DOI 10.1073/pnas.86.10.3723; HANNA W, 1984, THROMB HAEMOSTASIS, V51, P275; HASHIMOTO K, 1972, ORAL SURG ORAL MED O, V34, P751, DOI 10.1016/0030-4220(72)90293-9; HODGSON CH, 1959, NEW ENGL J MED, V261, P624, DOI 10.1056/NEJM195909242611301; HOLMBERG L, 1985, CLIN HAEMATOL, V14, P461; HOYER LW, 1983, BRIT J HAEMATOL, V55, P493, DOI 10.1111/j.1365-2141.1983.tb02165.x; IANNUZZI MC, 1987, NUCLEIC ACIDS RES, V15, P5909, DOI 10.1093/nar/15.14.5909; IANNUZZI MC, 1989, AM J HUM GENET, V44, P695; IANNUZZI MC, 1987, NUCLEIC ACIDS RES, V15, P5755; JAHNKE V, 1970, ARCHIV OTOLARYNGOL, V91, P262; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MENEFEE MG, 1975, ARCH OTOLARYNGOL, V101, P246; MORTON NE, 1955, AM J HUM GENET, V7, P277; NICHOLS WC, 1989, GENOMICS, V5, P535, DOI 10.1016/0888-7543(89)90020-7; OKAYAMA H, 1989, J LAB CLIN MED, V114, P105; PEERY WH, 1987, AM J MED, V82, P989, DOI 10.1016/0002-9343(87)90162-8; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; RAMSAY DM, 1976, LANCET, V2, P275; REILLY PJ, 1984, AM J GASTROENTEROL, V79, P363; RODEGHIERO F, 1987, BLOOD, V69, P454; ROTH MS, 1990, TRANSPLANTATION, V49, P714, DOI 10.1097/00007890-199004000-00012; RUGGERI ZM, 1987, BLOOD, V70, P895; VERWEIJ CL, 1988, J CLIN INVEST, V81, P1116, DOI 10.1172/JCI113425; ZIMMERMAN TS, 1987, ANN NY ACAD SCI, V509, P53, DOI 10.1111/j.1749-6632.1987.tb30983.x	36	42	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					757	763						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1673047				2022-12-18	WOS:A1991FK47800015
J	SHETH, P; ABDELHAK, S; BACHELOT, MF; BURLET, P; MASSET, M; HILLAIRE, D; CLERGETDARPOUX, F; FREZAL, J; LATHROP, GM; MUNNICH, A; MELKI, J				SHETH, P; ABDELHAK, S; BACHELOT, MF; BURLET, P; MASSET, M; HILLAIRE, D; CLERGETDARPOUX, F; FREZAL, J; LATHROP, GM; MUNNICH, A; MELKI, J			LINKAGE ANALYSIS IN SPINAL MUSCULAR-ATROPHY, BY 6 CLOSELY FLANKING MARKERS ON CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RFLP; MAP; CHILDHOOD; M4	The proximal spinal muscular atrophies (SMA) represent the second most common autosomal recessive disorder, after cystic fibrosis. The gene responsible for chronic SMA has recently been mapped to chromosome 5q by using genetic linkage studies. Among six markers mapping to this region, five were shown to be linked with the SMA locus in 39 chronic SMA families each containing at least two affected individuals. Multilocus analysis by the method of location score was used to establish the best estimate of the SMA gene location. Our data suggest that the most likely location for SMA is between loci D5S6 and D5S39. The genetic distances between these two markers are estimated to be 6.4 cM in males and 11.9 cM in females. Since meiosis were informative with D5S39 and D5S6 in 92% and 87% of SMA families, respectively, it is hoped that the present study will contribute to the calculation of genetic risk in SMA families.	HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH HANDICAPS GENET ENFANT,149 RUE SEVRES,F-75743 PARIS 15,FRANCE; CTR ETUD POLYMORPHISME HUMAIN,PARIS,FRANCE; INSERM,U155,F-75005 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)			Clerget-Darpoux, Francoise/I-4825-2017; Abdelhak, Sonia/L-2831-2013	Clerget-Darpoux, Francoise/0000-0003-4816-6619; Abdelhak, Sonia/0000-0001-8466-5525				ABDELHAK S, 1990, NUCLEIC ACIDS RES, V18, P5580, DOI 10.1093/nar/18.18.5580-a; ALITALO T, 1987, CYTOGENET CELL GENET, V46, P570; ARMSTRONG RM, 1966, ARCH NEUROL-CHICAGO, V14, P208, DOI 10.1001/archneur.1966.00470080092014; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; DIETZSCH E, 1986, NUCLEIC ACIDS RES, V14, P1923, DOI 10.1093/nar/14.4.1923; DONISKELLER H, 1986, COLD SPRING HARB SYM, V51, P317, DOI 10.1101/SQB.1986.051.01.037; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EMERY AEH, 1971, J MED GENET, V8, P481, DOI 10.1136/jmg.8.4.481; HAUSMANOWAPETRUSEWICZ I, 1985, J MED GENET, V22, P350, DOI 10.1136/jmg.22.5.350; KHAN PM, 1989, CYTOGENET CELL GENET, V51, P1043; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, GENOMICS, V2, P157; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P649; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; OTT J, 1985, ANAL HUMAN GENETIC L; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; STEPHENS K, 1987, CYTOGENET CELL GENET, V46, P699; WEIFFENBACH B, 1989, CYTOGENET CELL GENET, V51, P1104; ZERRES K, 1988, THESIS U BONN BONN	20	42	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					764	768						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014799				2022-12-18	WOS:A1991FK47800016
J	IANNUZZI, MC; STERN, RC; COLLINS, FS; HON, CT; HIDAKA, N; STRONG, T; BECKER, L; DRUMM, ML; WHITE, MB; GERRARD, B; DEAN, M				IANNUZZI, MC; STERN, RC; COLLINS, FS; HON, CT; HIDAKA, N; STRONG, T; BECKER, L; DRUMM, ML; WHITE, MB; GERRARD, B; DEAN, M			2 FRAMESHIFT MUTATIONS IN THE CYSTIC-FIBROSIS GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; DNA; IDENTIFICATION; POLYMORPHISMS	Cystic fibrosis (CF) is a recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. We have identified in exon 7 two frameshift mutations, one caused by a two-nucleotide insertion and the other caused by a one-nucleotide deletion; these mutations-CF1154insTC and CF1213delT, respectively, are predicted to shift the reading frame of the protein and to introduce UAA(ochre) termination codons at residues 369 and 368.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PEDIAT,CLEVELAND,OH 44106; RAINBOW BABIES & CHILDRENS HOSP,CLEVELAND,OH 44106; NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701; FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC,FREDERICK,MD	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	IANNUZZI, MC (corresponding author), UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,MSRB 1,ROOM 5520-B,ANN ARBOR,MI 48109, USA.		Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Strong, Theresa/GSM-6652-2022	Dean, Michael C/0000-0003-2234-0631; Strong, Theresa/0000-0001-6783-8703	NCI NIH HHS [N01-CO-74102] Funding Source: Medline; NIDDK NIH HHS [DK2756, DK 32960] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; IVASCHENKO T, IN PRESS GENOMICS; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WHITE MB, IN PRESS GENOMICS; 1990, AM J HUM GENET, V47, P359	14	42	45	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					227	231						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990834				2022-12-18	WOS:A1991EV74400007
J	ASTON, CE; HILL, SY				ASTON, CE; HILL, SY			SEGREGATION ANALYSIS OF ALCOHOLISM IN FAMILIES ASCERTAINED THROUGH A PAIR OF MALE ALCOHOLICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	ASTON, CE (corresponding author), WESTERN PSYCHIAT INST & CLIN,ALCOHOL & GENET RES PROGRAM,3811 OHARA ST,PITTSBURGH,PA 15213, USA.				NIAAA NIH HHS [AA05909] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005909] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BOHMAN M, 1978, ARCH GEN PSYCHIAT, V35, P269; BUYDENSBRANCHEY L, 1989, ARCH GEN PSYCHIAT, V46, P225; CADORET RJ, 1980, ARCH GEN PSYCHIAT, V37, P561; CADORET RJ, 1978, BRIT J PSYCHIAT, V132, P252, DOI 10.1192/S000712500028330X; COTTON NS, 1979, J STUD ALCOHOL, V40, P89, DOI 10.15288/jsa.1979.40.89; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; EATON WW, 1989, ACTA PSYCHIAT SCAND, V79, P163, DOI 10.1111/j.1600-0447.1989.tb08584.x; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; GILLIGAN SB, 1987, GENET EPIDEMIOL, V4, P395, DOI 10.1002/gepi.1370040602; GOODWIN DW, 1973, ARCH GEN PSYCHIAT, V28, P238; GOODWIN DW, 1974, ARCH GEN PSYCHIAT, V31, P164; HELZER JE, 1977, ARCH GEN PSYCHIAT, V34, P136; HILL SY, 1975, J STUD ALCOHOL, V36, P981, DOI 10.15288/jsa.1975.36.981; HILL SY, 1988, ALCOHOL CLIN EXP RES, V12, P811, DOI 10.1111/j.1530-0277.1988.tb01351.x; KAIJ L, 1960, ALCOHOLISM TWINS; KOJIC T, 1977, ALCOHOL INTOXICATION, V3, P7; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; Partanen J., 1966, INHERITANCE DRINKING; REICH T, 1988, ALCOHOL CLIN EXP RES, V12, P458, DOI 10.1111/j.1530-0277.1988.tb00227.x; Reich T., 1981, Genetic research strategies for psychobiology and psychiatry., P353; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Swinson R P, 1983, Recent Dev Alcohol, V1, P9; SWINSON RP, 1973, Q J STUD ALCOHOL, V34, P64; TANNA VL, 1988, J STUD ALCOHOL, V49, P472, DOI 10.15288/jsa.1988.49.472; WILLIAMS W R, 1986, American Journal of Human Genetics, V39, pA248; WINOKUR G, 1976, J STUD ALCOHOL, V37, P1313, DOI 10.15288/jsa.1976.37.1313	29	42	42	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					879	887						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DD896	2339688				2022-12-18	WOS:A1990DD89600003
J	KENWRICK, S; GITSCHIER, J				KENWRICK, S; GITSCHIER, J			A CONTIGUOUS, 3-MB PHYSICAL MAP OF XQ28 EXTENDING FROM THE COLOR-BLINDNESS LOCUS TO DXS15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, ROOM U-426, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco								ANAND R, 1988, GENOMICS, V3, P177, DOI 10.1016/0888-7543(88)90077-8; ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; AUBOURG PR, 1987, ANN NEUROL, V21, P349, DOI 10.1002/ana.410210406; BOSWINKEL E, 1985, CYTOGENET CELL GENET, V40, P586; CASARINO L, 1986, RES CLIN LAB, V16, P227; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GROSS A C, 1988, American Journal of Human Genetics, V43, pA145; HARPER K, 1984, LANCET, V2, P6; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KNOERS N, 1988, HUM GENET, V80, P31, DOI 10.1007/BF00451451; LEHESJOKI AE, UNPUB HEMOPHILIA A G; LEVINSON B, 1988, American Journal of Human Genetics, V43, pA192; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MULLIGAN LM, 1987, AM J MED GENET, V26, P751, DOI 10.1002/ajmg.1320260334; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; PATTERSON M, 1987, NUCLEIC ACIDS RES, V15, P2639, DOI 10.1093/nar/15.6.2639; PATTERSON M, 1988, AM J MED GENET, V30, P581, DOI 10.1002/ajmg.1320300159; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PATTERSON M, 1989, AM J HUM GENET, V44, P679; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; TONIOLO D, 1988, EMBO J, V7, P401, DOI 10.1002/j.1460-2075.1988.tb02827.x; UPADHYAYA M, 1986, HUM GENET, V74, P391, DOI 10.1007/BF00280492; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WARREN ST, 1989, GENOME MAPPING SEQUE, P126; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	33	42	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					873	882						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2589319				2022-12-18	WOS:A1989CF40300006
J	WANG, T; OKANO, Y; EISENSMITH, R; HUANG, SZ; ZENG, YT; LO, WHY; WOO, SLC				WANG, T; OKANO, Y; EISENSMITH, R; HUANG, SZ; ZENG, YT; LO, WHY; WOO, SLC			MOLECULAR-GENETICS OF PHENYLKETONURIA IN ORIENTALS - LINKAGE DISEQUILIBRIUM BETWEEN AN TERMINATION MUTATION AND HAPLOTYPE-4 OF THE PHENYLALANINE-HYDROXYLASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV,HOWARD HUGHES MED INST,DEPT CELL BIOL,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030; SHANGHAI CHILDRENS HOSP,MED GENET LAB,SHANGHAI,PEOPLES R CHINA; CHINESE ACAD MED SCI,INST BASIC MED SCI,DEPT MED GENET,BEIJING,PEOPLES R CHINA	Baylor College of Medicine; Baylor University; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17711] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHEN SH, 1989, HUM GENET, V81, P226; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI 10.1515/bchm2.1934.227.1-4.169; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1980, ACTA PAEDIATR SC   S, V280, P7; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1988, J PEDIATR-US, V113, P463, DOI 10.1016/S0022-3476(88)80629-2; LEDLEY FD, 1985, SCIENCE, V228, P77, DOI 10.1126/science.3856322; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LIU SR, 1985, CHIN PEDIATR J, V23, P321; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; SCRIVER CR, 1980, ANNU REV GENET, V14, P179, DOI 10.1146/annurev.ge.14.120180.001143; WOO SLC, 1989, BIOCHEMISTRY-US, V28, P1, DOI 10.1021/bi00427a001; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	20	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					675	680						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2816939				2022-12-18	WOS:A1989AZ04900003
J	DAHL, N; GOONEWARDENA, P; MALMGREN, H; GUSTAVSON, KH; HOLMGREN, G; SEEMANOVA, E; ANNEREN, G; FLOOD, A; PETTERSSON, U				DAHL, N; GOONEWARDENA, P; MALMGREN, H; GUSTAVSON, KH; HOLMGREN, G; SEEMANOVA, E; ANNEREN, G; FLOOD, A; PETTERSSON, U			LINKAGE ANALYSIS OF FAMILIES WITH FRAGILE-X MENTAL-RETARDATION, USING A NOVEL RFLP MARKER (DXS 304)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UPPSALA, CTR BIOMED, DEPT MED GENET, BOX 589, S-75123 UPPSALA, SWEDEN; UNIV HOSP UPPSALA, DEPT CLIN GENET, UPPSALA, SWEDEN; CHARLES UNIV, DEPT MED GENET, CS-11636 PRAGUE 1, CZECHOSLOVAKIA; CTY HOSP HAGFORS, DEPT PEDIAT, HAGFORS, SWEDEN	Uppsala University; Uppsala University; Uppsala University Hospital; Charles University Prague								ANTONARAKIS SE, 1987, MOL BIOL MED, V4, P81; ARVEILER B, 1988, AM J HUM GENET, V42, P380; BHATTACHARYA SS, 1987, CYTOGENET CELL GENET, V46, P580; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BROWN WT, 1987, LANCET, V1, P280; BROWN WT, 1988, HUM GENET, V78, P201, DOI 10.1007/BF00291662; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAHL N, IN PRESS NUCLEIC ACI; DAHL N, IN PRESS HUM GENET; DAVIES KE, 1985, HUM GENET, V70, P249; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; MULLEY J, 1988, AM J MED GENET, V30, P567, DOI 10.1002/ajmg.1320300158; MULLIGAN LM, 1987, AM J MED GENET, V26, P751, DOI 10.1002/ajmg.1320260334; OBERLE I, 1987, HUM GENET, V77, P60; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; OTT J, 1974, AM J HUM GENET, V26, P588; PATTERSON M, 1988, AM J HUM GENET, V43, P684; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PROUTY LA, 1988, AM J MED GENET, V30, P123, DOI 10.1002/ajmg.1320300111; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TANTRAVAHI U, 1986, CYTOGENET CELL GENET, V42, P75, DOI 10.1159/000132255; THIBODEAU SN, 1988, HUM GENET, V79, P219, DOI 10.1007/BF00366240; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; VEENEMA H, 1987, J MED GENET, V24, P413, DOI 10.1136/jmg.24.7.413; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151	29	42	42	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					304	309						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2569270				2022-12-18	WOS:A1989AK38000013
J	DAIGER, SP; REED, L; HUANG, SS; ZENG, YT; WANG, T; LO, WHY; OKANO, Y; HASE, Y; FUKUDA, Y; OURA, T; TADA, K; WOO, SLC				DAIGER, SP; REED, L; HUANG, SS; ZENG, YT; WANG, T; LO, WHY; OKANO, Y; HASE, Y; FUKUDA, Y; OURA, T; TADA, K; WOO, SLC			POLYMORPHIC DNA HAPLOTYPES AT THE PHENYLALANINE-HYDROXYLASE (PAH) LOCUS IN ASIAN FAMILIES WITH PHENYLKETONURIA (PKU)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS MED CTR OSAKA, OSAKA, JAPAN; BAYLOR UNIV, INST MOLEC GENET, HOUSTON, TX 77030 USA; BAYLOR UNIV, HOWARD HUGHES MED INST, DEPT CELL BIOL, HOUSTON, TX 77030 USA; SHANGHAI CHILDRENS HOSP, MED GENET LAB, SHANGHAI, PEOPLES R CHINA; CHINESE ACAD MED SCI, INST BASIC MED SCI, DEPT MED GENET, BEIJING, PEOPLES R CHINA; TOKOKA UNIV, SCH MED, DEPT PEDIAT, SENDAI, JAPAN	Baylor College of Medicine; Baylor University; Baylor University; Howard Hughes Medical Institute; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	DAIGER, SP (corresponding author), UNIV TEXAS, HLTH SCI CTR, GRAD SCH BIOMED SCI, POB 20334, HOUSTON, TX 77225 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017711, R37HD017711] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17711] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1986, LANCET, V1, P229; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; HERTZBERG M, 1989, AM J HUM GENET, V44, P382; KIDD KK, 1987, NATURE, V327, P282, DOI 10.1038/327282a0; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; MORTON NE, 1988, AM J HUM GENET, V42, P173; THALHAMMER O, 1975, HUMANGENETIK, V30, P273, DOI 10.1007/BF00275139; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	16	42	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					319	324						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2569272				2022-12-18	WOS:A1989AK38000015
J	SCHEFFER, H; MEERMAN, GJT; KRUIZE, YCM; VANDENBERG, AHM; PENNINGA, DP; TAN, KEWP; DERKINDEREN, DJ; BUYS, CHCM				SCHEFFER, H; MEERMAN, GJT; KRUIZE, YCM; VANDENBERG, AHM; PENNINGA, DP; TAN, KEWP; DERKINDEREN, DJ; BUYS, CHCM			LINKAGE ANALYSIS OF FAMILIES WITH HEREDITARY RETINOBLASTOMA - NONPENETRANCE OF MUTATION, REVEALED BY COMBINED USE OF MARKERS WITHIN AND FLANKING THE RBI GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STATE UNIV GRONINGEN,DEPT HUMAN GENET,ANTONIUS DEUSINGLAAN 4,9713 AW GRONINGEN,NETHERLANDS; STATE UNIV UTRECHT,DEPT OPHTHALMOL,UTRECHT,NETHERLANDS; STATE UNIV UTRECHT,DEPT EXPTL PATHOL,UTRECHT,NETHERLANDS	University of Groningen; Utrecht University; Utrecht University			Scheffer, Hans/E-4644-2012; van den Berg, Anke/H-1718-2011	Scheffer, Hans/0000-0002-2986-0915; van den Berg, Anke/0000-0002-8894-2638				BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; CARRITT B, 1986, AM J HUM GENET, V38, P428; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHAUM E, 1984, CYTOGENET CELL GENET, V38, P82, DOI 10.1159/000132037; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONNOLLY MJ, 1983, HUM GENET, V65, P122, DOI 10.1007/BF00286647; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; Ellsworth R M, 1969, Trans Am Ophthalmol Soc, V67, P462; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GALLIE BL, 1982, BRIT J CANCER, V45, P513, DOI 10.1038/bjc.1982.87; HORSTHEMKE B, 1987, LANCET, V1, P511; KNUDSON AG, 1983, PROG NUCLEIC ACID RE, V29, P17, DOI 10.1016/S0079-6603(08)60425-0; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; MATSUNAGA E, 1976, HUM GENET, V33, P1, DOI 10.1007/BF00447281; MITCHELL CD, 1988, HUM GENET, V81, P57, DOI 10.1007/BF00283730; SCHEFFER H, 1986, HUM GENET, V74, P249, DOI 10.1007/BF00282543; SCHEFFER H, 1986, NUCLEIC ACIDS RES, V14, P3148, DOI 10.1093/nar/14.7.3148; SCHEFFER H, 1987, CYTOGENET CELL GENET, V46, P688; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; SQUIRE J, 1986, P NATL ACAD SCI USA, V83, P6573, DOI 10.1073/pnas.83.17.6573; TURLEAU C, 1985, CANCER GENET CYTOGEN, V16, P321, DOI 10.1016/0165-4608(85)90240-7; VANOMMEN GJB, 1986, HUMAN GENETIC DISEAS, P113; VOGEL F, 1979, HUM GENET, V52, P1; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305	33	42	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					252	260						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2569269				2022-12-18	WOS:A1989AK38000007
J	OLSEN, DR; NAGAYOSHI, T; FAZIO, M; MATTEI, MG; PASSAGE, E; WEIL, D; TIMPL, R; CHU, ML; UITTO, J				OLSEN, DR; NAGAYOSHI, T; FAZIO, M; MATTEI, MG; PASSAGE, E; WEIL, D; TIMPL, R; CHU, ML; UITTO, J			HUMAN NIDOGEN - CDNA CLONING, CELLULAR EXPRESSION, AND MAPPING OF THE GENE TO CHROMOSOME-IQ43	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT DERMATOL, 1020 LOCUST ST, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT PHARMACOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON INST MOLEC MED, PHILADELPHIA, PA 19107 USA; INSERM, CTR GENET MED, F-13258 MARSEILLE 09, FRANCE; INSERM, UNITE RECH GENET MED, F-75005 PARIS, FRANCE; MAX PLANCK INST BIOCHEM, D-8033 MARTINSRIED, FED REP GER	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR028450, R01AR035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028833] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-35297, AR-28450] Funding Source: Medline; NIGMS NIH HHS [GM-28833] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALITALO K, 1980, EUR J BIOCHEM, V109, P247, DOI 10.1111/j.1432-1033.1980.tb04790.x; AUMAILLEY M, 1987, J BIOL CHEM, V262, P11532; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BERNARD MP, 1985, BIOCHEMISTRY-US, V24, P2698, DOI 10.1021/bi00332a016; BOYD CD, 1988, AM J HUM GENET, V42, P309; CARLIN B, 1981, J BIOL CHEM, V256, P5209; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1985, J BIOL CHEM, V260, P2315; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; DURKIN ME, 1987, P NATL ACAD SCI USA, V84, P1570, DOI 10.1073/pnas.84.6.1570; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; DZIADEK M, 1988, EUR J BIOCHEM, V172, P219, DOI 10.1111/j.1432-1033.1988.tb13876.x; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HART GW, 1979, J BIOL CHEM, V254, P9747; HOGAN BLM, 1982, J CELL BIOL, V95, P197, DOI 10.1083/jcb.95.1.197; KLEINMAN HK, 1985, J CELL BIOCHEM, V27, P317, DOI 10.1002/jcb.240270402; KLEINMAN HK, 1987, DEV BIOL, V122, P373, DOI 10.1016/0012-1606(87)90302-2; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MANN K, 1988, EUR J BIOCHEM, V178, P71, DOI 10.1111/j.1432-1033.1988.tb14430.x; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; MATTEI MG, 1988, HUM GENET, V79, P235, DOI 10.1007/BF00366243; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; NAGAYOSHI T, UNPUB HUMAN LAMININ; OHTA A, 1987, ARTHRITIS RHEUM, V30, P404, DOI 10.1002/art.1780300407; OLSEN DR, 1988, J INVEST DERMATOL, V90, P734, DOI 10.1111/1523-1747.ep12560934; OLSEN DR, IN PRESS LAB INVEST; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; PAULSSON M, 1986, EUR J BIOCHEM, V156, P467, DOI 10.1111/j.1432-1033.1986.tb09605.x; PAULSSON M, 1987, ARTHRITIS RHEUM, V263, P5425; PETERS BP, 1985, J BIOL CHEM, V260, P4732; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; PIHLAJANIEMI T, 1985, J BIOL CHEM, V260, P7681; PIHLAJANIEMI T, 1981, BIOCHEMISTRY-US, V20, P7409, DOI 10.1021/bi00529a014; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; PIKKARAINEN T, 1988, J BIOL CHEM, V263, P6751; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SCHITTNY JC, 1988, J CELL BIOL, V107, P1599, DOI 10.1083/jcb.107.4.1599; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TIMPL R, 1986, INT REV EXP PATHOL, V29, P1; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; UITTO J, 1989, J INVEST DERMATOL, V92, pS61, DOI 10.1111/1523-1747.ep13075039	49	42	45	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					876	885						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2471408				2022-12-18	WOS:A1989U854900013
J	REY, F; BERTHELON, M; CAILLAUD, C; LYONNET, S; ABADIE, V; BLANDINSAVOJA, F; FEINGOLD, J; SAUDUBRAY, JM; FREZAL, J; MUNNICH, A; REY, J				REY, F; BERTHELON, M; CAILLAUD, C; LYONNET, S; ABADIE, V; BLANDINSAVOJA, F; FEINGOLD, J; SAUDUBRAY, JM; FREZAL, J; MUNNICH, A; REY, J			CLINICAL AND MOLECULAR HETEROGENEITY OF PHENYLALANINE-HYDROXYLASE DEFICIENCIES IN FRANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP NECKER ENFANTS MALAD,DEPT PEDIAT,199 RUE SEVRES,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH GENET MED,F-75743 PARIS 15,FRANCE; CTR INT ENFANCE,INSERM,U155,UNITE RECH GENET EPIDEMIOL,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)			Lyonnet, Stanislas/H-5483-2017	Lyonnet, Stanislas/0000-0001-5426-9417				BARTHOLOME K, 1984, HUM GENET, V65, P405, DOI 10.1007/BF00291569; BARTHOLOME K, 1975, PEDIATR RES, V9, P899, DOI 10.1203/00006450-197509120-00006; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DILELLA AG, 1985, LANCET, V1, P160; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; EFRON ML, 1967, AMINO ACID METABOLIS, P115; FRIEDMAN PA, 1973, P NATL ACAD SCI USA, V70, P552, DOI 10.1073/pnas.70.2.552; GUTTLER F, 1987, J PEDIATR-US, V110, P68, DOI 10.1016/S0022-3476(87)80290-1; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1986, NEW ENGL J MED, V314, P1276, DOI 10.1056/NEJM198605153142002; LICHTNERKONECKI U, 1987, AM J HUM GENET, V30; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LYONNET S, 1988, LANCET, V2, P507; LYONNET S, UNPUB MOL GENETICS P; ORKIN SH, 1984, ANNU REV GENET, V18, P131; REY F, 1979, PEDIATR RES, V13, P21, DOI 10.1203/00006450-197901000-00005; REY F, 1987, ARCH FR PEDIATR, V44, P639; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; WOO SLC, 1986, COLD SPRING HARB SYM, V51, P395, DOI 10.1101/SQB.1986.051.01.047	21	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					914	921						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	2904221				2022-12-18	WOS:A1988R344900012
J	WILLEMS, PJ; DARBY, JK; DICIOCCIO, RA; NAKASHIMA, P; ENG, C; KRETZ, KA; CAVALLISFORZA, LL; SHOOTER, EM; OBRIEN, JS				WILLEMS, PJ; DARBY, JK; DICIOCCIO, RA; NAKASHIMA, P; ENG, C; KRETZ, KA; CAVALLISFORZA, LL; SHOOTER, EM; OBRIEN, JS			IDENTIFICATION OF A MUTATION IN THE STRUCTURAL ALPHA-L-FUCOSIDASE GENE IN FUCOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN DIEGO,CTR MOLEC GENET M 034,DEPT NEUROSCI,LA JOLLA,CA 92093; UNIV INSTELLING ANTWERP,DEPT MED GENET,B-2610 WILRIJK,BELGIUM; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT GENET,BUFFALO,NY 14263; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT NEUROBIOL,BUFFALO,NY 14263; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT GYNECOL ONCOL,BUFFALO,NY 14263; MT SINAI MED CTR,DEPT MED GENET,NEW YORK,NY 10029	University of California System; University of California San Diego; University of Antwerp; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Icahn School of Medicine at Mount Sinai					NICHD NIH HHS [HD 18983] Funding Source: Medline; NIGMS NIH HHS [GM 28428] Funding Source: Medline; NINDS NIH HHS [NS 08682] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALHADEFF JA, 1980, BIOCHEM J, V187, P45, DOI 10.1042/bj1870045; ANDREWSSMITH GL, 1982, BIOCHIM BIOPHYS ACTA, V715, P90, DOI 10.1016/0304-4165(82)90053-8; ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; BERATIS NG, 1977, PEDIATR RES, V11, P862, DOI 10.1203/00006450-197707000-00017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTOMANOU H, 1983, EUR J PEDIATR, V140, P27, DOI 10.1007/BF00661900; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; DARBY JK, 1986, NUCLEIC ACIDS RES, V14, P9543, DOI 10.1093/nar/14.23.9543; DARBY JK, 1988, AM J HUM GENET, V43, P749; DEWET JR, 1984, DNA-J MOLEC CELL BIO, V3, P437, DOI 10.1089/dna.1.1984.3.437; DICIOCCIO RA, 1986, BIOCHEM GENET, V24, P115, DOI 10.1007/BF00502983; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DIMATTEO G, 1976, BIOCHIM BIOPHYS ACTA, V429, P538, DOI 10.1016/0005-2744(76)90301-6; DURAND P, 1969, J PEDIATR, V75, P665, DOI 10.1016/S0022-3476(69)80464-6; DURAND P, 1966, LANCET, V2, P1313; DURAND P, 1982, GENETIC ERRORS GLYCO, P49; FEARON ER, 1985, HUM GENET, V70, P207; FOWLER ML, 1986, CYTOGENET CELL GENET, V43, P103, DOI 10.1159/000132304; FUKUSHIMA H, 1985, P NATL ACAD SCI USA, V82, P1262, DOI 10.1073/pnas.82.4.1262; GATTI R, 1973, LANCET, V2, P1024; JOHNSON K, 1985, BIOCHEM BIOPH RES CO, V133, P90, DOI 10.1016/0006-291X(85)91845-5; KESSLER RM, 1981, AM J NEURORADIOL, V2, P591; KOUSSEFF BG, 1976, PEDIATRICS, V57, P205; KOUSSEFF BG, 1973, LANCET, V2, P1387; LOEB H, 1969, HELV PAEDIATR ACTA, V5, P519; OBRIEN JS, 1987, ENZYME, V38, P45, DOI 10.1159/000469189; PATEL V, 1972, SCIENCE, V176, P426, DOI 10.1126/science.176.4033.426; THORPE R, 1978, CLIN CHIM ACTA, V86, P21, DOI 10.1016/0009-8981(78)90453-9; TROOST J, 1976, CLIN CHIM ACTA, V73, P329, DOI 10.1016/0009-8981(76)90180-7; TURNER BM, 1978, SOMAT CELL GENET, V4, P45, DOI 10.1007/BF01546492; TURNER BM, 1975, NATURE, V27, P391; VANHOOF F, 1968, LANCET, V1, P1198; VANHOOF F, 1973, LYSOSOMES STORAGE DI, P227; WARNER TG, 1983, ANNU REV GENET, V17, P395, DOI 10.1146/annurev.ge.17.120183.002143; WILLEMS PJ, 1988, CLIN GENET, V34, P7	36	42	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					756	763						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903668				2022-12-18	WOS:A1988Q933600024
J	COX, NJ; BELL, GI; XIANG, KS				COX, NJ; BELL, GI; XIANG, KS			LINKAGE DISEQUILIBRIUM IN THE HUMAN INSULIN INSULIN-LIKE GROWTH FACTOR-II REGION OF HUMAN CHROMOSOME-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,DEPT BIOCHEM,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MOLEC BIOL,CHICAGO,IL 60637	University of Chicago; University of Chicago; University of Chicago	COX, NJ (corresponding author), UNIV CHICAGO,HOWARD HUGHES MED INST,920 E 58TH ST,CHICAGO,IL 60637, USA.							BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; FUKUMOTO H, 1988, DIABETES, V37, P657, DOI 10.2337/diabetes.37.5.657; HEDRICK PW, 1987, GENETICS, V117, P331; JOWETT NJ, 1984, BR MED J, V228, P96; LEWONTIN RC, 1964, GENETICS, V49, P49; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; MANDRUPPOULSEN T, 1984, LANCET, V1, P250; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; XIANG K, 1988, NUCLEIC ACIDS RES, V16, P3599, DOI 10.1093/nar/16.8.3599; XIANG K, 1987, NUCLEIC ACIDS RES, V15, P7655, DOI 10.1093/nar/15.18.7655	16	42	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					495	501						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902788				2022-12-18	WOS:A1988Q473600017
J	GERBER, MJ; DRABKIN, HA; FIRNHABER, C; MILLER, YE; SCOGGIN, CH; SMITH, DI				GERBER, MJ; DRABKIN, HA; FIRNHABER, C; MILLER, YE; SCOGGIN, CH; SMITH, DI			REGIONAL LOCALIZATION OF CHROMOSOME-3-SPECIFIC DNA FRAGMENTS BY USING A HYBRID CELL DELETION MAPPING PANEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WAYNE STATE UNIV,DEPT MOLEC BIOL & GENET,DETROIT,MI 48202; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV PULM,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,VET ADM HOSP,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV MED ONCOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,HUMAN GENET SECT,DENVER,CO 80262	Wayne State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	GERBER, MJ (corresponding author), ELEANOR ROOSEVELT INST CANC RES INC,1899 GAYLORD ST,DENVER,CO 80206, USA.				NATIONAL CANCER INSTITUTE [K08CA001017, F32CA007909] Funding Source: NIH RePORTER; NCI NIH HHS [5K08 CA 01017-0, CA 07909-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGER R, 1985, CYTOGENET CELL GENET, V40, P490, DOI 10.1159/000132181; BONNER T, 1984, SCIENCE, V223, P71, DOI 10.1126/science.6691137; CARLOCK LR, 1986, SOMAT CELL MOLEC GEN, V12, P163, DOI 10.1007/BF01560663; CARRITT B, 1986, AM J HUM GENET, V38, P428; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; DONLON TA, 1984, CYTOGENET CELL GENET, V37, P454; DRABKIN H, IN PRESS P NATL ACAD; DRABKIN HA, 1985, P NATL ACAD SCI USA, V82, P6980, DOI 10.1073/pnas.82.20.6980; FALOR WH, 1985, CANCER GENET CYTOGEN, V16, P175, DOI 10.1016/0165-4608(85)90012-3; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIRNHABER C, 1985, American Journal of Human Genetics, V37, pA28; GEMMILL R M, 1986, American Journal of Human Genetics, V39, pA199; GERBER MJ, 1986, CYTOGENET CELL GENET, V42, P72, DOI 10.1159/000132254; GILBERT J D, 1987, American Journal of Human Genetics, V41, pA166; GOLEMBIESKI W, 1987, American Journal of Human Genetics, V41, pA167; GOODE ME, 1986, AM J HUM GENET, V38, P437; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KIDD KK, 1985, CYTOGENET CELL GENET, V40, P107, DOI 10.1159/000132171; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MANIATIS T, 1982, MOL CLONING LABORATO; MARK J, 1980, CANCER GENET CYTOGEN, V2, P231, DOI 10.1016/0165-4608(80)90030-8; MILLER YE, 1983, AM J HUM GENET, V35, P573; MILLER YE, 1985, J CELL BIOCHEM, V9, P29; MORSE HG, 1982, HUM GENET, V61, P141, DOI 10.1007/BF00274204; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; PATHAK S, 1982, SCIENCE, V217, P939, DOI 10.1126/science.7112106; PATTERSON D, 1983, SOMAT CELL GENET, V9, P359, DOI 10.1007/BF01539144; SMEETS DFCM, 1986, HUM GENET, V72, P215, DOI 10.1007/BF00291880; SMITH D, 1985, American Journal of Human Genetics, V37, pA176; SOLOMON E, 1984, NATURE, V309, P111, DOI 10.1038/309111a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VOSS R, 1980, ANN HUM GENET, V44, P1, DOI 10.1111/j.1469-1809.1980.tb00940.x; WANG N, 1984, CANCER GENET CYTOGEN, V11, P479, DOI 10.1016/0165-4608(84)90028-1; WHANGPENG J, 1982, CANCER GENET CYTOGEN, V6, P119, DOI 10.1016/0165-4608(82)90077-2	39	42	45	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					442	451						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902784				2022-12-18	WOS:A1988Q473600011
J	WANG, JH; PALMER, RM; CHUNG, CS				WANG, JH; PALMER, RM; CHUNG, CS			THE ROLE OF MAJOR GENE IN CLUBFOOT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PALMER TRAINER & CLAYTON MDS INC,INDIANAPOLIS,IN		WANG, JH (corresponding author), UNIV HAWAII,DEPT PUBL HLTH SCI,HONOLULU,HI 96822, USA.							BOOK JA, 1948, HEREDITAS, V34, P289; CARTLIDGE I, 1984, J MED GENET, V21, P290, DOI 10.1136/jmg.21.4.290; CARTLIDGE IJ, 1983, NEW ZEAL MED J, V96, P515; CHING GHS, 1969, AM J HUM GENET, V21, P556; CHUNG CS, 1969, HUM HERED, V19, P321, DOI 10.1159/000152236; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; IDELBERGER K, 1939, Z ORTHOP, V69, P1; ISIGKEIT E, 1927, ARCH ORTHOP U UNFALL, V25, P535; Kite J, 1964, CLUBFOOT; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; PALMER RM, 1964, J BONE JOINT SURG AM, V46, P542, DOI 10.2106/00004623-196446030-00008; PALMER RM, 1974, ORTHOP CLIN N AM, V5, P99; Somppi E, 1984, Acta Orthop Scand Suppl, V209, P1; STEWART SF, 1951, J BONE JOINT SURG AM, V33, P557; WYNNE-DAVIES RUTH, 1965, J MED GENET, V2, P227, DOI 10.1136/jmg.2.4.227; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P445, DOI 10.1302/0301-620X.46B3.445; YAMAMOTO H, 1979, JPN J HUM GENET, V24, P37, DOI 10.1007/BF01890110; YANG HY, 1987, GENET EPIDEMIOL, V4, P299, DOI 10.1002/gepi.1370040408	21	42	43	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					772	776						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3358425				2022-12-18	WOS:A1988N143800013
J	COMINGS, DE; COMINGS, BG				COMINGS, DE; COMINGS, BG			A CONTROLLED-STUDY OF TOURETTE SYNDROME .3. PHOBIAS AND PANIC ATTACKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,1500 E DUARTE RD,DUARTE,CA 91010, USA.							Brown F W, 1942, Proc R Soc Med, V35, P785; COHEN ME, 1951, AM J HUM GENET, V3, P126; COMINGS DE, 1987, AM J HUM GENET, V41, P742; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1984, AM J HUM GENET, V36, P586; COMINGS DE, 1987, IN PRESS BR J PSYCHI, V148; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; CROWE RR, 1982, J AFFECT DISORDERS, V4, P121, DOI 10.1016/0165-0327(82)90042-8; DEVOR EJ, 1984, AM J HUM GENET, V36, P704; LIEBOWITZ MR, 1984, ARCH GEN PSYCHIAT, V41, P764; LINET LS, 1985, AM J PSYCHIAT, V142, P613; MCGRATH PJ, 1985, AM J PSYCHIAT, V142, P1224; McInnes R G, 1937, Proc R Soc Med, V30, P895; MIKKELSEN EJ, 1981, AM J PSYCHIAT, V138, P1572; MONTGOMERY MA, 1982, GILLES TOURETTE SYND, P335; NOYES R, 1978, ARCH GEN PSYCHIAT, V35, P1057; PAULS DL, 1980, AM J HUM GENET, V32, P639; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1979, J AFFECT DISORDERS, V1, P287, DOI 10.1016/0165-0327(79)90015-6; PAULS DL, 1979, J AFFECT DISORDERS, V1, P279, DOI 10.1016/0165-0327(79)90014-4; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SLATER E, 1969, STUDIES ANXIETY, P62; TORGERSEN S, 1983, ARCH GEN PSYCHIAT, V40, P1085; 1980, DIAGNOSTIC STATISTIC	25	42	43	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					761	781						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	K9361	3479014				2022-12-18	WOS:A1987K936100003
J	FORD, JH; RUSSELL, JA				FORD, JH; RUSSELL, JA			DIFFERENCES IN THE ERROR MECHANISMS AFFECTING SEX AND AUTOSOMAL CHROMOSOMES IN WOMEN OF DIFFERENT AGES WITHIN THE REPRODUCTIVE AGE GROUP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											FORD, JH (corresponding author), QUEEN ELIZABETH HOSP,DEPT GENET,WOODVILLE,SA 5011,AUSTRALIA.		Ford, Judith/AAG-8609-2019; Ford, Judith Helen/C-1355-2009	Ford, Judith Helen/0000-0001-8978-1744				BROWN T, 1983, MUTAT RES, V122, P403, DOI 10.1016/0165-7992(83)90027-1; COX DM, 1969, CYTOGENETICS, V8, P158, DOI 10.1159/000130032; FITZGERALD P, 1975, HUM GENET, V28, P152; FORD JH, 1984, HUM GENET, V68, P295, DOI 10.1007/BF00292587; FORD JH, 1982, CYTOGENET CELL GENET, V33, P327, DOI 10.1159/000131779; FORD JH, 1984, CYTOBIOS, V39, P81; FORD JH, 1984, HUM GENET, V66, P302, DOI 10.1007/BF00287633; FORD JH, 1983, CYTOGENET CELL GENET, V36, P537, DOI 10.1159/000131969; FORD JH, 1983, CYTOBIOS, V37, P163; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; HECHT F, 1984, CLIN GENET, V26, P43; JACKSON-COOK C K, 1984, American Journal of Human Genetics, V36, p97S; KAISER P, 1984, HUM GENET, V68, P1, DOI 10.1007/BF00293869; NIELSEN J, 1968, BR J PSYCHIATRY, V144, P303; Penrose L.S., 1966, DOWNS ANOMALY; SANDBERG AA, 1967, AM J HUM GENET, V19, P633; SMITH A, 1980, J MENT DEFIC RES, V24, P158; STAESSEN C, 1983, CLIN GENET, V24, P184	18	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					973	983						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	4050792				2022-12-18	WOS:A1985ASD5500015
J	BENN, PA; HSU, LYF				BENN, PA; HSU, LYF			INCIDENCE AND SIGNIFICANCE OF SUPERNUMERARY MARKER CHROMOSOMES IN PRENATAL-DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NYU,SCH MED,DEPT PATHOL,NEW YORK,NY 10003; NYU,SCH MED,DEPT PEDIAT,NEW YORK,NY 10003	New York University; New York University	BENN, PA (corresponding author), PRENATAL DIAG LAB NEW YORK CITY,455 1ST AVE,NEW YORK,NY 10016, USA.							BARASH AH, 1980, S AFR MED J, V58, P485; BARTSCH HD, 1980, HUM GENET, V54, P319, DOI 10.1007/BF00291576; BENN P, 1984, PRENATAL DIAG, V4, P1, DOI 10.1002/pd.1970040102; BERNSTEIN R, 1978, J MED GENET, V15, P136, DOI 10.1136/jmg.15.2.136; CHEN H, 1980, ANN GENET-PARIS, V23, P97; CHUNDLEY AE, 1983, AM J MED GENET, V16, P89; CRANDALL BF, 1980, AM J MED GENET, V5, P345, DOI 10.1002/ajmg.1320050405; DANIEL A, 1982, AM J MED GENET, V11, P61, DOI 10.1002/ajmg.1320110109; DEGUTIERREZ AC, 1975, ANN GENET, V18, P45; FITZGERALD PH, 1980, CLIN GENET, V17, P433; FRYNS JP, 1982, J GENET HUM, V30, P215; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HAASANDELA H, 1981, CLIN GENET, V19, P46; HOOK EB, 1983, AM J HUM GENET, V35, P96; HSU LYF, 1981, AM J MED GENET, V8, P331, DOI 10.1002/ajmg.1320080312; KETTERER D, 1983, AM J HUM GENET, V35, pA100; KOHN G, 1978, AM J MED GENET, V2, P167, DOI 10.1002/ajmg.1320020208; LEDDETCHEVALLIER I, 1983, CLIN GENET, V23, P386; LEE ML, 1978, J GENET HUM, V26, P275; LIEBER E, 1978, CLIN GENET, V14, P130; NERI G, 1980, CLIN GENET, V18, P253; NIELSEN KB, 1978, HUM GENET, V44, P59; PESCIA G, 1980, J GENET HUM, V28, P175; PFEIFFER RA, 1967, ANN GENET-PARIS, V10, P124; ROMAIN DR, 1979, CLIN GENET, V16, P183; SALAMANCA F, 1974, ANN GENET-PARIS, V17, P135; SOUDEK D, 1973, ANN GENET-PARIS, V16, P101; SOUDEK D, 1979, CLIN GENET, V15, P543; SOUDEK D, 1977, CLIN GENET, V12, P285; SQUIRE JA, 1982, HUM GENET, V61, P215, DOI 10.1007/BF00296445; SUTHERLAND GR, 1975, CLIN GENET, V7, P400; UCHIDA LA, 1974, HUMAN CHROMOSOME MET, P47; WALZER S, 1972, AM J HUM GENET, V24, pA38; WARBURTON D, 1983, JUN MARCH DIM BIRTH; Warburton D, 1982, CLIN GENETICS PROBLE, P63; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391; [No title captured]	37	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1092	1102						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6594043				2022-12-18	WOS:A1984TS30200014
J	GO, RCP; LAMIELL, JM; HSIA, YE; YUEN, JWM; PAIK, Y				GO, RCP; LAMIELL, JM; HSIA, YE; YUEN, JWM; PAIK, Y			SEGREGATION AND LINKAGE ANALYSES OF VONHIPPEL LINDAU DISEASE AMONG 220 DESCENDANTS FROM ONE KINDRED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,DEPT PUBL HLTH,CHAPEL HILL,NC 27514; TRIPLER ARMY MED CTR,DEPT MED,HONOLULU,HI 96859; UNIV HAWAII,DEPT GENET,MED GENET SERV,HONOLULU,HI 96826; UNIV HAWAII,DEPT PEDIAT,MED GENET SERV,HONOLULU,HI 96826; ST FRANCIS HOSP,DEPT PATHOL,HONOLULU,HI 96817	University of North Carolina; University of North Carolina Chapel Hill; United States Department of Defense; United States Army; University of Hawaii System; University of Hawaii System								BLIGHT EM, 1980, J UROLOGY, V124, P695, DOI 10.1016/S0022-5347(17)55614-1; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COMINGS DE, 1983, AM J HUM GENET, V35, P134; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; ELSTON RC, 1975, AM J HUM GENET, V27, P31; ELSTON RC, 1978, GENETIC EPIDEMIOLOGY, P223; ERBE RW, 1978, NEW ENGL J MED, V298, P95; FILL WL, 1979, RADIOLOGY, V133, P289, DOI 10.1148/133.2.289; Giblett ER., 1969, GENETIC MARKERS HUMA; GO RCP, 1978, AM J HUM GENET, V30, P28; Harris, 1976, HDB ENZYME ELECTROPH; HOUSMAN D, 1981, GENETIC RES STRATEGI, P17; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; LAMIELL JM, 1978, AM J HUM GENET, V30, pA57; LAMIELL JM, 1980, UROLOGY, V15, P287, DOI 10.1016/0090-4295(80)90448-3; LAMIELL JM, UNPUB VONHIPPEL LIND; LANGE K, 1982, AM J HUM GENET, V34, P842; MARSHALL M, 1978, AM J HUM GENET, V30, pA60; MARSHALL M, 1979, THESIS U HAWAII; MCKUSICK VA, 1982, HUMAN GENE MAP; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; MORTON NE, 1955, AM J HUM GENET, V7, P277; Murphy EA, 1975, PRINCIPLES GENETIC C; PAIK YK, 1974, DHEW NIH75545 PUBL, P81; PEARSON JC, 1980, J UROLOGY, V124, P910, DOI 10.1016/S0022-5347(17)55726-2; RASHAD MN, 1977, GENETICS HUMAN CANCE, P203; SALAZAR FG, 1980, AM J OPHTHALMOL, V89, P540, DOI 10.1016/0002-9394(80)90063-X; SHOKEIR M H K, 1970, Journal of Medical Genetics, V7, P155, DOI 10.1136/jmg.7.2.155; STEVENS DL, 1973, ADV NEUROL, V1, P191; SYBERT VP, 1978, AM J HUM GENET, V30, pA69; WEGMAN TG, 1968, TRANSFUSION, V6, P68	34	42	42	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					131	142						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6582782				2022-12-18	WOS:A1984SC43000012
J	MELNICK, M; MYRIANTHOPOULOS, NC; CHRISTIAN, JC				MELNICK, M; MYRIANTHOPOULOS, NC; CHRISTIAN, JC			EFFECTS OF CHORION TYPE ON VARIATION IN IQ IN NCPP TWIN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,MED CTR,DEPT MED GENET,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis	MELNICK, M (corresponding author), NINCDS,DEV NEUROL BRANCH,BETHESDA,MD 20014, USA.							BULMER MG, 1970, BIOL TWINNIJNG MAN, P33; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1977, ACTA GENET MED GEMEL, V26, P49, DOI 10.1017/S0001566000010187; COREY LA, 1976, AM J HUM GENET, V28, P433; Myrianthopoulos N C, 1975, Birth Defects Orig Artic Ser, V11, P1; MYRIANTHOPOULOS NC, 1971, HUMAN GENETICS, P244; RAUSEN AR, 1965, J PEDIATR-US, V66, P613, DOI 10.1016/S0022-3476(65)80125-1; SCARRSALAPATEK S, 1971, SCIENCE, V174, P1285, DOI 10.1126/science.174.4016.1285; VANDENBERG SG, 1970, ACTA GENET MED GEMEL, V19, P280, DOI 10.1017/S1120962300025695; WECHSLER D, 1952, WECHSLER INTELLIGENC	10	42	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	4					425	433						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP353	568880				2022-12-18	WOS:A1978FP35300010
J	WOLF, B; HSIA, YE; ROSENBERG, LE				WOLF, B; HSIA, YE; ROSENBERG, LE			BIOCHEMICAL DIFFERENCES BETWEEN MUTANT PROPIONYL-COA CARBOXYLASES FROM 2 COMPLEMENTATION GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,DEPT PEDIAT,NEW HAVEN,CT 06520	Yale University; Yale University								BARDEN RE, 1975, P NATL ACAD SCI USA, V72, P4308, DOI 10.1073/pnas.72.11.4308; EDWARDS JB, 1968, BIOCHIM BIOPHYS ACTA, V159, P167, DOI 10.1016/0005-2744(68)90255-6; FLAVIN M, 1957, J BIOL CHEM, V229, P965; GIORGIO AJ, 1967, BIOCHIM BIOPHYS ACTA, V139, P487, DOI 10.1016/0005-2744(67)90052-6; GIORGIO AJ, 1973, BIOCHEM MED METAB B, V7, P473, DOI 10.1016/0006-2944(73)90069-0; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585; HALENZ DR, 1960, J BIOL CHEM, V235, P878; HALENZ DR, 1961, BIOCHIM BIOPHYS ACTA, V48, P426, DOI 10.1016/0006-3002(61)90505-4; HALENZ DR, 1962, J BIOL CHEM, V237, P2140; HECTOR ML, 1976, BIOCHEMISTRY-US, V15, P3465, DOI 10.1021/bi00661a011; HOPKINSON DA, 1976, ANN HUM GENET, V39, P383, DOI 10.1111/j.1469-1809.1976.tb00144.x; HSIA YE, 1971, J CLIN INVEST, V50, P127, DOI 10.1172/JCI106466; HSIA YE, 1973, J PEDIATR-US, V83, P625, DOI 10.1016/S0022-3476(73)80226-4; HSIA YE, PEDIATR RES; KAZIRO Y, 1961, J BIOL CHEM, V236, P1917; LANE MD, 1960, BIOCHEM BIOPH RES CO, V2, P436, DOI 10.1016/0006-291X(60)90144-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNEN F, 1961, BIOCHEM Z, V335, P123; LYNEN F, 1975, ENERGY REGULATION BI, P671; MOSS J, 1971, ADV ENZYMOL RAMB, V35, P321; NEUJAHR HY, 1963, ACTA CHEM SCAND, V17, P1777, DOI 10.3891/acta.chem.scand.17-1777; OBERMAYER M, 1976, TRENDS BIOCHEM SCI, V1, P169, DOI 10.1016/0968-0004(76)90198-5; SCHIELE U, 1975, EUR J BIOCHEM, V60, P259, DOI 10.1111/j.1432-1033.1975.tb20998.x	24	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					455	464						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA288	736038				2022-12-18	WOS:A1978GA28800001
J	GOAD, WB; ROBINSON, A; PUCK, TT				GOAD, WB; ROBINSON, A; PUCK, TT			INCIDENCE OF ANEUPLOIDY IN A HUMAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									LOS ALAMOS SCI LAB,LOS ALAMOS,NM 87544; NATL JEWISH HOSP & RES CTR,DENVER,CO; UNIV COLORADO,MED CTR,ELEANOR ROOSEVELT INST CANC RES,DENVER,CO	United States Department of Energy (DOE); Los Alamos National Laboratory; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								Carter C, 1951, BR J SOC MED, V5, P83; GREENSHER A, 1971, J PEDIATR-US, V79, P305, DOI 10.1016/S0022-3476(71)80121-X; MANTEL N, 1961, B INT STAT I, V38, P227; ROBINSON A, 1969, AM J HUM GENET, V21, P466; ROBINSON A, 1967, AM J HUM GENET, V19, P112	5	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					62	68						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	1247021				2022-12-18	WOS:A1976BC88800008
J	GOLDSTEIN, JL; ALBERS, JJ; SCHROTT, HG; HAZZARD, WR; BIERMAN, EL; MOTULSKY, AG				GOLDSTEIN, JL; ALBERS, JJ; SCHROTT, HG; HAZZARD, WR; BIERMAN, EL; MOTULSKY, AG			PLASMA LIPID-LEVELS AND CORONARY HEART-DISEASE IN ADULT RELATIVES OF NEWBORNS WITH NORMAL AND ELEVATED CORD BLOOD LIPIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT MED,NW LIPID RES CLIN,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,DIV METAB & GERONTOL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; VET ADM HOSP,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle								BRODY S, 1962, CLIN CHIM ACTA, V7, P694, DOI 10.1016/0009-8981(62)90152-3; CARLSON LA, 1972, LANCET, V1, P865; DARMADY JM, 1972, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5815.685; EPSTEIN F H, 1971, Progress in Cardiovascular Diseases, V13, P324, DOI 10.1016/S0033-0620(71)80010-5; Glueck C J, 1972, Trans Assoc Am Physicians, V85, P139; GLUECK CJ, 1971, METABOLISM, V20, P597, DOI 10.1016/0026-0495(71)90008-4; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KAPLAN A, 1965, CLIN CHIM ACTA, V12, P258, DOI 10.1016/0009-8981(65)90044-6; Kessler G., 1966, AUTOMATION ANALYTICA, P341; KWITEROVICH PO, 1973, LANCET, V1, P118; TSANG R, 1974, AM J DIS CHILD, V127, P78, DOI 10.1001/archpedi.1974.02110200080011; 1965, AUTOANALYZER MANUAL; 1972, REFERENCE MANUAL LIP, V2	15	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					727	735						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4440681				2022-12-18	WOS:A1974V091100008
J	CHASE, GA; MCKUSICK, VA				CHASE, GA; MCKUSICK, VA			CONTROVERSY IN HUMAN GENETICS - FOUNDER EFFECT IN TAY-SACHS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; ELDRIDGE K, 1970, NEUROLOGY MINNEAP, V20, P1; Haldane JBS, 1939, ANN EUGENIC, V9, P232, DOI 10.1111/j.1469-1809.1939.tb02210.x; LIVINGSTONE FB, 1969, AM J PHYS ANTHROPOL, V30, P55, DOI 10.1002/ajpa.1330300107; McKusick V A, 1966, Ala J Med Sci, V3, P408; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; MCKUSICK VA, 1967, J CHRON DIS, V20, P115, DOI 10.1016/0021-9681(67)90045-8; MYRIANTHOPOULOS NC, 1970, NATURE, V227, P609, DOI 10.1038/227609a0; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; SHAW RF, 1969, NATURE, V224, P1214, DOI 10.1038/2241214b0	10	42	43	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					339	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028971				2022-12-18	WOS:A1972M694800014
J	CHEN, SH; FOSSUM, BLG; GIBLETT, ER				CHEN, SH; FOSSUM, BLG; GIBLETT, ER			GENETIC-VARIATION OF SOLUBLE FORM OF NADP-DEPENDENT ISOCITRIC DEHYDROGENASE IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BELL JL, 1964, BIOCHEM J, V90, pP8; CHEN SH, 1971, AM J HUM GENET, V23, P87; CHEN SH, 1971, AM J HUM GENET, V23, P419; DAVIDSON RG, 1970, SCIENCE, V169, P391, DOI 10.1126/science.169.3943.391; DAVIDSON RG, 1967, NATURE, V215, P761, DOI 10.1038/215761a0; DAVIDSON RG, 1967, SCIENCE, V157, P1569, DOI 10.1126/science.157.3796.1569; FOX DJ, 1971, BIOCHEM GENET, V5, P69, DOI 10.1007/BF00485732; HENDERSON NS, 1968, ANN NY ACAD SCI, V151, P429, DOI 10.1111/j.1749-6632.1968.tb11906.x; HENDERSON NS, 1965, J EXP ZOOL, V158, P263, DOI 10.1002/jez.1401580303; LOWENSTEIN JM, 1961, J BIOL CHEM, V235, P1217; OPHER AW, 1969, EXP MED SURG, V27, P256; Plaut G.E.W., 1963, ENZYMES, V7, P105; PLAUT GWE, 1962, METHOD ENZYMOL, V5, P645, DOI 10.1016/S0076-6879(62)05290-8; QUIROZGUTIERREZ A, 1970, BIOCHEM GENET, V4, P93, DOI 10.1007/BF00484021; TAIT A, 1970, BIOCHEM GENET, V4, P461, DOI 10.1007/BF00486596; TAIT A, 1970, NATURE, V225, P181, DOI 10.1038/225181a0	16	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					325	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	4112899				2022-12-18	WOS:A1972M694800012
J	COHEN, BH				COHEN, BH			ABO AND RH INCOMPATIBILITY .1. FETAL AND NEONATAL MORTALITY WITH ABO AND RH INCOMPATIBILITY - SOME NEW INTERPRETATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEHRMAN SJ, 1960, AM J OBSTET GYNECOL, V79, P847, DOI 10.1016/0002-9378(60)90677-3; BRYCE LM, 1950, ANN EUGENIC, V15, P271; CHUNG CS, 1961, AM J HUM GENET, V13, P9; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COHEN BH, 1968, AM J HUM GENET, V20, P310; COHEN BH, 1960, AM J HUM GENET, V12, P180; COHEN BH, 1970, AM J HUM GENET, V22, P441; GLASS B, 1949, AM J OBSTET GYNECOL, V57, P323; HAGA H, 1959, JPN J HUM GENET, V4, P1; Halbrecht I, 1944, AM J DIS CHILD, V68, P248; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HIRAIZUM.Y, 1964, COLD SPRING HARB SYM, V29, P51, DOI 10.1101/SQB.1964.029.01.010; JAKOBOWICZ R, 1968, VOX SANG, V14, P357, DOI 10.1111/j.1423-0410.1968.tb01725.x; Kirk RL, 1955, BRIT J PREV SOC MED, V9, P104; Kirk RL, 1953, BRIT J PREV SOC MED, V7, P1; LEVENE HOWARD, 1961, PROGR MED GENET, V1, P120; MATSUNAGA E, 1955, AM J HUM GENET, V7, P66; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MATSUNAGA E, 1956, Blut, V2, P188, DOI 10.1007/BF01630045; NEWCOMBE HB, 1963, AM J HUM GENET, V15, P449; OVERSTREET EW, 1947, AM J OBSTET GYNECOL, V54, P235; PERITZ E, 1967, ANN HUM GENET, V30, P259, DOI 10.1111/j.1469-1809.1967.tb00026.x; RACE RR, 1962, BLOOD GROUPS MAN; REED TE, 1967, AM J HUM GENET, V19, P732; REED TE, 1964, AM J HUM GENET, V16, P161; REED TE, 1968, AM J HUM GENET, V20, P129; REED TE, 1957, ANN HUM GENET, V22, P165, DOI 10.1111/j.1469-1809.1957.tb01932.x; REED TE, 1959, NATURE, V184, P611, DOI 10.1038/184611a0; REED TE, 1968, AM J HUM GENET, V20, P119; REED TE, 1967, P WORLD POPULATION C, V2, P498; SEVER LE, 1969, AM J PHYS ANTHROPOL, V31, P177, DOI 10.1002/ajpa.1330310206; SOLISH GI, 1969, AM J HUM GENET, V21, P23; SOLISH GI, 1969, J REPROD FERTIL, V18, P459; SZULMAN AE, 1966, ANNU REV MED, V17, P307, DOI 10.1146/annurev.me.17.020166.001515; SZULMAN AE, 1966, 3 INT C HUM GEN, P97; SZULMAN AE, UNPUBLISHED ABSTRACT; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; YERUSHALMY J, 1964, AM J OBSTET GYNECOL, V88, P505	38	42	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					412	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	4988275				2022-12-18	WOS:A1970H022700007
J	KIRK, RL; KINNS, H; MORTON, NE				KIRK, RL; KINNS, H; MORTON, NE			INTERACTION BETWEEN ABO BLOOD GROUP AND HAPTOGLOBIN SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BECKMAN L, 1964, ACTA GENET STAT MED, V14, P159; KIRK RL, 1968, 4 MON HUM GEN; MORTON NE, 1966, AM J HUM GENET, V18, P153; MORTON NE, 1964, COLD SPRING HARBOR S, V24, P69; RITTER H, 1966, HUMANGENETIK, V2, P21, DOI 10.1007/BF00285905	5	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					384	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	5464585				2022-12-18	WOS:A1970H022700004
J	REYS, L; MANSO, C; STAMATOYANNOPOULOS, G				REYS, L; MANSO, C; STAMATOYANNOPOULOS, G			GENETIC STUDIES ON SOUTHEASTERN BANTU OF MOZAMBIQUE .1. VARIANTS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; ALLISON AC, 1961, BRIT MED J, V1, P1346, DOI 10.1136/bmj.1.5236.1346; [Anonymous], 1967, B WHO, V36, P319; BALINSKY D, 1966, S AFR J MED SCI, V31, P124; BERNSTEIN RALPH E., 1963, S AFRICAN MED JOUR, V37, P447; BERNSTEIN RE, 1966, 3 INT C HUM GEN CHIC, P7; CHARLTON RW, 1961, BMJ-BRIT MED J, V1, P941, DOI 10.1136/bmj.1.5230.941; Gordon H, 1966, S Afr Med J, V40, P1031; JENKINS T, 1968, AM J HUM GENET, V20, P299; KIRKMAN HN, 1964, J LAB CLIN MED, V63, P715; KIRKMAN HN, 1964, J LAB CLIN MED, V63, P726; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; KNIGHT RH, 1965, T ROY SOC TROP MED H, V59, P46; LUTTRELL V, 1965, East Afr Med J, V42, P313; LUZZATTO L, 1968, J CLIN INVEST, V47, P1833, DOI 10.1172/JCI105873; MANSO C, 1966, THESIS U LISBON; MATHAI CK, 1966, NATURE, V210, P115, DOI 10.1038/210115a0; Motulsky A.G., 1969, BIOCH METHODS RED CE, P51; MOTULSKY AG, 1964, AM J TROP MED HYG, V13, P147, DOI 10.4269/ajtmh.1964.13.147; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; MURDOCK GP, 1959, AFRICA ITS PEOPLES T, P374; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; PORTER IH, 1964, LANCET, V1, P895; RATTAZZI M. C., 1967, ATTT ASS GENET ITAL, V12, P158; RATTAZZI MC, 1969, AM J HUM GENET, V21, P154; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; REYS LESSEPS, 1965, REV ESTUD GERALS UNIV MOCAMBIQUE SER HI CIENCI MED, V2, P3; ROBERTSON D, 1961, ANN TROP MED PARASIT, V55, P49, DOI 10.1080/00034983.1961.11686018; SALDANHA P H, 1969, Journal of Medical Genetics, V6, P48, DOI 10.1136/jmg.6.1.48; SANTOSDAVID JH, 1965, ARQ ANAT ANTROPOLOGI, V33, P141; SIMOESALBERTO M, 1962, MEM I INVEST CIENT M, V4, P1; SMINK DA, 1965, TROP GEOGR MED, V17, P236; VELEZGRILO VH, 1960, B I INVEST CIENT MOC, V1, P126; YOSHIDA A, 1967, SCIENCE, V155, P97, DOI 10.1126/science.155.3758.97	35	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	2					203	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F9213	5435642				2022-12-18	WOS:A1970F921300008
J	WEITKAMP, L; NEEL, JV				WEITKAMP, L; NEEL, JV			GENE FREQUENCIES AND MICRODIFFERENTIATION AMONG MAKIRITARE INDIANS .3. 9 ERYTHROCYTE ENZYME SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1970, AM J HUM GENET, V22, P526; ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; ARENDS T, 1970, BLOOD, V33, P414; BOWMAN JE, 1967, NATURE, V214, P1156, DOI 10.1038/2141156a0; BOWMAN JE, 1966, NATURE, V210, P811, DOI 10.1038/210811a0; BREWER GJ, 1967, AM J HUM GENET, V19, P674; DERN RJ, 1966, J LAB CLIN MED, V67, P255; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; LISKER R, 1967, AM J HUM GENET, V19, P174; RAPLEY S, 1967, ANN HUM GENET, V31, P237; SHOWS TB, 1964, SCIENCE, V145, P1056, DOI 10.1126/science.145.3636.1056; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; WEITKAMP LR, 1969, AM J HUM GENET, V21, P600; WRIGHT S, 1966, P NATL ACAD SCI USA, V55, P1074, DOI 10.1073/pnas.55.5.1074	17	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					533	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H6097	5516236				2022-12-18	WOS:A1970H609700005
J	WIENER, AS				WIENER, AS			BLOOD GROUPS AND DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDRESEN E, 1966, SCIENCE, V153, P1660, DOI 10.1126/science.153.3744.1660; ARFORS KE, 1963, ACTA GENET STAT MED, V13, P366; BECKMAN L, 1968, Series Haematologica, V1, P137; BILLINGTON B, 1956, LANCET, V271, P1308; BILLINGTON BP, 1956, LANCET, V271, P859; BOURDEL L, 1960, GROUPES SANGUINS TEM; BUCKWALTER JA, 1962, JAMA-J AM MED ASSOC, V179, P479, DOI 10.1001/jama.1962.03050070001001; CHAKRAV.MR, 1967, HUMANGENETIK, V5, P1, DOI 10.1007/BF00286207; COHEN BH, 1962, B JOHNS HOPKINS HOSP, V110, P1; EVANS D A P, 1968, Journal of Medical Genetics, V5, P310, DOI 10.1136/jmg.5.4.310; GRAUBARD D J, 1954, J Int Coll Surg, V21, P15; GRUBB R, 1948, NATURE, V162, P933, DOI 10.1038/162933a0; HARTMANN O, 1964, LANCET, V1, P1305; HIGGINS ITT, 1963, BRIT MED J, P1167, DOI 10.1136/bmj.2.5366.1167; KAKLAMANIS E, 1964, LANCET, V1, P788; KAUF PK, 1969, J MEMBRANE BIOL, V1, P177; Levine P, 1941, AM J OBSTET GYNECOL, V42, P925, DOI 10.1016/S0002-9378(41)90260-0; MCCONNELL RB, 1966, GENETICS GASTROINTES; MCINTYRE PA, 1959, B JOHNS HOPKINS HOSP, V104, P309; MUSCHEL LH, 1966, BACTERIOL REV, V30, P427, DOI 10.1128/MMBR.30.2.427-441.1966; PROKOP O, 1969, HUMAN BLOOD SERUM GR; RACE RR, 1962, BLOOD GROUPS MAN; RASMUSEN BA, 1966, SCIENCE, V151, P1551, DOI 10.1126/science.151.3717.1551; SHREFFLER DC, 1965, AM J HUM GENET, V17, P71; SPRINGER GF, 1962, NATURE, V193, P444, DOI 10.1038/193444a0; SPRINGER GF, 1966, ANGEW CHEM INT EDIT, V5, P809; VOGEL F, 1964, 10 P C INT SOC BLOOD, P268; WIENER A S, 1960, J Forensic Med, V7, P166; WIENER AS, 1962, LANCET, V1, P813; WIENER AS, 1956, LANCET, V271, P1308; WIENER AS, 1963, RH HR SYLLABUS; WIENER AS, 1954, RH HR BLOOD TYPES; WIENER AS, 1965, ADVANCES BLOOD GROUP, V2; WIENER AS, 1943, BLOOD GROUPS TRANSFU; WIENER AS, 1961, ADVANCES BLOOD GROUP, V1	35	42	43	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					476	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	4988277				2022-12-18	WOS:A1970H022700012
J	YASUDA, N				YASUDA, N			AN EXTENSION OF WAHLUNDS PRINCIPLE TO EVALUATE MATING TYPE FREQUENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARRAI I, 1962, ANN HUM GENET, V25, P347, DOI 10.1111/j.1469-1809.1962.tb01772.x; BERNSTEIN F, 1930, Z INDUKT ABSTAMM VER, V56, P223; CAVALLISFORZA LL, 1966, GENETICS, V45, P37; CAVALLISFORZA LL, 1962, DEPLACEMENTS HUMAINS, P139; CAVALLISFORZA LL, 1958, 10 P INT C GEN MONTR, V1, P389; Cramer Harald, 1946, MATH METHODS STAT, DOI [10.1515/9781400883868, DOI 10.1515/9781400883868]; CROW JF, 1966, 3 INT C HUM GEN J ED, P98; HAJNAL J, 1963, PROC R SOC SER B-BIO, V159, P125, DOI 10.1098/rspb.1963.0071; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; HOLGATE P, 1964, HEREDITY, V19, P507, DOI 10.1038/hdy.1964.58; KIMURA M, 1964, GENETICS, V49, P561; Mal?cot, 1955, COLD SPRING HARB SYM, V20, P52; MALECOT G, 1948, MATHEMATIQUE HEREDIT; MALECOT G, 1950, ANN U LYON SCIENCE A, V13, P37; MOOD AM, 1963, INTRODUCTION THEORY; MOORJANKOWSKI JK, 1957, ACTA GENET STAT MED, V6, P527; MORONI A, 1962, UNWHO SEM US VIT HEA; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; NEEL JV, 1965, GENETICS EPIDEMIO ED, P45; SANGHVI LD, 1955, AM NAT, V89, P247, DOI 10.1086/281889; SCHULL WJ, 1965, GENETICS EPIDEMIOLOG, P45; SUTTER J, 1962, DEPLACEMENTS HUMAINS, P139; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1921, GENETICS, V6, P111; WRIGHT S, 1945, P NATL ACAD SCI USA, V31, P382, DOI 10.1073/pnas.31.12.382; Wright S, 1943, GENETICS, V28, P114; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414; YASUDA N, 1966, THESIS U HAWAII; YASUDA N, 1967, GENETICAL STRUCTURE; YASUDA N, 1966, 3 INT C HUM GEN JOHN, P98; YASUDA N, 1967, ESTIMATION INBREEDIN	34	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5889	5635670				2022-12-18	WOS:A1968A588900001
J	CHOWN, B; LEWIS, M; KAITA, H				CHOWN, B; LEWIS, M; KAITA, H			DUFFY BLOOD GROUP SYSTEM IN CAUCASIANS - EVIDENCE FOR A NEW ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN F H Jr, 1957, Vox Sang, V2, P81; CHOWN B, 1963, AM J HUM GENET, V15, P322; CHOWN B, 1962, AM J HUM GENET, V14, P301; GOLDSCHMIDT E, 1963, GENETICS MIGRANT  ED, P69; GOLDSCHMIDT E, 1963, GENETICS MIGRANT ISO, P253; MOURANT AE, 1954, DISTRIBUTION HUMAN B, P100; MOURANT AE, 1963, GENETICS MIGRANT ISO, P253; MOURANT AE, 1954, DISTRIBUTION HUMAN B, P70; MOURANT AE, 1954, DISTRIBUTION HUMAN B, P74; RACE RR, 1962, BLOOD GROUPS MAN; SZEINBERG A, 1963, GENETICS MIGRANT ISO, P69	11	42	44	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	5					384	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	67851	14334737				2022-12-18	WOS:A19656785100002
J	OSBORNE, RH; DEGEORGE, FV				OSBORNE, RH; DEGEORGE, FV			ABO BLOOD GROUPS IN NEOPLASTIC DISEASE OF OVARY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Osborne, Richard H/A-9447-2010	Osborne, Richard H/0000-0002-9081-2699				AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; ANDERSON WAD, 1948, PATHOLOGY; CAMERON JM, 1958, LANCET, V1, P238; CLARKE CA, 1959, J MED EDUC, V34, P400; CORSCADEN JA, 1956, GYNECOLOGIC CANCER; EVANS WR, 1956, HISTOLOGIC APPEARANC; FRAZELL EL, 1954, CANCER, V7, P637, DOI 10.1002/1097-0142(195407)7:4<637::AID-CNCR2820070403>3.0.CO;2-#; HAM AW, 1961, HISTOLOGY; HELMBOLD VW, 1961, ACTA GENET, V11, P29; MATSUNAGA E, 1959, J MED EDUC, V34, P405; OSBORNE RH, 1962, AM J HUM GENET, V14, P199; ROBERTS J A F, 1957, Br J Prev Soc Med, V11, P107; ROBERTS JAF, 1959, BRIT MED BULL, V15, P129, DOI 10.1093/oxfordjournals.bmb.a069736; STEWART FW, 1945, ANN SURG, V122, P820, DOI 10.1097/00000658-194511000-00005; WILLIS RA, 1958, EMBRYOLOGY PATHOLOGY; WILLIS RA, 1960, PATHOLOGY TUMOURS; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	17	42	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					380	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097232				2022-12-18	WOS:A19632968A00011
J	KROOTH, RS; HILBISH, TF; MACKLIN, MT				KROOTH, RS; HILBISH, TF; MACKLIN, MT			DIAPHYSIAL ACLASIS (MULTIPLE EXOTOSES) ON GUAM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BELL J, 1922, TREASURY HUMAN INHER, V2, P112; BEST F, 1934, KLIN MONATSBL AUGENH, V93, P209; FALLS HF, 1951, AMA ARCH OPHTHALMOL, V46, P367; HAMRE CJ, 1958, ARCH PATHOL, V65, P215; HARRIS H, 1948, ANN EUGENIC, V14, P166; HIRANO A, 1961, BRAIN; Jaffe HL, 1943, ARCH PATHOL, V36, P335; KURLAND LT, 1954, NEUROLOGY, V4, P438, DOI 10.1212/WNL.4.6.438; KURLAND LT, 1954, NEUROLOGY, V4, P355, DOI 10.1212/WNL.4.5.355; LORINCZ AE, 1961, PROC NY ACAD SCI; McKusick V.A., 1956, HERITABLE DISORDERS; PENTSCHEW A, 1958, HDB SPEZIELLEN PAT 2, V13, P2341; PONSETI IV, 1954, J BONE JOINT SURG AM, V36-A, P1031, DOI 10.2106/00004623-195436050-00012; PRICE CHG, 1958, J BONE JOINT SURG BR, V40, P574, DOI 10.1302/0301-620X.40B3.574; SCHILLING ED, 1954, J AM CHEM SOC, V76, P2848, DOI 10.1021/ja01639a084; STOCKS P, 1925, TREASURY HUMAN INHER, V3; TODD JN, 1959, AM J MED, V27, P327, DOI 10.1016/0002-9343(59)90415-2; TODD JN, 1961, AM J MED, V30, P289, DOI 10.1016/0002-9343(61)90100-0; WAITZ R, 1946, PRESSE MED, V54, P322; WAWZONEK S, 1955, SCIENCE, V121, P63, DOI 10.1126/science.121.3133.63; Weller CV, 1941, CANCER RES, V1, P517; YEAGER VL, 1957, ARCH PATHOL, V64, P171	22	42	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	3					340	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2961A	13754517				2022-12-18	WOS:A19612961A00002
J	NEEL, JV; SUTTON, HE; ROBINSON, AR; ZUELZER, WW; LIVINGSTONE, FB				NEEL, JV; SUTTON, HE; ROBINSON, AR; ZUELZER, WW; LIVINGSTONE, FB			FREQUENCY OF ELEVATIONS IN A2 AND FETAL HEMOGLOBIN FRACTIONS IN NATIVES OF LIBERIA AND ADJACENT REGIONS, WITH DATA ON HAPTOGLOBIN AND TRANSFERRIN TYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON A. C., 1960, ACTA GENET ET STATIST MED, V10, P17; ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; BARNICOT NA, 1960, ANN HUM GENET, V24, P171; Ceppellini R., 1955, COLD SPRING HARB SYM, V20, P252; CEPPELLINI R, 1959, BIOCHEMISTRY HUMAN G, P133; COHEN F, 1959, BLOOD, V14, P816, DOI 10.1182/blood.V14.7.816.816; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; EDINGTON GM, 1955, BRIT MED J, V2, P1328, DOI 10.1136/bmj.2.4951.1328; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; FOY H, 1951, East Afr Med J, V28, P1; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P248; GERALD PS, 1958, BLOOD, V13, P61, DOI 10.1182/blood.V13.1.61.61; GIBLETT ER, 1959, NATURE, V183, P1589, DOI 10.1038/1831589a0; GIBLETT ER, 1959, NATURE, V183, P192, DOI 10.1038/183192a0; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; Haldane J.B.S., 1949, HEREDITAS, V35, P267; HARRIS H, 1958, NATURE, V182, P452, DOI 10.1038/182452a0; HARRIS H, 1958, NATURE, V182, P1324, DOI 10.1038/1821324b0; HERMAN EC, 1960, AM J MED, V29, P9, DOI 10.1016/0002-9343(60)90003-6; ITANO HA, 1953, ARCH BIOCHEM BIOPHYS, V47, P148, DOI 10.1016/0003-9861(53)90444-5; ITANO HA, 1951, P NATL ACAD SCI USA, V37, P775, DOI 10.1073/pnas.37.12.775; JACOB GF, 1958, BRIT J HAEMATOL, V4, P138, DOI 10.1111/j.1365-2141.1958.tb03844.x; KUNKEL HG, 1955, SCIENCE, V122, P288, DOI 10.1126/science.122.3163.288; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; LAMBOTTE-LEGRAND J, 1955, Ann Soc Belg Med Trop (1920), V35, P53; LAMBOTTELEGRAND J, 1951, MEM INST ROY COL BEL, V19, P93; LIVINGSTONE FB, 1958, AM J HUM GENET, V10, P33; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P1, DOI 10.1002/ajpa.1330180102; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P161, DOI 10.1002/ajpa.1330180302; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; LIVINGSTONE FRANK B., 1960, HUMAN BIOL, V32, P197; MOTULSKY A, 1960, FIRST MACY CONF GENE, P155; MURDOCK GP, 1959, AFRICA PEOPLES CULTU, P13; MURDOCK GP, 1959, AFRICA PEOPLES CULTU, P456; NEEL JV, 1956, AM J HUM GENET, V8, P138; NEEL JV, 1958, PROC 6 INT CON IN SO, P665; NYMAN M, 1958, CLIN CHIM ACTA, V3, P111, DOI 10.1016/0009-8981(58)90067-6; OLESEN EB, 1959, BMJ-BRIT MED J, V1, P1385, DOI 10.1136/bmj.1.5134.1385; SANSARRICQ H, 1959, Sangre (Barc), V30, P503; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITHIES O, 1959, BIOCHEM J, V72, P121, DOI 10.1042/bj0720121; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; SMITHIES O, 1958, GENETICS, V43, P374; SUTTON H E, 1959, Ann Hum Genet, V23, P175; VALENTINE WN, 1948, AM J MED SCI, V215, P456, DOI 10.1097/00000441-194804000-00016; VANDEPITTE J, 1954, Ann Soc Belg Med Trop (1920), V34, P501; VANDEPITTE J, 1959, ABNORMAL HAEMOGLOBIN, P271; WENT LN, 1958, BLOOD, V13, P559, DOI 10.1182/blood.V13.6.559.559	48	42	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	2					262	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2960A	13728115				2022-12-18	WOS:A19612960A00004
J	ROSENFIELD, RE; HABER, GV; SCHROEDER, R; BALLARD, R				ROSENFIELD, RE; HABER, GV; SCHROEDER, R; BALLARD, R			PROBLEMS IN RH TYPING AS REVEALED BY A SINGLE NEGRO FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN, 1958, VOX SANG, V3, P321; CEPPELLINI R, 1955, P NATL ACAD SCI USA, V41, P283, DOI 10.1073/pnas.41.5.283; CHOWN B, 1957, ANN HUM GENET, V22, P58, DOI 10.1111/j.1469-1809.1957.tb01300.x; DENATALE A, 1955, JAMA-J AM MED ASSOC, V159, P247; GIBLETT ER, 1957, J LAB CLIN MED, V49, P433; LAWLER SD, 1950, P INTERN SOC HEMAT, P168; LEVINE P, 1957, PH ANDERSEN FESTSKRI, P144; MCGEE R, 1957, SCIENCE, V125, P1043, DOI 10.1126/science.125.3256.1043; Mourant A., 1954, DISTRIBUTION HUMAN B; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; Race Robert Russell, 1958, BLOOD GROUPS MAN; RACE RR, 1954, NATURE, V174, P460; ROSENFIELD RE, 1953, BRIT MED J, V1, P975, DOI 10.1136/bmj.1.4817.975; ROSENFIELD RE, 1958, AM J HUM GENET, V10, P474; ROSENFIELD RE, 1960, AM J HUM GENET, V12, P143; ROSENFIELD RE, UNPUB; ROSENFIELD RE, 1958, 7 P C INT SOC BLOOD, P557; SANGER R, 1953, P NATL ACAD SCI USA, V39, P824, DOI 10.1073/pnas.39.8.824; STURGEON P, 1958, 7 P C INT SOC BLOOD, P293; UNGER LJ, 1942, P SOC EXP BIOL, V70, P629; WIENER AS, 1952, AM J HUM GENET, V4, P363; WIENER AS, 1959, COMMUNICATION; WIENER AS, 1958, HEREDITY BLOOD GROUP	23	42	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	2					147	159						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF078	14439006				2022-12-18	WOS:A1960WF07800002
J	RIFE, DC				RIFE, DC			POPULATIONS OF HYBRID ORIGIN AS SOURCE MATERIAL FOR THE DETECTION OF LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DAVENPORT CB, 1913, CARNEGIE I PUB, V188; Fisher R. A., 1947, AM SCI, V35, P113; FISHER RA, 1947, AM SCIENTIST, V35, P92; Haldane JBS, 1926, P CAMB PHILOS SOC, V23, P363, DOI DOI 10.1017/S0305004100015176; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; LEE B. F., 1934, OHIO JOUR SCI, V34, P337; Li C.C., 1948, INTRO POPULATION GEN; Parr LW, 1934, J HERED, V25, P187, DOI 10.1093/oxfordjournals.jhered.a103914; PONS J, 1952, TRABAJOS I BERNARDIN, V13, P7; RIFE CD, 1953, AM J HUM GENETICS, V5, P389; RIFE DAVID C., 1948, OHIO JOUR SCI, V48, P116; Rife DC, 1943, GENETICS, V28, P41; RIFE DC, 1953, AM J PHYS ANTHROP; Robbins RB, 1918, GENETICS, V3, P375; WIENER AS, 1946, ANN NEW YORK ACADEMY, V46, P883	15	42	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	1					26	33						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB732	13138567				2022-12-18	WOS:A1954YB73200004
J	Stark, Z; Boughtwood, T; Phillips, P; Christodoulou, J; Hansen, DP; Braithwaite, J; Newson, AJ; Gaff, CL; Sinclair, AH; North, KN				Stark, Zornitza; Boughtwood, Tiffany; Phillips, Peta; Christodoulou, John; Hansen, David P.; Braithwaite, Jeffrey; Newson, Ainsley J.; Gaff, Clara L.; Sinclair, Andrew H.; North, Kathryn N.			Australian Genomics: A Federated Model for Integrating Genomics into Healthcare	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COST-EFFECTIVENESS	Australian Genomics is a national collaborative research partnership of more than 80 organizations piloting a whole-of-system approach to integrating genomics into healthcare that is based on federation principles. The aim of Australian Genomics is to assess the application of genomic testing in healthcare at the translational interface between research and clinical delivery, with an emphasis on robust evaluation of outcomes. It encompasses two bodies of work: a research program prospectively providing genomic testing through exemplar clinical projects in rare diseases, cancers, and reproductive carrier screening and interdependent programs for advancing the diagnostic, health informatics, regulatory, ethical, policy, and workforce infrastructure necessary for the integration of genomics into the Australian health system.	[Stark, Zornitza; Boughtwood, Tiffany; Phillips, Peta; Christodoulou, John; Hansen, David P.; Braithwaite, Jeffrey; Newson, Ainsley J.; Gaff, Clara L.; Sinclair, Andrew H.; North, Kathryn N.] Australian Genom Hlth Alliance, Melbourne, Vic 3052, Australia; [Stark, Zornitza; Boughtwood, Tiffany; Phillips, Peta; Christodoulou, John; Sinclair, Andrew H.; North, Kathryn N.] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Stark, Zornitza; Christodoulou, John; Gaff, Clara L.; Sinclair, Andrew H.; North, Kathryn N.] Univ Melbourne, Melbourne, Vic 3052, Australia; [Hansen, David P.] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [Braithwaite, Jeffrey] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW 2109, Australia; [Newson, Ainsley J.] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney Hlth Eth, Sydney, NSW 2006, Australia; [Gaff, Clara L.] Melbourne Genom Hlth Alliance, Melbourne, Vic 3052, Australia; [Gaff, Clara L.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Royal Brisbane & Women's Hospital; Macquarie University; University of Sydney; Walter & Eliza Hall Institute	North, KN (corresponding author), Australian Genom Hlth Alliance, Melbourne, Vic 3052, Australia.; North, KN (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.; North, KN (corresponding author), Univ Melbourne, Melbourne, Vic 3052, Australia.	kathryn.north@mcri.edu.au	Sinclair, Andrew H/A-3598-2010; North, Kathryn N/K-6476-2012; Gaff, Clara/ABD-5691-2021; Newson, Ainsley/AAQ-9177-2021; Braithwaite, Jeffrey/AAN-1467-2020	Sinclair, Andrew H/0000-0003-2741-7992; North, Kathryn N/0000-0003-0841-8009; Newson, Ainsley/0000-0002-3460-772X; Braithwaite, Jeffrey/0000-0003-0296-4957; Boughtwood, Tiffany/0000-0002-9634-3731; Gaff, Clara/0000-0003-0160-4159	National Health and Medical Research Council (NHMRC) [GNT1113531]; Genomics Health Futures Mission, Australian government's Medical Research Futures Fund; Victorian government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Genomics Health Futures Mission, Australian government's Medical Research Futures Fund(Medical Research Future Fund (MRFF)); Victorian government's Operational Infrastructure Support Program	The Australian Genomics Health Alliance (Australian Genomics) project is funded by a National Health and Medical Research Council (NHMRC) Targeted Call for Research grant (GNT1113531). Mackenzie's Mission and the Australian Genomics Cardiovascular Genetics Disorders flagship are funded by the Genomics Health Futures Mission, which is part of the Australian government's Medical Research Futures Fund. The research conducted at the Murdoch Children's Research Institute was supported by the Victorian government's Operational Infrastructure Support Program.	Australian Council of Learned Academies, 2018, FUT PREC MED AUSTR; Australian Government Department of Health, 2017, NAT HLTH GEN POL FRA; Birney E., 2017, GENOMICS HEALTHCARE, DOI [10.1101/203554, DOI 10.1101/203554]; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Donnelly K, 2006, STUD HEALTH TECHNOL, V121, P279; GAFF CL, 2017, NPJ GENOM MED, V2, DOI DOI 10.1038/S41525-017-0017-4; Global Alliance Genomics Hlth, 2016, SCIENCE, V352, P1278, DOI 10.1126/science.aaf6162; Gyngell C, 2019, PEDIATRICS, V143, pS14, DOI 10.1542/peds.2018-1099D; Hansen DP, 2019, MED J AUSTRALIA, V210, pS30, DOI 10.5694/mja2.50032; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Innovation and Science Australia, 2018, AUSTR 2030 PROSP INN; Janinski M., 2018, PERSPECTIVES ED PROV; Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1; Long JC, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1274-0; McClaren B., 2018, MAPPING EXISTING ED; Nisselle A, 2019, J GENET COUNS, V28, P367, DOI 10.1002/jgc4.1101; Porter S, 2018, PATHOLOGY, V50, pS32; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8; Stark Z, 2017, GENET MED, V19, P867, DOI 10.1038/gim.2016.221; Stark Z, 2016, GENET MED, V18, P1090, DOI 10.1038/gim.2016.1; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Taylor N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024681; Turnbull C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1687; Wolf SM, 2018, GENET MED, V20, P545, DOI 10.1038/gim.2017.137	26	41	41	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					7	14		10.1016/j.ajhg.2019.06.003	http://dx.doi.org/10.1016/j.ajhg.2019.06.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31271757	Green Published, Bronze			2022-12-18	WOS:000473723000002
J	Nguyen, NMP; Ge, ZJ; Reddy, R; Fahiminiya, S; Sauthier, P; Bagga, R; Sahin, FI; Mahadevan, S; Osmond, M; Breguet, M; Rahimi, K; Lapensee, L; Hovanes, K; Srinivasan, R; Van den Veyver, IB; Sahoo, T; Ao, A; Majewski, J; Taketo, T; Slim, R				Ngoc Minh Phuong Nguyen; Ge, Zhao-Jia; Reddy, Ramesh; Fahiminiya, Somayyeh; Sauthier, Philippe; Bagga, Rashmi; Sahin, Feride Iffet; Mahadevan, Sangeetha; Osmond, Matthew; Breguet, Magali; Rahimi, Kurosh; Lapensee, Louise; Hovanes, Karine; Srinivasan, Radhika; Van den Veyver, Ignatia B.; Sahoo, Trilochan; Ao, Asangla; Majewski, Jacek; Taketo, Teruko; Slim, Rima			Causative Mutations and Mechanism of Androgenetic Hydatidiform Moles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GESTATIONAL TROPHOBLASTIC DISEASE; STRAND BREAK FORMATION; CAENORHABDITIS-ELEGANS; SUBSEQUENT PREGNANCY; MEIOTIC CHROMOSOMES; RISK-FACTORS; SYNAPSIS; OOCYTES; EPIDEMIOLOGY; NONSENSE	Androgenetic complete hydatidiform moles are human pregnancies with no embryos and affect 1 in every 1,400 pregnancies. They have mostly androgenetic monospermic genomes with all the chromosomes originating from a haploid sperm and no maternal chromosomes. Androgenetic complete hydatidiform moles were described in 1977, but how they occur has remained an open question. We identified bi-allelic deleterious mutations in MEI1, TOP6BL/C11orf80, and REC114, with roles in meiotic double-strand breaks formation in women with recurrent androgenetic complete hydatidiform moles. We investigated the occurrence of androgenesis in Mei1-deficient female mice and discovered that 8% of their oocytes lose all their chromosomes by extruding them with the spindles into the first polar body. We demonstrate that Mei1(-/-) oocytes are capable of fertilization and 5% produce androgenetic zygotes. Thus, we uncover a meiotic abnormality in mammals and a mechanism for the genesis of androgenetic zygotes that is the extrusion of all maternal chromosomes and their spindles into the first polar body.	[Ngoc Minh Phuong Nguyen; Ge, Zhao-Jia; Reddy, Ramesh; Fahiminiya, Somayyeh; Osmond, Matthew; Ao, Asangla; Majewski, Jacek; Slim, Rima] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H4A 3J1, Canada; [Fahiminiya, Somayyeh; Osmond, Matthew; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Sauthier, Philippe; Breguet, Magali] Ctr Hosp Univ Montreal, Div Gynecol Oncol, Dept Obstet & Gynecol, Reseau Malad Trophoblast Quebec, Montreal, PQ H2X 0C1, Canada; [Bagga, Rashmi] PGIMER, Dept Obstet & Gynecol, Chandigarh 160012, India; [Sahin, Feride Iffet] Baskent Univ, Fac Med, Dept Med Genet, TR-06810 Ankara, Turkey; [Mahadevan, Sangeetha; Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Rahimi, Kurosh] Ctr Hosp Univ Montreal, Dept Pathol, Montreal, PQ H2X 0C1, Canada; [Lapensee, Louise] Ovo Clin, Montreal, PQ H4P 2S4, Canada; [Lapensee, Louise] Ctr Hosp Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ H2X 0C1, Canada; [Hovanes, Karine; Sahoo, Trilochan] Invitae, Irvine, CA 92618 USA; [Srinivasan, Radhika] Post Grad Inst Med Educ & Res PGIMER, Cytol & Gynecol Pathol, Chandigarh 160012, India; [Ao, Asangla; Taketo, Teruko; Slim, Rima] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H4A 3J1, Canada; [Taketo, Teruko] McGill Univ, Ctr Hlth, Dept Surg, Montreal, PQ H4A 3J1, Canada; [Taketo, Teruko] McGill Univ, Dept Biol, Montreal, PQ H3A 0G4, Canada	McGill University; Universite de Montreal; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Baskent University; Baylor College of Medicine; Universite de Montreal; Universite de Montreal; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; McGill University; McGill University; McGill University	Slim, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H4A 3J1, Canada.; Slim, R (corresponding author), McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H4A 3J1, Canada.	rima.slim@muhc.mcgill.ca	Sahin, Feride Iffet/AAC-7232-2020; Slim, Rima/J-4104-2019; ao, asangla/Q-5454-2019; Van den Veyver, Ignatia B/AAF-4510-2021; Lapensee, Louise/AAN-3206-2021; Bagga, Rashmi/Y-1680-2019; Guggilla, Ramesh Reddy/I-3679-2016	Sahin, Feride Iffet/0000-0001-7308-9673; Slim, Rima/0000-0002-4060-2159; Van den Veyver, Ignatia B/0000-0002-0651-5924; Bagga, Rashmi/0000-0003-2693-2343; Guggilla, Ramesh Reddy/0000-0002-6457-966X; Taketo, Teruko/0000-0002-7077-3768	McGill Faculty of Medicine; CRRD; Canadian Institute of Health Research [MOP-130364]; RQR; RI-MUHC, Desjardins Studentship in Child Heath Research	McGill Faculty of Medicine; CRRD; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); RQR; RI-MUHC, Desjardins Studentship in Child Heath Research	We thank Maria Galvez for her help in communicating with some individuals and coordinating the collection of samples from family members; Nawel Mechtouf and Yassemine Khawajkie for recruiting individuals and retrieving and analyzing some HM tissues; Xiao Yun Zhang for her help in the collection of human oocytes; Conceptions Reproductive Associates of Colorado for providing medical information; and Jyun-Yuan Huang, Pao-Lin Kuo, Farah Khan, and Surksha Agrawal for providing samples from individuals with recurrent miscarriages. We acknowledge the use of the McGill University and Genome Quebec Innovation Centre for whole exome, Sanger, and targeted sequencing. We also acknowledge the use of Molecular Imaging Platform of the Research Institute of the McGill University Health Centre and thank Min Fu and Shibo Feng for their invaluable help. N.M.P.N. was supported by the RQR, McGill Faculty of Medicine, RI-MUHC, Desjardins Studentship in Child Heath Research, and the CRRD. This work was supported by the Canadian Institute of Health Research (MOP-130364) to R. Slim.	ACAIA B, 1988, GYNECOL ONCOL, V31, P310, DOI 10.1016/S0090-8258(88)80009-X; Altieri A, 2003, LANCET ONCOL, V4, P670, DOI 10.1016/S1470-2045(03)01245-2; Anton E, 2008, GENET MED, V10, P730, DOI 10.1097/GIM.0b013e318187760f; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Banet N, 2014, MODERN PATHOL, V27, P238, DOI 10.1038/modpathol.2013.143; Ben Khelifa M, 2018, HUM REPROD, V33, P1034, DOI 10.1093/humrep/dey073; BERKOWITZ RS, 1995, AM J OBSTET GYNECOL, V173, P788, DOI 10.1016/0002-9378(95)90342-9; Berkowitz RS, 1998, J REPROD MED, V43, P81; Boufettal H, 2011, J GYNECOL OBST BIO R, V40, P419, DOI 10.1016/j.jgyn.2011.02.008; Carofiglio F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003538; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; COULAM CB, 1991, AM J REPROD IMMUNOL, V26, P23, DOI 10.1111/j.1600-0897.1991.tb00697.x; Eagles N, 2016, HUM REPROD, V31, P1379, DOI 10.1093/humrep/dew079; Ferguson KA, 2008, HUM REPROD, V23, P988, DOI 10.1093/humrep/den013; Golubovsky MD, 2003, HUM REPROD, V18, P236, DOI 10.1093/humrep/deg060; Hiraoka Y, 2000, CHROMOSOMA, V109, P103, DOI 10.1007/s004120050417; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Horn LC, 2006, EUR J OBSTET GYN R B, V128, P10, DOI 10.1016/j.ejogrb.2006.01.024; Hu MW, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120220; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kim JH, 1998, GYNECOL ONCOL, V71, P108, DOI 10.1006/gyno.1998.5167; Kronfol N M, 1969, J Med Liban, V22, P507; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; LAVECCHIA C, 1985, AM J EPIDEMIOL, V121, P457; LAWLER SD, 1982, CANCER GENET CYTOGEN, V5, P309, DOI 10.1016/0165-4608(82)90096-6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libby BJ, 2003, P NATL ACAD SCI USA, V100, P15706, DOI 10.1073/pnas.2432067100; Libby BJ, 2002, DEV BIOL, V242, P174, DOI 10.1006/dbio.2001.0535; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Mahadevan S, 2013, PRENATAL DIAG, V33, P1242, DOI 10.1002/pd.4239; MAINS PE, 1990, GENETICS, V126, P593; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Mathilde G, 2003, PLANT J, V35, P465, DOI 10.1046/j.1365-313X.2003.01820.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Miao YL, 2004, MOL REPROD DEV, V69, P66, DOI 10.1002/mrd.20148; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nguyen NMP, 2018, MODERN PATHOL, V31, P1116, DOI 10.1038/s41379-018-0031-9; Parry DA, 2011, AM J HUM GENET, V89, P451, DOI 10.1016/j.ajhg.2011.08.002; Pujol A, 2003, REPRODUCTION, V126, P701, DOI 10.1530/reprod/126.6.701; Reddy R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107326; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Sahoo T, 2017, GENET MED, V19, P83, DOI 10.1038/gim.2016.69; Savage P, 2010, J REPROD MED, V55, P341; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Sebire NJ, 2003, BJOG-INT J OBSTET GY, V110, P22, DOI 10.1016/S1470-0328(02)02988-9; Srayko M, 2000, GENE DEV, V14, P1072; Taylor DM, 2001, MOL HUM REPROD, V7, P147, DOI 10.1093/molehr/7.2.147; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu BZ, 2014, DEV BIOL, V385, P242, DOI 10.1016/j.ydbio.2013.11.004	53	41	44	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					740	751		10.1016/j.ajhg.2018.10.007	http://dx.doi.org/10.1016/j.ajhg.2018.10.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30388401	Bronze, Green Published			2022-12-18	WOS:000448942100009
J	Alkanderi, S; Molinari, E; Shaheen, R; Elmaghloob, Y; Stephen, LA; Sammut, V; Ramsbottom, SA; Srivastava, S; Cairns, G; Edwards, N; Rice, SJ; Ewida, N; Alhashem, A; White, K; Miles, CG; Steel, DH; Alkuraya, FS; Ismail, S; Sayer, JA				Alkanderi, Sumaya; Molinari, Elisa; Shaheen, Ranad; Elmaghloob, Yasmin; Stephen, Louise A.; Sammut, Veronica; Ramsbottom, Simon A.; Srivastava, Shalabh; Cairns, George; Edwards, Noel; Rice, Sarah J.; Ewida, Nour; Alhashem, Amal; White, Kathryn; Miles, Colin G.; Steel, David H.; Alkuraya, Fowzan S.; Ismail, Shehab; Sayer, John A.			ARL3 Mutations Cause Joubert Syndrome by Disrupting Ciliary Protein Composition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL-MOLECULE INHIBITION; RETINITIS-PIGMENTOSA; CILIOPATHY PHENOTYPES; GENE; INPP5E; CARGO; NEPHRONOPHTHISIS; CILIOGENESIS; MECHANISMS; RELEASE	Joubert syndrome (JBTS) is a genetically heterogeneous autosomal-recessive neurodevelopmental ciliopathy. We investigated further the underlying genetic etiology of Joubert syndrome by studying two unrelated families in whom JBTS was not associated with pathogenic variants in known JBTS-associated genes. Combined autozygosity mapping of both families highlighted a candidate locus on chromosome 10 (chr10: 101569997-109106128, UCSC Genome Browser hg 19), and exome sequencing revealed two missense variants in ARL3 within the candidate locus. The encoded protein, ADP ribosylation factor-like GTPase 3 (ARL3), is a small GTP-binding protein that is involved in directing lipid-modified proteins into the cilium in a GTP-dependent manner. Both missense variants replace the highly conserved Arg149 residue, which we show to be necessary for the interaction with its guanine nucleotide exchange factor ARL13B, such that the mutant protein is associated with reduced INPP5E and NPHP3 localization in cilia. We propose that ARL3 provides a potential hub in the network of proteins implicated in ciliopathies, whereby perturbation of ARL3 leads to the mislocalization of multiple ciliary proteins as a result of abnormal displacement of lipidated protein cargo.	[Alkanderi, Sumaya; Molinari, Elisa; Sammut, Veronica; Ramsbottom, Simon A.; Srivastava, Shalabh; Cairns, George; Edwards, Noel; Rice, Sarah J.; Miles, Colin G.; Steel, David H.; Sayer, John A.] Newcastle Univ, Int Ctr Life, Inst Genet Med, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Shaheen, Ranad; Ewida, Nour; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Elmaghloob, Yasmin; Stephen, Louise A.; Ismail, Shehab] Beatson Inst Canc Res, Struct Biol Cilia Lab, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Srivastava, Shalabh; Sayer, John A.] Newcastle Hosp NHS Fdn Trust, Renal Serv, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Alhashem, Amal] Prince Sultan Med Mil City, Dept Pediat, Riyadh 12233, Saudi Arabia; [Alhashem, Amal; Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [White, Kathryn] Newcastle Univ, Electron Microscopy Res Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Steel, David H.] Sunderland Eye Infirm, Queen Alexandra Rd, Sunderland SR2 9HP, Tyne & Wear, England; [Ismail, Shehab] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland	Newcastle University - UK; King Faisal Specialist Hospital & Research Center; Beatson Institute; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Prince Sultan Military Medical City; Alfaisal University; Newcastle University - UK; University of Glasgow	Sayer, JA (corresponding author), Newcastle Univ, Int Ctr Life, Inst Genet Med, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.; Ismail, S (corresponding author), Beatson Inst Canc Res, Struct Biol Cilia Lab, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.; Sayer, JA (corresponding author), Newcastle Hosp NHS Fdn Trust, Renal Serv, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.; Ismail, S (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland.	s.ismail@beatson.gla.ac.uk; john.sayer@ncl.ac.uk	Molinari, Elisa/GPC-5319-2022; Steel, David/I-8053-2015	Molinari, Elisa/0000-0002-1840-915X; ElMaghloob, Yasmin/0000-0002-5613-0678; Ismail, Shehab/0000-0002-4150-1077; Steel, David/0000-0001-8734-3089; Rice, Sarah/0000-0003-3343-5986; Stephen, Louise/0000-0001-6795-0383; SHAHEEN, RANAD/0000-0002-2590-1759; Alhashem, Amal/0000-0002-9668-7809	Medical Research Council [MR/M012212/1]; Kidney Research UK [PDF_003_20151124]; King Salman Center for Disability Research; King Abdulaziz City for Science and Technology [13-BIO1113-20]; Saudi Human Genome Program; Northern Counties Kidney Research Fund; Cancer Research UK [A19257]; MRC [MR/M012212/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); King Salman Center for Disability Research; King Abdulaziz City for Science and Technology; Saudi Human Genome Program; Northern Counties Kidney Research Fund; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MR/M012212/1), Kidney Research UK (post-doctoral fellowship PDF_003_20151124 to S.A.R.), King Salman Center for Disability Research (F.S.A.), King Abdulaziz City for Science and Technology (13-BIO1113-20 to F.S.A.), Saudi Human Genome Program (F.S.A.), Northern Counties Kidney Research Fund (J.A.S. and E.M.), and Cancer Research UK (core funding award A19257 to Y.E., L.S., and S.I.).	Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Cuvillier A, 2000, J CELL SCI, V113, P2065; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Fansa EK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11366; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hartill V, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00244; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/NCHEMBIO.686, 10.1038/nchembio.686]; Jaiswal M, 2016, J BIOL CHEM, V291, P20766, DOI 10.1074/jbc.M116.741827; Khaliq S, 2005, J MED GENET, V42, P436, DOI 10.1136/jmg.2004.024281; Lewis KE, 1999, DEVELOPMENT, V126, P2397; Lokaj M, 2015, STRUCTURE, V23, P2122, DOI 10.1016/j.str.2015.08.016; Mejuch T, 2017, ANGEW CHEM INT EDIT, V56, P6181, DOI 10.1002/anie.201701905; Monies D, 2017, GENET MED, V19, P1144, DOI 10.1038/gim.2017.22; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Romani M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-72; Romani M, 2013, LANCET NEUROL, V12, P894, DOI 10.1016/S1474-4422(13)70136-4; Roosing S, 2016, J MED GENET, V53, P608, DOI 10.1136/jmedgenet-2016-103832; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Srivastava S, 2017, HUM MOL GENET, V26, P4657, DOI 10.1093/hmg/ddx347; Stephen LA, 2015, ELIFE, V4, DOI 10.7554/eLife.08077; Strom SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150944; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Tory K, 2009, KIDNEY INT, V75, P839, DOI 10.1038/ki.2008.662; Van De Weghe JC, 2017, AM J HUM GENET, V101, P23, DOI 10.1016/j.ajhg.2017.05.010; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Zhang Q, 2013, EXP CELL RES, V319, P2316, DOI 10.1016/j.yexcr.2013.03.024; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	44	41	43	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					612	620		10.1016/j.ajhg.2018.08.015	http://dx.doi.org/10.1016/j.ajhg.2018.08.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30269812	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000446312200013
J	Richardson, TG; Zheng, J; Smith, GD; Timpson, NJ; Gaunt, TR; Relton, CL; Hemani, G				Richardson, Tom G.; Zheng, Jie; Smith, George Davey; Timpson, Nicholas J.; Gaunt, Tom R.; Relton, Caroline L.; Hemani, Gibran			Mendelian Randomization Analysis Identifies CpG Sites as Putative Mediators for Genetic Influences on Cardiovascular Disease Risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; DNA METHYLATION; LOCI; GWAS; EXPRESSION; VARIANTS; SUSCEPTIBILITY; REVEALS	The extent to which genetic influences on cardiovascular disease risk are mediated by changes in DNA methylation levels has not been systematically explored. We developed an analytical framework that integrates genetic fine mapping and Mendelian randomization with epigenome-wide association studies to evaluate the causal relationships between methylation levels and 14 cardiovascular disease traits. We identified ten genetic loci known to influence proximal DNA methylation which were also associated with cardiovascular traits after multiple-testing correction. Bivariate fine mapping provided evidence that the individual variants responsible for the observed effects on cardiovascular traits at the ADCY3 and ADIPOQ loci were potentially mediated through changes in DNA methylation, although we highlight that we are unable to reliably separate causality from horizontal pleiotropy. Estimates of causal effects were replicated with results from large-scale consortia. Genetic variants and CpG sites identified in this study were enriched for histone mark peaks in relevant tissue types and gene promoter regions. Integrating our results with expression quantitative trait loci data, we provide evidence that variation at these regulatory regions is likely to also influence gene expression levels at these loci.	[Richardson, Tom G.; Zheng, Jie; Smith, George Davey; Timpson, Nicholas J.; Gaunt, Tom R.; Relton, Caroline L.; Hemani, Gibran] Univ Bristol, Bristol Med Sch Populat Hlth Sci, MRC Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England	University of Bristol	Richardson, TG (corresponding author), Univ Bristol, Bristol Med Sch Populat Hlth Sci, MRC Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England.	tom.g.richardson@bristol.ac.uk	Timpson, Nicholas John/O-7548-2015; Davey Smith, George/A-7407-2013; Fox, Laura J/C-6249-2016; Gaunt, Tom R/O-3918-2014; Relton, Caroline/AAC-5904-2019; Attrill, Lauren/V-1688-2018	Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Gaunt, Tom R/0000-0003-0924-3247; Zheng, Jie/0000-0002-6623-6839; Hemani, Gibran/0000-0003-0920-1055; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Relton, Caroline/0000-0003-2052-4840; s, hema/0000-0002-3440-9475; Richardson, Tom/0000-0002-7918-2040	Wellcome Trust [102215/2/13/2]; 23andMe; UK BBSRC [BB/I025751/1, BB/I025263/1]; UK Medical Research Council (MRC Integrative Epidemiology Unit) [MC UU 12013/1, MC UU 12013/2, MC UU 12013/3, MC UU 12013/8]; Elizabeth Blackwell Institute [EBI 424]; UK Medical Research Council [102215/2/13/2]; BBSRC [BB/I025751/1, BB/I025263/1] Funding Source: UKRI; MRC [MC_UU_12013/1, MC_PC_16067, MC_UU_12013/8, MC_PC_15049, MC_UU_12013/3, MC_UU_12013/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025263/1, BB/I025751/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1, MC_PC_15018, MC_UU_12013/3, MC_UU_12013/8, MC_UU_12013/2, G9815508, MC_PC_15049, MC_PC_16067] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); 23andMe; UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council (MRC Integrative Epidemiology Unit)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Elizabeth Blackwell Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole Avon Longitudinal Study of Parents and Children (ALSPAC) team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council and the Wellcome Trust (grant 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. GWAS data were generated by Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute and LabCorp (Laboratory Corporation of America) with support from 23andMe. Methylation data in the ALSPAC cohort were generated as part of the UK BBSRC-funded (BB/I025751/1 and BB/I025263/1) Accessible Resource for Integrated Epigenomic Studies (ARIES). This publication is the work of the authors, and T.G.R. will serve as guarantor for the contents of this paper. This work was supported by the UK Medical Research Council (MRC Integrative Epidemiology Unit) (MC UU 12013/1, MC UU 12013/2, MC UU 12013/3, and MC UU 12013/8). T.G.R. is supported by the Elizabeth Blackwell Institute Proximity to Discovery award (EBI 424).	[Anonymous], 2017, BIORXIV; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bowden J, 2017, INT J EPIDEMIOLOGY; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Burkhardt R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005510; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Dastani Z, 2013, ATHEROSCLEROSIS, V229, P145, DOI 10.1016/j.atherosclerosis.2013.03.034; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gaunt TR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0926-z; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Hannon E, 2017, AM J HUM GENET, V100, P954, DOI 10.1016/j.ajhg.2017.04.013; Hemani G, 2016, BIORXIV; Henningsen A, 2007, J STAT SOFTW, V23; Hinds DA, 2016, HUM MOL GENET, V25, P1867, DOI 10.1093/hmg/ddw037; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kurano M, 2016, J HUM GENET, V61, P427, DOI 10.1038/jhg.2015.170; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Liu L, 2015, NUCLEIC ACIDS RES, V43, P3873, DOI 10.1093/nar/gkv255; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu XF, 2016, CIRC-CARDIOVASC GENE, V9, P37, DOI 10.1161/CIRCGENETICS.115.001096; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; MYERS GL, 2000, HDB LIPOPROTEIN TEST, P717; Naeem H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-51; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pavlides JMW, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0338-4; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Powell JE, 2016, HUM MOL GENET, V25, P5046, DOI 10.1093/hmg/ddw320; Rawlik K, 2016, GENETICS, V204, P771, DOI 10.1534/genetics.115.185967; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Relton CL, 2015, INT J EPIDEMIOL, V44, P1181, DOI 10.1093/ije/dyv072; Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233; Richmond RC, 2016, HUM MOL GENET, V25, pR149, DOI 10.1093/hmg/ddw197; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Shi JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4365; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; St Pourcain B, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-34; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; van Dongen J, 2014, BEHAV GENET, V44, P368, DOI 10.1007/s10519-014-9656-8; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; WARNICK GR, 1990, CLIN CHEM, V36, P15; Warrington NM, 2015, INT J EPIDEMIOL, V44, P700, DOI 10.1093/ije/dyv077; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	79	41	42	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					590	602		10.1016/j.ajhg.2017.09.003	http://dx.doi.org/10.1016/j.ajhg.2017.09.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28985495	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000412277300009
J	Zhou, SR; Ambalavanan, A; Rochefort, D; Xie, PX; Bourassa, CV; Hince, P; Dionne-Laporte, A; Spiegelman, D; Gan-Or, Z; Mirarchi, C; Zaharieva, V; Dupre, N; Kobayashi, H; Hitomi, T; Harada, K; Koizumi, A; Xiong, L; Dion, PA; Rouleau, GA				Zhou, Sirui; Ambalavanan, Amirthagowri; Rochefort, Daniel; Xie, Pingxing; Bourassa, Cynthia V.; Hince, Pascale; Dionne-Laporte, Alexandre; Spiegelman, Dan; Gan-Or, Ziv; Mirarchi, Cathy; Zaharieva, Vessela; Dupre, Nicolas; Kobayashi, Hatasu; Hitomi, Toshiaki; Harada, Kouji; Koizumi, Akio; Xiong, Lan; Dion, Patrick A.; Rouleau, Guy A.			RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MICE LACKING RNF213; MAJOR ARTERY STENOSIS/OCCLUSION; DISEASE SUSCEPTIBILITY GENE; BURROWS-WHEELER TRANSFORM; MOYAMOYA-DISEASE; SUBARACHNOID HEMORRHAGE; R4810K RS112735431; ENDOTHELIAL-CELLS; NATURAL-HISTORY	Intracranial aneurysms (IAs) are the result of focal weakness in the artery wall and have a complex genetic makeup. To date, genome-wide association and sequencing studies have had limited success in identifying IA risk factors. Distinct populations, such as the French-Canadian (FC) population, have increased IA prevalence. In our study, we used exome sequencing to prioritize risk variants in a discovery cohort of six FC families affected by IA, and the analysis revealed an increased variation burden for ring finger protein 213 (RNF213). We resequenced RNF213 in a larger FC validation cohort, and association tests on further identified variants supported our findings (SKAT-O, p = 0.006). RNF213 belongs to the AAA+ protein family, and two variants (p.Arg2438Cys and p.Ala2826Thr) unique to affected FC individuals were found to have increased ATPase activity, which could lead to increased risk of IA by elevating angiogenic activities. Common SNPs in RNF213 were also extracted from the NeuroX SNP-chip genotype data, comprising 257 FC IA-affected and 1,988 control individuals. We discovered that the non-ancestral allele of rs6565666 was significantly associated with the affected individuals (p = 0.03), and it appeared as though the frequency of the risk allele had changed through genetic drift. Although RNF213 is a risk factor for moyamoya disease in East Asians, we demonstrated that it might also be a risk factor for IA in the FC population. It therefore appears that the function of RNF213 can be differently altered to predispose distinct populations to dissimilar neurovascular conditions, highlighting the importance of a population's background in genetic studies of heterogeneous disease.	[Zhou, Sirui; Ambalavanan, Amirthagowri; Rochefort, Daniel; Xie, Pingxing; Bourassa, Cynthia V.; Hince, Pascale; Dionne-Laporte, Alexandre; Spiegelman, Dan; Gan-Or, Ziv; Mirarchi, Cathy; Zaharieva, Vessela; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Zhou, Sirui; Xiong, Lan] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3T 1J4, Canada; [Ambalavanan, Amirthagowri; Gan-Or, Ziv] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Xie, Pingxing] McGill Univ, Fac Med, Montreal, PQ H3A 0G4, Canada; [Gan-Or, Ziv; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada; [Dupre, Nicolas] Ctr Hosp Univ Quebec, Dept Neurol Sci, Quebec City, PQ G1V 0A6, Canada; [Dupre, Nicolas] Univ Laval, Dept Med, Fac Med, Quebec City, PQ G1V 0A6, Canada; [Kobayashi, Hatasu; Hitomi, Toshiaki; Harada, Kouji; Koizumi, Akio] Kyoto Univ, Dept Hlth & Environm Sci, Grad Sch Med, Yoshida Konoecho, Kyoto 6068501, Japan; [Xiong, Lan] Inst Univ Sante Mentale Montreal, Ctr Rech, Montreal, PQ H1N 3M5, Canada	McGill University; Universite de Montreal; McGill University; McGill University; McGill University; Laval University; Laval University; Kyoto University; Universite de Montreal	Rouleau, GA (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada.	guy.rouleau@mcgill.ca	Kobayashi, Hatasu/R-8012-2019; Xie, Pingxing/AAK-1965-2020; Dupre, Nicolas/Y-1828-2019	Kobayashi, Hatasu/0000-0002-5664-6869; spiegelman, dan/0000-0003-4971-8868	Canadian Institutes of Health Research; Canadian Hearth and Stroke Foundation; Michael J. Fox Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Hearth and Stroke Foundation; Michael J. Fox Foundation	P.X. and Z.G.O. are recipients of a fellowship from the Canadian Institutes of Health Research. G.A.R. funded this study from the Canadian Hearth and Stroke Foundation. G.A.R. holds the Canada's Research Chair in Neurogenetics and the Wilder Penfield Chair in Neuroscience. The NeuroX SNP genotyping was partially funded by a grant from the Michael J. Fox Foundation to Z.G.O.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bang OY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130663; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; BROWN RD, 1990, J NEUROSURG, V73, P859, DOI 10.3171/jns.1990.73.6.0859; Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clare C E, 1992, Neurosurg Clin N Am, V3, P551; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farlow JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121104; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Foroud T, 2014, STROKE, V45, P3194, DOI 10.1161/STROKEAHA.114.006096; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Fukushima Yuta, 2015, Surg Neurol Int, V6, P41, DOI 10.4103/2152-7806.153709; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HALAL F, 1983, AM J MED GENET, V15, P89, DOI 10.1002/ajmg.1320150112; Herve D, 2014, AM J HUM GENET, V94, P385, DOI 10.1016/j.ajhg.2014.01.018; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V439, P419, DOI 10.1016/j.bbrc.2013.08.067; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Hoh BL, 2014, J NEUROSURG, V120, P73, DOI 10.3171/2013.9.JNS122074; Imai Y, 2010, ANN BIOMED ENG, V38, P927, DOI 10.1007/s10439-009-9864-1; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Ito A, 2015, BRAIN RES, V1594, P310, DOI 10.1016/j.brainres.2014.11.014; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kessler K, 2014, CARDIOVASC RES, V104, P147, DOI 10.1093/cvr/cvu196; Kiando SR, 2015, J HYPERTENS, V33, P1802, DOI 10.1097/HJH.0000000000000625; Kobayashi H, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002146; Koizumi A, 2016, ENVIRON HEALTH PREV, V21, P55, DOI 10.1007/s12199-015-0498-7; Koizumi A, 2013, ENVIRON HEALTH PREV, V18, P121, DOI 10.1007/s12199-012-0299-1; Krischek B, 2006, J HUM GENET, V51, P587, DOI 10.1007/s10038-006-0407-4; Kurki MI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004134; Lee MJ, 2015, J NEUROL SCI, V353, P161, DOI 10.1016/j.jns.2015.04.019; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058490; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindner Christian, 2012, Exp Transl Stroke Med, V4, P9, DOI 10.1186/2040-7378-4-9; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Mathieu J, 1996, CAN J NEUROL SCI, V23, P184, DOI 10.1017/S0317167100038488; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Miyawaki S, 2012, STROKE, V43, P3371, DOI 10.1161/STROKEAHA.112.663864; Morito D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04442; Moteki Y., 2015, J AM HEART ASSOC, V4, P4, DOI DOI 10.1161/JAHA.115.001862; Ohkubo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13191; Pierron D, 2014, P NATL ACAD SCI USA, V111, P936, DOI 10.1073/pnas.1321860111; Power ASC, 2016, AM J PHYSIOL-HEART C, V310, pH1649, DOI 10.1152/ajpheart.00050.2016; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Qureshi AI, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000163081.55025.CD; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rinkel GJE, 2008, J NEURORADIOLOGY, V35, P99, DOI 10.1016/j.neurad.2007.11.004; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Shoemaker LD, 2016, G3-GENES GENOM GENET, V6, P41, DOI 10.1534/g3.115.020321; Smith KR, 2014, INT J STROKE, V9, pE26, DOI 10.1111/ijs.12306; Sonobe S, 2014, NEUROREPORT, V25, P1442, DOI 10.1097/WNR.0000000000000289; Sonobe S, 2014, BRAIN RES, V1552, P64, DOI 10.1016/j.brainres.2014.01.011; Stehbens WE, 1983, INTRACRANIAL ANEURYS, P272; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; Van 't Hof FNG, 2014, NEUROLOGY, V83, P34, DOI 10.1212/WNL.0000000000000547; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179; Yan JX, 2015, STROKE, V46, P620, DOI 10.1161/STROKEAHA.114.007286; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563	75	41	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1072	1085		10.1016/j.ajhg.2016.09.001	http://dx.doi.org/10.1016/j.ajhg.2016.09.001			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745834	Green Published, Bronze			2022-12-18	WOS:000387529600006
J	Izumi, K; Brett, M; Nishi, E; Drunat, S; Tan, ES; Fujiki, K; Lebon, S; Cham, B; Masuda, K; Arakawa, M; Jacquinet, A; Yamazumi, Y; Chen, ST; Verloes, A; Okada, Y; Katou, Y; Nakamura, T; Akiyama, T; Gressens, P; Foo, R; Passemard, S; Tan, EC; El Ghouzzi, V; Shirahige, K				Izumi, Kosuke; Brett, Maggie; Nishi, Eriko; Drunat, Severine; Tan, Ee-Shien; Fujiki, Katsunori; Lebon, Sophie; Cham, Breana; Masuda, Koji; Arakawa, Michiko; Jacquinet, Adeline; Yamazumi, Yusuke; Chen, Shu-Ting; Verloes, Alain; Okada, Yuki; Katou, Yuki; Nakamura, Tomohiko; Akiyama, Tetsu; Gressens, Pierre; Foo, Roger; Passemard, Sandrine; Tan, Ene-Choo; El Ghouzzi, Vincent; Shirahige, Katsuhiko			ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LENTICULO-SUTURAL DYSPLASIA; TO-GOLGI TRAFFICKING; ENDOPLASMIC-RETICULUM; SNARE COMPLEX; ER STRESS; VARIANTS; DEFICIENCY; COMPONENT; SEC23B	Cellular homeostasis is maintained by the highly organized cooperation of intracellular trafficking systems, including COPI, COPII, and clathrin complexes. COPI is a coatomer protein complex responsible for intracellular protein transport between the endoplasmic reticulum and the Golgi apparatus. The importance of such intracellular transport mechanisms is underscored by the various disorders, including skeletal disorders such as cranio-lenticulo-sutural dysplasia and osteogenesis imperfect, caused by mutations in the COPII coatomer complex. In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI. ARCN1 mutant cell lines were revealed to have endoplasmic reticulum stress, suggesting the involvement of ER stress response in the pathogenesis of this disorder. Given that ARCN1 deficiency causes defective type I collagen transport, reduction of collagen secretion represents the likely mechanism underlying the skeletal phenotype that characterizes this condition. Our findings demonstrate the importance of COPI-mediated transport in human development, including skeletogenesis and brain growth.	[Izumi, Kosuke; Fujiki, Katsunori; Masuda, Koji; Chen, Shu-Ting; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Izumi, Kosuke; Nishi, Eriko; Arakawa, Michiko] Nagano Childrens Hosp, Div Med Genet, Azumino 3998205, Japan; [Izumi, Kosuke] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Brett, Maggie; Tan, Ene-Choo] KK Womens & Childrens Hosp, KK Res Ctr, Singapore 229899, Singapore; [Nishi, Eriko] Shinshu Univ, Grad Sch Med, Dept Med Genet, Matsumoto, Nagano 3900802, Japan; [Nishi, Eriko; Nakamura, Tomohiko] Nagano Childrens Hosp, Life Sci Res Ctr, Azumino 3998205, Japan; [Drunat, Severine; Lebon, Sophie; Verloes, Alain; Gressens, Pierre; Passemard, Sandrine; El Ghouzzi, Vincent] Hop Robert Debre, INSERM, UMR1141, F-75019 Paris, France; [Drunat, Severine; Verloes, Alain; Passemard, Sandrine] Hop Robert Debre, Dept Genet, F-75019 Paris, France; [Tan, Ee-Shien; Cham, Breana; Foo, Roger] KK Womens & Childrens Hosp, Dept Paediat, Genet Serv, Singapore 229899, Singapore; [Jacquinet, Adeline] Ctr Hosp Univ, Dept Genet, B-4000 Liege, Belgium; [Jacquinet, Adeline] Univ Liege, B-4000 Liege, Belgium; [Yamazumi, Yusuke; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo 1130032, Japan; [Verloes, Alain; Gressens, Pierre; Passemard, Sandrine; El Ghouzzi, Vincent] Univ Paris 07, Hop Robert Debre, F-75019 Paris, France; [Okada, Yuki] Univ Tokyo, Lab Pathol & Dev, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Gressens, Pierre] St Thomas Hosp, Kings Coll London, Ctr Dev Brain, London SE1 7EH, England; [Foo, Roger] Genome Inst Singapore, Singapore 138672, Singapore; [Tan, Ene-Choo] SingHlth Duke NUS Med Sch, Paediat ACP, Singapore 169857, Singapore; [Shirahige, Katsuhiko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; KK Women's & Children's Hospital; Shinshu University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; KK Women's & Children's Hospital; University of Liege; University of Liege; University of Tokyo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Tokyo; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Japan Science & Technology Agency (JST)	Izumi, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan.; Izumi, K (corresponding author), Nagano Childrens Hosp, Div Med Genet, Azumino 3998205, Japan.; Izumi, K (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.	izumik1@email.chop.edu	Tan, EC/W-6304-2019; gressens, pierre/M-7557-2017; /AAK-8500-2021; EL GHOUZZI, Vincent/X-4364-2018	gressens, pierre/0000-0002-0909-4221; EL GHOUZZI, Vincent/0000-0001-5894-8978; Shirahige, Katsuhiko/0000-0002-7862-1144; Foo, Roger/0000-0002-8079-4618; Lebon, Sophie/0000-0003-0039-5519	MEXT [15H02369, 15H05976]; AMED-CREST from AMED; National Medical Research Council, Ministry of Health, Republic of Singapore [NMRC/PPG/KKH12010-Theme3, NMRC/CG/006/2013]; Programmes Hospitaliers de Recherche Clinique (PHRC) from the French Ministry of Health [P100128 / IDRCB: 2010-A01481-38, HAO11011/ ExoMicro: NI11016]; European ERA-NET grant for research on rare diseases [ANR-13-RARE-0007-01 2013]; Grants-in-Aid for Scientific Research [16K18469] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from AMED; National Medical Research Council, Ministry of Health, Republic of Singapore; Programmes Hospitaliers de Recherche Clinique (PHRC) from the French Ministry of Health; European ERA-NET grant for research on rare diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors greatly appreciate the family members of the probands for their participation in our research study. We thank Keiko Nakagawa, Masashi Minamino, and Kazuhiro Akiyama for their technical assistance and Dagmar Wieczorek and Elizabeth Bhoj for sharing their research cohort information. ARCN1 was submitted as a candidate gene to GeneMatcher by three independent research groups in Japan, Singapore, and France.<SUP>38</SUP> The authors appreciate the GeneMatcher website for facilitating the collaboration. This work was supported by a Grant-in-Aid for Scientific Research (15H02369 and 15H05976 to K.S.) from MEXT and AMED-CREST from AMED; NMRC/PPG/KKH12010-Theme3 and NMRC/CG/006/2013 from the National Medical Research Council, Ministry of Health, Republic of Singapore; two Programmes Hospitaliers de Recherche Clinique (PHRC) grants from the French Ministry of Health (P100128 / IDRCB: 2010-A01481-38 and HAO11011/ ExoMicro: NI11016); and a European ERA-NET grant for research on rare diseases (ANR-13-RARE-0007-01 2013).	Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; Barat-Houari M, 2016, HUM MUTAT, V37, P7, DOI 10.1002/humu.22915; Boyadjiev SA, 2011, CLIN GENET, V80, P169, DOI 10.1111/j.1399-0004.2010.01550.x; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Cafiero C, 2015, EUR J HUM GENET, V23, P1499, DOI 10.1038/ejhg.2015.19; Consortium EA, 2015, BIORXIV; Dupuis N, 2015, HUM MOL GENET, V24, P2771, DOI 10.1093/hmg/ddv038; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Garbes L, 2015, AM J HUM GENET, V96, P432, DOI 10.1016/j.ajhg.2015.01.002; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hoornaert KP, 2010, EUR J HUM GENET, V18, P872, DOI 10.1038/ejhg.2010.23; Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830; Ishikura-Kinoshita S, 2012, J INVEST DERMATOL, V132, P2010, DOI 10.1038/jid.2012.103; Izumi K, 2015, NAT GENET, V47, P338, DOI 10.1038/ng.3229; Jackson LP, 2014, CURR OPIN CELL BIOL, V29, P67, DOI 10.1016/j.ceb.2014.04.009; Jiang HB, 2010, J BIOL CHEM, V285, P31634, DOI 10.1074/jbc.M110.128645; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Namba T, 2007, BIOCHEM BIOPH RES CO, V355, P543, DOI 10.1016/j.bbrc.2007.02.004; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Okada M, 2015, HUM MOL GENET, V24, P299, DOI 10.1093/hmg/ddu444; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Park SY, 2015, NATURE, V521, P529, DOI 10.1038/nature14457; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ramakrishnan NA, 2012, MOL CELL NEUROSCI, V50, P58, DOI 10.1016/j.mcn.2012.03.009; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sovolyova N, 2014, BIOL CHEM, V395, P1, DOI 10.1515/hsz-2013-0174; Stephens DJ, 2002, J CELL SCI, V115, P1149; Sun E, 2013, J VIROL, V87, P2673, DOI 10.1128/JVI.02277-12; Todd AG, 2013, HUM MOL GENET, V22, P729, DOI 10.1093/hmg/dds480; Verloes A, 1997, AM J MED GENET, V68, P455, DOI 10.1002/(SICI)1096-8628(19970211)68:4<455::AID-AJMG16>3.0.CO;2-R; Verrier SE, 2008, EUR J CELL BIOL, V87, P863, DOI 10.1016/j.ejcb.2008.07.003; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Xu XJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000956; Yehia L, 2015, AM J HUM GENET, V97, P661, DOI 10.1016/j.ajhg.2015.10.001; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Zhang XC, 2007, INT J DEV NEUROSCI, V25, P455, DOI 10.1016/j.ijdevneu.2007.08.007	38	41	43	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					451	459		10.1016/j.ajhg.2016.06.011	http://dx.doi.org/10.1016/j.ajhg.2016.06.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27476655	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000381617200017
J	Vattathil, S; Scheet, P				Vattathil, Selina; Scheet, Paul			Extensive Hidden Genomic Mosaicism Revealed in Normal Tissue	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; CANCER; ASSOCIATION; NUMBER; AGE; DISEASE; BLOOD; MODEL; RISK	Genomic mosaicism arising from post-zygotic mutation has recently been demonstrated to occur in normal tissue of individuals ascertained with varied phenotypes, indicating that detectable mosaicism may be less an exception than a rule in the general population. A challenge to comprehensive cataloging of mosaic mutations and their consequences is the presence of heterogeneous mixtures of cells, rendering low-frequency clones difficult to discern. Here we applied a computational method using estimated haplotypes to characterize mosaic megabase-scale structural mutations in 31,100 GWA study subjects. We provide in silico validation of 293 previously identified somatic mutations and identify an additional 794 novel mutations, most of which exist at lower aberrant cell fractions than have been demonstrated in previous surveys. These mutations occurred across the genome but in a nonrandom manner, and several chromosomes and loci showed unusual levels of mutation. Our analysis supports recent findings about the relationship between clonal mosaicism and old age. Finally, our results, in which we demonstrate a nearly 3-fold higher rate of clonal mosaicism, suggest that SNP-based population surveys of mosaic structural mutations should be conducted with haplotypes for optimal discovery.	[Vattathil, Selina; Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Vattathil, Selina; Scheet, Paul] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Vattathil, Selina] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle	Vattathil, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.; Vattathil, S (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Vattathil, S (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	svattathil@utexas.edu			NIH [R01HG005859, R01HG005855]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005859, R01HG005855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Laurie for sharing sample identifiers for mutations called in their analysis. X. Xiao and J. Fowler provided assistance with array processing and workflows. L. Huang performed haplotype phasing and ran hapLOH on multiple data sets. C. Huff and Y. M. Chen provided helpful comments on analyses. This work was supported by NIH grants R01HG005859 and R01HG005855.	Aviv A, 1998, HUM GENET, V103, P2, DOI 10.1007/s004390050774; Baugher JD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-367; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Goriely A, 2013, AM J PSYCHIAT, V170, P599, DOI 10.1176/appi.ajp.2013.12101352; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Vattathil S, 2013, GENOME RES, V23, P152, DOI 10.1101/gr.141374.112; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	21	41	41	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					571	578		10.1016/j.ajhg.2016.02.003	http://dx.doi.org/10.1016/j.ajhg.2016.02.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942289	Bronze, Green Published			2022-12-18	WOS:000372383100019
